PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Miyamoto, S; Howes, AL; Adams, JW; Dorn, GW; Brown, JH				Miyamoto, S; Howes, AL; Adams, JW; Dorn, GW; Brown, JH			Ca2+ dysregulation induces mitochondrial depolarization and apoptosis - Role of Na+/Ca2+ exchanger and Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM SIGNAL TRANSMISSION; CARDIAC MYOCYTE APOPTOSIS; CARDIOMYOCYTES IN-VITRO; HEART-FAILURE; PERMEABILITY TRANSITION; RYANODINE RECEPTORS; NA+-CA2+ EXCHANGE; SURVIVAL PATHWAY; DEATH PATHWAY; CELL-DEATH	We previously reported that constitutively activated G alpha(q) (Q209L) expression in cardiomyocytes induces apoptosis through opening of the mitochondrial permeability transition pore. We assessed the hypothesis that disturbances in Ca2+ handling linked G alpha(q) activity to apoptosis because resting Ca2+ levels were significantly increased prior to development of apoptosis. Treating cells with EGTA lowered Ca2+ and blocked both loss of mitochondrial membrane potential ( an indicator of permeability transition pore opening) and apoptosis ( assessed by DNA fragmentation). When cytosolic Ca2+ and mitochondrial membrane potential were simultaneously measured by confocal microscopy, sarcoplasmic reticulum (SR)-driven slow Ca2+ oscillations (time-to-peak similar to 4 s) were observed in Q209L-expressing cells. These oscillations were seen to transition into sustained increases in cytosolic Ca2+, directly paralleled by loss of mitochondrial membrane potential. Ca2+ transients generated by caffeine-induced release of SR Ca2+ were greatly prolonged in Q209L-expressing cells, suggesting a decreased ability to extrude Ca2+. Indeed, the Na+/Ca2+ exchanger (NCX), which removes Ca2+ from the cell, was markedly down-regulated at the mRNA and protein levels. Adenoviral NCX expression normalized cytosolic Ca2+ levels and prevented DNA fragmentation in cells expressing Q209L. Interestingly, constitutively activated Akt, which rescues cells from Q209L-induced apoptosis, prevented the decrease in NCX expression, normalized cytosolic Ca2+ levels and spontaneous Ca2+ oscillations, shortened caffeine-induced Ca2+ transients, and prevented loss of the mitochondrial membrane potential. Our findings demonstrate that NCX down-regulation and consequent increases in cytosolic and SR Ca2+ can lead to Ca2+ overloading-induced loss of mitochondrial membrane potential and suggest that recovery of Ca2+ dysregulation is a target of Akt-mediated protection.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Arena Pharmaceut, San Diego, CA 92121 USA; Univ Cincinnati, Dept Med, Cincinnati, OH 45267 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Ohio; University of Cincinnati	Brown, JH (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jhbrown@ucsd.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL028143, R01HL028143] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL28143] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; Adams JW, 2000, CIRC RES, V87, P1180, DOI 10.1161/01.RES.87.12.1180; Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Akao M, 2003, CIRC RES, V92, P186, DOI 10.1161/01.RES.0000051861.21316.E9; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Borutaite V, 2003, FEBS LETT, V541, P1, DOI 10.1016/S0014-5793(03)00278-3; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Csordas G, 2001, TRENDS CARDIOVAS MED, V11, P269, DOI 10.1016/S1050-1738(01)00123-2; Di Lisa F, 1998, MOL CELL BIOCHEM, V184, P379, DOI 10.1023/A:1006810523586; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; FABIATO A, 1981, J GEN PHYSIOL, V78, P457, DOI 10.1085/jgp.78.5.457; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Golfman L, 1998, MOL CELL BIOCHEM, V188, P91, DOI 10.1023/A:1006824623496; Hattori Y, 2000, J PHYSIOL-LONDON, V527, P85, DOI 10.1111/j.1469-7793.2000.00085.x; Hayakawa Y, 2003, CIRCULATION, V108, P3036, DOI 10.1161/01.CIR.0000101920.72665.58; Henderson SA, 2004, CIRC RES, V95, P604, DOI 10.1161/01.RES.0000142316.08250.68; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Howes AL, 2003, J BIOL CHEM, V278, P40343, DOI 10.1074/jbc.M305964200; Jaconi M, 2000, MOL BIOL CELL, V11, P1845, DOI 10.1091/mbc.11.5.1845; Ju HS, 1998, CIRCULATION, V97, P892, DOI 10.1161/01.CIR.97.9.892; Kang PM, 2003, TRENDS MOL MED, V9, P177, DOI 10.1016/S1471-4914(03)00025-X; Korge P, 2002, P NATL ACAD SCI USA, V99, P3312, DOI 10.1073/pnas.052713199; Lai HC, 2003, MOL CELL ENDOCRINOL, V205, P99, DOI 10.1016/S0303-7207(03)00200-4; Matsui T, 2001, CIRCULATION, V104, P330; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; Metivier D, 1998, IMMUNOL LETT, V61, P157, DOI 10.1016/S0165-2478(98)00013-3; Mitarai S, 2000, AM J PHYSIOL-HEART C, V279, pH139, DOI 10.1152/ajpheart.2000.279.1.H139; Murata M, 2001, CIRC RES, V89, P891, DOI 10.1161/hh2201.100205; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Pogwizd SM, 1999, CIRC RES, V85, P1009; Sakata Y, 1998, CIRCULATION, V97, P1488; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shiraishi I, 2004, CIRC RES, V94, P884, DOI 10.1161/01.RES.0000124394.01180.BE; Singh K, 2000, CARDIOVASC RES, V45, P713, DOI 10.1016/S0008-6363(99)00370-3; Sipido KR, 2002, CARDIOVASC RES, V53, P782, DOI 10.1016/S0008-6363(01)00470-9; Song QJ, 2003, J CLIN INVEST, V111, P859, DOI 10.1172/JCI200316738; SWEDBERG K, 1984, AM J CARDIOL, V54, P783, DOI 10.1016/S0002-9149(84)80208-8; Szalai G, 2000, J BIOL CHEM, V275, P15305, DOI 10.1074/jbc.275.20.15305; Uchiyama T, 2004, CIRCULATION, V109, P3042, DOI 10.1161/01.CIR.0000130647.29030.90; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Yussman MG, 2002, NAT MED, V8, P725, DOI 10.1038/nm719	46	59	60	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2005	280	46					38505	38512		10.1074/jbc.M505223200	http://dx.doi.org/10.1074/jbc.M505223200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	983NR	16061478	hybrid			2022-12-27	WOS:000233239800048
J	Rishavy, MA; Hallgren, KW; Yakubenko, AV; Zuerner, RL; Runge, KW; Berkner, KL				Rishavy, MA; Hallgren, KW; Yakubenko, AV; Zuerner, RL; Runge, KW; Berkner, KL			The vitamin K-dependent carboxylase has been acquired by Leptospira pathogens and shows altered activity that suggests a role other than protein carboxylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYL CARBOXYLASE; POSTTRANSLATIONAL MODIFICATION; CONUS-TEXTILE; IDENTIFICATION; EXPRESSION; HYDROQUINONE; COAGULATION; PHYSIOLOGY; DROSOPHILA; MECHANISM	Leptospirosis is an emerging infectious disease whose pathology includes a hemorrhagic response, and sequencing of the Leptospira interrogans genome revealed an ortholog of the vitamin K-dependent (VKD) carboxylase as one of several hemostatic proteins present in the bacterium. Until now, the VKD carboxylase was known to be present only in the animal kingdom (i.e. metazoans that include mammals, fish, snails, and insects), and this restricted distribution and high sequence similarity between metazoan and Leptospira orthologs strongly suggests that Leptospira acquired the VKD carboxylase by horizontal gene transfer. In metazoans, the VKD carboxylase is bifunctional, acting as an epoxidase that oxygenates vitamin K to a strong base and a carboxylase that uses the base to carboxylate Glu residues in VKD proteins, rendering them active in hemostasis and other physiologies. In contrast, the Leptospira ortholog showed epoxidase but not detectable carboxylase activity and divergence in a region of identity in all known metazoan VKD carboxylases that is important to Glu interaction. Furthermore, although the mammalian carboxylase is regulated so that vitamin K epoxidation does not occur unless Glu substrate is present, the Leptospira VKD epoxidase showed unfettered epoxidation in the absence of Glu substrate. Finally, human VKD protein orthologs were not detected in the L. interrogans genome. The combined data, then, suggest that Leptospira exapted the metazoan VKD carboxylase for some use other than VKD protein carboxylation, such as using the strong vitamin K base to drive a new reaction or to promote oxidative damage or depleting vitamin K to indirectly inhibit host VKD protein carboxylation.	Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Lerner Res Inst,Dept Mol Cardiol, Cleveland, OH 44195 USA; Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Lerner Res Inst,Dept Mol Genet, Cleveland, OH 44195 USA; ARS, Bacterial Dis Livestock Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; United States Department of Agriculture (USDA)	Berkner, KL (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol NB50, 9500 Euclid Ave, Cleveland, OH 44195 USA.	berknek@ccf.org	Runge, Kurt/AAW-9308-2021; Zuerner, Richard/AAG-7645-2021	Runge, Kurt/0000-0001-8492-0530; Berkner, Kathleen/0000-0001-8054-8081	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019960] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL055666-08, HL55666] Funding Source: Medline; NIA NIH HHS [R01 AG019960] Funding Source: Medline; NIGMS NIH HHS [R01 GM050752] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bandyopadhyay PK, 2002, P NATL ACAD SCI USA, V99, P1264, DOI 10.1073/pnas.022637099; Berkner KL, 1997, METHOD ENZYMOL, V282, P313; Berkner KL, 2004, J THROMB HAEMOST, V2, P2118, DOI 10.1111/j.1538-7836.2004.00968.x; Blandl T, 2000, FEBS LETT, V470, P139, DOI 10.1016/S0014-5793(00)01309-0; Bracey MH, 2004, FEBS LETT, V567, P159, DOI 10.1016/j.febslet.2004.04.084; Bush KA, 1999, BIOCHEMISTRY-US, V38, P14660, DOI 10.1021/bi991640l; Czerwiec E, 2002, EUR J BIOCHEM, V269, P6162, DOI 10.1046/j.1432-1033.2002.03335.x; DOWD P, 1995, SCIENCE, V269, P1684, DOI 10.1126/science.7569894; Faine S., 1994, LEPTOSPIRA LEPTOSPIR; Jiang Y, 2003, P NATL ACAD SCI USA, V100, P7527, DOI 10.1073/pnas.0932632100; KARUDAPURAM S, 1995, J BACTERIOL, V177, P3235, DOI 10.1128/jb.177.11.3235-3240.1995; Li T, 2000, J BIOL CHEM, V275, P18291, DOI 10.1074/jbc.M001790200; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Meganathan R, 2001, VITAM HORM, V61, P173; Morris DP, 1995, J BIOL CHEM, V270, P30491, DOI 10.1074/jbc.270.51.30491; Mutucumarana VP, 2003, J BIOL CHEM, V278, P46488, DOI 10.1074/jbc.M307707200; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Pudota BN, 2000, P NATL ACAD SCI USA, V97, P13033, DOI 10.1073/pnas.97.24.13033; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Rishavy MA, 2004, P NATL ACAD SCI USA, V101, P13732, DOI 10.1073/pnas.0404989101; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; ROTH DA, 1993, P NATL ACAD SCI USA, V90, P8372, DOI 10.1073/pnas.90.18.8372; ROTH DA, 1995, J BIOL CHEM, V270, P5305, DOI 10.1074/jbc.270.10.5305; Schultz J, 2004, TRENDS BIOCHEM SCI, V29, P4, DOI 10.1016/j.tibs.2003.11.002; Stenina O, 2001, BIOCHEMISTRY-US, V40, P10301, DOI 10.1021/bi0107039; Sugiura I, 1997, P NATL ACAD SCI USA, V94, P9069, DOI 10.1073/pnas.94.17.9069; SUTTIE JW, 1985, ANNU REV BIOCHEM, V54, P459, DOI 10.1146/annurev.bi.54.070185.002331; Syvanen M., 2002, HORIZONTAL GENE TRAN; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Walker CS, 2001, J BIOL CHEM, V276, P7769, DOI 10.1074/jbc.M009576200; WU SM, 1991, SCIENCE, V254, P1634, DOI 10.1126/science.1749935; Zuerner R, 2001, SPIROCHETES: MOLECULAR AND CELLULAR BIOLOGY, P137	32	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34870	34877		10.1074/jbc.M504345200	http://dx.doi.org/10.1074/jbc.M504345200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16061481	hybrid			2022-12-27	WOS:000232403900059
J	Bradley, PJ; Ward, C; Cheng, SJ; Alexander, DL; Coller, S; Coombs, GH; Dunn, JD; Ferguson, DJ; Sanderson, SJ; Wastling, JM; Boothroyd, JC				Bradley, PJ; Ward, C; Cheng, SJ; Alexander, DL; Coller, S; Coombs, GH; Dunn, JD; Ferguson, DJ; Sanderson, SJ; Wastling, JM; Boothroyd, JC			Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITOPHOROUS VACUOLE MEMBRANE; CELL INVASION; PLASMODIUM-FALCIPARUM; MICRONEME PROTEINS; APICAL ORGANELLES; DENSE GRANULES; IDENTIFICATION; GENE; ROP1; EXPRESSION	Rhoptries are specialized secretory organelles that are uniquely present within protozoan parasites of the phylum Apicomplexa. These obligate intracellular parasites comprise some of the most important parasites of humans and animals, including the causative agents of malaria ( Plasmodium spp.) and chicken coccidiosis ( Eimeria spp.). The contents of the rhoptries are released into the nascent parasitophorous vacuole during invasion into the host cell, and the resulting proteins often represent the literal interface between host and pathogen. We have developed a method for highly efficient purification of rhoptries from one of the best studied Apicomplexa, Toxoplasma gondii, and we carried out a detailed proteomic analysis using mass spectrometry that has identified 38 novel proteins. To confirm their rhoptry origin, antibodies were raised to synthetic peptides and/or recombinant protein. Eleven of 12 of these yielded antibody that showed strong rhoptry staining by immunofluorescence within the rhoptry necks and/or their bulbous base. Hemagglutinin epitope tagging confirmed one additional novel protein as from the rhoptry bulb. Previously identified rhoptry proteins from Toxoplasma and Plasmodium were unique to one or the other organism, but our elucidation of the Toxoplasma rhoptry proteome revealed homologues that are common to both. This study also identified the first Toxoplasma genes encoding rhoptry neck proteins, which we named RONs, demonstrated that toxofilin and Rab11 are rhoptry proteins, and identified novel kinases, phosphatases, and proteases that are likely to play a key role in the ability of the parasite to invade and co-opt the host cell for its own survival and growth.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland; Univ Liverpool, Dept Preclin Vet Sci, Liverpool L69 7ZJ, Merseyside, England; Univ Liverpool, Dept Vet Pathol, Liverpool L69 7ZJ, Merseyside, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Pathol, Oxford OX3 9DU, England	Stanford University; University of California System; University of California Los Angeles; University of Glasgow; University of Liverpool; University of Liverpool; University of Oxford	Boothroyd, JC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	john.boothroyd@stanford.edu		Boothroyd, John C./0000-0001-9719-745X; Ferguson, David/0000-0001-5045-819X; Dunn, Joe Dan/0000-0002-5091-4527	NIAID NIH HHS [F32AI10552, R01AI45057, R01AI 21423] Funding Source: Medline; NIGMS NIH HHS [T32GM07276] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021423, R01AI045057, F32AI010552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIKAWA M, 1990, EXP PARASITOL, V71, P326, DOI 10.1016/0014-4894(90)90037-D; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anthony RN, 2000, J EUKARYOT MICROBIOL, V47, P319, DOI 10.1111/j.1550-7408.2000.tb00053.x; ASAI T, 1983, J BIOL CHEM, V258, P6816; Baldi DL, 2002, INFECT IMMUN, V70, P5236, DOI 10.1128/IAI.70.9.5236-5245.2002; Bannister LH, 2003, J CELL SCI, V116, P3825, DOI 10.1242/jcs.00665; BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; Beckers CJM, 1997, MOL BIOCHEM PARASIT, V89, P209, DOI 10.1016/S0166-6851(97)00120-5; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0; Bradley PJ, 2002, MOL BIOCHEM PARASIT, V125, P189, DOI 10.1016/S0166-6851(02)00162-7; Bradley PJ, 2001, INT J PARASITOL, V31, P1177, DOI 10.1016/S0020-7519(01)00242-9; Bradley PJ, 1999, MOL BIOCHEM PARASIT, V100, P103, DOI 10.1016/S0166-6851(99)00035-3; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Carey KL, 2004, EUKARYOT CELL, V3, P1320, DOI 10.1128/EC.3.5.1320-1330.2004; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Carruthers Vern B., 1999, Parasitology International, V48, P1; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; Conseil V, 1999, ANTIMICROB AGENTS CH, V43, P1358, DOI 10.1128/AAC.43.6.1358; Coppens I, 2003, MOL BIOL CELL, V14, P3804, DOI 10.1091/mbc.E02-12-0830; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Cowman A F, 1984, Mol Biol Med, V2, P207; Delorme V, 2003, MOL BIOL CELL, V14, P1900, DOI 10.1091/mbc.E02-08-0462; DESOUZA W, 1978, Z PARASITENKD, V56, P123; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Dubey J. P., 1977, PARASITIC PROTOZOA, V3, P101; Dubremetz JF, 1998, INT J PARASITOL, V28, P1007, DOI 10.1016/S0020-7519(98)00076-9; Ferguson DJP, 1999, EXP PARASITOL, V91, P203, DOI 10.1006/expr.1998.4384; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gardiner DL, 2004, PARASITOL RES, V93, P590, DOI 10.1007/s00436-004-1098-4; Gromov P, 1998, ELECTROPHORESIS, V19, P1803, DOI 10.1002/elps.1150191043; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; He XL, 2002, NAT STRUCT BIOL, V9, P606, DOI 10.1038/nsb819; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; HOLDER AA, 1992, MEM I OSWALDO CRUZ, V87, P37, DOI 10.1590/S0074-02761992000700004; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Hoppe HC, 2000, NAT CELL BIOL, V2, P449, DOI 10.1038/35017090; Kaneko O, 2001, MOL BIOCHEM PARASIT, V118, P223, DOI 10.1016/S0166-6851(01)00391-7; Karasov AO, 2005, INT J PARASITOL, V35, P285, DOI 10.1016/j.ijpara.2004.11.015; KASPER LH, 1983, J IMMUNOL, V130, P2407; Khan SM, 2001, MOL BIOCHEM PARASIT, V117, P1, DOI 10.1016/S0166-6851(01)00333-4; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Kong JT, 2003, J INFECT DIS, V187, P1484, DOI 10.1086/374647; LERICHE MA, 1991, MOL BIOCHEM PARASIT, V45, P249, DOI 10.1016/0166-6851(91)90092-K; LEVINE ND, 1988, J PROTOZOOL, V35, P518, DOI 10.1111/j.1550-7408.1988.tb04141.x; Lobo CA, 2003, MOL BIOCHEM PARASIT, V128, P59, DOI 10.1016/S0166-6851(03)00050-1; Meissner M, 2002, J CELL SCI, V115, P563; Miller SA, 2003, MOL MICROBIOL, V49, P883, DOI 10.1046/j.1365-2958.2003.03604.x; Miller SA, 2001, J BIOL CHEM, V276, P45341, DOI 10.1074/jbc.M106665200; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Molestina RE, 2005, CELL MICROBIOL, V7, P351, DOI 10.1111/j.1462-5822.2004.00463.x; MORRISSETTE NS, 1994, EXP PARASITOL, V79, P445, DOI 10.1006/expr.1994.1106; Ngo HM, 2004, MOL MICROBIOL, V52, P1531, DOI 10.1111/j.1365-2958.2004.04056.x; NICHOLS BA, 1983, J ULTRA MOL STRUCT R, V83, P85, DOI 10.1016/S0022-5320(83)90067-9; Opitz C, 2002, MOL MICROBIOL, V45, P597, DOI 10.1046/j.1365-2958.2002.03056.x; OSSORIO PN, 1992, MOL BIOCHEM PARASIT, V50, P1, DOI 10.1016/0166-6851(92)90239-G; Poupel O, 2000, MOL BIOL CELL, V11, P355, DOI 10.1091/mbc.11.1.355; Que XC, 2002, J BIOL CHEM, V277, P25791, DOI 10.1074/jbc.M202659200; Reichmann G, 2002, MOL BIOCHEM PARASIT, V119, P43, DOI 10.1016/S0166-6851(01)00397-8; SADAK A, 1988, MOL BIOCHEM PARASIT, V29, P203, DOI 10.1016/0166-6851(88)90075-8; Sam-Yellowe TY, 2004, J PROTEOME RES, V3, P995, DOI 10.1021/pr049926m; SamYellowe TY, 1996, PARASITOL TODAY, V12, P308, DOI 10.1016/0169-4758(96)10030-2; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; SCHOFIELD L, 1991, PARASITOL TODAY, V7, P99, DOI 10.1016/0169-4758(91)90166-L; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; SCHWARTZMAN JD, 1986, INFECT IMMUN, V51, P760, DOI 10.1128/IAI.51.3.760-764.1986; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Sinai AP, 2001, J CELL BIOL, V154, P95, DOI 10.1083/jcb.200101073; Soldati D, 1998, MOL BIOCHEM PARASIT, V96, P37, DOI 10.1016/S0166-6851(98)00090-5; Soldati D, 2001, INT J PARASITOL, V31, P1293, DOI 10.1016/S0020-7519(01)00257-0; Stenmark H, 2001, GENOME BIOL, V2; Striepen B, 2001, MOL BIOCHEM PARASIT, V113, P45, DOI 10.1016/S0166-6851(00)00379-0; Topolska AE, 2004, J BIOL CHEM, V279, P4648, DOI 10.1074/jbc.M307859200; WALLIS AE, 1994, EXP PARASITOL, V78, P161, DOI 10.1006/expr.1994.1016; Weiss LM, 2000, FRONT BIOSCI-LANDMRK, V5, pD391, DOI 10.2741/Weiss; Zhou XW, 2005, J BIOL CHEM, V280, P34233, DOI 10.1074/jbc.M504160200	78	294	326	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34245	34258		10.1074/jbc.M504158200	http://dx.doi.org/10.1074/jbc.M504158200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16002398	hybrid			2022-12-27	WOS:000232229700067
J	Glukhov, E; Stark, M; Burrows, LL; Deber, CM				Glukhov, E; Stark, M; Burrows, LL; Deber, CM			Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE ENERGY-TRANSFER; ANTIBACTERIAL PEPTIDES; PHOSPHOLIPID-MEMBRANES; TRANSMEMBRANE DOMAIN; LIPID BILAYERS; CDNA SEQUENCE; GRAMICIDIN-S; MOSES SOLE; HYDROPHOBICITY; ANALOGS	Novel cationic antimicrobial peptides typified by structures such as KKKKKKAAXAAWAAXAA- NH2, where X = Phe/Trp, and several of their analogues display high activity against a variety of bacteria but exhibit no hemolytic activity even at high dose levels in mammalian erythrocytes. To elucidate their mechanism of action and source of selectivity for bacterial membranes, phospholipid mixtures mimicking the compositions of natural bacterial membranes ( containing anionic lipids) and mammalian membranes ( containing zwitterionic lipids + cholesterol) were challenged with the peptides. We found that peptides readily inserted into bacterial lipid mixtures, although no insertion was detected in model "mammalian" membranes. The depth of peptide insertion into model bacterial membranes was estimated by Trp fluorescence quenching using doxyl groups variably positioned along the phospholipid acyl chains. Peptide antimicrobial activity generally increased with increasing depth of peptide insertion. The overall results, in conjunction with molecular modeling, support an initial electrostatic interaction step in which bacterial membranes attract and bind peptide dimers onto the bacterial surface, followed by the "sinking" of the hydrophobic core segment to a peptide sequence-dependent depth of similar to 2.5-8 angstrom into the membrane, largely parallel to the membrane surface. Antimicrobial activity was likely enhanced by the fact that the peptide sequences contain AXXXA sequence motifs, which promote their dimerization, and possibly higher oligomerization, as assessed by SDS-polyacrylamide gel analysis and fluorescence resonance energy transfer experiments. The high selectivity of these peptides for nonmammalian membranes, combined with their activity toward a wide spectrum of Gram-negative and Gram-positive bacteria and yeast, while retaining water solubility, represent significant advantages of this class of peptides.	Hosp Sick Children, Div Struct Biol & Biochem, Res Inst, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Infect Immun Injury & Repair, Res Inst, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Surg, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Deber, CM (corresponding author), Hosp Sick Children, Div Struct Biol & Biochem, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	deber@sickkids.ca	Glukhov, Evgenia/ABB-2769-2020; Burrows, Lori/D-1142-2010	Burrows, Lori/0000-0003-0838-5040; Glukhov, Evgenia/0000-0001-6513-9909				ADAIR BD, 1994, BIOCHEMISTRY-US, V33, P5539, DOI 10.1021/bi00184a024; Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; ARGIOLAS A, 1984, J BIOL CHEM, V259, P106; BESSALLE R, 1990, FEBS LETT, V274, P151, DOI 10.1016/0014-5793(90)81351-N; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Choi MY, 2004, BIOCHEMISTRY-US, V43, P8077, DOI 10.1021/bi0494525; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; Deber CM, 2001, PROTEIN SCI, V10, P212, DOI 10.1110/ps.30301; Dimarcq JL, 1998, BIOPOLYMERS, V47, P465, DOI 10.1002/(SICI)1097-0282(1998)47:6<465::AID-BIP5>3.0.CO;2-#; Gennis R. B., 1989, BIOMEMBRANE, P1; HABERMANN E, 1967, H-S Z PHYSIOL CHEM, V348, P37, DOI 10.1515/bchm2.1967.348.1.37; Hancock R E, 2001, Lancet Infect Dis, V1, P156, DOI 10.1016/S1473-3099(01)00092-5; Hara T, 2001, BIOCHEMISTRY-US, V40, P12395, DOI 10.1021/bi011413v; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Johnstone SA, 2000, ANTI-CANCER DRUG DES, V15, P151; Kondejewski LH, 2002, J BIOL CHEM, V277, P67, DOI 10.1074/jbc.M107825200; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lear JD, 2004, BIOPHYS J, V87, P3421, DOI 10.1529/biophysj.103.032839; Lee KH, 2003, BIOCHEM BIOPH RES CO, V309, P591, DOI 10.1016/j.bbrc.2003.08.043; LEE WJ, 1994, ANAL BIOCHEM, V217, P231, DOI 10.1006/abio.1994.1113; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; Liu LP, 1998, J BIOL CHEM, V273, P23645, DOI 10.1074/jbc.273.37.23645; Liu LP, 1997, BIOCHEMISTRY-US, V36, P5476, DOI 10.1021/bi970030n; LONDON E, 1982, MOL CELL BIOCHEM, V45, P181; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Melnyk RA, 2002, J MOL BIOL, V315, P63, DOI 10.1006/jmbi.2001.5214; Melnyk RA, 2001, BIOCHEMISTRY-US, V40, P11106, DOI 10.1021/bi010642e; Oren Z, 1998, BIOPOLYMERS, V47, P451; Oren Z, 1996, EUR J BIOCHEM, V237, P303, DOI 10.1111/j.1432-1033.1996.0303n.x; Oren Z, 1997, BIOCHEMISTRY-US, V36, P1826, DOI 10.1021/bi962507l; Papo N, 2004, BIOCHEMISTRY-US, V43, P6393, DOI 10.1021/bi049944h; Papo N, 2003, PEPTIDES, V24, P1693, DOI 10.1016/j.peptides.2003.09.013; Porter EA, 2002, J AM CHEM SOC, V124, P7324, DOI 10.1021/ja0260871; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; Prenner EJ, 2005, J BIOL CHEM, V280, P2002, DOI 10.1074/jbc.M406509200; Prenner EJ, 1997, BIOCHEMISTRY-US, V36, P7906, DOI 10.1021/bi962785k; Sal-Man N, 2002, BIOCHEMISTRY-US, V41, P11921, DOI 10.1021/bi0260482; Sawai MV, 2001, BIOCHEMISTRY-US, V40, P3810, DOI 10.1021/bi002519d; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; SHAI Y, 1988, FEBS LETT, V242, P161, DOI 10.1016/0014-5793(88)81007-X; Stark M, 2002, ANTIMICROB AGENTS CH, V46, P3585, DOI 10.1128/AAC.46.11.3585-3590.2002; STEINER H, 1988, BIOCHIM BIOPHYS ACTA, V939, P260, DOI 10.1016/0005-2736(88)90069-7; STORICI P, 1993, BIOCHEM BIOPH RES CO, V196, P1363, DOI 10.1006/bbrc.1993.2403; VEATCH W, 1977, J MOL BIOL, V113, P89, DOI 10.1016/0022-2836(77)90042-0; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0; Voglino L, 1999, BIOCHEMISTRY-US, V38, P7509, DOI 10.1021/bi990099q; Wieprecht T, 1996, BIOCHEMISTRY-US, V35, P10844, DOI 10.1021/bi960362c; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	53	219	226	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					33960	33967		10.1074/jbc.M507042200	http://dx.doi.org/10.1074/jbc.M507042200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16043484	hybrid			2022-12-27	WOS:000232229700033
J	He, JCJ; Gomes, I; Nguyen, T; Jayaram, G; Ram, PT; Devi, LA; Iyengar, R				He, JCJ; Gomes, I; Nguyen, T; Jayaram, G; Ram, PT; Devi, LA; Iyengar, R			The G alpha(o/)i-coupled cannabinoid receptor-mediated neurite outgrowth involves rap regulation of Src and Stat3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH CONE GUIDANCE; PC12 CELLS; MAP KINASE; ACTIVATION; PROTEIN; PATHWAY; GTPASE; JNK; PHOSPHORYLATION; TRANSFORMATION	The study of the signaling pathways regulating neurite outgrowth in culture is important because of their potential role in neuronal differentiation in vivo. We have previously shown that the G alpha(o/i)-coupled CB1 cannabinoid receptor (CB1R) activates Rap1 to induce neurite outgrowth. G alpha(o/i) also activates the Src-Stat3 pathway. Here, we studied the relationship between the G alpha(o/i)-Rap1 and Src-Stat3 pathways and the role of these signaling pathways in CB1R-mediated neurite outgrowth in Neuro-2A cells. The CB1 agonist HU-210 induced pertussis toxin-sensitive Src and Stat3 phosphorylation. Dominant negative (DN) mutants of Src and Stat3 blocked CB1R-induced neurite outgrowth. Constitutively active Rap 1B and Ral-activated Src and CB1R-induced Src phosphorylation was inhibited by Rap1-DN and Ral-DN, indicating that both Rap1 and Ral mediate downstream signaling from G alpha(o/i) for Src activation. Rap1-activated Ral and Ral-DN blocked Rap-induced Src phosphorylation. G alpha(o)-induced Stat3 activation was blocked by Ral-DN, whereas v-Src-induced Stat3 activation was not inhibited by Ral-DN, indicating that the CB1R, through G alpha(o), mediates the sequential activation of Rap1 to Ral to Src to Stat3 in Neuro-2A cells. Downstream of Src, the CB1R also activated Rac1 and JNK, which enhanced CBR1-mediated Stat3 activation. Rac-DN blocked CB1R-induced activation of JNK. Pharmacological inhibition of JNK blocked Src and CB1R activation of Stat3, indicating that Rac and JNK are also involved in CB1R-mediated neurite outgrowth. Overall, this study demonstrated that G alpha(o/i)-coupled CB1R triggers neurite outgrowth in Neuro-2A through the activation of a signaling network containing two pathways that bifurcate at Src and converge at Stat3.	Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Iyengar, R (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, Box 1215,1 Gustave Levy Pl, New York, NY 10029 USA.	ravi.iyengar@mssm.edu	Devi P, Lakshmi/GXM-5982-2022	Devi P, Lakshmi/0000-0001-9274-4776; Ram, Prahlad/0000-0003-4739-3166; Hwangpo, Tracy Anh/0000-0002-4851-599X	NCI NIH HHS [CA-81050] Funding Source: Medline; NHLBI NIH HHS [HL-07824] Funding Source: Medline; NIDA NIH HHS [DA-019521, DA-08863] Funding Source: Medline; NIDDK NIH HHS [DK-65495] Funding Source: Medline; NIGMS NIH HHS [GM-54508] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK065495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA008863, R01DA008863, R56DA008863, K05DA019521] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anneren C, 2000, J BIOL CHEM, V275, P29153, DOI 10.1074/jbc.M003926200; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Causeret F, 2004, DEVELOPMENT, V131, P2841, DOI 10.1242/dev.01162; Chan ASL, 2004, CELL SIGNAL, V16, P823, DOI 10.1016/j.cellsig.2003.12.007; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; De Ruiter ND, 2000, MOL CELL BIOL, V20, P8480, DOI 10.1128/MCB.20.22.8480-8488.2000; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Goi T, 2000, EMBO J, V19, P623, DOI 10.1093/emboj/19.4.623; Goi T, 1999, MOL CELL BIOL, V19, P1731; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Ihara S, 1997, EMBO J, V16, P5345, DOI 10.1093/emboj/16.17.5345; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kishida S, 1997, ONCOGENE, V15, P2899, DOI 10.1038/sj.onc.1201473; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Linnemann T, 2002, J BIOL CHEM, V277, P7831, DOI 10.1074/jbc.M110800200; Lotto B, 1999, NEUROSCI LETT, V269, P87, DOI 10.1016/S0304-3940(99)00422-X; Marignani PA, 2001, J CELL BIOL, V154, P177, DOI 10.1083/jcb.200103134; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Ram PT, 2000, SCIENCE, V287, P142, DOI 10.1126/science.287.5450.142; Reinoso BS, 1996, J NEUROSCI RES, V43, P439, DOI 10.1002/(SICI)1097-4547(19960215)43:4<439::AID-JNR5>3.0.CO;2-G; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; STRITTMATTER SM, 1994, J NEUROSCI, V14, P2327; Waetzig V, 2003, MOL CELL NEUROSCI, V24, P238, DOI 10.1016/S1044-7431(03)00126-X; Wu YY, 2000, J BIOL CHEM, V275, P2147, DOI 10.1074/jbc.275.3.2147; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Xiao JN, 2003, J NEUROCHEM, V86, P1516, DOI 10.1046/j.1471-4159.2003.01961.x; Yang LT, 2002, J BIOL CHEM, V277, P17406, DOI 10.1074/jbc.M111902200; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895	39	84	88	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33426	33434		10.1074/jbc.M502812200	http://dx.doi.org/10.1074/jbc.M502812200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16046413	hybrid			2022-12-27	WOS:000232058100041
J	Rochette-Egly, C				Rochette-Egly, C			Dynamic combinatorial networks in nuclear receptor-mediated transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RNA-POLYMERASE-II; RETINOIC ACID; RAR-GAMMA; REGULATED TRANSCRIPTION; GLUCOCORTICOID-RECEPTOR; ANDROGEN RECEPTOR; FACTOR TFIIH; HISTONE H2B; PROTEASOME; ACTIVATION	The nuclear hormone receptor ( NR)(2) superfamily describes a diverse array of transcription activators working in a ligand- dependent manner and exerting action by regulating the expression of specific subsets of genes ( 1, 2). The receptors for steroid hormones, which include the estrogen ( ER), androgen ( AR), progesterone ( PR), and glucocorticoid ( GR) receptors, are held in the cytoplasm, in association with chaperone complexes. Ligand binding acts as an on- switch, inducing their release from the chaperone molecules, their dimerization, their entrance into the nucleus, and their binding to hormone response elements ( HREs) within the regulatory regions of target genes. In contrast, the receptors for non- steroidal hormones such as the vitamin D ( VDR), retinoic acid ( RARs), and peroxisome proliferator- activated ( PPAR) receptors are found primarily in the nucleus and bound at HREs as heterodimers with the retinoid X receptor ( RXR). They are associated with histone deacetylase- containing complexes tethered through corepressors ( N- CoR and SMRT), resulting in chromatin compaction and gene silencing. Upon ligand binding, the corepressor- binding interface of NRs is destabilized, leading to the dissociation of corepressors ( 3). The basic mechanism for switching on gene transcription by liganded NRs ( either steroid or non- steroid) relies on a complex and ever growing network of interactions with coregulatory proteins. For most NRs, this network is directed by a specific domain, the activation function 2 ( AF- 2) domain, located in the C- terminal ligand- binding domain ( LBD) ( Fig. 1A). The LBD is composed of 12 alpha helices organized as an antiparallel sandwich ( Fig. 1B). Upon ligand binding, the AF- 2 domain undergoes major structural rearrangements ( 4, 5), creating a new binding surface for coactivators ( Fig. 1B). The AF- 2 domain cooperates with a second activation domain residing in the N terminus, the AF- 1 domain ( 4), to recruit multiple complexes to alter the chromatin structure surrounding the promoter of target genes ( 6 - 8). In the end these events pave the way for the recruitment of the transcription machinery, including RNA polymerase II ( RNA PolII) and the general transcription factors ( GTFs) ( 9). A concept that has developed over the last several years is that NRs and their coregulators are subjected to rapid modifications ( phosphorylation, ubiquitination, acetylation, methylation) and proteasomal degradation. Therefore it emerged that they exert transcriptional control in a combinatorial, coordinated, coordinated, and sequential manner. These findings challenged the conventional view of stable, NR- based, template- bound complexes and suggested a dynamic and multistep model involving rapid and carefully orchestrated series of exchanges between NRs, coregulators, and the promoter. In this review, we will focus on the dynamics of the interactions between NRs and their coregulators and on their fine tuning by a variety of post- translational modifications or degradation processes that occur in response to the ligand or to other cellular signalings, so that, in the end, the correct proteins are present with the right activity, at the right place, and at the right time.	Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire,UMR 7104,Dept, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Rochette-Egly, C (corresponding author), Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire,UMR 7104,Dept, BP 10142, F-67404 Illkirch Graffenstaden, France.	cegly@igbmc.u-strasbg.fr						Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bastien J, 2000, J BIOL CHEM, V275, P21896, DOI 10.1074/jbc.M001985200; Belandia B, 2003, CELL, V114, P277, DOI 10.1016/S0092-8674(03)00599-3; Bour G, 2005, J BIOL CHEM, V280, P17027, DOI 10.1074/jbc.M501344200; Brondani V, 2005, BIOCHEM BIOPH RES CO, V328, P6, DOI 10.1016/j.bbrc.2004.12.130; Bruck N, 2005, CELL SIGNAL, V17, P1229, DOI 10.1016/j.cellsig.2004.12.006; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Cheng SW, 2000, COMB OPT (SER), V6, P137; Compe E, 2005, MOL CELL BIOL, V25, P6065, DOI 10.1128/MCB.25.14.6065-6076.2005; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Dennis AP, 2005, J STEROID BIOCHEM, V93, P139, DOI 10.1016/j.jsbmb.2004.12.015; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Drane P, 2004, MOL CELL, V16, P187, DOI 10.1016/j.molcel.2004.10.007; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Gianni M, 2002, EMBO J, V21, P3760, DOI 10.1093/emboj/cdf374; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Glass CK, 2000, GENE DEV, V14, P121; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Hager GL, 2004, BBA-GENE STRUCT EXPR, V1677, P46, DOI 10.1016/j.bbaexp.2003.09.016; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jonas BA, 2004, J BIOL CHEM, V279, P54676, DOI 10.1074/jbc.M410128200; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Keriel A, 2002, CELL, V109, P125, DOI 10.1016/S0092-8674(02)00692-X; Kopf E, 2000, J BIOL CHEM, V275, P33280, DOI 10.1074/jbc.M002840200; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; LAUDET V, 2001, NUCL RECEPTOR FACTSH; Lee DK, 2000, J BIOL CHEM, V275, P9308, DOI 10.1074/jbc.275.13.9308; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Lee JW, 2001, CELL MOL LIFE SCI, V58, P289, DOI 10.1007/PL00000856; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Lonard DM, 2005, TRENDS BIOCHEM SCI, V30, P126, DOI 10.1016/j.tibs.2005.01.001; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nawaz Z, 2004, MOL ENDOCRINOL, V18, P493, DOI 10.1210/me.2003-0388; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Shen TJ, 2001, MOL CELL BIOL, V21, P6122, DOI 10.1128/MCB.21.18.6122-6131.2001; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Sun LP, 2002, BIOCHEM BIOPH RES CO, V296, P991, DOI 10.1016/S0006-291X(02)02026-0; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Taneja R, 1997, EMBO J, V16, P6452, DOI 10.1093/emboj/16.21.6452; Tansey WP, 2001, GENE DEV, V15, P1045, DOI 10.1101/gad.896501; Thomas D, 2000, CURR BIOL, V10, pR341, DOI 10.1016/S0960-9822(00)00462-0; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3	69	73	73	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32565	32568		10.1074/jbc.R500008200	http://dx.doi.org/10.1074/jbc.R500008200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16076839	hybrid			2022-12-27	WOS:000231920300002
J	Yang, JY; Walicki, J; Abderrahmani, A; Cornu, M; Waeber, GR; Thorens, B; Widmann, C				Yang, JY; Walicki, J; Abderrahmani, A; Cornu, M; Waeber, GR; Thorens, B; Widmann, C			Expression of an uncleavable N-terminal RasGAP fragment in insulin-secreting cells increases their resistance toward apoptotic stimuli without affecting their glucose-induced insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; CYTOKINE-INDUCED APOPTOSIS; BETA-CELLS; CLEAVAGE; DEATH; SURVIVAL; AKT; PROLIFERATION; INHIBITION; REPRESSOR	Apoptosis of pancreatic beta cells is implicated in the onset of type 1 and type 2 diabetes. Consequently, strategies aimed at increasing the resistance of beta cells toward apoptosis could be beneficial in the treatment of diabetes. RasGAP, a regulator of Ras and Rho GTPases, is an atypical caspase substrate, since it inhibits, rather than favors, apoptosis when it is partially cleaved by caspase-3 at position 455. The antiapoptotic signal generated by the partial processing of RasGAP is mediated by the N-terminal fragment (fragment N) in a Ras-phosphatidylinositol 3-kinase-Akt-dependent, but NF-kappa B-independent, manner. Further cleavage of fragment N at position 157 abrogates its antiapoptotic properties. Here we demonstrate that an uncleavable form of fragment N activates Akt, represses NF-kappa B activity, and protects the conditionally immortalized pancreatic -insulinoma beta TC-tet cell line against various insults, including exposure to genotoxins, trophic support withdrawal, and incubation with inflammatory cytokines. Fragment N also induced Akt activity and protection against cytokine- induced apoptosis in primary pancreatic islet cells. Fragment N did not alter insulin cell content and insulin secretion in response to glucose. These data indicate that fragment N protects beta cells without affecting their function. The pathways regulated by fragment N are therefore promising targets for antidiabetogenic therapy.	Univ Lausanne, Dept Cellular Biol, Biol & Med Fac, CH-1005 Lausanne, Switzerland; Univ Lausanne, Dept Physiol, Biol & Med Fac, CH-1005 Lausanne, Switzerland; Univ Lausanne Hosp, Dept Internal Med, CH-1011 Lausanne, Switzerland	University of Lausanne; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Widmann, C (corresponding author), Univ Lausanne, Dept Cellular Biol, Biol & Med Fac, Bugnon 9, CH-1005 Lausanne, Switzerland.	Christian.Widmann@unil.ch	Abderrahmani, Amar/O-3124-2017; Widmann, Christian/N-9851-2013	Abderrahmani, Amar/0000-0003-0752-0343; Widmann, Christian/0000-0002-6881-0363; Waeber, Gerard/0000-0003-4193-788X				Baker MS, 2001, J SURG RES, V97, P117, DOI 10.1006/jsre.2001.6121; BEG AA, 1996, SCIENCE, V274, P784; Bonvin C, 2002, CELL SIGNAL, V14, P123, DOI 10.1016/S0898-6568(01)00219-4; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dupraz P, 1999, GENE THER, V6, P1160, DOI 10.1038/sj.gt.3300922; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Fleischer N, 1998, DIABETES, V47, P1419, DOI 10.2337/diabetes.47.9.1419; Giannoukakis N, 2000, J BIOL CHEM, V275, P36509, DOI 10.1074/jbc.M005943200; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Jarpe MB, 1998, ONCOGENE, V17, P1475, DOI 10.1038/sj.onc.1202183; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Karlsen AE, 2004, DIABETOLOGIA, V47, P1998, DOI 10.1007/s00125-004-1568-3; Lawlor MA, 2001, J CELL SCI, V114, P2903; Mauricio D, 1998, DIABETES, V47, P1537, DOI 10.2337/diabetes.47.10.1537; Ozes ON, 1999, NATURE, V401, P82; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Shapiro AMJ, 2003, IMMUNOL REV, V196, P219, DOI 10.1046/j.1600-065X.2003.00085.x; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; VALIUS M, 1995, MOL CELL BIOL, V15, P3058; WIDMANN C, 1995, BIOCHEM J, V310, P203, DOI 10.1042/bj3100203; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Yang JY, 2005, MOL BIOL CELL, V16, P3511, DOI 10.1091/mbc.E05-01-0080; Yang JY, 2004, BIOCHEM PHARMACOL, V68, P1027, DOI 10.1016/j.bcp.2004.03.043; Yang JY, 2004, MOL CELL BIOL, V24, P10425, DOI 10.1128/MCB.24.23.10425-10436.2004; Yang JY, 2002, J BIOL CHEM, V277, P14641, DOI 10.1074/jbc.M111540200; Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001	31	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32835	32842		10.1074/jbc.M504058200	http://dx.doi.org/10.1074/jbc.M504058200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16046410	hybrid			2022-12-27	WOS:000231920300036
J	Bredeston, LM; Caffaro, CE; Samuelson, J; Hirschberg, CB				Bredeston, LM; Caffaro, CE; Samuelson, J; Hirschberg, CB			Golgi and endoplasmic reticulum functions take place in different subcellular compartments of Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED GLYCANS; PROTEIN; DIPHOSPHATASE; TROPHOZOITES; TRANSPORT; VESICLES; YEAST; GLYCOSYLATION; TOPOGRAPHY; EXPRESSION	Entamoeba histolytica is a protozoan parasite that causes dysentery in developing countries of Africa, Asia, and Latin America. The lack of a defined Golgi apparatus in E. histolytica as well as in other protists led to the hypothesis that they had evolved prior to the acquisition of such organelle even though glycoproteins, glycolipids, and antigens have been detected, the latter of which react with antibodies against Golgi apparatus proteins of higher eukaryotes. We here provide direct evidence for Golgi apparatus-like functions in E. histolytica as well as for components of glycoprotein folding quality control. Using a combination of bioinformatic, cell biological, and biochemical approaches we have ( a) cloned and expressed the E. histolytica UDP-galactose transporter in Saccharomyces cerevisiae; its Km for UDP-galactose is 2.9 mu M; (b) characterized vesicles in an extract of the above protist, which transport UDPgalactose into their lumen with a Km of 2.7 mu M; ( c) detected galactosyltransferase activity(ies) in the lumen of the above vesicles with the Km for UDP-galactose, using endogenous acceptors, being 93 mu M; (d) measured latent apyrase activities in the above vesicles, suggesting they are in the lumen; ( e) characterized UDP-glucose transport activities in Golgi apparatus and endoplasmic reticulum-like vesicles with K(m)s for UDP-glucose of similar to 2-4 mu M. Although the endoplasmic reticulum-like fraction showed UDP-glucose: glycoprotein glucosyltransferase activity, the Golgi apparatus-like fraction did not. This fraction contained other glucosyltransferases. Together, these studies demonstrate that E. histolytica has different vesicles that play a role in protein glycosylation and folding quality control, analogous to the above organellar functions of higher eukaryotes.	Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA	Boston University	Hirschberg, CB (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, 715 Albany St,Evans 437, Boston, MA 02118 USA.	chirschb@bu.edu		Samuelson, John/0000-0001-9533-3040; Hirschberg, Carlos/0000-0003-2299-7721	NIAID NIH HHS [AI 44070] Funding Source: Medline; NIGMS NIH HHS [GM 30365] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030365, R01GM030365] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEIJON C, 1989, P NATL ACAD SCI USA, V86, P6935, DOI 10.1073/pnas.86.18.6935; Arya R, 2003, MOL BIOCHEM PARASIT, V126, P1, DOI 10.1016/S0166-6851(02)00252-9; BAKKERGRUNWALD T, 1993, PARASITOL TODAY, V9, P27, DOI 10.1016/0169-4758(93)90161-8; Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; Berninsone P, 1997, J BIOL CHEM, V272, P12616, DOI 10.1074/jbc.272.19.12616; Berninsone PM, 2000, CURR OPIN STRUC BIOL, V10, P542, DOI 10.1016/S0959-440X(00)00128-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chavez-Munguia B, 2000, ARCH MED RES, V31, pS165, DOI 10.1016/S0188-4409(00)00158-2; D'Alessio C, 2003, J BIOL CHEM, V278, P22379, DOI 10.1074/jbc.M300892200; DACKS JB, 2003, P R SOC LOND B S, V270, P168; Dai JY, 2004, CELL, V116, P649, DOI 10.1016/S0092-8674(04)00172-2; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; ENYEDI A, 1993, J BIOL CHEM, V268, P10621; Ghosh SK, 1999, INFECT IMMUN, V67, P3073, DOI 10.1128/IAI.67.6.3073-3081.1999; Guillen E, 1998, P NATL ACAD SCI USA, V95, P7888, DOI 10.1073/pnas.95.14.7888; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirschberg CB, 2001, J CLIN INVEST, V108, P3; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.bi.56.070187.000431; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Manning-Cela R, 2003, CELL MICROBIOL, V5, P921, DOI 10.1046/j.1462-5822.2003.00332.x; Mazzuco A, 1997, MICRON, V28, P241, DOI 10.1016/S0968-4328(97)00024-3; Moody-Haupt S, 2000, J MOL BIOL, V297, P409, DOI 10.1006/jmbi.2000.3577; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; PEREZ M, 1987, METHOD ENZYMOL, V138, P709; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; STANLEY SL, 1995, J BIOL CHEM, V270, P4121, DOI 10.1074/jbc.270.8.4121; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; STANLEY SL, 1995, VACCINE, V13, P947, DOI 10.1016/0264-410X(95)00001-H; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; TROMBETTA SE, 1989, BIOCHEMISTRY-US, V28, P8108, DOI 10.1021/bi00446a022; Uccelletti D, 2004, J BIOL CHEM, V279, P27390, DOI 10.1074/jbc.M402624200; YANAGISAWA K, 1990, J BIOL CHEM, V265, P19351	37	33	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32168	32176		10.1074/jbc.M507035200	http://dx.doi.org/10.1074/jbc.M507035200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16027148	hybrid			2022-12-27	WOS:000231794800017
J	Jiang, T; Wang, ZW; Proctor, G; Moskowitz, S; Liebman, SE; Rogers, T; Lucia, MS; Li, JP; Levi, M				Jiang, T; Wang, ZW; Proctor, G; Moskowitz, S; Liebman, SE; Rogers, T; Lucia, MS; Li, JP; Levi, M			Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC KIDNEY-DISEASE; METABOLIC SYNDROME; INSULIN-RESISTANCE; DIABETIC-NEPHROPATHY; LIVER; EXPRESSION; HYPERINSULINEMIA; OVEREXPRESSION; COMPLICATIONS; CHOLESTEROL	Obesity and metabolic syndrome are associated with glomerulosclerosis and proteinuria, but the mechanisms are not known. The purpose of this study was to determine if there is altered renal lipid metabolism and increased expression of sterol regulatory element-binding proteins (SREBPs) in a model of diet-induced obesity. C57BL/6J mice that were fed a high fat, 60 kcal % saturated ( lard) fat diet (HFD) developed obesity, hyperglycemia, and hyperinsulinemia compared with those that were fed a low fat, 10 kcal % fat diet (LFD). In contrast, A/J mice were resistant when fed the same diet. C57BL/6J mice with HFD exhibited significantly higher levels of renal SREBP-1 and SREBP-2 expression than those mice with LFD, whereas in A/J mice there were no changes with the same treatment. The increases in SREBP-1 and SREBP-2 expression in C57BL/6J mice resulted in renal accumulation of triglyceride and cholesterol. There were also significant increases in the renal expression of plasminogen activator inhibitor-1 (PAI-1), vascular endothelial growth factor ( VEGF), type IV collagen, and fibronectin, resulting in glomerulosclerosis and proteinuria. To determine a role for SREBPs per se in modulating renal lipid metabolism and glomerulosclerosis we performed studies in SREBP-1c(-/-) mice. In contrast to control mice, in the SREBP-1c(-/-) mice with HFD the accumulation of triglyceride was prevented, as well as the increases in PAI-1, VEGF, type IV collagen, and fibronectin expression. Our results therefore suggest that diet-induced obesity causes increased renal lipid accumulation and glomerulosclerosis in C57BL/6J mice via an SREBP-1 dependent pathway.	Univ Colorado, Hlth Sci Ctr, Div Renal Dis & Hypertens, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Physiol & Biophys, Denver, CO 80262 USA; Univ Texas, SW Med Ctr, Vet Affairs Med Ctr, Dallas, TX 75216 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Levi, M (corresponding author), Univ Colorado, Hlth Sci Ctr, Div Renal Dis & Hypertens, Dept Med, 4200 E 9th Ave, Denver, CO 80262 USA.	Moshe.Levi@UCHSC.edu	Liebman, Scott/CAH-4604-2022	Levi, Moshe/0000-0002-6225-946X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062209, F32DK065407, T32DK007038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG020361] Funding Source: NIH RePORTER; NIA NIH HHS [7R03-AG20361-2] Funding Source: Medline; NIDDK NIH HHS [T32 DK-07038-29, 5R01-DK062209-02, 1F32 DK065407-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abrass CK, 2004, J AM SOC NEPHROL, V15, P2768, DOI 10.1097/01.ASN.0000141963.04540.3E; Bagby SP, 2004, J AM SOC NEPHROL, V15, P2775, DOI 10.1097/01.ASN.0000141965.28037.EE; BARICOS WH, 1995, KIDNEY INT, V47, P1039, DOI 10.1038/ki.1995.150; Bianchi S, 2003, AM J KIDNEY DIS, V41, P565, DOI 10.1053/ajkd.2003.50140; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonnet F, 2000, DIABETES METAB, V26, P254; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993; El-Atat FA, 2004, J AM SOC NEPHROL, V15, P2816, DOI 10.1097/01.ASN.0000133698.80390.37; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Fried LF, 2001, KIDNEY INT, V59, P260, DOI 10.1046/j.1523-1755.2001.00487.x; Gin H, 2000, DIABETES METAB, V26, P45; Guan YF, 2004, J AM SOC NEPHROL, V15, P2801, DOI 10.1097/01.ASN.0000139067.83419.46; Guidance Document on Using In Vitro Data to Estimate In Vivo Starting Doses for Acute Toxicity, 2001, GUID DOC US IN VITR; Harte RA, 1999, HORM METAB RES, V31, P570, DOI 10.1055/s-2007-978797; Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211; Horton JD, 2003, J BIOL CHEM, V278, P36652, DOI 10.1074/jbc.M306540200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Inman SR, 1999, AM J MED SCI, V317, P215, DOI 10.1097/00000441-199904000-00001; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kimmelstiel P, 1936, AM J PATHOL, V12, P83; Kirschenbaum MA, 1996, MINER ELECTROL METAB, V22, P47; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Le Lay S, 2002, J BIOL CHEM, V277, P35625, DOI 10.1074/jbc.M203913200; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marcantoni C, 2002, KIDNEY INT, V62, P172, DOI 10.1046/j.1523-1755.2002.00420.x; Mingrone G, 2003, ATHEROSCLEROSIS, V170, P155, DOI 10.1016/S0021-9150(03)00254-5; Molnar J, 2005, CIRC RES, V96, P1178, DOI 10.1161/01.RES.0000168634.74330.ed; MOROOKA H, 1995, J BIOL CHEM, V270, P30084; NARVA AS, 2003, KIDNEY INT S, V83, pS3; Nishida Y, 1999, KIDNEY INT, V56, pS51, DOI 10.1046/j.1523-1755.1999.07113.x; Parekh PI, 1998, METABOLISM, V47, P1089, DOI 10.1016/S0026-0495(98)90283-9; Popov D, 2003, DIABETOLOGIA, V46, P1408, DOI 10.1007/s00125-003-1185-6; Praga M, 2002, NEPHROL DIAL TRANSPL, V17, P1157, DOI 10.1093/ndt/17.7.1157; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; ROVIN BH, 1993, KIDNEY INT, V43, P218, DOI 10.1038/ki.1993.35; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Smith BK, 2000, AM J PHYSIOL-REG I, V278, pR797, DOI 10.1152/ajpregu.2000.278.4.R797; Spencer MW, 2004, AM J NEPHROL, V24, P20, DOI 10.1159/000075362; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; *US DEP HHS, 1996, JAMA-J AM MED ASSOC, V276, P522, DOI DOI 10.1001/JAMA.1996.03540070018010; Virchow R, 1860, CELLULAR PATHOLOGY B, P383; Wang DQH, 1999, J LIPID RES, V40, P2066; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; World Health Organization, 1999, DEF DIAGN CLASS DI 1; Xu J, 2002, J NUTR, V132, P3333, DOI 10.1093/jn/132.11.3333; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; Young BA, 2005, J AM SOC NEPHROL, V16, P219, DOI 10.1681/ASN.2004030162	53	272	287	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32317	32325		10.1074/jbc.M500801200	http://dx.doi.org/10.1074/jbc.M500801200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16046411	hybrid			2022-12-27	WOS:000231794800035
J	Constable, JRL; Graham, ME; Morgan, A; Burgoyne, RD				Constable, JRL; Graham, ME; Morgan, A; Burgoyne, RD			Amisyn regulates exocytosis and fusion pore stability by both syntaxin-dependent and syntaxin-independent mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; MEMBRANE-FUSION; SNARE COMPLEX; SYNAPTIC VESICLES; CHROMAFFIN CELLS; ALPHA-SNAP; TOMOSYN; RELEASE; SECRETION; LAYER	Amisyn and tomosyn are related by the possession of a C-terminal vesicle-associated membrane protein- like domain that allows them to bind to syntaxin 1 and assemble into SNARE complexes. The formation of inactive complexes may sequester syntaxin and allow tomosyn and amisyn to act as inhibitors of exocytosis. We aimed to use adrenal chromaffin and PC12 cells to probe this possible mode of action of amisyn and tomosyn in dense core granule exocytosis. Although tomosyn is expressed by adrenal chromaffin and PC12 cells, amisyn expression could not be detected allowing examination of the effect of introduction of amisyn expression onto a neuronal-like background. Overexpression of m-tomosyn1 and expression of amisyn both inhibited Ca2+-induced exocytosis in transfected PC12 cells. Surprisingly, this inhibition was not removed when amisyn and tomosyn constructs were used in which key residues required for efficient binding to syntaxin1 were mutated. The effect of amisyn was further characterized using carbon fiber amperometry in chromaffin cells. Expression of amisyn had no effect on the basic characteristics of the amperometric spikes but reduced the number of spikes elicited. This inhibitory action on the extent of exocytosis was also seen with the amisyn mutant deficient in syntaxin1 binding. In addition, expression of amisyn resulted in an increase in the lifetime of the prespike foot, and this effect was abolished by the mutations. These results show that tomosyn and amisyn can negatively regulate exocytosis independently of syntaxin and also that amisyn can regulate the stability of the fusion pore.	Univ Liverpool, Sch Biomed Sci, Physiol Lab, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Burgoyne, RD (corresponding author), Univ Liverpool, Sch Biomed Sci, Physiol Lab, Crown St, Liverpool L69 3BX, Merseyside, England.	burgoyne@liv.ac.uk	Morgan, Alan/AAI-8875-2020; Burgoyne, Robert D/P-6641-2019; Burgoyne, Robert/C-6706-2008	Burgoyne, Robert D/0000-0002-9219-0387; Burgoyne, Robert/0000-0002-9219-0387; Morgan, Alan/0000-0002-0346-1289	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Archer DA, 2002, J BIOL CHEM, V277, P18249, DOI 10.1074/jbc.C200166200; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Barclay JW, 2003, J BIOL CHEM, V278, P10538, DOI 10.1074/jbc.M211114200; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; BURGOYNE RD, 1992, NEUROMETHODS, V20, P433; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Ciufo LF, 2005, MOL BIOL CELL, V16, P470, DOI 10.1091/mbc.E04-08-0685; CORCORAN JJ, 1984, J BIOL CHEM, V259, P6208; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Graham ME, 2000, J NEUROSCI, V20, P1281; Graham ME, 2000, BIOCHIMIE, V82, P469, DOI 10.1016/S0300-9084(00)00196-6; Graham ME, 2004, J BIOL CHEM, V279, P32751, DOI 10.1074/jbc.M400827200; Graham ME, 2001, J CELL SCI, V114, P4397; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; HOLGADO AM, 2004, W COAST WORM M; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; JANKOWSKI JA, 1992, J BIOL CHEM, V267, P18329; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Scales SJ, 2002, J BIOL CHEM, V277, P28271, DOI 10.1074/jbc.M204929200; Scales SJ, 2001, P NATL ACAD SCI USA, V98, P14262, DOI 10.1073/pnas.251547598; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Schroeder TJ, 1996, BIOPHYS J, V70, P1061, DOI 10.1016/S0006-3495(96)79652-2; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Wei SH, 2000, EMBO J, V19, P1279, DOI 10.1093/emboj/19.6.1279; WICK PF, 1993, J BIOL CHEM, V268, P10983; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Yokoyama S, 1999, BIOCHEM BIOPH RES CO, V256, P218, DOI 10.1006/bbrc.1999.0300	53	33	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31615	31623		10.1074/jbc.M505858200	http://dx.doi.org/10.1074/jbc.M505858200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16033762	hybrid			2022-12-27	WOS:000231665200036
J	Kubo, S; Nemani, VM; Chalkley, RJ; Anthony, MD; Hattori, N; Mizuno, Y; Edwards, RH; Fortin, DL				Kubo, S; Nemani, VM; Chalkley, RJ; Anthony, MD; Hattori, N; Mizuno, Y; Edwards, RH; Fortin, DL			A combinatorial code for the interaction of alpha-synuclein with membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY BODY DEMENTIA; PARKINSONS-DISEASE; LIPID RAFTS; FATTY-ACIDS; HIPPOCAMPAL-NEURONS; SRC-FAMILY; PROTEIN; CELLS; MUTATION; BINDING	Considerable genetic and pathological evidence has implicated the small, soluble protein alpha-synuclein in the pathogenesis of familial and sporadic forms of Parkinsons disease (PD). However, the precise role of alpha-synuclein in the disease process as well as its normal function remain poorly understood. We recently found that an interaction with lipid rafts is crucial for the normal, pre-synaptic localization of alpha-synuclein. To understand how alpha-synuclein interacts with lipid rafts, we have now developed an in vitro binding assay to rafts purified from native membranes. Recapitulating the specificity observed in vivo, recombinant wild type but not PD-associated A30P mutant alpha-synuclein binds to lipid rafts isolated from cultured cells and purified synaptic vesicles. Proteolytic digestion of the rafts does not disrupt the binding of alpha-synuclein, indicating an interaction with lipid rather than protein components of these membranes. We have also found that alpha-synuclein binds directly to artificial membranes whose lipid composition mimics that of lipid rafts. The binding of alpha-synuclein to these raft-like liposomes requires acidic phospholipids, with a preference for phosphatidylserine ( PS). Interestingly, a variety of synthetic PS with defined acyl chains do not support binding when used individually. Rather, the interaction with alpha-synuclein requires a combination of PS with oleic ( 18: 1) and polyunsaturated ( either 20: 4 or 22: 6) fatty acyl chains, suggesting a role for phase separation within the membrane. Furthermore, alpha-synuclein binds with higher affinity to artificial membranes with the PS head group on the polyunsaturated fatty acyl chain rather than on the oleoyl side chain, indicating a stringent combinatorial code for the interaction of alpha-synuclein with membranes.	Univ Calif San Francisco, Sch Med, Dept Neurol & Physiol, Grad Program Biomed Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Neurol & Physiol, Grad Program Cell Biol & Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, Mass Spectrometry Facil, San Francisco, CA 94143 USA; Juntendo Univ, Sch Med, Dept Neurol, Tokyo 1138421, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Juntendo University	Edwards, RH (corresponding author), Univ Calif San Francisco, Sch Med, Dept Neurol & Physiol, Grad Program Biomed Sci, 600 16th St,GH-N272B, San Francisco, CA 94143 USA.	edwards@itsa.ucsf.edu		Nemani, Venu/0000-0001-8895-7090; Chalkley, Robert/0000-0002-9757-7302	NCRR NIH HHS [RR014606] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014606] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ahn BH, 2002, J BIOL CHEM, V277, P12334, DOI 10.1074/jbc.M110414200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Ellis CE, 2001, J BIOL CHEM, V276, P3879, DOI 10.1074/jbc.M010316200; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hell J. W, 1994, CELL BIOL LAB HDB, P567; Higgins D., 1998, CULTURING NERVE CELL, P37; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nakamura T, 2002, FEBS LETT, V521, P190, DOI 10.1016/S0014-5793(02)02861-2; Nakamura T, 2001, BIOCHEM BIOPH RES CO, V280, P1085, DOI 10.1006/bbrc.2000.4253; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Veatch SL, 2003, BIOPHYS J, V84, P725, DOI 10.1016/S0006-3495(03)74891-7; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Withers GS, 1997, DEV BRAIN RES, V99, P87, DOI 10.1016/S0165-3806(96)00210-6; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	49	155	156	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31664	31672		10.1074/jbc.M504894200	http://dx.doi.org/10.1074/jbc.M504894200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16020543	hybrid			2022-12-27	WOS:000231665200042
J	Lee, ER; Kang, YJ; Kim, JH; Lee, HT; Cho, SG				Lee, ER; Kang, YJ; Kim, JH; Lee, HT; Cho, SG			Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; TRANSDUCTION PATHWAYS; CASPASE-3 CASCADE; DEPENDENT KINASE; OXIDATIVE STRESS; MAPK PATHWAYS; CYTOCHROME-C; CANCER CELLS; ACTIVATION; INHIBITION	The exact molecular mechanisms underlying the cellular effects associated with various flavonoids have yet to be fully explained. In the present study, we have administered several flavonoids to human HaCaT keratinocytes and determined that 3,4'-dihydroxy flavone (3,4'-DHF) exerts a slight stimulatory effect on cell growth, although other flavonoids, including kaempferol, quercetin, and isorhamnetin, exhibited growth inhibitory properties. 3,4'-DHF was found to exert an anti-apoptotic effect on etoposide-induced cell death of HaCaT keratinocytes. We were also able to determine that sustained ERK activation was intimately associated with the etoposide-induced apoptosis of HaCaT cells, and treatment with 3,4'-DHF induced a significant suppression of etoposide-induced ERK activation, concomitant with the repression of poly(ADP-ribose) polymerase or the cleavage of pro-caspase 3. ERK overexpression significantly overrode the anti-apoptotic function of 3,4'-DHF, but this was not true of ERK-DN. Moreover, treatment with 3,4'-DHF resulted in the protection of cells from H2O2-induced cell death and exerted an apparent suppressive effect on the stress-induced generation of reactive oxygen species (ROS). Finally, we showed that 3,4'-DHF almost completely abolished kaempferol-induced apoptosis, coupled with a concomitant suppression of both intracellular ROS generation and the activation of ERK. Taken together, our data clearly indicate that a host of phytochemicals, including etoposide and a variety of flavonoids, differentially regulate the apoptosis of human HaCaT keratinocytes via the differential modulation of intracellular ROS production, coupled with the concomitant activation of the ERK signaling pathway. According to these results, we are able to conclude the distinct structure-activity relationship between several flavonoids.	Konkuk Univ, Dept Anim Biotechnol, Biomol Informat Ctr, Seoul 143701, South Korea; Konkuk Univ, Inst Biomed Sci & Technol, Seoul 143701, South Korea	Konkuk University; Konkuk University	Cho, SG (corresponding author), Konkuk Univ, Dept Anim Biotechnol, Biomol Informat Ctr, Seoul 143701, South Korea.	ssangoo@konkuk.ac.kr	Kim, Jung-Hyun/AAK-8795-2021	Kim, Jung-Hyun/0000-0001-7176-409X; Cho, Ssang-Goo/0000-0002-0968-7932				Aligiannis N, 2001, PLANTA MED, V67, P468, DOI 10.1055/s-2001-15807; Areias FM, 2001, BIOCHEM PHARMACOL, V62, P111, DOI 10.1016/S0006-2952(01)00621-9; Basu S, 1998, J BIOL CHEM, V273, P30419, DOI 10.1074/jbc.273.46.30419; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Cemeli E, 2004, ENVIRON MOL MUTAGEN, V44, P420, DOI 10.1002/em.20071; Chen YC, 2002, ARCH TOXICOL, V76, P351, DOI 10.1007/s00204-002-0346-6; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Cho SG, 2003, J CELL BIOL, V163, P71, DOI 10.1083/jcb.200303003; Cody V, 1988, Prog Clin Biol Res, V280, P29; Diker-Cohen T, 2003, ANN NY ACAD SCI, V1010, P350, DOI 10.1196/annals.1299.064; FIALKOW L, 1994, J BIOL CHEM, V269, P31234; Fu Y, 2004, BIOCHEM BIOPH RES CO, V322, P263, DOI 10.1016/j.bbrc.2004.07.094; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Hendriks JJA, 2003, BIOCHEM PHARMACOL, V65, P877, DOI 10.1016/S0006-2952(02)01609-X; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HERTOG MGL, 1993, NUTR CANCER, V20, P21, DOI 10.1080/01635589309514267; Hsu YL, 2004, BIOCHEM PHARMACOL, V67, P823, DOI 10.1016/j.bcp.2003.09.042; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Ko CH, 2005, BIOCHEM PHARMACOL, V69, P913, DOI 10.1016/j.bcp.2004.12.005; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lee K, 2002, FREE RADICAL BIO MED, V33, P1121, DOI 10.1016/S0891-5849(02)01000-6; LEE SH, 1995, BIOCHEM BIOPH RES CO, V213, P837, DOI 10.1006/bbrc.1995.2205; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Lenferink AEG, 2001, CANCER RES, V61, P6583; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Marshall C, 1999, CURR OPIN CELL BIOL, V11, P732, DOI 10.1016/S0955-0674(99)00044-7; MOODIE SA, 1994, TRENDS GENET, V10, P44, DOI 10.1016/0168-9525(94)90147-3; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Nguyen TTT, 2003, J CELL PHYSIOL, V197, P110, DOI 10.1002/jcp.10340; PLOTKIN LI, 2005, IN PRESS AM J PHYSL; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Ryoo K, 2004, J BIOL CHEM, V279, P43589, DOI 10.1074/jbc.M404359200; Rytomaa M, 2000, ONCOGENE, V19, P4461, DOI 10.1038/sj.onc.1203805; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shen SC, 2004, INT J CANCER, V108, P502, DOI 10.1002/ijc.11581; Shen SC, 2003, J CELL BIOCHEM, V89, P1044, DOI 10.1002/jcb.10559; Sheppard BC, 1999, CANCER, V85, P1454, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1454::AID-CNCR5>3.3.CO;2-R; Studzinski GP, 1999, INT REV CYTOL, V189, P1, DOI 10.1016/S0074-7696(08)61384-4; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Tantini B, 2004, AMINO ACIDS, V27, P207, DOI 10.1007/s00726-004-0101-9; Townsend KJ, 1998, ONCOGENE, V17, P1223, DOI 10.1038/sj.onc.1202035; Tran SEF, 2001, J BIOL CHEM, V276, P16484, DOI 10.1074/jbc.M010384200; van den Brink MRM, 1999, J BIOL CHEM, V274, P11178, DOI 10.1074/jbc.274.16.11178; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; WARD NE, 1995, J BIOL CHEM, V270, P8056, DOI 10.1074/jbc.270.14.8056; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang YL, 2000, CELL RES, V10, P169, DOI 10.1038/sj.cr.7290046; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	54	93	96	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31498	31507		10.1074/jbc.M505537200	http://dx.doi.org/10.1074/jbc.M505537200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16014620	hybrid			2022-12-27	WOS:000231665200021
J	Rider, SD; Cai, XM; Sullivan, WJ; Smith, AT; Radke, J; White, M; Zhu, G				Rider, SD; Cai, XM; Sullivan, WJ; Smith, AT; Radke, J; White, M; Zhu, G			The protozoan parasite Cryptosporidium parvum possesses two functionally and evolutionarily divergent replication protein a large subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; GENETIC COMPLEMENTATION; CRITHIDIA-FASCICULATA; BINDING-PROTEIN; LIFE-CYCLE; RPA; DISTINCT; APICOMPLEXAN; EXPRESSION; GENOME	Very little is known about protozoan replication protein A (RPA), a heterotrimeric complex critical for DNA replication and repair. We have discovered that in medically and economically important apicomplexan parasites, two unique RPA complexes may exist based on two different types of large subunit RPA1. In this study, we characterized the single-stranded DNA binding features of two distinct types (i.e. short and long) of RPA1 subunits from Cryptosporidium parvum (CpRPA1A and CpRPA1B). These two proteins differ from human RPA1 in their intrinsic single-stranded DNA binding affinity (K) and have significantly lower cooperativity (omega). We also identified the RPA2 and RPA3 subunits from C. parvum, the latter of which had yet to be reported to exist in any protozoan. Using fluorescence resonance energy transfer technology and pull-down assays, we confirmed that these two subunits interact with each other and with CpRPA1A and CpRPA1B. This suggests that the heterotrimeric structure of RPA complexes may be universally conserved from lower to higher eukaryotes. Bioinformatic analyses indicate that multiple types of RPA1 are present in the other apicomplexans Plasmodium and Toxoplasma. Apicomplexan RPA1 proteins are phylogenetically more related to plant homologues and probably arose from a single gene duplication event prior to the expansion of the apicomplexan lineage. Differential expression during the life cycle stages in three apicomplexan parasites suggests that the two RPA1 types exercise specialized biological functions.	Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA; Texas A&M Univ, Fac Genet Program, College Stn, TX 77843 USA; Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Indiana University System; Indiana University-Purdue University Indianapolis; Montana State University System; Montana State University Bozeman	Zhu, G (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, 4467 TAMU, College Stn, TX 77843 USA.	gzhu@cvm.tamu.edu	ZHU, GUAN/GQB-0299-2022; ZHU, GUAN/D-8147-2011; White, Michael/A-4978-2012; Zhu, Guan/AFJ-2945-2022	ZHU, GUAN/0000-0003-3888-0659; Zhu, Guan/0000-0003-3888-0659	NIAID NIH HHS [U01 AI046397, R21 AI055278] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046397, R21AI055278] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; ACKERS GK, 1983, J MOL BIOL, V170, P223, DOI 10.1016/S0022-2836(83)80234-4; ARROWOOD MJ, 1987, J PARASITOL, V73, P314, DOI 10.2307/3282084; Belanger KD, 2004, J BIOL CHEM, V279, P43530, DOI 10.1074/jbc.M407641200; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkarev A, 1999, EMBO J, V18, P4498, DOI 10.1093/emboj/18.16.4498; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Bohne W, 1997, MOL BIOCHEM PARASIT, V88, P115, DOI 10.1016/S0166-6851(97)00087-X; BROWN GW, 1994, MOL BIOCHEM PARASIT, V63, P135, DOI 10.1016/0166-6851(94)90016-7; Brown LM, 1997, NUCLEIC ACIDS RES, V25, P3281, DOI 10.1093/nar/25.16.3281; Cai XM, 2005, EUKARYOT CELL, V4, P1211, DOI 10.1128/EC.4.7.1211-1220.2005; Chen XM, 2002, NEW ENGL J MED, V346, P1723, DOI 10.1056/NEJMra013170; Fayer R, 2000, INT J PARASITOL, V30, P1305, DOI 10.1016/S0020-7519(00)00135-1; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; HAUSMANN K, 1996, PROTOZOOLOGY, P87; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jackson D, 2002, J MOL BIOL, V321, P133, DOI 10.1016/S0022-2836(02)00541-7; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jullien D, 1999, EMBO J, V18, P4348, DOI 10.1093/emboj/18.15.4348; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; Kissinger JC, 2002, NATURE, V419, P490, DOI 10.1038/419490a; LAEMMLI UK, 1975, P NATL ACAD SCI USA, V72, P4288, DOI 10.1073/pnas.72.11.4288; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Liu C, 1999, INFECT IMMUN, V67, P3960, DOI 10.1128/IAI.67.8.3960-3969.1999; Millership JJ, 2004, MICROBIOL-SGM, V150, P1197, DOI 10.1099/mic.0.26833-0; Millership JJ, 2002, INT J PARASITOL, V32, P1477, DOI 10.1016/S0020-7519(02)00135-2; Radke JR, 2004, MOL MICROBIOL, V52, P93, DOI 10.1111/j.1365-2958.2003.03967.x; ROBERTSON LJ, 1993, PARASITOLOGY, V106, P13, DOI 10.1017/S003118200007476X; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Singh SB, 2002, J ORG CHEM, V67, P815, DOI 10.1021/jo016088w; Striepen B, 2002, P NATL ACAD SCI USA, V99, P6304, DOI 10.1073/pnas.092525699; Voss TS, 2002, J BIOL CHEM, V277, P17493, DOI 10.1074/jbc.M200100200; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zhu G, 1999, FEMS MICROBIOL LETT, V176, P367, DOI 10.1111/j.1574-6968.1999.tb13685.x; Zhu G, 1997, MOL BIOCHEM PARASIT, V90, P307, DOI 10.1016/S0166-6851(97)00168-0	40	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31460	31469		10.1074/jbc.M504466200	http://dx.doi.org/10.1074/jbc.M504466200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16014411	hybrid			2022-12-27	WOS:000231665200017
J	Bilton, R; Mazure, N; Trottier, E; Hattab, M; Dery, MA; Richard, DE; Pouyssegur, J; Brahimi-Horn, MC				Bilton, R; Mazure, N; Trottier, E; Hattab, M; Dery, MA; Richard, DE; Pouyssegur, J; Brahimi-Horn, MC			Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1 alpha and is not induced by hypoxia or HIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL ACETYLTRANSFERASE; FACTOR-L-ALPHA; GENE-EXPRESSION; HIF-1-ALPHA; FACTOR-1-ALPHA; IDENTIFICATION; TUBEDOWN-1; ARD1; HIF-2-ALPHA; INDUCTION	The hypoxia-inducible factor (HIF) is a key player in a transcriptional pathway that controls the hypoxic response of mammalian cells. Post-translational modification of the alpha subunit of HIF determines its half-life and activity. Among the multiple reported modifications, acetylation, by an acetyltransferase termed arrest-defective-1 protein (ARD1), has been reported to decrease HIF-1 alpha stability and therefore impact on hypoxic gene expression. In contrast, we report that both overexpression and silencing of ARD1 had no impact on the stability of HIF-1 alpha or -2 alpha and that cells silenced for ARD1 maintained hypoxic nuclear localization of HIF-1 alpha. In addition, we show that the ARD1 mRNA and protein levels are not regulated by hypoxia in several human tumor cell lines, including cervical adenocarcinoma HeLa cells, fibrosarcoma HT1080 cells, adenovirus-transformed human kidney HEK293 cells, and human breast cancer MCF-7 cells. Using two model systems ((a) wild-type and HIF-1 alpha-null mouse embryo fibroblasts and (b) HeLa cells silenced for HIF-1 alpha or -2 alpha by RNA interference), we demonstrate that the level of expression of the ARD1 protein is independent of HIF-1 alpha and -2 alpha. We also demonstrate that ARD1 is a stable, predominantly cytoplasmic protein expressed in a broad range of tissues, tumor cell lines, and endothelial cells. Taken together, our findings demonstrate that ARD1 has limited, if any, impact on the HIF signaling pathway.	CNRS, Inst Signal Dev Biol & Canc Res, UMR 6543, Ctr Antoine Lacassagne, F-06189 Nice, France; Hop Hotel Dieu, Ctr Rech, Quebec City, PQ G1R 2J6, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne	Brahimi-Horn, MC (corresponding author), CNRS, Inst Signal Dev Biol & Canc Res, UMR 6543, Ctr Antoine Lacassagne, 33 Ave Valombrose, F-06189 Nice, France.	brahimi@unice.fr	Richard, Darren E./K-6760-2019	Mazure, Nathalie/0000-0003-1350-7161; Richard, Darren/0000-0003-2690-0480; Bilton, Rebecca/0000-0003-1932-8957				Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Brahimi-Horn C, 2005, CELL SIGNAL, V17, P1, DOI 10.1016/j.cellsig.2004.04.010; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chun YS, 2003, CANCER RES, V63, P8700; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fisher TS, 2005, J BIOL CHEM, V280, P17749, DOI 10.1074/jbc.M412055200; Fluge O, 2002, ONCOGENE, V21, P5056, DOI 10.1038/sj.onc.1205687; Gendron RL, 2000, DEV DYNAM, V218, P300, DOI 10.1002/(SICI)1097-0177(200006)218:2<300::AID-DVDY5>3.0.CO;2-K; Gendron RL, 2001, INVEST OPHTH VIS SCI, V42, P3000; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kim JH, 2001, COMPOS INTERFACE, V7, P443, DOI 10.1163/156855400750262932; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lin SK, 2004, MOL PHARMACOL, V66, P612; Line A, 2002, BRIT J CANCER, V86, P1824, DOI 10.1038/sj.bjc.6600321; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Onesto C, 2004, J BIOL CHEM, V279, P34217, DOI 10.1074/jbc.M400219200; Paradis H, 2002, DEV BIOL, V249, P140, DOI 10.1006/dbio.2002.0757; PARK EC, 1992, EMBO J, V11, P2087, DOI 10.1002/j.1460-2075.1992.tb05267.x; Park SK, 2003, MOL CELL BIOL, V23, P4959, DOI 10.1128/MCB.23.14.4959-4971.2003; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Ryan HE, 2000, CANCER RES, V60, P4010; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Sheta EA, 2001, ONCOGENE, V20, P7624, DOI 10.1038/sj.onc.1204972; Sowter HM, 2003, CANCER RES, V63, P6130; Sugiura N, 2003, J BIOL CHEM, V278, P40113, DOI 10.1074/jbc.M301218200; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Vouret-Craviari V, 2002, J CELL SCI, V115, P2475; WHITEWAY M, 1985, CELL, V43, P483, DOI 10.1016/0092-8674(85)90178-3; Willis DM, 2002, J BIOL CHEM, V277, P37280, DOI 10.1074/jbc.M206482200	38	86	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31132	31140		10.1074/jbc.M504482200	http://dx.doi.org/10.1074/jbc.M504482200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994306	hybrid			2022-12-27	WOS:000231487800059
J	Christen, M; Christen, B; Folcher, M; Schauerte, A; Jenal, U				Christen, M; Christen, B; Folcher, M; Schauerte, A; Jenal, U			Identification and characterization of a cyclic di-GMP-specific phosphodiesterase and its allosteric control by GTP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETOBACTER-XYLINUM; CELLULOSE SYNTHESIS; BACILLUS-SUBTILIS; STRINGENT RESPONSE; BIOFILM FORMATION; DIGUANYLATE; PROTEIN; GGDEF; SPORULATION; REGULATOR	Cyclic diguanylic acid (c-di-GMP) is a global second messenger controlling motility and adhesion in bacterial cells. Synthesis and degradation of c-di-GMP is catalyzed by diguanylate cyclases (DGC) and c-di-GMP-specific phosphodiesterases (PDE), respectively. Whereas the DGC activity has recently been assigned to the widespread GGDEF domain, the enzymatic activity responsible for c-di-GMP cleavage has been associated with proteins containing an EAL domain. Here we show biochemically that CC3396, a GGDEF-EAL composite protein from Caulobacter crescentus is a soluble PDE. The PDE activity, which rapidly converts c-di-GMP into the linear dinucleotide pGpG, is confined to the C-terminal EAL domain of CC3396, depends on the presence of Mg2+ ions, and is strongly inhibited by Ca2+ ions. Remarkably, the associated GGDEF domain, which contains an altered active site motif (GEDEF), lacks detectable DGC activity. Instead, this domain is able to bind GTP and in response activates the PDE activity in the neighboring EAL domain. PDE activation is specific for GTP (K-D 4 mu M) and operates by lowering the K-m for c-di-GMP of the EAL domain to a physiologically significant level (420 nM). Mutational analysis suggested that the substrate-binding site (A-site) of the GGDEF domain is involved in the GTP-dependent regulatory function, arguing that a catalytically inactive GGDEF domain has retained the ability to bind GTP and in response can activate the neighboring EAL domain. Based on this we propose that the c-di-GMP-specific PDE activity is confined to the EAL domain, that GGDEF domains can either catalyze the formation of c-di-GMP or can serve as regulatory domains, and that c-di-GMP-specific phosphodiesterase activity is coupled to the cellular GTP level in bacteria.	Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland	University of Basel	Jenal, U (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.	urs.jenal@unibas.ch	Christen, Beat/AAC-2974-2021	Christen, Beat/0000-0002-9528-3685; Christen, Matthias/0000-0001-7724-4562				Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Bergara F, 2003, J BACTERIOL, V185, P3118, DOI 10.1128/JB.185.10.3118-3126.2003; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Bomchil N, 2003, J BACTERIOL, V185, P1384, DOI 10.1128/JB.185.4.1384-1390.2003; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; CHIAVEROTTI TA, 1981, J BACTERIOL, V145, P1463, DOI 10.1128/JB.145.3.1463-1465.1981; Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004; Conti M, 2000, PROG NUCLEIC ACID RE, V63, P1; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; D'Argenio DA, 2004, MICROBIOL-SGM, V150, P2497, DOI 10.1099/mic.0.27099-0; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; ELY B, 1991, METHOD ENZYMOL, V204, P372; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; FREESE E, 1979, J GEN MICROBIOL, V115, P193, DOI 10.1099/00221287-115-1-193; Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P543, DOI 10.1111/j.1462-2920.2004.00652.x; Garcia B, 2004, MOL MICROBIOL, V54, P264, DOI 10.1111/j.1365-2958.2004.04269.x; Guvener ZT, 2003, J BACTERIOL, V185, P5431, DOI 10.1128/JB.185.18.5431-5441.2003; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Johnson MR, 2005, MOL MICROBIOL, V55, P664, DOI 10.1111/j.1365-2958.2004.04419.x; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kirillina O, 2004, MOL MICROBIOL, V54, P75, DOI 10.1111/j.1365-2958.2004.04253.x; LOPEZ JM, 1979, BIOCHIM BIOPHYS ACTA, V587, P238, DOI 10.1016/0304-4165(79)90357-X; Lucas KA, 2000, PHARMACOL REV, V52, P375; OCHI K, 1987, J BACTERIOL, V169, P3608, DOI 10.1128/jb.169.8.3608-3616.1987; OCHI K, 1982, J BACTERIOL, V151, P1062, DOI 10.1128/JB.151.2.1062-1065.1982; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Spiers AJ, 2002, GENETICS, V161, P33; Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998; Thomas C, 2004, MICROBIOL-SGM, V150, P1031, DOI 10.1099/mic.0.26915-0; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7	41	358	372	2	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30829	30837		10.1074/jbc.M504429200	http://dx.doi.org/10.1074/jbc.M504429200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994307	hybrid			2022-12-27	WOS:000231487800023
J	Keilhack, H; David, FS; McGregor, M; Cantley, LC; Neel, BG				Keilhack, H; David, FS; McGregor, M; Cantley, LC; Neel, BG			Diverse biochemical properties of Shp2 mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GROWTH-FACTOR RECEPTOR; GENOTYPE-PHENOTYPE CORRELATION; NOONAN-SYNDROME; PTPN11 MUTATIONS; FUNCTIONAL-ANALYSIS; INSULIN-RECEPTOR; SH2 DOMAIN; ACTIVATION; LEUKEMIA	Mutations in the Src homology 2 ( SH2)- containing protein- tyrosine phosphatase Shp2 ( PTPN11) underlie half of the cases of the autosomal dominant genetic disorder Noonan syndrome, and somatic Shp2 mutations are found in several hematologic and solid malignancies. Earlier studies of small numbers of mutants suggested that disease- associated mutations cause constitutive ( SH2 binding- independent) activation and that cancer- associated mutants are more active than those associated with Noonan syndrome. We have characterized a larger panel of Shp2 mutants and find that this " activity- centric" model cannot explain the behaviors of all pathogenic Shp2 mutations. Instead, enzymatic, structural, and mathematical modeling analyses show that these mutants can affect basal activation, SH2 domain phosphopeptide affinity, and/ or substrate specificity to varying degrees. Furthermore, there is no absolute correlation between the mutants' extents of basal activation and the diseases they induce. We propose that activated mutants of Shp2 modulate signaling from specific stimuli to a subset of effectors and provide a theoretical framework for understanding the complex relationship between Shp2 activation, intracellular signaling, and pathology.	Beth Israel Deaconess Med Ctr, Canc Biol Program, Dept Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Serono Reprod Biol Res Inst, Rockland, MA 02370 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Neel, BG (corresponding author), Beth Israel Deaconess Med Ctr, Canc Biol Program, Dept Med, 330 Brookline Ave, Boston, MA 02215 USA.	bneel@bidmc.harvard.edu	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; David, Frank/0000-0002-8025-4427	NCI NIH HHS [R37CA49152] Funding Source: Medline; NHLBI NIH HHS [T32HL07627] Funding Source: Medline; NIGMS NIH HHS [R01GM56203] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA049152] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD S, 1993, P NATL ACAD SCI USA, V90, P2197, DOI 10.1073/pnas.90.6.2197; Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Cheng A, 2001, J BIOL CHEM, V276, P25848, DOI 10.1074/jbc.M009734200; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Ernst M, 2004, TRENDS GENET, V20, P23, DOI 10.1016/j.tig.2003.11.003; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; JOHANNES JM, 1995, PEDIATR HEMAT ONCOL, V12, P571, DOI 10.3109/08880019509030771; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; Kosaki K, 2002, J CLIN ENDOCR METAB, V87, P3529, DOI 10.1210/jc.87.8.3529; KRATZ CP, 2005, IN PRESS BLOOD; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; Loh ML, 2004, LEUKEMIA, V18, P1831, DOI 10.1038/sj.leu.2403492; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Maheshwari M, 2002, HUM MUTAT, V20, P298, DOI 10.1002/humu.10129; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Marino B, 1999, J PEDIATR-US, V135, P703, DOI 10.1016/S0022-3476(99)70088-0; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Musante L, 2003, EUR J HUM GENET, V11, P201, DOI 10.1038/sj.ejhg.5200935; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Niihori T, 2005, J HUM GENET, V50, P192, DOI 10.1007/s10038-005-0239-7; Noonan JA, 1999, J PEDIATR-US, V135, P667, DOI 10.1016/S0022-3476(99)70082-X; O'Reilly AM, 2000, MOL CELL BIOL, V20, P299, DOI 10.1128/MCB.20.1.299-311.2000; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Piao XH, 1996, P NATL ACAD SCI USA, V93, P14665, DOI 10.1073/pnas.93.25.14665; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Sarkozy A, 2003, J MED GENET, V40, P704, DOI 10.1136/jmg.40.9.704; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; Shimada H, 2004, LEUKEMIA, V18, P1142, DOI 10.1038/sj.leu.2403374; Side LE, 1997, J PEDIATR-US, V130, P857; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; SUGIMOTO S, 1994, J BIOL CHEM, V269, P13614; SUGIMOTO S, 1993, J BIOL CHEM, V268, P22771; Tartaglia M, 2004, CURR OPIN HEMATOL, V11, P44, DOI 10.1097/00062752-200401000-00007; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; WEISMANN CG, 2005, IN PRESS AM J MED GE; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Yoshida R, 2004, J CLIN ENDOCR METAB, V89, P3359, DOI 10.1210/jc.2003-032091; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	51	215	227	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30984	30993		10.1074/jbc.M504699200	http://dx.doi.org/10.1074/jbc.M504699200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15987685	hybrid			2022-12-27	WOS:000231487800041
J	Zhang, YW; Rudnick, G				Zhang, YW; Rudnick, G			Cysteine-scanning mutagenesis of serotonin transporter intracellular loop 2 suggests an alpha-helical conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REUPTAKE INHIBITORS; EXTERNAL LOOP; RAT-BRAIN; BINDING; CLONING; EXPRESSION; RECEPTORS; MECHANISM; DEPENDENCE; COMPLEX	Like other proteins involved in neurotransmitter transport, serotonin transporter (SERT) activity is regulated by multiple intracellular signal transduction pathways. The second intracellular loop (IL2) of SERT contains consensus sequences for cGMP-dependent protein kinase and protein kinase C. A 24-residue region of SERT including IL2, from Ile-270 through Ser-293, was analyzed by cysteine-scanning mutagenesis and chemical modification. 2-(Aminoethyl)methanethiosulfonate hydrobromide ( MTSEA) failed to inhibit serotonin transport or binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[I-125]iodophenyl)tropane (beta-CIT) in intact cells expressing these mutants, but it inactivated beta-CIT binding in membrane preparations. From the pattern of sensitivity, IL2 appears to extend from Trp-271 through Ile-290, a significantly longer region than that initially predicted by hydropathy analysis. Six mutants reacted with MTSEA much faster than the others, and the pattern of the more reactive mutations suggested that IL2 is in an alpha-helical conformation. Some of the mutants had significantly elevated transport rates, suggesting a possible mechanism for the regulation of SERT activity.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Rudnick, G (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	gary.rudnick@yale.edu		ZHANG, YUAN-WEI/0000-0002-4276-9251				Androutsellis-Theotokis A, 2001, J BIOL CHEM, V276, P45933, DOI 10.1074/jbc.M107462200; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; Hansra N, 2004, J NEUROSCI, V24, P4082, DOI 10.1523/JNEUROSCI.0664-04.2004; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; HUMPHREYS CJ, 1994, BIOCHEMISTRY-US, V33, P9118, DOI 10.1021/bi00197a014; Javitch JA, 1996, MOL PHARMACOL, V49, P692; Jones BJ, 2002, PHARMACOL BIOCHEM BE, V71, P555, DOI 10.1016/S0091-3057(01)00745-6; Keller PC, 2004, BIOCHEMISTRY-US, V43, P8510, DOI 10.1021/bi035971g; Kilic F, 2003, MOL PHARMACOL, V64, P440, DOI 10.1124/mol.64.2.440; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; MILLER KJ, 1994, J BIOL CHEM, V269, P27351; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; Murphy DL, 1998, J CLIN PSYCHIAT, V59, P4; Ozaki N, 2003, MOL PSYCHIATR, V8, P933, DOI 10.1038/sj.mp.4001365; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; RUDNICK G, 1991, MOL PHARMACOL, V40, P421; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; Rudnick G., 2002, TRANSMEMBRANE TRANSP, P125; Rudnick Gary, 2002, P25; Sato Y, 2004, J BIOL CHEM, V279, P22926, DOI 10.1074/jbc.M312194200; Sher L, 1999, J AFFECT DISORDERS, V53, P203, DOI 10.1016/S0165-0327(98)00194-3; Smits KM, 2004, MOL PSYCHIATR, V9, P433, DOI 10.1038/sj.mp.4001488; Stahl SM, 1998, J AFFECT DISORDERS, V51, P215, DOI 10.1016/S0165-0327(98)00221-3; Stephan MM, 1997, BIOCHEMISTRY-US, V36, P1322, DOI 10.1021/bi962150l; TATE CG, 1994, J BIOL CHEM, V269, P26303; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; WALL SC, 1993, MOL PHARMACOL, V43, P264; WALL SC, 1995, MOL PHARMACOL, V47, P544; Weizman A, 2000, Pharmacogenomics, V1, P335, DOI 10.1517/14622416.1.3.335; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	35	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30807	30813		10.1074/jbc.M504087200	http://dx.doi.org/10.1074/jbc.M504087200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994310	hybrid			2022-12-27	WOS:000231487800021
J	Bykov, VJN; Issaeva, N; Zache, N; Shilov, A; Hultcrantz, M; Bergman, J; Selivanova, G; Wiman, KG				Bykov, VJN; Issaeva, N; Zache, N; Shilov, A; Hultcrantz, M; Bergman, J; Selivanova, G; Wiman, KG			Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPROTECTIVE AMINOTHIOL WR1065; DNA-BINDING; PHOSPHATIDYLSERINE EXTERNALIZATION; CLINICAL-IMPLICATIONS; REDOX CONTROL; CANCER CELLS; LUNG-CANCER; IN-VITRO; MUTATIONS; RESTORATION	Reactivation of mutant p53 is likely to provide important benefits for treatment of chemotherapy- and radio-therapy-resistant tumors. We demonstrate here that the maleimide-derived molecule MIRA-1 can reactivate DNA binding and preserve the active conformation of mutant p53 protein in vitro and restore transcriptional transactivation to mutant p53 in living cells. MIRA-1 induced mutant p53-dependent cell death in different human tumor cells carrying tetracycline-regulated mutant p53. The structural analog MIRA-3 showed antitumor activity in vivo against human mutant p53-carrying tumor xenografts in SCID mice. The MIRA scaffold is a novel lead for the development of anticancer drugs specifically targeting mutant p53.	Karolinska Univ Hosp, Dept Oncol Pathol, Ctr Canc, Stockholm, Sweden; Karolinska Inst, MTC, SE-17177 Stockholm, Sweden; Inst Cytol & Genet, Novosibirsk 630090, Russia; Karolinska Inst, Dept Biosci, SE-14157 Huddinge, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Karolinska Institutet	Selivanova, G (corresponding author), Karolinska Univ Hosp, Dept Oncol Pathol, Ctr Canc, Stockholm, Sweden.	Galina.Selivanova@mtc.ki.se; Wiman@cck.ki.se	Wiman, Klas/AAB-8399-2021; Issaeva, Natalia/K-4577-2019	Wiman, Klas/0000-0002-7113-524X; Issaeva, Natalia/0000-0001-5483-6610; Selivanova, Galina/0000-0002-8698-4332; Nakade Bykov, Vladimir/0000-0002-7199-8942				BARTEK J, 1991, ONCOGENE, V6, P1699; Beroud C, 1998, NUCLEIC ACIDS RES, V26, P200, DOI 10.1093/nar/26.1.200; Bhanoori M, 2003, ONCOGENE, V22, P117, DOI 10.1038/sj.onc.1206065; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Buzek J, 2002, NUCLEIC ACIDS RES, V30, P2340, DOI 10.1093/nar/30.11.2340; Bykov VJN, 2003, EUR J CANCER, V39, P1828, DOI 10.1016/S0959-8049(03)00454-4; Bykov VJN, 2002, CARCINOGENESIS, V23, P2011, DOI 10.1093/carcin/23.12.2011; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Campling Barbara G, 2003, Methods Mol Med, V75, P53; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Elnemr A, 2000, INT J ONCOL, V16, P1111; Forsberg AJ, 2004, ANTIOXID REDOX SIGN, V6, P203, DOI 10.1089/152308604322899279; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Gadducci A, 2002, EUR J GYNAECOL ONCOL, V23, P390; Geisler S, 2003, CLIN CANCER RES, V9, P5582; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Hainaut P, 2001, ANTIOXID REDOX SIGN, V3, P611, DOI 10.1089/15230860152542961; Hamilton David, 2004, Curr Oncol Rep, V6, P116, DOI 10.1007/s11912-004-0023-4; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Honda T, 2004, CANCER GENE THER, V11, P249, DOI 10.1038/sj.cgt.7700684; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Nikolova PV, 2000, EMBO J, V19, P370, DOI 10.1093/emboj/19.3.370; North S, 2002, MOL CARCINOGEN, V33, P181, DOI 10.1002/mc.10038; Pluquet O, 2003, BIOCHEM PHARMACOL, V65, P1129, DOI 10.1016/S0006-2952(02)01655-6; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; Selivanova G, 1996, NUCLEIC ACIDS RES, V24, P3560, DOI 10.1093/nar/24.18.3560; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; Seo YR, 2002, P NATL ACAD SCI USA, V99, P14548, DOI 10.1073/pnas.212319799; Sherr C J, 2000, Harvey Lect, V96, P73; Sun XZ, 2003, ANTIOXID REDOX SIGN, V5, P655, DOI 10.1089/152308603770310338; Ueda S, 2002, ANTIOXID REDOX SIGN, V4, P405, DOI 10.1089/15230860260196209; Wang JJ, 1997, CHEMOTHERAPY, V43, P182, DOI 10.1159/000239557; Wang JJ, 2002, ANTI-CANCER DRUG, V13, P533, DOI 10.1097/00001813-200206000-00012	36	177	187	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30384	30391		10.1074/jbc.M501664200	http://dx.doi.org/10.1074/jbc.M501664200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15998635	hybrid			2022-12-27	WOS:000231362500050
J	Cain, SA; Baldock, C; Gallagher, J; Morgan, A; Bax, DV; Weiss, AS; Shuttleworth, CA; Kielty, CM				Cain, SA; Baldock, C; Gallagher, J; Morgan, A; Bax, DV; Weiss, AS; Shuttleworth, CA; Kielty, CM			Fibrillin-1 interactions with heparin - Implications for microfibril and elastic fiber assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TROPOELASTIN; DIVALENT-CATIONS; INTEGRIN BINDING; TERNARY COMPLEX; MARFAN-SYNDROME; CELL-ADHESION; IN-VIVO; SULFATE; PROTEIN; DOMAIN	Fibrillin-1 assembly into microfibrils and elastic fiber formation involves interactions with glycosaminoglycans. We have used BIAcore technology to investigate fibrillin-1 interactions with heparin and with heparin saccharides that are analogous to S-domains of heparan sulfate. We have identified four high affinity heparin-binding sites on fibrillin-1, localized three of these sites, and defined their binding kinetics. Heparin binding to the fibrillin-1 N terminus has particularly rapid kinetics. Hyaluronan and chondroitin sulfate did not interact significantly with fibrillin-1. Heparin saccharides with more than 12 monosaccharide units bound strongly to all four fibrillin-1 sites. Heparin did not inhibit fibrillin-1 N- and C-terminal interactions or RGD-dependent cell attachment, but heparin and MAGP-1 competed for binding to the fibrillin-1 N terminus, and heparin and tropoelastin competed for binding to a central fibrillin-1 sequence. By regulating these key interactions, heparin can profoundly influence microfibril and elastic fiber assembly.	Univ Manchester, Fac Life Sci, UK Ctr Tissue Engn, Manchester M13 9PT, Lancs, England; Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; Christie Hosp NHS Trust, Canc Res UK, Manchester M20 4BX, Lancs, England; Univ Manchester, Christie Hosp NHS Trust, Dept Med Oncol, Manchester M20 4BX, Lancs, England; Univ Sydney, Sch Mol & Microbial Biosci G08, Sydney, NSW 2006, Australia	University of Manchester; University of Manchester; Cancer Research UK; Christie NHS Foundation Trust; Christie Hospital; University of Manchester; Christie NHS Foundation Trust; Christie Hospital; University of Manchester; University of Sydney	Kielty, CM (corresponding author), Univ Manchester, Fac Life Sci, UK Ctr Tissue Engn, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	cay.kielty@manchester.ac.uk	Weiss, Anthony S/F-8103-2010; Weiss, Anthony S/GYV-0157-2022; Cain, Stuart A/G-2836-2017	Weiss, Anthony S/0000-0002-8106-4836; McGovern, Amanda/0000-0001-7727-3283; Cain, Stuart/0000-0001-8417-1058; Baldock, Clair/0000-0003-3497-1959				Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Blackhall FH, 2003, BIOCHEM J, V375, P131, DOI 10.1042/BJ20030730; Buczek-Thomas JA, 2002, J CELL PHYSIOL, V192, P294, DOI 10.1002/jcp.10135; Clarke AW, 2004, EUR J BIOCHEM, V271, P3085, DOI 10.1111/j.1432-1033.2004.04246.x; Gallagher JT, 2000, PROTEOGLYCANS STRUCT, P27; IMBERTY A, 1999, PERSPECTIVES STRUCTU, P392; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jemth P, 2002, J BIOL CHEM, V277, P30567, DOI 10.1074/jbc.M203404200; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Kielty CM, 1996, FEBS LETT, V386, P169, DOI 10.1016/0014-5793(96)00423-1; Kielty CM, 2002, J CELL SCI, V115, P2817; Kozel BA, 2004, MATRIX BIOL, V23, P23, DOI 10.1016/j.matbio.2004.02.004; Kramer KL, 2003, ANNU REV GENET, V37, P461, DOI 10.1146/annurev.genet.37.061103.090226; Kreuger J, 2002, EMBO J, V21, P6303, DOI 10.1093/emboj/cdf638; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; Lin GQ, 2002, J BIOL CHEM, V277, P50795, DOI 10.1074/jbc.M210611200; LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026; Marson A, 2005, J BIOL CHEM, V280, P5013, DOI 10.1074/jbc.M409029200; MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M; Mecham R. P., 1994, EXTRACELLULAR MATRIX, P281; Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nardella C, 2004, ANAL BIOCHEM, V332, P368, DOI 10.1016/j.ab.2004.05.050; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oh ES, 2004, MOL CELLS, V17, P181; Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Pfaff M, 1996, FEBS LETT, V384, P247, DOI 10.1016/0014-5793(96)00325-0; Quondamatteo F, 2002, MATRIX BIOL, V21, P637, DOI 10.1016/S0945-053X(02)00100-2; Reinboth B, 2002, J BIOL CHEM, V277, P3950, DOI 10.1074/jbc.M109540200; Reinhardt DP, 2000, J BIOL CHEM, V275, P2205, DOI 10.1074/jbc.275.3.2205; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; Ritty TM, 2003, BIOCHEM J, V375, P425, DOI 10.1042/BJ20030649; Robinson PN, 2001, CELL MOL LIFE SCI, V58, P1698, DOI 10.1007/PL00000807; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Segade F, 2002, J BIOL CHEM, V277, P11050, DOI 10.1074/jbc.M110347200; Smallridge RS, 2003, J BIOL CHEM, V278, P12199, DOI 10.1074/jbc.M208266200; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200; Trask BC, 2000, MOL BIOL CELL, V11, P1499, DOI 10.1091/mbc.11.5.1499; Wallis DD, 2003, J CELL BIOCHEM, V90, P641, DOI 10.1002/jcb.10657; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a	50	79	83	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30526	30537		10.1074/jbc.M501390200	http://dx.doi.org/10.1074/jbc.M501390200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15980072	hybrid			2022-12-27	WOS:000231362500067
J	Uttenweiler, A; Schwarz, H; Mayer, A				Uttenweiler, A; Schwarz, H; Mayer, A			Microautophagic vacuole invagination requires calmodulin in a Ca2+-independent function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST VACUOLE; PEROXISOME DEGRADATION; PICHIA-PASTORIS; VTC PROTEINS; CELL-GROWTH; H+-ATPASE; V-ATPASE; AUTOPHAGY; MUTANTS	Microautophagy is the uptake of cytosolic compounds by direct invagination of the vacuolar/lysosomal membrane. In Saccharomyces cerevisiae microautophagic uptake of soluble cytosolic proteins occurs via an autophagic tube, a highly specialized vacuolar membrane invagination. Autophagic tubes are topologically equivalent to the invaginations at multivesicular endosomes. At the tip of an autophagic tube, vesicles ( autophagic bodies) pinch off into the vacuolar lumen for degradation. In this study we have identified calmodulin (Cmd1p) as necessary for microautophagy. Temperature-sensitive mutants for Cmd1p displayed reduced frequencies of vacuolar tube formation and/or abnormal tube morphologies. Microautophagic vacuole invagination was sensitive to Cmd1p antagonists as well as to antibodies to Cmd1p. cmd1 mutants with substitutions in the Ca2+-binding domains showed full invagination activity, and vacuolar membrane invagination was independent of the free Ca2+ concentration. Thus, rather than acting as a calcium-triggered switch, Cmd1p has a constitutive Ca2+-independent role in the formation of autophagic tubes. Kinetic analysis indicates that calmodulin is required for autophagic tube formation rather than for the final scission of vesicles from the tip of the tube.	Univ Lausanne, Dept Biochim, CH-1066 Epalinges, Switzerland; Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany	University of Lausanne; Max Planck Society	Mayer, A (corresponding author), Univ Lausanne, Dept Biochim, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	andreas.mayer@unil.ch	Mayer, Andreas/AAE-4315-2020	Mayer, Andreas/0000-0001-6131-313X				BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; BACHS O, 1990, J BIOL CHEM, V265, P18595; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; BROCKERHOFF SE, 1992, J CELL BIOL, V118, P619, DOI 10.1083/jcb.118.3.619; BROCKERHOFF SE, 1994, J CELL BIOL, V124, P315, DOI 10.1083/jcb.124.3.315; Brodsky FM, 2002, TRAFFIC, V3, P1, DOI 10.1034/j.1600-0854.2002.30101.x; Burgoyne RD, 2003, BBA-MOL CELL RES, V1641, P137, DOI 10.1016/S0167-4889(03)00089-2; Cohen A, 1999, J BIOL CHEM, V274, P26885, DOI 10.1074/jbc.274.38.26885; COX JA, 1988, BIOCHEM J, V249, P621, DOI 10.1042/bj2490621; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; DUNN T, 1994, J BIOL CHEM, V269, P7273; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Gaunitz F, 1998, Methods Mol Biol, V107, P361; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; GEISER JR, 1993, MOL CELL BIOL, V13, P7913, DOI 10.1128/MCB.13.12.7913; HALACHMI D, 1989, FEBS LETT, V256, P55, DOI 10.1016/0014-5793(89)81717-X; HALACHMI D, 1993, FEBS LETT, V316, P73, DOI 10.1016/0014-5793(93)81739-M; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HOHENBERG H, 1994, J MICROSC-OXFORD, V175, P34, DOI 10.1111/j.1365-2818.1994.tb04785.x; Hutchins MU, 1999, J CELL SCI, V112, P4079; IIDA H, 1990, J BIOL CHEM, V265, P13391; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; KAO JPY, 1990, J CELL BIOL, V111, P183, DOI 10.1083/jcb.111.1.183; Kim J, 1999, MOL BIOL CELL, V10, P1337, DOI 10.1091/mbc.10.5.1337; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; KUBLER E, 1994, EMBO J, V13, P5539, DOI 10.1002/j.1460-2075.1994.tb06891.x; Kunz JB, 2004, J BIOL CHEM, V279, P9987, DOI 10.1074/jbc.M307905200; LUAN Y, 1987, J BIOCHEM-TOKYO, V102, P1531, DOI 10.1093/oxfordjournals.jbchem.a122201; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; MATSUURA I, 1991, J BIOCHEM-TOKYO, V109, P190, DOI 10.1093/oxfordjournals.jbchem.a123344; Mukaiyama H, 2004, MOL BIOL CELL, V15, P58, DOI 10.1091/mbc.e03-05-0340; Mukaiyama H, 2002, GENES CELLS, V7, P75, DOI 10.1046/j.1356-9597.2001.00499.x; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Muller O, 2003, J CELL SCI, V116, P1107, DOI 10.1242/jcs.00328; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; Muller O, 2001, EMBO J, V20, P5657, DOI 10.1093/emboj/20.20.5657; Noda T, 2002, TRENDS CELL BIOL, V12, P231, DOI 10.1016/S0962-8924(02)02278-X; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; OHYA Y, 1994, SCIENCE, V263, P963, DOI 10.1126/science.8310294; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Peters C, 2004, CELL, V119, P667, DOI 10.1016/j.cell.2004.11.023; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Sakai Y, 1998, J CELL BIOL, V141, P625, DOI 10.1083/jcb.141.3.625; Sattler T, 2000, J CELL BIOL, V151, P529, DOI 10.1083/jcb.151.3.529; Scott SV, 1998, CURR OPIN CELL BIOL, V10, P523, DOI 10.1016/S0955-0674(98)80068-9; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; STAROVASNIK MA, 1993, BIOCHEMISTRY-US, V32, P3261, DOI 10.1021/bi00064a008; STIRLING DA, 1994, EMBO J, V13, P4329, DOI 10.1002/j.1460-2075.1994.tb06753.x; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Stromhaug PE, 2001, J BIOL CHEM, V276, P42422, DOI 10.1074/jbc.M104087200; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tang FS, 2003, NATURE, V422, P87, DOI 10.1038/nature01453; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; Thumm M, 2000, MICROSC RES TECHNIQ, V51, P563, DOI 10.1002/1097-0029(20001215)51:6<563::AID-JEMT6>3.0.CO;2-8; TITORENKO VI, 1995, J BACTERIOL, V177, P357, DOI 10.1128/jb.177.2.357-363.1995; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; TUTTLE DL, 1993, EUR J CELL BIOL, V60, P283; TUTTLE DL, 1995, J CELL SCI, V108, P25; VEENHUIS M, 1983, ARCH MICROBIOL, V134, P193, DOI 10.1007/BF00407757; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wiech H, 1996, J BIOL CHEM, V271, P22453, DOI 10.1074/jbc.271.37.22453; Yazawa M, 1999, MOL CELL BIOCHEM, V190, P47, DOI 10.1023/A:1006951710440; Yuan WP, 1999, MOL BIOL CELL, V10, P1353, DOI 10.1091/mbc.10.5.1353; Zhang MJ, 1998, BIOCHEM CELL BIOL, V76, P313, DOI 10.1139/bcb-76-2-3-313	79	36	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33289	33297		10.1074/jbc.M506086200	http://dx.doi.org/10.1074/jbc.M506086200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16055436	hybrid			2022-12-27	WOS:000232058100024
J	Adair, JE; Kwon, Y; Dement, GA; Smerdon, MJ; Reeves, R				Adair, JE; Kwon, Y; Dement, GA; Smerdon, MJ; Reeves, R			Inhibition of nucleotide excision repair by high mobility group protein HMGA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR IIIA; RIBOSOMAL-RNA GENE; GROUP A1A PROTEIN; DNA-REPAIR; UV PHOTOPRODUCTS; POSITIONED NUCLEOSOME; DIMER FORMATION; BREAST-CANCER; THYMINE DIMER; DAMAGED DNA	The mammalian non-histone "high mobility group" A ( HMGA) proteins are the primary nuclear proteins that bind to the minor groove of AT-rich DNA. They may, therefore, influence the formation and/or repair of DNA lesions that occur in AT-rich DNA, such as cyclobutane pyrimidine dimers (CPDs) induced by UV radiation. Employing both stably transfected lines of human MCF7 cells containing tetracycline-regulated HMGA1 transgenes and primary Hs578T tumor cells, which naturally overexpress HMGA1 proteins, we have shown that cells overexpressing HMGA1a protein exhibit increased UV sensitivity. Moreover, we demonstrated that knockdown of intracellular HMGA1 concentrations via two independent methods abrogated this sensitivity. Most significantly, we observed that HMGA1a overexpression inhibited global genomic nucleotide excision repair of UV-induced CPD lesions in MCF-7 cells. Consistent with these findings in intact cells, DNA repair experiments employing Xenopus oocyte nuclear extracts and lesion-containing DNA substrates demonstrated that binding of HMGA1a markedly inhibits removal of CPDs in vitro. Furthermore, UV "photo-footprinting" demonstrated that CPD formation within a long run of Ts (T-18-tract) in a DNA substrate changes significantly when HMGA1 is bound prior to UV irradiation. Together, these results suggest that HMGA1 directly influences both the formation and repair of UV-induced DNA lesions in intact cells. These findings have important implications for the role that HMGA protein overexpression might play in the accumulation of mutations and genomic instabilities associated with many types of human cancers.	Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Smerdon, MJ (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	smerdon@mail.wsu.edu; reevesr@wsu.edu		Adair, Jennifer/0000-0003-4599-016X	NIEHS NIH HHS [ES02614] Funding Source: Medline; NIGMS NIH HHS [GM46352, GM71760, T-32 GM008336] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002614, R01ES002614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071760, T32GM008336, R01GM046352] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balajee AS, 2000, GENE, V250, P15, DOI 10.1016/S0378-1119(00)00172-4; Bespalov VA, 2001, ENVIRON MOL MUTAGEN, V38, P166, DOI 10.1002/em.1068; Birger Y, 2003, EMBO J, V22, P1665, DOI 10.1093/emboj/cdg142; Bohr VA, 1988, DNA REPAIR LABORATOR, V3, P347; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Conconi A, 1999, EMBO J, V18, P1387, DOI 10.1093/emboj/18.5.1387; Cordonnier AM, 1999, MUTAT RES-DNA REPAIR, V435, P111, DOI 10.1016/S0921-8777(99)00047-6; de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Diana F, 2001, J BIOL CHEM, V276, P11354, DOI 10.1074/jbc.M009521200; Douki T, 2000, J BIOL CHEM, V275, P11678, DOI 10.1074/jbc.275.16.11678; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P653; Frit P, 2002, MOL CELL, V10, P1391, DOI 10.1016/S1097-2765(02)00732-3; Gontijo AMDC, 2003, BIOCHIMIE, V85, P1133, DOI 10.1016/j.biochi.2003.10.018; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Hill DA, 1999, NUCLEIC ACIDS RES, V27, P2135, DOI 10.1093/nar/27.10.2135; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P10394, DOI 10.1073/pnas.91.22.10394; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; JOHN S, 1995, MOL CELL BIOL, V15, P1786; Kosmoski JV, 2001, P NATL ACAD SCI USA, V98, P10113, DOI 10.1073/pnas.181073398; Kwon YH, 2003, J BIOL CHEM, V278, P45451, DOI 10.1074/jbc.M308645200; KWON YH, 2005, IN PRESS MUTAT RES; LATHAM KA, 1994, ANN NY ACAD SCI, V726, P181, DOI 10.1111/j.1749-6632.1994.tb52813.x; LATHAM KA, 1994, ANN NY ACAD SCI, V726, P196; Li SS, 2000, METHODS, V22, P170, DOI 10.1006/meth.2000.1058; Liu XQ, 1997, BIOCHEMISTRY-US, V36, P13710, DOI 10.1021/bi9716736; Liu XQ, 2000, J BIOL CHEM, V275, P23729, DOI 10.1074/jbc.M002206200; LYAMICHEV V, 1991, NUCLEIC ACIDS RES, V19, P4491, DOI 10.1093/nar/19.16.4491; Malina J, 2002, CHEM BIOL, V9, P629, DOI 10.1016/S1074-5521(02)00134-5; Nacht M, 1999, CANCER RES, V59, P5464; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; NISSEN MS, 1995, J BIOL CHEM, V270, P4355, DOI 10.1074/jbc.270.9.4355; NISSEN MS, 1991, J BIOL CHEM, V266, P19945; Oda N, 1996, J BIOL CHEM, V271, P13816, DOI 10.1074/jbc.271.23.13816; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; Pfeifer GP, 1997, PHOTOCHEM PHOTOBIOL, V65, P270, DOI 10.1111/j.1751-1097.1997.tb08560.x; Reeves R, 1995, Prog Cell Cycle Res, V1, P339; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Reeves R, 1999, METHOD ENZYMOL, V304, P155; REEVES R, 1993, J BIOL CHEM, V268, P21137; Reeves R, 2000, MOL CELL BIOL, V20, P4666, DOI 10.1128/MCB.20.13.4666-4679.2000; Reeves R, 1996, BIOCHEMISTRY-US, V35, P5063, DOI 10.1021/bi952424p; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Reeves R, 2001, MOL CELL BIOL, V21, P575, DOI 10.1128/MCB.21.2.575-594.2001; SAMBROOK J, 1989, MOL CLONING LAB MANU, V2, P6; Schieferstein U, 1996, BIOCHEMISTRY-US, V35, P7705, DOI 10.1021/bi953011r; Shimizu M, 2000, EMBO J, V19, P3358, DOI 10.1093/emboj/19.13.3358; Smerdon MJ, 1999, PROG NUCLEIC ACID RE, V62, P227; SOLOMON MJ, 1986, P NATL ACAD SCI USA, V83, P1276, DOI 10.1073/pnas.83.5.1276; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Takaha N, 2002, CANCER RES, V62, P647; Tallini G, 1999, ADV ANAT PATHOL, V6, P237, DOI 10.1097/00125480-199909000-00001; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Tommasi S, 1996, BIOCHEMISTRY-US, V35, P15693, DOI 10.1021/bi962117z; Tornaletti S, 1999, BIOCHIMIE, V81, P139, DOI 10.1016/S0300-9084(99)80046-7; Treff NR, 2004, ONCOGENE, V23, P777, DOI 10.1038/sj.onc.1207167; Vichi P, 1997, EMBO J, V16, P7444, DOI 10.1093/emboj/16.24.7444; Wang D, 2003, BIOCHEMISTRY-US, V42, P6747, DOI 10.1021/bi034264k; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046; Wood LJ, 2000, CANCER RES, V60, P4256; YOON C, 1988, P NATL ACAD SCI USA, V85, P6332, DOI 10.1073/pnas.85.17.6332	61	41	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32184	32192		10.1074/jbc.M505600200	http://dx.doi.org/10.1074/jbc.M505600200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16033759	hybrid			2022-12-27	WOS:000231794800019
J	Mazerbourg, S; Sangkuhl, K; Luo, CW; Sudo, S; Klein, C; Hsueh, AJW				Mazerbourg, S; Sangkuhl, K; Luo, CW; Sudo, S; Klein, C; Hsueh, AJW			Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MAD-RELATED PROTEIN; NEURAL CREST CELLS; ACTIVIN RECEPTOR; I RECEPTOR; ROOF PLATE; FUNCTIONAL-CHARACTERIZATION; EXPRESSION CLONING; MESODERM INDUCTION; MEMBER	There are more than 30 human transforming growth factor beta/bone morphogenetic protein/growth differentiation factor (TGF beta/BMP/GDF)-related ligands known to be important during embryonic development, organogenesis, bone formation, reproduction, and other physiological processes. Although select TGF beta/BMP/GDF proteins were found to interact with type II and type I serine/threonine receptors to activate downstream Smad and other proteins, the receptors and signaling pathways for one-third of these TGF beta/BMP/GDF paralogs are still unclear. Based on a genomic analysis of the entire repertoire of TGF beta/BMP/GDF ligands and serine/threonine kinase receptors, we tested the ability of three orphan BMP/GDF ligands to activate a limited number of phylogenetically related receptors. We characterized the dimeric nature of recombinant GDF6 ( also known as BMP13), GDF7 ( also known as BMP12), and BMP10. We demonstrated their bioactivities based on the activation of Smad1/5/8-, but not Smad2/3-, responsive promoter constructs in the MC3T3 cell line. Furthermore, we showed their ability to induce the phosphorylation of Smad1, but not Smad2, in these cells. In COS7 cells transfected with the seven known type I receptors, overexpression of ALK3 or ALK6 conferred ligand signaling by GDF6, GDF7, and BMP10. In contrast, transfection of MC3T3 cells with ALK3 small hairpin RNA suppressed Smad signaling induced by all three ligands. Based on the coevolution of ligands and receptors, we also tested the role of BMPRII and ActRIIA as the type II receptor candidates for the three orphan ligands. We found that transfection of small hairpin RNA for BMPRII and ActRIIA in MC3T3 cells suppressed the signaling of GDF6, GDF7, and BMP10. Thus, the present approach provides a genomic paradigm for matching paralogous polypeptide ligands with a limited number of evolutionarily related receptors capable of activating specific downstream Smad proteins.	Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Stanford, CA 94305 USA	Stanford University	Hsueh, AJW (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Stanford, CA 94305 USA.	aaron.hsueh@stanford.edu	Mazerbourg, Sabine/AAN-4958-2020		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD031398] Funding Source: NIH RePORTER; NICHD NIH HHS [U54 HD31398] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; Attisano L, 1996, MOL CELL BIOL, V16, P1066; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; BAARENDS WM, 1994, DEVELOPMENT, V120, P189; Bianco C, 2002, MOL CELL BIOL, V22, P2586, DOI 10.1128/MCB.22.8.2586-2597.2002; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; CAMERON VA, 1994, ENDOCRINOLOGY, V134, P799, DOI 10.1210/en.134.2.799; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Chang CB, 1999, DEVELOPMENT, V126, P3347; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Chen YG, 1999, J BIOL CHEM, V274, P3672, DOI 10.1074/jbc.274.6.3672; Cheng SK, 2004, PLOS BIOL, V2, P215, DOI 10.1371/journal.pbio.0020030; Cheng SK, 2003, GENE DEV, V17, P31, DOI 10.1101/gad.1041203; Chuen FS, 2004, J HISTOCHEM CYTOCHEM, V52, P1151, DOI 10.1369/jhc.3A6232.2004; Clarke TR, 2001, MOL ENDOCRINOL, V15, P946, DOI 10.1210/me.15.6.946; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; Danila DC, 2002, J CLIN ENDOCR METAB, V87, P4741, DOI 10.1210/jc.2002-020527; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; DICLEMENTE N, 1994, MOL ENDOCRINOL, V8, P1006, DOI 10.1210/me.8.8.1006; Ebisawa T, 1999, J CELL SCI, V112, P3519; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Fu SC, 2003, LIFE SCI, V72, P2965, DOI 10.1016/S0024-3205(03)00169-3; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Inada M, 1996, BIOCHEM BIOPH RES CO, V222, P317, DOI 10.1006/bbrc.1996.0742; Ishisaki A, 1999, J BIOL CHEM, V274, P13637, DOI 10.1074/jbc.274.19.13637; Itoh S, 1998, J BIOL CHEM, V273, P29195, DOI 10.1074/jbc.273.44.29195; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; Jornvall H, 2001, J BIOL CHEM, V276, P5140, DOI 10.1074/jbc.M005200200; Josso N, 2001, MOL CELL ENDOCRINOL, V179, P25, DOI 10.1016/S0303-7207(01)00467-1; Kaivo-Oja N, 2003, J CLIN ENDOCR METAB, V88, P755, DOI 10.1210/jc.2002-021317; Kaivo-Oja N, 2005, J CLIN ENDOCR METAB, V90, P271, DOI 10.1210/jc.2004-1288; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LIU F, 1995, MOL CELL BIOL, V15, P3479; Lo LC, 2005, P NATL ACAD SCI USA, V102, P7192, DOI 10.1073/pnas.0502581102; Lutz M, 2002, CELL SIGNAL, V14, P977, DOI 10.1016/S0898-6568(02)00058-X; Lux A, 1999, J BIOL CHEM, V274, P9984, DOI 10.1074/jbc.274.15.9984; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MATHEWS LS, 1992, SCIENCE, V255, P1702, DOI 10.1126/science.1313188; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P653, DOI 10.1210/me.2003-0393; Monteiro RM, 2004, J CELL SCI, V117, P4653, DOI 10.1242/jcs.01337; Moore RK, 2003, J BIOL CHEM, V278, P304, DOI 10.1074/jbc.M207362200; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Nakahara T, 2003, CELL SIGNAL, V15, P181, DOI 10.1016/S0898-6568(02)00088-8; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Neuhaus H, 1999, MECH DEVELOP, V80, P181, DOI 10.1016/S0925-4773(98)00221-4; Nishimatsu S, 1998, MECH DEVELOP, V74, P75, DOI 10.1016/S0925-4773(98)00070-7; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; NOHNO T, 1995, J BIOL CHEM, V270, P22522, DOI 10.1074/jbc.270.38.22522; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; RISSI M, 1995, MECH DEVELOP, V49, P223, DOI 10.1016/0925-4773(94)00320-M; Roh JS, 2003, ENDOCRINOLOGY, V144, P172, DOI 10.1210/en.2002-220618; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Sammar M, 2004, GENES CELLS, V9, P1227, DOI 10.1111/j.1365-2443.2004.00799.x; Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590; Settle S, 2001, DEV BIOL, V234, P138, DOI 10.1006/dbio.2001.0244; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Somi S, 2004, ANAT REC PART A, V279A, P579, DOI 10.1002/ar.a.20052; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Stottmann RW, 2004, DEVELOPMENT, V131, P2205, DOI 10.1242/dev.01086; Suzuki A, 1997, BIOCHEM BIOPH RES CO, V232, P153, DOI 10.1006/bbrc.1997.6219; Teichmann U, 2004, DEV GENES EVOL, V214, P96, DOI 10.1007/s00427-003-0380-2; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; TENDIJKE P, 1993, ONCOGENE, V8, P2879; Visser JA, 2001, MOL ENDOCRINOL, V15, P936, DOI 10.1210/me.15.6.936; Vitt UA, 2002, BIOL REPROD, V67, P473, DOI 10.1095/biolreprod67.2.473; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Watanabe R, 1999, BIOCHEM BIOPH RES CO, V254, P707, DOI 10.1006/bbrc.1998.0118; Wiater E, 2003, J BIOL CHEM, V278, P7934, DOI 10.1074/jbc.M209710200; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; YAMAJI N, 1994, BIOCHEM BIOPH RES CO, V205, P1944, DOI 10.1006/bbrc.1994.2898; YAMASHITA H, 1994, J BIOL CHEM, V269, P20172; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zhang DM, 1998, J NEUROSCI, V18, P3314	100	83	95	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32122	32132		10.1074/jbc.M504629200	http://dx.doi.org/10.1074/jbc.M504629200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16049014	hybrid			2022-12-27	WOS:000231794800012
J	Reynolds, PR; Hoidal, JR				Reynolds, PR; Hoidal, JR			Temporal-spatial expression and transcriptional regulation of alpha(7) nicotinic acetylcholine receptor by thyroid transcription factor-1 and early growth response factor-1 during murine lung development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY EPITHELIAL-CELLS; ENHANCER-BINDING PROTEIN; NICOTINIC RECEPTORS; FUNCTIONAL-CHARACTERIZATION; FACTOR EGR-1; MORPHOGENESIS; EXPOSURE; TTF-1; GENE; DIFFERENTIATION	Nicotinic acetylcholine receptors are ligand-gated ion channels formed by five homologous subunits that are involved in processes including signal transduction, proliferation, and apoptosis. The developmental role of these receptors, however, is unclear. In the present investigation, alpha(7) nicotinic acetylcholine receptor expression was assessed by immunohistochemistry in mouse lungs from embryonic day (E)13.5 to postnatal day (PN)20. Transcriptional mechanisms that regulate alpha(7) were assessed by the transfection of murine bronchiolar cells with a reporter containing 1.1 kb of the mouse alpha(7) promoter, TTF- 1, and Egr- 1. alpha(7) was initially detected at E13.5 in pulmonary mesenchymal cells and in the epithelium of the primitive tubules at E15.5. From E18.5 to PN1, alpha(7) was expressed in conducting airway and saccule epithelial cells. By PN10, expression was observed in the peripheral epithelium and on luminal membranes of bronchiolar epithelial cells in the proximal lung, a pattern that continued through PN20. From E15.5 to PN20, type II alveolar cells expressed both prosurfactant protein C and alpha(7). From E18.5 to PN20, Clara cells in the bronchiolar epithelium co-expressed Clara cell secretory protein and alpha(7). TTF-1 dose-dependently activated alpha(7) transcription in vitro by binding specific TTF- 1 regulatory elements in the mouse alpha(7) promoter. Furthermore, alpha(7) was not detected in TTF-1-null mice and markedly increased in TTF-1-overexpressing mice. Conversely, Egr-1 inhibited alpha(7) expression. Temporal-spatial alpha(7) expression supports the concept that these receptors function during normal pulmonary morphogenesis. A model is also supported whereby alpha(7) is induced by the essential pulmonary transcription factor TTF-1 and suppressed by Egr-1 during pulmonary development.	Univ Utah, Hlth Sci Ctr, Div Pulm, Dept Internal Med, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Hoidal, JR (corresponding author), 30N 1900 E,Rm 4C107 SOM, Salt Lake City, UT 84132 USA.	john.hoidal@hsc.utah.edu		Reynolds, Paul/0000-0002-0931-3025	NHLBI NIH HHS [HL72903, HL07636] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL072903] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; BENOWITZ NL, 1982, CLIN PHARMACOL THER, V32, P758, DOI 10.1038/clpt.1982.233; BENOWITZ NL, 1986, ANNU REV MED, V37, P21; Berger F, 1998, J NEUROSCI, V18, P6871; BERTRAND D, 1995, NEUROSCIENCES, V7, P75; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; Carrasco-Serrano C, 2000, J NEUROCHEM, V74, P932, DOI 10.1046/j.1471-4159.2000.0740932.x; CHAN J, 1993, NEUROSCIENCE, V56, P441, DOI 10.1016/0306-4522(93)90344-F; CODIGNOLA A, 1994, FEBS LETT, V342, P286, DOI 10.1016/0014-5793(94)80518-0; Criado M, 1997, J NEUROSCI, V17, P6554; Gahring LC, 2004, J COMP NEUROL, V468, P334, DOI 10.1002/cne.10943; GUAZZI S, 1990, EMBO J, V9, P3631, DOI 10.1002/j.1460-2075.1990.tb07574.x; HORYLEE F, 1995, J NEUROSCI, V15, P6453; Hsia Shao-Hsuan, 2003, Acta Paediatrica Taiwanica, V44, P150; Huang RP, 1997, J CELL BIOCHEM, V66, P489, DOI 10.1002/(SICI)1097-4644(19970915)66:4<489::AID-JCB8>3.0.CO;2-H; IKEGAMI M, 1992, TRENDS NEUROSCI, V155, P117; Kawai H, 2001, J NEUROCHEM, V78, P1367, DOI 10.1046/j.1471-4159.2001.00526.x; Keijzer R, 2001, DEVELOPMENT, V128, P503; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Lindstrom J, 1996, PROG BRAIN RES, V109, P125; LIPTON SA, 1988, SCIENCE, V239, P1293, DOI 10.1126/science.3344435; Maus ADJ, 1998, MOL PHARMACOL, V54, P779, DOI 10.1124/mol.54.5.779; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MIZUNO K, 1991, MOL CELL BIOL, V11, P4927, DOI 10.1128/MCB.11.10.4927; Nagavarapu U, 2001, J BIOL CHEM, V276, P16749, DOI 10.1074/jbc.M009712200; Okuda T, 2000, FEBS LETT, V484, P92, DOI 10.1016/S0014-5793(00)02134-7; Olale F, 1997, J PHARMACOL EXP THER, V283, P675; Perl AKT, 1999, CLIN GENET, V56, P14, DOI 10.1034/j.1399-0004.1999.560103.x; Proskocil BJ, 2004, ENDOCRINOLOGY, V145, P2498, DOI 10.1210/en.2003-1728; PUGH PC, 1994, J NEUROSCI, V14, P889; QUICK M, 1994, BRAIN RES, V655, P161; Sandberg K, 2004, PEDIATR RES, V56, P432, DOI 10.1203/01.PDR.0000136276.52104.61; Sekhon HS, 1999, J CLIN INVEST, V103, P637, DOI 10.1172/JCI5232; Sher E, 1998, ANN NY ACAD SCI, V841, P606, DOI 10.1111/j.1749-6632.1998.tb10993.x; SUKHATME VP, 1990, J AM SOC NEPHROL, V1, P859; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; TAGER IB, 1993, AM REV RESPIR DIS, V147, P811, DOI 10.1164/ajrccm/147.4.811; TAYLOR B, 1987, ARCH DIS CHILD, V62, P786, DOI 10.1136/adc.62.8.786; TREININ M, 1995, NEURON, V14, P871, DOI 10.1016/0896-6273(95)90231-7; Wang Y, 2001, MOL PHARMACOL, V60, P1201, DOI 10.1124/mol.60.6.1201; Wert SE, 2002, DEV BIOL, V242, P75, DOI 10.1006/dbio.2001.0540; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084; Zia S, 1997, RES COMMUN MOL PATH, V97, P243	46	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32548	32554		10.1074/jbc.M502231200	http://dx.doi.org/10.1074/jbc.M502231200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16033766	hybrid			2022-12-27	WOS:000231794800064
J	Xie, YX; Bezard, E; Zhao, BL				Xie, YX; Bezard, E; Zhao, BL			Investigating the receptor-independent neuroprotective mechanisms of nicotine in mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; CYTOCHROME-C RELEASE; COMPLEX-I; ELECTRON-TRANSPORT; RESPIRATORY-CHAIN; CELL-DEATH; OXIDATIVE STRESS; RAT-BRAIN; PYRIDINE-NUCLEOTIDES; DISTINCT MECHANISMS	Although nicotine has been associated with a decreased risk of developing Parkinson disease, the underlying mechanisms are still unclear. By using isolated brain mitochondria, we found that nicotine inhibited N-methyl-4-phenylpyridine (MPP+) and calcium-induced mitochondria high amplitude swelling and cytochrome c release from intact mitochondria. Intra-mitochondria redox state was also maintained by nicotine, which could be attributed to an attenuation of mitochondria permeability transition. Further investigation revealed that nicotine did not prevent MPP+- or calcium-induced mitochondria membrane potential loss, but instead decreased the electron leak at the site of respiratory chain complex I. In the presence of mecamylamine hydrochloride, a nonselective nicotinic acetylcholine receptor inhibitor, nicotine significantly postponed mitochondria swelling and cytochrome c release induced by a mixture of neurotoxins (MPP+ and 6- hydroxydopamine) in SH-SY5Y cells, suggesting that there is a receptor-independent nicotine-mediated neuroprotective effect of nicotine. These results show that interaction of nicotine with mitochondria respiratory chain together with its antioxidant effects should be considered in the neuroprotective effects of nicotine.	Acad Sinica, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; Univ Bordeaux 2, CNRS, UMR5543, F-33076 Bordeaux, France; Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhao, BL (corresponding author), Acad Sinica, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.	zhaobl@sun5.ibp.ac.cn	Bezard, Erwan/A-8173-2008; Bezard, Erwan/ABD-5153-2021	Xie, Yuxiang/0000-0002-8559-1967; Bezard, Erwan/0000-0002-0410-4638				Allam MF, 2002, REV NEUROLOGIA, V34, P686, DOI 10.33588/rn.3407.2001480; Alves G, 2004, MOVEMENT DISORD, V19, P1087, DOI 10.1002/mds.20117; Armstrong JS, 2003, J BIOL CHEM, V278, P49079, DOI 10.1074/jbc.M307841200; Armstrong JS, 2002, FASEB J, V16, P1263, DOI 10.1096/fj.02-0097fje; Aronis A, 2002, ANTIOXID REDOX SIGN, V4, P647, DOI 10.1089/15230860260220157; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; BEHMAND RA, 1992, J NEUROCHEM, V58, P776, DOI 10.1111/j.1471-4159.1992.tb09786.x; BENOWITZ NL, 1982, CLIN PHARMACOL THER, V32, P758, DOI 10.1038/clpt.1982.233; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Broekemeier KM, 1998, BIOCHEMISTRY-US, V37, P13059, DOI 10.1021/bi980820c; Brunner M, 2001, COMP BIOCHEM PHYS B, V128, P31, DOI 10.1016/S1096-4959(00)00315-8; Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0; Chan TS, 2002, FREE RADICAL RES, V36, P421, DOI 10.1080/10715760290021270; Chauvin C, 2001, J BIOL CHEM, V276, P41394, DOI 10.1074/jbc.M106417200; Chavez E, 1997, BIOCHEM MOL BIOL INT, V41, P961; Chernyak BV, 1996, EUR J BIOCHEM, V238, P623, DOI 10.1111/j.1432-1033.1996.0623w.x; Chernyak BV, 1997, BIOSCIENCE REP, V17, P293, DOI 10.1023/A:1027384628678; Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Cormier A, 2003, NEUROPHARMACOLOGY, V44, P642, DOI 10.1016/S0028-3908(03)00041-8; Cormier A, 2001, BRAIN RES, V900, P72, DOI 10.1016/S0006-8993(01)02254-5; DALE LC, 1995, JAMA-J AM MED ASSOC, V274, P1353, DOI 10.1001/jama.274.17.1353; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; EHRINGER H, 1960, KLIN WOCHENSCHR, V38, P1236, DOI 10.1007/BF01485901; Fonck C, 2003, BRAIN RES, V975, P214, DOI 10.1016/S0006-8993(03)02675-1; Fonck C, 2001, BRAIN RES, V905, P199, DOI 10.1016/S0006-8993(01)02551-3; Fontaine E, 1999, J BIOENERG BIOMEMBR, V31, P335, DOI 10.1023/A:1005475802350; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Gao WH, 2001, J CELL SCI, V114, P2855; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; Hirsch T, 1997, BIOSCIENCE REP, V17, P67, DOI 10.1023/A:1027339418683; Huang XX, 2001, MOL CELL BIOCHEM, V224, P1, DOI 10.1023/A:1011990300114; Jarvik ME, 2000, PHARMACOL BIOCHEM BE, V66, P553, DOI 10.1016/S0091-3057(00)00261-6; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lemasters JJ, 1997, BIOSCIENCE REP, V17, P281, DOI 10.1023/A:1027332611839; Leverve XM, 2001, IUBMB LIFE, V52, P221; Linert W, 1999, BBA-MOL BASIS DIS, V1454, P143, DOI 10.1016/S0925-4439(99)00029-0; Liu Q, 2003, APPL MAGN RESON, V24, P105, DOI 10.1007/BF03166682; Lotharius J, 1999, J NEUROSCI, V19, P1284; Maciel EN, 2004, J NEUROCHEM, V90, P1025, DOI 10.1111/j.1471-4159.2004.02565.x; Mazzio EA, 2004, BRAIN RES, V1004, P29, DOI 10.1016/j.brainres.2003.12.034; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; Newhouse P, 2004, CURR TOP MED CHEM, V4, P267, DOI 10.2174/1568026043451401; O'Neill MJ, 2002, CNS NEUROL DISORD-DR, V1, P399, DOI 10.2174/1568007023339166; PRYOR WA, 1992, FREE RADICAL BIO MED, V12, P365, DOI 10.1016/0891-5849(92)90085-U; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Quik M, 2002, NEUROTOXICOLOGY, V23, P581, DOI 10.1016/S0161-813X(02)00036-0; REED DJ, 1995, BBA-MOL BASIS DIS, V1271, P43, DOI 10.1016/0925-4439(95)00008-R; Ross GW, 2001, DRUG AGING, V18, P797, DOI 10.2165/00002512-200118110-00001; Salvi M, 2002, BBA-BIOENERGETICS, V1556, P187, DOI 10.1016/S0005-2728(02)00361-4; SAVAGE MK, 1994, BIOCHEM BIOPH RES CO, V200, P1615, DOI 10.1006/bbrc.1994.1636; Scarlett JL, 1996, BIOCHEM PHARMACOL, V52, P1047, DOI 10.1016/0006-2952(96)99426-5; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; SERSHEN H, 1986, NEUROPHARMACOLOGY, V25, P1231, DOI 10.1016/0028-3908(86)90140-1; Seyfried J, 2000, NEUROCHEM INT, V36, P489, DOI 10.1016/S0197-0186(99)00156-4; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Soto-Otero R, 2002, BIOCHEM PHARMACOL, V64, P125, DOI 10.1016/S0006-2952(02)01070-5; Stoltz M, 1996, J BIOL CHEM, V271, P25208, DOI 10.1074/jbc.271.41.25208; Yang CF, 2000, ARCH BIOCHEM BIOPHYS, V380, P319, DOI 10.1006/abbi.2000.1939; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200	60	43	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32405	32412		10.1074/jbc.M504664200	http://dx.doi.org/10.1074/jbc.M504664200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	15985439	hybrid			2022-12-27	WOS:000231794800046
J	Yang, H; Mergler, S; Sun, XC; Wang, Z; Lu, L; Bonanno, JA; Pleyer, U; Reinach, PS				Yang, H; Mergler, S; Sun, XC; Wang, Z; Lu, L; Bonanno, JA; Pleyer, U; Reinach, PS			TRPC4 knockdown suppresses epidermal growth factor-induced store-operated channel activation and growth in human corneal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CA2+ ENTRY; 2-AMINOETHOXYDIPHENYL BORATE; CALCIUM-CHANNELS; PATCH-CLAMP; MUSCLE-CELLS; CURRENTS; RECEPTOR; INFLUX; DEPLETION; PATHWAYS	Epidermal growth factor (EGF) in corneal epithelial cells stimulates proliferation by inducing capacitative calcium entry (CCE). However, neither the identity nor the mechanism of activation of the plasma membrane influx pathway that mediates CCE is known. Accordingly, we determined, in human corneal epithelial cells, whether or not (i) CCE is dependent upon stimulation of store-operated channel (SOC) activity, (ii) the canonical transient receptor potential (TRP) protein isoform TRPC4 is a component of such channels, and (iii) suppression of TRPC4 protein expression decreases EGF-induced stimulation of SOC activity and proliferation. The whole cell patch-clamp technique was used to monitor TRPC4-mediated stimulation of SOC activity following intracellular calcium store depletion and induction of CCE. TRPC4 small interfering RNA transfection suppressed TRPC4 protein expression. Reverse transcription-PCR and Western blot analysis were used to assess knockdown efficiency of mRNA and protein expression. [3H] Thymidine incorporation was used to evaluate EGF-induced mitogenesis. Ca2+ transients were measured by single-cell fluorescence imaging. TRPC4 knockdown decreased mRNA and protein expression by 89 and 87%, respectively. In these cells, EGF-induced SOC activation elicited by intracellular calcium store depletion was obviated; 2) EGF-induced CCE fell by 76%; 3) EGF-induced stimulation of SOC activity was eliminated; and 4) EGF-induced increases in proliferation fell by 54%. Thus, TRPC4 is a component of SOC in human corneal epithelial cells whose activation by EGF is requisite for an optimum mitogenic response to this growth factor.	SUNY, Coll Optometry, New York, NY 10036 USA; Charite, EyeCli, D-13353 Berlin, Germany; Indiana Univ, Sch Optometry, Bloomington, IN 47405 USA; Harbor UCLA Med Ctr, Div Mol Med, Torrance, CA 90502 USA	State University of New York (SUNY) System; SUNY Community College; SUNY Maritime College; SUNY Optometry; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Indiana University System; Indiana University Bloomington; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Reinach, PS (corresponding author), SUNY, Coll Optometry, 33 W 42nd St, New York, NY 10036 USA.	preinach@sunyopt.edu	Reinach, Peter/AAI-3582-2021	Mergler, Stefan/0000-0001-8608-648X	NATIONAL EYE INSTITUTE [R01EY004795, R01EY008834, R01EY012953, R24EY016661, R56EY004795] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY004795, EY04795, EY08834, R24 EY016661, EY1582, R01 EY008834, EY12953, R01 EY012953, R56 EY004795] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bradley JE, 2004, AM J PHYSIOL-CELL PH, V286, pC1078, DOI 10.1152/ajpcell.00463.2003; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Csutora P, 1999, P NATL ACAD SCI USA, V96, P121, DOI 10.1073/pnas.96.1.121; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Golovina VA, 2001, AM J PHYSIOL-HEART C, V280, pH746, DOI 10.1152/ajpheart.2001.280.2.H746; Gregory RB, 2001, BIOCHEM J, V354, P285, DOI 10.1042/0264-6021:3540285; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harks EGA, 2003, FASEB J, V17, P941, DOI 10.1096/fj.02-0786fje; Harteneck C, 2003, CELL CALCIUM, V33, P303, DOI 10.1016/S0143-4160(03)00043-5; Hobai IA, 2000, AM J PHYSIOL-HEART C, V279, pH692, DOI 10.1152/ajpheart.2000.279.2.H692; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Islam M, 2000, EXP EYE RES, V70, P261, DOI 10.1006/exer.1999.0783; KLYCE SD, 1977, INVEST OPHTH VIS SCI, V16, P968; Landsberg JW, 2004, NEWS PHYSIOL SCI, V19, P44, DOI 10.1152/nips.01457.2003; Larsson KP, 2005, J BIOL CHEM, V280, P1771, DOI 10.1074/jbc.M406073200; Lee YM, 2003, AM J PHYSIOL-GASTR L, V284, pG604, DOI 10.1152/ajpgi.00069.2002; Li WP, 2004, J BIOL CHEM, V279, P4570, DOI 10.1074/jbc.M304334200; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma R, 2001, J AM SOC NEPHROL, V12, P47, DOI 10.1681/ASN.V12147; McDaniel SS, 2001, AM J PHYSIOL-LUNG C, V280, pL870, DOI 10.1152/ajplung.2001.280.5.L870; Mergler S, 2005, EXP EYE RES, V80, P285, DOI 10.1016/j.exer.2004.09.012; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Ng LC, 2001, CIRC RES, V89, P923, DOI 10.1161/hh2201.100315; NILIUS B, 2004, SCI STKE, pPE36; Padar S, 2005, BIOCHEM PHARMACOL, V69, P1177, DOI 10.1016/j.bcp.2005.01.011; Petkov GV, 2001, ACTA PHYSIOL SCAND, V173, P257, DOI 10.1046/j.1365-201X.2001.00907.x; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1993, ENDOCR REV, V14, P610, DOI 10.1210/er.14.5.610; PUTNEY JW, 1993, CELL, V75, P199, DOI 10.1016/0092-8674(93)80061-I; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; RICH A, 1995, J MEMBRANE BIOL, V144, P177; Rychkov GY, 2005, CELL CALCIUM, V37, P183, DOI 10.1016/j.ceca.2004.09.001; Schindl R, 2002, J BIOL CHEM, V277, P26950, DOI 10.1074/jbc.M203700200; Skryma R, 2000, J PHYSIOL-LONDON, V527, P71, DOI 10.1111/j.1469-7793.2000.00071.x; Spassova MA, 2004, BBA-MOL CELL RES, V1742, P9, DOI 10.1016/j.bbamcr.2004.09.001; Sui GP, 2001, J UROLOGY, V165, P621, DOI 10.1097/00005392-200102000-00084; SUN X, 2004, BMC PHYSL; Sun XC, 2003, EXP EYE RES, V77, P287, DOI 10.1016/S0014-4835(03)00150-7; Sweeney M, 2002, AM J PHYSIOL-LUNG C, V283, pL144, DOI 10.1152/ajplung.00412.2001; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; van Rossum DB, 2000, J BIOL CHEM, V275, P28562, DOI 10.1074/jbc.M003147200; Venkatachalam K, 2004, NOVART FDN SYMP, V258, P185; VENKATACHALAM K, 2004, NOVART FDN SYMP, V258, P263; Venkatachalam Kartik, 2004, Novartis Found Symp, V258, P172; Voets T, 2001, J BIOL CHEM, V276, P47767, DOI 10.1074/jbc.C100607200; Wang XX, 2004, AM J PHYSIOL-CELL PH, V287, pC357, DOI 10.1152/ajpcell.00068.2004; Xu SZ, 2005, BRIT J PHARMACOL, V145, P405, DOI 10.1038/sj.bjp.0706197; Yang H, 2003, J MEMBRANE BIOL, V194, P47, DOI 10.1007/s00232-003-2025-9; Yang H, 2001, J MEMBRANE BIOL, V183, P93, DOI 10.1007/s00232-001-0057-6; Yu Y, 2003, AM J PHYSIOL-CELL PH, V284, pC316, DOI 10.1152/ajpcell.00125.2002; Zhang S, 2004, AM J PHYSIOL-CELL PH, V287, pC1192, DOI 10.1152/ajpcell.00158.2004; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333; Zweifach A, 1996, J GEN PHYSIOL, V107, P597, DOI 10.1085/jgp.107.5.597	63	70	75	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32230	32237		10.1074/jbc.M504553200	http://dx.doi.org/10.1074/jbc.M504553200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16033767	Green Accepted, hybrid			2022-12-27	WOS:000231794800024
J	Berke, SJS; Chai, YH; Marrs, GL; Wen, H; Paulson, HL				Berke, SJS; Chai, YH; Marrs, GL; Wen, H; Paulson, HL			Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR INCLUSION FORMATION; DEUBIQUITINATING ENZYMES; INTRANUCLEAR INCLUSIONS; PROTEASOME PATHWAY; BINDING; AGGREGATION; NEURODEGENERATION; UBIQUITYLATION; DEGRADATION; PROTEOLYSIS	Polyglutamine (polyQ) expansions cause neurodegeneration that is associated with protein misfolding and influenced by functional properties of the host protein. The polyQ disease protein, ataxin-3, has predicted ubiquitin-specific protease and ubiquitin-binding domains, which suggest that ataxin-3 functions in ubiquitin-dependent protein surveillance. Here we investigate direct links between the ubiquitin-proteasome pathway and ataxin-3. In neural cells we show that, through its ubiquitin interaction motifs (UIMs), normal or expanded ataxin-3 binds a broad range of ubiquitinated proteins that accumulate when the proteasome is inhibited. The expression of a catalytically inactive ataxin-3 (normal or expanded) causes ubiquitinated proteins to accumulate in cells, even in the absence of proteasome inhibitor. This accumulation of ubiquitinated proteins occurs primarily in the cell nucleus in transfected cells and requires intact UIMs in ataxin-3. We further show that both normal and expanded ataxin-3 can undergo oligoubiquitination. Although this post-translational modification occurs in a UIM-dependent manner, it becomes independent of UIMs when the catalytic cysteine residue of ataxin-3 is mutated, suggesting that ataxin-3 ubiquitination is itself regulated in trans by its own de-ubiquitinating activity. Finally, pulse-chase labeling reveals that ataxin-3 is degraded by the proteasome, with expanded ataxin-3 being as efficiently degraded as normal ataxin-3. Mutating the UIMs does not alter degradation, suggesting that UIM-mediated oligoubiquitination of ataxin-3 modulates ataxin-3 function rather than stability. The function of ataxin-3 as a de-ubiquitinating enzyme, its post-translational modification by ubiquitin, and its degradation via the proteasome link this polyQ protein to ubiquitin-dependent pathways already implicated in disease pathogenesis.	Univ Iowa, Dept Neurol, Paulson Lab, Iowa City, IA 52242 USA; Univ Iowa, Grad Program Neurosci, Iowa City, IA 52242 USA; Univ Iowa, Grad Program Genet, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Paulson, HL (corresponding author), Univ Iowa, Dept Neurol, Paulson Lab, 240 A EMRB, Iowa City, IA 52242 USA.	henry-paulson@uiowa.edu			NIA NIH HHS [TG32 AG 00214] Funding Source: Medline; NINDS NIH HHS [R01 NS38712, NS043076] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038712, F31NS043076] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albrecht M, 2003, PROTEINS, V50, P355, DOI 10.1002/prot.10280; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Berke SJS, 2003, CURR OPIN GENET DEV, V13, P253, DOI 10.1016/S0959-437X(03)00053-4; Bevivino AE, 2001, P NATL ACAD SCI USA, V98, P11955, DOI 10.1073/pnas.211305198; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chai YH, 2001, J BIOL CHEM, V276, P44889, DOI 10.1074/jbc.M106575200; Chow MKM, 2004, BIOCHEM BIOPH RES CO, V322, P387, DOI 10.1016/j.bbrc.2004.07.131; Chung CH, 1999, BIOCHEM BIOPH RES CO, V266, P633, DOI 10.1006/bbrc.1999.1880; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Kumada S, 2002, J NEUROPATH EXP NEUR, V61, P984, DOI 10.1093/jnen/61.11.984; La Spada AR, 2003, NEURON, V38, P681, DOI 10.1016/S0896-6273(03)00328-3; Li FS, 2002, J BIOL CHEM, V277, P45004, DOI 10.1074/jbc.M205259200; Marchal S, 2003, J BIOL CHEM, V278, P31554, DOI 10.1074/jbc.M304205200; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Schmidt T, 1998, BRAIN PATHOL, V8, P669, DOI 10.1111/j.1750-3639.1998.tb00193.x; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Shekhtman A, 2002, BIOCHEM BIOPH RES CO, V296, P1222, DOI 10.1016/S0006-291X(02)02006-5; Takahashi J, 2001, J NEUROPATH EXP NEUR, V60, P369, DOI 10.1093/jnen/60.4.369; Uchihara T, 2001, ACTA NEUROPATHOL, V102, P149; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Wing SS, 2003, INT J BIOCHEM CELL B, V35, P590, DOI 10.1016/S1357-2725(02)00392-8; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6	49	79	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					32026	32034		10.1074/jbc.M506084200	http://dx.doi.org/10.1074/jbc.M506084200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16040601	hybrid			2022-12-27	WOS:000231665200083
J	Wajih, N; Hutson, SM; Owen, J; Wallin, R				Wajih, N; Hutson, SM; Owen, J; Wallin, R			Increased production of functional recombinant human clotting factor IX by baby hamster kidney cells engineered to overexpress VKORC1, the vitamin K 2,3-epoxide-reducing enzyme of the vitamin K cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYLATION; EXPRESSION; WARFARIN; COAGULATION; ACTIVATION; PRECURSOR; REDUCTASE; FURIN	Some recombinant vitamin K-dependent blood coagulation factors ( factors VII, IX, and protein C) have become valuable pharmaceuticals in the treatment of bleeding complications and sepsis. Because of their vitamin K-dependent post-translational modification, their synthesis by eukaryotic cells is essential. The eukaryotic cell harbors a vitamin K-dependent gamma-carboxylation system that converts the proteins to gamma-carboxyglutamic acid-containing proteins. However, the system in eukaryotic cells has limited capacity, and cell lines over-expressing vitamin K-dependent clotting factors produce only a fraction of the recombinant proteins as fully gamma-carboxylated, physiologically competent proteins. In this work we have used recombinant human factor IX (r-hFIX)-producing baby hamster kidney (BHK) cells, engineered to stably overexpress various components of the gamma-carboxylation system of the cell, to determine whether increased production of functional r-hFIX can be accomplished. All BHK cell lines secreted r-hFIX into serum-free medium. Overexpression of gamma-carboxylase is shown to inhibit production of functional r-hFIX. On the other hand, cells overexpressing VKORC1,the reduced vitamin K cofactor-producing enzyme of the vitamin K-dependent gamma-carboxylation system, produced 2.9-fold more functional r-hFIX than control BHK cells. The data are consistent with the notion that VKORC1 is the rate-limiting step in the system and is a key regulatory protein in synthesis of active vitamin K-dependent proteins. The data suggest that overexpression of VKORC1 can be utilized for increased cellular production of recombinant vitamin K-dependent proteins.	Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University	Wallin, R (corresponding author), Wake Forest Univ, Sch Med, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	rwallin@wfubmc.edu	Wajih, Nadeem/GMW-6625-2022		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069331] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL69331] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERKNER KL, 1993, METHOD ENZYMOL, V222, P450; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BRISTOL JA, 1994, BIOCHEMISTRY-US, V33, P14136, DOI 10.1021/bi00251a024; Cain D, 1997, J BIOL CHEM, V272, P29068, DOI 10.1074/jbc.272.46.29068; Dahlback B, 2005, J INTERN MED, V257, P209, DOI 10.1111/j.1365-2796.2004.01444.x; DISCIPIO RG, 1978, J CLIN INVEST, V61, P1528, DOI 10.1172/JCI109073; Hallgren KW, 2002, BIOCHEMISTRY-US, V41, P15045, DOI 10.1021/bi026016e; Hedner U, 2001, SEMIN HEMATOL, V38, P43, DOI 10.1016/S0037-1963(01)90147-7; KAUFMAN RJ, 1986, J BIOL CHEM, V261, P9622; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; OUCHTERLONY O, 1948, ACTA PATHOL MIC SC, V25, P186; Preininger A, 1999, CYTOTECHNOLOGY, V30, P1, DOI 10.1023/A:1008030407679; REHEMTULLA A, 1993, P NATL ACAD SCI USA, V90, P4611, DOI 10.1073/pnas.90.10.4611; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Roth DA, 2001, BLOOD, V98, P3600, DOI 10.1182/blood.V98.13.3600; Wajih N, 2005, J BIOL CHEM, V280, P10540, DOI 10.1074/jbc.M413982200; Wallin R, 2004, TRENDS MOL MED, V10, P299, DOI 10.1016/j.molmed.2004.05.003; Wallin R, 2002, THROMB RES, V108, P221, DOI 10.1016/S0049-3848(03)00060-4; WALLIN R, 1977, BIOCHIM BIOPHYS ACTA, V491, P317, DOI 10.1016/0005-2795(77)90067-8; WASLEY LC, 1993, J BIOL CHEM, V268, P8458; WU GY, 1994, J NUTR, V124, P415, DOI 10.1093/jn/124.3.415; WU SM, 1991, SCIENCE, V254, P1634, DOI 10.1126/science.1749935	22	60	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31603	31607		10.1074/jbc.M505373200	http://dx.doi.org/10.1074/jbc.M505373200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16030016	hybrid			2022-12-27	WOS:000231665200034
J	Kuznetsova, SA; Day, AJ; Mahoney, DJ; Rugg, MS; Mosher, DF; Roberts, DD				Kuznetsova, SA; Day, AJ; Mahoney, DJ; Rugg, MS; Mosher, DF; Roberts, DD			The n-terminal module of thrombospondin-1 interacts with the link domain of TSG-6 and enhances its covalent association with the heavy chains of inter-alpha-trypsin inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-STIMULATED GENE-6; NECROSIS-FACTOR-ALPHA; BINDING PROTEIN TSG-6; SMOOTH-MUSCLE CELLS; COLLAGEN-INDUCED ARTHRITIS; INFLAMMATORY T-CELLS; HYALURONAN-BINDING; EXTRACELLULAR-MATRIX; IN-VIVO; HEPARIN-BINDING	We recently found that leukocytes from thrombospondin-1 (TSP1)-deficient mice exhibit significant reductions in cell surface CD44 relative to those from wild type mice. Because TSG-6 modulates CD44-mediated cellular interactions with hyaluronan, we examined the possibility that TSP1 interacts with TSG-6. We showed that recombinant full-length human TSG-6 (TSG-6Q) and the Link module of TSG-6 (Link_TSG6) bind I-125-TSP1 with comparable affinities. Trimeric recombinant constructs containing the N-modules of TSP1 or TSP2 inhibit binding of TSP1 to TSG-6Q and Link_TSG6, but other recombinant regions of TSP1 do not. Therefore, the N-modules of both TSP1 and TSP2 specifically recognize the Link module of TSG-6. Heparin, which binds to these domains of both proteins, strongly inhibits binding of TSP1 to Link_TSG6 and TSG-6Q, but hyaluronan does not. Inhibition by heparin results from its binding to TSP1, because heparin also inhibits TSP1 binding to Link_TSG6 mutants deficient in heparin binding. Removal of bound Ca2+ from TSP1 reduces its binding to full-length TSG-6. Binding of TSP1 to Link_TSG6, however, is enhanced by chelating divalent cations. In contrast, divalent cations do not influence binding of the N-terminal region of TSP1 to TSG-6Q. This implies that divalent cation dependence is due to conformational effects of calcium-binding to the C-terminal domains of TSP1. TSP1 enhances covalent modification of the inter-alpha-trypsin inhibitor by TSG-6 and transfer of its heavy chains to hyaluronan, suggesting a physiological function of TSP1 binding to TSG-6 in regulation of hyaluronan metabolism at sites of inflammation.	NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England; Univ Wisconsin, Dept Med, Madison, WI 53706 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; University of Wisconsin System; University of Wisconsin Madison	Roberts, DD (corresponding author), NCI, Pathol Lab, NIH, Bldg 10 Rm 2A33,10 Ctr Dr,MSC1500, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Day, Anthony/O-1658-2015; Roberts, David D./A-9699-2008	Day, Anthony/0000-0002-1415-3134; Roberts, David D./0000-0002-2481-2981	Intramural NIH HHS Funding Source: Medline; Medical Research Council [MC_U138274352] Funding Source: Medline; MRC [MC_U138274352] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [Z01SC009174, ZIASC009174, ZIASC009172, Z01SC009172] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Anilkumar N, 2002, J CELL SCI, V115, P2357; Bagavandoss P, 1998, J HISTOCHEM CYTOCHEM, V46, P1043, DOI 10.1177/002215549804600908; Barazi HO, 2002, J BIOL CHEM, V277, P42859, DOI 10.1074/jbc.M206849200; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Beckmann G, 1998, J MOL BIOL, V275, P725, DOI 10.1006/jmbi.1997.1510; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Bornstein P, 2004, INT J BIOCHEM CELL B, V36, P1115, DOI 10.1016/j.biocel.2004.01.012; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; Calzada MJ, 2004, J BIOL CHEM, V279, P41734, DOI 10.1074/jbc.M406267200; Calzada MJ, 2003, J BIOL CHEM, V278, P40679, DOI 10.1074/jbc.M302014200; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; DAY A, 2005, IN PRESS HYALURONAN; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; DIXIT VM, 1984, J BIOL CHEM, V259, P100; Doyen V, 2003, J EXP MED, V198, P1277, DOI 10.1084/jem.20030705; Engel MFM, 2002, J BIOL CHEM, V277, P10922, DOI 10.1074/jbc.M106005200; Flahaut C, 1998, BIOCHEM J, V333, P749, DOI 10.1042/bj3330749; Friedl P, 2000, Dev Immunol, V7, P249, DOI 10.1155/2000/56473; Fujimoto T, 2002, AM J PATHOL, V160, P1495, DOI 10.1016/S0002-9440(10)62575-8; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; GotisGraham I, 1997, ARTHRITIS RHEUM, V40, P1780, DOI 10.1002/art.1780401009; GUO NH, 1992, P NATL ACAD SCI USA, V89, P3040, DOI 10.1073/pnas.89.7.3040; Hannah BLA, 2003, J BIOL CHEM, V278, P8929, DOI 10.1074/jbc.M211185200; HOLLANDER Z, 1986, MOL IMMUNOL, V23, P927, DOI 10.1016/0161-5890(86)90122-7; HUANG SW, 1993, ALLERGY PROC, V14, P357, DOI 10.2500/108854193778774074; Hugo C, 2003, NEPHROL DIAL TRANSPL, V18, P1241, DOI 10.1093/ndt/gfg159; Jessen TE, 2004, OSTEOARTHR CARTILAGE, V12, P142, DOI 10.1016/j.joca.2003.10.004; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Kehlen A, 2003, ARTHRITIS RES THER, V5, pR186, DOI 10.1186/ar762; Koch AE, 1998, CLIN IMMUNOL IMMUNOP, V86, P199, DOI 10.1006/clin.1997.4480; KOCH AE, 1993, PATHOBIOLOGY, V61, P1, DOI 10.1159/000163752; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Krutzsch HC, 1999, J BIOL CHEM, V274, P24080, DOI 10.1074/jbc.274.34.24080; Kuznetsova SA, 2004, INT J BIOCHEM CELL B, V36, P1126, DOI 10.1016/j.biocel.2003.12.006; KUZNETSOVA SA, 2005, HYALURONAN ITS STRUC; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Lange-Asschenfeldt B, 2002, BLOOD, V99, P538, DOI 10.1182/blood.V99.2.538; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Lee RT, 2001, J BIOL CHEM, V276, P13847, DOI 10.1074/jbc.M010556200; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Li ZQ, 2001, J IMMUNOL, V166, P2427, DOI 10.4049/jimmunol.166.4.2427; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Mahoney DJ, 2004, ANAL BIOCHEM, V330, P123, DOI 10.1016/j.ab.2004.03.055; Mahoney DJ, 2001, J BIOL CHEM, V276, P22764, DOI 10.1074/jbc.M100666200; MANSFIELD PJ, 1994, J IMMUNOL, V153, P4219; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; Mindrescu C, 2000, ARTHRITIS RHEUM, V43, P2668, DOI 10.1002/1529-0131(200012)43:12<2668::AID-ANR6>3.0.CO;2-E; MISENHEIMER TM, 1995, J BIOL CHEM, V270, P1729, DOI 10.1074/jbc.270.4.1729; Misenheimer TM, 2000, J BIOL CHEM, V275, P40938, DOI 10.1074/jbc.M007022200; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; Petrik JJ, 2002, BIOL REPROD, V67, P1522, DOI 10.1095/biolreprod.102.007153; Pierson BA, 1996, BLOOD, V87, P180, DOI 10.1182/blood.V87.1.180.bloodjournal871180; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Riessen R, 1998, AM HEART J, V135, P357, DOI 10.1016/S0002-8703(98)70105-X; Roberts David D., 1994, Journal of Tissue Culture Methods, V16, P217, DOI 10.1007/BF01540654; Roberts DD, 1996, FASEB J, V10, P1183, DOI 10.1096/fasebj.10.10.8751720; Rodrigues RG, 2001, J BIOL CHEM, V276, P27913, DOI 10.1074/jbc.M009518200; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Savill J, 1997, BRIT MED BULL, V53, P491; Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X; Schor H, 2000, Dev Immunol, V7, P227, DOI 10.1155/2000/51902; Seidita G, 2000, CARCINOGENESIS, V21, P2203, DOI 10.1093/carcin/21.12.2203; Stenina OI, 2004, INT J BIOCHEM CELL B, V36, P1013, DOI 10.1016/j.biocel.2004.01.005; SUCHARD SJ, 1991, J IMMUNOL, V147, P651; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Vallejo AN, 2000, J IMMUNOL, V164, P2947, DOI 10.4049/jimmunol.164.6.2947; Vallejo AN, 2003, J IMMUNOL, V171, P1732, DOI 10.4049/jimmunol.171.4.1732; Vanguri VK, 2000, BIOCHEM J, V347, P469, DOI 10.1042/0264-6021:3470469; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; Wang Q, 2002, AM J PATHOL, V161, P2219, DOI 10.1016/S0002-9440(10)64498-7; Wisniewski Hans-Georg, 1996, Pfluegers Archiv European Journal of Physiology, V431, pR225, DOI 10.1007/BF02346350; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Ye L, 1997, CIRC RES, V81, P289, DOI 10.1161/01.RES.81.3.289; Yu HN, 2000, ARCH BIOCHEM BIOPHYS, V374, P13, DOI 10.1006/abbi.1999.1597; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	99	30	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30899	30908		10.1074/jbc.M500701200	http://dx.doi.org/10.1074/jbc.M500701200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16006654	Green Accepted, hybrid			2022-12-27	WOS:000231487800031
J	Nomikos, M; Blayney, LM; Larman, MG; Campbell, K; Rossbach, A; Saunders, CM; Swann, K; Lai, FA				Nomikos, M; Blayney, LM; Larman, MG; Campbell, K; Rossbach, A; Saunders, CM; Swann, K; Lai, FA			Role of phospholipase C-zeta domains in Ca2+-dependent phosphatidylinositol 4,5-bisphosphate hydrolysis and cytoplasmic Ca2+ oscillations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CYTOSOLIC SPERM FACTOR; MOUSE EGGS; SPATIOTEMPORAL DYNAMICS; CALCIUM OSCILLATIONS; PLC-ZETA; PARTHENOGENETIC ACTIVATION; INTRACELLULAR CALCIUM; MAMMALIAN EGGS; HAMSTER EGGS	The sperm- specific phospholipase C- xi( PLC xi) elicits fertilization-like Ca2+ oscillations and activation of embryo development when microinjected into mammalian eggs ( Saunders, C. M., Larman, M. G., Parrington, J., Cox, L. J., Royse, J., Blayney, L. M., Swann, K., and Lai, F. A. ( 2002) Development ( Camb.) 129, 3533 - 3544; Cox, L. J., Larman, M. G., Saunders, C. M., Hashimoto, K., Swann, K., and Lai, F. A. ( 2002) Reproduction 124, 611 - 623). PLC xi may represent the physiological stimulus for egg activation and development at mammalian fertilization. PLC xi is the smallest known mammalian PLC isozyme, comprising two EF hand domains, a C2 domain, and the catalytic X and Y core domains. To gain insight into PLC xi structure- function, we assessed the ability of PLC xi and a series of domain-deletion constructs to cause phosphatidylinositol 4,5- bisphosphate hydrolysis in vitro and also to generate cytoplasmic Ca2+ changes in intact mouse eggs. PLC xi and the closely related PLC xi 1 had similar Km values for phosphatidylinositol 4,5- bisphosphate, but PLC xi was around 100 times more sensitive to Ca2+ than was PLC delta 1. Notably, specific phosphatidylinositol 4,5- bisphosphate hydrolysis activity was retained in PLC xi constructs that had either EF hand domains or the C2 domain removed, or both. In contrast, Ca2+ sensitivity was greatly reduced when either one, or both, of the EF hand domains were absent, and the Hill coefficient was reduced upon deletion of the C2 domain. Microinjection into intact mouse eggs revealed that all domain- deletion constructs were ineffective at initiating Ca2+ oscillations. These data suggest that the exquisite Ca2+ - dependent features of PLC xi regulation are essential for it to generate inositol 1,4,5-trisphosphate and Ca2+ oscillations in intact mouse eggs.	Cardiff Univ, Sch Med, Wales Heart Res Inst, Cell Signalling Lab, Cardiff CF14 4XN, Wales; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Cardiff Univ, Sch Med, Dept Obstet & Gynaecol, Cardiff CF14 4XN, Wales	Cardiff University; University of London; University College London; Cardiff University	Lai, FA (corresponding author), Cardiff Univ, Sch Med, Wales Heart Res Inst, Cell Signalling Lab, Cardiff CF14 4XN, Wales.	lait@cf.ac.uk		Nomikos, Michail/0000-0001-9761-6327; Lai, Tony/0000-0003-2852-8547; Rossbach, Andreas/0000-0002-6041-7348; Swann, Karl/0000-0002-4355-1449	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; Allue I, 1996, BIOCHEM J, V319, P463, DOI 10.1042/bj3190463; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Cox LJ, 2002, REPRODUCTION, V124, P611, DOI 10.1530/rep.0.1240611; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; FABIATO A, 1981, J GEN PHYSIOL, V78, P457, DOI 10.1085/jgp.78.5.457; Fujimoto S, 2004, DEV BIOL, V274, P370, DOI 10.1016/j.ydbio.2004.07.025; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; IGUSA Y, 1983, J PHYSIOL-LONDON, V340, P611, DOI 10.1113/jphysiol.1983.sp014783; Jellerette T, 2000, DEV BIOL, V223, P238, DOI 10.1006/dbio.2000.9675; Jones KT, 2000, BIOCHEM J, V346, P743, DOI 10.1042/0264-6021:3460743; Jones KT, 2000, DEV BIOL, V225, P1, DOI 10.1006/dbio.2000.9826; KATAN M, 1987, EUR J BIOCHEM, V168, P413, DOI 10.1111/j.1432-1033.1987.tb13435.x; Katan M, 1998, BBA-MOL CELL BIOL L, V1436, P5, DOI 10.1016/S0005-2760(98)00125-8; Katan M, 1997, SEMIN CELL DEV BIOL, V8, P287, DOI 10.1006/scdb.1997.0150; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Kouchi Z, 2005, J BIOL CHEM, V280, P21015, DOI 10.1074/jbc.M412123200; Kouchi Z, 2004, J BIOL CHEM, V279, P10408, DOI 10.1074/jbc.M313801200; Kyozuka K, 1998, DEVELOPMENT, V125, P4099; Larman MG, 2004, J CELL SCI, V117, P2513, DOI 10.1242/jcs.01109; Lawrence Y, 1998, BIOCHEM J, V335, P335, DOI 10.1042/bj3350335; Mehlmann LM, 2001, DEV BIOL, V236, P492, DOI 10.1006/dbio.2001.0329; MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497; MIYAZAKI S, 1993, DEV BIOL, V158, P62, DOI 10.1006/dbio.1993.1168; Nakano Y, 1997, MOL HUM REPROD, V3, P1087, DOI 10.1093/molehr/3.12.1087; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P3089, DOI 10.1021/bi001968a; Parrington J, 2002, REPRODUCTION, V123, P31, DOI 10.1530/rep.0.1230031; Parrington J, 1998, DEV BIOL, V203, P451, DOI 10.1006/dbio.1998.9071; Pawelczyk T, 1997, ACTA BIOCHIM POL, V44, P221; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rice A, 2000, DEV BIOL, V228, P125, DOI 10.1006/dbio.2000.9929; Rogers NT, 2004, REPRODUCTION, V128, P697, DOI 10.1530/rep.1.00484; Runft LL, 2002, DEV BIOL, V245, P237, DOI 10.1006/dbio.2002.0600; Saunders CM, 2002, DEVELOPMENT, V129, P3533; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Stricker SA, 1997, DEV BIOL, V186, P185, DOI 10.1006/dbio.1997.8594; Summers MC, 2000, HUM REPROD, V15, P1791, DOI 10.1093/humrep/15.8.1791; Swann K, 2004, REPRODUCTION, V127, P431, DOI 10.1530/rep.1.00169; SWANN K, 1990, DEVELOPMENT, V110, P1295; SWANN K, 1994, CELL CALCIUM, V15, P331, DOI 10.1016/0143-4160(94)90072-8; SWANN K, 1994, INT REV CYTOL, V152, P183, DOI 10.1016/S0074-7696(08)62557-7; Tang TS, 2000, DEVELOPMENT, V127, P1141; Williams RL, 1999, BBA-MOL CELL BIOL L, V1441, P255, DOI 10.1016/S1388-1981(99)00150-X; Wu H, 1998, DEV BIOL, V203, P369, DOI 10.1006/dbio.1998.9070; Wu H, 1997, MOL REPROD DEV, V46, P176, DOI 10.1002/(SICI)1098-2795(199702)46:2&lt;176::AID-MRD8&gt;3.0.CO;2-N; Wu H, 2001, BIOL REPROD, V64, P1338, DOI 10.1095/biolreprod64.5.1338; Yoda A, 2004, DEV BIOL, V268, P245, DOI 10.1016/j.ydbio.2003.12.028	49	102	110	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31011	31018		10.1074/jbc.M500629200	http://dx.doi.org/10.1074/jbc.M500629200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16000311	hybrid			2022-12-27	WOS:000231487800044
J	Rave-Harel, N; Miller, NLG; Givens, ML; Mellon, PL				Rave-Harel, N; Miller, NLG; Givens, ML; Mellon, PL			The groucho-related gene family regulates the gonadotropin-releasing hormone gene through interaction with the homeodomain proteins MSX1 and OCT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURON-SPECIFIC EXPRESSION; CELL-SPECIFIC EXPRESSION; BINDING TRANSCRIPTION FACTORS; GNRH GENE; GLUCOCORTICOID-RECEPTOR; DNA-BINDING; DROSOPHILA-ENHANCER; COREPRESSOR GROUCHO; PROMOTER ELEMENTS; TRANSGENIC MICE	Gonadotropin- releasing hormone ( GnRH) is exclusively expressed in a unique population of hypothalamic neurons that controls reproductive function. GnRH gene expression is highly dynamic. Its transcriptional activity is regulated in a complex spatiotemporal manner during embryonic development and postnatal life. Although a variety of transcription factors have been identified as regulators of GnRH transcription, most are promiscuous in their DNA- binding requirements, and none are solely expressed in GnRH neurons. Their specific activity is probably determined by interactions with distinct cofactors. Here we find that the Grouchorelated gene ( GRG) family of co- repressors is expressed in a model cell line for the GnRH neuron and co- expresses with GnRH during prenatal development. GRG proteins associate in vivo with the GnRH promoter. Furthermore, GRG proteins interact with two regulators of GnRH transcription, the homeodomain proteins MSX1 and OCT1. Co- transfection experiments indicate that GRG proteins regulate GnRH promoter activity. The long GRG forms enhance MSX1 repression and counteract OCT1 activation of the GnRH gene. In contrast, the short form, GRG5, has a dominant- negative effect on MSX1- dependent repression. Taken together, these data suggest that the dynamic switch between activation and repression of GnRH transcription is mediated by recruitment of the GRG co- regulators.	Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Mellon, PL (corresponding author), Univ Calif San Diego, Dept Reprod Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pmellon@ucsd.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072754, P50HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NICHD NIH HHS [P50 HD012303, R01 HD072754] Funding Source: Medline; NIDA NIH HHS [DA07315] Funding Source: Medline; NIDDK NIH HHS [R01 DK044838-14, R01 DK044838-16, R01 DK044838-15, R01 DK44838, R01 DK044838] Funding Source: Medline; NIGMS NIH HHS [GM08666] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aronson BD, 1997, MOL CELL BIOL, V17, P5581, DOI 10.1128/MCB.17.9.5581; Belsham DD, 2000, MOL ENDOCRINOL, V14, P212, DOI 10.1210/me.14.2.212; Biggin MD, 1997, DEVELOPMENT, V124, P4425; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Brinkmeier ML, 2003, MOL ENDOCRINOL, V17, P2152, DOI 10.1210/me.2003-0225; CATRON KM, 1995, MOL CELL BIOL, V15, P861; Chandran UR, 1999, J BIOL CHEM, V274, P2372, DOI 10.1074/jbc.274.4.2372; Chandran UR, 1996, J BIOL CHEM, V271, P20412, DOI 10.1074/jbc.271.34.20412; Chandran UR, 1999, BEHAV BRAIN RES, V105, P29, DOI 10.1016/S0166-4328(99)00080-7; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Choi CY, 1999, J BIOL CHEM, V274, P31543, DOI 10.1074/jbc.274.44.31543; CLARK ME, 1995, MOL CELL BIOL, V15, P6169; Coss D, 2004, J BIOL CHEM, V279, P152, DOI 10.1074/jbc.M304697200; COUREY AJ, 1995, BBA-GENE STRUCT EXPR, V1261, P1, DOI 10.1016/0167-4781(94)00234-T; Courey AJ, 2001, GENE DEV, V15, P2786; Dasen JS, 2001, GENE DEV, V15, P3193, DOI 10.1101/gad.932601; DEHNI G, 1995, MECH DEVELOP, V53, P369, DOI 10.1016/0925-4773(95)00452-1; Dintilhac A, 2002, J BIOL CHEM, V277, P7021, DOI 10.1074/jbc.M108417200; Dubnicoff T, 1997, GENE DEV, V11, P2952, DOI 10.1101/gad.11.22.2952; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Ebling FJP, 2000, NEUROREPORT, V11, pR23, DOI 10.1097/00001756-200011090-00002; ERALY SA, 1995, MOL ENDOCRINOL, V9, P848, DOI 10.1210/me.9.7.848; Eraly SA, 1998, MOL ENDOCRINOL, V12, P469, DOI 10.1210/me.12.4.469; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Flores-Saaib RD, 2001, DEVELOPMENT, V128, P1869; Givens ML, 2005, J BIOL CHEM, V280, P19156, DOI 10.1074/jbc.M502004200; Givens ML, 2004, MOL ENDOCRINOL, V18, P2950, DOI 10.1210/me.2003-0437; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Jacobs SBR, 2003, MOL ENDOCRINOL, V17, P1470, DOI 10.1210/me.2002-0286; Jimenez G, 1999, MOL CELL BIOL, V19, P2080; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Kelley CG, 2000, MOL ENDOCRINOL, V14, P1246, DOI 10.1210/me.14.8.1246; Kelley CG, 2002, MOL ENDOCRINOL, V16, P2413, DOI 10.1210/me.2002-0189; Kepa JK, 1996, NUCLEIC ACIDS RES, V24, P3614, DOI 10.1093/nar/24.18.3614; Lawson MA, 1996, MOL CELL BIOL, V16, P3596; Lawson MA, 2002, ENDOCRINOLOGY, V143, P1404, DOI 10.1210/en.143.4.1404; Leon C, 1997, DEV DYNAM, V208, P11, DOI 10.1002/(SICI)1097-0177(199701)208:1<11::AID-AJA2>3.0.CO;2-4; MALLO M, 1995, DEV DYNAM, V204, P338, DOI 10.1002/aja.1002040311; MALLO M, 1993, MECH DEVELOP, V42, P67, DOI 10.1016/0925-4773(93)90099-J; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MONICA K, 1991, MOL CELL BIOL, V11, P6149, DOI 10.1128/MCB.11.12.6149; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nelson SB, 2000, MOL ENDOCRINOL, V14, P1509, DOI 10.1210/me.14.9.1509; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; Pape JR, 1999, MOL ENDOCRINOL, V13, P2203, DOI 10.1210/me.13.12.2203; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Prefontaine GG, 1998, MOL CELL BIOL, V18, P3416, DOI 10.1128/MCB.18.6.3416; RADOVICK S, 1991, P NATL ACAD SCI USA, V88, P3402, DOI 10.1073/pnas.88.8.3402; Rave-Harel N, 2004, J BIOL CHEM, V279, P30287, DOI 10.1074/jbc.M402960200; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHREIBER E, 1994, NEUROSURGERY, V34, P129; Simonian SX, 2001, NEUROENDOCRINOLOGY, V73, P149, DOI 10.1159/000054631; Skynner MJ, 1999, J NEUROSCI, V19, P5955, DOI 10.1523/JNEUROSCI.19-14-05955.1999; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Suter KJ, 2000, ENDOCRINOLOGY, V141, P412, DOI 10.1210/en.141.1.412; TANAKA M, 1994, MOL CELL BIOL, V14, P6046, DOI 10.1128/MCB.14.9.6046; Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804, DOI 10.1128/MCB.18.5.2804; VALE W, 1977, ANNU REV PHYSIOL, V39, P473, DOI 10.1146/annurev.ph.39.030177.002353; VERRIJZER CP, 1992, MOL CELL BIOL, V12, P542, DOI 10.1128/MCB.12.2.542; Welting TJM, 2004, NUCLEIC ACIDS RES, V32, P2138, DOI 10.1093/nar/gkh539; WHYTE DB, 1995, MOL ENDOCRINOL, V9, P467, DOI 10.1210/me.9.4.467; Wolberger C, 1998, CURR OPIN GENET DEV, V8, P552, DOI 10.1016/S0959-437X(98)80010-5; Wolfe A, 2002, MOL ENDOCRINOL, V16, P435, DOI 10.1210/me.16.3.435; Wolfe AM, 1996, J BIOL CHEM, V271, P20018, DOI 10.1074/jbc.271.33.20018; Wong MW, 1998, MOL CELL BIOL, V18, P368, DOI 10.1128/MCB.18.1.368; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; Yao J, 2001, MOL CELL BIOL, V21, P1962, DOI 10.1128/MCB.21.6.1962-1972.2001; Yao J, 2000, MECH DEVELOP, V93, P105, DOI 10.1016/S0925-4773(00)00278-1; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; ZAPPAVIGNA V, 1994, GENE DEV, V8, P732, DOI 10.1101/gad.8.6.732; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920; Zhu CQC, 2002, DEVELOPMENT, V129, P2835	80	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30975	30983		10.1074/jbc.M502315200	http://dx.doi.org/10.1074/jbc.M502315200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16002402	Green Accepted, hybrid			2022-12-27	WOS:000231487800040
J	Toth, J; Kovacs, M; Wang, F; Nyitray, L; Sellers, JR				Toth, J; Kovacs, M; Wang, F; Nyitray, L; Sellers, JR			Myosin V from Drosophila reveals diversity of motor mechanisms within the myosin V family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC MECHANISM; 50/20-KDA JUNCTION; NUCLEOTIDE-BINDING; FLUORESCENT-PROBE; MOLECULAR MOTOR; ATPASE ACTIVITY; REAL-TIME; ACTIN; ACTOMYOSIN; DOMAIN	Myosin V is the best characterized vesicle transporter in vertebrates, but it has been unknown as to whether all members of the myosin V family share a common, evolutionarily conserved mechanism of action. Here we show that myosin V from Drosophila has a strikingly different motor mechanism from that of vertebrate myosin Va, and it is a nonprocessive, ensemble motor. Our steady-state and transient kinetic measurements on single-headed constructs reveal that a single Drosophila myosin V molecule spends most of its mechanochemical cycle time detached from actin, therefore it has to function in processive units that comprise several molecules. Accordingly, in in vitro motility assays, double-headed Drosophila myosin V requires high surface concentrations to exhibit a continuous translocation of actin filaments. Our comparison between vertebrate and fly myosin V demonstrates that the well preserved function of myosin V motors in cytoplasmic transport can be accomplished by markedly different underlying mechanisms.	NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Eotvos Lorand University	Sellers, JR (corresponding author), NHLBI, Lab Mol Physiol, NIH, 9000 Rockville Pike,Bldg 10,Rm 8N202,MSC 1762, Bethesda, MD 20892 USA.	sellersj@nhlbi.nih.gov	Nyitray, László/AAE-5910-2020; Kovacs, Mihaly/A-6841-2011	Nyitray, László/0000-0003-4717-5994; Kovacs, Mihaly/0000-0002-1200-4741	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004227, Z01HL004227] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Batra R, 1999, BIOL CHEM, V380, P1017, DOI 10.1515/BC.1999.126; Bonafe N, 1998, J MUSCLE RES CELL M, V19, P129, DOI 10.1023/A:1005356511634; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Brune M, 2001, BIOCHEMISTRY-US, V40, P5087, DOI 10.1021/bi002484h; Catlett NL, 1998, P NATL ACAD SCI USA, V95, P14799, DOI 10.1073/pnas.95.25.14799; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Cuda G, 1997, BIOPHYS J, V72, P1767, DOI 10.1016/S0006-3495(97)78823-4; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; HOMSHER E, 1992, AM J PHYSIOL, V262, P714; Hu AH, 2002, J BIOL CHEM, V277, P46512, DOI 10.1074/jbc.M208506200; Joel PB, 2001, J BIOL CHEM, V276, P2998, DOI 10.1074/jbc.M006930200; Knetsch MLW, 1999, J BIOL CHEM, V274, P20133, DOI 10.1074/jbc.274.29.20133; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kovacs M, 2005, J BIOL CHEM, V280, P15071, DOI 10.1074/jbc.M500616200; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; Murphy CT, 1999, BIOCHEMISTRY-US, V38, P3785, DOI 10.1021/bi9826815; Park S, 2000, BIOCHEMISTRY-US, V39, P11732, DOI 10.1021/bi000945t; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; Robblee JP, 2004, J BIOL CHEM, V279, P38608, DOI 10.1074/jbc.M403504200; Rodriguez OC, 2002, J CELL SCI, V115, P991; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Urbanke C, 2001, BIOCHEM J, V358, P165, DOI 10.1042/0264-6021:3580165; UYEDA TQP, 1994, NATURE, V368, P567, DOI 10.1038/368567a0; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Yamashita RA, 2000, J MUSCLE RES CELL M, V21, P491, DOI 10.1023/A:1026589626422; Yengo CM, 2000, J BIOL CHEM, V275, P25481, DOI 10.1074/jbc.M002910200; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024	48	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30594	30603		10.1074/jbc.M505209200	http://dx.doi.org/10.1074/jbc.M505209200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15980429	hybrid			2022-12-27	WOS:000231362500076
J	Ungermannova, D; Gao, YF; Liu, XD				Ungermannova, D; Gao, YF; Liu, XD			Ubiquitination of p27(Kip1) requires physical interaction with cyclin E and probable phosphate recognition by SKP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT-KINASE INHIBITOR; CDK INHIBITOR; DEGRADATION; BINDING; CKS1; SCF; P27; PHOSPHORYLATION; LIGASE; SCFSKP2	p27(Kip1) is an essential cell cycle inhibitor of Cyclin-dependent kinases. Ubiquitin- mediated proteolysis of p27(Kip1) is an important mechanism for activation of Cyclin E-Cdk2 and facilitates G(1)/S transition. Ubiquitination of p27 is primarily catalyzed by a multisubunit E3 ubiquitin ligase, SCFSkp2, and requires an adapter protein Cks1. In addition, phosphorylation of p27 at Thr(187) by Cyclin E and Cdk2 is also essential for triggering substrate ubiquitination. Here we investigate the molecular mechanism of p27 ubiquitination. We show that Cyclin E-Cdk2 is essential for targeting the p27 substrate to SCFSkp2. Direct physical contact between Cyclin E but not Cdk2 and p27 is required for p27 recruitment to SCFSkp2. In a search for positively charged amino acid residues that may be involved in recognition of the Thr187 phosphate group, we found that Arg(306) of Skp2 is required for association and ubiquitination of phosphorylated p27 but dispensable for ubiquitination of unphosphorylated p21. Thus, our data unravel the molecular organization of the ubiquitination complex that catalyzes p27 ubiquitination and provide unique insights into the specificity of substrate recognition by SCFSkp2.	Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Liu, XD (corresponding author), Univ Colorado, Dept Chem & Biochem, UCB 215, Boulder, CO 80309 USA.	Xuedong.Liu@colorado.edu		LIU, XUEDONG/0000-0001-7209-4964	NCI NIH HHS [CA107098-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA107098] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; HADWIGER JA, 1989, MOL CELL BIOL, V9, P2034, DOI 10.1128/MCB.9.5.2034; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Keyomarsi K, 2003, NAT MED, V9, P152, DOI 10.1038/nm0203-152; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Seeliger MA, 2003, NAT STRUCT BIOL, V10, P718, DOI 10.1038/nsb962; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sitry D, 2002, J BIOL CHEM, V277, P42233, DOI 10.1074/jbc.M205254200; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wang W, 2004, J BIOL CHEM, V279, P51362, DOI 10.1074/jbc.M405944200; Wang W, 2003, J BIOL CHEM, V278, P32390, DOI 10.1074/jbc.M305241200; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xu K, 2003, BIOCHEM J, V371, P957, DOI 10.1042/BJ20021722; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhu XH, 2004, MOL CELL BIOL, V24, P6058, DOI 10.1128/MCB.24.13.6058-6066.2004	39	30	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30301	30309		10.1074/jbc.M411103200	http://dx.doi.org/10.1074/jbc.M411103200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15980415	hybrid			2022-12-27	WOS:000231362500039
J	Valverde, RHF; Tortelote, GG; Lemos, T; Mintz, E; Vieyra, A				Valverde, RHF; Tortelote, GG; Lemos, T; Mintz, E; Vieyra, A			Ca2+/calmodulin-dependent protein kinase II is an essential mediator in the coordinated regulation of electrocyte Ca2+-ATPase by calmodulin and protein kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE CA2+ PUMP; PLASMA-MEMBRANE; ELECTROPHORUS-ELECTRICUS; SARCOPLASMIC-RETICULUM; CALCIUM-BINDING; ATPASE; PHOSPHORYLATION; ACTIVATION; INHIBITION; TRANSPORT	The aim of this study was to investigate ( a) whether Ca2+/calmodulin-dependent protein kinase II ( CaM kinase II) participates in the regulation of plasma membrane Ca2+-ATPase and ( b) its possible cross-talk with other kinase-mediated modulatory pathways of the pump. Using isolated innervated membranes of the electrocytes from Electrophorus electricus L., we found that stimulation of endogenous protein kinase A ( PKA) strongly phosphorylated membrane-bound CaM kinase II with simultaneous substantial activation of the Ca2+ pump ( approximate to 2-fold). The addition of cAMP ( 5-50 pM), forskolin ( 10 nM), or cholera toxin ( 10 or 100 nM) stimulated both CaM kinase II phosphorylation and Ca2+-ATPase activity, whereas these activation processes were cancelled by an inhibitor of the PKA alpha-catalytic subunit. When CaM kinase II was blocked by its specific inhibitor KN-93, the Ca2+-ATPase activity decreased to the levels measured in the absence of calmodulin; the unusually high Ca2+ affinity dropped 2-fold; and the PKA-mediated stimulation of Ca2+-ATPase was no longer seen. Hydroxylamine-resistant phosphorylation of the Ca2+-ATPase strongly increased when the PKA pathway was activated, and this phosphorylation was suppressed by inhibition of CaM kinase II. We conclude that CaM kinase II is an intermediate in a complex regulatory network of the electrocyte Ca2+ pump, which also involves calmodulin and PKA.	Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil; Univ Grenoble 1, Lab Biophys Mol & Cellulaire, UMR 5090, CEA,CNRS, F-38054 Grenoble, France	Universidade Federal do Rio de Janeiro; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Vieyra, A (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil.	avieyra@biof.ufrj.br	Lemos, Thiago/Q-9518-2017; Valverde, Rafael H.F./K-6567-2012	Lemos, Thiago/0000-0002-6657-5689; Valverde, Rafael H.F./0000-0002-1244-814X; Tortelote, Giovane/0000-0002-9312-3442				ALMEIDA DF, 1963, EXP CELL RES, V29, P42; AMENDE LM, 1983, J NEUROCHEM, V40, P1040, DOI 10.1111/j.1471-4159.1983.tb08090.x; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; BENAIM G, 1984, J BIOL CHEM, V259, P8471; BORKE JL, 1989, AM J PHYSIOL, V257, pF842, DOI 10.1152/ajprenal.1989.257.5.F842; BOUMENDILPODEVIN EF, 1983, BIOCHIM BIOPHYS ACTA, V735, P86, DOI 10.1016/0005-2736(83)90263-8; Bruce JIE, 2002, J BIOL CHEM, V277, P48172, DOI 10.1074/jbc.M208393200; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Carafoli E, 2000, CURR OPIN CHEM BIOL, V4, P152, DOI 10.1016/S1367-5931(99)00069-1; Caruso-Neves C, 2000, BBA-BIOMEMBRANES, V1468, P107, DOI 10.1016/S0005-2736(00)00248-0; CHAGAS C, 1972, CR ACAD SCI D NAT, V274, P1526; COELHOSAMPAIO T, 1991, J BIOL CHEM, V266, P22266; EMERICK MC, 1989, BIOCHEMISTRY-US, V28, P8367, DOI 10.1021/bi00447a016; ERONDU NE, 1985, J NEUROSCI, V5, P3270; ESQUIBEL MA, 1970, THESIS FEDERAL U RIO; FILOTEO AG, 1992, J BIOL CHEM, V267, P11800; Gotter AL, 1998, COMP BIOCHEM PHYS A, V119, P225, DOI 10.1016/S1095-6433(97)00414-5; Gotter AL, 1997, COMP BIOCHEM PHYS A, V118, P81, DOI 10.1016/S0300-9629(96)00411-2; GRAF E, 1981, J BIOL CHEM, V256, P1587; Gromadzinska E, 2001, BBA-PROTEIN STRUCT M, V1549, P19, DOI 10.1016/S0167-4838(01)00244-8; Guerini D, 1998, CELL TISSUE RES, V292, P191, DOI 10.1007/s004410051050; HAO LN, 1994, J BIOL CHEM, V269, P14268; HOFMANN F, 1994, J BIOL CHEM, V269, P24298; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; INESI G, 1980, J BIOL CHEM, V255, P3025; Isshiki M, 1999, CELL CALCIUM, V26, P201, DOI 10.1054/ceca.1999.0073; Isshiki M, 1998, P NATL ACAD SCI USA, V95, P5009, DOI 10.1073/pnas.95.9.5009; KEYNES RD, 1953, J PHYSIOL-LONDON, V119, P315, DOI 10.1113/jphysiol.1953.sp004849; Lowe J, 2004, BBA-BIOMEMBRANES, V1661, P40, DOI 10.1016/j.bbamem.2003.11.020; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; MUNJAAL RP, 1986, MOL CELL BIOL, V6, P950, DOI 10.1128/MCB.6.3.950; NIGGLI V, 1981, J BIOL CHEM, V256, P395; OLIVEIRA MM, 1978, COMP BIOCHEM PHYS C, V61, P17, DOI 10.1016/0306-4492(78)90104-1; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SAITOH T, 1985, J CELL BIOL, V100, P835, DOI 10.1083/jcb.100.3.835; Schoffeniels E., 1961, BIOELECTROGENESIS, P147; Shull GE, 2000, EUR J BIOCHEM, V267, P5284, DOI 10.1046/j.1432-1327.2000.01568.x; SORENSON MM, 1986, J MEMBRANE BIOL, V90, P219, DOI 10.1007/BF01870128; SOUZA WD, 1979, CELL TISSUE RES, V202, P275, DOI 10.1007/BF00232241; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; TAFFAREL M, 1989, J HISTOCHEM CYTOCHEM, V37, P953, DOI 10.1177/37.7.2525141; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Tortelote GG, 2004, FEBS LETT, V576, P31, DOI 10.1016/j.febslet.2004.08.055; VIEYRA A, 1986, J BIOL CHEM, V261, P4247; Wang K K, 1992, Trends Cell Biol, V2, P46, DOI 10.1016/0962-8924(92)90162-G; Xu A, 1997, J MOL CELL CARDIOL, V29, P405, DOI 10.1006/jmcc.1996.0284; Yamaotsu N, 2001, BIOPOLYMERS, V58, P410, DOI 10.1002/1097-0282(20010405)58:4<410::AID-BIP1017>3.0.CO;2-0; Yao YH, 1996, BIOCHEMISTRY-US, V35, P2767, DOI 10.1021/bi951712i; Yin D, 1999, BIOCHEMISTRY-US, V38, P13654, DOI 10.1021/bi991152d; Yue CP, 2001, MOL CELL ENDOCRINOL, V175, P149, DOI 10.1016/S0303-7207(01)00383-5	57	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30611	30618		10.1074/jbc.M501880200	http://dx.doi.org/10.1074/jbc.M501880200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15987689	hybrid			2022-12-27	WOS:000231362500078
J	Matsuda, S; Giliberto, L; Matsuda, Y; Davies, P; McGowan, E; Pickford, F; Ghiso, J; Frangione, B; D'Adamio, L				Matsuda, S; Giliberto, L; Matsuda, Y; Davies, P; McGowan, E; Pickford, F; Ghiso, J; Frangione, B; D'Adamio, L			The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE; MISSENSE MUTATIONS; A-BETA; DISEASE; EXPRESSION; NOTCH; CDNA; CLEAVAGE; SEQUENCE; CLONING	Alzheimer disease (AD), the most common senile dementia, is characterized by amyloid plaques, vascular amyloid, neurofibrillary tangles, and progressive neurodegeneration. Amyloid is mainly composed by amyloid-beta (A beta) peptides, which are derive from processing of the beta-amyloid precursor protein (APP), better named amyloid-beta precursor protein (A beta PP), by secretases. The (A) under bar beta PP intracellular domain (AID), which is released together with A beta, has signaling function, since it modulates apoptosis and transcription. Despite its biological and pathological importance, the mechanisms regulating A beta PP processing are poorly understood. As cleavage of other gamma-secretase substrates is regulated by membrane bound proteins, we have postulated the existence of integral membrane proteins that bind A beta PP and regulate its processing. Here, we show that BRI2, a type II membrane protein, interacts with A beta PP. Interestingly, 17 amino acids corresponding to the NH2-terminal portion of A beta are necessary for this interaction. Moreover, BRI2 expression regulates A beta PP processing resulting in reduced A beta and AID levels. Altogether, these findings characterize the BRI2-A beta PP interaction as a regulatory mechanism of A beta PP processing that inhibits A beta production. Notably, BRI2 mutations cause familial British (FBD) and Danish dementias (FDD) that are clinically and pathologically similar to AD. Finding that BRI2 pathogenic mutations alter the regulatory function of BRI2 on A beta PP processing would define dysregulation of A beta PP cleavage as a pathogenic mechanism common to AD, FDD, and FBD.	Albert Einstein Coll Med, Bronx, NY 10461 USA; Mayo Clin, Jacksonville, FL 32224 USA; NYU, Sch Med, New York, NY 10016 USA	Yeshiva University; Albert Einstein College of Medicine; Mayo Clinic; New York University	D'Adamio, L (corresponding author), Albert Einstein Coll Med, Bronx, NY 10461 USA.	ldadamio@aecom.yu.edu		D'Adamio, Luciano/0000-0002-9820-4882; D'Adamio, Luciano/0000-0002-2204-9441	NIA NIH HHS [R01 AG21588, R01 AG022595, R01AG05891, R01 AG08721, R01 AG22024] Funding Source: Medline; NINDS NIH HHS [R01NS38777] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005891, R01AG022595, R01AG008721, R01AG022024, R01AG021588] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gianni D, 2003, J BIOL CHEM, V278, P9290, DOI 10.1074/jbc.M211899200; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Holton JL, 2002, J NEUROPATH EXP NEUR, V61, P254, DOI 10.1093/jnen/61.3.254; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; Kopan R, 2002, J CELL SCI, V115, P1095; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Pickford F, 2003, NEUROSCI LETT, V338, P95, DOI 10.1016/S0304-3940(02)01356-3; Pittois K, 1998, GENE, V217, P141, DOI 10.1016/S0378-1119(98)00354-0; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; ROSTAGNO A, 2005, IN PRESS CELL MOL LI; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Scheinfeld MH, 2003, J BIOL CHEM, V278, P42058, DOI 10.1074/jbc.M304853200; Scheinfeld MH, 2002, J BIOL CHEM, V277, P44195, DOI 10.1074/jbc.M208110200; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Vidal R, 2001, GENE, V266, P95, DOI 10.1016/S0378-1119(01)00374-2; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399	31	110	117	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2005	280	32					28912	28916		10.1074/jbc.C500217200	http://dx.doi.org/10.1074/jbc.C500217200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	952QT	15983050	hybrid			2022-12-27	WOS:000231021300011
J	Saladino, R; Crestini, C; Busiello, V; Ciciriello, F; Costanzo, G; Di Mauro, E				Saladino, R; Crestini, C; Busiello, V; Ciciriello, F; Costanzo, G; Di Mauro, E			Differential stability of 3 '- and 5 '-phosphoester bonds in deoxy monomers and oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARBERTON GREENSTONE-BELT; DEOXYRIBONUCLEIC-ACID; PREBIOTIC SYNTHESIS; PURINE NUCLEOSIDES; NUCLEIC-ACIDS; SPHERULE BEDS; COLD ORIGIN; DNA ENZYME; FORMAMIDE; LIFE	To survive, an informational macromolecule must solve the major problem set by its very polymeric nature: instability. This is especially true in prebiotic terms because of the presumed initial absence of protective structures ( proteins, lipids, etc.). We have analyzed the stability of the beta-glycosidic and of the 3'- and 5'- phosphoester bonds in both deoxy monomers and deoxy oligomers under a large set of conditions. The results show a strong dependence of the relative stability of these bonds on the physico- chemical environment. A set of conditions has been identified in which the stability of polymers becomes comparable with that of the precursor monomers. In certain instances the stability of the 5'- phosphoester bond is even higher in the polymer than in the mononucleotide.	Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Fdn Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; Univ Tuscia, Dipartimento Agrobiol & Agrochim, I-01100 Viterbo, Italy; Univ Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy; CNR, Ist Biol & Patol Mol, I-00185 Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Tuscia University; University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Di Mauro, E (corresponding author), Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Fdn Ist Pasteur, Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	Ernesto.dimauro@uniroma1.it	Ciciriello, Fabiana/AAA-8065-2020; Crestini, Claudia/O-6781-2015	Ciciriello, Fabiana/0000-0003-1493-9767; Crestini, Claudia/0000-0001-9903-2675				Arndt N.T., 1994, ARCHEAN CRUSTAL EVOL, P11, DOI [10.1016/ S0166- 2635(08)70219-6, DOI 10.1016/S0166-2635(08)70219-6]; Bada JL, 2002, SCIENCE, V296, P1982, DOI 10.1126/science.1069487; Bhattacharyya AJ, 2001, TALANTA, V55, P943, DOI 10.1016/S0039-9140(01)00493-3; Butlerow A., 1861, ANN CHEM PHARM, V120, P295, DOI [10.1002/jlac.18611200308, DOI 10.1002/JLAC.18611200308]; BUZAYAN JM, 1986, NATURE, V323, P349, DOI 10.1038/323349a0; Carmi N, 2001, BIOORGAN MED CHEM, V9, P2589, DOI 10.1016/S0968-0896(01)00035-9; CECH TR, 1986, ANNU REV BIOCHEM, V55, P599, DOI 10.1146/annurev.biochem.55.1.599; CECH TR, 1985, INT REV CYTOL, V93, P3, DOI 10.1016/S0074-7696(08)61370-4; Cornish EC, 1998, BIOTECHNIQUES, V25, P948, DOI 10.2144/98256bm04; DECKER P, 1982, J CHROMATOGR, V244, P281, DOI 10.1016/S0021-9673(00)85692-7; DUNLOP JSR, 1978, NATURE, V274, P676, DOI 10.1038/274676a0; FORTERRE P, 1995, ORIGINS LIFE EVOL B, V25, P235, DOI 10.1007/BF01581587; Fu AP, 2003, J MOL STRUC-THEOCHEM, V623, P315, DOI 10.1016/S0166-1280(02)00772-8; GARRETT ER, 1972, J AM CHEM SOC, V94, P8542, DOI 10.1021/ja00779a041; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; Hofmann HJ, 1999, GEOL SOC AM BULL, V111, P1256, DOI 10.1130/0016-7606(1999)111<1256:OOGCSI>2.3.CO;2; Imai E, 1999, SCIENCE, V283, P831, DOI 10.1126/science.283.5403.831; JONES AS, 1968, J CHEM SOC C, P2042, DOI 10.1039/j39680002042; JOYCE GF, 1987, P NATL ACAD SCI USA, V84, P4398, DOI 10.1073/pnas.84.13.4398; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; Kochetkov N.K., 1972, ORGANIC CHEM NUCLE B, P425; KOCHETKOV NK, 1972, ORGANIC CHEM NUCLE B, P477; Kyte FT, 2003, GEOLOGY, V31, P283, DOI 10.1130/0091-7613(2003)031<0283:EASBCI>2.0.CO;2; LAWLEY PD, 1964, BIOCHEM J, V92, pC19, DOI 10.1042/bj0920019C; LAZCANO A, 1994, J MOL EVOL, V39, P546, DOI 10.1007/BF00160399; LAZCANO A, 1988, J MOL EVOL, V27, P283, DOI 10.1007/BF02101189; Levy M, 1998, P NATL ACAD SCI USA, V95, P7933, DOI 10.1073/pnas.95.14.7933; Levy M, 2000, ICARUS, V145, P609, DOI 10.1006/icar.2000.6365; LINDAHL T, 1973, BIOCHEMISTRY-US, V12, P5151, DOI 10.1021/bi00749a020; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Lowe DR, 2003, ASTROBIOLOGY, V3, P7, DOI 10.1089/153110703321632408; Millar TJ, 2004, ASTROPHYS SPACE SC L, V305, P17; MILLER SL, 1988, NATURE, V334, P609, DOI 10.1038/334609a0; Miller SL, 1995, J MOL EVOL, V41, P689; Miyakawa S, 2002, ORIGINS LIFE EVOL B, V32, P209, DOI 10.1023/A:1019514022822; Miyakawa S, 2002, ORIGINS LIFE EVOL B, V32, P195, DOI 10.1023/A:1016514305984; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Negri R, 1996, BIOTECHNIQUES, V21, P910; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Orgel LE, 1998, TRENDS BIOCHEM SCI, V23, P491, DOI 10.1016/S0968-0004(98)01300-0; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PACE NR, 1985, ORIGINS LIFE EVOL B, V16, P97, DOI 10.1007/BF01809465; PITSCH S, 1995, ORIGINS LIFE EVOL B, V25, P297, DOI 10.1007/BF01581773; Rozas I, 2004, J PHYS CHEM B, V108, P3335, DOI 10.1021/jp036901m; Saladino R, 2005, CHEMBIOCHEM, V6, P1368, DOI 10.1002/cbic.200500035; Saladino R, 2004, ASTROPHYS SPACE SC L, V305, P393; Saladino R, 2004, CHEMBIOCHEM, V5, P1558, DOI 10.1002/cbic.200400119; Saladino R, 2004, CURR ORG CHEM, V8, P1425, DOI 10.2174/1385272043369836; Saladino R, 2003, CHEMBIOCHEM, V4, P514, DOI 10.1002/cbic.200300567; Saladino R, 2001, BIOORGAN MED CHEM, V9, P1249, DOI 10.1016/S0968-0896(00)00340-0; Saladino R, 1997, BIOORGAN MED CHEM, V5, P2041, DOI 10.1016/S0968-0896(97)00140-5; Saladino R, 1996, J AM CHEM SOC, V118, P5615, DOI 10.1021/ja953527y; Santoro SW, 2000, J AM CHEM SOC, V122, P2433, DOI 10.1021/ja993688s; SCHOFFSTALL AM, 1976, ORIGINS LIFE EVOL B, V7, P399, DOI 10.1007/BF00927935; SCHOFFSTALL AM, 1982, ORIGINS LIFE EVOL B, V12, P143, DOI 10.1007/BF00927141; Schoning KU, 2000, SCIENCE, V290, P1347, DOI 10.1126/science.290.5495.1347; Schwartzman DW, 2004, BIOCHEM SOC T, V32, P168, DOI 10.1042/BST0320168; SHAPIRO HS, 1957, BIOCHIM BIOPHYS ACTA, V26, P596, DOI 10.1016/0006-3002(57)90107-5; SHAPIRO R, 1973, BIOCHIM BIOPHYS ACTA, V319, P5, DOI 10.1016/0005-2787(73)90035-X; SHAPIRO R, 1969, BIOCHEMISTRY-US, V8, P1806, DOI 10.1021/bi00833a004; Sheppard TL, 2000, P NATL ACAD SCI USA, V97, P7802, DOI 10.1073/pnas.97.14.7802; Sponer J, 2000, J PHYS CHEM A, V104, P4592, DOI 10.1021/jp9943880; TOWNSEND LB, 1963, J AM CHEM SOC, V85, P242, DOI 10.1021/ja00885a039; TRAVERS A, 1993, DNA PROTEIN INTERACT, P28; van Zuilen MA, 2002, NATURE, V418, P627, DOI 10.1038/nature00934; VENNER H, 1966, H-S Z PHYSIOL CHEM, V344, P189, DOI 10.1515/bchm2.1966.344.1-3.189; WALSH MM, 1992, PRECAMBRIAN RES, V54, P271, DOI 10.1016/0301-9268(92)90074-X; Westall F, 2004, ASTROPHYS SPACE SC L, V305, P287; Westall F, 2004, ESA SPEC PUBL, V545, P37; Westall F, 2001, PRECAMBRIAN RES, V106, P93, DOI 10.1016/S0301-9268(00)00127-3; Wiegel J., 1998, THERMOPHILES KEYS MO; ZAKHARYAN R. A., 1967, BIOKHIMIYA, V32, P1068	73	22	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2005	280	42					35658	35669		10.1074/jbc.M504537200	http://dx.doi.org/10.1074/jbc.M504537200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973ZN	16036914	hybrid			2022-12-27	WOS:000232561200069
J	Aguiar, RCT; Takeyama, K; He, CY; Kreinbrink, K; Shipp, MA				Aguiar, RCT; Takeyama, K; He, CY; Kreinbrink, K; Shipp, MA			B-aggressive lymphoma family proteins have unique domains that modulate transcription and exhibit poly(ADP-ribose) polymerase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INACTIVE X-CHROMOSOME; CRYSTAL-STRUCTURES; HISTONE MACROH2A; CORE HISTONE; BINDING; CELLS; GENE; PARP; IDENTIFICATION; COREPRESSOR	BAL1 (B-aggressive lymphoma 1) was originally identified as a risk- related gene in diffuse large B-cell lymphoma. BAL1 encodes a nuclear protein with N-terminal macro domains and a putative C-terminal poly( ADP-ribose) polymerase ( PARP) active site. Macro domains are sequences homologous to the non-histone region of histone macroH2A. Several lines of evidence suggest that these domains may modulate transcription, including a high concentration of histone macroH2A in the inactive X chromosome, direct interference with transcription factor binding in a positioned nucleosome, and structural similarity to DNA binding domains. Poly( ADP-ribosyl) ation is a critical post-translational modification that regulates chromatin configuration and transcription. In this report we describe two additional BAL family members, BAL2 and BAL3, with N-terminal macro domains and putative C-terminal PARP active sites and assess the function of these specific regions in BAL family members. Herein, we demonstrate that BAL macro domains repress transcription when tethered to a promoter. In addition, we show that BAL2 and BAL3, but not BAL1, exhibit PARP activity. In agreement with these data, BAL1 lacks several critical donor and acceptor residues that are conserved in the BAL2 and -3 PARP active sites. Of interest, BAL family members with inactive or functional PARP domains differed in their ability to repress transcription. BAL family members are the only described proteins with both PARP and macro domains, underscoring the potential functional significance of this unique combination.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Div Hematol Malignancies, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Shipp, MA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Div Hematol Malignancies, 44 Binney St,Rm M513, Boston, MA 02115 USA.	margaret_shipp@dfci.harvard.edu						Aguiar RCT, 1999, BLOOD, V94, P2403, DOI 10.1182/blood.V94.7.2403.419k39_2403_2413; Aguiar RCT, 1997, BLOOD, V90, P3130, DOI 10.1182/blood.V90.8.3130; Aguiar RCT, 2000, BLOOD, V96, P4328, DOI 10.1182/blood.V96.13.4328.h8004328_4328_4334; Allen MD, 2003, J MOL BIOL, V330, P503, DOI 10.1016/S0022-2836(03)00473-X; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Angelov D, 2003, MOL CELL, V11, P1033, DOI 10.1016/S1097-2765(03)00100-X; Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X; Augustin A, 2003, J CELL SCI, V116, P1551, DOI 10.1242/jcs.00341; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chadwick BP, 2001, HUM MOL GENET, V10, P1101, DOI 10.1093/hmg/10.10.1101; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Costanzi C, 2001, J BIOL CHEM, V276, P21776, DOI 10.1074/jbc.M010919200; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Han WD, 2003, ENDOCR-RELAT CANCER, V10, P217, DOI 10.1677/erc.0.0100217; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Ladurner AG, 2003, MOL CELL, V12, P1, DOI 10.1016/S1097-2765(03)00284-3; Liu H, 1999, J NEUROCHEM, V72, P1781, DOI 10.1046/j.1471-4159.1999.0721781.x; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; PEHRSON JR, 1992, SCIENCE, V257, P1398; Perche PY, 2000, CURR BIOL, V10, P1531, DOI 10.1016/S0960-9822(00)00832-0; Rolli V, 1997, BIOCHEMISTRY-US, V36, P12147, DOI 10.1021/bi971055p; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Ruf A, 1998, J MOL BIOL, V278, P57, DOI 10.1006/jmbi.1998.1673; Ruf A, 1998, BIOCHEMISTRY-US, V37, P3893, DOI 10.1021/bi972383s; Seimiya H, 2005, CANCER CELL, V7, P25, DOI 10.1016/j.ccr.2004.11.021; SIMONIN F, 1993, J BIOL CHEM, V268, P8529; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Takeyama K, 2003, J BIOL CHEM, V278, P21930, DOI 10.1074/jbc.M301157200; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Wang AH, 1999, MOL CELL BIOL, V19, P7816	35	126	131	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					33756	33765		10.1074/jbc.M505408200	http://dx.doi.org/10.1074/jbc.M505408200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16061477	hybrid			2022-12-27	WOS:000232229700011
J	Uwabe, KI; Matsumoto, M; Nagata, K				Uwabe, KI; Matsumoto, M; Nagata, K			Monokine induced by interferon-gamma acts as a neurotrophic factor on PC12 cells and rat primary sympathetic neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; CYCLASE-ACTIVATING POLYPEPTIDE; PROTEIN-COUPLED RECEPTOR; CHEMOKINE RECEPTORS; PHEOCHROMOCYTOMA CELLS; SIGNALING CASCADES; KINASE ACTIVATION; NEURITE OUTGROWTH; TYROSINE KINASE; HIV-1 ENTRY	We found that a monokine induced by interferon-gamma (Mig, CXCL9), which belongs to the CXC chemokine subfamily, acts as a neurotrophic factor on PC12 cells and rat primary sympathetic neurons. PC12 cells were shown to express a single class of high affinity binding sites for Mig ( 670 receptors/cell, K-d = 2.9 nM). Mig induced neurite outgrowth in PC12 cells in a dose-dependent manner. Comparison of extracellular signal-regulated kinase signaling pathways between Mig and nerve growth factor (NGF) revealed that these pathways are crucial for Mig action as well as NGF. K252a, an inhibitor of tyrosine autophosphorylation of tyrosine kinase receptors (Trks) did not inhibit the action of Mig, suggesting that Mig action occurs via a different receptor from that of NGF. Furthermore, Mig as well as NGF promoted PC12 survival under serum-free conditions and activated Akt/protein kinase B downstream from phosphatidylinositol 3-kinase (PI3K). Because the PI3K inhibitor LY294002 prevented the Mig- and NGF-induced survival effect, this effect is probably mediated by the PI3K signaling pathway. Mig also promoted survival of rat primary sympathetic neurons that die when deprived of NGF. These results suggest that chemokines, including Mig ( CXCL9) have neurotrophic effects on the nervous system.	Shionogi & Co Ltd, Discovery Res Labs, Fukushima Ku, Osaka 5530002, Japan	Shionogi & Company Limited	Uwabe, KI (corresponding author), Shionogi & Co Ltd, Discovery Res Labs, Fukushima Ku, 12-4 Sagisu 5 Chome, Osaka 5530002, Japan.	ken-ichiro.uwabe@shionogi.co.jp						Ashcroft M, 1999, ONCOGENE, V18, P4586, DOI 10.1038/sj.onc.1202814; Banisadr G, 2002, J NEUROCHEM, V81, P257, DOI 10.1046/j.1471-4159.2002.00809.x; Barrie AP, 1997, J BIOL CHEM, V272, P19666, DOI 10.1074/jbc.272.32.19666; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Cowell RM, 2003, J COMP NEUROL, V457, P7, DOI 10.1002/cne.10554; De Groot C J, 2001, Prog Brain Res, V132, P533; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; DEUTSCH PJ, 1992, J BIOL CHEM, V267, P5108; FARBER JM, 1993, BIOCHEM BIOPH RES CO, V192, P223, DOI 10.1006/bbrc.1993.1403; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Horuk R, 1997, J IMMUNOL, V158, P2882; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; KOUBA M, 1993, FEBS LETT, V321, P173, DOI 10.1016/0014-5793(93)80102-Z; Lahrtz F, 1998, J NEUROIMMUNOL, V85, P33, DOI 10.1016/S0165-5728(97)00267-1; LAMOURY JC, 2003, GLIA, V41, P354; LAW NM, 1994, BIOCHEM BIOPH RES CO, V201, P458, DOI 10.1006/bbrc.1994.1723; LEWIS IC, 2003, J BIOL CHEM, V278, P289; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Liu MT, 2001, J IMMUNOL, V166, P1790, DOI 10.4049/jimmunol.166.3.1790; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mantovani A, 2001, TRENDS IMMUNOL, V22, P328, DOI 10.1016/S1471-4906(01)01941-X; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsumoto T, 1997, J LEUKOCYTE BIOL, V62, P581, DOI 10.1002/jlb.62.5.581; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Oestreicher AB, 1997, PROG NEUROBIOL, V53, P627, DOI 10.1016/S0301-0082(97)00043-9; Park MK, 2002, J IMMUNOL, V169, P1433, DOI 10.4049/jimmunol.169.3.1433; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; ROVELLI G, 1993, P NATL ACAD SCI USA, V90, P8717, DOI 10.1073/pnas.90.18.8717; Soejima K, 2001, J IMMUNOL, V167, P6576, DOI 10.4049/jimmunol.167.11.6576; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Stumm RK, 2003, J NEUROSCI, V23, P5123; Vaudry D, 1999, P NATL ACAD SCI USA, V96, P9415, DOI 10.1073/pnas.96.16.9415; Vaudry D, 2002, ANN NY ACAD SCI, V971, P491, DOI 10.1111/j.1749-6632.2002.tb04513.x; Wang XK, 1998, J NEUROCHEM, V71, P1194; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	47	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34268	34277		10.1074/jbc.M502667200	http://dx.doi.org/10.1074/jbc.M502667200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16055446	hybrid			2022-12-27	WOS:000232229700069
J	Goettig, P; Brandstetter, H; Groll, M; Gohring, W; Konarev, PV; Svergun, DI; Huber, R; Kim, JS				Goettig, P; Brandstetter, H; Groll, M; Gohring, W; Konarev, PV; Svergun, DI; Huber, R; Kim, JS			X-ray snapshots of peptide processing in mutants of tricorn-interacting factor F1 from Thermoplasma acidophilum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PROTEASE; AMINOPEPTIDASE; SCATTERING; DIFFRACTION; REVEALS; SYSTEMS; FAMILY	The tricorn-interacting factor F1 of the archaeon Thermoplasma acidophilum cleaves small hydrophobic peptide products of the proteasome and tricorn protease. F1 mutants of the active site residues that are involved in substrate recognition and catalysis displayed distinct activity patterns toward fluorogenic test substrates. Crystal structures of the mutant proteins complexed with peptides Phe-Leu, Pro-Pro, or Pro-Leu-Gly-Gly showed interaction of glutamates 213 and 245 with the N termini of the peptides and defined the S1 and S1' sites and the role of the catalytic residues. Evidence was found for processive peptide cleavage in the N-to-C direction, whereby the P1' product is translocated into the S1 site. A functional interaction of F1 with the tricorn protease was observed with the inactive F1 mutant G37A. Moreover, small angle x-ray scattering measurements for tricorn and inhibited F1 have been interpreted as formation of transient and substrate-induced complexes.	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany; Max Planck Inst Biochem, Abt Mol Med, D-82152 Martinsried, Germany; Salzburg Univ, Dept Nat Sci, A-5020 Salzburg, Austria; Adolf Butenandt Inst Gebaude B, D-81377 Munich, Germany; Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia; Deutsch Elekt Synchrotron, European Mol Biol Lab Hamburg, D-22603 Hamburg, Germany; Korea Res Inst Biosci & Biotechnol, Taejon 305333, South Korea	Max Planck Society; Max Planck Society; Salzburg University; University of Munich; Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Goettig, P (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, Klopferspitz 18, D-82152 Martinsried, Germany.	goettig@biochem.mpg.de; jsunkim@kribb.re.kr	Konarev, Petr V/W-1380-2017; Goettig, Peter/K-4508-2019; Goettig, Peter/R-7996-2017; Groll, Michael/F-5572-2015; Groll, Michael/C-1174-2010; Brandstetter, Hans/E-6754-2011	Goettig, Peter/0000-0002-2430-1970; Goettig, Peter/0000-0002-2430-1970; Brandstetter, Hans/0000-0002-6089-3045; Konarev, Petr/0000-0002-5606-1596; Svergun, Dmitri/0000-0003-0830-5696				Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; BOULIN CJ, 1988, NUCL INSTRUM METH A, V269, P312, DOI 10.1016/0168-9002(88)90895-9; Brandstetter H, 2002, BIOL CHEM, V383, P1157, DOI 10.1515/BC.2002.127; Brandstetter H, 2001, NATURE, V414, P466, DOI 10.1038/35106609; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandu D, 2003, J BIOL CHEM, V278, P5548, DOI 10.1074/jbc.M207926200; DeLano W.L, PYMOL MOL GRAPHICS S; Dunn BM, 2002, CHEM REV, V102, P4431, DOI 10.1021/cr010167q; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; GABRIEL A, 1982, NUCL INSTRUM METHODS, V201, P223, DOI 10.1016/0167-5087(82)90031-X; Goettig P, 2002, EMBO J, V21, P5343, DOI 10.1093/emboj/cdf552; GOETTIG P, 2003, APPL GENOMICS PROTEO, V2, P239; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Gustchina A, 2002, BIOCHEM BIOPH RES CO, V295, P1020, DOI 10.1016/S0006-291X(02)00742-8; Ishikawa T, 2001, P NATL ACAD SCI USA, V98, P4328, DOI 10.1073/pnas.081543698; Kim JS, 2002, J MOL BIOL, V324, P1041, DOI 10.1016/S0022-2836(02)01153-1; KOCH MHJ, 1983, NUCL INSTRUM METHODS, V208, P461, DOI 10.1016/0167-5087(83)91169-9; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kyrieleis OJP, 2005, J MOL BIOL, V349, P787, DOI 10.1016/j.jmb.2005.03.070; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Medrano FJ, 1998, EMBO J, V17, P1, DOI 10.1093/emboj/17.1.1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHOEPFER R, 1993, GENE, V124, P83, DOI 10.1016/0378-1119(93)90764-T; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Tamura N, 1998, CELL, V95, P637, DOI 10.1016/S0092-8674(00)81634-7; Tamura T, 1996, FEBS LETT, V398, P101, DOI 10.1016/S0014-5793(96)01163-5; Tamura T, 1996, SCIENCE, V274, P1385, DOI 10.1126/science.274.5291.1385; TURK D, 1992, THESIS TU MUNCHEN MU; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Walz J, 1997, MOL CELL, V1, P59, DOI 10.1016/S1097-2765(00)80007-6; Yoshimoto T, 1999, J BIOCHEM, V126, P559, DOI 10.1093/oxfordjournals.jbchem.a022486	42	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33387	33396		10.1074/jbc.M505030200	http://dx.doi.org/10.1074/jbc.M505030200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	15994304	hybrid			2022-12-27	WOS:000232058100036
J	Yang, L; Xie, SZ; Jamaluddin, MS; Altuwajiri, S; Ni, J; Kim, E; Chen, YT; Hu, YC; Wang, L; Chuang, KH; Wu, CT; Chang, CS				Yang, L; Xie, SZ; Jamaluddin, MS; Altuwajiri, S; Ni, J; Kim, E; Chen, YT; Hu, YC; Wang, L; Chuang, KH; Wu, CT; Chang, CS			Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells *	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; GENE PROMOTER; BINDING-SITE; PHOSPHO-AKT; GROWTH; PROLIFERATION; PATHWAY; TRANSACTIVATION; SURVIVAL; DIFFERENTIATION	The phosphatidylinositol 3-kinase (PI3K)/Akt pathway plays important roles for prostate cancer cell survival, and the androgen receptor (AR) plays essential roles for prostate cancer cell proliferation. How these two signals cooperate to control cell growth and death, however, remains unclear and debated. Here we provide the first linkage by the identification of Forkhead transcription factor FOXO3a, the PI3K/Akt downstream substrate, as a positive regulator for the induction of AR gene expression. Both Western blot and real time PCR assays demonstrate that FOXO3a can induce AR expression at the protein and mRNA levels, and gel shift and chromatin immunoprecipitation assays further demonstrate that FOXO3a can induce 5' AR promoter activity via binding to the consensus DNA-binding sequence in the AR 5' promoter - 1290 to - 1297 (5'-TTGTTTCA-3'). Under normal growth conditions, blocking PI3K/Akt signals by LY294002 causes LNCaP cell arrest in G(1) phase rather than apoptosis. However, further blocking of AR functions by AR small interfering RNA leads to dramatic LNCaP cell death, suggesting that AR may play important protective roles when the PI3K/Akt signal pathway is blocked by LY294002. Together, our data provide the first model to explain how PI3K/Akt and AR can cooperate to control LNCaP cell growth and death under normal conditions.	Univ Rochester, George Whipple Lab Canc Res, Rochester, NY 14642 USA; Univ Rochester, Dept Pathol, Rochester, NY 14642 USA; Univ Rochester, Dept Urol, Rochester, NY 14642 USA; Univ Rochester, Dept Radiat Oncol, Rochester, NY 14642 USA; Univ Rochester, Ctr Canc, Rochester, NY 14642 USA; MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77054 USA; Baylor Coll Med, Dept Med, Sect Atherosclerosis, Houston, TX 77030 USA; Chang Gung Univ & Mem Hosp, Dept Urol, Taipei 105, Taiwan	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Chang Gung University	Chang, CS (corresponding author), Univ Rochester, George Whipple Lab Canc Res, 601 Elmwood Ave, Rochester, NY 14642 USA.	Chang@urmc.rochester.edu	Hu, Yueh-Chiang/AAX-2370-2020	Chang, Chawnshang/0000-0001-8510-3516; Hu, Yueh-Chiang/0000-0002-7992-0525; Chen, Yei-Tsung/0000-0002-3891-5172	NCI NIH HHS [CA55639, CA71870] Funding Source: Medline; NIDDK NIH HHS [DK60948, DK67686] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA071870, R29CA055639, R01CA055639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067686, R01DK060948] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Altuwaijri S, 2003, CANCER RES, V63, P7106; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; CHANG CS, 1995, CRIT REV EUKAR GENE, V5, P97, DOI 10.1615/CritRevEukarGeneExpr.v5.i2.10; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Godoy-Tundidor S, 2005, PROSTATE, V64, P209, DOI 10.1002/pros.20235; Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Keller ET, 1996, FRONT BIOSCI, V1, pd59, DOI DOI 10.2741/A116; Lee DK, 2003, J CLIN ENDOCR METAB, V88, P4043, DOI 10.1210/jc.2003-030261; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Liao ZM, 2005, PROSTATE, V64, P186, DOI 10.1002/pros.20224; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lin HK, 2003, J BIOL CHEM, V278, P50902, DOI 10.1074/jbc.M300676200; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Lin JQ, 1999, CANCER RES, V59, P2891; Malik SN, 2002, CLIN CANCER RES, V8, P1168; MIZOKAMI A, 1994, MOL ENDOCRINOL, V8, P77, DOI 10.1210/me.8.1.77; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Ni J, 2003, BIOCHEM BIOPH RES CO, V300, P357, DOI 10.1016/S0006-291X(02)02851-6; Ren FG, 2000, ONCOGENE, V19, P1924, DOI 10.1038/sj.onc.1203511; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Song CS, 1999, MOL ENDOCRINOL, V13, P1487, DOI 10.1210/me.13.9.1487; Takane KK, 1996, MOL CELL ENDOCRINOL, V119, P83, DOI 10.1016/0303-7207(96)03800-2; Thomas D, 2002, IEEE SOFTWARE, V19, P22, DOI 10.1109/MS.2002.1003449; Torring N, 2003, PROSTATE, V56, P142, DOI 10.1002/pros.10245; Truica CI, 2000, CANCER RES, V60, P4709; Wang H, 2004, J BIOL CHEM, V279, P22674, DOI 10.1074/jbc.M401257200; Wang L, 2004, J BIOL CHEM, V279, P32444, DOI 10.1074/jbc.M313963200; Wen Y, 2000, CANCER RES, V60, P6841; Xie SZ, 2004, PROSTATE, V60, P61, DOI 10.1002/pros.20048; Yang L, 2003, J BIOL CHEM, V278, P16820, DOI 10.1074/jbc.M213163200; Yang L, 2003, BIOCHEM BIOPH RES CO, V305, P462, DOI 10.1016/S0006-291X(03)00792-7; Yeh SY, 2003, J EXP MED, V198, P1899, DOI 10.1084/jem.20031233; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhang LY, 2004, ENDOCRINOLOGY, V145, P781, DOI 10.1210/en.2003-0987	41	109	118	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33558	33565		10.1074/jbc.M504461200	http://dx.doi.org/10.1074/jbc.M504461200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16061480	hybrid			2022-12-27	WOS:000232058100056
J	Bayrer, JR; Zhang, W; Weiss, MA				Bayrer, JR; Zhang, W; Weiss, MA			Dimerization of doublesex is mediated by a cryptic ubiquitin-associated domain fold - Implications for sex-specific gene regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; DROSOPHILA-MELANOGASTER; TRANSCRIPTION-FACTOR; PROTEIN MODELS; UBA DOMAINS; C-CBL; DIFFERENTIATION; OLIGOMERIZATION; INTERSEX; ENHANCER	Male- and female-specific isoforms of the Doublesex (DSX) transcription factor regulate somatic sexual differentiation in Drosophila. The isoforms (DSXM and DSXF) share an N-terminal DNA-binding domain ( the DM motif), broadly conserved among metazoan sex-determining pathways. DM-DNA recognition is enhanced by a C-terminal dimerization domain. The crystal structure of this domain, determined at a resolution of 1.6 angstrom, reveals a novel dimeric arrangement of ubiquitin-associated (UBA) folds. Although this alpha-helical motif is well characterized in pathways of DNA repair and subcellular trafficking, to our knowledge this is its first report in a transcription factor. Dimerization is mediated by a non-canonical hydrophobic interface extrinsic to the putative ubiquitin binding surface. Key side chains at this interface, identified by alanine scanning mutagenesis, are conserved among DSX homologs. The mechanism of dimerization is thus unrelated to the low affinity domain swapping observed among ubiquitin-associated CUE domains. The unexpected observation of a ubiquitin-associated fold in DSX extends the repertoire of alpha-helical dimerization elements in transcription factors. The possibility that the ubiquitination machinery participates in the regulation of sexual dimorphism is discussed.	Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Weiss, MA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.	michael.weiss@case.edu	zhang, wei/A-7015-2011		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM07250] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AN WQ, 1995, EMBO J, V14, P1221, DOI 10.1002/j.1460-2075.1995.tb07105.x; An WQ, 1996, MOL CELL BIOL, V16, P3106; AN WQ, 1995, GENE DEV, V9, P256, DOI 10.1101/gad.9.2.256; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bayrer J, 2004, ACTA CRYSTALLOGR D, V60, P1328, DOI 10.1107/S0907444904012223; Bertolaet BL, 2001, J MOL BIOL, V313, P955, DOI 10.1006/jmbi.2001.5105; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Burtis KC, 1993, CURR OPIN CELL BIOL, V5, P1006, DOI 10.1016/0955-0674(93)90085-5; Calkhoven CF, 1996, BIOCHEM J, V317, P329, DOI 10.1042/bj3170329; Cavey JR, 2005, J BONE MINER RES, V20, P619, DOI 10.1359/JBMR.041205; Cho S, 1997, J BIOL CHEM, V272, P3185, DOI 10.1074/jbc.272.6.3185; Cho S, 1998, BIOCHEMISTRY-US, V37, P11301, DOI 10.1021/bi972916x; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; COSCHIGANO KT, 1993, GENE DEV, V7, P42, DOI 10.1101/gad.7.1.42; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; DeLano WL, 2002, PYMOL USERS MANUAL; Erdman SE, 1996, GENETICS, V144, P1639; ERDMAN SE, 1993, EMBO J, V12, P527, DOI 10.1002/j.1460-2075.1993.tb05684.x; Garrett-Engele CM, 2002, DEVELOPMENT, V129, P4661; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Liu J, 2003, J BIOL CHEM, V278, P36754, DOI 10.1074/jbc.M300664200; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Narayana N, 2001, J MOL BIOL, V310, P635, DOI 10.1006/jmbi.2001.4780; Narendra U, 2002, J BIOL CHEM, V277, P43463, DOI 10.1074/jbc.M204616200; NOTHIGER R, 1987, GENET RES, V50, P113, DOI 10.1017/S001667230002351X; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Sato S, 2003, J BIOL CHEM, V278, P49671, DOI 10.1074/jbc.C300444200; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; van den Akker F, 1999, ACTA CRYSTALLOGR D, V55, P206, DOI 10.1107/S0907444998007161; Waterbury JA, 1999, GENETICS, V152, P1653; ZHU BY, 1993, PROTEIN SCI, V2, P383; Zhu LY, 2000, GENE DEV, V14, P1750	46	40	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32989	32996		10.1074/jbc.M507990200	http://dx.doi.org/10.1074/jbc.M507990200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16049008	hybrid			2022-12-27	WOS:000231920300053
J	Chen, FH; Thomas, AO; Hecht, JT; Goldring, MB; Lawler, J				Chen, FH; Thomas, AO; Hecht, JT; Goldring, MB; Lawler, J			Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; MULTIPLE EPIPHYSEAL DYSPLASIA; HUMAN ARTICULAR-CARTILAGE; ALPHA-5-BETA-1 INTEGRIN; GENE-EXPRESSION; COMP; MUTATIONS; CALCIUM; PSEUDOACHONDROPLASIA; COLLAGEN	Cartilage oligomeric matrix protein/ thrombospondin 5 ( COMP/ TSP5) is a major component of the extracellular matrix of the musculoskeletal system. Although COMP/ TSP5 abnormalities are associated with several pathological conditions, its normal function remains unclear. This study was undertaken to delineate the function( s) of COMP/ TSP5 in cartilage, especially regarding its interaction with chondrocytes. We show that COMP/ TSP5 can support chondrocyte attachment and that the RGD sequence in COMP/ TSP5 and the integrin receptors alpha 5 beta 1 and alpha V beta 3 on the chondrocytes are involved in mediating this attachment. The interactions of COMP/ TSP5 with the integrins are dependent on COMP/ TSP5 conformation. Chondrocyte attachment to COMP/ TSP5 in the calcium- replete conformation was inhibited by function- blocking integrin alpha 5 and beta 1 antibodies, suggesting the involvement of the alpha 5 beta 1 integrin. Under this condition, a function- blocking antibody against alpha V beta 3 did not have any effect on cell attachment. On the other hand, chondrocyte attachment to reduced COMP/ TSP5 was instead sensitive to alpha V beta 3 function- blocking antibodies, suggesting that COMP/ TSP5 mediates attachment through chondrocyte alpha V beta 3 integrin under this condition. Cell attachment to reduced COMP/ TSP5 was not inhibited by beta 1 antibodies. These data indicate that COMP/ TSP5 in different conformations can utilize different integrin receptors. These results are the first to demonstrate that COMP/ TSP5 can mediate chondrocyte attachment through interactions with integrins. Through these interactions, COMP/ TSP5 may be able to regulate cellular activities and respond to environment in the surrounding cartilage matrix.	Columbia Univ, Dept Orthopaed Surg, New York, NY 10032 USA; Univ Texas, Sch Med, Dept Pediat, Houston, TX 77225 USA; Shriners Hosp Children, Houston, TX 77225 USA; Beth Israel Deaconess Med Ctr, Div Rheumatol, Dept Med, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Pathol, Div Tumor Biol & Angiogenesis, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Columbia University; University of Texas System; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Chen, FH (corresponding author), Columbia Univ, Dept Orthopaed Surg, New York, NY 10032 USA.	chenf1@mail.nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022021, R56AG022021] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL049081, R01 HL049081-12, R01 HL049081-07, R01 HL049081-08, R01 HL049081-13, R01 HL049081-10, R01 HL049081-09, R01 HL049081-11] Funding Source: Medline; NIA NIH HHS [R56 AG022021, R01 AG022021] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Attur MG, 2000, J IMMUNOL, V164, P2684, DOI 10.4049/jimmunol.164.5.2684; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Chen H, 2000, J BIOL CHEM, V275, P26538, DOI 10.1074/jbc.M909780199; CHEN H, 1994, J BIOL CHEM, V269, P32226; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; CLEMMENSEN I, 1982, HISTOCHEMISTRY, V76, P51, DOI 10.1007/BF00493284; Deere M, 1998, AM J MED GENET, V80, P510, DOI 10.1002/(SICI)1096-8628(19981228)80:5<510::AID-AJMG14>3.0.CO;2-F; Di Cesare PE, 2000, J ORTHOPAED RES, V18, P713, DOI 10.1002/jor.1100180506; Di Cesare PE, 2002, MATRIX BIOL, V21, P461, DOI 10.1016/S0945-053X(02)00015-X; DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6; DiCesare PE, 1996, J ORTHOPAED RES, V14, P946, DOI 10.1002/jor.1100140615; DICESARE PE, 1995, J ORTHOPAED RES, V13, P422, DOI 10.1002/jor.1100130316; DICESARE PE, 1994, EUR J BIOCHEM, V223, P927, DOI 10.1111/j.1432-1033.1994.tb19070.x; DiCesare PE, 1997, FEBS LETT, V412, P249, DOI 10.1016/S0014-5793(97)00789-8; Dodge GR, 1998, OSTEOARTHR CARTILAGE, V6, P435, DOI 10.1053/joca.1998.0147; DURR J, 1993, EXP CELL RES, V207, P235, DOI 10.1006/excr.1993.1189; Finger F, 2003, ARTHRITIS RHEUM-US, V48, P3395, DOI 10.1002/art.11341; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Hauser N, 1995, ACTA ORTHOP SCAND, V66, P71, DOI 10.3109/17453679509157651; Hausler G, 2002, CALCIFIED TISSUE INT, V71, P212, DOI 10.1007/s00223-001-2083-x; Hecht JT, 1998, MATRIX BIOL, V17, P269, DOI 10.1016/S0945-053X(98)90080-4; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Kipnes J, 2003, OSTEOARTHR CARTILAGE, V11, P442, DOI 10.1016/S1063-4584(03)00055-4; Kokenyesi R, 2000, ARCH BIOCHEM BIOPHYS, V383, P79, DOI 10.1006/abbi.2000.2044; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LAWLER J, 2002, ENCY MOL MED, P481; Lee HS, 2000, J BONE MINER RES, V15, P1501, DOI 10.1359/jbmr.2000.15.8.1501; Loeser RF, 2002, BIORHEOLOGY, V39, P119; LOESER RF, 1993, ARTHRITIS RHEUM, V36, P1103, DOI 10.1002/art.1780360811; Loeser RF, 2000, BIORHEOLOGY, V37, P109; Ma SU, 1998, ANN NY ACAD SCI, V857, P241, DOI 10.1111/j.1749-6632.1998.tb10122.x; Millward-Sadler SJ, 2000, ARTHRITIS RHEUM, V43, P2091, DOI 10.1002/1529-0131(200009)43:9<2091::AID-ANR21>3.0.CO;2-C; Millward-Sadler SJ, 1999, J CELL BIOL, V145, P183, DOI 10.1083/jcb.145.1.183; Millward-Sadler SJ, 2000, OSTEOARTHR CARTILAGE, V8, P272, DOI 10.1053/joca.1999.0301; Murphy JM, 1999, MATRIX BIOL, V18, P487, DOI 10.1016/S0945-053X(99)00042-6; Neidhart M, 1997, BRIT J RHEUMATOL, V36, P1151; NEWTON G, 1994, GENOMICS, V24, P435, DOI 10.1006/geno.1994.1649; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Petersson IF, 1998, BRIT J RHEUMATOL, V37, P46; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; SALTER DM, 1992, BRIT J RHEUMATOL, V31, P231; Salter DM, 2002, BIORHEOLOGY, V39, P97; SALTER DM, 1995, J HISTOCHEM CYTOCHEM, V43, P447, DOI 10.1177/43.4.7897185; Salter DM, 2001, CLIN ORTHOP RELAT R, pS49; Shakibaei M, 1998, EXP CELL RES, V240, P95, DOI 10.1006/excr.1998.3933; Smith RKW, 1997, MATRIX BIOL, V16, P255, DOI 10.1016/S0945-053X(97)90014-7; SOMMARIN Y, 1989, EXP CELL RES, V184, P181, DOI 10.1016/0014-4827(89)90376-5; SUN X, 1992, J CELL BIOL, V118, P693, DOI 10.1083/jcb.118.3.693; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; WOODS VL, 1994, ARTHRITIS RHEUM, V37, P537, DOI 10.1002/art.1780370414; Wright MO, 1997, J ORTHOPAED RES, V15, P742, DOI 10.1002/jor.1100150517	58	104	111	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32655	32661		10.1074/jbc.M504778200	http://dx.doi.org/10.1074/jbc.M504778200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16051604	hybrid, Green Accepted			2022-12-27	WOS:000231920300014
J	Shimada, M; Namikawa-Yamada, C; Nakanishi, M; Murakami, H				Shimada, M; Namikawa-Yamada, C; Nakanishi, M; Murakami, H			Regulation of Cdc2p and Cdc13p is required for cell cycle arrest induced by defective RNA splicing in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-II; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; S-PHASE; MUTANTS; GENE; CHECKPOINT; MITOSIS; PROTEIN	Screening of cdc mutants of fission yeast for those whose cell cycle arrest is independent of the DNA damage checkpoint identified the RNA splicing- deficient cdc28 mutant. A search for mutants of cdc28 cells that enter mitosis with unspliced RNA resulted in the identification of an orb5 point mutant. The orb5(+) gene, which encodes a catalytic subunit of casein kinase II, was found to be required for cell cycle arrest in other mutants with defective RNA metabolism but not for operation of the DNA replication or DNA damage checkpoints. Loss of function of wee1(+) or rad24(+) also suppressed the arrest of several splicing mutants. Overexpression of the major B- type cyclin Cdc13p induced cdc28 cells to enter mitosis. The abundance of Cdc13p was reduced, and the phosphorylation of Cdc2p on tyrosine 15 was maintained in splicing- defective cells. These results suggest that regulation of Cdc13p and Cdc2p is required for G(2) arrest in splicing mutants.	Nagoya City Univ, Grad Sch Med, Dept Biochem & Cell Biol, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Nagoya City University	Murakami, H (corresponding author), Nagoya City Univ, Grad Sch Med, Dept Biochem & Cell Biol, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	hmura@med.nagoya-cu.ac.jp						Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bernstein HS, 1998, J BIOL CHEM, V273, P4666, DOI 10.1074/jbc.273.8.4666; Berry LD, 1997, J CELL BIOL, V137, P1337, DOI 10.1083/jcb.137.6.1337; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Burns CG, 2002, MOL CELL BIOL, V22, P801, DOI 10.1128/MCB.22.3.801-815.2002; Dahan O, 2002, NUCLEIC ACIDS RES, V30, P4361, DOI 10.1093/nar/gkf563; Elder RT, 2001, VIROLOGY, V287, P359, DOI 10.1006/viro.2001.1007; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Habara Y, 2001, RNA, V7, P671, DOI 10.1017/S1355838201001200; HAYLES J, 1995, EMBO J, V14, P2760, DOI 10.1002/j.1460-2075.1995.tb07276.x; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; JOHNSTON LH, 1982, MOL GEN GENET, V186, P439, DOI 10.1007/BF00729466; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Lundgren K, 1996, MOL BIOL CELL, V7, P1083, DOI 10.1091/mbc.7.7.1083; MACNEILL SA, 1997, MOL CELLULAR BIOL YE, P697; Masuda M, 2000, J VIROL, V74, P2636, DOI 10.1128/JVI.74.6.2636-2646.2000; McDonald WH, 1999, MOL CELL BIOL, V19, P5352; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murakami H, 1999, GENE DEV, V13, P2581, DOI 10.1101/gad.13.19.2581; Murakami H, 2000, BIOCHEM J, V349, P1, DOI 10.1042/0264-6021:3490001; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Nam K, 1997, MOL CELL BIOL, V17, P809, DOI 10.1128/MCB.17.2.809; NASMYTH KA, 1977, CELL, V12, P1109, DOI 10.1016/0092-8674(77)90173-8; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; Ohi R, 1998, MOL CELL BIOL, V18, P4097, DOI 10.1128/MCB.18.7.4097; OHI R, 1994, EMBO J, V13, P471, DOI 10.1002/j.1460-2075.1994.tb06282.x; Okamoto Y, 1998, BIOCHEM BIOPH RES CO, V249, P872, DOI 10.1006/bbrc.1998.9247; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Potashkin J, 1998, CURR GENET, V34, P153, DOI 10.1007/s002940050381; ROUSSOU I, 1994, MOL CELL BIOL, V14, P576, DOI 10.1128/MCB.14.1.576; Rowley R, 1996, INT J RADIAT BIOL, V69, P565, DOI 10.1080/095530096145571; Russell P, 1998, TRENDS BIOCHEM SCI, V23, P399, DOI 10.1016/S0968-0004(98)01291-2; Seghezzi W, 1998, MOL CELL BIOL, V18, P4526, DOI 10.1128/MCB.18.8.4526; Shin CS, 2002, CELL, V111, P407, DOI 10.1016/S0092-8674(02)01038-3; SNELL V, 1994, EMBO J, V13, P2066, DOI 10.1002/j.1460-2075.1994.tb06481.x; Sun XJ, 2004, J BIOL CHEM, V279, P32839, DOI 10.1074/jbc.M402522200; Suzuki M, 2004, NAT CELL BIOL, V6, P861, DOI 10.1038/ncb1162; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; Urushiyama S, 1996, MOL GEN GENET, V253, P118, DOI 10.1007/s004380050304; VAISMAN N, 1995, MOL GEN GENET, V247, P123, DOI 10.1007/BF00705642; VIJAYRAGHAVAN U, 1989, GENE DEV, V3, P1206, DOI 10.1101/gad.3.8.1206; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	44	5	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32640	32648		10.1074/jbc.M504746200	http://dx.doi.org/10.1074/jbc.M504746200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16049013	hybrid			2022-12-27	WOS:000231920300012
J	Hahn-Windgassen, A; Nogueira, V; Chen, CC; Skeen, JE; Sonenberg, N; Hay, N				Hahn-Windgassen, A; Nogueira, V; Chen, CC; Skeen, JE; Sonenberg, N; Hay, N			Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; TUBEROUS SCLEROSIS COMPLEX; SERINE THREONINE KINASE; JEGHERS CANCER SYNDROME; TUMOR-SUPPRESSOR GENE; SIGNALING PATHWAY; PHOSPHORYLATION SITES; SKELETAL-MUSCLE; MTOR; TSC2	The serine/threonine kinase Akt is an upstream positive regulator of the mammalian target of rapamycin ( mTOR). However, the mechanism by which Akt activates mTOR is not fully understood. The known pathway by which Akt activates mTOR is via direct phosphorylation and inhibition of tuberous sclerosis complex 2 (TSC2), which is a negative regulator of mTOR. Here we establish an additional pathway by which Akt inhibits TSC2 and activates mTOR. We provide for the first time genetic evidence that Akt regulates intracellular ATP level and demonstrate that Akt is a negative regulator of the AMP-activated protein kinase ( AMPK), which is an activator of TSC2. We show that in Akt1/Akt2 DKO cells AMP/ATP ratio is markedly elevated with concomitant increase in AMPK activity, whereas in cells expressing activated Akt there is a dramatic decrease in AMP/ATP ratio and a decline in AMPK activity. Currently, the Akt-mediated phosphorylation of TSC2 and the inhibition of AMPK-mediated phosphorylation of TSC2 are viewed as two separate pathways, which activate mTOR. Our results demonstrate that Akt lies upstream of these two pathways and induces full inhibition of TSC2 and activation of mTOR both through direct phosphorylation and by inhibition of AMPK-mediated phosphorylation of TSC2. We propose that the activation of mTOR by Akt-mediated cellular energy and inhibition of AMPK is the predominant pathway by which Akt activates mTOR in vivo.	Univ Illinois, Coll Med, Dept Biochem & Mol Genet MC 669, Chicago, IL 60607 USA; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Ctr Canc, Montreal, PQ H3G 1Y6, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; McGill University; McGill University	Hay, N (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet MC 669, 900 S Ashland Ave, Chicago, IL 60607 USA.	nhay@uic.edu			NATIONAL CANCER INSTITUTE [R01CA090764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016927] Funding Source: NIH RePORTER; NCI NIH HHS [CA090764] Funding Source: Medline; NIA NIH HHS [AG016927] Funding Source: Medline; NIDDK NIH HHS [T32DK007739] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Eves EM, 1998, MOL CELL BIOL, V18, P2143, DOI 10.1128/MCB.18.4.2143; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; HA J, 1994, J BIOL CHEM, V269, P22162; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Parsons Ramon, 2003, Methods Mol Biol, V222, P147; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Sekulic A, 2000, CANCER RES, V60, P3504; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	48	427	443	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32081	32089		10.1074/jbc.M502876200	http://dx.doi.org/10.1074/jbc.M502876200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16027121	hybrid, Green Published			2022-12-27	WOS:000231794800007
J	Paine, ML; Luo, W; Wang, HJ; Bringas, P; Ngan, AYW; Miklus, VG; Zhu, DH; MacDougall, M; White, SN; Snead, ML				Paine, ML; Luo, W; Wang, HJ; Bringas, P; Ngan, AYW; Miklus, VG; Zhu, DH; MacDougall, M; White, SN; Snead, ML			Dentin sialoprotein and dentin phosphoprotein overexpression during amelogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPERFECTA TYPE-III; DENTINOGENESIS-IMPERFECTA; ENAMEL JUNCTION; IN-VIVO; GENE-EXPRESSION; HUMAN TEETH; SEQUENCE DETERMINATION; MONOCLONAL-ANTIBODIES; MECHANICAL-PROPERTIES; MATRIX	The gene for dentin sialophosphoprotein produces a single protein that is post-translationally modified to generate two distinct extracellular proteins: dentin sialoprotein and dentin phosphoprotein. In teeth, dentin sialophosphoprotein is expressed primarily by odontoblast cells, but is also transiently expressed by presecretory ameloblasts. Because of this expression profile it appears that dentin sialophosphoprotein contributes to the early events of amelogenesis, and in particular to those events that result in the formation of the dentino-enamel junction and the adjacent "aprismatic" enamel. Using a transgenic animal approach we have extended dentin sialoprotein or dentin phosphoprotein expression throughout the developmental stages of amelogenesis. Overexpression of dentin sialoprotein results in an increased rate of enamel mineralization, however, the enamel morphology is not significantly altered. In wildtype animals, the inclusion of dentin sialoprotein in the forming aprismatic enamel may account for its increased hardness properties, when compared with bulk enamel. In contrast, the overexpression of dentin phosphoprotein creates "pitted" and "chalky" enamel of non-uniform thickness that is more prone to wear. Disruptions to the prismatic enamel structure are also a characteristic of the dentin phosphoprotein overexpressing animals. These data support the previous suggestion that dentin sialoprotein and dentin phosphoprotein have distinct functions related to tooth formation, and that the dentino-enamel junction should be viewed as a unique transition zone between enamel and the underlying dentin. These results support the notion that the dentin proteins expressed by presecretory ameloblasts contribute to the unique properties of the dentino-enamel junction.	Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA; Univ Texas, Hlth Sci Ctr, Sch Dent, Dept Pediat Dent, San Antonio, TX 78284 USA	University of Southern California; University of California System; University of California Los Angeles; University of Texas System; University of Texas Health San Antonio	Paine, ML (corresponding author), Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA.	paine@usc.edu	MacDougall, Mary/ABG-8212-2021		NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K22DE014189, R01DE009875, R01DE013404, P01DE013221, R29DE009875, R37DE013045] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE14189, DE13404, DE13221, DE13045, DE09875] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ARSENAULT AL, 1989, CALCIFIED TISSUE INT, V45, P111, DOI 10.1007/BF02561410; Baba O, 2004, EUR J ORAL SCI, V112, P163, DOI 10.1111/j.0909-8836.2004.00110.x; Balooch G, 2004, J BIOMECH, V37, P1223, DOI 10.1016/j.jbiomech.2003.12.012; Begue-Kirn C, 1998, EUR J ORAL SCI, V106, P963, DOI 10.1046/j.0909-8836.1998.eos106510.x; Begue-Kirn C, 1998, EUR J ORAL SCI, V106, P254, DOI 10.1111/j.1600-0722.1998.tb02184.x; BRONCKERS ALJJ, 1986, COLLAGEN REL RES, V6, P1; CROSBY AH, 1995, AM J HUM GENET, V57, P832; Dong J, 2005, AM J MED GENET A, V132A, P305, DOI 10.1002/ajmg.a.30460; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; ELLIOTT P, 1994, J X-RAY SCI TECHNOL, V4, P102; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FINCHAM AG, 1995, J STRUCT BIOL, V115, P50, DOI 10.1006/jsbi.1995.1029; Fong H, 2000, MAT SCI ENG C-BIO S, V7, P119, DOI 10.1016/S0928-4931(99)00133-2; HOGAN B, 1986, MANIPULATING MOUSE E; IGNELZI MA, 1995, CRIT REV ORAL BIOL M, V6, P181, DOI 10.1177/10454411950060030201; Kantaputra PN, 2001, AM J MED GENET, V104, P75, DOI 10.1002/ajmg.10031; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; LEVIN LS, 1983, ORAL SURG ORAL MED O, V56, P267, DOI 10.1016/0030-4220(83)90008-7; LIN CP, 1994, J DENT RES, V73, P1072, DOI 10.1177/00220345940730050901; LIN CP, 1993, J HISTOCHEM CYTOCHEM, V41, P381, DOI 10.1177/41.3.8429200; Lu Ping, 2004, Zhonghua Kou Qiang Yi Xue Za Zhi, V39, P414; Luo W, 2004, CELLS TISSUES ORGANS, V177, P212, DOI 10.1159/000080134; LYNGSTADAAS SP, 1995, EMBO J, V14, P5224, DOI 10.1002/j.1460-2075.1995.tb00207.x; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; MacDougall M, 1998, CONNECT TISSUE RES, V39, P25, DOI 10.3109/03008209809023909; Marshall GW, 2001, J BIOMED MATER RES, V54, P87, DOI 10.1002/1097-4636(200101)54:1<87::AID-JBM10>3.0.CO;2-Z; Moradian-Oldak J, 2000, J STRUCT BIOL, V131, P27, DOI 10.1006/jsbi.2000.4237; Nagano T, 2003, J DENT RES, V82, P982, DOI 10.1177/154405910308201209; Oida S, 2002, J DENT RES, V81, P103, DOI 10.1177/154405910208100204; Paine CT, 2000, J BIOL CHEM, V275, P22284, DOI 10.1074/jbc.M000118200; Paine ML, 2003, J BIOL CHEM, V278, P19447, DOI 10.1074/jbc.M300445200; Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6; Paine ML, 2004, CELLS TISSUES ORGANS, V176, P7, DOI 10.1159/000075023; Paine ML, 2000, J STRUCT BIOL, V132, P191, DOI 10.1006/jsbi.2000.4324; Papagerakis P, 2002, CONNECT TISSUE RES, V43, P372, DOI [10.1080/713713533, 10.1080/03008200290000655]; Qin CL, 2001, J BIOL CHEM, V276, P904, DOI 10.1074/jbc.M006271200; RISNES S, 1985, SCAND J DENT RES, V93, P135; RITCHIE HH, 1994, J BIOL CHEM, V269, P3698; Ritchie HH, 1997, EUR J ORAL SCI, V105, P405, DOI 10.1111/j.1600-0722.1997.tb02137.x; Sambrook J., 2001, MOL CLONING LAB MANU; Snead ML, 1996, CONNECT TISSUE RES, V35, P41, DOI 10.3109/03008209609029173; Snead ML, 1998, CONNECT TISSUE RES, V38, P279, DOI 10.3109/03008209809017048; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; TAKAGI Y, 1986, J ORAL PATHOL MED, V15, P463, DOI 10.1111/j.1600-0714.1986.tb00659.x; TAKAGI Y, 1988, J ORAL PATHOL MED, V17, P208, DOI 10.1111/j.1600-0714.1988.tb01526.x; von Ebner V, 1906, ARCH MIKRO ANAT ENTW, V67, P18; Wang HJ, 2005, J BONE MINER RES, V20, P1032, DOI 10.1359/JBMR.050111; Wang RZ, 1998, J BIOMECH, V31, P135, DOI 10.1016/S0021-9290(97)00131-0; WEIDENREICH F, 1925, ANAT ENTW GERSCH, V76, P218; White SN, 2000, J AM CERAM SOC, V83, P238, DOI 10.1111/j.1151-2916.2000.tb01181.x; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yamakoshi Y, 2003, EUR J ORAL SCI, V111, P60, DOI 10.1034/j.1600-0722.2003.00009.x; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765	55	42	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31991	31998		10.1074/jbc.M502991200	http://dx.doi.org/10.1074/jbc.M502991200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16014627	hybrid			2022-12-27	WOS:000231665200079
J	Rilla, K; Siiskonen, H; Spicer, AP; Hyttinen, JMT; Tammi, MI; Tammi, RH				Rilla, K; Siiskonen, H; Spicer, AP; Hyttinen, JMT; Tammi, MI; Tammi, RH			Plasma membrane residence of hyaluronan synthase is coupled to its enzymatic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-C; BREFELDIN-A; IN-VIVO; ACTIVATION; BIOSYNTHESIS; CELLS; KERATINOCYTES; CD44; GENE	Hyaluronan is a multifunctional glycosaminoglycan up to 10(7) Da molecular mass produced by the integral membrane glycosyltransferase, hyaluronan synthase ( HAS). When expressed in keratinocytes, N-terminally tagged green fluorescent protein-HAS2 and -HAS3 isoenzymes were found to travel through endoplasmic reticulum ( ER), Golgi, plasma membrane, and endocytic vesicles. A distinct enrichment of plasma membrane HAS was found in cell protrusions. The total turnover time of HAS3 was 4 - 5 h as judged by the green fluorescent protein signal decay and hyaluronan synthesis inhibition in cycloheximide-treated cells. The transfer from ER to Golgi took about 1 h, and the dwell time on the plasma membrane was less than 2 h in experiments with a relief and introduction, respectively, of brefeldin A. Constructs of HAS3 with 16- and 45-amino-acid C-terminal deletions mostly stayed within the ER, whereas a D216A missense mutant was localized within the Golgi complex but not the plasma membrane. Both types of mutations were almost or completely inactive, similar to the wild type enzyme that had its entry to the plasma membrane experimentally blocked by brefeldin A. Inhibition of hyaluronan synthesis by UDP-glucuronic acid starvation using 4-methyl-umbelliferone also prevented HAS access to the plasma membrane. The results demonstrate that 1) a latent pool of HAS exists within the ER-Golgi pathway; 2) this pool can be rapidly mobilized and activated by insertion into the plasma membrane; and 3) inhibition of HAS activity through mutation or substrate starvation results in exclusion of HAS from the plasma membrane.	Univ Kuopio, Dept Anat, FIN-70211 Kuopio, Finland; Texas A&M Univ, Syst Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	University of Eastern Finland; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Rilla, K (corresponding author), Univ Kuopio, Dept Anat, POB 1627, FIN-70211 Kuopio, Finland.	kirsi.rilla@uku.fi	Tammi, Markku/AAQ-7878-2021	Rilla, Kirsi/0000-0002-7862-5727; Hyttinen, Juha/0000-0002-3414-4032				Anggiansah CL, 2003, J PHYSIOL-LONDON, V550, P631, DOI 10.1113/jphysiol.2003.038943; BADEN HP, 1983, J INVEST DERMATOL, V80, P124, DOI 10.1111/1523-1747.ep12532899; BANSAL MK, 1986, BIOCHEM J, V236, P515, DOI 10.1042/bj2360515; Bodevin-Authelet S, 2005, J BIOL CHEM, V280, P8813, DOI 10.1074/jbc.M412803200; Brinck J, 1999, EXP CELL RES, V252, P342, DOI 10.1006/excr.1999.4645; CALABRO A, 1994, J BIOL CHEM, V269, P22764; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; DeAngelis PL, 2002, ANAT RECORD, V268, P317, DOI 10.1002/ar.10163; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Heldermon C, 2001, J BIOL CHEM, V276, P2037, DOI 10.1074/jbc.M002276200; HELDIN P, 1992, BIOCHEM J, V283, P165, DOI 10.1042/bj2830165; Hiltunen ELJ, 2002, CANCER RES, V62, P6410; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; KITCHEN JR, 1995, BIOCHEM J, V309, P649, DOI 10.1042/bj3090649; Koprunner M, 2000, MECH DEVELOP, V90, P275, DOI 10.1016/S0925-4773(99)00238-5; Mullegger J, 2003, BIOL CHEM, V384, P175, DOI 10.1515/BC.2003.019; NG CK, 1989, BIOCHEM J, V263, P761, DOI 10.1042/bj2630761; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; PRYDZ K, 1992, J CELL BIOL, V119, P259, DOI 10.1083/jcb.119.2.259; Pummill PE, 2003, J BIOL CHEM, V278, P19808, DOI 10.1074/jbc.M301097200; Rilla K, 2004, J INVEST DERMATOL, V123, P708, DOI 10.1111/j.0022-202X.2004.23409.x; Semino CE, 1996, P NATL ACAD SCI USA, V93, P4548, DOI 10.1073/pnas.93.10.4548; SMITH TJ, 1995, AM J PHYSIOL-CELL PH, V268, pC382, DOI 10.1152/ajpcell.1995.268.2.C382; Spicer AP, 1999, BIOCHEM SOC T, V27, P109, DOI 10.1042/bst0270109; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; SUZUKI M, 1995, BIOCHEM J, V307, P817, DOI 10.1042/bj3070817; Tammi R, 1998, J BIOL CHEM, V273, P28878, DOI 10.1074/jbc.273.44.28878; Tlapak-Simmons VL, 2005, J BIOL CHEM, V280, P13012, DOI 10.1074/jbc.M409788200; WANG C, 1992, HISTOCHEMISTRY, V98, P105, DOI 10.1007/BF00717001; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; WONGPALMS S, 1995, ARCH BIOCHEM BIOPHYS, V319, P383, DOI 10.1006/abbi.1995.1308; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497; YUSPA SH, 1980, BIOCHEM BIOPH RES CO, V97, P700, DOI 10.1016/0006-291X(80)90321-6	36	79	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31890	31897		10.1074/jbc.M504736200	http://dx.doi.org/10.1074/jbc.M504736200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16014622	hybrid			2022-12-27	WOS:000231665200068
J	Thimmaiah, KN; Easton, JB; Germain, GS; Morton, CL; Kamath, S; Buolamwini, JK; Houghton, PJ				Thimmaiah, KN; Easton, JB; Germain, GS; Morton, CL; Kamath, S; Buolamwini, JK; Houghton, PJ			Identification of N-10-substituted phenoxazines as potent and specific inhibitors of Akt signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; FORKHEAD TRANSCRIPTION FACTOR; PLECKSTRIN HOMOLOGY DOMAIN; VINCA ALKALOID RESISTANCE; PHOSPHOINOSITIDE 3-KINASE; CANCER-CELLS; TUMOR-SUPPRESSOR; PHOSPHATIDYLINOSITOL; PATHWAY; SURVIVAL	A series of 30 N-10-substituted phenoxazines were synthesized and screened as potential inhibitors of Akt. In cellular assays at 5 mu M, 17 compounds inhibited insulin-like growth factor 1 (IGF-I)-stimulated phosphorylation of Akt (Ser-473) by at least 50% but did not inhibit IGF-I-stimulated phosphorylation of Erk-1/2 (Thr-202/Tyr-204). Substitutions at the 2-position (Cl or CF3) did not alter inhibitory activity, whereas N-10-substitutions with derivatives having acetyl (20B) or morpholino (12B) side chain lost activity compared with propyl or butyl substituents ( 7B and 14B). Inhibition of Akt phosphorylation was associated with the inhibition of IGF-I stimulation of the mammalian target of rapamycin phosphorylation (Ser-2448 and Ser-2481), phosphorylation of p70 S6 kinase (Thr-389), and ribosomal protein S6 (Ser-235/ 236) in Rh1, Rh18, and Rh30 cell lines. The two most potent compounds 10-[4'-(N- diethylamino) butyl]-2-chlorophenoxazine (10B) and 10-[4'-[(beta-hydroxyethyl) piperazino]-butyl]2-chlorophenoxazine (15B) ( in vitro, IC50 similar to 1-2 mu M) were studied further. Inhibition of Akt phosphorylation correlated with inhibition of its kinase activity as determined in vitro after immunoprecipitation. Akt inhibitory phenoxazines did not inhibit the activity of recombinant phosphatidylinositol 3'-kinase, PDK1, or SGK1 but potently inhibited the kinase activity of recombinant Akt and Akt Delta PH, a mutant lacking the pleckstrin homology domain. Akt inhibitory phenoxazines blocked IGF-I-stimulated nuclear translocation of Akt in Rh1 cells and suppressed growth of Rh1, Rh18, and Rh30 cells (IC50 2-5 mu M), whereas " inactive" derivatives were >= 10-fold less potent inhibitors of cell growth. In contrast to rapamycin analogs, Akt inhibitory phenoxazines induced significant levels of apoptosis under serum-containing culture conditions at concentrations of agent consistent with Akt inhibition. Thus, the cellular responses to phenoxazine inhibitors of Akt appear qualitatively different from the rapamycin analogs. Modeling studies suggest inhibitory phenoxazines may bind in the ATP-binding site, although ATP competition studies were unable to distinguish between competitive and noncompetitive inhibition.	St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; Western Illinois Univ, Dept Chem, Macomb, IL 61455 USA; Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA	St Jude Children's Research Hospital; Western Illinois University; University of Tennessee System; University of Tennessee Health Science Center	Houghton, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Mol Pharmacol, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.houghton@stjude.org	Houghton, Peter/E-3265-2011	Easton, John/0000-0003-4503-6608	NATIONAL CANCER INSTITUTE [P01CA023099, R01CA077776, R01CA100202] Funding Source: NIH RePORTER; NCI NIH HHS [CA100202, CA77776, CA96996, CA23099, CA21675] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2002, CELL, V111, P9, DOI 10.1016/S0092-8674(02)01009-7; Barrett SF, 2005, BIOCHEM J, V385, P399; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Breitenlechner CB, 2004, J MED CHEM, V47, P1375, DOI 10.1021/jm0310479; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; Cheng JQ, 1996, P NATL ACAD SCI USA, V93, P3636, DOI 10.1073/pnas.93.8.3636; Cheng JQ, 2001, ENCY REFERENCE CANC, P35; Coffer PJ, 1998, BIOCHEM J, V335, P1; CZARNECKI JJ, 1984, BIOCHIM BIOPHYS ACTA, V800, P41, DOI 10.1016/0304-4165(84)90092-8; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Eregowda GB, 1999, ASIAN J CHEM, V11, P878; Eregowda GB, 2000, INDIAN J CHEM B, V39, P243; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; HORTON JK, 1993, MOL PHARMACOL, V44, P552; Hosoi H, 1999, CANCER RES, V59, P886; Hu YH, 2000, J MED CHEM, V43, P3045, DOI 10.1021/jm000117y; Hu YH, 2001, BIOORG MED CHEM LETT, V11, P173, DOI 10.1016/S0960-894X(00)00640-5; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kozikowski AP, 2003, J AM CHEM SOC, V125, P1144, DOI 10.1021/ja0285159; Krasilnikov MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P59; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Luo Y, 2004, BIOCHEMISTRY-US, V43, P1254, DOI 10.1021/bi034515p; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; McIlroy J, 1997, MOL CELL BIOL, V17, P248, DOI 10.1128/MCB.17.1.248; Meuillet EJ, 2003, MOL CANCER THER, V2, P389; Moore SM, 1998, CANCER RES, V58, P5239; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Reuveni H, 2002, BIOCHEMISTRY-US, V41, P10304, DOI 10.1021/bi0202530; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SHAYRESIEH L, 1999, NAT GENET, V2, P99; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; STEPHENS L, 1994, CURR BIOL, V4, P203, DOI 10.1016/S0960-9822(00)00049-X; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; THIMMAIAH KN, 1992, J MED CHEM, V35, P3358, DOI 10.1021/jm00096a009; THIMMAIAH KN, 1990, CANCER COMMUN, V2, P249, DOI 10.3727/095535490820874308; Thompson FH, 1996, CANCER GENET CYTOGEN, V87, P55, DOI 10.1016/0165-4608(95)00248-0; VANHAESEBROECK B, 1997, TRENDS BIOCHEM SCI, V276, P1848; VARTICOVSKI L, 1994, BBA-MOL BASIS DIS, V1226, P1, DOI 10.1016/0925-4439(94)90051-5; VAZQUEZ E, 2000, BIOCHIM BIOPHYS ACTA, V1470, pM21; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yu JH, 1998, J BIOL CHEM, V273, P30199, DOI 10.1074/jbc.273.46.30199	57	91	94	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31924	31935		10.1074/jbc.M507057200	http://dx.doi.org/10.1074/jbc.M507057200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16009706	hybrid			2022-12-27	WOS:000231665200072
J	Vullhorst, D; Buonanno, A				Vullhorst, D; Buonanno, A			Multiple GTF2I-like repeats of general transcription factor 3 exhibit DNA binding properties - Evidence for a common origin as a sequence-specific dna interaction module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILLIAMS-BEUREN-SYNDROME; TFII-I FAMILY; PROMOTER ACTIVITY; PROTEIN; RECOGNITION; EXPRESSION; DOMAIN	A hallmark of general transcription factor 3 (GTF3) is the presence of multiple GTF2I-like repeats that were suggested to mediate protein-protein interactions. However, we have recently demonstrated that repeat 4 is necessary and sufficient for binding of GTF3 to the bicoid-like motif of the Troponin I slow enhancer. Given the sequence similarity between different GTF2I-like repeats we hypothesized that DNA binding might be a common property of this domain type. We subjected five repeats of GTF3 to random oligonucleotide selection (SELEX) to assess their DNA binding potentials. We delineated the consensus sequence G(TC)G(A)GATTA(G)BG(A) for repeat 4 and showed that binding sites for GTF3 in enhancers for Troponin I and homeobox c8 (HOXc8) are in very good agreement with this motif. SELEX selections for repeats 5 and 2 enriched for oligonucleotides that were also bound by R4, suggesting that they share common sequence preferences, whereas repeat 3 exhibited relaxed sequence requirements for DNA binding. No binding was observed for repeat 1. We also show that GTF2I-like repeats 4 and 6 of transcription factor II-I (TFII- I) exhibit modest DNA binding properties. Lastly, we identified several amino acids of GTF3 repeat 4 required for high affinity protein-DNA interaction. Based on the ability of many repeats to bind DNA in vitro, we suggest that GTF2I-like domains evolved by duplication and diversification of a prototypic DNA-binding ancestor.	NICHD, Mol Neurobiol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Vullhorst, D (corresponding author), NICHD, Mol Neurobiol Sect, NIH, 35 Lincoln Dr, Bethesda, MD 20892 USA.	vullhord@mail.nih.gov		Vullhorst, Detlef/0000-0002-7947-8044	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000711] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000711] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bayarsaihan D, 2000, P NATL ACAD SCI USA, V97, P7342, DOI 10.1073/pnas.97.13.7342; Calvo S, 2001, MOL CELL BIOL, V21, P8490, DOI 10.1128/MCB.21.24.8490-8503.2001; Cheriyath V, 2001, J BIOL CHEM, V276, P8377, DOI 10.1074/jbc.M008411200; CHITTENDEN T, 1991, CELL, V65, P1073, DOI 10.1016/0092-8674(91)90559-H; Feledy JA, 1999, NUCLEIC ACIDS RES, V27, P764, DOI 10.1093/nar/27.3.764; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Hinsley TA, 2004, PROTEIN SCI, V13, P2588, DOI 10.1110/ps.04747604; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Nakayama M, 1996, MOL CELL BIOL, V16, P2408; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; O'Mahoney JV, 1998, MOL CELL BIOL, V18, P6641, DOI 10.1128/MCB.18.11.6641; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; Roy AL, 1997, EMBO J, V16, P7091, DOI 10.1093/emboj/16.23.7091; Roy AL, 2001, GENE, V274, P1, DOI 10.1016/S0378-1119(01)00625-4; Tantin D, 2004, J BIOL CHEM, V279, P5460, DOI 10.1074/jbc.M311177200; Tassabehji M, 2003, HUM MOL GENET, V12, pR229, DOI 10.1093/hmg/ddg299; Tay ESE, 2003, BIOCHEM J, V374, P359, DOI 10.1042/BJ20030189; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tussie-Luna MI, 2002, P NATL ACAD SCI USA, V99, P12807, DOI 10.1073/pnas.192464499; Vullhorst D, 2003, J BIOL CHEM, V278, P8370, DOI 10.1074/jbc.M209361200; Yan XM, 2000, BIOCHEM J, V345, P749, DOI 10.1042/0264-6021:3450749	22	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31722	31731		10.1074/jbc.M500593200	http://dx.doi.org/10.1074/jbc.M500593200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15987678	hybrid			2022-12-27	WOS:000231665200049
J	Maloney, G; Schroder, M; Bowie, AG				Maloney, G; Schroder, M; Bowie, AG			Vaccinia virus protein A52R activates p38 mitogen-activated protein kinase and potentiates lipopolysaccharide-induced interleukin-10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR-2; IL-10 GENE-EXPRESSION; REGULATORY T-CELLS; HOST-DEFENSE; STRANDED-RNA; ADAPTERS; PATHWAY; TARGETS; DOMAIN	Vaccinia virus (VV) has many mechanisms to suppress and modulate the host immune response. The VV protein A52R was previously shown to act as an intracellular inhibitor of nuclear factor kappa B (NF kappa B) signaling by Toll-like receptors (TLRs). Co-immunoprecipitation studies revealed that A52R interacted with both tumor necrosis factor receptor-associated factor 6 (TRAF6) and interleukin-1 receptor-associated kinase 2 (IRAK2). The effect of A52R on signals other than NF kappa B was not determined. Here, we show that A52R does not inhibit TLR-induced p38 or c-Jun amino N-terminal kinase (JNK) mitogen activating protein (MAP) kinase activation. Rather, A52R could drive activation of these kinases. Two lines of evidence suggested that the A52R/TRAF6 interaction was critical for these effects. First, A52R-induced p38 MAP kinase activation was inhibited by overexpression of the TRAF domain of TRAF6, which sequestered A52R and inhibited its interaction with endogenous TRAF6. Second, a truncated version of A52R, which interacted with IRAK2 and not TRAF6, was unable to activate p38. Because interleukin 10 (IL-10) production is strongly p38-dependent, we examined the effect of A52R on IL-10 gene induction. A52R was found to be capable of inducing the IL-10 promoter through a TRAF6-dependent mechanism. Furthermore, A52R enhanced lipopolysaccharide/TLR4-induced IL-10 production, while inhibiting the TLR-induced NF kappa B-dependent genes IL-8 and RANTES. These results show that although A52R inhibits NF kappa B activation by multiple TLRs it can simultaneously activate MAP kinases. A52R-mediated enhancement of TLR-induced IL-10 may be important to virulence, given the role of IL-10 in immunoregulation.	Trinity Coll Dublin, Dept Biochem, Sch Biochem & Immunol, Viral Immune Evas Grp, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Trinity Coll Dublin, Dept Biochem, Sch Biochem & Immunol, Viral Immune Evas Grp, Dublin 2, Ireland.	agbowie@tcd.ie	Schroder, Martina/E-5493-2010	Schroeder, Martina/0000-0003-1899-6048; Bowie, Andrew/0000-0001-5316-4373				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bartlett N, 2002, J GEN VIROL, V83, P1965, DOI 10.1099/0022-1317-83-8-1965; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fleming SB, 1997, J VIROL, V71, P4857, DOI 10.1128/JVI.71.6.4857-4861.1997; Foey AD, 1998, J IMMUNOL, V160, P920; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Huang YS, 2004, J BIOL CHEM, V279, P51697, DOI 10.1074/jbc.M410369200; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Jung YD, 2002, CYTOKINE, V18, P206, DOI 10.1006/cyto.2002.1034; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; LaMonica R, 2001, J BIOL CHEM, V276, P19889, DOI 10.1074/jbc.M100499200; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; McCoy SL, 2005, J IMMUNOL, V174, P3006, DOI 10.4049/jimmunol.174.5.3006; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moss B, 2001, FIELDS VIROLOGY, P2849; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Netea MG, 2004, TRENDS MICROBIOL, V12, P484, DOI 10.1016/j.tim.2004.09.004; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Park KJ, 2003, J BIOL CHEM, V278, P30711, DOI 10.1074/jbc.M209623200; Powell MJ, 2000, J IMMUNOL, V165, P292, DOI 10.4049/jimmunol.165.1.292; Rassa JC, 2003, MICROBES INFECT, V5, P961, DOI 10.1016/S1286-4579(03)00193-X; Schultheiss U, 2001, EMBO J, V20, P5678, DOI 10.1093/emboj/20.20.5678; Sing A, 2002, J IMMUNOL, V168, P1315, DOI 10.4049/jimmunol.168.3.1315; Sing A, 2002, J EXP MED, V196, P1017, DOI 10.1084/jem.20020908; Slezak K, 2000, CYTOKINE, V12, P900, DOI 10.1006/cyto.1999.0646; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; van den Broek M, 2000, J IMMUNOL, V164, P371, DOI 10.4049/jimmunol.164.1.371; Vockerodt M, 2001, VIROLOGY, V280, P183, DOI 10.1006/viro.2000.0768; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	49	62	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30838	30844		10.1074/jbc.M501917200	http://dx.doi.org/10.1074/jbc.M501917200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15998638	hybrid, Green Accepted			2022-12-27	WOS:000231487800024
J	Swarthout, JT; Lobo, S; Farh, L; Croke, MR; Greentree, WK; Deschenes, RJ; Linder, ME				Swarthout, JT; Lobo, S; Farh, L; Croke, MR; Greentree, WK; Deschenes, RJ; Linder, ME			DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H- and N-Ras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE LOCALIZATION; ZINC-FINGER DOMAIN; GOLGI-APPARATUS; PALMITOYLTRANSFERASE ACTIVITY; SACCHAROMYCES-CEREVISIAE; PALMITOYL TRANSFERASE; ENDOPLASMIC-RETICULUM; GENE-PRODUCT; IDENTIFICATION; TRAFFICKING	Covalent lipid modifications mediate the membrane attachment and biological activity of Ras proteins. All Ras isoforms are farnesylated and carboxyl-methylated at the terminal cysteine; H-Ras and N-Ras are further modified by palmitoylation. Yeast Ras is palmitoylated by the DHHC cysteine-rich domain-containing protein Erf2 in a complex with Erf4. Here we report that H- and N-Ras are palmitoylated by a human protein palmitoyltransferase encoded by the ZDHHC9 and GCP16 genes. DHHC9 is an integral membrane protein that contains a DHHC cysteine-rich domain. GCP16 encodes a Golgi-localized membrane protein that has limited sequence similarity to yeast Erf4. DHHC9 and GCP16 codistribute in the Golgi apparatus, a location consistent with the site of mammalian Ras palmitoylation in vivo. Like yeast Erf2(.)Erf4, DHHC9 and GCP16 form a protein complex, and DHHC9 requires GCP16 for protein fatty acyltransferase activity and protein stability. Purified DHHC9(.)GCP16 exhibits substrate specificity, palmitoylating H- and N-Ras but not myristoylated G(alpha i1) or GAP-43, proteins with N-terminal palmitoylation motifs. Hence, DHHC9(.)GCP16 displays the properties of a functional human ortholog of the yeast Ras palmitoyltransferase.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; Univ Iowa, Genet Program, Iowa City, IA 52242 USA; Natl Pingtung Teachers Coll, Dept Nat Sci Educ, Pingtung 900, Taiwan	Washington University (WUSTL); University of Iowa; University of Iowa	Linder, ME (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	mlinder@cellbiology.wustl.edu	Deschenes, Robert J/E-4926-2010; Linder, Maurine/AAU-9999-2021	Deschenes, Robert J/0000-0001-8325-4257; Linder, Maurine/0000-0003-2202-9712; Swarthout, John/0000-0002-3043-9386	NATIONAL CANCER INSTITUTE [R01CA050211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466] Funding Source: NIH RePORTER; NCI NIH HHS [CA050211, R01 CA050211, R01 CA050211-15A2] Funding Source: Medline; NIGMS NIH HHS [GM51466] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDREASEN TJ, 1983, BIOCHEMISTRY-US, V22, P4615, DOI 10.1021/bi00289a001; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Bivona TG, 2003, CURR OPIN CELL BIOL, V15, P136, DOI 10.1016/S0955-0674(03)00016-4; BOS JL, 1989, CANCER RES, V49, P4682; CAMP LA, 1993, J BIOL CHEM, V268, P22566; Chaudhary J, 2002, ENDOCRINOLOGY, V143, P426, DOI 10.1210/en.143.2.426; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Ducker CE, 2004, ONCOGENE, V23, P9230, DOI 10.1038/sj.onc.1208171; Dudler T, 1996, J BIOL CHEM, V271, P11541, DOI 10.1074/jbc.271.19.11541; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; Dunphy JT, 2001, J BIOL CHEM, V276, P43300, DOI 10.1074/jbc.M104275200; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Li BJ, 2002, J BIOL CHEM, V277, P28870, DOI 10.1074/jbc.M202388200; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; Ohta E, 2003, J BIOL CHEM, V278, P51957, DOI 10.1074/jbc.M310014200; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; SCHAFER WR, 1992, ANNU REV GENET, V26, P209, DOI 10.1146/annurev.ge.26.120192.001233; SCHUH SM, 1991, BRAIN RES, V565, P85, DOI 10.1016/0006-8993(91)91739-N; Seedorf M, 1999, MOL CELL BIOL, V19, P1547; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Washbourne P, 2004, NEURON, V44, P901, DOI 10.1016/S0896-6273(04)00799-8; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; Willumsen BM, 1996, ONCOGENE, V13, P1901; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhao LH, 2002, J BIOL CHEM, V277, P49352, DOI 10.1074/jbc.M209760200	41	240	249	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31141	31148		10.1074/jbc.M504113200	http://dx.doi.org/10.1074/jbc.M504113200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16000296	hybrid			2022-12-27	WOS:000231487800060
J	Spies, M; Dillingham, MS; Kowalczykowski, SC				Spies, M; Dillingham, MS; Kowalczykowski, SC			Translocation by the RecB motor is an absolute requirement for chi-recognition and RecA protein loading by RecBCD enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINATION HOTSPOT-CHI; SINGLE-STRANDED-DNA; SITE-DIRECTED MUTAGENESIS; CONSERVED LYSINE RESIDUE; ESCHERICHIA-COLI; HELICASE ACTIVITY; ATP HYDROLYSIS; BIOCHEMICAL-CHARACTERIZATION; HOMOLOGOUS RECOMBINATION; CONFORMATIONAL-CHANGES	RecBCD enzyme is a heterotrimeric helicase/nuclease that initiates homologous recombination at double-stranded DNA breaks. The enzyme is driven by two motor subunits, RecB and RecD, translocating on opposite single-strands of the DNA duplex. Here we provide evidence that, although both motor subunits can support the translocation activity for the enzyme, the activity of the RecB subunit is necessary for proper function of the enzyme both in vivo and in vitro. We demonstrate that the RecBCD(K177Q) enzyme, in which RecD helicase is disabled by mutation of the ATPase active site, complements recBCD deletion in vivo and displays all of the enzymatic activities that are characteristic of the wild-type enzyme in vitro. These include helicase and nuclease activities and the abilities to recognize the recombination hotspot chi and to coordinate the loading of RecA protein onto the ssDNA it produces. In contrast, the RecB(K29Q)CD enzyme, carrying a mutation in the ATPase site of RecB helicase, fails to complement recBCD deletion in vivo. We further show that even though RecBK29QCD enzyme displays helicase and nuclease activities, its inability to translocate along the 3'-terminated strand results in the failure to recognize chi and to load RecA protein. Our findings argue that translocation by the RecB motor is required to deliver RecC subunit to chi, whereas the RecD subunit has a dispensable motor activity but an indispensable regulatory function.	Univ Calif Davis, Microbiol Sect, Ctr Genet & Dev, Davis, CA 95616 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Ctr Genet & Dev, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Microbiol Sect, Ctr Genet & Dev, 1 shields Ave,Briggs Hall 310, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Dillingham, Mark/0000-0002-4612-7141; Spies, Maria/0000-0002-7375-8037	NIGMS NIH HHS [GM-41347] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041347] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; Amundsen SK, 2000, P NATL ACAD SCI USA, V97, P7399, DOI 10.1073/pnas.130192397; AMUNDSEN SK, 1990, GENETICS, V126, P25; AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; Arnold DA, 2000, J MOL BIOL, V300, P469, DOI 10.1006/jmbi.2000.3861; Arnold DA, 1998, J BIOL CHEM, V273, P16476, DOI 10.1074/jbc.273.26.16476; Arnold DA, 2000, J BIOL CHEM, V275, P12261, DOI 10.1074/jbc.275.16.12261; ARNOLD DA, 1999, ENCY LIFE SCI, P55; Bianco PR, 1997, P NATL ACAD SCI USA, V94, P6706, DOI 10.1073/pnas.94.13.6706; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; BOEHMER PE, 1992, J BIOL CHEM, V267, P4981; CHAUDHURY AM, 1984, J BACTERIOL, V160, P788, DOI 10.1128/JB.160.2.788-791.1984; CHAUDHURY AM, 1984, P NATL ACAD SCI-BIOL, V81, P7850, DOI 10.1073/pnas.81.24.7850; Chen HW, 1997, J BIOL CHEM, V272, P10072; Churchill JJ, 1999, GENE DEV, V13, P901, DOI 10.1101/gad.13.7.901; DEVRIES J, 1992, J GEN MICROBIOL, V138, P31, DOI 10.1099/00221287-138-1-31; Dillingham MS, 2005, J BIOL CHEM, V280, P37069, DOI 10.1074/jbc.M505520200; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; DIXON DA, 1991, CELL, V66, P361, DOI 10.1016/0092-8674(91)90625-9; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; DIXON DA, 1995, J BIOL CHEM, V270, P16360, DOI 10.1074/jbc.270.27.16360; DIXON DA, 1994, P NATL ACAD SCI USA, V91, P2980, DOI 10.1073/pnas.91.8.2980; EGGLESTON AK, 1993, J MOL BIOL, V231, P621, DOI 10.1006/jmbi.1993.1314; EGGLESTON AK, 1993, J MOL BIOL, V231, P605, DOI 10.1006/jmbi.1993.1313; Eggleston AK, 1996, NUCLEIC ACIDS RES, V24, P1179, DOI 10.1093/nar/24.7.1179; EGGLESTON AK, 1995, J BIOL CHEM, V270, P2024, DOI 10.1074/jbc.270.5.2024; Farah JA, 1997, J MOL BIOL, V272, P699, DOI 10.1006/jmbi.1997.1259; GANESAN S, 1993, J MOL BIOL, V229, P67, DOI 10.1006/jmbi.1993.1008; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; GRIFFITH J, 1985, BIOCHEMISTRY-US, V24, P158, DOI 10.1021/bi00322a022; Hall MC, 1998, J MOL BIOL, V277, P257, DOI 10.1006/jmbi.1997.1614; Handa N, 1997, GENES CELLS, V2, P525, DOI 10.1046/j.1365-2443.1997.1410339.x; HSIEH S, 1992, NUCLEIC ACIDS RES, V20, P5647, DOI 10.1093/nar/20.21.5647; KORANGY F, 1994, BIOCHEMISTRY-US, V33, P9552, DOI 10.1021/bi00198a022; KORANGY F, 1993, BIOCHEMISTRY-US, V32, P4873, DOI 10.1021/bi00069a024; KORANGY F, 1992, J BIOL CHEM, V267, P1727; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; LAM ST, 1974, GENETICS, V77, P425; LEBOWITZ J, 1985, BIOCH MECH STRAND IN; Mirshad JK, 2003, BIOCHEMISTRY-US, V42, P5945, DOI 10.1021/bi027233i; MYERS RS, 1994, ANNU REV GENET, V28, P49, DOI 10.1146/annurev.ge.28.120194.000405; PONTICELLI AS, 1985, CELL, V41, P145, DOI 10.1016/0092-8674(85)90069-8; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2863, DOI 10.1021/bi00433a018; ROMAN LJ, 1992, J BIOL CHEM, V267, P4207; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Soultanas P, 1999, J MOL BIOL, V290, P137, DOI 10.1006/jmbi.1999.2873; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Spies Maria, 2005, P389; TAYLOR AF, 1995, J BIOL CHEM, V270, P24451, DOI 10.1074/jbc.270.41.24451; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; TAYLOR AF, 1985, CELL, V41, P153, DOI 10.1016/0092-8674(85)90070-4; TAYLOR AF, 1995, J BIOL CHEM, V270, P24459, DOI 10.1074/jbc.270.41.24459	58	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2005	280	44					37078	37087		10.1074/jbc.M505521200	http://dx.doi.org/10.1074/jbc.M505521200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	978VT	16041060	hybrid			2022-12-27	WOS:000232901800066
J	Laudon, H; Hansson, EM; Melen, K; Bergman, A; Farmery, MR; Winblad, B; Lendahl, U; von Heijne, G; Naslund, J				Laudon, H; Hansson, EM; Melen, K; Bergman, A; Farmery, MR; Winblad, B; Lendahl, U; von Heijne, G; Naslund, J			A nine-transmembrane domain topology for presenilin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL PEPTIDE PEPTIDASE; GAMMA-SECRETASE COMPLEX; C-TERMINUS; PROTEIN TOPOLOGY; INTRAMEMBRANE PROTEOLYSIS; CAENORHABDITIS-ELEGANS; MEMBRANE TOPOLOGY; PRECURSOR PROTEIN; APH-1 INTERACTS; CELL-SURFACE	Presenilin ( PS) provides the catalytic core of the gamma- secretase complex. gamma- Secretase activity leads to generation of the amyloid beta- peptide, a key event implicated in the pathogenesis of Alzheimer disease. PS has ten hydrophobic regions, which can all theoretically form membrane- spanning domains. Various topology models have been proposed, and the prevalent view holds that PS has an eight-transmembrane ( TM) domain organization; however, the precise topology has not been unequivocally determined. Previous topological studies are based on non- functional truncated variants of PS proteins fused to reporter domains, or immunocytochemical staining. In this study, we used a more subtle N- linked glycosylation scanning approach, which allowed us to assess the topology of functional PS1 molecules. Glycosylation acceptor sequences were introduced into full- length human PS1, and the results showed that the first hydrophilic loop is oriented toward the lumen of the endoplasmic reticulum, whereas the N terminus and large hydrophilic loop are in the cytosol. Although this is in accordance with most current models, our data unexpectedly revealed that the C terminus localized to the luminal side of the endoplasmic reticulum. Additional studies on the glycosylation pattern after TM domain deletions, combined with computer- based TM protein topology predictions and biotinylation assays of different PS1 mutants, led us to conclude that PS1 has nine TM domains and that the C terminus locates to the lumen/ extracellular space.	Karolinska Inst, Novum, Dept Neurotec, Div Expt Geriatr, SE-14186 Huddinge, Sweden; Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; Stockholm Univ, Stockholm Bioinformat Ctr, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Stockholm University	Laudon, H (corresponding author), Karolinska Inst, Novum, Dept Neurotec, Div Expt Geriatr, SE-14186 Huddinge, Sweden.	Hanna.Laudon@neurotec.ki.se	von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011	von Heijne, Gunnar/0000-0002-4490-8569; Lendahl, Urban/0000-0001-9543-8141				Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; Bergman A, 2004, J BIOL CHEM, V279, P16744, DOI 10.1074/jbc.M313999200; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; DeStrooper B, 1997, J BIOL CHEM, V272, P3590, DOI 10.1074/jbc.272.6.3590; Dewji NN, 1997, P NATL ACAD SCI USA, V94, P14025, DOI 10.1073/pnas.94.25.14025; Dewji NN, 2004, P NATL ACAD SCI USA, V101, P1057, DOI 10.1073/pnas.0307290101; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Hansson EM, 2005, J NEUROCHEM, V92, P1010, DOI 10.1111/j.1471-4159.2004.02926.x; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Karlstrom H, 2002, J BIOL CHEM, V277, P6763, DOI 10.1074/jbc.C100649200; Kim J, 2004, P NATL ACAD SCI USA, V101, P905, DOI 10.1073/pnas.0307297101; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Laudon H, 2004, J NEUROCHEM, V89, P44, DOI 10.1046/j.1471-4159.2003.02298.x; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Lehmann S, 1997, J BIOL CHEM, V272, P12047, DOI 10.1074/jbc.272.18.12047; Li XJ, 1996, NEURON, V17, P1015, DOI 10.1016/S0896-6273(00)80231-7; Li XJ, 1998, P NATL ACAD SCI USA, V95, P7109, DOI 10.1073/pnas.95.12.7109; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Mathews PM, 2000, MOL MED, V6, P878, DOI 10.1007/BF03401825; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; Nakai T, 1999, J BIOL CHEM, V274, P23647, DOI 10.1074/jbc.274.33.23647; Nilsson I, 2000, J BIOL CHEM, V275, P17338, DOI 10.1074/jbc.M002317200; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Seeger M, 1997, P NATL ACAD SCI USA, V94, P5090, DOI 10.1073/pnas.94.10.5090; Smine A, 1998, J BIOL CHEM, V273, P16281, DOI 10.1074/jbc.273.26.16281; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Taniguchi Y, 2002, P NATL ACAD SCI USA, V99, P4014, DOI 10.1073/pnas.052017699; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; WELPLY JK, 1983, J BIOL CHEM, V258, P1856; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xu XM, 1999, J BIOL CHEM, V274, P32543, DOI 10.1074/jbc.274.46.32543; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	50	152	156	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2005	280	42					35352	35360		10.1074/jbc.M507217200	http://dx.doi.org/10.1074/jbc.M507217200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973ZN	16046406	hybrid			2022-12-27	WOS:000232561200034
J	Botte, C; Jeanneau, C; Snajdrova, L; Bastien, O; Imberty, A; Breton, C; Marechal, E				Botte, C; Jeanneau, C; Snajdrova, L; Bastien, O; Imberty, A; Breton, C; Marechal, E			Molecular modeling and site-directed mutagenesis of plant chloroplast monogalactosyldiacylglycerol synthase reveal critical residues for activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATE DEPRIVATION; PAIRWISE ALIGNMENTS; ENVELOPE MEMBRANES; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GALACTOLIPIDS; BIOSYNTHESIS; MGDG; PURIFICATION; INFORMATION	Monogalactosyldiacylglycerol ( MGDG), the major lipid of plant and algal plastids, is synthesized by MGD ( or MGDG synthase), a dimeric and membrane-bound glycosyltransferase of the plastid envelope that catalyzes the transfer of a galactosyl group from a UDP-galactose donor onto a diacylglycerol acceptor. Although this enzyme is essential for biogenesis, and therefore an interesting target for herbicide design, no structural information is available. MGD monomers share sequence similarity with MURG, a bacterial glycosyltransferase catalyzing the transfer of N-acetyl-glucosamine on Lipid 1. Using the x-ray structure of Escherichia coli MURG as a template, we computed a model for the fold of Spinacia oleracea MGD. This structural prediction was supported by site-directed mutagenesis analyses. The predicted monomer architecture is a double Rossmann fold. The binding site for UDP-galactose was predicted in the cleft separating the two Rossmann folds. Two short segments of MGD ([beta 2-alpha 2] and [beta 6-beta 7] loops) have no counterparts in MURG, and their structure could not be determined. Combining the obtained model with phylogenetic and biochemical information, we collected evidence supporting the [beta 2-alpha 2] loop in the N-domain as likely to be involved in diacylglycerol binding. Additionally, the monotopic insertion of MGD in one membrane leaflet of the plastid envelope occurs very likely at the level of hydrophobic amino acids of the N-terminal domain.	Univ Grenoble 1, INRA, CEA,CNRS,UMR 5168, Dept Response & Dynam Cellulaires, F-38054 Grenoble, France; CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble, France; Gene IT, F-92500 Rueil Malmaison, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Marechal, E (corresponding author), Univ Grenoble 1, INRA, CEA,CNRS,UMR 5168, Dept Response & Dynam Cellulaires, 17 Rue Martyrs, F-38054 Grenoble, France.	emarechal@cea.fr	Botte, Cyrille/G-1972-2014; Bastien, Olivier/B-9723-2008; Imberty, Anne/P-6451-2018	Botte, Cyrille/0000-0002-2245-536X; Imberty, Anne/0000-0001-6825-9527				Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; Archibald JM, 2002, TRENDS GENET, V18, P577, DOI 10.1016/S0168-9525(02)02777-4; Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; BAKER PJ, 1992, J MOL BIOL, V228, P662, DOI 10.1016/0022-2836(92)90848-E; Bastien O, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-49; Bastien O, 2004, BIOINFORMATICS, V20, P534, DOI 10.1093/bioinformatics/btg440; Benning C, 2005, J BIOL CHEM, V280, P2397, DOI 10.1074/jbc.R400032200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOCK MA, 1983, J BIOL CHEM, V258, P3281; BLUNDELL T, 1988, EUR J BIOCHEM, V172, P513, DOI 10.1111/j.1432-1033.1988.tb13917.x; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; CLINE K, 1983, PLANT PHYSIOL, V85, P780; Codani JJ, 1999, METHOD MICROBIOL, V28, P229; Cohen Z, 2000, BIOCHEM SOC T, V28, P740, DOI 10.1042/BST0280740; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Comet JP, 1999, COMPUT CHEM, V23, P317, DOI 10.1016/S0097-8485(99)00008-X; Coutinho Pedro M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P307; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Crouvoisier M, 1999, FEBS LETT, V449, P289, DOI 10.1016/S0014-5793(99)00412-3; Dormann P, 1999, SCIENCE, V284, P2181, DOI 10.1126/science.284.5423.2181; Douce, 1987, BIOCH PLANTS, P215, DOI 10.1016/B978-0-12-675409-4.50015-0; DOUCE R, 1974, SCIENCE, V183, P852, DOI 10.1126/science.183.4127.852; DOUCE R, 1973, J BIOL CHEM, V248, P7215; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Feige G, 1980, BIOGENESIS FUNCTION, P135; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FERRARI RA, 1961, ARCH BIOCHEM BIOPHYS, V93, P185, DOI 10.1016/0003-9861(61)90248-X; GOUNARIS K, 1983, TRENDS BIOCHEM SCI, V8, P378, DOI 10.1016/0968-0004(83)90366-3; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; Hartel H, 2000, P NATL ACAD SCI USA, V97, P10649, DOI 10.1073/pnas.180320497; Hartel H, 2000, BIOCHEM SOC T, V28, P729, DOI 10.1042/BST0280729; Heinz E., 1977, Lipids and lipid polymers in higher plants., P102; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; IMBERTY A, 1999, PERSPECTIVES STRUCTU, P392; JANERO DR, 1981, J LIPID RES, V22, P1119; JONES D, 1993, J COMPUT AID MOL DES, V7, P439, DOI 10.1007/BF02337560; Jouhet J, 2004, J CELL BIOL, V167, P863, DOI 10.1083/jcb.200407022; Joyard Jacques, 1993, P231; Keeling Patrick J, 2004, Science, V306, P2191; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MARECHAL E, 1995, J BIOL CHEM, V270, P5714, DOI 10.1074/jbc.270.11.5714; MARECHAL E, 1994, J BIOL CHEM, V269, P5788; Marechal E, 2002, EUKARYOT CELL, V1, P653, DOI 10.1128/EC.1.4.653-656.2002; Marechal E, 2000, BIOCHEM SOC T, V28, P732, DOI 10.1042/BST0280732; MARECHAL E, 1991, CR ACAD SCI III-VIE, V313, P521; MATSON RS, 1970, PLANT PHYSIOL, V45, P531, DOI 10.1104/pp.45.4.531; Miege C, 1999, EUR J BIOCHEM, V265, P990, DOI 10.1046/j.1432-1327.1999.00801.x; MURATA N, 1982, BIOCH METABOLISM PLA, P165; NEUFELD EF, 1964, BIOCHEM BIOPH RES CO, V14, P503, DOI 10.1016/0006-291X(64)90259-1; Nishiyama Y, 2003, PROTEIN EXPRES PURIF, V31, P79, DOI 10.1016/S1046-5928(03)00158-X; Pali T, 2003, CELL MOL LIFE SCI, V60, P1591, DOI 10.1007/s00018-003-3173-x; Petrova P, 1999, J AM CHEM SOC, V121, P5535, DOI 10.1021/ja983854g; Qi YH, 2004, PLANTA, V219, P450, DOI 10.1007/s00425-004-1245-2; Sanina NM, 2004, PHYTOCHEMISTRY, V65, P721, DOI 10.1016/j.phytochem.2004.01.013; Sato N, 2003, BBA-MOL CELL BIOL L, V1633, P27, DOI 10.1016/S1388-1981(03)00069-6; Shimojima M, 1997, P NATL ACAD SCI USA, V94, P333, DOI 10.1073/pnas.94.1.333	59	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34691	34701		10.1074/jbc.M505622200	http://dx.doi.org/10.1074/jbc.M505622200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16009708	Green Published, hybrid			2022-12-27	WOS:000232403900039
J	Ceci, P; Ilari, A; Falvo, E; Giangiacomo, L; Chiancone, E				Ceci, P; Ilari, A; Falvo, E; Giangiacomo, L; Chiancone, E			Reassessment of protein stability, DNA binding, and protection of Mycobacterium smegmatis Dps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI DPS; LISTERIA-INNOCUA; DODECAMERIC FERRITIN; STATIONARY-PHASE; IRON; CELLS; PARATUBERCULOSIS; AGGREGATION; SITE	The structure and function of Mycobacterium smegmatis Dps (DNA-binding proteins from starved cells) and of the protein studied by Gupta and Chatterji ( Gupta, S., and Chatterji, D. ( 2003) J. Biol. Chem. 278, 5235 - 5241), in which the C terminus that is used for binding DNA contains a histidine tag, have been characterized in parallel. The native dodecamer dissociated reversibly into dimers above pH 7.5 and below pH 6.0, with apparent pK(a) values of similar to 7.65 and 4.75; at pH similar to 4.0, dimers formed monomers. Based on structural analysis, the two dissociation steps have been attributed to breakage of the salt bridges between Glu(157) and Arg(99) located at the 3-fold symmetry axes and to protonation of Asp(66) hydrogen-bonded to Lys(36) across the dimer interface, respectively. The C-terminal tag did not affect subunit dissociation, but altered DNA binding dramatically. At neutral pH, protonation of the histidine tag promoted DNA condensation, whereas in the native C terminus, compensation of negative and positive charges led to DNA binding without condensation. This different mode of interaction with DNA has important functional consequences as indicated by the failure of the native protein to protect DNA from DNase-mediated cleavage and by the efficiency of the tagged protein in doing so as a result of DNA sequestration in the condensates. Chemical protection of DNA from oxidative damage is realized by Dps proteins in a multistep iron oxidation/ uptake/ mineralization process. Dimers have a decreased protection efficiency due to disruption of the dodecamer internal cavity, where iron is deposited and mineralized after oxidation at the ferroxidase center.	Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Natl Res Council, Inst Mol Biol & Pathol, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Chiancone, E (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Biochim, CNR, Ist Biol & Patol Mol, Ple A Moro 5, I-00185 Rome, Italy.	emilia.chiancone@uniroma1.it	Ilari, Andrea/AAC-7670-2022; Ilari, Andrea/T-5501-2017	Ilari, Andrea/0000-0002-7754-399X; Ilari, Andrea/0000-0002-7754-399X; Ceci, Pierpaolo/0000-0001-7712-8430; Falvo, Elisabetta/0000-0001-9584-8669				ANTONINI E, 1977, ANNU REV BIOPHYS BIO, V6, P239, DOI 10.1146/annurev.bb.06.060177.001323; Bozzi M, 1997, J BIOL CHEM, V272, P3259, DOI 10.1074/jbc.272.6.3259; Ceci P, 2004, NUCLEIC ACIDS RES, V32, P5935, DOI 10.1093/nar/gkh915; Ceci P, 2003, J BIOL CHEM, V278, P20319, DOI 10.1074/jbc.M302114200; Chacon O, 2004, ANNU REV MICROBIOL, V58, P329, DOI 10.1146/annurev.micro.58.030603.123726; Chiaraluce R, 2000, EUR J BIOCHEM, V267, P5733, DOI 10.1046/j.1432-1327.2000.01639.x; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Ergan B, 2004, RESPIROLOGY, V9, P283, DOI 10.1111/j.1440-1843.2004.00570.x; Fitch CA, 2002, BIOPHYS J, V82, P3289, DOI 10.1016/S0006-3495(02)75670-1; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Gupta S, 2003, J BIOL CHEM, V278, P5235, DOI 10.1074/jbc.M208825200; Gupta S, 2002, PROTEIN ENG, V15, P503, DOI 10.1093/protein/15.6.503; Ilari A, 2000, NAT STRUCT BIOL, V7, P38; Ilari A, 2002, J BIOL CHEM, V277, P37619, DOI 10.1074/jbc.M206186200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LARY JW, 1998, REEDIT; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; MCREE DE, 1993, PRACTICAL PROTEIN CR, P365; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papinutto E, 2002, J BIOL CHEM, V277, P15093, DOI 10.1074/jbc.M112378200; Pulliainen AT, 2003, J BIOL CHEM, V278, P7996, DOI 10.1074/jbc.M210174200; Rao M, 2001, MICROBIOL-UK, V147, P1017, DOI 10.1099/00221287-147-4-1017; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Roy S, 2004, J MOL BIOL, V339, P1103, DOI 10.1016/j.jmb.2004.04.042; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Skiest DJ, 1998, SOUTHERN MED J, V91, P36, DOI 10.1097/00007611-199801000-00007; Whittington RJ, 2004, APPL ENVIRON MICROB, V70, P2989, DOI 10.1128/AEM.70.5.2989-3004.2004; Wolf SG, 1999, NATURE, V400, P83, DOI 10.1038/21918; Yamamoto Y, 2000, J BACTERIOL, V182, P3740, DOI 10.1128/JB.182.13.3740-3747.2000; YPHANTIS DA, 1997, WINNONLIN; Zanotti G, 2002, J MOL BIOL, V323, P125, DOI 10.1016/S0022-2836(02)00879-3; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	36	50	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34776	34785		10.1074/jbc.M502343200	http://dx.doi.org/10.1074/jbc.M502343200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16030020	hybrid			2022-12-27	WOS:000232403900049
J	Kim, W; Hecht, MH				Kim, W; Hecht, MH			Sequence determinants of enhanced amyloidogenicity of Alzheimer A beta 42 peptide relative to A beta 40	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOFLAVINE-T INTERACTION; AMYLOID FIBRIL FORMATION; PROTEIN A-BETA; FORMING PROTEINS; IN-VIVO; DISEASE; AGGREGATION; MUTATIONS; PATHOLOGY; BRAIN	Aggregation of proteins into insoluble deposits is associated with a variety of human diseases. In Alzheimer disease, the aggregation of amyloid beta(A beta) peptides is believed to play a key role in pathogenesis. Although the 40-mer (A beta 40) is produced in vivo at higher levels than the 42-mer (A beta 42), senile plaque in diseased brains is composed primarily of A beta 42. Likewise, in vitro, A beta 42 forms fibrils more rapidly than A4 beta 0. The enhanced amyloidogenicity of A beta 42 could be due simply to its greater length. Alternatively, specific properties of residues Ile(41) and Ala(42) might favor aggregation. To distinguish between these two possibilities, we constructed a library of sequences in which residues 41 and 42 were randomized. The aggregation behavior of the resulting sequences was assessed using a high throughput screen, based on the finding that fusions of A beta 42 to green fluorescence protein (GFP) prevent the folding and fluorescence of GFP, whereas mutations in A beta 42 that disrupt aggregation produce green fluorescent fusions. Correlations between the sequences of A beta 42 mutants and the fluorescence of A beta 42-GFP fusions in vivo were confirmed in vitro through biophysical studies of synthetic 42-residue peptides. The data reveal a strong correlation between aggregation propensity and the hydrophobicity and beta-sheet propensities of residues at positions 41 and 42. Moreover, several mutants containing hydrophilic residues and/or beta-sheet breakers at positions 41 and/or 42 were less prone to aggregate than A beta 40 wherein these two residues are deleted entirely. Thus, properties of the side chains at positions 41 and 42, rather than length per se, cause A beta 42 to aggregate more readily than A beta 40.	Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University	Hecht, MH (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	hecht@princeton.edu		Hecht, Michael/0000-0002-5538-9813				Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bonifacio MJ, 1996, BBA-MOL BASIS DIS, V1316, P35, DOI 10.1016/0925-4439(96)00014-2; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BURDICK D, 1992, J BIOL CHEM, V267, P546; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; CREIGHTON T, 1992, PROTEINS, P171; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hecht MH, 2004, PROTEIN SCI, V13, P1711, DOI 10.1110/ps.04690804; Jao SC, 1997, AMYLOID, V4, P240, DOI 10.3109/13506129709003835; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Johansson J, 2004, CELL MOL LIFE SCI, V61, P326, DOI 10.1007/s00018-003-3274-6; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Kuo YM, 1996, J BIOL CHEM, V271, P4077; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Murakami K, 2002, BIOCHEM BIOPH RES CO, V294, P5, DOI 10.1016/S0006-291X(02)00430-8; NAIKI H, 1993, LAB INVEST, V68, P332; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; SLIPE JD, 1992, ANNU REV BIOCHEM, V61, P947; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wurth C, 2002, J MOL BIOL, V319, P1279, DOI 10.1016/S0022-2836(02)00399-6	44	104	106	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					35069	35076		10.1074/jbc.M505763200	http://dx.doi.org/10.1074/jbc.M505763200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16079141	hybrid			2022-12-27	WOS:000232403900080
J	Wei, YN; Fu, D				Wei, YN; Fu, D			Selective metal binding to a membrane-embedded aspartate in the Escherichia coli metal transporter YiiP (FieF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC TRANSPORTER; METALLIDURANS CH34; RESISTANCE; PROTEINS; FAMILY; MECHANISM; SYSTEM; MODEL; UHPT; CZCD	The cation diffusion facilitators (CDF) are a ubiquitous family of metal transporters that play important roles in homeostasis of a wide range of divalent metal cations. Molecular identities of substrate-binding sites and their metal selectivity in the CDF family are thus far unknown. By using isothermal titration calorimetry and stopped-flow spectrofluorometry, we directly examined metal binding to a highly conserved aspartate in the Escherichia coli CDF transporter YiiP (FieF). A D157A mutation abolished a Cd2+-binding site and impaired the corresponding Cd2+ transport. In contrast, substitution of Asp-157 with a cysteinyl coordination residue resulted in intact Cd2+ binding as well as full transport activity. A similar correlation was found for Zn2+ binding and transport, suggesting that Asp-157 is a metal coordination residue required for binding and transport of Cd2+ and Zn2+. The location of Asp-157 was mapped topologically to the hydrophobic core of transmembrane segment 5 (TM-5) where D157C was found partially accessible to thiol-specific labeling of maleimide polyethylene-oxide biotin. Binding of Zn2+ and Cd2+, but not Fe2+, Hg2+, Co2+, Ni2+, Mn2+, Ca2+, and Mg2+, protected D157C from maleimide polyethyleneoxide biotin labeling in a concentration-dependent manner. Furthermore, isothermal titration calorimetry analysis of YiiP(D157A) showed no detectable change in Fe2+ and Hg2+ calorimetric titrations, indicating that Asp-157 is not a coordination residue for Fe2+ and Hg2+ binding. Our results provided direct evidence for selective binding of Zn2+ and Cd2+ to the highly conserved Asp-157 and defined its functional role in metal transport.	Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Wei, YN (corresponding author), Brookhaven Natl Lab, Dept Biol, Bldg 463, Upton, NY 11973 USA.	dax@bnl.gov		Fu, Dax/0000-0002-2663-1316	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065137] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM65137] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anton A, 1999, J BACTERIOL, V181, P6876, DOI 10.1128/JB.181.22.6876-6881.1999; Anton A, 2004, J BACTERIOL, V186, P7499, DOI 10.1128/JB.186.22.7499-7507.2004; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bloss T, 2002, PLANTA, V214, P783, DOI 10.1007/s00425-001-0677-1; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Chao Y, 2004, J BIOL CHEM, V279, P17173, DOI 10.1074/jbc.M400208200; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; DASILVA JJR, 2001, BIOL CHEM ELEMENTS I, P39; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Fann MC, 1998, J BIOL CHEM, V273, P33735, DOI 10.1074/jbc.273.50.33735; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Haney CJ, 2005, J IND MICROBIOL BIOT, V32, P215, DOI 10.1007/s10295-005-0224-3; Hantke K, 2001, BIOMETALS, V14, P239, DOI 10.1023/A:1012984713391; Harris ED, 2002, NUTR REV, V60, P121, DOI 10.1301/00296640260085877; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kimura T, 1998, J BIOL CHEM, V273, P5243, DOI 10.1074/jbc.273.9.5243; Matos M, 1996, J BIOL CHEM, V271, P18571, DOI 10.1074/jbc.271.31.18571; Munkelt D, 2004, J BACTERIOL, V186, P8036, DOI 10.1128/JB.186.23.8036-8043.2004; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; NIES DH, 1992, J BACTERIOL, V174, P8102, DOI 10.1128/JB.174.24.8102-8110.1992; NIES DH, 1989, P NATL ACAD SCI USA, V86, P7351, DOI 10.1073/pnas.86.19.7351; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Persans MW, 2001, P NATL ACAD SCI USA, V98, P9995, DOI 10.1073/pnas.171039798; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200	27	76	77	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					33716	33724		10.1074/jbc.M506107200	http://dx.doi.org/10.1074/jbc.M506107200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16049012	hybrid			2022-12-27	WOS:000232229700006
J	Zimina, EP; Bruckner-Tuderman, L; Franzke, CW				Zimina, EP; Bruckner-Tuderman, L; Franzke, CW			Shedding of collagen XVII ectodomain depends on plasma membrane microenvironment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BULLOUS-PEMPHIGOID ANTIGEN; LIPID RAFTS; CHOLESTEROL DEPLETION; CELLULAR CHOLESTEROL; EPIDERMAL-KERATINOCYTES; PROTEIN; MICRODOMAINS; INHIBITION; ACTIVATION; MECHANISMS	Collagen XVII, a hemidesmosomal component, mediates the adhesion of epidermal keratinocytes to the underlying basement membrane. It exists as a full-length transmembrane protein and a soluble ectodomain that is proteolytically released from the cell surface by sheddases of a disintegrin and metalloproteinase ( ADAM) family; TACE, the tumor necrosis factor-alpha-converting enzyme, is the major physiological proteinase. Because both collagen XVII and the ADAMs are transmembrane proteins, their plasma membrane microenvironment can influence shedding. Lipid rafts, assemblies of sphingolipids and cholesterol within the plasma membrane, are responsible for the separation of membrane proteins and are thought to regulate shedding of cell surface proteins. In this study we analyzed the influence of the cholesterol-depleting agent methyl-beta-cyclodextrin ( M beta CD), which disintegrates lipid rafts, on the shedding of collagen XVII in HaCaT keratinocytes and in transfected COS-7 cells. Increasing concentrations of M beta CD led to a dose-dependent decrease of membrane cholesterol levels and to stimulation of collagen XVII shedding. The stimulation was completely inhibited by sheddase inhibitors, and experiments with COS-7 cells co-transfected with TACE and collagen XVII demonstrated that TACE mediated the low cholesterol-dependent shedding. Co-patching analysis by double immunofluorescence staining revealed co-localization of collagen XVII with the raft resident phosphatidylinositol-linked placental alkaline phosphatase and segregation from the non-raft protein human transferrin receptor, indicating that a majority of collagen XVII molecules was incorporated into lipid rafts. These data deliver the first evidence for the role of plasma membrane lipid organization in the regulation of collagen XVII shedding and, therefore, in the regulation of keratinocyte migration and differentiation.	Univ Freiburg, Dept Dermatol, D-79104 Freiburg, Germany	University of Freiburg	Zimina, EP (corresponding author), Univ Freiburg, Dept Dermatol, Hauptstr 7, D-79104 Freiburg, Germany.	zimina@haut.ukl.uni-freiburg.de; claus_franzke@haut.ukl.uni-freiburg.de						Diatchuk V, 1997, J BIOL CHEM, V272, P13292, DOI 10.1074/jbc.272.20.13292; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Franzke CW, 2002, EMBO J, V21, P5026, DOI 10.1093/emboj/cdf532; Franzke CW, 2004, J BIOL CHEM, V279, P24521, DOI 10.1074/jbc.M308835200; Franzke CW, 2005, J BIOL CHEM, V280, P4005, DOI 10.1074/jbc.R400034200; Gagnoux-Palacios L, 2003, J CELL BIOL, V162, P1189, DOI 10.1083/jcb.200305006; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; Gniadecki R, 2002, J INVEST DERMATOL, V118, P582, DOI 10.1046/j.1523-1747.2002.01716.x; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hirako Y, 1998, J BIOL CHEM, V273, P9711, DOI 10.1074/jbc.273.16.9711; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Jans R, 2004, J INVEST DERMATOL, V123, P564, DOI 10.1111/j.0022-202X.2004.23221.x; KATUNUMA N, 1995, METHOD ENZYMOL, V251, P382, DOI 10.1016/0076-6879(95)51142-3; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; MENON GK, 1992, J INVEST DERMATOL, V98, P209, DOI 10.1111/1523-1747.ep12555880; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; NISHIZAWA Y, 1993, J BIOCHEM-TOKYO, V113, P493, DOI 10.1093/oxfordjournals.jbchem.a124072; Phong MC, 2003, BIOCHEM BIOPH RES CO, V300, P563, DOI 10.1016/S0006-291X(02)02886-3; Saslowsky DE, 2002, J BIOL CHEM, V277, P26966, DOI 10.1074/jbc.M204669200; Schacke H, 1998, J BIOL CHEM, V273, P25937, DOI 10.1074/jbc.273.40.25937; SCHMIDT R, 1991, J INVEST DERMATOL, V97, P771, DOI 10.1111/1523-1747.ep12486720; Schumann H, 2000, AM J PATHOL, V156, P685, DOI 10.1016/S0002-9440(10)64772-4; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Tasanen K, 2004, AM J PATHOL, V164, P2027, DOI 10.1016/S0002-9440(10)63762-5; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Wakatsuki S, 2004, J NEUROCHEM, V89, P119, DOI 10.1046/j.1471-4159.2003.02303.x; Zheng XJ, 2003, J INVEST DERMATOL, V121, P1487, DOI 10.1111/j.1523-1747.2003.12614.x	30	44	46	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34019	34024		10.1074/jbc.M503751200	http://dx.doi.org/10.1074/jbc.M503751200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16020548	hybrid			2022-12-27	WOS:000232229700040
J	Hirose, M; Tohda, H; Giga-Hama, Y; Tsushima, R; Zako, T; Iizuka, R; Pack, C; Kinjo, M; Ishii, N; Yohda, M				Hirose, M; Tohda, H; Giga-Hama, Y; Tsushima, R; Zako, T; Iizuka, R; Pack, C; Kinjo, M; Ishii, N; Yohda, M			Interaction of a small heat shock protein of the fission yeast, Schizosaccharomyces pombe, with a denatured protein at elevated temperature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CRYSTALLIN; SUBSTRATE; DISSOCIATION; HSP16.3; BINDING; ATP; ACTIVATION; EXPRESSION; MECHANISM; GROEL	We have expressed, purified, and characterized one small heat shock protein of the fission yeast Schizosaccharomyces pombe, SpHsp16.0. SpHsp16.0 was able to protect citrate synthase from thermal aggregation at 45 degrees C with high efficiency. It existed as a hexadecameric globular oligomer near the physiological growth temperature. At elevated temperatures, the oligomer dissociated into small species, probably dimers. The dissociation was completely reversible, and the original oligomer reformed immediately after the temperature dropped. Large complexes of SpHsp16.0 and denatured citrate synthase were observed by size exclusion chromatography and electron microscopy following incubation at 45 degrees C and then cooling. However, such large complexes did not elute from the size exclusion column incubated at 45 degrees C. The denatured citrate synthase protected from aggregation was trapped by a GroEL trap mutant at 45 degrees C. These results suggest that the complex of SpHsp16.0 and denatured citrate synthase at elevated temperatures is in the transient state and has a hydrophobic nature. Analyses of the interaction between SpHsp16.0 and denatured citrate synthase by fluorescence cross- correlation spectrometry have also shown that the characteristics of SpHsp16.0- denatured citrate synthase complex at the elevated temperature are different from those of the large complex obtained after the shift to lowered temperatures.	Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; Asahi Glass Co Ltd, ASPEX Div, Kanagawa Ku, Yokohama, Kanagawa 2218755, Japan; Hokkaido Univ, Res Inst Elect Sci, Lab Supramol Biophys, Kita Ku, Sapporo, Hokkaido 0600812, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tsukuba, Ibaraki 3058566, Japan	Tokyo University of Agriculture & Technology; AGC Inc; Hokkaido University; National Institute of Advanced Industrial Science & Technology (AIST)	Yohda, M (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	yohda@cc.tuat.ac.jp	Tohda, Hideki/H-3162-2013; Tohda, Hideki/O-5132-2019; Ishii, Noriyuki/E-5661-2011; Yohda, Masafumi/A-5149-2013; Kinjo, Masataka/F-5267-2011; Zako, Tamotsu/C-3004-2012	Ishii, Noriyuki/0000-0002-4120-6203; Yohda, Masafumi/0000-0001-8307-9671; Kinjo, Masataka/0000-0001-8889-8369; Iizuka, Ryo/0000-0002-9328-5628				Buchner J, 1998, METHOD ENZYMOL, V290, P339, DOI 10.1016/S0076-6879(98)90030-1; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Franzmann TM, 2005, J MOL BIOL, V350, P1083, DOI 10.1016/j.jmb.2005.05.034; Fu XM, 2004, BIOCHEM BIOPH RES CO, V316, P291, DOI 10.1016/j.bbrc.2004.02.053; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Gu LX, 2002, J MOL BIOL, V319, P517, DOI 10.1016/S0022-2836(02)00311-X; Haley DA, 2000, J MOL BIOL, V298, P261, DOI 10.1006/jmbi.2000.3657; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Iizuka R, 2001, BIOCHEM BIOPH RES CO, V289, P1118, DOI 10.1006/bbrc.2001.6139; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Leroux MR, 1997, J BIOL CHEM, V272, P12847, DOI 10.1074/jbc.272.19.12847; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; Muchowski PJ, 1998, P NATL ACAD SCI USA, V95, P1004, DOI 10.1073/pnas.95.3.1004; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Okochi M, 2002, BIOCHEM BIOPH RES CO, V291, P769, DOI 10.1006/bbrc.2002.6523; Pack CG, 2000, BIOCHEM BIOPH RES CO, V267, P300, DOI 10.1006/bbrc.1999.1864; Pack CG, 1999, CYTOMETRY, V36, P247, DOI 10.1002/(SICI)1097-0320(19990701)36:3<247::AID-CYTO15>3.0.CO;2-#; PLESOFSKYVIG N, 1995, P NATL ACAD SCI USA, V92, P5032, DOI 10.1073/pnas.92.11.5032; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saito K, 2004, BIOCHEM BIOPH RES CO, V324, P849, DOI 10.1016/j.bbrc.2004.09.126; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Taricani L, 2001, NUCLEIC ACIDS RES, V29, P3030, DOI 10.1093/nar/29.14.3030; Usui K, 2004, PROTEIN SCI, V13, P134, DOI 10.1110/ps.03264204; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; VANDENIJSSEL PRLA, 1994, FEBS LETT, V355, P54, DOI 10.1016/0014-5793(94)01175-3; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Yoshida T, 2002, J MOL BIOL, V315, P73, DOI 10.1006/jmbi.2001.5220	34	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32586	32593		10.1074/jbc.M504121200	http://dx.doi.org/10.1074/jbc.M504121200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16055437	hybrid			2022-12-27	WOS:000231920300005
J	Kim, Y; Sato, K; Asagiri, M; Morita, I; Soma, K; Takayanagi, H				Kim, Y; Sato, K; Asagiri, M; Morita, I; Soma, K; Takayanagi, H			Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; ADAPTER PROTEINS; BONE HOMEOSTASIS; DIFFERENTIATION; RANKL; MOTIF; BEARING; KINASE; FAMILY; LIGAND	Bone homeostasis depends on the coordination of osteoclastic bone resorption and osteoblastic bone formation. Receptor activator of NF-kappa B ligand (RANKL) induces osteoclast differentiation through activating a transcriptional program mediated by the key transcription factor nuclear factor of activated T cells ( NFAT) c1. Immunoreceptors, including osteoclast-associated receptor (OSCAR) and triggering receptor expressed by myeloid cells (TREM)-2, constitute the co-stimulatory signals required for RANKL-mediated activation of calcium signaling, which leads to the activation of NFATc1. However, it remains unknown whether the expression of immunoreceptors are under the control of NFATc1. Here we demonstrate that the expression of OSCAR, but not that of TREM-2, is up-regulated during osteoclastogenesis and markedly suppressed by the calcineurin inhibitor FK506, suggesting that OSCAR is transcriptionally regulated by NFATc1. NFATc1 expression results in the activation of the OSCAR promoter, which was found to be further enhanced by co-expression of PU.1 and microphthalmia-associated transcription factor (MITF). We further provide evidence that NFATc1 specifically regulates OSCAR by chromatin immunoprecipitation assay and quantification of OSCAR and TREM-2 mRNAin NFATc1(-/-) cells. Thus, OSCAR but not TREM-2 is involved in the positive feedback loop of the immunoreceptor-NFATc1 pathway during osteoclastogenesis. Although several immunoreceptors have been identified as co-stimulatory molecules for RANKL, the expression and function are differentially regulated. These mechanisms, possibly together with the delicate regulation of their ligands on osteoblasts, may provide the exquisite machinery for the modulation of osteoclastogenesis in the maintenance of bone homeostasis.	Tokyo Med & Dent Univ, Dept Cell Signaling, Grad Sch, Bunkyo Ku, Tokyo 1138549, Japan; Ctr Excellence COE, Program Frontier Res Mol Destruct & Reconstruct T, Tokyo 1138549, Japan; Grad Sch, Div Oral Hlth Sci, Dept Orofacial Dev & Funct, Tokyo 1138549, Japan; Tokyo Med & Dent Univ, Grad Sch, Dept Cellular Physiol Chem, Tokyo 1138549, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Takayanagi, H (corresponding author), Tokyo Med & Dent Univ, Dept Cell Signaling, Grad Sch, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138549, Japan.	taka.csi@tmd.ac.jp		Kim, Yoonji/0000-0002-1664-3137; Sato, Kojiro/0000-0003-4105-3726				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Dietrich J, 2000, J IMMUNOL, V164, P9, DOI 10.4049/jimmunol.164.1.9; Eissner G, 2004, CYTOKINE GROWTH F R, V15, P353, DOI 10.1016/j.cytogfr.2004.03.011; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsumoto M, 2001, J BIOL CHEM, V276, P33086, DOI 10.1074/jbc.M104299200; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190	38	49	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32905	32913		10.1074/jbc.M505820200	http://dx.doi.org/10.1074/jbc.M505820200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16046394	hybrid			2022-12-27	WOS:000231920300045
J	Rouet, V; Hamma-Kourbali, Y; Petit, E; Panagopoulou, P; Katsoris, P; Barritault, D; Caruelle, JP; Courty, J				Rouet, V; Hamma-Kourbali, Y; Petit, E; Panagopoulou, P; Katsoris, P; Barritault, D; Caruelle, JP; Courty, J			A synthetic glycosaminoglycan mimetic binds vascular endothelial growth factor and modulates angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; SUBSTITUTED DEXTRAN; TYROSINE KINASE; FACTOR FAMILY; RECEPTOR; REPAIR; EXPRESSION; CELLS; VASCULOGENESIS; IDENTIFICATION	In a previous study, we showed that in situ injection of glycosaminoglycan mimetics called RGTAs (R) (ReGeneraTing Agents) enhanced neovascularization after skeletal muscular ischemia ( Desgranges, P., Barbaud, C., Caruelle, J. P., Barritault, D., and Gautron, J. ( 1999) FASEB J. 13, 761 - 766). In the present study, we showed that the RGTA (R) OTR4120 modulated angiogenesis in the chicken embryo chorioallantoic membrane assay, in a dose-dependent manner. We therefore investigated the effect of OTR4120 on one of the most specific angiogenesis-regulating heparin-binding growth factors, vascular endothelial growth factor 165 ( VEGF(165)). OTR4120 showed high affinity binding to VEGF(165) (K-d = 2.2 nM), as compared with heparin (K-d = 15 nM), and potentiated the affinity of VEGF(165) for VEGF receptor-1 and -2 and for neuropilin-1. In vitro, OTR4120 potentiated VEGF(165)-induced proliferation and migration of human umbilical vein endothelial cells. In the in vivo Matrigel (TM) plug angiogenesis assay, OTR4120 in a concentration as low as 3 ng/ml caused a 6-fold increase in VEGF(165)-induced angiogenesis. Immunohistochemical staining showed a larger number of well differentiated VEGFR-2-expressing-cells in Matrigel (TM) sections of OTR4120-treated plug than in control sections. These findings indicate that OTR4120 enhances the VEGF(165)-induced angiogenesis and therefore may hold promise for treating disorders characterized by deficient angiogenesis.	Univ Paris 12, Lab Rech Croissance Cellulaire Reparat & Regenera, CNRS, UMR 7149, F-94010 Creteil, France; SAS, Organes Tissus Regenerat Reparat Remplacement, OTR3, F-75001 Paris, France; Univ Patras, Div Genet Cell & Dev Biol, Dept Biol, GR-26504 Patras, Greece	Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Patras	Courty, J (corresponding author), Univ Paris 12, Lab Rech Croissance Cellulaire Reparat & Regenera, CNRS, UMR 7149, Ave Gen de Gaulle, F-94010 Creteil, France.	courty@univ-paris12.fr	Hamma-Kourbali, Yamina/R-3692-2018; Courty, Jose/Q-3702-2018	Hamma-Kourbali, Yamina/0000-0002-2754-8928; 				AAMIRI A, 1995, CR ACAD SCI III-VIE, V318, P1037; Alexakis C, 2004, FASEB J, V18, P1147, DOI 10.1096/fj.03-1126fje; Alexakis C, 2001, FASEB J, V15, P1546, DOI 10.1096/fj.00-0756com; Barbosa I, 2005, J CELL SCI, V118, P253, DOI 10.1242/jcs.01607; Bechard D, 2001, J BIOL CHEM, V276, P48341, DOI 10.1074/jbc.M108395200; Bernard-Pierrot I, 2001, J BIOL CHEM, V276, P12228, DOI 10.1074/jbc.M010913200; Blanquaert F, 1995, BONE, V17, P499, DOI 10.1016/8756-3282(95)00402-5; Cochran S, 2003, J MED CHEM, V46, P4601, DOI 10.1021/jm030180y; Desgranges P, 1999, FASEB J, V13, P761, DOI 10.1096/fasebj.13.6.761; Desgranges P, 2001, J BIOMED MATER RES, V58, P1, DOI 10.1002/1097-4636(2001)58:1<1::AID-JBM10>3.0.CO;2-8; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Escartin Q, 2003, FASEB J, V17, P644, DOI 10.1096/fj.02-0708com; Fannon M, 2003, FASEB J, V17, P902, DOI 10.1096/fj.02-0935fje; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; Francis DJ, 2003, CIRC RES, V92, pE70, DOI 10.1161/01.RES.0000071345.76095.07; FREDJREYGROBELLET D, 1994, OPHTHALMIC RES, V26, P325, DOI 10.1159/000267497; Gengrinovitch S, 1999, J BIOL CHEM, V274, P10816, DOI 10.1074/jbc.274.16.10816; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hamma-Kourbali Y, 2001, J BIOL CHEM, V276, P39748, DOI 10.1074/jbc.M101117200; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009; Hiratsuka S, 2001, CANCER RES, V61, P1207; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; Iivanainen E, 2003, MICROSC RES TECHNIQ, V60, P13, DOI 10.1002/jemt.10238; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Ito N, 1999, Angiogenesis, V3, P159, DOI 10.1023/A:1009008926710; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Meddahi A, 2002, J BIOMED MATER RES, V60, P497, DOI 10.1002/jbm.1293; Meddahi A, 2002, J BIOMED MATER RES, V62, P525, DOI 10.1002/jbm.10283; Meddahi A, 1996, DIABETES METAB, V22, P274; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MUNSON PJ, 1983, METHOD ENZYMOL, V92, P543; Nangia-Makker P, 2000, CANCER METAST REV, V19, P51, DOI 10.1023/A:1026540129688; Pacini S, 2002, BIOCHEM BIOPH RES CO, V290, P820, DOI 10.1006/bbrc.2001.6254; Papadimitriou E, 2001, BIOCHEM BIOPH RES CO, V282, P306, DOI 10.1006/bbrc.2001.4574; PAPYGARCIA D, 2005, IN PRESS MACROMOLECU; PERETZ D, 1992, BIOCHEM BIOPH RES CO, V182, P1340, DOI 10.1016/0006-291X(92)91880-Y; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915; Phongkitkarun S, 2004, ACAD RADIOL, V11, P573, DOI 10.1016/S1076-6332(03)00728-1; Plouet J, 1997, J BIOL CHEM, V272, P13390, DOI 10.1074/jbc.272.20.13390; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; Ribatti D, 2002, CYTOKINE, V17, P262, DOI 10.1006/cyto.2002.1002; RIBATTI D, 1987, ACTA ANAT, V130, P257; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SASISEKHARAN R, 1994, P NATL ACAD SCI USA, V91, P1524, DOI 10.1073/pnas.91.4.1524; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soulie P, 2002, J IMMUNOASS IMMUNOCH, V23, P33, DOI 10.1081/IAS-120002273; TARDIEU M, 1992, J CELL PHYSIOL, V150, P194, DOI 10.1002/jcp.1041500126; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; TESSLER S, 1994, J BIOL CHEM, V269, P12456; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Tuomisto TT, 2004, ATHEROSCLEROSIS, V174, P111, DOI 10.1016/j.atherosclerosis.2004.01.015; Vives RR, 1999, BIOCHEM J, V339, P767, DOI 10.1042/0264-6021:3390767; Yamauchi H, 2000, FASEB J, V14, P2133; Zakine G, 2003, ANN THORAC SURG, V75, P549, DOI 10.1016/S0003-4975(02)04332-1	57	62	65	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32792	32800		10.1074/jbc.M504492200	http://dx.doi.org/10.1074/jbc.M504492200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16014624	hybrid			2022-12-27	WOS:000231920300031
J	Okuno, T; Yokomizo, T; Hori, T; Miyano, M; Shimizu, T				Okuno, T; Yokomizo, T; Hori, T; Miyano, M; Shimizu, T			Leukotriene B-4 receptor and the function of its helix 8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-COUPLED RECEPTOR; T-CELL RECRUITMENT; B-4 RECEPTOR; POLYMORPHONUCLEAR LEUKOCYTES; ARACHIDONIC-ACID; AIRWAY HYPERRESPONSIVENESS; GPCR FUNCTION; B4 RECEPTOR; BINDING; BLT1	More than 30 lipid ligands, which express their biological activities through cognate G-protein-coupled receptors (GPCRs), have been reported. Among them, leukotriene B-4 (LTB4) is a potent lipid mediator involved in host defense, inflammation, and the immune responses. Two GPCRs for LTB4 (BLT1 and BLT2) have been cloned and analyzed. Recent studies using genetically engineered mice suggest that BLT1 plays an important role in several inflammatory diseases including ischemic reperfusion tissue injury, atherosclerosis, and bronchial asthma. BLT1 is also a good tool to study the molecular mechanism of GPCR activation and inactivation in vitro. In this brief review, we focus on the biological and biochemical properties of BLT1 with special attention to the putative helix 8 of the receptor.	Univ Tokyo, Fac Med, Dept Biochem, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Dept Mol Biol & Metabolome, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sic & Technol Agcy, PRESTO, Bunkyo Ku, Tokyo 1130033, Japan; RIKEN, Harima Inst, Spring8, Struct Biophys Lab, Harima, Hyogo 6795148, Japan	University of Tokyo; University of Tokyo; RIKEN	Okuno, T (corresponding author), Univ Tokyo, Fac Med, Dept Biochem, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	t-okuno@umin.ac.jp	Miyano, Masashi/R-2785-2016; Shimizu, Takao/AAV-7052-2021; Yokomizo, Takehiko/P-5673-2016	Miyano, Masashi/0000-0003-2253-6175; Yokomizo, Takehiko/0000-0002-5219-1553				Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; BOMALASKI JS, 1987, PROSTAGLANDINS, V33, P855, DOI 10.1016/0090-6980(87)90114-6; BORGEAT P, 1979, J BIOL CHEM, V254, P7865; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Chen ZG, 2004, MOL PHARMACOL, V66, P377; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Gaudreau R, 2004, J BIOL CHEM, V279, P10338, DOI 10.1074/jbc.M309207200; Gaudreau R, 2002, J BIOL CHEM, V277, P31567, DOI 10.1074/jbc.M202723200; GOLDMAN DW, 1982, J IMMUNOL, V129, P1600; GOLDMAN DW, 1984, J EXP MED, V159, P1027, DOI 10.1084/jem.159.4.1027; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Haeggstrom JZ, 2004, J BIOL CHEM, V279, P50639, DOI 10.1074/jbc.R400027200; Haribabu B, 2000, J EXP MED, V192, P433, DOI 10.1084/jem.192.3.433; Haribabu B, 1999, J BIOL CHEM, V274, P37087, DOI 10.1074/jbc.274.52.37087; Igarashi T, 1999, EUR J BIOCHEM, V259, P419, DOI 10.1046/j.1432-1327.1999.00054.x; Iizuka Y, 2005, J BIOL CHEM, V280, P24816, DOI 10.1074/jbc.M413257200; Ito N, 2002, J BIOL CHEM, V277, P44898, DOI 10.1074/jbc.M208051200; Jala VR, 2004, TRENDS IMMUNOL, V25, P315, DOI 10.1016/j.it.2004.04.003; Kamohara M, 2000, J BIOL CHEM, V275, P27000; Kato K, 2000, J EXP MED, V192, P413, DOI 10.1084/jem.192.3.413; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; LIN AH, 1984, PROSTAGLANDINS, V28, P837, DOI 10.1016/0090-6980(84)90038-8; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; Luster AD, 2004, NAT REV IMMUNOL, V4, P711, DOI 10.1038/nri1438; Masuda K, 2003, J BIOL CHEM, V278, P24552, DOI 10.1074/jbc.M302801200; MIKI I, 1990, BIOCHEM BIOPH RES CO, V166, P342, DOI 10.1016/0006-291X(90)91951-N; Miyahara N, 2005, AM J RESP CRIT CARE, V172, P161, DOI 10.1164/rccm.200502-205OC; Miyahara N, 2005, J IMMUNOL, V174, P4979, DOI 10.4049/jimmunol.174.8.4979; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Ott VL, 2003, NAT IMMUNOL, V4, P974, DOI 10.1038/ni971; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; SAMUELSSON B, 1989, J BIOL CHEM, V264, P19469; Schoenberger SP, 2003, NAT IMMUNOL, V4, P937, DOI 10.1038/ni1003-937; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Tryselius Y, 2000, BIOCHEM BIOPH RES CO, V274, P377, DOI 10.1006/bbrc.2000.3152; Wang SK, 2000, J BIOL CHEM, V275, P40686, DOI 10.1074/jbc.M004512200; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200	46	51	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32049	32052		10.1074/jbc.R500007200	http://dx.doi.org/10.1074/jbc.R500007200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16046389	hybrid			2022-12-27	WOS:000231794800002
J	Jamieson, E; Chong, MMW; Steinberg, GR; Jovanovska, V; Fam, BC; Bullen, DVR; Chen, Y; Kemp, BE; Proietto, J; Kay, TWH; Andrikopoulos, S				Jamieson, E; Chong, MMW; Steinberg, GR; Jovanovska, V; Fam, BC; Bullen, DVR; Chen, Y; Kemp, BE; Proietto, J; Kay, TWH; Andrikopoulos, S			Socs1 deficiency enhances hepatic insulin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN SKELETAL-MUSCLE; METABOLISM IN-VIVO; CYTOKINE SIGNALING-1; RECEPTOR SUBSTRATE-2; INTERFERON-GAMMA; ISLET NEOGENESIS; MICE LACKING; BETA-CELLS; RESISTANCE	Suppressor of cytokine signaling 1 (SOCS1) is an intracellular inhibitor of cytokine, growth factor, and hormone signaling. Socs1(-/-) mice die before weaning from a multiorgan inflammatory disease. Neonatal Socs1(-/-) mice display severe hypoglycemia and hypoinsulinemia. Concurrent interferon gamma gene deletion (Ifng(-/-)) prevented inflammation and corrected the hypoglycemia. In hyperinsulinemic clamp studies, however, Socs1(-/-) Ifng(-/-) mice had enhanced hepatic insulin sensitivity demonstrated by greater suppression of endogenous glucose production compared with controls with no difference in glucose disposal. Socs1(-/-) Ifng(-/-) mice had elevated liver insulin receptor substrate 2 expression (IRS-2) and IRS-2 tyrosine phosphorylation. This was associated with lower phosphoenolpyruvate carboxykinase mRNA expression. These effects were not associated with elevated hepatic AMP-activated protein kinase activity. Hepatic insulin sensitivity and IRS-2 levels play central roles in the pathogenesis of type 2 diabetes. Socs1 deficiency increases IRS-2 expression and enhances hepatic insulin sensitivity in vivo indicating that inhibition of SOCS1 may be a logical strategy in type 2 diabetes.	St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Melbourne, Heidelberg Repatriat Hosp, Dept Med, Heidelberg, Vic 3081, Australia; CSIRO Sci & Nutr, Parkville, Vic 3052, Australia	St. Vincent's Institute of Medical Research; Walter & Eliza Hall Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Kay, TWH (corresponding author), St Vincents Inst Med Res, 41 Victria Parade, Fitzroy, Vic 3065, Australia.	tkay@svi.edu.au	Proietto, Joe/B-3780-2012; Kemp, Bruce E/L-2633-2014; Kemp, Bruce/G-9602-2019; Chong, Mark/H-6684-2016	Kemp, Bruce E/0000-0001-6735-5082; Kemp, Bruce/0000-0001-6735-5082; Chong, Mark/0000-0002-3701-7397; Jamieson, Emma/0000-0002-5549-6459; Steinberg, Gregory/0000-0001-5425-8275				Alexander WS, 1999, J LEUKOCYTE BIOL, V66, P588, DOI 10.1002/jlb.66.4.588; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Brady MJ, 2004, J CLIN INVEST, V114, P886, DOI 10.1172/JC1200423108; Bullen DVR, 2001, IMMUNOLOGY, V104, P92, DOI 10.1046/j.1365-2567.2001.01294.x; Chen Y, 2004, AM J PATHOL, V165, P913, DOI 10.1016/S0002-9440(10)63353-6; Chen ZP, 2000, AM J PHYSIOL-ENDOC M, V279, pE1202, DOI 10.1152/ajpendo.2000.279.5.E1202; GU DL, 1993, DEVELOPMENT, V118, P33; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Johnston AM, 2003, FEBS LETT, V546, P32, DOI 10.1016/S0014-5793(03)00438-1; Kawazoe Y, 2001, J EXP MED, V193, P263, DOI 10.1084/jem.193.2.263; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kooptiwut S, 2002, ENDOCRINOLOGY, V143, P2085, DOI 10.1210/en.143.6.2085; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; KREBS DL, 2003, SCI STKE, pPE6; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Lamont BJ, 2003, DIABETOLOGIA, V46, P1338, DOI 10.1007/s00125-003-1180-y; Lauro D, 1998, NAT GENET, V20, P294, DOI 10.1038/3112; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Metcalf D, 2000, P NATL ACAD SCI USA, V97, P9174, DOI 10.1073/pnas.160255197; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Mooney RA, 2001, J BIOL CHEM, V276, P25889, DOI 10.1074/jbc.M010579200; Previs SF, 2000, J BIOL CHEM, V275, P38990, DOI 10.1074/jbc.M006490200; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1998, INT J BIOCHEM CELL B, V30, P1081, DOI 10.1016/S1357-2725(98)00067-3; Steinberg GR, 2004, J CLIN ENDOCR METAB, V89, P4575, DOI 10.1210/jc.2004-0308; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	33	33	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31516	31521		10.1074/jbc.M502163200	http://dx.doi.org/10.1074/jbc.M502163200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15983045	hybrid			2022-12-27	WOS:000231665200023
J	Roca, H; Phimphilai, M; Gopalakrishnan, R; Xiao, GZ; Franceschi, RT				Roca, H; Phimphilai, M; Gopalakrishnan, R; Xiao, GZ; Franceschi, RT			Cooperative interactions between RUNX2 and homeodomain protein-binding sites are critical for the osteoblast-specific expression of the bone sialoprotein gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; OSTEOCALCIN GENE; TRANSGENIC MICE; IN-VITRO; DIFFERENTIATION; PROMOTER; CELLS; DLX5; MSX2; CBFA1	The bone sialoprotein (Bsp) gene provides an excellent model for studying mechanisms controlling osteoblast-specific gene expression. Although the RUNX2 transcription factor directly regulates many osteoblast-related genes, its function in Bsp expression remains uncertain. By using chromatin immunoprecipitation (ChIP) analysis in MC3T3-E1 (clone MC-4) preosteoblast cells, RUNX2 was shown to bind a chromatin fragment containing the proximal Bsp promoter. Two putative RUNX2-binding sites (R1 and R2) were identified within this region of the mouse, rat, and human genes and were shown to bind RUNX2 in vitro and in vivo (by ChIP assay). Site-specific mutagenesis established that both sites act as osteoblast-specific transcriptional enhancers and together account for nearly two-thirds of the total promoter activity. In addition, functional cooperativity was observed between the R2 site and an adjacent homeodomain protein-binding site previously characterized by this laboratory (the C site). All three sites (R1, R2, and C) are necessary for maximal promoter activity in osteoblasts. DLX5 in MC-4 cell nuclear extracts binds to the C site in vitro. Furthermore, ChIP assays revealed that DLX5 is selectively associated with chromatin in the vicinity of the C site only when Bsp is transcriptionally active. Finally, co-immunoprecipitation assays detected a physical complex containing DLX5 and RUNX2. Taken together, our data show that RUNX2 is a direct regulator of Bsp in osteoblasts and that it functions in cooperation with DLX5 or a related factor to activate osteoblast-specific gene expression.	Univ Michigan, Dept Periodont Prevent & Geriatr, Sch Dent, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Craniofacial Regenerat, Sch Dent, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Franceschi, RT (corresponding author), Univ Michigan, Dept Periodont Prevent & Geriatr, Sch Dent, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	rennyf@umich.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE011723, R01DE012211] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR46024] Funding Source: Medline; NIDCR NIH HHS [DE 12211, DE 11723] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Acampora D, 1999, DEVELOPMENT, V126, P3795; Barnes GL, 2003, CANCER RES, V63, P2631; Barnes GL, 2002, J CELL BIOCHEM, V87, P458, DOI 10.1002/jcb.10351; Benson MD, 2000, J BIOL CHEM, V275, P13907, DOI 10.1074/jbc.275.18.13907; Benson MD, 1999, J BONE MINER RES, V14, P396, DOI 10.1359/jbmr.1999.14.3.396; Chen JK, 1996, J BONE MINER RES, V11, P654; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Cowles EA, 1998, CALCIFIED TISSUE INT, V62, P74, DOI 10.1007/s002239900397; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Franceschi RT, 2003, CALCIFIED TISSUE INT, V72, P638, DOI 10.1007/s00223-002-1053-2; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Gopalakrishnan R, 2003, CONNECT TISSUE RES, V44, P154, DOI 10.1080/03008200390152250; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Hoshi K, 1999, BONE, V25, P639, DOI 10.1016/S8756-3282(99)00223-9; KAMACHI Y, 1990, J VIROL, V64, P4808, DOI 10.1128/JVI.64.10.4808-4819.1990; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Newberry EP, 1999, BIOCHEMISTRY-US, V38, P10678, DOI 10.1021/bi990967j; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ryoo HM, 1997, MOL ENDOCRINOL, V11, P1681, DOI 10.1210/me.11.11.1681; Shirakabe K, 2001, GENES CELLS, V6, P851, DOI 10.1046/j.1365-2443.2001.00466.x; Tadic T, 2002, J BONE MINER RES, V17, P1008, DOI 10.1359/jbmr.2002.17.6.1008; Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Willis DM, 2002, J BIOL CHEM, V277, P37280, DOI 10.1074/jbc.M206482200; Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang RJ, 1997, J CELL BIOCHEM, V64, P77, DOI 10.1002/(SICI)1097-4644(199701)64:1<77::AID-JCB11>3.0.CO;2-H; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460; Zimmerman D, 2000, DEV BIOL, V220, P2, DOI 10.1006/dbio.2000.9633	41	82	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30845	30855		10.1074/jbc.M503942200	http://dx.doi.org/10.1074/jbc.M503942200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16000302	hybrid			2022-12-27	WOS:000231487800025
J	Xiao, GZ; Jiang, D; Ge, CX; Zhao, ZR; Lai, YM; Boules, H; Phimphilai, M; Yang, XL; Karsenty, G; Franceschi, RT				Xiao, GZ; Jiang, D; Ge, CX; Zhao, ZR; Lai, YM; Boules, H; Phimphilai, M; Yang, XL; Karsenty, G; Franceschi, RT			Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; SIGNALING PATHWAYS; MC3T3-E1 CELLS; IN-VIVO; CLEIDOCRANIAL DYSPLASIA; DEPENDENT ACTIVATION; RESPONSE ELEMENT; ASCORBIC-ACID; CBF-BETA; DIFFERENTIATION	The role of ATF4 ( activating transcription factor 4) in osteoblast differentiation and bone formation was recently described using ATF4- deficient mice ( Yang, X., Matsuda, K., Bialek, P., Jacquot, S., Masuoka, H. C., Schinke, T., Li, L., Brancorsini, S., Sassone- Corsi, P., Townes, T. M., Hanauer, A., and Karsenty, G. ( 2004) Cell 117, 387 - 398). However, the mechanisms of ATF4 in bone cells are still not clear. In this study, we determined the molecular mechanisms through which ATF4 activates the mouse osteocalcin ( Ocn) gene 2 ( mOG2) expression and mOG2 promoter activity. ATF4 increased the levels of Ocn mRNA and mOG2 promoter activity in Runx2- containing osteoblasts but not in non- osteoblastic cells that lack detectable Runx2 protein. However, ATF4 increased Ocn mRNA and mOG2 promoter activity in non- osteoblastic cells when Runx2 was co- expressed. Mutational analysis of the OSE1 ( ATF4- binding site) and the two OSE2s ( Runx2-binding sites) in the 657- bp mOG2 promoter demonstrated that ATF4 and Runx2 activate Ocn via cooperative interactions with these sites. Pull- down assays using nuclear extracts from osteoblasts or COS- 7 cells overexpressing ATF4 and Runx2 showed that both factors are present in either anti- ATF4 and anti- Runx2 immunoprecipitates. In contrast, pull- down assays using purified glutathione S- transferase fusion proteins were unable to demonstrate a direct physical interaction between ATF4 and Runx2. Thus, accessory factors are likely involved in stabilizing interactions between these two molecules. Regions within Runx2 required for ATF4 complex formation and activation were identified. Deletion analysis showed that the leucine zipper domain of ATF4 is critical for Runx2 activation. This study is the first demonstration that cooperative interactions between ATF4 and Runx2/ Cbfa1 stimulate osteoblast- specific Ocn expression and suggests that this regulation may represent a novel intramolecular mechanism regulating Runx2 activity and, thereby, osteoblast differentiation and bone formation.	Univ Michigan, Sch Dent, Dept Periodont Prevent & Geriatr, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Baylor College of Medicine	Xiao, GZ (corresponding author), Univ Michigan, Sch Dent, Dept Periodont Prevent & Geriatr, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	xiaogz@umich.edu			NIDCR NIH HHS [DE14454, DE11723, DE12211, DE13386] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE011723, R03DE014454, R01DE012211, R01DE013386] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aslam F, 1999, ENDOCRINOLOGY, V140, P63, DOI 10.1210/en.140.1.63; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; CELESTE AJ, 1986, EMBO J, V5, P1885, DOI 10.1002/j.1460-2075.1986.tb04440.x; D'Alonzo RC, 2002, J BIOL CHEM, V277, P24788, DOI 10.1074/jbc.M202604200; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Franceschi RT, 2003, CALCIFIED TISSUE INT, V72, P638, DOI 10.1007/s00223-002-1053-2; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Frendo JL, 1998, J BIOL CHEM, V273, P30509, DOI 10.1074/jbc.273.46.30509; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Hai T, 1999, GENE EXPRESSION, V7, P321; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Javed A, 2000, J CELL SCI, V113, P2221; Jiang D, 2004, J BIOL CHEM, V279, P5329, DOI 10.1074/jbc.M311547200; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; KARPINSKI BA, 1992, P NATL ACAD SCI USA, V89, P4820, DOI 10.1073/pnas.89.11.4820; Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003; Krishnan V, 2003, MOL ENDOCRINOL, V17, P423, DOI 10.1210/me.2002-0225; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; McLarrent FW, 2001, J BIOL CHEM, V276, P1578, DOI 10.1074/jbc.M007629200; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; Miller J, 2002, NAT GENET, V32, P645, DOI 10.1038/ng1049; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SASSONECORSI P, 1994, EMBO J, V13, P4717, DOI 10.1002/j.1460-2075.1994.tb06797.x; Schinke T, 1999, J BIOL CHEM, V274, P30182, DOI 10.1074/jbc.274.42.30182; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; ZIFF EB, 1990, TRENDS GENET, V6, P69, DOI 10.1016/0168-9525(90)90081-G	47	186	202	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30689	30696		10.1074/jbc.M500750200	http://dx.doi.org/10.1074/jbc.M500750200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16000305	hybrid			2022-12-27	WOS:000231487800007
J	Chao, C; Ives, KL; Goluszko, E; Kolokoltsov, AA; Davey, RA; Townsend, CM; Hellmich, MR				Chao, C; Ives, KL; Goluszko, E; Kolokoltsov, AA; Davey, RA; Townsend, CM; Hellmich, MR			Src regulates constitutive internalization and rapid resensitization of a cholecystokinin 2 receptor splice variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B/GASTRIN RECEPTOR; TYROSINE KINASES; BETA-ARRESTIN; PROTEIN; GASTRIN; ACTIVATION; PHOSPHORYLATION; ENDOCYTOSIS; GROWTH; CCK	The third intracellular loop domain of G protein-coupled receptors regulates their desensitization, internalization, and resensitization. Colorectal and pancreatic cancers, but not the nonmalignant tissue, express a splice variant of the cholecystokinin 2 receptor (CCK2R) called CCK2i4svR that, because of intron 4 retention, contains an additional 69 amino acids within its third intracellular loop domain. This structural alteration is associated with agonist-independent activation of Src kinase (Olszewska-Pazdrak, B., Townsend, C. M., Jr., and Hellmich, M. R. ( 2004) J. Biol. Chem. 279, 40400 - 40404). The purpose of the study was to determine the roles of intron 4 retention and Src kinase on CCK2i4svR desensitization, internalization, and resensitization. Gastrin1 - 17 (G17) binds to both CCK2R andCCK(2i4sv)R and induces intracellular Ca2+ ([Ca2+](i)) increases. Agonist-induced increases in [Ca2+](i) were used to assess receptor activity. Src kinase activity was inhibited by transducing cells with a retrovirus containing a dominant-negative mutant Src (A430V). The subcellular location of enhanced green fluorescent protein-tagged receptors was monitored using laser scanning confocal microscopy. Both receptor variants desensitized at the same rate; however, CCK2i4svR resensitized five times faster than CCK2R. Without agonist, 80% of CCK2i4svR is located in an intracellular compartment. In contrast, 80% of CCK2R was located on the plasma membrane. Treatment with inverse agonist (YM022) or expression of dominant-negative Src blocked the constitutive internalization of CCK2i4svR, resulting in its accumulation on the plasma membrane. Expression of dominant-negative Src slowed the rate of CCK2i4svR resensitization. Inhibition of Src did not affect G17-induced internalization of either receptor variant. Constitutive internalization of CCK2i4svR increases its rate of resensitization by creating an intracellular pool of receptors that can rapidly recycle back to the plasma membrane.	Univ Texas, Med Branch, Dept Surg, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Microbiol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Hellmich, MR (corresponding author), Univ Texas, Med Branch, Dept Surg, 301 Univ Blvd, Galveston, TX 77555 USA.	mhellmic@utmb.edu		Davey, Robert/0000-0001-9168-2892	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048345, R01DK058119] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK48345, R01 DK58119] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Banker N, 1996, SURG ONCOL, V5, P201, DOI 10.1016/S0960-7404(96)80023-5; Beinborn M, 1998, J BIOL CHEM, V273, P14146, DOI 10.1074/jbc.273.23.14146; Bierkamp C, 2002, ONCOGENE, V21, P7656, DOI 10.1038/sj.onc.1205999; CHAO C, 2005, IN PRESS J SURG RES; CHAO C, 2005, P AM ASSOC CANC RES, V46, P5245; Ding WQ, 2002, CANCER RES, V62, P947; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fessart D, 2005, MOL ENDOCRINOL, V19, P491, DOI 10.1210/me.2004-0246; Grady EF, 1997, AM J PHYSIOL-GASTR L, V273, pG586, DOI 10.1152/ajpgi.1997.273.3.G586; Harris JC, 2004, CANCER RES, V64, P1915, DOI 10.1158/0008-5472.CAN-03-2713; Hata Jonathan A, 2003, Mol Interv, V3, P264, DOI 10.1124/mi.3.5.264; Heasley LE, 2001, ONCOGENE, V20, P1563, DOI 10.1038/sj.onc.1204183; Hellmich MR, 2000, J BIOL CHEM, V275, P32122, DOI 10.1074/jbc.M005754200; Hellmich MR, 1997, P NATL ACAD SCI USA, V94, P751, DOI 10.1073/pnas.94.2.751; HELLMICH MR, 2004, GASTRIN NEW MILLENNI, P71; Ishizawar RC, 2004, J BIOL CHEM, V279, P23773, DOI 10.1074/jbc.M312368200; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Kolokoltsov AA, 2005, J VIROL, V79, P756, DOI 10.1128/JVI.79.2.756-763.2005; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Li SW, 1996, J BIOL CHEM, V271, P3863; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mayor F, 1998, TRENDS CARDIOVAS MED, V8, P234, DOI 10.1016/S1050-1738(98)00008-5; NISHIDA A, 1994, J PHARMACOL EXP THER, V269, P725; Olszewska-Pazdrak B, 2004, J BIOL CHEM, V279, P40400, DOI 10.1074/jbc.C400208200; Olszewska-Pazdrak B, 2004, J BIOL CHEM, V279, P1853, DOI 10.1074/jbc.M309481200; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Rozengurt E, 2001, ANNU REV PHYSIOL, V63, P49, DOI 10.1146/annurev.physiol.63.1.49; Russello SV, 2003, FRONT BIOSCI-LANDMRK, V8, pS1068, DOI 10.2741/1138; SEVA C, 1994, SCIENCE, V265, P410, DOI 10.1126/science.8023165; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Smith JP, 2004, PANCREAS, V29, P271, DOI 10.1097/00006676-200411000-00005; Smith JP, 2002, INT J MOL MED, V10, P689; Steinlein O, 1998, BEHAV BRAIN RES, V95, P31, DOI 10.1016/S0166-4328(97)00207-6	34	13	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33368	33373		10.1074/jbc.M506337200	http://dx.doi.org/10.1074/jbc.M506337200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16079138	hybrid			2022-12-27	WOS:000232058100034
J	Kitsos, CM; Sankar, U; Illario, M; Colomer-Font, JM; Duncan, AW; Ribr, TJ; Reya, T; Means, AR				Kitsos, CM; Sankar, U; Illario, M; Colomer-Font, JM; Duncan, AW; Ribr, TJ; Reya, T; Means, AR			Calmodulin-dependent protein kinase IV regulates hematopoietic stem cell maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING PROTEIN; TRANSCRIPTION FACTOR; SELF-RENEWAL; GENE-EXPRESSION; DEFICIENT MICE; CYCLE ENTRY; ACTIVATION; CBP; APOPTOSIS; SURVIVAL	The hematopoietic stem cell (HSC) gives rise to all mature, terminally differentiated cells of the blood. Here we show that calmodulin-dependent protein kinase IV (CaMKIV) is present in c-Kit(+) ScaI(+) Lin(-/low) hematopoietic progenitor cells (KLS cells) and that its absence results in hematopoietic failure, characterized by a diminished KLS cell population and by an inability of these cells to reconstitute blood cells upon serial transplantation. KLS cell failure in the absence of CaMKIV is correlated with increased apoptosis and proliferation of these cells in vivo and in vitro. In turn, these cell biological defects are correlated with decreases in CREB-serine 133 phosphorylation as well as in CREB-binding protein (CBP) and Bcl-2 levels. Re-expression of CaMKIV in Camk4(-/-) KLS cells results in the rescue of the proliferation defects in vitro as well as in the restoration of CBP and Bcl-2 to wild type levels. These studies show that CaMKIV is a regulator of HSC homeostasis and suggest that its effects may be in part mediated via regulation of CBP and Bcl-2.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27715 USA; Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; Transform Pharmaceut, Emerging Sci & Technol Div, Lexington, MA 02421 USA	Duke University; University of Naples Federico II	Means, AR (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27715 USA.	means001@mc.duke.edu	Sankar, Uma/AHE-2383-2022	Duncan, Andrew/0000-0003-4962-4191; Illario, Maddalena/0000-0001-9834-6517				Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Anderson KA, 2002, MOL CELL BIOL, V22, P23, DOI 10.1128/MCB.22.1.23-29.2002; Anderson KA, 1997, MOL ENDOCRINOL, V11, P725, DOI 10.1210/me.11.6.725; Apati A, 2003, J BIOL CHEM, V278, P9235, DOI 10.1074/jbc.M205528200; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Corcoran EE, 2001, J BIOL CHEM, V276, P2975, DOI 10.1074/jbc.R000027200; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Domen J, 1999, MOL MED TODAY, V5, P201, DOI 10.1016/S1357-4310(99)01464-1; Greider C, 2002, ONCOGENE, V21, P7765, DOI 10.1038/sj.onc.1205928; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Kane CD, 2000, EMBO J, V19, P691, DOI 10.1093/emboj/19.4.691; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kung AL, 2000, GENE DEV, V14, P272; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lawson ND, 1999, EXP HEMATOL, V27, P1682, DOI 10.1016/S0301-472X(99)00108-3; Lemischka IR, 1997, STEM CELLS, V15, P63, DOI 10.1002/stem.5530150810; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wang SL, 2001, CELL GROWTH DIFFER, V12, P351; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Wu JY, 2000, J BIOL CHEM, V275, P7994, DOI 10.1074/jbc.275.11.7994; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419	39	59	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33101	33108		10.1074/jbc.M505208200	http://dx.doi.org/10.1074/jbc.M505208200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16020540	hybrid			2022-12-27	WOS:000232058100003
J	Thammavongsa, V; Mancino, L; Raghavan, M				Thammavongsa, V; Mancino, L; Raghavan, M			Polypeptide substrate recognition by calnexin requires specific conformations of the calnexin protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; QUALITY-CONTROL; ALPHA-BETA; ER STRESS; CALRETICULIN; BINDING; PEPTIDE; PATHWAY	Calnexin is an endoplasmic reticulum chaperone that binds to substrates containing monoglucosylated oligosaccharides. Whether calnexin can also directly recognize polypeptide components of substrates is controversial. We found that calnexin displayed significant conformational lability for a chaperone and that heat treatment and calcium depletion induced the formation of calnexin dimers and higher order oligomers. These conditions enhanced the chaperone activity of calnexin toward glycosylated and non-glycosylated major histocompatibility complex (MHC) class I heavy chains, and enhanced calnexin binding to MHC class I heavy chains. In contrast to these observations, calnexin binding to oligosaccharide substrates has been reported to be impaired under calcium-depleting conditions. Calnexin dimers were induced in HeLa cells upon heat shock and under calcium-depleting conditions, and heat shock enhanced calnexin binding to MHC class I heavy chains in HeLa cells. Virus-induced endoplasmic reticulum stress also resulted in the appearance of calnexin dimers. Tunicamycin treatment of HeLa cells induced a slow accumulation of calnexin dimers, the appearance of which correlated with enhanced calnexin binding to deglycosylated MHC class I heavy chains. In vitro, the presence of calnexin-specific oligosaccharides inhibited the formation of calnexin dimers and higher order structures. Together, these data indicate that polypeptide binding is favored by conditions that induce partial unfolding of calnexin monomers, whereas oligosaccharide binding is favored by conditions that enhance the structural stability ( folding) of calnexin monomers. Conditions that induce the calnexin "polypeptide-binding" conformation also induce self-association of calnexin if the concentration is sufficiently high; however, calnexin dimerization/ oligomerization per se is not essential for polypeptide substrate binding.	Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Grad Program Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Raghavan, M (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 5641 Med Sci Bldg 2, Ann Arbor, MI 48109 USA.	malinir@umich.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044115, R56AI044115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI044115, AI44115] Funding Source: Medline; NIAMS NIH HHS [AR48310-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARUNACHALAM B, 1995, J BIOL CHEM, V270, P2784, DOI 10.1074/jbc.270.6.2784; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; High S, 2000, FEBS LETT, V476, P38, DOI 10.1016/S0014-5793(00)01666-5; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Jorgensen CS, 2003, EUR J BIOCHEM, V270, P4140, DOI 10.1046/j.1432-1033.2003.03808.x; Lapinski PE, 2001, J BIOL CHEM, V276, P7526, DOI 10.1074/jbc.M009448200; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Mancino L, 2002, P NATL ACAD SCI USA, V99, P5931, DOI 10.1073/pnas.092031799; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; ROMAGNOLI P, 1995, J EXP MED, V182, P2027, DOI 10.1084/jem.182.6.2027; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; STAM NJ, 1990, INT IMMUNOL, V2, P113, DOI 10.1093/intimm/2.2.113; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Yamashita Y, 1996, J VIROL, V70, P2237, DOI 10.1128/JVI.70.4.2237-2246.1996	29	23	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33497	33505		10.1074/jbc.M503648200	http://dx.doi.org/10.1074/jbc.M503648200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16061483	hybrid			2022-12-27	WOS:000232058100049
J	Boyanovsky, BB; van der Westhuyzen, DR; Webb, NR				Boyanovsky, BB; van der Westhuyzen, DR; Webb, NR			Group V secretory phospholipase A(2)-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; HEPARAN-SULFATE PROTEOGLYCANS; MACROPHAGE SCAVENGER RECEPTORS; SMOOTH-MUSCLE CELLS; PHOSPHOLIPASE A(2); IN-VITRO; REMNANT LIPOPROTEINS; CHYLOMICRON REMNANTS; PLASMA-LIPOPROTEINS; LIPID-PEROXIDATION	Accumulating evidence indicates that secretory phospholipase A(2) (sPLA(2)) enzymes promote atherogenic processes. We have previously showed the presence of Group V sPLA(2) (GV sPLA(2)) in human and mouse atherosclerotic lesions, its hydrolysis of low density lipoprotein (LDL) particles, and the ability of GV sPLA(2)-modified LDL (GV- LDL) to induce macrophage foam cell formation in vitro. The goal of this study was to investigate the mechanisms involved in macrophage uptake of GV-LDL. Peritoneal macrophages from C57BL/6 mice (wild type (WT)), C57BL/6 mice deficient in LDL receptor (LDLR-/-), or SR-A and CD36 (DKO) were treated with control LDL, GV-LDL, oxidized LDL (ox-LDL) or LDL aggregated by vortexing (vx-LDL). As expected, ox- LDL induced significantly more cholesterol ester accumulation in WT and LDLR-/- compared with DKO macrophages. In contrast, there was no difference in the accumulation of GV-LDL or vx-LDL in the three cell types. I-125-ox-LDL exhibited high affinity, saturable binding to WT cells that was significantly reduced in DKO cells. Vx-LDL and GV-LDL showed low affinity, non-saturable binding that was similar for both cell types, and significantly higher compared with control LDL. GV-LDL degradation in WT and DKO cells was similar. Analyses by confocal microscopy indicated a distinct intracellular distribution of Alexa-568-labeled GV-LDL and Alexa-488-labeled ox-LDL. Uptake of GV-LDL (but not ox-LDL or vx-LDL) was significantly reduced in cells preincubated with heparin or NaClO3, suggesting a role for proteoglycans in GV-LDL uptake. Our data point to a physiological modification of LDL that has the potential to promote macrophage foam cell formation independent of scavenger receptors.	Univ Kentucky, Med Ctr, Dept Internal Med, Lexington, KY 40536 USA; Univ Kentucky, Med Ctr, Vet Affairs Med Ctr, Lexington, KY 40536 USA; Univ Kentucky, Med Ctr, Grad Ctr Nutrit Sci, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; University of Kentucky	Webb, NR (corresponding author), Univ Kentucky, Med Ctr, Dept Internal Med, 535 CT Wethington Bldg,900 S Limestone St, Lexington, KY 40536 USA.	nrwebb1@uky.edu	Webb, Nancy/AAL-7030-2021; Boyanovsky, Boris/AAQ-5194-2021		NHLBI NIH HHS [R01 HL071098, HL-65730, HL071098] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065730, R01HL071098] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AVIRAM M, 1995, BIOCHEM BIOPH RES CO, V216, P501, DOI 10.1006/bbrc.1995.2651; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BEISIEGEL U, 1994, ANN NY ACAD SCI, V737, P53, DOI 10.1111/j.1749-6632.1994.tb44301.x; BIERMAN EL, 1974, CIRC RES, V35, P136, DOI 10.1161/01.RES.35.1.136; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; Boren J, 1998, J CLIN INVEST, V101, P2658, DOI 10.1172/JCI2265; CHAPPELL DA, 1993, J BIOL CHEM, V268, P14168; Chen YJ, 1998, BBA-LIPID LIPID MET, V1394, P57, DOI 10.1016/S0005-2760(98)00098-8; Cho W, 2000, BBA-MOL CELL BIOL L, V1488, P48, DOI 10.1016/S1388-1981(00)00109-8; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Flood C, 2004, ARTERIOSCL THROM VAS, V24, P564, DOI 10.1161/01.ATV.0000117174.19078.85; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Fuki IV, 2003, J BIOL CHEM, V278, P34331, DOI 10.1074/jbc.M302181200; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Gorshkova IN, 1996, BBA-LIPID LIPID MET, V1300, P103, DOI 10.1016/0005-2760(95)00237-5; HAKALA JK, 2001, ARTERIOSCLER THROMB, V21; Han SK, 1998, BIOCHEM J, V331, P353, DOI 10.1042/bj3310353; Hanasaki K, 2002, J BIOL CHEM, V277, P29116, DOI 10.1074/jbc.M202867200; HEINECKE JW, 1984, J CLIN INVEST, V74, P1890, DOI 10.1172/JCI111609; HENRIKSEN T, 1981, P NATL ACAD SCI-BIOL, V78, P6499, DOI 10.1073/pnas.78.10.6499; HOFF HF, 1985, ANN NY ACAD SCI, V454, P183, DOI 10.1111/j.1749-6632.1985.tb11857.x; HOOGEWERF AJ, 1991, J BIOL CHEM, V266, P16564; HUETTINGER M, 1992, J BIOL CHEM, V267, P18551; HUETTINGER M, 1988, CLIN BIOCHEM, V21, P87, DOI 10.1016/S0009-9120(88)80093-6; Hurt-Camejo E, 2000, CURR OPIN LIPIDOL, V11, P465, DOI 10.1097/00041433-200010000-00004; HurtCamejo E, 1997, ARTERIOSCL THROM VAS, V17, P1011, DOI 10.1161/01.ATV.17.6.1011; JI ZS, 1994, J BIOL CHEM, V269, P13429; JI ZS, 1994, ARTERIOSCLER THROMB, V14, P2025, DOI 10.1161/01.ATV.14.12.2025; KHOO JC, 1988, ARTERIOSCLEROSIS, V8, P348, DOI 10.1161/01.ATV.8.4.348; KLEINMAN Y, 1988, J LIPID RES, V29, P729; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; MAHLEY RW, 1994, ANN NY ACAD SCI, V737, P39, DOI 10.1111/j.1749-6632.1994.tb44300.x; MEILINGER M, 1995, FEBS LETT, V360, P70, DOI 10.1016/0014-5793(95)00082-K; Murakami M, 2003, CURR OPIN LIPIDOL, V14, P431, DOI 10.1097/00041433-200310000-00003; Neuzil J, 1998, BIOCHEMISTRY-US, V37, P9203, DOI 10.1021/bi9730745; NOBLE RP, 1968, J LIPID RES, V9, P693; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sartipy P, 1999, J BIOL CHEM, V274, P25913, DOI 10.1074/jbc.274.36.25913; SPARROW CP, 1988, J LIPID RES, V29, P745; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; SUITS AG, 1989, P NATL ACAD SCI USA, V86, P2713, DOI 10.1073/pnas.86.8.2713; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tabas I, 1999, ANNU REV NUTR, V19, P123, DOI 10.1146/annurev.nutr.19.1.123; VANDIJK MCM, 1991, BIOCHEM J, V279, P863, DOI 10.1042/bj2790863; WEISGRABER KH, 1987, J BIOL CHEM, V262, P11097; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172; Wooton-Kee CR, 2004, ARTERIOSCL THROM VAS, V24, P762, DOI 10.1161/01.ATV.0000122363.02961.c1; XU XX, 1991, J BIOL CHEM, V266, P24849; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271	54	64	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32746	32752		10.1074/jbc.M502067200	http://dx.doi.org/10.1074/jbc.M502067200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16040605	hybrid			2022-12-27	WOS:000231920300025
J	Hook, P; Mikami, A; Shafer, B; Chait, BT; Rosenfeld, SS; Vallee, RB				Hook, P; Mikami, A; Shafer, B; Chait, BT; Rosenfeld, SS; Vallee, RB			Long range allosteric control of cytoplasmic dynein ATPase activity by the stalk and C-terminal domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN; NUCLEOTIDE-BINDING; ADP RELEASE; SITES; HYDROLYSIS; MECHANISM; DISTINCT; KINESIN	The dynein motor domain consists of a ring of six AAA domains with a protruding microtubule-binding stalk and a C-terminal domain of unknown function. To understand how conformational information is communicated within this complex structure, we produced a series of recombinant and proteolytic rat motor domain fragments, which we analyzed enzymatically. A recombinant 210-kDa half-motor domain fragment surprisingly exhibited a 6-fold higher steady state ATPase activity than a 380-kDa complete motor domain fragment. The increased ATPase activity was associated with a complete loss of sensitivity to inhibition by vanadate and an similar to 100-fold increase in the rate of ADP release. The time course of product release was discovered to be biphasic, and each phase was stimulated similar to 1000-fold by microtubule binding to the 380-kDa motor domain. Both the half-motor and full motor domain fragments were remarkably resistant to tryptic proteolysis, exhibiting either two or three major cleavage sites. Cleavage near the C terminus of the 380-kDa motor domain released a 32-kDa fragment and abolished sensitivity to vanadate. Cleavage at this site was insensitive to ATP or 5'-adenylyl-beta, gamma-imidodiphosphate but was blocked by ADP-AlF3 or ADP-vanadate. Based on these data, we proposed a model for long range allosteric control of product release at AAA1 and AAA3 through the microtubule-binding stalk and the C-terminal domain, the latter of which may interact with AAA1 to close the motor domain ring in a cross-bridge cycle-dependent manner.	Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; Rockefeller Univ, Lab Mass Spect & Gaseous Ion Chem, New York, NY 10022 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA	Columbia University; Rockefeller University; Columbia University	Vallee, RB (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	rv2025@columbia.edu			NCRR NIH HHS [RR00862] Funding Source: Medline; NIGMS NIH HHS [GM47434] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047434, R01GM047434] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Cadene M, 2000, ANAL CHEM, V72, P5655, DOI 10.1021/ac000811l; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Fan J, 2001, J MOL BIOL, V307, P1317, DOI 10.1006/jmbi.2001.4566; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; GIBBONS IR, 1987, J BIOL CHEM, V262, P2780; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HOLZBAUR ELF, 1989, BIOCHEMISTRY-US, V28, P5577, DOI 10.1021/bi00439a036; HOLZBAUR ELF, 1989, BIOCHEMISTRY-US, V28, P7010, DOI 10.1021/bi00443a034; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; LEHRER SS, 1978, METHOD ENZYMOL, V49, P220; Mocz G, 2001, STRUCTURE, V9, P93, DOI 10.1016/S0969-2126(00)00557-8; Neuwald AF, 1999, GENOME RES, V9, P27; Nishiura M, 2004, J BIOL CHEM, V279, P22799, DOI 10.1074/jbc.M313362200; PORTER ME, 1983, J BIOL CHEM, V258, P6582; Reck-Peterson SL, 2004, P NATL ACAD SCI USA, V101, P1491, DOI 10.1073/pnas.2637011100; Rosenfeld SS, 1996, J BIOL CHEM, V271, P30212, DOI 10.1074/jbc.271.47.30212; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; SHPETNER HS, 1988, J CELL BIOL, V107, P1001, DOI 10.1083/jcb.107.3.1001; Silvanovich A, 2003, MOL BIOL CELL, V14, P1355, DOI 10.1091/mbc.E02-10-0675; Straube A, 2001, EMBO J, V20, P5091, DOI 10.1093/emboj/20.18.5091; Takahashi Y, 2004, P NATL ACAD SCI USA, V101, P12865, DOI 10.1073/pnas.0403429101; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88	27	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					33045	33054		10.1074/jbc.M504693200	http://dx.doi.org/10.1074/jbc.M504693200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16030013	hybrid			2022-12-27	WOS:000231920300059
J	Zhao, X; Zhuang, SH; Chen, YC; Boss, GR; Pilz, RB				Zhao, X; Zhuang, SH; Chen, YC; Boss, GR; Pilz, RB			Cyclic GMP-dependent protein kinase regulates CCAAT enhancer-binding protein beta functions through inhibition of glycogen synthase kinase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; NITRIC-OXIDE SYNTHASE; C/EBP-BETA; SIGNAL-TRANSDUCTION; NATRIURETIC PEPTIDE; GENE-TRANSCRIPTION; LEUCINE ZIPPER; BONE-FORMATION; DNA-BINDING; PHOSPHORYLATION	The CCAAT enhancer- binding protein ( C/ EBP beta) plays an important role in the regulation of gene expression during cell proliferation, differentiation, and apoptosis. We previously showed that C/ EBP beta participates in cGMP- regulated transcription of c- fos in osteoblasts ( Chen, Y., Zhuang, S., Cassenaer, S., Casteel, D. E., Gudi, T., Boss, G. R., and Pilz, R. B. ( 2003) Mol. Cell. Biol. 23, 4066 4082). In the present work, we show that cGMP/ cGMP- dependent protein kinase ( PKG) induced dephosphorylation and activation of C/ EBP beta by inhibiting glycogen synthase kinase- 3 beta ( GSK- 3 beta). Phosphorylation of GSK- 3 beta on Ser(9) negatively regulates the enzyme activity, and we found that PKG phosphorylated this site both in vitro and in vivo; the in vivo phosphorylation occurred rapidly and preceded C/ EBP beta dephosphorylation. Previous studies with GSK- 3 inhibitors suggest that GSK- 3 beta is a C/ EBP beta kinase in resting cells. We determined that GSK- 3 beta phosphorylated C/ EBP beta in vitro on Thr(189), Ser(185), Ser(181), and Ser(177); C/ EBP beta was phosphorylated on these same sites in intact, unstimulated osteoblasts, and phosphorylation was decreased in cGMP- treated cells. Mutation of the GSK- 3 phosphorylation sites in C/ EBP beta prevented C/ EBP beta phosphorylation in resting cells, enhanced C/ EBP beta DNA binding, and led to increased target gene transactivation, mimicking the stimulatory effects of cGMP on C/ EBP beta. cGMP regulation of C/ EBP beta was disrupted by a mutant GSK- 3 beta( Ala(9)) resistant to cGMP/ PKG phosphorylation and inhibition. We conclude that cGMP increases the DNA binding potential of C/ EBP beta by preventing the negative effects of GSK- 3 phosphorylation.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Pilz, RB (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rpilz@ucsd.edu		Boss, Gerry/0000-0002-9758-8714	NATIONAL CANCER INSTITUTE [R01CA090932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300] Funding Source: NIH RePORTER; NCI NIH HHS [CA90932] Funding Source: Medline; NIAMS NIH HHS [AR51300] Funding Source: Medline; NIGMS NIH HHS [GM55586] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguirre J, 2001, AM J PATHOL, V158, P247, DOI 10.1016/S0002-9440(10)63963-6; Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Armour KE, 2001, ENDOCRINOLOGY, V142, P760, DOI 10.1210/en.142.2.760; Belsham DD, 1996, EMBO J, V15, P538, DOI 10.1002/j.1460-2075.1996.tb00386.x; Bollen M, 2002, TRENDS CELL BIOL, V12, P138, DOI 10.1016/S0962-8924(01)02247-4; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Bradley MN, 2003, MOL CELL BIOL, V23, P4841, DOI 10.1128/MCB.23.14.4841-4858.2003; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Buck M, 2001, EMBO J, V20, P6712, DOI 10.1093/emboj/20.23.6712; Chen YC, 2003, MOL CELL BIOL, V23, P4066, DOI 10.1128/MCB.23.12.4066-4082.2003; Chinery R, 1997, J BIOL CHEM, V272, P30356, DOI 10.1074/jbc.272.48.30356; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Ciani E, 2002, J NEUROCHEM, V81, P218, DOI 10.1046/j.1471-4159.2002.00857.x; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dowsett M, 2000, EUR J CANCER, V36, P170, DOI 10.1016/S0959-8049(99)00264-6; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fiedler B, 2002, P NATL ACAD SCI USA, V99, P11363, DOI 10.1073/pnas.162100799; FRENCH PJ, 1995, J BIOL CHEM, V270, P26626, DOI 10.1074/jbc.270.44.26626; Gudi T, 1999, FASEB J, V13, P2143, DOI 10.1096/fasebj.13.15.2143; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Ha KS, 2003, FASEB J, V17, P1036, DOI 10.1096/fj.02-0738com; Hagiwara H, 1996, AM J PHYSIOL-CELL PH, V270, pC1311, DOI 10.1152/ajpcell.1996.270.5.C1311; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005; Iyer VV, 2004, EXP CELL RES, V295, P128, DOI 10.1016/j.yexcr.2004.01.004; JARCHAU T, 1994, P NATL ACAD SCI USA, V91, P9426, DOI 10.1073/pnas.91.20.9426; Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003; Kim KH, 2004, J BIOL CHEM, V279, P51999, DOI 10.1074/jbc.M405522200; Kousteni S, 2003, J CLIN INVEST, V111, P1651, DOI 10.1172/JCI200317261; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; Mancini L, 2000, BIOCHEM BIOPH RES CO, V274, P477, DOI 10.1006/bbrc.2000.3164; Martos-Rodriguez A, 2003, J BONE JOINT SURG BR, V85B, P1190, DOI 10.1302/0301-620X.85B8.13516; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Ogasawara A, 2001, J BIOL CHEM, V276, P7048, DOI 10.1074/jbc.M008070200; PEUNOVA N, 1993, NATURE, V364, P450, DOI 10.1038/364450a0; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pigazzi A, 1999, J BIOL CHEM, V274, P14368, DOI 10.1074/jbc.274.20.14368; Pilz RB, 2005, FRONT BIOSCI-LANDMRK, V10, P1239, DOI 10.2741/1616; Piwien-Pilipuk G, 2001, J BIOL CHEM, V276, P19664, DOI 10.1074/jbc.M010193200; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; Ross SE, 1999, MOL CELL BIOL, V19, P8433; SEARS RC, 1994, MOL CELL BIOL, V14, P4855, DOI 10.1128/MCB.14.7.4855; Shuman JD, 2004, MOL CELL BIOL, V24, P7380, DOI 10.1128/MCB.24.17.7380-7391.2004; SNYDER GL, 1992, J NEUROSCI, V12, P3071, DOI 10.1523/JNEUROSCI.12-08-03071.1992; Suda M, 1998, P NATL ACAD SCI USA, V95, P2337, DOI 10.1073/pnas.95.5.2337; TRAUTWEIN C, 1994, J CLIN INVEST, V93, P2554, DOI 10.1172/JCI117266; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	58	37	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32683	32692		10.1074/jbc.M505486200	http://dx.doi.org/10.1074/jbc.M505486200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16055922	hybrid			2022-12-27	WOS:000231920300018
J	Celil, AB; Campbell, PG				Celil, AB; Campbell, PG			BMP-2 and insulin-like growth factor-I mediate osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MU; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; GENE-EXPRESSION; HOMOLOGY DOMAIN; KAPPA-B; ACTIVATION; BINDING; RAS	Genetic studies place the transcription factor Osterix (Osx) downstream of Runx2, but limited information is available about Osx regulation during osteoblastic differentiation. An important role for bone morphogenetic protein-2 (BMP-2) and insulin-like growth factor-I (IGF-I) on Osx expression and the requirement for p38 for the BMP-2-mediated effect was reported previously by our group. In this study, we continued to investigate the molecular mechanisms by which BMP-2 and IGF-1 regulate Osx expression during osteoblast lineage progression. IGF-I-mediated Osx expression required all three MAPK components (Erk, p38, and JNK), whereas BMP-2 required p38 and JNK signaling. As a common mediator of growth factor signaling, we also investigated the involvement of protein kinase C/D (PKC/D) signaling. BMP-2- and IGF-I-mediated Osx expression was blocked in response to a PKD inhibitor. A selective inhibitor of conventional PKCs had no effect on the BMP-2-mediated Osx expression. BMP-2 and IGF-I induced a selective phosphorylation of PKD, and PKD was required for mineralization. PKC/D and MAPK signaling also mediate Runx2 activity. Therefore, to document the implication for Runx2 in Osx regulation, we blocked Runx2 activity using a dominant negative Runx2 construct and an ubiquitination mediator for Runx2 degradation. We showed that blocking Runx2 activity inhibited the BMP-2-mediated induction of Osx. These studies implicated that multiple signaling pathways mediate Osx, a critical gene for osteoblast differentiation and bone formation. In addition to Runx2, other signaling components may be necessary to regulate Osx during osteoblast lineage progression.	Carnegie Mellon Univ, Inst Complex Engineered Syst, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Campbell, PG (corresponding author), Carnegie Mellon Univ, Inst Complex Engineered Syst, 1213 Hamburg Hall,5000 Forbes Ave, Pittsburgh, PA 15213 USA.	pcampbel@cs.cmu.edu						Akiyama H, 1999, J CELL PHYSIOL, V181, P169, DOI 10.1002/(SICI)1097-4652(199910)181:1<169::AID-JCP18>3.0.CO;2-5; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Brandlin I, 2002, J BIOL CHEM, V277, P45451, DOI 10.1074/jbc.M205299200; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Chang MS, 2005, CELL SIGNAL, V17, P299, DOI 10.1016/j.cellsig.2004.07.008; Cheng JJ, 2001, J BIOL CHEM, V276, P31368, DOI 10.1074/jbc.M011317200; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Cook SJ, 1997, J BIOL CHEM, V272, P13309, DOI 10.1074/jbc.272.20.13309; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gschwendt M, 1997, J BIOL CHEM, V272, P20742, DOI 10.1074/jbc.272.33.20742; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; HEIDENREICH KA, 1993, J BIOL CHEM, V268, P14663; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Johannes FJ, 1998, EUR J BIOCHEM, V257, P47, DOI 10.1046/j.1432-1327.1998.2570047.x; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; KIKUCHI A, 1994, MOL CELL BIOL, V14, P7483, DOI 10.1128/MCB.14.11.7483; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kooijman R, 2003, CELL SIGNAL, V15, P1091, DOI 10.1016/S0898-6568(03)00069-X; Kuriyama M, 1996, J BIOL CHEM, V271, P607, DOI 10.1074/jbc.271.2.607; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lemonnier J, 2004, J BIOL CHEM, V279, P259, DOI 10.1074/jbc.M308665200; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; Milona M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-43; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Peron P, 2001, J BIOL CHEM, V276, P10524, DOI 10.1074/jbc.M005919200; Prestle J, 1996, J CELL BIOL, V134, P1401, DOI 10.1083/jcb.134.6.1401; Qiang YW, 2004, BLOOD, V103, P301, DOI 10.1182/blood-2003-06-2066; Qiao M, 2004, J BIOL CHEM, V279, P42709, DOI 10.1074/jbc.M404480200; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Selvamurugan N, 2004, J BIOL CHEM, V279, P19327, DOI 10.1074/jbc.M314048200; Sudhakar S, 2001, BIOCHEM BIOPH RES CO, V289, P616, DOI 10.1006/bbrc.2001.6033; Thomas T, 1999, ENDOCRINOLOGY, V140, P5036, DOI 10.1210/en.140.11.5036; Tintut Y, 1999, J BIOL CHEM, V274, P28875, DOI 10.1074/jbc.274.41.28875; TRANQUE PA, 1992, ENDOCRINOLOGY, V131, P1948, DOI 10.1210/en.131.4.1948; Umayahara Y, 2002, J BIOL CHEM, V277, P15261, DOI 10.1074/jbc.M110827200; Van Lint J, 2002, INT J BIOCHEM CELL B, V34, P577, DOI 10.1016/S1357-2725(01)00163-7; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Walsh PT, 2002, IMMUNOLOGY, V107, P461, DOI 10.1046/j.1365-2567.2002.01525.x; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Yagi K, 2003, J CELL BIOCHEM, V88, P1077, DOI 10.1002/jcb.10467; Yamamoto T, 1999, J BIOCHEM-TOKYO, V126, P799, DOI 10.1093/oxfordjournals.jbchem.a022519; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200	57	251	270	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31353	31359		10.1074/jbc.M503845200	http://dx.doi.org/10.1074/jbc.M503845200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16000303	hybrid			2022-12-27	WOS:000231665200004
J	Gu, PL; Morgan, DH; Sattar, M; Xu, XP; Wagner, R; Raviscioni, M; Lichtarge, O; Cooney, AJ				Gu, PL; Morgan, DH; Sattar, M; Xu, XP; Wagner, R; Raviscioni, M; Lichtarge, O; Cooney, AJ			Evolutionary trace-based peptides identify a novel asymmetric interaction that mediates oligomerization in nuclear receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; RETINOID-X-RECEPTOR; DNA-BINDING; CRYSTAL-STRUCTURE; HORMONE-RECEPTORS; MOLECULAR-BASIS; DIFFERENTIAL EXPRESSION; RESPONSE ELEMENTS; STRUCTURAL BASIS; RXR TETRAMERS	Germ cell nuclear factor ( GCNF) is an orphan nuclear receptor that plays important roles in development and reproduction, by repressing the expression of essential genes such as Oct4, GDF9, and BMP15, through binding to DR0 elements. Surprisingly, whereas recombinant GCNF binds to DR0 sequences as a homodimer, endogenous GCNF does not exist as a homodimer but rather as part of a large complex termed the transiently retinoid-induced factor ( TRIF). Here, we use evolutionary trace ( ET) analysis to design mutations and peptides that probe the molecular basis for the formation of this unusual complex. We find that GCNF homodimerization and TRIF complex formation are DNA-dependent, and ET suggests that dimerization involves key functional sites on both helix 3 and helix 11, which are located on opposing surfaces of the ligand binding domain. Targeted mutations in either helix of GCNF disrupt the formation of both the homodimer and the endogenous TRIF complex. Moreover, peptide mimetics of both of these ET-determined sites inhibit dimerization and TRIF complex formation. This suggests that a novel helix 3-helix 11 heterotypic interaction mediates GCNF interaction and would facilitate oligomerization. Indeed, it was determined that the endogenous TRIF complex is composed of a GCNF oligomer. These findings shed light on an evolutionarily selected mechanism that reveals the unusual DNA-binding, dimerization, and oligomerization properties of GCNF.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; Baylor Coll Med, WM Keck Ctr Computat & Struct Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Cooney, AJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	acooney@bcm.tmc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066099] Funding Source: NIH RePORTER; NIDDK NIH HHS [U19DK6234-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM066099] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aarnisalo P, 2002, J BIOL CHEM, V277, P35118, DOI 10.1074/jbc.M201707200; ALLAN GF, 1992, J BIOL CHEM, V267, P19513; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Barnea E, 2000, J BIOL CHEM, V275, P6608, DOI 10.1074/jbc.275.9.6608; Bauer UM, 1998, FEBS LETT, V439, P208, DOI 10.1016/S0014-5793(98)01327-1; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; Borgmeyer U, 1997, EUR J BIOCHEM, V244, P120, DOI 10.1111/j.1432-1033.1997.00120.x; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; BURBACH JPH, 1994, J BIOL CHEM, V269, P15046; BUTLER AJ, 1995, NUCLEIC ACIDS RES, V23, P4143, DOI 10.1093/nar/23.20.4143; CHEN F, 1994, MOL ENDOCRINOL, V8, P1434, DOI 10.1210/me.8.10.1434; Chen ZP, 1998, J MOL BIOL, V275, P55, DOI 10.1006/jmbi.1997.1413; Cooney AJ, 1998, BIOCHEM BIOPH RES CO, V245, P94, DOI 10.1006/bbrc.1998.8391; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Fuhrmann G, 1999, CELL MOL BIOL, V45, P717; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Greschik H, 1999, MOL CELL BIOL, V19, P690; Greschik I, 2003, CURR TOP MED CHEM, V3, P1573, DOI 10.2174/1568026033451736; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Heinzer C, 1998, BIOL CHEM, V379, P349, DOI 10.1515/bchm.1998.379.3.349; Hentschke M, 2002, EUR J BIOCHEM, V269, P4086, DOI 10.1046/j.1432-1033.2002.03102.x; Hummelke GC, 1998, MOL REPROD DEV, V50, P396, DOI 10.1002/(SICI)1098-2795(199808)50:4<396::AID-MRD3>3.0.CO;2-D; Ikeda Y, 1996, ACTA PAEDIATR JAPON, V38, P412; KERSTEN S, 1995, P NATL ACAD SCI USA, V92, P8645, DOI 10.1073/pnas.92.19.8645; Kersten S, 1997, J BIOL CHEM, V272, P29759, DOI 10.1074/jbc.272.47.29759; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; Lan ZJ, 2003, EMBO J, V22, P4070, DOI 10.1093/emboj/cdg405; Lee WY, 2002, BIOCHEMISTRY-US, V41, P2500, DOI 10.1021/bi011764+; Lichtarge O, 1997, J MOL BIOL, V274, P325, DOI 10.1006/jmbi.1997.1395; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Madabushi S, 2002, J MOL BIOL, V316, P139, DOI 10.1006/jmbi.2001.5327; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; Quan XJ, 2004, DEVELOPMENT, V131, P1679, DOI 10.1242/dev.01055; RIBEIRO RCJ, 1995, ANNU REV MED, V46, P443, DOI 10.1146/annurev.med.46.1.443; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Schmitz TP, 1999, BBA-GENE STRUCT EXPR, V1446, P173, DOI 10.1016/S0167-4781(99)00079-2; Seol W, 1997, MOL CELL BIOL, V17, P7126, DOI 10.1128/MCB.17.12.7126; Shan L, 2004, MOL CELL, V16, P907, DOI 10.1016/S1097-2765(04)00728-2; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Susens U, 1997, DEV NEUROSCI-BASEL, V19, P410, DOI 10.1159/000111238; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Whitfield GK, 1999, J CELL BIOCHEM, P110; Xu RX, 2004, MOL CELL, V16, P919, DOI 10.1016/j.molcel.2004.11.042; Yan ZH, 1997, J BIOL CHEM, V272, P10565; Yan ZJ, 2000, J BIOL CHEM, V275, P35077, DOI 10.1074/jbc.M005566200; Yao H, 2003, J MOL BIOL, V326, P255, DOI 10.1016/S0022-2836(02)01336-0; Yasmin R, 2004, J MOL BIOL, V343, P327, DOI 10.1016/j.jmb.2004.08.070; ZENG ZM, 1994, ENDOCRINOLOGY, V135, P248, DOI 10.1210/en.135.1.248; Zhang YL, 1998, MOL REPROD DEV, V50, P93, DOI 10.1002/(SICI)1098-2795(199805)50:1&lt;93::AID-MRD12&gt;3.0.CO;2-Z; Zhang ZD, 2004, GENOME RES, V14, P580, DOI 10.1101/gr.2160004	63	25	25	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31818	31829		10.1074/jbc.M501924200	http://dx.doi.org/10.1074/jbc.M501924200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15994320	hybrid, Green Published			2022-12-27	WOS:000231665200061
J	Ludemann, N; Clement, A; Hans, VH; Leschik, J; Behl, C; Brandt, R				Ludemann, N; Clement, A; Hans, VH; Leschik, J; Behl, C; Brandt, R			O-glycosylation of the tail domain of neurofilament protein M in human neurons and in spinal cord tissue of a rat model of amyotrophic lateral sclerosis (ALS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONAL HOT-SPOT; DYNAMIC INTERPLAY; NF-H; PHOSPHORYLATION SITES; LINKED GLYCOSYLATION; NERVOUS-SYSTEM; AXONAL CALIBER; RADIAL GROWTH; HEAVY SUBUNIT; C-MYC	Mammalian neurofilaments ( NFs) are modified by post-translational modifications that are thought to regulate NF assembly and organization. Whereas phosphorylation has been intensely studied, the role of another common modification, the attachment of O-linked N-acetylglucosamine ( GlcNAc) to individual serine and threonine residues, is hardly understood. We generated a novel monoclonal antibody that specifically recognizes an O-glycosylated epitope in the tail domain of NF-M and allows determination of the glycosylation state at this residue. The antibody displays strong species preference for human NF-M, shows some reactivity with rat but not with mouse or bovine NF-M. By immunohistochemistry and Western blot analysis of biopsy-derived human temporal lobe tissue we show that immunoreactivity is highly enriched in axons parallel to hyperphosphorylated NFs. Treatment of cultured neurons with the GlcNAcase inhibitor PUGNAc causes a 40% increase in immunoreactivity within 1 h, which is completely reversible and parallels the total increase in cellular O-GlcNAc modification. Treatment with the mitogen-activated protein kinase kinase inhibitor PD-98059 leads to a similar increase in immunoreactivity. In spinal cord tissue of a transgenic rat model for amyotrophic lateral sclerosis, immunoreactivity is strongly decreased compared with wild-type animals while phosphorylation is increased. The data suggest that hyper-phosphorylation and tail domain O-glycosylation of NFs are synchronously regulated in axons of human neurons in situ and that O-glycosylation of NF-M is highly dynamic and closely interweaved with phosphorylation cascades and may have a pathophysiological role.	Univ Osnabruck, Dept Neurobiol, D-49076 Osnabruck, Germany; Heidelberg Univ, IZN, Dept Neurobiol, D-69120 Heidelberg, Germany; Johannes Gutenberg Univ Mainz, Inst Physiol Chem & Pathobiochem, D-55099 Mainz, Germany; Univ Hosp Bonn, Inst Neuropathol, D-53105 Bonn, Germany	University Osnabruck; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; University of Bonn	Brandt, R (corresponding author), Univ Osnabruck, Dept Neurobiol, Barbarastr 11, D-49076 Osnabruck, Germany.	Brandt@biologie.uni-osnabrueck.de		Behl, Christian/0000-0001-8453-2378; Brandt, Roland/0000-0003-0101-1257				ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ANDO S, 1989, BIOCHEMISTRY-US, V28, P2974, DOI 10.1021/bi00433a035; BIEDLER JL, 1978, CANCER RES, V38, P3751; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BRANDT R, 1993, J BIOL CHEM, V268, P3414; CHIN SSM, 1991, J CELL SCI, V99, P335; CHOU CF, 1992, J BIOL CHEM, V267, P3901; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; COLE JS, 1994, J NEUROSCI, V14, P6956; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Dong DLY, 1996, J BIOL CHEM, V271, P20845, DOI 10.1074/jbc.271.34.20845; DONG DLY, 1993, J BIOL CHEM, V268, P16679; Duk M, 1997, ANAL BIOCHEM, V253, P98, DOI 10.1006/abio.1997.9994; ELHANANY E, 1994, J NEUROCHEM, V63, P2324; FAISSNER A, 1990, NEURON, V5, P627, DOI 10.1016/0896-6273(90)90217-4; Garcia ML, 2003, J CELL BIOL, V163, P1011, DOI 10.1083/jcb.200308159; GRIFFITH LS, 1995, BIOCHEM BIOPH RES CO, V213, P424, DOI 10.1006/bbrc.1995.2149; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Haltiwanger RS, 1997, BIOCHEM BIOPH RES CO, V231, P237, DOI 10.1006/bbrc.1997.6110; Harlow E., 1988, ANTIBODIES LAB MANUA; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; HIROKAWA N, 1984, J CELL BIOL, V98, P1523, DOI 10.1083/jcb.98.4.1523; Hollander BA, 1996, J NEUROCHEM, V66, P412; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; JULIEN JP, 1983, J BIOL CHEM, V258, P4019; Julien JP, 1997, TRENDS CELL BIOL, V7, P243, DOI 10.1016/S0962-8924(97)01049-0; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; KEARSE KP, 1991, P NATL ACAD SCI USA, V88, P1701, DOI 10.1073/pnas.88.5.1701; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kempf M, 1996, J NEUROSCI, V16, P5583; Kikuchi S, 2003, BRAIN RES REV, V41, P306, DOI 10.1016/S0165-0173(02)00273-4; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; LEE VMY, 1987, J NEUROSCI, V7, P3474; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P1998, DOI 10.1073/pnas.85.6.1998; MANETTO V, 1988, J NEUROPATH EXP NEUR, V47, P642, DOI 10.1097/00005072-198811000-00007; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Piontek J, 2003, J BIOL CHEM, V278, P38970, DOI 10.1074/jbc.M306749200; Piontek J, 1999, J NEUROCHEM, V73, P139, DOI 10.1046/j.1471-4159.1999.0730139.x; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Rao MV, 2002, J CELL BIOL, V158, P681, DOI 10.1083/jcb.200202037; Rao MV, 1998, J CELL BIOL, V143, P171, DOI 10.1083/jcb.143.1.171; Rao MV, 2003, J CELL BIOL, V163, P1021, DOI 10.1083/jcb.200308076; Rao MV, 2003, NEUROCHEM RES, V28, P1041, DOI 10.1023/A:1023259207015; Riederer BM, 1996, J COMP NEUROL, V364, P704, DOI 10.1002/(SICI)1096-9861(19960122)364:4<704::AID-CNE8>3.0.CO;2-7; RIEDERER BM, 1993, J HISTOCHEM CYTOCHEM, V41, P609, DOI 10.1177/41.4.8450200; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; SIHAG RK, 1991, J BIOL CHEM, V266, P18861; SIHAG RK, 1990, J BIOL CHEM, V265, P4166; Slawson C, 2003, CURR OPIN STRUC BIOL, V13, P631, DOI 10.1016/j.sbi.2003.08.003; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; Song J, 1997, NEUROBIOL AGING, V18, P475, DOI 10.1016/S0197-4580(97)00043-2; Sun DM, 1996, J BIOL CHEM, V271, P14245, DOI 10.1074/jbc.271.24.14245; TODARO GJ, 1965, VIROLOGY, V27, P179, DOI 10.1016/0042-6822(65)90157-1; TURNER JR, 1990, P NATL ACAD SCI USA, V87, P5608, DOI 10.1073/pnas.87.15.5608; Veeranna, 1998, J NEUROSCI, V18, P4008; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; XU ZS, 1992, J BIOL CHEM, V267, P4467	66	62	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31648	31658		10.1074/jbc.M504395200	http://dx.doi.org/10.1074/jbc.M504395200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16006557	hybrid			2022-12-27	WOS:000231665200040
J	Weng, Y; DiRusso, CC; Reilly, AA; Black, PN; Ding, XX				Weng, Y; DiRusso, CC; Reilly, AA; Black, PN; Ding, XX			Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene - Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-ALPHA; CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X RECEPTOR; BILE-ACID SYNTHESIS; COA DESATURASE 1; P450 OXIDOREDUCTASE; NUCLEAR RECEPTOR; MICROARRAY DATA; FEEDBACK-REGULATION; LIPOPROTEIN-LIPASE	NADPH-cytochrome P450 reductase (CPR) is an essential component for the function of many enzymes, including microsomal cytochrome P450 ( P450) monooxygenases and heme oxygenases. In liver-Cpr-null ( with liver-specific Cpr deletion) and Cpr-low ( with reduced CPR expression in all organs examined) mouse models, a reduced serum cholesterol level and an induction of hepatic P450s were observed, whereas hepatomegaly and fatty liver were only observed in the liver-Cpr- null model. Our goal was to identify hepatic gene expression changes related to these phenotypes. Cpr-lox mice ( with a floxed Cpr gene and normal CPR expression) were used as the control. Through microarray analysis, we identified many genes that were differentially expressed among the three groups of mice. We also recognized the 12 gene ontology terms that contained the most significantly changed gene expression in at least one of the two mouse models. We further uncovered potential mechanisms, such as an increased activation of constitutive androstane receptor and a decreased activation of peroxisomal proliferatoractivated receptor-alpha by precursors of cholesterol biosynthesis, that underlie common changes ( e. g. induction of multiple P450s and suppression of genes for fatty acid metabolism) in response to CPR loss in the two mouse models. Additionally, we observed model-specific gene expression changes, such as the induction of a fatty-acid translocase (Cd36 antigen) and the suppression of carnitine O-palmitoyltransferase 1 (Cpt1a) and acyl-CoA synthetase long chain family member 1 (Acsl1), that are potentially responsible for the severe hepatic lipidosis and an altered fatty acid profile observed in liver-Cpr-null mice.	New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; SUNY Albany, Albany, NY 12201 USA; Ordway Res Inst Inc, Albany, NY 12208 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Ordway Research Institute	Ding, XX (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Empire State Plaza,Box 509, Albany, NY 12201 USA.	xding@wadsworth.org	DiRusso, Concetta C/M-1884-2014	Black, Paul/0000-0002-6272-6881	NCI NIH HHS [CA092596] Funding Source: Medline; NIEHS NIH HHS [ES07462] Funding Source: Medline; NIGMS NIH HHS [GM5685] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007462] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Anderson SP, 2004, MOL PHARMACOL, V66, P1440, DOI 10.1124/mol.104.005496; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Bae YJ, 2004, DNA CELL BIOL, V23, P81, DOI 10.1089/104454904322759894; CASTILLOOLIVARE.A, 2001, NUCLEIC ACIDS RES, V29, P4035; CASTILLOOLIVARE.A, 2004, J BIOL CHEM, V279, P16813; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Coon M J, 1978, Methods Enzymol, V52, P109; Coort SLM, 2004, DIABETES, V53, P1655, DOI 10.2337/diabetes.53.7.1655; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Dussault I, 2003, P NATL ACAD SCI USA, V100, P833, DOI 10.1073/pnas.0336235100; ENOCH HG, 1979, J BIOL CHEM, V254, P8976; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Ferguson SS, 2002, MOL PHARMACOL, V62, P737, DOI 10.1124/mol.62.3.737; Fiske CH, 1925, J BIOL CHEM, V66, P375; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; FOLCH J, 1957, J BIOL CHEM, V226, P497; Glatz JFC, 2002, MOL CELL BIOCHEM, V239, P3, DOI 10.1023/A:1020529918782; Goldberg IJ, 1996, J LIPID RES, V37, P693; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Goodwin B, 2003, P NATL ACAD SCI USA, V100, P223, DOI 10.1073/pnas.0237082100; Gu J, 1998, J PHARMACOL EXP THER, V285, P1287; Gu J, 2005, MOL PHARMACOL, V67, P623, DOI 10.1124/mol.104.007898; Gu J, 2003, J BIOL CHEM, V278, P25895, DOI 10.1074/jbc.M303125200; Harmon SD, 2003, LIPIDS, V38, P469, DOI 10.1007/s11745-003-1086-9; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Huang NW, 2005, AM J HUM GENET, V76, P729, DOI 10.1086/429417; Huebert RC, 2002, J BIOL CHEM, V277, P22710, DOI 10.1074/jbc.M202394200; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Inoue I, 2002, BIOCHEM BIOPH RES CO, V290, P131, DOI 10.1006/bbrc.2001.6141; Ishida H, 1999, J BIOCHEM-TOKYO, V126, P19, DOI 10.1093/oxfordjournals.jbchem.a022422; JELINEK DF, 1990, BIOCHEMISTRY-US, V29, P7781, DOI 10.1021/bi00486a001; Kocarek TA, 1998, MOL PHARMACOL, V54, P474, DOI 10.1124/mol.54.3.474; Kocarek TA, 2002, MOL PHARMACOL, V62, P1177, DOI 10.1124/mol.62.5.1177; Landrier JF, 2004, J BIOL CHEM, V279, P45512, DOI 10.1074/jbc.M407461200; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; Martin GG, 2003, BIOCHEMISTRY-US, V42, P11520, DOI 10.1021/bi0346749; Mascaro C, 1998, J BIOL CHEM, V273, P8560, DOI 10.1074/jbc.273.15.8560; Meier PJ, 2002, ANNU REV PHYSIOL, V64, P635, DOI 10.1146/annurev.physiol.64.082201.100300; Miller CW, 1996, P NATL ACAD SCI USA, V93, P9443, DOI 10.1073/pnas.93.18.9443; Nishino H, 2000, ARCH BIOCHEM BIOPHYS, V374, P293, DOI 10.1006/abbi.1999.1602; Norlin M, 2004, BIOCHEM BIOPH RES CO, V316, P158, DOI 10.1016/j.bbrc.2004.02.029; Obukowicz M, 1999, LIPIDS, V34, pS149, DOI 10.1007/BF02562269; ONO T, 1975, J BIOL CHEM, V250, P1571; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; Pereira SL, 2003, PROSTAG LEUKOTR ESS, V68, P97, DOI 10.1016/S0952-3278(02)00259-4; Porter TD, 2002, J BIOCHEM MOL TOXIC, V16, P311, DOI 10.1002/jbt.10052; PORTER TD, 1991, J BIOL CHEM, V266, P13469; Roglans N, 2002, J PHARMACOL EXP THER, V302, P232, DOI 10.1124/jpet.302.1.232; Rosenfeld JM, 2003, MOL ENDOCRINOL, V17, P1268, DOI 10.1210/me.2002-0421; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sampath H, 2004, NUTR REV, V62, P333, DOI [10.1301/nr.2004.sept.333-339, 10.1111/j.1753-4887.2004.tb00058.x]; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; SCHOONJANS K, 1995, J BIOL CHEM, V270, P19269, DOI 10.1074/jbc.270.33.19269; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Simpson AECM, 1997, GEN PHARMACOL-VASC S, V28, P351, DOI 10.1016/S0306-3623(96)00246-7; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Stith BJ, 2000, J LIPID RES, V41, P1448; Szczesna-Skorupa E, 2004, J BIOL CHEM, V279, P13953, DOI 10.1074/jbc.M312170200; Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603; Wang XJ, 2005, BIOCHEM J, V388, P857, DOI 10.1042/BJ20042087; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; Wu L, 2005, J PHARMACOL EXP THER, V312, P35, DOI 10.1124/jpet.104.073353; Wu L, 2003, GENESIS, V36, P177, DOI 10.1002/gene.10214; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; ZHANG QY, 1989, P NATL ACAD SCI USA, V86, P8294, DOI 10.1073/pnas.86.21.8294; Zou ZY, 2002, J BIOL CHEM, V277, P31062, DOI 10.1074/jbc.M205034200	76	56	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31686	31698		10.1074/jbc.M504447200	http://dx.doi.org/10.1074/jbc.M504447200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16006652	hybrid			2022-12-27	WOS:000231665200045
J	McIntosh, JM; Plazas, PV; Watkins, M; Gomez-Casati, ME; Olivera, BM; Elgoyhen, AB				McIntosh, JM; Plazas, PV; Watkins, M; Gomez-Casati, ME; Olivera, BM; Elgoyhen, AB			A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha 9 alpha 10 and alpha 7 nicotinic cholinergic receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; INNER HAIR-CELLS; LATERAL-LINE ORGAN; CHICK OPTIC LOBE; ACETYLCHOLINE-RECEPTOR; PHARMACOLOGICAL-PROPERTIES; SUBUNIT COMPOSITION; MOLECULAR-CLONING; GENE FAMILY; BETA 2	The alpha 9 and alpha 10 nicotinic cholinergic subunits assemble to form the receptor believed to mediate synaptic transmission between efferent olivocochlear fibers and hair cells of the cochlea, one of the few examples of postsynaptic function for a non-muscle nicotinic acetylcholine receptor ( nAChR). However, it has been suggested that the expression profile of alpha 9 and alpha 10 overlaps with that of alpha 7 in the cochlea and in sites such as dorsal root ganglion neurons, peripheral blood lymphocytes, developing thymocytes, and skin. We now report the cloning, total synthesis, and characterization of a novel toxin alpha-conotoxin PeIA that discriminates between alpha 9 alpha 10 and alpha 7 nAChRs. This is the first toxin to be identified from Conus pergrandis, a species found in deep waters of the Western Pacific. alpha-Conotoxin PeIA displayed a 260-fold higher selectivity for alpha-bungarotoxin-sensitive alpha 9 alpha 10 nAChRs compared with alpha-bungarotoxin-sensitive alpha 7 receptors. The IC50 of the toxin was 6.9 +/- 0.5 nM and 4.4 +/- 0.5 nM for recombinant alpha 9 alpha 10 and wild-type hair cell nAChRs, respectively. alpha-Conotoxin PeIA bears high resemblance to alpha-conotoxins MII and GIC isolated from Conus magus and Conus geographus, respectively. However, neither alpha-conotoxin MII nor alpha-conotoxin GIC at concentrations of 10 mu M blocked acetylcholine responses elicited in Xenopus oocytes injected with the alpha 9 and alpha 10 subunits. Among neuronal non-alpha-bungarotoxin-sensitive receptors, alpha-conotoxin PeIA was also active at alpha 3 beta 2 receptors and chimeric alpha 6/alpha 3 beta 2 beta 3 receptors. alpha-Conotoxin PeIA represents a novel probe to differentiate responses mediated either through alpha 9 alpha 10 or alpha 7 nAChRs in those tissues where both receptors are expressed.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol, RA-1428 Buenos Aires, DF, Argentina	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	McIntosh, JM (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	mcintosh.mike@gmail.com		Gomez-Casati, Maria/0000-0003-4923-8274; Plazas, Paola/0000-0001-8195-484X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH053631, R01MH053631] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48677] Funding Source: Medline; NIMH NIH HHS [MH53631] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arredondo J, 2002, J CELL BIOL, V159, P325, DOI 10.1083/jcb.200206096; Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Baker ER, 2004, MOL PHARMACOL, V65, P453, DOI 10.1124/mol.65.2.453; Balestra B, 2000, MOL PHARMACOL, V58, P300, DOI 10.1124/mol.58.2.300; Bleckmann H., 1993, BEHAV TELEOST FISHES, P201; BOBBIN RP, 1978, ANN OTO RHINOL LARYN, V87, P185; BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Chernyavsky AI, 2004, J CELL SCI, V117, P5665, DOI 10.1242/jcs.01492; Colquhoun LM, 1997, J NEUROCHEM, V69, P2355; Conroy WG, 1998, MOL PHARMACOL, V53, P392, DOI 10.1124/mol.53.3.392; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Dawkins R, 2005, J NEUROPHYSIOL, V93, P2541, DOI 10.1152/jn.01283.2004; DENERIS ES, 1988, NEURON, V1, P45, DOI 10.1016/0896-6273(88)90208-5; Drescher DG, 2004, NEUROSCIENCE, V127, P737, DOI 10.1016/j.neuroscience.2004.05.037; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; FLOCK A, 1962, J CELL BIOL, V15, P19, DOI 10.1083/jcb.15.1.19; Fuchs PA, 1996, CURR OPIN NEUROBIOL, V6, P514, DOI 10.1016/S0959-4388(96)80058-4; Genzen JR, 2001, J NEUROPHYSIOL, V86, P1773, DOI 10.1152/jn.2001.86.4.1773; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; GOLDMAN D, 1987, CELL, V48, P965, DOI 10.1016/0092-8674(87)90705-7; Gotti C, 2005, MOL PHARMACOL, V67, P2007, DOI 10.1124/mol.105.011940; GOTTI C, 1994, EUR J NEUROSCI, V6, P1281, DOI 10.1111/j.1460-9568.1994.tb00318.x; Groot-Kormelink PJ, 1998, J BIOL CHEM, V273, P15317, DOI 10.1074/jbc.273.25.15317; Guinan J.J., 1996, COCHLEA EDITED, P435; Haberberger RV, 2004, AUTON NEUROSCI-BASIC, V113, P32, DOI 10.1016/j.autneu.2004.05.008; Jones AK, 2003, GENOMICS, V82, P441, DOI 10.1016/S0888-7543(03)00153-8; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Katz E, 2000, HEARING RES, V141, P117, DOI 10.1016/S0378-5955(99)00214-2; Katz E, 2004, J NEUROSCI, V24, P7814, DOI 10.1523/JNEUROSCI.2102-04.2004; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kurzen H, 2005, EXP DERMATOL, V14, P155, DOI 10.1111/j.0906-6705.2005.0266i.x; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Lips KS, 2002, NEUROSCIENCE, V115, P1, DOI 10.1016/S0306-4522(02)00274-9; LUEBKE AE, 1995, ABS ASS RES OTOLARYN, V18, P193; Lustig LR, 2001, GENOMICS, V73, P272, DOI 10.1006/geno.2000.6503; McIntosh JM, 2002, J BIOL CHEM, V277, P33610, DOI 10.1074/jbc.M205102200; McIntosh JM, 1999, ANNU REV BIOCHEM, V68, P59, DOI 10.1146/annurev.biochem.68.1.59; MIHOVILOVIC M, 1993, J IMMUNOL, V151, P6517; Morley BJ, 1998, MOL BRAIN RES, V53, P78, DOI 10.1016/S0169-328X(97)00272-6; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Nicke A, 2004, EUR J BIOCHEM, V271, P2305, DOI 10.1111/j.1432-1033.2004.04145.x; Peng HS, 2004, LIFE SCI, V76, P263, DOI 10.1016/j.lfs.2004.05.031; Pohlmann K, 2004, J EXP BIOL, V207, P2971, DOI 10.1242/jeb.01129; Rothlin CV, 2003, MOL PHARMACOL, V63, P1067, DOI 10.1124/mol.63.5.1067; RUSSELL IJ, 1971, J EXP BIOL, V54, P643; Santos AD, 2004, J BIOL CHEM, V279, P17596, DOI 10.1074/jbc.M309654200; Sato KZ, 1999, NEUROSCI LETT, V266, P17, DOI 10.1016/S0304-3940(99)00259-1; SEGUELA P, 1993, J NEUROSCI, V13, P596; Sgard F, 2002, MOL PHARMACOL, V61, P150, DOI 10.1124/mol.61.1.150; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Walker CS, 1999, J BIOL CHEM, V274, P30664, DOI 10.1074/jbc.274.43.30664; WALS JG, 1979, CONE SHELLS SYNOPSIS, P790; Weisstaub N, 2002, HEARING RES, V167, P122, DOI 10.1016/S0378-5955(02)00380-5	60	107	116	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30107	30112		10.1074/jbc.M504102200	http://dx.doi.org/10.1074/jbc.M504102200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15983035	hybrid, Green Published			2022-12-27	WOS:000231362500016
J	Papaconstantinou, ME; Carrell, CJ; Pineda, AO; Bobofchak, KM; Mathews, FS; Flordellis, CS; Maragoudakis, ME; Tsopanoglou, NE; Di Cera, E				Papaconstantinou, ME; Carrell, CJ; Pineda, AO; Bobofchak, KM; Mathews, FS; Flordellis, CS; Maragoudakis, ME; Tsopanoglou, NE; Di Cera, E			Thrombin functions through its RGD sequence in a non-canonical conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOVALENT CATION SPECIFICITY; INDUCED ANGIOGENESIS; ADHESIVE PROPERTIES; CRYSTAL-STRUCTURE; ALPHA(V)BETA(3)-INTEGRIN; HIRUDIN; BINDING; CELLS; INVOLVEMENT	Previous studies have suggested that thrombin interacts with integrins in endothelial cells through its RGD (Arg-187, Gly-188, Asp-189) sequence. All existing crystal structures of thrombin show that most of this sequence is buried under the 220-loop and therefore interaction via RGD implies either partial unfolding of the enzyme or its proteolytic digestion. Here, we demonstrate that surface-absorbed thrombin promotes attachment and migration of endothelial cells through interaction with alpha(v)beta(3) and alpha(5)beta(1) integrins. Using site-directed mutants of thrombin we prove that this effect is mediated by the RGD sequence and does not require catalytic activity. The effect is abrogated when residues of the RGD sequence are mutated to Ala and is not observed with proteases like trypsin and tissue-type plasminogen activator, unless the RGD sequence is introduced at position 187-189. The potent inhibitor hirudin does not abrogate the effect, suggesting that thrombin functions through its RGD sequence in a non-canonical conformation. A 1.9-angstrom resolution crystal structure of free thrombin grown in the presence of high salt (400 mM KCl) shows two molecules in the asymmetric unit, one of which assumes an unprecedented conformation with the autolysis loop shifted 20 angstrom away from its canonical position, the 220-loop entirely disordered, and the RGD sequence exposed to the solvent.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Univ Patras, Sch Med, Dept Pharmacol, Patras 26500, Greece	Washington University (WUSTL); University of Patras	Tsopanoglou, NE (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	ntsopan@med.upatras.gr; enrico@wustl.edu			NHLBI NIH HHS [HL49413, HL58141, HL73813] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL049413, R01HL058141, R01HL049413, R01HL073813] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; BANFIELD DK, 1992, P NATL ACAD SCI USA, V89, P2779, DOI 10.1073/pnas.89.7.2779; BarShavit R, 1996, J CELL BIOCHEM, V61, P278, DOI 10.1002/(SICI)1097-4644(19960501)61:2<278::AID-JCB11>3.0.CO;2-I; BARSHAVIT R, 1983, SCIENCE, V220, P728, DOI 10.1126/science.6836310; BARSHAVIT R, 1993, J CELL BIOL, V123, P1279, DOI 10.1083/jcb.123.5.1279; BARSHAVIT R, 1991, J CELL BIOL, V112, P335, DOI 10.1083/jcb.112.2.335; Bobofchak KM, 2005, J BIOL CHEM, V280, P25644, DOI 10.1074/jbc.M503499200; BODE W, 1992, PROTEIN SCI, V1, P426; Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Di Cera E, 2004, CR BIOL, V327, P1065, DOI 10.1016/j.crvi.2004.07.011; Di Cera E, 2003, CHEST, V124, p11S, DOI 10.1378/chest.124.3_suppl.11S; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Frenette PS, 1996, NEW ENGL J MED, V334, P1526, DOI 10.1056/NEJM199606063342308; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Mengwasser KE, 2005, J BIOL CHEM, V280, P26997, DOI 10.1074/jbc.M502678200; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Pineda AO, 2004, BIOPHYS CHEM, V112, P253, DOI 10.1016/j.bpc.2004.07.027; Pineda AO, 2002, J BIOL CHEM, V277, P32015, DOI 10.1074/jbc.M205009200; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Prasad S, 2003, P NATL ACAD SCI USA, V100, P13785, DOI 10.1073/pnas.2333109100; Prasad S, 2004, J BIOL CHEM, V279, P10103, DOI 10.1074/jbc.M312614200; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Sajid M, 2003, AM J PHYSIOL-CELL PH, V285, pC1330, DOI 10.1152/ajpcell.00475.2002; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; Stouffer GA, 2003, ARTERIOSCL THROM VAS, V23, P1971, DOI 10.1161/01.ATV.0000093470.51580.0F; Tsopanoglou NE, 2004, THROMB HAEMOSTASIS, V92, P846, DOI 10.1160/TH04-04-0208; Tsopanoglou NE, 2002, AM J PHYSIOL-CELL PH, V283, pC1501, DOI 10.1152/ajpcell.00162.2002; Vindigni A, 1998, PROTEIN SCI, V7, P1728, DOI 10.1002/pro.5560070807	30	31	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2005	280	33					29393	29396		10.1074/jbc.C500248200	http://dx.doi.org/10.1074/jbc.C500248200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	954SX	15998637	hybrid			2022-12-27	WOS:000231176200002
J	Bedhomme, M; Hoffmann, M; McCarthy, EA; Gambonnet, B; Moran, RG; Rebeille, F; Ravanel, S				Bedhomme, M; Hoffmann, M; McCarthy, EA; Gambonnet, B; Moran, RG; Rebeille, F; Ravanel, S			Folate metabolism in plants - An Arabidopsis homolog of the mammalian mitochondrial folate transporter mediates folate import into chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-CARBON METABOLISM; PROTOZOAN PARASITE LEISHMANIA; INTEGRAL MEMBRANE-PROTEINS; P-AMINOBENZOATE BRANCH; TETRAHYDROFOLATE SYNTHESIS; METHOTREXATE RESISTANCE; THALIANA; BIOSYNTHESIS; EXPRESSION; ENVELOPE	The distribution of folates in plant cells suggests a complex traffic of the vitamin between the organelles and the cytosol. The Arabidopsis thaliana protein AtFOLT1 encoded by the At5g66380 gene is the closest homolog of the mitochondrial folate transporters (MFTs) characterized in mammalian cells. AtFOLT1 belongs to the mitochondrial carrier family, but GFP-tagging experiments and Western blot analyses indicated that it is targeted to the envelope of chloroplasts. By using the glycine auxotroph Chinese hamster ovary glyB cell line, which lacks a functional MFT and is deficient in folates transport into mitochondria, we showed by complementation that AtFOLT1 functions as a folate transporter in a hamster background. Indeed, stable transfectants bearing the AtFOLT1 cDNA have enhanced levels of folates in mitochondria and can support growth in glycine-free medium. Also, the expression of AtFOLT1 in Escherichia coli allows bacterial cells to uptake exogenous folate. Disruption of the AtFOLT1 gene in Arabidopsis does not lead to phenotypic alterations in folate-sufficient or folate-deficient plants. Also, the atfolt1 null mutant contains wild-type levels of folates in chloroplasts and preserves the enzymatic capacity to catalyze folate-dependent reactions in this subcellular compartment. These findings suggest strongly that, despite many common features shared by chloroplasts and mitochondria from mammals regarding folate metabolism, the folate import mechanisms in these organelles are not equivalent: folate uptake by mammalian mitochondria is mediated by a unique transporter, whereas there are alternative routes for folate import into chloroplasts.	Univ Grenoble 1, Dept Reponse & Dynam Cellulaires, Physiol Cellulaire Vegetale Lab, INRA,CNRS,UMR5168,CEA Grenoble, F-38054 Grenoble, France; Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Virginia Commonwealth University; Virginia Commonwealth University	Ravanel, S (corresponding author), Univ Grenoble 1, Dept Reponse & Dynam Cellulaires, Physiol Cellulaire Vegetale Lab, INRA,CNRS,UMR5168,CEA Grenoble, 17 Rue Martyrs, F-38054 Grenoble, France.	sravanel@cea.fr		Ravanel, Stephane/0000-0001-9475-4222				ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; Basset G, 2002, P NATL ACAD SCI USA, V99, P12489, DOI 10.1073/pnas.192278499; Basset GJC, 2004, PLANT J, V40, P453, DOI 10.1111/j.1365-313X.2004.02231.x; Basset GJC, 2004, P NATL ACAD SCI USA, V101, P1496, DOI 10.1073/pnas.0308331100; BAULCOMBE DC, 1986, NATURE, V321, P446, DOI 10.1038/321446a0; Block MA, 2002, EUR J BIOCHEM, V269, P240, DOI 10.1046/j.0014-2956.2001.02643.x; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; ESTELLE MA, 1987, MOL GEN GENET, V206, P200, DOI 10.1007/BF00333575; Ferro M, 2003, MOL CELL PROTEOMICS, V2, P325, DOI 10.1074/mcp.M300030-MCP200; Ferro M, 2002, P NATL ACAD SCI USA, V99, P11487, DOI 10.1073/pnas.172390399; Gambonnet B, 2001, J SCI FOOD AGR, V81, P835, DOI 10.1002/jsfa.870; Goyer A, 2004, PLANT PHYSIOL, V135, P103, DOI 10.1104/pp.103.038430; Hanson AD, 2001, ANNU REV PLANT PHYS, V52, P119, DOI 10.1146/annurev.arplant.52.1.119; Ishikawa T, 2003, PLANT J, V33, P235, DOI 10.1046/j.1365-313X.2003.01621.x; Jabrin S, 2003, PLANT PHYSIOL, V131, P1431, DOI 10.1104/pp.016915; KAO FT, 1969, P NATL ACAD SCI USA, V64, P1284, DOI 10.1073/pnas.64.4.1284; Klein M, 2004, PLANT J, V39, P219, DOI 10.1111/j.1365-313X.2004.02125.x; Kundig C, 1999, EMBO J, V18, P2342, DOI 10.1093/emboj/18.9.2342; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; McCarty EA, 2004, J BIOL CHEM, V279, P33829, DOI 10.1074/jbc.M403677200; Neuburger M, 1996, J BIOL CHEM, V271, P9466, DOI 10.1074/jbc.271.16.9466; Palmieri F, 2004, ADV PHOTO RESPIRAT, V17, P247; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Prabhu V, 1998, PLANT PHYSIOL, V116, P137, DOI 10.1104/pp.116.1.137; Ravanel S, 2004, ADV PHOTO RESPIRAT, V17, P277; Ravanel S, 2004, J BIOL CHEM, V279, P22548, DOI 10.1074/jbc.M313250200; Ravanel S, 2001, P NATL ACAD SCI USA, V98, P15360, DOI 10.1073/pnas.261585098; Rebeille F, 1997, EMBO J, V16, P947, DOI 10.1093/emboj/16.5.947; Richard D, 2004, J BIOL CHEM, V279, P54494, DOI 10.1074/jbc.M409264200; Richard D, 2002, J BIOL CHEM, V277, P29460, DOI 10.1074/jbc.M204796200; Roje S, 1999, J BIOL CHEM, V274, P36089, DOI 10.1074/jbc.274.51.36089; Sambrook J., 2001, MOL CLONING LAB MANU; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; TAYLOR RT, 1982, ARCH BIOCHEM BIOPHYS, V217, P609, DOI 10.1016/0003-9861(82)90543-4; Titus SA, 2000, J BIOL CHEM, V275, P36811, DOI 10.1074/jbc.M005163200; Weber APM, 2005, ANNU REV PLANT BIOL, V56, P133, DOI 10.1146/annurev.arplant.56.032604.144228; Zeng H, 2001, CANCER RES, V61, P7225; Zeng H, 2000, CANCER RES, V60, P4779; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	44	94	102	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34823	34831		10.1074/jbc.M506045200	http://dx.doi.org/10.1074/jbc.M506045200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16055441	Green Published, hybrid			2022-12-27	WOS:000232403900054
J	Rho, SB; Lee, KW; Chun, T; Lee, SH; Park, K; Lee, JH				Rho, SB; Lee, KW; Chun, T; Lee, SH; Park, K; Lee, JH			The identification of apoptosis-related residues in human thymosin beta-10 by mutational analysis and computational modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING-SITE; XENOPUS-LAEVIS; EXPRESSION; PROTEINS; CANCER; CELLS; GENE; OVEREXPRESSION; METASTASIS; INHIBITION	Thymosin beta-10 (TB10) is an actin monomer-sequestering peptide that consists of 43 amino acid residues and that tends to form alpha-helical structures. Previously, we showed that the overexpression of TB10 dramatically increases the frequency of apoptosis in human ovarian cancer cells. To identify the critical residues responsible for TB10-mediated apoptosis, we used a series of computational methods. First, a three-dimensional structure of human TB10 was constructed using the homology modeling method with the calf thymosin beta-9 NMR structure as a template. Although the sequences of both of these structures are almost identical, 200-ps molecular dynamics simulation results showed that their secondary structures differ. Analyses of molecular dynamics snapshot structures suggested that the TB10 structure is conformationally more complicated than the TB9 structure. The conserved (LKKTET22)-L-17 motif region of TB10 was tested by Ala and Ser scanning mutagenesis using computational and biochemical methods, and 12 mutants were transfected into cancer cell lines and tested for their effects on growth arrest. Of the 12 mutants examined, only the Thr(20) to Ser(20) mutation showed reduced growth arrest. These results strongly suggest that Thr(20) is specifically required for actin sequestration by TB10 in ovarian cancer cells. These results may provide useful information for the development of a new ovarian cancer therapy.	Sungkyunkwan Univ, Samsung Med Ctr, Mol Therapy Res Ctr, Seoul 135710, South Korea; Sungkyunkwan Univ, Samsung Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Seoul 135710, South Korea; Gyeongsang Natl Univ, Env Biotech Natl Core Res Ctr, Div Appl Life Sci, Jinju 660701, South Korea; Hanyang Univ, Sch Med, Dept Microbiol & Immunol, Seoul 133791, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Gyeongsang National University; Hanyang University	Lee, JH (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Mol Therapy Res Ctr, Annex 8F,50 Ilwon Dong, Seoul 135710, South Korea.	jeholee@unitel.co.kr	Chun, Taehoon/F-2052-2013					Califano D, 1998, CANCER RES, V58, P823; Carpintero P, 1996, FEBS LETT, V394, P103, DOI 10.1016/0014-5793(96)00888-5; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; Devineni N, 1999, BRAIN RES, V823, P129, DOI 10.1016/S0006-8993(99)01147-6; Eadie JS, 2000, J CELL BIOCHEM, V77, P277, DOI 10.1002/(SICI)1097-4644(20000501)77:2<277::AID-JCB10>3.0.CO;2-Q; Fidler I J, 1978, Adv Cancer Res, V28, P149, DOI 10.1016/S0065-230X(08)60648-X; Gutierrez-Pabello JA, 2002, INFECT IMMUN, V70, P2121, DOI 10.1128/IAI.70.4.2121-2127.2002; HALL AK, 1995, CELL MOL BIOL RES, V41, P167; HANNAPPEL E, 1993, BIOL CHEM H-S, V374, P117, DOI 10.1515/bchm3.1993.374.1-6.117; HANNAPPEL E, 1988, ARCH BIOCHEM BIOPHYS, V260, P546, DOI 10.1016/0003-9861(88)90480-8; HEINTZ D, 1993, FEBS LETT, V329, P9, DOI 10.1016/0014-5793(93)80181-S; HORECKER BL, 1984, LYMPHOKINES, V9, P15; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; Huff T, 1997, FEBS LETT, V414, P39, DOI 10.1016/S0014-5793(97)00946-0; HUFF T, 1995, EUR J BIOCHEM, V230, P650; JEAN C, 1994, J MUSCLE RES CELL M, V15, P278; Lee SH, 2001, ONCOGENE, V20, P6700, DOI 10.1038/sj.onc.1204683; LIN SC, 1990, J MOL NEUROSCI, V2, P35, DOI 10.1007/BF02896924; LOW TLK, 1981, P NATL ACAD SCI-BIOL, V78, P1162, DOI 10.1073/pnas.78.2.1162; Philp D, 2003, FASEB J, V17, P2103, DOI 10.1096/fj.03-0121fje; Rho SB, 1996, P NATL ACAD SCI USA, V93, P10128, DOI 10.1073/pnas.93.19.10128; RUGGIERI S, 1983, ARCH BIOCHEM BIOPHYS, V226, P388, DOI 10.1016/0003-9861(83)90305-3; Stoll R, 1997, BIOPOLYMERS, V41, P623, DOI 10.1002/(SICI)1097-0282(199705)41:6<623::AID-BIP3>3.0.CO;2-S; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; VANCOMPERNOLLE K, 1992, EMBO J, V11, P4739, DOI 10.1002/j.1460-2075.1992.tb05579.x; VANCOMPERNOLLE K, 1991, J BIOL CHEM, V266, P15427; VanTroys M, 1996, EMBO J, V15, P201, DOI 10.1002/j.1460-2075.1996.tb00350.x; VergheseNikolakaki S, 1996, BRIT J CANCER, V74, P1441, DOI 10.1038/bjc.1996.562; YAMAMOTO M, 1992, BIOCHEM BIOPH RES CO, V184, P93, DOI 10.1016/0006-291X(92)91162-J; YU FX, 1993, J BIOL CHEM, V268, P502; ZETTER BR, 1990, NEW ENGL J MED, V322, P605	31	10	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34003	34007		10.1074/jbc.M501629200	http://dx.doi.org/10.1074/jbc.M501629200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16012174	hybrid			2022-12-27	WOS:000232229700038
J	Ceballos-Chavez, M; Vioque, A				Ceballos-Chavez, M; Vioque, A			Sequence-dependent cleavage site selection by RNase Z from the cyanobacterium Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3' PROCESSING ENDORIBONUCLEASE; ESCHERICHIA-COLI; THERMOTOGA-MARITIMA; BACILLUS-SUBTILIS; BETA-LACTAMASE; RIBONUCLEASE-P; END MATURATION; TRNASE-Z; CCA; GENOME	Biosynthesis of transfer RNA requires processing from longer precursors at the 5'- and 3'-ends. In eukaryotes, in archaea, and in those bacteria where the 3'-terminal CCA sequence is not encoded, 3' processing is carried out by the endonuclease RNase Z, which cleaves after the discriminator nucleotide to generate a mature 3'-end ready for the addition of the CCA sequence. We have identified and cloned the gene coding for RNase Z in the cyanobacterium Synechocystis sp. PCC 6803. The gene has been expressed in Escherichia coli, and the recombinant protein was purified. The enzymatic activity of RNase Z from Synechocystis has been studied in vitro with a variety of substrates. The presence of C or CC after the discriminator nucleotide modifies the cleavage site of RNase Z so that it is displaced by one and two nucleotides to the 3'-side, respectively. The presence of the complete 3'-terminal CCA sequence in the precursor of the tRNA completely inhibits RNase Z activity. The inactive CCA-containing precursor binds to Synechocystis RNase Z with similar affinity than the mature tRNA. The properties of the enzyme described here could be related with the mechanism by which CCA is added in this organism, with the participation of two separate nucleotidyl transferases, one specific for the addition of C and another for the addition of A. This work is the first characterization of RNase Z from a cyanobacterium, and the first from an organism with two separate nucleotidyl transferases.	Univ Sevilla, CSIC, Inst Bioquim Vegetal & Fotosintesis, E-41092 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF)	Vioque, A (corresponding author), Univ Sevilla, CSIC, Inst Bioquim Vegetal & Fotosintesis, Amer Vespucio 49, E-41092 Seville, Spain.	vioque@us.es	Vioque, Agustín/K-1809-2014	Vioque, Agustín/0000-0002-3975-7348				Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; Deutscher MP, 2001, PROG NUCLEIC ACID RE, V66, P67; Dufresne A, 2003, P NATL ACAD SCI USA, V100, P10020, DOI 10.1073/pnas.1733211100; ELHAI J, 1988, GENE, V68, P119, DOI 10.1016/0378-1119(88)90605-1; Ezraty B, 2005, J BIOL CHEM, V280, P16542, DOI 10.1074/jbc.C500098200; GUERRIERTAKADA C, 1984, BIOCHEMISTRY-US, V23, P6327, DOI 10.1021/bi00321a006; Ishii R, 2005, J BIOL CHEM, V280, P14138, DOI 10.1074/jbc.M500355200; Kaneko T, 1997, PLANT CELL PHYSIOL, V38, P1171, DOI 10.1093/oxfordjournals.pcp.a029103; Kruszka K, 2003, EMBO J, V22, P621, DOI 10.1093/emboj/cdg040; Kunzmann A, 1998, P NATL ACAD SCI USA, V95, P108, DOI 10.1073/pnas.95.1.108; Matsunaga T, 2001, Breast Cancer, V8, P213, DOI 10.1007/BF02967511; Mayer M, 2000, BIOCHEMISTRY-US, V39, P2096, DOI 10.1021/bi992253e; Minagawa A, 2004, J BIOL CHEM, V279, P15688, DOI 10.1074/jbc.M313951200; Mohan A, 1999, RNA, V5, P245, DOI 10.1017/S1355838299981256; Nashimoto M, 1999, J MOL BIOL, V287, P727, DOI 10.1006/jmbi.1999.2639; Ow MC, 2002, GENE DEV, V16, P1102, DOI 10.1101/gad.983502; Pascual A, 1996, EUR J BIOCHEM, V241, P17, DOI 10.1111/j.1432-1033.1996.0017t.x; Pellegrini O, 2003, EMBO J, V22, P4534, DOI 10.1093/emboj/cdg435; Qin H, 2001, BIOCHEMISTRY-US, V40, P11202, DOI 10.1021/bi010076n; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Schierling K, 2002, J MOL BIOL, V316, P895, DOI 10.1006/jmbi.2001.5395; Schiffer S, 2003, BIOL CHEM, V384, P333, DOI 10.1515/BC.2003.039; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schilling O, 2005, J BIOL CHEM, V280, P17857, DOI 10.1074/jbc.M500591200; Takaku H, 2004, NUCLEIC ACIDS RES, V32, P4429, DOI 10.1093/nar/gkh774; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomita K, 2002, J BIOL CHEM, V277, P48192, DOI 10.1074/jbc.M207527200; Tous C, 2001, J BIOL CHEM, V276, P29059, DOI 10.1074/jbc.M103418200; Vogel A, 2002, J BIOL CHEM, V277, P29078, DOI 10.1074/jbc.M112047200; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; Weiner AM, 2004, CURR BIOL, V14, pR883, DOI 10.1016/j.cub.2004.09.069; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	34	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33461	33469		10.1074/jbc.M504691200	http://dx.doi.org/10.1074/jbc.M504691200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16051605	hybrid, Green Published			2022-12-27	WOS:000232058100045
J	Koves, TR; Li, P; An, J; Akimoto, T; Slentz, D; Ilkayeva, O; Dohm, GL; Yan, Z; Newgard, CB; Muoio, DM				Koves, TR; Li, P; An, J; Akimoto, T; Slentz, D; Ilkayeva, O; Dohm, GL; Yan, Z; Newgard, CB; Muoio, DM			Peroxisome proliferator-activated receptor-gamma co-activator 1 alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; VASCULAR SMOOTH-MUSCLE; FATTY-ACID-METABOLISM; GENE-EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; NULL MICE; ENERGY-EXPENDITURE; GLUCOSE-METABOLISM; PGC-1-ALPHA; ALPHA	Peroxisome proliferator-activated receptor-gamma co- activator 1 alpha (PGC1 alpha) is a promiscuous co- activator that plays a key role in regulating mitochondrial biogenesis and fuel homeostasis. Emergent evidence links decreased skeletal muscle PGC1 alpha activity and coincident impairments in mitochondrial performance to the development of insulin resistance in humans. Here we used rodent models to demonstrate that muscle mitochondrial efficiency is compromised by diet-induced obesity and is subsequently rescued by exercise training. Chronic high fat feeding caused accelerated rates of incomplete fatty acid oxidation and accumulation of beta-oxidative intermediates. The capacity of muscle mitochondria to fully oxidize a heavy influx of fatty acid depended on factors such as fiber type and exercise training and was positively correlated with expression levels of PGC1 alpha. Likewise, an efficient lipid-induced substrate switch in cultured myocytes depended on adenovirus-mediated increases in PGC1 alpha expression. Our results supported a novel paradigm in which a high lipid supply, occurring under conditions of low PGC1 alpha, provokes a disconnect between mitochondrial beta-oxidation and tricarboxylic acid cycle activity. Conversely, the metabolic remodeling that occurred in response to PGC1 alpha overexpression favored a shift from incomplete to complete beta-oxidation. We proposed that PGC1 alpha enables muscle mitochondria to better cope with a high lipid load, possibly reflecting a fundamental metabolic benefit of exercise training.	Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; Duke Univ, Dept Med, Durham, NC 27704 USA; Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27704 USA; Duke Univ, Dept Med, Durham, NC 27710 USA; E Carolina Univ, Brody Med Sch, Dept Physiol, Greenville, NC 27834 USA	Duke University; Duke University; Duke University; Duke University; University of North Carolina; East Carolina University	Muoio, DM (corresponding author), Duke Univ, Sarah W Stedman Nutr & Metab Ctr, 4321 Med Pk Dr,Ste 200, Durham, NC 27704 USA.	muoio@duke.edu	Akimoto, Takayuki/H-6704-2012; Muoio, Debbie Marie/E-1147-2012; Koves, Tim/I-4806-2012	Akimoto, Takayuki/0000-0002-8874-7779; Koves, Tim/0000-0001-8763-5866; Yan, Zhen/0000-0002-4826-9813; Muoio, Deborah/0000-0003-3760-9277	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398, R01DK056112] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-56112, P01 DK58398] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adhihetty PJ, 2003, EXP PHYSIOL, V88, P99, DOI 10.1113/eph8802505; Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Astrup A, 2001, Public Health Nutr, V4, P499; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Barron JT, 1998, J MOL CELL CARDIOL, V30, P1571, DOI 10.1006/jmcc.1998.0722; Barron JT, 1999, MOL CELL BIOCHEM, V194, P283, DOI 10.1023/A:1006928516648; BECKER TC, 1994, J BIOL CHEM, V269, P21234; Cortright RN, 1997, J NUTR BIOCHEM, V8, P228, DOI 10.1016/S0955-2863(97)89660-X; de Fourmestraux V, 2004, J BIOL CHEM, V279, P50743, DOI 10.1074/jbc.M408014200; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Gilde AJ, 2003, ACTA PHYSIOL SCAND, V178, P425, DOI 10.1046/j.1365-201X.2003.01161.x; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Hittel DS, 2005, J APPL PHYSIOL, V98, P168, DOI 10.1152/japplphysiol.00331.2004; Iossa S, 2004, DIABETES, V53, P2861, DOI 10.2337/diabetes.53.11.2861; Jones JP, 1998, J APPL PHYSIOL, V84, P1661, DOI 10.1152/jappl.1998.84.5.1661; Kim JY, 2002, AM J PHYSIOL-ENDOC M, V282, pE1014, DOI 10.1152/ajpendo.00233.2001; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Lichtenstein AH, 2000, ATHEROSCLEROSIS, V150, P227, DOI 10.1016/S0021-9150(99)00504-3; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muoio DM, 2002, DIABETES, V51, P901, DOI 10.2337/diabetes.51.4.901; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Muoio DM, 1999, AM J PHYSIOL-ENDOC M, V276, pE913, DOI 10.1152/ajpendo.1999.276.5.E913; Patti ME, 2004, CURR OPIN CLIN NUTR, V7, P383, DOI 10.1097/01.mco.0000134359.23288.72; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perseghin G, 2003, INT J OBESITY, V27, pS6, DOI 10.1038/sj.ijo.0802491; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Tordjman K, 2001, J CLIN INVEST, V107, P1025, DOI 10.1172/JCI11497; VANHOVE JLK, 1993, AM J HUM GENET, V52, P958; Waters RE, 2004, AM J PHYSIOL-CELL PH, V287, pC1342, DOI 10.1152/ajpcell.00247.2004; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	48	361	374	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33588	33598		10.1074/jbc.M507621200	http://dx.doi.org/10.1074/jbc.M507621200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16079133	hybrid			2022-12-27	WOS:000232058100060
J	Stephenson, SEM; Dubach, D; Lim, CM; Mercer, JFB; La Fontaine, S				Stephenson, SEM; Dubach, D; Lim, CM; Mercer, JFB; La Fontaine, S			A single PDZ domain protein interacts with the Menkes copper ATPase, ATP7A - A NEw protein implicated in copper homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; WILSONS-DISEASE PROTEIN; TERMINAL DI-LEUCINE; METAL-BINDING SITES; PLASMA-MEMBRANE; TRANSMEMBRANE PROTEINS; FUNCTIONAL-ANALYSIS; GOLGI PROTEIN; TRAFFICKING; LOCALIZATION	The homeostatic regulation of essential elements such as copper requires many proteins whose activities are often mediated and tightly coordinated through protein-protein interactions. This regulation ensures that cells receive enough copper without intracellular concentrations reaching toxic levels. To date, only a small number of proteins implicated in copper homeostasis have been identified, and little is known of the protein-protein interactions required for this process. To identify other proteins important for copper homeostasis, while also elucidating the protein-protein interactions that are integral to the process, we have utilized a known copper protein, the copper ATPase ATP7A, as a bait in a yeast two-hybrid screen of a human cDNA library to search for interacting partners. One of the ATP7A-interacting proteins identified is a novel protein with a single PDZ domain. This protein was recently identified to interact with the plasma membrane calcium ATPase b-splice variants. We propose a change in name for this protein from PISP ( plasmamembrane calcium ATPase-interacting single-PDZ protein) to AIPP1 ( ATPase-interacting PDZ protein) and suggest that it represents the protein that interacts with the class I PDZ binding motif identified at the ATP7A C terminus. The interaction in mammalian cells was confirmed and an additional splice variant of AIPP1 was identified. This study represents an essential step forward in identifying the proteins and elucidating the network of protein-protein interactions involved in maintaining copper homeostasis and validates the use of the yeast two-hybrid approach for this purpose.	Deakin Univ, Sch Biol & Chem Sci, Ctr Cellular & Mol Biol, Burwood, Vic 3125, Australia	Deakin University	La Fontaine, S (corresponding author), Deakin Univ, Sch Biol & Chem Sci, Ctr Cellular & Mol Biol, 221 Burwood Hwy, Burwood, Vic 3125, Australia.	sharonl@deakin.edu.au	La Fontaine, Sharon/G-7113-2018; Stephenson, Sarah E M/AGK-4623-2022; Stephenson, Sarah/O-5742-2015; Mercer, Julian/R-8583-2019	La Fontaine, Sharon/0000-0002-9948-074X; Stephenson, Sarah/0000-0001-7860-9527; 				AGATEP R, 1998, TECHNICAL TIPS ONLIN, V1, P51; Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Burke D., 2000, METHODS YEAST GENETI, P171; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Cater MA, 2004, BIOCHEM J, V380, P805, DOI 10.1042/BJ20031804; Charest A, 2001, J BIOL CHEM, V276, P29456, DOI 10.1074/jbc.M104137200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Francis MJ, 1999, J CELL SCI, V112, P1721; Francis MJ, 1998, HUM MOL GENET, V7, P1245, DOI 10.1093/hmg/7.8.1245; Goellner GM, 2003, ANN NY ACAD SCI, V986, P461, DOI 10.1111/j.1749-6632.2003.tb07230.x; Greenough M, 2004, AM J PHYSIOL-CELL PH, V287, pC1463, DOI 10.1152/ajpcell.00179.2004; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hamza I, 1999, P NATL ACAD SCI USA, V96, P13363, DOI 10.1073/pnas.96.23.13363; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; Harlow E., 1988, ANTIBODIES LAB MANUA; Harris BZ, 2001, J CELL SCI, V114, P3219; Hassel B, 2003, J BIOL CHEM, V278, P40136, DOI 10.1074/jbc.M305577200; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kachinsky AM, 1999, J CELL BIOL, V145, P391, DOI 10.1083/jcb.145.2.391; La Fontaine S, 1998, HUM MOL GENET, V7, P1293, DOI 10.1093/hmg/7.8.1293; La Fontaine S, 1998, J BIOL CHEM, V273, P31375; La Fontaine S, 1998, PLASMID, V39, P245, DOI 10.1006/plas.1997.1334; Lumeng C, 1999, NAT NEUROSCI, V2, P611, DOI 10.1038/10165; Lutsenko S, 2002, J BIOENERG BIOMEMBR, V34, P351, DOI 10.1023/A:1021297919034; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; Mercer JFB, 2003, BIOMETALS, V16, P175, DOI 10.1023/A:1020719016675; Mercer JFB, 2001, TRENDS MOL MED, V7, P64, DOI 10.1016/S1471-4914(01)01920-7; Miles AT, 2000, CRIT REV BIOCHEM MOL, V35, P35, DOI 10.1080/10409230091169168; Muth TR, 2003, ANNU REV CELL DEV BI, V19, P333, DOI 10.1146/annurev.cellbio.19.110701.161425; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neudauer CL, 2001, BIOCHEM BIOPH RES CO, V280, P541, DOI 10.1006/bbrc.2000.4160; OLSEN O, 2004, AM J PHYSIOL, V288, pF345; Pagel P, 2003, ANN NY ACAD SCI, V986, P360, DOI 10.1111/j.1749-6632.2003.tb07215.x; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pawson T, 2002, FEBS LETT, V513, P2, DOI 10.1016/S0014-5793(01)03292-6; PAYNTER JA, 1994, FEBS LETT, V351, P186, DOI 10.1016/0014-5793(94)00868-X; Petris MJ, 1999, HUM MOL GENET, V8, P2107, DOI 10.1093/hmg/8.11.2107; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Petris MJ, 1998, HUM MOL GENET, V7, P2063, DOI 10.1093/hmg/7.13.2063; Petris MJ, 2004, PFLUG ARCH EUR J PHY, V447, P752, DOI 10.1007/s00424-003-1092-1; Petris MJ, 2002, J BIOL CHEM, V277, P46736, DOI 10.1074/jbc.M208864200; Prohaska JR, 2004, J NUTR, V134, P1003, DOI 10.1093/jn/134.5.1003; Roelofsen H, 2000, GASTROENTEROLOGY, V119, P782, DOI 10.1053/gast.2000.17834; Schaefer M, 1999, GASTROENTEROLOGY, V117, P1380, DOI 10.1016/S0016-5085(99)70288-X; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG639, DOI 10.1152/ajpgi.1999.276.3.G639; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Sharp PA, 2003, INT J BIOCHEM CELL B, V35, P288, DOI 10.1016/S1357-2725(02)00134-6; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; Straight SW, 2001, MOL BIOL CELL, V12, P1329, DOI 10.1091/mbc.12.5.1329; Strausak D, 1999, J BIOL CHEM, V274, P11170, DOI 10.1074/jbc.274.16.11170; Strausak D, 2003, J BIOL CHEM, V278, P20821, DOI 10.1074/jbc.M212437200; Strausak D, 2001, BRAIN RES BULL, V55, P175, DOI 10.1016/S0361-9230(01)00454-3; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vaccaro P, 2002, FEBS LETT, V512, P345, DOI 10.1016/S0014-5793(02)02220-2; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493; Voskoboinik I, 2003, BIOCHEM BIOPH RES CO, V303, P337, DOI 10.1016/S0006-291X(03)00329-2; Voskoboinik I, 2003, BIOCHEM BIOPH RES CO, V301, P488, DOI 10.1016/S0006-291X(03)00010-X; Voskoboinik I, 2002, J BIOENERG BIOMEMBR, V34, P363, DOI 10.1023/A:1021250003104; Voskoboinik I, 2001, J BIOL CHEM, V276, P28620, DOI 10.1074/jbc.M103532200; Voskoboinik N, 1999, J BIOL CHEM, V274, P22008, DOI 10.1074/jbc.274.31.22008; Wijmenga C, 2004, P NUTR SOC, V63, P31, DOI 10.1079/PNS2003316; Yao RJ, 2001, BIOCHEM BIOPH RES CO, V286, P771, DOI 10.1006/bbrc.2001.5430; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200	69	30	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33270	33279		10.1074/jbc.M505889200	http://dx.doi.org/10.1074/jbc.M505889200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16051599	Green Published, hybrid			2022-12-27	WOS:000232058100022
J	van Thor, JJ; Georgiev, GY; Towrie, M; Sage, JT				van Thor, JJ; Georgiev, GY; Towrie, M; Sage, JT			Ultrafast and low barrier motions in the photoreactions of the green fluorescent protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED STRUCTURAL-CHANGES; CRYSTAL-STRUCTURE; STATE; DYNAMICS; INTERMEDIATE; EXCITATION; SOLVENT	Green fluorescent protein (GFP) fluoresces efficiently under blue excitation despite major electrostatic rearrangements resulting from photoionization of the chromophore and neutralization of Glu-222. A competing phototransformation process, which ionizes the chromophore and decarboxylates Glu-222, mimics the electrostatic and structural changes in the fluorescence photocycle. Structural and spectroscopic analysis of the cryogenically stabilized photoproduct at 100 K and a structurally annealed intermediate of the phototransformed protein at 170 K reveals distinct structural relaxations involving protein, chromophore, solvent, and photogenerated CO2. Strong structural changes of the 100 K photoproduct after decarboxylation appear exclusively within 15 angstrom of the chromophore and include the electrostatically driven perturbations of Gln-69, Cys-70, and water molecules in an H-bonding network connecting the chromophore. X-ray crystallography to 1.85 angstrom resolution and static and picosecond time-resolved IR spectroscopy identify structural mechanisms common to phototransformation and to the fluorescence photocycle. In particular, the appearance of a 1697 cm(-1) (+) difference band in both photocycle and phototransformation intermediates is a spectroscopic signature for the structural perturbation of Gln-69. This is taken as evidence for an electrostatically driven dynamic response that is common to both photoreaction pathways. The interactions between the chromophore and the perturbed residues and solvent are decreased or removed in the T203H single and T203H/Q69L double mutants, resulting in a strong reduction of the fluorescence quantum yield. This suggests that the electrostatic response to the transient formation of a buried charge in the wild type is important for the bright fluorescence.	Univ Oxford, Mol Biophys Lab, Oxford OX1 3QU, England; Northeastern Univ, Dept Phys, Boston, MA 02115 USA; Northeastern Univ, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA; Rutherford Appleton Lab, Res Councils, Council Cent Lab, Cent Laser Facil, Didcot OX11 0QX, Oxon, England	University of Oxford; Northeastern University; Northeastern University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	van Thor, JJ (corresponding author), Univ Oxford, Mol Biophys Lab, Rex Richards Bldg,S Parks Rd, Oxford OX1 3QU, England.	jasper@biop.ox.ac.uk		Towrie, Mike/0000-0002-1305-701X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052002, R29GM052002] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-52002] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agmon N, 2005, BIOPHYS J, V88, P2452, DOI 10.1529/biophysj.104.055541; Agmon N, 2005, J PHYS CHEM A, V109, P13, DOI 10.1021/jp047465m; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Baxter RHG, 2004, J AM CHEM SOC, V126, P16728, DOI 10.1021/ja0448115; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Chu K, 2000, NATURE, V403, P921, DOI 10.1038/35002641; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; DELAGRAVE S, 1995, BIO-TECHNOL, V13, P151, DOI 10.1038/nbt0295-151; Edman K, 1999, NATURE, V401, P822, DOI 10.1038/44623; Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101; FORSTER T, 1950, Z ELEKTROCHEM, V54, P531; He X, 2002, ORG LETT, V4, P1523, DOI 10.1021/ol0200403; Kennis JTM, 2004, P NATL ACAD SCI USA, V101, P17988, DOI 10.1073/pnas.0404262102; Kriminski S, 2003, ACTA CRYSTALLOGR D, V59, P697, DOI 10.1107/S0907444903002713; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Nie BN, 2005, BIOPHYS J, V88, P2833, DOI 10.1529/biophysj.104.047639; Niwa H, 1996, P NATL ACAD SCI USA, V93, P13617, DOI 10.1073/pnas.93.24.13617; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Palm GJ, 1997, NAT STRUCT BIOL, V4, P361, DOI 10.1038/nsb0597-361; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; Stoner-Ma D, 2005, J AM CHEM SOC, V127, P2864, DOI 10.1021/ja042466d; Sutcliffe MJ, 2002, EUR J BIOCHEM, V269, P3096, DOI 10.1046/j.1432-1033.2002.03020.x; TENG TY, 1994, NAT STRUCT BIOL, V1, P701, DOI 10.1038/nsb1094-701; Towrie M, 2003, APPL SPECTROSC, V57, P367, DOI 10.1366/00037020360625899; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; van Thor JJ, 2005, J PHYS CHEM B, V109, P16099, DOI 10.1021/jp051315+; van Thor JJ, 1998, BIOCHEMISTRY-US, V37, P16915, DOI 10.1021/bi981170f; van Thor JJ, 2002, NAT STRUCT BIOL, V9, P37, DOI 10.1038/nsb739; Vitkup D, 2000, NAT STRUCT BIOL, V7, P34; WELLER A, 1952, Z ELEKTROCHEM, V56, P662; Xie AH, 2001, BIOCHEMISTRY-US, V40, P1510, DOI 10.1021/bi002449a; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	40	55	58	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33652	33659		10.1074/jbc.M505473200	http://dx.doi.org/10.1074/jbc.M505473200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16033764	hybrid			2022-12-27	WOS:000232058100067
J	Ohhashi, Y; Kihara, M; Naiki, H; Goto, Y				Ohhashi, Y; Kihara, M; Naiki, H; Goto, Y			Ultrasonication-induced amyloid fibril formation of beta(2)-microglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTENSION IN-VITRO; PROTEIN AGGREGATION; NEUTRAL PH; HYDROPHOBIC INTERACTIONS; PHYSIOLOGICAL CONDITIONS; KINETIC-MODEL; ULTRASOUND; BETA-2-MICROGLOBULIN; PEPTIDE; FIBRILLOGENESIS	To obtain insight into the mechanism of fibril formation, we examined the effects of ultrasonication, a strong agitator, on beta(2)-microglobulin (beta 2-m), a protein responsible for dialysis-related amyloidosis. Upon sonication of an acid-unfolded beta 2-m solution at pH 2.5, thioflavin T fluorescence increased markedly after a lag time of 1 - 2 h with a simultaneous increase of light scattering. Atomic force microscopy images showed the formation of a large number of short fibrils 3 nm in diameter. When the sonication- induced fibrils were used as seeds in the next seeding experiment at pH 2.5, a rapid and intense formation of long fibrils 3 nm in diameter was observed demonstrating seed- dependent fibril growth. We then examined the effects of sonication on the native beta(2)-m at neutral pH, conditions under which amyloid deposits occur in patients. In the presence of 0.5 mM sodium dodecyl sulfate, a model compound of potential trigger and stabilizer of amyloid fibrils in patients, a marked increase of thioflavin T fluorescence was observed after 1 day of sonication at pH 7.0. The products of sonication caused the accelerated fibril formation at pH 7.0. Atomic force microscopy images showed that the fibrils formed at pH 7.0 have a diameter of more than 7 nm, thicker than those prepared at pH 2.5. These results indicate that ultrasonication is one form of agitation triggering the formation of amyloid fibrils of beta 2-m, producing fibrils adapted to the respective pH.	Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Japan Sci & Technol Agcy, CREST, Suita, Osaka 5650871, Japan; Univ Fukui, Fac Med Sci, Dept Pathol Sci, Matsuoka, Fukui 9101193, Japan; Japan Sci & Technol Agcy, CREST, Matsuoka, Fukui 9101193, Japan	Osaka University; Japan Science & Technology Agency (JST); University of Fukui; Japan Science & Technology Agency (JST)	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Naiki, Hironobu/G-5599-2014					Ashush H, 2000, CANCER RES, V60, P1014; Bam NB, 1998, J PHARM SCI, V87, P1554, DOI 10.1021/js980175v; Beerlage HP, 1999, UROLOGY, V54, P273, DOI 10.1016/S0090-4295(99)00104-1; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Chiti F, 2001, J BIOL CHEM, V276, P46714, DOI 10.1074/jbc.M107040200; Corazza A, 2004, J BIOL CHEM, V279, P9176, DOI 10.1074/jbc.M310779200; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dzwolak W, 2004, PROTEIN SCI, V13, P1927, DOI 10.1110/ps.03607204; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Feril LB, 2004, J RADIAT RES, V45, P479, DOI 10.1269/jrr.45.479; Feril LB, 2004, INT J RADIAT BIOL, V80, P165, DOI 10.1080/09553000310001654684; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Floege J, 2001, KIDNEY INT, V59, pS164, DOI 10.1046/j.1523-1755.2001.59780164.x; Gejyo F, 1997, KIDNEY INT, V52, pS75; Gupta MN, 2004, EUR J BIOCHEM, V271, P2575, DOI 10.1111/j.1432-1033.2004.04163.x; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Jones S, 2003, J MOL BIOL, V330, P935, DOI 10.1016/S0022-2836(03)00688-0; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Katou H, 2002, PROTEIN SCI, V11, P2218, DOI 10.1110/ps.0213202; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Kihara M, 2005, J BIOL CHEM, V280, P12012, DOI 10.1074/jbc.M411949200; Mason TJ, 2003, ULTRASON SONOCHEM, V10, P175, DOI 10.1016/S1350-4177(03)00086-5; Morgan CJ, 2001, J MOL BIOL, V309, P339, DOI 10.1006/jmbi.2001.4661; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Naiki H, 1996, LAB INVEST, V74, P374; NAIKI H, 1991, LAB INVEST, V65, P104; Ohhashi Y, 2004, J BIOL CHEM, V279, P10814, DOI 10.1074/jbc.M310334200; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; RIESZ P, 1992, FREE RADICAL BIO MED, V13, P247, DOI 10.1016/0891-5849(92)90021-8; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Satheeshkumar KS, 2002, CHEM COMMUN, P2244, DOI 10.1039/b206886a; SLUZKY V, 1991, P NATL ACAD SCI USA, V88, P9377, DOI 10.1073/pnas.88.21.9377; Stathopulos PB, 2004, PROTEIN SCI, V13, P3017, DOI 10.1110/ps.04831804; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; YAMAGUCHI K, 2005, IN PRESS J MOL BIOL; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yu TH, 2004, ULTRASON SONOCHEM, V11, P95, DOI 10.1016/S1350-4177(03)00157-3	49	142	144	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32843	32848		10.1074/jbc.M506501200	http://dx.doi.org/10.1074/jbc.M506501200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16046408	hybrid, Green Published			2022-12-27	WOS:000231920300037
J	Kaufmann, A; Musset, B; Limberg, SH; Renigunta, V; Sus, R; Dalpke, AH; Heeg, KM; Robaye, B; Hanley, PJ				Kaufmann, A; Musset, B; Limberg, SH; Renigunta, V; Sus, R; Dalpke, AH; Heeg, KM; Robaye, B; Hanley, PJ			"Host tissue damage" signal ATP promotes non-directional migration and negatively regulates Toll-like receptor signaling in human monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PHARMACOLOGICAL CHARACTERIZATION; ALPHA PRODUCTION; IMMUNE-RESPONSE; DENDRITIC CELLS; EXPRESSION; INNATE; LIPOPOLYSACCHARIDE; RESPONSIVENESS; ACTIVATION	The activation of Toll-like receptors (TLRs) by lipopolysaccharide or other ligands evokes a proinflammatory immune response, which is not only capable of clearing invading pathogens but can also inflict damage to host tissues. It is therefore important to prevent an overshoot of the TLR-induced response where necessary, and here we show that extracellular ATP is capable of doing this in human monocytes. Using reverse transcription-PCR, we showed that monocytes express P2Y(1), P2Y(2), P2Y(4), P2Y(11), and P2Y(13) receptors, as well as several P2X receptors. To elucidate the function of these receptors, we first studied Ca2+ signaling in single cells. ATP or UTP induced a biphasic increase in cytosolic Ca2+, which corresponded to internal Ca2+ release followed by activation of store- operated Ca2+ entry. The evoked Ca2+ signals stimulated Ca2+-activated K+ channels, producing transient membrane hyperpolarization. In addition, ATP promoted cytoskeleton reorganization and cell migration; however, unlike chemoattractants, the migration was non-directional and further analysis showed that ATP did not activate Akt, essential for sensing gradients. When TLR2, TLR4, or TLR2/6 were stimulated with their respective ligands, ATP gamma S profoundly inhibited secretion of proinflammatory cytokines (tumor necrosis factor-alpha and monocyte chemoattractant protein-1) but increased the production of interleukin-10, an anti-inflammatory cytokine. In radioimmune assays, we found that ATP ( or ATP gamma S) strongly increased cAMP levels, and, moreover, the TLR- response was inhibited by forskolin, whereas UTP neither increased cAMP nor inhibited the TLR- response. Thus, our data suggest that ATP promotes non-directional migration and, importantly, acts as a "host tissue damage" signal via the Gs protein-coupled P2Y(11) receptor and increased cAMP to negatively regulate TLR signaling.	Univ Marburg, Inst Physiol, D-35037 Marburg, Germany; Univ Marburg, Inst Immunol, D-35037 Marburg, Germany; Inst Hyg, D-69120 Heidelberg, Germany; Univ Libre Bruxelles, Inst Interdisciplinary Res, Inst Biol & Med Mol, B-6041 Gosselies, Belgium	Philipps University Marburg; Philipps University Marburg; Universite Libre de Bruxelles	Hanley, PJ (corresponding author), Univ Marburg, Inst Physiol, Deutschhausstr 2, D-35037 Marburg, Germany.	hanley@mailer.uni-marburg.de	Hanley, Peter J/H-4915-2017; Musset, Boris/J-2520-2013; Musset, Boris/AAD-4158-2022	Musset, Boris/0000-0001-8242-8817; Musset, Boris/0000-0001-8242-8817				Aga M, 2004, AM J PHYSIOL-CELL PH, V286, pC923, DOI 10.1152/ajpcell.00417.2003; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bulanova E, 2005, J IMMUNOL, V174, P3880, DOI 10.4049/jimmunol.174.7.3880; Chessell IP, 1998, BRIT J PHARMACOL, V124, P1314, DOI 10.1038/sj.bjp.0701958; Communi D, 1999, BRIT J PHARMACOL, V128, P1199, DOI 10.1038/sj.bjp.0702909; Communi D, 2001, J BIOL CHEM, V276, P41479, DOI 10.1074/jbc.M105912200; Communi D, 1997, J BIOL CHEM, V272, P31969, DOI 10.1074/jbc.272.51.31969; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Gingras S, 2004, J BIOL CHEM, V279, P54702, DOI 10.1074/jbc.M411043200; Guerra AN, 2003, J ENDOTOXIN RES, V9, P256, DOI 10.1179/096805103225001468; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Horrigan LA, 2004, INT IMMUNOPHARMACOL, V4, P1409, DOI 10.1016/j.intimp.2004.06.005; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hu Y, 1998, J BIOL CHEM, V273, P27170, DOI 10.1074/jbc.273.42.27170; Kaufmann A, 1999, INFECT IMMUN, V67, P6303; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; la Sala A, 2001, J IMMUNOL, V166, P1611, DOI 10.4049/jimmunol.166.3.1611; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Marteau F, 2004, J LEUKOCYTE BIOL, V76, P796, DOI 10.1189/jlb.0104032; Marteau F, 2003, MOL PHARMACOL, V64, P104, DOI 10.1124/mol.64.1.104; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; NAIN M, 1990, J IMMUNOL, V145, P1921; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; Ralevic V, 1998, PHARMACOL REV, V50, P413; Salentin R, 2003, J LEUKOCYTE BIOL, V74, P252, DOI 10.1189/jlb.1102565; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; SEVERN A, 1992, J IMMUNOL, V148, P3441; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sprenger H, 1996, J EXP MED, V184, P1191, DOI 10.1084/jem.184.3.1191; SUNDERMAN FW, 1990, ANN CLIN LAB SCI, V20, P123; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; VANDERPOLL T, 1995, SHOCK, V3, P1; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Wilkin F, 2002, EUR J IMMUNOL, V32, P2409, DOI 10.1002/1521-4141(200209)32:9<2409::AID-IMMU2409>3.0.CO;2-H	51	68	73	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32459	32467		10.1074/jbc.M505301200	http://dx.doi.org/10.1074/jbc.M505301200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16030017	hybrid			2022-12-27	WOS:000231794800053
J	Durand, E; Michel, G; Voulhoux, R; Kurner, J; Bernadac, A; Filloux, A				Durand, E; Michel, G; Voulhoux, R; Kurner, J; Bernadac, A; Filloux, A			XcpX controls biogenesis of the Pseudomonas aeruginosa XcpT-containing pseudopilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SECRETION; IDENTIFICATION; GENES; APPARATUS; PILI; COMPONENTS; MEMBRANE; CLONING; LOCALIZATION; TRANSPORT	Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen equipped with multiple secretion systems. The type II secretion machinery (Xcp secreton) is involved in the release of toxins and enzymes. The Xcp secreton is a multiprotein complex, and most of its components share homology with proteins involved in type IV pili biogenesis. Among them, the XcpT-X pseudopilins possess characteristics of the major constituent of the type IV pili, the pilin PilA. We have shown previously that XcpT can be assembled in a multifibrillar structure that was called the pseudopilus. By using two different microscopic approaches, we show here that the pseudopili are preferentially isolated fibers rather than tight bundles. Moreover, none of the other four pseudopilins are able to form a pseudopilus, suggesting that the assembly of such a structure is a unique property of XcpT. Moreover, we show that 5 of the 12 Xcp proteins are not required for pseudopilus biogenesis, whereas they are for type II secretion. Most interestingly, we showed that one pseudopilin, XcpX, controls the assembly of XcpT into a pseudopilus. Indeed, when the number of XcpX subunits increases, the length of the pseudopilus decreases. Conversely, in the absence of XcpX, the pseudopilus length is abnormally long. Our results indicate that XcpT and XcpX directly interact with each other. Furthermore, this interaction induces a clear destabilization of XcpT. The interaction between XcpT and XcpX could be part of the molecular mechanism underlying the dynamic control of pseudopilus elongation, which could be crucial for type II-dependent protein secretion.	CNRS, IBSM, UPR9027, Lab Ingn Syst Macromol, F-13402 Marseille, France; Max Planck Inst Biochem, Dept Struct Biol, D-82152 Martinsried, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Max Planck Society	Filloux, A (corresponding author), CNRS, IBSM, UPR9027, Lab Ingn Syst Macromol, 31 Chem Joseph Aiguier, F-13402 Marseille, France.	filloux@ibsm.cnrs-mrs.fr	Voulhoux, Rome/AAT-5333-2021; Durand, Eric/E-6739-2017	Durand, Eric/0000-0002-0577-8220				Alm RA, 1996, MOL MICROBIOL, V22, P161; Ball G, 2002, MOL MICROBIOL, V43, P475, DOI 10.1046/j.1365-2958.2002.02759.x; Ball G, 1999, J BACTERIOL, V181, P382, DOI 10.1128/JB.181.2.382-388.1999; BALLY M, 1992, MOL MICROBIOL, V6, P1121, DOI 10.1111/j.1365-2958.1992.tb01550.x; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; Bleves S, 1996, J BACTERIOL, V178, P4297, DOI 10.1128/jb.178.14.4297-4300.1996; Bleves S, 1998, MOL MICROBIOL, V27, P31, DOI 10.1046/j.1365-2958.1998.00653.x; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Duthy TG, 2002, J BACTERIOL, V184, P1065, DOI 10.1128/jb.184.4.1065-1077.2002; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; GEBHART W, 1979, BRIT J VENER DIS, V55, P83; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lee MS, 2005, J BIOL CHEM, V280, P4585, DOI 10.1074/jbc.M409362200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Martinez A, 1998, MOL MICROBIOL, V28, P1235, DOI 10.1046/j.1365-2958.1998.00888.x; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Michel G, 1998, MICROBIOL-SGM, V144, P3379, DOI 10.1099/00221287-144-12-3379; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; NUNN DN, 1991, P NATL ACAD SCI USA, V88, P3281, DOI 10.1073/pnas.88.8.3281; NUNN DN, 1993, J BACTERIOL, V175, P4375, DOI 10.1128/JB.175.14.4375-4382.1993; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Planet PJ, 2001, P NATL ACAD SCI USA, V98, P2503, DOI 10.1073/pnas.051436598; Resch GP, 2002, J CELL SCI, V115, P1877; Robert V, 2002, J BACTERIOL, V184, P1779, DOI 10.1128/JB.184.6.1779-1782.2002; Sambrook J, 1989, MOL CLONING; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; SIMPSON DA, 1992, INFECT IMMUN, V60, P3771, DOI 10.1128/IAI.60.9.3771-3779.1992; SWANSON J, 1971, J EXP MED, V134, P886, DOI 10.1084/jem.134.4.886; TODD WJ, 1984, J BACTERIOL, V159, P312, DOI 10.1128/JB.159.1.312-320.1984; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Vignon G, 2003, J BACTERIOL, V185, P3416, DOI 10.1128/JB.185.11.3416-3428.2003; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408	43	65	66	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31378	31389		10.1074/jbc.M505812200	http://dx.doi.org/10.1074/jbc.M505812200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16012171	hybrid			2022-12-27	WOS:000231665200007
J	Koyanagi, M; Baguet, A; Martens, J; Margueron, R; Jenuwein, T; Bix, M				Koyanagi, M; Baguet, A; Martens, J; Margueron, R; Jenuwein, T; Bix, M			EZH2 and histone 3 trimethyl lysine 27 associated with Il4 and Il13 gene silencing in T(H)1 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-4 GENE; METHYLATION; H3; CHROMATIN; DIFFERENTIATION; EXPRESSION; STATES; LOCUS	Differentiation of naive CD4 T cells toward the T helper 1 (T(H)1) and T helper 2 (T(H)2) fates involves the transcriptional repression and enhancement, respectively, of Il4 and Il13, adjacent chromosome 11 genes encoding the canonical T(H)2 cytokines interleukin-4 and interleukin-13. Proper execution of this developmental fate choice during immune responses is critical to host defense and, when misregulated, leads to susceptibility to infectious microbes and to allergic and autoimmune diseases. Here, using chromatin immunoprecipitation and real time reverse transcription PCR we identify the Polycomb family histone methyltransferase EZH2 as the enzyme responsible for methylating lysine 27 of histone H3 at the Il4-Il13 locus of T(H)1 but not T(H)2 cells, implicating EZH2 in the mechanism of Il4 and Il13 transcriptional silencing.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA	University of Washington; University of Washington Seattle; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Rutgers State University New Brunswick; Rutgers State University Medical Center	Bix, M (corresponding author), Univ Washington, Dept Immunol, 1959 NE Pacific St,HSC 16071, Seattle, WA 98195 USA.	mbix@u.washington.edu	Martens, Joost/D-4966-2012; Margueron, Raphael F/B-9996-2015	Martens, Joost/0000-0003-2008-6537; Margueron, Raphael F/0000-0002-9093-7977; Bix, Mark/0000-0003-4617-0497	NIAID NIH HHS [AI48636] Funding Source: Medline; NIGMS NIH HHS [GM37120] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048636, R01AI048636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037120, R01GM037120] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Baguet A, 2004, P NATL ACAD SCI USA, V101, P11410, DOI 10.1073/pnas.0403334101; Cao BH, 2003, NAT CELL BIOL, V5, P640, DOI 10.1038/ncb1008; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Grogan JL, 2003, J IMMUNOL, V171, P6672, DOI 10.4049/jimmunol.171.12.6672; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Moss RB, 2004, EXPERT OPIN BIOL TH, V4, P1887, DOI 10.1517/14712598.4.12.1887; Perez-Burgos L, 2004, METHOD ENZYMOL, V376, P234; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schotta Gunnar, 2004, Novartis Found Symp, V259, P22; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Wang Y., 2004, NOVART FDN SYMP, V259, P3; Wang Yanming, 2004, Novartis Found Symp, V259, P3	26	112	115	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31470	31477		10.1074/jbc.M504766200	http://dx.doi.org/10.1074/jbc.M504766200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16009709	hybrid			2022-12-27	WOS:000231665200018
J	Merkley, N; Barber, KR; Shaw, GS				Merkley, N; Barber, KR; Shaw, GS			Ubiquitin manipulation by an E2 conjugating enzyme using a novel covalent intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUBIQUITIN CHAINS; BINDING INTERFACE; UBA DOMAINS; YEAST UBC4; PROTEIN; INSIGHTS; COMPLEX; TAIL; IDENTIFICATION; UBIQUITYLATION	Degradation of misfolded and damaged proteins by the 26 S proteasome requires the substrate to be tagged with a polyubiquitin chain. Assembly of polyubiquitin chains and subsequent substrate labeling potentially involves three enzymes, an E1, E2, and E3. E2 proteins are key enzymes and form a thioester intermediate through their catalytic cysteine with the C-terminal glycine (Gly(76)) of ubiquitin. This thioester intermediate is easily hydrolyzed in vitro and has eluded structural characterization. To overcome this, we have engineered a novel ubiquitin-E2 disulfide-linked complex by mutating Gly76 to Cys(76) in ubiquitin. Reaction of Ubc1, an E2 from Saccharomyces cerevisiae, with this mutant ubiquitin resulted in an ubiquitin-E2 disulfide that could be purified and was stable for several weeks. Chemical shift perturbation analysis of the disulfide ubiquitin- Ubc1 complex by NMR spectroscopy reveals an ubiquitin- Ubc1 interface similar to that for the ubiquitin- E2 thioester. In addition to the typical E2 catalytic domain, Ubc1 contains an ubiquitin- associated (UBA) domain, and we have utilized NMR spectroscopy to demonstrate that in this disulfide complex the UBA domain is freely accessible to non-covalently bind a second molecule of ubiquitin. The ability of the Ubc1 to bind two ubiquitin molecules suggests that the UBA domain does not interact with the thioester-bound ubiquitin during polyubiquitin chain formation. Thus, construction of this novel ubiquitin- E2 disulfide provides a method to characterize structurally the first step in polyubiquitin chain assembly by Ubc1 and its related class II enzymes.	Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Shaw, GS (corresponding author), Univ Western Ontario, Dept Biochem, Med Sci Bldg, London, ON N6A 5C1, Canada.	gshaw1@uwo.ca	Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625				Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; COOK WJ, 1993, BIOCHEMISTRY-US, V32, P13809, DOI 10.1021/bi00213a009; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GWOZD CS, 1995, BIOCHEMISTRY-US, V34, P6296, DOI 10.1021/bi00019a006; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Hamilton KS, 2000, J BIOMOL NMR, V18, P319, DOI 10.1023/A:1026773008237; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; McKenna S, 2003, BIOCHEMISTRY-US, V42, P7922, DOI 10.1021/bi034480t; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Merkley N, 2003, J BIOMOL NMR, V26, P147, DOI 10.1023/A:1023571703783; Miura T, 1999, J MOL BIOL, V290, P213, DOI 10.1006/jmbi.1999.2859; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Rajesh S, 1999, BIOCHEMISTRY-US, V38, P9242, DOI 10.1021/bi9903953; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; SULLIVAN ML, 1993, J BIOL CHEM, V268, P8777; SUNG P, 1991, J MOL BIOL, V221, P745, DOI 10.1016/0022-2836(91)80169-U; Varelas X, 2003, MOL CELL BIOL, V23, P5388, DOI 10.1128/MCB.23.15.5388-5400.2003; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Winn PJ, 2005, PROTEINS, V58, P367, DOI 10.1002/prot.20318; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	37	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31732	31738		10.1074/jbc.M505205200	http://dx.doi.org/10.1074/jbc.M505205200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16014632	hybrid			2022-12-27	WOS:000231665200050
J	Kota, RS; Ramana, CV; Tenorio, FA; Enelow, RI; Rutledge, JC				Kota, RS; Ramana, CV; Tenorio, FA; Enelow, RI; Rutledge, JC			Differential effects of lipoprotein lipase on tumor necrosis factor-alpha and interferon-gamma-mediated gene expression in human endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; NF-KAPPA-B; TRIGLYCERIDE-RICH LIPOPROTEINS; INTESTINAL POLYP FORMATION; C-REACTIVE PROTEIN; LIPID RAFTS; MACROPHAGE; ROLES; ATHEROSCLEROSIS; LIPOLYSIS	Lipoprotein lipase ( LPL) is a key enzyme in the hydrolysis of triglyceride- rich lipoproteins. In vascular diseases, such as atherosclerosis, inflammation plays an important role in the pathogenesis of the disease. We examined the role of LPL in modulating tumor necrosis factor-alpha ( TNF-alpha)- and interferon-gamma ( IFN-gamma)- mediated inflammatory cytokine signal transduction pathways in human aortic endothelial cells ( HAECs). LPL significantly suppressed TNF-alpha- induced gene expression, and this suppression was reversed by tetrahydrolipstatin and heparinase. In contrast, LPL synergistically enhanced IFN-gamma- induced gene expression in HAECs. To elucidate the molecular mechanisms of LPL action, we investigated the role of transcription factors nuclear factor kappa B ( NF- kappa B) and signal transducer and activator of transcription factor 1 ( Stat1). The anti- inflammatory response of LPL in suppressing TNF-alpha- induced gene expression was a result of its inhibition of NF- kappa B activity by the abrogation of I kappa B-alpha degradation and phosphorylation of the p65 subunit. Although LPL alone had no effect on Stat1 activation, LPL enhanced IFN-gamma-induced phosphorylation of Stat1 on tyrosine 701 and serine 727, as well as Stat1- mediated transactivation. The synergistic effect of LPL on IFN-gamma-induced Stat1 activation was mediated by enhanced activation of the tyrosine kinase JAK2 and was abrogated by LY294002, a specific inhibitor of the phosphatidylinositol 3 '- kinase pathway. Our studies indicate that LPL has differential effects on several inflammatory pathways known to be important in atherosclerosis.	Univ Calif Davis, Sch Med,Dept Internal Med, Genome & Biomed Sci Facil 5303, Div Endocrinol Clin Nutr & Vasc Med, Davis, CA 95616 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA	University of California System; University of California Davis; Yale University	Kota, RS (corresponding author), Univ Calif Davis, Sch Med,Dept Internal Med, Genome & Biomed Sci Facil 5303, Div Endocrinol Clin Nutr & Vasc Med, 451 E Hlth Sci Dr, Davis, CA 95616 USA.	rskota@ucdavis.edu		chilakamarti, ramana/0000-0002-5153-8252	NHLBI NIH HHS [HL78615, HL70816, HL58660, HL55667] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055667, R29HL058660, R01HL058660, R01HL078615] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agnoletti L, 1999, CIRCULATION, V100, P1983, DOI 10.1161/01.CIR.100.19.1983; Agrawal A, 2001, J IMMUNOL, V166, P2378, DOI 10.4049/jimmunol.166.4.2378; Augustus AS, 2003, AM J PHYSIOL-ENDOC M, V284, pE331, DOI 10.1152/ajpendo.00298.2002; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; BEISIEGEL U, 1995, CURR OPIN LIPIDOL, V6, P117, DOI 10.1097/00041433-199506000-00002; BENNION SD, 1995, J INVEST DERMATOL, V105, pS71, DOI 10.1111/1523-1747.ep12316107; Bruce WR, 2000, NUTR CANCER, V37, P19, DOI 10.1207/S15327914NC3701_2; Brunzell J.D., 1995, METABOLIC MOL BASES, P1913; Castrillo A, 2001, J BIOL CHEM, V276, P34082, DOI 10.1074/jbc.M102472200; Cha-Molstad H, 2000, J IMMUNOL, V165, P4592, DOI 10.4049/jimmunol.165.8.4592; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; Fichtlscherer S, 2001, CIRCULATION, V104, P3023, DOI 10.1161/hc5001.101749; Glass CK, 2001, J ENDOCRINOL, V169, P461, DOI 10.1677/joe.0.1690461; Goldberg IJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD388, DOI 10.2741/Goldberg; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; HOU JZ, 1994, P NATL ACAD SCI USA, V91, P11641, DOI 10.1073/pnas.91.24.11641; Ichikawa T, 2004, LAB INVEST, V84, P715, DOI 10.1038/labinvest.3700102; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kuvin JT, 2002, AM HEART J, V144, P165, DOI 10.1067/mhj.2002.123145; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; LOOKENE A, 1994, EUR J BIOCHEM, V222, P395, DOI 10.1111/j.1432-1033.1994.tb18878.x; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Maziere C, 2001, FREE RADICAL BIO MED, V31, P1334, DOI 10.1016/S0891-5849(01)00649-9; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; MEDH JD, 1995, J BIOL CHEM, V270, P536, DOI 10.1074/jbc.270.2.536; Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200; Niho N, 2005, P NATL ACAD SCI USA, V102, P2970, DOI 10.1073/pnas.0500153102; Niho N, 2003, CANCER RES, V63, P6090; Pober JS, 2002, ARTHRITIS RES THER, V4, pS109, DOI 10.1186/ar576; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; RENIER G, 1995, ARTERIOSCL THROM VAS, V15, P392, DOI 10.1161/01.ATV.15.3.392; REYMER PWA, 1995, NAT GENET, V10, P28, DOI 10.1038/ng0595-28; Ricote M, 2004, ARTERIOSCL THROM VAS, V24, P230, DOI 10.1161/01.ATV.0000103951.67680.B1; ROJAS C, 1991, EUR J BIOCHEM, V197, P315, DOI 10.1111/j.1432-1033.1991.tb15913.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SHIMADA K, 1981, J CLIN INVEST, V68, P995, DOI 10.1172/JCI110354; Shimada M, 1996, P NATL ACAD SCI USA, V93, P7242, DOI 10.1073/pnas.93.14.7242; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Tellides G, 2000, NATURE, V403, P207, DOI 10.1038/35003221; Yagyu H, 1999, J LIPID RES, V40, P1677; Yin BY, 1997, J CLIN INVEST, V100, P649, DOI 10.1172/JCI119576; Ziouzenkova O, 2003, J BIOL CHEM, V278, P39874, DOI 10.1074/jbc.M306786200; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100; Zohlnhofer D, 2001, MOL CELL, V7, P1059, DOI 10.1016/S1097-2765(01)00239-8	53	32	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31076	31084		10.1074/jbc.M412189200	http://dx.doi.org/10.1074/jbc.M412189200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994321	hybrid			2022-12-27	WOS:000231487800052
J	Sauvage, E; Herman, R; Petrella, S; Duez, C; Bouillenne, F; Frere, JM; Charlier, P				Sauvage, E; Herman, R; Petrella, S; Duez, C; Bouillenne, F; Frere, JM; Charlier, P			Crystal structure of the Actinomadura R39 DD-peptidase reveals new domains in penicillin-binding proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-ALBUS G; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE; ENZYME; LOCALIZATION; DEACYLATION; PRECURSOR; PROGRAM; COMPLEX; ROLES	Actinomadura sp. R39 produces an exocellular DD-peptidase/penicillin- binding protein (PBP) whose primary structure is similar to that of Escherichia coli PBP4. It is characterized by a high alpha-lactam-binding activity ( second order rate constant for the acylation of the active site serine by benzylpenicillin: k(2)/K = 300 mM(-1)s(-1)). The crystal structure of the DD-peptidase from Actinomadura R39 was solved at a resolution of 1.8 angstrom by single anomalous dispersion at the cobalt resonance wavelength. The structure is composed of three domains: a penicillin-binding domain similar to the penicillin-binding domain of E. coli PBP5 and two domains of unknown function. In most multimodular PBPs, additional domains are generally located at the C or N termini of the penicillin-binding domain. In R39, the other two domains are inserted in the penicillin-binding domain, between the SXXK and SXN motifs, in a manner similar to "Matryoshka dolls." One of these domains is composed of a five-stranded beta-sheet with two helices on one side, and the other domain is a double three-stranded beta-sheet inserted in the previous domain. Additionally, the 2.4-angstrom structure of the acyl-enzyme complex of R39 with nitrocefin reveals the absence of active site conformational change upon binding the beta-lactams.	Univ Liege, Inst Phys, Ctr Ingn Prot, B-4000 Sart Tilman Par Liege, Belgium	University of Liege	Sauvage, E (corresponding author), Univ Liege, Inst Phys, Ctr Ingn Prot, B5, B-4000 Sart Tilman Par Liege, Belgium.	eric.sauvage@ulg.ac.be		Petrella, Stephanie/0000-0001-6641-5901				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURMAN LG, 1984, P NATL ACAD SCI-BIOL, V81, P1844, DOI 10.1073/pnas.81.6.1844; Cordell SC, 2001, EMBO J, V20, P2454, DOI 10.1093/emboj/20.10.2454; Davies C, 2001, J BIOL CHEM, V276, P616, DOI 10.1074/jbc.M004471200; DIDEBERG O, 1987, BIOCHEM J, V245, P911, DOI 10.1042/bj2450911; Dive G, 1999, INT J QUANTUM CHEM, V73, P161, DOI 10.1002/(SICI)1097-461X(1999)73:2<161::AID-QUA10>3.0.CO;2-E; Duez C, 2001, J BACTERIOL, V183, P1595, DOI 10.1128/JB.183.5.1595-1599.2001; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FANUEL L, 1994, FEBS LETT, V351, P49, DOI 10.1016/0014-5793(94)00822-1; Ferri-Fioni ML, 2001, J BIOL CHEM, V276, P47285, DOI 10.1074/jbc.M106550200; Fonze E, 1999, J BIOL CHEM, V274, P21853, DOI 10.1074/jbc.274.31.21853; FRERE JM, 1985, CRC CR REV MICROBIOL, V11, P299; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Gordon E, 2000, J MOL BIOL, V299, P477, DOI 10.1006/jmbi.2000.3740; GRANIER B, 1992, BIOCHEM J, V282, P781, DOI 10.1042/bj2820781; Harris F, 2002, EUR J BIOCHEM, V269, P5821, DOI 10.1046/j.1432-1033.2002.03295.x; Hoch J.A., 2001, BACILLUS SUBTILIS IT, P21, DOI 10.1128/9781555817992.ch4; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Inagaki N, 2001, FEBS LETT, V509, P197, DOI 10.1016/S0014-5793(01)03180-5; JACOBDUBUISSON F, 1991, PROTEIN ENG, V4, P811, DOI 10.1093/protein/4.7.811; KELLY JA, 1995, J MOL BIOL, V254, P223, DOI 10.1006/jmbi.1995.0613; KORAT B, 1991, MOL MICROBIOL, V5, P675, DOI 10.1111/j.1365-2958.1991.tb00739.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUZIN AP, 1995, BIOCHEMISTRY-US, V34, P9532, DOI 10.1021/bi00029a030; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P50; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; McDonough MA, 2002, J MOL BIOL, V322, P111, DOI 10.1016/S0022-2836(02)00742-8; Meberg BM, 2004, J BACTERIOL, V186, P8326, DOI 10.1128/JB.186.24.8326-8336.2004; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MOTTL H, 1992, J BACTERIOL, V174, P3261, DOI 10.1128/jb.174.10.3261-3269.1992; Muller JJ, 1998, J BIOL CHEM, V273, P3438, DOI 10.1074/jbc.273.6.3438; NAGASAWA H, 1989, J BACTERIOL, V171, P5890, DOI 10.1128/jb.171.11.5890-5893.1989; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nicholas RA, 2003, J BIOL CHEM, V278, P52826, DOI 10.1074/jbc.M310177200; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Pares S, 1996, NAT STRUCT BIOL, V3, P284, DOI 10.1038/nsb0396-284; Pedersen LB, 1998, J BACTERIOL, V180, P4967, DOI 10.1128/JB.180.18.4967-4973.1998; Popham DL, 1999, J BACTERIOL, V181, P126, DOI 10.1128/JB.181.1.126-132.1999; Rico AI, 2004, MOL MICROBIOL, V53, P1359, DOI 10.1111/j.1365-2958.2004.04245.x; Roussel A., 1989, SILICON GRAPHICS GEO; Sauvage E, 2002, CELL MOL LIFE SCI, V59, P1223, DOI 10.1007/s00018-002-8500-0; Scheffers DJ, 2004, MOL MICROBIOL, V51, P749, DOI 10.1046/j.1365-2958.2003.03854.x; Silvaggi NR, 2005, J MOL BIOL, V345, P521, DOI 10.1016/j.jmb.2004.10.076; Stefanova ME, 2003, BIOCHEMISTRY-US, V42, P14614, DOI 10.1021/bi0350607; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Varma A, 2004, J BACTERIOL, V186, P6768, DOI 10.1128/JB.186.20.6768-6774.2004	50	45	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31249	31256		10.1074/jbc.M503271200	http://dx.doi.org/10.1074/jbc.M503271200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15987687	Green Published, hybrid			2022-12-27	WOS:000231487800072
J	Wang, HC; Liu, YD; Chen, YX; Robinson, H; Ke, HM				Wang, HC; Liu, YD; Chen, YX; Robinson, H; Ke, HM			Multiple elements jointly determine inhibitor selectivity of cyclic nucleotide phosphodiesterases 4 and 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; MESSENGER-RNA; CAMP; MECHANISM; AMP; PDE7A; IDENTIFICATION; LYMPHOCYTES; COMPLEX	Phosphodiesterase (PDE) inhibitors have been widely studied as therapeutics for treatment of human diseases. However, the mechanism by which each PDE family recognizes selectively a category of inhibitors remains a puzzle. Here we report the crystal structure of PDE7A1 catalytic domain in complex with non-selective inhibitor 3-isobutyl-1-methylxanthine and kinetic analysis on the mutants of PDE7A1 and PDE4D2. Our studies suggest at least three elements play critical roles in inhibitor selectivity: 1) the conformation and position of an invariant glutamine, 2) the natures of scaffolding residues, and 3) residues that alter shape and size of the binding pocket. Kinetic analysis shows that single PDE7 to PDE4 mutations increase the sensitivity of PDE7 to PDE4 inhibitors but are not sufficient to render the engineered enzymes comparable with the wild types. The triple S373Y/S377T/I412S mutation of PDE7A1 produces a PDE4-like enzyme, implying that multiple elements must work together to determine inhibitor selectivity.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; Cent S Univ, Sch Biosci & Technol, Changsha 410008, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Brookhaven National Laboratory; Central South University	Ke, HM (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hke@med.unc.edu		Wang, Huanchen/0000-0003-2701-7155	NIGMS NIH HHS [GM59791] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059791] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antoni FA, 2000, FRONT NEUROENDOCRIN, V21, P103, DOI 10.1006/frne.1999.0193; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bloom TJ, 1996, P NATL ACAD SCI USA, V93, P14188, DOI 10.1073/pnas.93.24.14188; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Card GL, 2004, STRUCTURE, V12, P2233, DOI 10.1016/j.str.2004.10.004; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Castro A, 2005, MED RES REV, V25, P229, DOI 10.1002/med.20020; Corbin JD, 2002, INT J CLIN PRACT, V56, P453; Gardner C, 2000, BIOCHEM BIOPH RES CO, V272, P186, DOI 10.1006/bbrc.2000.2743; Giembycz M A, 2002, Monaldi Arch Chest Dis, V57, P48; Giembycz MA, 1996, BRIT J PHARMACOL, V118, P1945, DOI 10.1111/j.1476-5381.1996.tb15629.x; Han P, 1997, J BIOL CHEM, V272, P16152, DOI 10.1074/jbc.272.26.16152; Hetman JM, 2000, P NATL ACAD SCI USA, V97, P472, DOI 10.1073/pnas.97.1.472; Huai Q, 2004, P NATL ACAD SCI USA, V101, P9624, DOI 10.1073/pnas.0401120101; Huai Q, 2004, J BIOL CHEM, V279, P13095, DOI 10.1074/jbc.M311556200; Huai Q, 2003, BIOCHEMISTRY-US, V42, P13220, DOI 10.1021/bi034653e; Huai Q, 2003, STRUCTURE, V11, P865, DOI 10.1016/S0969-2126(03)00123-0; Huang Z, 2001, CURR OPIN CHEM BIOL, V5, P432, DOI 10.1016/S1367-5931(00)00224-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lee ME, 2002, FEBS LETT, V530, P53, DOI 10.1016/S0014-5793(02)03396-3; Lee R, 2002, CELL SIGNAL, V14, P277, DOI 10.1016/S0898-6568(01)00250-9; Li LS, 1999, SCIENCE, V283, P848, DOI 10.1126/science.283.5403.848; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Liu YG, 2001, CARDIOVASC DRUG REV, V19, P369, DOI 10.1111/j.1527-3466.2001.tb00076.x; Mehats C, 2002, TRENDS ENDOCRIN MET, V13, P29, DOI 10.1016/S1043-2760(01)00523-9; MICHAELI T, 1993, J BIOL CHEM, V268, P12925; Miro X, 2001, SYNAPSE, V40, P201, DOI 10.1002/syn.1043; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Richter W, 2002, PROTEIN EXPRES PURIF, V25, P138, DOI 10.1006/prep.2002.1620; Rotella DP, 2002, NAT REV DRUG DISCOV, V1, P674, DOI 10.1038/nrd893; Scapin G, 2004, BIOCHEMISTRY-US, V43, P6091, DOI 10.1021/bi049868i; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Sung BJ, 2003, NATURE, V425, P98, DOI 10.1038/nature01914; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Truss MC, 2001, WORLD J UROL, V19, P344, DOI 10.1007/s003450100221; Xu RX, 2004, J MOL BIOL, V337, P355, DOI 10.1016/j.jmb.2004.01.040; Xu RX, 2000, SCIENCE, V288, P1822, DOI 10.1126/science.288.5472.1822; Yang GC, 2003, J IMMUNOL, V171, P6414, DOI 10.4049/jimmunol.171.12.6414; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005	40	64	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30949	30955		10.1074/jbc.M504398200	http://dx.doi.org/10.1074/jbc.M504398200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994308	hybrid			2022-12-27	WOS:000231487800037
J	Ding, HG; Harrison, K; Lu, JX				Ding, HG; Harrison, K; Lu, JX			Thioredoxin reductase system mediates iron binding in IscA and iron delivery for the iron-sulfur cluster assembly in IscU	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-S CLUSTER; ESCHERICHIA-COLI; AZOTOBACTER-VINELANDII; CYSTEINE DESULFURASE; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; SCAFFOLD PROTEIN; 2FE-2S CLUSTERS; MARITIMA ISCU	IscA is a key member of the iron-sulfur cluster assembly machinery found in bacteria and eukaryotes. Previously, IscA was characterized as an alternative iron-sulfur cluster assembly scaffold, as purified IscA can host transient iron-sulfur clusters. However, recent studies indicated that IscA is an iron-binding protein that can provide iron for the iron-sulfur cluster assembly in a proposed scaffold IscU ( Ding H., Clark, R. J., and Ding, B. ( 2004) J. Biol. Chem. 279, 37499 - 37504). To further elucidate the roles of IscA in the biogenesis of iron-sulfur clusters, we reevaluate the iron binding activity of IscA under physiologically relevant conditions. The results indicate that in the presence of the thioredoxin reductase system, Escherichia coli IscA binds iron with an iron association constant of 2.0 x 10(19) M-1 in vitro. Whereas all three components (thioredoxin 1, thioredoxin reductase and NADPH) in the thioredoxin reductase system are essential for mediating the iron binding in IscA, only catalytic amounts of thioredoxin 1 and thioredoxin reductase are required. In contrast, IscU fails to bind iron in the presence of the thioredoxin reductase system, suggesting that the iron binding in IscA is specific. Nevertheless, the thioredoxin reductase system can promote the iron-sulfur cluster assembly in IscU in the presence of the iron-loaded IscA, cysteine desulfurase ( IscS), and L-cysteine, demonstrating a physiologically relevant system for the biogenesis of iron-sulfur clusters. The results provide additional evidence for the hypothesis that IscA is capable of recruiting intracellular "free" iron and delivering the iron for the iron-sulfur cluster assembly in IscU.	Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; Wenzhou Med Coll, Inst Cellular & Mol Med, Wenzhou 325035, Zhejiang, Peoples R China	Louisiana State University System; Louisiana State University; Wenzhou Medical University	Ding, HG (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	hding@lsu.edu	Ding, Huangen/AAJ-8550-2020	Ding, Huangen/0000-0002-4815-7336				Achebach S, 2004, FEBS LETT, V565, P203, DOI 10.1016/j.febslet.2004.04.007; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Aslund F, 1999, J BACTERIOL, V181, P1375; Beinert H, 2000, EUR J BIOCHEM, V267, P5657, DOI 10.1046/j.1432-1327.2000.01637.x; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Bertini I, 2003, J MOL BIOL, V331, P907, DOI 10.1016/S0022-2836(03)00768-X; Bilder PW, 2004, BIOCHEMISTRY-US, V43, P133, DOI 10.1021/bi035440s; Cozar-Castellano I, 2004, BBA-PROTEINS PROTEOM, V1700, P179, DOI 10.1016/j.bbapap.2004.05.004; Crichton R R, 1990, Adv Protein Chem, V40, P281, DOI 10.1016/S0065-3233(08)60288-0; Cupp-Vickery JR, 2004, J MOL BIOL, V338, P127, DOI 10.1016/j.jmb.2004.02.027; Ding BJ, 2005, BIOCHEM J, V389, P797, DOI 10.1042/BJ20050405; Ding H, 2004, J BIOL CHEM, V279, P37499, DOI 10.1074/jbc.M404533200; Ding HG, 2004, BIOCHEM J, V379, P433, DOI 10.1042/BJ20031702; Ding HG, 1998, BIOCHEMISTRY-US, V37, P17280, DOI 10.1021/bi980532g; Duby G, 2002, HUM MOL GENET, V11, P2635, DOI 10.1093/hmg/11.21.2635; Flint DH, 1996, J BIOL CHEM, V271, P16068; Hoff KG, 2003, J BIOL CHEM, V278, P37582, DOI 10.1074/jbc.M305292200; Jensen LT, 2000, MOL CELL BIOL, V20, P3918, DOI 10.1128/MCB.20.11.3918-3927.2000; Johnson DC, 2005, BIOCHEM SOC T, V33, P90, DOI 10.1042/BST0330090; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; KEYER K, 1995, J BACTERIOL, V177, P6782, DOI 10.1128/jb.177.23.6782-6790.1995; Krebs C, 2001, BIOCHEMISTRY-US, V40, P14069, DOI 10.1021/bi015656z; Li DS, 1999, FEBS LETT, V456, P13, DOI 10.1016/S0014-5793(99)00896-0; Mansy SS, 2002, J BIOL CHEM, V277, P21397, DOI 10.1074/jbc.M201439200; Morimoto K, 2003, J BIOCHEM, V134, P211, DOI 10.1093/jb/mvg131; Morimoto K, 2002, FEBS LETT, V519, P123, DOI 10.1016/S0014-5793(02)02736-9; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Mulrooney SB, 1997, PROTEIN EXPRES PURIF, V9, P372, DOI 10.1006/prep.1996.0698; Ollagnier-de-Choudens S, 2004, J BIOL INORG CHEM, V9, P828, DOI 10.1007/s00775-004-0581-9; Ollagnier-de-Choudens S, 2001, J BIOL CHEM, V276, P22604, DOI 10.1074/jbc.M102902200; Puccio H, 2002, CURR OPIN GENET DEV, V12, P272, DOI 10.1016/S0959-437X(02)00298-8; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Ramelot TA, 2004, J MOL BIOL, V344, P567, DOI 10.1016/j.jmb.2004.08.038; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Silberg JJ, 2004, J BIOL CHEM, V279, P53924, DOI 10.1074/jbc.M410117200; Smith AD, 2001, J AM CHEM SOC, V123, P11103, DOI 10.1021/ja016757n; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Veine DM, 1998, PROTEIN SCI, V7, P1441, DOI 10.1002/pro.5560070621; Wollenberg M, 2003, EUR J BIOCHEM, V270, P1662, DOI 10.1046/j.1432-1033.2003.03522.x; Wu G, 2002, J BIOL INORG CHEM, V7, P526, DOI 10.1007/s00775-001-0330-2; Wu SP, 2003, BIOCHEMISTRY-US, V42, P5784, DOI 10.1021/bi026939+; Yang WY, 2002, J BIOL CHEM, V277, P12868, DOI 10.1074/jbc.M109485200; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, J BIOL CHEM, V269, P18723; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	54	65	69	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30432	30437		10.1074/jbc.M504638200	http://dx.doi.org/10.1074/jbc.M504638200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15985427	Green Published, hybrid			2022-12-27	WOS:000231362500056
J	Wang, PJ; Wang, JJ; Xiao, YS; Murray, JW; Novikoff, PM; Angeletti, RH; Orr, GA; Lan, DD; Silver, DL; Wolkoff, AW				Wang, PJ; Wang, JJ; Xiao, YS; Murray, JW; Novikoff, PM; Angeletti, RH; Orr, GA; Lan, DD; Silver, DL; Wolkoff, AW			Interaction with PDZK1 is required for expression of organic anion transporting protein 1A1 on the hepatocyte surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR-B; RAT-LIVER; TARGETED DISRUPTION; SULFOBROMOPHTHALEIN; IDENTIFICATION; BILIRUBIN; DOMAIN; SUPERFAMILY; COMPLEX; CLONING	Although many organic anion transport protein (Oatp) family members have PDZ consensus binding sites at their C termini, the functional significance is unknown. In the present study, we utilized rat Oatp1a1 (NM_017111) as a prototypical member of this family to examine the mechanism governing its subcellular trafficking. A peptide corresponding to the C-terminal 16 amino acids of rat Oatp1a1 was used to affinity-isolate interacting proteins from rat liver cytosol. Protein mass fingerprinting identified PDZK1 as the major interacting protein. This was confirmed by immunoprecipitation of an Oatp1a1-PDZK1 complex from cotransfected 293T cells as well as from native rat liver membrane extracts. Oatp1a1 bound predominantly to the first and third PDZ binding domains of PDZK1, whereas the high density lipoprotein receptor, scavenger receptor B type I binds to the first domain. Although it is possible that PDZK1 forms a complex with these two integral membrane proteins, this did not occur, suggesting that as yet undescribed factors lead to selectivity in the interaction of these protein ligands with PDZK1. Oatp1a1 protein expression was near normal in PDZK1 knock-out mouse liver. However, it was located predominantly in intracellular structures, in contrast to its normal basolateral plasma membrane distribution. Plasma disappearance of the Oatp1a1 ligand [S-35] sulfobromophthalein was correspondingly delayed in knock-out mice. These studies show a critical role for oligomerization of Oatp1a1 with PDZK1 for its proper subcellular localization and function. Because its ability to transport substances into the cell requires surface expression, this must be considered in any assessment of physiologic function.	Albert Einstein Coll Med, Liver Res Ctr, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Columbia Univ, Div Mol Med, Dept Med, New York, NY 10032 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Columbia University	Wolkoff, AW (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, 625 Ullmann Bldg,1300 Morris Pk Ave, Bronx, NY 10461 USA.	wolkoff@aecom.yu.edu		Silver, David/0000-0002-7289-9890	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK023026, P30DK041296] Funding Source: NIH RePORTER; NCI NIH HHS [CA06576] Funding Source: Medline; NCRR NIH HHS [S10 RR019352, S10 RR019352-01] Funding Source: Medline; NIDDK NIH HHS [DK23026, DK41296] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ADDONA T, 2005, CURRENT PROTOCOLS PR; Angeletti RH, 1998, AM J PHYSIOL-CELL PH, V275, pC882, DOI 10.1152/ajpcell.1998.275.3.C882; Angeletti RH, 1997, P NATL ACAD SCI USA, V94, P283, DOI 10.1073/pnas.94.1.283; Bao Y, 2002, AM J PHYSIOL-RENAL, V282, pF1103, DOI 10.1152/ajprenal.00152.2001; Bergwerk AJ, 1996, AM J PHYSIOL-GASTR L, V271, pG231, DOI 10.1152/ajpgi.1996.271.2.G231; Capuano P, 2005, PFLUG ARCH EUR J PHY, V449, P392, DOI 10.1007/s00424-004-1351-9; Cvetkovic M, 1999, DRUG METAB DISPOS, V27, P866; Gao B, 2004, J HEPATOL, V41, P201, DOI 10.1016/j.jhep.2004.04.029; GARTNER U, 1982, GASTROENTEROLOGY, V83, P1163; Gartner U, 1997, GASTROENTEROLOGY, V113, P1707, DOI 10.1053/gast.1997.v113.pm9352876; Gisler SM, 2003, KIDNEY INT, V64, P1746, DOI 10.1046/j.1523-1755.2003.00267.x; Glavy JS, 2000, J BIOL CHEM, V275, P1479, DOI 10.1074/jbc.275.2.1479; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hagenbuch B, 1996, BIOCHEM J, V316, P901, DOI 10.1042/bj3160901; Hata S, 2003, AM J PHYSIOL-GASTR L, V285, pG829, DOI 10.1152/ajpgi.00352.2002; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; JACQUEMIN E, 1994, P NATL ACAD SCI USA, V91, P133, DOI 10.1073/pnas.91.1.133; JACQUEMIN E, 1991, J CLIN INVEST, V88, P2146, DOI 10.1172/JCI115546; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; Kato Y, 2004, PHARM RES-DORDR, V21, P1886, DOI 10.1023/B:PHAM.0000045244.83999.43; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; KURISU H, 1989, ANAL BIOCHEM, V179, P72, DOI 10.1016/0003-2697(89)90202-9; Lan DB, 2005, J BIOL CHEM, V280, P23390, DOI 10.1074/jbc.M502777200; Lu R, 1996, J CLIN INVEST, V98, P1142, DOI 10.1172/JCI118897; Mohan S, 2003, ONCOGENE, V22, P5270, DOI 10.1038/sj.onc.1206592; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; SHI XY, 1995, J BIOL CHEM, V270, P25591, DOI 10.1074/jbc.270.43.25591; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; STOLLMAN YR, 1983, J CLIN INVEST, V72, P718, DOI 10.1172/JCI111021; van Montfoort JE, 2002, BBA-BIOMEMBRANES, V1564, P183, DOI 10.1016/S0005-2736(02)00445-5	35	61	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30143	30149		10.1074/jbc.M503969200	http://dx.doi.org/10.1074/jbc.M503969200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15994332	hybrid			2022-12-27	WOS:000231362500021
J	Bhattacharya, R; SenBanerjee, S; Lin, ZY; Mir, S; Hamik, A; Wang, P; Mukherjee, P; Mukhopadhyay, D; Jain, MK				Bhattacharya, R; SenBanerjee, S; Lin, ZY; Mir, S; Hamik, A; Wang, P; Mukherjee, P; Mukhopadhyay, D; Jain, MK			Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR-2; EXPRESSION; PROMOTER; PROLIFERATION; SP1; IDENTIFICATION; ACTIVATION; REGULATOR; MIGRATION; KDR/FLK-1	The Kruppel-like factor KLF2 was recently identified as a novel regulator of endothelial pro-inflammatory and pro-thrombotic function. Here it is shown that overexpression of KLF2 potently inhibits vascular permeability factor/vascular endothelial growth factor (VEGFA)mediated angiogenesis and tissue edema in the nude ear mouse model of angiogenesis. In vitro, KLF2 expression retards VEGF-mediated calcium flux, proliferation and induction of pro-inflammatory factors in endothelial cells. This effect is due to a potent inhibition of VEGFR2/KDR expression and promoter activity. These observations identify KLF2 as a regulator of VEGFR2/KDR and provide a foundation for novel approaches to regulate angiogenesis.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Program Cardiovasc Transcriptional Biol, Boston, MA 02115 USA; Mayo Clin & Mayo Fdn, Mayo Clin Canc Ctr, Rochester, MN 55905 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Mayo Clinic	Jain, MK (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Program Cardiovasc Transcriptional Biol, Boston, MA 02115 USA.	mjain@rics.bwh.harvard.edu			NATIONAL CANCER INSTITUTE [R29CA078383, R01CA078383] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075427, R01HL072178, R01HL070567, R01HL076754, R01HL072952, R01HL069477] Funding Source: NIH RePORTER; NCI NIH HHS [CA78383] Funding Source: Medline; NHLBI NIH HHS [HL70567, HL69477, HL072178, HL-76754, HL-72952, HL75427] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BOOCOCK CA, 1995, JNCI-J NATL CANCER I, V87, P506, DOI 10.1093/jnci/87.7.506; BROWN LF, 1993, AM J PATHOL, V143, P1255; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Dang DT, 2002, NUCLEIC ACIDS RES, V30, P2736, DOI 10.1093/nar/gkf400; Feinberg MW, 2004, TRENDS CARDIOVAS MED, V14, P241, DOI 10.1016/j.tcm.2004.06.005; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; GALLAND F, 1993, ONCOGENE, V8, P1233; Giraudo E, 1998, J BIOL CHEM, V273, P22128, DOI 10.1074/jbc.273.34.22128; HATVA E, 1995, AM J PATHOL, V146, P368; Higaki Y, 2002, NUCLEIC ACIDS RES, V30, P2270, DOI 10.1093/nar/30.11.2270; Illi B, 2000, CIRC RES, V86, pE110; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kim I, 2001, FASEB J, V15, P126, DOI 10.1096/fj.01-0556fje; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; MATTHEWS W, 1991, P NATL ACAD SCI USA, V88, P9026, DOI 10.1073/pnas.88.20.9026; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Mukhopadhyay D, 2004, MOL CELL BIOCHEM, V264, P51, DOI 10.1023/B:MCBI.0000044374.85095.df; PAJUSOLA K, 1992, CANCER RES, V52, P5738; PATTERSON C, 1995, J BIOL CHEM, V270, P23111, DOI 10.1074/jbc.270.39.23111; Patterson C, 1997, J BIOL CHEM, V272, P8410, DOI 10.1074/jbc.272.13.8410; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; PLATE KH, 1993, CANCER RES, V53, P5822; Ruminy P, 2003, GENE, V315, P133, DOI 10.1016/S0378-1119(03)00727-3; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SHIBUYA M, 1990, ONCOGENE, V5, P519; Sundberg C, 2001, AM J PATHOL, V158, P1145, DOI 10.1016/S0002-9440(10)64062-X; TERMAN BI, 1991, ONCOGENE, V6, P1677; Wang F, 2005, ONCOGENE, V24, P3875, DOI 10.1038/sj.onc.1208546; Yoshiji H, 1996, CANCER RES, V56, P2013; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200; Zeng HY, 2001, J BIOL CHEM, V276, P32714, DOI 10.1074/jbc.M103130200; Zhang WQ, 1998, J BIOL CHEM, V273, P17917, DOI 10.1074/jbc.273.28.17917	41	122	132	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2005	280	32					28848	28851		10.1074/jbc.C500200200	http://dx.doi.org/10.1074/jbc.C500200200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	952QT	15980434	hybrid			2022-12-27	WOS:000231021300003
J	Barnett, ME; Nagy, M; Kedzierska, S; Zolkiewski, M				Barnett, ME; Nagy, M; Kedzierska, S; Zolkiewski, M			The amino-terminal domain of ClpB supports binding to strongly aggregated proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLUS CHAPERONE CLPB; ESCHERICHIA-COLI; DNAK; THERMOTOLERANCE; OLIGOMERIZATION; SYSTEM; AAA(+); ATPASE; DISAGGREGATION; HSP104	Bacterial heat-shock proteins, ClpB and DnaK form a bichaperone system that efficiently reactivates aggregated proteins. ClpB undergoes nucleotide-dependent self-association and forms ring-shaped oligomers. The ClpB-assisted dissociation of protein aggregates is linked to translocation of substrates through the central channel in the oligomeric ClpB. Events preceding the translocation step, such as recognition of aggregates by ClpB, have not yet been explored, and the location of the aggregate-binding site in ClpB has been under discussion. We investigated the reactivation of aggregated glucose-6-phosphate dehydrogenase (G6PDH) by ClpB and its N-terminally truncated variant ClpB Delta N in the presence of DnaK, DnaJ, and GrpE. We found that the chaperone activity of ClpB Delta N becomes significantly lower than that of the full-length ClpB as the size of G6PDH aggregates increases. Using a "substrate trap" variant of ClpB with mutations of Walker B motifs in both ATP-binding modules (E279Q/E678Q), we demonstrated that ClpB Delta N binds to G6PDH aggregates with a significantly lower affinity than the full-length ClpB. Moreover, we identified two conserved acidic residues at the surface of the N-terminal domain of ClpB that support binding to G6PDH aggregates. Those N-terminal residues (Asp-103, Glu-109) contribute as much substrate-binding capability to ClpB as the conserved Tyr located at the entrance to the ClpB channel. In summary, we provided evidence for an essential role of the N-terminal domain of ClpB in recognition and binding strongly aggregated proteins.	Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Kansas State University	Zolkiewski, M (corresponding author), Kansas State Univ, Dept Biochem, 104 Willard Hall, Manhattan, KS 66506 USA.	michalz@ksu.edu	Kędzierska-Mieszkowska, Sabina/AAF-2737-2021	Kędzierska-Mieszkowska, Sabina/0000-0001-5756-3013	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058626] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58626] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604; Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200; Beinker P, 2002, J BIOL CHEM, V277, P47160, DOI 10.1074/jbc.M207853200; Clarke AK, 2000, J BACTERIOL, V182, P7092, DOI 10.1128/JB.182.24.7092-7096.2000; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Li JZ, 2003, STRUCTURE, V11, P323, DOI 10.1016/S0969-2126(03)00030-3; Liu ZH, 2002, J MOL BIOL, V321, P111, DOI 10.1016/S0022-2836(02)00591-0; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; Tanaka N, 2004, PROTEIN SCI, V13, P3214, DOI 10.1110/ps.04780704; Tek V, 2002, PROTEIN SCI, V11, P1192, DOI 10.1110/ps.4860102; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; WOO KM, 1992, J BIOL CHEM, V267, P20429; Xia D, 2004, J STRUCT BIOL, V146, P166, DOI 10.1016/j.jsb.2003.11.025; Zmijewski MA, 2004, J MOL BIOL, V336, P539, DOI 10.1016/j.jmb.2003.12.053; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083; Zolkiewski M, 1999, PROTEIN SCI, V8, P1899, DOI 10.1110/ps.8.9.1899; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591	34	78	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34940	34945		10.1074/jbc.M505653200	http://dx.doi.org/10.1074/jbc.M505653200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16076845	hybrid			2022-12-27	WOS:000232403900067
J	Gomez, GA; Daniotti, JL				Gomez, GA; Daniotti, JL			H-Ras dynamically interacts with recycling endosomes in CHO-K1 cells - Involvement of Rab5 and Rab11 in the trafficking of H-Ras to this pericentriolar endocytic compartment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; NUCLEOTIDE EXCHANGE FACTORS; GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE; K-RAS; LIPID RAFTS; N-RAS; ENDOPLASMIC-RETICULUM; ACTIVATE RAF-1; CAAX MOTIF	H-, N-, and K-Ras are isoforms of Ras proteins, which undergo different lipid modifications at the C terminus. These post-translational events make possible the association of Ras proteins both with the inner plasma membrane and to the cytosolic surface of endoplasmic reticulum and Golgi complex, which is also required for the proper function of these proteins. To better characterize the intracellular distribution and sorting of Ras proteins, constructs were engineered to express the C-terminal domain of H- and K-Ras fused to variants of green fluorescent protein. Using confocal microscopy, we found in CHO-K1 cells that H-Ras, which is palmitoylated and farnesylated, localized at the recycling endosome in addition to the inner leaflet of the plasma membrane. In contrast, K-Ras, which is farnesylated and nonpalmitoylated, mainly localized at the plasma membrane. Moreover, we demonstrate that sorting signals of H- and K-Ras are contained within the C-terminal domain of these proteins and that palmitoylation on this region of H-Ras might operate as a dominant sorting signal for proper subcellular localization of this protein in CHO-K1 cells. Using selective photobleaching techniques, we demonstrate the dynamic nature of H-Ras trafficking to the recycling endosome from plasma membrane. We also provide evidence that Rab5 and Rab11 activities are required for proper delivery of H-Ras to the endocytic recycling compartment. Using a chimera containing the Ras binding domain of c-Raf-1 fused to a fluorescent protein, we found that a pool of GTP-bound H-Ras localized on membranes from Rab11-positive recycling endosome after serum stimulation. These results suggest that H-Ras present in membranes of the recycling endosome might be activating signal cascades essential for the dynamic and function of the organelle.	Univ Nacl Cordoba, Ctr Invest & Quim Biol Cordoba, CIQUIBIC UNC CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Daniotti, JL (corresponding author), Univ Nacl Cordoba, Ctr Invest & Quim Biol Cordoba, CIQUIBIC UNC CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina.	daniotti@dqb.fcq.unc.edu.ar	Gomez, Guillermo/J-2993-2014	Gomez, Guillermo/0000-0002-0494-2404				Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Arni S, 1998, J BIOL CHEM, V273, P28478, DOI 10.1074/jbc.273.43.28478; Arozarena I, 2004, MOL CELL BIOL, V24, P1516, DOI 10.1128/MCB.24.4.1516-1530.2004; Bivona TG, 2003, CURR OPIN CELL BIOL, V15, P136, DOI 10.1016/S0955-0674(03)00016-4; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Chen W, 2001, METHOD ENZYMOL, V329, P165; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Crespo PM, 2004, BIOCHEM J, V377, P561, DOI 10.1042/BJ20031016; Crespo PM, 2002, J BIOL CHEM, V277, P44731, DOI 10.1074/jbc.M204604200; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; Edidin M, 2001, TRENDS CELL BIOL, V11, P492, DOI 10.1016/S0962-8924(01)02139-0; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Feig LA, 1996, TRENDS BIOCHEM SCI, V21, P438, DOI 10.1016/S0968-0004(96)10058-X; GHOMASHCHI F, 1995, BIOCHEMISTRY-US, V34, P11910, DOI 10.1021/bi00037a032; Giraudo CG, 1999, BIOCHEM J, V342, P633, DOI 10.1042/0264-6021:3420633; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Jackson C L, 2000, Subcell Biochem, V34, P233; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leventis R, 1998, BIOCHEMISTRY-US, V37, P7640, DOI 10.1021/bi973077h; Luo JQ, 1998, P NATL ACAD SCI USA, V95, P3632, DOI 10.1073/pnas.95.7.3632; Martina JA, 2000, NEUROCHEM RES, V25, P725, DOI 10.1023/A:1007527523734; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Rizzo MA, 2001, J BIOL CHEM, V276, P34928, DOI 10.1074/jbc.M105918200; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roy S, 2002, MOL CELL BIOL, V22, P5128, DOI 10.1128/MCB.22.14.5128-5140.2002; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Silvius JR, 2002, J MEMBRANE BIOL, V190, P83, DOI 10.1007/s00232-002-1026-4; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; Teter K, 1998, J BIOL CHEM, V273, P19625, DOI 10.1074/jbc.273.31.19625; Trischler M, 1999, J CELL SCI, V112, P4773; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; URBE S, 1993, FEBS LETT, V334, P175, DOI 10.1016/0014-5793(93)81707-7; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Walker SA, 2004, J CELL SCI, V117, P2879, DOI 10.1242/jcs.01285; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Xu LZ, 2003, MOL CELL BIOL, V23, P645, DOI 10.1128/MCB.23.2.645-654.2003; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Zheng Yi, 2003, EMBO Reports, V4, P463, DOI 10.1038/sj.embor.embor831	64	46	46	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34997	35010		10.1074/jbc.M506256200	http://dx.doi.org/10.1074/jbc.M506256200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16079139	hybrid			2022-12-27	WOS:000232403900073
J	Mackenzie, AB; Young, MT; Adinolfi, E; Surprenant, A				Mackenzie, AB; Young, MT; Adinolfi, E; Surprenant, A			Pseudoapoptosis induced by brief activation of ATP-gated P2X(7) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; INDEPENDENT CELL-DEATH; CYTOCHROME-C RELEASE; NUCLEOTIDE RECEPTOR; ROCK-I; BLEB FORMATION; APOPTOSIS; CASPASES; PROLIFERATION; PROTEINS	P2X(7) receptors are ATP-gated ion channels primarily expressed on antigen-presenting immune cells where they play a role in the acute inflammatory response. These ion channels couple not only to influx of cations, including calcium, but also to rapid alterations in cell morphology ( membrane blebbing, phosphatidylserine exposure, microvesicle shedding). These features resemble the extranuclear events associated with end stages of apoptosis but cell death does not occur if receptor activation is brief. Here we delineate two signaling pathways underlying these apoptotic-like processes. Loss of membrane asymmetry occurs within seconds, which directly triggers cytoskeletal disruption and zeiotic membrane blebbing; this is readily reversible and requires both calcium influx through P2X7 channels and mitochondrial calcium increase but is not associated with cytochrome c release. A slower, calcium-independent, ROCK-1-dependent cascade that does not involve rapid loss of membrane asymmetry but is associated with cytochrome c release is secondarily activated. The ROCK-1 pathway appears largely responsible for cell death, which occurs after prolonged stimulation of P2X(7) receptors. We suggest that the former mechanism underlies the reversible pseudoapoptotic events induced by brief activation of P2X(7) receptors.	Univ Sheffield, Inst Mol Physiol, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Surprenant, A (corresponding author), Univ Sheffield, Inst Mol Physiol, Dept Biomed Sci, Addison Bldg,Western Bank, Sheffield S10 2TN, S Yorkshire, England.	a.surprenant@sheffield.ac.uk	Adinolfi, Elena/F-9169-2010; Young, Mark T/E-8928-2010	Adinolfi, Elena/0000-0001-8129-9929; Young, Mark T/0000-0002-9615-9002; /0000-0002-9935-4188	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Barros LF, 2003, CELL DEATH DIFFER, V10, P687, DOI 10.1038/sj.cdd.4401236; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bohm Ingrid, 2003, Mol Imaging Biol, V5, P2, DOI 10.1016/S1536-1632(03)00024-6; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; Camilleri-Broet S, 1998, EXP CELL RES, V239, P277, DOI 10.1006/excr.1997.3899; Chiozzi P, 1997, J CELL BIOL, V138, P697, DOI 10.1083/jcb.138.3.697; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Coutinho-Silva R, 1999, AM J PHYSIOL-CELL PH, V276, pC1139, DOI 10.1152/ajpcell.1999.276.5.C1139; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Di Virgilio F, 1999, J LEUKOCYTE BIOL, V66, P723, DOI 10.1002/jlb.66.5.723; Falzoni S, 2000, MOL BIOL CELL, V11, P3169, DOI 10.1091/mbc.11.9.3169; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Green DR, 2000, METHOD ENZYMOL, V322, P15; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guimaraes CA, 2004, EUR J BIOCHEM, V271, P1638, DOI 10.1111/j.1432-1033.2004.04084.x; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Humphreys BD, 2000, J BIOL CHEM, V275, P26792; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Leverrier Y, 2001, NAT CELL BIOL, V3, pE91, DOI 10.1038/35070151; Lim MLR, 2001, FEBS LETT, V503, P69, DOI 10.1016/S0014-5793(01)02693-X; Lockshin RA, 2004, ONCOGENE, V23, P2766, DOI 10.1038/sj.onc.1207514; Lum MG, 2003, J CELL SCI, V116, P1437, DOI 10.1242/jcs.00320; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; MacKenzie AB, 1999, ANN NY ACAD SCI, V868, P716, DOI 10.1111/j.1749-6632.1999.tb11351.x; MAJNO G, 1995, AM J PATHOL, V146, P3; Mayer B, 2003, NEWS PHYSIOL SCI, V18, P89, DOI 10.1152/nips.01433.2002; Mills JC, 1999, J CELL BIOL, V146, P703, DOI 10.1083/jcb.146.4.703; Minamikawa T, 1999, EXP CELL RES, V246, P26, DOI 10.1006/excr.1998.4290; Morelli A, 2003, MOL BIOL CELL, V14, P2655, DOI 10.1091/mbc.02-04-0061; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pfeiffer ZA, 2004, J LEUKOCYTE BIOL, V75, P1173, DOI 10.1189/jlb.1203648; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Segundo C, 1999, BLOOD, V94, P1012, DOI 10.1182/blood.V94.3.1012.415k05_1012_1020; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Single B, 2001, EXP CELL RES, V262, P8, DOI 10.1006/excr.2000.5059; Sloviter RS, 2002, TRENDS PHARMACOL SCI, V23, P19, DOI 10.1016/S0165-6147(00)01867-8; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Wen LT, 2003, MOL PHARMACOL, V63, P706, DOI 10.1124/mol.63.3.706; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Zeuner A, 1999, CELL DEATH DIFFER, V6, P1075, DOI 10.1038/sj.cdd.4400596	51	129	130	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					33968	33976		10.1074/jbc.M502705200	http://dx.doi.org/10.1074/jbc.M502705200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	15994333	hybrid			2022-12-27	WOS:000232229700034
J	Karakas, E; Wilson, HL; Graf, TN; Xiang, S; Jaramillo-Buswuets, S; Rajagopalan, KV; Kisker, C				Karakas, E; Wilson, HL; Graf, TN; Xiang, S; Jaramillo-Buswuets, S; Rajagopalan, KV; Kisker, C			Structural insights into sulfite oxidase deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ELECTRON-TRANSFER; AMINO-ACID SEQUENCE; MOLECULAR-CLONING; MOLYBDENUM; EXPRESSION; DOMAIN; REFINEMENT; MUTATION; BINDING; ANIONS	Sulfite oxidase deficiency is a lethal genetic disease that results from defects either in the genes encoding proteins involved in molybdenum cofactor biosynthesis or in the sulfite oxidase gene itself. Several point mutations in the sulfite oxidase gene have been identified from patients suffering from this disease worldwide. Although detailed biochemical analyses have been carried out on these mutations, no structural data could be obtained because of problems in crystallizing recombinant human and rat sulfite oxidases and the failure to clone the chicken sulfite oxidase gene. We synthesized the gene for chicken sulfite oxidase de novo, working backward from the amino acid sequence of the native chicken liver enzyme by PCR amplification of a series of 72 overlapping primers. The recombinant protein displayed the characteristic absorption spectrum of sulfite oxidase and exhibited steady state and rapid kinetic parameters comparable with those of the tissue-derived enzyme. We solved the crystal structures of the wild type and the sulfite oxidase deficiency- causing R138Q (R160Q in humans) variant of recombinant chicken sulfite oxidase in the resting and sulfate-bound forms. Significant alterations in the substrate-binding pocket were detected in the structure of the mutant, and a comparison between the wild type and mutant protein revealed that the active site residue Arg-450 adopts different conformations in the presence and absence of bound sulfate. The size of the binding pocket is thereby considerably reduced, and its position relative to the cofactor is shifted, causing an increase in the distance of the sulfur atom of the bound sulfate to the molybdenum.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rajagopalan, KV (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Box 3711, Durham, NC 27710 USA.	raj@biochem.duke.edu; kisker@pharm.stonybrook.edu	Kisker, Caroline/T-1724-2019; Xiang, Song/AAF-6422-2019	Xiang, Song/0000-0001-9314-4684; Graf, Tyler/0000-0003-4145-2815; Kisker, Caroline/0000-0002-0216-6026	NIGMS NIH HHS [GM44283, GM581980] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brody MS, 1999, BIOCHEMISTRY-US, V38, P6668, DOI 10.1021/bi9902539; Christopher JA, 1998, J MOL GRAPH MODEL, V16, P285; DeLano W.L, PYMOL MOL GRAPHICS S; Feng CJ, 2003, BIOCHEMISTRY-US, V42, P12235, DOI 10.1021/bi0350194; Feng CJ, 2002, BIOCHEMISTRY-US, V41, P5816, DOI 10.1021/bi016059f; GARRETT RM, 1994, J BIOL CHEM, V269, P272; GARRETT RM, 1995, BBA-GENE STRUCT EXPR, V1262, P147, DOI 10.1016/0167-4781(95)00068-R; Garrett RM, 1998, P NATL ACAD SCI USA, V95, P6394, DOI 10.1073/pnas.95.11.6394; Graves PR, 2005, J BIOL CHEM, V280, P9363, DOI 10.1074/jbc.M412538200; GUIARD B, 1979, EUR J BIOCHEM, V100, P441, DOI 10.1111/j.1432-1033.1979.tb04187.x; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; JOHNSON JL, 1988, METHOD ENZYMOL, V158, P371, DOI 10.1016/0076-6879(88)58069-2; Johnson JL., 2001, METABOLIC MOL BASES, P3163; KESSLER DL, 1974, BIOCHIM BIOPHYS ACTA, V370, P389, DOI 10.1016/0005-2744(74)90100-4; KIPKE CA, 1989, ARCH BIOCHEM BIOPHYS, V270, P383, DOI 10.1016/0003-9861(89)90041-6; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Kisker C., 2001, HDB METALLOPROTEINS, P1121; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HF, 2002, NEUROPEDIATRICS, V33, P174, DOI 10.1055/s-2002-34491; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEAME PJ, 1989, J BIOL CHEM, V264, P20894; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacheco A, 1999, J BIOL INORG CHEM, V4, P390, DOI 10.1007/s007750050325; Rudolph MJ, 2003, ACTA CRYSTALLOGR D, V59, P1183, DOI 10.1107/S0907444903009934; Schrader N, 2003, STRUCTURE, V11, P1251, DOI 10.1016/j.str.2003.09.001; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; SULLIVAN EP, 1993, BIOCHEMISTRY-US, V32, P12465, DOI 10.1021/bi00097a026; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wilson HL, 2004, J BIOL CHEM, V279, P15105, DOI 10.1074/jbc.M314288200	32	75	76	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33506	33515		10.1074/jbc.M505035200	http://dx.doi.org/10.1074/jbc.M505035200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16048997	hybrid			2022-12-27	WOS:000232058100050
J	Hata, AN; Lybrand, TP; Breyer, RM				Hata, AN; Lybrand, TP; Breyer, RM			Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D-2 receptor CRTH2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; C5A RECEPTOR; MOLECULAR PHARMACOLOGY; TRANSMEMBRANE DOMAIN; IN-VIVO; CELLS; ACTIVATION; ANTAGONIST; INFLAMMATION; EXPRESSION	The chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) is a G protein-coupled receptor that mediates the pro-inflammatory effects of prostaglandin D-2 (PGD(2)) generated in allergic inflammation. The CRTH2 receptor shares greatest sequence similarity with chemoattractant receptors compared with prostanoid receptors. To investigate the structural determinants of CRTH2 ligand binding, we performed site-directed mutagenesis of putative mCRTH2 ligand-binding residues, and we evaluated mutant receptor ligand binding and functional properties. Substitution of alanine at each of three residues in the transmembrane (TM) helical domains (His-106, TM III; Lys-209, TM V; and Glu-268, TM VI) and one in extracellular loop II (Arg-178) decreased PGD2 binding affinity, suggesting that these residues play a role in binding PGD2. In contrast, the H106A and E268A mutants bound indomethacin, a nonsteroidal anti-inflammatory drug, with an affinity similar to the wild-type receptor. HEK293 cells expressing the H106A, K209A, and E268A mutants displayed reduced inhibition of intracellular cAMP and chemotaxis in response to PGD2, whereas the H106A and E268A mutants had functional responses to indomethacin similar to the wild-type receptor. Binding of PGE2 by the E268A mutant was enhanced compared with the wild-type receptor, suggesting that Glu-268 plays a role in determining prostanoid ligand selectivity. Replacement of Tyr-261 with phenylalanine did not affect PGD2 binding but decreased the binding affinity for indomethacin. These results provided the first details of the ligand binding pocket of an eicosanoid-binding chemoattractant receptor.	Vanderbilt Univ, Sch Med, Div Nephrol, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ingram Canc Ctr, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Str Struct Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Breyer, RM (corresponding author), Vanderbilt Univ, Sch Med, Div Nephrol, Dept Pharmacol, S3223 MCN,1161 21st Ave, Nashville, TN 37232 USA.	rich.breyer@vanderbilt.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033290] Funding Source: NIH RePORTER; NIAID NIH HHS [AI59108] Funding Source: Medline; NIDDK NIH HHS [DK46205] Funding Source: Medline; NIGMS NIH HHS [GM15431] Funding Source: Medline; NINDS NIH HHS [NS33290] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Audoly L, 1997, MOL PHARMACOL, V51, P61, DOI 10.1124/mol.51.1.61; Audoly L, 1997, J BIOL CHEM, V272, P13475, DOI 10.1074/jbc.272.21.13475; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Baranski TJ, 1999, J BIOL CHEM, V274, P15757, DOI 10.1074/jbc.274.22.15757; BARR RM, 1988, BRIT J PHARMACOL, V94, P773, DOI 10.1111/j.1476-5381.1988.tb11588.x; Chang CS, 1997, BIOCHEM J, V322, P597, DOI 10.1042/bj3220597; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cosmi L, 2000, EUR J IMMUNOL, V30, P2972, DOI 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#; DEMARTINO JA, 1995, J BIOL CHEM, V270, P15966, DOI 10.1074/jbc.270.27.15966; Fujitani Y, 2002, J IMMUNOL, V168, P443, DOI 10.4049/jimmunol.168.1.443; FUNK CD, 1993, MOL PHARMACOL, V44, P934; Furse KE, 2003, J MED CHEM, V46, P4450, DOI 10.1021/jm0301437; Gosset P, 2003, J IMMUNOL, V170, P4943, DOI 10.4049/jimmunol.170.10.4943; Hammad H, 2003, J IMMUNOL, V171, P3936, DOI 10.4049/jimmunol.171.8.3936; Hata AN, 2005, MOL PHARMACOL, V67, P640, DOI 10.1124/mol.104.007971; Hata AN, 2003, J PHARMACOL EXP THER, V306, P463, DOI 10.1124/jpet.103.050955; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hirai H, 2002, J IMMUNOL, V168, P981, DOI 10.4049/jimmunol.168.3.981; Hirai K, 2001, CURR TOP MICROBIOL, V255, P261; Honda K, 2003, J EXP MED, V198, P533, DOI 10.1084/jem.20022218; Huang JL, 2004, HUM MOL GENET, V13, P2691, DOI 10.1093/hmg/ddh279; Iwasaki M, 2002, J INVEST DERMATOL, V119, P609, DOI 10.1046/j.1523-1747.2002.01862.x; Kobayashi T, 2000, J BIOL CHEM, V275, P24294, DOI 10.1074/jbc.M002437200; Kobayashi T, 1997, J BIOL CHEM, V272, P15154, DOI 10.1074/jbc.272.24.15154; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Miettinen HM, 1997, J IMMUNOL, V159, P4045; MURRAY JJ, 1986, NEW ENGL J MED, V315, P800, DOI 10.1056/NEJM198609253151304; Nag SS, 2003, J ALLERGY CLIN IMMUN, V111, P558, DOI 10.1067/mai.2003.131; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; Nagata K, 1999, J IMMUNOL, V162, P1278; Narita S, 1996, INT ARCH ALLERGY IMM, V109, P161, DOI 10.1159/000237215; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Quehenberger O, 1997, BIOCHEM BIOPH RES CO, V238, P377, DOI 10.1006/bbrc.1997.7298; Raffetseder U, 1996, EUR J BIOCHEM, V235, P82, DOI 10.1111/j.1432-1033.1996.00082.x; Rehwald M, 1999, FEBS LETT, V443, P357, DOI 10.1016/S0014-5793(99)00007-1; Sawyer N, 2002, BRIT J PHARMACOL, V137, P1163, DOI 10.1038/sj.bjp.0704973; Shichijo M, 2003, J PHARMACOL EXP THER, V307, P518, DOI 10.1124/jpet.103.055442; Shiraishi Y, 2005, J PHARMACOL EXP THER, V312, P954, DOI 10.1124/jpet.104.078212; SICILIANO SJ, 1994, P NATL ACAD SCI USA, V91, P1214, DOI 10.1073/pnas.91.4.1214; Sugimoto H, 2003, J PHARMACOL EXP THER, V305, P347, DOI 10.1124/jpet.102.046748; Ulven T, 2005, J MED CHEM, V48, P897, DOI 10.1021/jm049036i	43	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32442	32451		10.1074/jbc.M502563200	http://dx.doi.org/10.1074/jbc.M502563200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16030019	hybrid			2022-12-27	WOS:000231794800051
J	Wente, W; Stroh, T; Beaudet, A; Richter, D; Kreienkamp, HJ				Wente, W; Stroh, T; Beaudet, A; Richter, D; Kreienkamp, HJ			Interactions with PDZ domain proteins PIST/GOPC and PDZK1 regulate intracellular sorting of the somatostatin receptor subtype 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ETHYLMALEIMIDE-SENSITIVE FACTOR; COUPLED RECEPTORS; BINDING PHOSPHOPROTEIN-50; FUNCTIONAL EXPRESSION; PLASMA-MEMBRANE; GTPASE TC10; RAT-BRAIN; FAMILY; CELLS	By yeast two-hybrid screening we have identified interaction partners for the intracellular C-terminal tail of the human and rodent somatostatin receptor subtype 5 (SSTR5). Interactions with the PDZ domain-containing proteins PIST and PDZK1 are mediated by the PDZ ligand motif at the C terminus of the receptor; in case of the human and mouse ( but not the rat) receptors, a slight sequence variation of this motif also allows for binding of the peroxisomal receptor PEX5. PIST is Golgi-associated and retains SSTR5 in the Golgi apparatus when coexpressed with the receptor; PDZK1 on the other hand associates with the SSTR5 at the plasma membrane. Endogenous SSTR5 in the neuroendocrine AtT-20 tumor cell line is colocalized with PIST in the Golgi apparatus. On a functional level, removal of the PDZ ligand motif of the receptor does not interfere with agonist-dependent internalization of the receptor or its targeting to a Golgi-associated compartment; however, recycling of the receptor to the plasma membrane after washout of the agonist is inhibited, suggesting that the PDZ-mediated interaction of SSTR5 is required for postendocytic sorting.	Univ Krankenhaus Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; Univ Krankenhaus Hamburg Eppendorf, Inst Zellbiochem & Klin Neurobiol, D-20246 Hamburg, Germany; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; McGill University	Richter, D (corresponding author), Univ Krankenhaus Hamburg Eppendorf, Inst Human Genet, Martinistr 52, D-20246 Hamburg, Germany.	Richter@uke.uni_hamburg.de; Kreienkamp@uke.uni-hamburg.de						Benharouga M, 2003, J BIOL CHEM, V278, P22079, DOI 10.1074/jbc.M301030200; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; BRUNS C, 1995, CIBA F SYMP, V190, P89; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Charest A, 2001, J BIOL CHEM, V276, P29456, DOI 10.1074/jbc.M104137200; Cheng J, 2005, J BIOL CHEM, V280, P3731, DOI 10.1074/jbc.M410026200; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Cuadra AE, 2004, J NEUROSCI, V24, P7491, DOI 10.1523/JNEUROSCI.1255-04.2004; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gentzsch M, 2003, J BIOL CHEM, V278, P6440, DOI 10.1074/jbc.M211050200; Gisler SM, 2003, KIDNEY INT, V64, P1733, DOI 10.1046/j.1523-1755.2003.00266.x; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Hassel B, 2003, J BIOL CHEM, V278, P40136, DOI 10.1074/jbc.M305577200; He JQ, 2004, J BIOL CHEM, V279, P50190, DOI 10.1074/jbc.M404876200; Helboe L, 1998, J NEUROSCI, V18, P4938; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Kocher O, 1998, LAB INVEST, V78, P117; Kreienkamp HJ, 1997, FEBS LETT, V419, P92, DOI 10.1016/S0014-5793(97)01437-3; Kreienkamp HJ, 2002, J BIOL CHEM, V277, P39937, DOI 10.1074/jbc.M206931200; Kreienkamp HJ, 2002, CURR OPIN PHARMACOL, V2, P581, DOI 10.1016/S1471-4892(02)00203-5; Kuliawat R, 2004, MOL BIOL CELL, V15, P1690, DOI 10.1091/mbc.E03-08-0554; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Neudauer CL, 2001, BIOCHEM BIOPH RES CO, V280, P541, DOI 10.1006/bbrc.2000.4160; PATEL YC, 1994, BIOCHEM BIOPH RES CO, V198, P605, DOI 10.1006/bbrc.1994.1088; Roth A, 1997, J BIOL CHEM, V272, P23769, DOI 10.1074/jbc.272.38.23769; Roth A, 1997, DNA CELL BIOL, V16, P111, DOI 10.1089/dna.1997.16.111; Sarret P, 2004, J BIOL CHEM, V279, P8029, DOI 10.1074/jbc.M310792200; Schreff M, 2000, J NEUROSCI, V20, P3785, DOI 10.1523/JNEUROSCI.20-10-03785.2000; Schwarzler A, 2000, J BIOL CHEM, V275, P9557, DOI 10.1074/jbc.275.13.9557; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Simonin F, 2004, J NEUROCHEM, V89, P766, DOI 10.1111/j.1471-4159.2004.02411.x; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Stroh T, 2000, ENDOCRINOLOGY, V141, P354, DOI 10.1210/en.141.1.354; Stroh T, 1999, J COMP NEUROL, V412, P69, DOI 10.1002/(SICI)1096-9861(19990913)412:1<69::AID-CNE5>3.0.CO;2-V; Strowski MZ, 2000, ENDOCRINOLOGY, V141, P111, DOI 10.1210/en.141.1.111; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; VANETTI M, 1992, FEBS LETT, V311, P290, DOI 10.1016/0014-5793(92)81122-3; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Zitzer H, 1999, J BIOL CHEM, V274, P32997, DOI 10.1074/jbc.274.46.32997	47	60	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32419	32425		10.1074/jbc.M507198200	http://dx.doi.org/10.1074/jbc.M507198200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16012170	hybrid			2022-12-27	WOS:000231794800048
J	Aldridge, C; Moller, SG				Aldridge, C; Moller, SG			The plastid division protein AtMinD1 is a Ca2+-ATPase stimulated by AtMinE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-CELL DIVISION; ESCHERICHIA-COLI; CHLOROPLAST DIVISION; FTSZ RING; TOPOLOGICAL REGULATION; PROPER PLACEMENT; POLE OSCILLATION; SITE PLACEMENT; MIND ATPASE; RAPID POLE	Bacteria and plastids divide symmetrically through binary fission by accurately placing the division site at midpoint, a process initiated by FtsZ polymerization, which forms a Z-ring. In Escherichia coli precise Z-ring placement at midcell depends on controlled oscillatory behavior of MinD and MinE: In the presence of ATP MinD interacts with the FtsZ inhibitor MinC and migrates to the membrane where the MinD-MinC complex recruits MinE, followed by MinD-mediated ATP hydrolysis and membrane release. Although correct Z-ring placement during Arabidopsis plastid division depends on the precise localization of the bacterial homologs AtMinD1 and AtMinE1, the underlying mechanism of this process remains unknown. Here we have shown that AtMinD1 is a Ca2+ -dependent ATPase and through mutation analysis demonstrated the physiological importance of this activity where loss of ATP hydrolysis results in protein mislocalization within plastids. The observed mislocalization is not due to disrupted AtMinD1 dimerization, however; the active siteAtMinD1(K72A) mutant is unable to interact with the topological specificity factor AtMinE1. We have shown that AtMinE1, but not E. coli MinE, stimulates AtMinD1-mediated ATP hydrolysis, but in contrast to prokaryotes stimulation occurs in the absence of membrane lipids. Although AtMinD1 appears highly evolutionarily conserved, we found that important biochemical and cell biological properties have diverged. We propose that correct intraplastidic AtMinD1 localization is dependent on AtMinE1-stimulated, Ca2+-dependent AtMinD1 ATP hydrolysis, ultimately ensuring precise Z-ring placement and symmetric plastid division.	Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England; Univ Stavanger, Dept Sci & Technol, N-4036 Stavanger, Norway	University of Leicester; Universitetet i Stavanger	Moller, SG (corresponding author), Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England.	sgm5@le.ac.uk		Moller, Simon/0000-0002-0460-3592; Aldridge, Cassie/0000-0002-9162-3478				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Berger G, 2001, J BIOENERG BIOMEMBR, V33, P93, DOI 10.1023/A:1010792213254; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BOASSON R, 1972, AM J BOT, V59, P217, DOI 10.2307/2441420; Bouet JY, 1999, EMBO J, V18, P1415, DOI 10.1093/emboj/18.5.1415; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Colletti KS, 2000, CURR BIOL, V10, P507, DOI 10.1016/S0960-9822(00)00466-8; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; Dinkins R, 2001, PLANTA, V214, P180, DOI 10.1007/s004250100605; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Fujiwara M, 2001, BIOCHEM BIOPH RES CO, V287, P462, DOI 10.1006/bbrc.2001.5588; Fujiwara MT, 2004, J CELL SCI, V117, P2399, DOI 10.1242/jcs.01092; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Hayashi I, 2001, EMBO J, V20, P1819, DOI 10.1093/emboj/20.8.1819; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Itoh R, 2001, PLANT PHYSIOL, V127, P1644, DOI 10.1104/pp.010386; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; Ma LY, 2004, MOL MICROBIOL, V54, P99, DOI 10.1111/j.1365-2958.2004.04265.x; Ma LY, 2003, J BACTERIOL, V185, P4948, DOI 10.1128/JB.185.16.4948-4955.2003; Maple J, 2002, PLANT J, V31, P269, DOI 10.1046/j.1365-313X.2002.01358.x; MAPLE J, 2005, IN PRESS PLANT J; McAndrew RS, 2001, PLANT PHYSIOL, V127, P1656, DOI 10.1104/pp.010542; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; Pichoff S, 2001, J BACTERIOL, V183, P6630, DOI 10.1128/JB.183.22.6630-6635.2001; PLATTALOIA KA, 1977, NEW PHYTOL, V78, P599, DOI 10.1111/j.1469-8137.1977.tb02163.x; POSSINGH.JV, 1969, PLANTA, V86, P186, DOI 10.1007/BF00379826; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Sai JQ, 2002, PLANT CELL, V14, P1279, DOI 10.1105/tpc.000653; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Vitha S, 2001, J CELL BIOL, V153, P111, DOI 10.1083/jcb.153.1.111; Zhou HJ, 2004, J BACTERIOL, V186, P1546, DOI 10.1128/JB.186.5.1546-1555.2004	38	34	37	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31673	31678		10.1074/jbc.M505126200	http://dx.doi.org/10.1074/jbc.M505126200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16014621	hybrid			2022-12-27	WOS:000231665200043
J	Willoughby, D; Masada, N; Crossthwaite, AJ; Ciruela, A; Cooper, DMF				Willoughby, D; Masada, N; Crossthwaite, AJ; Ciruela, A; Cooper, DMF			Localized Na+/H+ exchanger 1 expression protects Ca2+-regulated adenylyl cyclases from changes in intracellular pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CA2+ ENTRY; CLAMPED SNAIL NEURONS; C6-2B GLIOMA-CELLS; VACUOLAR H+-ATPASE; PLASMA-MEMBRANE; NCB-20 CELLS; LIPID RAFTS; CALCIUM; CAMP; RECEPTORS	The Ca2+-sensitive adenylyl cyclases (ACs) are exclusively regulated by capacitative Ca2+ entry (CCE) in nonexcitable cells. The present study investigates whether this Ca2+-dependent modulation of AC activity is further regulated by local pH changes that can arise beneath the plasma membrane as a consequence of cellular activity. Ca2+ stimulation of AC8 expressed in HEK 293 cells and inhibition of endogenous AC6 in C6-2B glioma cells exhibited clear sensitivity to modest pH changes in vitro. Acid pH (pH 7.14) reduced the Ca2+ sensitivity of both ACs, whereas alkaline pH (pH 7.85) enhanced the responsiveness of the enzymes to Ca2+, compared with controls (pH 7.50). Surprisingly, in the intact cell, the response of AC8 and AC6 to CCE was largely unperturbed by similar changes in intracellular pH (pH(i)), imposed using a weak acid (propionate) or weak base (trimethylamine). A range of hypotheses were tested to identify the mechanism(s) that could underlie this lack of pH effect in the intact cell. The pH sensitivity of CCE in HEK 293 cells is likely to dampen the effects of pHi on Ca2+-regulated ACs and may partly explain the discrepancy between in vitro and in vivo data. However, we have found that the Na+/H+ exchanger (NHE), NHE1, is functionally active in these cells, and like AC8 (and AC6) it resides in lipid rafts or caveolae, which may create cellular microdomains where pHi is tightly regulated. An abundance of NHE1 in these cellular subdomains may generate a privileged environment that protects the Ca2+-sensitive ACs and other caveolar proteins from local acid shifts.	Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Cooper, DMF (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	dmfc2@cam.ac.uk			NIGMS NIH HHS [GM32483] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032483] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amos BJ, 1998, J NEUROPHYSIOL, V79, P695, DOI 10.1152/jn.1998.79.2.695; Bachmann O, 2003, AM J PHYSIOL-GASTR L, V284, pG37, DOI 10.1152/ajpgi.00209.2002; BIEMESDERFER D, 1992, AM J PHYSIOL, V263, pF833, DOI 10.1152/ajprenal.1992.263.5.F833; BIRNBAUMER L, 1974, J BIOL CHEM, V249, P7848; BOYAJIAN CL, 1991, J BIOL CHEM, V266, P4995; Breton S, 1998, J HISTOCHEM CYTOCHEM, V46, P205, DOI 10.1177/002215549804600209; Bullis BL, 2002, EUR J BIOCHEM, V269, P4887, DOI 10.1046/j.1432-1033.2002.03202.x; Busa W. B., 1984, AM J PHYSIOL, V246, P409; Carey KD, 2003, J BIOL CHEM, V278, P3185, DOI 10.1074/jbc.M207014200; CHIONO M, 1995, J BIOL CHEM, V270, P1149, DOI 10.1074/jbc.270.3.1149; Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061; Crossthwaite AJ, 2005, J BIOL CHEM, V280, P6380, DOI 10.1074/jbc.M411987200; DEBERNARDI MA, 1993, BIOCHEM J, V293, P325, DOI 10.1042/bj2930325; DEITMER JW, 1995, J PHYSIOL-LONDON, V485, P157, DOI 10.1113/jphysiol.1995.sp020720; EVANS T, 1984, MOL PHARMACOL, V26, P395; Fagan KA, 2000, J BIOL CHEM, V275, P26530, DOI 10.1074/jbc.M001369200; Fagan KA, 1998, J BIOL CHEM, V273, P9297, DOI 10.1074/jbc.273.15.9297; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Fagan KA, 2000, J BIOL CHEM, V275, P40187, DOI 10.1074/jbc.M006606200; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; GANZ MB, 1990, J BIOL CHEM, V265, P8989; GARRITSEN A, 1992, J NEUROCHEM, V59, P190, DOI 10.1111/j.1471-4159.1992.tb08890.x; Gende OA, 2003, PLATELETS, V14, P9, DOI 10.1080/0953710021000034465; GRINSTEIN S, 1993, EMBO J, V12, P5209, DOI 10.1002/j.1460-2075.1993.tb06216.x; Hu BA, 2002, J BIOL CHEM, V277, P33139, DOI 10.1074/jbc.M112373200; HUANG SL, 1994, J BIOL CHEM, V269, P7631; JOHNSON RA, 1982, ARCH BIOCHEM BIOPHYS, V218, P68, DOI 10.1016/0003-9861(82)90322-8; KAILA K, 1987, NATURE, V330, P163, DOI 10.1038/330163a0; KANDASAMY RK, 1995, J BIOL CHEM, V270, P29209, DOI 10.1074/jbc.270.49.29209; KLEE CB, 1980, ANNU REV BIOCHEM, V49, P489, DOI 10.1146/annurev.bi.49.070180.002421; Lang KS, 2003, CELL PHYSIOL BIOCHEM, V13, P257, DOI 10.1159/000074540; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; LIN MC, 1975, J BIOL CHEM, V250, P4246; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; Mineo C, 1996, EXP CELL RES, V224, P237, DOI 10.1006/excr.1996.0133; Nakhoul NK, 2002, J NEPHROL, V15, pS22; Nitschke R, 1996, PFLUG ARCH EUR J PHY, V433, P98, DOI 10.1007/s004240050254; Ogi M, 2000, J GASTROENTEROL, V35, P912, DOI 10.1007/s005350070005; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Petrecca K, 1999, AM J PHYSIOL-HEART C, V276, pH709, DOI 10.1152/ajpheart.1999.276.2.H709; Putney James W. Jr, 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P143; Ro HA, 2004, J BIOL CHEM, V279, P37115, DOI 10.1074/jbc.M403099200; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SCHNITZER JE, 1995, P NATL ACAD SCI USA, V92, P1759, DOI 10.1073/pnas.92.5.1759; SCHWIENING CJ, 1993, P ROY SOC B-BIOL SCI, V253, P285, DOI 10.1098/rspb.1993.0115; Schwiening CJ, 2002, J PHYSIOL-LONDON, V538, P371, DOI 10.1113/jphysiol.2001.013055; Smith GAM, 1998, J PHYSIOL-LONDON, V512, P487, DOI 10.1111/j.1469-7793.1998.487be.x; Smith KE, 2002, J BIOL CHEM, V277, P6025, DOI 10.1074/jbc.M109615200; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; TKACHUK V A, 1981, Biokhimiya, V46, P963; Trapp S, 1996, NEUROREPORT, V7, P2000, DOI 10.1097/00001756-199608120-00029; Trapp S, 1996, J PHYSIOL-LONDON, V496, P695, DOI 10.1113/jphysiol.1996.sp021720; Volk C, 1998, BBA-BIOMEMBRANES, V1372, P28, DOI 10.1016/S0005-2736(98)00044-3; Willoughby D, 2002, J PHYSIOL-LONDON, V544, P487, DOI 10.1113/jphysiol.2002.027508; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962	57	37	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30864	30872		10.1074/jbc.M414355200	http://dx.doi.org/10.1074/jbc.M414355200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16002403	hybrid			2022-12-27	WOS:000231487800027
J	Zakharov, SI; Morrow, JP; Liu, GX; Yang, L; Marx, SO				Zakharov, SI; Morrow, JP; Liu, GX; Yang, L; Marx, SO			Activation of the BK (SLO1) potassium channel by mallotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CA2+-DEPENDENT K+ CHANNELS; LARGE-CONDUCTANCE; VOLTAGE SENSOR; BETA-SUBUNIT; SMOOTH-MUSCLE; ROTTLERIN; DOMAIN; CELLS; PHOSPHORYLATION	Pharmacologic approaches to activate K+ channels represent an emerging strategy to regulate membrane excitability. Here we report the identification and characterization of a lipid soluble toxin, mallotoxin (rottlerin), which potently activates the large conductance voltage and Ca2+-activated K+ channel (BK) expressed in a heterologous expression system and human vascular smooth muscle cells, shifting the conductance/voltage relationship by >100 mV. Probing the mechanism of action, we discover that the BK channel can be activated in the absence of divalent cations (Ca2+, Mg2+), suggesting that the mallotoxin mechanism of action involves the voltage-dependent gating of the channel. Mallo-toxin-activated channels remain incrementally sensitive to Ca2+ and beta subunits. In comparison to other small hydrophobic poisons, anesthetic agents, and protein toxins that inhibit ion channel activity, mallotoxin potently activates channel activity. In certain respects, mallotoxin acts as a BK channel beta 1 subunit mimetic, preserving BK channel Ca2+ sensitivity yet adjusting the set-point for BK channel activation to a more hyperpolarized membrane potential.	Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; Dept Med, Div Cardiol, New York, NY 10029 USA; Ctr Mol Cardiol, New York, NY 10029 USA	Columbia University	Marx, SO (corresponding author), Columbia Univ, Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.	sm460@columbia.edu		Morrow, John/0000-0002-9264-5273				ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; Amberg GC, 2003, J CLIN INVEST, V112, P717, DOI 10.1172/JC1200318684; ANDERSON A, 1855, EDINBURGH NEW PHILOS, V1, P296; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Gribkoff VK, 2001, NAT MED, V7, P471, DOI 10.1038/86546; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Hu L, 2003, P NATL ACAD SCI USA, V100, P10488, DOI 10.1073/pnas.1834300100; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Kayali AG, 2002, ENDOCRINOLOGY, V143, P3884, DOI 10.1210/en.2002-220259; KHORANA M. L., 1949, INDIAN JOUR PHARM, V11, P37; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Nardi A, 2003, PLANTA MED, V69, P885, DOI 10.1055/s-2003-45095; Nelson MT, 2004, J CLIN INVEST, V113, P955, DOI 10.1172/JCI200421388; Nishimaru K, 2004, J PHYSIOL-LONDON, V559, P849, DOI 10.1113/jphysiol.2004.068676; Nishizawa S, 2003, J VASC RES, V40, P169, DOI 10.1159/000070714; OLESEN SP, 1994, EUR J PHARMACOL, V251, P53, DOI 10.1016/0014-2999(94)90442-1; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Semper A, 1910, ARCH EXP PATHOL PHAR, V63, P10, DOI 10.1007/BF01840850; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Susarla BTS, 2003, J NEUROCHEM, V86, P635, DOI 10.1046/j.1471-4159.2003.01886.x; Tang XD, 2004, ANNU REV PHYSIOL, V66, P131, DOI 10.1146/annurev.physiol.66.041002.142720; Tillman DM, 2003, CANCER RES, V63, P5118; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443	40	57	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30882	30887		10.1074/jbc.M505302200	http://dx.doi.org/10.1074/jbc.M505302200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15998639	hybrid			2022-12-27	WOS:000231487800029
J	Vaughan, AM; Oram, JF				Vaughan, AM; Oram, JF			ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-HEART-DISEASE; HDL CHOLESTEROL; P-GLYCOPROTEIN; EFFLUX; RECEPTOR; ABCA1; GENE; TRANSPORTER; EXPRESSION; MACROPHAGES	ATP binding cassette transporter G1 (ABCG1) mediates the transport of cholesterol from cells to high density lipoprotein (HDL) but not to lipid-depleted apolipoprotein A-I. Here we show that human ABCG1 overexpressed in baby hamster kidney cells in the absence of lipoproteins traffics to the plasma membrane and redistributes membrane cholesterol to cell-surface domains accessible to treatment with the enzyme cholesterol oxidase. Cholesterol removed by HDL was largely derived from these domains in ABCG1 transfectants but not in cells lacking ABCG1. Overexpression of ABCG1 also increased cholesterol esterification, which was decreased by the addition of HDL, suggesting that a proportion of the cell-surface cholesterol not removed by HDL is transported to the intracellular esterifying enzyme acyl-CoA:cholesterol acyltransferase. A 638-amino acid ABCG1, which lacked the 40 N-terminal amino acids of the predicted full-length protein, was fully functional and of a similar size to ABCG1 expressed by cholesterol-loaded human monocyte-derived macrophages. Mutating an essential glycine residue in the Walker A motif abolished ABCG1-dependent cholesterol efflux and esterification and prevented localization of ABCG1 to the cell surface, indicating that the ATP binding domain in ABCG1 is essential for both lipid transport activity and protein trafficking. These studies show that ABCG1 redistributes cholesterol to cell-surface domains where it becomes accessible for removal by HDL, consistent with a direct role of ABCG1 in cellular cholesterol transport.	Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Vaughan, AM (corresponding author), Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA.	smashie@u.washington.edu			NHLBI NIH HHS [HL-18645, HL-55362] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055362, P01HL018645] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aiello RJ, 2003, ARTERIOSCL THROM VAS, V23, P972, DOI 10.1161/01.ATV.0000054661.21499.FB; Annilo T, 2001, CYTOGENET CELL GENET, V94, P196, DOI 10.1159/000048816; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; CORTI MC, 1995, JAMA-J AM MED ASSOC, V274, P539, DOI 10.1001/jama.274.7.539; Costet P, 2000, J BIOL CHEM, V275, P28240; Croop JM, 1997, GENE, V185, P77, DOI 10.1016/S0378-1119(96)00633-6; Cserepes J, 2004, BIOCHEM BIOPH RES CO, V320, P860, DOI 10.1016/j.bbrc.2004.06.037; Engel T, 2001, BIOCHEM BIOPH RES CO, V288, P483, DOI 10.1006/bbrc.2001.5756; Escher G, 2003, J BIOL CHEM, V278, P11015, DOI 10.1074/jbc.M212780200; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Garrigues A, 2002, P NATL ACAD SCI USA, V99, P10347, DOI 10.1073/pnas.162366399; Glomset J A, 1980, Adv Intern Med, V25, P91; Goldbourt U, 1997, ARTERIOSCL THROM VAS, V17, P107, DOI 10.1161/01.ATV.17.1.107; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Graf GA, 2004, J BIOL CHEM, V279, P24881, DOI 10.1074/jbc.M402634200; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Kennedy MA, 2001, J BIOL CHEM, V276, P39438, DOI 10.1074/jbc.M105863200; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; LANGE Y, 1993, J BIOL CHEM, V268, P13838; Langmann T, 2000, BBA-GENE STRUCT EXPR, V1494, P175, DOI 10.1016/S0167-4781(00)00215-3; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Lorkowski S, 2001, BIOCHEM BIOPH RES CO, V280, P121, DOI 10.1006/bbrc.2000.4089; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; MENDEZ AJ, 1994, J CLIN INVEST, V94, P1698, DOI 10.1172/JCI117515; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; MILLER NE, 1977, LANCET, V1, P965, DOI 10.1016/S0140-6736(77)92274-7; Nakamura K, 2004, J BIOL CHEM, V279, P45980, DOI 10.1074/jbc.M408652200; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; O'Connell BJ, 2004, CIRCULATION, V110, P2881, DOI 10.1161/01.CIR.0000146333.20727.2B; Oldfield S, 2002, BBA-MOL CELL RES, V1591, P175, DOI 10.1016/S0167-4889(02)00269-0; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Vaisman BL, 2001, J CLIN INVEST, V108, P303; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; WILSON PWF, 1988, ARTERIOSCLEROSIS, V8, P737, DOI 10.1161/01.ATV.8.6.737; XU XX, 1991, J BIOL CHEM, V266, P17040; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD	50	212	223	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30150	30157		10.1074/jbc.M505368200	http://dx.doi.org/10.1074/jbc.M505368200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15994327	hybrid			2022-12-27	WOS:000231362500022
J	Potter, BM; Feng, LS; Parasuram, P; Matskevich, VA; Wilson, JA; Andrews, GK; Laity, JH				Potter, BM; Feng, LS; Parasuram, P; Matskevich, VA; Wilson, JA; Andrews, GK; Laity, JH			The six zinc fingers of metal-responsive element binding transcription factor-1 form stable and quasi-ordered structures with relatively small differences in zinc affinities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETERONUCLEAR NMR-SPECTROSCOPY; MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; DNA-BINDING; BACKBONE DYNAMICS; FACTOR MTF-1; METALLOTHIONEIN GENE; CHEMICAL-SHIFT; FUNCTIONAL-HETEROGENEITY; FACTOR IIIA	Six Cys(2)His(2) zinc fingers ( F1-6) comprise the DNA binding domain of metal-responsive element binding transcription factor-1 ( MTF-1). F1-6 is necessary for basal and zinc-induced expression of metallothionein genes. Analysis of NMR structural and dynamic data for an F1-6 protein construct demonstrates that each zinc finger adopts a stable beta beta alpha fold in the presence of stoichiometric Zn( II), provided that all cysteine ligands are in a reduced state. Parallel studies of protein constructs spanning the four N-terminal core DNA binding fingers ( F1-4) and two C-terminal low DNA affinity fingers ( F5-6) reveal similar stable zinc finger structures. In both the F1-6 and F5-6 proteins, the finger 5 cysteines were found to readily oxidize at neutral pH. Detailed spectral density and hydrodynamic analysis of N-15 relaxation data revealed quasi-ordered anisotropic rotational diffusion properties of the six F1-6 zinc fingers that could influence MTF-1 DNA binding function. A more general effect on the rotational diffusion properties of Cys2His2 zinc fingers was also uncovered that is dependent upon the position of each finger within multifinger domains. Analysis of NMR H-1-N-15-heteronuclear single quantum coherence spectral peak intensities measured as a function of added Zn( II) in conjunction with Zn( II) binding modeling studies indicated that the Zn( II) affinities of all MTF-1 zinc fingers are within similar to 10-50-fold. These analyses further suggested that metal sensing by MTF-1 in eukaryotic cells involves multiple zinc fingers and occurs over a 100-fold or less range of accessible Zn( II) concentration.	UMKC, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA; Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	University of Missouri System; University of Missouri Kansas City; University of Kansas; University of Kansas Medical Center	Laity, JH (corresponding author), UMKC, Sch Biol Sci, Div Cell Biol & Biophys, 103 BSB,5007 Rockhill Rd, Kansas City, MO 64110 USA.	laityj@umkc.edu	Matskevich, Viktor A/AAL-7806-2021		NIEHS NIH HHS [ES05704] Funding Source: Medline	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Andrews GK, 2001, BIOMETALS, V14, P223, DOI 10.1023/A:1012932712483; Apuy JL, 2001, BIOCHEMISTRY-US, V40, P15164, DOI 10.1021/bi0112208; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BERG JM, 1989, J AM CHEM SOC, V111, P3759, DOI 10.1021/ja00192a050; Bird AJ, 2003, EMBO J, V22, P5137, DOI 10.1093/emboj/cdg484; Bittel D, 1998, J BIOL CHEM, V273, P7127, DOI 10.1074/jbc.273.12.7127; Bittel DC, 2000, J BIOL CHEM, V275, P37194, DOI 10.1074/jbc.M003863200; Blasie CA, 2002, BIOCHEMISTRY-US, V41, P15068, DOI 10.1021/bi026621h; BRAUN D, 1994, J AM CHEM SOC, V116, P8466, DOI 10.1021/ja00098a005; BRUGNERA E, 1994, NUCLEIC ACIDS RES, V22, P3167, DOI 10.1093/nar/22.15.3167; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; Chen WY, 2002, BIOCHEM BIOPH RES CO, V291, P798, DOI 10.1006/bbrc.2002.6517; Chen XH, 2004, J BIOL CHEM, V279, P4515, DOI 10.1074/jbc.M308924200; Chen XH, 1999, BIOCHEMISTRY-US, V38, P12915, DOI 10.1021/bi9913000; Chen XH, 1998, BIOCHEMISTRY-US, V37, P11152, DOI 10.1021/bi980843r; CORNELL NW, 1972, ANAL BIOCHEM, V47, P203, DOI 10.1016/0003-2697(72)90293-X; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CULOTTA VC, 1989, MOL CELL BIOL, V9, P1376, DOI 10.1128/MCB.9.3.1376; Dalton TP, 1997, MOL CELL BIOL, V17, P2781, DOI 10.1128/MCB.17.5.2781; Dalton TP, 2000, COMP BIOCHEM PHYS B, V126, P325, DOI 10.1016/S0305-0491(00)00182-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; FARROW NA, 1995, BIOCHEMISTRY-US, V34, P868, DOI 10.1021/bi00003a021; Foster MP, 1997, NAT STRUCT BIOL, V4, P605, DOI 10.1038/nsb0897-605; Foster MP, 1998, J BIOMOL NMR, V12, P51, DOI 10.1023/A:1008290631575; FUSHMAN D, 1994, J BIOMOL NMR, V4, P61, DOI 10.1007/BF00178336; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Giedroc DP, 2001, J BIOL CHEM, V276, P42322, DOI 10.1074/jbc.M106517200; GRONENBORN AM, 1994, J BIOMOL NMR, V4, P455; Guerrerio AL, 2004, BIOCHEMISTRY-US, V43, P5437, DOI 10.1021/bi0358418; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Hyre DE, 1998, J MOL BIOL, V279, P929, DOI 10.1006/jmbi.1998.1811; Jiang HM, 2003, J BIOL CHEM, V278, P30394, DOI 10.1074/jbc.M303598200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Koizumi S, 2000, J CELL PHYSIOL, V185, P464, DOI 10.1002/1097-4652(200012)185:3<464::AID-JCP18>3.0.CO;2-4; KRIZEK BA, 1991, J AM CHEM SOC, V113, P4518, DOI 10.1021/ja00012a021; KRIZEK BA, 1993, PROTEIN SCI, V2, P1313, DOI 10.1002/pro.5560020814; Laity JH, 2000, P NATL ACAD SCI USA, V97, P11932, DOI 10.1073/pnas.97.22.11932; Laity JH, 2000, J MOL BIOL, V295, P719, DOI 10.1006/jmbi.1999.3406; LAITY JH, 2004, HDB METALLOPROTEINS, P307; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; Leopold M. F., 1994, Molecular Biotechnology, V2, P61, DOI 10.1007/BF02789290; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Maur AAD, 1999, BIOL CHEM, V380, P175, DOI 10.1515/BC.1999.026; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; OTSUKA F, 1994, J BIOL CHEM, V269, P23700; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Palmer AG, 2001, ANNU REV BIOPH BIOM, V30, P129, DOI 10.1146/annurev.biophys.30.1.129; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PELTON JG, 1995, ANNU REV PHYS CHEM, V46, P139; Peng JW, 1995, BIOCHEMISTRY-US, V34, P16733, DOI 10.1021/bi00051a023; POTTER BM, 2005, IN PRESS J BIOMOL NM; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; STUART GW, 1984, P NATL ACAD SCI-BIOL, V81, P7318, DOI 10.1073/pnas.81.23.7318; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Volkman BF, 1998, BIOCHEMISTRY-US, V37, P10906, DOI 10.1021/bi980810b; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuttke DS, 1997, J MOL BIOL, V273, P183, DOI 10.1006/jmbi.1997.1291; Zhang B, 2001, MOL CELL BIOL, V21, P4505, DOI 10.1128/MCB.21.14.4505-4514.2001; [No title captured]	72	38	39	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2005	280	31					28529	28540		10.1074/jbc.M505217200	http://dx.doi.org/10.1074/jbc.M505217200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	950KZ	16055450	hybrid			2022-12-27	WOS:000230857300043
J	Berquin, IM; Min, YN; Wu, RP; Wu, H; Chen, YQ				Berquin, IM; Min, YN; Wu, RP; Wu, H; Chen, YQ			Expression signature of the mouse prostate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROGEN-REGULATED EXPRESSION; GENE-EXPRESSION; SECRETORY PROTEIN; COMPLEMENTARY-DNA; SERINE-PROTEASE; SEMINAL-VESICLE; MICE LACKING; CANCER; FIBROBLASTS; HYPERPLASIA	Genetically engineered mice are being used increasingly for delineating the molecular mechanisms of prostate cancer development. Epithelium-stroma interactions play a critical role in prostate development and tumorigenesis. To better understand gene expression patterns in the normal sexually mature mouse prostate, epithelium and stroma were laser-capture microdissected from ventral, dorsolateral, and anterior prostate lobes. Genome-wide expression was measured by DNA microarrays. Our analysis indicated that the gene expression pattern in the mouse dorsolateral lobe was closest to that of the human prostate peripheral zone, supporting the hypothesis that these prostate compartments are functionally equivalent. Stroma from a given lobe had closer gene expression patterns with stroma from other lobes than epithelium from the same lobe. Stroma appeared to have higher expression complexity than epithelium. Specifically, stromal cells had higher expression levels of genes implicated in cell adhesion, muscle development, and contraction, in structural constituents of cytoskeleton and actin binding, and in components such as sarcomere and extracellular matrix collagen. Among the genes that were enriched in the epithelium were secretory proteins, including seminal vesicle protein secretion 2 and 5. Surprisingly, prostate stroma expressed many osteogenic molecules, as confirmed by immunohistochemistry. A "bone-like" environment in the prostate may predispose prostate cells for survival in the bone. Chemokine Cxcl12 but not its receptor, Cxcr4, was expressed in normal prostate. In prostate tumors, interestingly, Cxcl12 was up-regulated in epithelial cells with a concomitant expression of Cxcr4. Expression of both the receptor and ligand may provide an autocrine mechanism for tumor cell migration and invasion.	Wake Forest Univ Hlth Sci, Dept Canc Biol, Winston Salem, NC 27157 USA; Wake Forest Univ Hlth Sci, Dept Pathol, Winston Salem, NC 27157 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chen, YQ (corresponding author), Wake Forest Univ Hlth Sci, Dept Canc Biol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	yqchen@wfubmc.edu	Chen, Yong Q/AAI-9864-2021	Chen, Yong Q/0000-0003-4747-4708	NATIONAL CANCER INSTITUTE [R01CA107668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011124] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA107668] Funding Source: Medline; NIEHS NIH HHS [R01ES11124] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abate-Shen Cory, 2002, Trends Genet, V18, pS1, DOI 10.1016/S0168-9525(02)02683-5; Abbott DE, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r79; BENTZ H, 1989, J BIOL CHEM, V264, P20805; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Brekken RA, 2003, J CLIN INVEST, V111, P487, DOI 10.1172/JCI200316804; Bubendorf L, 1999, J NATL CANCER I, V91, P1758, DOI 10.1093/jnci/91.20.1758; Chen LL, 1998, BIOL REPROD, V59, P1498, DOI 10.1095/biolreprod59.6.1498; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; Delany AM, 2000, J CLIN INVEST, V105, P915, DOI 10.1172/JCI7039; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Economides KD, 2003, DEVELOPMENT, V130, P2061, DOI 10.1242/dev.00432; Epstein RJ, 2004, NAT REV CANCER, V4, P901, DOI 10.1038/nrc1473; HO KC, 1992, J BIOL CHEM, V267, P12660; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kasper S, 2004, J UROLOGY, V172, P12, DOI 10.1097/01.ju.0000132122.93436.aa; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; Kwong J, 2003, PROSTATE, V56, P81, DOI 10.1002/pros.10228; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Lin BY, 1999, CANCER RES, V59, P4180; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Luo J, 2001, CANCER RES, V61, P4683; Magee JA, 2001, CANCER RES, V61, P5692; MCDONALD CJ, 1984, EMBO J, V3, P2517, DOI 10.1002/j.1460-2075.1984.tb02166.x; MCNEAL JE, 1969, CANCER, V23, P24, DOI 10.1002/1097-0142(196901)23:1<24::AID-CNCR2820230103>3.0.CO;2-1; MILLS JS, 1987, NUCLEIC ACIDS RES, V15, P7709, DOI 10.1093/nar/15.19.7709; MILLS JS, 1987, MOL CELL ENDOCRINOL, V53, P111, DOI 10.1016/0303-7207(87)90197-3; Mirosevich J, 2005, PROSTATE, V62, P339, DOI 10.1002/pros.20131; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nelson PS, 2000, NUCLEIC ACIDS RES, V28, P212, DOI 10.1093/nar/28.1.212; PRICE DOROTHY, 1963, NATL CANCER INST MONOGR, V12, P1; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sakr WA, 1998, ANAL QUANT CYTOL, V20, P417; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sung SY, 2002, DIFFERENTIATION, V70, P506, DOI 10.1046/j.1432-0436.2002.700905.x; Taichman RS, 2002, CANCER RES, V62, P1832; Takayama TK, 2001, BIOCHEMISTRY-US, V40, P15341, DOI 10.1021/bi015775e; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Thota A, 2003, J CELL BIOCHEM, V88, P999, DOI 10.1002/jcb.10425; Waghray A, 2002, J BIOL CHEM, V277, P11533, DOI 10.1074/jbc.M109557200; Waghray A, 2001, CANCER RES, V61, P4283; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Welsh JB, 2001, CANCER RES, V61, P5974; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Zhao RB, 1999, DEV BIOL, V212, P68, DOI 10.1006/dbio.1999.9326	53	90	91	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2005	280	43					36442	36451		10.1074/jbc.M504945200	http://dx.doi.org/10.1074/jbc.M504945200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	976IM	16055444	hybrid			2022-12-27	WOS:000232726900078
J	Sarrias, MR; Rosello, S; Sanchez-Barbero, F; Sierra, JM; Vila, J; Yelamos, J; Vives, J; Casals, C; Lozano, F				Sarrias, MR; Rosello, S; Sanchez-Barbero, F; Sierra, JM; Vila, J; Yelamos, J; Vives, J; Casals, C; Lozano, F			A role for human SP alpha as a pattern recognition receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-BINDING CHARACTERISTICS; BACTERIA-BINDING; MACROPHAGE SURVIVAL; MOLECULAR-CLONING; SRCR DOMAIN; PROTEIN; MEMBER; FAMILY; ANCIENT; ANTIGEN	Human Sp alpha is a soluble protein belonging to group B of the scavenger receptor cysteine- rich ( SRCR) superfamily for which little functional information is available. It is expressed by macrophages present in lymphoid tissues ( spleen, lymph node, thymus, and bone marrow), and it binds to myelomonocytic and lymphoid cells, which suggests that it may play an important role in the regulation of the innate and adaptive immune systems. In the present study we show that recombinant human Sp alpha( rSp alpha) binds to the surface of several Gram- positive and Gram- negative bacterial strains. Competition studies indicated that such binding is mediated by the recognition of lipoteichoic acid ( LTA) and lipopolysaccharide ( LPS), respectively, through nonoverlapping sites on the Sp alpha molecule. The most conserved part of LPS ( 2- keto- 3- deoxyoctulosonic acid and lipid A) was shown to be involved in the recognition by Sp alpha. Bacterial binding studies using the SRCR domain 1 of Sp alpha showed that this domain retains both the LPS and LTA binding activities, indicating that both bacterial interacting sites are retained in a single SRCR domain. Furthermore, rSp alpha induced aggregation of Gram- positive and Gram- negative bacteria strains. On the other hand, rSp alpha inhibited tumor necrosis factor-alpha secretion by human monocytes stimulated with LPS or LTA. Binding of Sp alpha to conserved components of bacterial surfaces and modulation of the monocyte response indicate that this molecule is an active constituent of the innate immune response of the host.	Hosp Clin Barcelona, Serv Immunol, Inst Invest Biomed August Pi & Sunyer, Barcelona 08036, Spain; Hosp Clin Barcelona, Microbiol Serv, Inst Invest Biomed August Pi & Sunyer, Barcelona 08036, Spain; Univ Murcia, Dept Bioquim Biol Mol & Inmunol, E-30100 Murcia, Spain; Univ Complutense Madrid, Fac Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Murcia; Complutense University of Madrid	Lozano, F (corresponding author), Hosp Clin Barcelona, Serv Immunol, Villarroel 170, Barcelona 08036, Spain.	lozano@ub.edu	Sierra, Josep M/O-3429-2014; Vila, Jordi/P-3613-2016; Lozano-Soto, Francisco/AAB-7930-2019; Casals, Cristina/H-4658-2015; LOZANO, FRANCISCO/AAB-7888-2019; Yelamos, Jose/N-2842-2016; sarrias, maria rosa/D-6205-2014	Sierra, Josep M/0000-0002-0997-5619; Vila, Jordi/0000-0002-8025-3926; Lozano-Soto, Francisco/0000-0003-3714-2304; Casals, Cristina/0000-0003-2696-0918; LOZANO, FRANCISCO/0000-0003-1119-4368; sarrias, maria rosa/0000-0001-6929-8069; Yelamos, Jose/0000-0003-1195-1496				ARUFFO A, 1991, J EXP MED, V174, P949, DOI 10.1084/jem.174.4.949; Aruffo A, 1997, IMMUNOL TODAY, V18, P498, DOI 10.1016/S0167-5699(97)01130-4; Bikker FJ, 2004, J BIOL CHEM, V279, P47699, DOI 10.1074/jbc.M406095200; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; Brannstrom A, 2002, BIOCHEM BIOPH RES CO, V290, P1462, DOI 10.1006/bbrc.2002.6378; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Carlen A, 1998, J DENT RES, V77, P81, DOI 10.1177/00220345980770011301; DUNNE DW, 1994, P NATL ACAD SCI USA, V91, P1863, DOI 10.1073/pnas.91.5.1863; Elomaa O, 1998, J BIOL CHEM, V273, P4530, DOI 10.1074/jbc.273.8.4530; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; FREEMAN M, 1990, P NATL ACAD SCI USA, V87, P8810, DOI 10.1073/pnas.87.22.8810; GARCIAVERDUGO I, 2005, IN PRESS BIOCH J; Gebe JA, 1997, J BIOL CHEM, V272, P6151, DOI 10.1074/jbc.272.10.6151; Gebe JA, 2000, IMMUNOLOGY, V99, P78, DOI 10.1046/j.1365-2567.2000.00903.x; Gimferrer I, 2003, J BIOL CHEM, V278, P8564, DOI 10.1074/jbc.M209591200; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Haruta I, 2001, J BIOL CHEM, V276, P22910, DOI 10.1074/jbc.M100324200; Hohenester E, 1999, NAT STRUCT BIOL, V6, P228, DOI 10.1038/6669; Holmskov U, 1999, P NATL ACAD SCI USA, V96, P10794, DOI 10.1073/pnas.96.19.10794; JONES NH, 1986, NATURE, V323, P346, DOI 10.1038/323346a0; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; KOTHS K, 1993, J BIOL CHEM, V268, P14245; Kuwata Kazuhisa, 2004, Comp Hepatol, V3 Suppl 1, pS44, DOI 10.1186/1476-5926-2-S1-S44; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; Liu Y, 2001, TRENDS IMMUNOL, V22, P227, DOI 10.1016/S1471-4906(01)01902-0; Madsen J, 2003, EUR J IMMUNOL, V33, P2327, DOI 10.1002/eji.200323972; Miyazaki T, 1999, J EXP MED, V189, P413, DOI 10.1084/jem.189.2.413; NISCHT R, 1991, EUR J BIOCHEM, V200, P529, DOI 10.1111/j.1432-1033.1991.tb16214.x; Padilla O, 2002, IMMUNOGENETICS, V54, P621, DOI 10.1007/s00251-002-0507-z; PATEL DD, 1995, J EXP MED, V181, P1563, DOI 10.1084/jem.181.4.1563; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Sarrias MR, 2004, TISSUE ANTIGENS, V63, P335, DOI 10.1111/j.0001-2815.2004.00193.x; Tissot JD, 2002, ELECTROPHORESIS, V23, P1203, DOI 10.1002/1522-2683(200204)23:7/8<1203::AID-ELPS1203>3.0.CO;2-1; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; WIJNGAARD PLJ, 1992, J IMMUNOL, V149, P3273	37	87	98	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2005	280	42					35391	35398		10.1074/jbc.M505042200	http://dx.doi.org/10.1074/jbc.M505042200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973ZN	16030018	Green Published, hybrid			2022-12-27	WOS:000232561200038
J	Yin, SP; Li, XH; Meng, YH; Finley, RL; Sakr, W; Yang, H; Reddy, N; Sheng, SJ				Yin, SP; Li, XH; Meng, YH; Finley, RL; Sakr, W; Yang, H; Reddy, N; Sheng, SJ			Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR; HUMAN BREAST; EXPRESSION; ANGIOGENESIS; METASTASIS; DROSOPHILA; APOPTOSIS; MAMMARY; PROTEIN; SERPIN	Maspin, a novel serine protease inhibitor, suppresses tumor progression in several cancer models, including an in vivo model for prostate cancer bone metastasis. However, the molecular mechanism of maspin remains illusive, primarily because its molecular targets are unknown. To this end, we used a full-length maspin cDNA bait to screen against both a primary prostate tumor cDNA prey library and a HeLa cDNA prey library by the yeast two-hybrid method. We found that heat shock protein 90, glutathione S-transferase (GST), and heat shock protein 70 interacted with maspin with the highest frequencies. We confirmed the maspin/GST interaction using purified proteins, human epithelial cell lines, and human prostate tissues. A maspin variant that has a point mutation of Arg(340) to Ala (Mas(R340A)) showed a significantly decreased affinity for GST. Although purified maspin had no effect on the activity of purified GST in vitro, intracellular interaction between endogenous maspin and GST correlated with an elevated total GST activity in both MDA-MB-435- and DU145-derived stably transfected cells. Consistently, tumor cells treated with purified wild type maspin, but not Mas(R340A), enhanced cellular GST activity. Maspin expression in cancer cell lines also correlated with decreased basal levels of reactive oxygen species (ROS). Furthermore, H2O2 treatment not only induced GST expression but also increased intracellular maspin/GST interaction, which was inversely correlated with the level of ROS generation. Conversely, maspin knockdown by small interfering RNA increased the basal, as well as H2O2-induced, ROS generation. Furthermore, the maspin effect on ROS generation was completely abolished by a GST inhibitor, indicating an essential role of GST in maspin-mediated cellular response to oxidative stress. Consistently, oxidative stress-induced vascular endothelial growth factor A expression was significantly inhibited in maspin-expressing cells. Together, our data suggest a new mechanism by which maspin, through its direct interaction with GST, may inhibit oxidative stress-induced ROS generation and vascular endothelial growth factor A induction, thus preventing further adverse effects on tumor genetics and stromal reactivity.	Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Protease Program, Karmanos Canc Inst, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Sheng, SJ (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, 540 E Canfield Ave, Detroit, MI 48201 USA.	ssheng@med.wayne.edu	Li, Xiaohua/AAW-4713-2021	Li, Xiaohua/0000-0003-3490-916X; Finley, Russ/0000-0003-1144-6887	NCI NIH HHS [CA84176] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084176] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Ayyoubi M, 2004, J BIOL CHEM, V279, P55540, DOI 10.1074/jbc.M409957200; AUSUBEL QM, 1998, CURRENT PROTOCOLS MO; Biliran H, 2001, CANCER RES, V61, P8676; Blacque OE, 2002, J BIOL CHEM, V277, P10783, DOI 10.1074/jbc.M110992200; Cher ML, 2003, P NATL ACAD SCI USA, V100, P7847, DOI 10.1073/pnas.1331360100; Choi KS, 2003, J BIOCHEM MOL BIOL, V36, P120; Dachs GU, 2000, EUR J CANCER, V36, P1649, DOI 10.1016/S0959-8049(00)00159-3; FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980; FINLEY RL, 1995, DNA CLONING EXPRESSI, P169; Gaikwad A, 2005, CLIN CANCER RES, V11, P1953, DOI 10.1158/1078-0432.CCR-04-1704; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Habdous M, 2002, CLIN CHIM ACTA, V326, P131, DOI 10.1016/S0009-8981(02)00329-7; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hojo T, 2001, CANCER LETT, V171, P103, DOI 10.1016/S0304-3835(01)00569-9; Jiang N, 2002, ONCOGENE, V21, P4089, DOI 10.1038/sj.onc.1205507; Jones EL, 2004, INT J HYPERTHER, V20, P835, DOI 10.1080/02656730410001721807; Kolonin MG, 2000, DEV BIOL, V227, P661, DOI 10.1006/dbio.2000.9916; Kolonin MG, 1998, P NATL ACAD SCI USA, V95, P14266, DOI 10.1073/pnas.95.24.14266; Kolonin MG, 2000, METHOD ENZYMOL, V328, P26, DOI 10.1016/S0076-6879(00)28388-2; Latha K, 2005, MOL CELL BIOL, V25, P1737, DOI 10.1128/MCB.25.5.1737-1748.2005; Lefter LP, 2003, CLIN CANCER RES, V9, P5044; Li ZG, 2005, ONCOGENE, V24, P2008, DOI 10.1038/sj.onc.1208449; Liu JY, 2004, CANCER RES, V64, P1703, DOI 10.1158/0008-5472.CAN-03-2568; Maulik N, 2002, FREE RADICAL BIO MED, V33, P1047, DOI 10.1016/S0891-5849(02)01005-5; Maulik N, 2002, ANTIOXID REDOX SIGN, V4, P783, DOI 10.1089/152308602760598927; McGowen R, 2000, CANCER RES, V60, P4771; Muller P, 2005, J BIOL CHEM, V280, P6682, DOI 10.1074/jbc.M412767200; PEMBERTON PA, 1995, J BIOL CHEM, V270, P15832, DOI 10.1074/jbc.270.26.15832; Perquin M, 2000, CANCER LETT, V158, P7, DOI 10.1016/S0304-3835(00)00481-X; Pierson CR, 2002, PROSTATE, V53, P255, DOI 10.1002/pros.10107; ROBINSON JP, 1997, CURRENT PROTOCOLS CH; Seifried HE, 2003, CANCER RES, V63, P4295; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; Sheng SJ, 2004, FRONT BIOSCI-LANDMRK, V9, P2733, DOI 10.2741/1432; SHENG SJ, 1994, J BIOL CHEM, V269, P30988; Shi HY, 2003, HISTOL HISTOPATHOL, V18, P201, DOI 10.14670/HH-18.201; Shi HY, 2001, CANCER RES, V61, P6945; Song SY, 2002, DIGEST DIS SCI, V47, P1831, DOI 10.1023/A:1016409031562; Thomas BJ, 1997, GENE DEV, V11, P1289, DOI 10.1101/gad.11.10.1289; Toussaint-Smith E, 2004, ONCOGENE, V23, P2988, DOI 10.1038/sj.onc.1207442; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Vanden Berghe T, 2003, J BIOL CHEM, V278, P5622, DOI 10.1074/jbc.M208925200; Zhang M, 2000, ONCOGENE, V19, P6053, DOI 10.1038/sj.onc.1204006; Zou ZQ, 2002, CLIN CANCER RES, V8, P1172; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	45	67	70	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34985	34996		10.1074/jbc.M503522200	http://dx.doi.org/10.1074/jbc.M503522200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16049007	hybrid			2022-12-27	WOS:000232403900072
J	Bartl, FJ; Fritze, O; Ritter, E; Herrmann, R; Kuksa, V; Palczewski, K; Hofmann, KP; Ernst, OP				Bartl, FJ; Fritze, O; Ritter, E; Herrmann, R; Kuksa, V; Palczewski, K; Hofmann, KP; Ernst, OP			Partial agonism in a g protein-coupled receptor - Role of the retinal ring structure in rhodopsin activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-IONONE RING; METARHODOPSIN-II; FTIR SPECTROSCOPY; SIGNALING STATES; BOVINE RHODOPSIN; VISUAL PIGMENTS; BINDING-SITES; PROTON UPTAKE; GROUND-STATE; OPSIN	The visual process in rod cells is initiated by absorption of a photon in the rhodopsin retinal chromophore and consequent retinal cis/trans-isomerization. The ring structure of retinal is thought to be needed to transmit the photonic energy into conformational changes culminating in the active metarhodopsin II ( Meta II) intermediate. Here, we demonstrate that cis-acyclic retinals, lacking four carbon atoms of the ring, can activate rhodopsin. Detailed analysis of the activation pathway showed that, although the photoproduct pathway is more complex, Meta II formed with almost normal kinetics. However, lack of the ring structure resulted in a low amount of Meta II and a fast decay of activity. We conclude that the main role of the ring structure is to maintain the active state, thus specifying a mechanism of activation by a partial agonist of the G protein-coupled receptor rhodopsin.	Charite Univ Med Berlin, Inst Med Phys & Biophys, D-10098 Berlin, Germany; Humboldt Univ, Zentrum Biophys & Bioinformat, D-10015 Berlin, Germany; Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bartl, FJ (corresponding author), Charite Univ Med Berlin, Inst Med Phys & Biophys, Schumannstr 20-21, D-10098 Berlin, Germany.	franz.bartl@charite.de; oliver.ernst@charite.de						ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; ARNIS S, 1994, J BIOL CHEM, V269, P23879; Bartl F, 2000, FEBS LETT, V473, P259, DOI 10.1016/S0014-5793(00)01544-1; Bartl FJ, 2001, J BIOL CHEM, V276, P30161, DOI 10.1074/jbc.M101506200; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; Buczylko J, 1996, J BIOL CHEM, V271, P20621, DOI 10.1074/jbc.271.34.20621; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; CROUCH R, 1983, FEBS LETT, V158, P139, DOI 10.1016/0014-5793(83)80694-2; CROUCH RK, 1982, J AM CHEM SOC, V104, P4946, DOI 10.1021/ja00382a035; DeGrip W. J., 2000, HDB BIOL PHYS, P1, DOI 10.1016/s1383- 8121(00)80004- 4; FARAHBAKHSH ZT, 1993, SCIENCE, V262, P1416, DOI 10.1126/science.8248781; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Heck M, 2003, VISION RES, V43, P3003, DOI 10.1016/j.visres.2003.08.011; Herrmann R, 2004, J BIOL CHEM, V279, P24283, DOI 10.1074/jbc.M311166200; Hofmann K. P., 2000, HDB BIOL PHYSICS, P91, DOI 10.1016/s1383-8121(00)80006-8; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; JAGER F, 1994, BIOCHEMISTRY-US, V33, P7389; JAGER F, 1994, BIOCHEMISTRY-US, V33, P10878; Karnaukhova E, 1999, BIOORG CHEM, V27, P372, DOI 10.1006/bioo.1999.1146; KIBELBEK J, 1991, BIOCHEMISTRY-US, V30, P6761, DOI 10.1021/bi00241a019; Kuksa V, 2002, J BIOL CHEM, V277, P42315, DOI 10.1074/jbc.M206014200; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lou JH, 2000, METHOD ENZYMOL, V315, P219; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Meyer CK, 2000, J BIOL CHEM, V275, P19713, DOI 10.1074/jbc.M000603200; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PARKES JH, 1984, BIOCHEMISTRY-US, V23, P5054, DOI 10.1021/bi00316a035; Patel AB, 2004, P NATL ACAD SCI USA, V101, P10048, DOI 10.1073/pnas.0402848101; Ritter E, 2004, J BIOL CHEM, V279, P48102, DOI 10.1074/jbc.M406857200; Scheer A, 1997, P NATL ACAD SCI USA, V94, P808, DOI 10.1073/pnas.94.3.808; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Siebert F, 1995, ISRAEL J CHEM, V35, P309; Spooner PJR, 2004, J MOL BIOL, V343, P719, DOI 10.1016/j.jmb.2004.08.049; Spooner PJR, 2003, BIOCHEMISTRY-US, V42, P13371, DOI 10.1021/bi0354029; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Vogel R, 2000, BIOCHEMISTRY-US, V39, P8895, DOI 10.1021/bi000852b; Vogel R, 2001, BIOCHEMISTRY-US, V40, P13342, DOI 10.1021/bi0113667	42	42	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34259	34267		10.1074/jbc.M505260200	http://dx.doi.org/10.1074/jbc.M505260200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16027155	hybrid			2022-12-27	WOS:000232229700068
J	Austin, M; Cook, SJ				Austin, M; Cook, SJ			Increased expression of Mcl-1 is required for protection against serum starvation in phosphatase and tensin homologue on chromosome 10 null mouse embryonic fibroblasts, but repression of bim is favored in human glioblastomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY-MEMBER; FORKHEAD TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR PTEN; HUMAN GLIOMA-CELLS; SIGNALING PATHWAY; NEUTROPHIL APOPTOSIS; NEURONAL SURVIVAL; MALIGNANT GLIOMA; CYCLE ARREST; CANCER CELLS	Inactivating mutations in the tumor suppressor gene phosphatase and tensin homologue on chromosome 10 ( PTEN) result in elevated levels of phosphatidylinositol (3,4,5)-trisphosphate, activation of protein kinase B (PKB), and protection against apoptotic insults such as withdrawal of survival factors. Protection may arise through the inhibition of the pro-apoptotic protein Bim, which is normally repressed by a PKB-dependent mechanism. Here we show that PTEN-/- immortalized mouse embryonic fibroblasts (MEFs) exhibit elevated PKB phosphorylation and are resistant to serum withdrawal-induced death, but exhibit normal Bim expression following withdrawal of serum. In contrast, expression of Mcl-1, a prosurvival member of the Bcl-2 family, was elevated in PTEN-/- MEFs. Transient or stable overexpression of Mcl-1 in PTEN+/- MEFs conferred resistance to serum withdrawal, whereas ablating expression of Mcl-1 in PTEN-/- MEFs, using RNA interference, abolished their resistance to serum withdrawal-induced apoptosis. To determine if Mcl-1 is selected for overexpression in human tumors we examined human glioblastoma cell lines but found that loss of PTEN had no effect on Mcl-1 expression. In contrast, two of three PTEN-/- glioblastoma cell lines exhibited low expression of Bim, which was refractory to serum withdrawal. These results indicate that the resistance of PTEN-/- MEFs to serum withdrawal is largely due to the up-regulation of Mcl-1 but that loss of PTEN in tumor cell lines is more complex and may favor de-regulation of different apoptotic regulators such as Bim.	Babraham Inst, Mol Signalling Lab, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Austin, M (corresponding author), Babraham Inst, Mol Signalling Lab, Babraham Res Campus, Cambridge CB2 4AT, England.	mark.austin@bbsrc.ac.uk; simon.cook@bbsrc.ac.uk		Austin, Mark/0000-0003-4943-7265	Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H457, BBS/E/B/0000C199, BBS/E/B/0000H151] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies MA, 1998, CANCER RES, V58, P5285; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Edwards SW, 2004, BIOCHEM SOC T, V32, P489, DOI 10.1042/BST0320489; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Figueroa C, 2003, J BIOL CHEM, V278, P47922, DOI 10.1074/jbc.M307357200; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Garner AP, 2002, ONCOGENE, V21, P8089, DOI 10.1038/sj.onc.1206000; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kim AH, 2002, NEURON, V35, P697, DOI 10.1016/S0896-6273(02)00821-8; Kuo ML, 2001, ONCOGENE, V20, P677, DOI 10.1038/sj.onc.1204140; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Li J, 1998, CANCER RES, V58, P5667; Liu HT, 2001, J EXP MED, V194, P113, DOI 10.1084/jem.194.2.113; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Marani M, 2004, ONCOGENE, V23, P2431, DOI 10.1038/sj.onc.1207364; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Moulding DA, 2000, BLOOD, V96, P1756, DOI 10.1182/blood.V96.5.1756.h8001756_1756_1763; Moulding DA, 2001, J LEUKOCYTE BIOL, V70, P783; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Okaro AC, 2001, J CLIN PATHOL, V54, P927, DOI 10.1136/jcp.54.12.927; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; REYNOLDS JE, 1994, CANCER RES, V54, P6348; Schubert KM, 2001, BIOCHEM J, V356, P473, DOI 10.1042/0264-6021:3560473; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stiles B, 2002, MOL CELL BIOL, V22, P3842, DOI 10.1128/MCB.22.11.3842-3851.2002; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Tashiro H, 1997, CANCER RES, V57, P3935; Tian XX, 1999, J NEUROPATH EXP NEUR, V58, P472, DOI 10.1097/00005072-199905000-00006; Wagenknecht B, 1999, CELL DEATH DIFFER, V6, P370, DOI 10.1038/sj.cdd.4400503; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Weng LP, 2001, HUM MOL GENET, V10, P251, DOI 10.1093/hmg/10.3.251; Weston CR, 2003, ONCOGENE, V22, P1281, DOI 10.1038/sj.onc.1206261; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Yamada KM, 2001, J CELL SCI, V114, P2375; Zhao H, 2004, ONCOGENE, V23, P786, DOI 10.1038/sj.onc.1207162; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630	59	12	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33280	33288		10.1074/jbc.M508187200	http://dx.doi.org/10.1074/jbc.M508187200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16051596	hybrid			2022-12-27	WOS:000232058100023
J	Fujiwara, K; Toma, S; Okamura-Ikeda, K; Motokawa, Y; Nakagawa, A; Taniguchi, H				Fujiwara, K; Toma, S; Okamura-Ikeda, K; Motokawa, Y; Nakagawa, A; Taniguchi, H			Crystal structure of lipoate-protein ligase a from Escherichia coli - Determination of the lipoic acid-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE CLEAVAGE SYSTEM; ACYLTRANSFERASE COMPONENTS; MOLECULAR-CLONING; CARRIER PROTEIN; H-PROTEIN; LIPOYLATION; PROGRAM; IDENTIFICATION; EXPRESSION; SEQUENCE	Lipoate-protein ligase A (LplA) catalyzes the formation of lipoyl-AMP from lipoate and ATP and then transfers the lipoyl moiety to a specific lysine residue on the acyltransferase subunit of alpha-ketoacid dehydrogenase complexes and on H-protein of the glycine cleavage system. The lypoyllysine arm plays a pivotal role in the complexes by shuttling the reaction intermediate and reducing equivalents between the active sites of the components of the complexes. We have determined the X-ray crystal structures of Escherichia coli LplA alone and in a complex with lipoic acid at 2.4 and 2.9 angstrom resolution, respectively. The structure of LplA consists of a large N-terminal domain and a small C-terminal domain. The structure identifies the substrate binding pocket at the interface between the two domains. Lipoic acid is bound in a hydrophobic cavity in the N- terminal domain through hydrophobic interactions and a weak hydrogen bond between carboxyl group of lipoic acid and the Ser-72 or Arg-140 residue of LplA. No large conformational change was observed in the main chain structure upon the binding of lipoic acid.	Univ Tokushima, Inst Enzyme Res, Tokushima 7708503, Japan; Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; RIKEN, Harima Inst SPring8, Sayo, Hyogo 6795148, Japan	Tokushima University; Kumamoto University; Osaka University; Japan Synchrotron Radiation Research Institute; RIKEN	Fujiwara, K (corresponding author), Univ Tokushima, Inst Enzyme Res, Tokushima 7708503, Japan.	fujiwara@ier.tokushima-u.ac.jp	Nakagawa, Atsushi/D-4329-2009; Nakagawa, Atsushi/M-5731-2019; Taniguchi, Hisaaki/I-9171-2012	Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861; 				Aberg A, 1997, BIOCHEMISTRY-US, V36, P3084, DOI 10.1021/bi9618373; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BROOKFIELD DE, 1991, FEBS LETT, V295, P13, DOI 10.1016/0014-5793(91)81373-G; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Doublie S., 1992, CRYSTALLIZATION NUCL, P311; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Evans P. R., 1993, DATA COLLECTION PROC, P114; FUJIWARA K, 1992, J BIOL CHEM, V267, P20011; Fujiwara K, 1999, EUR J BIOCHEM, V260, P761, DOI 10.1046/j.1432-1327.1999.00204.x; Fujiwara K, 1997, J BIOL CHEM, V272, P31974, DOI 10.1074/jbc.272.51.31974; Fujiwara K, 1996, J BIOL CHEM, V271, P12932, DOI 10.1074/jbc.271.22.12932; FUJIWARA K, 1986, J BIOL CHEM, V261, P8836; GREEN DE, 1995, BIOCHEM J, V309, P853, DOI 10.1042/bj3090853; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Jordan SW, 2003, J BACTERIOL, V185, P1582, DOI 10.1128/JB.185.5.1582-1589.2003; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MORRIS TW, 1995, J BACTERIOL, V177, P1; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okamura-Ikeda K, 1999, J BIOL CHEM, V274, P17471, DOI 10.1074/jbc.274.25.17471; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Quinn J, 1997, METHOD ENZYMOL, V279, P193; REED LJ, 1990, J BIOL CHEM, V265, P8971; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257	42	51	60	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33645	33651		10.1074/jbc.M505010200	http://dx.doi.org/10.1074/jbc.M505010200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16043486	hybrid			2022-12-27	WOS:000232058100066
J	He, G; Ramachandran, A; Dahl, T; George, S; Schultz, D; Cookson, D; Veis, A; George, A				He, G; Ramachandran, A; Dahl, T; George, S; Schultz, D; Cookson, D; Veis, A; George, A			Phosphorylation of phosphophoryn is crucial for its function as a mediator of biomineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE DENTIN PHOSPHOPHORYN; CALCIUM-ION BINDING; X-RAY-SCATTERING; CRYSTAL ORGANIZATION; EXTRACELLULAR-MATRIX; COLLAGEN; PROTEINS; MINERALIZATION; PHOSPHOPROTEIN; HYDROXYAPATITE	Phosphoproteins of the organic matrix of bone and dentin have been implicated as regulators of the nucleation and growth of the inorganic Ca-P crystals of vertebrate bones and teeth. One such protein identified in the dentin matrix is phosphophoryn ( PP). It is highly acidic in nature because of a high content of aspartic acid and phosphate groups on serines. The 244-residue carboxyl-terminal domain of rat PP, predominantly containing the aspartic acid-serine repeats, has been cloned, and the corresponding protein has been expressed recombinantly in Escherichia coli. This portion of PP, named DMP2 ( dentin matrix protein 2), is not phosphorylated by the bacteria and thus provided a means to study the function of the phosphate groups, the major post-translational modification of native PP. The recombinant DMP2 (rDMP2) possessed much lower calcium binding capacity than native PP. Small angle x-ray scattering experiments demonstrated that PP folds to a compact globular structure upon calcium binding, whereas rDMP2 maintained an unfolded structure. In vitro nucleation experiments showed that PP could nucleate plate-like apatite crystals in pseudophysiological buffer, whereas rDMP2 failed to mediate the transformation of amorphous calcium phosphate to apatite crystals under the same experimental conditions. Collagen binding experiments demonstrated that PP favors the formation of collagen aggregates, whereas in the presence of rDMP2 thin fibrils are formed. Overall these results suggested that the phosphate moieties in phosphophoryn are important for its function as a mediator of dentin biomineralization.	Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA; Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA; ChemMatCARS, Argonne, IL 60439 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University	George, A (corresponding author), Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA.	anneg@uic.edu		GEORGE, ANNE/0000-0002-9008-7642	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013836] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE 13836] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Beniash E, 2000, J STRUCT BIOL, V132, P212, DOI 10.1006/jsbi.2000.4320; BUTLER WT, 1995, INT J DEV BIOL, V39, P169; COCKINGJOHNSON D, 1983, BIOCHIM BIOPHYS ACTA, V742, P49, DOI 10.1016/0167-4838(83)90357-6; Dahl T, 1998, J STRUCT BIOL, V123, P162, DOI 10.1006/jsbi.1998.4025; Dahl T, 2003, CONNECT TISSUE RES, V44, P206, DOI 10.1080/03008200390181672; Dahlin S, 1998, EUR J ORAL SCI, V106, P239, DOI 10.1111/j.1600-0722.1998.tb02182.x; DIMUZIO MT, 1978, J BIOL CHEM, V253, P6845; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; EANES ED, 1965, NATURE, V208, P365, DOI 10.1038/208365a0; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; George A, 1999, CONNECT TISSUE RES, V40, P49, DOI 10.3109/03008209909005277; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; Gu K, 2000, EUR J ORAL SCI, V108, P35, DOI 10.1034/j.1600-0722.2000.00765.x; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; KATAOKA M, 1996, FOLDING DESIGN, V1, P107; LEE SL, 1980, INT J PEPT PROT RES, V16, P231; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105; Rabie AM, 1995, CONNECT TISSUE RES, V31, P197, DOI 10.3109/03008209509010811; RAHIMA M, 1988, CALCIFIED TISSUE INT, V42, P104, DOI 10.1007/BF02556342; Ritchie HH, 2000, BBA-GENE STRUCT EXPR, V1493, P27, DOI 10.1016/S0167-4781(00)00150-0; SABSAY B, 1991, BIOCHEM J, V276, P699, DOI 10.1042/bj2760699; Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X; Semisotnov GV, 1996, J MOL BIOL, V262, P559, DOI 10.1006/jmbi.1996.0535; STETLERSTEVENSON WG, 1987, CALCIFIED TISSUE INT, V40, P97, DOI 10.1007/BF02555712; TAKAGI Y, 1983, CLIN ORTHOP RELAT R, P282; Torres-Quintana MA, 1998, ARCH ORAL BIOL, V43, P597, DOI 10.1016/S0003-9969(98)00037-5; TRAUB W, 1992, MATRIX, V12, P197, DOI 10.1016/S0934-8832(11)80062-4; Vachette P, 2003, METHOD ENZYMOL, V374, P584, DOI 10.1016/S0076-6879(03)74024-5; VEIS A, 1988, CIBA F SYMP, V136, P161; Veis A, 1997, CRIT REV ORAL BIOL M, V8, P360, DOI 10.1177/10454411970080040101; Veis A, 1988, COLLAGEN, V1, P113; Weiner S, 1999, J STRUCT BIOL, V126, P27, DOI 10.1006/jsbi.1999.4096; WEINER S, 1991, FEBS LETT, V285, P49, DOI 10.1016/0014-5793(91)80722-F; WEINSTOCK M, 1973, J CELL BIOL, V56, P838, DOI 10.1083/jcb.56.3.838	36	137	142	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33109	33114		10.1074/jbc.M500159200	http://dx.doi.org/10.1074/jbc.M500159200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16046405	hybrid			2022-12-27	WOS:000232058100004
J	Lynch, MJ; Baillie, GS; Mohamed, A; Li, X; Maisonneuve, C; Klussmann, E; van Heeke, G; Houslay, MD				Lynch, MJ; Baillie, GS; Mohamed, A; Li, X; Maisonneuve, C; Klussmann, E; van Heeke, G; Houslay, MD			RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with beta arrestin to control the protein kinase A/AKAP79-mediated switching of the beta(2)-adrenergic receptor to activation of ERK in HEK293B2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; CARDIAC MYOCYTES; MICE DEFICIENT; PHOSPHORYLATION; EXPRESSION; ISOFORMS; DESENSITIZATION; INHIBITORS; ROLIPRAM; BINDING	PDE4B and PDE4D provide > 90% of PDE4 cAMP phosphodiesterase activity in human embryonic kidney (HEK293B2) cells. Their selective small interference RNA ( siRNA)-mediated knockdown potentiates isoprenaline-stimulated protein kinase A (PKA) activation. Whereas endogenous PDE4D co-immunoprecipitates with beta arrestin, endogenous PDE4B does not, even upon PDE4D knockdown. Ectopic overexpression of PDE4B2 confers co-immunoprecipitation with beta arrestin. Knockdown of PDE4D, but not PDE4B, amplifies isoprenaline-stimulated phosphorylation of the beta(2)-adrenergic receptor (beta(2)-AR) by PKA and activation of extracellular signal-regulated kinase (ERK) through G(i). Isoform-selective knockdown identifies PDE4D5 as the functionally important species regulating isoprenaline stimulation of both these processes. Ht31-mediated disruption of the tethering of PKA to AKAP scaffold proteins attenuates isoprenaline activation of ERK, even upon PDE4D knockdown. Selective siRNA-mediated knockdown identifies AKAP79, which is constitutively associated with the beta(2)-AR, rather than isoprenaline-recruited gravin, as being the functionally relevant AKAP in this process. Isoprenaline-stimulated membrane recruitment of PDE4D is ablated upon beta arrestin knockdown. A mutation that compromises interactions with beta arrestin prevents catalytically inactive PDE4D5 from performing a dominant negative role in potentiating isoprenaline-stimulated ERK activation. beta arrestin-recruited PDE4D5 desensitizes isoprenaline-stimulated PKA phosphorylation of the beta(2)-AR and the consequential switching of its signaling to ERK. The ability to observe a cellular phenotype upon PDE4D5 knockdown demonstrates that other PDE4 isoforms, expressed at endogenous levels, are unable to afford rescue in HEK293B2 cells.	Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland; Novartis Inst Biomed Res, Resp Dis Area, Horsham RH12 5AB, W Sussex, England; Forschungsinst Mol Pharmakol, D-13125 Berlin, Germany	University of Glasgow; Novartis	Houslay, MD (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Wolfson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	M.Houslay@bio.gla.ac.uk	Houslay, Miles D/A-6825-2011; Houslay, Miles/AAM-5281-2020	Houslay, Miles/0000-0002-3826-8091	Medical Research Council [G8604010] Funding Source: Medline; MRC [G8604010] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Baillie GS, 2005, CURR OPIN CELL BIOL, V17, P129, DOI 10.1016/j.ceb.2005.01.003; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Banan M, 2004, CURR PHARM BIOTECHNO, V5, P441, DOI 10.2174/1389201043376643; Barber R, 2004, AM J PHYSIOL-LUNG C, V287, pL332, DOI 10.1152/ajplung.00384.2003; Barnette M S, 2000, Curr Opin Pulm Med, V6, P164, DOI 10.1097/00063198-200003000-00014; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bolger GB, 2003, J BIOL CHEM, V278, P49230, DOI 10.1074/jbc.M303772200; Bolger GB, 1997, BIOCHEM J, V328, P539; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; BRUNTON LL, 2003, SCI STKE, pPE44; Burnouf C, 2002, CURR PHARM DESIGN, V8, P1255, DOI 10.2174/1381612023394665; COGHLAN VM, 1994, J BIOL CHEM, V269, P7658; Conner DA, 1997, CIRC RES, V81, P1021; Conti M, 2000, PROG NUCLEIC ACID RE, V63, P1; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Feliciello A, 2005, CELL SIGNAL, V17, P279, DOI 10.1016/j.cellsig.2004.09.009; Francis SH, 2001, PROG NUCLEIC ACID RE, V65, P1; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Giembycz M A, 2002, Monaldi Arch Chest Dis, V57, P48; Hansen G, 2000, P NATL ACAD SCI USA, V97, P6751, DOI 10.1073/pnas.97.12.6751; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Huston E, 1997, BIOCHEM J, V328, P549, DOI 10.1042/bj3280549; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Jones SW, 2004, CURR OPIN PHARMACOL, V4, P522, DOI 10.1016/j.coph.2004.06.003; Jurevicius J, 2003, J PHYSIOL-LONDON, V551, P239, DOI 10.1113/jphysiol.2003.045211; Klussmann E, 1999, J BIOL CHEM, V274, P4934, DOI 10.1074/jbc.274.8.4934; Klussmann E, 2001, FEBS LETT, V507, P264, DOI 10.1016/S0014-5793(01)02995-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Jeune IR, 2002, J BIOL CHEM, V277, P35980, DOI 10.1074/jbc.M204832200; Lefkowitz RJ, 2002, MOL PHARMACOL, V62, P971, DOI 10.1124/mol.62.5.971; Lin FB, 2000, J BIOL CHEM, V275, P19025, DOI 10.1074/jbc.275.25.19025; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; MacKenzie SJ, 2000, BIOCHEM J, V347, P571, DOI 10.1042/0264-6021:3470571; Manganiello VC, 1999, THROMB HAEMOSTASIS, V82, P407, DOI 10.1055/s-0037-1615860; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; MARCHMONT RJ, 1980, BIOCHEM J, V187, P381, DOI 10.1042/bj1870381; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; McLean AJ, 2000, BRIT J PHARMACOL, V130, P1825, DOI 10.1038/sj.bjp.0703506; McPhee I, 1999, J BIOL CHEM, V274, P11796, DOI 10.1074/jbc.274.17.11796; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; Nemoz G, 1996, FEBS LETT, V384, P97, DOI 10.1016/0014-5793(96)00300-6; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; O'Donnell JM, 2004, TRENDS PHARMACOL SCI, V25, P158, DOI 10.1016/j.tips.2004.01.003; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pronin AN, 2002, METHOD ENZYMOL, V343, P547; Rochais F, 2004, J BIOL CHEM, V279, P52095, DOI 10.1074/jbc.M405697200; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Shepherd MC, 2004, BRIT J PHARMACOL, V142, P339, DOI 10.1038/sj.bjp.0705770; Spina D, 2003, CURR OPIN PULM MED, V9, P57, DOI 10.1097/00063198-200301000-00010; Tao JC, 2003, EMBO J, V22, P6419, DOI 10.1093/emboj/cdg628; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; THOMPSON WJ, 1971, BIOCHEMISTRY-US, V10, P311; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang HT, 2002, NEUROPSYCHOPHARMACOL, V27, P587; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	69	167	181	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33178	33189		10.1074/jbc.M414316200	http://dx.doi.org/10.1074/jbc.M414316200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16030021	hybrid			2022-12-27	WOS:000232058100012
J	Ferreira, IA; Mocking, AIM; Urbanus, RT; Varlack, S; Wnuk, M; Akkerman, JWN				Ferreira, IA; Mocking, AIM; Urbanus, RT; Varlack, S; Wnuk, M; Akkerman, JWN			Glucose uptake via glucose transporter 3 by human platelets is regulated by protein kinase B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-TYPE GLUT2; XENOPUS OOCYTES; PLASMA-MEMBRANE; LIPID RAFTS; CELL-LINE; TRANSPORTERS; TRANSLOCATION; EXPRESSION; RECEPTORS; THROMBIN	In insulin- responsive tissues, insulin is a potent activator of protein kinase B ( PKB)- mediated glucose uptake through the facilitative glucose transporter GLUT4. In platelets, glucose uptake is mediated through GLUT3, which is present in plasma ( 15%) and intracellular alpha- granule ( 85%) membranes. Here we report the PKB- mediated glucose uptake by platelets by agents that do ( thrombin) or do not ( insulin) induce alpha- granule translocation to the plasma membrane. Both thrombin and insulin activate PKB and induce glucose uptake albeit with different kinetics. Inhibition of PKB by the pharmacological inhibitor ML- 9 decreases thrombin- induced alpha- granule release and thrombin- and insulin- induced glucose uptake. At low glucose ( 0.1 mM), both agents stimulate glucose uptake by lowering the K-m for glucose ( thrombin and insulin) and increasing V-max ( thrombin). At high glucose ( 5 mM), stimulation of glucose uptake by insulin disappears, and insulin becomes an inhibitor of thrombin- induced glucose uptake via mechanisms independent of PKB. We conclude that in platelets glucose transport through GLUT3 is regulated by changes in surface expression and affinity modulation, which are both under control of PKB.	Univ Utrecht, Med Ctr, Dept Hematol, Thrombosis & Haemostasis Lab, NL-3584 CX Utrecht, Netherlands; Univ Utrecht, Biomembrane Inst, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University	Akkerman, JWN (corresponding author), Univ Utrecht, Med Ctr, Dept Hematol, Thrombosis & Haemostasis Lab, HP G03-647,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	j.w.n.akkerman@azu.nl	Urbanus, Rolf/AAG-7933-2020	Urbanus, Rolf/0000-0002-1601-9393				AKKERMAN JWN, 1987, PLATELET RESPONSES M, V2, P189; Arbuckle MI, 1996, BIOCHEMISTRY-US, V35, P16519, DOI 10.1021/bi962210n; Bettache N, 2003, J CELL SCI, V116, P2277, DOI 10.1242/jcs.00424; Bickel PE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1, DOI 10.1152/ajpendo.2002.282.1.E1; Cenni V, 2003, CELL MOL LIFE SCI, V60, P2710, DOI 10.1007/s00018-003-3349-4; Chamberlain LH, 2002, J BIOL CHEM, V277, P49750, DOI 10.1074/jbc.M206936200; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Cho MJ, 2002, BLOOD, V99, P2442, DOI 10.1182/blood.V99.7.2442; COLVILLE CA, 1993, BIOCHEM J, V290, P701, DOI 10.1042/bj2900701; Conejo R, 2001, J CELL PHYSIOL, V187, P96, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1058>3.0.CO;2-V; den Dekker E, 2002, J BIOL CHEM, V277, P29321, DOI 10.1074/jbc.M111390200; Dwyer DS, 2001, PROTEINS, V42, P531, DOI 10.1002/1097-0134(20010301)42:4<531::AID-PROT110>3.3.CO;2-0; ESTRADA DE, 1994, METABOLISM, V43, P591, DOI 10.1016/0026-0495(94)90201-1; Ferreira IA, 2004, J BIOL CHEM, V279, P3254, DOI 10.1074/jbc.M305474200; Fiory F, 2004, J BIOL CHEM, V279, P11137, DOI 10.1074/jbc.M308751200; Flaumenhaft R, 2003, ARTERIOSCL THROM VAS, V23, P1152, DOI 10.1161/01.ATV.0000075965.88456.48; Foran PGP, 1999, J BIOL CHEM, V274, P28087, DOI 10.1074/jbc.274.40.28087; FUGMAN DA, 1990, BLOOD, V75, P1252; Gachet C, 2001, THROMB HAEMOSTASIS, V86, P222; GREENBERG SM, 1988, BLOOD, V72, P1968; Grover-McKay M, 1999, BBA-BIOMEMBRANES, V1416, P145, DOI 10.1016/S0005-2736(98)00216-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hardy AR, 2004, BLOOD, V104, P1745, DOI 10.1182/blood-2004-02-0534; Heijnen HFG, 1997, J CELL BIOL, V138, P323, DOI 10.1083/jcb.138.2.323; Hill MM, 2002, CURR BIOL, V12, P1251, DOI 10.1016/S0960-9822(02)00973-9; HOFSTEE BHJ, 1959, NATURE, V184, P1296, DOI 10.1038/1841296b0; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; Knott RM, 1996, BIOCHEM J, V318, P313, DOI 10.1042/bj3180313; Kroner C, 2000, J BIOL CHEM, V275, P27790, DOI 10.1074/jbc.M000540200; Mairhofer M, 2002, BLOOD, V100, P897, DOI 10.1182/blood.V100.3.897; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; Nieuwland R, 1997, CIRCULATION, V96, P3534; NISHIMURA H, 1993, J BIOL CHEM, V268, P8514; OGURA M, 1985, BLOOD, V66, P1384; Rosado JA, 2000, J BIOL CHEM, V275, P9110, DOI 10.1074/jbc.275.13.9110; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Schwarz UR, 2001, BIOCHEM PHARMACOL, V62, P1153, DOI 10.1016/S0006-2952(01)00760-2; Somwar R, 2001, J BIOL CHEM, V276, P46079, DOI 10.1074/jbc.M109093200; Sorbara LR, 1997, BIOCHEM J, V328, P511; Stuart CA, 2001, METABOLISM, V50, P771, DOI 10.1053/meta.2001.24202; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267	45	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32625	32633		10.1074/jbc.M507221200	http://dx.doi.org/10.1074/jbc.M507221200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16049004	hybrid			2022-12-27	WOS:000231920300010
J	Taylor, EJ; Goyal, A; Guerreiro, CIPD; Prates, JAM; Money, VA; Ferry, N; Morland, C; Planas, A; Macdonald, JA; Stick, RV; Gilbert, HJ; Fontes, CMGA; Davies, GJ				Taylor, EJ; Goyal, A; Guerreiro, CIPD; Prates, JAM; Money, VA; Ferry, N; Morland, C; Planas, A; Macdonald, JA; Stick, RV; Gilbert, HJ; Fontes, CMGA; Davies, GJ			How family 26 glycoside hydrolases orchestrate catalysis on different polysaccharides - Structure and activity of a clostridium thermocellum lichenase, CtLic26A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULE; CRYSTAL-STRUCTURE; MARINE BACTERIUM; ISOFAGOMINE; HYDROLYSIS; MANNANASE; CELLULOSA; INSIGHTS; ENZYMES; BETA-1,3-XYLANASE	One of the most intriguing features of the 90 glycoside hydrolase families (GHs) is the range of specificities displayed by different members of the same family, whereas the catalytic apparatus and mechanism are often invariant. Family GH26 predominantly comprises beta-1,4 mannanases; however, a bifunctional Clostridium thermocellum GH26 member (hereafter CtLic26A) displays a markedly different specificity. We show that CtLic26A is a lichenase, specific for mixed (Glc beta 1,4Glc beta 1,4Glc beta 1,3)(n) oligo- and polysaccharides, and displays no activity on manno-configured substrates or beta-1,4-linked homopolymers of glucose or xylose. The three-dimensional structure of the native form of CtLic26A has been solved at 1.50-angstrom resolution, revealing a characteristic (beta/alpha)s barrel with Glu-109 and Glu-222 acting as the catalytic acid/base and nucleophile in a double-displacement mechanism. The complex with the competitive inhibitor, Glc-beta-1,3-isofagomine (K-i 1 mu M), at 1.60 angstrom sheds light on substrate recognition in the -2 and -1 subsites and illuminates why the enzyme is specific for lichenan-based substrates. Hydrolysis of beta-mannosides by GH26 members is thought to proceed through transition states in the B2+5 (boat) conformation in which structural distinction of glucosides versus mannosides reflects not the configuration at C2 but the recognition of the pseudoaxial O3 of the B2+5 conformation. We suggest a different conformational itinerary for the GH26 enzymes active on gluco-configured substrates.	Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England; Univ Tecn Lisboa, CIISA, Fac Med Vet, P-1300477 Lisbon, Portugal; Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Ramon Llull, Inst Quim Sarria, Biochem Lab, Barcelona 08017, Spain; Univ Western Australia, Sch Biomed & Chem Sci, Crawley, WA 6009, Australia	University of York - UK; Universidade de Lisboa; Newcastle University - UK; Universitat Ramon Llull; Institut Quimic de Sarria; University of Western Australia	Taylor, EJ (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England.	davies@ysbl.york.ac.uk	Davies, Gideon J/A-9042-2011; PLANAS, ANTONI/I-4803-2015; Money, Victoria/E-8851-2013; Macdonald, James M/H-4209-2013; Prates, José A M/K-9934-2013	Davies, Gideon J/0000-0002-7343-776X; PLANAS, ANTONI/0000-0001-7073-3320; Prates, José A M/0000-0003-1032-5987; Ferry, Natalie/0000-0003-3728-4302; Taylor, Edward/0000-0003-4024-0976; Fontes, Carlos/0000-0002-1219-9753	Biotechnology and Biological Sciences Research Council [BBS/B/05974] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Araki T, 2000, APPL ENVIRON MICROB, V66, P1741, DOI 10.1128/AEM.66.4.1741-1743.2000; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bolam DN, 1996, BIOCHEMISTRY-US, V35, P16195, DOI 10.1021/bi961866d; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brett CT, 1996, PHYSL BIOCH PLANT CE; Burmeister WP, 1997, STRUCTURE, V5, P663, DOI 10.1016/S0969-2126(97)00221-9; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Coutinho PM, 1999, ROY SOC CH, P3; DAVIES G, 1997, COMPREHENSIVE BIOL C, V1, P119; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; Dias FMV, 2004, J BIOL CHEM, V279, P25517, DOI 10.1074/jbc.M401647200; Ducros VMA, 2002, ANGEW CHEM INT EDIT, V41, P2824, DOI 10.1002/1521-3773(20020802)41:15<2824::AID-ANIE2824>3.0.CO;2-G; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FONTES CMGA, 1995, BIOCHEM J, V307, P151, DOI 10.1042/bj3070151; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; Henrissat B, 1998, FEBS LETT, V425, P352, DOI 10.1016/S0014-5793(98)00265-8; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; Lillelund VH, 2003, ORG BIOMOL CHEM, V1, P282, DOI 10.1039/b208784g; Macdonald JM, 2004, AUST J CHEM, V57, P187, DOI 10.1071/CH03227; Macdonald JM, 2002, AUST J CHEM, V55, P747, DOI 10.1071/CH02165; Malet C, 1997, BIOCHEMISTRY-US, V36, P13838, DOI 10.1021/bi9711341; Mark BL, 2001, J BIOL CHEM, V276, P42131, DOI 10.1074/jbc.M107154200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Notenboom V, 2000, BIOCHEMISTRY-US, V39, P11553, DOI 10.1021/bi0010625; Numao S, 2003, J BIOL CHEM, V278, P48074, DOI 10.1074/jbc.M309249200; Okazaki F, 2002, J BACTERIOL, V184, P2399, DOI 10.1128/JB.184.9.2399-2403.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Sabini E, 1999, CHEM BIOL, V6, P483, DOI 10.1016/S1074-5521(99)80066-0; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Vallee F, 2000, J BIOL CHEM, V275, P41287, DOI 10.1074/jbc.M006927200; Varrot A, 2003, J AM CHEM SOC, V125, P7496, DOI 10.1021/ja034917k; Varroto A, 2005, J BIOL CHEM, V280, P20181, DOI 10.1074/jbc.C500142200; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Vincent F, 2004, CHEMBIOCHEM, V5, P1596, DOI 10.1002/cbic.200400169; Zechel DL, 2003, J AM CHEM SOC, V125, P14313, DOI 10.1021/ja036833h	46	54	58	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32761	32767		10.1074/jbc.M506580200	http://dx.doi.org/10.1074/jbc.M506580200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	15987675	hybrid			2022-12-27	WOS:000231920300027
J	Grayson, C; Molday, RS				Grayson, C; Molday, RS			Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA-ELONGASE; RECESSIVE RETINITIS-PIGMENTOSA; PHOTORECEPTOR DISK MEMBRANES; CHAIN FATTY-ACIDS; DOCOSAHEXAENOIC ACID; PARTIAL-PURIFICATION; QUALITY-CONTROL; MUTANT ELOVL4; RIM PROTEIN; GENE ABCR	ELOVL4(elongation of very long chain fatty acids 4) is a member of the ELO family of proteins involved in the biosynthesis of very long chain fatty acids. Protein truncation mutations in ELOVL4 have been identified in patients with autosomal dominant Stargardt-like macular degeneration. To determine whether a dominant negative mechanism is responsible for the autosomal dominant inheritance pattern of this disease, we studied the subcellular localization and interaction of wild type and mutant ELOVL4 in COS-7 and HEK 293T cultured cells by immunofluorescence and co-immunoprecipitation. Wild type ELOVL4 containing an endoplasmic reticulum retention sequence was localized to the endoplasmic reticulum as expected. In contrast, disease-associated C-terminal truncation ELOVL4 mutants accumulated as large inclusions exhibiting aggresome-like characteristics in a juxtanuclear position within COS-7 cells. When the wild type and mutant proteins were co-expressed in cultured cells, wild type ELOVL4 co-purified with mutant ELOVL4 on an immunoaffinity column and co-localized with the mutant protein in aggresome-like inclusions adjacent to the nucleus. These results indicate that wild type and mutant ELOVL4 form a complex that exhibits an abnormal subcellular localization found for individually expressed mutant ELOVL4. From these studies, we conclude that disease-linked C-terminal truncation mutants of ELOVL4 exert a dominant negative effect on wild type ELOVL4, altering its subcellular localization. This dominant negative mechanism contributes to the autosomal dominant inheritance of Stargardt-like macular dystrophy.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Ophthalmol & Visual Sci, Ctr Mol Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Molday, RS (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	molday@interchange.ubc.ca			NEI NIH HHS [EY 02422] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002422] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahn J, 2000, J BIOL CHEM, V275, P20399, DOI 10.1074/jbc.M000555200; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Ambasudhan R, 2004, GENOMICS, V83, P615, DOI 10.1016/j.ygeno.2003.10.004; Anderson RE, 1999, LIPIDS, V34, pS235, DOI 10.1007/BF02562304; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Bernstein PS, 2001, INVEST OPHTH VIS SCI, V42, P3331; BESSOULE JJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P475, DOI 10.1016/0003-9861(89)90315-9; BRAUN A, 1995, AM J HUM GENET, V56, P854; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CINTI DL, 1992, PROG LIPID RES, V31, P1, DOI 10.1016/0163-7827(92)90014-A; CONVERSE CA, 1983, T OPHTHAL SOC UK, V103, P508; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Domergue F, 2000, LIPIDS, V35, P487, DOI 10.1007/s11745-000-548-4; Donoso LA, 2001, SURV OPHTHALMOL, V46, P149, DOI 10.1016/S0039-6257(01)00251-X; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; FEHLING E, 1992, BIOCHIM BIOPHYS ACTA, V1126, P88, DOI 10.1016/0005-2760(92)90221-G; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; GONG JX, 1992, INVEST OPHTH VIS SCI, V33, P2596; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HOFFMAN DR, 1995, INVEST OPHTH VIS SCI, V36, P1009; HOLMAN RT, 1994, LIPIDS, V29, P61, DOI 10.1007/BF02537092; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Karan G, 2005, P NATL ACAD SCI USA, V102, P4164, DOI 10.1073/pnas.0407698102; Karan G, 2004, MOL VIS, V10, P248; Kedzierski W, 2001, P NATL ACAD SCI USA, V98, P7718, DOI 10.1073/pnas.141124198; Klumperman J, 2000, CURR OPIN CELL BIOL, V12, P445, DOI 10.1016/S0955-0674(00)00115-0; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lagali PS, 2003, INVEST OPHTH VIS SCI, V44, P2841, DOI 10.1167/iovs.02-0991; Loewen CJR, 2003, MOL BIOL CELL, V14, P3400, DOI 10.1091/mbc.e03-02-0077; MACKENZIE D, 1982, J BIOL CHEM, V257, P7100; Mandal MNA, 2004, GENOMICS, V83, P626, DOI 10.1016/j.ygeno.2003.09.020; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Maude MB, 1998, INVEST OPHTH VIS SCI, V39, P2164; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; Maugeri A, 2004, INVEST OPHTH VIS SCI, V45, P4263, DOI 10.1167/iovs.04-0078; Molday LL, 2001, INVEST OPHTH VIS SCI, V42, P816; MOSSER J, 1994, HUM MOL GENET, V3, P265, DOI 10.1093/hmg/3.2.265; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Rapp LM, 2000, INVEST OPHTH VIS SCI, V41, P1200; Rivolta C, 2003, MOL VIS, V9, P49; Rotstein NP, 1996, J NEUROCHEM, V66, P1851; Saliba RS, 2002, J CELL SCI, V115, P2907; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Sprecher H, 1995, J LIPID RES, V36, P2471; Suh M, 2000, PEDIATR RES, V48, P524, DOI 10.1203/00006450-200010000-00017; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Tvrdik P, 2000, J CELL BIOL, V149, P707, DOI 10.1083/jcb.149.3.707; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817; Zhang XM, 2003, MOL VIS, V9, P301	58	72	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32521	32530		10.1074/jbc.M503411200	http://dx.doi.org/10.1074/jbc.M503411200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16036915	hybrid			2022-12-27	WOS:000231794800061
J	Ball, HL; Cortez, D				Ball, HL; Cortez, D			ATRIP oligomerization is required for ATR-dependent checkpoint signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; IONIZING-RADIATION; SECKEL-SYNDROME; DAMAGE; BINDING; COMPLEX; MEC1	The ATM and ATR kinases signal cell cycle checkpoint responses to DNA damage. Inactive ATM is an oligomer that is disrupted to form active monomers in response to ionizing radiation. We examined whether ATR is activated by a similar mechanism. We found that the ATRIP subunit of the ATR kinase and ATR itself exist as homo-oligomers in cells. We did not detect regulation of ATR or ATRIP oligomerization after DNA damage. The predicted coiled-coil domain of ATRIP is essential for ATRIP oligomerization, stable ATR binding, and accumulation of ATRIP at DNA lesions. Additionally, the ATRIP coiled-coil is also required for ATRIP to support ATR-dependent checkpoint signaling to Chk1. Replacing the ATRIP coiled-coil domain with a heterologous dimerization domain restored stable binding to ATR and localization to damage-induced intranuclear foci. Thus, the ATR-ATRIP complex exists in higher order oligomeric states within cells and ATRIP oligomerization is essential for its function.	Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu			NATIONAL CANCER INSTITUTE [K01CA093701, R01CA102729, T32CA078136] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA093701, T32 CA078136, R01 CA102729, K01CA93701, R01CA102729, T32 CA78136] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Barr SM, 2003, CURR BIOL, V13, P1047, DOI 10.1016/S0960-9822(03)00376-2; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Bomgarden RD, 2004, J BIOL CHEM, V279, P13346, DOI 10.1074/jbc.M311098200; Brown EJ, 2000, GENE DEV, V14, P397; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 2005, GENE DEV, V19, P1007, DOI 10.1101/gad.1316905; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lisby M, 2004, CURR OPIN CELL BIOL, V16, P328, DOI 10.1016/j.ceb.2004.03.011; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Paciotti V, 2000, GENE DEV, V14, P2046; Paciotti V, 2001, MOL CELL BIOL, V21, P3913, DOI 10.1128/MCB.21.12.3913-3925.2001; Parrilla-Castellar E, 2003, J BIOL CHEM, V278, P45507, DOI 10.1074/jbc.C300418200; Rouse J, 2000, EMBO J, V19, P5801, DOI 10.1093/emboj/19.21.5801; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; Wakayama T, 2001, MOL CELL BIOL, V21, P755, DOI 10.1128/MCB.21.3.755-764.2001; Wang Y, 2000, GENE DEV, V14, P927; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	32	62	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31390	31396		10.1074/jbc.M504961200	http://dx.doi.org/10.1074/jbc.M504961200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16027118	hybrid, Green Accepted			2022-12-27	WOS:000231665200008
J	Bevilacqua, MA; Iovine, B; Zambrano, N; D'Ambrosio, C; Scaloni, A; Russo, T; Cimino, F				Bevilacqua, MA; Iovine, B; Zambrano, N; D'Ambrosio, C; Scaloni, A; Russo, T; Cimino, F			Fibromodulin gene transcription is induced by ultraviolet irradiation, and its regulation is impaired in senescent human fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; CELLULAR SENESCENCE; NUCLEAR FACTOR; HUMAN-CELLS; REPAIR; INDUCTION; EFFICIENT; MICE; FE65; DDB	Cells undergoing replicative senescence display an altered pattern of gene expression. Senescent fibroblasts show significant changes in the expression of mRNAs encoding extracellular matrix-remodeling proteins; among these mRNAs, the mRNA encoding fibromodulin is highly decreased in these cells. To understand the molecular basis of this phenomenon, we explored the regulatory mechanisms of the human fibromodulin gene. We found that fibromodulin gene promoter contains a cis-element, crucial for its basal expression, that forms a DNA-protein complex when exposed to nuclear extracts from exponentially growing human fibroblasts and not to extracts from cells undergoing senescence by repeated in vitro passages or by mild oxidative stress. The purification of this complex showed that it contains the damage-specific DNA-binding protein DDB-1. The latter is known to be induced by UV irradiation; therefore we checked whether fibromodulin gene promoter is regulated upon the exposure of the cells to UV rays. The results showed that, in exponentially growing fibroblasts, the promoter efficiency is increased by UV irradiation and the DDB-1-containing complex is robustly enriched in cells exposed to UV light. Accordingly, in these experimental conditions the endogenous fibromodulin mRNA accumulates to very high levels. On the contrary, senescent cells did not show any activation of the fibromodulin gene promoter, any induction of the DDB-1-containing complex, or any accumulation of fibromodulin mRNA. These phenomena are accompanied in senescent cells by a decrease of the UV-damaged DNA binding activity.	Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, CEINGE Biotecnol Avanazate, I-80145 Naples, Italy; CNR, ISPAAM, Proteom & Mass Spectrometry Lab, I-80147 Naples, Italy	CEINGE Biotecnologie Avanzate; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR)	Cimino, F (corresponding author), Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, CEINGE Biotecnol Avanazate, Via Comunale Margherita 482, I-80145 Naples, Italy.	cimino@dbbm.unina.it	Russo, Tommaso/K-1331-2016; D'Ambrosio, Chiara/C-2753-2012; Zambrano, Nicola/B-9352-2014	Russo, Tommaso/0000-0003-4426-0106; D'Ambrosio, Chiara/0000-0003-2810-9270; Zambrano, Nicola/0000-0001-9395-3481; Scaloni, Andrea/0000-0001-9362-8515				Benanti JA, 2002, MOL CELL BIOL, V22, P7385, DOI 10.1128/MCB.22.21.7385-7397.2002; Bevilacqua MA, 1997, J BIOL CHEM, V272, P20736, DOI 10.1074/jbc.272.33.20736; BEVILACQUA MA, 1995, BIOCHEM J, V311, P769, DOI 10.1042/bj3110769; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brenneisen P, 2002, ANN NY ACAD SCI, V973, P31, DOI 10.1111/j.1749-6632.2002.tb04602.x; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Das S, 2004, J BIOL CHEM, V279, P7313, DOI 10.1074/jbc.M312585200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Faraonio R, 2002, CELL DEATH DIFFER, V9, P862, DOI 10.1038/sj.cdd.4401053; FELDBERG RS, 1980, NUCLEIC ACIDS RES, V8, P1133, DOI 10.1093/nar/8.5.1133; Gianni D, 2003, J BIOL CHEM, V278, P9290, DOI 10.1074/jbc.M211899200; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hayes S, 1998, MOL CELL BIOL, V18, P240, DOI 10.1128/MCB.18.1.240; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; KEENEY S, 1993, J BIOL CHEM, V268, P21293; Liu W, 2000, J BIOL CHEM, V275, P21429, DOI 10.1074/jbc.M000961200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000; Petri J B, 1999, Mol Cell Biol Res Commun, V1, P59, DOI 10.1006/mcbr.1999.0113; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Sitterlin D, 2000, ONCOGENE, V19, P4427, DOI 10.1038/sj.onc.1203770; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; SZTROLOVICS R, 1994, GENOMICS, V23, P715, DOI 10.1006/geno.1994.1567; Takata K, 2004, GENETICS, V168, P855, DOI 10.1534/genetics.103.025965; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Xu GG, 2000, MUTAT RES-DNA REPAIR, V459, P195, DOI 10.1016/S0921-8777(99)00069-5; Zambrano N, 1997, BIOCHEM J, V328, P293, DOI 10.1042/bj3280293	35	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31809	31817		10.1074/jbc.M414677200	http://dx.doi.org/10.1074/jbc.M414677200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16002407	hybrid			2022-12-27	WOS:000231665200060
J	Braithwaite, EK; Kedar, PS; Lan, L; Polosina, YY; Asagoshi, K; Poltoratsky, VP; Horton, JK; Miller, H; Teebor, GW; Yasui, A; Wilson, SH				Braithwaite, EK; Kedar, PS; Lan, L; Polosina, YY; Asagoshi, K; Poltoratsky, VP; Horton, JK; Miller, H; Teebor, GW; Yasui, A; Wilson, SH			DNA polymerase lambda protects mouse fibroblasts against oxidative DNA damage and is recruited to sites of DNA damage/repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; LYASE ACTIVITY; BETA; GENE; IDENTIFICATION; GLYCOSYLASE; REQUIREMENT; INVOLVEMENT; DEFICIENT	DNA polymerase lambda ( pol lambda) is a member of the X family of DNA polymerases that has been implicated in both base excision repair and non-homologous end joining through in vitro studies. However, to date, no phenotype has been associated with cells deficient in this DNA polymerase. Here we show that pol lambda null mouse fibroblasts are hypersensitive to oxidative DNA damaging agents, suggesting a role of pol lambda in protection of cells against the cytotoxic effects of oxidized DNA. Additionally, pol lambda co-immunoprecipitates with an oxidized base DNA glycosylase, single-strand-selective monofunctional uracil-DNA glycosylase (SMUG1), and localizes to oxidative DNA lesions in situ. From these data, we conclude that pol lambda protects cells against oxidative stress and suggest that it participates in oxidative DNA damage base excision repair.	NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Genet, Sendai, Miyagi 9808575, Japan; SUNY Stony Brook, Dept Pharmacol Sci, Biol Chem Lab, Stony Brook, NY 11794 USA; NYU, Dept Pathol, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Tohoku University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York University	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Miller, Holly/I-6942-2015; Wilson, Samuel H/E-6644-2019	Miller, Holly/0000-0002-9076-5335; Wilson, Samuel H/0000-0002-1702-5293; Teebor, George/0000-0002-7397-2500	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aoufouchi S, 2000, NUCLEIC ACIDS RES, V28, P3684, DOI 10.1093/nar/28.18.3684; Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137; Bertocci B, 2002, J IMMUNOL, V168, P3702, DOI 10.4049/jimmunol.168.8.3702; BOORSTEIN RJ, 1992, MOL CELL BIOL, V12, P5536, DOI 10.1128/MCB.12.12.5536; Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; Braithwaite EK, 2005, J BIOL CHEM, V280, P18469, DOI 10.1074/jbc.M411864200; BUTLER WB, 1984, ANAL BIOCHEM, V141, P70, DOI 10.1016/0003-2697(84)90426-3; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Fortini P, 2000, NUCLEIC ACIDS RES, V28, P3040, DOI 10.1093/nar/28.16.3040; Garcia-Diaz M, 2001, J BIOL CHEM, V276, P34659, DOI 10.1074/jbc.M106336200; Garcia-Diaz M, 2000, J MOL BIOL, V301, P851, DOI 10.1006/jmbi.2000.4005; Horton JK, 2003, DNA REPAIR, V2, P27, DOI 10.1016/S1568-7864(02)00184-2; Horton JK, 2002, DNA REPAIR, V1, P317, DOI 10.1016/S1568-7864(02)00008-3; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; KAUFMAN ER, 1986, SOMAT CELL MOLEC GEN, V12, P501, DOI 10.1007/BF01539921; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Kobayashi Y, 2002, MOL CELL BIOL, V22, P2769, DOI 10.1128/MCB.22.8.2769-2776.2002; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Lee JW, 2004, J BIOL CHEM, V279, P805, DOI 10.1074/jbc.M307913200; LEEM SH, 1994, NUCLEIC ACIDS RES, V22, P3011, DOI 10.1093/nar/22.15.3011; LIMOLI CL, 1993, RADIAT RES, V134, P160, DOI 10.2307/3578455; McInnis M, 2002, DNA REPAIR, V1, P311, DOI 10.1016/S1568-7864(02)00007-1; Nakamura J, 2003, NUCLEIC ACIDS RES, V31, P1790, DOI 10.1093/nar/gkg263; Polosina YY, 2004, DNA REPAIR, V3, P1469, DOI 10.1016/j.dnarep.2004.05.011; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Ramadan K, 2004, NAT REV MOL CELL BIO, V5, P1038, DOI 10.1038/nrm1530; ROBERTSON EJ, 1987, TERATOCARCINOMAS EMB, P7; SHCHERBAKOVA PV, 2003, SCI AGING KNOWL ENV, V26, pRE3; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Wilson TE, 1999, J BIOL CHEM, V274, P23599, DOI 10.1074/jbc.274.33.23599	33	96	97	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31641	31647		10.1074/jbc.C500256200	http://dx.doi.org/10.1074/jbc.C500256200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16002405	hybrid			2022-12-27	WOS:000231665200039
J	Kang, DE; Yoon, IS; Repetto, E; Busse, T; Yermian, N; Ie, L; Koo, EH				Kang, DE; Yoon, IS; Repetto, E; Busse, T; Yermian, N; Ie, L; Koo, EH			Presenilins mediate phosphatidylinositol 3-kinase/AKT and ERK activation via select signaling receptors - Selectivity of PS2 in platelet-derived growth factor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; INTRACELLULAR TRAFFICKING; HIPPOCAMPAL-NEURONS; MISSENSE MUTATIONS; BETA-CATENIN; 2 INTERACTS; FHL2; TURNOVER	The Alzheimer's disease-linked genes, PS1 and PS2, are required for intramembrane proteolysis of multiple type I proteins, including Notch and amyloid precursor protein. In addition, it has been documented that PS1 positively regulates, whereas PS1 familial Alzheimer disease mutations suppress, phosphatidylinositol 3-kinase (PI3K)/Akt activation, a pathway known to inactivate glycogen synthase kinase-3 and reduce tau phosphorylation. In this study, we show that the loss of presenilins not only inhibits PI3K/Akt signaling and increases tau phosphorylation but also suppresses the MEK/ERK pathway. The deficits in Akt and ERK activation in cells deficient in both PS1 and PS2 (PS-/-) are evident after serum withdrawal and stimulation with fetal bovine serum or ligands of select receptor tyrosine kinases, platelet-derived growth factor receptor beta (PDGFR beta) and PDGFR alpha, but not insulin-like growth factor-1R and epidermal growth factor receptor. The defects in PDGF signaling in PS-/- cells are due to reduced expression of PDGF receptors. Whereas fetal bovine serum-induced Akt activation is reconstituted by both PS1 and PS2 in PS-/- cells, PDGF signaling is selectively restored by PS2 but not PS1 and is dependent on the N-terminal fragment of PS2 but not gamma-secretase activity or the hydrophilic loop of PS2. The rescue of PDGF receptor expression and activation by PS2 is facilitated by FHL2, a PS2-interacting transcriptional co-activator. Finally, we present evidence that PS1 mutations interfere with this PS2-mediated activity by reducing PS2 fragments. These findings highlight important roles of both presenilins in Akt and ERK signaling via select signaling receptors.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kang, DE (corresponding author), Univ Calif San Diego, Dept Neurosci, Leichtg Biomed Res 380, La Jolla, CA 92093 USA.	dekang@ucsd.edu	Kang, David E./E-5234-2012	REPETTO, EMANUELA/0000-0002-6270-3540; Kang, David E./0000-0002-7132-821X				Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Beher D, 2001, J BIOL CHEM, V276, P45394, DOI 10.1074/jbc.M103075200; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; CHENG B, 1995, J NEUROSCI, V15, P7095; Dermaut B, 2004, ANN NEUROL, V55, P617, DOI 10.1002/ana.20083; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Kang DE, 2004, NEUROBIOL AGING, V25, pS559, DOI 10.1016/S0197-4580(04)81853-0; Kang DE, 1999, J NEUROSCI, V19, P4229; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kashour T, 2003, BIOCHEM J, V370, P1063, DOI 10.1042/BJ20021197; Kawabe T, 1997, NEUROSCI RES, V29, P335, DOI 10.1016/S0168-0102(97)00105-3; Labalette C, 2004, MOL CELL BIOL, V24, P10689, DOI 10.1128/MCB.24.24.10689-10702.2004; Laffont I, 2002, BIOCHEM BIOPH RES CO, V292, P83, DOI 10.1006/bbrc.2002.6586; Lee MK, 1997, NAT MED, V3, P756, DOI 10.1038/nm0797-756; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; MORI S, 1993, J BIOL CHEM, V268, P577; Morlon A, 2003, P NATL ACAD SCI USA, V100, P3977, DOI 10.1073/pnas.0735923100; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Pack-Chung E, 2000, J BIOL CHEM, V275, P14440, DOI 10.1074/jbc.M909882199; Pearl LH, 2002, CURR OPIN STRUC BIOL, V12, P761, DOI 10.1016/S0959-440X(02)00386-X; Periz G, 2004, J NEUROSCI RES, V77, P309, DOI 10.1002/jnr.20203; Pigino G, 2003, J NEUROSCI, V23, P4499; Raux G, 2000, NEUROLOGY, V55, P1577, DOI 10.1212/WNL.55.10.1577; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Ryder J, 2004, CELL SIGNAL, V16, P187, DOI 10.1016/j.cellsig.2003.07.004; Saura CA, 2000, J BIOL CHEM, V275, P17136, DOI 10.1074/jbc.M909624199; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Simakajornboon N, 2001, BRAIN RES, V895, P111, DOI 10.1016/S0006-8993(01)02054-6; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Stabler SM, 1999, J CELL BIOL, V145, P1277, DOI 10.1083/jcb.145.6.1277; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Tanahashi H, 2000, HUM MOL GENET, V9, P2281, DOI 10.1093/oxfordjournals.hmg.a018919; Tang-Wai D, 2002, DEMENT GERIATR COGN, V14, P13, DOI 10.1159/000058328; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Uemura K, 2003, J NEUROSCI RES, V74, P184, DOI 10.1002/jnr.10753; Uramoto H, 2004, J CELL SCI, V117, P5323, DOI 10.1242/jcs.01384; Wang H, 2004, J BIOL CHEM, V279, P40560, DOI 10.1074/jbc.M404345200; Weihl CC, 1999, J NEUROSCI, V19, P5360; Wilson CA, 2004, J CELL BIOL, V165, P335, DOI 10.1083/jcb.200403061; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436	53	91	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31537	31547		10.1074/jbc.M500833200	http://dx.doi.org/10.1074/jbc.M500833200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16014629	hybrid			2022-12-27	WOS:000231665200026
J	Ye, M; Shima, F; Muraoka, S; Liao, JL; Okamoto, H; Yamamoto, M; Tamura, A; Yagi, N; Ueki, T; Kataoka, T				Ye, M; Shima, F; Muraoka, S; Liao, JL; Okamoto, H; Yamamoto, M; Tamura, A; Yagi, N; Ueki, T; Kataoka, T			Crystal structure of M-Ras reveals a GTP-bound "off" state conformation of Ras family small GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING DOMAIN; ACTIVATING PROTEIN; P21; IDENTIFICATION; SPECTROSCOPY; SWITCH; GDP	Although some members of Ras family small GTPases, including M-Ras, share the primary structure of their effector regions with Ras, they exhibit vastly different binding properties to Ras effectors such as c-Raf-1. We have solved the crystal structure of M-Ras in the GDP-bound and guanosine 5'-(beta, gamma-imido) triphosphate (Gpp(NH) p)-bound forms. The overall structure of M-Ras resembles those of H-Ras and Rap2A, except that M-Ras-Gpp( NH) p exhibits a distinctive switch I conformation, which is caused by impaired intramolecular interactions between Thr-45 (corresponding to Thr-35 of H-Ras) of the effector region and the gamma-phosphate of Gpp(NH) p. Previous P-31 NMR studies showed that H-Ras-Gpp( NH) p exists in two interconverting conformations, states 1 and 2. Whereas state 2 is a predominant form of H-Ras and corresponds to the "on" conformation found in the complex with effectors, state 1 is thought to represent the "off" conformation, whose tertiary structure remains unknown. P-31 NMR analysis shows that free M-Ras-Gpp(NH)p predominantly assumes the state 1 conformation, which undergoes conformational transition to state 2 upon association with c-Raf-1. These results indicate that the solved structure of M-Ras-Gpp(NH) p corresponds to the state 1 conformation. The predominance of state 1 in M-Ras is likely to account for its weak binding ability to the Ras effectors, suggesting the importance of the tertiary structure factor in small GTPase-effector interaction. Further, the first determination of the state 1 structure provides a molecular basis for developing novel anti-cancer drugs as compounds that hold Ras in the state 1 "off" conformation.	Kobe Univ, Div Mol Biol, Dept Mol & Cellular Biol, Grad Sch Med,Chuo Ku, Kobe, Hyogo 6500017, Japan; JASRI SPring 8, Mikazuki, Hyogo 6795198, Japan; Kobe Univ, Grad Sch Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; RIKEN, SPring 8, Mikazuki, Hyogo 6795148, Japan	Kobe University; Japan Synchrotron Radiation Research Institute; Kobe University; Japan Synchrotron Radiation Research Institute; RIKEN	Kataoka, T (corresponding author), Kobe Univ, Div Mol Biol, Dept Mol & Cellular Biol, Grad Sch Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kataoka@kobe-u.ac.jp	Yamamoto, Masaki/B-7844-2015	Yamamoto, Masaki/0000-0002-1311-1768; Tamura, Atsuo/0000-0001-8238-8851				BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bellew BF, 1996, BIOCHEMISTRY-US, V35, P12186, DOI 10.1021/bi960594b; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cherfils J, 1997, EMBO J, V16, P5582, DOI 10.1093/emboj/16.18.5582; Corbett KD, 2001, TRENDS BIOCHEM SCI, V26, P710, DOI 10.1016/S0968-0004(01)01974-0; Gao XL, 2001, J BIOL CHEM, V276, P42219, DOI 10.1074/jbc.M105760200; Geyer M, 1997, NAT STRUCT BIOL, V4, P694, DOI 10.1038/nsb0997-694; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Halkides CJ, 1996, BIOCHEMISTRY-US, V35, P12194, DOI 10.1021/bi9605954; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Iuga A, 2004, J MOL BIOL, V342, P1033, DOI 10.1016/j.jmb.2004.07.077; Kimmelman A, 1997, ONCOGENE, V15, P2675, DOI 10.1038/sj.onc.1201674; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLIE AGW, 1992, JOINT CCP4 PLUS ESF, V26; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925	31	51	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31267	31275		10.1074/jbc.M505503200	http://dx.doi.org/10.1074/jbc.M505503200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994326	hybrid			2022-12-27	WOS:000231487800074
J	Carmody, M; Murphy, B; Byrne, B; Power, P; Rai, D; Rawlings, B; Caffrey, P				Carmody, M; Murphy, B; Byrne, B; Power, P; Rai, D; Rawlings, B; Caffrey, P			Biosynthesis of amphotericin derivatives lacking exocyclic carboxyl groups	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-CLUSTER; POLYKETIDE SYNTHASE; MACROLIDES; PIMARICIN; TOXICITY	Amphotericin B is a medically important antifungal antibiotic that is also active against human immunodeficiency virus, Leishmania parasites, and prion diseases. The therapeutic use of amphotericin B is restricted by severe side effects that can be moderated by liposomal formulation or structural alteration. Chemical modification has shown that suppression of charge on the exocyclic carboxyl group of amphotericin B substantially reduces toxicity. We report targeted deletions of the amphN cytochrome P450 gene from the chromosome of the amphotericin-producing bacterium Streptomyces nodosus. The mutant strains produced amphotericin analogues in which methyl groups replace the exocyclic carboxyl groups. These compounds retained antifungal activity and had reduced hemolytic activity.	Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Ctr Synth & Chem Biol, Dept Ind Microbiol, Dublin 4, Ireland; Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Ctr Synth & Chem Biol, Dept Chem, Dublin 4, Ireland; Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England	University College Dublin; University College Dublin; University of Leicester	Caffrey, P (corresponding author), Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Ctr Synth & Chem Biol, Dept Ind Microbiol, Dublin 4, Ireland.	Patrick.caffrey@ucd.ie	K., Dilip/E-9022-2011; Caffrey, Patrick/B-1409-2008	K., Dilip/0000-0002-8073-4981; Murphy, Barry/0000-0003-2305-5875				Aparicio JF, 2000, CHEM BIOL, V7, P895, DOI 10.1016/S1074-5521(00)00038-7; Brautaset T, 2000, CHEM BIOL, V7, P395, DOI 10.1016/S1074-5521(00)00120-4; Byrne B, 2003, CHEM BIOL, V10, P1215, DOI 10.1016/j.chembiol.2003.12.001; Caffrey P, 2001, CHEM BIOL, V8, P713, DOI 10.1016/S1074-5521(01)00046-1; CALDERON M, 1970, J LIPID RES, V11, P167; Campelo AB, 2002, MICROBIOL-SGM, V148, P51, DOI 10.1099/00221287-148-1-51; Canuto MM, 2002, LANCET INFECT DIS, V2, P550, DOI 10.1016/S1473-3099(02)00371-7; Carmody M, 2004, GENE, V343, P107, DOI 10.1016/j.gene.2004.08.006; Chen S, 2003, CHEM BIOL, V10, P1065, DOI 10.1016/j.chembiol.2003.10.007; CHERON M, 1988, BIOCHEM PHARMACOL, V37, P827, DOI 10.1016/0006-2952(88)90168-2; Georgopapadakou NH, 1996, ANTIMICROB AGENTS CH, V40, P279, DOI 10.1128/AAC.40.2.279; Hartsel S, 1996, TRENDS PHARMACOL SCI, V17, P445, DOI 10.1016/S0165-6147(96)01012-7; HERVE M, 1989, BIOCHIM BIOPHYS ACTA, V980, P261, DOI 10.1016/0005-2736(89)90312-X; Jones J, 2005, VIROLOGY, V331, P106, DOI 10.1016/j.virol.2004.10.013; KIESER T, 2000, PRACTICAL STREPTOMYC, P289; Lemke A, 2005, APPL MICROBIOL BIOT, V68, P151, DOI 10.1007/s00253-005-1955-9; Maki M, 2002, EUR J BIOCHEM, V269, P593, DOI 10.1046/j.0014-2956.2001.02688.x; Mange A, 2000, J NEUROCHEM, V74, P754, DOI 10.1046/j.1471-4159.2000.740754.x; McNamara CM, 1998, J CHEM SOC PERK T 1, P83, DOI 10.1039/a704545j; Mendes MV, 2001, CHEM BIOL, V8, P635, DOI 10.1016/S1074-5521(01)00033-3; NICOLAOU KC, 1988, J AM CHEM SOC, V110, P4696, DOI 10.1021/ja00222a030; Omura S., 1986, MACROLIDE ANTIBIOTIC, P351; Petit C, 1999, ANTIMICROB AGENTS CH, V43, P390, DOI 10.1128/AAC.43.2.390; POCCHIARI M, 1987, J GEN VIROL, V68, P219, DOI 10.1099/0022-1317-68-1-219; Seco EM, 2004, CHEM BIOL, V11, P357, DOI 10.1016/j.chembiol.2004.02.017; Szlinder-Richert J, 2001, BBA-GEN SUBJECTS, V1528, P15, DOI 10.1016/S0304-4165(01)00166-0; TAYLOR AW, 1993, J ANTIBIOT, V46, P486, DOI 10.7164/antibiotics.46.486; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727	28	87	97	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34420	34426		10.1074/jbc.M506689200	http://dx.doi.org/10.1074/jbc.M506689200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16079135	hybrid, Green Submitted			2022-12-27	WOS:000232403900007
J	Kawai, C; Prado, FM; Nunes, GLC; Di Mascio, P; Carmona-Ribeiro, AM; Nantes, IL				Kawai, C; Prado, FM; Nunes, GLC; Di Mascio, P; Carmona-Ribeiro, AM; Nantes, IL			pH-dependent interaction of cytochrome c with mitochondrial mimetic membranes - The role of an array of positively charged amino acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; BINDING; FUSION; CONFORMATION; ASSOCIATION; APOPTOSIS; BILAYERS; RELEASE	The interaction of cytochrome c (cyt c) with mitochondrial mimetic vesicles of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine, and heart cardiolipin (PCPECL) was investigated over the 7.4 - 6.2 pH range by means of turbidimetry and photon correlation spectroscopy. In the presence of cyt c, the decrease of pH induced an increase in vesicle turbidity and mean diameter resulting from vesicle fusion as determined by a rapid decrease in the excimer/monomer ratio of 2-(10-(1-pyrene)-decanoyl)-phosphatidylcholine (PyPC). N-acetylated cyt c and protamine, a positively charged protein, increased vesicle turbidity in a pH-independent manner, whereas albumin did not affect PCPECL vesicle turbidity. pH-dependent turbidity kinetics revealed a role for cyt c-ionizable groups with a pK(a(app)) of similar to 7.0. The carbethoxylation of these groups by diethylpyrocarbonate prevented cyt c-induced vesicle fusion, although cyt c association to vesicles remained unaffected. Matrix-assisted laser desorption ionization time-of-flight analysis revealed that Lys-22, Lys-27, His-33, and Lys-87 cyt c residues were the main targets for carbethoxylation performed at low pH values (< 7.5). In fact, these amino acid residues belong to clusters of positively charged amino acids that lower the pKa. Thus, at low pH, protonation of these invariant and highly conserved amino acid residues produced a second positively charged region opposite to the Lys-72 and Lys-73 region in the cyt c structure. These two opposing sites allowed two vesicles to be brought together by the same cyt c molecule for fusion. Therefore, a novel pH-dependent site associating cyt c to mitochondrial mimetic membranes was established in this study.	Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, BR-08780911 Sao Paulo, Brazil; Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508970 Sao Paulo, Brazil	Universidade de Mogi das Cruzes; Universidade de Sao Paulo	Nantes, IL (corresponding author), Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, Predio 1,Sala 1S-15, BR-08780911 Sao Paulo, Brazil.	ilnantes@umc.br	Nantes, Iseli Lourenço/B-9517-2012; Carmona-Ribeiro, Ana M./B-4768-2016; Kawai, Cintia/H-2979-2013; Di Mascio, Paolo/D-1264-2014; Carmona-Ribeiro, Ana M/A-6235-2008	Nantes, Iseli Lourenço/0000-0003-1434-3154; Carmona-Ribeiro, Ana M./0000-0001-8500-2707; Di Mascio, Paolo/0000-0003-4125-8350; Carmona-Ribeiro, Ana M/0000-0001-8500-2707				ANTALIK M, 1999, BIOCHIM BIOPHYS ACTA, V1434, P347; Banci L, 1997, BIOCHEMISTRY-US, V36, P9867, DOI 10.1021/bi970724w; Barros MH, 2003, FREE RADICAL BIO MED, V35, P179, DOI 10.1016/S0891-5849(03)00307-1; CARMONARIBEIRO AM, 1985, J PHYS CHEM-US, V89, P2928, DOI 10.1021/j100259a045; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; DEKRUIJFF B, 1980, BIOCHIM BIOPHYS ACTA, V602, P477, DOI 10.1016/0005-2736(80)90327-2; Dickerson R. E., 1979, PORPHYRINS, P397; Ernster L., 1992, MOL MECH BIOENERGETI; Grabowski E., 1983, MEASUREMENT SUSPENDE, P199; KINNUNEN PKJ, 1992, CHEM PHYS LIPIDS, V63, P251, DOI 10.1016/0009-3084(92)90041-M; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kostrzewa A, 2000, BIOCHEMISTRY-US, V39, P6066, DOI 10.1021/bi992559l; Kowaltowski A, 2000, CELL DEATH DIFFER, V7, P903, DOI 10.1038/sj.cdd.4400722; Kowaltowski AJ, 1999, J BIOENERG BIOMEMBR, V31, P581, DOI 10.1023/A:1005421112345; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; LEE S, 1989, ARCH BIOCHEM BIOPHYS, V271, P188, DOI 10.1016/0003-9861(89)90269-5; Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0; Matroule JY, 2001, ONCOGENE, V20, P4070, DOI 10.1038/sj.onc.1204546; Nantes IL, 2001, J BIOL CHEM, V276, P153, DOI 10.1074/jbc.M006338200; Nicholls D.G., 1992, BIOENERGETICS, V2, P22; NICHOLLS P, 1974, BIOCHIM BIOPHYS ACTA, V346, P261, DOI 10.1016/0304-4173(74)90003-2; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; PINHEIRO TJT, 1994, BIOCHIMIE, V76, P489, DOI 10.1016/0300-9084(94)90173-2; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; RYTOMAA M, 1992, J BIOL CHEM, V267, P22243; RYTOMAA M, 1994, J BIOL CHEM, V269, P1770; SCHENKMAN S, 1981, BIOCHIM BIOPHYS ACTA, V649, P633, DOI 10.1016/0005-2736(81)90168-1; Sugawara T, 2002, FASEB J, V16, P1997, DOI 10.1096/fj.02-0251fje; TAKANO T, 1981, J MOL BIOL, V153, P79, DOI 10.1016/0022-2836(81)90528-3; Tuominen EKJ, 2002, J BIOL CHEM, V277, P8822, DOI 10.1074/jbc.M200056200; WUTHRICH K, 1971, BIOCHIM BIOPHYS ACTA, V253, P98, DOI 10.1016/0005-2728(71)90237-4; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c; Zucchi MR, 2003, BIOCHEM J, V370, P671, DOI 10.1042/BJ20021521	36	94	95	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34709	34717		10.1074/jbc.M412532200	http://dx.doi.org/10.1074/jbc.M412532200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16012169	hybrid			2022-12-27	WOS:000232403900041
J	Marin, F; Amons, R; Guichard, N; Stigter, M; Hecker, A; Luquet, G; Layrolle, P; Alcaraz, G; Riondet, C; Westbroek, P				Marin, F; Amons, R; Guichard, N; Stigter, M; Hecker, A; Luquet, G; Layrolle, P; Alcaraz, G; Riondet, C; Westbroek, P			Caspartin and calprismin, two proteins of the shell calcitic prisms of the Mediterranean fan mussel Pinna nobilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AMINO-ACID-SEQUENCE; SNAIL BIOMPHALARIA-GLABRATA; NACREOUS LAYER FORMATION; O-GLYCOSYLATION SITES; MATRIX PROTEIN; ORGANIC MATRIX; SOLUBLE MATRIX; MOLLUSK SHELLS; POLYACRYLAMIDE GELS; HALIOTIS-LAEVIGATA	We used the combination of preparative electrophoresis and immunological detection to isolate two new proteins from the shell calcitic prisms of Pinna nobilis, the Mediterranean fan mussel. The amino acid composition of these proteins was determined. Both proteins are soluble, intracrystalline, and acidic. The 38-kDa protein is glycosylated; the 17-kDa one is not. Ala, Asx, Thr, and Pro represent the dominant residues of the 38-kDa protein, named calprismin. An N-terminal sequence was obtained from calprismin. This sequence, which comprises a pattern of 4 cysteine residues, is not related to any known protein. The second protein, named caspartin, exhibits an unusual amino acid composition, since Asx constitutes by far the main amino acid residue. Preliminary sequencing surprisingly suggests that the first 75 N-terminal residues are all Asp. Caspartin self-aggregates spontaneously into multimers. In vitro tests show that it inhibits the precipitation of calcium carbonate. Furthermore, it strongly interferes with the growth of calcite crystals. A polyclonal antiserum raised against caspartin was used to localize this protein in the shell by immunogold. The immunolocalization demonstrates that caspartin is distributed within the prisms and makes a continuous film at the interface between the prisms and the surrounding insoluble sheets. Our finding emphasizes the prominent role of aspartic acid-rich proteins for the building of calcitic prisms among molluscs.	Univ Bourgogne, CNRS, UMR Biogeosci 5561, F-21000 Dijon, France; IsoTis NV, NL-3723 MB Bilthoven, Netherlands; Leiden Univ, Sylvius Labs, NL-2300 RA Leiden, Netherlands; Univ Paris 11, CNRS, UMR 8621, Inst Genet Mol,Equipe BMGE, F-91405 Orsay, France; ENESAD, INRA, UMR Biochim Interact Cellulaires 692, F-21079 Dijon, France; Leiden Univ, Leiden Inst Chem, Gorlaeus Labs, NL-2300 RA Leiden, Netherlands	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Leiden University; Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; Leiden University; Leiden University - Excl LUMC	Marin, F (corresponding author), Univ Bourgogne, CNRS, UMR Biogeosci 5561, 6 Bd Gabriel, F-21000 Dijon, France.	frederic.marin@u-bourgogne.fr	HECKER, Arnaud/AAA-4853-2019; Layrolle, Pierre/K-9257-2015	HECKER, Arnaud/0000-0003-4511-5410; Layrolle, Pierre/0000-0001-9800-5210				ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732; Albeck S, 1996, CHEM-EUR J, V2, P278, DOI 10.1002/chem.19960020308; ALBECK S, 1993, J AM CHEM SOC, V115, P11691, DOI 10.1021/ja00078a005; Almeida MJ, 2000, J EXP ZOOL, V288, P327, DOI 10.1002/1097-010X(20001215)288:4<327::AID-JEZ5>3.0.CO;2-#; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARMSTRONG DJ, 1993, BIOCHEM BIOPH RES CO, V192, P1380, DOI 10.1006/bbrc.1993.1569; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Bedouet L, 2001, COMP BIOCHEM PHYS B, V128, P389, DOI 10.1016/S1096-4959(00)00337-7; Belcher Angela M., 2000, P221; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; Carter J.G., 1990, SKELETAL BIOMINERALI; Checa A, 2000, TISSUE CELL, V32, P405, DOI 10.1054/tice.2000.0129; Checa AG, 2001, P ROY SOC B-BIOL SCI, V268, P771, DOI 10.1098/rspb.2000.1415; Christlet THT, 2001, BIOPHYS J, V80, P952, DOI 10.1016/S0006-3495(01)76074-2; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; CLEGG DO, 1988, J CELL BIOL, V107, P699, DOI 10.1083/jcb.107.2.699; Cuif J.P., 1983, Haliotis, V13, P131; Cuif J.P., 1991, P391; CUIF JP, 1987, CR ACAD SCI II, V304, P475; Currey JD, 1999, J EXP BIOL, V202, P3285; Dauphin Y, 2003, J STRUCT BIOL, V142, P272, DOI 10.1016/S1047-8477(03)00054-6; Dauphin Y, 2003, J BIOL CHEM, V278, P15168, DOI 10.1074/jbc.M204375200; Dauphin Y, 2002, COMP BIOCHEM PHYS A, V132, P577, DOI 10.1016/S1095-6433(02)00099-5; DEVINE PL, 1990, BIOTECHNIQUES, V8, P492; *DION CORP, 1998, 40 DION CORP, P1; DONACHY JE, 1992, MAR BIOL, V114, P423, DOI 10.1007/BF00350033; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; GASPARD D, 1978, Annales de Paleontologie Invertebres, V64, P1; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gotliv BA, 2005, CHEMBIOCHEM, V6, P304, DOI 10.1002/cbic.200400221; HALLORAN BA, 1995, COMP BIOCHEM PHYS B, V111, P221, DOI 10.1016/0305-0491(94)00245-P; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; HARDY MR, 1989, METHOD ENZYMOL, V179, P76; Hattan SJ, 2001, J BIOL CHEM, V276, P4461, DOI 10.1074/jbc.M006803200; HEYWOOD BR, 1994, ADV MATER, V6, P9, DOI 10.1002/adma.19940060103; HUTTNER WB, 1987, TRENDS BIOCHEM SCI, V12, P361, DOI 10.1016/0968-0004(87)90166-6; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Kaplan DL, 1998, CURR OPIN SOLID ST M, V3, P232, DOI 10.1016/S1359-0286(98)80096-X; KEITH J, 1993, COMP BIOCHEM PHYS B, V105, P487, DOI 10.1016/0305-0491(93)90078-J; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; Kouchinsky A, 2000, ACTA PALAEONTOL POL, V45, P119; KRAMPITZ G, 1983, BIOMINERALIZATION BI, P231; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEONG MML, 1986, J HISTOCHEM CYTOCHEM, V34, P1645, DOI 10.1177/34.12.3537113; Lopez Evelyne, 1995, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P49; Lowenstam HA, 1989, BIOMINERALIZATION; Mann K, 2000, EUR J BIOCHEM, V267, P5257, DOI 10.1046/j.1432-1327.2000.01602.x; MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0; Mann S., 2001, BIOMINERALIZATION PR; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; Marin F, 2003, PROTEIN EXPRES PURIF, V30, P246, DOI 10.1016/S1046-5928(03)00105-0; Marin F, 2001, PROTEIN EXPRES PURIF, V23, P175, DOI 10.1006/prep.2001.1487; MARIN F, 1994, CR ACAD SCI II, V318, P1653; Marin F, 2000, J BIOL CHEM, V275, P20667, DOI 10.1074/jbc.M003006200; Marin Frederic, 2003, ScientificWorldJournal, V3, P342; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6; Marxen JC, 1997, COMP BIOCHEM PHYS B, V118, P23, DOI 10.1016/S0305-0491(97)00010-2; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCCALDON P, 1988, PROTEINS, V4, P99, DOI 10.1002/prot.340040204; Michenfelder M, 2003, BIOPOLYMERS, V70, P522, DOI 10.1002/bip.10536; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyashita T, 2000, MAR BIOTECHNOL, V2, P409; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; Nakahara H., 1980, JPN J MALACOL, V39, P167; Reddi AH, 2000, BIOCHEM SOC T, V28, P345, DOI 10.1042/0300-5127:0280345; Ritchie HH, 1996, J BIOL CHEM, V271, P21695, DOI 10.1074/jbc.271.36.21695; RUNNEGAR B, 1985, ALCHERINGA, V9, P245, DOI 10.1080/03115518508618971; RUSENKO KW, 1991, ACS SYM SER, V444, P107; SALEUDDIN ASM, 1983, MOLLUSCA, V4, P199; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Sarashina I, 1998, AM MINERAL, V83, P1510, DOI 10.2138/am-1998-11-1239; Sarashina I, 2001, MAR BIOTECHNOL, V3, P362, DOI 10.1007/s10126-001-0013-6; SCHUSTER R, 1988, J CHROMATOGR-BIOMED, V431, P271, DOI 10.1016/S0378-4347(00)83096-0; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Simkiss K., 1968, EGG QUALITY STUDY HE, P3; Simkiss K, 1989, BIOMINERALIZATION CE; STETLERSTEVENSON WG, 1983, BIOCHEMISTRY-US, V22, P4326, DOI 10.1021/bi00287a025; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Takeuchi K, 2003, J BIOL CHEM, V278, P47416, DOI 10.1074/jbc.M309415200; TAYLOR JD, 1969, B BRIT MUSEUM NATU S, V3, P1; TISDELL CA, 2000, SPC PEARL OYSTER INF, V14, P21; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; UBUKATA T, 1994, PALAEONTOLOGY, V37, P241; Ubukata T, 1997, VELIGER, V40, P165; VEIS A, 1991, ACS SYM SER, V444, P1; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; WALL RS, 1988, ANAL BIOCHEM, V175, P298, DOI 10.1016/0003-2697(88)90392-2; WEINER S, 1979, CALCIFIED TISSUE INT, V29, P163, DOI 10.1007/BF02408072; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; WEINER S, 1983, BIOCHEMISTRY-US, V22, P4139, DOI 10.1021/bi00286a023; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; Weiner S., 1983, BIOMINER BIOL MET AC, P205, DOI [10.1007/978-94-009-7944-4_18, DOI 10.1007/978-94-009-7944-4_18]; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; Weiss IM, 2001, BIOCHEM BIOPH RES CO, V285, P244, DOI 10.1006/bbrc.2001.5170; Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798; WHEELER AP, 1987, COMP BIOCHEM PHYS B, V87, P953, DOI 10.1016/0305-0491(87)90418-4; WHEELER AP, 1981, SCIENCE, V212, P1397, DOI 10.1126/science.212.4501.1397; Wilkins MR, 1996, BIOCHEM BIOPH RES CO, V221, P609, DOI 10.1006/bbrc.1996.0643; Wilt FH, 2003, DIFFERENTIATION, V71, P237, DOI 10.1046/j.1432-0436.2003.7104501.x; YAZAKI PJ, 1990, BIOCHEM BIOPH RES CO, V170, P1089, DOI 10.1016/0006-291X(90)90504-G; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6	106	110	112	4	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					33895	33908		10.1074/jbc.M506526200	http://dx.doi.org/10.1074/jbc.M506526200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	15994301	Green Published, hybrid			2022-12-27	WOS:000232229700026
J	Medunjanin, S; Hermani, A; De Servi, B; Grisouard, J; Rincke, G; Mayer, D				Medunjanin, S; Hermani, A; De Servi, B; Grisouard, J; Rincke, G; Mayer, D			Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor alpha and is involved in the regulation of receptor activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ACTIVATED PROTEIN-KINASE; KAPPA-B ACTIVATION; TRANSCRIPTIONAL ACTIVATION; NUCLEAR RECEPTORS; GENE-EXPRESSION; BETA-CATENIN; CELL-GROWTH; ESTRADIOL; INHIBITION	Like other steroid hormone receptors, estrogen receptor-alpha (ER alpha) is a substrate for protein kinases, and phosphorylation has profound effects on the function and activity of this receptor. A number of different kinases have been implicated in ER alpha regulation. In this report we show by mutational analysis and in vitro kinase assays that ER alpha is a substrate for glycogen synthase kinase-3 (GSK-3) in vitro and is phosphorylated on two sites, the Ser-102, -104, and -106 motif and Ser-118, both located in the N-terminal transcription activation function (AF-1) domain. GSK-3 forms a complex with ER alpha in vivo as demonstrated by co-immunoprecipitation from cell lysates. The GSK-3 inhibitor lithium chloride was used to determine the role of GSK-3 in phosphorylation of Ser-102, -104, and -106 and Ser-118 in vivo and to explore the role of these serines in the regulation of ER alpha function. Treatment of cells with lithium chloride resulted in dephosphorylation of Ser-104 and -106 and Ser-118, which suggests these serine residues as targets for GSK-3 in vivo. Our results further suggest that ER alpha phosphorylation by GSK-3 stabilizes ER alpha under resting conditions and modulates ER alpha transcriptional activity upon ligand binding. Inhibition and constitutive activation of GSK-3, both, resulted in inhibition of ER alpha transcriptional activity, indicating a function of active as well as inactive GSK-3 in ER alpha regulation. These findings uncover a novel mechanism for the regulation of ER alpha-mediated estrogen signaling controlled by a dual action of GSK-3.	German Canc Res Ctr, Hormones & Signal Transduct Grp, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Mayer, D (corresponding author), German Canc Res Ctr, Hormones & Signal Transduct Grp, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	d.mayer@dkfz.de						Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Balaguer P, 2001, LUMINESCENCE, V16, P153, DOI 10.1002/bio.630; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Cardona-Gomez P, 2004, MOL CELL NEUROSCI, V25, P363, DOI 10.1016/j.mcn.2003.10.008; Castano E, 1998, J STEROID BIOCHEM, V65, P101, DOI 10.1016/S0960-0760(97)00179-9; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Cheng SW, 2000, COMB OPT (SER), V6, P137; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Servi B, 2005, ONCOGENE, V24, P4946, DOI 10.1038/sj.onc.1208676; DEGROOT RP, 1993, ONCOGENE, V8, P841; Demarchi F, 2003, J BIOL CHEM, V278, P39583, DOI 10.1074/jbc.M305676200; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Glass CK, 2000, GENE DEV, V14, P121; GOODE N, 1992, J BIOL CHEM, V267, P16878; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Joel PB, 1998, J BIOL CHEM, V273, P13317, DOI 10.1074/jbc.273.21.13317; JOEL PB, 1995, MOL ENDOCRINOL, V9, P1041, DOI 10.1210/me.9.8.1041; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; KEOWN WA, 1990, METHOD ENZYMOL, V185, P527, DOI 10.1016/0076-6879(90)85043-N; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; LE GP, 1994, J BIOL CHEM, V269, P4458; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; MacAulay K, 2003, EUR J BIOCHEM, V270, P3829, DOI 10.1046/j.1432-1033.2003.03777.x; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mazor M, 2004, ONCOGENE, V23, P7882, DOI 10.1038/sj.onc.1208068; MIGLIACCIO A, 1993, ONCOGENE, V8, P2183; Nemeth ZH, 2002, J BIOL CHEM, V277, P7713, DOI 10.1074/jbc.M109711200; Rogatsky I, 1999, J BIOL CHEM, V274, P22296, DOI 10.1074/jbc.274.32.22296; Rogatsky I, 1998, J BIOL CHEM, V273, P14315, DOI 10.1074/jbc.273.23.14315; Salas TR, 2004, J BIOL CHEM, V279, P19191, DOI 10.1074/jbc.M309560200; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Takeda K, 2000, HUM MOL GENET, V9, P125, DOI 10.1093/hmg/9.1.125; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Turenne GA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-12; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004; Wang L, 2004, J BIOL CHEM, V279, P32444, DOI 10.1074/jbc.M313963200; Watcharasit P, 2003, J BIOL CHEM, V278, P48872, DOI 10.1074/jbc.M305870200; WOODGETT JR, 1991, METHOD ENZYMOL, V200, P564	49	111	116	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					33006	33014		10.1074/jbc.M506758200	http://dx.doi.org/10.1074/jbc.M506758200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16076840	hybrid			2022-12-27	WOS:000231920300055
J	Hong, M; Xu, W; Yoshida, T; Tanaka, K; Wolff, DJ; Zhou, FF; Inouye, M; You, GF				Hong, M; Xu, W; Yoshida, T; Tanaka, K; Wolff, DJ; Zhou, FF; Inouye, M; You, GF			Human organic anion transporter hOAT1 forms homooligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; MOLECULAR-CLONING; EXPRESSION CLONING; CATION TRANSPORTER; LLC-PK1 CELLS; KIDNEY; CHANNEL; IDENTIFICATION; GLYCOSYLATION; MEMBRANE	Human organic anion transporter hOAT1 belongs to a superfamily of organic anion transporters, which play critical roles in the body disposition of clinically important drugs, including anti-human immunodeficiency virus therapeutics, anti-tumor drugs, antibiotics, anti-hypertensives, and anti-inflammatories. To gain insight into the regulation of hOAT1, detailed information on its structural assembly is essential. In the present study, we investigate the quaternary structure of hOAT1 using combined approaches of chemical cross-linking, gel filtration chromatography, co-immunoprecipitation, cell surface biotinylation, and metabolic labeling. Chemical cross-linking of intact membrane proteins from LLC-PK1 cells stably expressing hOAT1 converted quantitatively hOAT1 monomer to putative trimer and higher order of oligomer, indicating that hOAT1 is present in the membrane as multimeric complexes. When co-expressed in LLC-PK1 cells, FLAG-tagged hOAT1 co-immunoprecipitated with myc-tagged hOAT1. The hOAT1 oligomer was also detected in gel filtration chromatography of total membranes from hOAT1-expressing LLC-PK1 cells. Cell surface biotinylation with membrane-impermeable reagents and metabolic labeling with [S-35] methionine followed by immunoprecipitation showed that the oligomeric hOAT1 did not contain any other proteins. Taken together, this is the first study demonstrating that hOAT1 exists in the plasma membrane as a homooligomer, possibly trimer, and higher order of oligomer.	Rutgers State Univ, Dept Pharmaceut, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	You, GF (corresponding author), Rutgers State Univ, Dept Pharmaceut, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	gyou@rci.rutgers.edu	Zhou, Fanfan/M-4404-2013; Zhou, Fanfan/J-2327-2019	Zhou, Fanfan/0000-0002-1982-1541; Zhou, Fanfan/0000-0002-1982-1541; Yoshida, Takeshi/0000-0003-0133-5067; Hong, Mei/0000-0001-9219-2844	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060034] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK 60034] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brown D, 1996, PHYSIOL REV, V76, P245, DOI 10.1152/physrev.1996.76.1.245; Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; Cihlar T, 1999, MOL PHARMACOL, V56, P570, DOI 10.1124/mol.56.3.570; de Jong JC, 2003, J BIOL CHEM, V278, P24302, DOI 10.1074/jbc.M303101200; Ekaratanawong S, 2004, J PHARMACOL SCI, V94, P297, DOI 10.1254/jphs.94.297; Grundemann D, 1997, J BIOL CHEM, V272, P10408; Hong M, 2004, J BIOL CHEM, V279, P31478, DOI 10.1074/jbc.M404686200; HORI R, 1993, AM J PHYSIOL, V264, pF975, DOI 10.1152/ajprenal.1993.264.6.F975; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Kusuhara H, 1999, J BIOL CHEM, V274, P13675, DOI 10.1074/jbc.274.19.13675; Kuze K, 1999, J BIOL CHEM, V274, P1519, DOI 10.1074/jbc.274.3.1519; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Lu R, 1999, AM J PHYSIOL-RENAL, V276, pF295, DOI 10.1152/ajprenal.1999.276.2.F295; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; PRESTON GM, 1993, J BIOL CHEM, V268, P17; Ramjeesingh M, 2001, BIOCHEMISTRY-US, V40, P10700, DOI 10.1021/bi0108195; Regeer RR, 2004, AM J PHYSIOL-CELL PH, V287, pC365, DOI 10.1152/ajpcell.00502.2003; Sekine T, 1998, FEBS LETT, V429, P179, DOI 10.1016/S0014-5793(98)00585-7; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; Tanaka K, 2004, J BIOL CHEM, V279, P14961, DOI 10.1074/jbc.M400197200; Wolff NA, 1997, FEBS LETT, V417, P287, DOI 10.1016/S0014-5793(97)01304-5; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; You GF, 2004, CURR DRUG METAB, V5, P55, DOI 10.2174/1389200043489207; You GF, 2000, J BIOL CHEM, V275, P10278, DOI 10.1074/jbc.275.14.10278; You GF, 2002, MED RES REV, V22, P602, DOI 10.1002/med.10019; Youngblood GL, 2004, AM J PHYSIOL-RENAL, V287, pF236, DOI 10.1152/ajprenal.00012.2004; Zhou FF, 2005, MOL PHARMACOL, V67, P868, DOI 10.1124/mol.104.007583	29	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32285	32290		10.1074/jbc.M501447200	http://dx.doi.org/10.1074/jbc.M501447200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16046403	hybrid			2022-12-27	WOS:000231794800031
J	Chan, SSL; Longley, MJ; Copeland, WC				Chan, SSL; Longley, MJ; Copeland, WC			The common A467T mutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE DELETIONS; SPACER-REGION; GAMMA; IDENTIFICATION; DISORDERS; DEFECTS; PROCESSIVITY; DEPLETION; BINDING; ATAXIA	dAmong the nearly 50 disease mutations in the gene for the catalytic subunit of human DNA polymerase gamma, POLG, the A467T substitution is the most common and has been found in 0.6% of the Belgian population. The A467T mutation is associated with a wide range of mitochondrial disorders, including Alpers syndrome, juvenile spinocerebellar ataxia-epilepsy syndrome, and progressive external ophthalmoplegia, each with vastly different clinical presentations, tissue specificities, and ages of onset. The A467T mutant enzyme possesses only 4% of wild-type DNA polymerase activity, and the catalytic defect is manifest primarily through a 6-fold reduction in k(cat) with minimal effect on exonuclease function. Human DNA polymerase gamma (pol gamma) requires association of a 55-kDa accessory subunit for enhanced DNA binding and highly processive DNA synthesis. However, the A467T mutant enzyme failed to interact with and was not stimulated by the accessory subunit, as judged by processivity, heat inactivation, and N-ethylmaleimide protection assays in vitro. Thermolysin digestion and immunoprecipitation experiments further indicate weak association of the subunits for A467T pol gamma. This is the first example of a mutation in POLG that disrupts physical association of the pol gamma subunits. We propose that reduced polymerase activity and loss of accessory subunit interaction are responsible for the depletion and deletion of mitochondrial DNA observed in patients with this POLG mutation.	NIEHS, NIH, Lab Mol Genet, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Copeland, WC (corresponding author), NIEHS, NIH, Lab Mol Genet, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.	copelan1@niehs.nih.gov	Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953				Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C; Bienstock RJ, 2004, MITOCHONDRION, V4, P203, DOI 10.1016/j.mito.2004.05.018; CHAN SSL, 2005, IN PRESS DNA REPAIR; Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Fan L, 2001, BIOCHEMISTRY-US, V40, P4780, DOI 10.1021/bi010102h; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279; HUBER HE, 1987, J BIOL CHEM, V262, P16224; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Longley Matthew J, 2002, Methods Mol Biol, V197, P245, DOI 10.1385/1-59259-284-8:245; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; LONGLEY MJ, 1991, J BIOL CHEM, V266, P24702; LONGLEY MJ, 2005, IN PRESS GENE; Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196; Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079; Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B; NGUYEN KV, 2005, IN PRESS NEUROLOGY; POLESKY AH, 1990, J BIOL CHEM, V265, P14579; Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200; Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759; SPINAZZOLA A, 2005, IN PRESS GENE; TABOR S, 1987, J BIOL CHEM, V262, P16212; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83; Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65; Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X; Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	35	105	105	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31341	31346		10.1074/jbc.M506762200	http://dx.doi.org/10.1074/jbc.M506762200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16024923	hybrid			2022-12-27	WOS:000231665200002
J	Grech, AP; Gardam, S; Chan, TN; Quinn, R; Gonzales, R; Basten, A; Brink, R				Grech, AP; Gardam, S; Chan, TN; Quinn, R; Gonzales, R; Basten, A; Brink, R			Tumor necrosis factor receptor 2 (TNFR2) signaling is negatively regulated by a novel, carboxyl-terminal TNFR-associated factor 2 (TRAF2)-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; RECEPTOR-ASSOCIATED FACTOR-2; CELL-DEATH; CYTOPLASMIC DOMAIN; ADAPTER PROTEINS; STRUCTURAL BASIS; HUMAN TRAF2; ACTIVATION; CD40	Tumor necrosis factor (TNF) superfamily receptors typically induce both NF-kappa B and JNK activation by recruiting the TRAF2 signal transduction protein to their cytoplasmic domain. The type 2 TNF receptor (TNFR2), however, is a poor activator of these signaling pathways despite its high TRAF2 binding capability. This apparent paradox is resolved here by the demonstration that TNFR2 carries a novel carboxyl-terminal TRAF2-binding site (T2bs-C) that prevents the delivery of activation signals from its conventional TRAF2-binding site (T2bsN). T2bs-C does not conform to canonical TRAF2 binding motifs and appears to bind TRAF2 indirectly via an as yet unidentified intermediary. Specific inactivation of T2bs-N by site-directed mutagenesis eliminated most of the TRAF2 recruited to the TNFR2 cytoplasmic domain but had no effect on ligand-dependent activation of the NF-kappa B or JNK pathways. By contrast, inactivation of T2bs-C had little effect on the amount of TRAF2 recruited but greatly enhanced ligand-dependent NF-kappa B and JNK activation. In wild-type TNFR2 therefore, T2bs-C acts in a dominant fashion to attenuate signaling by the intrinsically more active T2bs-N but not by preventing TRAF2 recruitment. This unique uncoupling of TRAF2 recruitment and signaling at T2bs-N may be important in the modulation by TNFR2 of signaling through coexpressed TNFR1.	Centenary Inst Canc Med & Cell Biol, Newtown, NSW 4042, Australia	University of Sydney; Centenary Institute	Brink, R (corresponding author), Centenary Inst Canc Med & Cell Biol, Locked Bag 6, Newtown, NSW 4042, Australia.	r.brink@centenary.usyd.edu.au	Brink, Robert/B-7910-2010	Brink, Robert/0000-0002-9586-3655; Chan, Tyani/0000-0001-9276-8479				Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BAENS M, 1993, GENOMICS, V16, P214, DOI 10.1006/geno.1993.1161; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; BEG AA, 1996, SCIENCE, V274, P784; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Brink R, 1998, J BIOL CHEM, V273, P4129, DOI 10.1074/jbc.273.7.4129; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chainy GBN, 1996, J IMMUNOL, V157, P2410; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; CLEMENT MV, 1994, J EXP MED, V180, P557, DOI 10.1084/jem.180.2.557; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Grech A, 2000, MOL IMMUNOL, V37, P721, DOI 10.1016/S0161-5890(00)00098-5; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Grell M, 1998, EUR J IMMUNOL, V28, P257, DOI 10.1002/(SICI)1521-4141(199801)28:01<257::AID-IMMU257>3.0.CO;2-G; Haridas V, 1998, J IMMUNOL, V160, P3152; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; LAEGREID A, 1994, J BIOL CHEM, V269, P7785; Lee SY, 1996, J EXP MED, V183, P669, DOI 10.1084/jem.183.2.669; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lucas R, 1998, EUR J IMMUNOL, V28, P3577, DOI 10.1002/(SICI)1521-4141(199811)28:11<3577::AID-IMMU3577>3.0.CO;2-#; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; MUNROE ME, 2004, J BIOL CHEM; Pan S, 2002, MOL CELL BIOL, V22, P7512, DOI 10.1128/MCB.22.21.7512-7523.2002; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TORRES RM, 1992, J IMMUNOL, V148, P620; VAN AD, 1996, SCIENCE, V274, P787; Wajant H, 2001, INT J BIOCHEM CELL B, V33, P19, DOI 10.1016/S1357-2725(00)00064-9; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Weiss T, 1997, J IMMUNOL, V158, P2398; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	47	37	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31572	31581		10.1074/jbc.M504849200	http://dx.doi.org/10.1074/jbc.M504849200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16020544	hybrid			2022-12-27	WOS:000231665200030
J	Ho, JGS; Kitov, PI; Paszkiewicz, E; Sadowska, J; Bundle, DR; Ng, KKS				Ho, JGS; Kitov, PI; Paszkiewicz, E; Sadowska, J; Bundle, DR; Ng, KKS			Ligand-assisted aggregation of proteins - Dimerization of serum amyloid p component by bivalent ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR REPLACEMENT; TARGETED DELETION; MASS-SPECTROMETRY; X-RAY; GENE; AUTOIMMUNITY; COMPLEXES; PROGRAM; TOXINS; MODEL	A comprehensive series of solution and crystallographic studies reveal how simple, achiral, bivalent ligands of the cyclic pyruvate of glycerol promote face-to-face complex formation of the pentraxin, serum amyloid P component (SAP) into decamers. SAP, a protein of the human innate immune system, is universally present in amyloids, including cerebral amyloid deposits found in the brain of Alzheimer disease patients. Removal of SAP through a specific aggregation mechanism mediated by multivalent ligands appears to provide therapeutic benefit in the progression of this disease. Crystallographic studies reveal that in our novel series of ligands only the methyl and carboxylate moieties of the pyruvate ketal directly interact with the protein, but the geometric constraints imposed by the tether dictate which of two chair conformations are adopted by the pyruvate dioxane ring. Solution studies, as interpreted through a simple thermodynamic model, account for the distribution of pentameric and decameric bound states at different ligand concentrations and indicate that differences in the flexibility of the tether determine the geometry and stability of the specific aggregates formed between SAP and two different bivalent ligands. The factors affecting the design of ligands promoting face-to-face protein dimerization as well as potential biological implications are discussed.	Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Univ Alberta, Alberta Ingenu Ctr Carbohydrate Sci, Dept Chem, Edmonton, AB T6G 2G2, Canada	University of Calgary; University of Alberta	Ng, KKS (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	ngk@ucalgary.ca	Kitov, Pavel/J-3714-2014	Ng, Kenneth K.S./0000-0001-7280-8445				Aquilina JA, 2003, BIOCHEM J, V375, P323, DOI 10.1042/BJ20030541; Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Boas U, 2004, CHEM SOC REV, V33, P43, DOI 10.1039/b309043b; Botto M, 1997, NAT MED, V3, P855, DOI 10.1038/nm0897-855; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Fan EK, 2000, J AM CHEM SOC, V122, P2663, DOI 10.1021/ja993388a; Gargano JM, 2001, J AM CHEM SOC, V123, P12909, DOI 10.1021/ja016305a; Gillmore JD, 2004, IMMUNOLOGY, V112, P255, DOI 10.1111/j.1365-2567.2004.01860.x; Hohenester E, 1997, J MOL BIOL, V269, P570, DOI 10.1006/jmbi.1997.1075; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hutchinson WL, 2000, MOL MED, V6, P482, DOI 10.1007/BF03401789; Kitov PI, 2003, J AM CHEM SOC, V125, P16271, DOI 10.1021/ja038223n; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; Kitova EN, 2001, GLYCOBIOLOGY, V11, P605, DOI 10.1093/glycob/11.7.605; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Noursadeghi M, 2000, P NATL ACAD SCI USA, V97, P14584, DOI 10.1073/pnas.97.26.14584; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; Pepys MB, 1997, AMYLOID, V4, P274, DOI 10.3109/13506129709003838; Pollock R, 2002, CURR OPIN BIOTECH, V13, P459, DOI 10.1016/S0958-1669(02)00373-7; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Thompson D, 2002, J MOL BIOL, V320, P1081, DOI 10.1016/S0022-2836(02)00514-4; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhang ZS, 2002, J AM CHEM SOC, V124, P12991, DOI 10.1021/ja027584k	31	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31999	32008		10.1074/jbc.M504403200	http://dx.doi.org/10.1074/jbc.M504403200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16036920	hybrid			2022-12-27	WOS:000231665200080
J	Johnson, A; Gin, P; Marbois, BN; Hsieh, EJ; Wu, M; Barros, MH; Clarke, CF; Tzagoloff, A				Johnson, A; Gin, P; Marbois, BN; Hsieh, EJ; Wu, M; Barros, MH; Clarke, CF; Tzagoloff, A			COQ9, a new gene required for the biosynthesis of coenzyme Q in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-METHYLTRANSFERASE STEPS; UBIQUINONE BIOSYNTHESIS; MITOCHONDRIAL PROTEIN; MULTISUBUNIT COMPLEX; C-METHYLTRANSFERASE; YEAST; DEFECT; TRANSLATION; SUPPRESSION; MUTANTS	Currently, eight genes are known to be involved in coenzyme Q(6) biosynthesis in Saccharomyces cerevisiae. Here, we report a new gene designated COQ9 that is also required for the biosynthesis of this lipoid quinone. The respiratory-deficient pet mutant C92 was found to be deficient in coenzyme Q and to have low mitochondrial NADH-cytochrome c reductase activity, which could be restored by addition of coenzyme Q(2). The mutant was used to clone COQ9, corresponding to reading frame YLR201c on chromosome XII. The respiratory defect of C92 is complemented by COQ9 and suppressed by COQ8/ABC1. The latter gene has been shown to be required for coenzyme Q biosynthesis in yeast and bacteria. Suppression by COQ8/ABC1 of C92, but not other coq9 mutants tested, has been related to an increase in the mitochondrial concentration of several enzymes of the pathway. Coq9p may either catalyze a reaction in the coenzyme Q biosynthetic pathway or have a regulatory role similar to that proposed for Coq8p.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	Columbia University; University of California System; University of California Los Angeles	Tzagoloff, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	spud@cubpet2.bio.columbia.edu	Barros, Mario/Q-6358-2019; Barros, Mario H/B-8118-2012	Barros, Mario/0000-0003-2977-9815; Wu, Mian/0000-0002-2714-0500	NHLBI NIH HHS [R01 HL022174, HL2274] Funding Source: Medline; NIGMS NIH HHS [GM45952] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL022174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045952] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baba SW, 2004, J BIOL CHEM, V279, P10052, DOI 10.1074/jbc.M313712200; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Belogrudov GI, 2001, ARCH BIOCHEM BIOPHYS, V392, P48, DOI 10.1006/abbi.2001.2448; Benko AL, 2000, P NATL ACAD SCI USA, V97, P61, DOI 10.1073/pnas.97.1.61; BOTSTEIN D, 1982, MOL BIOL YEAST SACCH, P607; BOUSQUET I, 1991, EMBO J, V10, P2023, DOI 10.1002/j.1460-2075.1991.tb07732.x; CASEY J, 1978, BIOCHIM BIOPHYS ACTA, V530, P487, DOI 10.1016/0005-2760(78)90168-6; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; FAYE G, 1974, J MOL BIOL, V88, P105, DOI 10.1016/0022-2836(74)90304-0; GIBSON F, 1973, Biochemical Society Transactions, V1, P317; Gin P, 2005, J BIOL CHEM, V280, P2676, DOI 10.1074/jbc.M411527200; Gin P, 2003, J BIOL CHEM, V278, P25308, DOI 10.1074/jbc.M303234200; Glerum DM, 1996, J BIOL CHEM, V271, P20531, DOI 10.1074/jbc.271.34.20531; Glick BS, 1995, METHOD ENZYMOL, V260, P224, DOI 10.1016/0076-6879(95)60140-6; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hsieh EJ, 2004, BIOCHEM BIOPH RES CO, V317, P648, DOI 10.1016/j.bbrc.2004.03.096; Hsu AY, 2000, BBA-MOL CELL BIOL L, V1484, P287, DOI 10.1016/S1388-1981(00)00019-6; Jiang N, 2001, J BIOL CHEM, V276, P29218, DOI 10.1074/jbc.M103686200; Jonassen T, 1998, J BIOL CHEM, V273, P3351, DOI 10.1074/jbc.273.6.3351; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; Marbois B, 2005, J BIOL CHEM, V280, P20231, DOI 10.1074/jbc.M501315200; MARTIN NC, 1980, NATURE, V285, P579, DOI 10.1038/285579a0; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; Ohara K, 2004, PLANT J, V40, P734, DOI 10.1111/j.1365-313X.2004.02246.x; OLSON RE, 1983, VITAM HORM, V40, P1, DOI 10.1016/S0083-6729(08)60431-8; Poon WW, 2000, J BACTERIOL, V182, P5139, DOI 10.1128/JB.182.18.5139-5146.2000; Poon WW, 1999, J BIOL CHEM, V274, P21665, DOI 10.1074/jbc.274.31.21665; POON WW, 1995, ARCH BIOCHEM BIOPHYS, V320, P305, DOI 10.1016/0003-9861(95)90014-4; Poon WW, 1997, MOL ASPECTS MED, V18, pS121; RODEL G, 1986, CURR GENET, V11, P41, DOI 10.1007/BF00389424; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Soutourina J, 2000, J BIOL CHEM, V275, P11626, DOI 10.1074/jbc.275.16.11626; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228	41	74	75	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31397	31404		10.1074/jbc.M503277200	http://dx.doi.org/10.1074/jbc.M503277200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16027161	hybrid			2022-12-27	WOS:000231665200009
J	Enyeart, JJ; Danthi, SJ; Liu, HY; Enyeart, JA				Enyeart, JJ; Danthi, SJ; Liu, HY; Enyeart, JA			Angiotensin II inhibits bTREK-1 K+ channels in adrenocortical cells by separate Ca2(+)- and ATP hydrolysis-dependent mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL GLOMERULOSA CELLS; GATED TRANSIENT CURRENTS; ZONA-FASCICULATA CELLS; T-TYPE; CORTICAL CELLS; POTASSIUM CHANNELS; ADENOSINE-TRIPHOSPHATE; ALDOSTERONE PRODUCTION; PHOSPHOLIPASE-C; CA2+ CHANNELS	Bovine adrenocortical cells express bTREK-1 K+ channels that set the resting membrane potential (V-m) and couple angiotensin II (AngII) and adrenocorticotropic hormone (ACTH) receptors to membrane depolarization and corticosteroid secretion. In this study, it was discovered that AngII inhibits bTREK-1 by separate Ca2+- and ATP hydrolysis-dependent signaling pathways. When whole cell patch clamp recordings were made with pipette solutions that support activation of both Ca2+- and ATP-dependent pathways, AngII was significantly more potent and effective at inhibiting bTREK-1 and depolarizing adrenal zona fasciculata cells, than when either pathway is activated separately. External ATP also inhibited bTREK-1 through these two pathways, but ACTH displayed no Ca2+-dependent inhibition. AngII-mediated inhibition of bTREK-1 through the novel Ca2+-dependent pathway was blocked by the AT(1) receptor antagonist losartan, or by including guanosine-5 '-O-(2-thiodiphosphate) in the pipette solution. The Ca2+- dependent inhibition of bTREK-1 by AngII was blunted in the absence of external Ca2+ or by including the phospholipase C antagonist U73122, the inositol 1,4,5-trisphosphate receptor antagonist 2-amino-ethoxydiphenyl borate, or a calmodulin inhibitory peptide in the pipette solution. The activity of unitary bTREK-1 channels in inside-out patches from adrenal zona fasciculata cells was inhibited by application of Ca2+ ( 5 or 10 mu M) to the cytoplasmic membrane surface. The Ca2+ ionophore ionomycin also inhibited bTREK-1 currents through channels expressed in CHO-K1 cells. These results demonstrate that AngII and selected paracrine factors that act through phospholipase C inhibit bTREK-1 in adrenocortical cells through simultaneous activation of separate Ca2+- and ATP hydrolysis-dependent signaling pathways, providing for efficient membrane depolarization. The novel Ca2+- dependent pathway is distinctive in its lack of ATP dependence, and is clearly different from the calmodulin kinase-dependent mechanism by which AngII modulates T-type Ca2+ channels in these cells.	Ohio State Univ, Coll Med & Publ Hlth, Dept Neurosci, Columbus, OH 43210 USA; Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Enyeart, JJ (corresponding author), Ohio State Univ, Coll Med & Publ Hlth, Dept Neurosci, 5196 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	enyeart.1@osu.edu			NIDDK NIH HHS [R01-DK47875] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047875] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; BURNAY MM, 1994, ENDOCRINOLOGY, V135, P751, DOI 10.1210/en.135.2.751; CAPPONI AM, 1984, J BIOL CHEM, V259, P8863; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; Chen XL, 1999, AM J PHYSIOL-RENAL, V276, pF674, DOI 10.1152/ajprenal.1999.276.5.F674; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Doronin SV, 2004, J BIOL CHEM, V279, P48231, DOI 10.1074/jbc.M405789200; DUDLEY DT, 1990, MOL PHARMACOL, V38, P370; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; Enyeart JA, 2000, J BIOL CHEM, V275, P34640, DOI 10.1074/jbc.M004214200; Enyeart JA, 2004, AM J PHYSIOL-ENDOC M, V287, pE1154, DOI 10.1152/ajpendo.00223.2004; Enyeart JJ, 1997, J GEN PHYSIOL, V110, P679, DOI 10.1085/jgp.110.6.679; Enyeart JJ, 2002, J BIOL CHEM, V277, P49186, DOI 10.1074/jbc.M207233200; ENYEART JJ, 1993, MOL ENDOCRINOL, V7, P1031, DOI 10.1210/me.7.8.1031; Enyeart JJ, 1996, J GEN PHYSIOL, V108, P251, DOI 10.1085/jgp.108.4.251; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Gomora JC, 1998, AM J PHYSIOL-CELL PH, V275, pC1526, DOI 10.1152/ajpcell.1998.275.6.C1526; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOEY ED, 1994, ENDOCRINOLOGY, V134, P1553, DOI 10.1210/en.134.3.1553; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Kang D, 2005, J PHYSIOL-LONDON, V564, P103, DOI 10.1113/jphysiol.2004.081059; Kim D, 2003, TRENDS PHARMACOL SCI, V24, P648, DOI 10.1016/j.tips.2003.10.008; LU HK, 1994, AM J PHYSIOL, V267, pF183, DOI 10.1152/ajprenal.1994.267.1.F183; LYMANGROVER JR, 1982, ENDOCRINOLOGY, V110, P462, DOI 10.1210/endo-110-2-462; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MATTHEWS EK, 1967, J PHYSIOL-LONDON, V189, P139, DOI 10.1113/jphysiol.1967.sp008159; MATTHEWS EK, 1973, J PHYSIOL-LONDON, V234, P43, DOI 10.1113/jphysiol.1973.sp010333; MLINAR B, 1993, J BIOL CHEM, V268, P8640; MLINAR B, 1993, J GEN PHYSIOL, V102, P239, DOI 10.1085/jgp.102.2.239; MLINAR B, 1993, J GEN PHYSIOL, V102, P217, DOI 10.1085/jgp.102.2.217; MLINAR B, 1995, J BIOL CHEM, V270, P20942, DOI 10.1074/jbc.270.36.20942; NADLER JL, 1987, J CLIN INVEST, V80, P1763, DOI 10.1172/JCI113269; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Philipp S, 2000, J BIOL CHEM, V275, P23965, DOI 10.1074/jbc.M003408200; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rossier M F, 2000, Vitam Horm, V60, P229, DOI 10.1016/S0083-6729(00)60021-3; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Smith RD, 1999, ENDOCRINOLOGY, V140, P1385, DOI 10.1210/en.140.3.1385; SMITH RD, 1992, ANNU REV PHARMACOL, V32, P135; Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; TOKOK K, 1994, BIOCHEMISTRY-US, V33, P12807; Venema RC, 1998, J BIOL CHEM, V273, P7703, DOI 10.1074/jbc.273.13.7703; Webb TE, 1996, MOL PHARMACOL, V50, P258; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Williams MC, 1997, ELEC SOC S, V97, P3; Wolfe JT, 2002, J PHYSIOL-LONDON, V538, P343, DOI 10.1113/jphysiol.2001.012839; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xu L, 1999, J PHYSIOL-LONDON, V521, P81, DOI 10.1111/j.1469-7793.1999.00081.x; Xu L, 2001, AM J PHYSIOL-CELL PH, V280, pC199, DOI 10.1152/ajpcell.2001.280.1.C199; Xu L, 1999, MOL PHARMACOL, V55, P364, DOI 10.1124/mol.55.2.364	62	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30814	30828		10.1074/jbc.M504283200	http://dx.doi.org/10.1074/jbc.M504283200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994319	hybrid			2022-12-27	WOS:000231487800022
J	Martinez-Vicente, M; Yim, L; Villarroya, M; Mellado, M; Perez-Paya, E; Bjork, GR; Armengod, ME				Martinez-Vicente, M; Yim, L; Villarroya, M; Mellado, M; Perez-Paya, E; Bjork, GR; Armengod, ME			Effects of mutagenesis in the switch I region and conserved arginines of Escherichia coli MnmE protein, a GTPase involved in tRNA modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR G; WOBBLE MODIFICATION DEFICIENCY; GUANYLATE-BINDING PROTEIN-1; GUANINE-NUCLEOTIDE-BINDING; HUMAN MITOCHONDRIAL DISEASE; MUTANT TRANSFER-RNAS; RIBOSOMAL-RNA; TRANSLATION INITIATION; CONFORMATIONAL-CHANGES; MODIFICATION DEFECT	MnmE is an evolutionarily conserved, three domain GTPase involved in tRNA modification. In contrast to Ras proteins, MnmE exhibits a high intrinsic GTPase activity and requires GTP hydrolysis to be functionally active. Its G domain conserves the GTPase activity of the full protein, and thus, it should contain the catalytic residues responsible for this activity. In this work, mutational analysis of all conserved arginine residues of the MnmE G- domain indicates that MnmE, unlike other GTPases, does not use an arginine finger to drive catalysis. In addition, we show that residues in the G2 motif ( (249)GTTRD(253)), which resides in the switch I region, are not important for GTP binding but play some role in stabilizing the transition state, specially Gly(249) and Thr(251). On the other hand, G2 mutations leading to a minor loss of the GTPase activity result in a non- functional MnmE protein. This indicates that GTP hydrolysis is a required but non- sufficient condition so that MnmE can mediate modification of tRNA. The conformational change of the switch I region associated with GTP hydrolysis seems to be crucial for the function of MnmE, and the invariant threonine ( Thr251) of the G2 motif would be essential for such a change, because it cannot be substituted by serine. MnmE defects result in impaired growth, a condition that is exacerbated when defects in other genes involved in the decoding process are simultaneously present. This behavior is reminiscent to that found in yeast and stresses the importance of tRNA modification for gene expression.	Ctr Invest Principe Felipe, Genet Mol Lab, Valencia 46013, Spain; Ctr Invest Principe Felipe, Lab Peptidos & Desarrollo Ensayos, Valencia 46013, Spain; Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden	Prince Felipe Research Center; Prince Felipe Research Center; Umea University	Armengod, ME (corresponding author), Ctr Invest Principe Felipe, Genet Mol Lab, Avda Autopista Saler 16, Valencia 46013, Spain.	armengod@ochoa.fib.es	Martinez-Vicente, Marta/K-4312-2014; Villarroya, M Magdalena/K-7621-2014; Björk, Glenn/AAE-8219-2022; Armengod, Maria Eugenia/K-6030-2014; Armengod, M. Eugenia/A-9609-2014	Martinez-Vicente, Marta/0000-0001-7053-2625; Villarroya, M Magdalena/0000-0003-4542-7430; Armengod, Maria Eugenia/0000-0003-1512-2687; Mellado, Maravillas/0000-0002-6025-8383				Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; BACHMANN BJ, 1996, ESCHERICHIA COLI SAL, P2460; Bourne HR, 1997, NATURE, V389, P673, DOI 10.1038/39470; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bregeon D, 2001, GENE DEV, V15, P2295, DOI 10.1101/gad.207701; Bujnicki JM, 2004, RNA, V10, P1236, DOI 10.1261/rna.7470904; Cabedo H, 1999, EMBO J, V18, P7063, DOI 10.1093/emboj/18.24.7063; CHING WM, 1985, CURR TOP CELL REGUL, V27, P497; CHING WM, 1982, P NATL ACAD SCI-BIOL, V79, P374, DOI 10.1073/pnas.79.2.374; Curran J. F., 1998, MODIFICATION EDITING, P493; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; DECOSTER E, 1993, J MOL BIOL, V232, P79, DOI 10.1006/jmbi.1993.1371; ELSEVIERS D, 1984, NUCLEIC ACIDS RES, V12, P3521, DOI 10.1093/nar/12.8.3521; EMILSSON V, 1990, EMBO J, V9, P4359, DOI 10.1002/j.1460-2075.1990.tb07885.x; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; GEHRKE CW, 1989, J CHROMATOGR, V471, P3, DOI 10.1016/S0021-9673(00)94152-9; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Hagervall TG, 1998, J MOL BIOL, V284, P33, DOI 10.1006/jmbi.1998.2162; HAGERVALL TG, 1987, J BIOL CHEM, V262, P8488; JOHN J, 1993, J BIOL CHEM, V268, P923; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Krab IM, 1999, BIOCHEMISTRY-US, V38, P13035, DOI 10.1021/bi9909748; KRAMER GF, 1988, J BACTERIOL, V170, P736, DOI 10.1128/jb.170.2.736-743.1988; Kruger MK, 1998, J MOL BIOL, V284, P609, DOI 10.1006/jmbi.1998.2197; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Li GP, 2004, J MOL BIOL, V340, P921, DOI 10.1016/j.jmb.2004.06.007; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Lin B, 1999, J BACTERIOL, V181, P5825, DOI 10.1128/JB.181.18.5825-5832.1999; Lin B, 2001, MOL MICROBIOL, V39, P924, DOI 10.1046/j.1365-2958.2001.02285.x; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mohr D, 2000, EMBO J, V19, P3458, DOI 10.1093/emboj/19.13.3458; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Praefcke GJK, 1999, J MOL BIOL, V292, P321, DOI 10.1006/jmbi.1999.3062; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; RICHTER MF, 1995, J BIOL CHEM, V270, P13512, DOI 10.1074/jbc.270.22.13512; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Rodnina MV, 1999, P NATL ACAD SCI USA, V96, P9586, DOI 10.1073/pnas.96.17.9586; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scrima A, 2005, EMBO J, V24, P23, DOI 10.1038/sj.emboj.7600507; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Shimamoto T, 1996, FEMS MICROBIOL LETT, V136, P57, DOI 10.1016/0378-1097(95)00493-9; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Tomsic J, 2000, EMBO J, V19, P2127, DOI 10.1093/emboj/19.9.2127; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WITTWER AJ, 1986, ARCH BIOCHEM BIOPHYS, V248, P540, DOI 10.1016/0003-9861(86)90507-2; Wolfe MD, 2004, J BIOL CHEM, V279, P1801, DOI 10.1074/jbc.M310442200; Yamanaka K, 2000, J BACTERIOL, V182, P7078, DOI 10.1128/JB.182.24.7078-7082.2000; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200; Yasukawa T, 2005, FEBS LETT, V579, P2948, DOI 10.1016/j.febslet.2005.04.038; Yasukawa T, 2002, MITOCHONDRION, V2, P129, DOI 10.1016/S1567-7249(02)00033-8; Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794; Yim L, 2003, J BIOL CHEM, V278, P28378, DOI 10.1074/jbc.M301381200; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1; Zhang BL, 1999, J BIOL CHEM, V274, P2609, DOI 10.1074/jbc.274.5.2609	66	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30660	30670		10.1074/jbc.M503223200	http://dx.doi.org/10.1074/jbc.M503223200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15983041	hybrid			2022-12-27	WOS:000231487800004
J	Dillingham, MS; Webb, MR; Kowalczykowski, SC				Dillingham, MS; Webb, MR; Kowalczykowski, SC			Bipolar DNA translocation contributes to highly processive DNA unwinding by RecBCD enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINATION HOTSPOT-CHI; SINGLE-STRANDED-DNA; SITE-DIRECTED MUTAGENESIS; CONSERVED LYSINE RESIDUE; ESCHERICHIA-COLI UVRD; ATP-BINDING SEQUENCE; HELICASE ACTIVITY; NUCLEASE ACTIVITY; STEP-SIZE; IN-VITRO	We recently demonstrated that the RecBCD enzyme is a bipolar DNA helicase that employs two single-stranded DNA motors of opposite polarity to drive translocation and unwinding of duplex DNA. We hypothesized that this organization may explain the exceptionally high rate and processivity of DNA unwinding catalyzed by the RecBCD enzyme. Using a stopped-flow dye displacement assay for unwinding activity, we test this idea by analyzing mutant RecBCD enzymes in which either of the two helicase motors is inactivated by mutagenesis. Like the wild-type RecBCD enzyme, the two mutant proteins maintain the ability to bind tightly to blunt duplex DNA ends in the absence of ATP. However, the rate of forward translocation for the RecB motor-defective enzyme is only similar to 30% of the wild-type rate, whereas for the RecD motor-defective enzyme, it is similar to 50%. More significantly, the processivity of translocation is substantially reduced by similar to 25- and 6-fold for each mutant enzyme, respectively. Despite retaining the capacity to bind blunt dsDNA, the RecB-mutant enzyme has lost the ability to unwind DNA unless the substrate contains a short 5'-terminated single-stranded DNA overhang. The consequences of this observation for the architecture of the single-stranded DNA motors in the initiation complex are discussed.	Univ Calif Davis, Microbiol Sect, Ctr Genet & Dev, Davis, CA 95616 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Ctr Genet & Dev, Davis, CA 95616 USA; Natl Inst Med Res, London NW7 1AA, England	University of California System; University of California Davis; University of California System; University of California Davis; MRC National Institute for Medical Research	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Microbiol Sect, Ctr Genet & Dev, 1 Shields Ave,Briggs Hall 310, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Dillingham, Mark/0000-0002-4612-7141; Webb, Martin/0000-0002-0134-9621	NIGMS NIH HHS [GM-41347] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041347] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Anderson DG, 1998, J MOL BIOL, V282, P275, DOI 10.1006/jmbi.1998.2013; ARAI N, 1981, J BIOL CHEM, V256, P5294; BENZINGER R, 1975, J VIROL, V15, P861, DOI 10.1128/JVI.15.4.861-871.1975; Bianco PR, 1997, P NATL ACAD SCI USA, V94, P6706, DOI 10.1073/pnas.94.13.6706; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; CARDON LR, 1993, NUCLEIC ACIDS RES, V21, P3875, DOI 10.1093/nar/21.16.3875; Chedin F, 2002, MOL MICROBIOL, V43, P823, DOI 10.1046/j.1365-2958.2002.02785.x; Chen HW, 1998, J MOL BIOL, V278, P89, DOI 10.1006/jmbi.1998.1694; Cheng W, 2001, J MOL BIOL, V310, P327, DOI 10.1006/jmbi.2001.4758; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; DIXON DA, 1991, CELL, V66, P361, DOI 10.1016/0092-8674(91)90625-9; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; DIXON DA, 1995, J BIOL CHEM, V270, P16360, DOI 10.1074/jbc.270.27.16360; EGGLESTON AK, 1993, J MOL BIOL, V231, P621, DOI 10.1006/jmbi.1993.1314; Eggleston AK, 1996, NUCLEIC ACIDS RES, V24, P1179, DOI 10.1093/nar/24.7.1179; EGGLESTON AK, 1995, J BIOL CHEM, V270, P2024, DOI 10.1074/jbc.270.5.2024; GANESAN S, 1993, J MOL BIOL, V229, P67, DOI 10.1006/jmbi.1993.1008; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; HSIEH S, 1992, NUCLEIC ACIDS RES, V20, P5647, DOI 10.1093/nar/20.21.5647; KORANGY F, 1992, J BIOL CHEM, V267, P3088; KORANGY F, 1994, BIOCHEMISTRY-US, V33, P9552, DOI 10.1021/bi00198a022; KORANGY F, 1993, BIOCHEMISTRY-US, V32, P4873, DOI 10.1021/bi00069a024; KORANGY F, 1992, J BIOL CHEM, V267, P1727; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; LEBOWITZ J, 1985, THESIS J HOPKINS U B; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lucius AL, 2004, J MOL BIOL, V339, P751, DOI 10.1016/j.jmb.2004.04.010; Lucius AL, 2004, J MOL BIOL, V339, P731, DOI 10.1016/j.jmb.2004.04.009; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Nanduri B, 2002, P NATL ACAD SCI USA, V99, P14722, DOI 10.1073/pnas.232401899; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Phillips RJ, 1997, MOL GEN GENET, V254, P319, DOI 10.1007/PL00008605; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2863, DOI 10.1021/bi00433a018; ROMAN LJ, 1992, J BIOL CHEM, V267, P4207; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Soultanas P, 1999, NUCLEIC ACIDS RES, V27, P1421, DOI 10.1093/nar/27.6.1421; Soultanas P, 1999, J MOL BIOL, V290, P137, DOI 10.1006/jmbi.1999.2873; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Spies M, 2005, J BIOL CHEM, V280, P37078, DOI 10.1074/jbc.M505521200; Spies Maria, 2005, P389; TAYLOR AF, 1995, J BIOL CHEM, V270, P24451, DOI 10.1074/jbc.270.41.24451; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; TAYLOR AF, 1985, CELL, V41, P153, DOI 10.1016/0092-8674(85)90070-4; TAYLOR AF, 1985, J MOL BIOL, V185, P431, DOI 10.1016/0022-2836(85)90414-0; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981	57	39	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2005	280	44					37069	37077		10.1074/jbc.M505520200	http://dx.doi.org/10.1074/jbc.M505520200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	978VT	16041061	hybrid, Green Published			2022-12-27	WOS:000232901800065
J	Esteban, R; Vega, L; Fujimura, T				Esteban, R; Vega, L; Fujimura, T			Launching of the yeast 20 S RNA narnavirus by expressing the genomic or antigenomic viral RNA in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; BIPARTITE 3'-CIS-ACTING SIGNAL; SACCHAROMYCES-CEREVISIAE; POLYNUCLEOTIDE PHOSPHORYLASE; POLY(A) POLYMERASE; MESSENGER-RNAS; VIRUS; REPLICATION; POLYMERIZATION; FORM	20 S RNA virus is a persistent positive strand RNA virus found in Saccharomyces cerevisiae. The viral genome encodes only its RNA polymerase, p91, and resides in the cytoplasm in the form of a ribonucleoprotein complex with p91. We succeeded in generating 20 S RNA virus in vivo by expressing, from a vector, genomic strands fused at the 3'-ends to the hepatitis delta virus antigenomic ribozyme. Using this launching system, we analyzed 3'-cis-signals present in the genomic strand for replication. The viral genome has five-nucleotide inverted repeats at both termini ( 5'-GGGGC... GCCCC-OH). The fifth G from the 3'-end was dispensable for replication, whereas the third and fourth Cs were essential. The 3'-terminal and penultimate Cs could be eliminated or modified to other nucleotides; however, the generated viruses recovered these terminal Cs. Furthermore, extra nucleotides added at the viral 3'-end were eliminated in the launched viruses. Therefore, 20 S RNA virus has amechanism(s) to maintain the correct size and sequence of the viral 3'-end. This may contribute to its persistent infection in yeast. We also succeeded in generating 20 S RNA virus similarly from antigenomic strands provided active p91 was supplied from a second vector in trans. Again, a cluster of four Cs at the 3'-end in the antigenomic strand was essential for replication. In this work, we also present the first conclusive evidence that 20 S and 23 S RNA viruses are independent replicons.	Univ Salamanca, CSIC, Inst Microbiol Bioquim, Dept Genet & Microbiol, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Esteban, R (corresponding author), Univ Salamanca, CSIC, Inst Microbiol Bioquim, Dept Genet & Microbiol, Avda Campo Charro S-N, Salamanca 37007, Spain.	mrosa@gugu.usal.es	Esteban, Rosa/K-4356-2014; Fujimura, Tsutomu/K-5807-2014	Esteban, Rosa/0000-0001-6804-7209; Fujimura, Tsutomu/0000-0002-9457-6769				Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Buck KW, 1996, ADV VIRUS RES, V47, P159, DOI 10.1016/S0065-3527(08)60736-8; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; ESTEBAN LM, 1992, J BIOL CHEM, V267, P10874; ESTEBAN LM, 1994, J BIOL CHEM, V269, P29771; ESTEBAN R, 1989, EMBO J, V8, P947, DOI 10.1002/j.1460-2075.1989.tb03456.x; ESTEBAN R, 1993, PROG NUCLEIC ACID RE, V46, P155, DOI 10.1016/S0079-6603(08)61021-1; Esteban R, 2003, P NATL ACAD SCI USA, V100, P2568, DOI 10.1073/pnas.0530167100; Fujimura T, 2005, J BIOL CHEM, V280, P7398, DOI 10.1074/jbc.M412048200; FUJIMURA T, 1990, CELL, V62, P819, DOI 10.1016/0092-8674(90)90125-X; Fujimura T, 2004, J BIOL CHEM, V279, P44219, DOI 10.1074/jbc.M408530200; Fujimura T, 2004, J BIOL CHEM, V279, P13215, DOI 10.1074/jbc.M313797200; GARCIACUELLAR MP, 1995, J BIOL CHEM, V270, P20084, DOI 10.1074/jbc.270.34.20084; GARCIACUELLAR MP, 1996, THESIS U SALAMANCA S; Guan HC, 2000, P NATL ACAD SCI USA, V97, P12451, DOI 10.1073/pnas.97.23.12451; HARTLEY JL, 1980, NATURE, V286, P860, DOI 10.1038/286860a0; KADOWAKI K, 1971, J BACTERIOL, V105, P826, DOI 10.1128/JB.105.3.826-830.1971; Lopez V, 2002, YEAST, V19, P545, DOI 10.1002/yea.848; Maniatis T., 1982, MOL CLONING; MATSUMOTO Y, 1991, J BIOL CHEM, V266, P12779; Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997; Ng KKS, 2002, J BIOL CHEM, V277, P1381, DOI 10.1074/jbc.M109261200; PERROTTA AT, 1991, NATURE, V350, P434, DOI 10.1038/350434a0; Reuven NB, 1997, J BIOL CHEM, V272, P33255, DOI 10.1074/jbc.272.52.33255; Rodriguez-Cousino N, 1998, J BIOL CHEM, V273, P20363, DOI 10.1074/jbc.273.32.20363; RODRIGUEZCOUSINO N, 1992, NUCLEIC ACIDS RES, V20, P2761, DOI 10.1093/nar/20.11.2761; RODRIGUEZCOUSINO N, 1991, J BIOL CHEM, V266, P12772; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Shi PY, 1998, RNA, V4, P276; Solorzano A, 2000, J BIOL CHEM, V275, P26428, DOI 10.1074/jbc.M002281200; Sprinzl M., 1989, Nucleic Acids Research, V17, P1; VALLE RPC, 1993, J VIROL, V67, P2764, DOI 10.1128/JVI.67.5.2764-2771.1993; VREKEN P, 1992, MOL CELL BIOL, V12, P2986, DOI 10.1128/MCB.12.7.2986; WEJKSNORA PJ, 1978, J BACTERIOL, V134, P246, DOI 10.1128/JB.134.1.246-260.1978; WESOLOWSKI M, 1984, MOL CELL BIOL, V4, P181, DOI 10.1128/MCB.4.1.181; WICKNER RB, 1991, J VIROL, V65, P155, DOI 10.1128/JVI.65.1.155-161.1991; WICKNER RB, 1980, CELL, V21, P217, DOI 10.1016/0092-8674(80)90129-4; WICKNER RB, 2000, VIRUS TAXONOMY, P651; WIDNER WR, 1991, MOL CELL BIOL, V11, P2905, DOI 10.1128/MCB.11.5.2905; YAO WS, 1995, J VIROL, V69, P1917, DOI 10.1128/JVI.69.3.1917-1919.1995; Zuo YH, 2002, J BIOL CHEM, V277, P29654, DOI 10.1074/jbc.M204252200	43	22	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					33725	33734		10.1074/jbc.M506546200	http://dx.doi.org/10.1074/jbc.M506546200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16049000	hybrid			2022-12-27	WOS:000232229700007
J	Faye, G; Luger, K; Hansen, JC				Faye, G; Luger, K; Hansen, JC			The core histone n-terminal tail domains function independently and additively during salt-dependent oligomerization of nucleosomal arrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHER-ORDER STRUCTURE; CHROMATIN FIBER; RECOMBINANT HISTONES; LINKER HISTONES; VARIANT H2A.Z; ORGANIZATION; ACETYLATION; TRANSCRIPTION; IDENTIFICATION; MECHANISMS	Salt- dependent oligomerization of nucleosomal arrays is related to fiber- fiber interactions and global chromosome structure. Previous studies have shown that the H2A/ H2B and H3/ H4 N- terminal domain ( NTD) pairs are able to mediate array oligomerization. However, because of technical barriers, the function( s) of the individual core histone NTDs have not been investigated. To address this question, all possible combinations of " tailless" nucleosomal arrays were assembled from native and NTD- deleted recombinant Xenopus core histones and tandemly repeated 5 S rDNA. The recombinant arrays were characterized by differential centrifugation over the range of 0 - 50 mM MgCl2 to determine how each NTD affects salt- dependent oligomerization. Results indicate that all core histone NTDs participate in the oligomerization process and that the NTDs function additively and independently. These observations provide direct biochemical evidence linking all four core histone NTDs to the assembly and maintenance of global chromatin structures.	Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA	Colorado State University; University of Texas System; University of Texas Health San Antonio	Hansen, JC (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Campus Delivery 1870, Ft Collins, CO 80523 USA.	Jeffrey.C.Hansen@colostate.edu	Martin, Faye/I-1759-2012	SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045916, R29GM045916] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45916] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Carruthers LM, 2000, J BIOL CHEM, V275, P37285, DOI 10.1074/jbc.M006801200; Carruthers LM, 2000, METHOD ENZYMOL, V321, P66; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; Demeler B, 1997, BIOPHYS J, V72, P397, DOI 10.1016/S0006-3495(97)78680-6; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; FLETCHER TM, 1994, BIOCHEMISTRY-US, V33, P10859, DOI 10.1021/bi00202a002; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; Fletcher TM, 1996, CRIT REV EUKAR GENE, V6, P149, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.40; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; GEORGEL P, 1993, J BIOL CHEM, V268, P1947; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; HANSEN JC, 1993, J BIOL CHEM, V268, P5840; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Henikoff S, 2005, P NATL ACAD SCI USA, V102, P5308, DOI 10.1073/pnas.0501853102; Horn PJ, 2002, SCIENCE, V297, P1824, DOI 10.1126/science.1074200; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 2003, CURR OPIN GENET DEV, V13, P127, DOI 10.1016/S0959-437X(03)00026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Moore SC, 1997, BIOCHEM BIOPH RES CO, V230, P136, DOI 10.1006/bbrc.1996.5903; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pollard KJ, 1999, EMBO J, V18, P5622, DOI 10.1093/emboj/18.20.5622; Ridgway P, 2004, J BIOL CHEM, V279, P43815, DOI 10.1074/jbc.M408409200; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Strick R, 2001, J CELL BIOL, V155, P899, DOI 10.1083/jcb.200105026; Tse C, 1997, BIOCHEMISTRY-US, V36, P11381, DOI 10.1021/bi970801n; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; WIDOM J, 1989, ANNU REV BIOPHYS BIO, V18, P365, DOI 10.1146/annurev.biophys.18.1.365; Wolffe A., 1998, CHROMATIN STRUCTURE; WOODCOCK CL, 1995, TRENDS CELL BIOL, V5, P272, DOI 10.1016/S0962-8924(00)89038-8; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6	45	103	104	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					33701	33706		10.1074/jbc.M507048200	http://dx.doi.org/10.1074/jbc.M507048200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16033758	hybrid			2022-12-27	WOS:000232229700004
J	Heller, RC; Marians, KJ				Heller, RC; Marians, KJ			Unwinding of the nascent lagging strand by rep and PriA enables the direct restart of stalled replication forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; COORDINATED LEADING-STRAND; DNA-REPLICATION; PROTEIN PRIA; DOUBLE MUTANTS; IN-VITRO; HELICASE; PURIFICATION; MUTATION; ORIGIN	During origin-independent replisome assembly, the replication restart protein PriC prefers to load the replication fork helicase, DnaB, to stalled replication forks where there is a gap in the nascent leading strand. However, this activity can be obstructed if the 5'-end of the nascent lagging strand is near the template branch point. Here we provide biochemical evidence that the helicase activities of Rep and PriA function to unwind the nascent lagging strand DNA at such stalled replication forks. PriC then loads the replicative helicase, DnaB, onto the newly generated, single-stranded template for the purposes of replisome assembly and duplex unwinding ahead of the replication fork. Direct rescue of replication forks by the Rep-PriC and PriA-PriC pathways in this manner may contribute to genomic stability by avoiding the potential dangers of fork breakage inherent to recombination-dependent restart pathways.	Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	kmarians@sloankettering.edu			NIGMS NIH HHS [GM34557, R37 GM034557] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034557, R01GM034557] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAI N, 1981, J BIOL CHEM, V256, P5294; BAKER TA, 1986, CELL, V45, P53, DOI 10.1016/0092-8674(86)90537-4; BAKER TA, 1987, J BIOL CHEM, V262, P6877; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; COLASANTI J, 1987, MOL GEN GENET, V209, P382, DOI 10.1007/BF00329669; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; Harinarayanan R, 2004, GENETICS, V166, P1165, DOI 10.1534/genetics.166.3.1165; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Hiasa H, 1996, J BIOL CHEM, V271, P21529, DOI 10.1074/jbc.271.35.21529; Higuchi K, 2003, GENES CELLS, V8, P437, DOI 10.1046/j.1365-2443.2003.00646.x; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2129, DOI 10.1021/bi952345d; Jones JM, 2001, J MOL BIOL, V312, P935, DOI 10.1006/jmbi.2001.4930; Jones JM, 1999, J MOL BIOL, V289, P503, DOI 10.1006/jmbi.1999.2783; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; LANE HED, 1974, J BACTERIOL, V120, P805, DOI 10.1128/JB.120.2.805-814.1974; LANE HED, 1975, J MOL BIOL, V97, P99; LASKEN RS, 1988, J BIOL CHEM, V263, P5512; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; LEE EH, 1991, P NATL ACAD SCI USA, V88, P3029, DOI 10.1073/pnas.88.8.3029; LEE MS, 1987, P NATL ACAD SCI USA, V84, P8345, DOI 10.1073/pnas.84.23.8345; Liu J, 1999, J BIOL CHEM, V274, P25033, DOI 10.1074/jbc.274.35.25033; Liu JI, 1999, P NATL ACAD SCI USA, V96, P3552, DOI 10.1073/pnas.96.7.3552; LOHMAN TM, 1989, J BIOL CHEM, V264, P10139; Maisnier-Patin S, 2001, MOL MICROBIOL, V42, P1371, DOI 10.1046/j.1365-2958.2001.02718.x; Marians KJ, 1995, METHOD ENZYMOL, V262, P507; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; McCool JD, 2004, GENETICS, V167, P569, DOI 10.1534/genetics.103.025296; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; MOK M, 1987, J BIOL CHEM, V262, P16644; Nurse P, 1999, J BIOL CHEM, V274, P25026, DOI 10.1074/jbc.274.35.25026; NURSE P, 1991, J BACTERIOL, V173, P6686, DOI 10.1128/jb.173.21.6686-6693.1991; Sandler SJ, 2000, GENETICS, V155, P487; Sandler SJ, 1999, MOL MICROBIOL, V34, P91, DOI 10.1046/j.1365-2958.1999.01576.x; Sandler SJ, 2001, MOL MICROBIOL, V41, P697, DOI 10.1046/j.1365-2958.2001.02547.x; SCOTT JF, 1978, J BIOL CHEM, V253, P3292; SCOTT JF, 1977, P NATL ACAD SCI USA, V74, P193, DOI 10.1073/pnas.74.1.193; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; SMITH KR, 1989, J BIOL CHEM, V264, P6119; TOUGU K, 1994, J BIOL CHEM, V269, P4675; Trun N, 2003, FEMS MICROBIOL LETT, V226, P187, DOI 10.1016/S0378-1097(03)00595-0; UZEST M, 1995, MOL MICROBIOL, V17, P1177, DOI 10.1111/j.1365-2958.1995.mmi_17061177.x; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P921, DOI 10.1073/pnas.72.3.921; WU CA, 1992, J BIOL CHEM, V267, P4030; WU CA, 1992, J BIOL CHEM, V267, P4074; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3; YANCEYWRONA JE, 1992, NUCLEIC ACIDS RES, V20, P6713, DOI 10.1093/nar/20.24.6713; YARRANTON GT, 1979, P NATL ACAD SCI USA, V76, P1658, DOI 10.1073/pnas.76.4.1658; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4; ZAVITZ KH, 1992, J BIOL CHEM, V267, P6933	52	75	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34143	34151		10.1074/jbc.M507224200	http://dx.doi.org/10.1074/jbc.M507224200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16079128	hybrid			2022-12-27	WOS:000232229700055
J	Diao, JY; Asghar, Z; Chan, CB; Wheeler, MB				Diao, JY; Asghar, Z; Chan, CB; Wheeler, MB			Glucose-regulated glucagon secretion requires insulin receptor expression in pancreatic alpha-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ACTIVATED PROTEIN-KINASE; SWITCH-OFF HYPOTHESIS; ISLET BETA-CELL; DIABETES-MELLITUS; ENDOCRINE PANCREAS; SIGNAL-TRANSDUCTION; MAMMALIAN TARGET; GENE-EXPRESSION; TRANSGENIC MICE	The insulin receptor (IR) and its signaling appear to be essential for insulin secretion from pancreatic beta-cells. However, much less is known about the role of the IR in alpha-cells. To assess the role of the IR in glucagon and insulin secretion, we engineered adenoviruses for high efficiency small interference RNA ( siRNA)-IR expression in isolated mouse pancreatic islets and lentiviruses for siRNA-IR expression in pancreatic alpha- and beta-cell lines (alpha-TC6 and MIN6) with specific, long term stable IR knockdown. Western blot analysis showed that these strategies resulted in 60 - 80% reduction of IR protein in islets and alpha- and beta-cell lines. Cell growth was reduced by 35 - 50% in alpha-TC and MIN6 cells stably expressing siRNA-IR, respectively. Importantly, glucagon secretion, in response to glucose ( 25 to 2.8 mM), was completely abolished in islets expressing siRNA-IR, whereas secretion increased 1.7-fold in islets expressing control siRNA. In contrast, there was no difference in glucose-stimulated insulin secretion when comparing siRNA-IR and siRNA control, with both groups showing a 1.7-fold increase. Islet glucagon and insulin content were also unaffected by IR knockdown. To further explore the role of the IR, siRNA-IR was stably expressed in pancreatic cell lines, which dramatically suppressed glucose-regulated glucagon secretion in alpha-TC6 cells (3.4-fold) but did not affect GSIS in MIN6 cells. Defects in siRNA-IR-expressing alpha-cells were associated with an alteration in the activity of Akt and p70(S6K) where insulin-induced phosphorylation of protein kinase B/AKt was greatly reduced while p70(S6K) activation was enhanced, suggesting that the related pathways play important roles in alpha cell function. This study provides direct evidence that appropriate expression of the IR in alpha-cells is required for glucose-dependent glucagon secretion.	Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Prince Edward Isl, Atlantic Vet Coll, Dept Biomed Sci, Charlottetown, PE C1A 4P3, Canada	University of Toronto; University of Toronto; University of Prince Edward Island	Wheeler, MB (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	michael.wheeler@utoronto.ca	Chan, Catherine/C-1162-2011	Chan, Catherine/0000-0003-3882-0592; Wheeler, Michael B./0000-0002-7480-7267; Asghar Shyr, Zeenat/0000-0001-8710-9938				Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Antinozzi PA, 1999, ANNU REV NUTR, V19, P511, DOI 10.1146/annurev.nutr.19.1.511; Ashcroft F, 2004, HUM MOL GENET, V13, pR21, DOI 10.1093/hmg/ddh066; ASPLIN CM, 1981, J CLIN INVEST, V68, P314, DOI 10.1172/JCI110251; Ayuso E, 2004, HUM GENE THER, V15, P805, DOI 10.1089/1043034041648426; BAETENS D, 1979, SCIENCE, V206, P1323, DOI 10.1126/science.390711; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Bhanot S, 1999, AM J PHYSIOL-ENDOC M, V277, pE299, DOI 10.1152/ajpendo.1999.277.2.E299; BOLLI G, 1983, DIABETES, V32, P134, DOI 10.2337/diabetes.32.2.134; BRUBAKER PL, 1992, J BIOL CHEM, V267, P20728; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CAPRIO S, 1993, DIABETES, V42, P550, DOI 10.2337/diabetes.42.4.550; Chan CB, 1999, DIABETES, V48, P1482, DOI 10.2337/diabetes.48.7.1482; Cline GW, 2002, DIABETES, V51, P2903, DOI 10.2337/diabetes.51.10.2903; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen P, 1999, PHILOS T R SOC B, V354, P485, DOI 10.1098/rstb.1999.0399; Coutant A, 2002, HEPATOLOGY, V36, P1079, DOI 10.1053/jhep.2002.36160; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DA S, 2004, BIOCHEM J, V377, P149; Del Prato S, 2004, HORM METAB RES, V36, P775, DOI 10.1055/s-2004-826163; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Edlund H, 1999, CURR OPIN CELL BIOL, V11, P663, DOI 10.1016/S0955-0674(99)00033-2; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fisher TL, 2004, CURR BIOL, V14, pR1005, DOI 10.1016/j.cub.2004.11.024; FRIESEN SR, 1982, NEW ENGL J MED, V306, P580, DOI 10.1056/NEJM198203113061005; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; GERICH J, 1980, METABOLISM, V29, P1164, DOI 10.1016/0026-0495(80)90026-8; GERICH JE, 1973, SCIENCE, V182, P171, DOI 10.1126/science.182.4108.171; GREENBAUM CJ, 1991, J CLIN INVEST, V88, P767, DOI 10.1172/JCI115375; Gromada J, 2004, DIABETES, V53, pS181, DOI 10.2337/diabetes.53.suppl_3.S181; HAMAGUCHI K, 1990, DIABETES, V39, P415, DOI 10.2337/diabetes.39.4.415; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hayashi M, 2003, DIABETES, V52, P2066, DOI 10.2337/diabetes.52.8.2066; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hope KM, 2004, DIABETES, V53, P1488, DOI 10.2337/diabetes.53.6.1488; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Kitamura T, 2003, ANNU REV PHYSIOL, V65, P313, DOI 10.1146/annurev.physiol.65.092101.142540; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Lim HK, 2003, J BIOL CHEM, V278, P45117, DOI 10.1074/jbc.M303789200; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; MARUYAMA H, 1984, J CLIN INVEST, V74, P2296, DOI 10.1172/JCI111658; Mizusawa N, 2004, GENE, V331, P53, DOI 10.1016/j.gene.2004.01.016; MORRICE NA, 1994, J BIOL CHEM, V269, P20040; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Narushima M, 2004, ASAIO J, V50, P586, DOI 10.1097/01.MAT.0000142877.18621.BC; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Ohsugi M, 2005, J BIOL CHEM, V280, P4992, DOI 10.1074/jbc.M411727200; PALMER RH, 1995, J BIOL CHEM, V270, P22412, DOI 10.1074/jbc.270.38.22412; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; PORTE D, 1995, CLIN INVEST MED, V18, P247; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Raju B, 2005, DIABETES, V54, P757, DOI 10.2337/diabetes.54.3.757; RASKIN P, 1975, J CLIN INVEST, V56, P1132, DOI 10.1172/JCI108188; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Rhodes CJ, 2002, EUR J CLIN INVEST, V32, P3, DOI 10.1046/j.1365-2362.32.s3.2.x; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; SAMOLS E, 1988, J CLIN INVEST, V82, P350, DOI 10.1172/JCI113593; Segel SA, 2002, DIABETES, V51, P724, DOI 10.2337/diabetes.51.3.724; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; TEITELMAN G, 1993, DEVELOPMENT, V118, P1031; Thomas G, 2002, BIOL RES, V35, P305, DOI 10.4067/S0716-97602002000200022; Ueno M, 2005, DIABETOLOGIA, V48, P506, DOI 10.1007/s00125-004-1662-6; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Yoshimitsu M, 2004, P NATL ACAD SCI USA, V101, P16909, DOI 10.1073/pnas.0407572101; Zhou HR, 2004, DIABETES, V53, P1482, DOI 10.2337/diabetes.53.6.1482	78	68	75	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33487	33496		10.1074/jbc.M506276200	http://dx.doi.org/10.1074/jbc.M506276200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16027126	hybrid			2022-12-27	WOS:000232058100048
J	Gal, P; Harmat, V; Kocsis, A; Bian, T; Barna, L; Ambrus, G; Vegh, B; Balczer, J; Sim, RB; Naray-Szabo, G; Zavodszky, P				Gal, P; Harmat, V; Kocsis, A; Bian, T; Barna, L; Ambrus, G; Vegh, B; Balczer, J; Sim, RB; Naray-Szabo, G; Zavodszky, P			A true autoactivating enzyme - Structural insight into mannose-binding lectin-associated serine protease-2 activations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; TERNARY COMPLEX; REFINEMENT; ZYMOGEN; MBL; C1; TRYPSINOGEN; COMPONENTS; MOLSCRIPT	Few reports have described in detail a true autoactivation process, where no extrinsic cleavage factors are required to initiate the autoactivation of a zymogen. Herein, we provide structural and mechanistic insight into the autoactivation of a multidomain serine protease: mannose-binding lectin-associated serine protease-2 (MASP-2), the first enzymatic component in the lectin pathway of complement activation. We characterized the proenzyme form of a MASP-2 catalytic fragment encompassing its C-terminal three domains and solved its crystal structure at 2.4 angstrom resolution. Surprisingly, zymogen MASP-2 is capable of cleaving its natural substrate C4, with an efficiency about 10% that of active MASP-2. Comparison of the zymogen and active structures of MASP-2 reveals that, in addition to the activation domain, other loops of the serine protease domain undergo significant conformational changes. This additional flexibility could play a key role in the transition of zymogen MASP-2 into a proteolytically active form. Based on the three-dimensional structures of proenzyme and active MASP-2 catalytic fragments, we present model for the active zymogen MASP-2 complex and propose a mechanism for the autoactivation process.	Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1518 Budapest, Hungary; Eotvos Lorand Univ, Hungarian Acad Sci, Prot Modeling Grp, H-1117 Budapest, Hungary; Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; University of Oxford	Zavodszky, P (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, POB 7, H-1518 Budapest, Hungary.	zxp@enzim.hu	Gal, Peter/B-5886-2011; Ambrus-Aikelin, Geza/E-9410-2010; Sim, Bob/A-1354-2008; Harmat, Veronika/B-8033-2016; Zavodszky, Peter/C-1214-2008	Sim, Bob/0000-0002-2855-7455; Harmat, Veronika/0000-0002-1866-9904; Barna, Laszlo/0000-0002-3856-5774				Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BODE W, 1978, FEBS LETT, V90, P265, DOI 10.1016/0014-5793(78)80382-2; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; Budayova-Spano M, 2002, STRUCTURE, V10, P1509, DOI 10.1016/S0969-2126(02)00881-X; Budayova-Spano M, 2002, EMBO J, V21, P231, DOI 10.1093/emboj/21.3.231; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; DeLano W.L, PYMOL MOL GRAPHICS S; DODDS AW, 1993, METHOD ENZYMOL, V223, P46; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Gal P, 2001, CURR PROTEIN PEPT SC, V2, P43, DOI 10.2174/1389203013381242; GOMISRUTH FX, 1995, EMBO J, V14, P4387, DOI 10.1002/j.1460-2075.1995.tb00117.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kardos J, 2001, J IMMUNOL, V167, P5202, DOI 10.4049/jimmunol.167.9.5202; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lacroix M, 2001, J BIOL CHEM, V276, P36233, DOI 10.1074/jbc.M105688200; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Morley B.J., 1999, COMPLEMENT FACTSBOOK, P1; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; PIGNOL D, 1994, EMBO J, V13, P1763, DOI 10.1002/j.1460-2075.1994.tb06444.x; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Renatus M, 1997, EMBO J, V16, P4797, DOI 10.1093/emboj/16.16.4797; Rossi V, 1998, J BIOL CHEM, V273, P1232, DOI 10.1074/jbc.273.2.1232; Schwaeble W, 2002, IMMUNOBIOLOGY, V205, P455, DOI 10.1078/0171-2985-00146; Sim RB, 2004, BIOCHEM SOC T, V32, P21, DOI 10.1042/BST0320021; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Thomsen R, 2003, BIOSYSTEMS, V72, P57, DOI 10.1016/S0303-2647(03)00135-7; TUDOS E, 1990, INT J PEPT PROT RES, V36, P236; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Volanakis J., 1998, COMPLEMENT ENZYMES H, P49; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	42	83	99	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33435	33444		10.1074/jbc.M506051200	http://dx.doi.org/10.1074/jbc.M506051200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16040602	hybrid			2022-12-27	WOS:000232058100042
J	Kofler, M; Motzny, K; Beyermann, M; Freund, C				Kofler, M; Motzny, K; Beyermann, M; Freund, C			Novel interaction partners of the CD2BP2-GYF domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SH3 DOMAIN; GYF DOMAIN; PROTEIN; PROLINE; BINDING; MOTIF; CD2; IDENTIFICATION; ACTIVATION; PROTEASOME	The GYF domain of CD2BP2 serves as an adapter that recognizes proline-rich sequences in intracellular proteins. Although the T cell adhesion molecule CD2 and the core splicing protein SmB/B' were previously shown to interact with CD2BP2-GYF, we are now using a general approach to identify putative GYF domain target sites within the human proteome. The phage display-derived recognition motif for CD2BP2-GYF is PPG(W/F/Y/M/L). SPOT analysis confirmed that the GYF domain interacts with peptides from human proteins containing the consensus site. Epitope mapping by NMR spectroscopy performed for several peptides revealed a conserved binding surface. A direct interaction of the CD2BP2-GYF domain with the novel protein interaction partners PI31 and NPWBP was verified by yeast two-hybrid analysis.	Forschungsinst Mol Pharmakol, Prot Engn Grp, D-13125 Berlin, Germany; Free Univ Berlin, D-13125 Berlin, Germany	Free University of Berlin	Freund, C (corresponding author), Forschungsinst Mol Pharmakol, Prot Engn Grp, Robert Rossle Str 10, D-13125 Berlin, Germany.	freund@fmp-berlin.de						Beyermann M, 1996, J MED CHEM, V39, P3324, DOI 10.1021/jm960116z; Bialkowska A, 2002, YEAST, V19, P1323, DOI 10.1002/yea.919; CHANG HC, 1990, J EXP MED, V172, P351, DOI 10.1084/jem.172.1.351; Craggs G, 2001, J BIOL CHEM, V276, P30552, DOI 10.1074/jbc.M103142200; FELICI F, 1991, J MOL BIOL, V222, P301, DOI 10.1016/0022-2836(91)90213-P; Freund C, 2002, EMBO J, V21, P5985, DOI 10.1093/emboj/cdf602; Freund C, 1999, NAT STRUCT BIOL, V6, P656, DOI 10.1038/10712; HAHN WC, 1993, J EXP MED, V178, P1831, DOI 10.1084/jem.178.5.1831; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Heuer K, 2004, STRUCTURE, V12, P603, DOI 10.1016/j.str.2004.02.021; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kofler M, 2004, J BIOL CHEM, V279, P28292, DOI 10.1074/jbc.M402008200; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; Kramer A, 1998, METH MOL B, V87, P25; Kramer A, 1999, J PEPT RES, V54, P319, DOI 10.1034/j.1399-3011.1999.00108.x; Laggerbauer B, 2005, RNA, V11, P598, DOI 10.1261/rna.2300805; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; Nishizawa K, 1998, P NATL ACAD SCI USA, V95, P14897, DOI 10.1073/pnas.95.25.14897; Reuter K, 1999, J MOL BIOL, V294, P515, DOI 10.1006/jmbi.1999.3258; Waragai M, 2000, BIOCHEM BIOPH RES CO, V273, P592, DOI 10.1006/bbrc.2000.2992; YAMAMOTO KR, 1970, VIROLOGY, V40, P734, DOI 10.1016/0042-6822(70)90218-7; Zaiss DMW, 2002, P NATL ACAD SCI USA, V99, P14344, DOI 10.1073/pnas.212257299; Zhang YZ, 2000, GENE, V257, P33, DOI 10.1016/S0378-1119(00)00372-3; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	25	18	19	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33397	33402		10.1074/jbc.M503989200	http://dx.doi.org/10.1074/jbc.M503989200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16000308	hybrid			2022-12-27	WOS:000232058100037
J	Levitin, F; Stern, O; Weiss, M; Gil-Henn, C; Ziv, R; Prokocimer, Z; Smorodinsky, NI; Rubinstein, DB; Wreschner, DH				Levitin, F; Stern, O; Weiss, M; Gil-Henn, C; Ziv, R; Prokocimer, Z; Smorodinsky, NI; Rubinstein, DB; Wreschner, DH			The MUC1 SEA module is a self-cleaving domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA-ASSOCIATED ANTIGEN; N-TERMINAL THREONINE; CANCER CELL-LINES; BREAST-CANCER; MONOCLONAL-ANTIBODY; SPLICE VARIANTS; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; BETA-CATENIN; TYROSINE PHOSPHORYLATION	MUC1, a glycoprotein overexpressed by a variety of human adenocarcinomas, is a type I transmembrane protein (MUC1/TM) that soon after its synthesis undergoes proteolytic cleavage in its extracellular domain. This cleavage generates two subunits, alpha and beta, that specifically recognize each other and bind together in a strong noncovalent interaction. Proteolysis occurs within the SEA module, a 120-amino acid domain that is highly conserved in a number of heavily glycosylated mucin-like proteins. Post-translational cleavage of the SEA module occurs at a site similar to that in MUC1 in the glycoproteins IgHepta and MUC3. However, as in the case of other proteins containing the cleaved SEA module, the mechanism of MUC1 proteolysis has not been elucidated. Alternative splicing generates two transmembrane MUC1 isoforms, designated MUC1/Y and MUC1/X. We demonstrated here that MUC1/X, whose extracellular domain is comprised solely of the SEA module in addition to 30 MUC1N-terminal amino acids, undergoes proteolytic cleavage at the same site as the MUC1/TM protein. In contrast, the MUC1/Y isoform, composed of an N-terminally truncated SEA module, is not cleaved. Cysteine or threonine mutations of the MUC1/X serine residue (Ser-63) immediately C-terminal to the cleavage site generated cleaved proteins, whereas mutation of the Ser-63 residue of MUC1/X to any other of 17 amino acids did not result in cleavage. In vitro incubation of highly purified precursor MUC1/X protein resulted in self-cleavage. Furthermore, addition of hydroxylamine, a strong nucleophile, markedly enhanced cleavage. Both these features are signature characteristics of self-cleaving proteins, and we concluded that MUC1 undergoes autoproteolysis mediated by an N-->O-acyl rearrangement at the cleavage site followed by hydrolytic resolution of the unstable ester and concomitant cleavage. It is likely that all cleaved SEA module-containing proteins follow a similar route.	Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Ramat Aviv, Israel; Tel Aviv Univ, Akec & Myra Marmot Hybridoma Lab, IL-69978 Ramat Aviv, Israel; Assaf Harofeh Med Ctr, Dept Endocrinol, IL-70300 Zerifin, Israel; US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20851 USA	Tel Aviv University; Tel Aviv University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; US Food & Drug Administration (FDA)	Wreschner, DH (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Ramat Aviv, Israel.	danielhw@post.tau.ac.il		Wreschner, Daniel/0000-0003-2102-2164				Abe J, 2002, J BIOL CHEM, V277, P23391, DOI 10.1074/jbc.M110877200; Albert A, 1998, NAT STRUCT BIOL, V5, P289, DOI 10.1038/nsb0498-289; Aronson NN, 1996, GLYCOBIOLOGY, V6, P669, DOI 10.1093/glycob/6.7.669; Baldus SE, 2004, CLIN CANCER RES, V10, P2790, DOI 10.1158/1078-0432.CCR-03-0163; Baruch A, 1999, CANCER RES, V59, P1552; Baruch A, 1997, INT J CANCER, V71, P741; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Burton J, 1999, CLIN CANCER RES, V5, p3065S; CHOI KS, 1992, J BACTERIOL, V174, P6270, DOI 10.1128/JB.174.19.6270-6276.1992; Coughlin Sr, 2002, COLD SPRING HARB SYM, V67, P197, DOI 10.1101/sqb.2002.67.197; Croce MV, 2003, J HISTOCHEM CYTOCHEM, V51, P781, DOI 10.1177/002215540305100609; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; Fujita K, 1999, BRIT J CANCER, V80, P301, DOI 10.1038/sj.bjc.6690355; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; GIRLING A, 1989, INT J CANCER, V43, P1072, DOI 10.1002/ijc.2910430620; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; Hadden JW, 1999, INT J IMMUNOPHARMACO, V21, P79, DOI 10.1016/S0192-0561(98)00077-0; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Hamann PR, 2005, BIOCONJUGATE CHEM, V16, P354, DOI 10.1021/bc049794n; Hartman ML, 1999, INT J CANCER, V82, P256, DOI 10.1002/(SICI)1097-0215(19990719)82:2<256::AID-IJC17>3.0.CO;2-C; HILKENS J, 1984, INT J CANCER, V34, P197, DOI 10.1002/ijc.2910340210; Hinojosa-Kurtzberg AM, 2003, AM J PHYSIOL-GASTR L, V284, pG853, DOI 10.1152/ajpgi.00326.2002; Howard MR, 2002, BIOTECHNIQUES, V32, P1282, DOI 10.2144/02326st03; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Isupov MN, 1996, STRUCTURE, V4, P801, DOI 10.1016/S0969-2126(96)00087-1; Kawamoto T, 2001, CLIN CANCER RES, V7, P1333; Khatri IA, 2003, BIOCHEM J, V372, P263, DOI 10.1042/BJ20021333; Kisselev AF, 2000, J BIOL CHEM, V275, P14831, DOI 10.1074/jbc.275.20.14831; Kontani K, 2001, BRIT J CANCER, V84, P1258, DOI 10.1054/bjoc.2000.1744; Koumarianou AA, 1999, BRIT J CANCER, V81, P431, DOI 10.1038/sj.bjc.6690712; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Levitin F, 2005, J BIOL CHEM, V280, P10655, DOI 10.1074/jbc.M406943200; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; LIGTENBERG MJL, 1990, J BIOL CHEM, V265, P5573; Lillehoj EP, 2003, BIOCHEM BIOPH RES CO, V307, P743, DOI 10.1016/S0006-291X(03)01260-9; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Maeda T, 2004, J BIOL CHEM, V279, P13174, DOI 10.1074/jbc.M309417200; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Mukherjee P, 2005, J LEUKOCYTE BIOL, V77, P90, DOI 10.1189/jlb.0604333; O'Connor JC, 2005, PROSTATE CANCER P D, V8, P36, DOI 10.1038/sj.pcan.4500762; Obermair A, 2002, INT J CANCER, V100, P166, DOI 10.1002/ijc.10456; Obermair A, 2001, GYNECOL ONCOL, V83, P343, DOI 10.1006/gyno.2001.6396; Ohgami A, 1999, ANN THORAC SURG, V67, P810, DOI 10.1016/S0003-4975(99)00041-7; OINONEN C, 1995, NAT STRUCT BIOL, V2, P1102, DOI 10.1038/nsb1295-1102; Oosterkamp HM, 1997, INT J CANCER, V72, P87, DOI 10.1002/(SICI)1097-0215(19970703)72:1<87::AID-IJC13>3.0.CO;2-7; PANDEY P, 1995, CANCER RES, V55, P4000; Parry S, 2001, BIOCHEM BIOPH RES CO, V283, P715, DOI 10.1006/bbrc.2001.4775; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Perler FB, 1998, CELL, V92, P1, DOI 10.1016/S0092-8674(00)80892-2; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Quin RJ, 2000, INT J CANCER, V87, P499, DOI 10.1002/1097-0215(20000815)87:4<499::AID-IJC6>3.0.CO;2-9; Saarela J, 1998, J BIOL CHEM, V273, P25320, DOI 10.1074/jbc.273.39.25320; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shao Y, 1996, BIOCHEMISTRY-US, V35, P3810, DOI 10.1021/bi952592h; Snijdewint FGM, 2001, INT J CANCER, V93, P97, DOI 10.1002/ijc.1286; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Suzuki H, 2002, J BIOL CHEM, V277, P43536, DOI 10.1074/jbc.M207680200; TAKAHASHI T, 1994, J IMMUNOL, V153, P2102; Tikkanen R, 1996, EMBO J, V15, P2954, DOI 10.1002/j.1460-2075.1996.tb00658.x; Treon SP, 2000, BLOOD, V96, P3147, DOI 10.1182/blood.V96.9.3147.h8003147_3147_3153; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Wreesmann VB, 2004, CANCER RES, V64, P3780, DOI 10.1158/0008-5472.CAN-03-1460; Wreschner DH, 2002, PROTEIN SCI, V11, P698, DOI 10.1110/ps.16502; WRESCHNER DH, 1990, EUR J BIOCHEM, V189, P463, DOI 10.1111/j.1432-1033.1990.tb15511.x; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; XU MQ, 1994, EMBO J, V13, P5517, DOI 10.1002/j.1460-2075.1994.tb06888.x; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; YONEZAWA S, 1991, BIOCHEM J, V276, P599, DOI 10.1042/bj2760599; ZARETSKY JZ, 1990, FEBS LETT, V265, P46, DOI 10.1016/0014-5793(90)80880-R; ZRIHANLICHT S, 1994, EUR J BIOCHEM, V224, P787, DOI 10.1111/j.1432-1033.1994.00787.x; ZRIHANLICHT S, 1994, FEBS LETT, V356, P130, DOI 10.1016/0014-5793(94)01251-2	86	153	175	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33374	33386		10.1074/jbc.M506047200	http://dx.doi.org/10.1074/jbc.M506047200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	15987679	hybrid			2022-12-27	WOS:000232058100035
J	Dodd, JR; Christie, DL				Dodd, JR; Christie, DL			Substituted cysteine accessibility of the third transmembrane domain of the creatine transporter - Defining a transport pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN-I; NEUROTRANSMITTER TRANSPORTERS; SEROTONIN TRANSPORTER; GABA TRANSPORTER; CULTURED-CELLS; CLONING; BRAIN; RAT; EXPRESSION; SUBSTRATE	Twenty- two amino acid residues from transmembrane domain 3 of the creatine transporter were replaced, one at a time, with cysteine. The background for mutagenesis was a C144S mutant retaining similar to 75% of wild- type transport activity but resistant to methanethiosulfonate ( MTS) reagents. Each substitution mutant was tested for creatine transport activity and sensitivity to the following MTS reagents: 2- aminoethyl methanethiosulfonate ( MTSEA), 2-( trimethylammonium) ethyl methanethiosulfonate ( MTSET), and 2- sulfonatoethyl methanethiosulfonate ( MTSES). Two mutants ( G134C and Y148C) were inactive, but most mutants showed significant levels of creatine transport. Treatment with MTSEA inhibited the activity of the W154C, Y147C, and I140C mutants. Creatine partially protected I140C from inactivation, and this residue, like Cys- 144 in the wild- type CreaT, is predicted to be close to a creatine binding site. MTSEA inactivation of Y147C was dependent on Na+ and Cl- suggesting that solvent accessibility was ion- dependent. Helical wheel and helical net projections indicate that the three MTSEA- sensitive mutants ( W154C, Y147C, and I140C) and two inactive mutants ( V151C and Y148C) are aligned on a face of an alpha- helix, suggesting that they form part of a substrate pathway. The W154C mutant, located near the external face of the membrane, was accessible to the larger MTS reagents, whereas those implicated in creatine binding were only accessible to the smaller MTSEA. Consideration of our data, together with a study on the serotonin transporter ( Chen, J. G., Sachpatzidis, A., and Rudnick, G. ( 1997) J. Biol. Chem. 272, 28321 - 28327), suggests that involvement of residues from transmembrane domain 3 is a common feature of the substrate pathway of Na+- and Cl+- dependent neurotransmitter transporters.	Univ Auckland, Sch Biol Sci, Cell Biol & Biochem Sect, Auckland, New Zealand	University of Auckland	Christie, DL (corresponding author), Univ Auckland, Sch Biol Sci, Cell Biol & Biochem Sect, Private Bag 92019, Auckland, New Zealand.	d.christie@auckland.ac.nz	Christie, David L/C-8065-2009					AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; DALY MM, 1980, ARCH BIOCHEM BIOPHYS, V203, P317, DOI 10.1016/0003-9861(80)90182-4; Dodd JR, 2001, J BIOL CHEM, V276, P46983, DOI 10.1074/jbc.M107137200; FITSCH CD, 1968, J BIOL CHEM, V243, P2024; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; GUIMBAL C, 1993, J BIOL CHEM, V268, P8418; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Javitch JA, 1998, METHOD ENZYMOL, V296, P331; LOIKE JD, 1986, AM J PHYSIOL, V251, pC128, DOI 10.1152/ajpcell.1986.251.1.C128; Melamed N, 2004, MOL PHARMACOL, V65, P1452, DOI 10.1124/mol.65.6.1452; MOLLER A, 1989, J NEUROCHEM, V52, P544, DOI 10.1111/j.1471-4159.1989.tb09154.x; Nakashima T, 2004, J NEUROCHEM, V89, P1454, DOI 10.1111/j.1471-4159.2004.02437.x; Nelson N, 1998, J NEUROCHEM, V71, P1785; Ohtsuki S, 2002, J CEREBR BLOOD F MET, V22, P1327, DOI 10.1097/01.WCB.0000033966.83623.7D; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; Peral MJ, 2002, J PHYSIOL-LONDON, V545, P133, DOI 10.1113/jphysiol.2002.026377; Rosenberg EH, 2004, AM J HUM GENET, V75, P97, DOI 10.1086/422102; Salomons GS, 2003, J INHERIT METAB DIS, V26, P309, DOI 10.1023/A:1024405821638; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200	26	15	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32649	32654		10.1074/jbc.M506723200	http://dx.doi.org/10.1074/jbc.M506723200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16049011	hybrid			2022-12-27	WOS:000231920300013
J	Goeckeler, ZM; Wysolmerski, RB				Goeckeler, ZM; Wysolmerski, RB			Myosin phosphatase and cofilin mediate cAMP/cAMP-dependent protein kinase-induced decline in endothelial cell isometric tension and myosin II regulatory light chain phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CONTRACTION; INHIBITS RHOA ACTIVATION; ACTIN DYNAMICS; LEADING-EDGE; CYCLIC-AMP; LIM KINASE; CAMP; DEPHOSPHORYLATION; EXPRESSION; SLINGSHOT	This study determined the effects of increased intracellular cAMP and cAMP-dependent protein kinase activation on endothelial cell basal and thrombin-induced isometric tension development. Elevation of cAMP and maximal cAMP-dependent protein kinase activation induced by 10 mu M forskolin, 40 mu M 3-isobutyl-1-methylxanthine caused a 50% reduction in myosin II regulatory light chain (RLC) phosphorylation and a 35% drop in isometric tension, but it did not inhibit thrombin-stimulated increases in RLC phosphorylation and isometric tension. Elevation of cAMP did not alter myosin light chain kinase catalytic activity. However, direct inhibition of myosin light chain kinase with KT5926 resulted in a 90% decrease in RLC phosphorylation and only a minimal decrease in isometric tension, but it prevented thrombin-induced increases in RLC phosphorylation and isometric tension development. We showed that elevated cAMP increases phosphorylation of RhoA 10-fold, and this is accompanied by a 60% decrease in RhoA activity and a 78% increase in RLC phosphatase activity. Evidence is presented that it is this inactivation of RhoA that regulates the decrease in isometric tension through a pathway involving cofilin. Activated cofilin correlates with increased F-actin severing activity in cell extracts from monolayers treated with forskolin/3-isobutyl-1-methylxanthine. Pretreatment of cultures with tautomycin, a protein phosphatase type 1 inhibitor, blocked the effect of cAMP on 1) the dephosphorylation of cofilin, 2) the decrease in RLC phosphorylation, and 3) the decrease in isometric tension. Together, these data provide in vivo evidence that elevated intracellular cAMP regulates endothelial cell isometric tension and RLC phosphorylation through inhibition of RhoA signaling and its downstream pathways that regulate myosin II activity and actin reorganization.	St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA	Saint Louis University	Wysolmerski, RB (corresponding author), St Louis Univ, Sch Med, Dept Pathol, 1402 S Grand Blvd, St Louis, MO 63104 USA.	wysolmrb@slu.edu			NHLBI NIH HHS [HL-45788] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL045788, R01HL045788] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADELSTEIN RS, 1982, METHOD ENZYMOL, V85, P298; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BAORTO DM, 1992, J CELL BIOL, V117, P357, DOI 10.1083/jcb.117.2.357; BDELLATIF AA, 2001, EXP BIOL MED, V226, P153; Birukov KG, 1998, J CELL BIOCHEM, V70, P402, DOI 10.1002/(SICI)1097-4644(19980901)70:3<402::AID-JCB13>3.0.CO;2-M; BLUE EK, 2001, AM J PHYSIOL, V282, pC451; BRYAN J, 1986, METHOD ENZYMOL, V134, P13; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; CARSON MR, 1989, AM J PHYSIOL, V257, pL259, DOI 10.1152/ajplung.1989.257.4.L259; CASNOCHA SA, 1989, J APPL PHYSIOL, V67, P1997, DOI 10.1152/jappl.1989.67.5.1997; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x; Chew TL, 1998, J MUSCLE RES CELL M, V19, P839, DOI 10.1023/A:1005417926585; Cohen PTW, 2002, J CELL SCI, V115, P241; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; CONTI MA, 1981, J BIOL CHEM, V256, P3178; DELANEROLLE P, 1984, SCIENCE, V223, P1415, DOI 10.1126/science.6322302; DELANEROLLE P, 1991, AM J PHYSIOL, V261, pL1, DOI 10.1152/ajplung.1991.261.2.L1; DELVECCHIO PJ, 1981, J CELL PHYSIOL, V108, P337, DOI 10.1002/jcp.1041080307; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Emmert DA, 2004, AM J PHYSIOL-CELL PH, V286, pC8, DOI 10.1152/ajpcell.00428.2002; Endo M, 2003, J NEUROSCI, V23, P2527; Essler M, 2000, J IMMUNOL, V164, P6543, DOI 10.4049/jimmunol.164.12.6543; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; GALLAGHER PJ, 1995, J BIOL CHEM, V270, P29090, DOI 10.1074/jbc.270.49.29090; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23936; GALLINA C, 1997, TUTELA, V1, P16; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Garcia JGN, 1997, AM J RESP CELL MOL, V16, P489, DOI 10.1165/ajrcmb.16.5.9160829; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Goeckeler ZM, 2000, J BIOL CHEM, V275, P18366, DOI 10.1074/jbc.M001339200; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Gungabissoon RA, 2003, J HISTOCHEM CYTOCHEM, V51, P411, DOI 10.1177/002215540305100402; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; KELLEY C, 1988, J MUSCLE RES CELL M, V9, P184, DOI 10.1007/BF01773740; KOBAYASHI H, 1992, J BIOCHEM-TOKYO, V112, P786, DOI 10.1093/oxfordjournals.jbchem.a123976; KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; KURISAKI T, 1992, J ANTIBIOT, V45, P252, DOI 10.7164/antibiotics.45.252; LAMB NJC, 1988, J CELL BIOL, V106, P1955, DOI 10.1083/jcb.106.6.1955; LAMPUGNANI MG, 1990, LAB INVEST, V63, P521; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Laudanna C, 1997, J BIOL CHEM, V272, P24141, DOI 10.1074/jbc.272.39.24141; Lum H, 1996, CAN J PHYSIOL PHARM, V74, P787, DOI 10.1139/cjpp-74-7-787; MCDANIEL NL, 1994, CAN J PHYSIOL PHARM, V72, P1380, DOI 10.1139/y94-199; McGrath JL, 2000, P NATL ACAD SCI USA, V97, P6532, DOI 10.1073/pnas.100023397; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; Meyer G, 2002, J NEUROCHEM, V83, P490, DOI 10.1046/j.1471-4159.2002.01185.x; MILLER JR, 1983, MOL PHARMACOL, V24, P235; Moriyama K, 1999, EMBO J, V18, P6752, DOI 10.1093/emboj/18.23.6752; Moriyama K, 2002, BIOCHEM J, V365, P147, DOI 10.1042/BJ20020231; MOY AB, 1993, J CLIN INVEST, V92, P1198, DOI 10.1172/JCI116690; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Murthy KS, 2000, AM J PHYSIOL-GASTR L, V279, pG201, DOI 10.1152/ajpgi.2000.279.1.G201; Murthy KS, 2003, AM J PHYSIOL-GASTR L, V284, pG1006, DOI 10.1152/ajpgi.00465.2002; NAKANISHI S, 1990, MOL PHARMACOL, V37, P482; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; OLSON NJ, 1990, P NATL ACAD SCI USA, V87, P2284, DOI 10.1073/pnas.87.6.2284; Patterson CE, 2000, ENDOTHELIUM-NEW YORK, V7, P287, DOI 10.3109/10623320009072215; PERRIE WT, 1970, BIOCHEM J, V119, P31, DOI 10.1042/bj1190031; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; SAITO T, 1994, EXP CELL RES, V212, P49, DOI 10.1006/excr.1994.1117; Samstag Y, 2003, ADV ENZYME REGUL, V43, P197, DOI 10.1016/S0065-2571(02)00031-6; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; SATOH M, 1995, GEN PHARMACOL, V26, P357, DOI 10.1016/0306-3623(94)00198-V; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; SHELDON R, 1993, AM J PHYSIOL, V265, pL606, DOI 10.1152/ajplung.1993.265.6.L606; Skuta G, 1999, J BIOL CHEM, V274, P30163, DOI 10.1074/jbc.274.42.30163; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; STULL JT, 1991, HYPERTENSION, V17, P723, DOI 10.1161/01.HYP.17.6.723; Takuma T, 1996, J BIOCHEM, V120, P35; Verin AD, 1998, AM J RESP CELL MOL, V19, P758, DOI 10.1165/ajrcmb.19.5.3125; Verin AD, 1998, AM J RESP CELL MOL, V19, P767, DOI 10.1165/ajrcmb.19.5.3126; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; WATTERSON DM, 1995, FEBS LETT, V373, P217; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wiggan O, 2005, NAT CELL BIOL, V7, P8, DOI 10.1038/ncb0105-8; WYSOLMERSKI RB, 1991, AM J PHYSIOL, V261, pC32, DOI 10.1152/ajpcell.1991.261.1.C32; Yee HF, 2001, BIOCHEM BIOPH RES CO, V280, P1340, DOI 10.1006/bbrc.2001.4291; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119	94	42	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					33083	33095		10.1074/jbc.M503173200	http://dx.doi.org/10.1074/jbc.M503173200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16055445				2022-12-27	WOS:000231920300063
J	Miura, P; Thompson, J; Chakkalakal, JV; Holcik, M; Jasmin, BJ				Miura, P; Thompson, J; Chakkalakal, JV; Holcik, M; Jasmin, BJ			The utrophin A 5 '-untranslated region confers internal ribosome entry site-mediated translational control during regeneration of skeletal muscle fibers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIN-RELATED PROTEIN; MESSENGER-RNA; EXPRESSION; INITIATION; ACETYLCHOLINESTERASE; IRES; RAT; IDENTIFICATION; LOCALIZATION; ACTIVATION	Utrophin up-regulation in muscle fibers of Duchenne muscular dystrophy patients represents a potential therapeutic strategy. It is thus important to delineate the regulatory events presiding over utrophin in muscle in attempts to develop pharmacological interventions aimed at increasing utrophin expression. A number of studies have now shown that under several experimental conditions, the abundance of utrophin is increased without a corresponding elevation in its mRNA. Here, we examine whether utrophin expression is regulated at the translational level in regenerating muscle fibers. Treatment of mouse tibialis anterior muscles with cardiotoxin to induce muscle degeneration/regeneration led to a large (similar to 14-fold) increase in the levels of utrophin A with a modest change in expression of its transcript (40%). Isolation of the mouse utrophin A 5'-untranslated region (UTR) revealed that it is relatively long with a predicted high degree of secondary structure. In control muscles, the 5'-UTR of utrophin A caused an inhibition upon translation of a reporter protein. Strikingly, this inhibition was removed during regeneration, indicating that expression of utrophin A in regenerating muscles is translationally regulated via its 5'-UTR. Using bicistronic reporter vectors, we observed that this translational effect involves an internal ribosome entry site in the utrophin A 5'-UTR. Thus, internal ribosome entry site-mediated translation of utrophin A can, at least partially, account for the discordant expression of utrophin A protein and transcript in regenerating muscle. These findings provide a novel target for up-regulating levels of utrophin A in Duchenne muscular dystrophy muscle fibers via pharmacological interventions.	Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; Univ Ottawa, Fac Med, Ctr Neuromuscular Dis, Ottawa, ON K1H 8M5, Canada; Childrens Hosp Eastern Ontario, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada; Ottawa Hosp, Ottawa Hlth Res Inst, Ottawa, ON K1H 8L6, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Ottawa Hospital Research Institute	Jasmin, BJ (corresponding author), Univ Ottawa, Fac Med, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	jasmin@uottawa.ca	Chakkalakal, Joe/ABD-2865-2020; Holcik, Martin/E-5372-2011; Holcik, Martin/AAC-6660-2019; Holcik, Martin/A-9768-2008; Miura, Pedro/N-4604-2013	Chakkalakal, Joe/0000-0002-8440-7312; Holcik, Martin/0000-0002-1922-5299; Miura, Pedro/0000-0002-8434-5027				ANDERSON MS, 1992, TRENDS BIOCHEM SCI, V17, P289, DOI 10.1016/0968-0004(92)90437-E; Belanger G, 2003, J NEUROCHEM, V86, P669, DOI 10.1046/j.1471-4159.2003.01883.x; Bernstein J, 1997, J BIOL CHEM, V272, P9356; BEWICK GS, 1992, NEUROREPORT, V3, P857, DOI 10.1097/00001756-199210000-00009; Brank M, 1998, EUR J BIOCHEM, V251, P374, DOI 10.1046/j.1432-1327.1998.2510374.x; Burton EA, 1999, P NATL ACAD SCI USA, V96, P14025, DOI 10.1073/pnas.96.24.14025; Chakkalakal JV, 2005, FASEB J, V19, P880, DOI 10.1096/fj.04-1956rev; Chakkalakal JV, 2004, HUM MOL GENET, V13, P379, DOI 10.1093/hmg/ddh037; Chakkalakal JV, 2003, P NATL ACAD SCI USA, V100, P7791, DOI 10.1073/pnas.0932671100; Chakkalakal JV, 2003, BIOESSAYS, V25, P25, DOI 10.1002/bies.10205; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Courdier-Fruh I, 2002, NEUROMUSCULAR DISORD, V12, pS95, DOI 10.1016/S0960-8966(02)00089-5; Creancier L, 2000, J CELL BIOL, V150, P275, DOI 10.1083/jcb.150.1.275; Deconinck N, 1997, NAT MED, V3, P1216, DOI 10.1038/nm1197-1216; Dennis CL, 1996, NUCLEIC ACIDS RES, V24, P1646, DOI 10.1093/nar/24.9.1646; Eberwine J, 2001, P NATL ACAD SCI USA, V98, P7080, DOI 10.1073/pnas.121146698; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Giraud S, 2001, J BIOL CHEM, V276, P5668, DOI 10.1074/jbc.M005928200; Gramolini AO, 1999, J NEUROPATH EXP NEUR, V58, P235, DOI 10.1097/00005072-199903000-00003; Gramolini AO, 1998, J BIOL CHEM, V273, P736, DOI 10.1074/jbc.273.2.736; Gramolini AO, 2001, J CELL BIOL, V154, P1173, DOI 10.1083/jcb.200101108; Gramolini AO, 2001, AM J PHYSIOL-CELL PH, V281, pC1300, DOI 10.1152/ajpcell.2001.281.4.C1300; Gramolini AO, 1999, P NATL ACAD SCI USA, V96, P3223, DOI 10.1073/pnas.96.6.3223; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; HELLIWELL TR, 1992, NEUROMUSCULAR DISORD, V2, P177, DOI 10.1016/0960-8966(92)90004-P; Holcik M, 2000, MOL CELL BIOL, V20, P4648, DOI 10.1128/MCB.20.13.4648-4657.2000; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; HOROVITZ O, 1989, J CELL BIOL, V108, P1817, DOI 10.1083/jcb.108.5.1817; Jasmin BJ, 2002, J PHYSIOL-PARIS, V96, P31, DOI 10.1016/S0928-4257(01)00078-X; JASMIN BJ, 1993, NEURON, V11, P467, DOI 10.1016/0896-6273(93)90151-G; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Khurana TS, 1999, MOL BIOL CELL, V10, P2075, DOI 10.1091/mbc.10.6.2075; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Lefaucheur JP, 1995, NEUROSCI LETT, V202, P121, DOI 10.1016/0304-3940(95)12223-0; LEVINOVITZ A, 1992, MOL ENDOCRINOL, V6, P1227, DOI 10.1210/me.6.8.1227; Lu JY, 2004, J BIOL CHEM, V279, P12974, DOI 10.1074/jbc.M310433200; Martineau Y, 2004, MOL CELL BIOL, V24, P7622, DOI 10.1128/MCB.24.17.7622-7635.2004; Menon KP, 2004, NEURON, V44, P663, DOI 10.1016/j.neuron.2004.10.028; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; MICHEL RN, 1994, J CELL BIOL, V127, P1061, DOI 10.1083/jcb.127.4.1061; Moghadaszadeh B, 2003, HUM MOL GENET, V12, P2467, DOI 10.1093/hmg/ddg264; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; Pedersen SK, 2002, BIOCHEM J, V363, P37, DOI 10.1042/0264-6021:3630037; Pinkstaff JK, 2001, P NATL ACAD SCI USA, V98, P2770, DOI 10.1073/pnas.051623398; Pozner A, 2000, MOL CELL BIOL, V20, P2297, DOI 10.1128/MCB.20.7.2297-2307.2000; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Roma J, 2004, ACTA NEUROPATHOL, V108, P443, DOI 10.1007/s00401-004-0908-1; Sachs AB, 2000, CELL, V101, P243, DOI 10.1016/S0092-8674(00)80834-X; Shao Y, 2001, ARCH BIOCHEM BIOPHYS, V390, P78, DOI 10.1006/abbi.2001.2354; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Teshima-Kondo S, 2004, FASEB J, V18, P1583, DOI 10.1096/fj.03-1118fje; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; VITADELLO M, 1994, HUM GENE THER, V5, P11, DOI 10.1089/hum.1994.5.1-11; Waheed I, 2005, HUM GENE THER, V16, P489, DOI 10.1089/hum.2005.16.489; Weir AP, 2002, J BIOL CHEM, V277, P45285, DOI 10.1074/jbc.M205177200; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	64	50	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32997	33005		10.1074/jbc.M503994200	http://dx.doi.org/10.1074/jbc.M503994200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16061482	hybrid			2022-12-27	WOS:000231920300054
J	Nabokina, SM; Reidling, JC; Said, HM				Nabokina, SM; Reidling, JC; Said, HM			Differentiation-dependent up-regulation of intestinal thiamin uptake - Cellular and molecular mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANE; CACO-2 CELLS; POLARIZED EXPRESSION; IN-VITRO; TRANSPORTER; GENE; SLC19A2; ABSORPTION; ANEMIA; FAMILY	Differentiation of intestinal epithelial cells is associated with up- and- down regulation of expression of a variety of genes including those involved in nutrient uptake. Nothing is known about possible differentiation- dependent regulation of the intestinal thiamin uptake process and the cellular and molecular mechanisms involved in such regulation. Using as models human- derived intestinal epithelial Caco- 2 cells and crypt/ villus epithelial cells isolated from wild- type and transgenic mice carrying promoters for human thiamin transporter- 1 and - 2 ( hTHTR- 1 and hTHTR- 2), we addressed this issue. Our results showed that differentiation of Caco- 2 cells is associated with a significant up- regulation in carrier- mediated thiamin uptake. Up- regulation was associated with a significant increase in the level of expression of hTHTR- 1 and hTHTR- 2 protein and mRNA as well as in activity of the corresponding transfected human thiamin transporter- 1 ( SLC19A2) and - 2 ( SLC19A3) promoters. Deletion analysis identified the differentiation- responsive region to be at position -356 to -275 bp for the SLC19A2 promoter and at position -77 to -13 bp for the SLC19A3 promoter. In addition, a critical and specific role in the differentiation- mediated effects for an NF1 binding site ( -348 to -345 bp) in the SLC19A2 promoter and a SP1/ GC- box binding site ( -48 to -45 bp) in the SLC19A3 promoter were established using mutational analysis. The physiological relevance of in vitro findings with Caco- 2 cells was confirmed in wild- type and transgenic mice by demonstrating that thiamin uptake and mRNA levels of the mouse THTR- 1 and THTR- 2, as well as activity of human SLC19A2 and SLC19A3 promoters expressed in transgenic mice, were all significantly higher in intestinal villus compared with crypt epithelial cells. These studies demonstrate for the first time that differentiation of intestinal epithelial cells is associated with an up- regulation in thiamin uptake process and that this up- regulation appears to be mediated via transcriptional regulatory mechanisms that involve the SLC19A2 and SLC19A3 genes.	Vet Affairs Healthcare Syst, Long Beach, CA 90822 USA; Univ Calif Irvine, Coll Med, Irvine, CA 92697 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine	Said, HM (corresponding author), Vet Affairs Med Ctr 151, Long Beach, CA 90822 USA.	hmsaid@uci.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056061, F32DK062629, R01DK058057, R37DK056061] Funding Source: NIH RePORTER; NIDDK NIH HHS [1-F32-DK062629, DK56061, DK58057] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bedrine-Ferran H, 2004, GENOMICS, V83, P772, DOI 10.1016/j.ygeno.2003.11.014; Berdanier C.D., 2018, ADV NUTR MACRONUTRIE; Boulware MJ, 2003, BIOCHEM J, V376, P43, DOI 10.1042/BJ20031220; Costa C, 2000, BBA-BIOMEMBRANES, V1509, P95, DOI 10.1016/S0005-2736(00)00281-9; Diaz GA, 1999, NAT GENET, V22, P309, DOI 10.1038/10385; Dudeja PK, 2003, DIGEST DIS SCI, V48, P109, DOI 10.1023/A:1021794600864; Dudeja PK, 2001, AM J PHYSIOL-CELL PH, V281, pC786, DOI 10.1152/ajpcell.2001.281.3.C786; Dutta B, 1999, J BIOL CHEM, V274, P31925, DOI 10.1074/jbc.274.45.31925; Eudy JD, 2000, MOL GENET METAB, V71, P581, DOI 10.1006/mgme.2000.3112; Fleming JC, 1999, NAT GENET, V22, P305, DOI 10.1038/10379; Fleming JC, 2001, MOL GENET METAB, V74, P273, DOI 10.1006/mgme.2001.3241; HOPFER U, 1973, J BIOL CHEM, V248, P25; Labay V, 1999, NAT GENET, V22, P300, DOI 10.1038/10372; Laforenza U, 1997, AM J CLIN NUTR, V66, P320, DOI 10.1093/ajcn/66.2.320; Maulen NP, 2003, J BIOL CHEM, V278, P9035, DOI 10.1074/jbc.M205119200; Nabokina SM, 2004, AM J PHYSIOL-GASTR L, V287, pG822, DOI 10.1152/ajpgi.00234.2004; NABOKINA SM, 2003, AM J PHYSIOL, V284, pG737; Oishi K, 2001, MOL GENET METAB, V73, P149, DOI 10.1006/mgme.2001.3184; Pinkus L M, 1981, Methods Enzymol, V77, P154; Rajgopal A, 2001, BBA-MOL BASIS DIS, V1537, P175, DOI 10.1016/S0925-4439(01)00073-4; REIDLING CJ, 2005, AM J PHYSIOL, V288, pG1127; Reidling JC, 2004, GASTROENTEROLOGY, V126, pA659; Reidling JC, 2003, AM J PHYSIOL-CELL PH, V285, pC633, DOI 10.1152/ajpcell.00076.2003; Reidling JC, 2002, BBA-BIOMEMBRANES, V1561, P180, DOI 10.1016/S0005-2736(02)00341-3; RINDI G, 1977, EXPERIENTIA, V33, P211, DOI 10.1007/BF02124072; Said HM, 1999, AM J PHYSIOL-CELL PH, V277, pC645, DOI 10.1152/ajpcell.1999.277.4.C645; Said HM, 2004, AM J PHYSIOL-GASTR L, V286, pG491, DOI 10.1152/ajpgi.00361.2003; Said HM, 2001, AM J PHYSIOL-GASTR L, V281, pG144, DOI 10.1152/ajpgi.2001.281.1.G144; Subramanian VS, 2003, J BIOL CHEM, V278, P3976, DOI 10.1074/jbc.M210717200; TALLAKSEN CME, 1993, ALCOHOL CLIN EXP RES, V17, P712, DOI 10.1111/j.1530-0277.1993.tb00825.x; Tanphaichirt V., 1994, MODERN NUTR HLTH DIS; TOMASULO PA, 1968, AM J CLIN NUTR, V21, P1341, DOI 10.1093/ajcn/21.11.1341; VACHON PH, 1992, GASTROENTEROLOGY, V103, P414, DOI 10.1016/0016-5085(92)90829-N; Wang LY, 2004, AM J PHYSIOL-GASTR L, V287, pG943, DOI 10.1152/ajpgi.00121.2004; Wong WK, 2003, J BIOL CHEM, V278, P36227, DOI 10.1074/jbc.M305549200	35	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32676	32682		10.1074/jbc.M505243200	http://dx.doi.org/10.1074/jbc.M505243200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16055442	hybrid			2022-12-27	WOS:000231920300017
J	Chen, YC; Su, YN; Chou, PC; Chiang, WC; Chang, MC; Wang, LS; Teng, SC; Wu, KJ				Chen, YC; Su, YN; Chou, PC; Chiang, WC; Chang, MC; Wang, LS; Teng, SC; Wu, KJ			Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAKAGE-SYNDROME GENE; C-MYC; MRE11 COMPLEX; TARGETED DISRUPTION; IN-VITRO; CANCER; EXPRESSION; AKT; PATHWAY; GROWTH	Nijmegen breakage syndrome (NBS) is a chromosomal instability syndrome associated with cancer predisposition, radiosensitivity, microcephaly, and growth retardation. The NBS gene product, NBS1 (p95) or nibrin, is a part of the hMre11 complex, a central player associated with double strand break repair. We previously demonstrated that c-Myc directly activates NBS1 expression. Here we have shown that constitutive expression of NBS1 in Rat1a and HeLa cells induces/enhances their transformation. Repression of endogenous NBS1 levels using short interference RNA reduces the transformation activity of two tumor cell lines. Increased NBS1 expression is observed in 40-52% of non-small cell lung carcinoma, hepatoma, and esophageal cancer samples. NBS1 overexpression stimulates phosphatidylinositol ( PI) 3-kinase activity, leading to increased phosphorylation levels of Akt and its downstream targets such as glycogen synthase kinase 3 beta and mammalian target of rapamycin in different cell lines and tumor samples. Transformation induced by NBS1 overexpression can be inhibited by a PI3-kinase inhibitor (LY294002). Repression of endogenous Akt expression by short interference RNA decreases the transformation activity of Rat1a cells overexpressing NBS1. These results indicate that overexpression of NBS1 is an oncogenic event that contributes to transformation through the activation of PI3-kinase/Akt.	Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; Natl Taiwan Univ Hosp, Dept Med Genet, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei 100, Taiwan; Taipei Vet Gen Hosp, Div Thorac Surg, Dept Surg, Taipei 112, Taiwan; Natl Taiwan Univ, Grad Inst Microbiol, Coll Med, Taipei 100, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; National Taiwan University	Wu, KJ (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	kjwu2@ym.edu.tw	Wu, Kou-Juey/P-4654-2015	Chiang, Wei-Chung/0000-0003-3149-435X; TENG, SHU-CHUN/0000-0002-6492-2560				Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bitzer M, 2003, ANTICANCER RES, V23, P1489; Brognard J, 2001, CANCER RES, V61, P3986; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cerosaletti KM, 2002, GENE CHROMOSOME CANC, V35, P282, DOI 10.1002/gcc.10114; Chiang YC, 2003, J BIOL CHEM, V278, P19286, DOI 10.1074/jbc.M212043200; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; Crowell JA, 2003, J NATL CANCER I, V95, P252, DOI 10.1093/jnci/95.4.252; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Dang CV, 1999, MOL CELL BIOL, V19, P1; Ehlers JP, 2005, CLIN CANCER RES, V11, P1849, DOI 10.1158/1078-0432.CCR-04-2054; Hu LM, 2002, CANCER RES, V62, P1087; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Lee SH, 2002, APMIS, V110, P587, DOI 10.1034/j.1600-0463.2002.11007811.x; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Nakanishi K, 2002, CANCER RES, V62, P2971; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Plisiecka-Halasa J, 2002, ANN HUM GENET, V66, P353, DOI [10.1046/j.1469-1809.2002.00122.x, 10.1017/S0003480002001227]; Rieger-Christ KM, 2004, ONCOGENE, V23, P4745, DOI 10.1038/sj.onc.1207629; ROBINSON WS, 1994, ANNU REV MED, V45, P297; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Stumm P, 2001, CANCER GENET CYTOGEN, V126, P60, DOI 10.1016/S0165-4608(00)00390-3; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Ueki K, 2000, MOL CELL BIOL, V20, P8035, DOI 10.1128/MCB.20.21.8035-8046.2000; VANDERZWET MK, 1999, MUTAT RES, V434, P17; Varon R, 2001, CANCER RES, V61, P3570; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wilda M, 2000, HUM MOL GENET, V9, P1739, DOI 10.1093/hmg/9.12.1739; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	42	56	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32505	32511		10.1074/jbc.M501449200	http://dx.doi.org/10.1074/jbc.M501449200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16036916	hybrid			2022-12-27	WOS:000231794800059
J	Mulvenna, JP; Foley, FM; Craik, DJ				Mulvenna, JP; Foley, FM; Craik, DJ			Discovery, structural determination, and putative processing of the precursor protein that produces the cyclic trypsin inhibitor sunflower trypsin inhibitor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE CALCULATION; SPIN COUPLING-CONSTANTS; BOWMAN-BIRK INHIBITOR; COMMON AMINO-ACIDS; CIRCULAR PROTEINS; MOMORDICA-COCHINCHINENSIS; ASPARAGINYL ENDOPEPTIDASE; SPECTROSCOPY; CYCLOTIDES; RESOLUTION	Backbone-cyclized proteins are becoming increasingly well known, although the mechanism by which they are processed from linear precursors is poorly understood. In this report the sequence and structure of the linear precursor of a cyclic trypsin inhibitor, sunflower trypsin inhibitor 1 (SFTI-1) from sunflower seeds, is described. The structure indicates that the major elements of the reactive site loop of SFTI-1 are present before processing. This may have importance for a protease-mediated cyclizing reaction as the rigidity of SFTI-1 may drive the equilibrium of the reaction catalyzed by proteolytic enzymes toward the formation of a peptide bond rather than the normal cleavage reaction. The occurrence of residues in the SFTI-1 precursor susceptible to cleavage by asparaginyl proteases strengthens theories that involve this enzyme in the processing of SFTI-1 and further implicates it in the processing of another family of plant cyclic proteins, the cyclotides. The precursor reported here also indicates that despite strong active site sequence homology, SFTI-1 has no other similarities with the Bowman-Birk trypsin inhibitors, presenting interesting evolutionary questions.	Univ Queensland, Inst Mol Biosci, Asutralian Res Council, Ctr Funct & Appl Genom, Brisbane, Qld 4072, Australia	University of Queensland	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Asutralian Res Council, Ctr Funct & Appl Genom, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Mulvenna, Jason/H-7110-2014; Craik, David/B-1695-2010	Mulvenna, Jason/0000-0003-3521-8061; Craik, David/0000-0003-0007-6796				BIRK Y, 1985, INT J PEPT PROT RES, V25, P113, DOI 10.1111/j.1399-3011.1985.tb02155.x; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; Craik DJ, 2004, CURR PROTEIN PEPT SC, V5, P297, DOI 10.2174/1389203043379512; Craik DJ, 2002, CURR OPIN DRUG DI DE, V5, P251; Dutton JL, 2004, J BIOL CHEM, V279, P46858, DOI 10.1074/jbc.M407421200; Eisenbrandt R, 2000, J BACTERIOL, V182, P6751, DOI 10.1128/JB.182.23.6751-6761.2000; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; Fliess A, 2002, PROTEINS, V48, P377, DOI 10.1002/prot.10156; GODDARD TC, 2004, SPARKY 3 MANUAL; GRIESINGER C, 1987, J MAGN RESON, V75, P474, DOI 10.1016/0022-2364(87)90102-8; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haase J, 1997, J BACTERIOL, V179, P5728, DOI 10.1128/jb.179.18.5728-5735.1997; HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; ISHII S, 1994, METHOD ENZYMOL, V244, P604; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Kalkum M, 2002, TRENDS MICROBIOL, V10, P382, DOI 10.1016/S0966-842X(02)02399-5; Konarev A. V., 1999, Genetics and breeding for crop quality and resistance. Proceedings of the XV EUCARPIA Congress, Viterbo, Italy, September 20-25, 1998., P135; Konarev AV, 2002, PHYTOCHEMISTRY, V59, P279, DOI 10.1016/S0031-9422(01)00463-0; Korsinczky MLJ, 2004, CURR PROTEIN PEPT SC, V5, P351, DOI 10.2174/1389203043379594; Korsinczky MLJ, 2001, J MOL BIOL, V311, P579, DOI 10.1006/jmbi.2001.4887; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Marx UC, 2003, J BIOL CHEM, V278, P21782, DOI 10.1074/jbc.M212996200; McBride JD, 2002, BIOPOLYMERS, V66, P79, DOI 10.1002/bip.10228; Mello MO, 2003, MOL PHYLOGENET EVOL, V27, P103, DOI 10.1016/S1055-7903(02)00373-1; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; ODANI S, 1986, J BIOCHEM-TOKYO, V100, P975, DOI 10.1093/oxfordjournals.jbchem.a121810; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Prakash B, 1996, J MOL EVOL, V42, P560, DOI 10.1007/BF02352286; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCOTT MP, 1992, P NATL ACAD SCI USA, V89, P658, DOI 10.1073/pnas.89.2.658; Song HK, 1999, J MOL BIOL, V293, P1133, DOI 10.1006/jmbi.1999.3239; TAKEDA O, 1994, J BIOCHEM-TOKYO, V116, P541, DOI 10.1093/oxfordjournals.jbchem.a124559; Trabi M, 2002, TRENDS BIOCHEM SCI, V27, P132, DOI 10.1016/S0968-0004(02)02057-1; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P130; Zhou HX, 2004, ACCOUNTS CHEM RES, V37, P123, DOI 10.1021/ar0302282; Zhu SY, 2003, FASEB J, V17, P1765, DOI 10.1096/fj.02-1044fje	45	33	41	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32245	32253		10.1074/jbc.M506060200	http://dx.doi.org/10.1074/jbc.M506060200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16036912	hybrid			2022-12-27	WOS:000231794800026
J	Naoe, Y; Arita, K; Hashimoto, H; Kanazawa, H; Sato, M; Shimizu, T				Naoe, Y; Arita, K; Hashimoto, H; Kanazawa, H; Sato, M; Shimizu, T			Structural characterization of calcineurin B homologous protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT SIGNALS; CA2+-BINDING PROTEIN; CRYSTAL-STRUCTURE; BINDING PROTEIN; NA+/H+ EXCHANGERS; DEPENDENT MANNER; LAMM EQUATION; CELL-DEATH; P22; LOCALIZATION	Calcineurin B homologous protein 1( CHP1), also known as p22, is a calcium-binding EF-hand protein that plays a role in membrane trafficking. It binds to multiple effector proteins, including Na+/H+ exchangers, a serine/threonine kinase, and calcineurin, potentially modulating their function. The crystal structure of calcium-bound CHP1 from rat has been determined at 2.2 angstrom of resolution. The molecule has a compact alpha-helical structure containing four EF-hands. The overall folding topology of the protein is similar to that of the regulatory B subunit of calcineurin and to that of calcium-and integrin-binding protein. The calcium ion is coordinated in typical fashion in the third and fourth EF-hands, but the first and second EF-hands contain no calcium ion. The first EF-hand is maintained by internal interactions, and the second EF- hand is stabilized by hydrophobic interactions. CHP1 contains a hydrophobic pocket on the opposite side of the protein to the EF- hands that has been implicated in ligand binding.	Yokohama City Univ, Int Grad Sch Arts & Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan	Yokohama City University; Osaka University	Shimizu, T (corresponding author), Yokohama City Univ, Int Grad Sch Arts & Sci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	shimizu@tsurumi.yokohama-cu.ac.jp	Arita, Kyohei/AAJ-6402-2020	Arita, Kyohei/0000-0002-9762-8405; Hashimoto, Hiroshi/0000-0003-1503-6789				Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Andrade J, 2004, MOL BIOL CELL, V15, P481, DOI 10.1091/mbc.E03-07-0500; Barroso MR, 1996, J BIOL CHEM, V271, P10183, DOI 10.1074/jbc.271.17.10183; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dam J, 2004, METHOD ENZYMOL, V384, P185; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Inoue H, 2003, BIOL PHARM BULL, V26, P148, DOI 10.1248/bpb.26.148; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuwahara H, 2003, J BIOCHEM, V134, P245, DOI 10.1093/jb/mvg137; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; Matsumoto M, 2001, J BIOCHEM, V130, P217, DOI 10.1093/oxfordjournals.jbchem.a002975; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2003, J BIOL CHEM, V278, P42240, DOI 10.1074/jbc.M303630200; Nagita M, 2003, J BIOCHEM, V134, P919, DOI 10.1093/jb/mvg223; Nakamura N, 2002, J BIOCHEM, V132, P483, DOI 10.1093/oxfordjournals.jbchem.a003246; Naoe Y, 2005, ACTA CRYSTALLOGR F, V61, P612, DOI 10.1107/S1744309105016325; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Pang TX, 2004, BIOCHEMISTRY-US, V43, P3628, DOI 10.1021/bi0360004; Pang TX, 2002, J BIOL CHEM, V277, P43771, DOI 10.1074/jbc.M208313200; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shock DD, 1999, BIOCHEM J, V342, P729, DOI 10.1042/0264-6021:3420729; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Timm S, 1999, MOL BIOL CELL, V10, P3473, DOI 10.1091/mbc.10.10.3473; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Yap Kyoko L, 2002, Methods Mol Biol, V173, P317; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5	44	21	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32372	32378		10.1074/jbc.M503390200	http://dx.doi.org/10.1074/jbc.M503390200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	15987692	hybrid			2022-12-27	WOS:000231794800042
J	Ueki, T; Inouye, S				Ueki, T; Inouye, S			Identification of a gene involved in polysaccharide export as a transcription target of FruA, an essential factor for Myxococcus xanthus development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRUITING-BODY DEVELOPMENT; SIGNALING PROTEIN; ESCHERICHIA-COLI; C-FACTOR; EXPRESSION; LOCUS; PHOSPHORYLATION; MORPHOGENESIS; BINDING; SYSTEM	Fruiting body development in Myxococcus xanthus is a multicellular event that is coordinated by exchanging intercellular signals. FruA is a transcription factor essential for fruiting body development and is thought to play a key role in the C-signal pathway. Here we present the first identification of a gene regulated by FruA. The gene was isolated from a genomic library via in vitro selection in a DNA binding assay by using the DNA-binding domain of FruA tagged with His(8) at the C-terminal end (FruA-DBD-H-8). The gene, named fdgA (FruA-dependent gene A), encodes a protein homologous to the outer-membrane auxiliary family protein involved in the polysaccharide export system. FruA-DBD-H8 bound the upstream promoter region of the fdgA gene from nucleotide -89 to nucleotide -64 with respect to the transcription initiation site, which was required for the induction of fdgA expression during development. fdgA mRNA induced during development was absent in a fruA deletion strain. The deletion of fdgA resulted in defective fruiting body formation and reduced sporulation efficiency (1% that of the parent strain). Moreover, FruA was required for the developmental expression of sasA, which is also involved in the biosynthesis of the lipopolysaccharide O-antigen and is required for fruiting body development. Furthermore, the expression of both fdgA and sasA was partially dependent on the C-signal. These findings expand our understanding of the signal transduction pathway mediated by FruA during development in M. xanthus.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Inouye, S (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Lane, Piscataway, NJ 08854 USA.	inouyesu@umdnj.edu	Inouye, Sharon/R-7216-2019					CAMPOS JM, 1978, J MOL BIOL, V119, P167, DOI 10.1016/0022-2836(78)90431-X; DOWNARD J, 1993, J BACTERIOL, V175, P7762, DOI 10.1128/JB.175.24.7762-7770.1993; Dworkin M, 1993, MYXOBACTERIA, P63; Ellehauge E, 1998, MOL MICROBIOL, V30, P807, DOI 10.1046/j.1365-2958.1998.01113.x; FORST S, 1989, P NATL ACAD SCI USA, V86, P6052, DOI 10.1073/pnas.86.16.6052; Guo DC, 1996, J BACTERIOL, V178, P1631, DOI 10.1128/jb.178.6.1631-1639.1996; HAGAN DC, 1978, DEV BIOL, V64, P284; HAGEN TJ, 1990, J BACTERIOL, V172, P15, DOI 10.1128/JB.172.1.15-23.1990; Horiuchi T, 2002, J BIOL CHEM, V277, P26753, DOI 10.1074/jbc.M111214200; INOUE S, 1999, TRANSCRIPTION FACTOR, P165; INOUYE M, 1979, DEV BIOL, V68, P579, DOI 10.1016/0012-1606(79)90228-8; Kaiser D, 2004, ANNU REV MICROBIOL, V58, P75, DOI 10.1146/annurev.micro.58.030603.123620; KAPLAN HB, 1991, J BACTERIOL, V173, P1460, DOI 10.1128/jb.173.4.1460-1470.1991; KIM SK, 1990, CELL, V61, P19, DOI 10.1016/0092-8674(90)90211-V; KROOS L, 1986, DEV BIOL, V117, P252, DOI 10.1016/0012-1606(86)90368-4; Lobedanz S, 2003, GENE DEV, V17, P2151, DOI 10.1101/gad.274203; Miller J. H., 1972, EXPT MOL GENETICS, P439; Ogawa M, 1996, MOL MICROBIOL, V22, P757, DOI 10.1046/j.1365-2958.1996.d01-1725.x; Paulsen IT, 1997, MICROBIOL-SGM, V143, P2685, DOI 10.1099/00221287-143-8-2685; SAGER B, 1994, GENE DEV, V8, P2793, DOI 10.1101/gad.8.23.2793; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; Sogaard-Andersen L, 2003, MOL MICROBIOL, V48, P1, DOI 10.1046/j.1365-2958.2003.03399.x; SogaardAndersen L, 1996, P NATL ACAD SCI USA, V93, P2675, DOI 10.1073/pnas.93.7.2675; SogaardAndersen L, 1996, GENE DEV, V10, P740, DOI 10.1101/gad.10.6.740; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sun H, 2001, J BACTERIOL, V183, P6733, DOI 10.1128/JB.183.23.6733-6739.2001; Sun H, 2001, J BACTERIOL, V183, P4786, DOI 10.1128/JB.183.16.4786-4795.2001; Ueki T, 2003, P NATL ACAD SCI USA, V100, P8782, DOI 10.1073/pnas.1533026100; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WEISS V, 1992, P NATL ACAD SCI USA, V89, P5088, DOI 10.1073/pnas.89.11.5088; WHITE D, 1993, MYXOBACTERIA, V2, P307; Wu HC, 1996, ESCHERICHIA COLI SAL, V1, P1005	32	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32279	32284		10.1074/jbc.M507191200	http://dx.doi.org/10.1074/jbc.M507191200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16040607	hybrid			2022-12-27	WOS:000231794800030
J	Kawahara, T; Ritsick, D; Cheng, GJ; Lambeth, JD				Kawahara, T; Ritsick, D; Cheng, GJ; Lambeth, JD			Point mutations in the proline-rich region of p22(phox) are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; PHAGOCYTE NADPH OXIDASE; SRC HOMOLOGY-3 DOMAINS; NAD(P)H OXIDASE; ACTIVATION DOMAIN; MOLECULAR-BASIS; CYTOCHROME-B; SUPEROXIDE; P47(PHOX); PROTEINS	The integral membrane protein p22(phox) is an indispensable component of the superoxide-generating phagocyte NADPH oxidase, whose catalytic core is the membrane-associated gp91(phox) ( also known as Nox2). p22(phox) associates with gp91(phox) and, through its proline-rich C terminus, provides a binding site for the tandem Src homology 3 domains of the activating subunit p47(phox). Whereas p22(phox) is expressed ubiquitously, its participation in regulating the activity of other Nox enzymes is less clear. This study investigates the requirement of p22phox for Nox enzyme activity and explores the role of its proline-rich region ( PRR) for regulating activity. Co-expression of specific Nox catalytic subunits ( Nox1, Nox2, Nox3, Nox4, or Nox5) along with their corresponding regulatory subunits ( NOXO1/NOXA1 for Nox1; p47(phox)/p67(phox)/Rac for Nox2; NOXO1 for Nox3; no subunits for Nox4 or Nox5) resulted in marked production of reactive oxygen. Small interfering RNAs decreased endogenous p22(phox) expression and inhibited reactive oxygen generation from Nox1, Nox2, Nox3, and Nox4 but not Nox5. Truncated forms of p22(phox) that disrupted the PRR-inhibited reactive oxygen generation from Nox1, Nox2, and Nox3 but not from Nox4 and Nox5. Similarly, p22(phox) ( P156Q), a mutation that disrupts Src homology 3 binding by the PRR, potently inhibited reactive oxygen production from Nox1 and Nox2 but not from Nox4 and Nox5. Expression of p22(phox) ( P156Q) inhibited NOXO1-stimulated Nox3 activity, but co-expression of NOXA1 overcame the inhibitory effect. The P157Q and P160Q mutations of p22(phox) showed selective inhibition of Nox2/p47(phox)/p67(phox), and selectivity was specific for the organizing subunit ( p47(phox) or NOXO1) rather than the Nox catalytic subunit. These studies stress the importance of p22(phox) for the function of Nox1, Nox2, Nox3, and Nox4, and emphasize the key role of the PRR for regulating Nox proteins whose activity is dependent upon p47phox or NOXO1.	Emory Univ, Sch Med, Dept Pathol & Expt Med, Atlanta, GA 30322 USA; Emory Univ, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Lambeth, JD (corresponding author), Emory Univ, Sch Med, Dept Pathol & Expt Med, 148 Whitehead Bldg,615 Michael St, Atlanta, GA 30322 USA.	noxdoc@mac.com		Cheng, Guangjie/0000-0002-9368-379X	NCI NIH HHS [CA84138, CA105116] Funding Source: Medline; NIGMS NIH HHS [GM067717] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R56CA105116, R01CA105116, R01CA084138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067717] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Baker MA, 2004, MOL CELL ENDOCRINOL, V216, P47, DOI 10.1016/j.mce.2003.10.068; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Banfi B, 2000, SCIENCE, V287, P138, DOI 10.1126/science.287.5450.138; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Cheng GJ, 2004, J BIOL CHEM, V279, P34250, DOI 10.1074/jbc.M400660200; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; CORVILAIN B, 1991, ENDOCRINOLOGY, V128, P779, DOI 10.1210/endo-128-2-779; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; De Deken X, 2002, EXP CELL RES, V273, P187, DOI 10.1006/excr.2001.5444; DELAMIRANDE E, 1995, FREE RADICAL BIO MED, V18, P487, DOI 10.1016/0891-5849(94)00169-K; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; DINAUER MC, 1991, P NATL ACAD SCI USA, V88, P11231, DOI 10.1073/pnas.88.24.11231; DINAUER MC, 1993, CRIT REV CL LAB SCI, V30, P329, DOI 10.3109/10408369309082591; Ebert BL, 1999, BLOOD, V94, P1864; Gao XP, 2002, J IMMUNOL, V168, P3974, DOI 10.4049/jimmunol.168.8.3974; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Gelbart WM, 2002, NUCLEIC ACIDS RES, V30, P106; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; JESAITIS AJ, 1990, J CLIN INVEST, V85, P821, DOI 10.1172/JCI114509; Kawahara T, 2005, AM J PHYSIOL-CELL PH, V288, pC450, DOI 10.1152/ajpcell.00319.2004; Kawahara T, 2004, J IMMUNOL, V172, P3051, DOI 10.4049/jimmunol.172.5.3051; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; KEY LL, 1994, BONE, V15, P431, DOI 10.1016/8756-3282(94)90821-4; Kuribayashi F, 2002, EMBO J, V21, P6312, DOI 10.1093/emboj/cdf642; Lambeth JD, 2002, CURR OPIN HEMATOL, V9, P11, DOI 10.1097/00062752-200201000-00003; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; LEUSEN JHW, 1994, J EXP MED, V180, P2329, DOI 10.1084/jem.180.6.2329; Liu JH, 2004, CIRC RES, V95, P587, DOI 10.1161/01.RES.0000142317.88591.e6; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paffenholz R, 2004, GENE DEV, V18, P486, DOI 10.1101/gad.1172504; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Ritsick DR, 2004, BIOCHEM SOC SYMP, V71, P85; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Touyz RM, 2002, CIRC RES, V90, P1205, DOI 10.1161/01.RES.0000020404.01971.2F; Tsunawaki S, 2004, INFECT IMMUN, V72, P3373, DOI 10.1128/IAI.72.6.3373-3382.2004; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; van de Loo FAJ, 2003, AM J PATHOL, V163, P1525, DOI 10.1016/S0002-9440(10)63509-2; Williams MS, 2004, FREE RADICAL BIO MED, V37, P1144, DOI 10.1016/j.freeradbiomed.2004.05.029; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680	61	184	191	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31859	31869		10.1074/jbc.M501882200	http://dx.doi.org/10.1074/jbc.M501882200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15994299	hybrid			2022-12-27	WOS:000231665200065
J	Sebollela, A; Cagliari, TC; Limaverde, GSCS; Chapeaurouge, A; Sorgine, MHF; Coelho-Sampaio, T; Ramos, CHI; Ferreira, ST				Sebollela, A; Cagliari, TC; Limaverde, GSCS; Chapeaurouge, A; Sorgine, MHF; Coelho-Sampaio, T; Ramos, CHI; Ferreira, ST			Heparin-binding sites in granulocyte-macrophage colony-stimulating factor - Localization and regulation by histidine ionization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR GM-CSF; GROWTH-FACTOR; SULFATE PROTEOGLYCANS; NERVE REGENERATION; MITOGENIC ACTIVITY; ESCHERICHIA-COLI; CELL-LINES; RECEPTOR; ACTIVATION; GLYCOSAMINOGLYCANS	The biological activity of granulocyte-macrophage colony-stimulating factor (GM-CSF) is modulated by the sulfated glycosaminoglycans (GAGs) heparan sulfate and heparin. However, the molecular mechanisms involved in such interactions are still not completely understood. We have proposed previously that helix C, one of the four alpha-helices of human GM-CSF (hGM-CSF), contains a GAG-binding site in which positively charged residues are spatially positioned for interaction with the sulfate moieties of the GAGs (Wettreich, A., Sebollela, A., Carvalho, M. A., Azevedo, S. P., Borojevic, R., Ferreira, S. T., and Coelho-Sampaio, T. (1999) J. Biol. Chem. 274, 31468-31475). Protonation of two histidine residues ( His(83) and His(87)) in helix C of hGM-CSF appears to act as a pH-dependent molecular switch to control the interaction with GAGs. Based on these findings, we have now generated a triple mutant form of murine GM-CSF (mGM-CSF) in which three noncharged residues in helix C of the murine factor (Tyr(83), Gln(85), and Tyr(87)) were replaced by the corresponding basic residues present in hGM-CSF (His(83), Lys(85), and His87). Binding assays on heparin-Sepharose showed that, at acidic pH, the triple mutant mGM-CSF binds to immobilized heparin with significantly higher affinity than wild type (WT) mGM-CSF and that neither protein binds to the column at neutral pH. The fact that even WT mGM-CSF binds to heparin at acidic pH indicates the existence of a distinct, lower affinity heparin-binding site in the protein. Chemical modification of the single histidine residue (His(15)) located in helix A of WT mGM-CSF with diethyl pyrocarbonate totally abolished binding to immobilized heparin. Moreover, replacement of His(15) for an alanine residue significantly reduced the affinity of mGM-CSF for heparin at pH 5.0 and completely blocked heparin binding to a synthetic peptide corresponding to helix A of GM-CSF. These results indicate a major role of histidine residues in the regulation of the binding of GM-CSF to GAGs, supporting the notion that an acidic microenvironment is required for GM-CSF-dependent regulation of target cells. In addition, our results provide insight into the molecular basis of the strict species specificity of the biological activity of GM-CSF.	Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med, BR-21940590 Rio De Janeiro, Brazil; Univ Fed Rio de Janeiro, Lab Modelagem & Dinam Mol, Inst Biofis Carlos Chagas Filho, BR-21940590 Rio De Janeiro, Brazil; Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Histol & Embriol, BR-21940590 Rio De Janeiro, Brazil; UNICAMP, Dept Bioquim, Inst Biol, BR-13084971 Campinas, SP, Brazil; Fiocruz MS, Dept Fisiol & Farmacodinam, BR-21045900 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Estadual de Campinas; Fundacao Oswaldo Cruz	Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med, BR-21940590 Rio De Janeiro, Brazil.	ferreira@bioqmed.ufrj.br	Sebollela, Adriano/O-4385-2014; Ferreira, Sergio/AAZ-1576-2020; Ramos, CH/C-1571-2012	Sebollela, Adriano/0000-0002-7444-9156; Ferreira, Sergio/0000-0001-7160-9866; Ramos, CH/0000-0002-7246-9081				AlvarezSilva M, 1996, J LEUKOCYTE BIOL, V59, P435, DOI 10.1002/jlb.59.3.435; ALVAREZSILVA M, 1993, J CELL SCI, V104, P477; Arcanjo K, 2002, J CELL BIOCHEM, V87, P160, DOI 10.1002/jcb.10293; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Borojevic R, 2003, CELL TISSUE RES, V313, P55, DOI 10.1007/s00441-003-0726-0; BURGESS AW, 1987, BLOOD, V69, P43; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Carneiro FA, 2003, J BIOL CHEM, V278, P13789, DOI 10.1074/jbc.M210615200; Carvalho MA, 2000, BIOL CELL, V92, P605, DOI 10.1016/S0248-4900(01)01113-3; D'Andrea RJ, 2000, EXP HEMATOL, V28, P231, DOI 10.1016/S0301-472X(99)00159-9; DECRISTAN G, 1990, J CELL PHYSIOL, V144, P505; DELAMARTER JF, 1985, EMBO J, V4, P2575, DOI 10.1002/j.1460-2075.1985.tb03973.x; DeLano W.L, PYMOL MOL GRAPHICS S; DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036; Freire E, 2004, J CELL SCI, V117, P4067, DOI 10.1242/jcs.01276; Freire E, 2002, J CELL SCI, V115, P4867, DOI 10.1242/jcs.00173; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Hallgren J, 2004, J IMMUNOL, V173, P1868, DOI 10.4049/jimmunol.173.3.1868; Harmer NJ, 2004, J MOL BIOL, V339, P821, DOI 10.1016/j.jmb.2004.04.031; Harmer NJ, 2003, BIOPHYS CHEM, V100, P545, DOI 10.1016/S0301-4622(02)00305-8; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; KAUSHANSKY K, 1988, J CLIN INVEST, V81, P92, DOI 10.1172/JCI113316; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; LUNDBLAD RL, 1984, CHEM REAGENTS PROTEI, P105; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; MATSUMOTO R, 1995, J BIOL CHEM, V270, P19524, DOI 10.1074/jbc.270.33.19524; MEOTNER M, 1991, J AM CHEM SOC, V113, P4448, DOI 10.1021/ja00012a012; METCALF D, 1991, SCIENCE, V254, P529, DOI 10.1126/science.1948028; Miles E W, 1977, Methods Enzymol, V47, P431; Modrowski D, 1998, J CELL PHYSIOL, V177, P187, DOI 10.1002/(SICI)1097-4652(199810)177:1<187::AID-JCP19>3.0.CO;2-A; Modrowski D, 2000, J BIOL CHEM, V275, P9178, DOI 10.1074/jbc.275.13.9178; Monfardini C, 2002, CURR PHARM DESIGN, V8, P2185, DOI 10.2174/1381612023393198; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mulloy B, 2001, CURR OPIN STRUC BIOL, V11, P623, DOI 10.1016/S0959-440X(00)00257-8; Sasaki T, 1999, EMBO J, V18, P6240, DOI 10.1093/emboj/18.22.6240; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schnaar RL, 2004, ARCH BIOCHEM BIOPHYS, V426, P163, DOI 10.1016/j.abb.2004.02.019; SCHRIMSHER JL, 1987, BIOCHEM J, V247, P195, DOI 10.1042/bj2470195; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; WALTER MR, 1992, J MOL BIOL, V224, P1075, DOI 10.1016/0022-2836(92)90470-5; WANG HM, 1991, BIOCHEM J, V278, P689, DOI 10.1042/bj2780689; Wettreich A, 1999, J BIOL CHEM, V274, P31468, DOI 10.1074/jbc.274.44.31468; WINGFIELD P, 1988, EUR J BIOCHEM, V173, P65, DOI 10.1111/j.1432-1033.1988.tb13967.x	47	37	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31949	31956		10.1074/jbc.M505314200	http://dx.doi.org/10.1074/jbc.M505314200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16027123	hybrid			2022-12-27	WOS:000231665200074
J	Seth, R; Yang, C; Kaushal, V; Shah, SV; Kaushal, GP				Seth, R; Yang, C; Kaushal, V; Shah, SV; Kaushal, GP			p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CISPLATIN-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; SUPEROXIDE-DISMUTASE; FACTOR AIF; IN-VITRO; DEATH; P53; DYSFUNCTION; INHIBITION; UPSTREAM	We activation in the mitochondrial release of apoptosis-inducing factor (AIF) in cisplatin-treated renal tubular epithelial cells. Gene silencing of AIF with its small interfering RNA ( siRNA) suppressed cisplatin-induced AIF expression and provided a marked protection against cell death. Subcellular fractionation and immunofluorescence studies revealed cisplatin-induced translocation of AIF from the mitochondria to the nuclei. Pancaspase inhibitor benzyloxycarbonyl-Val-Ala-Asp- fluoromethylketone or p53 inhibitor pifithrin-alpha markedly prevented mitochondrial release of AIF, suggesting that caspases and p53 are involved in this release. Caspase-2 and -3 that were predominantly activated in response to cisplatin provided a unique model to study the role of these caspases in AIF release. Cisplatin-treated caspase-3 (+/+) and caspase-3 (-/-) cells exhibited similar AIF translocation to the nuclei, suggesting that caspase- 3 does not affect AIF translocation, and thus, caspase- 2 may be involved in the translocation. Caspase-2 inhibitor benzyloxycarbonyl-Val-Asp-Val- Ala-Asp-fluoromethylketone or down-regulation of caspase- 2 by its siRNA significantly prevented translocation of AIF. Caspase-2 activation was a critical response from p53, which was markedly induced and phosphorylated in cisplatin-treated cells. Overexpression of p53 not only resulted in caspase- 2 activation but also mitochondrial release of AIF. The p53 inhibitor pifithrin-alpha or p53 siRNA prevented both cisplatin-induced caspase- 2 activation and mitochondrial release of AIF. Caspase-2 activation was dependent on the p53-responsive gene, PIDD, a death domain-containing protein that was induced by cisplatin in a p53-dependent manner. These results suggest that caspase- 2 activation mediated by p53 is an important pathway involved in the mitochondrial release of AIF in response to cisplatin injury.	Univ Arkansas Med Sci Hosp, Dept Med, Little Rock, AR 72205 USA; Univ Arkansas Med Sci Hosp, Dept Biochem, Little Rock, AR 72205 USA; Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Kaushal, GP (corresponding author), Univ Arkansas Med Sci Hosp, Dept Med, 4301 W Markham St,Slot 501, Little Rock, AR 72205 USA.	kaushalgurp@uams.edu			NIDDK NIH HHS [DK-58324] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058324] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Arnoult D, 2001, MOL BIOL CELL, V12, P3016, DOI 10.1091/mbc.12.10.3016; Baek SM, 2003, J LAB CLIN MED, V142, P178, DOI 10.1016/S0022-2143(03)00111-2; Bergin E, 2000, AM J PHYSIOL-RENAL, V278, pF758, DOI 10.1152/ajprenal.2000.278.5.F758; BRADY HR, 1990, AM J PHYSIOL, V258, pF1181, DOI 10.1152/ajprenal.1990.258.5.F1181; Cande C, 2004, CELL DEATH DIFFER, V11, P591, DOI 10.1038/sj.cdd.4401400; Cande C, 2004, ONCOGENE, V23, P1514, DOI 10.1038/sj.onc.1207279; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cilenti L, 2005, AM J PHYSIOL-RENAL, V288, pF371, DOI 10.1152/ajprenal.00154.2004; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Cregan SP, 2000, GENE THER, V7, P1200, DOI 10.1038/sj.gt.3301208; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Cummings BS, 2002, J PHARMACOL EXP THER, V302, P8, DOI 10.1124/jpet.302.1.8; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Davis CA, 2001, J AM SOC NEPHROL, V12, P2683, DOI 10.1681/ASN.V12122683; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Enoksson M, 2004, J BIOL CHEM, V279, P49575, DOI 10.1074/jbc.C400374200; Fukuoka K, 1998, LIFE SCI, V62, P1125, DOI 10.1016/S0024-3205(98)00036-8; Gabriel B, 2003, EXP CELL RES, V289, P195, DOI 10.1016/S0014-4827(03)00255-6; GORDON JA, 1986, AM J PHYSIOL, V250, pF991, DOI 10.1152/ajprenal.1986.250.6.F991; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; JAGJIT S, 1998, J CLIN INVEST, V101, P2842; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Justo P, 2003, KIDNEY INT, V64, pS52, DOI 10.1046/j.1523-1755.64.s86.10.x; Kaushal GP, 1998, AM J PHYSIOL-RENAL, V274, pF587, DOI 10.1152/ajprenal.1998.274.3.F587; Kaushal GP, 2001, KIDNEY INT, V60, P1726, DOI 10.1046/j.1523-1755.2001.00026.x; Kim JS, 2004, BIOCHEM PHARMACOL, V67, P1459, DOI 10.1016/j.bcp.2003.12.013; Kruidering M, 1997, J PHARMACOL EXP THER, V280, P638; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lin CF, 2004, J BIOL CHEM, V279, P40755, DOI 10.1074/jbc.M404726200; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nishikawa M, 2001, ARCH BIOCHEM BIOPHYS, V387, P78, DOI 10.1006/abbi.2000.2237; Nowak G, 2003, AM J PHYSIOL-RENAL, V285, pF440, DOI 10.1152/ajprenal.00233.2002; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Park MS, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134858; Penninger JM, 2003, NAT CELL BIOL, V5, P97, DOI 10.1038/ncb0203-97; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; ROZENCWEIG M, 1977, ANN INTERN MED, V86, P803, DOI 10.7326/0003-4819-86-6-803; SAFIRSTEIN R, 1987, INT J ANDROL, V10, P325, DOI 10.1111/j.1365-2605.1987.tb00200.x; Satoh M, 2003, J PHARMACOL EXP THER, V305, P1183, DOI 10.1124/jpet.102.047522; Sauerwald TM, 2002, BIOTECHNOL BIOENG, V77, P704, DOI 10.1002/bit.10154; Sax JK, 2003, CELL DEATH DIFFER, V10, P413, DOI 10.1038/sj.cdd.4401227; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Schwerdt G, 2003, KIDNEY INT, V63, P1725, DOI 10.1046/j.1523-1755.2003.00934.x; SHERIDAN AM, 1993, AM J PHYSIOL, V265, pF342, DOI 10.1152/ajprenal.1993.265.3.F342; Slee EA, 2004, ONCOGENE, V23, P2809, DOI 10.1038/sj.onc.1207516; Stennicke HR, 2000, METHOD ENZYMOL, V322, P91; SUGIYAMA S, 1989, BIOCHEM BIOPH RES CO, V159, P1121, DOI 10.1016/0006-291X(89)92225-0; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Takeda M, 1997, ARCH TOXICOL, V71, P612, DOI 10.1007/s002040050434; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; WOOD ER, 1990, J CELL BIOL, V111, P2839, DOI 10.1083/jcb.111.6.2839; Yakovlev AG, 2004, J BIOL CHEM, V279, P28367, DOI 10.1074/jbc.M313526200; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhan Y, 1999, ONCOGENE, V18, P6505, DOI 10.1038/sj.onc.1203060; ZHANG JG, 1993, BIOCHEM PHARMACOL, V45, P2215	68	145	157	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31230	31239		10.1074/jbc.M503305200	http://dx.doi.org/10.1074/jbc.M503305200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15983031	hybrid			2022-12-27	WOS:000231487800070
J	Alarcon, R; Fuenzalida, C; Santibanez, M; von Bernhardi, R				Alarcon, R; Fuenzalida, C; Santibanez, M; von Bernhardi, R			Expression of scavenger receptors in glial cells - Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; ALZHEIMERS-DISEASE BRAIN; PLAQUE CORE PROTEIN; CLASS-B; NERVOUS-SYSTEM; SENILE PLAQUES; HOST-DEFENSE; IN-VITRO; INFLAMMATORY RESPONSE; CULTURED ASTROCYTES	Astrocytes and microglia associate to amyloid plaques, a pathological hallmark of Alzheimer disease. Microglia are activated by and can phagocytose beta-amyloid ( A beta). Scavenger receptors ( SRs) are among the receptors mediating the uptake of fibrillar A beta in vitro. However, little is known about the function of the astrocytes surrounding the plaques or the nature of their interaction with A beta. It is unknown whether glial cells bind to nonfibrillar A beta and if binding of astrocytes to A beta depends on the same Scavenger receptors described for microglia. We determined the binding of glia to A beta by an adhesion assay and evaluated the presence of scavenger receptors in glial cells by immunocytochemistry, immunohistochemistry of brain sections, and immunoblot. We found that astrocytes and microglia from neonatal rats adhered in a concentration-dependent manner to surfaces coated with fibrillar A beta or nonfibrillar A beta. Fucoidan and poly( I), known ligands for SR-type A, inhibited adhesion of microglia and astrocytes to A beta and also inhibited A beta phagocytosis. In contrast, a ligand for SR-type B like low density lipoprotein, did not compete glial adhesion to A beta. Microglia presented immunodetectable SR-BI, SR-AI/AII, RAGE, and SR-MARCO ( macrophage receptor with collagenous structure, a member of the SR-A family). Astrocytes presented SR-BI and SR-MARCO. To our knowledge, this is the first description of the presence of SR-MARCO in astrocytes. Our results indicate that both microglia and astrocytes adhere to fibrillar and nonfibrillar A beta. Adhesion was mediated by a fucoidan-sensitive receptor. We propose that SR-MARCO could be the Scavenger receptor responsible for the adhesion of astrocytes and microglia to A beta.	Pontificia Univ Catolica Chile, Dept Neurol, Fac Med, Santiago, Chile	Pontificia Universidad Catolica de Chile	von Bernhardi, R (corresponding author), Pontificia Univ Catolica Chile, Dept Neurol, Fac Med, Marcoleta 391, Santiago, Chile.	rvonb@med.puc.cl	von Bernhardi, Rommy/F-7232-2013	von Bernhardi, Rommy/0000-0002-9022-7676				ACTON SL, 1994, J BIOL CHEM, V269, P21003; Alvarez A, 1997, J MOL BIOL, V272, P348, DOI 10.1006/jmbi.1997.1245; Bechmann I, 1997, HISTOCHEM CELL BIOL, V107, P391, DOI 10.1007/s004180050125; BELL MD, 1994, J NEUROCYTOL, V23, P605, DOI 10.1007/BF01191555; Burudi EME, 1999, GLIA, V25, P44, DOI 10.1002/(SICI)1098-1136(19990101)25:1<44::AID-GLIA5>3.0.CO;2-C; Christie RH, 1996, AM J PATHOL, V148, P399; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; DeWitt DA, 1998, EXP NEUROL, V149, P329, DOI 10.1006/exnr.1997.6738; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; ElKhoury J, 1996, NATURE, V382, P716; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Gough PJ, 2000, MICROBES INFECT, V2, P305, DOI 10.1016/S1286-4579(00)00297-5; Granucci F, 2003, BLOOD, V102, P2940, DOI 10.1182/blood-2002-12-3651; Greaves DR, 1998, CURR OPIN LIPIDOL, V9, P425, DOI 10.1097/00041433-199810000-00006; Gu XJ, 2000, J BIOL CHEM, V275, P9120, DOI 10.1074/jbc.275.13.9120; HAASS C, 1992, NATURE, V359, P325; HAYES GM, 1988, J NEUROIMMUNOL, V19, P177, DOI 10.1016/0165-5728(88)90001-X; Herrera-Molina R, 2005, NEUROBIOL DIS, V19, P229, DOI 10.1016/j.nbd.2005.01.003; Honda M, 1998, BIOCHEM BIOPH RES CO, V245, P734, DOI 10.1006/bbrc.1998.8120; Hsu HY, 2001, J BIOL CHEM, V276, P28719, DOI 10.1074/jbc.M011117200; Hu JG, 1998, BRAIN RES, V785, P195, DOI 10.1016/S0006-8993(97)01318-8; Hu JR, 1999, BRAIN RES, V842, P46, DOI 10.1016/S0006-8993(99)01804-1; Husemann J, 2001, J NEUROIMMUNOL, V114, P142, DOI 10.1016/S0165-5728(01)00239-9; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Husemann J, 2001, AM J PATHOL, V158, P825, DOI 10.1016/S0002-9440(10)64030-8; Inestrosa N., 1997, ALZHEIMERS DIS BIOL, P501; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Kim WS, 2003, BIOCHEM BIOPH RES CO, V310, P542, DOI 10.1016/j.bbrc.2003.09.049; Kraal G, 2000, MICROBES INFECT, V2, P313, DOI 10.1016/S1286-4579(00)00296-3; Krieger M, 1997, CURR OPIN LIPIDOL, V8, P275, DOI 10.1097/00041433-199710000-00006; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Kurt MA, 1999, EXP NEUROL, V158, P221, DOI 10.1006/exnr.1999.7096; LENZ ML, 1990, J LIPID RES, V31, P1043; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Makranz C, 2004, NEUROBIOL DIS, V15, P279, DOI 10.1016/j.nbd.2003.11.007; Marzolo MP, 1999, J NEUROSCI RES, V58, P387, DOI 10.1002/(SICI)1097-4547(19991101)58:3<387::AID-JNR4>3.3.CO;2-C; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Nilsson KPR, 2005, BIOCHEMISTRY-US, V44, P3718, DOI 10.1021/bi047402u; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; PIKE CJ, 1995, EXP NEUROL, V132, P172, DOI 10.1016/0014-4886(95)90022-5; Ramirez G, 2005, NEUROBIOL DIS, V19, P243, DOI 10.1016/j.nbd.2005.01.007; Re FB, 2002, J IMMUNOL, V169, P2264, DOI 10.4049/jimmunol.169.5.2264; Rezaie P, 2002, GLIA, V37, P64, DOI 10.1002/glia.1128; ROHER A, 1986, P NATL ACAD SCI USA, V83, P2662, DOI 10.1073/pnas.83.8.2662; ROHER AE, 1988, J CELL BIOL, V107, P2703, DOI 10.1083/jcb.107.6.2703; ROZEMULLER JM, 1989, NEUROSCI LETT, V101, P288, DOI 10.1016/0304-3940(89)90547-8; Sasaki A, 1997, ACTA NEUROPATHOL, V94, P316, DOI 10.1007/s004010050713; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHENG JG, 1995, NEUROPATH APPL NEURO, V21, P290, DOI 10.1111/j.1365-2990.1995.tb01063.x; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SOTO C, 1994, J NEUROCHEM, V63, P1191; SOTO C, 1995, J BIOL CHEM, V270, P3063, DOI 10.1074/jbc.270.7.3063; Tezel G, 2001, GLIA, V34, P178, DOI 10.1002/glia.1052; van der Laan LJW, 1999, J IMMUNOL, V162, P939; VINORES SA, 1993, J NEUROIMMUNOL, V43, P169, DOI 10.1016/0165-5728(93)90088-G; von Bernhardi R, 2004, BRAIN RES, V1025, P186, DOI 10.1016/j.brainres.2004.07.084; Von Bernhardi R, 2001, BIOL RES, V34, P123; von Bernhardi R, 2001, EUR J NEUROSCI, V14, P946, DOI 10.1046/j.0953-816x.2001.01715.x; Wallace MN, 1997, EXP NEUROL, V144, P266, DOI 10.1006/exnr.1996.6373; Wegiel J, 2000, ACTA NEUROPATHOL, V100, P356, DOI 10.1007/s004010000199; WOLF BB, 1992, AM J PATHOL, V141, P37; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yamada Y, 1998, CELL MOL LIFE SCI, V54, P628, DOI 10.1007/s000180050191; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	71	135	138	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30406	30415		10.1074/jbc.M414686200	http://dx.doi.org/10.1074/jbc.M414686200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15987691	hybrid			2022-12-27	WOS:000231362500053
J	Hinckley, MB; Reynolds, CM; Ribeiro, AA; McGrath, SC; Cotter, RJ; Lauw, FN; Golenbock, DT; Raetz, CRH				Hinckley, MB; Reynolds, CM; Ribeiro, AA; McGrath, SC; Cotter, RJ; Lauw, FN; Golenbock, DT; Raetz, CRH			A Leptospira interrogans enzyme with similarity to yeast Ste14p that methylates the 1-phosphate group of lipid A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; LINKED ACYL CHAINS; ESCHERICHIA-COLI; RHIZOBIUM-LEGUMINOSARUM; EXPRESSION CLONING; 3-DEOXY-D-MANNO-OCTULOSONIC ACID; LIPOPOLYSACCHARIDE BIOSYNTHESIS; NMR-SPECTROSCOPY; INNER MEMBRANE; MSBA	Distinct from other spirochetes, cells of Leptospira interrogans contain orthologues of all the Escherichia coli lpx genes required for lipid A biosynthesis, but they synthesize a modified form of lipopolysaccharide that supposedly activates toll-like receptor 2 ( TLR2) instead of TLR4. The recent determination of the L. interrogans lipid A structure revealed an unprecedented O-methylation of its 1-phosphate group ( Que-Gewirth, N. L. S., Ribeiro, A. A., Kalb, S. R., Cotter, R. J., Bulach, D. M., Adler, B., Saint Girons, I., Werts, C., and Raetz, C. R. H. ( 2004) J. Biol. Chem. 279, 25420 - 25429). The enzymatic activity responsible for selective 1-phosphate methylation has not been previously explored. A membrane enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine ( SAM) to the 1-phosphate moiety of E. coli Kdo(2)-[4'-P-32] lipid A has now been discovered. The gene encoding this enzyme was identified based on the hypothesis that methylation of a phosphate group is chemically analogous to methylation of a carboxylate moiety at a membrane-water interface. Database searching revealed a candidate gene ( renamed lmtA) in L. interrogans showing distant homology to the yeast isoprenylcysteine carboxyl methyltransferase, encoded by sterile-14, which methylates the a-type mating factor. Orthologues of lmtA were not present in E. coli, the lipid A of which normally lacks the 1-phosphomethyl group, or in other spirochetes, which do not synthesize lipid A. Expression of the lmtA gene behind the lac promoter on a low copy plasmid resulted in the appearance of SAM-dependent methyltransferase activity in E. coli inner membranes and methylation of about 30% of the endogenous E. coli lipid A. Inactivation of the ABC transporter MsbA did not inhibit methylation of newly synthesized lipid A. Methylated E. coli lipid A was analyzed by mass spectrometry and NMR spectroscopy to confirm the location of the phosphomethyl group at the 1-position. In human cells, engineered to express the individual TLR subtypes, 1-phosphomethyl-lipid A purified from lmtA-expressing E. coli potently activated TLR4 but not TLR2.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Duke NMR Spect Ctr, Durham, NC 27710 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Middle Atlantic Mass Spect Lab, Baltimore, MD 21205 USA; Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	Duke University; Duke University; Johns Hopkins University; University of Massachusetts System; University of Massachusetts Worcester	Raetz, CRH (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	raetz@biochem.duke.edu			NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054882, R01GM051796, R01GM054060, R01GM051310, R37GM054060, F32GM073251, R37GM051796] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA014236] Funding Source: Medline; NIAID NIH HHS [AI057784, P01 AI057784] Funding Source: Medline; NIGMS NIH HHS [R37 GM054060, GM-54882, R37 GM051796-09, R01 GM054060, R37 GM051796, 1-F32-GM073251-01, F32 GM073251, GM-54060, R01 GM051796, GM-51796, GM-51310, R01 GM051310] Funding Source: Medline; PHS HHS [P30-AC-14236] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Anderson JL, 2005, J BIOL CHEM, V280, P7336, DOI 10.1074/jbc.M410292200; Basu SS, 1999, J BIOL CHEM, V274, P11139, DOI 10.1074/jbc.274.16.11139; Basu SS, 2002, J BIOL CHEM, V277, P28959, DOI 10.1074/jbc.M204525200; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Brozek KA, 1996, J BIOL CHEM, V271, P32112, DOI 10.1074/jbc.271.50.32119; BROZEK KA, 1989, J BIOL CHEM, V264, P6956; Bulach DM, 2000, J MOL MICROB BIOTECH, V2, P375; Coggins BE, 2003, NAT STRUCT BIOL, V10, P645, DOI 10.1038/nsb948; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; FREEZE HH, 1992, J BIOL CHEM, V267, P4431; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; GONZALEZROMO P, 1992, ANAL BIOCHEM, V200, P235, DOI 10.1016/0003-2697(92)90458-J; GUYCAFFEY JK, 1992, J BACTERIOL, V174, P2460, DOI 10.1128/jb.174.8.2460-2465.1992; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Karbarz MJ, 2003, J BIOL CHEM, V278, P39269, DOI 10.1074/jbc.M305830200; KARBARZ MJ, 2004, THESIS DUKE U MED CT; KATES M, 1993, BIOCHIM BIOPHYS ACTA, V1169, P46, DOI 10.1016/0005-2760(93)90080-S; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Miller J.H., 1972, EXPT MOL GENTICS; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; Osborn M J, 1974, Methods Enzymol, V31, P642; Pereira MM, 2000, J CLIN MICROBIOL, V38, P450; Que NLS, 2000, J BIOL CHEM, V275, P28017; Que-Gewirth NLS, 2004, J BIOL CHEM, V279, P25420, DOI 10.1074/jbc.M400598200; Que-Gewirth NLS, 2003, J BIOL CHEM, V278, P12120, DOI 10.1074/jbc.M300379200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; Ribeiro AA, 1999, MAGN RESON CHEM, V37, P620, DOI 10.1002/(SICI)1097-458X(199909)37:9<620::AID-MRC517>3.0.CO;2-Q; Romano JD, 2001, MOL BIOL CELL, V12, P1957, DOI 10.1091/mbc.12.7.1957; Sweet CR, 2004, J BIOL CHEM, V279, P25400, DOI 10.1074/jbc.M400596200; Sweet CR, 2004, J BIOL CHEM, V279, P25411, DOI 10.1074/jbc.M400597200; Tran AX, 2004, J BIOL CHEM, V279, P55780, DOI 10.1074/jbc.M406480200; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wang XY, 2004, J BIOL CHEM, V279, P49470, DOI 10.1074/jbc.M409078200; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	47	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30214	30224		10.1074/jbc.M506103200	http://dx.doi.org/10.1074/jbc.M506103200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15994324	Green Accepted, hybrid			2022-12-27	WOS:000231362500030
J	Regoes, A; Zourmpanou, D; Leon-Avila, G; van der Giezen, M; Tovar, J; Hehl, AB				Regoes, A; Zourmpanou, D; Leon-Avila, G; van der Giezen, M; Tovar, J; Hehl, AB			Protein import, replication, and inheritance of a vestigial mitochondrion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIARDIA-LAMBLIA; TRICHOMONAS-VAGINALIS; ENTAMOEBA-HISTOLYTICA; REMNANT ORGANELLES; GENOME; GENES; HYDROGENOSOMES; INTESTINALIS; EUKARYOTES; MACHINERY	Mitochondrial remnant organelles ( mitosomes) that exist in a range of "amitochondrial" eukaryotic organisms represent ideal models for the study of mitochondrial evolution and for the establishment of the minimal set of proteins required for the biogenesis of an endosymbiosis-derived organelle. Giardia intestinalis, often described as the earliest branching eukaryote, contains double membrane-bounded structures involved in iron-sulfur cluster biosynthesis, an essential function of mitochondria. Here we present evidence that Giardia mitosomes also harbor Cpn60, mtHsp70, and ferredoxin and that despite their advanced state of reductive evolution they have retained vestiges of presequence-dependent and -independent protein import pathways akin to those that operate in mammalian mitochondria. Although import of IscU and ferredoxin is still reliant on their amino-terminal presequences, targeting of Giardia Cpn60, IscS, or mtHsp70 into mitosomes no longer requires cleavable presequences, a derived feature from their mitochondrial homologues. In addition, we found that division and segregation of a single centrally positioned mitosome tightly associated with the microtubular cytoskeleton is coordinated with the cell cycle, whereas peripherally located mitosomes are inherited into daughter cells stochastically.	Univ London Royal Holloway & Bedford New Coll, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland	University of London; Royal Holloway University London; University of Zurich	Tovar, J (corresponding author), Univ London Royal Holloway & Bedford New Coll, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	j.tovar@rhul.ac.uk	van der Giezen, Mark/J-9550-2019	van der Giezen, Mark/0000-0002-1033-1335; Hehl, Adrian/0000-0002-2110-4445	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; AMAYA Y, 1988, J BIOL CHEM, V263, P14463; ARAKAWA H, 1990, J BIOCHEM-TOKYO, V107, P160, DOI 10.1093/oxfordjournals.jbchem.a123001; Arisue N, 2002, PARASITOL INT, V51, P9, DOI 10.1016/S1383-5769(01)00093-9; Bakatselou C, 2000, ARCH MED RES, V31, pS176, DOI 10.1016/S0188-4409(00)00211-3; Benchimol M, 1996, BIOL CELL, V87, P197, DOI 10.1016/S0248-4900(97)89276-3; Benchimol M, 2004, BIOL CELL, V96, P291, DOI 10.1016/j.biolcel.2004.01.007; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Boxma B, 2005, NATURE, V434, P74, DOI 10.1038/nature03343; Bradley PJ, 1997, EMBO J, V16, P3484, DOI 10.1093/emboj/16.12.3484; Bui ETN, 1996, P NATL ACAD SCI USA, V93, P9651, DOI 10.1073/pnas.93.18.9651; CLARK CG, 1995, P NATL ACAD SCI USA, V92, P6518, DOI 10.1073/pnas.92.14.6518; Dyall SD, 2003, J BIOL CHEM, V278, P30548, DOI 10.1074/jbc.M304032200; Emelyanov VV, 2003, FEMS MICROBIOL LETT, V226, P257, DOI 10.1016/S0378-1097(03)00598-6; FILICE FRANCIS P., 1952, UNIV CALIFORNIA PUBL ZOOL, V57, P53; Gray MW, 2005, NATURE, V434, P29, DOI 10.1038/434029a; Gribaldo S, 2002, THEOR POPUL BIOL, V61, P391, DOI 10.1006/tpbi.2002.1593; Hehl AB, 2000, MOL BIOL CELL, V11, P1789, DOI 10.1091/mbc.11.5.1789; Hehl AB, 2004, MOL MICROBIOL, V53, P19, DOI 10.1111/j.1365-2958.2004.04115.x; Inagaki Y, 2003, NUCLEIC ACIDS RES, V31, P4227, DOI 10.1093/nar/gkg440; JARVIS JA, 1995, J BIOL CHEM, V270, P1323, DOI 10.1074/jbc.270.3.1323; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Knight J, 2004, NATURE, V429, P236, DOI 10.1038/429236a; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; LaGier MJ, 2003, MICROBIOL-SGM, V149, P3519, DOI 10.1099/mic.0.26365-0; Leon-Avila G, 2004, MICROBIOL-SGM, V150, P1245, DOI 10.1099/mic.0.26923-0; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lucattini R, 2004, MOL BIOL EVOL, V21, P652, DOI 10.1093/molbev/msh058; Marti M, 2003, J BIOL CHEM, V278, P24837, DOI 10.1074/jbc.M302082200; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Morgan GW, 2004, J BIOL CHEM, V279, P10692, DOI 10.1074/jbc.M312178200; Morrison HG, 2001, MOL BIOL EVOL, V18, P530, DOI 10.1093/oxfordjournals.molbev.a003832; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muller M., 2003, MOL MED PARASITOLOGY, P125, DOI DOI 10.1016/B978-012473346-6/50008-9; Nasirudeen AMA, 2004, J MICROBIOL METH, V58, P101, DOI 10.1016/j.mimet.2004.03.008; Nixon JEJ, 2002, EUKARYOT CELL, V1, P181, DOI 10.1128/EC.1.2.181-190.2002; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Plumper E, 2000, MOL BIOCHEM PARASIT, V106, P11, DOI 10.1016/S0166-6851(99)00196-6; Riordan CE, 2003, CURR GENET, V44, P138, DOI 10.1007/s00294-003-0432-1; Roger AJ, 2002, NATURE, V418, P827, DOI 10.1038/418827a; Roger AJ, 1998, P NATL ACAD SCI USA, V95, P229, DOI 10.1073/pnas.95.1.229; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; SINGH B, 1990, BIOCHEM BIOPH RES CO, V169, P391, DOI 10.1016/0006-291X(90)90344-M; Slapeta J, 2004, EUKARYOT CELL, V3, P483, DOI 10.1128/EC.3.2.483-494.2004; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; SOLTYS BJ, 1994, J PARASITOL, V80, P580, DOI 10.2307/3283195; Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101; Tachezy J, 2001, MOL BIOL EVOL, V18, P1919, DOI 10.1093/oxfordjournals.molbev.a003732; Tielens AGM, 2002, TRENDS BIOCHEM SCI, V27, P564, DOI 10.1016/S0968-0004(02)02193-X; Tovar J, 1999, MOL MICROBIOL, V32, P1013, DOI 10.1046/j.1365-2958.1999.01414.x; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; WEBSTER TJ, 1994, DNA CELL BIOL, V13, P1213, DOI 10.1089/dna.1994.13.1213; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Yu LZ, 2002, EUKARYOT CELL, V1, P191, DOI 10.1128/EC.1.2.191-199.2002	60	82	86	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30557	30563		10.1074/jbc.M500787200	http://dx.doi.org/10.1074/jbc.M500787200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15985435	hybrid			2022-12-27	WOS:000231362500071
J	Krawitz, P; Haffner, C; Fluhrer, R; Steiner, H; Schmid, B; Haass, C				Krawitz, P; Haffner, C; Fluhrer, R; Steiner, H; Schmid, B; Haass, C			Differential localization and identification of a critical aspartate suggest non-redundant proteolytic functions of the presenilin homologues SPPL2b and SPPL3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; AMYLOID-BETA-PEPTIDE; REGULATED INTRAMEMBRANE PROTEOLYSIS; TRANSMEMBRANE ASPARTATES; EMBRYONIC-DEVELOPMENT; PRECURSOR PROTEIN; COMPLEX; PROTEASES; NICASTRIN; ZEBRAFISH	Signal peptide peptidase (SPP) is an unusual aspartyl protease that mediates clearance of signal peptides by proteolysis within the endoplasmic reticulum ( ER). Like presenilins, which provide the proteolytically active subunit of the gamma-secretase complex, SPP contains a critical GXGD motif in its C-terminal catalytic center. Although SPP is known to be an aspartyl protease of the GXGD type, several presenilin homologues/SPP-like proteins (PSHs/SPPL) of unknown function have been identified by data base searches. We now investigated the subcellular localization and a putative proteolytic activity of PSHs/SPPLs in cultured cells and in an in vivo model. We demonstrate that SPPL2b is targeted through the secretory pathway to endosomes/lysosomes, whereas SPP and SPPL3 are restricted to the ER. As suggested by the differential subcellular localization of SPPL2b compared with SPP and SPPL3, we found distinct phenotypes upon antisense gripNA-mediated knockdown in zebrafish. spp and sppl3 knockdowns in zebrafish result in cell death within the central nervous system, whereas reduction of sppl2b expression causes erythrocyte accumulation in an enlarged caudal vein. Moreover, expression of D/A mutations of the putative C-terminal active sites of spp, sppl2, and sppl3 produced phenocopies of the respective knockdown phenotypes. Thus, our data suggest that all investigated PSHs/SPPLs are members of the novel family of GXGD aspartyl proteases. Furthermore, SPPL2b is shown to be the first member of the SPP/PSH/SPPL family that is not located within the ER but in endosomal/lysosomal vesicles.	Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, D-80336 Munich, Germany	University of Munich	Schmid, B (corresponding author), Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, Schillerstr 44, D-80336 Munich, Germany.	beschmid@med.uni-muenchen.de; Christian.Haass@med.uni-muenchen.de	Haffner, Christof/AAG-6676-2020; Fluhrer, Regina/F-2642-2011; Krawitz, Peter M/F-3142-2012	Krawitz, Peter M/0000-0002-3194-8625				Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CHEN JW, 1985, J CELL BIOL, V101, P85, DOI 10.1083/jcb.101.1.85; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fluhrer R, 2002, J NEUROCHEM, V81, P1011, DOI 10.1046/j.1471-4159.2002.00908.x; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; FURUTANISEIKI M, 1996, DEVELOPMENT, V123, P223; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; GRIBORENKO AP, 2004, P NATL ACAD SCI USA, V101, P14955; Grigorenko AP, 2002, BIOCHEMISTRY-MOSCOW+, V67, P826, DOI 10.1023/A:1016365227942; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; Haffner C, 2004, EMBO J, V23, P3041, DOI 10.1038/sj.emboj.7600307; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Kim SH, 2005, J BIOL CHEM, V280, P1992, DOI 10.1074/jbc.M412404200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Leimer U, 1999, BIOCHEMISTRY-US, V38, P13602, DOI 10.1021/bi991453n; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; MARGOGLIO B, 2003, HUM MOL GENET, V12, P201; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Van Uden E, 2002, J NEUROSCI, V22, P9298; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	49	72	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2005	280	47					39515	39523		10.1074/jbc.M501645200	http://dx.doi.org/10.1074/jbc.M501645200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	985FL	15998642	hybrid, Green Published			2022-12-27	WOS:000233362200074
J	Lee, NV; Rodriguez-Manzaneque, JC; Thai, SNM; Twal, WO; Luque, A; Lyons, KM; Argraves, WS; Iruela-Arispe, ML				Lee, NV; Rodriguez-Manzaneque, JC; Thai, SNM; Twal, WO; Luque, A; Lyons, KM; Argraves, WS; Iruela-Arispe, ML			Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOTIC THROMBOCYTOPENIC PURPURA; EXTRACELLULAR-MATRIX; IN-VIVO; BINDING-PROTEIN; AGGRECAN; DOMAIN; FIBRONECTIN; VERSICAN; INHIBITORS; ABNORMALITIES	ADAMTS-1 is a metalloprotease that has been implicated in the inhibition of angiogenesis and is a mediator of proteolytic cleavage of the hyaluronan binding proteoglycans, aggrecan and versican. In an attempt to further understand the biological function of ADAMTS-1, a yeast two-hybrid screen was performed using the carboxyl-terminal region of ADAMTS-1 as bait. As a result, the extracellular matrix protein fibulin-1 was identified as a potential interacting molecule. Through a series of analyses that included ligand affinity chromatography, co-immunoprecipitation, pulldown assays, and enzyme-linked immunosorbent assay, the ability of these two proteins to interact was substantiated. Additional studies showed that ADAMTS-1 and fibulin-1 colocalized in vivo. Furthermore, fibulin-1 was found to enhance the capacity of ADAMTS-1 to cleave aggrecan, a proteoglycan known to bind to fibulin-1. We confirmed that fibulin-1 was not a proteolytic substrate for ADAMTS-1. Together, these findings indicate that fibulin-1 is a new regulator of ADAMTS-1-mediated proteoglycan proteolysis and thus may play an important role in proteoglycan turnover in tissues where there is overlapping expression.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Medical University of South Carolina	Iruela-Arispe, ML (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Paul D Boyer Hall,611 Charles Young Dr E, Los Angeles, CA 90095 USA.	arispe@mbi.ucla.edu	Rodriguez-Manzaneque, Juan Carlos/F-3899-2012; Luque, Alfonso/C-5846-2018; Iruela-Arispe, M. Luisa/AAJ-1297-2020	Rodriguez-Manzaneque, Juan Carlos/0000-0001-5951-7029; Iruela-Arispe, M. Luisa/0000-0002-3050-4168	NATIONAL CANCER INSTITUTE [R01CA077420] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL052813, R01HL061873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; NCI NIH HHS [CA077420] Funding Source: Medline; NHLBI NIH HHS [HL61873, HL52813] Funding Source: Medline; NIGMS NIH HHS [GM07185] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; ARGRAVES WS, 1989, CELL, V58, P623, DOI 10.1016/0092-8674(89)90097-4; Aspberg A, 1999, J BIOL CHEM, V274, P20444, DOI 10.1074/jbc.274.29.20444; BALBONA K, 1992, J BIOL CHEM, V267, P20120; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Godyna S, 1996, BLOOD, V88, P2569, DOI 10.1182/blood.V88.7.2569.bloodjournal8872569; Hashimoto G, 2004, J BIOL CHEM, V279, P32483, DOI 10.1074/jbc.M314216200; Heissig B, 2003, CURR OPIN HEMATOL, V10, P136, DOI 10.1097/00062752-200303000-00007; Hesselson D, 2004, CURR BIOL, V14, P2005, DOI 10.1016/j.cub.2004.11.006; Hulmes DJS, 1997, MATRIX BIOL, V16, P41, DOI 10.1016/S0945-053X(97)90115-3; Jonnsson-Rylander AC, 2005, ARTERIOSCL THROM VAS, V25, P180, DOI 10.1161/01.ATV.0000150045.27127.37; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kostka G, 2001, MOL CELL BIOL, V21, P7025, DOI 10.1128/MCB.21.20.7025-7034.2001; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Kuno K, 1999, J BIOL CHEM, V274, P18821, DOI 10.1074/jbc.274.26.18821; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Li SW, 2001, BIOCHEM J, V355, P271, DOI 10.1042/0264-6021:3550271; Little CB, 2005, ARTHRITIS RHEUM-US, V52, P1461, DOI 10.1002/art.21022; Liu B, 2003, GROWTH HORM IGF RES, V13, P89, DOI 10.1016/S1096-6374(03)00007-8; Miosge N, 1999, FASEB J, V13, P1743, DOI 10.1096/fasebj.13.13.1743; Mittaz L, 2004, BIOL REPROD, V70, P1096, DOI 10.1095/biolreprod.103.023911; Murphy G, 1997, MATRIX BIOL, V15, P511, DOI 10.1016/S0945-053X(97)90025-1; Nguyen AD, 2004, CIRC RES, V95, P1067, DOI 10.1161/01.RES.0000149568.85071.FB; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; Overall CM, 2004, BIOL CHEM, V385, P493, DOI 10.1515/BC.2004.058; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Oxford JT, 2004, J BIOL CHEM, V279, P10939, DOI 10.1074/jbc.M310291200; Parks WC, 1999, WOUND REPAIR REGEN, V7, P423, DOI 10.1046/j.1524-475X.1999.00423.x; Porter S, 2004, BIOCH J; Rodriguez-Manzaneque JC, 2000, J BIOL CHEM, V275, P33471, DOI 10.1074/jbc.M002599200; Rodriguez-Manzaneque JC, 2002, BIOCHEM BIOPH RES CO, V293, P501; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Shindo T, 2000, J CLIN INVEST, V105, P1345, DOI 10.1172/JCI8635; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Thai SNM, 2002, MECH DEVELOP, V115, P181, DOI 10.1016/S0925-4773(02)00115-6; TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9; TRAN H, 1995, J BIOL CHEM, V270, P19458, DOI 10.1074/jbc.270.33.19458; Tran H, 1997, J BIOL CHEM, V272, P22600, DOI 10.1074/jbc.272.36.22600; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Werneck CC, 2004, J BIOL CHEM, V279, P23045, DOI 10.1074/jbc.M402656200; Zhang HY, 1996, DEV DYNAM, V205, P348, DOI 10.1002/(SICI)1097-0177(199603)205:3<348::AID-AJA13>3.0.CO;2-0; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200; Zheng XL, 2002, CURR OPIN HEMATOL, V9, P389, DOI 10.1097/00062752-200209000-00001	47	77	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34796	34804		10.1074/jbc.M506980200	http://dx.doi.org/10.1074/jbc.M506980200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16061471	hybrid			2022-12-27	WOS:000232403900051
J	Bailey, CM; Khalkhali-Ellis, Z; Kondo, S; Margaryan, NV; Seftor, REB; Wheaton, WW; Amir, S; Pins, MR; Schutte, BC; Hendrix, MJC				Bailey, CM; Khalkhali-Ellis, Z; Kondo, S; Margaryan, NV; Seftor, REB; Wheaton, WW; Amir, S; Pins, MR; Schutte, BC; Hendrix, MJC			Mammary serine protease inhibitor (maspin) binds directly to interferon regulatory factor 6 - Identification of a novel serpin partnership	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; TRANSACTIVATION DOMAIN; DNA-BINDING; PHOSPHORYLATION; LOCALIZATION; EXPRESSION; APOPTOSIS; INVASION; GLAND; ACTIVATION	Since its reported discovery in 1994, maspin ( mammary serine protease inhibitor) has been characterized as a class II tumor suppressor by its ability to promote apoptosis and inhibit cell invasion. Maspin is highly expressed in normal mammary epithelial cells but reduced or absent in aggressive breast carcinomas. However, despite efforts to characterize the mechanism(s) by which maspin functions as a tumor suppressor, its molecular characterization has remained somewhat elusive. Therefore, in an attempt to identify maspin-interacting proteins and thereby gain insight into the functional pathways of maspin, we employed amaspin-baited yeast two-hybrid system and subsequently identified Interferon Regulatory Factor 6 (IRF6) as a maspin-binding protein. IRF6 belongs to the IRF family of transcription factors, which is best known for its regulation of interferon and interferon-inducible genes following a pathogenic stimulus. Although many of the IRF family members have been well characterized, IRF6 remains poorly understood. We report that IRF6 is expressed in normal mammary epithelial cells and that it directly associates with maspin in a yeast two-hybrid system and in vitro. The interaction occurs via the conserved IRF protein association domain and is regulated by phosphorylation of IRF6. We have shown that, similar to maspin, IRF6 expression is inversely correlated with breast cancer invasiveness. We further demonstrated that the transient re-expression of IRF6 in breast cancer cells results in an increase of N-cadherin and a redistribution of vimentin commensurate with changes in cell morphology, suggestive of an epithelial-to-mesenchymal transition event. Concomitantly, we showed that maspin acts as a negative regulator of this process. These findings help to elucidate the molecular mechanisms of maspin and suggest an interactive role between maspin and IRF6 in regulating cellular phenotype, the loss of which can lead to neoplastic transformation.	Univ Iowa, Roy A & Lucille J Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; Univ Iowa, Roy A & Lucille J Carver Coll Med, Dept Pediat, Iowa City, IA 52242 USA; Northwestern Univ, Childrens Mem Res Ctr, Chicago, IL 60011 USA; Northwestern Univ, Dept Pathol & Urol, Chicago, IL 60011 USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60011 USA	University of Iowa; University of Iowa; Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine	Hendrix, MJC (corresponding author), Childrens Mem Res Ctr, 2300 Childrens Plaza,Box 222, Chicago, IL 60614 USA.	mjchendrix@childrensmemorial.org			NATIONAL CANCER INSTITUTE [R01CA075681] Funding Source: NIH RePORTER; NCI NIH HHS [CA 75681, R01 CA075681-10, R01 CA075681] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Boecker W, 2003, CELL PROLIFERAT, V36, P73, DOI 10.1046/j.1365-2184.36.s.1.7.x; Civas A, 2002, BIOCHIMIE, V84, P643, DOI 10.1016/S0300-9084(02)01431-1; Cuervo R, 2002, DEV BIOL, V245, P145, DOI 10.1006/dbio.2002.0620; De Creus A, 2002, J IMMUNOL, V168, P6486, DOI 10.4049/jimmunol.168.12.6486; Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5; Duguay D, 2002, CANCER RES, V62, P5148; Eroshkin A, 1999, J MOL MED, V77, P403, DOI 10.1007/s001090050369; FITCHETT JE, 1989, DEV BIOL, V131, P455, DOI 10.1016/S0012-1606(89)80017-X; Fulda S, 2002, ONCOGENE, V21, P2295, DOI 10.1038/sj.onc.1205255; Hatada S, 1997, GENE, V203, P183, DOI 10.1016/S0378-1119(97)00512-X; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hendrix MJC, 1997, AM J PATHOL, V150, P483; Jiang N, 2002, ONCOGENE, V21, P4089, DOI 10.1038/sj.onc.1205507; Khalkhali-Ellis Z, 2004, CLIN CANCER RES, V10, P449, DOI 10.1158/1078-0432.CCR-1002-03; Kim TY, 2003, J BIOL CHEM, V278, P15272, DOI 10.1074/jbc.M205792200; Kirschmann DA, 2002, CANCER RES, V62, P4478; Knudsen KA, 2005, J CELL BIOCHEM, V95, P488, DOI 10.1002/jcb.20419; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Lau JF, 2000, P NATL ACAD SCI USA, V97, P7278, DOI 10.1073/pnas.97.13.7278; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Martinez-Alvarez C, 2000, DEV BIOL, V220, P343, DOI 10.1006/dbio.2000.9644; Masumi A, 2003, J BIOL CHEM, V278, P25401, DOI 10.1074/jbc.M213037200; Meraro D, 1999, J IMMUNOL, V163, P6468; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Moriyama Y, 2001, CLIN CANCER RES, V7, P1293; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Reich NC, 2002, J INTERF CYTOK RES, V22, P103, DOI 10.1089/107999002753452719; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; Strizzi L, 2004, J CELL PHYSIOL, V201, P266, DOI 10.1002/jcp.20062; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Williams BRG, 2003, SCIENCE, V300, P1100, DOI 10.1126/science.1085277; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; Zhang M, 1999, DEV BIOL, V215, P278, DOI 10.1006/dbio.1999.9442; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	39	77	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34210	34217		10.1074/jbc.M503523200	http://dx.doi.org/10.1074/jbc.M503523200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16049006	Green Accepted, hybrid			2022-12-27	WOS:000232229700063
J	Ikejiri, M; Bernardo, MM; Bonfil, RD; Toth, M; Chang, ML; Fridman, R; Mobashery, S				Ikejiri, M; Bernardo, MM; Bonfil, RD; Toth, M; Chang, ML; Fridman, R; Mobashery, S			Potent mechanism-based inhibitors for matrix metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE INHIBITOR; BINDING INHIBITORS; IV COLLAGENASE; ACTIVATION; SLOW; TIMP-2; MATRIX-METALLOPROTEINASE-9; PROGRESSION; PRO-MMP-2; DESIGN	Matrix metalloproteinases ( MMPs) are zinc-dependent endopeptidases that play important roles in physiological and pathological conditions. Both gelatinases (MMP-2 and - 9) and membrane-type 1 MMP (MMP-14) are important targets for inhibition, since their roles in various diseases, including cancer, have been well established. We describe herein a set of mechanism-based inhibitors that show high selectivity to gelatinases and MMP-14( inhibitor 3) and to only MMP-2 ( inhibitors 5 and 7). These molecules bind to the active sites of these enzymes, initiating a slow binding profile for the onset of inhibition, which leads to covalent enzyme modification. The full kinetic analysis for the inhibitors is reported. These are nanomolar inhibitors (K-i) for the formation of the noncovalent enzyme-inhibitor complexes. The onset of slow binding inhibition is rapid (k(on) of 10(2) to 10(4) M-1 s(-1)), and the reversal of the process is slow (k(off) of 10(-3) to 10(-4) s(-1)). However, with the onset of covalent chemistry with the best of these inhibitors ( e. g. inhibitor 3), very little recovery of activity (< 10%) was seen over 48 h of dialysis. We previously reported that broad spectrum MMP inhibitors like GM6001 enhance MT1-MMP-dependent activation of pro-MMP-2 in the presence of tissue inhibitor of metalloproteinases-2. Herein, we show that inhibitor 3, in contrast to GM6001, had no effect on pro-MMP-2 activation by MT1-MMP. Furthermore, inhibitor 3 reduced tumor cell migration and invasion in vitro. These results show that these new inhibitors are promising candidates for selective inhibition of MMPs in animal models of relevant human diseases.	Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46565 USA; Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46565 USA; Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; Karmanos Canc Inst, Proteases & Canc Program, Detroit, MI 48201 USA	University of Notre Dame; University of Notre Dame; Walther Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute	Mobashery, S (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46565 USA.	mobashery@nd.edu		Bonfil, R. Daniel/0000-0002-1605-8317	NCI NIH HHS [CA-100475] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100475] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bernardo MM, 2002, J BIOL CHEM, V277, P11201, DOI 10.1074/jbc.M111021200; Brown S, 2004, CURR TOP MED CHEM, V4, P1227, DOI 10.2174/1568026043387854; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; DUGGLEBY RG, 1982, BIOCHEMISTRY-US, V21, P3364, DOI 10.1021/bi00257a018; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FUERST TR, 1987, MOL CELL BIOL, V7, P2538, DOI 10.1128/MCB.7.7.2538; Gervasi DC, 1996, BIOCHEM BIOPH RES CO, V228, P530, DOI 10.1006/bbrc.1996.1694; GOUX C, 1994, TETRAHEDRON, V50, P10321, DOI 10.1016/S0040-4020(01)81764-6; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Kleifeld O, 2001, J BIOL CHEM, V276, P17125, DOI 10.1074/jbc.M011604200; KNIGHT CG, 1995, METHOD ENZYMOL, V248, P18; Kruger A, 2005, CANCER RES, V65, P3523, DOI 10.1158/0008-5472.CAN-04-3570; Matrisian Lynn M., 2003, Cancer Research, V63, P6105; McCawley LJ, 2000, MOL MED TODAY, V6, P149, DOI 10.1016/S1357-4310(00)01686-5; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MULLERSTEFFNER HM, 1992, J BIOL CHEM, V267, P9606; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Pavlaki M, 2003, CANCER METAST REV, V22, P177, DOI 10.1023/A:1023047431869; Segel I.H., 1975, ENZYME KINETICS; Skiles JW, 2004, CURR MED CHEM, V11, P2911, DOI 10.2174/0929867043364018; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; SZEDLACSEK SE, 1995, METHOD ENZYMOL, V249, P144; Toth M, 2000, J BIOL CHEM, V275, P41415, DOI 10.1074/jbc.M006871200; Toth M, 1997, CANCER RES, V57, P3159; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119	28	117	123	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					33992	34002		10.1074/jbc.M504303200	http://dx.doi.org/10.1074/jbc.M504303200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16046398	hybrid			2022-12-27	WOS:000232229700037
J	Zhu, H; Wang, LK; Shuman, S				Zhu, H; Wang, LK; Shuman, S			Essential constituents of the 3 '-phosphoesterase domain of bacterial DNA ligase D, a nonhomologous end-joining enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T4 POLYNUCLEOTIDE KINASE; ACID PHOSPHATASE-EXONUCLEASE; STRAND BREAK REPAIR; ESCHERICHIA-COLI; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; GENETIC-ANALYSIS; TRANSFER-RNA; KU; TOPOISOMERASE	DNA ligase D (LigD) catalyzes end-healing and end-sealing steps during nonhomologous end joining in bacteria. Pseudomonas aeruginosa LigD consists of a central ATP-dependent ligase domain fused to a C-terminal polymerase domain and an N-terminal 3'-phosphoesterase ( PE) module. The PE domain catalyzes manganese-dependent phosphodiesterase and phosphomonoesterase reactions at a duplex primer-template with a short 3'-ribonucleotide tract. The phosphodiesterase, which cleaves a 3'-terminal diribonucleotide to yield a primer strand with a ribonucleoside 3'-PO4 terminus, requires the vicinal 2'-OH of the penultimate ribose. The phosphomonoesterase converts the terminal ribonucleoside 3'-PO4 to a 3'-OH. Here we show that the PE domain has a 3'-phosphatase activity on an all-DNA primer-template, signifying that the phosphomonoesterase reaction does not depend on a 2'-OH. The distinctions between the phosphodiesterase and phosphomonoesterase activities are underscored by the results of alanine-scanning, limited proteolysis, and deletion analysis, which show that the two reactions depend on overlapping but nonidentical ensembles of protein functional groups, including: (i) side chains essential for both ribonuclease and phosphatase activity ( His-42, His-48, Asp-50, Arg-52, His-84, and Tyr-88); ( ii) side chains important for 3'-phosphatase activity but not for 3' ribonucleoside removal (Arg-14, Asp-15, Glu-21, Gln-40, and Glu-82); and ( iii) side chains required selectively for the 3'-ribonuclease (Lys-66 and Arg-76). These constellations of critical residues are unique to LigD-like proteins, which we propose comprise a new bifunctional phosphoesterase family.	Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA.	s-shuman@ski.mskcc.org			NIGMS NIH HHS [GM63611] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMITSUR M, 1987, EMBO J, V6, P2499, DOI 10.1002/j.1460-2075.1987.tb02532.x; Aravind L, 2001, GENOME RES, V11, P1365, DOI 10.1101/gr.181001; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; CAMERON V, 1977, BIOCHEMISTRY-US, V16, P5120, DOI 10.1021/bi00642a027; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; Davies DR, 2003, CHEM BIOL, V10, P139, DOI 10.1016/S1074-5521(03)00021-8; Della M, 2004, SCIENCE, V306, P683, DOI 10.1126/science.1099824; Doherty AJ, 2001, FEBS LETT, V500, P186, DOI 10.1016/S0014-5793(01)02589-3; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Galburt EA, 2002, STRUCTURE, V10, P1249, DOI 10.1016/S0969-2126(02)00835-3; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Gong CL, 2004, J BIOL CHEM, V279, P20594, DOI 10.1074/jbc.M401841200; HENNER WD, 1983, J BIOL CHEM, V258, P711; HENNER WD, 1983, J BIOL CHEM, V258, P5198; HENNER WD, 1982, J BIOL CHEM, V257, P1750; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Krogh BO, 2000, BIOCHEMISTRY-US, V39, P6422, DOI 10.1021/bi000184u; Lisby M, 1998, BIOCHEMISTRY-US, V37, P10815, DOI 10.1021/bi980757r; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Rasouli-Nia A, 2004, P NATL ACAD SCI USA, V101, P6905, DOI 10.1073/pnas.0400099101; RICHARDSON CC, 1964, J BIOL CHEM, V239, P251; RICHARDSON CC, 1964, J BIOL CHEM, V239, P242; Wang LK, 2002, NUCLEIC ACIDS RES, V30, P1073, DOI 10.1093/nar/30.4.1073; Wang LK, 2001, J BIOL CHEM, V276, P26868, DOI 10.1074/jbc.M103663200; WEBER DJ, 1992, PROTEINS, V13, P275, DOI 10.1002/prot.340130402; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534; Zharkov DO, 2003, DNA REPAIR, V2, P839, DOI 10.1016/S1568-7864(03)00084-3; Zhu H, 2005, J BIOL CHEM, V280, P25973, DOI 10.1074/jbc.M504002200; Zhu H, 2005, J BIOL CHEM, V280, P418, DOI 10.1074/jbc.M410110200	33	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					33707	33715		10.1074/jbc.M506838200	http://dx.doi.org/10.1074/jbc.M506838200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16046407	hybrid			2022-12-27	WOS:000232229700005
J	Zong, XG; Eckert, C; Yuan, HX; Wahl-Schott, C; Abicht, H; Fang, LF; Li, RX; Mistrik, P; Gerstner, A; Much, B; Baumann, L; Michalakis, S; Zeng, R; Chen, ZJ; Biel, M				Zong, XG; Eckert, C; Yuan, HX; Wahl-Schott, C; Abicht, H; Fang, LF; Li, RX; Mistrik, P; Gerstner, A; Much, B; Baumann, L; Michalakis, S; Zeng, R; Chen, ZJ; Biel, M			A novel mechanism of modulation of hyperpolarization-activated cyclic nucleotide-gated channels by Src kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTION; CARDIAC-PACEMAKER CHANNELS; RABBIT SINOATRIAL NODE; TYROSINE KINASE; CATION CHANNELS; HCN CHANNELS; SH3 DOMAIN; FUNCTIONAL-CHARACTERIZATION; TERMINAL REGION; CAMP MODULATION	Hyperpolarization-activated cyclic nucleotide-gated channels (HCN1-4) play a crucial role in the regulation of cell excitability. Importantly, they contribute to spontaneous rhythmic activity in brain and heart. HCN channels are principally activated by membrane hyperpolarization and binding of cAMP. Here, we identify tyrosine phosphorylation by Src kinase as another mechanism affecting channel gating. Inhibition of Src by specific blockers slowed down activation kinetics of native and heterologously expressed HCN channels. The same effect on HCN channel activation was observed in cells cotransfected with a dominant-negative Src mutant. Immunoprecipitation demonstrated that Src binds to and phosphorylates native and heterologously expressed HCN2. Src interacts via its SH3 domain with a sequence of HCN2 encompassing part of the C-linker and the cyclic nucleotide binding domain. We identified a highly conserved tyrosine residue in the C-linker of HCN channels ( Tyr(476) in HCN2) that confers modulation by Src. Replacement of this tyrosine by phenylalanine in HCN2 or HCN4 abolished sensitivity to Src inhibitors. Mass spectrometry confirmed that Tyr476 is phosphorylated by Src. Our results have functional implications for HCN channel gating. Furthermore, they indicate that tyrosine phosphorylation contributes in vivo to the fine tuning of HCN channel activity.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; Univ Munich, Dept Pharm Pharmakol Nat Wissensch, D-81377 Munich, Germany	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Munich	Biel, M (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	mbiel@cup.uni-muenchen.de	Fang, Longhou/G-6582-2013; Mistrik, Pavel/Q-3947-2019; Mistrik, Pavel/A-9999-2008; Michalakis, Stylianos/M-4677-2019; Wahl-Schott, Christian A/J-2623-2015; Biel, Martin/G-1175-2014; Michalakis, Stylianos/W-2094-2018	Mistrik, Pavel/0000-0002-0448-4730; Michalakis, Stylianos/0000-0001-5092-9238; Biel, Martin/0000-0002-9974-3052; Michalakis, Stylianos/0000-0001-5092-9238				Bender RA, 2003, J NEUROSCI, V23, P6826, DOI 10.1523/jneurosci.23-17-06826.2003; Biel M, 2002, TRENDS CARDIOVAS MED, V12, P206, DOI 10.1016/S1050-1738(02)00162-7; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Davis MJ, 2001, AM J PHYSIOL-HEART C, V281, pH1835, DOI 10.1152/ajpheart.2001.281.5.H1835; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Hua L, 2005, J GEN PHYSIOL, V125, P335, DOI 10.1085/jgp.200409187; Johnson JP, 2005, P NATL ACAD SCI USA, V102, P2742, DOI 10.1073/pnas.0408323102; Kaneko T, 2003, J BIOL CHEM, V278, P48162, DOI 10.1074/jbc.M306677200; Kang H, 2000, EMBO J, V19, P2889, DOI 10.1093/emboj/19.12.2889; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kimura K, 2004, GENES CELLS, V9, P631, DOI 10.1111/j.1356-9597.2004.00752.x; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Ma YC, 2002, CELL MOL LIFE SCI, V59, P456, DOI 10.1007/s00018-002-8438-2; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Molokanova E, 1999, J NEUROSCI, V19, P4786; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Poolos Nicholas P., 2004, Epilepsy Curr, V4, P3, DOI 10.1111/j.1535-7597.2004.04101.x; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Sartiani L, 2002, J PHYSIOL-LONDON, V545, P81, DOI 10.1113/jphysiol.2002.021535; Savchenko A, 2001, P NATL ACAD SCI USA, V98, P5880, DOI 10.1073/pnas.101524998; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; Shibata S, 1999, BRIT J PHARMACOL, V128, P1284, DOI 10.1038/sj.bjp.0702903; SNYDER MA, 1985, MOL CELL BIOL, V5, P1772, DOI 10.1128/MCB.5.7.1772; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Tu HY, 2004, J NEUROSCI RES, V76, P713, DOI 10.1002/jnr.20109; Ueda K, 2004, J BIOL CHEM, V279, P27194, DOI 10.1074/jbc.M311953200; Wahl-Schott C, 2005, J BIOL CHEM, V280, P13694, DOI 10.1074/jbc.M413197200; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Wu JY, 1997, PFLUG ARCH EUR J PHY, V434, P509, DOI 10.1007/s004240050430; WU JY, 2000, BIOCHIM BIOPHYS ACTA, V463, P15; Wu ZZ, 2004, BRAIN RES, V1029, P251, DOI 10.1016/j.brainres.2004.09.051; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Yu HG, 2004, PFLUG ARCH EUR J PHY, V447, P392, DOI 10.1007/s00424-003-1204-y; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012; Zong XG, 1998, EMBO J, V17, P353, DOI 10.1093/emboj/17.2.353	56	83	87	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34224	34232		10.1074/jbc.M506544200	http://dx.doi.org/10.1074/jbc.M506544200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16079136	hybrid			2022-12-27	WOS:000232229700065
J	Aurikko, JP; Ruotolo, BT; Grossmann, JG; Moncrieffe, MC; Stephens, E; Leppanen, VM; Robinson, CV; Saarma, M; Bradshaw, RA; Blundell, TL				Aurikko, JP; Ruotolo, BT; Grossmann, JG; Moncrieffe, MC; Stephens, E; Leppanen, VM; Robinson, CV; Saarma, M; Bradshaw, RA; Blundell, TL			Characterization of symmetric complexes of nerve growth factor and the ectodomain of the pan-neurotrophin receptor, p75(NTR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CEREBROSPINAL-FLUID; RAY SOLUTION SCATTERING; NF-KAPPA-B; CELL-DEATH; FUNCTIONAL INTERACTIONS; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; GENE-TRANSFER; PC12 CELLS; P75	Nerve growth factor (NGF) is the ligand for two unrelated cellular receptors, TrkA and p75(NTR), and acts as a mediator in the development and maintenance of the mammalian nervous system. Signaling through TrkA kinase domains promotes neuronal survival, whereas activation of the p75(NTR) "death domains" induces apoptosis under correct physiological conditions. However, co-expression of these receptors leads to enhanced neuronal survival upon NGF stimulation, possibly through a ternary p75(NTR) center dot NGF center dot TrkA complex. We have expressed human p75NTR ligand binding domain as a secreted glycosylated protein in Trichoplusia ni cells. Following assembly and purification of soluble p75(NTR) center dot NGF complexes, mass spectrometry, analytical ultracentrifugation, and solution x-ray scattering measurements are indicative of 2: 2 stoichiometry, which implies a symmetric complex. Molecular models of the 2: 2 p75(NTR) center dot NGF complex based on these data are not consistent with the further assembly of either symmetric ( 2: 2: 2) or asymmetric (2: 2: 1) ternary p75(NTR) center dot NGF center dot TrkA complexes.	Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; CCLRC Daresbury Lab, Synchrotron Radiat Dept, Warrington WA4 AD, Cheshire, England; Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of Cambridge; University of Cambridge; STFC Daresbury Laboratory; University of Helsinki; University of California System; University of California Irvine	Aurikko, JP (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Ct Rd, Cambridge CB2 1GA, England.	jukka@cryst.bioc.cam.ac.uk	Bradshaw, Ralph A/K-1515-2013; Ruotolo, Brandon/F-2669-2013	Ruotolo, Brandon/0000-0002-6084-2328; Leppanen, Veli-Matti/0000-0001-7100-965X; robinson, carol/0000-0001-7829-5505	Wellcome Trust [064597] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARIBAULT TJ, 1985, J NEUROSCI RES, V14, P49, DOI 10.1002/jnr.490140105; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Butler M, 2003, GLYCOBIOLOGY, V13, P601, DOI 10.1093/glycob/cwg079; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; CHAO MV, 1994, J NEUROBIOL, V25, P1373, DOI 10.1002/neu.480251106; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Coulson EJ, 2000, J BIOL CHEM, V275, P30537, DOI 10.1074/jbc.M005214200; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Falck S, 2004, EMBO J, V23, P3010, DOI 10.1038/sj.emboj.7600310; Foehr ED, 2000, J NEUROSCI, V20, P7556; GROB PM, 1985, J BIOL CHEM, V260, P8044; Grossmann JG, 2002, BIOCHEMISTRY-US, V41, P3613, DOI 10.1021/bi015955o; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HOFFMANN A, 1994, J NEUROCHEM, V63, P2185; HOFFMANN A, 1995, FEBS LETT, V359, P164, DOI 10.1016/0014-5793(95)00034-7; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ibanez CF, 2002, TRENDS NEUROSCI, V25, P284, DOI 10.1016/S0166-2236(02)02169-0; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; Jurchen JC, 2003, J AM CHEM SOC, V125, P2817, DOI 10.1021/ja0211508; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; LIGHTWAHL KJ, 1994, J AM CHEM SOC, V116, P5271, DOI 10.1021/ja00091a035; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Mamidipudi V, 2002, J NEUROSCI RES, V68, P373, DOI 10.1002/jnr.10244; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; Neet KE, 2001, CELL MOL LIFE SCI, V58, P1021, DOI 10.1007/PL00000917; NELSON N, 1987, ANAL BIOCHEM, V165, P287, DOI 10.1016/0003-2697(87)90271-5; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Rabizadeh S, 2003, CYTOKINE GROWTH F R, V14, P225, DOI 10.1016/S1359-6101(03)00018-2; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; Rudd PM, 2000, BIOCHEMISTRY-US, V39, P1596, DOI 10.1021/bi9918285; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK A, 1991, J APPL CRYSTALLOGR, V22, P537; Shooter EM, 2001, ANNU REV NEUROSCI, V24, P601, DOI 10.1146/annurev.neuro.24.1.601; Sobott F, 2002, CURR OPIN STRUC BIOL, V12, P729, DOI 10.1016/S0959-440X(02)00400-1; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TYSON DR, 2003, HDB CELL SIGNALING, V1, P361; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Weber ANR, 2005, J BIOL CHEM, V280, P22793, DOI 10.1074/jbc.M502074200; Ye X, 1999, J BIOL CHEM, V274, P30202, DOI 10.1074/jbc.274.42.30202; Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004	49	27	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33453	33460		10.1074/jbc.M503189200	http://dx.doi.org/10.1074/jbc.M503189200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16009712	Green Accepted, hybrid			2022-12-27	WOS:000232058100044
J	Silipo, A; Molinaro, A; Sturiale, L; Dow, JM; Erbs, G; Lanzetta, R; Newman, MA; Parrilli, M				Silipo, A; Molinaro, A; Sturiale, L; Dow, JM; Erbs, G; Lanzetta, R; Newman, MA; Parrilli, M			The elicitation of plant innate immunity by lipooligosaccharide of Xanthomonas campestris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; MASS-SPECTROMETRY; BACTERIAL LIPOPOLYSACCHARIDES; ABSOLUTE-CONFIGURATION; RESISTANCE; GENE; RECOGNITION; MODULATION; EXTRACTION; EXPRESSION	Lipopolysaccharides (LPSs) and lipooligosaccharides (LOSs) are major components of the cell surface of Gram-negative bacteria with diverse roles in bacterial pathogenesis of animals and plants that include elicitation of host defenses. Little is known about the mechanisms of perception of these molecules by plants and about the associated signal transduction pathways that trigger plant immunity. Here we address the issue of the molecular basis of elicitation of plant defenses through the structural determination of the LOS of the plant pathogen Xanthomonas campestris pv. campestris strain 8004 and examination of the effects of LOS and fragments obtained by chemical treatments on the immune response in Arabidopsis thaliana. The structure shows a strong accumulation of negatively charged groups in the lipid A-inner core region and has a number of novel features, including a galacturonyl phosphate attached at a 3-deoxy-D-manno-oct-2-ulosonic acid residue and a unique phosphoramide group in the inner core region. Intact LOS and the lipid A and core oligosaccharides derived from it were all able to induce the defense-related genes PR1 and PR2 in Arabidopsis and to prevent the hypersensitive response caused by avirulent bacteria. Although LOS induced defense-related gene transcription in two temporal phases, the core oligosaccharide induced only the earlier phase, and lipid A induced only the later phase. These findings suggest that plant cells can recognize lipid A and core oligosaccharide structures within LOS to trigger defensive cellular responses and that this may occur via two distinct recognition events.	Univ Naples Federico II, Dipartimento Chim Organ & Biochim, I-80126 Naples, Italy; CNR, ICTMP, I-95123 Catania, Italy; Natl Univ Ireland, BioSci Inst, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland; Royal Vet & Agr Univ, Sect Plant Pathol, DK-1871 Copenhagen, Denmark	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); University College Cork; University of Copenhagen	Molinaro, A (corresponding author), Univ Naples Federico II, Dipartimento Chim Organ & Biochim, Complesso Univ Monte Sant Angelo,Via Cintia 4, I-80126 Naples, Italy.	molinaro@unina.it	Newman, Mari-Anne/M-1550-2013; Silipo, Alba/L-5929-2014; Molinaro, Antonio/J-1866-2012	Newman, Mari-Anne/0000-0001-5782-6071; Molinaro, Antonio/0000-0002-3456-7369; Erbs, Gitte/0000-0003-3764-6473; silipo, alba/0000-0002-5394-6532; LANZETTA, Rosa/0000-0002-1472-5825; STURIALE, LUISELLA/0000-0002-3996-1138; Parrilli, Michelangelo/0000-0001-8858-3623				Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Bedini E, 2005, J AM CHEM SOC, V127, P2414, DOI 10.1021/ja0452166; BIRNBAUM GI, 1987, J CARBOHYD CHEM, V6, P17, DOI 10.1080/07328308708058858; Borregaard N, 2000, IMMUNOL TODAY, V21, P68, DOI 10.1016/S0167-5699(99)01570-4; Conrath U, 2001, EUR J PLANT PATHOL, V107, P113, DOI 10.1023/A:1008768516313; DOW JM, 1995, MOL PLANT MICROBE IN, V8, P768, DOI 10.1094/MPMI-8-0768; Dow M, 2000, ANNU REV PHYTOPATHOL, V38, P241, DOI 10.1146/annurev.phyto.38.1.241; Erbs G, 2003, MOL PLANT PATHOL, V4, P421, DOI [10.1046/j.1364-3703.2003.00179.x, 10.1046/J.1364-3703.2003.00179.X]; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gibson BW, 1997, J AM SOC MASS SPECTR, V8, P645, DOI 10.1016/S1044-0305(97)00042-1; Gilard V, 1999, J MED CHEM, V42, P2542, DOI 10.1021/jm980587g; HAKOMORI SI, 1964, J BIOCHEM-TOKYO, V55, P205; Hinsch M, 1996, MOL PLANT MICROBE IN, V9, P55, DOI 10.1094/MPMI-9-0055; HOLST O, 2000, METHODS MOL BIOL BAC, P345; Korner R, 1998, J MASS SPECTROM, V33, P836; LEONTEIN K, 1978, CARBOHYD RES, V62, P359, DOI 10.1016/S0008-6215(00)80882-4; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Molinaro A, 2003, CARBOHYD RES, V338, P277, DOI 10.1016/S0008-6215(02)00433-0; Molinaro A, 2002, J BIOL CHEM, V277, P10058, DOI 10.1074/jbc.M110283200; Newman MA, 1997, MOL PLANT MICROBE IN, V10, P926, DOI 10.1094/MPMI.1997.10.7.926; Newman MA, 2002, PLANT J, V29, P487, DOI 10.1046/j.0960-7412.2001.00233.x; NEWMAN MA, 1995, MOL PLANT MICROBE IN, V8, P778, DOI 10.1094/MPMI-8-0778; Nurnberger T, 2002, CURR OPIN PLANT BIOL, V5, P318, DOI 10.1016/S1369-5266(02)00265-0; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; RIETSCHEL ET, 1976, EUR J BIOCHEM, V64, P423, DOI 10.1111/j.1432-1033.1976.tb10318.x; RITTER E, 1991, MOL GEN GENET, V227, P81, DOI 10.1007/BF00260710; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Schromm AB, 1998, J IMMUNOL, V161, P5464; Silipo A, 2004, EUR J ORG CHEM, V2004, P1336, DOI 10.1002/ejoc.200300721; Silipo A, 2002, J LIPID RES, V43, P2188, DOI 10.1194/jlr.D200021-JLR200; Silipo A, 2002, EUR J BIOCHEM, V269, P2498, DOI 10.1046/j.1432-1033.2002.02914.x; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Stern AS, 2002, J AM CHEM SOC, V124, P1982, DOI 10.1021/ja011669o; Sturiale L, 2005, RAPID COMMUN MASS SP, V19, P1829, DOI 10.1002/rcm.1994; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101	42	142	148	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33660	33668		10.1074/jbc.M506254200	http://dx.doi.org/10.1074/jbc.M506254200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16048996	hybrid			2022-12-27	WOS:000232058100068
J	Kunzler, D; Sasso, S; Gamper, M; Hilvert, D; Kast, P				Kunzler, D; Sasso, S; Gamper, M; Hilvert, D; Kast, P			Mechanistic insights into the isochorismate pyruvate lyase activity of the catalytically promiscuous PchB from combinatorial mutagenesis and selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOFUNCTIONAL CHORISMATE MUTASE; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; PSEUDOMONAS-AERUGINOSA; GENETIC SELECTION; TRANSITION-STATE; ELECTROSTATIC CATALYSIS; SALICYLATE BIOSYNTHESIS; ACID	PchB from Pseudomonas aeruginosa possesses isochorismate pyruvate lyase (IPL) and weak chorismate mutase (CM) activity. Homology modeling based on a structurally characterized CM, coupled with randomization of presumed key active site residues (Arg(54), Glu(90), Gln(91)) and in vivo selection for CM activity, was used to derive mechanistic insights into the IPL activity of PchB. Mutation of Arg(54) was incompatible with viability, and the CM and IPL activities of an engineered R54K variant were reduced 1,000-fold each. The observation that position 90 was tolerant to substitution but position 91 was essentially confined to Gln or Glu in functional variants rules out involvement of Glu90 in general base catalysis. Counter to the generally accepted mechanistic hypothesis for pyruvate lyases, we propose for PchB a rare [ 1,5]- sigmatropic reaction mechanism that invokes electrostatic catalysis in analogy to the [ 3,3]- pericyclic rearrangement of chorismate in CMs. A common catalytic principle for both PchB functions is also supported by the covariance of the catalytic parameters for the CM and IPL activities and the shared functional requirement for a protonated Glu(91) in Q91E variants. The experiments demonstrate that focusing directed evolution strategies on the readily accessible surrogate activity of an enzyme can provide valuable insights into the mechanism of the primary reaction.	ETH Honggerberg, Swiss Fed Inst Technol, Organ Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Kast, P (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Organ Chem Lab, HCI F333, CH-8093 Zurich, Switzerland.	kast@org.chem.ethz.ch		Sasso, Severin/0000-0002-2226-845X				BARTLETT PA, 1988, J ORG CHEM, V53, P3195, DOI 10.1021/jo00249a013; BARTLETT PA, 1985, J AM CHEM SOC, V107, P7792, DOI 10.1021/ja00311a111; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; CHAO HSI, 1982, BIOCHEMISTRY-US, V21, P2778, DOI 10.1021/bi00540a031; CHOTHIA C, 1984, ANNU REV BIOCHEM, V53, P537; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Creighton T. E., 1993, PROTEINS STRUCTURES; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; EGGERTSSON G, 1988, MICROBIOL REV, V52, P354, DOI 10.1128/MMBR.52.3.354-374.1988; Gaille C, 2002, J BIOL CHEM, V277, P21768, DOI 10.1074/jbc.M202410200; GAJEWSKI JJ, 1987, J AM CHEM SOC, V109, P1170, DOI 10.1021/ja00238a029; Gallagher DT, 2001, PROTEINS, V44, P304, DOI 10.1002/prot.1095; Gamper M, 2000, BIOCHEMISTRY-US, V39, P14087, DOI 10.1021/bi0016570; GRAY JV, 1990, BIOCHEMISTRY-US, V29, P8872, DOI 10.1021/bi00489a051; Grisostomi C, 1997, BIOORG CHEM, V25, P297, DOI 10.1006/bioo.1997.1073; Gu W, 1997, Microb Comp Genomics, V2, P141, DOI 10.1089/omi.1.1997.2.141; Gustin DJ, 1999, J AM CHEM SOC, V121, P1756, DOI 10.1021/ja9841759; Kast P, 2000, J BIOL CHEM, V275, P36832, DOI 10.1074/jbc.M006351200; Kast P, 1997, CURR OPIN STRUC BIOL, V7, P470, DOI 10.1016/S0959-440X(97)80109-1; Kast P, 1996, TETRAHEDRON LETT, V37, P2691, DOI 10.1016/0040-4039(96)00338-3; Kast P, 1996, J AM CHEM SOC, V118, P3069, DOI 10.1021/ja953701i; Kast P, 1996, P NATL ACAD SCI USA, V93, P5043, DOI 10.1073/pnas.93.10.5043; KAST P, 1994, GENE, V138, P109, DOI 10.1016/0378-1119(94)90790-0; Kast P, 1996, PURE APPL CHEM, V68, P2017, DOI 10.1351/pac199668112017; Kienhofer A, 2003, J AM CHEM SOC, V125, P3206, DOI 10.1021/ja0341992; LEE AY, 1995, J AM CHEM SOC, V117, P3627, DOI 10.1021/ja00117a038; Liu DR, 1996, J AM CHEM SOC, V118, P1789, DOI 10.1021/ja953151o; MacBeath G, 1998, BIOTECHNIQUES, V24, P789, DOI 10.2144/98245st02; MacBeath G, 1998, BIOCHEMISTRY-US, V37, P10062, DOI 10.1021/bi980449t; MacBeath G, 1998, PROTEIN SCI, V7, P325; Mandal A, 2003, J AM CHEM SOC, V125, P5598, DOI 10.1021/ja029447t; MARSHALL BJ, 1972, BIOCHIM BIOPHYS ACTA, V264, P106, DOI 10.1016/0304-4165(72)90122-5; Mattei P, 1999, EUR J BIOCHEM, V261, P25, DOI 10.1046/j.1432-1327.1999.00169.x; Nakai T, 2000, J BIOCHEM, V128, P29, DOI 10.1093/oxfordjournals.jbchem.a022727; OKUJO N, 1994, BIOMETALS, V7, P109; Patrick WM, 2003, PROTEIN ENG, V16, P451, DOI 10.1093/protein/gzg057; Payne RJ, 2005, ORG BIOMOL CHEM, V3, P1825, DOI 10.1039/b503800f; Pelludat C, 2003, J BACTERIOL, V185, P5648, DOI 10.1128/JB.185.18.5648-5653.2003; Reimmann C, 2001, J BACTERIOL, V183, P813, DOI 10.1128/JB.183.3.813-820.2001; RUSNAK F, 1990, BIOCHEMISTRY-US, V29, P1425, DOI 10.1021/bi00458a013; Sambrook J., 2001, MOL CLONING LAB MANU; Sasso S, 2005, FEBS J, V272, P375, DOI 10.1111/j.1742-4658.2004.04478.x; SCHELL MA, 1986, J BACTERIOL, V166, P9, DOI 10.1128/jb.166.1.9-14.1986; SCHMIDT K, 1995, BIOTECHNOL BIOENG, V45, P285, DOI 10.1002/bit.260450402; Schnappauf G, 1997, P NATL ACAD SCI USA, V94, P8491, DOI 10.1073/pnas.94.16.8491; Segel I.H., 1976, BIOCH CALCULATIONS S; SERINO L, 1995, MOL GEN GENET, V249, P217, DOI 10.1007/BF00290369; Serino L, 1997, J BACTERIOL, V179, P248, DOI 10.1128/jb.179.1.248-257.1997; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; SNOW GA, 1970, BACTERIOL REV, V34, P99, DOI 10.1128/MMBR.34.2.99-125.1970; Spraggon G, 2001, P NATL ACAD SCI USA, V98, P6021, DOI 10.1073/pnas.111150298; Taylor SV, 2001, ANGEW CHEM INT EDIT, V40, P3310, DOI 10.1002/1521-3773(20010917)40:18<3310::AID-ANIE3310>3.0.CO;2-P; Taylor SV, 2001, P NATL ACAD SCI USA, V98, P10596, DOI 10.1073/pnas.191159298; WALSH CT, 1990, CHEM REV, V90, P1105, DOI 10.1021/cr00105a003; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; WRIGHT SK, IN PRESS J AM CHEM S; Zhang S, 1996, BIOORGAN MED CHEM, V4, P1015, DOI 10.1016/0968-0896(96)00099-5	58	45	46	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32827	32834		10.1074/jbc.M506883200	http://dx.doi.org/10.1074/jbc.M506883200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16036918	hybrid			2022-12-27	WOS:000231920300035
J	Carlson, AE; Quill, TA; Westenbroek, RE; Schuh, SM; Hille, B; Babcock, DF				Carlson, AE; Quill, TA; Westenbroek, RE; Schuh, SM; Hille, B; Babcock, DF			Identical phenotypes of CatSper1 and CatSper2 null sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLDEN-HAMSTER SPERMATOZOA; DEPENDENT CA2+ CHANNEL; GUINEA-PIG SPERMATOZOA; MICE LACKING; MOUSE SPERM; HYPERACTIVATED MOTILITY; CALCIUM-CHANNEL; GENE-EXPRESSION; ION CHANNELS; ACTIVATION	Among several candidate Ca2+ entry channels in sperm, only CatSper1 and CatSper2 are known to have required roles in male fertility. Past work with CatSper1 null sperm indicates that a critical lesion in hyperactivated motility underlies the infertility phenotype and is associated with an absence of depolarization-evoked Ca2+ entry. Here we show that failure of hyperactivation of CatSper2 null sperm similarly correlates with an absence of depolarization-evoked Ca2+ entry. Additional shared aspects of the phenotypes of CatSper1 and -2 null sperm include unperturbed regional distributions of conventional voltage-gated Ca2+ channel proteins and robust acceleration of the flagellar beat by bicarbonate. Further study reveals that treatment of both wild-type and CatSper2 null sperm with procaine increases beat asymmetry, a characteristic of the flagellar waveform of hyperactivation. This partial rescue of the loss-of-hyperactivation phenotype suggests that an absence of CatSper2 precludes hyperactivation by preventing delivery of needed Ca2+ messenger rather than by preventing flagellar responses to Ca2+. CatSper2 null sperm also have an increased basal cAMP content and beat frequency. Protein kinase A inhibitor H89 lowers beat frequency to that of wild-type sperm, suggesting that CatSper2 is required for protein kinase A-mediated, tonic control of resting cAMP content. Relative to wild-type testis, CatSper1 and -2 null testes contain normal amounts of CatSper2 and -1 transcripts, respectively. However, CatSper1 null sperm lack CatSper2 protein and CatSper2 null sperm lack CatSper1 protein. Hence, stable expression of CatSper1 protein requires CatSper2 and vice versa. This co-dependent expression dictates identical loss-of-function sperm phenotypes for CatSper1 and -2 null mutants.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Texas, SW Med Ctr, Cecil H & Ida Green Ctr Reprod Biol Sci, Dept Pharmacol, Dallas, TX 75390 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Washington; University of Washington Seattle	Babcock, DF (corresponding author), Univ Washington, Dept Physiol & Biophys, MS 357290, Seattle, WA 98195 USA.	donner@u.washington.edu	Oka, Yoshitaka/C-9670-2010; Schuh, Sonya/W-2941-2019; Carlson, Anne/I-9495-2019	Oka, Yoshitaka/0000-0002-3482-3051; Carlson, Anne/0000-0003-2724-1325; Babcock, Donner/0000-0002-4461-4544	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD012629, R01HD036022] Funding Source: NIH RePORTER; NICHD NIH HHS [5R01-HD36022, U54 HD12629, T32 HD007183] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Avidan N, 2003, EUR J HUM GENET, V11, P497, DOI 10.1038/sj.ejhg.5200991; BABCOCK DF, 1987, J BIOL CHEM, V262, P15041; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; BROKAW CJ, 1979, J CELL BIOL, V82, P401, DOI 10.1083/jcb.82.2.401; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; COOPER TG, 1984, GAMETE RES, V9, P55, DOI 10.1002/mrd.1120090106; DOMINO SE, 1991, METHOD ENZYMOL, V195, P345; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; FRASER LR, 1982, J ANDROL, V3, P412; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Garbers DL, 2001, NATURE, V413, P579, DOI 10.1038/35098164; GARBERS DL, 1982, J BIOL CHEM, V257, P8980; Gu Y, 2004, DEV BIOL, V274, P308, DOI 10.1016/j.ydbio.2004.06.025; Ho HC, 2003, BIOL REPROD, V68, P1590, DOI 10.1095/biolreprod.102.011320; Ino M, 2001, P NATL ACAD SCI USA, V98, P5323, DOI 10.1073/pnas.081089398; Ishijima S, 2002, MOL REPROD DEV, V61, P376, DOI 10.1002/mrd.10017; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; LINDEMANN CB, 1987, CELL MOTIL CYTOSKEL, V8, P324, DOI 10.1002/cm.970080405; Lobley Anna, 2003, Reprod Biol Endocrinol, V1, P53, DOI 10.1186/1477-7827-1-53; Marquez B, 2004, BIOL REPROD, V70, P1626, DOI 10.1095/biolreprod.103.026476; Nikpoor P, 2004, HUM REPROD, V19, P124, DOI 10.1093/humrep/deh043; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Quill TA, 2003, P NATL ACAD SCI USA, V100, P14869, DOI 10.1073/pnas.2136654100; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Saegusa H, 2000, P NATL ACAD SCI USA, V97, P6132, DOI 10.1073/pnas.100124197; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Serrano CJ, 1999, FEBS LETT, V462, P171, DOI 10.1016/S0014-5793(99)01518-5; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; SINGH JP, 1983, ARCH BIOCHEM BIOPHYS, V221, P291, DOI 10.1016/0003-9861(83)90146-7; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; SUAREZ SS, 1983, BIOL REPROD, V29, P1277, DOI 10.1095/biolreprod29.5.1277; VIJAYARAGHAVAN S, 1985, BIOL REPROD, V32, P489, DOI 10.1095/biolreprod32.3.489; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wennemuth G, 2000, J BIOL CHEM, V275, P21210, DOI 10.1074/jbc.M002068200; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; Westenbroek RE, 1999, DEV BIOL, V207, P457, DOI 10.1006/dbio.1998.9172; YANAGIMA.R, 1970, J REPROD FERTIL, V23, P193, DOI 10.1530/jrf.0.0230193; YANAGIMACHI R, 1974, EXP CELL RES, V89, P161, DOI 10.1016/0014-4827(74)90199-2; Yanagimachi R., 1994, P189	46	132	143	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32238	32244		10.1074/jbc.M501430200	http://dx.doi.org/10.1074/jbc.M501430200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16036917	hybrid			2022-12-27	WOS:000231794800025
J	Gagnon, E; Bergeron, MJ; Daigle, ND; Lefoll, MH; Isenring, P				Gagnon, E; Bergeron, MJ; Daigle, ND; Lefoll, MH; Isenring, P			Molecular mechanisms of cation transport by the renal Na+-K+-Cl(-)cotransporter - Structural insight into the operating characteristics of the ion transport sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL COTRANSPORTER; NA+-K+-2CL(-) COTRANSPORTER; FUNCTIONAL EXPRESSION; BUMETANIDE BINDING; NA; LOCALIZATION; CLONING; FAMILY; CELLS; POTASSIUM	Two variants of the renal Na+- K+-Cl- cotransporter ( NKCC2), called NKCC2A and NKCC2F, display marked differences in Na+, Rb+, and Cl- affinities, yet are identical to one another except for a 23-residue membrane-associated domain that is derived from alternatively spliced exons. The proximal portion of these exons is predicted to encode the second transmembrane domain (tm2) in the form of an alpha-helix, and the distal portion, part of the following connecting segment (cs1a). In recent studies, we have taken advantage of the A-F differences in kinetic behavior to determine which regions in tm2-cs1a are involved in ion transport. Functional characterizations of chimeras in which tm2 or cs1a were interchanged between the variants showed that both regions are important in specifying ion affinities, but did not allow delineating the contribution of individual residues. Here, we have extended these structure-function analyses by studying additional mutants in which variant residues between A and F were interchanged individually in the tm2-cs1a region (amino acid number 216, 220, 223, 229, or 233 in NKCC2). None of the substitutions were found to affect K-m(C1 (-)), suggesting that the affinity difference for anion transport is conveyed by a combination of variant residues in this domain. However, 2 substitutions in the tm2 of F were found to affect cation constants specifically; interestingly, one of these mutations ( residue 216) only affected Km(Rb+) while the other (residue 220) only affected Km(Na+). We have thus identified two novel residues in NKCC2 that play a key role in cation transport. Because such residues should be adjacent to one another on the vertical axis of the tm2 alpha-helix, our results imply, furthermore, that the ion transport sites in NKCC2 could be physically linked.	Univ Laval, Fac Med, Dept Med, Nephrol Res Grp, Quebec City, PQ G1R 2J6, Canada	Laval University	Isenring, P (corresponding author), Hop Hotel Dieu, Quebec Res Ctr, 10 Rue McMahon Rm 3852, Quebec City, PQ G1R 2J6, Canada.	paul.isenring@crhdq.ulaval.ca						Benjamin BA, 1997, AM J PHYSIOL-RENAL, V273, pF473, DOI 10.1152/ajprenal.1997.273.3.F473; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; DELPIRE E, 1994, J BIOL CHEM, V269, P25677; Doyle DA, 2004, EUR BIOPHYS J BIOPHY, V33, P175, DOI 10.1007/s00249-003-0382-z; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Gagnon E, 2004, J BIOL CHEM, V279, P5648, DOI 10.1074/jbc.M311218200; Gagnon E, 2003, AM J PHYSIOL-CELL PH, V284, pC365, DOI 10.1152/ajpcell.00262.2002; Gagnon E, 2002, AM J PHYSIOL-RENAL, V283, pF1046, DOI 10.1152/ajprenal.00107.2002; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Garon L, 2000, J BIOL CHEM, V275, P32027, DOI 10.1074/jbc.M000108200; GECK P, 1980, BIOCHIM BIOPHYS ACTA, V600, P432, DOI 10.1016/0005-2736(80)90446-0; Gerelsaikhan T, 2000, J BIOL CHEM, V275, P40471, DOI 10.1074/jbc.M007751200; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Gimenez I, 2002, J BIOL CHEM, V277, P8767, DOI 10.1074/jbc.C200021200; GREGER R, 1985, PHYSIOL REV, V65, P760, DOI 10.1152/physrev.1985.65.3.760; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; IGARASHI P, 1995, AM J PHYSIOL-RENAL, V269, pF405, DOI 10.1152/ajprenal.1995.269.3.F405; Isenring P, 1998, J BIOL CHEM, V273, P11295, DOI 10.1074/jbc.273.18.11295; Isenring P, 1998, J GEN PHYSIOL, V112, P549, DOI 10.1085/jgp.112.5.549; Isenring P, 1998, P NATL ACAD SCI USA, V95, P7179, DOI 10.1073/pnas.95.12.7179; Isenring P, 1997, J BIOL CHEM, V272, P24556, DOI 10.1074/jbc.272.39.24556; Isenring P, 2001, COMP BIOCHEM PHYS A, V130, P487, DOI 10.1016/S1095-6433(01)00420-2; Kaplan MR, 1996, KIDNEY INT, V49, P40, DOI 10.1038/ki.1996.6; Lytle C, 1998, AM J PHYSIOL-CELL PH, V274, pC299, DOI 10.1152/ajpcell.1998.274.2.C299; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; MIYAMOTO H, 1986, J MEMBRANE BIOL, V92, P135, DOI 10.1007/BF01870703; Park JH, 1996, J MEMBRANE BIOL, V149, P161, DOI 10.1007/s002329900016; PAYNE JA, 1995, J BIOL CHEM, V270, P17977, DOI 10.1074/jbc.270.30.17977; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; Plata C, 2002, J BIOL CHEM, V277, P11004, DOI 10.1074/jbc.M110442200; RUSSELL JM, 1983, J GEN PHYSIOL, V81, P909, DOI 10.1085/jgp.81.6.909; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201; Yang TX, 1996, AM J PHYSIOL-RENAL, V271, pF931, DOI 10.1152/ajprenal.1996.271.4.F931	36	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32555	32563		10.1074/jbc.M505511200	http://dx.doi.org/10.1074/jbc.M505511200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16027154	hybrid			2022-12-27	WOS:000231794800065
J	Morin, S; Pozzulo, G; Robitaille, L; Cross, J; Nemer, M				Morin, S; Pozzulo, G; Robitaille, L; Cross, J; Nemer, M			MEF2-dependent recruitment of the HAND1 transcription factor results in synergistic activation of target promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL CREST DERIVATIVES; LOOP-HELIX PROTEINS; CARDIAC MORPHOGENESIS; GENE-EXPRESSION; COOPERATIVE INTERACTION; VASCULAR DEVELOPMENT; BHLH PROTEINS; FACTOR MEF2C; MADS-BOX; HEART	HAND proteins are tissue-restricted members of the basic helix-loop-helix transcription factor family that play critical roles in cell differentiation and organogenesis including placental, cardiovascular, and craniofacial development. Nevertheless, the molecular basis underlying the developmental action of HAND proteins remains undefined. Within the embryo, HAND1 is first detected in the developing heart where it becomes restricted to the atrial and left ventricular compartments, a pattern identical to that of the Nppa gene, which encodes atrial natriuretic factor, the major secretory product of the heart. We hereby report that the cardiac atrial natriuretic factor promoter is directly activated by HAND1, making it the first known HAND1 transcriptional target. The action of HAND1 does not require heterodimerization with class I basic helix-loop-helix factors or DNA binding through E-box elements. Instead, HAND1 is recruited to the promoter via physical interaction with MEF2 proteins. MEF2/HAND1 interaction results in synergistic activation of MEF2-dependent promoters, and MEF2 binding sites are sufficient to mediate this synergy. MEF2 binding to DNA is not enhanced in the presence of HAND1. Instead, cooper-ativity likely results from corecruitment of co-activators such as CREB-binding protein. The related HAND2 protein can also synergize with MEF2. Thus, HAND proteins act as cell-specific developmental co-activators of the MEF2 family of transcription factors. These findings identify a novel mechanism for HAND action in the heart and provide a general paradigm to understand the mechanism of HAND action in organogenesis.	Inst Rech Clin Montreal, Lab Cardiac Growth & Differentiat, Montreal, PQ H2W 1R7, Canada; Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; Univ Calgary, Hlth Sci Ctr, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba	Nemer, M (corresponding author), Inst Rech Clin Montreal, Lab Cardiac Growth & Differentiat, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada.	mona.nemer@ircm.qc.ca	Cross, James/AAU-2973-2020; Cross, James/F-4814-2011	Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378				Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Black BL, 1996, J BIOL CHEM, V271, P26659, DOI 10.1074/jbc.271.43.26659; Charron F, 1999, MOL CELL BIOL, V19, P4355; Cohen-Kaminsky S, 1998, EMBO J, V17, P5151, DOI 10.1093/emboj/17.17.5151; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; Dai YS, 2002, J BIOL CHEM, V277, P12604, DOI 10.1074/jbc.M200283200; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Fernandez-Teran M, 2003, DEV DYNAM, V226, P690, DOI 10.1002/dvdy.10271; Firulli AB, 2003, GENE, V312, P27, DOI 10.1016/S0378-1119(03)00669-3; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/ng0398-266; Firulli BA, 2003, MOL CELL, V12, P1225, DOI 10.1016/S1097-2765(03)00425-8; Hill AA, 2004, MOL CELL BIOL, V24, P9835, DOI 10.1128/MCB.24.22.9835-9847.2004; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Knofler M, 2002, BIOCHEM J, V361, P641, DOI 10.1042/0264-6021:3610641; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Mao ZX, 1996, J BIOL CHEM, V271, P14371, DOI 10.1074/jbc.271.24.14371; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; McFadden DG, 2002, DEVELOPMENT, V129, P3077; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Morikawa Y, 2004, DEVELOPMENT, V131, P2195, DOI 10.1242/dev.01091; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Morin S, 2001, MOL CELL BIOL, V21, P1036, DOI 10.1128/MCB.21.4.1036-1044.2001; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Nemer G, 2002, DEVELOPMENT, V129, P4045; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Smith SJ, 2000, DEV DYNAM, V219, P575, DOI 10.1002/1097-0177(200012)219:4<575::AID-DVDY1075>3.0.CO;2-Y; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; Sparrow DB, 1998, MECH DEVELOP, V71, P151, DOI 10.1016/S0925-4773(98)00010-0; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Thattaliyath BD, 2002, J MOL CELL CARDIOL, V34, P1335, DOI 10.1006/jmcc.2002.2085; Thattaliyath BD, 2002, BIOCHEM BIOPH RES CO, V297, P870, DOI 10.1016/S0006-291X(02)02297-0; Togi K, 2004, MOL CELL BIOL, V24, P4627, DOI 10.1128/MCB.24.11.4627-4635.2004; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Yamagishi H, 2000, J CLIN INVEST, V105, P261, DOI 10.1172/JCI8856; Yanagisawa H, 2003, DEVELOPMENT, V130, P1069, DOI 10.1242/dev.00337; Yelon D, 2000, DEVELOPMENT, V127, P2573	46	38	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32272	32278		10.1074/jbc.M507640200	http://dx.doi.org/10.1074/jbc.M507640200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16043483	hybrid			2022-12-27	WOS:000231794800029
J	Locher, M; Lehnert, B; Krauss, K; Heesemann, J; Groll, M; Wilharm, G				Locher, M; Lehnert, B; Krauss, K; Heesemann, J; Groll, M; Wilharm, G			Crystal structure of the Yersinia enterocolitica type III secretion chaperone SycT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL PATHOGENS; FUNCTIONAL CONSERVATION; 3-DIMENSIONAL STRUCTURE; EFFECTOR PROTEIN; SYSTEM; PESTIS; RECOGNITION; POLYPEPTIDE; REFINEMENT; MACHINERY	Several Gram-negative pathogens deploy type III secretion systems (TTSSs) as molecular syringes to inject effector proteins into host cells. Prior to secretion, some of these effectors are accompanied by specific type III secretion chaperones. The Yersinia enterocolitica TTSS chaperone SycT escorts the effector YopT, a cysteine protease that inactivates the small GTPase RhoA of targeted host cells. We solved the crystal structure of SycT at 2.5 angstrom resolution. Despite limited sequence similarity among TTSS chaperones, the SycT structure revealed a global fold similar to that exhibited by other structurally solved TTSS chaperones. The dimerization domain of SycT, however, differed from that of all other known TTSS chaperone structures. Thus, the dimerization domain of TTSS chaperones does not likely serve as a general recognition pattern for downstream processing of effector/chaperone complexes. Yersinia Yop effectors are bound to their specific Syc chaperones close to the Yop N termini, distinct from their catalytic domains. Here, we showed that the catalytically inactive YopT(C139S) is reduced in its ability to bind SycT, suggesting an ancillary interaction between YopT and SycT. This interaction could maintain the protease inactive prior to secretion or could influence the secretion competence and folding of YopT.	Univ Munich, Adolf Butenandt Inst, Lehrstuhl Physiol Chem, D-81377 Munich, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Univ Munich, Leh Bakteriol, Max Von Pettenkofer Inst, D-80336 Munich, Germany	University of Munich; Max Planck Society; University of Munich	Wilharm, G (corresponding author), Univ Munich, Adolf Butenandt Inst, Lehrstuhl Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.	maier@m3401.mpk.med.unimuenchen.de	Groll, Michael/C-1174-2010; Groll, Michael/F-5572-2015	Wilharm, Gottfried/0000-0002-1771-6799				BALZER D, 1992, NUCLEIC ACIDS RES, V20, P1851, DOI 10.1093/nar/20.8.1851; Birtalan S, 2001, NAT STRUCT BIOL, V8, P974, DOI 10.1038/nsb1101-974; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Boyd AP, 2000, J BACTERIOL, V182, P4811, DOI 10.1128/JB.182.17.4811-4821.2000; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cornelis GR, 2003, MOL MICROBIOL, V50, P1091, DOI 10.1046/j.1365-2958.2003.03812.x; Cornelis GR, 2002, INT J MED MICROBIOL, V291, P455; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Evdokimov AG, 2003, NAT STRUCT BIOL, V10, P789, DOI 10.1038/nsb982; Evdokimov AG, 2002, ACTA CRYSTALLOGR D, V58, P398, DOI 10.1107/S090744490200015X; Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; GINOCCHIO CC, 1995, INFECT IMMUN, V63, P729, DOI 10.1128/IAI.63.2.729-732.1995; Gophna U, 2003, GENE, V312, P151, DOI 10.1016/S0378-1119(03)00612-7; HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x; Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Neumayer W, 2004, PROTEIN EXPRES PURIF, V35, P237, DOI 10.1016/j.pep.2004.02.017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x; Pallen MJ, 2003, FEMS MICROBIOL LETT, V223, P53, DOI 10.1016/S0378-1097(03)00344-6; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Phan J, 2004, ACTA CRYSTALLOGR D, V60, P1591, DOI 10.1107/S0907444904017597; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1095, DOI 10.1046/j.1365-2958.2003.03777.x; ROSQVIST R, 1995, EMBO J, V14, P4187, DOI 10.1002/j.1460-2075.1995.tb00092.x; Rossier O, 1999, P NATL ACAD SCI USA, V96, P9368, DOI 10.1073/pnas.96.16.9368; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SCHOMAKER V, 1968, ACTA CRYSTALL B-STRU, VB 24, P63, DOI 10.1107/S0567740868001718; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Singer AU, 2004, STRUCTURE, V12, P1669, DOI 10.1016/j.str.2004.06.023; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Trame CB, 2003, ACTA CRYSTALLOGR D, V59, P389, DOI 10.1107/S0907444902020826; Turk D., 1992, THESIS TU MUENCHEN; van Eerde A, 2004, EMBO REP, V5, P477, DOI 10.1038/sj.embor.7400144; Wilharm G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-27; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x; Yip CK, 2005, NAT STRUCT MOL BIOL, V12, P75, DOI 10.1038/nsmb879; Zhu MF, 2004, P NATL ACAD SCI USA, V101, P302, DOI 10.1073/pnas.2036536100	45	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31149	31155		10.1074/jbc.M500603200	http://dx.doi.org/10.1074/jbc.M500603200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16000312	hybrid			2022-12-27	WOS:000231487800061
J	Yusa, K; Maeda, Y; Fujioka, A; Monde, K; Harada, S				Yusa, K; Maeda, Y; Fujioka, A; Monde, K; Harada, S			Isolation of TAK-779-resistant HIV-1 from an R5 HIV-1 GP120 v3 loop library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 ENVELOPE GLYCOPROTEIN; AMINO-ACID SUBSTITUTION; V3 LOOP; SMALL-MOLECULE; CELL TROPISM; CORECEPTOR USAGE; CCR5 UTILIZATION; ENTRY INHIBITOR; IDENTIFICATION	The human immunodeficiency virus (HIV-1) envelope glycoprotein (GP) 120 interacts with CD4 and the CCR5 coreceptor for viral entry. The V3 loop in GP120 is a crucial region for determining coreceptor usage during viral entry, and a variety of amino acid substitutions has been observed in clinical isolates. To construct an HIV-1 V3 loop library, we chose 10 amino acid positions in the V3 loop and incorporated random combinations (27,648 possibilities) of the amino acid substitutions derived from 31 R5 viruses into the V3 loop of HIV-1(JR-FL) proviral DNA. The constructed HIV-1 library contained 6.6 x 106 independent clones containing a set of 0 - 10 amino acid substitutions in the V3 loop. To address whether restricted steric alteration in the V3 loop could confer resistance to an entry inhibitor, TAK-779, we selected entry inhibitor-resistant HIV-1 by increasing the concentration of TAK-779 from 0.10 to 0.30 mu M in PM1-CCR5 cells with high expression of CCR5. The selected viruses at passage 8 contained five amino acid substitutions in the V3 loop without any other mutations in GP120 and showed 15-fold resistance compared with the parental virus. These results indicated that a certain structure of the V3 loop containing amino acid substitutions derived from 31 R5 viruses can contribute to the acquisition of resistance to entry inhibitors binding to CCR5. Taken together, this type of HIV-1 V3 loop library is useful for isolating and analyzing the specific biological features of HIV-1 with respect to alterations of the V3 loop structure.	Kumamoto Univ, Grad Sch Med Sci, Dept Med Virol, Kumamoto 8608556, Japan	Kumamoto University	Yusa, K (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Med Virol, 2-1-1 Honjo, Kumamoto 8608556, Japan.	yusak@kaiju.medic.kumamoto-u.ac.jp	Monde, Kazuaki/I-6493-2019	Monde, Kazuaki/0000-0002-8314-5306				Aarons EJ, 2001, VIROLOGY, V287, P382, DOI 10.1006/viro.2001.1046; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; BERKHOUT B, 1993, NUCLEIC ACIDS RES, V21, P5020, DOI 10.1093/nar/21.22.5020; BOYD MT, 1993, J VIROL, V67, P3649, DOI 10.1128/JVI.67.6.3649-3652.1993; Briggs DR, 2000, AIDS, V14, P2937, DOI 10.1097/00002030-200012220-00016; Carrillo A, 1996, J VIROL, V70, P1301, DOI 10.1128/JVI.70.2.1301-1309.1996; CATASTI P, 1995, J BIOL CHEM, V270, P2224, DOI 10.1074/jbc.270.5.2224; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chen ZW, 1997, J VIROL, V71, P2705, DOI 10.1128/JVI.71.4.2705-2714.1997; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Cho MW, 1998, J VIROL, V72, P2509, DOI 10.1128/JVI.72.3.2509-2515.1998; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Derdeyn CA, 2001, J VIROL, V75, P8605, DOI 10.1128/JVI.75.18.8605-8614.2001; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; FOUCHIER RAM, 1995, J CLIN MICROBIOL, V33, P906, DOI 10.1128/JCM.33.4.906-911.1995; Hoffman TL, 1999, MOL MEMBR BIOL, V16, P57, DOI 10.1080/096876899294760; Hu QX, 2000, J MOL BIOL, V302, P359, DOI 10.1006/jmbi.2000.4076; Hung CS, 1999, J VIROL, V73, P8216, DOI 10.1128/JVI.73.10.8216-8226.1999; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; KOITO A, 1994, J VIROL, V68, P2253, DOI 10.1128/JVI.68.4.2253-2259.1994; Kuhmann SE, 2004, J VIROL, V78, P2790, DOI 10.1128/JVI.78.6.2790-2807.2004; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; Maeda Y, 2000, J VIROL, V74, P1787, DOI 10.1128/JVI.74.4.1787-1793.2000; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; OBRIEN WA, 1990, NATURE, V348, P69, DOI 10.1038/348069a0; Platt EJ, 2001, J VIROL, V75, P12266, DOI 10.1128/JVI.75.24.12266-12278.2001; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Reeves JD, 2005, J VIROL, V79, P4991, DOI 10.1128/JVI.79.8.4991-4999.2005; Ross TM, 1998, P NATL ACAD SCI USA, V95, P7682, DOI 10.1073/pnas.95.13.7682; SCHWENK HU, 1975, BLUT, V31, P299, DOI 10.1007/BF01634146; Shimizu N, 1999, VIROLOGY, V259, P324, DOI 10.1006/viro.1999.9764; SHIODA T, 1991, NATURE, V349, P167, DOI 10.1038/349167a0; Trkola A, 2002, P NATL ACAD SCI USA, V99, P395, DOI 10.1073/pnas.012519099; Trujillo JR, 1996, VIROLOGY, V217, P613, DOI 10.1006/viro.1996.0158; Tugarinov V, 2000, STRUCT FOLD DES, V8, P385, DOI 10.1016/S0969-2126(00)00119-2; Verrier F, 1999, AIDS RES HUM RETROV, V15, P731, DOI 10.1089/088922299310827; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Yusa K, 2002, J VIROL, V76, P3031, DOI 10.1128/JVI.76.6.3031-3037.2002	44	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30083	30090		10.1074/jbc.M414360200	http://dx.doi.org/10.1074/jbc.M414360200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15983047	hybrid			2022-12-27	WOS:000231362500013
J	Zhang, DD; Lo, SC; Sun, Z; Habib, GM; Lieberman, MW; Hannink, M				Zhang, DD; Lo, SC; Sun, Z; Habib, GM; Lieberman, MW; Hannink, M			Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; CUL3-BASED E3 LIGASE; F-BOX PROTEIN; OXIDATIVE STRESS; GENE-EXPRESSION; GLUTATHIONE SYNTHESIS; DROSOPHILA KELCH; COP9 SIGNALOSOME; SCF; BINDING	Keap1 is a BTB-Kelch protein that functions as a substrate adaptor protein for a Cul3-dependent E3 ubiquitin ligase complex. Keap1 targets its substrate, the Nrf2 transcription factor, for ubiquitination and subsequent degradation by the 26 S proteasome. Inhibition of Keap1-dependent ubiquitination of Nrf2 increases steady-state levels of Nrf2 and enables activation of cytoprotective Nrf2-dependent genes. In this report, we demonstrate that Keap1 and three other BTB-Kelch proteins, including GAN1, ENC1, and Sarcosin, are ubiquitinated by a Cul3-dependent complex. Ubiquitination of Keap1 is markedly increased in cells exposed to quinone-induced oxidative stress, occurs in parallel with inhibition of Keap1-dependent ubiquitination of Nrf2, and results in decreased steady-state levels of Keap1, particularly in cells that are unable to synthesize glutathione. Degradation of Keap1 is independent of the 26 S proteasome, because inhibitors of the 26 S proteasome do not prevent loss of Keap1 following exposure of cells to quinone-induced oxidative stress. Our results suggest that a switch from substrate to substrate adaptor ubiquitination is a critical regulatory step that controls steady-state levels of both BTB-Kelch substrate adaptor proteins and their cognate substrates.	Univ Missouri, Life Sci Ctr, Dept Biochem, Columbia, MO 65212 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	University of Missouri System; University of Missouri Columbia; Baylor College of Medicine	Hannink, M (corresponding author), Univ Missouri, Life Sci Ctr, Dept Biochem, 1201 E Rollins St, Columbia, MO 65212 USA.	hanninkm@missouri.edu	Sun, Zheng/C-1146-2012; Zhang, Donna/B-1015-2012	Sun, Zheng/0000-0002-6858-0633; Lo, Shih-Ching/0000-0002-5187-0730	NATIONAL CANCER INSTITUTE [P50CA103130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059213] Funding Source: NIH RePORTER; NCI NIH HHS [P50-CA103130] Funding Source: Medline; NIGMS NIH HHS [1-R01-GM59213] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam J, 2000, J BIOL CHEM, V275, P27694; AMES BN, 1993, OXIDANTS ARE MAJOR C, P1; Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Bomont P, 2003, HUM MOL GENET, V12, P813, DOI 10.1093/hmg/ddg092; Bruno C, 2004, NEUROLOGY, V62, P13, DOI 10.1212/01.WNL.0000101676.41505.A7; Butterfield DA, 2001, CURR MED CHEM, V8, P815, DOI 10.2174/0929867013373048; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cullen VC, 2004, NEUROREPORT, V15, P873, DOI 10.1097/00001756-200404090-00028; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Fujita M, 2001, CANCER RES, V61, P7722; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kelso RJ, 2002, J CELL BIOL, V156, P703, DOI 10.1083/jcb.200110063; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Li XC, 2004, J BIOL CHEM, V279, P54750, DOI 10.1074/jbc.M410073200; Li Y, 2004, J BIOL CHEM, V279, P11074, DOI 10.1074/jbc.M312301200; Liang XQ, 2004, ONCOGENE, V23, P5890, DOI 10.1038/sj.onc.1207776; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lu SJ, 2003, J CELL SCI, V116, P2169, DOI 10.1242/jcs.00425; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rao AV, 2002, NUTR NEUROSCI, V5, P291, DOI 10.1080/1028415021000033767; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Sekhar KR, 2003, CANCER RES, V63, P5636; Shi ZZ, 2000, P NATL ACAD SCI USA, V97, P5101, DOI 10.1073/pnas.97.10.5101; Spence HJ, 2000, ONCOGENE, V19, P1266, DOI 10.1038/sj.onc.1203433; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Talalay P, 2001, J NUTR, V131, p3027S, DOI 10.1093/jn/131.11.3027S; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	55	225	237	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30091	30099		10.1074/jbc.M501279200	http://dx.doi.org/10.1074/jbc.M501279200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15983046	hybrid			2022-12-27	WOS:000231362500014
J	Vitale, N; Mawet, J; Camonis, J; Regazzi, R; Bader, MF; Chasserot-Golaz, S				Vitale, N; Mawet, J; Camonis, J; Regazzi, R; Bader, MF; Chasserot-Golaz, S			The small GTPase RalA controls exocytosis of large dense core secretory granules by interacting with ARF6-dependent phospholipase D1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-REGULATED EXOCYTOSIS; PLASMA-MEMBRANE; CHROMAFFIN CELLS; BINDING PROTEINS; EXOCYST COMPLEX; SYNAPTIC VESICLES; SEC6/8 COMPLEX; NEUROTRANSMITTER RELEASE; PUTATIVE EFFECTOR; EPITHELIAL-CELLS	RalA and RalB constitute a family of highly similar Ras-related GTPases widely distributed in different tissues. Recently, active forms of Ral proteins have been shown to bind to the exocyst complex, implicating them in the regulation of cellular secretion. Since RalA is present on the plasma membrane in neuroendocrine chromaffin and PC12 cells, we investigated the potential role of RalA in calcium-regulated exocytotic secretion. We show here that endogenous RalA is activated during exocytosis. Expression of the constitutively active RalA (G23V) mutant enhances secretagogue-evoked secretion from PC12 cells. Conversely, expression of the constitutively inactive GDP-bound RalA (G26A) or silencing of the RalA gene by RNA interference led to a strong impairment of the exocytotic response. RalA was found to co-localize with phospholipase D1 ( PLD1) at the plasma membrane in PC12 cells. We demonstrate that cell stimulation triggers a direct interaction between RalA and ARF6-activated PLD1. Moreover, reduction of endogenous RalA expression level interfered with the activation of PLD1 observed in secretagogue-stimulated cells. Finally, using various RalA mutants selectively impaired in their ability to activate downstream effectors, we show that PLD1 activation is essential for the activation of secretion by GTP-loaded RalA. Together, these results provide evidence that RalA is a positive regulator of calcium-evoked exocytosis of large dense core secretory granules and suggest that stimulation of PLD1 and consequent changes in plasma membrane phospholipid composition is the major function RalA undertakes in calcium-regulated exocytosis.	CNRS, UPR 2356, F-67084 Strasbourg, France; INSERM, Inst Curie, U 528, F-75248 Paris, France; Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Lausanne	Bader, MF (corresponding author), CNRS, UPR 2356, 5 Rue Blaise Pascal, F-67084 Strasbourg, France.	bader@neurochem.u-strasbg.fr	Bader, Marie-France/O-2098-2016; Chasserot-Golaz, Sylvette/K-7625-2017; Vitale, Nicolas/G-5967-2014	Vitale, Nicolas/0000-0002-4752-4907; Regazzi, Romano/0000-0002-9773-2915; Chasserot-Golaz, Sylvette/0000-0002-7437-2558				BADER MF, 1986, J BIOL CHEM, V261, P5777; Bhullar RP, 1998, MOL CELL BIOCHEM, V179, P49, DOI 10.1023/A:1006891815211; BIELINSKI DF, 1993, BIOCHIM BIOPHYS ACTA, V1151, P246, DOI 10.1016/0005-2736(93)90109-D; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Burgoyne RD, 2003, BBA-MOL CELL RES, V1641, P137, DOI 10.1016/S0167-4889(03)00089-2; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Caumon AS, 2000, J BIOL CHEM, V275, P15637, DOI 10.1074/jbc.M908347199; Caumont AS, 1998, J BIOL CHEM, V273, P1373, DOI 10.1074/jbc.273.3.1373; CHAMBERLAIN LH, 1995, J CELL BIOL, V130, P1063, DOI 10.1083/jcb.130.5.1063; CHARDIN P, 1989, NUCLEIC ACIDS RES, V17, P4380, DOI 10.1093/nar/17.11.4380; ChasserotGolaz S, 1996, J CELL BIOL, V133, P1217, DOI 10.1083/jcb.133.6.1217; Chen YA, 1999, J BIOL CHEM, V274, P26469, DOI 10.1074/jbc.274.37.26469; Clough RR, 2002, J BIOL CHEM, V277, P28972, DOI 10.1074/jbc.M201504200; EHRHART M, 1986, J HISTOCHEM CYTOCHEM, V34, P1673, DOI 10.1177/34.12.2878021; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Gasman S, 1999, J CELL SCI, V112, P4763; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hazuka CD, 1999, J NEUROSCI, V19, P1324; Hsu SC, 1999, TRENDS CELL BIOL, V9, P150, DOI 10.1016/S0962-8924(99)01516-0; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Humeau Y, 2001, P NATL ACAD SCI USA, V98, P15300, DOI 10.1073/pnas.261358698; Ikeda M, 1998, J BIOL CHEM, V273, P814, DOI 10.1074/jbc.273.2.814; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jullien-Flores V, 2000, J CELL SCI, V113, P2837; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kee Y, 1997, P NATL ACAD SCI USA, V94, P14438, DOI 10.1073/pnas.94.26.14438; Kim JH, 1998, FEBS LETT, V430, P231, DOI 10.1016/S0014-5793(98)00661-9; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Luo JQ, 1998, P NATL ACAD SCI USA, V95, P3632, DOI 10.1073/pnas.95.7.3632; Mark BL, 1996, BIOCHEM BIOPH RES CO, V225, P40, DOI 10.1006/bbrc.1996.1128; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; NGSEE JK, 1991, J BIOL CHEM, V266, P2675; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Park SH, 1995, ONCOGENE, V11, P2349; Polzin A, 2002, MOL CELL BIOL, V22, P1714, DOI 10.1128/MCB.22.6.1714-1722.2002; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Vik-Mo EO, 2003, NEUROSCIENCE, V119, P73, DOI 10.1016/S0306-4522(03)00065-4; Vitale N, 2002, J CELL BIOL, V159, P79, DOI 10.1083/jcb.200203027; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; VOLKNANDT W, 1993, FEBS LETT, V317, P53, DOI 10.1016/0014-5793(93)81490-Q; Wang KL, 1999, J BIOL CHEM, V274, P14525, DOI 10.1074/jbc.274.21.14525; Wang L, 2004, J BIOL CHEM, V279, P19875, DOI 10.1074/jbc.M400522200; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Yamaguchi A, 1997, J BIOL CHEM, V272, P31230, DOI 10.1074/jbc.272.50.31230	57	59	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2005	280	33					29921	29928		10.1074/jbc.M413748200	http://dx.doi.org/10.1074/jbc.M413748200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	954SX	15980073	hybrid			2022-12-27	WOS:000231176200064
J	Chellaiah, MA				Chellaiah, MA			Regulation of actin ring formation by Rho GTPases in Osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; ALDRICH-SYNDROME MACROPHAGES; SRC KINASE-ACTIVITY; N-WASP; ARP2/3 COMPLEX; BINDING-PROTEIN; ACTIVATION MECHANISMS; BONE-RESORPTION; PHOSPHOLIPASE-D; EXCHANGE FACTOR	Actin ring formation is a prerequisite for osteoclast bone resorption. Although gelsolin null osteoclasts failed to exhibit podosomes, actin ring was observed in these osteoclasts. Wiscott-Aldrich syndrome protein (WASP) was observed in the actin ring of gelsolin null osteoclast. Osteoclasts stimulated with osteopontin simulated the effects of Rho and Cdc42 in phosphatidylinositol 4,5-bisphosphate (PIP2) association with WASP as well as formation of podosomes, peripheral microfilopodia-like structures, and actin ring. To explore the potential functions of Rho and Cdc42, TAT-mediated delivery of Rho proteins into osteoclasts was performed. Although Rho and Cdc42 are required for actin ring formation, transduction of either one of the proteins alone is insufficient for this process. Addition of osteopontin to osteoclasts transduced with Cdc42(Val12) or transduction of osteoclasts with both Rho(Val14) and Cdc42(Val12) augments the formation of WASP-Arp2/3 complex and actin ring. Neomycin, an antibiotic, blocked the effects of osteopontin or TAT-Rho(Val14) on PIP2 interaction with WASP. WASP distribution was found to be cytosolic in these osteoclasts. Depletion of WASP by short interfering RNA-mediated gene silencing blocked actin polymerization as well as actin ring formation in osteoclasts. These results suggest that Rho-mediated PIP2 interaction with WASP may contribute to the activation and membrane targeting of WASP. Subsequent interaction of Cdc42 and Arp2/3 with WASP may enhance cortical actin polymerization in the process of actin ring formation in osteoclasts.	Univ Maryland, Sch Dent, Dept Biomed Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Chellaiah, MA (corresponding author), Univ Maryland, Sch Dent, Dept Biomed Sci, Baltimore, MD 21201 USA.	mac001@dental.umaryland.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046292] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01-AR46292] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Arbuzova A, 2000, BBA-BIOMEMBRANES, V1464, P35, DOI 10.1016/S0005-2736(99)00243-6; Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200; Biswas RS, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-19; BISWAS RS, 2003, J BONE MINER RES  S1, V18, P279; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Burns S, 2001, BLOOD, V98, P1142, DOI 10.1182/blood.V98.4.1142; Calle Y, 2004, BLOOD, V103, P3552, DOI 10.1182/blood-2003-04-1259; Carron CP, 2000, J ENDOCRINOL, V165, P587, DOI 10.1677/joe.0.1650587; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chellaiah M, 1996, MOL BIOL CELL, V7, P743, DOI 10.1091/mbc.7.5.743; Chellaiah M, 1998, J BIOL CHEM, V273, P11908, DOI 10.1074/jbc.273.19.11908; Chellaiah MA, 2000, J BIOL CHEM, V275, P11993, DOI 10.1074/jbc.275.16.11993; Chellaiah MA, 2001, J BIOL CHEM, V276, P47434, DOI 10.1074/jbc.M107494200; Chellaiah MA, 2003, J BIOL CHEM, V278, P29086, DOI 10.1074/jbc.M211074200; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; CHUANG TH, 1993, J BIOL CHEM, V268, P26206; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; Cunningham CC, 2001, J BIOL CHEM, V276, P43390, DOI 10.1074/jbc.M105289200; Demeter J, 1998, J CELL BIOL, V143, P415, DOI 10.1083/jcb.143.2.415; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; DILLON ST, 1995, METHOD ENZYMOL, V256, P174; Duong LT, 2001, J BIOL CHEM, V276, P7484, DOI 10.1074/jbc.M008368200; Fukuoka M, 2001, J CELL BIOL, V152, P471, DOI 10.1083/jcb.152.3.471; Glogauer M, 2000, J CELL BIOL, V150, P785, DOI 10.1083/jcb.150.4.785; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Huang M, 1999, CURR BIOL, V9, P979, DOI 10.1016/S0960-9822(99)80428-X; Huang YA, 1999, MOL CELL BIOCHEM, V197, P195, DOI 10.1023/A:1006930706311; Hufner K, 2002, FEBS LETT, V514, P168, DOI 10.1016/S0014-5793(02)02358-X; Hurst IR, 2004, J BONE MINER RES, V19, P499, DOI 10.1359/JBMR.0301238; Insall RH, 2004, CELL, V118, P140, DOI 10.1016/j.cell.2004.07.005; JACKSON TR, 1992, J BIOL CHEM, V267, P16627; Janmey PA, 1998, CHEM BIOL, V5, pR81, DOI 10.1016/S1074-5521(98)90631-7; JANMEY PA, 1989, J BIOL CHEM, V264, P4825; Jones GE, 2002, INT J BIOCHEM CELL B, V34, P806, DOI 10.1016/S1357-2725(01)00162-5; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kurz T, 2004, J MOL CELL CARDIOL, V36, P225, DOI 10.1016/j.yjmcc.2003.11.008; Lakkakorpi PT, 2003, J BIOL CHEM, V278, P11502, DOI 10.1074/jbc.M206579200; Linder S, 2000, J IMMUNOL, V165, P221, DOI 10.4049/jimmunol.165.1.221; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Machesky LM, 1999, CURR OPIN CELL BIOL, V11, P117, DOI 10.1016/S0955-0674(99)80014-3; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003; NAKAMURA I, 1995, FEBS LETT, V361, P79, DOI 10.1016/0014-5793(95)00153-Z; Nakamura I, 1996, J BONE MINER RES, V11, P1873; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; Peterson JR, 2004, NAT STRUCT MOL BIOL, V11, P747, DOI 10.1038/nsmb796; Pfaff M, 2001, J CELL SCI, V114, P2775; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Sechi AS, 2000, J CELL SCI, V113, P3685; Takenawa T, 2001, J CELL SCI, V114, P1801; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Violette SM, 2000, CHEM BIOL, V7, P225, DOI 10.1016/S1074-5521(00)00090-9; Vocero-Akbani A, 2001, METHOD ENZYMOL, V332, P36; Wang Q, 2003, J CELL BIOL, V160, P565, DOI 10.1083/jcb.200207036; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; Yonemura S, 2002, J CELL SCI, V115, P2569; ZHANG J, 1993, J BIOL CHEM, V268, P22251; Zhang Z, 2002, BONE, V31, P359, DOI 10.1016/S8756-3282(02)00834-7; Zigmond SH, 2000, J CELL BIOL, V150, pF117, DOI 10.1083/jcb.150.6.F117; Zigmond SH, 1997, J CELL BIOL, V138, P363, DOI 10.1083/jcb.138.2.363	77	53	54	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32930	32943		10.1074/jbc.M500154200	http://dx.doi.org/10.1074/jbc.M500154200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16006560	hybrid			2022-12-27	WOS:000231920300048
J	Mandal, AK; Ray, R; Zhang, ZJ; Chowdhury, B; Pattabiraman, N; Mukherjee, AB				Mandal, AK; Ray, R; Zhang, ZJ; Chowdhury, B; Pattabiraman, N; Mukherjee, AB			Uteroglobin inhibits prostaglandin F-2 alpha receptor-mediated expression of genes critical for the production of pro-inflammatory lipid mediators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RECOMBINANT HUMAN UTEROGLOBIN; CYTOSOLIC PHOSPHOLIPASE A(2); ENDOPEROXIDE-H SYNTHASE-1; INVITRO CHARACTERIZATION; PROSTANOID RECEPTOR; HUMAN MYOMETRIUM; BINDING-PROTEIN; AMNIOTIC-FLUID; NUCLEAR-FACTOR	Prematurity is one of the leading causes of infant mortality. It may result from intrauterine infection, which mediates premature labor by stimulating the production of inflammatory lipid mediators such as prostaglandin F-2 alpha (PGF2(alpha)). The biological effects of PGF(2 alpha) are mediated via the G protein-coupled receptor FP; however, the molecular mechanism(s) of FP signaling that mediates inflammatory lipid mediator production remains unclear. We reported previously that in the human uterus, a composite organ in which fibroblast, epithelial, and smooth muscle cells are the major constituents, an inverse relationship exists between the levels of PGF(2 alpha) and a steroid-inducible anti-inflammatory protein, uteroglobin. Here we report that, in NIH 3T3 fibroblasts and human uterine smooth muscle cells, FP signaling is mediated via multi-kinase pathways in a cell type-specific manner to activate NF-kappa B, thus stimulating the expression of cyclooxygenase-2. Cyclooxygenase-2 is a critical enzyme for the production of prostaglandins from arachidonic acid, which is released from membrane phospholipids by phospholipase A(2), the expression of which is also stimulated by PGF(2 alpha). Most importantly, uteroglobin inhibits FP-mediated NF-kappa B activation and cyclooxygenase- 2 gene expression by binding and most likely by sequestering PGF(2 alpha) into its central hydrophobic cavity, thereby preventing FP-PGF(2 alpha) interaction and suppressing the production of inflammatory lipid mediators. We propose that uteroglobin plays important roles in maintaining homeostasis in organs that are vulnerable to inadvertent stimulation of FP-mediated inflammatory response.	NICHD, Sect Dev Genet, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA; Georgetown Univ, Vincent T Lombardi Canc Res Ctr, Dept Oncol, Washington, DC 20057 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Georgetown University	Mukherjee, AB (corresponding author), NICHD, Sect Dev Genet, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA.	mukherja@exchange.nih.gov						BEATO M, 1976, J STEROID BIOCHEM, V7, P327, DOI 10.1016/0022-4731(76)90091-1; CSEPLI J, 1975, PROSTAGLANDINS, V10, P689, DOI 10.1016/S0090-6980(75)80017-7; DAcquisto F, 1997, FEBS LETT, V418, P175, DOI 10.1016/S0014-5793(97)01377-X; DEASUA LJ, 1977, NATURE, V265, P450, DOI 10.1038/265450a0; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Fujino H, 2003, EUR J PHARMACOL, V465, P39, DOI 10.1016/S0014-2999(03)01485-7; GOLDBERG VJ, 1975, PHYSIOL REV, V55, P325, DOI 10.1152/physrev.1975.55.3.325; GU W, 1990, PROSTAG LEUKOTR ESS, V40, P27, DOI 10.1016/0952-3278(90)90112-X; HARD T, 1995, NAT STRUCT BIOL, V2, P983, DOI 10.1038/nsb1195-983; Hewetson A, 1997, MOL CELL ENDOCRINOL, V136, P1, DOI 10.1016/S0303-7207(97)00203-7; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; KEIRSE MJNC, 1977, BRIT J OBSTET GYNAEC, V84, P743, DOI 10.1111/j.1471-0528.1977.tb12484.x; KIKUKAWA T, 1988, J CLIN ENDOCR METAB, V67, P315, DOI 10.1210/jcem-67-2-315; KLUG J, 2000, ANN NY ACAD SCI, V923, P349; KRISHNAN RS, 1967, SCIENCE, V158, P490, DOI 10.1126/science.158.3800.490; Kundu GC, 1996, P NATL ACAD SCI USA, V93, P2915, DOI 10.1073/pnas.93.7.2915; Kundu GC, 1998, J BIOL CHEM, V273, P22819, DOI 10.1074/jbc.273.35.22819; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; MANTILE G, 1993, J BIOL CHEM, V268, P20343; McCracken J A, 1973, Adv Biosci, V9, P599; MIELE L, 1990, J BIOL CHEM, V265, P6427; MIELE L, 1988, NATURE, V335, P726, DOI 10.1038/335726a0; MINAMI T, 1992, PAIN, V50, P223, DOI 10.1016/0304-3959(92)90166-9; MONCADA S, 1985, PHARMACOL BASIS THER, V7, P660; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Mukherjee AB, 1999, CELL MOL LIFE SCI, V55, P771, DOI 10.1007/s000180050331; Murakami M, 2003, ADV EXP MED BIOL, V525, P87; NAKAO A, 1993, J CELL PHYSIOL, V155, P257, DOI 10.1002/jcp.1041550206; NORDLUNDMOLLER L, 1990, J BIOL CHEM, V265, P12690; Norman RJ, 2004, FERTIL STERIL, V81, P493, DOI 10.1016/j.fertnstert.2003.10.016; Pattabiraman N, 2000, ANN NY ACAD SCI, V923, P113; PERI A, 1995, J CLIN INVEST, V96, P343, DOI 10.1172/JCI118040; POYSER NL, 1995, PROSTAG LEUKOTR ESS, V53, P147, DOI 10.1016/0952-3278(95)90115-9; QUARLES LD, 1993, ENDOCRINOLOGY, V132, P1505, DOI 10.1210/en.132.4.1505; Rice GE, 1998, PLACENTA, V19, P13, DOI 10.1016/S0143-4004(98)90093-5; ROMERO R, 1987, AM J OBSTET GYNECOL, V157, P1461, DOI 10.1016/S0002-9378(87)80245-4; Romero Roberto, 2002, Semin Neonatol, V7, P259, DOI 10.1053/siny.2002.0121; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sapirstein A, 1996, J BIOL CHEM, V271, P21505, DOI 10.1074/jbc.271.35.21505; SCHLAFF S, 1983, PROSTAGLANDINS, V26, P111, DOI 10.1016/0090-6980(83)90079-5; SENIOR J, 1993, BRIT J PHARMACOL, V108, P501, DOI 10.1111/j.1476-5381.1993.tb12832.x; SENIOR J, 1992, BRIT J PHARMACOL, V107, P215, DOI 10.1111/j.1476-5381.1992.tb14489.x; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; Soloff MS., 1989, BIOL UTERUS, P559; Sontag E, 1997, EMBO J, V16, P5662, DOI 10.1093/emboj/16.18.5662; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; Tsuboi K, 2000, ENDOCRINOLOGY, V141, P315, DOI 10.1210/en.141.1.315; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Vielhauer GA, 2004, ARCH BIOCHEM BIOPHYS, V421, P175, DOI 10.1016/j.abb.2003.10.021; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Watanabe T, 1996, J CELL PHYSIOL, V169, P401, DOI 10.1002/(SICI)1097-4652(199611)169:2<401::AID-JCP20>3.0.CO;2-A; WEINGES K, 1984, LIEBIGS ANN CHEM, P761; Wu KK, 2005, PROSTAG LEUKOTR ESS, V72, P89, DOI 10.1016/j.plefa.2004.11.001; Wu WX, 2004, ENDOCRINOLOGY, V145, P1444, DOI 10.1210/en.2003-1142; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315	58	15	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32897	32904		10.1074/jbc.M502375200	http://dx.doi.org/10.1074/jbc.M502375200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16061484	hybrid			2022-12-27	WOS:000231920300044
J	Marwaha, V; Chen, YH; Helms, E; Arad, S; Inoue, H; Bord, E; Kishore, R; Sarkissian, RD; Gilchrest, BA; Goukassian, DA				Marwaha, V; Chen, YH; Helms, E; Arad, S; Inoue, H; Bord, E; Kishore, R; Sarkissian, RD; Gilchrest, BA; Goukassian, DA			T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NF kappa B-dependent repression of the COX-2 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYCLOOXYGENASE-2 GENE-EXPRESSION; NITRIC-OXIDE SYNTHASE-2; BASAL-CELL CARCINOMAS; INDUCED SKIN TUMORS; NUCLEAR-FACTOR; DNA-DAMAGE; THYMIDINE DINUCLEOTIDES; WILD-TYPE; ENDOTHELIAL-CELLS; MOUSE SKIN	Chronically irradiated murine skin and UV light-induced squamous cell carcinomas overexpress the inducible isoform of cyclooxygenase (COX-2), and COX-2 inhibition reduces photocarcinogenesis in mice. We have reported previously that DNA oligonucleotides substantially homologous to the telomere 3'-overhang (T-oligos) induce DNA repair capacity and multiple other cancer prevention responses, in part through up-regulation and activation of p53. To determine whether T-oligos affect COX-2 expression, human newborn keratinocytes and fibroblasts were pretreated with T-oligos or diluent alone for 24 h, UV-irradiated, and processed for Western blotting. In both cell types, T-oligos transcriptionally down-regulated base-line and UV light-induced COX2 expression, coincident with p53 activation. In fibroblasts with wild type versus dominant negative p53 (p53(WT) versus p53(DN)), T-oligos decreased constitutive expression of a COX-2 reporter plasmid by>50%. Wethen examined NF kappa B, a known positive regulator of COX-2 transcription. In p53WT but not in p53DN fibroblasts and in human keratinocytes, T-oligos decreased readout of an NF kappa B promoter driven reporter plasmid and decreased NF kappa B binding to DNA. After T-oligo treatment and subsequent UV irradiation, binding of the transcriptional co-activator protein p300 to NF kappa B was decreased, whereas binding of p300 to p53 was increased. Human skin explants provided with T-oligos had markedly decreased COX-2 immunostaining both at base-line and post-UV light, coincident with increased p53 immunostaining. We conclude that T-oligos transcriptionally down-regulate COX-2 expression in human skin via activation and up-regulation of p53, at least in part by inhibiting NF kappa B transcriptional activation. Decreased COX-2 expression may contribute to the observed ability of T-oligos to reduce photocarcinogenesis.	Boston Univ, Sch Med, Dept Dermatol, Boston, MA 02118 USA; Boston Univ, Sch Med, Div Facial Plast & Reconstruct Surg, Boston, MA 02118 USA; Nara Womens Univ, Nara 6308506, Japan; St Elizabeths Med Ctr, Div Cardiovasc Res, Boston, MA 02135 USA	Boston University; Boston University; Nara Womens University; St. Elizabeth's Medical Center	Gilchrest, BA (corresponding author), Boston Univ, Sch Med, Dept Dermatol, 609 Albany St, Boston, MA 02118 USA.	bgilchre@bu.edu; dgoukass@bu.edu		Goukassian, David/0000-0001-5270-5270	NATIONAL CANCER INSTITUTE [R01CA105156] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGOFF SN, 1993, SCIENCE, V259, P84, DOI 10.1126/science.8418500; Ahmed S, 2002, FREE RADICAL BIO MED, V33, P1097, DOI 10.1016/S0891-5849(02)01004-3; Albert MR, 2003, CA-CANCER J CLIN, V53, P292, DOI 10.3322/canjclin.53.5.292; An KP, 2002, PHOTOCHEM PHOTOBIOL, V76, P73, DOI 10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2; Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Athar M, 2001, BIOCHEM BIOPH RES CO, V280, P1042, DOI 10.1006/bbrc.2000.4201; Aubin F, 2003, EUR J DERMATOL, V13, P515; Bielenberg DR, 1998, J INVEST DERMATOL, V111, P864, DOI 10.1046/j.1523-1747.1998.00378.x; Brash DE, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P136; Brash DE, 1998, CANCER SURV, V32, P69; Brecher Alexandra R, 2002, J Drugs Dermatol, V1, P44; Buckman SY, 1998, CARCINOGENESIS, V19, P723, DOI 10.1093/carcin/19.5.723; Caba E, 2004, ACTA NEUROPATHOL, V108, P173, DOI 10.1007/s00401-004-0876-5; Campbell KJ, 2001, BIOCHEM SOC T, V29, P688; Castelao JE, 2003, ANN THORAC SURG, V76, P1327, DOI 10.1016/S0003-4975(03)00334-5; CERUTTI PA, 1991, CANCER CELL-MON REV, V3, P1; Chen WX, 2001, ONCOGENE, V20, P3921, DOI 10.1038/sj.onc.1204530; Cruz PD, 2000, J INVEST DERMATOL, V114, P253, DOI 10.1046/j.1523-1747.2000.00866.x; Culmsee C, 2003, J NEUROSCI, V23, P8586; Curiel-Lewandrowski C, 2003, EXP DERMATOL, V12, P145, DOI 10.1034/j.1600-0625.2003.120204.x; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3; Dormond O, 2001, NAT MED, V7, P1041, DOI 10.1038/nm0901-1041; Eller MS, 2003, FASEB J, V17, P152, DOI 10.1096/fj.02-0197com; Eller MS, 2002, EXP CELL RES, V276, P185, DOI 10.1006/excr.2002.5531; ELLER MS, 1994, NATURE, V372, P413, DOI 10.1038/372413a0; Eller MS, 1996, P NATL ACAD SCI USA, V93, P1087, DOI 10.1073/pnas.93.3.1087; Eller MS, 1997, P NATL ACAD SCI USA, V94, P12627, DOI 10.1073/pnas.94.23.12627; Ferrandez A, 2003, CURR PHARM DESIGN, V9, P2229, DOI 10.2174/1381612033454036; Fischer SM, 1999, MOL CARCINOGEN, V25, P231; Fischer SM, 2003, CARCINOGENESIS, V24, P945, DOI 10.1093/carcin/bgg046; Fischer Susan M., 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P183; Fosslien E, 2001, ANN CLIN LAB SCI, V31, P325; FURSTENBERGER G, 1989, CARCINOGENESIS, V10, P91, DOI 10.1093/carcin/10.1.91; Gallo O, 2003, AM J PATHOL, V163, P723, DOI 10.1016/S0002-9440(10)63699-1; Gately S, 2004, SEMIN ONCOL, V31, P2, DOI 10.1053/j.seminoncol.2004.03.040; Geller AC, 2003, J AM ACAD DERMATOL, V48, P34, DOI 10.1067/mjd.2003.9; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; GILCHREST BA, 1993, J INVEST DERMATOL, V101, P666, DOI 10.1111/1523-1747.ep12371673; GILES G, 1996, CANC FORUM, V20, P188; GINSBERG D, 1991, P NATL ACAD SCI USA, V88, P9979, DOI 10.1073/pnas.88.22.9979; Goukassian DA, 1999, J INVEST DERMATOL, V112, P25, DOI 10.1046/j.1523-1747.1999.00468.x; Goukassian DA, 2004, P NATL ACAD SCI USA, V101, P3933, DOI 10.1073/pnas.0306389101; Goukassian DA, 2002, FASEB J, V16, P754, DOI 10.1096/fj.01-0829fje; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hadshiew IM, 2001, J DERMATOL SCI, V25, P127, DOI 10.1016/S0923-1811(00)00125-0; HALL PA, 1993, ONCOGENE, V8, P203; Han JA, 2002, EMBO J, V21, P5635, DOI 10.1093/emboj/cdf591; Han SJ, 2002, J BIOL CHEM, V277, P44715, DOI 10.1074/jbc.M202524200; Howe LR, 2001, ENDOCR-RELAT CANCER, V8, P97, DOI 10.1677/erc.0.0080097; HRUZA LL, 1993, J INVEST DERMATOL, V100, pS35, DOI 10.1111/1523-1747.ep12355240; Huang J, 2004, J BIOL CHEM, V279, P16847, DOI 10.1074/jbc.M309491200; Ikeda A, 2000, BIOCHEM BIOPH RES CO, V272, P375, DOI 10.1006/bbrc.2000.2786; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; Inoue H, 2002, ARTERIOSCL THROM VAS, V22, P1415, DOI 10.1161/01.ATV.0000028816.13582.13; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kishore R, 2003, CIRC RES, V93, P932, DOI 10.1161/01.RES.0000102400.22370.20; Kishore R, 2002, CIRC RES, V91, P307, DOI 10.1161/01.RES.0000031744.06353.D3; KLEY N, 1992, NUCLEIC ACIDS RES, V20, P4083, DOI 10.1093/nar/20.15.4083; Koki Alane T, 2002, Cancer Control, V9, P28; Kopnin BP, 2000, BIOCHEMISTRY-MOSCOW+, V65, P2; Kulkarni S, 2001, CLIN CANCER RES, V7, P429; Kundu M, 1997, J BIOL CHEM, V272, P29468, DOI 10.1074/jbc.272.47.29468; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; LAVKER RM, 1995, J AM ACAD DERMATOL, V32, P53, DOI 10.1016/0190-9622(95)90184-1; Li GZ, 2004, EXP CELL RES, V301, P189, DOI 10.1016/j.yexcr.2004.08.019; Li GZ, 2003, P NATL ACAD SCI USA, V100, P527, DOI 10.1073/pnas.0235444100; MACK DH, 1993, NATURE, V363, P281, DOI 10.1038/363281a0; Maeda T, 1999, MUTAT RES-DNA REPAIR, V433, P137, DOI 10.1016/S0921-8777(98)00071-8; MARGULIES L, 1993, J BIOL CHEM, V268, P15096; Marnett LJ, 2002, ANNU REV PHARMACOL, V42, P55, DOI 10.1146/annurev.pharmtox.42.082301.164620; McCormick Frank, 1999, Trends in Cell Biology, V9, pM53, DOI 10.1016/S0962-8924(99)01668-2; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; MIYASHITA T, 1994, CANCER RES, V54, P3131; Muller-Decker K, 2002, P NATL ACAD SCI USA, V99, P12483, DOI 10.1073/pnas.192323799; Orengo IF, 2002, ARCH DERMATOL, V138, P751, DOI 10.1001/archderm.138.6.751; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Osada H, 2002, ONCOGENE, V21, P7421, DOI 10.1038/sj.onc.1205802; Ospina JA, 2004, AM J PHYSIOL-HEART C, V286, pH2010, DOI 10.1152/ajpheart.00481.2003; Parente L, 2003, BIOCHEM PHARMACOL, V65, P153, DOI 10.1016/S0006-2952(02)01422-3; PATRICK MH, 1977, PHOTOCHEM PHOTOBIOL, V25, P357, DOI 10.1111/j.1751-1097.1977.tb07355.x; Pedeux R, 1998, J INVEST DERMATOL, V111, P472, DOI 10.1046/j.1523-1747.1998.00324.x; Pentland AP, 1999, CARCINOGENESIS, V20, P1939, DOI 10.1093/carcin/20.10.1939; Pentland AP, 2004, CANCER RES, V64, P5587, DOI 10.1158/0008-5472.CAN-04-1045; Pentland AP, 2002, ARCH DERMATOL, V138, P823, DOI 10.1001/archderm.138.6.823; Perfettini JL, 2004, J EXP MED, V199, P629, DOI 10.1084/jem.20031216; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Puri N, 2004, FASEB J, V18, P1373, DOI 10.1096/fj.04-1774com; RAGIMOV N, 1993, ONCOGENE, V8, P1183; Ramsay RG, 2003, INT J IMMUNOPATH PH, V16, P59; Ravi R, 1998, CANCER RES, V58, P4531; Remenyik E, 2003, ONCOGENE, V22, P6369, DOI 10.1038/sj.onc.1206657; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Rodel F, 2004, INT J RADIAT BIOL, V80, P115, DOI 10.1080/09553000310001654701; Sachs DL, 2001, CLIN GERIATR MED, V17, P715, DOI 10.1016/S0749-0690(05)70095-1; SANTHANAM U, 1991, P NATL ACAD SCI USA, V88, P7605, DOI 10.1073/pnas.88.17.7605; Schwarz T, 2002, PHOTODERMATOL PHOTO, V18, P141, DOI 10.1034/j.1600-0781.2002.180307.x; Scotto J, 1987, CANCER INVEST, V5, P275; Seo JY, 2003, MECH AGEING DEV, V124, P903, DOI 10.1016/S0047-6374(03)00150-7; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Shiota G, 1999, HEPATO-GASTROENTEROL, V46, P407; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Stansel RM, 2001, EMBO J, V20, P5532; STERENBORG HJCM, 1986, PHOTODERMATOLOGY, V3, P206; Subbaramaiah K, 1999, J BIOL CHEM, V274, P10911, DOI 10.1074/jbc.274.16.10911; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; TUBO RA, 1987, ONCOGENE RES, V1, P407; Tucker ON, 1999, CANCER RES, V59, P987; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; VANDERVEEN EE, 1986, ARCH DERMATOL, V122, P407, DOI 10.1001/archderm.122.4.407; Wang QJ, 1998, CANCER RES, V58, P5762; Webster GA, 1999, MOL CELL BIOL, V19, P3485; WERNINGHAUS K, 1991, PHOTODERMATOL PHOTO, V8, P236; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; Yoshimura R, 2000, CANCER-AM CANCER SOC, V89, P589, DOI 10.1002/1097-0142(20000801)89:3<589::AID-CNCR14>3.0.CO;2-C; Zhang WG, 2001, P NATL ACAD SCI USA, V98, P13948, DOI 10.1073/pnas.241353198; Zoumpourlis V, 2003, CARCINOGENESIS, V24, P1159, DOI 10.1093/carcin/bgg067	118	29	33	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32379	32388		10.1074/jbc.M503245200	http://dx.doi.org/10.1074/jbc.M503245200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16046401	hybrid			2022-12-27	WOS:000231794800043
J	van den Heuvel, RHH; Tahallah, N; Kamerbeek, NM; Fraaije, MW; van Berkel, WJH; Janssen, DB; Heck, AJR				van den Heuvel, RHH; Tahallah, N; Kamerbeek, NM; Fraaije, MW; van Berkel, WJH; Janssen, DB; Heck, AJR			Coenzyme binding during catalysis is beneficial for the stability of 4-hydroxyacetophenone monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BAEYER-VILLIGER MONOOXYGENASES; IONIZATION MASS-SPECTROMETRY; VANILLYL-ALCOHOL OXIDASE; ELECTROSPRAY-IONIZATION; ESCHERICHIA-COLI; METHYLENETETRAHYDROFOLATE REDUCTASE; CYCLOHEXANONE MONOOXYGENASE; SYNTHETIC APPLICATIONS; PROTEIN COMPLEXES; SPECIFICITY	The NADPH-dependent dimeric flavoenzyme 4-hydroxyacetophenone monooxygenase ( HAPMO) catalyzes Baeyer-Villiger oxidations of a wide range of ketones, thereby generating esters or lactones. In the current work, we probed HAPMO-coenzyme complexes present during the enzyme catalytic cycle with the aim to gain mechanistic insight. Moreover, we investigated the structural role of the nicotinamide coenzyme. For these studies, we used (i) wild type HAPMO, (ii) the R339A variant, which is active but has a low affinity toward NADPH, and (iii) the R440A variant, which is inactive but has a high affinity toward NADPH. Electrospray ionization mass spectrometry was used as the primary tool to directly observe noncovalent protein-coenzyme complexes in real time. These analyzes showed for the first time that the nicotinamide coenzyme remains bound to HAPMO during the entire catalytic cycle of the NADPH oxidase reaction. This may also have implications for other homologous Baeyer-Villiger monooxygenases. Together with the observations that NADP(+) only weakly interacts with oxidized enzyme and that HAPMO is mainly in the reduced form during catalysis, we concluded that NADP(+) interacts tightly with the reduced form of HAPMO. We also demonstrated that the association with the coenzyme is crucial for enzyme stability. The interaction with the coenzyme analog 3-aminopyridine adenine dinucleotide phosphate ( AADP(+)) strongly enhanced the thermal stability of wild type HAPMO. This coenzyme-induced stabilization may also be important for related enzymes.	Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Biomol Mass Spect, NL-3584 CA Utrecht, Netherlands; Univ Utrecht, Inst Pharmaceut Sci, NL-3584 CA Utrecht, Netherlands; Univ Groningen, Biomol Sci & Biotechnol Inst, Biochem Lab, NL-9747 AG Groningen, Netherlands; Univ Wageningen & Res Ctr, Biochem Lab, NL-6703 HA Wageningen, Netherlands	Utrecht University; Utrecht University; University of Groningen; Wageningen University & Research	van den Heuvel, RHH (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Biomol Mass Spect, Sorbonnelaan 16, NL-3584 CA Utrecht, Netherlands.	r.h.h.vandenheuvel@chem.uu.nl	van Berkel, Willem J.H./O-2431-2014; Fraaije, Marco/E-8421-2014; Heck, Albert/D-7098-2011	van Berkel, Willem J.H./0000-0002-6551-2782; Heck, Albert/0000-0002-2405-4404; Fraaije, Marco/0000-0001-6346-5014				Alphand V, 2003, TRENDS BIOTECHNOL, V21, P318, DOI 10.1016/S0167-7799(03)00144-6; Bollen YJM, 2005, J BIOL CHEM, V280, P7836, DOI 10.1074/jbc.M412871200; Bossi RT, 2002, BIOCHEMISTRY-US, V41, P8807, DOI 10.1021/bi025858a; Cattani L, 1994, Boll Soc Ital Biol Sper, V70, P75; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Fraaije MW, 2002, FEBS LETT, V518, P43, DOI 10.1016/S0014-5793(02)02623-6; Fraaije MW, 2000, J BIOL CHEM, V275, P38654, DOI 10.1074/jbc.M004753200; Georlette D, 2003, J BIOL CHEM, V278, P49945, DOI 10.1074/jbc.M307761200; Grandori R, 2002, J MASS SPECTROM, V37, P191, DOI 10.1002/jms.272; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; Heck AJR, 2004, MASS SPECTROM REV, V23, P368, DOI 10.1002/mas.10081; Hefti MH, 2003, EUR J BIOCHEM, V270, P4227, DOI 10.1046/j.1432-1033.2003.03802.x; Kamerbeek NM, 2004, EUR J BIOCHEM, V271, P2107, DOI 10.1111/j.1432-1033.2004.04126.x; Kamerbeek NM, 2003, APPL ENVIRON MICROB, V69, P419, DOI 10.1128/AEM.69.1.419-426.2003; Kamerbeek NM, 2001, EUR J BIOCHEM, V268, P2547, DOI 10.1046/j.1432-1327.2001.02137.x; KAMERGBEEK NM, 2002, FLAVINS FLAVOPROTEIN, P1005; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101; Mihovilovic MD, 2003, BIOORG MED CHEM LETT, V13, P1479, DOI 10.1016/S0960-894X(03)00137-9; Mulrooney SB, 1997, PROTEIN SCI, V6, P2188; Pai EF, 1991, CURR OPIN STRUC BIOL, V1, P796, DOI 10.1016/0959-440X(91)90181-R; Park IK, 1998, INT J BIOCHEM CELL B, V30, P1223, DOI 10.1016/S1357-2725(98)00088-0; PELLETIER JN, 1994, BIOCHEMISTRY-US, V33, P1900, DOI 10.1021/bi00173a037; POULSEN LL, 1995, CHEM-BIOL INTERACT, V96, P57, DOI 10.1016/0009-2797(94)03583-T; POULSEN LL, 1979, J BIOL CHEM, V254, P6449; Schmidt A, 2001, ANAL CHEM, V73, P6040, DOI 10.1021/ac010451h; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; SHRAKE A, 1990, J BIOL CHEM, V265, P5055; Sulzenbacher G, 2004, J MOL BIOL, V342, P489, DOI 10.1016/j.jmb.2004.07.034; Tahallah N, 2002, J BIOL CHEM, V277, P36425, DOI 10.1074/jbc.M205841200; Tahallah N, 2001, RAPID COMMUN MASS SP, V15, P596, DOI 10.1002/rcm.275; van den Bremer ETJ, 2002, PROTEIN SCI, V11, P1738, DOI 10.1110/ps.0200502; VANBERKEL WJH, 1991, EUR J BIOCHEM, V197, P769; WIERENGA RK, 1983, J MOL BIOL, V167, P725, DOI 10.1016/S0022-2836(83)80106-5; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Willetts A, 1997, TRENDS BIOTECHNOL, V15, P55, DOI 10.1016/S0167-7799(97)84204-7; Woodyer R, 2003, BIOCHEMISTRY-US, V42, P11604, DOI 10.1021/bi035018b; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998; Zambianchi F, 2002, BIOTECHNOL BIOENG, V78, P489, DOI 10.1002/bit.10207	39	23	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32115	32121		10.1074/jbc.M503758200	http://dx.doi.org/10.1074/jbc.M503758200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16049018	hybrid, Green Published			2022-12-27	WOS:000231794800011
J	Jacob, C; Yang, PC; Darmoul, D; Amadesi, S; Saito, T; Cottrell, GS; Coelho, AM; Singh, P; Grady, EF; Perdue, M; Bunnett, NW				Jacob, C; Yang, PC; Darmoul, D; Amadesi, S; Saito, T; Cottrell, GS; Coelho, AM; Singh, P; Grady, EF; Perdue, M; Bunnett, NW			Mast cell tryptase controls paracellular permeability of the intestine - Role of protease-activated receptor 2 and beta-arrestins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL BARRIER FUNCTION; ACTIVATED RECEPTOR 2; TIGHT JUNCTION; DEPENDENT ENDOCYTOSIS; MOLECULAR-CLONING; INFLAMMATION; EXPRESSION; PROTEINASES; INHIBITORS; TRANSPORT	Tight junctions between intestinal epithelial cells prevent ingress of luminal macromolecules and bacteria and protect against inflammation and infection. During stress and inflammation, mast cells mediate increased mucosal permeability by unknown mechanisms. We hypothesized that mast cell tryptase cleaves protease-activated receptor 2 (PAR2) on colonocytes to increase paracellular permeability. Colonocytes expressed PAR(2) mRNA and responded to PAR(2) agonists with increased [Ca2+](i). Supernatant from degranulated mast cells increased [Ca2+](i) in colonocytes, which was prevented by a tryptase inhibitor, and desensitized responses to PAR2 agonist, suggesting PAR2 cleavage. When applied to the basolateral surface of colonocytes, PAR2 agonists and mast cell supernatant decreased transepithelial resistance, increased transepithelial flux of macromolecules, and induced redistribution of tight junction ZO-1 and occludin and perijunctional F-actin. When mast cells were co-cultured with colonocytes, mast cell degranulation increased paracellular permeability of colonocytes. This was prevented by a tryptase inhibitor. We determined the role of ERK1/2 and of beta-arrestins, which recruit ERK1/2 to PAR2 in endosomes and retain ERK1/2 in the cytosol, on PAR2-mediated alterations in permeability. An ERK1/2 inhibitor abolished the effects of PAR2 agonist on permeability and redistribution of F-actin. Downregulation of beta-arrestins with small interfering RNA inhibited PAR2-induced activation of ERK1/2 and suppressed PAR2-induced changes in permeability. Thus, mast cells signal to colonocytes in a paracrine manner by release of tryptase and activation of PAR2. PAR2 couples to beta-arrestin-dependent activation of ERK1/2, which regulates reorganization of perijunctional F-actin to increase epithelial permeability. These mechanisms may explain the increased epithelial permeability of the intestine during stress and inflammation.	Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; McMaster Univ, Intestinal Dis Res Program, Hamilton, ON L8S 4L8, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; McMaster University	Bunnett, NW (corresponding author), Univ Calif San Francisco, Dept Surg, 521 Parnassus Ave, San Francisco, CA 94143 USA.	nigelb@itsa.ucsf.edu	Darmoul, Dalila/M-5812-2018; Yang, Ping-Chang/K-4669-2019; Jacob, Claire/C-1485-2012	Darmoul, Dalila/0000-0002-1206-0655; Jacob, Claire/0000-0001-9567-3950; Bunnett, Nigel W./0000-0003-3367-0644; Cottrell, Graeme/0000-0001-9098-7627	NIDDK NIH HHS [DK39957, DK43207, DK57840, DK52388] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039957, R01DK052388, R56DK043207, R37DK039957, R01DK057840, R01DK043207] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berin MC, 1999, AM J PHYSIOL-CELL PH, V276, pC1046, DOI 10.1152/ajpcell.1999.276.5.C1046; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Bohm SK, 1996, BIOCHEM J, V314, P1009; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Bustos D, 1998, MEDICINA-BUENOS AIRE, V58, P262; BUTTERFIELD JH, 1990, J LEUKOCYTE BIOL, V47, P409, DOI 10.1002/jlb.47.5.409; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; CAUGHEY GH, 1993, J PHARMACOL EXP THER, V264, P676; Cenac N, 2004, J PHYSIOL-LONDON, V558, P913, DOI 10.1113/jphysiol.2004.061721; Cenac N, 2003, J IMMUNOL, V170, P4296, DOI 10.4049/jimmunol.170.8.4296; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Chen ML, 2002, J BIOL CHEM, V277, P4247, DOI 10.1074/jbc.M109254200; Chin AC, 2003, P NATL ACAD SCI USA, V100, P11104, DOI 10.1073/pnas.1831452100; Corvera CU, 1999, J PHYSIOL-LONDON, V517, P741, DOI 10.1111/j.1469-7793.1999.0741s.x; Corvera CU, 1997, J CLIN INVEST, V100, P1383, DOI 10.1172/JCI119658; Costanzo MJ, 2003, J MED CHEM, V46, P3865, DOI 10.1021/jm030050p; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; Cuffe JE, 2002, J PHYSIOL-LONDON, V539, P209, DOI 10.1113/jphysiol.2001.013159; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Green BT, 2000, J PHARMACOL EXP THER, V295, P410; Kjeldsen J, 1998, SCAND J GASTROENTERO, V33, P637, DOI 10.1080/00365529850171927; Kong WY, 1997, P NATL ACAD SCI USA, V94, P8884, DOI 10.1073/pnas.94.16.8884; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; MAY GR, 1993, GASTROENTEROLOGY, V104, P1627, DOI 10.1016/0016-5085(93)90638-S; McDermott JR, 2003, P NATL ACAD SCI USA, V100, P7761, DOI 10.1073/pnas.1231488100; Miller HRP, 2002, IMMUNOLOGY, V105, P375, DOI 10.1046/j.1365-2567.2002.01375.x; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Mule F, 2004, GUT, V53, P229, DOI 10.1136/gut.2003.021899; Nguyen C, 2003, CAN J PHYSIOL PHARM, V81, P920, DOI 10.1139/Y03-080; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; PLAYFORD RJ, 1995, AM J PATHOL, V146, P310; Santos J, 1999, GUT, V45, P553, DOI 10.1136/gut.45.4.553; Santos J, 2001, GUT, V48, P630, DOI 10.1136/gut.48.5.630; Schmitz H, 1999, GASTROENTEROLOGY, V116, P301, DOI 10.1016/S0016-5085(99)70126-5; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; SCUDAMORE CL, 1995, J EXP MED, V182, P1871, DOI 10.1084/jem.182.6.1871; Soderholm JD, 2002, GASTROENTEROLOGY, V123, P1099, DOI 10.1053/gast.2002.36019; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Tarlton JF, 2000, AM J PATHOL, V157, P1927, DOI 10.1016/S0002-9440(10)64831-6; Vergnolle N, 1998, P NATL ACAD SCI USA, V95, P7766, DOI 10.1073/pnas.95.13.7766; Wang Y, 2004, EXP EYE RES, V78, P125, DOI 10.1016/j.exer.2003.09.002; Yang PC, 1999, J IMMUNOL, V163, P2769; Youakim A, 1999, AM J PHYSIOL-GASTR L, V276, pG1279, DOI 10.1152/ajpgi.1999.276.5.G1279	48	244	256	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31936	31948		10.1074/jbc.M506338200	http://dx.doi.org/10.1074/jbc.M506338200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16027150	hybrid			2022-12-27	WOS:000231665200073
J	Murakami, T; Takagi, H; Suzuma, K; Suzuma, I; Ohashi, H; Watanabe, D; Ojima, T; Suganami, E; Kurimoto, M; Kaneto, H; Honda, Y; Yoshimura, N				Murakami, T; Takagi, H; Suzuma, K; Suzuma, I; Ohashi, H; Watanabe, D; Ojima, T; Suganami, E; Kurimoto, M; Kaneto, H; Honda, Y; Yoshimura, N			Angiopoietin-1 attenuates H2O2-induced SEK1/JNK phosphorylation through the phosphatidylinositol 3-kinase/Akt pathway in vascular endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; N-TERMINAL KINASE; OXIDATIVE STRESS; INDUCED APOPTOSIS; DIABETIC-RETINOPATHY; BLOOD-VESSELS; TIE2 RECEPTOR; GROWTH-FACTOR; SURVIVAL; JNK	Oxidative stress activates various signal transduction pathways, including Jun N-terminal kinase ( JNK) and its substrates, that induce apoptosis. We reported here the role of angiopoietin-1 ( Ang1), which is a prosurvival factor in endothelial cells, during endothelial cell damage induced by oxidative stress. Hydrogen peroxide ( H2O2) increased apoptosis of endothelial cells through JNK activation, whereas Ang1 inhibited H2O2-induced apoptosis and concomitant JNK phosphorylation. The inhibition of H2O2-induced JNK phosphorylation was reversed by inhibitors of phosphatidylinositol ( PI) 3-kinase and dominant-negative Akt, and constitutively active-Akt attenuated JNK phosphorylation without Ang1. These data suggested that Ang1-dependent Akt phosphorylation through PI 3-kinase leads to the inhibition of JNK phosphorylation. H2O2-induced phosphorylation of SAPK/Erk kinase ( SEK1) at Thr(261), which is an upstream regulator of JNK, was also attenuated by Ang1-dependent activation of the PI 3-kinase/Akt pathway. In addition, Ang1 induced SEK1 phosphorylation at Ser(80), suggesting the existence of an additional signal transduction pathway through which Ang1 attenuates JNK phosphorylation. These results demonstrated that Ang1 attenuates H2O2-induced SEK1/JNK phosphorylation through the PI 3-kinase/Akt pathway and inhibits the apoptosis of endothelial cells to oxidative stress.	Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan; Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Suita, Osaka 5650871, Japan	Kyoto University; Osaka University	Takagi, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	hitoshi@kuhp.kyoto-u.ac.jp		Murakami, Tomoaki/0000-0002-0314-8807				Audero E, 2004, J BIOL CHEM, V279, P13224, DOI 10.1074/jbc.M307456200; Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200; Cuda G, 2002, CIRCULATION, V105, P968, DOI 10.1161/hc0802.104324; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Dumont A, 1999, ONCOGENE, V18, P747, DOI 10.1038/sj.onc.1202325; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Harfouche R, 2003, FASEB J, V17, P1523, DOI 10.1096/fj.02-0698fje; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hojo Y, 2002, CIRC RES, V91, P712, DOI 10.1161/01.RES.0000037981.97541.25; Inoshita S, 2002, J BIOL CHEM, V277, P43730, DOI 10.1074/jbc.M207951200; Jones N, 1999, J BIOL CHEM, V274, P30896, DOI 10.1074/jbc.274.43.30896; Joussen AM, 2002, AM J PATHOL, V160, P1683, DOI 10.1016/S0002-9440(10)61115-7; Kaneto H, 2002, J BIOL CHEM, V277, P3680, DOI 10.1074/jbc.M109647200; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim AH, 2002, NEURON, V35, P697, DOI 10.1016/S0896-6273(02)00821-8; Kim I, 2000, CIRC RES, V86, P952, DOI 10.1161/01.RES.86.9.952; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; KING GL, 1985, J CLIN INVEST, V75, P1028, DOI 10.1172/JCI111764; Kishore R, 2003, CIRC RES, V93, P932, DOI 10.1161/01.RES.0000102400.22370.20; Kwak HJ, 1999, FEBS LETT, V448, P249, DOI 10.1016/S0014-5793(99)00378-6; Kwak HJ, 2000, CIRCULATION, V101, P2317, DOI 10.1161/01.CIR.101.19.2317; KYRIAKIS JM, 1990, J BIOL CHEM, V265, P17355; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; Master Z, 2001, EMBO J, V20, P5919, DOI 10.1093/emboj/20.21.5919; Minamino T, 1999, P NATL ACAD SCI USA, V96, P15127, DOI 10.1073/pnas.96.26.15127; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Nambu H, 2004, GENE THER, V11, P865, DOI 10.1038/sj.gt.3302230; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Ohashi H, 2004, MOL VIS, V10, P608; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Sudoh N, 2001, CIRCULATION, V103, P724; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; Tadros A, 2003, BLOOD, V102, P4407, DOI 10.1182/blood-2003-05-1602; Thurston G, 2003, CELL TISSUE RES, V314, P61, DOI 10.1007/s00441-003-0749-6; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Wang NP, 1999, CIRC RES, V85, P387, DOI 10.1161/01.RES.85.5.387; YAN MH, 1994, NATURE, V372, P798; Yoshizumi M, 2004, EXP CELL RES, V292, P1, DOI 10.1016/j.yexcr.2003.08.003	44	29	33	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31841	31849		10.1074/jbc.M503108200	http://dx.doi.org/10.1074/jbc.M503108200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16000309	hybrid, Green Submitted			2022-12-27	WOS:000231665200063
J	Nagano, S; Poulos, TL				Nagano, S; Poulos, TL			Crystallographic study on the dioxygen complex of wild-type and mutant cytochrome P450cam - Implications for the dioxygen activation mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-PUTIDA CYTOCHROME-P-450; CRYSTAL-STRUCTURE; AMINO-ACID; OXYGEN ACTIVATION; HYDROXYLATION; MUTAGENESIS; SEQUENCE; MUTATION; ENDOR; EPR	Two key amino acids, Thr(252) and Asp(251), are known to be important for dioxygen activation by cytochrome P450cam. We have solved crystal structures of a critical intermediate, the ferrous dioxygen complex (Fe(II)-O-2), of the wild-type P450cam and its mutants, D251N and T252A. The wild-type dioxygen complex structure is very much the same as reported previously (Schlichting, I., Berendzen, J., Chu, K., Stock, A. M., Maves, S. A., Benson, D. E., Sweet, R. M., Ringe, D., Petsko, G. A., and Sligar, S. G. ( 2000) Science 287, 1615 - 1622) with the exception of higher occupancy and a more ordered structure of the iron-linked dioxygen and two "catalytic" water molecules that form part of a proton relay system to the iron-linked dioxygen. Due to of the altered conformation of the I helix groove these two waters are missing in the D251N dioxygen complex which explains its lower catalytic activity and slower proton transfer to the dioxygen ligand. Similarly, the T252A mutation was expected to disrupt the active site solvent structure leading to hydrogen peroxide formation rather than substrate hydroxylation. Unexpectedly, however, the two "catalytic" waters are retained in the T252A mutant. Based on these findings, we propose that the Thr252 accepts a hydrogen bond from the hydroperoxy (Fe(III)-OOH) intermediate that promotes the second protonation on the distal oxygen atom, leading to O-O bond cleavage and compound I formation.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Chem & Struct Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Nagano, S (corresponding author), RIKEN, Harima Inst SPring 8, 1-1-1 Koto, Sayo, Hyogo 6795148, Japan.	snagano@riken.jp; poulos@uci.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033688] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33688] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Davydov R, 1999, J AM CHEM SOC, V121, P10654, DOI 10.1021/ja9918829; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; de Montellano PR Ortiz, 1995, CYTOCHROME P450 STRU; GERBER NC, 1994, J BIOL CHEM, V269, P4260; GERBER NC, 1992, J AM CHEM SOC, V114, P8742, DOI 10.1021/ja00048a081; Gunsalus I C, 1978, Methods Enzymol, V52, P166; HANIU M, 1982, J BIOL CHEM, V257, P2664; HARRIS D, 1993, J AM CHEM SOC, V115, P8775, DOI 10.1021/ja00072a034; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; INGRAHAM LL, 1985, BIOCH DIOXYGEN; ISHIMURA Y, 1971, BIOCHEM BIOPH RES CO, V42, P140, DOI 10.1016/0006-291X(71)90373-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KATAGIRI M, 1968, J BIOL CHEM, V243, P3543; KIMATA Y, 1995, BIOCHEM BIOPH RES CO, V208, P96, DOI 10.1006/bbrc.1995.1310; MARTINIS SA, 1989, J AM CHEM SOC, V111, P9252, DOI 10.1021/ja00208a031; Nagano S, 2005, J BIOL CHEM, V280, P22102, DOI 10.1074/jbc.M501732200; Nagano S, 2004, J BIOL CHEM, V279, P42844, DOI 10.1074/jbc.M404217200; OMURA T, 1962, J BIOL CHEM, V237, P1375; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POULOS TL, 1985, J BIOL CHEM, V260, P6122; RAAG R, 1991, BIOCHEMISTRY-US, V30, P11420, DOI 10.1021/bi00112a008; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; SHIMADA H, 1991, INT S OXYGENASES OXY, P133; UNGER BP, 1986, J BIOL CHEM, V261, P1158; Vidakovic M, 1998, BIOCHEMISTRY-US, V37, P9211, DOI 10.1021/bi980189f	26	176	177	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31659	31663		10.1074/jbc.M505261200	http://dx.doi.org/10.1074/jbc.M505261200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15994329	hybrid			2022-12-27	WOS:000231665200041
J	Van Le, H; Minn, AJ; Massague, J				Van Le, H; Minn, AJ; Massague, J			Cyclin-dependent kinase inhibitors uncouple cell cycle progression from mitochondrial apoptotic functions in DNA-damaged cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLORECTAL-CANCER; MITOTIC CATASTROPHE; POTENTIAL MEDIATOR; CYTOCHROME-C; TUMOR-CELLS; S-PHASE; P53; PUMA; GENE; P21	DNA damage results in transcriptional induction of p53 target genes, including the cyclin-dependent kinase (CDK) inhibitor p21(Cip1) (CDKN1A) and the proapoptotic Bcl-2 family member p53 up-regulated modulator of apoptosis (PUMA). Depending on the cellular context, p21Cip1 and PUMA mediate cell cycle arrest and apoptosis, respectively. By imposing cell cycle arrest at the expense of apoptosis, p21Cip1 can sharply reduce the effectiveness of DNA-damaging anticancer agents in colorectal cancer cells. We investigated the link between cell cycle progression and the onset of apoptosis in DNA-damaged cells by analyzing the activation of the apoptotic cascade in p21(Cip1)-deficient HCT116 colorectal cancer cells. DNA damage induced a similar level of p53 activation and PUMA induction in p21(Cip1)-deficient cells compared with wild-type isogenic counterparts. p21Cip1 did not act as a direct blocker of PUMA. However, only p21(Cip1)-deficient cells showed extensive cytochrome c release, mitochondrial membrane depolarization, and caspase activation. An increase in caspase activation occurred as these cells reached M-phase and incurred polyploidy. When ectopically expressed in p21(Cip1)-deficient HCT116 cells, p21Cip1, its family member p27(Kip1), and the structurally unrelated CDK inhibitor p16(Ink4a) were similarly effective at causing cell cycle arrest and inhibiting DNA damage-induced apoptotic events such as cytochrome c release, mitochondrial membrane depolarization, and activation of the caspase cascade. These observations suggest that by blocking dysregulated cell cycle progression, CDK inhibitors can influence the sensitivity of the mitochondria to proapoptotic signals in DNA damage-induced cancer cells.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave,Box 116, New York, NY 10021 USA.	j-massague@mskcc.org		Minn, Andy/0000-0003-1418-0906; Massague, Joan/0000-0001-9324-8408				Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Brown M, 2003, CANCER BIOL THER, V2, P477, DOI 10.4161/cbt.2.5.450; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Castedo Maria, 2004, Journal de la Societe de Biologie, V198, P97; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Conklin Kenneth A, 2004, Integr Cancer Ther, V3, P294, DOI 10.1177/1534735404270335; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fang M, 2000, ANTICANCER RES, V20, P103; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P21429, DOI 10.1074/jbc.270.37.21429; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gorospe M, 1997, ONCOGENE, V14, P929, DOI 10.1038/sj.onc.1200897; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Jayaraman S, 2003, CYTOM PART A, V56A, P104, DOI 10.1002/cyto.a.10094; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lu YJ, 2000, MOL CARCINOGEN, V29, P1; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Prabhu NS, 1999, INT J ONCOL, V15, P209; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Rupnarain C, 2004, BIOL CHEM, V385, P449, DOI 10.1515/BC.2004.053; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Schmidt M, 2001, ONCOGENE, V20, P6164, DOI 10.1038/sj.onc.1204814; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Shao RG, 1997, CANCER RES, V57, P4029; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stanelle J, 2002, NUCLEIC ACIDS RES, V30, P1859, DOI 10.1093/nar/30.8.1859; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; Tse AN, 2004, CANCER RES, V64, P6635, DOI 10.1158/0008-5472.CAN-04-0841; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogel C, 2005, J BIOL CHEM, V280, P4025, DOI 10.1074/jbc.C400545200; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Waldman T, 1997, NAT MED, V3, P1034, DOI 10.1038/nm0997-1034; WALDMAN T, 1995, CANCER RES, V55, P5187; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wang XD, 2001, GENE DEV, V15, P2922; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100	53	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					32018	32025		10.1074/jbc.M504689200	http://dx.doi.org/10.1074/jbc.M504689200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16002406	hybrid			2022-12-27	WOS:000231665200082
J	Dittmann, K; Mayer, C; Fehrenbacher, B; Schaller, M; Raju, U; Milas, L; Chen, DJ; Kehlbach, R; Rodemann, HP				Dittmann, K; Mayer, C; Fehrenbacher, B; Schaller, M; Raju, U; Milas, L; Chen, DJ; Kehlbach, R; Rodemann, HP			Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; LIGAND-INDEPENDENT ACTIVATION; IN-VIVO; CATALYTIC SUBUNIT; EGF RECEPTOR; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; TYROSINE KINASE; CELLS; PHOSPHORYLATION	Ionizing radiation, but not stimulation with epidermal growth factor (EGF), triggers EGF receptor ( EGFR) import into the nucleus in a probably karyopherin alpha-linked manner. An increase in nuclear EGFR is also observed after treatment with H2O2, heat, or cisplatin. During this process, the proteins Ku70/80 and the protein phosphatase 1 are transported into the nucleus. As a consequence, an increase in the nuclear kinase activity of DNA-dependent kinase (DNA-PK) and increased formation of the DNA end-binding protein complexes containing DNA-PK, essential for repair of DNA-strand breaks, occurred. Blockade of EGFR import by the anti-EGFR monoclonal antibody C225 abolished EGFR import into the nucleus and radiation-induced activation of DNA-PK, inhibited DNA repair, and increased radiosensitivity of treated cells. Our data implicate a novel function of the EGFR during DNA repair processes.	Univ Tubingen, Dept Radiat Oncol, Div Radiobiol & Mol Environm Res, D-72076 Tubingen, Germany; Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; Utah SW Med Ctr, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA; Univ Tubingen, Dept Radiol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Texas System; UTMD Anderson Cancer Center; Eberhard Karls University of Tubingen	Dittmann, K (corresponding author), Univ Tubingen, Dept Radiat Oncol, Div Radiobiol & Mol Environm Res, Rontgenweg 11, D-72076 Tubingen, Germany.	klaus.dittmann@uni-tuebingen.de			NCI NIH HHS [CA16672, CA06294] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA006294, P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Apte UM, 2002, TOXICOL SCI, V69, P448, DOI 10.1093/toxsci/69.2.448; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Baselga J, 2002, ONCOLOGIST, V7, P2; Boerner JL, 2003, EXP CELL RES, V284, P111, DOI 10.1016/S0014-4827(02)00096-4; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chen X, 2002, J BIOL CHEM, V277, P49631, DOI 10.1074/jbc.M208327200; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; DahmDaphi J, 1996, INT J RADIAT BIOL, V69, P615, DOI 10.1080/095530096145625; DeFazio LG, 2002, EMBO J, V21, P3192, DOI 10.1093/emboj/cdf299; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Dittmann KH, 1998, RADIAT RES, V150, P648, DOI 10.2307/3579887; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Gatei M, 2001, J BIOL CHEM, V276, P17276, DOI 10.1074/jbc.M011681200; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Gueven N, 2001, J BIOL CHEM, V276, P8884, DOI 10.1074/jbc.M006190200; Gupta AK, 2002, CLIN CANCER RES, V8, P885; Harari PM, 2001, SEMIN RADIAT ONCOL, V11, P281, DOI 10.1053/srao.2001.26027; Herrlich A, 1998, P NATL ACAD SCI USA, V95, P8985, DOI 10.1073/pnas.95.15.8985; Huang SM, 1999, CANCER RES, V59, P1935; Karmakar P, 2002, J BIOL CHEM, V277, P18291, DOI 10.1074/jbc.M111523200; KHAZAIE K, 1993, CANCER METAST REV, V12, P255, DOI 10.1007/BF00665957; Kimura T, 2004, J CELL SCI, V117, P2259, DOI 10.1242/jcs.01076; Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x; Komurasaki T, 2002, GROWTH FACTORS, V20, P61, DOI 10.1080/08977190290024192; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Leuther KK, 1999, EMBO J, V18, P1114, DOI 10.1093/emboj/18.5.1114; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Maggiorella L, 2003, CANCER RES, V63, P2513; Manna SK, 2000, ONCOGENE, V19, P2110, DOI 10.1038/sj.onc.1203547; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Milas L, 2003, HEAD NECK-J SCI SPEC, V25, P152, DOI 10.1002/hed.10232; Milas L, 2000, CLIN CANCER RES, V6, P701; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Oksvold M, 2002, NAT CELL BIOL, V4, pE22, DOI 10.1038/ncb0202-e22a; Peus D, 2000, PHOTOCHEM PHOTOBIOL, V72, P135, DOI 10.1562/0031-8655(2000)072<0135:UIEGFR>2.0.CO;2; Prewett M, 1996, J IMMUNOTHER, V19, P419, DOI 10.1097/00002371-199611000-00006; Ritter CA, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.50027; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2001, CANCER RES, V61, P3886; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Simeonova PP, 2002, J BIOL CHEM, V277, P2945, DOI 10.1074/jbc.M109136200; Soubeyrand S, 2003, CANCER RES, V63, P1198; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155	48	426	457	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31182	31189		10.1074/jbc.M506591200	http://dx.doi.org/10.1074/jbc.M506591200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16000298	hybrid			2022-12-27	WOS:000231487800065
J	Milakovic, T; Johnson, GVW				Milakovic, T; Johnson, GVW			Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant Huntingtin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; KNOCK-IN MICE; 3-NITROPROPIONIC ACID; OXIDATIVE-PHOSPHORYLATION; SUCCINATE-DEHYDROGENASE; BRAIN MITOCHONDRIA; TRANSGENIC MOUSE; DISEASE; TRANSPORT; MUTATION	There is significant evidence that energy production impairment and mitochondrial dysfunction play a role in the pathogenesis of Huntington disease. Nonetheless, the specific mitochondrial defects due to the presence of mutant huntingtin have not been fully elucidated. To determine the effects of mutant huntingtin on mitochondrial energy production, a thorough analysis of respiration, ATP production, and functioning of the respiratory complexes was carried out in clonal striatal cells established from Hdh(Q7) (wild-type) and Hdh(Q111) (mutant huntingtin knock-in) mouse embryos. Mitochondrial respiration and ATP production were significantly reduced in the mutant striatal cells compared with the wild-type cells when either glutamate/malate or succinate was used as the substrate. However, mitochondrial respiration was similar in the two cell lines when the artificial electron donor TMPD/ascorbate, which feeds into complex IV, was used as the substrate. The attenuation of mitochondrial respiration and ATP production when either glutamate/malate or succinate was used as the substrate was not due to impairment of the respiratory complexes, because their activities were equivalent in both cell lines. Intriguingly, in the striatum of presymptomatic and pathological grade 1 Huntington disease cases there is also no impairment of mitochondrial complexes I-IV (Guidetti, P., Charles, V., Chen, E. Y., Reddy, P. H., Kordower, J. H., Whetsell, W. O., Jr., Schwarcz, R., and Tagle, D. A. (2001) Exp. Neurol. 169, 340-350). To our knowledge, this is the first comprehensive analysis of the effects of physiological levels of mutant huntingtin on mitochondrial respiratory function within an appropriate cellular context. These findings demonstrate that the presence of mutant huntingtin impairs mitochondrial ATP production through one or more mechanisms that do not directly affect the function of the respiration complexes.	Univ Alabama, Dept Psychiat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Johnson, GVW (corresponding author), Univ Alabama, Dept Psychiat, 1720 7th Ave S,SC1061, Birmingham, AL 35294 USA.	gvwj@uab.edu	Johnson, Gail V.W./K-4723-2012	Johnson, Gail V.W./0000-0003-3464-0404	NINDS NIH HHS [NS41744] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041744] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ardehali H, 2004, P NATL ACAD SCI USA, V101, P11880, DOI 10.1073/pnas.0401703101; BEAL MF, 1993, J NEUROSCI, V13, P4181; Bogdanov MB, 1998, J NEUROCHEM, V71, P2642; BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; CHRETIEN D, 1990, BIOCHEM BIOPH RES CO, V173, P26, DOI 10.1016/S0006-291X(05)81016-2; COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4; COLES CJ, 1979, J BIOL CHEM, V254, P5161; DARLEYUSMAR VM, 1987, MITOCHONDRIA PRACTIC, P113; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Davey GP, 1997, J NEUROCHEM, V69, P2564; Davey GP, 1996, J NEUROCHEM, V66, P1617; DUBINSKY WP, 1975, FEBS LETT, V59, P39, DOI 10.1016/0014-5793(75)80336-X; Feigin A, 2001, J NUCL MED, V42, P1591; FISKUM G, 1980, P NATL ACAD SCI-BIOL, V77, P3430, DOI 10.1073/pnas.77.6.3430; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; GRANGER DL, 1982, J CELL BIOL, V95, P527, DOI 10.1083/jcb.95.2.527; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Guidetti P, 2001, EXP NEUROL, V169, P340, DOI 10.1006/exnr.2000.7626; Hansson O, 2001, J NEUROCHEM, V78, P694, DOI 10.1046/j.1471-4159.2001.00482.x; HARRIS SI, 1981, J BIOL CHEM, V256, P319; Hatefi Y, 1978, Methods Enzymol, V53, P21; Helmerhorst EJ, 2002, BBA-BIOENERGETICS, V1556, P73, DOI 10.1016/S0005-2728(02)00308-0; Hickey MA, 2000, J NEUROCHEM, V75, P2163, DOI 10.1046/j.1471-4159.2000.0752163.x; Higgins DS, 1999, ANN NY ACAD SCI, V893, P298, DOI 10.1111/j.1749-6632.1999.tb07841.x; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; Holmuhamedov EL, 1999, J PHYSIOL-LONDON, V519, P347, DOI 10.1111/j.1469-7793.1999.0347m.x; JENKINS BG, 1993, NEUROLOGY, V43, P2689, DOI 10.1212/WNL.43.12.2689; Kuhl D E, 1985, Res Publ Assoc Res Nerv Ment Dis, V63, P199; KUHL DE, 1982, ANN NEUROL, V12, P425, DOI 10.1002/ana.410120504; KUHL DE, 1984, ANN NEUROL S, V15, P119; Kun E, 1979, Methods Enzymol, V55, P115; Li SH, 1999, J NEUROSCI, V19, P5159; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MALLAJOSYULA JK, 2004, 34 ANN M SOC NEUR SA; MANN VM, 1990, LANCET, V336, P749, DOI 10.1016/0140-6736(90)92242-A; MORENOSANCHEZ R, 1985, J BIOL CHEM, V260, P4028; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; ROBINSON JB, 1987, MITOCHONDRIA PRACTIC, P160; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Ruan QM, 2004, HUM MOL GENET, V13, P669, DOI 10.1093/hmg/ddh082; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166	47	190	196	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30773	30782		10.1074/jbc.M504749200	http://dx.doi.org/10.1074/jbc.M504749200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15983033	hybrid			2022-12-27	WOS:000231487800017
J	Clayton, AHA; Walker, F; Orchard, SG; Henderson, C; Fuchs, D; Rothacker, J; Nice, EC; Burgess, AW				Clayton, AHA; Walker, F; Orchard, SG; Henderson, C; Fuchs, D; Rothacker, J; Nice, EC; Burgess, AW			Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFETIME IMAGING MICROSCOPY; ERBB SIGNALING NETWORK; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; EGF RECEPTOR; CORRELATION SPECTROSCOPY; FACTOR-ALPHA; DIMERIZATION; ECTODOMAIN; BINDING	The epidermal growth factor receptor ( EGFR) is a member of the erbB tyrosine kinase family of receptors. For many years it has been believed that receptor activation occurs via a monomer-dimer transition that is associated with a conformational change to activate the kinase. However, little is known about the quaternary state of the receptor at normal levels of expression (< 105 receptors/cell). We employed multidimensional microscopy techniques to gain insight into the state of association of the human EGFR, in the absence and presence of ligand, on the surface of intact BaF/3 cells ( 50,000 receptors/cell). Image correlation microscopy of an EGFR-enhanced green fluorescent protein chimera was used to establish an average degree of aggregation on the submicron scale of 2.2 receptors/cluster in the absence of ligand increasing to 3.7 receptors/cluster in the presence of ligand. Energy transfer measurements between mixtures of fluorescein isothiocyanate-EGF and Alexa 555-EGF were performed using fluorescence lifetime imaging microscopy as a function of the donor: acceptor labeling ratio to gain insight into the spatial disposition of EGFR ligand binding sites on the nanometer scale. In the context of a two-state Forster resonance energy transfer ( FRET)/non-FRET model, the data are consistent with a minimum transfer efficiency of 75% in the FRET population. The microscopy data are related to biophysical data on the EGFR in the A431 cell line and the three-dimensional structure of the ligated EGFR extracellular domain. In the context of a monomerdimer-oligomer model, the biophysical data are consistent with a significant fraction of ligated EGFR tetramers comprising two dimers juxtaposed in a side-by-side ( or slightly staggered) arrangement. Our data are consistent with a specific higher order association of the ligand-bound EGFR on the nanometer scale and indicate the existence of distinct signaling entities beyond the level of the EGFR dimer which could play an important role in receptor transactivation.	Royal Melbourne Hosp, Cell Biophys Lab, Melbourne Tumour Biol Branch, Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia	Ludwig Institute for Cancer Research; Royal Melbourne Hospital	Clayton, AHA (corresponding author), Royal Melbourne Hosp, Cell Biophys Lab, Melbourne Tumour Biol Branch, Ludwig Inst Canc Res, POB 2008, Melbourne, Vic 3050, Australia.	andrew.clayton@ludwig.edu.au	Orchard, Suzanne/GXF-5346-2022; Nice, Edouard C/B-1026-2011	Orchard, Suzanne/0000-0003-0211-3183; Rothacker, Julie/0000-0001-7560-4982				Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Brock R, 2001, J CELL SCI, V114, P2437; BURGESS AW, 1983, EMBO J, V2, P2065, DOI 10.1002/j.1460-2075.1983.tb01701.x; CANALS F, 1992, BIOCHEMISTRY-US, V31, P4493, DOI 10.1021/bi00133a016; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; CHATELIER RC, 1986, EMBO J, V5, P1181, DOI 10.1002/j.1460-2075.1986.tb04344.x; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; DERYNCK R, 1987, CANCER RES, V47, P707; Domagala T, 2000, GROWTH FACTORS, V18, P11, DOI 10.3109/08977190009003231; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; Elleman TC, 2001, BIOCHEMISTRY-US, V40, P8930, DOI 10.1021/bi010037b; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Gamett DC, 1997, J BIOL CHEM, V272, P12052, DOI 10.1074/jbc.272.18.12052; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; Hanley QS, 2005, J MICROSC-OXFORD, V218, P62, DOI 10.1111/j.1365-2818.2005.01463.x; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Huang GC, 1998, BIOCHEM J, V331, P113, DOI 10.1042/bj3310113; Ichinose J, 2004, BIOCHEM BIOPH RES CO, V324, P1143, DOI 10.1016/j.bbrc.2004.09.173; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; KNUTSON VP, 1983, J BIOL CHEM, V258, P2139; LAKOWICZ JR, 1982, BIOPHYS CHEM, V16, P99, DOI 10.1016/0301-4622(82)85012-6; Magde D, 1999, PHOTOCHEM PHOTOBIOL, V70, P737, DOI 10.1111/j.1751-1097.1999.tb08277.x; Martin-Fernandez M, 2002, BIOPHYS J, V82, P2415, DOI 10.1016/S0006-3495(02)75585-9; Morris C F, 1990, Immunol Ser, V49, P177; Murali R, 1996, P NATL ACAD SCI USA, V93, P6252, DOI 10.1073/pnas.93.13.6252; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Petersen NO, 1998, FARADAY DISCUSS, V111, P289; PETERSEN NO, 1986, BIOPHYS J, V49, P809, DOI 10.1016/S0006-3495(86)83709-2; QIAN H, 1990, P NATL ACAD SCI USA, V87, P5479, DOI 10.1073/pnas.87.14.5479; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SOROKIN A, 1994, J BIOL CHEM, V269, P9752; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; van Munster EB, 2004, CYTOM PART A, V58A, P185, DOI 10.1002/cyto.a.20013; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Walker F, 1998, GROWTH FACTORS, V16, P53, DOI 10.3109/08977199809017491; Walker F, 2004, J BIOL CHEM, V279, P22387, DOI 10.1074/jbc.M401244200; WHITEHEAD RH, 1985, JNCI-J NATL CANCER I, V74, P759; Whitson KB, 2004, ANAL BIOCHEM, V324, P227, DOI 10.1016/j.ab.2003.09.023; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zhu HJ, 2003, GROWTH FACTORS, V21, P15, DOI 10.1080/0897719031000096424; ZIDOVETZKI R, 1981, P NATL ACAD SCI-BIOL, V78, P6981, DOI 10.1073/pnas.78.11.6981	53	204	215	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30392	30399		10.1074/jbc.M504770200	http://dx.doi.org/10.1074/jbc.M504770200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15994331	hybrid			2022-12-27	WOS:000231362500051
J	Shigaki, T; Barkla, BJ; Miranda-Vergara, MC; Zhao, J; Pantoja, O; Hirschi, KD				Shigaki, T; Barkla, BJ; Miranda-Vergara, MC; Zhao, J; Pantoja, O; Hirschi, KD			Identification of a crucial histidine involved in metal transport activity in the Arabidopsis cation/H+ exchanger CAX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; H+/CA2+ ANTIPORTER; AMINO-ACID; RESIDUES; DETERMINANTS; EXPRESSION; CHANNEL; PH	In plants, yeast, and bacteria, cation/H+ exchangers (CAXs) have been shown to translocate Ca2+ and other metal ions utilizing the H+ gradient. The best characterized of these related transporters is the plant vacuolar localized CAX1. We have used site-directed mutagenesis to assess the impact of altering the seven histidine residues to alanine within Arabidopsis CAX1. The mutants were expressed in a Saccharomyces cerevisiae strain that is sensitive to Ca2+ and other metals. By utilizing a yeast growth assay, the H338A mutant was the only mutation that appeared to alter Ca2+ transport activity. The CAX1 His(338) residue is conserved among various CAX transporters and may be located within a filter for cation selection. We proceeded to mutate His338 to every other amino acid residue and utilized yeast growth assays to estimate the transport properties of the 19 CAX mutants. Expression of 16 of these His338 mutants could not rescue any of the metal sensitivities. However, expression of H338N, H338Q, and H338K allowed for some growth on media containing Ca2+. Most interestingly, H338N exhibited increased tolerance to Cd2+ and Zn2+. Endomembrane fractions from yeast cells were used to measure directly the transport of H338N. Although the H338N mutant demonstrated 25% of the wild type Ca2+/H+ transport, it showed an increase in transport for both Cd2+ and Zn2+ reflected in a decrease in the Km for these substrates. This study provides insights into the CAX cation filter and novel mechanisms by which metals may be partitioned across membranes.	Baylor Coll Med, USDA, ARS,Dept Pediat, Plant Physiol Labs,Childrens Nutr Res Ctr, Houston, TX 77030 USA; Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Plant Mol Biol, Cuernavaca 62250, Morelos, Mexico; Texas A&M Univ, Dept Hort, Vegetable & Fruit Improvement Ctr, College Stn, TX 77845 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Universidad Nacional Autonoma de Mexico; Texas A&M University System; Texas A&M University College Station	Hirschi, KD (corresponding author), Baylor Coll Med, USDA, ARS,Dept Pediat, Plant Physiol Labs,Childrens Nutr Res Ctr, 1100 Bates St, Houston, TX 77030 USA.	kendalh@bcm.tmc.edu	Zhao, Jian/Q-8591-2019; Zhao, Jian/A-2336-2008; Barkla, Bronwyn J/O-6301-2017; Pantoja, Omar/H-5981-2012; hirschi, kendal/GNP-0351-2022	Zhao, Jian/0000-0002-4416-7334; Barkla, Bronwyn J/0000-0002-4691-8023; Pantoja, Omar/0000-0002-6538-9059; 				Ausubel FM, 1998, CURRENT PROTOCOLS MO; Barkla BJ, 1999, PLANT PHYSIOL, V120, P811, DOI 10.1104/pp.120.3.811; BENNETT AB, 1983, J MEMBRANE BIOL, V71, P95, DOI 10.1007/BF01870678; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Chen XZ, 2000, BIOCHEM BIOPH RES CO, V272, P726, DOI 10.1006/bbrc.2000.2851; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; Fei YJ, 2000, J BIOL CHEM, V275, P23707, DOI 10.1074/jbc.M002282200; GABER R, 1999, J EXP BOT, V50, P1073; Gaxiola RA, 2002, PLANT PHYSIOL, V129, P967, DOI 10.1104/pp.020009; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Hirschi KD, 1996, P NATL ACAD SCI USA, V93, P8782, DOI 10.1073/pnas.93.16.8782; Hirschi KD, 2004, PLANT PHYSIOL, V136, P2438, DOI 10.1104/pp.104.046490; Hoth S, 1997, P NATL ACAD SCI USA, V94, P4806, DOI 10.1073/pnas.94.9.4806; Kamiya T, 2004, J BIOL CHEM, V279, P812, DOI 10.1074/jbc.M309726200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lu JMY, 1998, P NATL ACAD SCI USA, V95, P9025, DOI 10.1073/pnas.95.15.9025; Nathan DF, 1999, P NATL ACAD SCI USA, V96, P1409, DOI 10.1073/pnas.96.4.1409; Park S, 2004, MOL BREEDING, V14, P275, DOI 10.1023/B:MOLB.0000047773.20175.ae; Pittman JK, 2003, CURR OPIN PLANT BIOL, V6, P257, DOI 10.1016/S1369-5266(03)00036-0; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; Rogers EE, 2000, P NATL ACAD SCI USA, V97, P12356, DOI 10.1073/pnas.210214197; Shigaki T, 2003, J BIOL CHEM, V278, P6610, DOI 10.1074/jbc.M209952200; Shigaki T, 2001, J BIOL CHEM, V276, P43152, DOI 10.1074/jbc.M106637200; Shigaki T, 2001, ANAL BIOCHEM, V298, P118, DOI 10.1006/abio.2001.5341; Uozumi N, 1998, P NATL ACAD SCI USA, V95, P9773, DOI 10.1073/pnas.95.17.9773; Wiebe CA, 2001, BIOCHEM J, V357, P1, DOI 10.1042/0264-6021:3570001; Zhou F, 2004, BIOCHEM J, V384, P87, DOI 10.1042/BJ20040751; Zong XG, 2001, J BIOL CHEM, V276, P6313, DOI 10.1074/jbc.M010326200	29	54	60	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30136	30142		10.1074/jbc.M503610200	http://dx.doi.org/10.1074/jbc.M503610200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15994298	hybrid			2022-12-27	WOS:000231362500020
J	Zhou, H; Yu, K; McCoy, KL; Lee, A				Zhou, H; Yu, K; McCoy, KL; Lee, A			Molecular mechanism for divergent regulation of Ca(v)1.2 Ca2+ channels by calmodulin and Ca2+-binding protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE CALCIUM-CHANNEL; GATED CA2+ CHANNELS; PROTEIN-KINASE-C; ALPHA(1C) SUBUNIT; CA2+-DEPENDENT INACTIVATION; CA2+-SENSITIVE INACTIVATION; FUNCTIONAL EXPRESSION; VOLTAGE; FACILITATION; MODULATION	Ca2+-binding protein-1 (CaBP1) and calmodulin (CaM) are highly related Ca2+-binding proteins that directly interact with, and yet differentially regulate, voltagegated Ca2+ channels. Whereas CaM enhances inactivation of Ca2+ currents through Ca(v)1.2 (L-type) Ca2+ channels, CaBP1 completely prevents this process. How CaBP1 and CaM mediate such opposing effects on Ca(v)1.2 inactivation is unknown. Here, we identified molecular determinants in the alpha(1)-subunit of Ca(v)1.2 (alpha(1)1.2) that distinguish the effects of CaBP1 and CaM on inactivation. Although both proteins bind to a well characterized IQ-domain in the cytoplasmic C-terminal domain of alpha(1)1.2, mutations of the IQ-domain that significantly weakened CaM and CaBP1 binding abolished the functional effects of CaM, but not CaBP1. Pulldown binding assays revealed Ca2+-independent binding of CaBP1 to the N-terminal domain (NT) of alpha(1)1.2, which was in contrast to Ca2+-dependent binding of CaM to this region. Deletion of the NT abolished the effects of CaBP1 in prolonging Ca(v)1.2 Ca2+ currents, but spared Ca2+-dependent inactivation due to CaM. We conclude that the NT and IQ-domains of alpha(1)1.2 mediate functionally distinct interactions with CaBP1 and CaM that promote conformational alterations that either stabilize or inhibit inactivation of Ca(v)1.2.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA	Emory University; Emory University	Lee, A (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 5123 Rollins Res Bldg,1510 Clifton Rd, Atlanta, GA 30322 USA.	alee@pharm.emory.edu		Lee, Amy/0000-0001-8021-0443	NIA NIH HHS [AG021723] Funding Source: Medline; NINDS NIH HHS [NS044922] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG021723] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; Blumenstein Y, 2002, J BIOL CHEM, V277, P3419, DOI 10.1074/jbc.C100642200; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Cens T, 1999, J BIOL CHEM, V274, P5483, DOI 10.1074/jbc.274.9.5483; Chakravarthy B, 1999, TRENDS NEUROSCI, V22, P12, DOI 10.1016/S0166-2236(98)01288-0; Dai BS, 2002, BIOCHEM BIOPH RES CO, V296, P429, DOI 10.1016/S0006-291X(02)00894-X; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; KINOSHITAKAWADA NN, 2005, IN PRESS PFLUGERS AR; Kobrinsky E, 2005, J BIOL CHEM, V280, P12474, DOI 10.1074/jbc.M412140200; KOCH WJ, 1990, J BIOL CHEM, V265, P17786; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; NAIRN AC, 1994, SEMIN CANCER BIOL, V5, P295; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; Pang L, 2003, FEBS LETT, V546, P349, DOI 10.1016/S0014-5793(03)00629-X; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Shistik E, 1998, J BIOL CHEM, V273, P17901, DOI 10.1074/jbc.273.28.17901; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; Soldatov MM, 2003, TRENDS PHARMACOL SCI, V24, P167, DOI 10.1016/S0165-6147(03)00065-8; Soldatov NM, 1998, J BIOL CHEM, V273, P957, DOI 10.1074/jbc.273.2.957; Stotz SC, 2000, J BIOL CHEM, V275, P24575, DOI 10.1074/jbc.M000399200; Tang W, 2003, BIOPHYS J, V85, P1538, DOI 10.1016/S0006-3495(03)74586-X; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Weiss JL, 2002, TRENDS NEUROSCI, V25, P489, DOI 10.1016/S0166-2236(02)02247-6; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	45	81	84	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2005	280	33					29612	29619		10.1074/jbc.M504167200	http://dx.doi.org/10.1074/jbc.M504167200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	954SX	15980432	hybrid			2022-12-27	WOS:000231176200029
J	Wray, LV; Fisher, SH				Wray, LV; Fisher, SH			A feedback-resistant mutant of Bacillus subtilis glutamine synthetase with pleiotropic defects in nitrogen-regulated gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR TNRA; ESCHERICHIA-COLI; METHIONINE SULFOXIMINE; SALMONELLA-TYPHIMURIUM; ALTERED REGULATION; ACTIVE-SITE; GLNA GENE; INHIBITION; MECHANISM; ENZYME	The Bacillus subtilis TnrA transcription factor regulates gene expression during nitrogen-limited growth. When cells are grown with excess nitrogen, feedback-inhibited glutamine synthetase forms a protein-protein complex with TnrA and prevents TnrA from binding to DNA. A mutation in glutamine synthetase with a phenylalanine replacement at the Ser-186 residue (S186F) was isolated by screening for B. subtilis mutants with constitutive TnrA activity. Although S186F glutamine synthetase has kinetic properties that are similar to the wild-type protein, the S186F enzyme is resistant to feedback inhibition by glutamine and AMP. Ligand binding experiments revealed that the S186F protein had a lower affinity for glutamine and AMP than the wild-type enzyme. S186F glutamine synthetase was defective in its ability to block DNA binding by TnrA in vitro. The properties of the feedback-resistant S186F mutant support the model in which the feedback-inhibited form of glutamine synthetase regulates TnrA activity in vivo.	Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	Boston University	Fisher, SH (corresponding author), Boston Univ, Sch Med, Dept Microbiol, 715 Albany St, Boston, MA 02118 USA.	shfisher@bu.edu		Wray, Lewis/0000-0001-7424-7450; Fisher, Susan/0000-0003-0831-4023	NCRR NIH HHS [P41 RR-01081] Funding Source: Medline; NIGMS NIH HHS [GM51127] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051127] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATKINSON MR, 1990, J BACTERIOL, V172, P4758, DOI 10.1128/jb.172.9.4758-4765.1990; Belitsky BR, 2000, J BACTERIOL, V182, P5939, DOI 10.1128/JB.182.21.5939-5947.2000; CHASIN LA, 1968, J BIOL CHEM, V243, P5165; COPELAND RA, 2000, ENZYMES PRACTICAL IN, P382; CORNISHBOWDEN A, 1995, FUNDAMENTALS ENZYME, P207; DEAN DR, 1977, J BACTERIOL, V131, P981, DOI 10.1128/JB.131.3.981-987.1977; DEAN DR, 1980, J BACTERIOL, V141, P985, DOI 10.1128/JB.141.2.985-988.1980; DEUEL TF, 1970, J BIOL CHEM, V245, P5195; DEUEL TF, 1972, J BIOL CHEM, V247, P3039; DEUEL TF, 1974, J BIOL CHEM, V249, P257; DEUEL TF, 1970, J BIOL CHEM, V245, P5206; EISENSTADT E, 1973, J BACTERIOL, V113, P1363, DOI 10.1128/JB.113.3.1363-1372.1973; FISHER SH, 1984, J BACTERIOL, V157, P612, DOI 10.1128/JB.157.2.612-621.1984; Fisher SH, 1999, MOL MICROBIOL, V32, P223, DOI 10.1046/j.1365-2958.1999.01333.x; Fisher SH, 2002, MOL MICROBIOL, V45, P627, DOI 10.1046/j.1365-2958.2002.03054.x; Gill HS, 2001, BIOCHEMISTRY-US, V40, P1903, DOI 10.1021/bi002438h; Gill HS, 2002, BIOCHEMISTRY-US, V41, P9863, DOI 10.1021/bi020254s; GINSBURG A, 1969, BIOCHEMISTRY-US, V8, P1726, DOI 10.1021/bi00832a056; Hu P, 1999, J BACTERIOL, V181, P5042, DOI 10.1128/JB.181.16.5042-5050.1999; Ikeda TP, 1996, J MOL BIOL, V259, P589, DOI 10.1006/jmbi.1996.0342; KUSTU S, 1984, MOL GEN GENET, V197, P309, DOI 10.1007/BF00330979; LIAW SH, 1994, BIOCHEMISTRY-US, V33, P675, DOI 10.1021/bi00169a007; LIAW SH, 1994, BIOCHEMISTRY-US, V33, P11184, DOI 10.1021/bi00203a014; LONDON WP, 1969, BIOCHEMISTRY-US, V8, P1767, DOI 10.1021/bi00832a061; NAKANO Y, 1990, J BIOCHEM-TOKYO, V108, P116, DOI 10.1093/oxfordjournals.jbchem.a123149; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; RONZIO RA, 1969, BIOCHEMISTRY-US, V8, P1066, DOI 10.1021/bi00831a038; RYESSET G, 1981, J BACTERIOL, V148, P653; SCHREIER HJ, 1986, J BACTERIOL, V167, P35, DOI 10.1128/jb.167.1.35-43.1986; SCHREIER HJ, 1985, P NATL ACAD SCI USA, V82, P3375, DOI 10.1073/pnas.82.10.3375; SCHREIER HJ, 1993, J BACTERIOL, V175, P892, DOI 10.1128/JB.175.3.892-897.1993; SCHREIER HJ, 1989, J MOL BIOL, V210, P51, DOI 10.1016/0022-2836(89)90290-8; STRAUCH MA, 1988, GENE, V71, P257, DOI 10.1016/0378-1119(88)90042-X; WEISBROD RE, 1973, J BIOL CHEM, V248, P3997; WOOLFOLK CA, 1967, ARCH BIOCHEM BIOPHYS, V118, P736, DOI 10.1016/0003-9861(67)90412-2; Wray LV, 2000, J MOL BIOL, V300, P29, DOI 10.1006/jmbi.2000.3846; Wray LV, 1996, P NATL ACAD SCI USA, V93, P8841, DOI 10.1073/pnas.93.17.8841; Wray LV, 1997, J BACTERIOL, V179, P5494, DOI 10.1128/jb.179.17.5494-5501.1997; Wray LV, 2001, CELL, V107, P427, DOI 10.1016/S0092-8674(01)00572-4; Yoshida K, 2003, MOL MICROBIOL, V49, P157, DOI 10.1046/j.1365-2958.2003.03567.x; ZHANG JK, 1989, J BACTERIOL, V171, P3572, DOI 10.1128/jb.171.6.3572-3574.1989	44	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33298	33304		10.1074/jbc.M504957200	http://dx.doi.org/10.1074/jbc.M504957200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16055443	hybrid			2022-12-27	WOS:000232058100025
J	Berzat, AC; Buss, JE; Chenette, EJ; Weinbaum, CA; Shutes, A; Der, CJ; Minden, A; Cox, AD				Berzat, AC; Buss, JE; Chenette, EJ; Weinbaum, CA; Shutes, A; Der, CJ; Minden, A; Cox, AD			Transforming activity of the Rho family GTPase, Wrch-1, a Wnt-regulated Cdc42 homolog, is dependent on a novel carboxyl-terminal palmitoylation motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; PLASMA-MEMBRANE; H-RAS; PROTEIN PALMITOYLATION; BIOLOGICAL-ACTIVITY; FARNESYLTRANSFERASE INHIBITORS; SACCHAROMYCES-CEREVISIAE; GERANYLGERANYLATED RHOB; PALMITATE TURNOVER; POLYBASIC DOMAIN	Wrch-1 is a Rho family GTPase that shares strong sequence and functional similarity with Cdc42. Like Cdc42, Wrch-1 can promote anchorage-independent growth transformation. We determined that activated Wrch-1 also promoted anchorage-dependent growth transformation of NIH 3T3 fibroblasts. Wrch-1 contains a distinct carboxyl-terminal extension not found in Cdc42, suggesting potential differences in subcellular location and function. Consistent with this, we found that Wrch-1 associated extensively with plasma membrane and endosomes, rather than with cytosol and perinuclear membranes like Cdc42. Like Cdc42, Wrch-1 terminates in a CAAX tetrapeptide (where C is cysteine, A is aliphatic amino acid, and X is any amino acid) motif (CCFV), suggesting that Wrch-1 may be prenylated similarly to Cdc42. Most surprisingly, unlike Cdc42, Wrch-1 did not incorporate isoprenoid moieties, and Wrch-1 membrane localization was not altered by inhibitors of protein prenylation. Instead, we showed that Wrch-1 is modified by the fatty acid palmitate, and pharmacologic inhibition of protein palmitoylation caused mislocalization of Wrch-1. Most interestingly, mutation of the second cysteine of the CCFV motif (CCFV > CSFV), but not the first, abrogated both Wrch-1 membrane localization and transformation. These results suggest that Wrch-1 membrane association, subcellular localization, and biological activity are mediated by a novel membrane-targeting mechanism distinct from that of Cdc42 and other isoprenylated Rho family GTPases.	Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Iowa State Univ, Dept Biochem Biophys & Mol Phys, Ames, IA 50011 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Iowa State University; Duke University; Columbia University	Cox, AD (corresponding author), Univ N Carolina, Dept Radiat Oncol, 101 Manning Dr,1050 NCCCC,CB 7512, Chapel Hill, NC 27599 USA.	adricox@med.unc.edu		Chenette, Emily/0000-0003-0393-395X; Buss, Janice/0000-0002-8086-265X; Cox, Adrienne D./0000-0002-4901-2454; Der, Channing/0000-0002-7751-2747	NCI NIH HHS [CA103143, CA63071, CA67771, CA51890, CA109550] Funding Source: Medline; NIGMS NIH HHS [GM46372] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F31CA103143, R01CA051890, R01CA109550, U19CA067771, R01CA063071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046372] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Aronheim A, 1998, CURR BIOL, V8, P1125, DOI 10.1016/S0960-9822(98)70468-3; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Baker TL, 2000, J BIOL CHEM, V275, P22037, DOI 10.1074/jbc.M001813200; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Booden MA, 1999, J BIOL CHEM, V274, P1423, DOI 10.1074/jbc.274.3.1423; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; Chenette EJ, 2005, J BIOL CHEM, V280, P13784, DOI 10.1074/jbc.M411300200; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cox AD, 2002, CURR OPIN PHARMACOL, V2, P388, DOI 10.1016/S1471-4892(02)00181-9; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Du W, 1999, MOL CELL BIOL, V19, P1831; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Fiordalisi JJ, 2001, METHOD ENZYMOL, V332, P3; Fu HW, 1999, RECENT PROG HORM RES, V54, P315; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Ivanchenko M, 2000, PLANT J, V24, P79, DOI 10.1046/j.1365-313x.2000.00855.x; Joyce PL, 2003, CANCER RES, V63, P7959; KHOSRAVIFAR R, 1992, J BIOL CHEM, V267, P24363; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Lavy M, 2002, PLANT CELL, V14, P2431, DOI 10.1105/tpc.005561; Lebowitz PF, 1997, J BIOL CHEM, V272, P16093, DOI 10.1074/jbc.272.26.16093; Lee CHJ, 1996, J NEUROSCI, V16, P6784; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Linder ME, 2004, J CELL SCI, V117, P521, DOI 10.1242/jcs.00989; Magee T, 2005, CURR OPIN CELL BIOL, V17, P190, DOI 10.1016/j.ceb.2005.02.003; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MITCHELL DA, 1994, J BIOL CHEM, V269, P21540; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rotblat B, 2004, MOL CELL BIOL, V24, P6799, DOI 10.1128/MCB.24.15.6799-6810.2004; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Saras J, 2004, EXP CELL RES, V299, P356, DOI 10.1016/j.yexcr.2004.05.029; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schweizer A, 2000, J BIOL CHEM, V275, P29694, DOI 10.1074/jbc.M000571200; Sebti SM, 2000, ONCOGENE, V19, P6584, DOI 10.1038/sj.onc.1204146; Shutes A, 2004, CURR BIOL, V14, P2052, DOI 10.1016/j.cub.2004.11.011; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Solski PA, 2002, CELL GROWTH DIFFER, V13, P363; Symons M, 2000, TRENDS CELL BIOL, V10, P415, DOI 10.1016/S0962-8924(00)01832-8; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; VAN AL, 1997, GENE DEV, V11, P2295; van Golen KL, 2000, CANCER RES, V60, P5832; Wang L, 2003, J BIOL CHEM, V278, P44617, DOI 10.1074/jbc.M308929200; Watson RT, 2003, MOL CELL BIOL, V23, P961, DOI 10.1128/MCB.23.3.961-974.2003; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Whitehead IP, 1998, MOL CELL BIOL, V18, P4689, DOI 10.1128/MCB.18.8.4689; Willumsen BM, 1996, ONCOGENE, V13, P1901; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; ZIMAN M, 1993, MOL BIOL CELL, V4, P1307, DOI 10.1091/mbc.4.12.1307; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	73	57	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					33055	33065		10.1074/jbc.M507362200	http://dx.doi.org/10.1074/jbc.M507362200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16046391	hybrid, Green Published			2022-12-27	WOS:000231920300060
J	Su, YP; Bakker, T; Harris, J; Tsang, C; Brown, GD; Wormald, MR; Gordon, S; Dwek, RA; Rudd, PM; Martinez-Pomares, L				Su, YP; Bakker, T; Harris, J; Tsang, C; Brown, GD; Wormald, MR; Gordon, S; Dwek, RA; Rudd, PM; Martinez-Pomares, L			Glycosylation influences the lectin activities of the macrophage mannose receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DENDRITIC CELLS; CYSTEINE-RICH DOMAIN; CARBOHYDRATE-RECOGNITION DOMAINS; BETA 1,4GLCNAC BETA; SIALIC ACIDS; MURINE MACROPHAGES; PIGMENT-EPITHELIUM; ENDOTHELIAL-CELLS; INTERFERON-GAMMA; DOWN-REGULATION	The mannose receptor ( MR) is a heavily glycosylated endocytic receptor that recognizes both mannosylated and sulfated ligands through its C- type lectin domains and cysteine- rich ( CR) domain, respectively. Differential binding properties have been described for MR isolated from different sources, and we hypothesized that this could be due to altered glycosylation. Using MR transductants and purified MR, we demonstrate that glycosylation differentially affects both MR lectin activities. MR transductants generated in glycosylation mutant cell lines lacked most mannose internalization activity, but could internalize sulfated glycans. Accordingly, purified MR bearing truncated Man(5)-GlcNAc(2) glycans (Man(5)-MR) or non-sialylated complex glycans (SA(0)-MR) did not bind mannosylated glycans, but could recognize SO4-3-Gal in vitro. Additional studies showed that, although mannose recognition was largely independent of the oligomerization state of the protein, recognition of sulfated carbohydrates was mostly mediated by self-associated MR and that, in SA(0)-MR, there was a higher proportion of oligomeric MR. These results suggest that self-association could lead to multiple presentation of CR domains and enhanced avidity for sulfated sugars and that non-sialylated MR is predisposed to oligomerize. Therefore, the glycosylation of MR, terminal sialylation in particular, could influence its binding properties at two levels. (i) It is required for mannose recognition; and ( ii) it modulates the tendency of MR to self-associate, effectively regulating the avidity of the CR domain for sulfated sugar ligands.	Univ Oxford, Glycobiol Inst, Oxford OX1 3QU, England; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; University of Oxford; University of Oxford	Martinez-Pomares, L (corresponding author), Univ Oxford, Glycobiol Inst, S Parks Rd, Oxford OX1 3QU, England.	pauline.rudd@bioch.ox.ac.uk	Wormald, Mark R/G-2785-2011; brown, gordon/B-4249-2012	Wormald, Mark R/0000-0002-4853-2773; Martinez-Pomares, Luisa/0000-0002-2331-127X; brown, gordon/0000-0002-0287-5383; Harris, James/0000-0002-5634-9637				AFROUN S, 1988, BIOCHIM BIOPHYS ACTA, V971, P137; Barnes YC, 1999, BLOOD, V93, P1245, DOI 10.1182/blood.V93.4.1245.404k09_1245_1252; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; BORN GVR, 1985, BRIT J EXP PATHOL, V66, P543; BRAESCHANDERSEN S, 1994, J BIOL CHEM, V269, P11783; BREWER GJ, 1992, BIOCHEMISTRY-US, V31, P1816, DOI 10.1021/bi00121a033; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; da Silva RP, 1999, BIOCHEM J, V338, P687, DOI 10.1042/bj3380687; DEVILLIERS WJS, 1994, IMMUNOL LETT, V43, P73, DOI 10.1016/0165-2478(94)00148-0; DOYLE AG, 1994, EUR J IMMUNOL, V24, P1441, DOI 10.1002/eji.1830240630; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; EZEKOWITZ RAB, 1991, NATURE, V351, P155, DOI 10.1038/351155a0; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; FERRO TJ, 1987, AM REV RESPIR DIS, V135, P1340; Fiete D, 1997, J BIOL CHEM, V272, P14629, DOI 10.1074/jbc.272.23.14629; Fiete D, 1997, P NATL ACAD SCI USA, V94, P11256, DOI 10.1073/pnas.94.21.11256; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; FREEMAN SD, 1995, BLOOD, V85, P2005, DOI 10.1182/blood.V85.8.2005.bloodjournal8582005; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; GUTHRIDGE JM, 1994, IMMUNOL INVEST, V23, P393, DOI 10.3109/08820139409066834; HARRIS N, 1992, BLOOD, V80, P2363; Irjala H, 2001, J EXP MED, V194, P1033, DOI 10.1084/jem.194.8.1033; Jordens R, 1999, INT IMMUNOL, V11, P1775, DOI 10.1093/intimm/11.11.1775; KELM S, 1994, GLYCOCONJUGATE J, V11, P576, DOI 10.1007/BF00731309; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; KERY V, 1992, ARCH BIOCHEM BIOPHYS, V298, P49, DOI 10.1016/0003-9861(92)90092-B; Lambotte O, 2003, J RHEUMATOL, V30, P1027; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Linehan SA, 1999, J EXP MED, V189, P1961, DOI 10.1084/jem.189.12.1961; Linehan SA, 2001, EUR J IMMUNOL, V31, P1857, DOI 10.1002/1521-4141(200106)31:6<1857::AID-IMMU1857>3.0.CO;2-D; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; MARODI L, 1991, J IMMUNOL, V146, P2783; Martinez-Pomares L, 1999, IMMUNOL LETT, V65, P9, DOI 10.1016/S0165-2478(98)00117-5; Martinez-Pomares L, 1998, J BIOL CHEM, V273, P23376, DOI 10.1074/jbc.273.36.23376; Martinez-Pomares L, 2003, J LEUKOCYTE BIOL, V73, P604, DOI 10.1189/jlb.0902450; MartinezPomares L, 1996, J EXP MED, V184, P1927, DOI 10.1084/jem.184.5.1927; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; ORIORDAN DM, 1995, INFECT IMMUN, V63, P779, DOI 10.1128/IAI.63.3.779-784.1995; PONTOW SE, 1992, INT REV CYTOL, V137B, P221; Pontow SE, 1996, J BIOL CHEM, V271, P30736, DOI 10.1074/jbc.271.48.30736; Ramakrishna V, 2004, J IMMUNOL, V172, P2845, DOI 10.4049/jimmunol.172.5.2845; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SHEPHERD VL, 1991, INVEST OPHTH VIS SCI, V32, P1779; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Taylor PR, 2004, P NATL ACAD SCI USA, V101, P1963, DOI 10.1073/pnas.0308490100; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; Wilt SD, 1999, EXP EYE RES, V69, P405, DOI 10.1006/exer.1999.0714; Wollenberg A, 2002, J INVEST DERMATOL, V118, P327, DOI 10.1046/j.0022-202x.2001.01665.x; YANG PF, 1994, J BIOL CHEM, V269, P23039; Yu P, 2002, J IMMUNOL, V168, P5117, DOI 10.4049/jimmunol.168.10.5117; Zamze S, 2002, J BIOL CHEM, V277, P41613, DOI 10.1074/jbc.M207057200	61	56	58	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32811	32820		10.1074/jbc.M503457200	http://dx.doi.org/10.1074/jbc.M503457200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	15983039	hybrid			2022-12-27	WOS:000231920300033
J	Ahmad, A; Kikuchi, H; Takami, Y; Nakayama, T				Ahmad, A; Kikuchi, H; Takami, Y; Nakayama, T			Different roles of N-terminal and C-terminal halves of HIRA in transcription regulation of cell cycle-related genes that contribute to control of vertebrate cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLY FACTOR-I; SYNDROME CRITICAL REGION; DNA-REPLICATION INVITRO; WD DIPEPTIDE MOTIFS; SACCHAROMYCES-CEREVISIAE; DIGEORGE-SYNDROME; HUMAN HOMOLOG; CANDIDATE GENE; HISTONE GENES; CHICKEN HIRA	We reported previously that chicken HIRA, a homolog of Saccharomyces cerevisiae transcriptional co-repressors Hir1p and Hir2p, possesses seven WD dipeptide motifs and an LXXLL motif in its N-terminal and C-terminal halves, respectively, required for transcription regulations. Here, by using the gene targeting technique, we generated the homozygous HIRA-deficient DT40 mutant Delta HIRA. The HIRA deficiency caused slightly delayed cell growth and affected the opposite transcriptions of cell cycle-related genes, i.e. repressions for P18, CDC25B, and BCL-2, activations for P19 and cyclin A, and histones H2A, H2B, H3, and H4. These altered expressions were completely revived by the artificial stable expression of hemagglutinin-tagged HIRA in Delta HIRA. The ability to rescue the delayed growth rate was preferentially aided by the N-terminal half instead of the C-terminal half. We cloned the chicken P18 genomic DNA, and we established that its promoter was located surrounding the sequence GCGGGCGC at positions -1157 to -1150. Chromatin immunoprecipitation assay revealed that the N-terminal half interacted directly or indirectly with the putative promoter region of the p18 gene, resulting in up-regulation of the gene. These results indicated that the N-terminal half of HIRA should contribute positively to the growth rate via up-regulation of a set of cell cycle-related genes, whereas the C-terminal half down-regulated another set of them without exhibiting any effect on the cell growth.	Miyazaki Univ, Coll Med, Frontier Sci Res Ctr, Dept Life Sci, Miyazaki 8891692, Japan; Miyazaki Univ, Coll Med, Dept Med Sci, Sect Biochem & Mol Biol, Miyazaki 8891692, Japan; Japan Sci & Technol, CREST, Chiba 2920818, Japan; Hasanuddin Univ, Dept Chem, Makassar 90245, Indonesia	University of Miyazaki; University of Miyazaki; Japan Science & Technology Agency (JST); Universitas Hasanuddin	Nakayama, T (corresponding author), Miyazaki Univ, Coll Med, Frontier Sci Res Ctr, Dept Life Sci, 5200 Kihara, Miyazaki 8891692, Japan.	tnakayam@med.miyazaki-u.ac.jp						Ahmad A, 2004, GENE, V342, P125, DOI 10.1016/j.gene.2004.07.031; Ahmad A, 2003, BIOCHEM BIOPH RES CO, V312, P1266, DOI 10.1016/j.bbrc.2003.11.073; Blackwell C, 2004, MOL CELL BIOL, V24, P4309, DOI 10.1128/MCB.24.10.4309-4320.2004; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; De Lucia F, 2001, BIOCHEM J, V358, P447, DOI 10.1042/0264-6021:3580447; Dimova D, 1999, MOL CELL, V4, P75, DOI 10.1016/S1097-2765(00)80189-6; Eberhardy SR, 2000, J BIOL CHEM, V275, P33798, DOI 10.1074/jbc.M005154200; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hall C, 2001, MOL CELL BIOL, V21, P1854, DOI 10.1128/MCB.21.5.1854-1865.2001; Ito T, 1996, J BIOL CHEM, V271, P25041, DOI 10.1074/jbc.271.40.25041; Kaufman PD, 1998, MOL CELL BIOL, V18, P4793, DOI 10.1128/MCB.18.8.4793; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Kikuchi H, 2005, GENE, V347, P83, DOI 10.1016/j.gene.2004.12.007; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; KRUDE T, 1995, CURR BIOL, V5, P1232, DOI 10.1016/S0960-9822(95)00245-4; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; Lorain S, 1998, MOL CELL BIOL, V18, P5546, DOI 10.1128/MCB.18.9.5546; Lorain S, 1996, GENOME RES, V6, P43, DOI 10.1101/gr.6.1.43; Magnaghi P, 1998, NAT GENET, V20, P74, DOI 10.1038/1739; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; OSLEY MA, 1987, MOL CELL BIOL, V7, P4204, DOI 10.1128/MCB.7.12.4204; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Roberts C, 1997, HUM MOL GENET, V6, P237, DOI 10.1093/hmg/6.2.237; Roberts C, 2002, MOL CELL BIOL, V22, P2318, DOI 10.1128/MCB.22.7.2318-2328.2002; SAMBROOK J, 1989, MOL CLONING, V2, P9; Scamps C, 1996, BBA-GENE STRUCT EXPR, V1306, P5, DOI 10.1016/0167-4781(96)00010-3; Sharp JA, 2002, GENE DEV, V16, P85, DOI 10.1101/gad.925302; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; SHERWOOD PW, 1993, MOL CELL BIOL, V13, P28, DOI 10.1128/MCB.13.1.28; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; SMITH S, 1991, J BIOL CHEM, V266, P12041; Spector MS, 1997, MOL CELL BIOL, V17, P545, DOI 10.1128/MCB.17.2.545; STILLMAN B, 1986, CELL, V45, P555, DOI 10.1016/0092-8674(86)90287-4; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Takami Y, 2000, J BIOL CHEM, V275, P16191, DOI 10.1074/jbc.M908066199; Takami Y, 1999, J BIOL CHEM, V274, P23977, DOI 10.1074/jbc.274.34.23977; Takami Y, 1995, J BIOL CHEM, V270, P30664, DOI 10.1074/jbc.270.51.30664; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Wilming LG, 1997, HUM MOL GENET, V6, P247, DOI 10.1093/hmg/6.2.247	41	19	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32090	32100		10.1074/jbc.M501426200	http://dx.doi.org/10.1074/jbc.M501426200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16024922	hybrid			2022-12-27	WOS:000231794800008
J	Kimura, T; Hosoda, Y; Sato, Y; Kitamura, Y; Ikeda, T; Horibe, T; Kikuchi, M				Kimura, T; Hosoda, Y; Sato, Y; Kitamura, Y; Ikeda, T; Horibe, T; Kikuchi, M			Interactions among yeast protein-disulfide isomerase proteins and endoplasmic reticulum chaperone proteins influence their activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL DIFFERENCES; MEMBRANE-PROTEINS; IN-VITRO; ERP57; BIP; CALRETICULIN; THIOREDOXIN; SEQUENCE; ENCODES; FAMILY	We previously reported that the reductive activities of yeast protein-disulfide isomerase (PDI) family proteins did not completely explain their contribution to the viability of Saccharomyces cerevisiae (Kimura, T., Hosoda, Y., Kitamura, Y., Nakamura, H., Horibe, T., and Kikuchi, M. (2004) Biochem. Biophys. Res. Commun. 320, 359-365). In this study, we examined oxidative refolding activities and found that Mpd1p, Mpd2, and Eug1p exhibit activities of 13.8, 16.0, and 2.16%, respectively, compared with Pdi1p and that activity for Eps1p is undetectable. In analyses of interactions between yeast PDI proteins and endoplasmic reticulum molecular chaperones, we found that Mpd1p alone does not have chaperone activity but that it interacts with and inhibits the chaperone activity of Cne1p, a homologue of mammalian calnexin, and that Cne1p increases the reductive activity of Mpd1p. These results suggest that the interface between Mpd1p and Cne1p is near the peptide-binding site of Cne1p. In addition, Eps1p interacts with Pdi1p, Eug1p, Mpd1p, and Kar2p with dissociation constants (K-D) in the range of 10(-7) to 10(-6) M. Interestingly, co-chaperone activities were completely suppressed in Eps1p-Pdi1p and Eps1p-Mpd1p complexes, although only Eps1p and Pdi1p have chaperone activity. The in vivo consequences of these results are discussed.	Ritsumeikan Univ, Coll Informat Sci & Engn, Dept Biosci & Bioinformat, Shiga 5258577, Japan	Ritsumeikan University	Kikuchi, M (corresponding author), Ritsumeikan Univ, Coll Informat Sci & Engn, Dept Biosci & Bioinformat, 1-1-1 Nojihigashi, Shiga 5258577, Japan.	kikuchi@is.ritsumei.ac.jp						Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Elliott JG, 1997, J BIOL CHEM, V272, P13849, DOI 10.1074/jbc.272.21.13849; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; GUNTHER R, 1991, J BIOL CHEM, V266, P24557; Hayano T, 1995, FEBS LETT, V377, P505, DOI 10.1016/0014-5793(95)01410-1; Horibe T, 2002, J BIOCHEM, V132, P401, DOI 10.1093/oxfordjournals.jbchem.a003236; Hosoda A, 2003, J BIOL CHEM, V278, P2669, DOI 10.1074/jbc.M208346200; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; IBBETSON AL, 1976, BIOCHEM J, V159, P377, DOI 10.1042/bj1590377; Katiyar S, 2001, BBA-PROTEIN STRUCT M, V1548, P47, DOI 10.1016/S0167-4838(01)00214-X; Kimura T, 2005, BIOCHEM BIOPH RES CO, V331, P224, DOI 10.1016/j.bbrc.2005.03.147; Kimura T, 2004, BIOCHEM BIOPH RES CO, V320, P359, DOI 10.1016/j.bbrc.2004.05.178; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Matsuo Y, 2001, J BIOL CHEM, V276, P10032, DOI 10.1074/jbc.M011037200; Mayer M, 2000, J BIOL CHEM, V275, P29421, DOI 10.1074/jbc.M002655200; Norgaard P, 2001, J CELL BIOL, V152, P553, DOI 10.1083/jcb.152.3.553; Norgaard P, 2001, BIOCHEM J, V358, P269, DOI 10.1042/0264-6021:3580269; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; Ohlmeier S, 2004, J BIOL CHEM, V279, P3956, DOI 10.1074/jbc.M310160200; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; OTSU M, 1995, J BIOL CHEM, V270, P14958, DOI 10.1074/jbc.270.25.14958; Primm TP, 1996, J BIOL CHEM, V271, P33664, DOI 10.1074/jbc.271.52.33664; PUIG A, 1994, J BIOL CHEM, V269, P25889; TACHIBANA C, 1992, MOL CELL BIOL, V12, P4601, DOI 10.1128/MCB.12.10.4601; Tachikawa H, 1997, BIOCHEM BIOPH RES CO, V239, P710, DOI 10.1006/bbrc.1997.7426; TACHIKAWA H, 1995, FEBS LETT, V369, P212, DOI 10.1016/0014-5793(95)00750-4; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Veijola J, 1996, BIOCHEM J, V315, P613, DOI 10.1042/bj3150613; Wang QQ, 1999, EMBO J, V18, P5972, DOI 10.1093/emboj/18.21.5972; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009	34	33	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31438	31441		10.1074/jbc.M503377200	http://dx.doi.org/10.1074/jbc.M503377200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16002399	hybrid			2022-12-27	WOS:000231665200014
J	Moore, J; Bailey, SES; Benmechernene, Z; Tzitzilonis, C; Griffiths, NJE; Virji, M; Derrick, JP				Moore, J; Bailey, SES; Benmechernene, Z; Tzitzilonis, C; Griffiths, NJE; Virji, M; Derrick, JP			Recognition of saccharides by the OpcA, OpaD, and OpaB outer membrane proteins from Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; CRYSTAL-STRUCTURE; PROTEOGLYCAN RECEPTORS; TYROSINE FLUORESCENCE; PATHOGENIC NEISSERIA; COMMENSAL NEISSERIA; N-ACETYLGLUCOSAMINE; INTEGRIN RECEPTORS; STRUCTURAL BASIS	The adhesion of the pathogen Neisseria meningitidis to host cell surface proteoglycan, mediated by the integral outer membrane proteins OpcA and Opa, plays an important part in the processes of colonization and invasion by the bacterium. The precise specificities of the OpcA and Opa proteins are, however, unknown. Here we use a fluorescence-based binding assay to show that both proteins bind to mono- and disaccharides with high affinity. Binding of saccharides caused a quench in the intrinsic fluorescence emission of both proteins, and mutation of selected Tyr residues within the external loop regions caused a substantial decrease in fluorescence. We suggest that the intrinsic fluorescence arises from resonance energy transfer from Tyr to Trp residues in the beta-barrel portion of the structure. OpcA bound sialic acid with a K-d of 0.31 mu M and was shown to be specific for pyranose saccharides. The binding specificities of two different Opa proteins were compared; unlike OpcA, neither protein bound to monosaccharides, but both bound to maltose, lactose, and sialic acid-containing oligosaccharides, with K-d values in the micromolar range. OpaB had a 10-fold higher affinity for sialic acid-containing ligands than OpaD as a result of the mutation Y165V, which was shown to restore this specificity to OpaD. Finally, the OpcA- and Opa-dependent adhesion of meningococci to epithelial cells was shown to be partially inhibited by exogenously added sialic acid and maltose. The results show that OpcA and the Opa proteins can be thought of as outer membrane lectins and that simple saccharides can modulate their recognition of complex proteoglycan receptors.	Univ Manchester, Fac Life Sci, Manchester M60 1QD, Lancs, England; Univ Bristol, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England	University of Manchester; University of Bristol	Derrick, JP (corresponding author), Univ Manchester, Fac Life Sci, Manchester M60 1QD, Lancs, England.	Jeremy.Derrick@manchester.ac.uk		Derrick, Jeremy/0000-0002-4350-5354	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ACHTMAN M, 1988, J EXP MED, V168, P507, DOI 10.1084/jem.168.2.507; APICELLA MA, 1990, PRINCIPLES PRACTICE; BHAT KS, 1991, MOL MICROBIOL, V5, P1889, DOI 10.1111/j.1365-2958.1991.tb00813.x; Billker O, 2000, TRENDS MICROBIOL, V8, P258, DOI 10.1016/S0966-842X(00)01771-6; Bos MP, 1998, P NATL ACAD SCI USA, V95, P9584, DOI 10.1073/pnas.95.16.9584; Buts L, 2003, MOL MICROBIOL, V49, P705, DOI 10.1046/j.1365-2958.2003.03600.x; Cartwright K, 1995, MENINGOCOCCAL DIS; Cesur N, 2002, J PHARMACEUT BIOMED, V28, P487, DOI 10.1016/S0731-7085(01)00675-6; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; CHIPMAN DM, 1967, J BIOL CHEM, V242, P4388; de Vries FP, 1998, MOL MICROBIOL, V27, P1203, DOI 10.1046/j.1365-2958.1998.00763.x; Dehio C, 1998, EXP CELL RES, V242, P528, DOI 10.1006/excr.1998.4116; Dehio C, 1998, TRENDS MICROBIOL, V6, P489, DOI 10.1016/S0966-842X(98)01365-1; Dehio M, 1998, FEBS LETT, V424, P84, DOI 10.1016/S0014-5793(98)00144-6; Derrick JP, 1999, INFECT IMMUN, V67, P2406, DOI 10.1128/IAI.67.5.2406-2413.1999; Douliez JP, 2000, BBA-BIOMEMBRANES, V1467, P65, DOI 10.1016/S0005-2736(00)00197-8; Duensing TD, 1998, BIOCHEM J, V334, P133, DOI 10.1042/bj3340133; Duensing TD, 1997, INFECT IMMUN, V65, P964, DOI 10.1128/IAI.65.3.964-970.1997; Eisenhawer M, 2001, BIOCHEMISTRY-US, V40, P12321, DOI 10.1021/bi0107694; Fotinou C, 2001, J BIOL CHEM, V276, P32274, DOI 10.1074/jbc.M103285200; Freissler E, 2000, CELL MICROBIOL, V2, P69, DOI 10.1046/j.1462-5822.2000.00036.x; Grant CCR, 1999, MOL MICROBIOL, V32, P233, DOI 10.1046/j.1365-2958.1999.01293.x; Hobbs MM, 1998, MICROBIOL-UK, V144, P157, DOI 10.1099/00221287-144-1-157; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Malorny B, 1998, J BACTERIOL, V180, P1323, DOI 10.1128/JB.180.5.1323-1330.1998; Merker P, 1997, MOL MICROBIOL, V23, P281, DOI 10.1046/j.1365-2958.1997.2051567.x; Nassif X, 1999, MOL MICROBIOL, V32, P1124, DOI 10.1046/j.1365-2958.1999.01416.x; Nassif X, 1999, CURR OPIN MICROBIOL, V2, P71, DOI 10.1016/S1369-5274(99)80012-5; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Prince SM, 2002, P NATL ACAD SCI USA, V99, P3417, DOI 10.1073/pnas.062630899; Prince SM, 2001, ACTA CRYSTALLOGR D, V57, P1164, DOI 10.1107/S0907444901009416; ROSENQVIST E, 1993, J INFECT DIS, V167, P1065, DOI 10.1093/infdis/167.5.1065; Seller A, 1996, MOL MICROBIOL, V19, P841, DOI 10.1046/j.1365-2958.1996.437970.x; Toleman M, 2001, CELL MICROBIOL, V3, P33, DOI 10.1046/j.1462-5822.2001.00089.x; Urwin R, 2002, MOL BIOL EVOL, V19, P1686, DOI 10.1093/oxfordjournals.molbev.a003991; van Putten JPM, 1998, MOL MICROBIOL, V29, P369, DOI 10.1046/j.1365-2958.1998.00951.x; Vandeputte-Rutten L, 2003, J BIOL CHEM, V278, P24825, DOI 10.1074/jbc.M302803200; vanPutten JPM, 1997, INFECT IMMUN, V65, P5028, DOI 10.1128/IAI.65.12.5028-5034.1997; VANPUTTEN JPM, 1995, EMBO J, V14, P2144, DOI 10.1002/j.1460-2075.1995.tb07208.x; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; Virji M, 2000, TRENDS MICROBIOL, V8, P260, DOI 10.1016/S0966-842X(00)01772-8; VIRJI M, 1994, MOL MICROBIOL, V14, P173, DOI 10.1111/j.1365-2958.1994.tb01277.x; VIRJI M, 1992, MOL MICROBIOL, V6, P2785, DOI 10.1111/j.1365-2958.1992.tb01458.x; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1995, MOL MICROBIOL, V18, P741, DOI 10.1111/j.1365-2958.1995.mmi_18040741.x; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; VIRJI M, 1993, MOL MICROBIOL, V10, P499, DOI 10.1111/j.1365-2958.1993.tb00922.x; VIRJI M, 1981, INFECT IMMUN, V31, P965, DOI 10.1128/IAI.31.3.965-970.1981; WOLFF K, 1995, FEMS MICROBIOL LETT, V125, P255; Zhu PX, 2003, GENE, V307, P31, DOI 10.1016/S0378-1119(02)01208-8; Zhu PX, 1999, MOL MICROBIOL, V33, P635, DOI 10.1046/j.1365-2958.1999.01514.x	53	42	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31489	31497		10.1074/jbc.M506354200	http://dx.doi.org/10.1074/jbc.M506354200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16006553	hybrid			2022-12-27	WOS:000231665200020
J	Morris, DP; Michelotti, GA; Schwinn, DA				Morris, DP; Michelotti, GA; Schwinn, DA			Evidence that phosphorylation of the RNA polymerase II carboxyl-terminal repeats is similar in yeast and humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; PRE-MESSENGER-RNA; HEAT-SHOCK GENES; CAPPING ENZYME; IN-VIVO; TRANSCRIPTIONAL ELONGATION; DROSOPHILA-MELANOGASTER; ASSOCIATING PROTEINS; PROCESSING FACTORS; PROXIMAL REGION	Using an improved chromatin immunoprecipitation assay designed to increase immunoprecipitation efficiency, we investigated changes in RNA polymerase II (Pol II) density and carboxyl-terminal domain (CTD) phosphorylation during transcription of the cyclophilin A (PPIA), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and several androgen-responsive genes in LNCaP cells. As generally observed in higher eukaryotes, promoter proximal pausing of Pol II appeared to occur on the PPIA and GAPDH genes, but apparently not on the androgen-responsive genes PSA and NKX3-1. Unlike some mammalian studies, we found that the CTD of Pol II in promoter regions contains little phosphorylation at Ser-2 of the heptad repeat, suggesting that Ser-2 phosphorylation is not involved in polymerase exit from the promoter region. In contrast, Pol II near the promoter displayed high levels of Ser-5 phosphorylation, which decreased as polymerase transcribed beyond the promoter region of the PPIA and GAPDH genes. However, total Pol II levels appear to decrease as much or more, suggesting that Ser-5 phosphorylation is maintained. In support of this conclusion, a phosphoserine 5-specific antibody quantitatively immunoprecipitates native hyperphosphorylated Pol II, suggesting that all polymerase with phosphoserine 2 also contains phosphoserine 5. Given reports indicating that phosphoserine 5 is present during elongation in yeast, our data suggest that gross changes in CTD phosphorylation patterns during transcription may be more conserved in yeast and humans than recognized previously.	Duke Univ, Ctr Med, Dept Anesthesiol, Durham, NC 27710 USA; Duke Univ, Ctr Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Ctr Med, Dept Surg, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Morris, DP (corresponding author), Duke Univ, Ctr Med, Dept Anesthesiol, 595 LaSalle St, Durham, NC 27710 USA.	morri082@mc.duke.edu		, Gregory/0000-0002-3936-4675; Michelotti, Gregory/0000-0002-7908-1979; Schwinn, Debra/0000-0002-9696-5231	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049103] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL049103-13, R37 HL049103, R37 HL049103-11, R37 HL049103-12, R37 HL049103-14] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; Carty SM, 2002, MOL CELL PROTEOMICS, V1, P598, DOI 10.1074/mcp.M200029-MCP200; Cheng CH, 2003, MOL CELL BIOL, V23, P1961, DOI 10.1128/MCB.23.6.1961-1967.2003; Cho EJ, 1998, GENE DEV, V12, P3482, DOI 10.1101/gad.12.22.3482; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; EICK D, 1994, ANAL BIOCHEM, V218, P347, DOI 10.1006/abio.1994.1190; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Guo ZH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-69; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Ho CK, 1998, J BIOL CHEM, V273, P9577, DOI 10.1074/jbc.273.16.9577; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Kotovic KM, 2003, MOL CELL BIOL, V23, P5768, DOI 10.1128/MCB.23.16.5768-5779.2003; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; KRUMM A, 1993, BIOESSAYS, V15, P659, DOI 10.1002/bies.950151005; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Mo XM, 2002, MOL CELL BIOL, V22, P8088, DOI 10.1128/MCB.22.22.8088-8099.2002; Morillon A, 2003, SCIENCE, V300, P492, DOI 10.1126/science.1081379; Myers LC, 2002, MOL CELL, V10, P883, DOI 10.1016/S1097-2765(02)00644-5; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Noble CG, 2005, NAT STRUCT MOL BIOL, V12, P144, DOI 10.1038/nsmb887; OBRIEN T, 1994, NATURE, V370, P75, DOI 10.1038/370075a0; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Prelich G, 2002, EUKARYOT CELL, V1, P153, DOI 10.1128/EC.1.2.153-162.2002; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; SIMS RJ, 2004, GENE DEV, V18, P2437, DOI DOI 10.1101/GAD.1235904; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; WEEKS JR, 1993, GENE DEV, V7, P2329, DOI 10.1101/gad.7.12a.2329; Wen YX, 1999, GENE DEV, V13, P1774, DOI 10.1101/gad.13.14.1774; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019	64	40	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31368	31377		10.1074/jbc.M501546200	http://dx.doi.org/10.1074/jbc.M501546200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16012166	Green Accepted, hybrid			2022-12-27	WOS:000231665200006
J	Hammar, EB; Irminger, JC; Rickenbach, K; Parnaud, G; Ribaux, P; Bosco, D; Rouiller, DG; Halban, PA				Hammar, EB; Irminger, JC; Rickenbach, K; Parnaud, G; Ribaux, P; Bosco, D; Rouiller, DG; Halban, PA			Activation of NF-kappa B by extracellular matrix is involved in spreading and glucose-stimulated insulin secretion of pancreatic beta cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; SIGNAL-TRANSDUCTION; ADHESION RECEPTORS; SHORT-TERM; IN-VITRO; INTEGRIN; APOPTOSIS; ISLETS; EXPRESSION; ALPHA	Laminin-5-rich extracellular matrix derived from 804G cells ( 804G-ECM) engages beta 1 integrins to induce spreading, improve glucose-stimulated insulin secretion ( GSIS), and increase survival of pancreatic beta cells. The present study examines whether 804G-ECM activates the transcriptional activity of NF-kappa B and the involvement of NF-kappa B in those effects of 804G-ECM on pancreatic beta cells. 804G-ECM induces nuclear translocation and the DNA binding activity of the p65 subunit of NF-kappa B. 804G-ECM-induced nuclear translocation of NF-kappa B was weak as compared with that induced by interleukin-1 beta. Transient 804G-ECM-induced DNA binding activity of NF-kappa B ( peak at 2 h) and overexpression of NF-kappa B target genes I kappa B alpha and NF-kappa B1( p105) ( peak at 4 h) were observed. When NF-kappa B was inhibited by an inhibitor of I kappa B alpha phosphorylation ( Bay 11-7082) or by a recombinant adenovirus expressing the nonphosphorylatable form of I kappa B alpha, 804G-ECM-induced cell spreading and actin cytoskeleton organization were reduced. GSIS from cells on 804G-ECM was inhibited 5-fold, whereas cell survival was not affected. In summary, the results indicate that 804G-ECM induces a transient and moderate NF-kappa B activity. This study shows for the first time that ECM- induced NF-kappa B activity is necessary in maintaining GSIS, although it does not affect survival of pancreatic beta cells. The effects of ECM- induced NF-kappa B activity contrast with the deleterious effects of cytokine-induced NF-kappa B activity. It is proposed that transient and moderate NF-kappa B activity is essential for proper function of the pancreatic beta cell.	Univ Geneva, Med Ctr, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Cell Isolat & Transplantat Ctr, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Hammar, EB (corresponding author), Univ Geneva, Med Ctr, Dept Genet Med & Dev, Rue Michel Servet 1, CH-1211 Geneva, Switzerland.	eva.hammar@medecine.unige.ch	Ferrante, Antonio/B-1927-2008	Ferrante, Antonio/0000-0001-7781-9784; Hammar, Eva/0000-0002-3267-2202; Bosco, Domenico/0000-0003-3453-9613				Alahari SK, 2002, INT REV CYTOL, V220, P145; Anrather J, 2005, J BIOL CHEM, V280, P244, DOI 10.1074/jbc.M409344200; BEATTIE GM, 1991, J CLIN ENDOCR METAB, V73, P93, DOI 10.1210/jcem-73-1-93; Bernal-Mizrachi E, 2002, DIABETES, V51, pS484, DOI 10.2337/diabetes.51.2007.S484; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; de Fougerolles AR, 2000, IMMUNITY, V13, P749, DOI 10.1016/S1074-7613(00)00073-X; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Furukawa K, 1998, J NEUROCHEM, V70, P1876; GABBIANI G, 1974, ENDOCRINOLOGY, V95, P1630, DOI 10.1210/endo-95-6-1630; Giannoukakis N, 2000, J BIOL CHEM, V275, P36509, DOI 10.1074/jbc.M005943200; Hammar E, 2004, DIABETES, V53, P2034, DOI 10.2337/diabetes.53.8.2034; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Kaido T, 2004, J BIOL CHEM, V279, P53762, DOI 10.1074/jbc.M411202200; KAISER N, 1988, ENDOCRINOLOGY, V123, P834, DOI 10.1210/endo-123-2-834; Klein S, 2002, MOL CELL BIOL, V22, P5912, DOI 10.1128/MCB.22.16.5912-5922.2002; LI GD, 1994, MOL BIOL CELL, V5, P1199, DOI 10.1091/mbc.5.11.1199; Malek S, 1998, J BIOL CHEM, V273, P25427, DOI 10.1074/jbc.273.39.25427; McGilvray ID, 1997, J BIOL CHEM, V272, P10287; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Nagata N, 2001, CELL TRANSPLANT, V10, P447; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; Norlin S, 2005, DIABETES, V54, P125, DOI 10.2337/diabetes.54.1.125; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Papaccio G, 2005, J CELL PHYSIOL, V204, P124, DOI 10.1002/jcp.20276; Parnaud G, 2005, AM J PHYSIOL-ENDOC M, V289, pE313, DOI 10.1152/ajpendo.00006.2005; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; QWARNSTROM EE, 1994, J BIOL CHEM, V269, P30765; Rehman KK, 2003, J BIOL CHEM, V278, P9862, DOI 10.1074/jbc.M207700200; Reyes-Reyes M, 2001, J CELL SCI, V114, P1579; Ris F, 2002, DIABETOLOGIA, V45, P841, DOI 10.1007/s00125-002-0840-7; Rosales C, 1996, CANCER RES, V56, P2302; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; ROUILLER DG, 1990, EXP CELL RES, V191, P305, DOI 10.1016/0014-4827(90)90019-7; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Thomas FT, 1999, SURGERY, V126, P299, DOI 10.1067/msy.1999.99164; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tian B, 2003, RECENT PROG HORM RES, V58, P95, DOI 10.1210/rp.58.1.95; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023; Zeender E, 2004, J CLIN ENDOCR METAB, V89, P5059, DOI 10.1210/jc.2004-0446	53	82	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30630	30637		10.1074/jbc.M502493200	http://dx.doi.org/10.1074/jbc.M502493200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15994334	hybrid, Green Published			2022-12-27	WOS:000231362500080
J	Kinclova-Zimmermannova, O; Zavrel, M; Sychrova, H				Kinclova-Zimmermannova, O; Zavrel, M; Sychrova, H			Identification of conserved prolyl residue important for transport activity and the substrate specificity range of yeast plasma membrane Na+/H+ antiporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROLINE RESIDUES; ESCHERICHIA-COLI; ZYGOSACCHAROMYCES-ROUXII; TRANSMEMBRANE HELICES; SALT-TOLERANCE; ALPHA-HELICES; NHA1 ANTIPORTER; CATION/H+ ANTIPORTERS; FUNCTIONAL-ANALYSIS	Yeast plasma membrane Na+/H+ antiporters are divided according to their substrate specificity in two distinct subfamilies. To identify amino acid residues responsible for substrate specificity determination ( recognition of K+), the Zygosaccharomyces rouxii Sod2-22 antiporter ( non-transporting K+) was mutagenized and a collection of ZrSod2-22 mutants that improved the KCl tolerance of a salt-sensitive Saccharomyces cerevisiae strain was isolated. Several independent ZrSod2-22 mutated alleles contained the replacement of a highly conserved proline 145 with a residue containing a hydroxyl group ( Ser, Thr). Site-directed mutagenesis of Pro(145) proved that an amino acid with a hydroxyl group at this position is enough to enable ZrSod2-22p to transport K+. Simultaneously, the P145( S/T) mutation decreased the antiporter transport activity for both Na+ and Li+. Replacement of Pro(145) with glycine resulted in a ZrSod2-22p with extremely low activity only for Na+, and the exchange of a charged residue ( Asp, Lys) for Pro(145) completely stopped the activity. Mutagenesis of the corresponding proline in the S. cerevisiae Nha1 antiporter ( Pro(146)) confirmed that this proline of the fifth transmembrane domain is a critical residue for antiporter function. This is the first evidence that a non-polar amino acid residue is important for the substrate specificity and activity of yeast Nha antiporters.	Acad Sci Czech Republ, Inst Physiol, Dept Membrane Transport, CR-14220 Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Kinclova-Zimmermannova, O (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Membrane Transport, Videnska 1083, CR-14220 Prague, Czech Republic.	kinclova@biomed.cas.cz	Sychrova, Hana/B-1350-2012; Zimmermannova, Olga/B-7925-2012; Zavrel, Martin/C-9918-2015	Sychrova, Hana/0000-0001-5967-5019; Zimmermannova, Olga/0000-0003-2538-4488; Zavrel, Martin/0000-0003-4740-876X				Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; Banuelos MA, 2002, YEAST, V19, P1365, DOI 10.1002/yea.922; BRANDL CJ, 1986, P NATL ACAD SCI USA, V83, P917, DOI 10.1073/pnas.83.4.917; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; BROWN AJP, 1998, METHOD MICROBIOL, V26, P59; Chakrabarti P, 1998, J MOL BIOL, V284, P867, DOI 10.1006/jmbi.1998.2199; Cliften PF, 2001, GENOME RES, V11, P1175, DOI 10.1101/gr.182901; CONSLER TG, 1991, BIOCHEMISTRY-US, V30, P1291, DOI 10.1021/bi00219a019; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Dibrov P, 1998, FEBS LETT, V424, P1, DOI 10.1016/S0014-5793(98)00119-7; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fliegel L, 2005, MOL CELL BIOCHEM, V268, P83; Fliegel L, 2002, ANN NY ACAD SCI, V976, P117; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; GRAY TM, 1984, J MOL BIOL, V175, P75, DOI 10.1016/0022-2836(84)90446-7; HARO R, 1991, FEBS LETT, V291, P189, DOI 10.1016/0014-5793(91)81280-L; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Iwaki T, 1998, YEAST, V14, P1167, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1167::AID-YEA318>3.0.CO;2-5; JIA ZP, 1992, EMBO J, V11, P1631, DOI 10.1002/j.1460-2075.1992.tb05209.x; Kamauchi S, 2002, J BIOCHEM, V131, P821, DOI 10.1093/oxfordjournals.jbchem.a003171; KAWAKAMI T, 1988, J BIOL CHEM, V263, P14276; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kinclova O, 2001, MOL MICROBIOL, V40, P656, DOI 10.1046/j.1365-2958.2001.02412.x; Kinclova O, 2002, MICROBIOL-SGM, V148, P1225, DOI 10.1099/00221287-148-4-1225; Kinclova O, 2001, FEBS LETT, V504, P11, DOI 10.1016/S0014-5793(01)02755-7; Kinclova O, 2001, J BIOTECHNOL, V88, P151, DOI 10.1016/S0168-1656(01)00274-7; Koike K, 2004, J BIOL CHEM, V279, P12325, DOI 10.1074/jbc.M311435200; Kuwabara N, 2004, J BIOL CHEM, V279, P40567, DOI 10.1074/jbc.M401132200; Lin ZC, 2000, FASEB J, V14, P715, DOI 10.1096/fasebj.14.5.715; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Maresova L, 2005, MOL MICROBIOL, V55, P588, DOI 10.1111/j.1365-2958.2004.04410.x; MCGREGOR MJ, 1987, J MOL BIOL, V198, P295, DOI 10.1016/0022-2836(87)90314-7; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NAKAMURA T, 1995, BBA-BIOENERGETICS, V1230, P170, DOI 10.1016/0005-2728(95)00053-L; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Noumi T, 1997, J BIOCHEM-TOKYO, V121, P661; Olivella M, 2002, BIOPHYS J, V82, P3207, DOI 10.1016/S0006-3495(02)75663-4; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Prior C, 1996, FEBS LETT, V387, P89, DOI 10.1016/0014-5793(96)00470-X; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Ramirez J, 1998, J BACTERIOL, V180, P5860; RAMOS J, 1986, EUR J BIOCHEM, V154, P307, DOI 10.1111/j.1432-1033.1986.tb09398.x; Regenberg B, 2001, YEAST, V18, P1429, DOI 10.1002/yea.792.abs; RODRIGUEZNAVARRO A, 1994, BBA-BIOENERGETICS, V1187, P203, DOI 10.1016/0005-2728(94)90111-2; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANSOM MSP, 1992, PROTEIN ENG, V5, P53, DOI 10.1093/protein/5.1.53; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Simon E, 2001, J BIOL CHEM, V276, P29740, DOI 10.1074/jbc.M101992200; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Soong TW, 2000, MICROBIOL-UK, V146, P1035, DOI 10.1099/00221287-146-5-1035; Sychrova H, 1999, FEMS MICROBIOL LETT, V171, P167, DOI 10.1111/j.1574-6968.1999.tb13428.x; Sychrova H, 2004, PHYSIOL RES, V53, pS91; Ulmschneider MB, 2005, PROTEINS, V59, P252, DOI 10.1002/prot.20334; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; Visiers I, 2000, PROTEIN ENG, V13, P603, DOI 10.1093/protein/13.9.603; WATANABE Y, 1995, YEAST, V11, P829, DOI 10.1002/yea.320110905; Watanabe Y, 2002, FEMS MICROBIOL LETT, V209, P39, DOI 10.1111/j.1574-6968.2002.tb11106.x; Wiebe CA, 2003, MOL CELL BIOCHEM, V254, P117, DOI 10.1023/A:1027311916247; WILLIAMS KA, 1991, BIOCHEMISTRY-US, V30, P8919, DOI 10.1021/bi00101a001; WOOLFSON DN, 1990, FEBS LETT, V277, P185, DOI 10.1016/0014-5793(90)80839-B; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	68	42	42	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30638	30647		10.1074/jbc.M506341200	http://dx.doi.org/10.1074/jbc.M506341200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15994323	hybrid			2022-12-27	WOS:000231362500081
J	Yamazaki, Y; Matsunaga, Y; Nakano, Y; Morita, T				Yamazaki, Y; Matsunaga, Y; Nakano, Y; Morita, T			Identification of vascular endothelial growth factor receptor-binding protein in the venom of eastern cottonmouth - A new role of snake venom myotoxic Lys(49)-phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING RECEPTOR; LYS49 PHOSPHOLIPASE A(2); CRYSTAL-STRUCTURE; VEGF BINDING; KINASE; LIGAND; DISSOCIATION; APOPTOSIS; VEGF(165); PEPTIDES	Vascular endothelial growth factor (VEGF(165)) and its receptor KDR ( kinase insert domain-containing receptor) are central regulators of blood vessel formation. We herein report a KDR-binding protein we have isolated in the venom of eastern cottonmouth (Agkistrodon piscivorus piscivorus). Sequence analysis revealed the isolated KDR-binding protein (designated KDR- bp) is identical to Lys49-phosholipase A(2) (Lys(49)PLA(2)), an inactive PLA(2) homologue with strong myotoxicity, in which Lys(49) substitutes Asp(49), a key residue for binding the essential cofactor Ca2+. KDR-bp binds to the extracellular domain of KDR with subnanomolar affinity. KDR- bp also binds to a lesser extent with Flt-1 and IgG but not to other receptors with similar immunoglobulin-like domain structures such as platelet-derived growth factor receptor alpha. The interaction between KDR-bp and KDR was blocked by VEGF165, and KDR- bp specifically inhibited VEGF165-stimulated endothelial cell proliferation, indicating KDR-bp is an antagonistic ligand for KDR. Lys(49)PLA(2)s from another snake venom were found to exhibit similar receptor binding properties to KDR-bp. This is the first report to demonstrate that an exogenous factor antagonizes VEGF and its receptor system. Our observation offers further insight into the as yet unknown molecular mechanism of myotoxic activity of snake venom Lys49PLA2s. Furthermore, KDR- bp would make a valuable tool for studying the structure and function of KDR, such as that expressed on skeletal muscle cells.	Meiji Pharmaceut Univ, Dept Biochem, Tokyo 2048588, Japan	Meiji Pharmaceutical University	Morita, T (corresponding author), Meiji Pharmaceut Univ, Dept Biochem, 2-522-1 Noshio, Tokyo 2048588, Japan.	tmorita@my-pharm.ac.jp		Matsunaga, Yukiko/0000-0002-1392-5681; Yamazaki, Yasuo/0000-0001-5297-9837				Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; de Oliveira AHC, 2001, BIOCHEMISTRY-US, V40, P6912, DOI 10.1021/bi0026728; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Dias S, 2000, J CLIN INVEST, V106, P511, DOI 10.1172/JCI8978; Dias S, 2002, BLOOD, V99, P2532, DOI 10.1182/blood.V99.7.2532; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197; Germani A, 2003, AM J PATHOL, V163, P1417, DOI 10.1016/S0002-9440(10)63499-2; Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005; HOLLAND DR, 1990, J BIOL CHEM, V265, P17649; Joukov V, 1996, EMBO J, V15, P290; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008; Lomonte B, 2003, TOXICON, V42, P307, DOI 10.1016/S0041-0101(03)00149-1; Mizuno H, 2001, P NATL ACAD SCI USA, V98, P7230, DOI 10.1073/pnas.131179698; Mora R, 2005, TOXICON, V45, P651, DOI 10.1016/j.toxicon.2005.01.008; Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Rocha SLG, 2002, EUR J BIOCHEM, V269, P6052, DOI 10.1046/j.1432-1033.2002.03308.x; Shinkai A, 1998, J BIOL CHEM, V273, P31283, DOI 10.1074/jbc.273.47.31283; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Suto K, 2005, J BIOL CHEM, V280, P2126, DOI 10.1074/jbc.M411395200; Tans G, 2001, HAEMOSTASIS, V31, P225; TESSLER S, 1994, J BIOL CHEM, V269, P12456; Ward RJ, 2002, BIOCHEM J, V362, P89, DOI 10.1042/0264-6021:3620089; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Yamazaki Y, 2003, J BIOL CHEM, V278, P51985, DOI 10.1074/jbc.C300454200	28	45	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					29989	29992		10.1074/jbc.C500236200	http://dx.doi.org/10.1074/jbc.C500236200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	16014630	hybrid			2022-12-27	WOS:000231362500002
J	Chen, S; Rani, S; Wu, YM; Unterbrink, A; Gu, TT; Gluhak-Heinrich, J; Chuang, HH; MacDougall, M				Chen, S; Rani, S; Wu, YM; Unterbrink, A; Gu, TT; Gluhak-Heinrich, J; Chuang, HH; MacDougall, M			Differential regulation of dentin sialophosphoprotein expression by Runx2 during odontoblast cytodifferentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; OSTEOCALCIN GENE-EXPRESSION; GROWTH-FACTOR BETA-1; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; CLEIDOCRANIAL DYSPLASIA; DSPP GENE; TOOTH DEVELOPMENT; SEQUENCE DETERMINATION; CELL-DIFFERENTIATION	Dentin sialophosphoprotein (DSPP) consists of dentin sialoprotein (DSP) and dentin phosphoprotein (DPP). The spatial-temporal expression of DSPP is largely restricted during differentiational stages of dental cells. DSPP plays a vital role in tooth development. It is known that an osteoblast-specific transcription factor, Runx2, is essential for osteoblast differentiation. However, effects of Runx2 on DSPP transcription remain unknown. Here, we studied different roles of Runx2 in controlling DSPP expression in mouse preodontoblast (MD10-F2) and odontoblast (MO6-G3) cells. Two Runx2 isoforms were expressed in preodontoblast and odontoblast cells, and in situ hybridization assay showed that DSPP expression increased, whereas Runx2 was down-regulated during odontoblast differentiation and maturation. Three potential Runx2 sites are present in promoters of mouse and rat DSPP genes. Runx2 binds to these sites as demonstrated by electrophoretic mobility shift assay and supershift experiments. Mutations of Runx2 sites in mouse DSPP promoter resulted in a decline of promoter activity in MD10-F2 cells compared with an increase of its activity in MO6-G3 cells. Multiple Runx2 sites were more active than a single site in regulating the DSPP promoter. Furthermore, forced overexpression of Runx2 isoforms induced increases of endogenous DSPP protein levels in MD10-F2 cells but reduced its expression in MO6-G3 cells consistent with the DSPP promoter analysis. Thus, our results suggest that differential positive and negative regulation of DSPP by Runx2 is dependent on use of cytodifferentiation of dental ectomesenchymal-derived cells that may contribute to the spatial-temporal expression of DSPP during tooth development.	Univ Texas, Hlth Sci Ctr, Dept Pediat Dent, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Dept Orthodont, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Chen, S (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Pediat Dent, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	chens0@uthscsa.edu	MacDougall, Mary/ABG-8212-2021		NIDCR NIH HHS [R03-DE01448401A2, P01-DE113221] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aberg T, 1997, DEV DYNAM, V210, P383, DOI 10.1002/(SICI)1097-0177(199712)210:4<383::AID-AJA3>3.0.CO;2-C; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; AUSUBEL FM, 1995, SHORT PROTOCOLS MOL, P15; Baba O, 2004, EUR J ORAL SCI, V112, P163, DOI 10.1111/j.0909-8836.2004.00110.x; Banerjee C, 1996, P NATL ACAD SCI USA, V93, P4968, DOI 10.1073/pnas.93.10.4968; Banerjee C, 2001, ENDOCRINOLOGY, V142, P4026, DOI 10.1210/en.142.9.4026; Barnes GL, 2003, CANCER RES, V63, P2631; Bidder M, 1998, J BONE MINER RES, V13, P609, DOI 10.1359/jbmr.1998.13.4.609; Bleicher F, 1999, MATRIX BIOL, V18, P133, DOI 10.1016/S0945-053X(99)00007-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen S, 2005, ARCH ORAL BIOL, V50, P227, DOI 10.1016/j.archoralbio.2004.10.014; Chen S, 2004, J BIOL CHEM, V279, P42182, DOI 10.1074/jbc.M402476200; Chen S, 2002, CONNECT TISSUE RES, V43, P338, DOI 10.1080/03008200290000691; CHEN S, 2001, J DENT RES, V80, P196; Couble ML, 2000, CALCIFIED TISSUE INT, V66, P129, DOI 10.1007/PL00005833; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; Dhamija S, 2001, J BIOL CHEM, V276, P35159, DOI 10.1074/jbc.M010719200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dong J, 2005, AM J MED GENET A, V132A, P305, DOI 10.1002/ajmg.a.30460; Drissi H, 2002, J CELL BIOCHEM, V86, P403, DOI 10.1002/jcb.10238; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Gaikwad J S, 2001, Adv Dent Res, V15, P19; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; GOLDBERG M, 1995, J DENT, V23, P15, DOI 10.1016/0300-5712(95)90655-2; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; HARRIS SE, 1994, J BONE MINER RES, V9, P389; He WX, 2004, ARCH ORAL BIOL, V49, P911, DOI 10.1016/j.archoralbio.2004.05.005; Ito Y, 2001, J BIOL CHEM, V276, P44163, DOI 10.1074/jbc.M011424200; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Jimenez MJG, 1999, MOL CELL BIOL, V19, P4431; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Kim JW, 2004, HUM GENET, V115, P248, DOI 10.1007/s00439-004-1143-5; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; MacDougall M, 1995, Connect Tissue Res, V33, P97, DOI 10.3109/03008209509016988; MacNeil R L, 1995, Connect Tissue Res, V33, P1, DOI 10.3109/03008209509016974; MERRIMAN HL, 1995, BIOCHEMISTRY-US, V34, P13125, DOI 10.1021/bi00040a025; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; Narayanan K, 2004, J BIOL CHEM, V279, P45423, DOI 10.1074/jbc.M405031200; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Petersen DN, 2000, J BIOL CHEM, V275, P36172, DOI 10.1074/jbc.M003622200; Qin C, 2002, J DENT RES, V81, P392, DOI 10.1177/154405910208100607; Rajpar MH, 2002, HUM MOL GENET, V11, P2559, DOI 10.1093/hmg/11.21.2559; REICHERT T, 1992, CALCIFIED TISSUE INT, V50, P468, DOI 10.1007/BF00296779; RITCHIE HH, 1994, J BIOL CHEM, V269, P3698; Ritchie HH, 2002, CONNECT TISSUE RES, V43, P331, DOI 10.1080/03008200290001041; Sommer B, 1996, BONE, V19, P371, DOI 10.1016/S8756-3282(96)00218-9; SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837; Thesleff I, 1996, CURR OPIN CELL BIOL, V8, P844, DOI 10.1016/S0955-0674(96)80086-X; Thirunavukkarasu K, 2000, J BIOL CHEM, V275, P25163, DOI 10.1074/jbc.M000322200; Thyagarajan T, 2001, J BIOL CHEM, V276, P11016, DOI 10.1074/jbc.M010502200; Tsuji K, 1998, BONE, V22, P87, DOI 10.1016/S8756-3282(97)00267-6; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Xiao ZS, 2001, J CELL BIOCHEM, V82, P647, DOI 10.1002/jcb.1192; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Xiong SB, 2000, P NATL ACAD SCI USA, V97, P3948, DOI 10.1073/pnas.040574197; Xu X, 2003, INT J DEV BIOL, V47, P31; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Zaidi SK, 2002, P NATL ACAD SCI USA, V99, P8048, DOI 10.1073/pnas.112664499; ZEICHNERDAVID M, 1995, INT J DEV BIOL, V39, P69; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597	76	130	139	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2005	280	33					29717	29727		10.1074/jbc.M502929200	http://dx.doi.org/10.1074/jbc.M502929200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	954SX	15980071	hybrid			2022-12-27	WOS:000231176200042
J	Bratt, A; Birot, O; Sinha, I; Veitonmaki, N; Aase, K; Ernkvist, M; Holmgren, L				Bratt, A; Birot, O; Sinha, I; Veitonmaki, N; Aase, K; Ernkvist, M; Holmgren, L			Angiomotin regulates endothelial cell-cell junctions and cell motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE; GROWTH-FACTOR; ANGIOSTATIN; PROTEIN; ANGIOGENESIS; CANCER; TIGHT; SECRETION; MIGRATION; DOMAINS	We have previously identified angiomotin by its ability to bind to and mediate the anti-angiogenic properties of angiostatin. In vivo and in vitro data indicate an essential role of angiomotin in endothelial cell motility. Here we show that angiostatin binds angiomotin on the cell surface and provide evidence for a transmembrane model for the topology of both p80 and p130 angiomotin isoforms. Immunofluorescence analysis shows that angiomotin co-localized with ZO-1 in cell-cell contacts in endothelial cells in vitro and in angiogenic blood vessels of the postnatal mouse retina in vivo. Transfection of p80 as well as p130 angiomotin in Chinese hamster ovary cells resulted in junctional localization of both isoforms. Furthermore, p130 angiomotin could recruit ZO-1 to actin stress fibers. The p130 but not p80 isoform could be coprecipitated with MAGI-1b, a component of endothelial tight junctions. Paracellular permeability, as measured by diffusion of fluorescein isothiocyanate-dextran, was reduced by p80 and p130 angiomotin expression with 70 and 88%, respectively, compared with control. Angiostatin did not have any effect on cell permeability but inhibited the migration of angiomotin-expressing cells in the Boyden chamber assay. We conclude that angiomotin, in addition to controlling cell motility, may play a role in the assembly of endothelial cell-cell junctions.	Karolinska Univ Hosp, Karolinska Inst, Canc Ctr Karolinska, Dept Pathol & Oncol, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Holmgren, L (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Canc Ctr Karolinska, Dept Pathol & Oncol, R8-03, S-17176 Stockholm, Sweden.	Lars.Holmgren@cck.ki.se						Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Beerepoot LV, 2003, CLIN CANCER RES, V9, P4025; BONIFACINO JS, 2005, CURRENT PROTOCOLS CE; Bouquet C, 2003, MOL THER, V7, P174, DOI 10.1016/S1525-0016(02)00057-6; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; CHANLING T, 1990, CURR EYE RES, V9, P459, DOI 10.3109/02713689008999612; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Claesson-Welsh L, 1998, P NATL ACAD SCI USA, V95, P5579, DOI 10.1073/pnas.95.10.5579; Corada M, 2002, BLOOD, V100, P905, DOI 10.1182/blood.V100.3.905; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gupta N, 2001, EMBO REP, V2, P536, DOI 10.1093/embo-reports/kve115; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hirata K, 2001, J BIOL CHEM, V276, P16223, DOI 10.1074/jbc.M100630200; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Ji WDR, 1998, FASEB J, V12, P1731, DOI 10.1096/fasebj.12.15.1731; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Langen R, 1998, P NATL ACAD SCI USA, V95, P14060, DOI 10.1073/pnas.95.24.14060; Levchenko T, 2004, ONCOGENE, V23, P1469, DOI 10.1038/sj.onc.1207264; Levchenko T, 2003, J CELL SCI, V116, P3803, DOI 10.1242/jcs.00694; Lucas R, 1998, BLOOD, V92, P4730; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Moreau J, 2005, GENE, V350, P137, DOI 10.1016/j.gene.2005.02.001; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Naik MU, 2003, BLOOD, V102, P2108, DOI 10.1182/blood-2003-04-1114; Naik MU, 2003, ARTERIOSCL THROM VAS, V23, P2165, DOI 10.1161/01.ATV.0000093982.84451.87; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nishimura M, 2002, J BIOL CHEM, V277, P5583, DOI 10.1074/jbc.M110154200; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Patrie KM, 2002, J BIOL CHEM, V277, P30183, DOI 10.1074/jbc.M203072200; Prudovsky I, 2002, J CELL BIOL, V158, P201, DOI 10.1083/jcb.200203084; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Ruffer C, 2004, BIOCHEMISTRY-US, V43, P5360, DOI 10.1021/bi035517c; Satchi-Fainaro R, 2005, CANCER CELL, V7, P251, DOI 10.1016/j.ccr.2005.02.007; SCHULZE C, 1993, J CELL SCI, V104, P773; Shimono A, 2003, CURR BIOL, V13, P613, DOI 10.1016/S0960-9822(03)00204-5; Tanudji M, 2003, AM J PHYSIOL-CELL PH, V284, pC1272, DOI 10.1152/ajpcell.00521.2002; Tarui T, 2001, J BIOL CHEM, V276, P39562, DOI 10.1074/jbc.M101815200; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Wajih N, 2003, BLOOD, V101, P1857, DOI 10.1182/blood-2002-02-0582; Wegmann F, 2004, EXP CELL RES, V300, P121, DOI 10.1016/j.yexcr.2004.07.010; Whitley P, 1996, J BIOL CHEM, V271, P7583, DOI 10.1074/jbc.271.13.7583	49	115	126	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34859	34869		10.1074/jbc.M503915200	http://dx.doi.org/10.1074/jbc.M503915200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16043488	hybrid			2022-12-27	WOS:000232403900058
J	Groth, S; Schulze, M; Kalthoff, H; Fandrich, F; Ungefroren, H				Groth, S; Schulze, M; Kalthoff, H; Fandrich, F; Ungefroren, H			Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta - Evidence for oxidative signaling through NADPH oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; RHO-FAMILY GTPASES; CANCER CELL-LINES; TGF-BETA; PANCREATIC-CANCER; DIABETIC-NEPHROPATHY; HUMAN NEUTROPHILS; PROTEOGLYCANS; GENERATION; MIGRATION	Both transforming growth factor-beta(TGF-beta)-induced expression of biglycan (BGN) and activation of p38 MAPK have been implicated in cellular adhesion and migration. Here, we analyzed the role of adhesive events and the small GTPase Rac1 in TGF-beta regulation of BGN. TGF-beta 1 induction of BGN expression and activation of p38 was abolished or strongly reduced when cells were kept in suspension or exposed to either the actin cytoskeleton-disrupting agent cytochalasin D or a specific chemical Rac1 inhibitor. Ectopic expression of a dominant negative mutant (T17N) of Rac1 abrogated both TGF-beta-induced p38 MAPK activation and BGN up-regulation but did not affect TGF-beta-induced phosphorylation of Smad3 or transcriptional induction of Growth Arrest DNA Damage 45 beta, previously shown to be crucial for TGF-beta regulation of BGN. Overexpression of wild type Rac1 greatly enhanced the TGF-beta effect on BGN in adherent cells, whereas ectopic expression of constitutively active Rac1 (Q61L) activated p38 and in the presence of exogenous TGF-beta was able to rescue BGN expression in nonadherent cells. Endogenous Rac1 was activated by TGF-beta treatment in PANC-1 cells in an adhesion-dependent fashion. Like Rac1-T17N, the NADPH oxidase inhibitor diphenylene iodonium and the tyrosine kinase inhibitor herbimycin A blocked TGF-beta-induced p38 activation and BGN expression, suggesting that Rac1 exerts its effect on BGN and p38 through increasing NADPH oxidase activity and subsequent production of reactive oxygen species. These results show that the TGF-beta effect on BGN is dependent on cell adhesion and that activated Rac1, presumably acting through NADPH oxidase(s), is necessary but not sufficient for TGF-beta-induced BGN expression.	Univ Hosp Schleswig Holstein, Dept Gen Surg & Thorac Surg, D-24105 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Ungefroren, H (corresponding author), Univ Hosp Schleswig Holstein, Dept Gen Surg & Thorac Surg, Campus Kiel,Arnold Heller Str 7, D-24105 Kiel, Germany.	hungefroren@chirurgie-sh.de	Kalthoff, Holger/B-1618-2010; Ungefroren, Hendrik/E-2933-2010; Faendrich, Fred/B-1705-2010; Goletz, Stephanie/K-1358-2014	Schulze, Maren/0000-0002-4577-6473				Bakin AV, 2002, J CELL SCI, V115, P3193; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Berrier AL, 2002, J CELL SCI, V115, P4285, DOI 10.1242/jcs.00109; Bhowmick NA, 2001, J BIOL CHEM, V276, P46707, DOI 10.1074/jbc.M106176200; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Chen WB, 2002, J BIOL CHEM, V277, P36118, DOI 10.1074/jbc.M203709200; Chiu C, 2001, INT J MOL MED, V8, P251; Crnogorac-Jurcevic T, 2001, ONCOGENE, V20, P7437, DOI 10.1038/sj.onc.1204935; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di-Poi N, 2001, BIOCHEMISTRY-US, V40, P10014, DOI 10.1021/bi010289c; Dusi S, 1996, J IMMUNOL, V157, P4615; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Ellenrieder V, 2001, CANCER RES, V61, P4222; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Kinsella MG, 1997, J BIOL CHEM, V272, P318; Kinsella MG, 2004, CRIT REV EUKAR GENE, V14, P203, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.40; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Lehnert L, 2001, J CELL BIOL, V152, P911, DOI 10.1083/jcb.152.5.911; Lohr M, 2001, CANCER RES, V61, P550; Major MB, 2004, J BIOL CHEM, V279, P5278, DOI 10.1074/jbc.M311517200; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Menke A, 2002, J GASTROINTEST CANC, V31, P41, DOI 10.1385/IJGC:31:1-3:41; Menke A, 2001, CANCER RES, V61, P3508; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Schaefer L, 2001, FASEB J, V15, P559; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Tufvesson E, 2003, J CELL SCI, V116, P4857, DOI 10.1242/jcs.00808; Ungefroren H, 2005, J BIOL CHEM, V280, P2644, DOI 10.1074/jbc.M411925200; Ungefroren H, 2003, J BIOL CHEM, V278, P11041, DOI 10.1074/jbc.M300035200; Wadhwa S, 2004, CRIT REV EUKAR GENE, V14, P301, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.50; Weber CK, 2001, GASTROENTEROLOGY, V121, P657, DOI 10.1053/gast.2001.27222; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; YAMAMOTO T, 1993, P NATL ACAD SCI USA, V90, P1814, DOI 10.1073/pnas.90.5.1814; Yang S, 2000, BIOCHEM CELL BIOL, V78, P11; Yokoyama H, 1996, DIABETIC MED, V13, P313, DOI 10.1002/(SICI)1096-9136(199604)13:4<313::AID-DIA56>3.3.CO;2-Z; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhao TM, 2003, J CLIN INVEST, V112, P1732, DOI 10.1172/JCI200319108	42	39	41	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33190	33199		10.1074/jbc.M504249200	http://dx.doi.org/10.1074/jbc.M504249200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16051607	hybrid			2022-12-27	WOS:000232058100013
J	Westerheide, SD; Morimoto, RI				Westerheide, SD; Morimoto, RI			Heat shock response modulators as therapeutic tools for diseases of protein conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MOLECULAR CHAPERONES; TRANSCRIPTION FACTOR; STRESS-PROTEINS; FACTOR-I; ANTIINFLAMMATORY DRUGS; HUNTINGTONS-DISEASE; ACTIVATION; INDUCTION; FACTOR-1; HSP70	The disruption of protein folding quality control results in the accumulation of non-native protein species that can form oligomers, aggregates, and inclusions indicative of neurodegenerative disease. Likewise for over 100 other human diseases of protein conformation, a common feature may be the formation of off-pathway folding intermediates that are unstable, self-associate, and with time lead to a chronic imbalance in protein homeostasis with deleterious consequences on cellular function. This has led to a hypothesis that enhancement of components of the cellular quality control machinery, specifically the levels and activities of molecular chaperones, suppress aggregation and toxicity phenotypes to allow cellular function to be restored. This review addresses the regulation of molecular chaperones and components of protein homeostasis by heat shock transcription factor 1 (HSF1), the master stress-inducible regulator, and our current understanding of pharmacologically active small molecule regulators of the heat shock response as a therapeutic strategy for protein conformational diseases.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Rice Inst Biomed Res, Evanston, IL 60208 USA	Northwestern University	Morimoto, RI (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Rice Inst Biomed Res, 2153 Sheridan Rd, Evanston, IL 60208 USA.	r-morimoto@northwestern.edu	Longo, Kenneth A/A-5631-2010		NCI NIH HHS [T32 CA70085] Funding Source: Medline; NIGMS NIH HHS [R37 GM038109] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA070085] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbott A, 2002, NATURE, V417, P109, DOI 10.1038/417109a; Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; AMICI C, 1992, P NATL ACAD SCI USA, V89, P6227, DOI 10.1073/pnas.89.14.6227; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hargitai J, 2003, BIOCHEM BIOPH RES CO, V307, P689, DOI 10.1016/S0006-291X(03)01254-3; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; HIGHTOWER LE, 1980, J CELL PHYSIOL, V102, P407, DOI 10.1002/jcp.1041020315; Holmberg CI, 2000, CELL STRESS CHAPERON, V5, P219, DOI 10.1379/1466-1268(2000)005<0219:FONHGV>2.0.CO;2; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jolly C, 1997, J CELL SCI, V110, P2935; Jolly C, 2004, J CELL BIOL, V164, P25, DOI 10.1083/jcb.200306104; JURIVICH DA, 1994, P NATL ACAD SCI USA, V91, P2280, DOI 10.1073/pnas.91.6.2280; Jurivich DA, 1996, J IMMUNOL, V157, P1669; JURIVICH DA, 1992, SCIENCE, V255, P1243, DOI 10.1126/science.1546322; Kakizuka A, 1998, TRENDS GENET, V14, P396, DOI 10.1016/S0168-9525(98)01559-5; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Kim HR, 1999, IUBMB LIFE, V48, P429, DOI 10.1080/713803536; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Kim SA, 2005, J BIOL CHEM, V280, P12653, DOI 10.1074/jbc.M411908200; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; LANDRY J, 1982, CANCER RES, V42, P2457; LEE BS, 1995, P NATL ACAD SCI USA, V92, P7207, DOI 10.1073/pnas.92.16.7207; LEE YJ, 1987, J CELL PHYSIOL, V132, P1, DOI 10.1002/jcp.1041320102; Mestril R, 2005, METHODS, V35, P165, DOI 10.1016/j.ymeth.2004.08.007; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; NAGAI N, 1995, BIOCHEM BIOPH RES CO, V208, P1099, DOI 10.1006/bbrc.1995.1447; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; OHNO K, 1988, J BIOL CHEM, V263, P19764; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rieger TR, 2005, BIOPHYS J, V88, P1646, DOI 10.1529/biophysj.104.055301; Rossi A, 1998, J BIOL CHEM, V273, P16446, DOI 10.1074/jbc.273.26.16446; Shamovsky I, 2004, MECH AGEING DEV, V125, P767, DOI 10.1016/j.mad.2004.07.006; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Soti C, 2003, EXP GERONTOL, V38, P1037, DOI 10.1016/S0531-5565(03)00185-2; Thomson S, 2004, MOL CELL, V15, P585, DOI 10.1016/j.molcel.2004.08.002; Vigh L, 1997, NAT MED, V3, P1150, DOI 10.1038/nm1097-1150; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2003, CURR CANCER DRUG TAR, V3, P349, DOI 10.2174/1568009033481787; Yokota S, 2000, CANCER RES, V60, P2942	57	362	391	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33097	33100		10.1074/jbc.R500010200	http://dx.doi.org/10.1074/jbc.R500010200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16076838	hybrid			2022-12-27	WOS:000232058100002
J	Mussig, K; Staiger, H; Fiedler, H; Moeschel, K; Beck, A; Kellerer, M; Haring, HU				Mussig, K; Staiger, H; Fiedler, H; Moeschel, K; Beck, A; Kellerer, M; Haring, HU			Shp2 is required for protein kinase C-dependent phosphorylation of serine 307 in insulin receptor substrate-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; PHORBOL ESTERS INCREASE; TYROSINE-PHOSPHATASE; RAT ADIPOCYTES; PHOSPHOTYROSINE PHOSPHATASE; GLYCOGEN-SYNTHESIS; DIABETES-MELLITUS; CELLS; ACTIVATION; MODULATION	The function of insulin receptor substrate-1 (IRS-1), a key molecule of insulin signaling, is modulated by phosphorylation at multiple serine/threonine residues. Phorbol ester stimulation of cells induces phosphorylation of two inhibitory serine residues in IRS-1, i.e. Ser-307 and Ser-318, suggesting that both sites may be targets of protein kinase C ( PKC) isoforms. However, in an in vitro system using a broad spectrum of PKC isoforms (alpha, beta 1, beta 2, delta, epsilon, eta, mu), we detected only Ser-318, but not Ser-307 phosphorylation, suggesting that phorbol ester-induced phosphorylation of this site in intact cells requires additional signaling elements and serine kinases that link PKC activation to Ser-307 phosphorylation. As we have observed recently that the tyrosine phosphatase Shp2, a negative regulator of insulin signaling, is a substrate of PKC, we studied the role of Shp2 in this context. We found that phorbol ester-induced Ser-307 phosphorylation is reduced markedly in Shp2-deficient mouse embryonic fibroblasts (Shp2(-/-)) whereas Ser-318 phosphorylation is unaltered. The Ser-307 phosphorylation was rescued by transfection of mouse embryonic fibroblasts with wild-type Shp2 or with a phosphatase-inactive Shp2 mutant, respectively. In this cell model, tumor necrosis factor-alpha-induced Ser-307 phosphorylation as well depended on the presence of Shp2. Furthermore, Shp2-dependent phorbol ester effects on Ser-307 were blocked by wortmannin, rapamycin, and the c-Jun NH2-terminal kinase (JNK) inhibitor SP600125. This suggests an involvement of the phosphatidylinositol 3-kinase/mammalian target of rapamycin cascade and of JNK in this signaling pathway resulting in IRS-1 Ser-307 phosphorylation. Because the activation of these kinases does not depend on Shp2, it is concluded that the function of Shp2 is to direct these activated kinases to IRS-1	Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Metab & Pathobiochem, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Haring, HU (corresponding author), Med Univ Klin Tubingen, Otfried Muller Str 10, D-72076 Tubingen, Germany.	Hans-Ulrich.Haering@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014	Staiger, Harald/0000-0002-9507-5333				Adachi M, 1996, CELL, V85, P15; Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; AHMAD F, 1995, METABOLISM, V44, P1175, DOI 10.1016/0026-0495(95)90012-8; AHMAD F, 1995, AM J PHYSIOL, V268, P932; Andreozzi F, 2004, CIRC RES, V94, P1211, DOI 10.1161/01.RES.0000126501.34994.96; Andreozzi F, 2004, ENDOCRINOLOGY, V145, P2845, DOI 10.1210/en.2003-0939; Avignon A, 1996, DIABETES, V45, P1396, DOI 10.2337/diabetes.45.10.1396; Beck A, 2003, J AM SOC MASS SPECTR, V14, P401, DOI 10.1016/S1044-0305(03)00122-3; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; BERTI L, 1994, J BIOL CHEM, V269, P3381; Bifulco G, 2003, GYNECOL ENDOCRINOL, V17, P239; Bossenmaier B, 1997, DIABETOLOGIA, V40, P863, DOI 10.1007/s001250050761; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; CARO JF, 1992, MOL CELL BIOCHEM, V109, P115; CONSIDINE RV, 1995, J CLIN INVEST, V95, P2938, DOI 10.1172/JCI118001; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; Desbois-Mouthon C, 1998, BIOCHEM BIOPH RES CO, V243, P765, DOI 10.1006/bbrc.1998.8181; DUBYAK GR, 1980, J BIOL CHEM, V255, P5306; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Greene MW, 2004, BIOCHEM J, V378, P105, DOI 10.1042/BJ20031493; Gual P, 2003, J BIOL CHEM, V278, P26550, DOI 10.1074/jbc.M212273200; HARING H, 1986, J BIOL CHEM, V261, P3869; Idris I, 2001, DIABETOLOGIA, V44, P659, DOI 10.1007/s001250051675; Jiang GQ, 2003, J BIOL CHEM, V278, P180, DOI 10.1074/jbc.M205565200; Kellerer M, 1998, DIABETOLOGIA, V41, P833, DOI 10.1007/s001250050995; KHARITONENKOV A, 1995, J BIOL CHEM, V270, P29189, DOI 10.1074/jbc.270.49.29189; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; LANDAU NR, 1992, J VIROL, V66, P5110, DOI 10.1128/JVI.66.8.5110-5113.1992; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; Miller BS, 1996, BIOCHEMISTRY-US, V35, P8769, DOI 10.1021/bi952651r; Moeschel K, 2004, J BIOL CHEM, V279, P25157, DOI 10.1074/jbc.M402477200; MORGAN SJ, 1990, EUR J BIOCHEM, V191, P761, DOI 10.1111/j.1432-1033.1990.tb19185.x; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; Ouwens DM, 2001, MOL CELL ENDOCRINOL, V175, P131, DOI 10.1016/S0303-7207(01)00389-6; Pugazhenthi S, 1996, ARCH BIOCHEM BIOPHYS, V335, P273, DOI 10.1006/abbi.1996.0508; Rocchi S, 1996, ENDOCRINOLOGY, V137, P4944, DOI 10.1210/en.137.11.4944; Ross SA, 1998, BIOCHEM BIOPH RES CO, V247, P487, DOI 10.1006/bbrc.1998.8821; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; STAUBS PA, 1994, J BIOL CHEM, V269, P27186; Strack V, 2002, BIOCHEMISTRY-US, V41, P603, DOI 10.1021/bi011327v; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Ugi S, 1996, J BIOL CHEM, V271, P12595, DOI 10.1074/jbc.271.21.12595; VANDEWERVE G, 1985, BIOCHEM J, V225, P523, DOI 10.1042/bj2250523; Walter AO, 1999, ONCOGENE, V18, P1911, DOI 10.1038/sj.onc.1202513; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; Wu CJ, 2001, ONCOGENE, V20, P6018, DOI 10.1038/sj.onc.1204699; Yart A, 2003, CURR CANCER DRUG TAR, V3, P177, DOI 10.2174/1568009033481976	53	24	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32693	32699		10.1074/jbc.M506549200	http://dx.doi.org/10.1074/jbc.M506549200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16055440	hybrid			2022-12-27	WOS:000231920300019
J	Ungar, D; Oka, T; Vasile, E; Krieger, M; Hughson, FM				Ungar, D; Oka, T; Vasile, E; Krieger, M; Hughson, FM			Subunit architecture of the conserved oligomeric golgi complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN COMPLEXES; COG COMPLEX; RETROGRADE; TRANSPORT; ORGANIZATION; EXOCYST; SEC34P; COPI; MANNOSYLTRANSFERASE; IDENTIFICATION	The conserved oligomeric Golgi (COG) complex is thought to function in intra-Golgi retrograde trafficking mediated by coat protein I vesicles, a pathway essential for the proper structure and function of the Golgi apparatus. Previous work suggested that COG might act as a tethering factor to mediate the initial attachment between coat protein I vesicles and Golgi membranes. Here, we present extensive in vitro co-translation and immunoprecipitation experiments leading to a new model for the overall architecture of the mammalian COG complex. The eight COG subunits (Cog1-8) are found to form two heterodimeric subassemblies (Cog2/3/4 and Cog5/6/7) linked by a heterodimer composed of the remaining subunits (Cog1/8). This model is in excellent agreement with in vivo data presented in an accompanying paper	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan	Princeton University; Massachusetts Institute of Technology (MIT); Kyushu University	Hughson, FM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu	Ungar, Daniel/A-5302-2012	Ungar, Daniel/0000-0002-9852-6160				Barlowe C, 2000, TRAFFIC, V1, P371, DOI 10.1034/j.1600-0854.2000.010501.x; Bruinsma P, 2004, J BIOL CHEM, V279, P39814, DOI 10.1074/jbc.M405500200; Fotso P, 2005, J BIOL CHEM, V280, P27613, DOI 10.1074/jbc.M504597200; Gaynor EC, 1998, BBA-MOL CELL RES, V1404, P33, DOI 10.1016/S0167-4889(98)00045-7; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Harris SL, 1996, J CELL BIOL, V132, P985, DOI 10.1083/jcb.132.6.985; James P, 1996, GENETICS, V144, P1425; Kim DW, 1999, MOL BIOL CELL, V10, P3317, DOI 10.1091/mbc.10.10.3317; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; Loh E, 2004, J BIOL CHEM, V279, P24640, DOI 10.1074/jbc.M400662200; Martinez-Menarguez JA, 2001, J CELL BIOL, V155, P1213, DOI 10.1083/jcb.200108029; Matern HT, 2001, P NATL ACAD SCI USA, V98, P9648, DOI 10.1073/pnas.171317898; Oka T, 2005, J BIOL CHEM, V280, P32736, DOI 10.1074/jbc.M505558200; Oka T, 2005, J BIOCHEM, V137, P109, DOI 10.1093/jb/mvi024; Oka T, 2004, MOL BIOL CELL, V15, P2423, DOI 10.1091/mbc.E03-09-0699; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; PODOS SD, 1994, J CELL BIOL, V127, P679, DOI 10.1083/jcb.127.3.679; Ram RJ, 2002, MOL BIOL CELL, V13, P1484, DOI 10.1091/mbc.01-10-0495; Sannerud R, 2003, CURR OPIN CELL BIOL, V15, P438, DOI 10.1016/S0955-0674(03)00077-2; Scheiffele P, 2000, ESSAYS BIOCHEM, V36, P27, DOI 10.1042/bse0360027; Serebriiskii IG, 2001, METH MOL B, V177, P123; Suvorova ES, 2002, J CELL BIOL, V157, P631, DOI 10.1083/jcb.200111081; Suvorova ES, 2001, J BIOL CHEM, V276, P22810, DOI 10.1074/jbc.M011624200; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; VanRheenen SM, 1998, J CELL BIOL, V141, P1107, DOI 10.1083/jcb.141.5.1107; Walter DM, 1998, J BIOL CHEM, V273, P29565, DOI 10.1074/jbc.273.45.29565; Warren G, 1998, CURR OPIN CELL BIOL, V10, P493, DOI 10.1016/S0955-0674(98)80064-1; Waters MG, 2000, TRAFFIC, V1, P588, DOI 10.1034/j.1600-0854.2000.010802.x; Whyte JRC, 2002, J CELL SCI, V115, P2627; Whyte JRC, 2001, DEV CELL, V1, P527, DOI 10.1016/S1534-5807(01)00063-6; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041; Zolov SN, 2005, J CELL BIOL, V168, P747, DOI 10.1083/jcb.200412003	38	79	91	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32729	32735		10.1074/jbc.M504590200	http://dx.doi.org/10.1074/jbc.M504590200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16020545	hybrid			2022-12-27	WOS:000231920300023
J	Buddha, MR; Crane, BR				Buddha, MR; Crane, BR			Structures of tryptophanyl-tRNA synthetase II from Deinococcus radiodurans bound to ATP and tryptophan - Insight into subunit cooperativity and domain motions linked to catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; CRYSTAL-STRUCTURE; RECOGNITION; MECHANISM	An auxiliary tryptophanyl tRNA synthetase (drTrpRS II) that interacts with nitric-oxide synthase in the radiation-resistant bacterium Deinococcus radiodurans charges tRNA with tryptophan and 4-nitrotryptophan, a specific nitration product of nitric-oxide synthase. Crystal structures of drTrpRS II, empty of ligands or bound to either Trp or ATP, reveal that drTrpRS II has an overall structure similar to standard bacterial TrpRSs but undergoes smaller amplitude motions of the helical tRNA anti-codon binding ( TAB) domain on binding substrates. TAB domain loop conformations that more closely resemble those of human TrpRS than those of Bacillus stearothermophilus TrpRS (bsTrpRS) indicate different modes of tRNA recognition by subclasses of bacterial TrpRSs. A compact state of drTrpRS II binds ATP, from which only minimal TAB domain movement is necessary to bring nucleotide in contact with Trp. However, the signature KMSKS loop of class I synthetases does not completely engage the ATP phosphates, and the adenine ring is not well ordered in the absence of Trp. Thus, progression of the KMSKS loop to a high energy conformation that stages acyl-adenylation requires binding of both substrates. In an asymmetric drTrpRS II dimer, the closed subunit binds ATP, whereas the open subunit binds Trp. A crystallographically symmetric dimer binds no ligands. Half-site reactivity for Trp binding is confirmed by thermodynamic measurements and explained by an asymmetric shift of the dimer interface toward the occupied active site. Upon Trp binding, Asp(68) propagates structural changes between subunits by switching its hydrogen bonding partner from dimer interface residue Tyr(139) to active site residue Arg(30). Since TrpRSIIs are resistant to inhibitors of standard TrpRSs, and pathogens contain drTrpRS II homologs, the structure of drTrpRS II provides a framework for the design of potentially useful antibiotics.	Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA	Cornell University	Crane, BR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA.	bc69@cornell.edu						BRICK P, 1987, J MOL BIOL, V194, P287, DOI 10.1016/0022-2836(87)90376-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buddha MR, 2005, NAT STRUCT MOL BIOL, V12, P274, DOI 10.1038/nsmb907; Buddha MR, 2004, J BIOL CHEM, V279, P49567, DOI 10.1074/jbc.C400418200; Buddha MR, 2004, P NATL ACAD SCI USA, V101, P15881, DOI 10.1073/pnas.0405483101; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Carter CW, 2002, MOL CELL, V10, P705, DOI 10.1016/S1097-2765(02)00688-3; Carter CW, 2000, BIOPHYS J, V78, p145A; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; DOUBLIE S, 1995, STRUCTURE, V3, P17, DOI 10.1016/S0969-2126(01)00132-0; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P8031, DOI 10.1021/bi00399a001; FIRST EA, 1995, BIOCHEMISTRY-US, V34, P5030, DOI 10.1021/bi00015a014; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jia J, 2002, BIOCHEM J, V365, P749, DOI 10.1042/BJ20020141; Kanamaru T, 2001, ANTIMICROB AGENTS CH, V45, P2455, DOI 10.1128/AAC.45.9.2455-2459.2001; Kitabatake M, 2002, J BIOL CHEM, V277, P23882, DOI 10.1074/jbc.M202639200; Lee JY, 2001, NAT STRUCT BIOL, V8, P789, DOI 10.1038/nsb0901-789; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; Matter H, 2002, J MED CHEM, V45, P2923, DOI 10.1021/jm020074g; MERLE M, 1986, BIOCHEMISTRY-US, V25, P1115, DOI 10.1021/bi00353a026; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; Retailleau P, 2001, ACTA CRYSTALLOGR D, V57, P1595, DOI 10.1107/S090744490101215X; Schimmel P, 1998, FASEB J, V12, P1599, DOI 10.1096/fasebj.12.15.1599; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Tzima E, 2003, P NATL ACAD SCI USA, V100, P14903, DOI 10.1073/pnas.2436330100; VALENTIN AI, 2000, PROTEIN SCI, V9, P218; WALTER HJ, 1988, BIOCHEMISTRY-US, V27, P5525; YADONG Y, 2004, J BIOL CHEM, V279, P8378; Yang XL, 2003, P NATL ACAD SCI USA, V100, P15376, DOI 10.1073/pnas.2136794100; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373	32	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31965	31973		10.1074/jbc.M501568200	http://dx.doi.org/10.1074/jbc.M501568200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15998643	hybrid			2022-12-27	WOS:000231665200076
J	Mokranjac, D; Sichting, M; Popov-Celeketic, D; Berg, A; Hell, K; Neupert, W				Mokranjac, D; Sichting, M; Popov-Celeketic, D; Berg, A; Hell, K; Neupert, W			The import motor of the yeast mitochondrial TIM23 preprotein translocase contains two different J proteins, Tim14 and Mdj2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PRESEQUENCE TRANSLOCASE; INNER MEMBRANE; J-DOMAIN; HSP70; SUBUNIT; TIM50; COCHAPERONE; COOPERATION; EXPRESSION	The import motor of the mitochondrial (mt) TIM23 complex drives translocation of presequence-containing preproteins across the mitochondrial inner membrane in an ATP-dependent manner. Tim44 is the central component of the motor. It recruits mtHsp70, which binds the incoming preproteins. The J protein Tim14 stimulates the ATPase activity of mtHsp70 and thereby enables efficient binding of mtHsp70 to preproteins. Tim16 is a J-like protein that forms a stable subcomplex with Tim14 and recruits it to the translocase. All subunits of the TIM23 translocase but one are essential for yeast cell viability. Yeast cells contain a close homologue of Tim14, Mdj2. In contrast to Tim14, its deletion leads to no obvious growth defect. In the present study we analyzed Mdj2 and compared it with Tim14. Mdj2 forms a complex with Tim16 and is recruited to the TIM23 translocase. It stimulates the ATPase activity of mtHsp70 to the same extent that Tim14 does. Mdj2 is expressed at a lower level compared with Tim14, and its complex with Tim16 is less stable. However, overexpressed Mdj2 fully restores the growth of cells lacking Tim14. We conclude that Mdj2 is a functional J protein and a component of the mitochondrial import motor.	Univ Munich, Inst Physiol Chem, D-81377 Munich, Germany	University of Munich	Neupert, W (corresponding author), Univ Munich, Inst Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.	neupert@med.uni-muenchen.de	Popov-Celeketic, Dusan/O-2371-2016	Popov-Celeketic, Dusan/0000-0002-0512-6900; Mokranjac, Dejana/0000-0002-4005-6979				Bauer MF, 1999, J MOL BIOL, V289, P69, DOI 10.1006/jmbi.1999.2751; Baumann F, 2000, FEBS LETT, V487, P307, DOI 10.1016/S0014-5793(00)02364-4; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Horst M, 1997, EMBO J, V16, P1842, DOI 10.1093/emboj/16.8.1842; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; Meier S, 2005, J BIOL CHEM, V280, P7777, DOI 10.1074/jbc.M412158200; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Shridhar V, 2001, CANCER RES, V61, P4258; SIKORSKI RS, 1989, GENETICS, V122, P19; Strub A, 2002, EMBO J, V21, P2626, DOI 10.1093/emboj/21.11.2626; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; Weiss C, 2002, PROTEIN EXPRES PURIF, V24, P268, DOI 10.1006/prep.2001.1563; Westermann B, 1997, J MOL BIOL, V272, P477, DOI 10.1006/jmbi.1997.1267; Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	29	25	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31608	31614		10.1074/jbc.M502397200	http://dx.doi.org/10.1074/jbc.M502397200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16027163	hybrid			2022-12-27	WOS:000231665200035
J	Arasada, RR; Carpenter, G				Arasada, RR; Carpenter, G			Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; NUCLEAR EXPRESSION; CELL CARCINOMA; MAMMARY-GLAND; CLEAVAGE; P53; PROTEIN; DIFFERENTIATION; TRANSCRIPTION; PROTEOLYSIS	Heregulin activation of the endogenous receptor tyrosine kinase ErbB-4 in ZR-75-1 breast cancer cells provokes tyrosine phosphorylation of Hdm2 in a manner that is sensitive to inhibition of alpha- or gamma-secretase activity, indicating that liberation of the tyrosine kinase intracellular domain (ICD) fragment is required. Similar results are obtained when Erbb-4 is exogenously expressed in 32D cells, which do not otherwise express any ErbB family members. Expression of the ErbB-4 ICD fragment leads to its constitutive association with Mdm2 and tyrosine phosphorylation of Mdm2, a protein that is predominantly localized in the nucleus and that regulates p53 levels. When the ErbB-4 ICD fragment was expressed in H1299 cells, it promoted Hdm2 ubiquitination and increased the levels of p53 and p21, a transcriptional target of p53. In addition, expression of the ICD fragment increased p53 activity toward the p21 promoter in a luciferase reporter assay.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Carpenter, G (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA.	graham.carpenter@vanderbilt.edu			NCI NIH HHS [CA97456] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA097456] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bei R, 2004, J PATHOL, V204, P317, DOI 10.1002/path.1642; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Cheng QC, 2003, J BIOL CHEM, V278, P38421, DOI 10.1074/jbc.M302111200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Flatt PM, 2000, MOL CELL BIOL, V20, P4210, DOI 10.1128/MCB.20.12.4210-4223.2000; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; Haas IG, 2005, J BIOL CHEM, V280, P9313, DOI 10.1074/jbc.M412909200; Hughes DPM, 2004, CANCER RES, V64, P2047, DOI 10.1158/0008-5472.CAN-03-3096; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Kim DY, 2002, J BIOL CHEM, V277, P49976, DOI 10.1074/jbc.M210179200; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Omerovic J, 2004, EXP CELL RES, V294, P469, DOI 10.1016/j.yexcr.2003.12.002; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sartor CI, 2001, MOL CELL BIOL, V21, P4265, DOI 10.1128/MCB.21.13.4265-4275.2001; Schulz JG, 2003, J BIOL CHEM, V278, P48651, DOI 10.1074/jbc.M308424200; Srinivasan R, 2000, CANCER RES, V60, P1483; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Vaskovsky A, 2000, J NEUROCHEM, V74, P979, DOI 10.1046/j.1471-4159.2000.0740979.x; Vecchi M, 1996, J BIOL CHEM, V271, P18989, DOI 10.1074/jbc.271.31.18989; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; Wilhelmsen K, 2004, MOL CELL BIOL, V24, P454, DOI 10.1128/MCB.24.1.454-464.2004; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhou WL, 2000, J BIOL CHEM, V275, P34737, DOI 10.1074/jbc.M003756200	40	46	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30783	30787		10.1074/jbc.M506057200	http://dx.doi.org/10.1074/jbc.M506057200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15985438	hybrid			2022-12-27	WOS:000231487800018
J	Tanaka, K; Tomisato, W; Hoshino, T; Ishihara, T; Namba, T; Aburaya, M; Katsu, T; Suzuki, K; Tsutsumi, S; Mizushima, T				Tanaka, K; Tomisato, W; Hoshino, T; Ishihara, T; Namba, T; Aburaya, M; Katsu, T; Suzuki, K; Tsutsumi, S; Mizushima, T			Involvement of intracellular Ca2+ levels in nonsteroidal anti-inflammatory drug-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-MUCOSAL CELLS; CELECOXIB-INDUCED APOPTOSIS; ENDOPLASMIC-RETICULUM; SULINDAC SULFONE; CANCER CELLS; ASPIRIN USE; CALCIUM; CALPAIN; CYCLOOXYGENASE-2; INHIBITOR	We recently reported that nonsteroidal anti- inflammatory drug ( NSAID)- induced gastric lesions involve NSAID- induced apoptosis of gastric mucosal cells, which in turn involves the endoplasmic reticulum stress response, in particular the up- regulation of CCAAT/ enhancerbinding protein homologous transcription factor ( CHOP). In this study, we have examined the molecular mechanism governing this NSAID- induced apoptosis in primary cultures of gastric mucosal cells. Various NSAIDs showed membrane permeabilization activity that correlated with their apoptosis- inducing activity. Various NSAIDs, particularly celecoxib, also increased intracellular Ca2+ levels. This increase was accompanied by K+ efflux from cells and was virtually absent when extracellular Ca2+ had been depleted. These data indicate that the increase in intracellular Ca2+ levels that is observed in the presence of NSAIDs is due to the stimulation of Ca2+ influx across the cytoplasmic membrane, which results from their membrane permeabilization activity. An intracellular Ca2+ chelator partially inhibited celecoxib- induced release of cytochrome c from mitochondria, reduced the magnitude of the celecoxib- induced decrease in mitochondrial membrane potential and inhibited celecoxib- induced apoptotic cell death. It is therefore likely that an increase in intracellular Ca2+ levels is involved in celecoxib- induced mitochondrial dysfunction and the resulting apoptosis. An inhibitor of calpain, a Ca2+ dependent cysteine protease, partially suppressed mitochondrial dysfunction and apoptosis in the presence of celecoxib. Celecoxib- dependent CHOP- induction was partially inhibited by the intracellular Ca2+ chelator but not by the calpain inhibitor. These results suggest that Ca2+- stimulated calpain activity and CHOP expression play important roles in celecoxib- induced apoptosis in gastric mucosal cells.	Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan; Okayama Univ, Fac Pharmaceut Sci, Okayama 7008530, Japan	Kumamoto University; Okayama University	Mizushima, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp	KATSU, Takashi/B-1640-2011					Baron JA, 2003, PROG EXP TUMOR RES, V37, P1; BARRIER CH, 1989, ARTHRITIS RHEUM, V32, P926; Belton O, 2000, CIRCULATION, V102, P840; Chan TA, 2002, LANCET ONCOL, V3, P166, DOI 10.1016/S1470-2045(02)00680-0; Ding HM, 2005, INT J CANCER, V113, P803, DOI 10.1002/ijc.20639; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; FRIES JF, 1989, GASTROENTEROLOGY, V96, P647, DOI 10.1016/S0016-5085(89)80061-7; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; Gil-Parrado S, 2002, J BIOL CHEM, V277, P27217, DOI 10.1074/jbc.M202945200; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hanif R, 1996, BIOCHEM PHARMACOL, V52, P237, DOI 10.1016/0006-2952(96)00181-5; Hawkey CJ, 2000, GASTROENTEROLOGY, V119, P521, DOI 10.1053/gast.2000.9561; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; Hsu AL, 2000, J BIOL CHEM, V275, P11397, DOI 10.1074/jbc.275.15.11397; JIANG S, 1994, EXP CELL RES, V212, P84, DOI 10.1006/excr.1994.1121; Johnson AJ, 2002, BIOCHEM J, V366, P831, DOI 10.1042/BJ20020279; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KATSU T, 1987, BIOCHIM BIOPHYS ACTA, V899, P159, DOI 10.1016/0005-2736(87)90396-8; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; KURATA JH, 1990, J CLIN GASTROENTEROL, V12, P260, DOI 10.1097/00004836-199006000-00005; LIGUMSKY M, 1983, GASTROENTEROLOGY, V84, P756; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; LUGIMSKY M, 1990, GASTROENTEROLOGY, V5, P1245; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; MILLER TA, 1983, AM J PHYSIOL, V245, pG601, DOI 10.1152/ajpgi.1983.245.5.G601; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Mukherjee D, 2002, BIOCHEM PHARMACOL, V63, P817, DOI 10.1016/S0006-2952(02)00842-0; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nozaki S, 2001, ONCOGENE, V20, P2178, DOI 10.1038/sj.onc.1204292; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Piazza GA, 1997, CANCER RES, V57, P2909; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Ray WA, 2004, NEW ENGL J MED, V351, P2767, DOI 10.1056/NEJMc045711; Reddy BS, 1999, CANCER RES, V59, P3387; Reddy RK, 1999, J BIOL CHEM, V274, P28476, DOI 10.1074/jbc.274.40.28476; Ristimaki A, 1997, CANCER RES, V57, P1276; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Singh D, 2004, BRIT MED J, V329, P816, DOI 10.1136/bmj.329.7470.816-a; SMALLEY WE, 1995, AM J EPIDEMIOL, V141, P539, DOI 10.1093/oxfordjournals.aje.a117469; Szabadkai G, 2004, FEBS LETT, V567, P111, DOI 10.1016/j.febslet.2004.04.059; Tomisato W, 2004, BIOCHEM BIOPH RES CO, V323, P1032, DOI 10.1016/j.bbrc.2004.08.205; Tomisato W, 2004, BIOCHEM PHARMACOL, V67, P575, DOI 10.1016/j.bcp.2003.09.020; Tomisato W, 2002, DIGEST DIS SCI, V47, P2125, DOI 10.1023/A:1019653719397; Tomisato W, 2001, AM J PHYSIOL-GASTR L, V281, pG1092, DOI 10.1152/ajpgi.2001.281.4.G1092; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Tsutsumi S, 2002, BBA-MOL CELL RES, V1589, P168, DOI 10.1016/S0167-4889(02)00171-4; VANE J, 1994, NATURE, V367, P215, DOI 10.1038/367215a0; Vane JR, 1996, SCAND J RHEUMATOL, P9; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang JL, 2004, BIOCHEM PHARMACOL, V67, P1123, DOI 10.1016/j.bcp.2003.11.004; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Zhang XP, 1999, J EXP MED, V190, P451, DOI 10.1084/jem.190.4.451; Zhang ZC, 2004, HEPATOLOGY, V39, P1028, DOI 10.1002/hep.20143; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	59	100	106	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31059	31067		10.1074/jbc.M502956200	http://dx.doi.org/10.1074/jbc.M502956200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15987693	hybrid			2022-12-27	WOS:000231487800050
J	Tang, L; Li, MH; Cao, P; Wang, F; Chang, WR; Bach, S; Reinhardt, J; Ferandin, Y; Galons, H; Wan, YQ; Gray, N; Meijer, L; Jiang, T; Liang, DC				Tang, L; Li, MH; Cao, P; Wang, F; Chang, WR; Bach, S; Reinhardt, J; Ferandin, Y; Galons, H; Wan, YQ; Gray, N; Meijer, L; Jiang, T; Liang, DC			Crystal structure of pyridoxal kinase in complex with roscovitine and derivatives	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; CDK INHIBITORS; R-ROSCOVITINE; PROTEIN; CANCER; PROGRAM; BRAIN; IDENTIFICATION; DEREGULATION; DISEASE	Pyridoxal kinase (PDXK) catalyzes the phosphorylation of pyridoxal, pyridoxamine, and pyridoxine in the presence of ATP and Zn2+. This constitutes an essential step in the synthesis of pyridoxal 5'- phosphate (PLP), the active form of vitamin B-6, a cofactor for over 140 enzymes. (R)- Roscovitine (CYC202, Seliciclib) is a relatively selective inhibitor of cyclin-dependent kinases (CDKs), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections. Affinity chromatography investigations have shown that ( R)- roscovitine also interacts with PDXK. To understand this interaction, we determined the crystal structure of PDXK in complex with (R)- roscovitine, N-6-methyl-(R)- roscovitine, and O-6-(R)roscovitine, the two latter derivatives being designed to bind to PDXK but not to CDKs. Structural analysis revealed that these three roscovitines bind similarly in the pyridoxal-binding site of PDXK rather than in the anticipated ATP-binding site. The pyridoxal pocket has thus an unexpected ability to accommodate molecules different from and larger than pyridoxal. This work provides detailed structural information on the interactions between PDXK and roscovitine and analogs. It could also aid in the design of roscovitine derivatives displaying strict selectivity for either PDXK or CDKs.	Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China; CNRS, Cell Cycle Grp, UPS 2682, F-29682 Roscoff, Bretagne, France; UMR Mer & Sante 7150, Biol Stn, F-29682 Roscoff, Bretagne, France; Univ Paris 05, Lab Chim Organ 2, F-75270 Paris, France; Novartis Res Fdn, Genomics Inst, Dept Chem, San Diego, CA 92121 USA; Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Novartis; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, T (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.	x-ray@sun5.ibp.ac.cn	MEIJER, Laurent/ABE-7465-2021	, laurent/0000-0003-3511-4916; , Peng/0000-0002-2044-3074				Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang YT, 1999, CHEM BIOL, V6, P361, DOI 10.1016/S1074-5521(99)80048-9; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; DAKSHINAMURTI K, 1990, ANN NY ACAD SCI, V585, P128, DOI 10.1111/j.1749-6632.1990.tb28049.x; de la Motte S, 2004, INT J CLIN PHARM TH, V42, P232; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; FISCHER PM, 2003, CELL CYCLE REGULATOR, V5, P235; Harper JW, 2001, CHEM REV, V101, P2511, DOI 10.1021/cr0001030; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KERRY JA, 1986, EUR J BIOCHEM, V158, P581, DOI 10.1111/j.1432-1033.1986.tb09794.x; Knockaert M, 2000, CHEM BIOL, V7, P411, DOI 10.1016/S1074-5521(00)00124-1; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LaineCessac P, 1997, BIOCHEM PHARMACOL, V54, P863, DOI 10.1016/S0006-2952(97)00252-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li MH, 2004, J BIOL CHEM, V279, P17459, DOI 10.1074/jbc.M312380200; Li MH, 2002, J BIOL CHEM, V277, P46385, DOI 10.1074/jbc.M208600200; Malumbres M, 2000, BIOL CHEM, V381, P827, DOI 10.1515/BC.2000.105; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Mapelli M, 2005, J MED CHEM, V48, P671, DOI 10.1021/jm049323m; McClue SJ, 2002, INT J CANCER, V102, P463, DOI 10.1002/ijc.10738; MCCORMICK DB, 1959, P NATL ACAD SCI USA, V45, P1371, DOI 10.1073/pnas.45.9.1371; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Meijer L, 2003, ACCOUNTS CHEM RES, V36, P417, DOI 10.1021/ar0201198; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Monaco EA, 2003, CURR MED CHEM, V10, P367, DOI 10.2174/0929867033368277; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; OTWINOWSKI Z, 1993, OSCILLATION DATA RED, P56; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Rosania GR, 1999, P NATL ACAD SCI USA, V96, P4797, DOI 10.1073/pnas.96.9.4797; Safo MK, 2004, J BACTERIOL, V186, P8074, DOI 10.1128/JB.186.23.8074-8082.2004; Smith PD, 2004, TRENDS MOL MED, V10, P445, DOI 10.1016/j.molmed.2004.07.003; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Wang SD, 2001, TETRAHEDRON-ASYMMETR, V12, P2891, DOI 10.1016/S0957-4166(01)00471-2; Zhang M, 2004, AM J PATHOL, V165, P843, DOI 10.1016/S0002-9440(10)63347-0	40	60	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31220	31229		10.1074/jbc.M500805200	http://dx.doi.org/10.1074/jbc.M500805200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15985434	hybrid			2022-12-27	WOS:000231487800069
J	Forget, G; Gregory, DJ; Olivier, M				Forget, G; Gregory, DJ; Olivier, M			Proteasome-mediated degradation of STAT1 alpha following infection of macrophages with Leishmania donovani	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; JAK-STAT PATHWAYS; ERYTHROPOIETIN RECEPTOR; TRANSCRIPTIONAL ACTIVATION; TYROSINE PHOSPHORYLATION; IMMUNE-RESPONSE; INHIBITION; EXPRESSION; PHOSPHATASE	Activation of the Janus-activated kinase 2 (JAK2)/ STAT1 alpha signaling pathway is repressed in Leishmania-infected macrophages. This represents an important mechanism by which this parasite subverts the microbicidal functions of the cell to promote its own survival and propagation. We recently provided evidence that the protein tyrosine phosphatase (PTP) SHP-1 was responsible for JAK2 inactivation. However, STAT1 translocation to the nucleus was not restored in the absence of SHP-1. In the present study, we have used B10R macrophages to study the mechanism by which this Leishmania-induced STAT1 inactivation occurs. STAT1 alpha nuclear localization was shown to be rapidly reduced by the infection. Western blot analysis revealed that cellular STAT1 alpha, but not STAT3, was degraded. Using PTP inhibitors and an immortalized bone marrow-derived macrophage cell line from SHP-1-deficient mice, we showed that STAT1 inactivation was independent of PTP activity. However, inhibition of macrophage proteasome activity significantly rescued Leishmania-induced STAT1 alpha degradation. We further demonstrated that degradation was receptor-mediated and involved protein kinase C alpha. All Leishmania species tested ( L. major, L. donovani, L. mexicana, L. braziliensis), but not the related parasite Trypanosoma cruzi, caused STAT1 alpha degradation. Collectively, results from this study revealed a new mechanism for STAT1 regulation by a microbial pathogen, which favors its establishment and propagation within the host.	McGill Univ, Dept Microbiol & Immunol, Ctr Hlth, Montreal, PQ H3A 2B4, Canada; McGill Univ, Ctr Study Host Resistance Inst, Ctr Hlth, Montreal, PQ H3A 2B4, Canada; McGill Univ, Div Expt Med, Montreal, PQ H3A 2B4, Canada; Univ Laval, Ctr Hosp, Ctr Rech Infectiol, Univ Quebec, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Ctr Hosp, Dept Med Biol, Univ Quebec, Quebec City, PQ G1V 4G2, Canada	McGill University; McGill University; McGill University; Laval University; University of Quebec; Laval University; University of Quebec	Forget, G (corresponding author), McGill Univ, Dept Microbiol & Immunol, Ctr Hlth, 3775 Univ St, Montreal, PQ H3A 2B4, Canada.	martin.olivier@mcgill.ca	Gregory, David/P-2582-2015	Gregory, David/0000-0001-6534-7150				Alvarez GR, 2003, J IMMUNOL, V171, P6766, DOI 10.4049/jimmunol.171.12.6766; Bertholet S, 2003, INFECT IMMUN, V71, P2095, DOI 10.1128/IAI.71.4.2095-2101.2003; BIONDI A, 1984, J IMMUNOL, V132, P1237; Blanchette J, 1999, EUR J IMMUNOL, V29, P3737, DOI 10.1002/(SICI)1521-4141(199911)29:11&lt;3737::AID-IMMU3737&gt;3.0.CO;2-S; Bogdan C, 1998, INT J PARASITOL, V28, P121, DOI 10.1016/S0020-7519(97)00169-0; Brittingham A, 1999, INFECT IMMUN, V67, P4477, DOI 10.1128/IAI.67.9.4477-4484.1999; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Callus BA, 1998, BLOOD, V91, P3182, DOI 10.1182/blood.V91.9.3182.3182_3182_3192; Carrera L, 1996, J EXP MED, V183, P515, DOI 10.1084/jem.183.2.515; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Duthie MS, 2002, J IMMUNOL, V168, P5778, DOI 10.4049/jimmunol.168.11.5778; EGAN TJ, 1994, FEBS LETT, V352, P54, DOI 10.1016/0014-5793(94)00921-X; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Forget G, 2001, EUR J IMMUNOL, V31, P3185, DOI 10.1002/1521-4141(200111)31:11&lt;3185::AID-IMMU3185&gt;3.0.CO;2-J; Frantsve J, 2001, MOL CELL BIOL, V21, P3547, DOI 10.1128/MCB.21.10.3547-3557.2001; Garcin D, 2004, J VIROL, V78, P8799, DOI 10.1128/JVI.78.16.8799-8811.2004; Gotoh B, 2002, REV MED VIROL, V12, P337, DOI 10.1002/rmv.357; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Johnston JA, 2004, J LEUKOCYTE BIOL, V75, P743, DOI 10.1189/jlb.1003507; Kile BT, 2001, CELL MOL LIFE SCI, V58, P1627, DOI 10.1007/PL00000801; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Knutson KL, 1998, J BIOL CHEM, V273, P645, DOI 10.1074/jbc.273.1.645; Komatsu T, 2000, J VIROL, V74, P2477, DOI 10.1128/JVI.74.5.2477-2480.2000; KWAN WC, 1992, INFECT IMMUN, V60, P2115, DOI 10.1128/IAI.60.5.2115-2120.1992; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Malek RL, 1999, CYTOKINE, V11, P192, DOI 10.1006/cyto.1998.0421; Mansfield John M., 2002, P379; Martiny A, 1999, MOL BIOCHEM PARASIT, V102, P1, DOI 10.1016/S0166-6851(99)00067-5; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Mosser David M., 1993, Seminars in Cell Biology, V4, P315, DOI 10.1006/scel.1993.1038; MOSSER DM, 1987, J EXP MED, V165, P140, DOI 10.1084/jem.165.1.140; MOSSER DM, 1985, J IMMUNOL, V135, P2785; NANDAN D, 1995, INFECT IMMUN, V63, P4495, DOI 10.1128/IAI.63.11.4495-4500.1995; Nandan D, 1999, INFECT IMMUN, V67, P4055, DOI 10.1128/IAI.67.8.4055-4063.1999; NEWMAN SL, 1991, J IMMUNOL, V146, P967; Olivier M, 1996, PARASITOL TODAY, V12, P145, DOI 10.1016/0169-4758(96)10006-5; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Olivier M, 1998, J BIOL CHEM, V273, P13944, DOI 10.1074/jbc.273.22.13944; OLIVIER M, 1992, P NATL ACAD SCI USA, V89, P7481, DOI 10.1073/pnas.89.16.7481; OLIVIER M, 1992, J IMMUNOL, V148, P1188; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Proudfoot L, 1996, P NATL ACAD SCI USA, V93, P10984, DOI 10.1073/pnas.93.20.10984; RADZIOCH D, 1991, J LEUKOCYTE BIOL, V50, P263, DOI 10.1002/jlb.50.3.263; Rogers RS, 2003, J BIOL CHEM, V278, P30091, DOI 10.1074/jbc.M301344200; Turco SJ, 1999, PARASITE IMMUNOL, V21, P597, DOI 10.1046/j.1365-3024.1999.00266.x; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; Ungureanu D, 2003, BLOOD, V102, P3311, DOI 10.1182/blood-2002-12-3816; Verdier F, 2000, J BIOL CHEM, V275, P18375, DOI 10.1074/jbc.275.24.18375; Verdier F, 1998, J BIOL CHEM, V273, P28185, DOI 10.1074/jbc.273.43.28185; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Yang WT, 2002, BLOOD CELL MOL DIS, V28, P63, DOI 10.1006/bcmd.2002.0485; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Yu CL, 1997, J BIOL CHEM, V272, P14017, DOI 10.1074/jbc.272.22.14017; Zakharova N, 2003, J BIOL CHEM, V278, P43067, DOI 10.1074/jbc.M308166200	62	55	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30542	30549		10.1074/jbc.M414126200	http://dx.doi.org/10.1074/jbc.M414126200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15983048	hybrid			2022-12-27	WOS:000231362500069
J	Johnson, EF; Mukhopadhyay, B				Johnson, EF; Mukhopadhyay, B			A new type of sulfite reductase, a novel coenzyme F-420-dependent enzyme, from the methanarchaeon Methanocaldococcus jannaschii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; BACTERIAL LUCIFERASE FAMILY; METHANOCOCCUS-JANNASCHII; ARCHAEOGLOBUS-FULGIDUS; METHANOBACTERIUM-THERMOAUTOTROPHICUM; DESULFOVIBRIO-VULGARIS; METHANOGENIC BACTERIA; METHANOSARCINA-MAZEI; MYCOBACTERIUM-SMEGMATIS; F420H2 DEHYDROGENASE	Methanocaldococcus jannaschii is a hypertheromphilic, strictly hydrogenotrophic, methanogenic archaeon of ancient lineage isolated from a deep-sea hydrothermal vent. It requires sulfide for growth. Sulfite is inhibitory to the methanogens. Yet, we observed that M. jannaschii grows and produces methane with sulfite as the sole sulfur source. We found that in this organism sulfite induces a novel, highly active, coenzyme F-420-dependent sulfite reductase (Fsr) with a cell extract specific activity of 0.57 mu mol sulfite reduced min(-1) mg(-1) protein. The cellular level of Fsr protein is comparable to that of methyl-coenzyme M reductase, an enzyme essential for methanogenesis and a possible target for sulfite. Purified Fsr reduces sulfite to sulfide using reduced F-420 (H2F420) as the electron source (K-m: sulfite, 12 mu M; H2F420, 21 mu M). Therefore, Fsr provides M. jannaschii an anabolic ability and protection from sulfite toxicity. The N-terminal half of the 70-kDa Fsr polypeptide represents a H2F420 dehydrogenase and the C-terminal half a dissimilatory-type siroheme sulfite reductase, and Fsr catalyzes the corresponding partial reactions. Previously described sulfite reductases use nicotinamides and cytochromes as electron carriers. Therefore, this is the first report of a coenzyme F-420-dependent sulfite reductase. Fsr homologs were found only in Methanopyrus kandleri and Methanothermobacter thermautotrophicus, two strictly hydrogenotrophic thermophilic methanogens. fsr is the likely ancestor of H2F420 dehydrogenases, which serve as electron input units for membranebased energy transduction systems of certain late evolving archaea, and dissimilatory sulfite reductases of bacteria and archaea. fsr could also have arisen from lateral gene transfer and gene fusion events.	Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; Virginia Polytech Inst & State Univ, Dept Biol, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Mukhopadhyay, B (corresponding author), Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, 0477 Washington St, Blacksburg, VA 24061 USA.	biswarup@vt.edu		Mukhopadhyay, Biswarup/0000-0003-0736-0298				Abken HJ, 1997, FEMS MICROBIOL LETT, V154, P231, DOI 10.1111/j.1574-6968.1997.tb12649.x; APPLEBY CA, 1969, DATA BIOCH RES, P380; Aufhammer SW, 2005, PROTEIN SCI, V14, P1840, DOI 10.1110/ps.041289805; Aufhammer SW, 2004, STRUCTURE, V12, P361, DOI 10.1016/j.str.2004.02.010; BALDERSTON WL, 1976, APPL ENVIRON MICROB, V32, P264, DOI 10.1128/AEM.32.2.264-269.1976; Baumer S, 2000, J BIOL CHEM, V275, P17968, DOI 10.1074/jbc.M000650200; Becker DF, 1998, BIOCHEMISTRY-US, V37, P2639, DOI 10.1021/bi972145x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruggemann H, 2000, EUR J BIOCHEM, V267, P5810, DOI 10.1046/j.1432-1327.2000.01657.x; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; CANTOR CR, 1980, TECHNIQUES STUDY BIO, V2, P674; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Crane BR, 1996, CURR OPIN STRUC BIOL, V6, P744, DOI 10.1016/S0959-440X(96)80003-0; DAHL C, 1993, J GEN MICROBIOL, V139, P1817, DOI 10.1099/00221287-139-8-1817; DANIELS L, 1986, APPL ENVIRON MICROB, V51, P703, DOI 10.1128/AEM.51.4.703-709.1986; Deppenmeier U, 2004, J BIOENERG BIOMEMBR, V36, P55, DOI 10.1023/B:JOBB.0000019598.64642.97; Dhillon A, 2005, ASTROBIOLOGY, V5, P18, DOI 10.1089/ast.2005.5.18; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; EIRICH LD, 1978, BIOCHEMISTRY-US, V17, P4583, DOI 10.1021/bi00615a002; FELSENSTEIN J, 1992, GENET RES, V60, P209, DOI 10.1017/S0016672300030962; HAASE P, 1992, EUR J BIOCHEM, V203, P527, DOI 10.1111/j.1432-1033.1992.tb16579.x; Hendrickson EL, 2004, J BACTERIOL, V186, P6956, DOI 10.1128/JB.186.20.6956-6969.2004; HUANG CJ, 1991, J BACTERIOL, V173, P1544, DOI 10.1128/jb.173.4.1544-1553.1991; Huber H, 1997, SYST APPL MICROBIOL, V20, P374, DOI 10.1016/S0723-2020(97)80005-7; HUBER R, 1989, NATURE, V342, P833, DOI 10.1038/342833a0; HUYNH BH, 1984, J BIOL CHEM, V259, P5373; JACOBSON FS, 1982, J BIOL CHEM, V257, P3385; JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; JONES WJ, 1983, ARCH MICROBIOL, V136, P254, DOI 10.1007/BF00425213; Kah LC, 2004, NATURE, V431, P834, DOI 10.1038/nature02974; KARKHOFFSCHWEIZER RR, 1995, APPL ENVIRON MICROB, V61, P290, DOI 10.1128/AEM.61.1.290-296.1995; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE JP, 1973, J BACTERIOL, V115, P453, DOI 10.1128/JB.115.1.453-455.1973; LEE JP, 1973, J BACTERIOL, V115, P529, DOI 10.1128/JB.115.2.529-542.1973; LeGall J., 1988, BIOL ANAEROBIC MICRO, P587; Leigh JA, 2002, BIODIVERSITY MICROBI, P103; Leustek T, 2000, ANNU REV PLANT PHYS, V51, P141, DOI 10.1146/annurev.arplant.51.1.141; Mahlert F, 2002, J BIOL INORG CHEM, V7, P500, DOI 10.1007/s00775-001-0325-z; MOURA I, 1986, BIOCHEM BIOPH RES CO, V141, P1032, DOI 10.1016/S0006-291X(86)80148-6; Mukhopadhyay B, 1999, APPL ENVIRON MICROB, V65, P5059; Mukhopadhyay B, 2000, P NATL ACAD SCI USA, V97, P11522, DOI 10.1073/pnas.97.21.11522; Mukhopadhyay B, 2000, ARCH MICROBIOL, V174, P406, DOI 10.1007/s002030000225; Mukhopadhyay B, 2000, BBA-GEN SUBJECTS, V1475, P191, DOI 10.1016/S0304-4165(00)00064-7; MUKHOPADHYAY B, 1989, CAN J MICROBIOL, V35, P499, DOI 10.1139/m89-077; Nakayama M, 2000, J INORG BIOCHEM, V82, P27, DOI 10.1016/S0162-0134(00)00138-0; Neumann A, 1996, J BIOL CHEM, V271, P16515, DOI 10.1074/jbc.271.28.16515; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; Purwantini E, 1996, J BACTERIOL, V178, P2861, DOI 10.1128/jb.178.10.2861-2866.1996; PURWANTINI E, 1992, ANAL BIOCHEM, V205, P342, DOI 10.1016/0003-2697(92)90446-E; Rothe O, 2000, EXTREMOPHILES, V4, P247, DOI 10.1007/PL00010716; ROUVIERE PE, 1987, ARCH MICROBIOL, V148, P253, DOI 10.1007/BF00456701; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; Slesarev AI, 2002, P NATL ACAD SCI USA, V99, P4644, DOI 10.1073/pnas.032671499; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Stahl DA, 2002, ANTON LEEUW INT J G, V81, P189, DOI 10.1023/A:1020506415921; Tchong SI, 2005, BIOCHEMISTRY-US, V44, P1659, DOI 10.1021/bi0484769; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; THOMAS I, 1987, ARCH MICROBIOL, V148, P193, DOI 10.1007/BF00414811; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRUEPER H G, 1964, Antonie Van Leeuwenhoek, V30, P225; WEAST RC, 1979, HDB CHEM PHYS, pD167; WEDZICHA BL, 1992, FOOD ADDIT CONTAM, V9, P449, DOI 10.1080/02652039209374097; WOLFE RS, 1992, BIOCHEM SOC SYMP, P41; ZEIKUS JG, 1972, J BACTERIOL, V109, P707, DOI 10.1128/JB.109.2.707-713.1972	70	61	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2005	280	46					38776	38786		10.1074/jbc.M503492200	http://dx.doi.org/10.1074/jbc.M503492200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	983NR	16048999	hybrid			2022-12-27	WOS:000233239800079
J	Cho, J; Degen, JL; Coller, BS; Mosher, DF				Cho, J; Degen, JL; Coller, BS; Mosher, DF			Fibrin but not adsorbed fibrinogen supports fibronectin assembly by spread platelets - Effects of the interaction of alpha IIb beta 3 with the C terminus of the fibrinogen gamma-chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; VON-WILLEBRAND-FACTOR; FLOWING WHOLE-BLOOD; MURINE MONOCLONAL-ANTIBODY; CROSS-LINKING; CELL-ADHESION; LYSOPHOSPHATIDIC ACID; EXTRACELLULAR-MATRIX; VONWILLEBRAND-FACTOR; ADHERENT PLATELETS	We investigated the assembly of soluble fibronectin by lysophosphatidic acid- activated platelets adherent to fibrinogen or fibrin. More fibronectin was assembled by activated platelets spread on fibrin matrices than by platelets spread on adsorbed fibrinogen. The difference between platelets adherent to fibrinogen and fibrin occurred under both static and flow conditions. Similar differences were seen in binding of the 70- kDa N- terminal fragment of fibronectin that recognizes fibronectin assembly sites on adherent cells. Antibody and peptide blocking studies demonstrated that alpha IIb beta 3 integrin mediates platelet adhesion to fibrinogen, whereas both alpha v beta 3 and alpha IIb beta 3 mediate platelet adhesion to fibrin. The hypothesis that engagement of the C- terminal QAGDV sequence of the fibrinogen gamma-chain by alpha IIb beta 3 inhibits the ability of the platelet to assemble fibronectin was tested by several experiments. Activated platelets adherent to adsorbed mutant fibrinogen lacking the QAGDV sequence ( gamma Delta 5FG) were assembly- competent, as were platelets adherent to adsorbed normal fibrinogen that had been pretreated with the 7E9 antibody to the C terminus of the gamma- chain. Moreover, adsorbed normal fibrinogen but not gamma Delta 5FG suppressed the ability of co- adsorbed fibronectin to direct assembly of soluble fibronectin by spread platelets. The suppressive effect was lost when a surface of co- adsorbed fibronectin and fibrinogen was pretreated with 7E9. These results support a model in which the engagement of alpha IIb beta 3 by the C- terminal sequence of the fibrinogen gamma-chain initiates signals that suppress subsequent fibronectin assembly by spread platelets. This interaction is less dominant when platelets adhere to fibrin, resulting in enhanced fibronectin assembly.	Univ Wisconsin, Dept Med, Med Sci Ctr 4285, Sch Med, Madison, WI 53706 USA; Univ Wisconsin, Sch Med, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA; Univ Cincinnati, Coll Med, Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA; Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10021 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Rockefeller University	Mosher, DF (corresponding author), Univ Wisconsin, Dept Med, Med Sci Ctr 4285, Sch Med, 1300 Univ Ave, Madison, WI 53706 USA.	dfmosher@wisc.edu		Cho, Jaehyung/0000-0003-2404-3446				Bach TL, 1998, J BIOL CHEM, V273, P30719, DOI 10.1074/jbc.273.46.30719; Bae E, 2004, J BIOL CHEM, V279, P35749, DOI 10.1074/jbc.M406283200; BARRY ELR, 1988, J BIOL CHEM, V263, P10464; BARRY ELR, 1989, J BIOL CHEM, V264, P4179; Belkin AM, 2005, BLOOD, V105, P3561, DOI 10.1182/blood-2004-10-4089; BITTORF SV, 1993, J BIOL CHEM, V268, P24838; Brown D C, 2001, BMC Immunol, V2, P9, DOI 10.1186/1471-2172-2-9; BUNCE LA, 1992, J CLIN INVEST, V89, P842, DOI 10.1172/JCI115663; CHEN R, 1969, P NATL ACAD SCI USA, V63, P420, DOI 10.1073/pnas.63.2.420; CHERESH DA, 1989, CELL, V58, P945, DOI 10.1016/0092-8674(89)90946-X; COLLER BS, 1991, BLOOD, V77, P75; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; COLLER BS, 1993, J CLIN INVEST, V92, P2796, DOI 10.1172/JCI116899; Corbett SA, 1996, BLOOD, V88, P158; Corbett SA, 1999, J BIOL CHEM, V274, P20943, DOI 10.1074/jbc.274.30.20943; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; DiazGonzalez F, 1996, MOL BIOL CELL, V7, P1939, DOI 10.1091/mbc.7.12.1939; Doolittle RF, 2001, ANN NY ACAD SCI, V936, P31; Dubois C, 2004, THROMB HAEMOSTASIS, V91, P233, DOI 10.1160/TH03-03-0126; ENDENBURG SC, 1993, BLOOD COAGUL FIBRIN, V4, P139, DOI 10.1097/00001721-199304010-00024; Farrell DH, 2004, CURR OPIN HEMATOL, V11, P151, DOI 10.1097/01.moh.0000131440.02397.a4; HAMAGUCHI M, 1993, BLOOD, V81, P2348; HANTGAN RR, 1990, BLOOD, V76, P345; HANTGAN RR, 1992, THROMB HAEMOSTASIS, V68, P694; Holmback K, 1996, EMBO J, V15, P5760, DOI 10.1002/j.1460-2075.1996.tb00962.x; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 1990, FIBRONECTINS; Jirouskova M, 1997, THROMB HAEMOSTASIS, V78, P1125; Jirouskova M, 2001, ANN NY ACAD SCI, V936, P464; Jirouskova M, 2001, THROMB HAEMOSTASIS, V86, P1047; Lengweiler S, 1999, BIOCHEM BIOPH RES CO, V262, P167, DOI 10.1006/bbrc.1999.1172; Li F, 2003, EUKARYOT CELL, V2, P1266, DOI 10.1128/EC.2.6.1266-1273.2003; LIMPER AH, 1991, J BIOL CHEM, V266, P9697; Litjens PEMH, 2003, J THROMB HAEMOST, V1, P2014, DOI 10.1046/j.1538-7836.2003.00381.x; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MOON KY, 1994, J BIOL CHEM, V269, P7651; Mosesson MW, 2003, J THROMB HAEMOST, V1, P231, DOI 10.1046/j.1538-7836.2003.00063.x; Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11; MOSHER DF, 1975, J BIOL CHEM, V250, P6614; MOSHER DF, 1995, THROMB HAEMOSTASIS, V74, P529; MOSHER DF, 1973, J BIOL CHEM, V248, P6896; Mosher DF, 1989, FIBRONECTIN; Moskowitz KA, 1998, THROMB HAEMOSTASIS, V79, P824, DOI 10.1055/s-0037-1615072; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; Olorundare OE, 2001, BLOOD, V98, P117, DOI 10.1182/blood.V98.1.117; PLOW EF, 1985, BLOOD, V66, P724; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; SAVAGE B, 1991, J BIOL CHEM, V266, P11227; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; SAVAGE B, 1992, J BIOL CHEM, V267, P11300; SHIMIZU A, 1992, P NATL ACAD SCI USA, V89, P2888, DOI 10.1073/pnas.89.7.2888; SPORN LA, 1995, BLOOD, V86, P1802, DOI 10.1182/blood.V86.5.1802.bloodjournal8651802; Suehiro K, 1996, J BIOL CHEM, V271, P10365, DOI 10.1074/jbc.271.17.10365; Wagner CL, 1996, BLOOD, V88, P907; Wang XN, 1996, J BIOL CHEM, V271, P17785, DOI 10.1074/jbc.271.30.17785; WAYNER EA, 1988, J CELL BIOL, V107, P1881, DOI 10.1083/jcb.107.5.1881; Wonerow P, 2003, J BIOL CHEM, V278, P37520, DOI 10.1074/jbc.M305077200; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Yang W, 1999, THROMB RES, V93, P279, DOI 10.1016/S0049-3848(98)00185-6; Yang Z, 2002, BIOCHEMISTRY-US, V41, P15610, DOI 10.1021/bi026666i; Yee KO, 1998, CIRC RES, V83, P241, DOI 10.1161/01.RES.83.3.241; Yokoyama K, 2000, J BIOL CHEM, V275, P16891, DOI 10.1074/jbc.M000610200; Zhang QH, 1996, J BIOL CHEM, V271, P33284, DOI 10.1074/jbc.271.52.33284; Zhang QH, 1999, J BIOL CHEM, V274, P368, DOI 10.1074/jbc.274.1.368	66	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2005	280	42					35490	35498		10.1074/jbc.M506289200	http://dx.doi.org/10.1074/jbc.M506289200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973ZN	16051597	hybrid			2022-12-27	WOS:000232561200049
J	Feyt, C; Kienlen-Campard, P; Leroy, K; N'Kuli, F; Courtoy, PJ; Brion, JP; Octave, JN				Feyt, C; Kienlen-Campard, P; Leroy, K; N'Kuli, F; Courtoy, PJ; Brion, JP; Octave, JN			Lithium chloride increases the production of amyloid-beta peptide independently from its inhibition of glycogen synthase kinase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; DISEASE-LIKE PHOSPHORYLATION; REDUCES TAU-PHOSPHORYLATION; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; SECRETASE CLEAVAGE; NEUROFIBRILLARY TANGLES; CYTOPLASMIC DOMAIN; INTACT-CELLS; IN-VITRO	Glycogen synthase kinase 3 (GSK3) is able to phosphorylate tau at many sites that are found to be phosphorylated in paired helical filaments in Alzheimer disease. Lithium chloride (LiCl) efficiently inhibits GSK3 and was recently reported to also decrease the production of amyloid-beta peptide (A beta) from its precursor, the amyloid precursor protein. Therefore, lithium has been proposed as a combined therapeutic agent, inhibiting both the hyperphosphorylation of tau and the production of A beta. Here, we demonstrate that the inhibition of GSK3 by LiCl induced the nuclear translocation of beta-catenin in Chinese hamster ovary cells and rat cultured neurons, in which a decrease in tau phosphorylation was observed. In both cellular models, a nontoxic concentration of LiCl increased the production of A beta by increasing the beta-cleavage of amyloid precursor protein, generating more substrate for an unmodified gamma-secretase activity. SB415286, another GSK3 inhibitor, induced the nuclear translocation of beta-catenin and slightly decreased A beta production. It is concluded that the LiCl-mediated increase in A beta production is not related to GSK3 inhibition.	Catholic Univ Louvain, Lab Expt Pharmacol, B-1200 Brussels, Belgium; Catholic Univ Louvain, Cell Unit, B-1200 Brussels, Belgium; Univ Libre Bruxelles, Lab Histol Neuroanat & Neuropathol, B-1070 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Libre de Bruxelles	Octave, JN (corresponding author), Catholic Univ Louvain, Lab Pharmacol Expt 54 10, Av Hippocrate 54, B-1200 Brussels, Belgium.	octave@nchm.ucl.ac.be	Brion, Jean-Pierre/C-6467-2009	Brion, Jean-Pierre/0000-0002-1917-775X; Leroy, Karelle/0000-0002-8661-5262; Kienlen-Campard, Pascal/0000-0003-1086-2942				Abbenante G, 2000, BIOCHEM BIOPH RES CO, V268, P133, DOI 10.1006/bbrc.2000.2098; Aplin AE, 1996, J NEUROCHEM, V67, P699; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; BRION JP, 1991, BIOCHEM J, V279, P831, DOI 10.1042/bj2790831; BRION JP, 1991, BIOCHEM J, V273, P127, DOI 10.1042/bj2730127; BRION JP, 1985, J SUBMICR CYTOL PATH, V17, P89; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cupers P, 1997, BIOCHEM BIOPH RES CO, V236, P661, DOI 10.1006/bbrc.1997.7033; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; DELACOURTE A, 1986, J NEUROL SCI, V76, P173, DOI 10.1016/0022-510X(86)90167-X; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Ermolieff J, 2000, BIOCHEMISTRY-US, V39, P12450, DOI 10.1021/bi001494f; Essalmani R, 1996, BIOCHEM BIOPH RES CO, V218, P89, DOI 10.1006/bbrc.1996.0017; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200; Kienlen-Campard P, 2002, PEPTIDES, V23, P1199, DOI 10.1016/S0196-9781(02)00055-4; Kumaraswamy S, 2004, P NATL ACAD SCI USA, V101, P7511, DOI 10.1073/pnas.0402367101; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LEIGHTON F, 1968, J CELL BIOL, V37, P482, DOI 10.1083/jcb.37.2.482; LEMARCHAND P, 1992, P NATL ACAD SCI USA, V89, P6482, DOI 10.1073/pnas.89.14.6482; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; Lovestone S, 1999, BIOL PSYCHIAT, V45, P995, DOI 10.1016/S0006-3223(98)00183-8; Macq AF, 1998, J BIOL CHEM, V273, P28931, DOI 10.1074/jbc.273.44.28931; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MunozMontano JR, 1997, FEBS LETT, V411, P183, DOI 10.1016/S0014-5793(97)00688-1; Octave JN, 1995, ACTA NEUROL BELG, V95, P197; Octave JN, 1995, REV NEUROSCIENCE, V6, P287; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Ryder J, 2003, BIOCHEM BIOPH RES CO, V312, P922, DOI 10.1016/j.bbrc.2003.11.014; SARASTE J, 1987, J CELL BIOL, V105, P2021, DOI 10.1083/jcb.105.5.2021; SPERBER BR, 1995, NEUROSCI LETT, V197, P149, DOI 10.1016/0304-3940(95)11902-9; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Standen CL, 2001, J NEUROCHEM, V76, P316, DOI 10.1046/j.1471-4159.2001.00102.x; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; Su Y, 2004, BIOCHEMISTRY-US, V43, P6899, DOI 10.1021/bi035627j; Sun X, 2002, NEUROSCI LETT, V321, P61, DOI 10.1016/S0304-3940(01)02583-6; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735	47	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33220	33227		10.1074/jbc.M501610200	http://dx.doi.org/10.1074/jbc.M501610200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16014628	hybrid			2022-12-27	WOS:000232058100017
J	McCartney, SA; Brignole, EJ; Kolegraff, KN; Loveland, AN; Ussin, LM; Gibson, W				McCartney, SA; Brignole, EJ; Kolegraff, KN; Loveland, AN; Ussin, LM; Gibson, W			Chemical rescue of I-site cleavage in living cells and in vitro discriminates between the cytomegalovirus protease, assemblin, and its precursor, pUL80a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTED MUTAGENESIS; MATURATIONAL PROTEINASE; HERPESVIRUS PROTEASES; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CATALYTIC DOMAIN; ACTIVE-SITE; VIRUS; DIMERIZATION; SUBSTRATE	Chemical rescue is an established approach that offers a directed strategy for designing mutant enzymes in which activity can be restored by supplying an appropriate exogenous compound. This method has been used successfully to study a broad range of enzymes in vitro, but its application to living systems has received less attention. We have investigated the feasibility of using chemical rescue to make a conditional-lethal mutant of the cytomegalovirus (CMV) maturational protease. The 28-kDa CMV serine protease, assemblin, has a Ser-His-His catalytic triad and an internal ( I) cleavage site near its midpoint. We found that imidazole can restore I-site cleavage to mutants inactivated by replacing the critical active site His with Ala or with Gly, which rescued better. Comparable rescue was observed for counterpart mutants of the human and simian CMV assemblin homologs and occurred in both living cells and in vitro. Cleavage was established to be at the correct site by amino acid sequencing and proceeded at similar to 11%/h in bacteria and similar to 30%/h in vitro. The same mutations were unresponsive to chemical rescue in the context of the assemblin precursor, pUL80a. This catalytic difference distinguishes the two forms of the CMV protease.	Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University	Gibson, W (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, 725 N Wolfe St, Baltimore, MD 21205 USA.	wgibson@jhmi.edu		Forcier, Amy/0000-0002-7773-7911; McCartney, Stephen/0000-0003-1102-6778	NIAID NIH HHS [AI13718, AI32957] Funding Source: Medline; NIGMS NIH HHS [GM61424] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI013718, R01AI032957, R56AI013718] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Admiraal SJ, 2001, BIOCHEMISTRY-US, V40, P403, DOI 10.1021/bi002472w; Batra R, 2001, NAT STRUCT BIOL, V8, P810, DOI 10.1038/nsb0901-810; BAUM EZ, 1993, J VIROL, V67, P497, DOI 10.1128/JVI.67.1.497-506.1993; Brown J, 2002, STRUCTURE FUNCTION R, P111; Buisson M, 2002, J MOL BIOL, V324, P89, DOI 10.1016/S0022-2836(02)01040-9; BURCK PJ, 1994, J VIROL, V68, P2937, DOI 10.1128/JVI.68.5.2937-2946.1994; CADADAY RJ, 2004, J VIROL, V78, P13501; CARTER P, 1987, SCIENCE, V237, P394, DOI 10.1126/science.3299704; Chan CK, 2002, J VIROL, V76, P8667, DOI 10.1128/JVI.76.17.8667-8674.2002; Chen P, 1996, CELL, V86, P835, DOI 10.1016/S0092-8674(00)80157-9; Cole JL, 1996, BIOCHEMISTRY-US, V35, P15601, DOI 10.1021/bi961719f; Darke PL, 1996, J BIOL CHEM, V271, P7445, DOI 10.1074/jbc.271.13.7445; Gibson W., 1995, PERSPECT DRUG DISCOV, V2, P413; Gibson W., 1993, MULTIDISCIPLINARY AP, P21; Hall MRT, 1996, J VIROL, V70, P5395, DOI 10.1128/JVI.70.8.5395-5404.1996; Holwerda BC, 1997, ANTIVIR RES, V35, P1, DOI 10.1016/S0166-3542(97)00012-0; HOLWERDA BC, 1994, J BIOL CHEM, V269, P25911; Iguchi K, 2002, APOPTOSIS, V7, P519, DOI 10.1023/A:1020691026578; JONES TR, 1994, J VIROL, V68, P3742, DOI 10.1128/JVI.68.6.3742-3752.1994; LADIN BF, 1982, VIROLOGY, V116, P544, DOI 10.1016/0042-6822(82)90147-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE JY, 1988, VIROLOGY, V167, P87, DOI 10.1016/0042-6822(88)90057-8; Lehoux IE, 2000, BIOCHEMISTRY-US, V39, P10055, DOI 10.1021/bi000161f; Liang PH, 1998, BIOCHEMISTRY-US, V37, P5923, DOI 10.1021/bi9726077; LIU FY, 1991, J VIROL, V65, P5149, DOI 10.1128/JVI.65.10.5149-5156.1991; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; Margosiak SA, 1996, BIOCHEMISTRY-US, V35, P5300, DOI 10.1021/bi952842u; Marnett AB, 2004, P NATL ACAD SCI USA, V101, P6870, DOI 10.1073/pnas.0401613101; MCCARTNEY SA, 2003, 9 INT CYT WORKSH MAY, P62; MCCARTNEY SA, 2003, PHIL HERP M JUN 4 PH; MCCARTNEY SA, 2003, 22 ANN M AM SOC VIR, P118; MCCARTNEY SA, 2003, 28 INT HERP WORKSH J; OBOYLE DR, 1995, J BIOL CHEM, V270, P4753, DOI 10.1074/jbc.270.9.4753; OCALLAGHAN DJ, 1976, PROG MED VIROL, V22, P152; Plafker SM, 1999, J VIROL, V73, P9053, DOI 10.1128/JVI.73.11.9053-9062.1999; Pray TR, 2002, BIOCHEMISTRY-US, V41, P1474, DOI 10.1021/bi011753g; PRESTON VG, 1992, VIROLOGY, V186, P87, DOI 10.1016/0042-6822(92)90063-U; PRESTON VG, 1983, J VIROL, V45, P1056, DOI 10.1128/JVI.45.3.1056-1064.1983; Qiu XY, 1996, NATURE, V383, P275, DOI 10.1038/383275a0; Robertson BJ, 1996, J VIROL, V70, P4317, DOI 10.1128/JVI.70.7.4317-4328.1996; Roizman B, 2001, FIELDS VIROL, P2381; Rynkiewicz MJ, 1996, BIOCHEMISTRY-US, V35, P16174, DOI 10.1021/bi961311i; SCHENK P, 1991, J VIROL, V65, P1525, DOI 10.1128/JVI.65.3.1525-1529.1991; Shieh HS, 1996, NATURE, V383, P279, DOI 10.1038/383279a0; SMITH MC, 1994, METHOD ENZYMOL, V244, P412; STEVEN AC, 1997, STRUCTURAL BIOL VIRU, P312; TONEY MD, 1989, SCIENCE, V243, P1485, DOI 10.1126/science.2538921; Tong L, 1996, NATURE, V383, P272, DOI 10.1038/383272a0; Venkataraman P, 2005, J BIOL CHEM, V280, P21463, DOI 10.1074/jbc.M412406200; Waxman L, 2000, ANTIVIR CHEM CHEMOTH, V11, P1; WELCH AR, 1991, P NATL ACAD SCI USA, V88, P10792, DOI 10.1073/pnas.88.23.10792; WELCH AR, 1991, J VIROL, V65, P4091, DOI 10.1128/JVI.65.8.4091-4100.1991; WELCH AR, 1993, J VIROL, V67, P7360, DOI 10.1128/JVI.67.12.7360-7372.1993; Williams DM, 2000, J BIOL CHEM, V275, P38127, DOI 10.1074/jbc.C000606200; Wittwer AJ, 2002, ANTIVIR RES, V55, P291, DOI 10.1016/S0166-3542(02)00051-7	55	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33206	33212		10.1074/jbc.M506876200	http://dx.doi.org/10.1074/jbc.M506876200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16036911	hybrid			2022-12-27	WOS:000232058100015
J	Dasgupta, S; Jana, M; Liu, XJ; Pahan, K				Dasgupta, S; Jana, M; Liu, XJ; Pahan, K			Myelin basic protein-primed T cells of female but not male mice induce nitric-oxide synthase and proinflammatory cytokines in microglia - Implications for gender bias in multiple sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; LIPOPOLYSACCHARIDE INDUCTION; EXPRESSION; MACROPHAGES; ACTIVATION; DISEASES; PEROXYNITRITE	Females are more susceptible than males to multiple sclerosis ( MS). However, the underlying mechanism behind this gender difference is poorly understood. Because the presence of neuroantigen- primed T cells within the CNS is necessary for the development of MS, the present study was undertaken to investigate the activation of microglia by myelin basic protein ( MBP)- primed T cells of male, female, and castrated male mice. Interestingly, MBP- primed T cells isolated from female and castrated male but not from male mice induced the expression of inducible nitric- oxide synthase ( iNOS) and proinflammatory cytokines ( interleukin- 1 beta ( IL- 1 beta), IL- 1 alpha, IL- 6, and tumor necrosis factor- alpha) in microglia by cell- cell contact. Again there was no apparent defect in male microglia, because MBP- primed T cells isolated from female and castrated male but not male mice were capable of inducing the production of NO in male primary microglia. Inhibition of female T cell contact- mediated microglial expression of proinflammatory molecules by dominant- negative mutants of p65 and C/ EBP beta suggest that female MBP- primed T cells induce microglial expression of proinflammatory molecules through the activation of NF- kappa B and C/ EBP beta. Interestingly, MBP- primed T cells of male, female, and castrated male mice were able to induce microglial activation of NF- kappa B. However, MBP- primed T cells of female and castrated male but not male mice induced microglial activation of C/ EBP beta. These studies suggest that microglial activation of C/ EBP beta but not NF- kappa B by T cell: microglial contact is a gender- specific event and that male MBP- primed T cells are not capable of inducing microglial expression of proinflammatory molecules due to their inability to induce the activation of C/ EBP beta in microglia. This novel gender- sensitive activation of microglia by neuroantigen- primed T cell contact could be one of the mechanisms behind the female- loving nature of MS.	Univ Nebraska, Med Ctr, Dept Oral Biol, Sect Neurosci, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center	Pahan, K (corresponding author), Univ Nebraska, Med Ctr, Dept Oral Biol, Sect Neurosci, 40th & Holdrege, Lincoln, NE 68583 USA.	kpahan@unmc.edu			NCRR NIH HHS [P20 RR018759, P20RR18759] Funding Source: Medline; NINDS NIH HHS [R01NS39940, R01 NS039940-05A1, R01 NS039940] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039940] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAGSRA O, 1996, P NATL ACAD SCI USA, V92, P12041; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenner T, 1997, J IMMUNOL, V158, P2940; Brosnan CF, 1996, BRAIN PATHOL, V6, P243, DOI 10.1111/j.1750-3639.1996.tb00853.x; Chabot S, 2000, NEUROLOGY, V55, P1497, DOI 10.1212/WNL.55.10.1497; CROSS AH, 1993, NEUROLOGY, V43, P1028, DOI 10.1212/WNL.43.5.1028; Dasgupta S, 2003, J BIOL CHEM, V278, P22424, DOI 10.1074/jbc.M301789200; Dasgupta S, 2002, J BIOL CHEM, V277, P39327, DOI 10.1074/jbc.M111841200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ding MZ, 1997, J NEUROIMMUNOL, V77, P99, DOI 10.1016/S0165-5728(97)00065-9; DUQUETTE P, 1992, CAN J NEUROL SCI, V19, P466, DOI 10.1017/S0317167100041664; ESIRI MM, 1997, MULTIPLE SCLEROSIS C, P173; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Heiss E, 2001, J BIOL CHEM, V276, P32008, DOI 10.1074/jbc.M104794200; Hooper DC, 1998, P NATL ACAD SCI USA, V95, P675, DOI 10.1073/pnas.95.2.675; Hooper DC, 1997, P NATL ACAD SCI USA, V94, P2528, DOI 10.1073/pnas.94.6.2528; Hu HM, 2000, J BIOL CHEM, V275, P16373, DOI 10.1074/jbc.M910269199; Iglesias A, 2001, GLIA, V36, P220, DOI 10.1002/glia.1111; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Jana M, 2003, J NEUROCHEM, V86, P519, DOI 10.1046/j.1471-4159.2003.01864.x; Jana M, 2002, J NEUROCHEM, V80, P197, DOI 10.1046/j.0022-3042.2001.00691.x; Jana M, 2001, J BIOL CHEM, V276, P44527, DOI 10.1074/jbc.M106771200; Liu HB, 2001, J NEUROIMMUNOL, V116, P83, DOI 10.1016/S0165-5728(01)00284-3; Liu XJ, 2002, J BIOL CHEM, V277, P39312, DOI 10.1074/jbc.M205107200; MAIMONE D, 1991, J NEUROIMMUNOL, V32, P67, DOI 10.1016/0165-5728(91)90073-G; Makino S, 1981, Jikken Dobutsu, V30, P137; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; Pahan K, 2001, J BIOL CHEM, V276, P7899, DOI 10.1074/jbc.M008262200; ROUBINIAN JR, 1978, J EXP MED, V147, P1568, DOI 10.1084/jem.147.6.1568; RUDDLE NH, 1990, J EXP MED, V172, P1193, DOI 10.1084/jem.172.4.1193; Samoilova EB, 1998, J IMMUNOL, V161, P6480; SATO EH, 1992, INVEST OPHTH VIS SCI, V33, P2537; Sedgwick JD, 1998, J IMMUNOL, V160, P5320; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; TRAUGOTT U, 1983, SCIENCE, V219, P308, DOI 10.1126/science.6217550; TYOR WR, 1993, NEUROLOGY, V43, P1002, DOI 10.1212/WNL.43.5.1002; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; UTZ U, 1994, J NEUROPATH EXP NEUR, V53, P351, DOI 10.1097/00005072-199407000-00005; Voskuhl RR, 1996, ANN NEUROL, V39, P724, DOI 10.1002/ana.410390608; Voskuhl RR, 2001, NEUROSCIENTIST, V7, P258, DOI 10.1177/107385840100700310; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795	45	23	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32609	32617		10.1074/jbc.M500299200	http://dx.doi.org/10.1074/jbc.M500299200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16046404	Green Accepted, hybrid			2022-12-27	WOS:000231920300008
J	Kandori, H; Nakamura, H; Yamazaki, Y; Mogi, T				Kandori, H; Nakamura, H; Yamazaki, Y; Mogi, T			Redox-induced protein structural changes in cytochrome bo revealed by Fourier transform infrared spectroscopy and [C-13]Tyr labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FTIR DIFFERENCE SPECTROSCOPY; HEME-COPPER OXIDASES; RESONANCE RAMAN CHARACTERIZATION; SITE-DIRECTED MUTAGENESIS; DIOXYGEN REDUCTION SITE; AMINO-ACID-RESIDUES; SUBUNIT-I PERTURB; C-OXIDASE; ESCHERICHIA-COLI; PARACOCCUS-DENITRIFICANS	Cytochrome bo is a heme-copper terminal ubiquinol oxidase of Escherichia coli under highly aerated growth conditions. Tyr-288 present at the end of the K- channel forms a C-epsilon-N-epsilon covalent bond with one of the Cu-B ligand histidines and has been proposed to be an acid-base catalyst essential for the O-O bond cleavage at the Oxy-to-P transition of the dioxygen reduction cycle ( Uchida, T., Mogi, T., and Kitagawa, T. (2000) Biochemistry 39, 6669 - 6678). To probe structural changes at tyrosine residues, we examined redox difference Fourier transform infrared difference spectra of the wild-type enzyme in which either L-[1-C-13] Tyr or L-[4-C-13] Tyr has been biosynthetically incorporated in the tyrosine auxotroph. Spectral comparison between [1-C-13] Tyr-labeled and unlabeled proteins indicated that substitution of the main chain carbonyl of a Tyr residue(s) significantly affected changes in the amide-I (similar to 1620 - 1680 cm(-1)) and -II (similar to 1540 - 1560 cm(-1)) regions. In contrast, spectral comparison between [4-C-13] Tyr-labeled and unlabeled proteins showed only negligible changes, which was the case for both the pulsed and the resting forms. Thus, protonation of an OH group of tyrosines including Tyr- 288 in the vicinity of the heme o-Cu-B binuclear center was not detected at pH 7.4 upon full reduction of cytochrome bo. Redox-induced main chain changes at a Tyr residue(s) are associated with structural changes at Glu-286 near the binuclear metal centers and may be related to switching of the K-channel operative at the reductive phase to D-channel at the oxidative phase of the dioxygen reduction cycle via conformational changes in the middle of helix VI.	Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan; RIKEN, Harima Inst, Mikazuki, Hyogo 6795148, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 2300045, Japan; Nara Inst Sci & Technol, Grad Sch Mat Sci, Dept Mat Sci, Ikoma, Nara 6300101, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Org, JST, ATP Syst Project, ERATO,Midori Ku, Yokohama, Kanagawa 2260026, Japan; Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Nagoya Institute of Technology; RIKEN; Yokohama City University; Nara Institute of Science & Technology; University of Tokyo; Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Kandori, H (corresponding author), Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.	kandori@nitech.ac.jp						Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Aki M, 2002, J PHYS CHEM A, V106, P3436, DOI 10.1021/jp012492n; Behr J, 2000, BIOCHEMISTRY-US, V39, P1356, DOI 10.1021/bi991504g; Berthomieu C, 1998, BIOCHEMISTRY-US, V37, P10547, DOI 10.1021/bi980788m; Blomberg MRA, 2000, J INORG BIOCHEM, V80, P261, DOI 10.1016/S0162-0134(00)00080-5; Buse G, 1999, PROTEIN SCI, V8, P985, DOI 10.1110/ps.8.5.985; Cappuccio JA, 2002, J AM CHEM SOC, V124, P1750, DOI 10.1021/ja011852h; Chen YR, 1999, J BIOL CHEM, V274, P3308, DOI 10.1074/jbc.274.6.3308; Colthup N.B., 1990, INTRO INFRARED RAMAN; FABIAN M, 1995, BIOCHEMISTRY-US, V34, P13802, DOI 10.1021/bi00042a011; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Gennis RB, 1998, BBA-BIOENERGETICS, V1365, P241, DOI 10.1016/S0005-2728(98)00075-9; Harada I, 1986, SPECTROSCOPY BIOL SY, P113; Harrenga A, 1999, J BIOL CHEM, V274, P33296, DOI 10.1074/jbc.274.47.33296; Hellwig P, 1996, FEBS LETT, V385, P53, DOI 10.1016/0014-5793(96)00342-0; Hellwig P, 1998, BIOCHEMISTRY-US, V37, P7390, DOI 10.1021/bi9725576; Hellwig P, 2002, BIOCHEMISTRY-US, V41, P9116, DOI 10.1021/bi012056r; Helwig P, 1999, FEBS LETT, V458, P83, DOI 10.1016/S0014-5793(99)01133-3; Hienerwadel R, 1997, BIOCHEMISTRY-US, V36, P14712, DOI 10.1021/bi971521a; HIROTA S, 1994, FEBS LETT, V352, P67, DOI 10.1016/0014-5793(94)00919-8; Iwaki M, 2005, BIOCHEMISTRY-US, V44, P4230, DOI 10.1021/bi047533v; Iwaki M, 2003, BIOCHEMISTRY-US, V42, P8809, DOI 10.1021/bi034522d; Iwaki M, 2002, BBA-BIOENERGETICS, V1555, P116, DOI 10.1016/S0005-2728(02)00265-7; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; KANDORI H, 1995, BIOCHEMISTRY-US, V34, P14220, DOI 10.1021/bi00043a029; Kannt A, 1998, J BIOENERG BIOMEMBR, V30, P81, DOI 10.1023/A:1020563629032; Karpefors M, 1998, BBA-BIOENERGETICS, V1365, P159, DOI 10.1016/S0005-2728(98)00058-9; Kawasaki M, 1997, J BIOCHEM, V122, P422; Kobayashi K, 2000, BIOCHEMISTRY-US, V39, P15620, DOI 10.1021/bi0014094; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lee HM, 2000, BIOCHEMISTRY-US, V39, P2989, DOI 10.1021/bi9924821; Lubben M, 1999, BIOCHEMISTRY-US, V38, P2048, DOI 10.1021/bi981859k; Lubben M, 1996, FEBS LETT, V397, P303, DOI 10.1016/S0014-5793(96)01174-X; Ma JX, 1998, BIOCHEMISTRY-US, V37, P11806, DOI 10.1021/bi9809977; MacMillan F, 1999, BIOCHEMISTRY-US, V38, P9179, DOI 10.1021/bi9911987; McCauley KM, 2000, J AM CHEM SOC, V122, P2403, DOI 10.1021/ja993774s; McMahon BH, 2004, BBA-BIOENERGETICS, V1655, P321, DOI 10.1016/j.bbabio.2004.01.007; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934; MITCHELL R, 1994, BBA-BIOENERGETICS, V1186, P19, DOI 10.1016/0005-2728(94)90130-9; Mogi T, 1998, BIOCHEMISTRY-US, V37, P1632, DOI 10.1021/bi971978k; Mogi T, 1999, FEBS LETT, V457, P61, DOI 10.1016/S0014-5793(99)01007-8; Mogi T., 1998, J BIOCH MOL BIOL BIO, V2, P79; MOODY AJ, 1994, EUR J BIOCHEM, V226, P731, DOI 10.1111/j.1432-1033.1994.tb20102.x; Noguchi T, 1997, BIOCHEMISTRY-US, V36, P14705, DOI 10.1021/bi971760y; Nyquist RM, 2003, P NATL ACAD SCI USA, V100, P8715, DOI 10.1073/pnas.1530408100; Nyquist RM, 2001, FEBS LETT, V505, P63, DOI 10.1016/S0014-5793(01)02769-7; Ogura T, 2004, BBA-BIOENERGETICS, V1655, P290, DOI 10.1016/j.bbabio.2003.10.013; Okuno D, 2003, J AM CHEM SOC, V125, P7209, DOI 10.1021/ja021302z; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Pfitzner U, 2000, BIOCHEMISTRY-US, V39, P6756, DOI 10.1021/bi992235x; Proshlyakov DA, 2000, SCIENCE, V290, P1588, DOI 10.1126/science.290.5496.1588; Proshlyakov DA, 1998, P NATL ACAD SCI USA, V95, P8020, DOI 10.1073/pnas.95.14.8020; Prutsch A, 2002, BBA-BIOENERGETICS, V1554, P22, DOI 10.1016/S0005-2728(02)00207-4; Puustinen A, 1997, BIOCHEMISTRY-US, V36, P13195, DOI 10.1021/bi971091o; PUUSTINEN A, 1989, FEBS LETT, V249, P163, DOI 10.1016/0014-5793(89)80616-7; Rich PR, 2002, BIOCHEMISTRY-US, V41, P967, DOI 10.1021/bi0109717; Riistama S, 1997, FEBS LETT, V414, P275, DOI 10.1016/S0014-5793(97)01003-X; ROTHSCHILD KJ, 1986, P NATL ACAD SCI USA, V83, P347, DOI 10.1073/pnas.83.2.347; Ruitenberg M, 2000, P NATL ACAD SCI USA, V97, P4632, DOI 10.1073/pnas.080079097; Sato-Watanabe M, 1998, BIOCHEMISTRY-US, V37, P5356, DOI 10.1021/bi9727592; Sato-Watanabe M, 1998, BIOCHEMISTRY-US, V37, P12744, DOI 10.1021/bi981184l; SATOWATANABE M, 1994, J BIOL CHEM, V269, P28908; Schmidt B, 2004, BBA-BIOENERGETICS, V1655, P248, DOI 10.1016/j.bbabio.2003.11.008; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Tomson F, 2002, BIOCHEMISTRY-US, V41, P14383, DOI 10.1021/bi026370c; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; Tsatsos PH, 1998, BIOCHEMISTRY-US, V37, P9884, DOI 10.1021/bi9809270; Tsubaki M, 2000, J INORG BIOCHEM, V82, P19, DOI 10.1016/S0162-0134(00)00140-9; TSUBAKI M, 1993, BIOCHEMISTRY-US, V32, P6065, DOI 10.1021/bi00074a018; Uchida T, 2004, J BIOL CHEM, V279, P53613, DOI 10.1074/jbc.M409719200; Uchida T, 2000, BIOCHEMISTRY-US, V39, P6669, DOI 10.1021/bi992538r; Verkhovskaya ML, 1997, P NATL ACAD SCI USA, V94, P10128, DOI 10.1073/pnas.94.19.10128; WANG JL, 1995, BIOCHEMISTRY-US, V34, P9819, DOI 10.1021/bi00031a001; Wikstrom M, 2000, BBA-BIOENERGETICS, V1459, P514, DOI 10.1016/S0005-2728(00)00191-2; Yamazaki Y, 1999, J BIOCHEM-TOKYO, V126, P194, DOI 10.1093/oxfordjournals.jbchem.a022423; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	79	9	9	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32821	32826		10.1074/jbc.M502072200	http://dx.doi.org/10.1074/jbc.M502072200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16040612	hybrid			2022-12-27	WOS:000231920300034
J	Lee, J; Sayegh, J; Daniel, J; Clarke, S; Bedford, MT				Lee, J; Sayegh, J; Daniel, J; Clarke, S; Bedford, MT			PRMT8, a new membrane-bound tissue-specific member of the protein arginine methyltransferase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; N-METHYLTRANSFERASE; GENE-EXPRESSION; METHYLATION; IDENTIFICATION; BINDING; OLIGOMERIZATION; MYRISTOYLATION; RESIDUES; SMN	Protein arginine methylation is a common post-translational modification that has been implicated in signal transduction, RNA processing, transcriptional regulation, and DNA repair. A search of the human genome for additional members of the protein arginine N-methyltransferase (PRMT) family of enzymes has identified a gene on chromosome 12 that we have termed PRMT8. This novel enzyme is most closely related to PRMT1, although it has a distinctive N-terminal region. The unique N-terminal end harbors a myr-istoylation motif, and we have shown here that PRMT8 is indeed modified by the attachment of a myristate to the glycine residue after the initiator methionine. The myristoylation of PRMT8 results in its association with the plasma membrane. The second singular property of PRMT8 is its tissue-specific expression pattern; it is largely expressed in the brain. A glutathione S-transferase fusion protein of PRMT8 has type I PRMT activity, catalyzing the formation of omega-N-G- monomethylated and asymmetrically omega-N-G, N-G-dimethylated arginine residues on a recombinant glycine- and arginine-rich substrate. PRMT8 is thus an active arginine methyltransferase that is membrane-associated and tissue-specific, two firsts for this family of enzymes.	Univ Texas, MD Anderson Canc Ctr, Div Sci Pk Res, Smithville, TX 78957 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, S (corresponding author), Univ Texas, MD Anderson Canc Ctr, Div Sci Pk Res, Smithville, TX 78957 USA.	clarke@mbi.ucla.edu; mtbedford@mdanderson.org	Bedford, Mark T/E-7856-2011		NIEHS NIH HHS [ES07784] Funding Source: Medline; NIGMS NIH HHS [GM26020] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; BOISVERT FM, 2005, SCI STKE, pRE2, DOI DOI 10.1126/STKE.2712005RE2; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cimato TR, 1997, J CELL BIOL, V138, P1089, DOI 10.1083/jcb.138.5.1089; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Gros L, 2003, CANCER RES, V63, P164; Henry MF, 1996, MOL CELL BIOL, V16, P3668; Hung CM, 2004, GENE, V340, P179, DOI 10.1016/j.gene.2004.07.039; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; KUJUBU DA, 1993, J NEUROSCI RES, V36, P58, DOI 10.1002/jnr.490360107; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Miranda TB, 2004, BIOCHEM BIOPH RES CO, V323, P382, DOI 10.1016/j.bbrc.2004.08.107; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Perez M, 2004, J VIROL, V78, P11443, DOI 10.1128/JVI.78.20.11443-11448.2004; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Resh MD, 2004, SUB CELL BIOCHEM, V37, P217; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; SEELEY PJ, 1984, J CELL BIOL, V98, P417, DOI 10.1083/jcb.98.2.417; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; SIWERCZ R, 2005, BIOCHEM J, V386, P85; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Utsumi T, 2004, EUR J BIOCHEM, V271, P863, DOI 10.1111/j.1432-1033.2004.03991.x; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Xu W, 2004, GENE DEV, V18, P144, DOI 10.1101/gad.1141704; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6	42	182	189	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32890	32896		10.1074/jbc.M506944200	http://dx.doi.org/10.1074/jbc.M506944200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16051612	Green Published, hybrid			2022-12-27	WOS:000231920300043
J	Yamada, T; Sakisaka, T; Hisata, S; Baba, T; Takai, Y				Yamada, T; Sakisaka, T; Hisata, S; Baba, T; Takai, Y			RA-RhoGAP, Rap-activated Rho GTPase-activating protein implicated in neurite outgrowth through Rho	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; ACTIN CYTOSKELETON; NEURONAL POLARITY; SIGNALING PATHWAY; EXCHANGE FACTOR; INVOLVEMENT; ADHERENS; CDC42; KINASE; NECTIN	Rap1 and Rho small G proteins have been implicated in the neurite outgrowth, but the functional relationship between Rap1 and Rho in the neurite outgrowth remains to be established. Here we identified a potent Rho GTPase-activating protein ( GAP), RA-RhoGAP, as a direct downstream target of Rap1 in the neurite outgrowth. RA-RhoGAP has the RA and GAP domains and showed GAP activity specific for Rho, which was enhanced by the binding of the GTP-bound active form of Rap1 to the RA domain. Overexpression of RA-RhoGAP induced inactivation of Rho for promoting the neurite outgrowth in a Rap1-dependent manner. Knockdown of RA-RhoGAP reduced the Rap1-induced neurite outgrowth. These results indicate that RA-RhoGAP transduces a signal from Rap1 to Rho and regulates the neurite outgrowth.	Osaka Univ, Dept Mol Biol & Biochem, Grad Sch Med, Fac Med, Suita, Osaka 5650871, Japan	Osaka University	Takai, Y (corresponding author), Osaka Univ, Dept Mol Biol & Biochem, Grad Sch Med, Fac Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ytakai@molbio.med.osaka-u.ac.jp						Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Curry BJ, 2004, GENOMICS, V84, P406, DOI 10.1016/j.ygeno.2004.03.004; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Fukuhara A, 2003, J BIOL CHEM, V278, P51885, DOI 10.1074/jbc.M308015200; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Gendron L, 2003, J BIOL CHEM, V278, P3606, DOI 10.1074/jbc.M202446200; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Hoshino T, 2004, MOL BIOL CELL, V15, P1077, DOI 10.1091/mbc.E03-05-0321; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; Kalla C, 2005, GENE CHROMOSOME CANC, V42, P128, DOI 10.1002/gcc.20131; Katoh M, 2003, INT J ONCOL, V23, P1471; KATOH M, 2005, IN PRESS GENES CHROM; Kinashi T, 2004, IMMUNOL LETT, V93, P1, DOI 10.1016/j.imlet.2004.02.008; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; Komuro R, 1996, GENES CELLS, V1, P943, DOI 10.1046/j.1365-2443.1996.760276.x; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Liao YH, 2001, J BIOL CHEM, V276, P28478, DOI 10.1074/jbc.M101737200; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Machida N, 2004, J BIOL CHEM, V279, P15711, DOI 10.1074/jbc.C300542200; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; NIRENBERG M, 1983, SCIENCE, V222, P794, DOI 10.1126/science.6314503; Price LS, 2004, NAT IMMUNOL, V5, P1007, DOI 10.1038/ni1004-1007; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Sasaki T, 1998, BIOCHEM BIOPH RES CO, V245, P641, DOI 10.1006/bbrc.1998.8253; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Umikawa M, 1999, J BIOL CHEM, V274, P25197, DOI 10.1074/jbc.274.36.25197; Yamada A, 2005, J BIOL CHEM, V280, P6016, DOI 10.1074/jbc.M408215200	47	57	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					33026	33034		10.1074/jbc.M504587200	http://dx.doi.org/10.1074/jbc.M504587200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16014623	hybrid			2022-12-27	WOS:000231920300057
J	Ja, WW; Adhikari, A; Austin, RJ; Sprang, SR; Roberts, RW				Ja, WW; Adhikari, A; Austin, RJ; Sprang, SR; Roberts, RW			A peptide core motif for binding to heterotrimeric G protein alpha subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO SELECTION; REGULATORY MOTIF; GAMMA-SUBUNIT; GDP; AGS3; DISSOCIATION; SIGNALING-3; INHIBITION; ACTIVATION; DISCOVERY	Recently, in vitro selection using mRNA display was used to identify a novel peptide sequence that binds with high affinity to G alpha(i1). The peptide was minimized to a 9-residue sequence (R6A-1) that retains high affinity and specificity for the GDP-bound state of G alpha(i1) and acts as a guanine nucleotide dissociation inhibitor (GDI). Here, we demonstrate that the R6A-1 peptide interacts with G alpha subunits representing all four G protein classes, acting as a core motif for G alpha interaction. This contrasts with the consensus G protein regulatory ( GPR) sequence, a 28-mer peptide GDI derived from the GoLoco (G alpha(i/o)-Loco interaction)/GPR motif that shares no homology with R6A-1 and binds only to G alpha(i1-3) in this assay. Binding of R6A-1 is generally specific to the GDP-bound state of the G alpha subunits and excludes association with G beta gamma. R6A-G alpha(i1) complexes are resistant to trypsin digestion and exhibit distinct stability in the presence of Mg2+, suggesting that the R6A and GPR peptides exert their activities using different mechanisms. Studies using G alpha(i1)/G alpha(s) chimeras identify two regions of G alpha(i1) (residues 1-35 and 57-88) as determinants for strong R6A-G(i alpha 1) interaction. Residues flanking the R6A-1 peptide confer unique binding properties, indicating that the core motif could be used as a starting point for the development of peptides exhibiting novel activities and/or specificity for particular G protein subclasses or nucleotide-bound states.	CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Mol Biophys Grad Program, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	California Institute of Technology; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Roberts, RW (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	rroberts@caltech.edu		Ja, William/0000-0002-4003-7356	NIDDK NIH HHS [R01 DK046371] Funding Source: Medline; NIGMS NIH HHS [R01 GM 60416] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060416] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adhikari A, 2003, J BIOL CHEM, V278, P51825, DOI 10.1074/jbc.M306300200; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Coleman DE, 1998, BIOCHEMISTRY-US, V37, P14376, DOI 10.1021/bi9810306; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Dower WJ, 2002, CURR OPIN CHEM BIOL, V6, P390, DOI 10.1016/S1367-5931(02)00332-0; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; FUNG BKK, 1983, J BIOL CHEM, V258, P503; GarciaHiguera I, 1996, J BIOL CHEM, V271, P528, DOI 10.1074/jbc.271.1.528; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; Holler C, 1999, CELL MOL LIFE SCI, V55, P257, DOI 10.1007/s000180050288; Howard AD, 2001, TRENDS PHARMACOL SCI, V22, P132, DOI 10.1016/S0165-6147(00)01636-9; HURLEY JB, 1984, SCIENCE, V226, P860, DOI 10.1126/science.6436980; Ja WW, 2005, TRENDS BIOCHEM SCI, V30, P318, DOI 10.1016/j.tibs.2005.04.001; Ja WW, 2004, BIOCHEMISTRY-US, V43, P9265, DOI 10.1021/bi0498398; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Lin HN, 2002, ANGEW CHEM INT EDIT, V41, P4403; MENDE U, 1995, J BIOL CHEM, V270, P15892, DOI 10.1074/jbc.270.26.15892; Natochin M, 2002, BIOCHEMISTRY-US, V41, P258, DOI 10.1021/bi015708k; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Natochin M, 2001, BIOCHEMISTRY-US, V40, P5322, DOI 10.1021/bi015505w; NEER EJ, 1994, METHOD ENZYMOL, V237, P226; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nurnberg B, 1999, EUR J MED CHEM, V34, P5, DOI 10.1016/S0223-5234(99)80037-3; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Peterson YK, 2002, J BIOL CHEM, V277, P6767, DOI 10.1074/jbc.C100699200; Radhika V, 2001, ONCOGENE, V20, P1607, DOI 10.1038/sj.onc.1204274; SCHMIDT CJ, 1991, J BIOL CHEM, V266, P4538; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Tsao KL, 1996, GENE, V169, P59, DOI 10.1016/0378-1119(95)00762-8	30	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32057	32060		10.1074/jbc.C500319200	http://dx.doi.org/10.1074/jbc.C500319200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16051611	Green Accepted, hybrid			2022-12-27	WOS:000231794800004
J	Kobayashi, Y; Shibusawa, A; Saito, H; Ohshiro, N; Ohbayashi, M; Kohyama, N; Yamamoto, T				Kobayashi, Y; Shibusawa, A; Saito, H; Ohshiro, N; Ohbayashi, M; Kohyama, N; Yamamoto, T			Isolation and functional characterization of a novel organic solute carrier protein, hOSCP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION CLONING; ANION TRANSPORTER; MOLECULAR-CLONING; HUMAN-PLACENTA; LIVER; IDENTIFICATION; SYSTEM; ACID	We succeeded in isolating a novel organic solute carrier from a human placenta cDNA library. The isolated cDNA consisted of 1137 base pairs that encoded a 379-amino acid protein, hOSCP1. Northern blot and reverse transcription PCR analyses revealed that the hOSCP1 mRNA is expressed in the placenta and testis and weakly expressed in the thymus and small intestine. When expressed in Xenopus laevis oocytes, hOSCP1 mediated the high affinity transport of p-aminohippurate ( PAH) (K-m = 35.0 +/- 7.5 mu M) and tetraethylammonium ( K-m = 62.3 +/- 12.2 mu M) in a sodium-independent manner. However, the hOSCP1-expressing oocyte did not mediate the transport of L-carnitine. The transport of PAH by hOSCP1 was sensitive to pH, but the tetraethylammonium was not transported at the high pH examined. hOSCP1 transported prostaglandin E-2, prostaglandin F-2 alpha, estrone sulfate, glutarate, L-leucine, L-ascorbic acid, and tetracycline. Thus, hOSCP1 also showed broad substrate specificity. A wide range of structurally unrelated organic compounds inhibited the hOSCP1-mediated PAH uptake. Immunohistochemical analysis revealed that the hOSCP1 protein is localized in the basal membrane of the syncytiotrophoblast in the human placenta. Our results suggest that hOSCP1 is a novel polyspecific organic solute carrier protein responsible for drug clearance from the human placenta.	Showa Univ, Sch Pharmaceut Sci, Dept Clin Pharm, Tokyo 1428555, Japan	Showa University	Yamamoto, T (corresponding author), Showa Univ, Sch Pharmaceut Sci, Dept Clin Pharm, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	yamagen@pharm.showa-u.ac.jp		Kohyama, Noriko/0000-0002-4681-5833				Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Griffiths M, 1997, BIOCHEM J, V328, P739, DOI 10.1042/bj3280739; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; JACQUEMIN E, 1994, P NATL ACAD SCI USA, V91, P133, DOI 10.1073/pnas.91.1.133; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kekuda R, 1998, J BIOL CHEM, V273, P15971, DOI 10.1074/jbc.273.26.15971; Kobayashi Y, 2002, MOL PHARMACOL, V62, P7, DOI 10.1124/mol.62.1.7; Li LQ, 1998, J BIOL CHEM, V273, P16184, DOI 10.1074/jbc.273.26.16184; Matthews JC, 1998, AM J PHYSIOL-CELL PH, V274, pC603, DOI 10.1152/ajpcell.1998.274.3.C603; Meier PJ, 1995, AM J PHYSIOL-GASTR L, V269, pG801, DOI 10.1152/ajpgi.1995.269.6.G801; MOLLER JV, 1982, PHARMACOL REV, V34, P315; PAJOR AM, 1995, J BIOL CHEM, V270, P5779, DOI 10.1074/jbc.270.11.5779; PETZINGER E, 1994, REV PHYSIOL BIOCH P, V123, P47, DOI 10.1007/BFb0030903; Prasad PD, 1998, J BIOL CHEM, V273, P7501, DOI 10.1074/jbc.273.13.7501; PRITCHARD JB, 1993, PHYSIOL REV, V73, P765, DOI 10.1152/physrev.1993.73.4.765; SAIGO K, 1990, REPROD TOXICOL, V4, P29, DOI 10.1016/0890-6238(90)90076-8; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; Seward DJ, 2003, J BIOL CHEM, V278, P27473, DOI 10.1074/jbc.M301106200; SHIN BC, 1997, ENDOCRINOLOGY, V138, P3397; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Ullrich KJ, 1997, PFLUG ARCH EUR J PHY, V433, P735, DOI 10.1007/s004240050339; VANDERAA EM, 1994, PLACENTA, V15, P279, DOI 10.1016/0143-4004(94)90019-1; Wang W, 2001, P NATL ACAD SCI USA, V98, P9431, DOI 10.1073/pnas.161099898; WHITSETT JA, 1980, J PEDIATR-US, V96, P600, DOI 10.1016/S0022-3476(80)80873-0	27	31	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32332	32339		10.1074/jbc.M504246200	http://dx.doi.org/10.1074/jbc.M504246200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16006562	hybrid			2022-12-27	WOS:000231794800037
J	Rampal, R; Arboleda-Velasquez, JF; Nita-Lazar, A; Kosik, KS; Haltiwanger, RS				Rampal, R; Arboleda-Velasquez, JF; Nita-Lazar, A; Kosik, KS; Haltiwanger, RS			Highly conserved O-fucose sites have distinct effects on Notch1 function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; PROTEIN O-FUCOSYL-TRANSFERASE-1; DELTA INTERACTIONS; LINKED FUCOSE; FRINGE; GLYCOSYLATION; RECEPTOR; GENE; GLYCOSYLTRANSFERASE; MODULATION	The extracellular domain of mouse Notch1 contains 36 tandem epidermal growth factor-like (EGF) repeats, many of which are modified with O-fucose. Previous work from several laboratories has indicated that O-fucosylation plays an important role in ligand mediated Notch activation. Nonetheless, it is not clear whether all, or a subset, of the EGF repeats need to be O-fucosylated. Three O-fucose sites are invariantly conserved in all Notch homologues with 36 EGF repeats ( within EGF repeats 12, 26, and 27). To investigate which O-fucose sites on Notch1 are important for ligand-mediated signaling, we mutated the three invariant O-fucose sites in mouse Notch1, along with several less highly conserved sites, and evaluated their ability to transduce Jagged1- and Delta1-mediated signaling in a cell-based assay. Our analysis revealed that mutation of any of the three invariant O-fucose sites resulted in significant changes in both Delta1 and Jagged1 mediated signaling, but mutations in less highly conserved sites had no detectable effect. Interestingly, mutation of each invariant site gave a distinct effect on Notch function. Mutation of the O-fucose site in EGF repeat 12 resulted in loss of Delta1 and Jagged1 signaling, while mutation of the O-fucose site in EGF repeat 26 resulted in hyperactivation of both Delta1 and Jagged1 signaling. Mutation of the O-fucose site in EGF repeat 27 resulted in faulty trafficking of the Notch receptor to the cell surface and a decreased S1 processing of the receptor. These results indicate that the most highly conserved O-fucose sites in Notch1 are important for both processing and ligand-mediated signaling in the context of a cell-based signaling assay.	SUNY Stony Brook, Inst Cell & Dev Biol, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Haltiwanger, RS (corresponding author), SUNY Stony Brook, Inst Cell & Dev Biol, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	rhaltiwanger@ms.cc.sunysb.edu	Nita-Lazar, Aleksandra/N-3740-2018	Nita-Lazar, Aleksandra/0000-0002-8523-605X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126, T32GM008444] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 61126, R01 GM061126, T32 GM008444] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arboleda-Velasquez JF, 2005, HUM MOL GENET, V14, P1631, DOI 10.1093/hmg/ddi171; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; de Celis JF, 2000, DEVELOPMENT, V127, P1291; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Lei L, 2003, DEVELOPMENT, V130, P6411, DOI 10.1242/dev.00883; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; Moloney DJ, 1997, J BIOL CHEM, V272, P19046, DOI 10.1074/jbc.272.30.19046; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614	30	82	82	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32133	32140		10.1074/jbc.M506104200	http://dx.doi.org/10.1074/jbc.M506104200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	15994302	hybrid, Green Accepted			2022-12-27	WOS:000231794800013
J	Cui, SJ; Guo, XQ; Chang, F; Cui, YW; Ma, LG; Sun, Y; Sun, D				Cui, SJ; Guo, XQ; Chang, F; Cui, YW; Ma, LG; Sun, Y; Sun, D			Apoplastic calmodulin receptor-like binding proteins in suspension-cultured cells of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEIN; EXTRACELLULAR CALMODULIN; SIGNAL-TRANSDUCTION; POLLEN GERMINATION; ENDOTHELIAL-CELLS; TUBE GROWTH; PLANTS; PROLIFERATION; RELEASE; SURFACE	Calmodulin, a highly conserved protein family that has long been well known as an intracellular calcium sensor, was identified in the culture medium and cell walls of Arabidopsis thaliana suspension-cultured cells by immunoblotting assay. A promotion effect by applying exogenous purified calmodulin and an inhibition effect by the addition of anti-calmodulin anti-serum or calmodulin antagonist to the medium on proliferation of suspension cells were found by monitoring incorporation of [methyl-H-3]thymidine into nuclear DNA. Radioligand binding analysis with S-35-labeled calmodulin indicated the presence of specific, reversible, and saturable calmodulin binding sites on the surface of both A. thaliana suspension-cultured cells and its protoplasts; among them at least one is on the surface of Arabidopsis protoplasts, with the K-d similar to 9.2 nM, and two are on the out-surface of Arabidopsis suspension-cultured cells, with K-d values of similar to 47.5 and 830 nM. Chemical cross-linking of S-35-labeled calmodulin to protoplasts revealed 117- and 41-kDa plasma membrane proteins specifically bound to calmodulin, whereas cross-linking with intact suspension-cultured cells verified more calmodulin binding proteins which might be cell wall-associated in addition to membrane-localized. Taking together, our data provide first evidence for the presence of apoplastic calmodulin receptor-like binding proteins on the cell surface of Arabidopsis suspension-cultured cells, which strongly supports our previous idea that apoplastic calmodulin functions as a peptide signal involved in regulation of cell growth and development.	Hebei Normal Univ, Inst Mol Cell Biol, Shijiazhuang 050016, Peoples R China	Hebei Normal University	Sun, D (corresponding author), Hebei Normal Univ, Inst Mol Cell Biol, 265 Yuhua Rd, Shijiazhuang 050016, Peoples R China.	cell@mail.hebtu.edu.cn						BANTING FG, 1922, J LAB CLIN MED, V7, P256; BIRO RL, 1984, PLANT PHYSIOL, V75, P382, DOI 10.1104/pp.75.2.382; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen YL, 2004, PLANT PHYSIOL, V136, P4096, DOI 10.1104/pp.104.047837; Clark GB, 2001, CURR SCI INDIA, V80, P170; CROCKER C, 1988, BIOCHEM J, V25, P877; CUI SJ, 2002, PROG BIOCHEM BIOPHYS, V29, P801; DAWSON RA, 1992, BRIT J HAEMATOL, V82, P151, DOI 10.1111/j.1365-2141.1992.tb04607.x; EDWARD EF, 1984, ANAL BIOCHEM, V141, P79; Endl I, 1996, MOL BIOL CELL, V7, P17, DOI 10.1091/mbc.7.1.17; Fromm H, 1992, PLANT MOL BIOL REP, V10, P199, DOI 10.1007/BF02668347; Han SC, 2003, NATURE, V425, P196, DOI 10.1038/nature01932; Houston DS, 1997, J BIOL CHEM, V272, P11778, DOI 10.1074/jbc.272.18.11778; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; LI JX, 1993, CELL RES, V3, P11; Lindsey K, 2002, TRENDS PLANT SCI, V7, P78, DOI 10.1016/S1360-1385(01)02194-X; LOURDES GG, 2002, TRENDS PLANT SCI, V7, P251; Ma LG, 1997, PLANTA, V202, P336, DOI 10.1007/s004250050135; Ma LG, 1999, PLANT CELL, V11, P1351, DOI 10.1105/tpc.11.7.1351; Ma LG, 2001, CHINESE SCI BULL, V46, P622, DOI 10.1007/BF03182819; Ma Li-Geng, 1998, Acta Phytophysiologica Sinica, V24, P196; MACNEIL S, 1988, J ENDOCRINOL, V118, P501, DOI 10.1677/joe.0.1180501; MACNEIL S, 1984, J INVEST DERMATOL, V83, P15, DOI 10.1111/1523-1747.ep12261637; Mao GH, 2005, PLANTA, V222, P428, DOI 10.1007/s00425-005-1558-9; Mao Guo-Hong, 1999, Acta Phytophysiologica Sinica, V25, P165; Marx J, 1996, SCIENCE, V273, P1338, DOI 10.1126/science.273.5280.1338; Matsubayashi Y, 2003, J CELL SCI, V116, P3863, DOI 10.1242/jcs.00733; Matsubayashi Y, 1997, P NATL ACAD SCI USA, V94, P13357, DOI 10.1073/pnas.94.24.13357; PERSHADSINGH HA, 1980, J BIOL CHEM, V255, P4087; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; REMGARD P, 1995, EUR J NEUROSCI, V7, P1386, DOI 10.1111/j.1460-9568.1995.tb01130.x; Ryan CA, 2002, PLANT CELL, V14, pS251, DOI 10.1105/tpc.010484; Scheer JM, 1999, PLANT CELL, V11, P1525, DOI 10.1105/tpc.11.8.1525; Shang ZL, 2005, PLANT CELL PHYSIOL, V46, P598, DOI 10.1093/pcp/pci063; SUN DY, 1995, PLANT CELL PHYSIOL, V36, P133; SUN DY, 1994, PLANT SCI, V99, P1, DOI 10.1016/0168-9452(94)90114-7; Sun DY, 2001, SCI CHINA SER C, V44, P449, DOI 10.1007/BF02882387; Tang J, 1996, PLANTA, V198, P510, DOI 10.1007/BF00262636; TANG WQ, 1997, J ENDOCRINOL, V155, P13; Thomas C, 2000, PLANT CELL, V12, P519, DOI 10.1105/tpc.12.4.519; Thomas C, 1999, PLANT PHYSIOL, V119, P543, DOI 10.1104/pp.119.2.543; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; YE ZH, 1988, CHINESE SCI BULL, V33, P624; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697; ZIELINSKI RE, 2000, METHOD MOL BIOL, V172, P1; 孙大业, 1995, 科学通报, V40, P1153	46	20	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31420	31427		10.1074/jbc.M501349200	http://dx.doi.org/10.1074/jbc.M501349200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16000297	hybrid			2022-12-27	WOS:000231665200012
J	Hong, F; Sekhar, KR; Freeman, ML; Liebler, DC				Hong, F; Sekhar, KR; Freeman, ML; Liebler, DC			Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUL3-BASED E3 LIGASE; TRANSCRIPTION FACTOR; COP9 SIGNALOSOME; GENE-EXPRESSION; SUBUNIT GENE; INDUCTION; PROTEIN; DEGRADATION; INDUCERS; ADAPTER	Activation of the transcription factor Nrf2 regulates expression of phase II enzymes and other adaptive responses to electrophile and oxidant stress. Nrf2 concentrations are regulated by the thiol-rich sensor protein Keap1, which is an adaptor protein for Cul3-dependent ubiquitination and degradation of Nrf2. However, the links between site specificity of Keap1 modification by electrophiles and mechanisms of Nrf2 activation are poorly understood. We studied the actions of the prototypical Nrf2 inducer tert-butylhydroquinone ( tBHQ) and two biotin-tagged, thiol-reactive electrophiles, Niodoacetyl-N-biotinylhexylenediamine ( IAB) and 1-biotinamido-4-( 4'-[ maleimidoethyl-cyclohexane]-carboxamido) butane ( BMCC). Both IAB and tBHQ induced antioxidant response element ( ARE)-directed green fluorescent protein ( GFP) expression in ARE/thymidine kinase GFP HepG2 cells, and both initiated nuclear Nrf2 accumulation and induction of heme oxygenase 1 in HEK293 cells. In contrast, BMCC produced none of these effects. Liquid chromatography tandem mass spectrometry ( MS-MS) analysis of human Keap1 modified by IAB or BMCC in vitro indicated that IAB adduction occurred primarily in the central linker domain, whereas BMCC modified other Keap1 domains. Treatment of FLAG-Keap1-transfected HEK293 with the Nrf2-activating compounds IAB and tBHQ generated high molecular weight Keap1 forms, which were identified as K-48linked polyubiquitin conjugates by immunoblotting and liquid chromatography MS-MS. Keap1 polyubiquitination coincided with Nrf2 stabilization and nuclear accumulation. In contrast, BMCC did not induce Keap1 polyubiquitination. Our results suggest that Nrf2 activation is regulated through the polyubiquitination of Keap1, which in turn is triggered by specific patterns of electrophile modification of the Keap1 central linker domain. These results suggest that Keap1 adduction triggers a switching of Cul3-dependent ubiquitination from Nrf2 to Keap1, leading to Nrf2 activation.	Vanderbilt Univ, Sch Med, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA; Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; University of Arizona; Vanderbilt University; Vanderbilt University; Vanderbilt University	Liebler, DC (corresponding author), Vanderbilt Univ, Sch Med, Mass Spectrometry Res Ctr, 9110A Med Res Bldg 3,465 21st Ave S, Nashville, TN 37232 USA.	daniel.liebler@vanderbilt.edu		Freeman, Michael/0000-0003-1881-366X; Konjeti, Sekhar/0000-0003-2930-0739; Liebler, Daniel/0000-0002-7873-3031	NATIONAL CANCER INSTITUTE [R01CA104590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010056, P30ES000267] Funding Source: NIH RePORTER; NCI NIH HHS [CA104590, R01 CA104590] Funding Source: Medline; NIEHS NIH HHS [ES010056, ES000267] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kensler TW, 1997, ENVIRON HEALTH PERSP, V105, P965, DOI 10.2307/3433311; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Moinova HR, 1999, BIOCHEM BIOPH RES CO, V261, P661, DOI 10.1006/bbrc.1999.1109; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Talalay P, 2003, ADV ENZYME REGUL, V43, P121, DOI 10.1016/S0065-2571(02)00038-9; Talalay P, 2000, BIOFACTORS, V12, P5, DOI 10.1002/biof.5520120102; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	31	257	267	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31768	31775		10.1074/jbc.M503346200	http://dx.doi.org/10.1074/jbc.M503346200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15985429	hybrid			2022-12-27	WOS:000231665200055
J	Ordaz, B; Tang, J; Xiao, R; Salgado, A; Sampieri, A; Zhu, MX; Vaca, L				Ordaz, B; Tang, J; Xiao, R; Salgado, A; Sampieri, A; Zhu, MX; Vaca, L			Calmodulin and calcium interplay in the modulation of TRPC5 channel activity - Identification of a novel C-terminal domain for calcium/calmodulin-mediated facilitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; NONSELECTIVE CATION CHANNELS; SF9 INSECT CELLS; TRANSIENT-RECEPTOR; BINDING-SITES; CA2+ INFLUX; PROTEIN; ACTIVATION; DROSOPHILA; GENE	TRPC5 forms Ca2+-permeable nonselective cation channels important for neurite outgrowth and growth cone morphology of hippocampal neurons. Here we studied the activation of mouse TRPC5 expressed in Chinese hamster ovary and human embryonic kidney 293 cells by agonist stimulation of several receptors that couple to the phosphoinositide signaling cascade and the role of calmodulin (CaM) on the activation. We showed that exogenous application of 10 mu m CaM through patch pipette accelerated the agonist-induced channel activation by 2.8-fold, with the time constant for half-activation reduced from 4.25 +/- 0.4 to 1.56 +/- 0.85 min. We identified a novel CaM-binding site located at the C terminus of TRPC5, 95 amino acids downstream from the previously determined common CaM/IP3R-binding (CIRB) domain for all TRPC proteins. Deletion of the novel CaM-binding site attenuated the acceleration in channel activation induced by CaM. However, disruption of the CIRB domain from TRPC5 rendered the channel irresponsive to agonist stimulation without affecting the cell surface expression of the channel protein. Furthermore, we showed that high (>5 mu m) intracellular free Ca2+ inhibited the current density without affecting the time course of TRPC5 activation by receptor agonists. These results demonstrated that intracellular Ca2+ has dual and opposite effects on the activation of TRPC5. The novel CaM-binding site is important for the Ca2+/CaM-mediated facilitation, whereas the CIRB domain is critical for the overall response of receptor-induced TRPC5 channel activation.	Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; Univ Nacl Autonoma Mexico, Dept Biol Celular, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Universidad Nacional Autonoma de Mexico	Zhu, MX (corresponding author), Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA.	zhu.55@osu.edu; lvaca@ifc.unam.mxn	Xiao, Rui/G-1193-2011; Sampieri, Alicia/L-3896-2019	Xiao, Rui/0000-0001-5541-6685; Vaca, Luis/0000-0003-2266-4847; Salgado, Alfonso/0000-0001-8102-3690	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042183] Funding Source: NIH RePORTER; NINDS NIH HHS [NS42183] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; HU YF, 1994, BIOCHEM BIOPH RES CO, V201, P1050, DOI 10.1006/bbrc.1994.1808; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kanki H, 2001, MOL PHARMACOL, V60, P989, DOI 10.1124/mol.60.5.989; Kunze DL, 1997, AM J PHYSIOL-CELL PH, V272, pC27, DOI 10.1152/ajpcell.1997.272.1.C27; LIU YC, 1990, TRENDS PHARMACOL SCI, V11, P107; Obukhov AG, 2004, J CELL PHYSIOL, V201, P227, DOI 10.1002/jcp.20057; Obukhov AG, 1998, NEUROSCIENCE, V85, P487, DOI 10.1016/S0306-4522(97)00616-7; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Singh BB, 2002, MOL CELL, V9, P739, DOI 10.1016/S1097-2765(02)00506-3; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Vaca L, 2002, J BIOL CHEM, V277, P42178, DOI 10.1074/jbc.M204531200; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200; Warr CG, 1996, BIOCHEM J, V314, P497, DOI 10.1042/bj3140497; Wedel BJ, 2003, J BIOL CHEM, V278, P25758, DOI 10.1074/jbc.M303890200; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zimmer S, 2000, PFLUG ARCH EUR J PHY, V440, P409, DOI 10.1007/s004240000292	26	73	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30788	30796		10.1074/jbc.M504745200	http://dx.doi.org/10.1074/jbc.M504745200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15987684	hybrid			2022-12-27	WOS:000231487800019
J	Pei, XH; An, XL; Guo, XH; Tarnawski, M; Coppel, R; Mohandas, N				Pei, XH; An, XL; Guo, XH; Tarnawski, M; Coppel, R; Mohandas, N			Structural and functional studies of interaction between Plasmodium falciparum knob-associated histidine-rich protein (KAHRP) and erythrocyte spectrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL MEMBRANE; SURFACE-ANTIGEN; BINDING DOMAIN; BETA-SPECTRIN; BLOOD-CELL; MALARIA; ACTIN; THROMBOSPONDIN; IDENTIFICATION; VIRULENCE	Plasmodium falciparum dramatically modifies the structure and function of the membrane of the parasitized host erythrocyte. Altered membrane properties are the consequence of the interaction of a group of exported malaria proteins with host cell membrane proteins. KAHRP (the knob-associated histidine-rich protein), a member of this group, has been shown to interact with erythrocyte membrane skeletal protein spectrin. However, the molecular basis for this interaction has yet to be defined. In the present study, we defined the binding motifs in both KAHRP and spectrin and identified a functional role for this interaction. We showed that spectrin bound to a 72-amino-acid KAHRP fragment (residues 370-441). Among nine-spectrin fragments, which encompass the entire alpha and beta spectrin molecules (four alpha spectrin and five beta spectrin fragments), KAHRP bound only to one, the alpha N-5 fragment. The KAHRP-binding site within the alpha N-5 fragment was localized uniquely to repeat 4. The interaction of full-length spectrin dimer to KAHRP was inhibited by repeat 4 of alpha spectrin. Importantly, resealing of this repeat peptide into erythrocytes mislocalized KAHRP in the parasitized cells. We concluded that the interaction of KAHRP with spectrin is critical for appropriate membrane localization of KAHRP in parasitized erythrocytes. As the presence of KAHRP at the erythrocyte membrane is necessary for cytoadherence in vivo, our findings have implications for the development of new therapies for mitigating the severity of malaria infection.	New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10021 USA; Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia	New York Blood Center; Monash University	Mohandas, N (corresponding author), New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10021 USA.	mnarla@nybloodcenter.org	Coppel, Ross L/A-6626-2008	Coppel, Ross L/0000-0002-4476-9124	NIDDK NIH HHS [DK 32094, DK 26263] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026263, P01DK032094, R37DK026263] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALEY SB, 1984, J EXP MED, V160, P1585, DOI 10.1084/jem.160.5.1585; ALEY SB, 1986, PARASITOLOGY, V92, P511, DOI 10.1017/S0031182000065410; ANDERS RF, 1987, UCLA S MOL CELL BIOL, V42, P333; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; BECKER PS, 1993, J CLIN INVEST, V92, P612, DOI 10.1172/JCI116628; Bennett BJ, 1997, J BIOL CHEM, V272, P15299, DOI 10.1074/jbc.272.24.15299; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BERENDT AR, 1994, PARASITOLOGY, V108, pS19, DOI 10.1017/S0031182000075685; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Cherry L, 1999, J BIOL CHEM, V274, P2077, DOI 10.1074/jbc.274.4.2077; Cooke BM, 2000, PARASITOL TODAY, V16, P416, DOI 10.1016/S0169-4758(00)01753-1; Cooke BM, 2004, SEMIN HEMATOL, V41, P173, DOI 10.1053/j.seminhematol.2004.01.004; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; DASILVA E, 1994, MOL BIOCHEM PARASIT, V66, P59, DOI 10.1016/0166-6851(94)90036-1; DE M, 2000, J CELL SCI, V113, P2331; DLUZEWSKI AR, 1983, PARASITOLOGY, V87, P429, DOI 10.1017/S0031182000082950; FOLEY M, 1991, MOL BIOCHEM PARASIT, V46, P137, DOI 10.1016/0166-6851(91)90207-M; FOLEY M, 1994, EXP PARASITOL, V79, P340, DOI 10.1006/expr.1994.1096; HERRERA S, 1993, EMBO J, V12, P1607, DOI 10.1002/j.1460-2075.1993.tb05805.x; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; KARINCH AM, 1990, J BIOL CHEM, V265, P11833; KILEJIAN A, 1991, MOL BIOCHEM PARASIT, V44, P175, DOI 10.1016/0166-6851(91)90003-O; KILEJIAN A, 1979, P NATL ACAD SCI USA, V76, P4650, DOI 10.1073/pnas.76.9.4650; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MAGOWAN C, 1995, BLOOD, V86, P3196; Magowan C, 2000, BBA-MOL BASIS DIS, V1502, P461, DOI 10.1016/S0925-4439(00)00069-7; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035; MULLER HM, 1993, EMBO J, V12, P2881, DOI 10.1002/j.1460-2075.1993.tb05950.x; Nicolas G, 1998, BIOCHEM J, V332, P81, DOI 10.1042/bj3320081; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; TAYLOR DW, 1987, MOL BIOCHEM PARASIT, V25, P165, DOI 10.1016/0166-6851(87)90005-3; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TYLER JM, 1979, P NATL ACAD SCI USA, V76, P5192, DOI 10.1073/pnas.76.10.5192; VERNOTHERNANDEZ JP, 1984, MOL BIOCHEM PARASIT, V12, P337, DOI 10.1016/0166-6851(84)90090-2; Waller KL, 1999, J BIOL CHEM, V274, P23808, DOI 10.1074/jbc.274.34.23808; Waller KL, 2003, BLOOD, V102, P1911, DOI 10.1182/blood-2002-11-3513	40	83	85	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31166	31171		10.1074/jbc.M505298200	http://dx.doi.org/10.1074/jbc.M505298200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16006556	hybrid			2022-12-27	WOS:000231487800063
J	Rhee, DK; Marcelino, J; Al-Mayouf, S; Schelling, DK; Bartels, CF; Cui, YJ; Laxer, R; Goldbach-Mansky, R; Warman, ML				Rhee, DK; Marcelino, J; Al-Mayouf, S; Schelling, DK; Bartels, CF; Cui, YJ; Laxer, R; Goldbach-Mansky, R; Warman, ML			Consequences of disease-causing mutations on lubricin protein synthesis, secretion, and post-translational processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPERFICIAL ZONE PROTEIN; BOVINE SYNOVIAL-FLUID; ARTICULAR-CARTILAGE; LUBRICATING FACTOR; GENE-EXPRESSION; GROWTH-FACTOR; 2-CHAIN FORM; VITRONECTIN; DOMAIN; BINDING	Lubricin, a protein product of the gene PRG4, is a secreted mucin-like proteoglycan that is a major lubricant in articulating joints. Mutations in PRG4 cause the autosomal recessive, human disorder camptodactyly-arthropathycoxa vara-pericarditis syndrome. We developed rabbit polyclonal antibodies against human lubricin to determine the consequence of disease-causing mutations at the protein level and to study the protein's normal post-translational processing. Antiserum generated against an epitope in the amino-terminal portion of lubricin detected protein in wild-type synovial fluid and in conditioned media from wild-type cultured synoviocytes. However, the antiserum did not detect lubricin in synovial fluid or cultured synoviocytes from several patients with frameshift or nonsense mutations in PRG4. Antiserum generated against an epitope in the protein's carboxyl-terminal, hemopexin-like domain identified a post-translational cleavage event in wild-type lubricin, mediated by a subtilisin-like proprotein convertase (SPC). Interestingly, in contrast to wild-type lubricin, one disease-causing mutation that removes the last 8 amino acids of the protein, including a conserved cysteine residue, was not cleaved within the hemopexin-like domain when expressed in COS-7 cells. This suggests that formation of an intrachain disulfide bond is required for SPC-mediated cleavage and that SPC-mediated cleavage is essential to protein function.	Case Western Reserve Univ, Dept Genet, Sch Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Human Genet, Sch Med, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia; Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Rheumatol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON M5G 1X8, Canada; NIAMS, NIH, Bethesda, MD 20892 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; King Faisal Specialist Hospital & Research Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Warman, ML (corresponding author), Case Western Reserve Univ, Dept Genet, Sch Med, Rm BRB-719,2109 Adelbert Rd, Cleveland, OH 44106 USA.	mlw14@case.edu	Goldbach-Mansky, Raphaela/N-5917-2017	Al-Mayouf, Sulaiman/0000-0003-0142-6698	NIAMS NIH HHS [AR050180] Funding Source: Medline; NICHD NIH HHS [HD07104, HD07518] Funding Source: Medline; NIGMS NIH HHS [GM08613, GM07250] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050180] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bahabri SA, 1998, ARTHRITIS RHEUM, V41, P730, DOI 10.1002/1529-0131(199804)41:4<730::AID-ART22>3.0.CO;2-Y; Blanchette F, 1997, J CLIN INVEST, V99, P1974, DOI 10.1172/JCI119365; CHAIN D, 1990, FEBS LETT, V269, P221, DOI 10.1016/0014-5793(90)81159-L; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Deng G, 2001, J CELL PHYSIOL, V189, P23, DOI 10.1002/jcp.1133; Elsaid KA, 2005, ARTHRITIS RHEUM-US, V52, P1746, DOI 10.1002/art.21038; Flannery CR, 1999, BIOCHEM BIOPH RES CO, V254, P535, DOI 10.1006/bbrc.1998.0104; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Ikegawa S, 2000, CYTOGENET CELL GENET, V90, P291, DOI 10.1159/000056791; Jay GD, 2001, J ORTHOPAED RES, V19, P677, DOI 10.1016/S0736-0266(00)00040-1; JAY GD, 1992, CONNECT TISSUE RES, V28, P71, DOI 10.3109/03008209209014228; JAY GD, 1992, CONNECT TISSUE RES, V28, P245, DOI 10.3109/03008209209016818; Liu YJ, 2004, BLOOD, V103, P4449, DOI 10.1182/blood-2003-06-1825; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; Matsuda A, 2003, J BIOL CHEM, V278, P36350, DOI 10.1074/jbc.M301509200; MERBERG DM, 1993, INT CONGR SER, V1042, P45; Murphy G, 1997, MATRIX BIOL, V15, P511, DOI 10.1016/S0945-053X(97)90025-1; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Rees SG, 2002, MATRIX BIOL, V21, P593, DOI 10.1016/S0945-053X(02)00056-2; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Schroeck F, 2002, BIOL CHEM, V383, P1143, DOI 10.1515/BC.2002.125; Schumacher BL, 1999, J ORTHOP RES, V17, P110, DOI 10.1002/jor.1100170117; SCHUMACHER BL, 1994, ARCH BIOCHEM BIOPHYS, V311, P144, DOI 10.1006/abbi.1994.1219; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; Seger D, 2000, FEBS LETT, V480, P169, DOI 10.1016/S0014-5793(00)01917-7; Sidenius N, 2000, FEBS LETT, V470, P40, DOI 10.1016/S0014-5793(00)01282-5; Su JL, 2001, HYBRIDOMA, V20, P149, DOI 10.1089/027245701750293475; SWANN DA, 1985, BIOCHEM J, V225, P195, DOI 10.1042/bj2250195; SWANN DA, 1977, BIOCHEM J, V161, P473, DOI 10.1042/bj1610473	31	51	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31325	31332		10.1074/jbc.M505401200	http://dx.doi.org/10.1074/jbc.M505401200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16000300	hybrid			2022-12-27	WOS:000231487800080
J	Zhou, XH; Li, F; Kong, L; Tomita, H; Li, C; Cao, W				Zhou, XH; Li, F; Kong, L; Tomita, H; Li, C; Cao, W			Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MATRIX METALLOPROTEINASES; INTRAOCULAR-PRESSURE; PIGMENTARY GLAUCOMA; SIGNALING PATHWAYS; DBA/2J MICE; P38 MAPK; EXTRACELLULAR-MATRIX; INCREASED EXPRESSION; PHOTORECEPTOR CELLS	Glaucoma is a common cause of blindness affecting at least 66 million people worldwide. Pigmentary glaucoma is one of the most common forms of secondary glaucoma, and its pathogenesis remains unclear. Interleukin-18 (IL-18) is an important regulator of innate and acquired immune responses and plays an important role in inflammatory/autoimmunity diseases. Using the DBA/2J mouse as an animal model of human pigmentary glaucoma, we demonstrated for the first time that the expression of the IL-18 protein and gene in the iris/ciliary body and level of IL-18 protein in the aqueous humor of DBA/2J mice are dramatically increased with age. This increase precedes the onset of clinical evidence of pigmentary glaucoma, implying a pathogenic role of inflammation/immunity in this disease. We also observed that activated NF-kappa B and phosphorylated MAPK are increased in the iris/ciliary body of DBA/2J mice, suggesting that both signaling pathways may be involved in IL-18 mediated pathogenesis of pigmentary glaucoma in the eyes of DBA/2J mice. In addition, matrix metalloproteinase-2 (MMP-2) expression in the iris/ciliary body and the activity of MMP-2 in the aqueous humor are increased whereas tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) expression in the iris/ciliary body is decreased, indicating that the degradation process is involved in this mouse model of pigmentary glaucoma. Furthermore, the expressions of apoptosis-related genes, caspase-8, Fas, FADD, FAP, and FAF, and the activity of caspase- 3 are increased in the iris/ciliary body of DBA/2J mice. Elucidation of biochemical and molecular mechanisms of IL-18 participation in the pathogenesis of pigmentary glaucoma should provide approaches for developing improved and targeted treatments to ameliorate this blinding disease. The possibility that altered IL-18 expression in the eye of DBA/2J mice initiates and/or amplifies the pathogenesis of pigmentary glaucoma requires further investigation.	Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA; Tohoku Univ, Biofunct Sci Biomed Engn Res Org, Sendai, Miyagi 9808575, Japan; Sichuan Univ, W China Hosp, Chengdu 610041, Sichuan, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; Tohoku University; Sichuan University	Cao, W (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Dean A McGee Eye Inst, 608 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	wei-cao@ouhsc.edu	Tomita, Hiroshi/O-2135-2018	Tomita, Hiroshi/0000-0003-1051-2301	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R03EY014427, P30EY012190] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR17703] Funding Source: Medline; NEI NIH HHS [EY014427, EY12190] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abraham M, 2002, INT IMMUNOL, V14, P1449, DOI 10.1093/intimm/dxf108; Ahn JH, 2002, BLOOD, V100, P1742, DOI 10.1182/blood.V100.5.1742.h81702001742_1742_1754; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Bachner Dietmar, 2002, Brain Res Gene Expr Patterns, V1, P159; Beaudeux JL, 2004, CLIN CHEM LAB MED, V42, P121, DOI 10.1515/CCLM.2004.024; Bora NS, 1997, INVEST OPHTH VIS SCI, V38, P2171; Burbach GJ, 2001, CURR EYE RES, V23, P64, DOI 10.1076/ceyr.23.1.64.5425; Campbell J, 2004, J IMMUNOL, V173, P6928, DOI 10.4049/jimmunol.173.11.6928; Cao W, 2003, ADV EXP MED BIOL, V533, P395; Cao W, 2000, J NEUROSCI RES, V60, P195, DOI 10.1002/(SICI)1097-4547(20000415)60:2<195::AID-JNR8>3.0.CO;2-7; Chandrasekar B, 2004, J BIOL CHEM, V279, P20221, DOI 10.1074/jbc.M313980200; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Chen L, 2003, CURR EYE RES, V26, P291, DOI 10.1076/ceyr.26.4.291.15432; Chintala SK, 2002, J BIOL CHEM, V277, P47461, DOI 10.1074/jbc.M204824200; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P1138, DOI 10.1167/iovs.02-0553; Delaleu N, 2004, PERIODONTOL 2000, V35, P42, DOI 10.1111/j.0906-6713.2004.003569.x; DiGirolamo N, 1996, CURR EYE RES, V15, P1060; DiGirolamo N, 1997, AM J PATHOL, V150, P653; FARRAR SM, 1993, SURV OPHTHALMOL, V37, P233, DOI 10.1016/0039-6257(93)90008-U; Goldblum D, 2002, GRAEF ARCH CLIN EXP, V240, P942, DOI 10.1007/s00417-002-0571-y; Gracie JA, 2004, CLIN EXP IMMUNOL, V136, P402, DOI 10.1111/j.1365-2249.2004.02475.x; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Huang WX, 2004, MULT SCLER J, V10, P482, DOI 10.1191/1352458504ms1071oa; Hue J, 2005, IMMUNOL LETT, V96, P211, DOI 10.1016/j.imlet.2004.08.008; Ishida Y, 2004, FEBS LETT, V569, P156, DOI 10.1016/j.febslet.2004.05.039; Jiang HR, 2001, INVEST OPHTH VIS SCI, V42, P177; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Kalina U, 2000, J IMMUNOL, V165, P1307, DOI 10.4049/jimmunol.165.3.1307; KAYA M, 1992, INVEST OPHTH VIS SCI, V33, P522; Kee C, 1999, J GLAUCOMA, V8, P51; Kermer P, 2000, J NEUROSCI, V20, P722, DOI 10.1523/JNEUROSCI.20-02-00722.2000; Kimura-Shimmyo A, 2002, J IMMUNOTHER, V25, pS42, DOI 10.1097/00002371-200203001-00007; Kirwan RP, 2004, J GLAUCOMA, V13, P327, DOI 10.1097/00061198-200408000-00011; Kontiola AI, 2001, EXP EYE RES, V73, P781, DOI 10.1006/exer.2001.1088; Lan J, 2003, BRIT J OPHTHALMOL, V87, P208, DOI 10.1136/bjo.87.2.208; Lee JK, 2004, P NATL ACAD SCI USA, V101, P8815, DOI 10.1073/pnas.0402800101; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Mahmoud Randa Abdel Kader, 2004, Ital J Biochem, V53, P73; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McGinnis JF, 2002, J NEUROSCI RES, V67, P290, DOI 10.1002/jnr.10120; Mo JS, 2003, J EXP MED, V197, P1335, DOI 10.1084/jem.20022041; Mook ORF, 2004, BBA-REV CANCER, V1705, P69, DOI 10.1016/j.bbcan.2004.09.006; Naib-Majani W, 2004, GRAEF ARCH CLIN EXP, V242, P332, DOI 10.1007/s00417-003-0846-y; Nakamura H, 1999, ANN RHEUM DIS, V58, P382, DOI 10.1136/ard.58.6.382; Nakazawa T, 2002, CURR EYE RES, V24, P114, DOI 10.1076/ceyr.24.2.114.8162; Narins CR, 2004, AM J CARDIOL, V94, P1285, DOI 10.1016/j.amjcard.2004.07.114; Nicoletti F, 2001, DIABETOLOGIA, V44, P309, DOI 10.1007/s001250051619; Noel A, 2004, J CLIN PATHOL, V57, P577, DOI 10.1136/jcp.2003.014472; Novak N, 2003, TRENDS IMMUNOL, V24, P570, DOI 10.1016/j.it.2003.09.009; Quiding-Jarbrink M, 2001, INFECT IMMUN, V69, P5661, DOI 10.1128/IAI.69.9.5661-5670.2001; Reddy P, 2004, CURR OPIN HEMATOL, V11, P405, DOI 10.1097/01.moh.0000141926.95319.42; Ruland J, 2003, SEMIN IMMUNOL, V15, P177, DOI 10.1016/S1044-5323(03)00034-4; Schuettauf F, 2002, VISION RES, V42, P2333, DOI 10.1016/S0042-6989(02)00188-8; Sergi B, 2004, J BIOL REG HOMEOS AG, V18, P55; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Sowka Joseph, 2004, Optometry, V75, P115, DOI 10.1016/S1529-1839(04)70023-8; Xue ML, 2003, INVEST OPHTH VIS SCI, V44, P2020, DOI 10.1167/iovs.02-0565; Yamaki K, 2000, J IMMUNOL, V165, P7323, DOI 10.4049/jimmunol.165.12.7323; Yu XR, 2004, J BIOL CHEM, V279, P13086, DOI 10.1074/jbc.M313283200; Zhang X, 2004, INVEST OPHTH VIS SCI, V45, P2374, DOI 10.1167/iovs.03-1239	63	115	123	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31240	31248		10.1074/jbc.M502641200	http://dx.doi.org/10.1074/jbc.M502641200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15985430	hybrid			2022-12-27	WOS:000231487800071
J	Minagawa, N; Kruglov, EA; Dranoff, JA; Robert, ME; Gores, GJ; Nathanson, MH				Minagawa, N; Kruglov, EA; Dranoff, JA; Robert, ME; Gores, GJ; Nathanson, MH			The anti-apoptotic protein Mcl-1 inhibits mitochondrial Ca2+ signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; BILE-DUCT EPITHELIA; CYTOCHROME-C; CALCIUM SIGNALS; BCL-2 FAMILY; PERMEABILITY TRANSITION; ENDOPLASMIC-RETICULUM; CELL-DIFFERENTIATION; DEATH RECEPTORS; BAX	Apoptosis contributes to the regulation of cell growth and regeneration and to the development of neoplasia. Mcl-1 is an anti-apoptotic protein that is particularly important for the development of hematological and biliary malignancies, but the mechanism of action of Mcl-1 is unknown. A number of pro- and anti-apoptotic proteins exhibit their effects by modulating Ca2+ signals, so we examined the effects of Mcl-1 on components of the Ca2+ signaling pathway that are known to regulate apoptosis. Expression of Mcl-1 did not affect expression of the inositol 1,4,5-trisphosphate receptor or the size of endoplasmic reticulum Ca2+ stores. However, mitochondrial Ca2+ signals induced by either Ca2+ agonists or apoptotic stimuli were decreased in cells overexpressing Mcl-1 and increased in cells in which Mcl-1 expression was inhibited. These findings provide evidence that Mcl-1 directly inhibits Ca2+ signals within mitochondria, which may provide a novel mechanism to inhibit apoptosis and thereby promote neoplasia.	Yale Univ, Sch Med, Sect Digest Dis, Dept Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; Mayo Clin & Mayo Grad Sch Med, Dept Med, Rochester, MN 55905 USA	Yale University; Yale University; Mayo Clinic	Nathanson, MH (corresponding author), Yale Univ, Sch Med, Sect Digest Dis, Dept Med, 1 Gilbert St,Rm TAC S241D, New Haven, CT 06520 USA.	michael.nathanson@yale.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061747, P30DK034989, R29DK045710, R01DK045710] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK61747, DK45710, DK34989] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Chami M, 2004, J BIOL CHEM, V279, P54581, DOI 10.1074/jbc.M409663200; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; GUNTER TE, 1990, AM J PHYSIOL, V258, P755; Hagar RE, 1998, NATURE, V396, P81, DOI 10.1038/23954; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hirata K, 1998, P NATL ACAD SCI USA, V95, P8381, DOI 10.1073/pnas.95.14.8381; Hirata K, 2002, HEPATOLOGY, V36, P284, DOI 10.1053/jhep.2002.34432; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005; JOUAVILLE IS, 1995, NATURE, V377, P438; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kaufmann SH, 1998, BLOOD, V91, P991, DOI 10.1182/blood.V91.3.991.991_991_1000; Khan AA, 1996, SCIENCE, V273, P503, DOI 10.1126/science.273.5274.503; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; LeSage G, 1999, GASTROENTEROLOGY, V117, P191, DOI 10.1016/S0016-5085(99)70567-6; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li C, 2002, P NATL ACAD SCI USA, V99, P9830, DOI 10.1073/pnas.152571899; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MCGILL JM, 1994, GASTROENTEROLOGY, V107, P236, DOI 10.1016/0016-5085(94)90082-5; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nathanson MH, 1996, AM J PHYSIOL-GASTR L, V271, pG86, DOI 10.1152/ajpgi.1996.271.1.G86; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shibao K, 2003, GASTROENTEROLOGY, V125, P1175, DOI 10.1016/S0016-5085(03)01201-0; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Vrana JA, 2002, CANCER RES, V62, P892; Yang T, 1996, J CELL PHYSIOL, V166, P523, DOI 10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R	43	59	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33637	33644		10.1074/jbc.M503210200	http://dx.doi.org/10.1074/jbc.M503210200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16027162	hybrid			2022-12-27	WOS:000232058100065
J	Tholander, F; Kull, F; Ohlson, E; Shafqat, J; Thunnissen, MMGM; Haeggstrom, JZ				Tholander, F; Kull, F; Ohlson, E; Shafqat, J; Thunnissen, MMGM; Haeggstrom, JZ			Leukotriene A(4) hydrolase, insights into the molecular evolution by homology modeling and mutational analysis of enzyme from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A(4) HYDROLASE; AMINOPEPTIDASE; PROGRAM; RESIDUE; SITE; IDENTIFICATION; INFLAMMATION; MECHANISMS; ALIGNMENT; CLONING	Mammalian leukotriene A(4) (LTA(4)) hydrolase is a bifunctional zinc metalloenzyme possessing an Arg/Ala aminopeptidase and an epoxide hydrolase activity, which converts LTA(4) into the chemoattractant LTB4. We have previously cloned an LTA(4) hydrolase from Saccharomyces cerevisiae with a primitive epoxide hydrolase activity and a Leu aminopeptidase activity, which is stimulated by LTA(4). Here we used a modeled structure of S. cerevisiae LTA(4) hydrolase, mutational analysis, and binding studies to show that Glu-316 and Arg-627 are critical for catalysis, allowing us to a propose a mechanism for the epoxide hydrolase activity. Guided by the structure, we engineered S. cerevisiae LTA(4) hydrolase to attain catalytic properties resembling those of human LTA(4) hydrolase. Thus, six consecutive point mutations gradually introduced a novel Arg aminopeptidase activity and caused the specific Ala and Pro aminopeptidase activities to increase 24 and 63 times, respectively. In contrast to the wild type enzyme, the hexuple mutant was inhibited by LTA(4) for all tested substrates and to the same extent as for the human enzyme. In addition, these mutations improved binding of LTA(4) and increased the relative formation of LTB4, whereas the turnover of this substrate was only weakly affected. Our results suggest that during evolution, the active site of an ancestral eukaryotic zinc aminopeptidase has been reshaped to accommodate lipid substrates while using already existing catalytic residues for a novel, gradually evolving, epoxide hydrolase activity. Moreover, the unique ability to catalyze LTB4 synthesis appears to be the result of multiple and subtle structural rearrangements at the catalytic center rather than a limited set of specific amino acid substitutions.	Karolinska Inst, Div Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Karolinska Inst, Div Chem 1, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Lund Univ, Kemicentrum, Dept Mol Biophys, S-22100 Lund, Sweden	Karolinska Institutet; Karolinska Institutet; Lund University	Haeggstrom, JZ (corresponding author), Karolinska Inst, Div Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	jesper.haeggstrom@mbb.ki.se	Thunnissen, Marjolein MGM/B-9366-2011					BARRET AJ, 1998, HDB PROTEOLYTIC ENZY, P994; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Baset HA, 1998, J BIOL CHEM, V273, P27978, DOI 10.1074/jbc.273.43.27978; Comuzzi C, 2003, TALANTA, V59, P67, DOI 10.1016/S0039-9140(02)00457-5; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GREEN FA, 1987, BIOCHEM BIOPH RES CO, V142, P309, DOI 10.1016/0006-291X(87)90274-9; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HABENICHT AJR, 1989, P NATL ACAD SCI USA, V86, P921, DOI 10.1073/pnas.86.3.921; Haeggstrom JZ, 2004, J BIOL CHEM, V279, P50639, DOI 10.1074/jbc.R400027200; Hogg JH, 1998, CHEM-EUR J, V4, P1698, DOI 10.1002/(SICI)1521-3765(19980904)4:9<1698::AID-CHEM1698>3.3.CO;2-A; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Kull F, 1999, J BIOL CHEM, V274, P34683, DOI 10.1074/jbc.274.49.34683; Kull F, 2001, BIOCHEMISTRY-US, V40, P12695, DOI 10.1021/bi011348p; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Laustsen PG, 2001, EUR J BIOCHEM, V268, P98, DOI 10.1046/j.1432-1327.2001.01848.x; Luciani N, 1998, BIOCHEMISTRY-US, V37, P686, DOI 10.1021/bi971705p; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mueller MJ, 1996, P NATL ACAD SCI USA, V93, P5931, DOI 10.1073/pnas.93.12.5931; Mueller MJ, 1996, J BIOL CHEM, V271, P24345, DOI 10.1074/jbc.271.40.24345; PETTITT TR, 1991, J BIOL CHEM, V266, P8720; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rudberg PC, 2004, J BIOL CHEM, V279, P27376, DOI 10.1074/jbc.M401031200; Rudberg PC, 2002, P NATL ACAD SCI USA, V99, P4215, DOI 10.1073/pnas.072090099; Rudberg PC, 2002, J BIOL CHEM, V277, P1398, DOI 10.1074/jbc.M106577200; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thunnissen MMGM, 2002, FASEB J, V16, P1648, DOI 10.1096/fj.01-1017fje; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Vazeux G, 1998, BIOCHEM J, V334, P407, DOI 10.1042/bj3340407; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; ZVELEBIL MJ, 1987, J MOL BIOL, V195, P957, DOI 10.1016/0022-2836(87)90501-8	34	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33477	33486		10.1074/jbc.M506821200	http://dx.doi.org/10.1074/jbc.M506821200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16024909	hybrid			2022-12-27	WOS:000232058100047
J	Bergefall, K; Trybala, E; Johansson, M; Uyama, T; Naito, S; Yamada, S; Kitagawa, H; Sugahara, K; Bergstrom, T				Bergefall, K; Trybala, E; Johansson, M; Uyama, T; Naito, S; Yamada, S; Kitagawa, H; Sugahara, K; Bergstrom, T			Chondroitin sulfate characterized by the E-disaccharide unit is a potent inhibitor of herpes simplex virus infectivity and provides the virus binding sites on gro2C cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GLAND EPITHELIAL-CELLS; PROTEIN LINKAGE REGION; TYPE-1 GLYCOPROTEIN-C; HEPARAN-SULFATE; STRUCTURAL DETERMINATION; ENVELOPED VIRUSES; DERMATAN SULFATE; GLUCURONIC-ACID; GROWTH-FACTORS	Although cell surface chondroitin sulfate ( CS) is regarded as an auxiliary receptor for binding of herpes simplex virus to cells, and purified CS chain types A, B, and C are known to interfere poorly or not at all with the virus infection of cells, we have found that CS type E (CS-E), derived from squid cartilage, exhibited potent antiviral activity. The IC50 values ranged from 0.06 to 0.2 mu g/ml and substantially exceeded the antiviral potency of heparin, the known inhibitor of virus binding to cells. Furthermore, in mutant gro2C cells that express CS but not heparan sulfate, CS-E showed unusually high anti-herpes virus activity with IC50 values of < 1 ng/ml. Enzymatic degradation of CS-E with chondroitinase ABC abolished its antiviral activity. CS-E inhibited the binding to cells of the purified virus attachment protein gC. A direct interaction of gC with immobilized CS-E and inhibition of this binding by CS-E oligosaccharide fragments greater than octasaccharide were demonstrated. Likewise, the gro2C-specific CS chains interfered with the binding of viral gC to these cells and were found to contain a considerable proportion (13%) of the E-disaccharide unit, suggesting that this unit is an essential component of the CS receptor for herpes simplex virus on gro2C cells and that the antiviral activity of CS-E was due to interference with the binding of viral gC to a CS-E-like receptor on the cell surface. Knowledge of the determinants of antiviral properties of CS-E will help in the development of inhibitors of herpes simplex virus infections in humans.	Gothenburg Univ, Dept Clin Virol, S-41346 Gothenburg, Sweden; Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan	University of Gothenburg; Kobe Pharmaceutical University	Bergstrom, T (corresponding author), Gothenburg Univ, Dept Clin Virol, Guldhedsgatan 10B, S-41346 Gothenburg, Sweden.	tomas.bergstrom@microbio.gu.se	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079; Trybala, Edward/0000-0003-2384-2123; Bergstrom, Tomas/0000-0002-9257-6757				BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742, DOI 10.1128/AAC.32.11.1742; BANFIELD BW, 1995, VIROLOGY, V208, P531, DOI 10.1006/viro.1995.1184; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Damonte EB, 1996, CHEMOTHERAPY, V42, P57, DOI 10.1159/000239422; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Deepa SS, 2004, J BIOL CHEM, V279, P37368, DOI 10.1074/jbc.M403031200; Di Caro A, 1999, ANTIVIR CHEM CHEMOTH, V10, P33, DOI 10.1177/095632029901000104; Duarte MER, 2001, PHYTOMEDICINE, V8, P53, DOI 10.1078/0944-7113-00007; DUFF R, 1971, NATURE-NEW BIOL, V233, P48, DOI 10.1038/newbio233048a0; GRUENHEID S, 1993, J VIROL, V67, P93, DOI 10.1128/JVI.67.1.93-100.1993; Gunalp A., 1965, P SOC EXP BIOL MED, V118, P185; HOLLAND TC, 1983, J VIROL, V45, P672, DOI 10.1128/JVI.45.2.672-682.1983; HOLLAND TC, 1984, J VIROL, V52, P566, DOI 10.1128/JVI.52.2.566-574.1984; KARGER A, 1993, VIROLOGY, V194, P654, DOI 10.1006/viro.1993.1305; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kinoshita A, 2001, BIOCHEMISTRY-US, V40, P12654, DOI 10.1021/bi015577n; Kinoshita-Toyoda A, 2004, BIOCHEMISTRY-US, V43, P11063, DOI 10.1021/bi049622d; LYCKE E, 1991, J GEN VIROL, V72, P1131, DOI 10.1099/0022-1317-72-5-1131; LYON M, 1994, J BIOL CHEM, V269, P11216; Marchetti M, 2004, VIROLOGY, V318, P405, DOI 10.1016/j.virol.2003.09.029; Mardberg K, 2002, J GEN VIROL, V83, P291, DOI 10.1099/0022-1317-83-2-291; Nyberg K, 2004, ANTIVIR RES, V63, P15, DOI 10.1016/j.antiviral.2004.01.001; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Sinha S, 2003, ANTIMICROB AGENTS CH, V47, P494, DOI 10.1128/AAC.47.2.494-500.2003; SUGAHARA K, 1995, J BIOL CHEM, V270, P7204, DOI 10.1074/jbc.270.13.7204; Sugahara K, 1996, J BIOL CHEM, V271, P26745, DOI 10.1074/jbc.271.43.26745; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Trybala E, 2000, J VIROL, V74, P9106, DOI 10.1128/JVI.74.19.9106-9114.2000; Tsuchida K, 2001, J BIOL CHEM, V276, P37155, DOI 10.1074/jbc.M105818200; Ueno M, 2001, J BIOL CHEM, V276, P29134, DOI 10.1074/jbc.M102089200; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; VAHERI A, 1964, ACTA PATHOL MIC SC, P7; Witvrouw M, 1997, GEN PHARMACOL-VASC S, V29, P497, DOI 10.1016/S0306-3623(96)00563-0	35	96	102	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32193	32199		10.1074/jbc.M503645200	http://dx.doi.org/10.1074/jbc.M503645200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16027159	hybrid			2022-12-27	WOS:000231794800020
J	Mendiratta, SS; Sekulic, N; Lavie, A; Colley, KJ				Mendiratta, SS; Sekulic, N; Lavie, A; Colley, KJ			Specific amino acids in the first fibronectin type III repeat of the neural cell adhesion molecule play a role in its recognition and polysialylation by the polysialyltransferase ST8Sia IV/PST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSIALIC ACID; N-CAM; LUNG-CARCINOMA; IN-VIVO; 3-DIMENSIONAL STRUCTURE; NEURITE OUTGROWTH; NERVOUS-SYSTEM; PROCATHEPSIN-D; NCAM; PROTEIN	Polysialic acid is an anti-adhesive protein modification that promotes cell migration and the plasticity of cell interactions. Because so few proteins carry polysialic acid, we hypothesized that polysialylation is a protein-specific event and that a specific polysialyltransferase-substrate interaction is the basis of this specificity. The major substrate for the polysialyltransferases is the neural cell adhesion molecule, NCAM. Previous work demonstrates that the first fibronectin type III repeat of NCAM (FN1) was necessary for the polysialylation of the N-glycans on the adjacent immunoglobulin domain (Ig5) ( Close, B. E., Mendiratta, S. S., Geiger, K. M., Broom, L. J., Ho, L. L., and Colley, K. J. ( 2003) J. Biol. Chem. 278, 30796 30805). This suggested that FN1 may be a recognition site for the polysialyltransferases. In this study, we showed that the second fibronectin type III repeat (FN2) of NCAM cannot replace FN1. Arg substitution of three unique acidic amino acids on the surface of FN1 eliminated polysialylation not only of a minimal Ig5-FN1 substrate but also of full-length NCAM. Ala substitution of these residues eliminated Ig5-FN1 polysialylation but not that of full-length NCAM, suggesting that the two proteins are interacting differently with the enzymes and that multiple residues are involved in the enzyme-NCAM interaction. By using another truncated protein, Ig5-FN1-FN2, we confirmed the importance of enzyme-substrate positioning for optimal recognition and polysialylation. In sum, we have found that acidic residues on the surface of FN1 are part of a larger protein interaction region that is critical for NCAM recognition and polysialylation by the polysialyltransferases.	Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu	Lavie, Arnon/H-4927-2012; Sekulic, Nikolina/N-5550-2016; Sekulic, Nikolina/F-8911-2013	Sekulic, Nikolina/0000-0001-7555-3222; Lavie, Arnon/0000-0001-5591-8722	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063483, R01GM063843] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM63483] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; BAENZIGER JU, 1994, FASEB J, V8, P1019, DOI 10.1096/fasebj.8.13.7926366; BARANSKI TJ, 1991, J BIOL CHEM, V266, P23365; BARANSKI TJ, 1992, J BIOL CHEM, V267, P23342; BARANSKI TJ, 1990, CELL, V63, P281, DOI 10.1016/0092-8674(90)90161-7; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 2000, J BIOL CHEM, V275, P4484, DOI 10.1074/jbc.275.6.4484; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Durbec P, 2001, MOL NEUROBIOL, V24, P53; DUSTIN ML, 1995, J BIOL CHEM, V270, P170, DOI 10.1074/jbc.270.1.170; DZHANDZHUGAZYAN K, 1993, FEBS LETT, V336, P279, DOI 10.1016/0014-5793(93)80820-K; Dzhandzhugazyan K, 1997, BIOCHEMISTRY-US, V36, P15381, DOI 10.1021/bi9709351; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; FINNE J, 1987, J IMMUNOL, V138, P4402; HALL AK, 1987, J CELL BIOL, V104, P1579, DOI 10.1083/jcb.104.6.1579; Hamlin JA, 2004, J COMP NEUROL, V474, P438, DOI 10.1002/cne.20133; Hildebrandt H, 1998, CANCER RES, V58, P779; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; HUBER AH, 1994, NEURON, V12, P717, DOI 10.1016/0896-6273(94)90326-3; Inoue S, 2001, J BIOL CHEM, V276, P31863, DOI 10.1074/jbc.M103336200; JAMES WM, 1987, BIOCHEM BIOPH RES CO, V148, P817, DOI 10.1016/0006-291X(87)90949-1; JAMES WM, 1989, BIOCHEMISTRY-US, V28, P6001, DOI 10.1021/bi00440a042; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; KIBBELAAR RE, 1989, J PATHOL, V159, P23, DOI 10.1002/path.1711590108; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; KOMMINOTH P, 1991, AM J PATHOL, V139, P297; KRIEG PA, 1989, NUCLEIC ACIDS RES, V17, P10321, DOI 10.1093/nar/17.24.10321; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; LIVINGSTON BD, 1988, J BIOL CHEM, V263, P9443; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PETERSEN TE, 1983, P NATL ACAD SCI-BIOL, V80, P137, DOI 10.1073/pnas.80.1.137; ROTH J, 1988, AM J PATHOL, V133, P227; ROTH J, 1987, P NATL ACAD SCI USA, V84, P1969, DOI 10.1073/pnas.84.7.1969; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; ROUGON G, 1993, EUR J CELL BIOL, V61, P197; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; SADOUL R, 1983, NATURE, V304, P347, DOI 10.1038/304347a0; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; Skladchikova G, 1999, J NEUROSCI RES, V57, P207; SMALL SJ, 1990, J CELL BIOL, V111, P2089, DOI 10.1083/jcb.111.5.2089; SMITH PL, 1992, P NATL ACAD SCI USA, V89, P329, DOI 10.1073/pnas.89.1.329; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Walmod PS, 2004, NEUROCHEM RES, V29, P2015, DOI 10.1007/s11064-004-6875-z; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; ZUBER C, 1992, J BIOL CHEM, V267, P9965	69	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32340	32348		10.1074/jbc.M506217200	http://dx.doi.org/10.1074/jbc.M506217200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16027151	hybrid			2022-12-27	WOS:000231794800038
J	Ashikari- Hada, S; Habuchi, H; Kariya, Y; Kimata, K				Ashikari- Hada, S; Habuchi, H; Kariya, Y; Kimata, K			Heparin regulates vascular endothelial growth factor(165)-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells - Comparison of the effects of heparin and modified heparins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTITHROMBIN-BINDING SEQUENCE; SULFATE PROTEOGLYCANS; FACTOR VEGF; SIGNAL-TRANSDUCTION; EXTRACELLULAR-MATRIX; TYROSINE KINASE; TUMOR-CELLS; VEGF(165); DOMAIN; KDR	Vascular endothelial growth factor (VEGF) is a family of glycoproteins with potent angiogenic activity. We reported previously that heparin has an affinity for VEGF(165), the major isoform of VEGF, whereas 2-O-desulfated heparin and 6-O-desulfated heparin have weak but significant affinity (Ashikari-Hada, S., Habuchi, H., Kariya, Y., Itoh, N., Reddi, A. H., and Kimata, K. (2004) J. Biol. Chem. 279, 12346-12354). In this study, we first examined the effect of heparin and modified heparins (completely desulfated N-sulfated heparin, 2-O-desulfated heparin, and 6-O-desulfated heparin) on VEGF(165)-dependent mitogenic activity and tube formation on type I collagen gels of human umbilical vein endothelial cells. Both were enhanced by heparin, but not by modified heparins, suggesting that both the 2-O-sulfate group of hexuronic acid and the 6-O-sulfation group of N-sulfoglucosamine in heparin/heparan sulfate are necessary for VEGF(165) activity. We then examined the activation of VEGF receptor (VEGFR) to understand the mechanism. We have made several new findings; 1) heparin yielded a 1.7-fold enhancement of VEGF(165)-induced phosphorylation of VEGFR-2; 2) depletion of cell surface heparan sulfate by heparinase/heparitinase treatment and preferential reduction of trisulfated disaccharide units of cell surface HS by sodium chlorate treatment resulted in the reduction of such phosphorylation, suggesting the involvement of a heparin-like domain in the phosphorylation of VEGFR-2; and 3) VEGF(121), an isoform without the exon 7-encoded region, which has no capacity to bind to heparin, did not show these effects. It is therefore likely that a heparin-like domain of heparan sulfate/heparin forms a complex with VEGF(165) and VEGFR-2 via the exon 7-encoded region, thereby enhancing VEGF(165)-dependent signaling.	Aichi Med Univ, Sch Med, Inst Mol, Nagakute, Aichi 4801195, Japan; Seikagaku Corp, Cent Res Labs, Tokyo 2070021, Japan	Aichi Medical University; Seikagaku Corporation	Kimata, K (corresponding author), Aichi Med Univ, Sch Med, Inst Mol, 21 Karimata, Nagakute, Aichi 4801195, Japan.	kimata@aichi-med-u.ac.jp						Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Chen E, 2004, BLOOD, V103, P1710, DOI 10.1182/blood-2003-06-1783; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; Dougher AM, 1997, GROWTH FACTORS, V14, P257, DOI 10.3109/08977199709021524; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Fuh G, 2000, J BIOL CHEM, V275, P26690; Gengrinovitch S, 1999, J BIOL CHEM, V274, P10816, DOI 10.1074/jbc.274.16.10816; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Habuchi H, 2000, J BIOL CHEM, V275, P2859, DOI 10.1074/jbc.275.4.2859; HajMohammadi S, 2003, J CLIN INVEST, V111, P989, DOI 10.1172/JCI200315809; KANAYASU T, 1989, BIOCHEM BIOPH RES CO, V159, P572, DOI 10.1016/0006-291X(89)90032-6; KINSELLA MG, 1988, BIOCHEMISTRY-US, V27, P2136, DOI 10.1021/bi00406a048; KOJIMA T, 1992, J BIOL CHEM, V267, P4870; LINDAHL U, 1979, P NATL ACAD SCI USA, V76, P3198, DOI 10.1073/pnas.76.7.3198; LINDAHL U, 1984, J BIOL CHEM, V259, P2368; LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551; Lundin L, 2003, EXP CELL RES, V287, P190, DOI 10.1016/S0014-4827(03)00125-3; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; MERTENS G, 1992, J BIOL CHEM, V267, P20435; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Ono K, 1999, GLYCOBIOLOGY, V9, P705, DOI 10.1093/glycob/9.7.705; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Poltorak Z, 1997, J BIOL CHEM, V272, P7151, DOI 10.1074/jbc.272.11.7151; Robinson CJ, 2001, J CELL SCI, V114, P853; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shibuya M, 1999, CURR TOP MICROBIOL, V237, P59; SILBERT JE, 1967, J BIOL CHEM, V242, P2301; SILBERT JE, 1963, J BIOL CHEM, V238, P3542; SILBERT JE, 1967, J BIOL CHEM, V242, P5153; SILBERT JE, 1967, J BIOL CHEM, V242, P5146; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; SOKER S, 1994, BIOCHEM BIOPH RES CO, V203, P1339, DOI 10.1006/bbrc.1994.2329; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Takazaki R, 2004, J BIOL CHEM, V279, P47335, DOI 10.1074/jbc.M408556200; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; TERMAN BI, 1994, GROWTH FACTORS, V11, P187, DOI 10.3109/08977199409046916; TESSLER S, 1994, J BIOL CHEM, V269, P12456; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Veikkola T, 2000, CANCER RES, V60, P203; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451	53	135	142	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31508	31515		10.1074/jbc.M414581200	http://dx.doi.org/10.1074/jbc.M414581200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16027124	hybrid			2022-12-27	WOS:000231665200022
J	Kelly, BL; Vassar, R; Ferreira, A				Kelly, BL; Vassar, R; Ferreira, A			beta-Amyloid-induced dynamin 1 depletion in hippocampal neurons - A potential mechanism for early cognitive decline in Alzheimer disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED NEUTRAL PROTEINASE; SYNAPTIC VESICLE TRAFFICKING; A-BETA; MEMORY DEFICITS; TRANSGENIC MICE; FRONTAL-CORTEX; CALPAIN; EXPRESSION; MEMBRANE; CULTURE	Synaptic dysfunction is one of the earliest events in the pathogenesis of Alzheimer disease ( AD). However, the molecular mechanisms underlying synaptic defects in AD are largely unknown. We report here that beta-amyloid ( A beta), the main component of senile plaques, induced a significant decrease in dynamin 1, a protein that is essential for synaptic vesicle recycling and, hence, for memory formation and information processing. The A beta-induced dynamin 1 decrease occurred in the absence of overt synaptic loss and was also observed in the Tg2576 mouse model of AD. In addition, our results provided evidence that the A beta-induced decrease in dynamin 1 was likely the result of a calpain-mediated cleavage of dynamin 1 protein and possibly the down-regulation of dynamin 1 gene expression. These data suggest a mechanism to explain the early cognitive loss without a major decline in synapse number observed in AD and propose a novel therapeutic target for AD intervention.	Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Inst Neurosci, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Ferreira, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	a-ferreira@northwestern.edu		Ferreira, Adriana/0000-0003-3705-3918	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022560, T32AG020506] Funding Source: NIH RePORTER; NIA NIH HHS [AG20506, T32 AG020506, R01 AG022560, R01AG022560] Funding Source: Medline; NINDS NIH HHS [R01 NS039080, NS39080] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAHR BA, 1995, J PHARMACOL EXP THER, V273, P902; BARTLETT WP, 1984, J NEUROSCI, V4, P1954; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Battaglia F, 2003, J MOL NEUROSCI, V20, P357, DOI 10.1385/JMN:20:3:357; BERTONIFREDDARI C, 1992, PATHOL RES PRACT, V188, P612, DOI 10.1016/S0344-0338(11)80066-X; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Clark SG, 1997, P NATL ACAD SCI USA, V94, P10438, DOI 10.1073/pnas.94.19.10438; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dawson HN, 2001, J CELL SCI, V114, P1179; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; FERREIRA A, 1992, J NEUROSCI RES, V32, P516, DOI 10.1002/jnr.490320407; Ferreira A, 1997, MOL CELL NEUROSCI, V9, P220, DOI 10.1006/mcne.1997.0615; Ferreira A, 1996, MOL CELL NEUROSCI, V8, P286, DOI 10.1006/mcne.1996.0064; Friedrich P, 2004, BIOCHEM BIOPH RES CO, V323, P1131, DOI 10.1016/j.bbrc.2004.08.194; Gastard MC, 2003, ANN NEUROL, V54, P393, DOI 10.1002/ana.10680; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Honer WG, 2003, NEUROBIOL AGING, V24, P1047, DOI 10.1016/j.neurobiolaging.2003.04.005; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; King DL, 2002, BRAIN RES, V926, P58, DOI 10.1016/S0006-8993(01)03294-2; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Rohlff C, 1997, J BIOL CHEM, V272, P21137, DOI 10.1074/jbc.272.34.21137; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; Sabbagh MN, 1999, ARCH NEUROL-CHICAGO, V56, P1458, DOI 10.1001/archneur.56.12.1458; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Savage MJ, 2002, J NEUROSCI, V22, P3376; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Suen KC, 2003, J NEUROCHEM, V87, P1413, DOI 10.1111/j.1471-4159.2003.02259.x; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tiraboschi P, 2000, NEUROLOGY, V55, P1278, DOI 10.1212/WNL.55.9.1278; Tsuji T, 1998, NEUROSCI LETT, V248, P109, DOI 10.1016/S0304-3940(98)00348-6; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Veeranna, 2004, AM J PATHOL, V165, P795, DOI 10.1016/S0002-9440(10)63342-1; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Yao PJ, 2004, TRENDS NEUROSCI, V27, P24, DOI 10.1016/j.tins.2003.10.012; Yao PJ, 2003, NEUROBIOL DIS, V12, P97, DOI 10.1016/S0969-9961(02)00009-8; Yoo J, 2002, J BIOL CHEM, V277, P11904, DOI 10.1074/jbc.M111788200	49	112	121	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31746	31753		10.1074/jbc.M503259200	http://dx.doi.org/10.1074/jbc.M503259200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16002400	Green Accepted, hybrid			2022-12-27	WOS:000231665200052
J	Nony, PA; Kennett, SB; Glasgow, WC; Olden, K; Roberts, JD				Nony, PA; Kennett, SB; Glasgow, WC; Olden, K; Roberts, JD			15(S)-lipoxygenase-2 mediates arachidonic acid-stimulated adhesion of human breast carcinoma cells through the activation of TAK1, MKK6, and p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIETARY FATTY-ACIDS; PROSTATE ADENOCARCINOMA; KINASE ISOFORMS; CANCER INVASION; IV COLLAGEN; LIPOXYGENASE; EXPRESSION; 15-LIPOXYGENASE-1; EICOSANOIDS; INDUCTION	The dietary cis-polyunsaturated fatty acid, arachidonic acid, stimulates adhesion of metastatic human breast carcinoma cells (MDA-MB-435) to the extracellular matrix, but the molecular mechanisms by which fatty acids modify the behavior of these cells are unclear. Exposure to arachidonic acid activates multiple signaling pathways. Activation of p38 mitogen-activated protein kinase (p38 MAPK) is required for increased cell adhesion to type IV collagen, and this activation is sensitive to inhibitors of lipoxygenases, suggesting a requirement for arachidonic acid metabolism. The goals of the current study were to identify the one or more key metabolites of arachidonic acid that are responsible for activation of p38 MAPK and to elucidate the upstream kinases that lead to p38 MAPK activation. High performance liquid chromatographic analysis revealed that MDA-MB-435 cells metabolize exogenous arachidonic acid predominantly to 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE). Immunoblot analysis with antibodies specific to 15(S)-lipoxygenase-1 (LOX-1) and 15(S)-lipoxygenase-2 (LOX-2) demonstrated the expression of 15-LOX-2, but not 15-LOX-1, in these tumor cells. A LOX inhibitor, nordihydroguaiaretic acid, attenuated production of 15(S)HETE and inhibited the phosphorylation of p38 MAPK following exposure to arachidonic acid. In contrast, overexpression of LOX-2 sensitized the cells to the addition of arachidonic acid, leading to increased activation of p38 MAPK. Addition of exogenous 15(S)-HETE to MDA-MB-435 cells stimulated cell adhesion to type IV collagen and activated the p38 MAPK pathway, including the upstream kinases transforming growth factor-beta(1)-activated protein kinase-1 (TAK1) and MAPK kinase 6. Transfection of these cells with a dominant negative form of TAK1 blocked arachidonic acid-stimulated p38 MAPK phosphorylation. These data demonstrate that 15(S)-LOX-2 generation of 15(S)HETE activates specific growth factor receptor-related signaling pathways, thereby initiating signal transduction events leading to increased cell adhesion to the extracellular matrix.	NIEHS, Lab Mol Carcinogenesis, NIH, Res Triangle Pk, NC 27709 USA; Mercer Univ, Sch Med, Div Bas Med Sci, Macon, GA 31207 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Mercer University	Roberts, JD (corresponding author), NIEHS, Lab Mol Carcinogenesis, NIH, POB 12233,Mail Drop D2-05, Res Triangle Pk, NC 27709 USA.	roberts1@niehs.nih.gov			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES023018] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alonso G, 2000, J BIOL CHEM, V275, P40641, DOI 10.1074/jbc.M007835200; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; BRYANT RW, 1982, J BIOL CHEM, V257, P6050; Cavallaro U, 2001, BBA-REV CANCER, V1552, P39, DOI 10.1016/S0304-419X(01)00038-5; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Engers R, 2000, J CANCER RES CLIN, V126, P682, DOI 10.1007/s004320000148; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; FAN XT, 1990, BIOCHEM BIOPH RES CO, V169, P933, DOI 10.1016/0006-291X(90)91983-Y; Funk CD, 1996, BBA-LIPID LIPID MET, V1304, P65, DOI 10.1016/S0005-2760(96)00107-5; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; HONN KV, 1994, CANCER METAST REV, V13, P365, DOI 10.1007/BF00666105; Hsi LC, 2002, J BIOL CHEM, V277, P40549, DOI 10.1074/jbc.M203522200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ikawa H, 1999, CANCER RES, V59, P360; Jack GS, 2000, HUM PATHOL, V31, P1146, DOI 10.1053/hupa.2000.16670; Kelavkar UP, 2000, CARCINOGENESIS, V21, P1777; Kennett SB, 2004, J BIOL CHEM, V279, P3300, DOI 10.1074/jbc.M305734200; Kilty I, 1999, EUR J BIOCHEM, V266, P83, DOI 10.1046/j.1432-1327.1999.00818.x; KOHN EC, 1995, CANCER RES, V55, P1856; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Leaver HA, 2002, PROSTAG LEUKOTR ESS, V66, P1, DOI 10.1054/plef.2001.0333; LIU B, 1991, CELL REGUL, V2, P1045, DOI 10.1091/mbc.2.12.1045; Liu XH, 1996, CLIN EXP METASTAS, V14, P145, DOI 10.1007/BF00121211; Monjazeb AM, 2002, PROSTAG LEUKOTR ESS, V66, P5, DOI 10.1054/plef.2001.0334; Natarajan R, 1997, J CLIN ENDOCR METAB, V82, P1790, DOI 10.1210/jc.82.6.1790; NATARAJAN R, 1998, FRONT BIOSCI, V3, P81; Nie D, 2000, E SCHERING RES FDN W, V31, P201; NOGUCHI M, 1995, ONCOLOGY-BASEL, V52, P265; Paine E, 2000, J BIOL CHEM, V275, P11284, DOI 10.1074/jbc.275.15.11284; Palmantier R, 1996, CANCER RES, V56, P2206; Palmantier R, 2001, CANCER RES, V61, P2445; Pidgeon GP, 2002, CANCER RES, V62, P2721; Piomelli D, 1993, CURR OPIN CELL BIOL, V5, P274, DOI 10.1016/0955-0674(93)90116-8; Raso E, 2001, THROMB HAEMOSTASIS, V85, P1037, DOI 10.1055/s-0037-1615960; Reddy N, 1997, BIOCHEM BIOPH RES CO, V231, P111, DOI 10.1006/bbrc.1997.6048; ROSE DP, 1994, NUTR CANCER, V21, P103, DOI 10.1080/01635589409514309; Rose DP, 1997, AM J CLIN NUTR, V66, P1513; Rose DP, 2000, NUTR CANCER, V37, P119, DOI 10.1207/S15327914NC372_1; ROSE DP, 1997, BREAST CANC, V4, P7; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Shappell SB, 1999, AM J PATHOL, V155, P235, DOI 10.1016/S0002-9440(10)65117-6; Shappell SB, 2001, J INVEST DERMATOL, V117, P36, DOI 10.1046/j.1523-1747.2001.01378.x; Shappell SB, 2001, CANCER RES, V61, P497; Shureiqi I, 2001, CANCER RES, V61, P6307; TANG DG, 1995, J CELL SCI, V108, P2629; Tang DG, 1996, P NATL ACAD SCI USA, V93, P5241, DOI 10.1073/pnas.93.11.5241; TIMAR J, 1992, INT J CANCER, V52, P594, DOI 10.1002/ijc.2910520418; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; YOUNG MRI, 1994, CANCER METAST REV, V13, P337, DOI 10.1007/BF00666103	50	49	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31413	31419		10.1074/jbc.M500418200	http://dx.doi.org/10.1074/jbc.M500418200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16000313	hybrid			2022-12-27	WOS:000231665200011
J	Sommer, U; Schmid, C; Sobota, RM; Lehmann, U; Stevenson, NJ; Johnston, JA; Schaper, F; Heinrich, PC; Haan, S				Sommer, U; Schmid, C; Sobota, RM; Lehmann, U; Stevenson, NJ; Johnston, JA; Schaper, F; Heinrich, PC; Haan, S			Mechanisms of SOCS3 phosphorylation upon interleukin-6 stimulation - Contributions of Src- and receptor-tyrosine kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; IL-6 SIGNAL-TRANSDUCTION; ONCOSTATIN-M-RECEPTOR; CYTOKINE SIGNALING-3; JANUS KINASE; MEDIATED DEGRADATION; CELL-PROLIFERATION; UBIQUITIN LIGASE; GLYCOPROTEIN 130; SH2 DOMAIN	The suppressors of cytokine signaling (SOCS) are negative feedback inhibitors of cytokine signal transduction. SOCS3 is a key negative regulator of interleuking-6 (IL-6) signal transduction. Furthermore, SOCS3 was shown to be phosphorylated upon treatment of cells with IL-2, and this has been reported to regulate its function and half-life. We set out to investigate whether SOCS3 phosphorylation may play a role in IL-6 signaling. Tyrosine-phosphorylated SOCS3 was detected upon treatment of mouse embryonic fibroblasts with IL-6. Interestingly, the observed SOCS3 phosphorylation does not require SOCS3 recruitment to phosphotyrosine (Tyr(P)) 759 of gp130, and the kinetics of SOCS3 phosphorylation do not match the activation kinetics of the Janus kinases. This suggests that other kinases may be involved in SOCS3 phosphorylation. Using Src and Janus kinase inhibitors as well as Src kinase-deficient mouse embryonic fibroblasts, we provide evidence that Src kinases, which we found to be constitutively active in these cells, are involved in the phosphorylation of IL-6-induced SOCS3. In addition, we found that receptor-tyrosine kinases such as platelet-derived growth factor receptor or epidermal growth factor receptor can very potently phosphorylate IL-6-induced SOCS3. Taken together, these results suggest that SOCS3 phosphorylation is not a JAK-mediated phenomenon but is dependent on the activity of other kinases such as Src kinases or receptor-tyrosine kinases, which can either be constitutively active or activated by an additional stimulus.	Rhein Westfal TH Aachen, Inst Biochem, D-52074 Aachen, Germany; Queens Univ Belfast, Dept Immunol, Belfast BT9 7BL, Antrim, North Ireland	RWTH Aachen University; Queens University Belfast	Haan, S (corresponding author), Rhein Westfal TH Aachen, Inst Biochem, Paulwelsstsr 30, D-52074 Aachen, Germany.	serge.haan@rwth-aachen.de	Stevenson, Nigel/X-5412-2018; Schaper, Fred/F-1403-2013	Stevenson, Nigel/0000-0002-6966-9314; Schaper, Fred/0000-0002-8899-5414				AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; ANDUS T, 1987, FEBS LETT, V221, P18, DOI 10.1016/0014-5793(87)80344-7; ARCONE R, 1991, EUR J BIOCHEM, V198, P541, DOI 10.1111/j.1432-1033.1991.tb16048.x; Behrmann I, 2004, J BIOL CHEM, V279, P35486, DOI 10.1074/jbc.M404202200; Cacalano NA, 2001, NAT CELL BIOL, V3, P460, DOI 10.1038/35074525; CARTWRIGHT CA, 1989, J CLIN INVEST, V83, P2025, DOI 10.1172/JCI114113; CASTELL JV, 1988, FEBS LETT, V232, P347, DOI 10.1016/0014-5793(88)80766-X; Cohney SJ, 1999, MOL CELL BIOL, V19, P4980; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Frantsve J, 2001, MOL CELL BIOL, V21, P3547, DOI 10.1128/MCB.21.10.3547-3557.2001; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; Gerhartz C, 1996, J BIOL CHEM, V271, P12991, DOI 10.1074/jbc.271.22.12991; Giese B, 2003, J BIOL CHEM, V278, P39205, DOI 10.1074/jbc.M303347200; Gnarra JR, 1996, BBA-REV CANCER, V1242, P201, DOI 10.1016/0304-419X(95)00012-5; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Haan C, 2001, J BIOL CHEM, V276, P37451, DOI 10.1074/jbc.M106135200; Haan S, 2003, J BIOL CHEM, V278, P31972, DOI 10.1074/jbc.M303170200; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hermanns HM, 1999, J IMMUNOL, V163, P6651; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Hortner M, 2002, EUR J BIOCHEM, V269, P2516, DOI 10.1046/j.1432-1033.2002.02916.x; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kamura T, 2002, J BIOL CHEM, V277, P30388, DOI 10.1074/jbc.M203344200; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kim HK, 1998, MOL CELL BIOL, V18, P1525, DOI 10.1128/MCB.18.3.1525; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Lehmann U, 2003, J BIOL CHEM, V278, P661, DOI 10.1074/jbc.M210552200; Limnander A, 2004, MOL CELL, V15, P329, DOI 10.1016/j.molcel.2004.06.041; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Peraldi P, 2001, J BIOL CHEM, V276, P24614, DOI 10.1074/jbc.M102209200; Radtke S, 2002, J BIOL CHEM, V277, P11297, DOI 10.1074/jbc.M100822200; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Schaeffer M, 2001, MOL CELL BIOL, V21, P8068, DOI 10.1128/MCB.21.23.8068-8081.2001; Schaper F, 1998, BIOCHEM J, V335, P557, DOI 10.1042/bj3350557; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Schmitz J, 2000, J IMMUNOL, V164, P848, DOI 10.4049/jimmunol.164.2.848; Schoenfeld AR, 2000, P NATL ACAD SCI USA, V97, P8507, DOI 10.1073/pnas.97.15.8507; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; WEIERGRABER O, 1995, EUR J BIOCHEM, V234, P661, DOI 10.1111/j.1432-1033.1995.661_b.x; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	68	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31478	31488		10.1074/jbc.M506008200	http://dx.doi.org/10.1074/jbc.M506008200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16000307	Green Published, hybrid			2022-12-27	WOS:000231665200019
J	Basso, AD; Mirza, A; Liu, GJ; Long, BJ; Bishop, WR; Kirschmeier, P				Basso, AD; Mirza, A; Liu, GJ; Long, BJ; Bishop, WR; Kirschmeier, P			The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling - Role in FTI enhancement of taxane and tamoxifen anti-tumor activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS GENE; BREAST-CANCER CELLS; RAS-RELATED PROTEIN; TSC2 GAP ACTIVITY; FARNESYLTRANSFERASE INHIBITOR; TRANSGENIC MICE; IN-VITRO; SACCHAROMYCES-CEREVISIAE; MAMMALIAN TARGET; EGFR MUTATIONS	Lonafarnib (SCH66336) is a farnesyl transferase inhibitor (FTI) that inhibits the post-translational lipid modification of H-Ras and other farnesylated proteins. K- and N-Ras are also substrates of farnesyl transferase; however, upon treatment with FTIs, they are alternatively prenylated by geranylgeranyl transferase-1. Despite the failure to abrogate prenylation of K- and N-Ras, growth of many tumors in preclinical models is inhibited by FTIs. This suggests that the anti-proliferative action of FTIs is dependent on blocking the farnesylation of other proteins. Rheb (Ras homologue enriched in brain) is a farnesylated small GTPase that positively regulates mTOR ( mammalian target of rapamycin) signaling. We found that Rheb and Rheb2 mRNA were elevated in various tumor cell lines relative to normal cells. Peptides derived from the carboxyl termini of human Rheb and Rheb2 are in vitro substrates for farnesyl transferase but not geranylgeranyl transferase-1. Rheb prenylation in cell culture was completely inhibited by SCH66336, indicating a lack of alternative prenylation. SCH66336 treatment also inhibited the phosphorylation of S6 ribosomal protein, a downstream target of Rheb and mTOR signaling. SCH66336 did not inhibit S6 phosphorylation in cells expressing Rheb-CSVL, a mutant construct of Rheb designed to be geranylgeranylated. Importantly, expression of Rheb-CSVL also abrogated SCH66336 enhancement of tamoxifen-and docetaxel-induced apoptosis in MCF-7 breast cancer cells and ES-2 ovarian cancer cells, respectively. Further, inhibition of Rheb signaling by rapamycin treatment, small interfering RNA, or dominant negative Rheb enhanced tamoxifen- and docetaxel-induced apoptosis, similar to FTI treatment. These studies demonstrated that Rheb is modified by farnesylation, is not a substrate for alternative prenylation, and plays a role in SCH66336 enhancement of the antitumor response to other chemotherapeutics.	Schering Plough Res Inst, Dept Tumor Biol, Kenilworth, NJ 07033 USA	Merck & Company; Schering-Plough Research Institute	Kirschmeier, P (corresponding author), Schering Plough Res Inst, Dept Tumor Biol, 2015 Galloping Hill Rd,K-15-4950, Kenilworth, NJ 07033 USA.	paul.kirschmeier@spcorp.com						Alsina M, 2004, BLOOD, V103, P3271, DOI 10.1182/blood-2003-08-2764; Ashar HR, 2000, J BIOL CHEM, V275, P30451, DOI 10.1074/jbc.M003469200; Ashar HR, 2001, EXP CELL RES, V262, P17, DOI 10.1006/excr.2000.5076; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; Bose S, 1998, ONCOGENE, V17, P123, DOI 10.1038/sj.onc.1201940; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Clark GJ, 1997, J BIOL CHEM, V272, P10608; DeGraffenried LA, 2004, CLIN CANCER RES, V10, P8059, DOI 10.1158/1078-0432.CCR-04-0035; Feilotter HE, 1998, ONCOGENE, V16, P1743, DOI 10.1038/sj.onc.1200205; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gromov PS, 1995, FEBS LETT, V377, P221, DOI 10.1016/0014-5793(95)01349-0; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANCOCK JF, 1991, EMBO J, V10, P641, DOI 10.1002/j.1460-2075.1991.tb07992.x; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; James G, 1996, P NATL ACAD SCI USA, V93, P4454, DOI 10.1073/pnas.93.9.4454; JAMES GL, 1995, J BIOL CHEM, V270, P6221, DOI 10.1074/jbc.270.11.6221; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; KIM CM, 1992, J BIOL CHEM, V267, P23113; KOHL NE, 1993, SCIENCE, V260, P1934, DOI 10.1126/science.8316833; Law BK, 2000, J BIOL CHEM, V275, P10796, DOI 10.1074/jbc.275.15.10796; Lebowitz PF, 1997, J BIOL CHEM, V272, P15591, DOI 10.1074/jbc.272.25.15591; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Liu M, 1998, CANCER RES, V58, P4947; Liu MY, 2002, CANCER RES, V62, P6475; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Mangues R, 1998, CANCER RES, V58, P1253; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Moasser MM, 1998, P NATL ACAD SCI USA, V95, P1369, DOI 10.1073/pnas.95.4.1369; Mondesire WH, 2004, CLIN CANCER RES, V10, P7031, DOI 10.1158/1078-0432.CCR-04-0361; NELLIST M, 1993, CELL, V75, P1305; Nielsen LL, 1999, CANCER RES, V59, P5896; Njoroge FG, 1998, J MED CHEM, V41, P4890, DOI 10.1021/jm980462b; Omer CA, 2000, CANCER RES, V60, P2680; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Pesche S, 1998, ONCOGENE, V16, P2879, DOI 10.1038/sj.onc.1202081; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; REISS Y, 1991, P NATL ACAD SCI USA, V88, P732, DOI 10.1073/pnas.88.3.732; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shi B, 2000, CANCER CHEMOTH PHARM, V46, P387, DOI 10.1007/s002800000170; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Wang J, 2002, J BIOL CHEM, V277, P46659, DOI 10.1074/jbc.M206407200; WOLDA SL, 1988, J BIOL CHEM, V263, P5997; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; YOKOYAMA K, 1991, P NATL ACAD SCI USA, V88, P5302, DOI 10.1073/pnas.88.12.5302; Zhang FL, 1997, J BIOL CHEM, V272, P10232; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	62	137	147	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31101	31108		10.1074/jbc.M503763200	http://dx.doi.org/10.1074/jbc.M503763200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16006564	hybrid			2022-12-27	WOS:000231487800055
J	Kassim, SY; Fu, XY; Liles, WC; Shapiro, SD; Parks, WC; Heinecke, JW				Kassim, SY; Fu, XY; Liles, WC; Shapiro, SD; Parks, WC; Heinecke, JW			NADPH oxidase restrains the matrix metalloproteinase activity of macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; LOW-DENSITY-LIPOPROTEIN; HYPOCHLOROUS ACID; SUPEROXIDE PRODUCTION; PROTEIN OXIDATION; TISSUE INHIBITOR; HOST-DEFENSE; ACTIVATION; MYELOPEROXIDASE; INFLAMMATION	Matrix metalloproteinases ( MMPs) regulate numerous functions in normal and disease processes; thus, irreversibly blocking their activity is a key step in regulating MMP catalysis. We previously showed in vitro that oxidizing intermediates generated by phagocytes inactivate MMPs by modifying specific amino acids. To assess whether this mechanism operates in vivo, we focused on MMP-12, a macrophage-specific MMP known to mediate emphysema in mouse models. We found that mice lacking gp91(phox), a phagocyte-specific component of the NADPH oxidase, developed extensive, spontaneous emphysematous destruction of their peripheral air spaces, whereas mice deficient in both NADPH oxidase and MMP-12 were protected from spontaneous emphysema. Although gp91(phox)-null and wild-type macrophages produced equivalent levels of MMP-12 protein, the oxidant-deficient cells had greater MMP-12 activity than wild-type macrophages. These findings indicate that reactive intermediates provide a physiological mechanism to protect tissues from excessive macrophage-mediated damage during inflammation.	Univ Washington, Div Metab Endocrinol & Nutr, Dept Med, Seattle, WA 98195 USA; Washington Univ, Dept Med, St Louis, MO 63110 USA; Washington Univ, Dept Pediat, St Louis, MO 63110 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; Washington University (WUSTL); Washington University (WUSTL); Harvard University; Brigham & Women's Hospital	Heinecke, JW (corresponding author), Univ Washington, Div Metab Endocrinol & Nutr, Dept Med, Box 356426, Seattle, WA 98195 USA.	heinecke@u.washington.edu	Parks, William C./AAH-6786-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075381, R01HL064344, R01HL078527, R01HL062995, P50HL073996, P01HL029594, R01HL077555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021191] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL77555, HL64344, HL075381, P01-HL29594, HL62995, HL078527, P50-HL073996] Funding Source: Medline; NIA NIH HHS [AG021191] Funding Source: Medline; NIEHS NIH HHS [P30-ES07033] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; Campbell EJ, 1999, J CLIN INVEST, V104, P337, DOI 10.1172/JCI6092; Caterina JJ, 2000, J BIOL CHEM, V275, P26416, DOI 10.1074/jbc.M001271200; Corry DB, 2004, FASEB J, V18, P995, DOI 10.1096/fj.03-1412fje; Corry DB, 2002, NAT IMMUNOL, V3, P347, DOI 10.1038/ni773; CURNUTTE JT, 1975, NEW ENGL J MED, V293, P628, DOI 10.1056/NEJM197509252931303; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; Filippov S, 2003, J EXP MED, V198, P925, DOI 10.1084/jem.20030626; Foster CB, 1998, J CLIN INVEST, V102, P2146, DOI 10.1172/JCI5084; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; Fu XY, 2004, J BIOL CHEM, V279, P6209, DOI 10.1074/jbc.C300506200; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Heinecke JW, 2002, FREE RADICAL BIO MED, V32, P1090, DOI 10.1016/S0891-5849(02)00792-X; Heinecke JW, 1998, ATHEROSCLEROSIS, V141, P1, DOI 10.1016/S0021-9150(98)00173-7; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Henderson JP, 2003, J BIOL CHEM, V278, P23522, DOI 10.1074/jbc.M303928200; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; MICHAELIS J, 1992, ARCH BIOCHEM BIOPHYS, V292, P555, DOI 10.1016/0003-9861(92)90030-Z; Mohammed FF, 2003, ANN RHEUM DIS, V62, P43; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Parks WC, 2001, RESP RES, V2, P10, DOI 10.1186/rr33; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076; SAVENKOVA MI, 1994, J BIOL CHEM, V269, P20394; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Shipley JM, 1996, P NATL ACAD SCI USA, V93, P3942, DOI 10.1073/pnas.93.9.3942; van de Loo FAJ, 2003, AM J PATHOL, V163, P1525, DOI 10.1016/S0002-9440(10)63509-2; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997	45	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30201	30205		10.1074/jbc.M503292200	http://dx.doi.org/10.1074/jbc.M503292200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15983040	hybrid			2022-12-27	WOS:000231362500028
J	Stahelin, RV; Wang, JY; Blatner, NR; Raftner, JD; Murray, D; Cho, WH				Stahelin, RV; Wang, JY; Blatner, NR; Raftner, JD; Murray, D; Cho, WH			The origin of C1A-C2 interdomain interactions in protein kinase C alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; CYSTEINE-RICH DOMAIN; MEMBRANE-BINDING; ACTIVATION MECHANISMS; PHORBOL ESTER; PKC-ALPHA; MACROMOLECULAR INTERACTIONS; DIFFERENTIAL ROLES; MOLECULAR-BASIS; DIACYLGLYCEROL	The regulatory domain of protein kinase C alpha (PKC alpha) contains three membrane-targeting modules, two C1 domains (C1A and C1B) that bind diacylglycerol and phorbol ester, and the C2 domain that is responsible for the Ca2+-dependent membrane binding. Accumulating evidence suggests that C1A and C2 domains of PKC alpha are tethered in the resting state and that the tethering is released upon binding to the membrane containing phosphatidylserine. The homology modeling and the docking analysis of C1A and C2 domains of PKC alpha revealed a highly complementary interface that comprises Asp(55) - Arg(252) and Arg(42) - Glu(282) ion pairs and a Phe(72) Phe(255) aromatic pair. Mutations of these residues in the predicted C1A-C2 interface showed large effects on in vitro membrane binding, enzyme activity, phosphatidylserine selectivity, and cellular membrane translocation of PKC alpha, supporting their involvement in interdomain interactions. In particular, D55A ( or D55K) and R252A ( or R252E) mutants showed much higher basal membrane affinity and enzyme activity and faster subcellular translocation than wild type, whereas a double charge-reversal mutant (D55K/ R252E) behaved analogously to wild type, indicating that a direct electrostatic interaction between the two residues is essential for the C1A-C2 tethering. Collectively, these studies provide new structural insight into PKC alpha C1A- C2 interdomain interactions and the mechanism of lipid-mediated PKC alpha activation.	Univ Illinois, Dept Chem, Chicago, IL 60607 USA; Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cornell University	Cho, WH (corresponding author), Univ Illinois, Dept Chem MC 111, 845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu	Stahelin, Robert/L-3567-2019		NIGMS NIH HHS [GM66147, GM53987] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053987, R01GM066147] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Ananthanarayanan B, 2002, J BIOL CHEM, V277, P3568, DOI 10.1074/jbc.M109705200; BAZZI MD, 1988, BIOCHEMISTRY-US, V27, P6776, DOI 10.1021/bi00418a020; BERS DM, 1982, AM J PHYSIOL, V242, P404; Bittova L, 2001, J BIOL CHEM, V276, P4218, DOI 10.1074/jbc.M008491200; BLUME A, 1979, BIOCHIM BIOPHYS ACTA, V557, P32, DOI 10.1016/0005-2736(79)90087-7; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; CHOW W, 2005, ANNU REV BIOPH BIOM, V34, P119; Conesa-Zamora P, 2000, BBA-MOL CELL BIOL L, V1487, P246, DOI 10.1016/S1388-1981(00)00099-8; Conesa-Zamora P, 2001, BIOCHEMISTRY-US, V40, P13898, DOI 10.1021/bi011303o; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOMMEL U, 1994, NAT STRUCT BIOL, V1, P383, DOI 10.1038/nsb0694-383; Irie K, 1998, J AM CHEM SOC, V120, P9159, DOI 10.1021/ja981087f; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; Kates M., 1986, TECHNIQUES LIPIDOLOG, P114; Kohout SC, 2002, BIOCHEMISTRY-US, V41, P11411, DOI 10.1021/bi026041k; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; Mott HR, 1996, P NATL ACAD SCI USA, V93, P8312, DOI 10.1073/pnas.93.16.8312; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P13216, DOI 10.1021/bi010761u; NEWTON AC, 1994, BIOCHEMISTRY-US, V33, P6651, DOI 10.1021/bi00187a035; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; NEWTON AC, 1993, ANNU REV BIOPH BIOM, V22, P1, DOI 10.1146/annurev.bb.22.060193.000245; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Ochoa WF, 2002, J MOL BIOL, V320, P277, DOI 10.1016/S0022-2836(02)00464-3; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4667, DOI 10.1021/bi00134a019; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Raghunath A, 2003, BIOCHEM J, V370, P901, DOI 10.1042/BJ20021420; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rodriguez-Alfaro JA, 2004, J MOL BIOL, V335, P1117, DOI 10.1016/j.jmb.2003.10.080; Russell RB, 2004, CURR OPIN STRUC BIOL, V14, P313, DOI 10.1016/j.sbi.2004.04.006; Schneidman-Duhovny D, 2004, CURR MED CHEM, V11, P91, DOI 10.2174/0929867043456223; Shen N, 2005, BIOCHEMISTRY-US, V44, P1089, DOI 10.1021/bi0476127; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; Slater SJ, 2002, J BIOL CHEM, V277, P15277, DOI 10.1074/jbc.M112207200; Slater SJ, 1999, BIOCHEMISTRY-US, V38, P3804, DOI 10.1021/bi982778r; SOUVIGNET C, 1991, J BIOL CHEM, V266, P40; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Tovchigrechko A, 2002, PROTEIN SCI, V11, P1888, DOI 10.1110/ps.4730102; Vakser IA, 1999, P NATL ACAD SCI USA, V96, P8477, DOI 10.1073/pnas.96.15.8477; Vakser IA, 1997, PROTEINS, P226; Vakser IA, 2002, METHOD ENZYMOL, V343, P313; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; VERGER R, 1982, CHEM PHYS LIPIDS, V30, P189, DOI 10.1016/0009-3084(82)90052-4; Xu RX, 1997, BIOCHEMISTRY-US, V36, P10709, DOI 10.1021/bi970833a; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zhou M, 2002, J MOL BIOL, V315, P435, DOI 10.1006/jmbi.2001.5263	66	44	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2005	280	43					36452	36463		10.1074/jbc.M506224200	http://dx.doi.org/10.1074/jbc.M506224200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	976IM	16079140	hybrid			2022-12-27	WOS:000232726900079
J	Bruysters, M; Jongejan, A; Akdemir, A; Bakker, RA; Leurs, R				Bruysters, M; Jongejan, A; Akdemir, A; Bakker, RA; Leurs, R			AG(q/11)-coupled mutant histamine H-1 receptor F435A activated solely by synthetic ligands (RASSL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESIGNED G(I)-COUPLED RECEPTOR; CONDITIONAL EXPRESSION; H-1-RECEPTOR AGONISTS; MUTATIONAL ANALYSIS; MOLECULAR-DYNAMICS; G-PROTEINS; CARDIOMYOPATHY; SIMULATION; ALGORITHM; GENE	Recently, G protein-coupled receptors activated solely by synthetic ligands (RASSLs) have been introduced as new tools to study G alpha(i) signaling in vivo ( 1, 2). Also, G alpha(s)-coupled G protein-coupled receptors have been engineered to generate G alpha(s)-coupled RASSLs ( 3, 4). In this study, we exploited the differences in binding pockets between different classes of H-1 receptor agonists and identified the first G alpha(q/11)-coupled RASSL. The mutant human H-1 receptor F435A (6.55) combines a strongly decreased affinity (25-fold) and potency for the endogenous ligand histamine (200-fold) with improved affinities (54-fold) and potencies (2600-fold) for 2-phenylhistamines, a synthetic class of H-1 receptor agonists. Molecular dynamics simulations provided a mechanism for distinct agonist binding to both wild-type and F435A mutant H-1 receptors.	Vrije Univ Amsterdam, Dept Med Chem, Fac Sci, Leiden Amsterdam Ctr Drug Res, NL-1081 HV Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Leurs, R (corresponding author), Vrije Univ Amsterdam, Dept Med Chem, Fac Sci, Leiden Amsterdam Ctr Drug Res, De Boelelaan 1083, NL-1081 HV Amsterdam, Netherlands.	r.leurs@few.vu.nl	Leurs, Rob/ABB-4299-2021; Akdemir, Atilla/G-2595-2015; Leurs, Rob/AAC-8508-2022	Akdemir, Atilla/0000-0001-8416-0471; Leurs, Rob/0000-0003-1354-2848				Baker AJ, 2001, AM J PHYSIOL-HEART C, V280, pH1653, DOI 10.1152/ajpheart.2001.280.4.H1653; Bakker RA, 2001, MOL PHARMACOL, V60, P1133, DOI 10.1124/mol.60.5.1133; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BRACKETT DJ, 1990, AGENTS ACTIONS, V31, P263, DOI 10.1007/BF01997618; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruysters M, 2004, EUR J PHARMACOL, V487, P55, DOI 10.1016/j.ejphar.2004.01.028; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Claeysen S, 2003, J BIOL CHEM, V278, P699, DOI 10.1074/jbc.C200588200; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Enwonwu CO, 2000, J NEURAL TRANSM, V107, P1273, DOI 10.1007/s007020070017; FUKUI H, 1994, BIOCHEM BIOPH RES CO, V201, P894, DOI 10.1006/bbrc.1994.1786; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Horn F, 2001, NUCLEIC ACIDS RES, V29, P346, DOI 10.1093/nar/29.1.346; Leopoldt D, 1997, N-S ARCH PHARMACOL, V356, P216, DOI 10.1007/PL00005044; LESCHKE C, 1995, J MED CHEM, V38, P1287, DOI 10.1021/jm00008a007; LEURS R, 1994, BIOCHEM BIOPH RES CO, V201, P295, DOI 10.1006/bbrc.1994.1701; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Matsuda N, 2002, N-S ARCH PHARMACOL, V366, P513, DOI 10.1007/s00210-002-0651-x; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Pertz HH, 2004, MINI-REV MED CHEM, V4, P935, DOI 10.2174/1389557043403198; Redfern CH, 2000, P NATL ACAD SCI USA, V97, P4826, DOI 10.1073/pnas.97.9.4826; Redfern CH, 1999, NAT BIOTECHNOL, V17, P165, DOI 10.1038/6165; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Scearce-Levie K, 2001, TRENDS PHARMACOL SCI, V22, P414, DOI 10.1016/S0165-6147(00)01743-0; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Seifert R, 2003, J PHARMACOL EXP THER, V305, P1104, DOI 10.1124/jpet.103.049619; Srinivasan S, 2003, ANN NY ACAD SCI, V994, P225, DOI 10.1111/j.1749-6632.2003.tb03184.x; TIMONEY AG, 1989, GUT, V30, P65, DOI 10.1136/gut.30.1.65; VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921; Wieland K, 1999, J BIOL CHEM, V274, P29994, DOI 10.1074/jbc.274.42.29994	35	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34741	34746		10.1074/jbc.M504165200	http://dx.doi.org/10.1074/jbc.M504165200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16027157	Green Published, hybrid			2022-12-27	WOS:000232403900045
J	Ferrao-Gonzales, AD; Robbs, BK; Moreau, VH; Ferreira, A; Juliano, L; Valente, AP; Almeida, FCL; Silva, JL; Foguel, D				Ferrao-Gonzales, AD; Robbs, BK; Moreau, VH; Ferreira, A; Juliano, L; Valente, AP; Almeida, FCL; Silva, JL; Foguel, D			Controlling beta-amyloid oligomerization by the use of naphthalene sulfonates - Trapping low molecular weight oligomeric species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; FIBRIL FORMATION; COMMON MECHANISM; DYES ATTENUATE; PRION PROTEIN; PEPTIDE; AGGREGATION; DEPOSITION; INHIBITION; TOXICITY	Aggregation of proteins and peptides has been shown to be responsible for several diseases known as amyloidoses, which include Alzheimer disease ( AD), prion diseases, among several others. AD is a neurodegenerative disorder caused primarily by the aggregation of beta-amyloid peptide (A beta). Here we describe the stabilization of small oligomers of A beta by the use of sulfonated hydrophobic molecules such as AMNS (1-amino-5-naphthalene sulfonate); 1,8-ANS (1-anilinonaphthalene-8-sulfonate) and bis-ANS (4,4'-dianilino1,1'-binaphthyl-5,5'-disulfonate). The experiments were performed with either A beta-1-42 or with A beta-13-23, a shorter version of A beta that is still able to form amyloid fibrils in vitro and contains amino acid residues 16 - 20, previously shown to be essential to peptide-peptide interaction and fibril formation. All sulfonated molecules tested were able to prevent A beta aggregation in a concentration dependent fashion in the following order of efficacy: 1,8ANS< AMNS< bis-ANS. Size exclusion chromatography revealed that in the presence of bis-ANS, A beta forms a heterogeneous population of low molecular weight species that proved to be toxic to cell cultures. Since the ANS compounds all have apolar rings and negative charges ( sulfonate groups), both hydrophobic and electrostatic interactions may contribute to interpeptide contacts that lead to aggregation. We also performed NMR experiments to investigate the structure of A beta-13-23 in SDSmicelles and found features of an alpha-helix from Lys(16) to Phe(20). H-1 TOCSY spectra of A beta-13 - 23 in the presence of AMNS displayed a chemical-shift dispersion quite similar to that observed in SDS, which suggests that in the presence of AMNS this peptide might adopt a conformation similar to that reported in the presence of SDS. Taken together, our studies provide evidence for the crucial role of small oligomers and their stabilization by sulfonate hydrophobic compounds.	Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Estrutural, BR-21941590 Rio De Janeiro, Brazil; Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl, BR-21941590 Rio De Janeiro, Brazil; Univ Fed Sao Paulo, Dept Biofis, BR-04023900 Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP)	Foguel, D (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Estrutural, Av Bauhinia 400, BR-21941590 Rio De Janeiro, Brazil.	foguel@bioqmed.ufrj.br	Juliano, Luiz/D-7204-2012; Moreau, Vitor Hugo/J-4829-2015; Gonzales, Astria Dias Ferrão-/D-3288-2015; Silva, Jerson/J-8984-2014; Almeida, Fabio/O-4989-2018; Robbs, Bruno/H-5553-2013; SILVA, JERSON Lima/GRF-1442-2022; Moreau, Vitor Hugo/B-8865-2009; Valente, Ana Paula/J-3010-2017	Juliano, Luiz/0000-0002-5589-2822; Moreau, Vitor Hugo/0000-0002-5393-0645; Gonzales, Astria Dias Ferrão-/0000-0003-4144-5244; Silva, Jerson/0000-0001-9523-9441; Almeida, Fabio/0000-0001-6046-7006; SILVA, JERSON Lima/0000-0001-9523-9441; Valente, Ana Paula/0000-0001-7219-1123; Foguel, Debora/0000-0001-7312-7115; Robbs, Bruno Kaufmann/0000-0002-3972-5530				Bornemann KD, 2000, ANN NY ACAD SCI, V908, P260; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Cordeiro Y, 2004, J BIOL CHEM, V279, P5346, DOI 10.1074/jbc.M312262200; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dobson CM, 2004, METHODS, V34, P4, DOI 10.1016/j.ymeth.2004.03.002; Dong MQ, 1996, J BIOL CHEM, V271, P28875, DOI 10.1074/jbc.271.46.28875; Esler WP, 1997, NAT BIOTECHNOL, V15, P258, DOI 10.1038/nbt0397-258; Fletcher TG, 1997, PROTEIN SCI, V6, P666; Foguel B, 2004, BIOCHEMISTRY-US, V43, P11361; Foguel D, 2003, P NATL ACAD SCI USA, V100, P9831, DOI 10.1073/pnas.1734009100; GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; Howlett DR, 1999, BIOCHEM J, V340, P283, DOI 10.1042/0264-6021:3400283; Ippel JH, 2002, P NATL ACAD SCI USA, V99, P8648, DOI 10.1073/pnas.132098999; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; KIRSCHNER DA, 1986, P NATL ACAD SCI USA, V83, P503, DOI 10.1073/pnas.83.2.503; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2002, NEUROBIOL AGING, V23, P231, DOI 10.1016/S0197-4580(01)00312-8; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; LeVine H, 2002, ARCH BIOCHEM BIOPHYS, V404, P106; Li LP, 1999, BIOPHYS J, V76, P2871, DOI 10.1016/S0006-3495(99)77442-4; Liu YB, 1997, J NEUROCHEM, V69, P2285; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; MAY PC, 1992, NEUROBIOL AGING, V13, P605, DOI 10.1016/0197-4580(92)90064-5; MAZUMDAR M, 1992, BIOCHEMISTRY-US, V31, P6470, DOI 10.1021/bi00143a016; Montserret R, 2000, BIOCHEMISTRY-US, V39, P8362, DOI 10.1021/bi000208x; Nakagami Y, 2002, EUR J PHARMACOL, V457, P11, DOI 10.1016/S0014-2999(02)02657-2; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; POLLACK SJ, 1995, NEUROSCI LETT, V184, P113, DOI 10.1016/0304-3940(94)11182-I; POLLACK SJ, 1995, NEUROSCI LETT, V197, P211, DOI 10.1016/0304-3940(95)11939-T; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; Solomon B, 1997, P NATL ACAD SCI USA, V94, P4109, DOI 10.1073/pnas.94.8.4109; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; SUMNERMAKIN O, 2005, P NATL ACAD SCI USA, V102, P315; TALAFOUS J, 1994, BIOCHEMISTRY-US, V33, P7788, DOI 10.1021/bi00191a006; TESCHKE CM, 1993, BIOCHEMISTRY-US, V32, P10658, DOI 10.1021/bi00091a016; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003	67	60	69	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34747	34754		10.1074/jbc.M501651200	http://dx.doi.org/10.1074/jbc.M501651200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16041062	hybrid			2022-12-27	WOS:000232403900046
J	Hatters, DM; Budamagunta, MS; Voss, JC; Weisgraber, KH				Hatters, DM; Budamagunta, MS; Voss, JC; Weisgraber, KH			Modulation of apolipoprotein E structure by domain interaction - Differences in lipid-bound and lipid-free forms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; RECEPTOR-BINDING DOMAIN; N-TERMINAL DOMAIN; ALZHEIMERS-DISEASE; E ISOFORMS; CONFORMATIONAL-CHANGES; AQUEOUS-SOLUTION; E APOPROTEIN; IN-VITRO; A-I	Interaction of the amino- and carboxyl-terminal domains in apolipoprotein (apo) E, referred to as domain interaction, is predicted to be more pronounced in apoE4 than in apoE3 and to underlie the association of apoE4 with Alzheimer and cardiovascular diseases. However, direct physical proof for the domain interaction concept is lacking. To address this issue, fluorescence resonance energy transfer and electron paramagnetic resonance spectroscopy were used to probe the spatial proximity of the two domains of apoE. Both methods demonstrated that the two domains are closer in both lipid-free and phospholipid-bound apoE4 than in apoE3 as a result of domain interaction. In addition, as shown by electron paramagnetic resonance, the domains of apoE4 move apart to resemble more closely the distance in apoE3 when the isoforms are bound to triglyceride-rich emulsion particles. These results demonstrate that domain interaction is a structural property of apoE4 and that apoE adopts different conformations when complexed to different lipids.	Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif Davis, Sch Med, Dept Biol Chem, Davis, CA 95616 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California Davis	Weisgraber, KH (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	kweisgraber@gladstone.ucsf.edu	Budamagunta, Madhu S/C-4628-2011	Voss, John/0000-0001-9279-209X; Hatters, Danny/0000-0002-9965-2847	NIA NIH HHS [P01 AG022074, R01 AG029246, R01 AG020235] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG029246, P01AG022074, R01AG020235] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Drury J, 2005, J BIOL CHEM, V280, P14605, DOI 10.1074/jbc.M414019200; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fisher CA, 1999, J LIPID RES, V40, P93; Fisher CA, 2000, J BIOL CHEM, V275, P33601, DOI 10.1074/jbc.M002643200; GIANTURCO SH, 1983, J BIOL CHEM, V258, P4526; Hatters DM, 2005, J BIOL CHEM, V280, P26477, DOI 10.1074/jbc.M503910200; Hess JF, 2004, J BIOL CHEM, V279, P44841, DOI 10.1074/jbc.M406257200; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; INNERARITY TL, 1979, J BIOL CHEM, V254, P4186; Kirby E. P., 1970, J PHYS CHEM-US, V74, P4480, DOI DOI 10.1021/J100720A004; Langen R, 2000, BIOCHEMISTRY-US, V39, P8396, DOI 10.1021/bi000604f; Lu B, 2000, J BIOL CHEM, V275, P20775, DOI 10.1074/jbc.M003508200; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m; Morrow JA, 1999, PROTEIN EXPRES PURIF, V16, P224, DOI 10.1006/prep.1999.1069; Narayanaswami V, 2001, J BIOL CHEM, V276, P37853; Narayanaswami V, 2004, J BIOL CHEM, V279, P14273, DOI 10.1074/jbc.M313318200; Narayanaswami V, 2000, BBA-MOL CELL BIOL L, V1483, P15, DOI 10.1016/S1388-1981(99)00176-6; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Perugini MA, 2002, EUR J BIOCHEM, V269, P5939, DOI 10.1046/j.1432-1033.2002.03319.x; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Raussens V, 1998, J BIOL CHEM, V273, P25825, DOI 10.1074/jbc.273.40.25825; Saito H, 2001, J BIOL CHEM, V276, P40949, DOI 10.1074/jbc.M106337200; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; TAJIMA S, 1983, J BIOL CHEM, V258, P73; WEISGRABER KH, 1990, J BIOL CHEM, V265, P22453; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; Weisgraber KH, 1996, FASEB J, V10, P1485, DOI 10.1096/fasebj.10.13.8940294; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Xu Q, 2004, J BIOL CHEM, V279, P25511, DOI 10.1074/jbc.M311256200; YOKOYAMA S, 1985, J BIOL CHEM, V260, P6375	44	68	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34288	34295		10.1074/jbc.M506044200	http://dx.doi.org/10.1074/jbc.M506044200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16076841	hybrid			2022-12-27	WOS:000232229700071
J	Dominguez-Soto, A; Puig-Kroger, A; Vega, MA; Corbi, AL				Dominguez-Soto, A; Puig-Kroger, A; Vega, MA; Corbi, AL			PU.1 regulates the tissue-specific expression of dendritic cell-specific intercellular adhesion molecule (ICAM)-3-grabbing nonintegrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; TRANSCRIPTION FACTOR PU.1; MANNOSE RECEPTOR PROMOTER; DC-SIGN; T-CELLS; (ICAM-3)-GRABBING NONINTEGRIN; SELECTIVE RECOGNITION; TGF-BETA; IN-VITRO; MACROPHAGE	Dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) is a cell surface C-type lectin expressed on myeloid dendritic cells and certain tissue macrophages, which mediates antigen capture for processing and presentation and participates in intercellular interactions with naive T lymphocytes or endothelial cells. In their strategy to evade immunosurveillance, numerous pathogenic microorganisms, including human immunodeficiency virus and Mycobacterium, bind to DC-SIGN in order to gain access to dendritic cells. We present evidence that PU.1 dictates the basal and cell-specific activity of DC-SIGN gene-regulatory region through in vivo occupancy of two functional Ets elements, whose integrity is required for PU.1 responsiveness and for the cooperative actions of PU.1 and other transcription factors (Myb, RUNX) on the DC-SIGN gene proximal regulatory region. In addition, protein analysis and gene profiling experiments indicate that DC-SIGN and PU.1 are coordinately expressed upon classical and alternative macrophage activation and during dendritic cell maturation. Moreover, small interfering RNA-mediated reduction of PU.1 expression results in diminished DC-SIGN cellular levels. Altogether, these results indicate that PU.1 is involved in the myeloid-specific expression of DC-SIGN inmyeloid cells, a contribution that can be framed within the role that PU.1 has on the acquisition of the antigen uptake molecular repertoire by dendritic cells and macrophages.	CSIC, Ctr Invest Biol, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Corbi, AL (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	acorbi@cib.csic.es	Corbi, Angel/B-7194-2011; Vega, Miguel A/M-1367-2016; Puig, Amaya/B-6164-2015; DOMINGUEZ-SOTO, ANGELES/K-5937-2014; Corbí, Angel L./ABC-8146-2020	Corbi, Angel/0000-0003-1980-5733; Vega, Miguel A/0000-0001-6151-4193; Puig, Amaya/0000-0003-2943-9757; Corbí, Angel L./0000-0003-1980-5733; Dominguez Soto, Angeles/0000-0003-1299-5992				Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Benjamini Y, 2001, ANN STAT, V29, P1165; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Chehimi J, 2003, J LEUKOCYTE BIOL, V74, P757, DOI 10.1189/jlb.0503231; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Durst KL, 2004, ONCOGENE, V23, P4220, DOI 10.1038/sj.onc.1207122; Egan BS, 1999, J BIOL CHEM, V274, P9098, DOI 10.1074/jbc.274.13.9098; Eichbaum Q, 1997, BLOOD, V90, P4135, DOI 10.1182/blood.V90.10.4135; Engering A, 2004, AM J PATHOL, V164, P1587, DOI 10.1016/S0002-9440(10)63717-0; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Engering A, 2002, BLOOD, V100, P1780, DOI 10.1182/blood-2001-12-0179; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Frison N, 2003, J BIOL CHEM, V278, P23922, DOI 10.1074/jbc.M302483200; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Iwama A, 2002, J EXP MED, V195, P547, DOI 10.1084/jem.20011465; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Li AC, 1998, J BIOL CHEM, V273, P5389, DOI 10.1074/jbc.273.9.5389; Liu HB, 2003, GENE, V313, P149, DOI 10.1016/S0378-1119(03)00674-7; Liu HL, 2004, J INFECT DIS, V190, P1055, DOI 10.1086/423209; LopezRodriguez C, 1997, EUR J IMMUNOL, V27, P1843, DOI 10.1002/eji.1830270804; Martin MP, 2004, J VIROL, V78, P14053, DOI 10.1128/JVI.78.24.14053-14056.2004; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mummidi S, 2001, J BIOL CHEM, V276, P33196, DOI 10.1074/jbc.M009807200; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; O'Reilly D, 2003, J BIOL CHEM, V278, P21909, DOI 10.1074/jbc.M212150200; Oelgeschlager M, 1996, MOL CELL BIOL, V16, P4717; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Park CG, 2001, INT IMMUNOL, V13, P1283, DOI 10.1093/intimm/13.10.1283; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Petrovick HS, 1998, MOL CELL BIOL, V18, P3915, DOI 10.1128/MCB.18.7.3915; Puig-Kroger A, 2003, BLOOD, V102, P3252, DOI 10.1182/blood-2003-02-0618; Puig-Kroger A, 2004, J BIOL CHEM, V279, P25680, DOI 10.1074/jbc.M311516200; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Relloso M, 2002, J IMMUNOL, V168, P2634, DOI 10.4049/jimmunol.168.6.2634; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Schjetne KW, 2002, INT IMMUNOL, V14, P1423, DOI 10.1093/intimm/dxf110; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Tsujimura H, 2003, BLOOD, V101, P961, DOI 10.1182/blood-2002-05-1327; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; van Lent PLEM, 2003, ARTHRITIS RHEUM, V48, P360, DOI 10.1002/art.10786	54	30	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33123	33131		10.1074/jbc.M503401200	http://dx.doi.org/10.1074/jbc.M503401200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16051608	hybrid, Green Published			2022-12-27	WOS:000232058100006
J	Kreikemeyer, B; Nakata, M; Oehmcke, S; Gschwendtner, C; Normann, J; Podbielski, A				Kreikemeyer, B; Nakata, M; Oehmcke, S; Gschwendtner, C; Normann, J; Podbielski, A			Streptococcus pyogenes collagen type I-binding Cpa surface protein - Expression profile, binding characteristics, biological functions, and potential clinical impact	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; VIRULENCE FACTOR REGULATION; COMPLETE GENOME SEQUENCE; TUMOR-NECROSIS-FACTOR; ANTIGEN I/II FAMILY; STAPHYLOCOCCUS-AUREUS; SECONDARY STRUCTURE; RHEUMATIC-FEVER; GENE FAMILY; ADHESIN	The Streptococcus pyogenes collagen type I-binding protein Cpa (collagen-binding protein of group A streptococci) expressed by 28 serotypes of group A streptococci has been extensively characterized at the gene and protein levels. Evidence for three distinct families of cpa genes was found, all of which shared a common sequence encoding a 60-amino acid domain that accounted for selective binding to type I collagen. Surface plasmon resonance-based affinity measurements and functional studies indicated that the expression of Cpa was consistent with an attachment role for bacteria to tissue containing collagen type I. A cpa mutant displayed a significantly decreased internalization rate when incubated with HEp-2 cells but had no effect on the host cell viability. By utilizing serum from patients with a positive titer for streptolysin/DNase antibody, an increased anti-Cpa antibody titer was noted for patients with a clinical history of arthritis or osteomyelitis. Taken together, these results suggest Cpa may be a relevant matrix adhesin contributing to the pathogenesis of S. pyogenes infection of bones and joints.	Hosp Rostock Univ, Dept Med Microbiol & Hosp Hyg, D-18057 Rostock, Germany	University of Rostock	Podbielski, A (corresponding author), Hosp Rostock Univ, Dept Med Microbiol & Hosp Hyg, Schillingallee 70, D-18057 Rostock, Germany.	andreas.podbielski@med.uni-rostock.de		Kreikemeyer, Bernd/0000-0001-9527-5098; Nakata, Masanobu/0000-0003-1686-5415				Baev D, 1999, INFECT IMMUN, V67, P4510, DOI 10.1128/IAI.67.9.4510-4516.1999; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Barnett TC, 2004, J BACTERIOL, V186, P5865, DOI 10.1128/JB.186.17.5865-5875.2004; Batchelor E, 2004, J BACTERIOL, V186, P7618, DOI 10.1128/JB.186.22.7618-7625.2004; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; BERGEY EJ, 1988, INFECT IMMUN, V56, P1715, DOI 10.1128/IAI.56.7.1715-1721.1988; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; BROOKS W, 1994, J MED MICROBIOL, V40, P330, DOI 10.1099/00222615-40-5-330; Chatenay-Rivauday C, 1998, MOL MICROBIOL, V29, P39, DOI 10.1046/j.1365-2958.1998.00881.x; COLMAN G, 1993, J MED MICROBIOL, V39, P165, DOI 10.1099/00222615-39-3-165; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; COURTNEY HS, 2004, BACTERIAL INVASION H, P239; Crowley PJ, 1999, INFECT IMMUN, V67, P1201, DOI 10.1128/IAI.67.3.1201-1206.1999; Darmstadt GL, 2000, INFECT IMMUN, V68, P1215, DOI 10.1128/IAI.68.3.1215-1221.2000; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Dinkla K, 2003, J CLIN INVEST, V111, P1905, DOI 10.1172/JCI200317247; Dinkla K, 2003, MOL MICROBIOL, V47, P861, DOI 10.1046/j.1365-2958.2003.03352.x; Elasri MO, 2002, BONE, V30, P275, DOI 10.1016/S8756-3282(01)00632-9; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; FRICK IM, 1994, MOL MICROBIOL, V12, P143, DOI 10.1111/j.1365-2958.1994.tb01003.x; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gillaspy AF, 1997, GENE, V196, P239, DOI 10.1016/S0378-1119(97)00256-4; GLURICH I, 1991, MICROB PATHOGENESIS, V10, P209, DOI 10.1016/0882-4010(91)90055-F; Hajishengallis G, 2002, CLIN DIAGN LAB IMMUN, V9, P403, DOI 10.1128/CDLI.9.2.403-411.2002; Hamada T, 2004, INFECT IMMUN, V72, P4819, DOI 10.1128/IAI.72.8.4819-4826.2004; Heddle C, 2003, MOL MICROBIOL, V50, P597, DOI 10.1046/j.1365-2958.2003.03711.x; Hienz SA, 1996, J INFECT DIS, V174, P83, DOI 10.1093/infdis/174.1.83; Holmes AR, 1998, INFECT IMMUN, V66, P4633, DOI 10.1128/IAI.66.10.4633-4639.1998; Hubble TS, 2003, ORAL MICROBIOL IMMUN, V18, P121, DOI 10.1034/j.1399-302X.2003.00059.x; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; Jenkinson HF, 1997, MOL MICROBIOL, V23, P183, DOI 10.1046/j.1365-2958.1997.2021577.x; Joh D, 1998, EUR J BIOCHEM, V258, P897, DOI 10.1046/j.1432-1327.1998.2580897.x; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; Johansson MU, 1997, J MOL BIOL, V266, P859, DOI 10.1006/jmbi.1996.0856; JOHNSON DR, 1992, J INFECT DIS, V166, P374, DOI 10.1093/infdis/166.2.374; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KAPLAN EL, 1994, J INFECT DIS, V170, P1346, DOI 10.1093/infdis/170.5.1346; KAUFHOLD A, 1992, J CLIN MICROBIOL, V30, P2391, DOI 10.1128/JCM.30.9.2391-2397.1992; KOSTRZYNSKA M, 1989, FEMS MICROBIOL LETT, V59, P229; Kreikemeyer B, 2004, INT J MED MICROBIOL, V294, P177, DOI 10.1016/j.ijmm.2004.06.017; Kreikemeyer B, 2004, J BIOL CHEM, V279, P15850, DOI 10.1074/jbc.M313613200; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kreikemeyer B, 2002, MICROBIOL-SGM, V148, P1501, DOI 10.1099/00221287-148-5-1501; KREIKEMEYER B, 1995, MOL MICROBIOL, V17, P137, DOI 10.1111/j.1365-2958.1995.mmi_17010137.x; Kreikemeyer B, 2001, MOL MICROBIOL, V39, P392, DOI 10.1046/j.1365-2958.2001.02226.x; Lannergard J, 2003, FEMS MICROBIOL LETT, V222, P69, DOI 10.1016/S0378-1097(03)00222-2; Love RM, 1997, INFECT IMMUN, V65, P5157, DOI 10.1128/IAI.65.12.5157-5164.1997; MAXTED WR, 1978, STREPTOCOCCI, P107; Mohamed JA, 2004, INFECT IMMUN, V72, P3658, DOI 10.1128/IAI.72.6.3658-3663.2004; Molinari G, 2000, CELL MICROBIOL, V2, P145, DOI 10.1046/j.1462-5822.2000.00040.x; Molinari G, 2001, MOL MICROBIOL, V40, P99, DOI 10.1046/j.1365-2958.2001.02373.x; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nallapareddy SR, 2000, INFECT IMMUN, V68, P5218, DOI 10.1128/IAI.68.9.5218-5224.2000; Nallapareddy SR, 2003, MOL MICROBIOL, V47, P1733, DOI 10.1046/j.1365-2958.2003.03417.x; Oehmcke S, 2004, INFECT IMMUN, V72, P4302, DOI 10.1128/IAI.72.7.4302-4308.2004; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; PATTI JM, 1993, BIOCHEMISTRY-US, V32, P11428, DOI 10.1021/bi00093a021; PATTI JM, 1995, J BIOL CHEM, V270, P12005, DOI 10.1074/jbc.270.20.12005; PATTI JM, 1994, INFECT IMMUN, V62, P152, DOI 10.1128/IAI.62.1.152-161.1994; PODBIELSKI A, 1991, MED MICROBIOL IMMUN, V180, P213; Podbielski A, 1999, MOL MICROBIOL, V31, P1051, DOI 10.1046/j.1365-2958.1999.01241.x; PODBIELSKI A, 1993, IMMUNOMETHODS, V2, P55; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Ponnuraj K, 2002, BBA-PROTEIN STRUCT M, V1596, P173, DOI 10.1016/S0167-4838(01)00328-4; Ramachandran V, 2004, J BACTERIOL, V186, P7601, DOI 10.1128/JB.186.22.7601-7609.2004; Rhem MN, 2000, INFECT IMMUN, V68, P3776, DOI 10.1128/IAI.68.6.3776-3779.2000; Rich RL, 1999, J BIOL CHEM, V274, P26939, DOI 10.1074/jbc.274.38.26939; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; Rich RL, 1998, BIOCHEMISTRY-US, V37, P15423, DOI 10.1021/bi981773r; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Ryding U, 1997, J INFECT DIS, V176, P1096, DOI 10.1086/516520; Samen U, 2004, J BACTERIOL, V186, P1398, DOI 10.1128/JB.186.5.1398-1408.2004; SCHMIDT KH, 1993, ZBL BAKT-INT J MED M, V279, P472, DOI 10.1016/S0934-8840(11)80419-6; Sciotti MA, 1997, FEMS MICROBIOL LETT, V153, P439, DOI 10.1016/S0378-1097(97)00287-5; Smeltzer MS, 1997, GENE, V196, P249, DOI 10.1016/S0378-1119(97)00237-0; Smeltzer MS, 1996, J CLIN MICROBIOL, V34, P1364, DOI 10.1128/JCM.34.6.1364-1372.1996; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Snodgrass JL, 1999, INFECT IMMUN, V67, P3952, DOI 10.1128/IAI.67.8.3952-3959.1999; SOELL M, 1994, INFECT IMMUN, V62, P1805, DOI 10.1128/IAI.62.5.1805-1812.1994; SWITALSKI LM, 1993, MOL MICROBIOL, V7, P99, DOI 10.1111/j.1365-2958.1993.tb01101.x; Symersky J, 1997, NAT STRUCT BIOL, V4, P833, DOI 10.1038/nsb1097-833; Towers RJ, 2003, J CLIN MICROBIOL, V41, P5398, DOI 10.1128/JCM.41.12.5398-5406.2003; VERCELLOTTI GM, 1985, AM J PATHOL, V120, P13; Vernier-Georgenthum A, 1998, CELL IMMUNOL, V187, P145, DOI 10.1006/cimm.1998.1327; VISAI L, 1995, J BIOL CHEM, V270, P347, DOI 10.1074/jbc.270.1.347; WANNAMAKER LW, 1970, NEW ENGL J MED, V282, P23, DOI 10.1056/NEJM197001082820206; WESTERLUND B, 1993, MOL MICROBIOL, V9, P687, DOI 10.1111/j.1365-2958.1993.tb01729.x; Widdowson JP, 1980, STREPTOCOCCAL DISEAS, P125; Xu Y, 2004, J INFECT DIS, V189, P2323, DOI 10.1086/420851	92	79	79	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33228	33239		10.1074/jbc.M502896200	http://dx.doi.org/10.1074/jbc.M502896200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16040603	hybrid			2022-12-27	WOS:000232058100018
J	Lee, ATC; Ren, JW; Wong, ET; Ban, KHK; Lee, LA; Lee, CGL				Lee, ATC; Ren, JW; Wong, ET; Ban, KHK; Lee, LA; Lee, CGL			The hepatitis B virus X protein sensitizes HepG2 cells to UV light-induced DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 TUMOR-SUPPRESSOR; NUCLEOTIDE EXCISION-REPAIR; HBX PROTEIN; HEPATOCELLULAR-CARCINOMA; TRANSGENIC MICE; TRANSFECTED CELLS; CYCLE CHECKPOINT; LIVER-CANCER; GENE; APOPTOSIS	Various reports have implicated the virally encoded HBx protein as a cofactor in hepatocarcinogenesis. However, direct evidence of the role of HBx as a promoter of oncogenesis in response to an initiating factor such as DNA damage remains inadequate. Here, we report the effects of HBx in HepG2 cells exposed to UV light-induced DNA damage. HBx expression was found not to affect the morphology, viability, and cell cycle/apoptotic profiles or DNA repair machinery of untreated cells. Nonetheless, upon UV treatment, HBx protein levels increased concomitantly with p53 levels. Both HBx and p53 proteins were found to interact and colocalize primarily in the nucleus. The binding of HBx to p53 modulated ( but did not inhibit) the transcriptional activation function of p53. Notably, HBx-expressing cells exhibited increased sensitivity to UV damage, resulting in greater G(2)/M arrest and apoptosis of these cells. Additionally, these cells displayed a reduced DNA repair capacity in response to UV damage. In conclusion, this work suggests that DNA damage may be an initiating factor in hepatocarcinogenesis and that HBx may act as the promoting factor by inhibiting DNA repair. In hepatitis B virus-infected hepatocytes, a chronic infection may present the opportunity for such a DNA-damaging event to occur, and accumulated errors caused by the inhibition of DNA repair by HBx may result in oncogenesis.	Natl Canc Ctr, Div Med Sci, Singapore 169610, Singapore; Natl Univ Singapore, Dept Biochem, Singapore 119077, Singapore; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA	National Cancer Centre Singapore (NCCS); National University of Singapore; Johns Hopkins University	Lee, CGL (corresponding author), Natl Canc Ctr, Div Med Sci, Level 6,Lab 5,11 Hosp Dr, Singapore 169610, Singapore.	bchleec@nus.edu.sg	Lee, Caroline G/M-8918-2019; Ban, Kenneth/A-1243-2012	Lee, Caroline G/0000-0002-4323-3635; Ban, Kenneth/0000-0001-7165-8713				ABRAMIC M, 1991, J BIOL CHEM, V266, P22493; Arbuthnot P, 2000, J GASTROEN HEPATOL, V15, P357, DOI 10.1046/j.1440-1746.2000.02069.x; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Becker SA, 1998, J VIROL, V72, P266, DOI 10.1128/JVI.72.1.266-272.1998; Bellamy COC, 1997, FASEB J, V11, P591, DOI 10.1096/fasebj.11.7.9212083; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Bergametti F, 1999, ONCOGENE, V18, P2860, DOI 10.1038/sj.onc.1202643; Bergametti F, 2002, J VIROL, V76, P6495, DOI 10.1128/JVI.76.13.6495-6501.2002; Bontron S, 2002, J BIOL CHEM, V277, P38847, DOI 10.1074/jbc.M205722200; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Butel JS, 2000, CARCINOGENESIS, V21, P405, DOI 10.1093/carcin/21.3.405; CHEN JD, 1995, MOL MED, V1, P142, DOI 10.1007/BF03401562; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Chirillo P, 1997, P NATL ACAD SCI USA, V94, P8162, DOI 10.1073/pnas.94.15.8162; CHISARI FV, 1995, SPRINGER SEMIN IMMUN, V17, P261, DOI 10.1007/BF00196169; Chresta C M, 1996, Behring Inst Mitt, P232; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; DORIA M, 1995, EMBO J, V14, P4747, DOI 10.1002/j.1460-2075.1995.tb00156.x; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Elmore LW, 1997, P NATL ACAD SCI USA, V94, P14707, DOI 10.1073/pnas.94.26.14707; FEITELSON MA, 1993, ONCOGENE, V8, P1109; FISCHER M, 1995, VIRUS GENES, V10, P99, DOI 10.1007/BF01724303; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gottlob K, 1998, J BIOL CHEM, V273, P33347, DOI 10.1074/jbc.273.50.33347; Groisman IJ, 1999, CARCINOGENESIS, V20, P479, DOI 10.1093/carcin/20.3.479; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hoare J, 2001, J MED VIROL, V64, P419, DOI 10.1002/jmv.1067; Hu ZY, 1999, J VIROL, V73, P7231, DOI 10.1128/JVI.73.9.7231-7240.1999; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Jia L, 1999, INT J CANCER, V80, P875, DOI 10.1002/(SICI)1097-0215(19990315)80:6<875::AID-IJC13>3.3.CO;2-Q; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; KOIKE K, 1994, J CLIN INVEST, V94, P44, DOI 10.1172/JCI117343; Koike K, 1998, CANCER LETT, V134, P181, DOI 10.1016/S0304-3835(98)00252-3; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kwun HJ, 2004, NUCLEIC ACIDS RES, V32, P2202, DOI 10.1093/nar/gkh553; Lau JYN, 1998, SEMIN LIVER DIS, V18, P169, DOI 10.1055/s-2007-1007152; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; LEE TH, 1995, J VIROL, V69, P1107, DOI 10.1128/JVI.69.2.1107-1114.1995; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Madden CR, 2000, J VIROL, V74, P5266, DOI 10.1128/JVI.74.11.5266-5272.2000; Nag A, 2001, J VIROL, V75, P10383, DOI 10.1128/JVI.75.21.10383-10392.2001; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Nomura T, 1999, BBA-MOL BASIS DIS, V1453, P330, DOI 10.1016/S0925-4439(99)00004-6; PICKSLEY SM, 1993, BIOESSAYS, V15, P689, DOI 10.1002/bies.950151008; Pollicino T, 1998, BIOMED PHARMACOTHER, V52, P363, DOI 10.1016/S0753-3322(99)80003-1; Prost S, 1998, J BIOL CHEM, V273, P33327, DOI 10.1074/jbc.273.50.33327; Qadri I, 1996, P NATL ACAD SCI USA, V93, P10578, DOI 10.1073/pnas.93.20.10578; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; SANDS AT, 1995, NATURE, V377, P162, DOI 10.1038/377162a0; Schwartz D, 1998, SEMIN CANCER BIOL, V8, P325, DOI 10.1006/scbi.1998.0095; Shih WL, 2000, J BIOL CHEM, V275, P25858, DOI 10.1074/jbc.M003578200; Shintani Y, 1999, J GEN VIROL, V80, P3257, DOI 10.1099/0022-1317-80-12-3257; Shirakata Y, 2003, J BIOL CHEM, V278, P22071, DOI 10.1074/jbc.M301606200; Sirma H, 1999, ONCOGENE, V18, P4848, DOI 10.1038/sj.onc.1202867; Sirma H, 1998, ONCOGENE, V16, P2051, DOI 10.1038/sj.onc.1201737; Slagle BL, 1996, MOL CARCINOGEN, V15, P261, DOI 10.1002/(SICI)1098-2744(199604)15:4<261::AID-MC3>3.0.CO;2-J; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; Su F, 1997, P NATL ACAD SCI USA, V94, P8744, DOI 10.1073/pnas.94.16.8744; Su Q, 2000, MUTAT RES-REV MUTAT, V462, P365, DOI 10.1016/S1383-5742(00)00026-0; Su Q, 1998, HEPATOLOGY, V27, P1109, DOI 10.1002/hep.510270428; Takada S, 1997, ONCOGENE, V15, P1895, DOI 10.1038/sj.onc.1201369; TAKADA S, 1995, J CANCER RES CLIN, V121, P593, DOI 10.1007/BF01197776; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Taylor WR, 1999, MOL BIOL CELL, V10, P3607, DOI 10.1091/mbc.10.11.3607; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Terradillos O, 1997, ONCOGENE, V14, P395, DOI 10.1038/sj.onc.1200850; Terradillos O, 1998, ONCOGENE, V17, P2115, DOI 10.1038/sj.onc.1202432; UEDA H, 1995, NAT GENET, V9, P41, DOI 10.1038/ng0195-41; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WANG XW, 1995, CANCER RES, V55, P6012; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; Yun CW, 2000, ONCOGENE, V19, P5163, DOI 10.1038/sj.onc.1203896	75	51	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33525	33535		10.1074/jbc.M506628200	http://dx.doi.org/10.1074/jbc.M506628200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16055925	hybrid			2022-12-27	WOS:000232058100052
J	Tondu, AL; Robichon, C; Yvan-Charvet, L; Donne, N; Le Liepvre, X; Hajduch, E; Ferre, P; Dugail, I; Dagher, G				Tondu, AL; Robichon, C; Yvan-Charvet, L; Donne, N; Le Liepvre, X; Hajduch, E; Ferre, P; Dugail, I; Dagher, G			Insulin and angiotensin II induce the translocation of scavenger receptor class B, type I from intracellular sites to the plasma membrane of adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; SELECTIVE LIPID UPTAKE; SR-BI; CHOLESTERYL ESTERS; TARGETED MUTATION; SKELETAL-MUSCLE; ACID-TRANSPORT; ADIPOSE-TISSUE; GLUCOSE; CELLS	Scavenger receptor class B, type I (SR-BI) mediates the selective uptake of lipids from high density lipoproteins and is expressed in several types of tissues. However, to date little is known about its role in adipocytes. In this study, we investigated the cellular distribution of SR-BI in 3T3-L1 adipocytes and its regulation by hormones known to increase lipid storage such as angiotensin II ( Ang II) and insulin. SR-BI was mainly distributed in the cytoplasm as determined by laser-scanning confocal analysis of the immunofluorescence labeling of SR-BI or the study of an enhanced green fluorescent protein-tagged SR-BI fusion protein. Exposure of cells to either insulin or Ang II ( 1 - 2 h) induced the mobilization of SR-BI from intracellular pools to the plasma membrane. This was further confirmed by Western blotting on purified plasma membrane and by fluorescence-activated cell sorter analysis of the SR-BI receptor. Similar results were also observed in primary adipocytes. We also demonstrated that, in the presence of either insulin or Ang II, SR-BI translocation to the cell membrane is functional, because insulin and Ang II induced a significant increase in the high density lipoprotein-delivered 22-(N-7-nitrobenz-2-oxa-1,3-diazo-4-yl)amino- 23,24-bisnor-5-cholen-3-ol uptake and in total cholesterol content. These data demonstrate that SR-BI can be acutely mobilized from intracellular stores to the cell surface by insulin or Ang II, two hormones that exert lipogenic effects in adipocytes. This suggests that SR-BI might participate in the storage of lipids in the adipose tissue.	Univ Paris 06, Inst Biomed Cordeliers, INSERM, U671, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Dagher, G (corresponding author), Univ Paris 06, Inst Biomed Cordeliers, INSERM, U671, 15 Rue Ecole Med, F-75006 Paris, France.	dagher@ccr.jussieu.fr	Dugail, Isabelle/L-1567-2017; Ferré, Pascal/K-1250-2013; Dagher, Georges/AAC-1556-2020; Hajduch, Eric/B-7332-2008	Dugail, Isabelle/0000-0003-3631-2252; Ferré, Pascal/0000-0003-0115-7045; Hajduch, Eric/0000-0002-0125-7751; Yvan-Charvet, Laurent/0000-0002-7748-4942				Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Azhar S, 1998, J LIPID RES, V39, P1616; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Backer Jonathan M., 2000, Molecular Cell Biology Research Communications, V3, P193, DOI 10.1006/mcbr.2000.0202; Boizard M, 1998, J BIOL CHEM, V273, P29164, DOI 10.1074/jbc.273.44.29164; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cherradi N, 2001, ENDOCRINOLOGY, V142, P4540, DOI 10.1210/en.142.10.4540; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; Dagher G, 2003, J LIPID RES, V44, P1811, DOI 10.1194/jlr.M300267-JLR200; FOLCH J, 1957, J BIOL CHEM, V226, P497; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hyde R, 2001, BIOCHEM J, V355, P563, DOI 10.1042/bj3550563; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; Li XL, 1998, ENDOCRINOLOGY, V139, P3043, DOI 10.1210/en.139.7.3043; Martys JL, 1996, J BIOL CHEM, V271, P10953, DOI 10.1074/jbc.271.18.10953; Massiera F, 2001, FASEB J, V15, P2727, DOI 10.1096/fj.01-0457fje; NISHIMURA H, 1993, J BIOL CHEM, V268, P19246; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; Reaven E, 1998, ENDOCRINOLOGY, V139, P2847, DOI 10.1210/en.139.6.2847; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Ruan H, 2001, DIABETES, V50, P233, DOI 10.2337/diabetes.50.2.233; Sato Y, 1996, TISSUE CELL, V28, P637, DOI 10.1016/S0040-8166(96)80067-X; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Trigatti BL, 2000, BBA-MOL CELL BIOL L, V1529, P276, DOI 10.1016/S1388-1981(00)00154-2; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Vassiliou G, 2004, J LIPID RES, V45, P1683, DOI 10.1194/jlr.M400051-JLR200; Wang N, 1998, J BIOL CHEM, V273, P32920, DOI 10.1074/jbc.273.49.32920; Wu-Wong JSR, 1999, J BIOL CHEM, V274, P8103, DOI 10.1074/jbc.274.12.8103	34	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33536	33540		10.1074/jbc.M502392200	http://dx.doi.org/10.1074/jbc.M502392200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16033765	hybrid			2022-12-27	WOS:000232058100053
J	Byfield, MP; Murray, JT; Backer, JM				Byfield, MP; Murray, JT; Backer, JM			hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX; PHOSPHATIDYLINOSITOL 3-KINASE; MAMMALIAN TARGET; PROTEIN-KINASE; CELL-GROWTH; DISTINCT ROLES; PHOSPHORYLATION SITE; ACTIN CYTOSKELETON; BINDING PARTNER; RAPAMYCIN MTOR	Mammalian cells respond to nutrient deprivation by inhibiting energy consuming processes, such as proliferation and protein synthesis, and by stimulating catabolic processes, such as autophagy. p70 S6 kinase (S6K1) plays a central role during nutritional regulation of translation. S6K1 is activated by growth factors such as insulin, and by mammalian target of rapamycin (mTOR), which is itself regulated by amino acids. The Class IA phosphatidylinositol (PI) 3-kinase plays a well recognized role in the regulation of S6K1. We now present evidence that the Class III PI 3-kinase, hVps34, also regulates S6K1, and is a critical component of the nutrient sensing apparatus. Overexpression of hVps34 or the associated hVps15 kinase activates S6K1, and insulin stimulation of S6K1 is blocked by microinjection of inhibitory anti-hVps34 antibodies, overexpression of a FYVE domain construct that sequesters the hVps34 product PI(3) P, or small interfering RNA-mediated knock-down of hVps34. hVps34 is not part of the insulin input to S6K1, as it is not stimulated by insulin, and inhibition of hVps34 has no effect on phosphorylation of Akt or TSC2 in insulin-stimulated cells. However, hVps34 is inhibited by amino acid or glucose starvation, suggesting that it lies on the nutrient-regulated pathway to S6K1. Consistent with this, hVps34 is also inhibited by activation of the AMP-activated kinase, which inhibits mTOR/S6K1 in glucose-starved cells. hVps34 appears to lie upstream of mTOR, as small interfering RNA knock- down of hVps34 inhibits the phosphorylation of another mTOR substrate, eIF4E-binding protein-1 (4EBP1). Our data suggest that hVps34 is a nutrient-regulated lipid kinase that integrates amino acid and glucose inputs to mTOR and S6K1.	Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland	Yeshiva University; Albert Einstein College of Medicine; University of Dundee	Backer, JM (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	Backer@aecom.yu.edu	Murray, James/AAC-6612-2019	Murray, James/0000-0002-6928-2347	NIGMS NIH HHS [T32 GM07491] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; FLOTOW H, 1992, J BIOL CHEM, V267, P3074; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gingras AC, 2001, GENE DEV, V15, P2852; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; KAPELLER R, 1991, MOL ENDOCRINOL, V5, P769, DOI 10.1210/mend-5-6-769; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; Lehman JA, 2003, J BIOL CHEM, V278, P28130, DOI 10.1074/jbc.M300376200; Leslie NR, 2001, CHEM REV, V101, P2365, DOI 10.1021/cr000091i; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 2001, CANCER RES, V61, P3443; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long X, 2003, CURR TOP MICROBIOL, V279, P115; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Michell BJ, 1996, J BIOL CHEM, V271, P28445, DOI 10.1074/jbc.271.45.28445; Murray JT, 2002, TRAFFIC, V3, P416, DOI 10.1034/j.1600-0854.2002.30605.x; Pan DJ, 2004, TRENDS CELL BIOL, V14, P78, DOI 10.1016/j.tcb.2003.12.006; Panaretou C, 1997, J BIOL CHEM, V272, P2477; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; POLLARD JW, 1979, J CELL PHYSIOL, V98, P571, DOI 10.1002/jcp.1040980315; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Siddhanta U, 1998, J CELL BIOL, V143, P1647, DOI 10.1083/jcb.143.6.1647; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; Tuma PL, 2001, J CELL BIOL, V154, P1197, DOI 10.1083/jcb.200105138; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	65	419	438	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					33076	33082		10.1074/jbc.M507201200	http://dx.doi.org/10.1074/jbc.M507201200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16049009	hybrid			2022-12-27	WOS:000231920300062
J	Turkson, J; Zhang, SM; Mora, LB; Burns, A; Sebti, S; Jove, R				Turkson, J; Zhang, SM; Mora, LB; Burns, A; Sebti, S; Jove, R			A novel platinum compound inhibits constitutive Stat3 signaling and induces cell cycle arrest and apoptosis of malignant cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CARCINOMA CELLS; CANCER DRUG DISCOVERY; DNA-BINDING ACTIVITY; HUMAN SERUM-ALBUMIN; U266 MYELOMA CELLS; MOLECULAR TARGETS; SRC ONCOPROTEIN; KINASE-ACTIVITY; GENE-REGULATION; TRANSCRIPTIONAL ACTIVATION	Previous studies have established constitutive activation of Stat3 protein as one of the molecular changes required for tumorigenesis. To develop novel therapeutics for tumors harboring constitutively active Stat3, compounds from the NCI 2000 diversity set were evaluated for inhibition of Stat3 DNA-binding activity in vitro. Of these, a novel platinum (IV) compound, IS3 295, interacted with Stat3 and inhibited its binding to specific DNA-response elements. Further analysis suggested noncompetitive-type kinetics for the inhibition of Stat3 binding to DNA. In human and mouse tumor cell lines with constitutively active Stat3, IS3 295 selectively attenuated Stat3 signaling, thereby inducing cell growth arrest at G(0)/G(1) phase and apoptosis. Moreover, in transformed cells, IS3 295 repressed expression of cyclin D1 and bcl-x(L), two of the known Stat3-regulated genes that are overexpressed in malignant cells, suggesting that IS3 295 mediates anti-tumor cell activity in part by blocking Stat3-mediated subversion of cell growth and apoptotic signals. Together, our findings provide evidence for the inhibition of Stat3 activity and biological functions by IS3 295 through interaction with Stat3 protein. This study represents a significant advance in small molecule-based approaches to target Stat3 and suggests potential new applications for platinum (IV) complexes as modulators of the Stat3 pathway for cancer therapy.	Univ S Florida, Mol Oncol Program, Coll Med, Tampa, FL 33612 USA; Univ S Florida, Drug Discovery Programs, Coll Med, H Lee Moffit Canc Ctr & Res Inst, Tampa, FL 33612 USA; Univ S Florida, Dept Oncol, Coll Med, Tampa, FL 33612 USA; Univ S Florida, Dept Biochem & Mol Biol, Coll Med, Tampa, FL 33612 USA; Univ S Florida, Dept Pathol, Coll Med, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Turkson, J (corresponding author), Univ Cent Florida, Dept Mol Biol & Microbiol, BioMol Sci Ctr, 12722 Res Pkwy, Orlando, FL 32826 USA.	jturkson@mail.ucf.edu			NATIONAL CANCER INSTITUTE [R01CA055652] Funding Source: NIH RePORTER; NCI NIH HHS [CA55652] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Allain P, 2000, DRUG METAB DISPOS, V28, P1379; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bose RN, 2002, MINI-REV MED CHEM, V2, P103, DOI 10.2174/1389557024605500; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2000, BREAST CANCER RES, V2, P86, DOI 10.1186/bcr38; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Buettner R, 2002, CLIN CANCER RES, V8, P945; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Coffer PJ, 2000, ONCOGENE, V19, P2511, DOI 10.1038/sj.onc.1203479; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; GOUILLEUX F, 1995, ENDOCRINOLOGY, V136, P5700, DOI 10.1210/en.136.12.5700; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Heudi O, 1999, BIOPHARM DRUG DISPOS, V20, P107, DOI 10.1002/(SICI)1099-081X(199903)20:2<107::AID-BDD161>3.0.CO;2-0; Heudi O, 2001, INT J CLIN PHARM TH, V39, P344; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; JOHNSON PJ, 1985, MOL CELL BIOL, V5, P1073, DOI 10.1128/MCB.5.5.1073; Karras JG, 2000, CELL IMMUNOL, V202, P124, DOI 10.1006/cimm.2000.1661; Kotenko SV, 2000, ONCOGENE, V19, P2557, DOI 10.1038/sj.onc.1203524; Lin TS, 2000, ONCOGENE, V19, P2496, DOI 10.1038/sj.onc.1203486; Mora LB, 2002, CANCER RES, V62, P6659; Nielsen M, 1997, P NATL ACAD SCI USA, V94, P6764, DOI 10.1073/pnas.94.13.6764; Nielsen M, 1999, LEUKEMIA, V13, P735, DOI 10.1038/sj.leu.2401415; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Niu GL, 1999, CANCER RES, V59, P5059; Oshiro MM, 2001, CLIN CANCER RES, V7, P4262; Oyajobi BO, 2003, BLOOD, V102, P311, DOI 10.1182/blood-2002-12-3905; Perez JM, 2003, MOL PHARMACOL, V63, P933, DOI 10.1124/mol.63.4.933; Persons DL, 1999, CLIN CANCER RES, V5, P1007; Sanchez-Perez I, 1998, ONCOGENE, V16, P533, DOI 10.1038/sj.onc.1201578; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; Smithgall TE, 2000, ONCOGENE, V19, P2612, DOI 10.1038/sj.onc.1203477; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Trynda-Lemiesz L, 2004, J INORG BIOCHEM, V98, P1851, DOI 10.1016/j.jinorgbio.2004.08.015; Trynda-Lemiesz L, 1999, J INORG BIOCHEM, V77, P141, DOI 10.1016/S0162-0134(99)00183-X; Turkson J, 2004, MOL CANCER THER, V3, P1533; Turkson J, 2004, MOL CANCER THER, V3, P261; Turkson J, 1999, MOL CELL BIOL, V19, P7519; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Wang GD, 2004, ONCOL REP, V12, P955; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; YAMAUCHI K, 1993, J BIOL CHEM, V268, P14597; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang DX, 1996, J BIOL CHEM, V271, P9503, DOI 10.1074/jbc.271.16.9503; Zhang Y, 2000, J BIOL CHEM, V275, P24935, DOI 10.1074/jbc.M002383200	64	149	166	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32979	32988		10.1074/jbc.M502694200	http://dx.doi.org/10.1074/jbc.M502694200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16046414	Green Published, hybrid			2022-12-27	WOS:000231920300052
J	Yamaguchi, K; Lantowski, A; Dannenberg, AJ; Subbaramaiah, K				Yamaguchi, K; Lantowski, A; Dannenberg, AJ; Subbaramaiah, K			RETRACTED: Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2 (Retracted article. See vol. 295, pg. 294, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							CARCINOMA CELL-LINES; RNA-POLYMERASE-II; CYCLOOXYGENASE-2 INHIBITOR; PHORBOL ESTER; CHEMOPREVENTIVE ACTIVITY; ANTITUMOR-ACTIVITY; EPITHELIAL-CELLS; BREAST-CANCER; IN-VITRO; ACTIVATION	Cyclooxygenase- 2 ( COX- 2) is considered to be a target for anticancer therapy. Histone deacetylase ( HDAC) inhibitors exhibit antitumor activity, but the mechanisms of action are incompletely understood. We investigated whether HDAC inhibitors blocked AP- 1- mediated activation of COX- 2 transcription. Trichostatin A and suberoylanilide hydroxamic acid, two structurally related inhibitors of HDAC activity, blocked AP- 1- mediated induction of COX- 2 expression and prostaglandin E2 biosynthesis. Chromatin immunoprecipitation assays indicated that HDAC inhibitors suppressed c- Jun binding to the COX- 2 promoter and thereby blocked transcription. The observed reduction in binding reflected reduced levels of c- Jun. HDAC inhibitors suppressed the induction of c- jun transcription by blocking the recruitment of the preinitiation complex ( RNA polymerase II and TFIIB) to the c- jun promoter. HDAC3 but not HDAC1 or HDAC2 was required for AP- 1- mediated stimulation of c- jun expression. Because HDAC inhibitors suppressed the induction of c- jun gene expression, resulting in reduced COX- 2 transcription, it was important to determine whether other known AP- 1 target genes were also modulated. Cyclin D1 and collagenase- 1 are AP- 1- dependent genes that have been implicated in carcinogenesis. HDAC inhibitors suppressed the induction of both cyclin D1 and collagenase- 1 transcription by inhibiting the binding of c- Jun to the respective promoters. Taken together, these results suggest that HDAC inhibitors block the induction of c- jun transcription by inhibiting the recruitment of the preinitiation complex to the c- jun promoter. This led, in turn, to reduced expression of several activator protein- 1- dependent genes ( COX- 2, cyclin D1, collagenase- 1). These findings provide new insights into the mechanisms underlying the antitumor activity of HDAC inhibitors.	Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA	Cornell University	Subbaramaiah, K (corresponding author), NY Presbyterian Hosp Cornell, 525 E 68th St,Rm F-203A, New York, NY 10021 USA.	ksubba@med.cornell.edu			NATIONAL CANCER INSTITUTE [R01CA111469, P01CA106451] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA111469, P01-CA106451] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albanese C, 1999, J BIOL CHEM, V274, P34186, DOI 10.1074/jbc.274.48.34186; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823; Carducci MA, 2001, CLIN CANCER RES, V7, P3047; Chulada PC, 2000, CANCER RES, V60, P4705; Chung JY, 1999, CANCER RES, V59, P4610; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; DUBOIS RN, 1994, J CLIN INVEST, V93, P493, DOI 10.1172/JCI116998; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Fass DM, 2003, J BIOL CHEM, V278, P43014, DOI 10.1074/jbc.M305905200; Fischer SM, 1999, MOL CARCINOGEN, V25, P231; Galasinski SC, 2002, J BIOL CHEM, V277, P19618, DOI 10.1074/jbc.M201174200; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Guo YS, 2001, J BIOL CHEM, V276, P22941, DOI 10.1074/jbc.M101801200; Harris RE, 2000, CANCER RES, V60, P2101; Hennigan RF, 2001, MOL BIOL CELL, V12, P2352, DOI 10.1091/mbc.12.8.2352; HERBER B, 1994, ONCOGENE, V9, P1295; HERUTH DP, 1993, J BIOL CHEM, V268, P20466; Howe LR, 2002, CANCER RES, V62, P5405; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; Janelle ME, 2002, J BIOL CHEM, V277, P30665, DOI 10.1074/jbc.M203041200; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; JONES DA, 1993, J BIOL CHEM, V268, P9049; Kawamori T, 1998, CANCER RES, V58, P409; Kelly WK, 2003, CLIN CANCER RES, V9, P3578; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; MARSH KA, 1993, J PATHOL, V170, P441, DOI 10.1002/path.1711700407; Mestre JR, 1997, CANCER RES, V57, P2890; MOTOKURA T, 1993, CURR OPIN GENET DEV, V3, P5, DOI 10.1016/S0959-437X(05)80334-X; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Qiu L, 1999, BRIT J CANCER, V80, P1252, DOI 10.1038/sj.bjc.6690493; Rascle A, 2003, MOL CELL BIOL, V23, P4162, DOI 10.1128/MCB.23.12.4162-4173.2003; Sacks PG, 1996, CANCER METAST REV, V15, P27, DOI 10.1007/BF00049486; SACKS PG, 1988, CANCER RES, V48, P2858; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Sakamoto S, 2004, J BIOL CHEM, V279, P40362, DOI 10.1074/jbc.M406400200; Sawaoka H, 1998, AM J PHYSIOL-GASTR L, V274, pG1061, DOI 10.1152/ajpgi.1998.274.6.G1061; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; SMITH WL, 1995, SEMIN NEPHROL, V15, P179; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Subbaramaiah K, 2002, CANCER RES, V62, P2522; Subbaramaiah K, 2002, J BIOL CHEM, V277, P18649, DOI 10.1074/jbc.M111415200; Subbaramaiah K, 1996, CANCER RES, V56, P4424; Tanaka H, 1996, INT J CANCER, V65, P372, DOI 10.1002/(SICI)1097-0215(19960126)65:3<372::AID-IJC16>3.3.CO;2-3; Tiano HF, 2002, CANCER RES, V62, P3395; Tong X, 2005, J BIOL CHEM, V280, P15503, DOI 10.1074/jbc.M411978200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VanLint C, 1996, GENE EXPRESSION, V5, P245; Vries RGJ, 2001, EMBO J, V20, P6095, DOI 10.1093/emboj/20.21.6095; Wei P, 1998, MOL ENDOCRINOL, V12, P1322, DOI 10.1210/me.12.9.1322; Weiss C, 2004, CELL CYCLE, V3, P111	61	73	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32569	32577		10.1074/jbc.M503201200	http://dx.doi.org/10.1074/jbc.M503201200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	15994313	hybrid			2022-12-27	WOS:000231920300003
J	Sjoberg, A; Onnerfjord, P; Morgelin, M; Heinegard, D; Blom, AM				Sjoberg, A; Onnerfjord, P; Morgelin, M; Heinegard, D; Blom, AM			The extracellular matrix and inflammation - Fibromodulin activates the classical pathway of complement by directly binding C1q	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-INDUCED ARTHRITIS; SHORT CONSENSUS REPEAT; C-REACTIVE PROTEIN; FACTOR-H; ALTERNATIVE PATHWAY; MONOCLONAL-ANTIBODY; ELECTRON-MICROSCOPY; 1ST COMPONENT; ALPHA-CHAIN; SITE	Components that propagate inflammation in joint disease may be derived from cartilage since the inflammation resolves after joint replacement. We found that the cartilage component fibromodulin has the ability to activate an inflammatory cascade, i.e. complement. Fibromodulin and immunoglobulins cause comparable deposition of C1q, C4b, and C3b from human serum. Using C1q and factor B-deficient sera in combination with varying contents of metal ions, we established that fibromodulin activates both the classical and the alternative pathways of complement. Further studies revealed that fibromodulin binds directly to the globular heads of C1q, leading to activation of C1. However, deposition of the membrane attack complex and C5a release were lower in the presence of fibromodulin as compared with IgG. This can be explained by the fact that fibromodulin also binds complement inhibitor factor H. Factor H and C1q bind to non-overlapping sites on fibromodulin, but none of the interactions is mediated by the negatively charged keratan sulfate substituents of fibromodulin. C1q but not factor H binds to an N-terminal fragment of fibromodulin previously implicated to be affected in cartilage stimulated with the inflammatory cytokine interleukin 1. Taken together our observations indicate fibromodulin as one factor involved in the sustained inflammation of the joint.	Lund Univ, Div Cell & Matrix Biol, Dept Expt Med Sci, BMC, SE-22184 Lund, Sweden; Malmo Univ Hosp, Dept Lab Med, SE-22184 Lund, Sweden	Lund University; Lund University; Skane University Hospital	Heinegard, D (corresponding author), Lund Univ, Div Cell & Matrix Biol, Dept Expt Med Sci, BMC, BMC Plan C12, SE-22184 Lund, Sweden.	dick.heinegard@med.lu.se	Blom, Anna/B-9607-2009; Onnerfjord, Patrik/R-3131-2019; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; Onnerfjord, Patrik/0000-0002-2345-2937; 				ANTONOPOULOS CA, 1969, ACTA CHEM SCAND, V23, P2616, DOI 10.3891/acta.chem.scand.23-2616; ANTONSSON P, 1991, J BIOL CHEM, V266, P16859; BASCHONG W, 1985, HISTOCHEMISTRY, V83, P409, DOI 10.1007/BF00509201; BING DH, 1982, P NATL ACAD SCI-BIOL, V79, P4198, DOI 10.1073/pnas.79.13.4198; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blom AM, 2003, J BIOL CHEM, V278, P43437, DOI 10.1074/jbc.M306620200; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; BOHNSACK JF, 1985, P NATL ACAD SCI USA, V82, P3824, DOI 10.1073/pnas.82.11.3824; Bradley K, 1996, IMMUNOLOGY, V88, P648; CROCKARD AD, 1992, CLIN IMMUNOL IMMUNOP, V65, P135, DOI 10.1016/0090-1229(92)90216-B; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Gewurz H, 1993, BEHRING I MITT, P138; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; Heathfield TF, 2004, J BIOL CHEM, V279, P6286, DOI 10.1074/jbc.M307765200; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HEDLUND H, 1994, MATRIX BIOL, V14, P227, DOI 10.1016/0945-053X(94)90186-4; HEINEGARD D, 1986, J BIOL CHEM, V261, P3866; Heinegard D., 2002, CONNECTIVE TISSUE IT, P271; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Hietala MA, 2004, EUR J IMMUNOL, V34, P1208, DOI 10.1002/eji.200424895; HOEKZEMA R, 1988, MOL IMMUNOL, V25, P485, DOI 10.1016/0161-5890(88)90169-1; Jarva H, 1999, J IMMUNOL, V163, P3957; Kemp P A, 1992, J Clin Lab Immunol, V37, P147; Kohl J, 2001, MOL IMMUNOL, V38, P175, DOI 10.1016/S0161-5890(01)00041-4; KRUMDIECK R, 1992, J IMMUNOL, V149, P3695; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; MERI S, 1994, BIOCHEM BIOPH RES CO, V198, P52, DOI 10.1006/bbrc.1994.1008; MORGAN BP, 1991, IMMUNOL TODAY, V12, P301, DOI 10.1016/0167-5699(91)90003-C; MORGAN BP, 1995, CRIT REV CL LAB SCI, V32, P265, DOI 10.3109/10408369509084686; Nadesalingam J, 2003, J BIOL CHEM, V278, P25678, DOI 10.1074/jbc.M210186200; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Onuma H, 2002, RHEUMATOL INT, V22, P52, DOI 10.1007/s00296-002-0199-6; PAQUES EP, 1979, H-S Z PHYSIOL CHEM, V360, P177, DOI 10.1515/bchm2.1979.360.1.177; PILLEMER L, 1954, SCIENCE, V120, P279, DOI 10.1126/science.120.3112.279; REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; Smith BO, 2002, CELL, V108, P769, DOI 10.1016/S0092-8674(02)00672-4; SORVILLO J, 1985, BIOCHEM J, V226, P207, DOI 10.1042/bj2260207; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; TENNER AJ, 1981, J IMMUNOL, V127, P648; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8955, DOI 10.1073/pnas.92.19.8955; Wang Y, 2000, J IMMUNOL, V164, P4340, DOI 10.4049/jimmunol.164.8.4340	46	141	142	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32301	32308		10.1074/jbc.M504828200	http://dx.doi.org/10.1074/jbc.M504828200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16046396	hybrid			2022-12-27	WOS:000231794800033
J	Imtiyaz, HZ; Zhang, YH; Zhang, JK				Imtiyaz, HZ; Zhang, YH; Zhang, JK			Structural requirements for signal-induced target binding of FADD determined by functional reconstitution of FADD deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; DEATH DOMAIN; TNF RECEPTOR; CELL-DEATH; INDUCED APOPTOSIS; MICE LACKING; MEDIATED APOPTOSIS; CD95 FAS/APO-1; FAS; PROTEIN	FADD is a key adaptor modulating several signaling pathways such as apoptosis induced by Fas (CD95) and tumor necrosis factor receptor 1, and cell proliferation induced by mitogens. Whereas mutations in Fas disrupt its binding to FADD and cause autoimmune lymphoproliferative (lpr) syndromes, a FADD deficiency blocks embryonic development in mice. To delineate the multifunction of FADD in vivo, we performed functional reconstitution analysis by introducing wild type and mutant FADD into FADD(-/-) cells or FADD(-/-) mice lacking the endogenous FADD. An lpr-like FADD mutant, V121N, was reported previously as being defective in Fas binding in vitro. However, we found that in mice V121N can bind to Fas and is functional in signaling apoptosis. Unexpectedly, this lpr-like mutant FADD failed to support mouse development, indicating that the death domain of FADD has an additional function required for embryogenesis, which is independent of that required for receptor-induced apoptosis. Further mutagenesis was targeted at charged residues in the FADD death domain, presumably mediating electrostatic interactions with Fas. We showed that the target binding and apoptosis signaling functions of FADD were not affected when mutations were introduced to a majority of the charged residues. In one exception, replacing arginine 117 with an uncharged residue disrupted target binding and apoptosis signaling, but restoring the positive charge at position 117 failed to reconstitute the FADD function. Therefore, in vivo target binding of FADD involves an additional mechanism distinct from electrostatic interaction.	Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Zhang, JK (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, 233 S 10th St,Rm 731 BLSB, Philadelphia, PA 19107 USA.	jzhang@mail.jci.tju.edu		Zhang, Yuhang/0000-0002-9738-5343; Zhang, Jianke/0000-0002-5822-2226	NATIONAL CANCER INSTITUTE [R01CA095454] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA95454] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; CHINNAIYAN AM, 1995, CELL, V81, P512; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Eberstadt M, 1997, NAT STRUCT BIOL, V4, P983, DOI 10.1038/nsb1297-983; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; Hill JM, 2004, J BIOL CHEM, V279, P1474, DOI 10.1074/jbc.M304996200; HOFMANN K, 1995, FEBS LETT, V371, P321, DOI 10.1016/0014-5793(95)00931-X; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; ITOH N, 1993, J BIOL CHEM, V268, P10932; Jeong EJ, 1999, J BIOL CHEM, V274, P16337, DOI 10.1074/jbc.274.23.16337; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Kabra NH, 2001, P NATL ACAD SCI USA, V98, P6307, DOI 10.1073/pnas.111158698; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; Matsumura H, 2000, J CELL BIOL, V151, P1247, DOI 10.1083/jcb.151.6.1247; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; RATHMELL JC, 2002, CELL S, V109, P97; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Sprick MR, 2004, BBA-MOL CELL RES, V1644, P125, DOI 10.1016/j.bbamcr.2003.11.002; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; WATANABEFUKUNAG.R, 1992, NATURE, V356, P317; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhou T, 1996, J IMMUNOL, V156, P2661	47	19	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31360	31367		10.1074/jbc.M504138200	http://dx.doi.org/10.1074/jbc.M504138200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16009710	hybrid			2022-12-27	WOS:000231665200005
J	McBride, AE; Cook, JT; Stemmler, EA; Rutledge, KL; McGrath, KA; Rubens, JA				McBride, AE; Cook, JT; Stemmler, EA; Rutledge, KL; McGrath, KA; Rubens, JA			Arginine methylation of yeast mRNA-binding protein Npl3 directly affects its function, nuclear export, and intranuclear protein interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORM MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; POLYMERASE-II; 3'-END FORMATION; METHYLTRANSFERASE; RESIDUES; COMPLEX; TRANSCRIPTION; PEPTIDES; IDENTIFICATION	Arginine methylation can affect both nucleocytoplasmic transport and protein-protein interactions of RNA-binding proteins. These effects are seen in cells that lack the yeast hnRNP methyltransferase (HMT1), raising the question of whether effects on specific proteins are direct or indirect. The presence of multiple arginines in individual methylated proteins also raises the question of whether overall methylation or methylation of a subset of arginines affects protein function. We have used the yeast mRNA-binding protein Npl3 to address these questions in vivo. Matrix-assisted laser desorption/ionization Fourier transform mass spectrometry was used to identify 17 methylated arginines in Npl3 purified from yeast: whereas 10 Arg-Gly-Gly (RGG) tripeptides were exclusively dimethylated, variable levels of methylation were found for 5 RGG and 2 RG motif arginines. We constructed a set of Npl3 proteins in which subsets of the RGG arginines were mutated to lysine. Expression of these mutant proteins as the sole form of Npl3 specifically affected growth of a strain that requires Hmt1. Although decreased growth generally correlated with increased numbers of Arg-to-Lys mutations, lysine substitutions in the N terminus of the RGG domain showed more severe effects. Npl3 with all 15 RGG arginines mutated to lysine exited the nucleus independent of Hmt1, indicating a direct effect of methylation on Npl3 transport. These mutations also resulted in a decreased, methylation-independent interaction of Npl3 with transcription elongation factor Tho2 and inhibited Npl3 self-association. These results support a model in which arginine methylation facilitates Npl3 export directly by weakening contacts with nuclear proteins.	Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA; Bowdoin Coll, Dept Chem, Brunswick, ME 04011 USA	Bowdoin College; Bowdoin College	McBride, AE (corresponding author), Bowdoin Coll, Dept Biol, 6500 Coll Stn, Brunswick, ME 04011 USA.	amcbride@bowdoin.edu						Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; BOFFA LC, 1977, BIOCHEM BIOPH RES CO, V74, P969, DOI 10.1016/0006-291X(77)91613-8; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; BOISVERT FM, 2005, SCI STKE, pRE2, DOI DOI 10.1126/STKE.2712005RE2; BOSSIE MA, 1992, MOL BIOL CELL, V3, P875, DOI 10.1091/mbc.3.8.875; Brame CJ, 2004, RAPID COMMUN MASS SP, V18, P877, DOI 10.1002/rcm.1421; Bucheli ME, 2005, EMBO J, V24, P2150, DOI 10.1038/sj.emboj.7600687; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Denman RB, 2002, CELL MOL BIOL LETT, V7, P877; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; FLACH J, 1994, MOL CELL BIOL, V14, P8399, DOI 10.1128/MCB.14.12.8399; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gehrig PM, 2004, J AM SOC MASS SPECTR, V15, P142, DOI 10.1016/j.jasms.2003.10.002; Gilbert W, 2001, RNA, V7, P302, DOI 10.1017/S1355838201002369; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Henry M, 1996, GENETICS, V142, P103; Henry MF, 1996, MOL CELL BIOL, V16, P3668; Hurt E, 2004, P NATL ACAD SCI USA, V101, P1858, DOI 10.1073/pnas.0308663100; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Lee JH, 2000, BIOCHEM BIOPH RES CO, V274, P105, DOI 10.1006/bbrc.2000.3049; Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233; Lee YH, 2005, P NATL ACAD SCI USA, V102, P3611, DOI 10.1073/pnas.0407159102; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Marfatia KA, 2003, J BIOL CHEM, V278, P6731, DOI 10.1074/jbc.M207571200; Marshall AG, 1998, MASS SPECTROM REV, V17, P1, DOI 10.1002/(SICI)1098-2787(1998)17:1<1::AID-MAS1>3.0.CO;2-K; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; Nichols RC, 2000, EXP CELL RES, V256, P522, DOI 10.1006/excr.2000.4827; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; O'Connor PB, 2000, ANAL CHEM, V72, P5881, DOI 10.1021/ac000770t; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Pellar GJ, 2003, CHROMOSOMA, V111, P461, DOI 10.1007/s00412-003-0231-y; Pritzker LB, 2000, BIOCHEMISTRY-US, V39, P5382, DOI 10.1021/bi9925571; QIN J, 1995, J AM CHEM SOC, V117, P5411, DOI 10.1021/ja00124a045; RAJPUROHIT R, 1994, BIOCHEM J, V304, P903, DOI 10.1042/bj3040903; Raman B, 2001, NUCLEIC ACIDS RES, V29, P3377, DOI 10.1093/nar/29.16.3377; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; Rose MD., 1990, METHODS YEAST GENETI; Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196; Shen EC, 2000, J BIOL CHEM, V275, P23718, DOI 10.1074/jbc.M002312200; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Siebel CW, 1996, P NATL ACAD SCI USA, V93, P13641, DOI 10.1073/pnas.93.24.13641; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P159; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; Stemmler EA, 2005, ANAL CHEM, V77, P3594, DOI 10.1021/ac0502347; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Tsaprailis G, 2000, INT J MASS SPECTROM, V195, P467, DOI 10.1016/S1387-3806(99)00221-3; Valentini SR, 1999, RNA, V5, P272, DOI 10.1017/S1355838299981633; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Windgassen M, 2004, MOL CELL BIOL, V24, P10479, DOI 10.1128/MCB.24.23.10479-10491.2004; Xu C, 2004, MOL CELL BIOL, V24, P10742, DOI 10.1128/MCB.24.24.10742-10756.2004; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707	63	87	87	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30888	30898		10.1074/jbc.M505831200	http://dx.doi.org/10.1074/jbc.M505831200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15998636	hybrid			2022-12-27	WOS:000231487800030
J	Morosinotto, T; Ballottari, M; Klimmek, F; Jansson, S; Bassi, R				Morosinotto, T; Ballottari, M; Klimmek, F; Jansson, S; Bassi, R			The association of the antenna system to photosystem I in higher plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; CHLAMYDOMONAS-REINHARDTII; PHOTOSYNTHETIC APPARATUS; ARABIDOPSIS-THALIANA; ANGSTROM RESOLUTION; PROTEIN-COMPOSITION; LHCA PROTEINS; PS II; ORGANIZATION; SUPERCOMPLEX	We report on the association of the antenna system to the reaction center in Photosystem I. Biochemical analysis of mutants depleted in antenna polypeptides showed that the binding of the antenna moiety is strongly cooperative. The minimal building block for the antenna system was shown to be a dimer. Specific protein- protein interactions play an important role in antenna association, and the gap pigments, bound at the interface between core and antenna, are proposed to mediate these interactions Gap pigments have been characterized by comparing the spectra of the Photosystem I to those of the isolated antenna and core components. CD spectroscopy showed that they are involved in pigment- pigment interactions, supporting their relevance in energy transfer from antenna to the reaction center. Moreover, gap pigments contribute to the redshifted emission forms of Photosystem I antenna. When compared with Photosystem II, the association of peripheral antenna complexes in PSI appears to be more stable, but far less flexible and functional implications are discussed.	Univ Verona, Dipartimento Sci & Tecnol, I-37134 Verona, Italy; Univ Aix Marseille 2, LGBP, Fac Sci Luminy, Dept Biol, F-13288 Marseille, France; Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden	University of Verona; UDICE-French Research Universities; Aix-Marseille Universite; Umea University	Bassi, R (corresponding author), Univ Verona, Dipartimento Sci & Tecnol, Str Grazie 15, I-37134 Verona, Italy.	bassi@sci.univr.it	Morosinotto, Tomas/AAC-3188-2019; Jansson, Stefan/A-1119-2009; Ballottari, Matteo/N-1916-2019	Morosinotto, Tomas/0000-0002-0803-7591; Jansson, Stefan/0000-0002-7906-6891; Ballottari, Matteo/0000-0001-8410-3397; bassi, roberto/0000-0002-4140-8446				BALL EH, 1986, ANAL BIOCHEM, V155, P23, DOI 10.1016/0003-2697(86)90218-6; Ballottari M, 2004, EUR J BIOCHEM, V271, P4659, DOI 10.1111/j.1432-1033.2004.04426.x; BASSI R, 1992, J BIOL CHEM, V267, P25714; BASSI R, 1987, EUR J BIOCHEM, V163, P221, DOI 10.1111/j.1432-1033.1987.tb10791.x; Ben-Shem A, 2004, PHOTOSYNTH RES, V81, P239, DOI 10.1023/B:PRES.0000036881.23512.42; Ben-Shem A, 2004, FEBS LETT, V564, P274, DOI 10.1016/S0014-5793(04)00360-6; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Boekema EJ, 2001, BIOCHEMISTRY-US, V40, P1029, DOI 10.1021/bi0015358; Bossmann B, 1997, PHOTOSYNTH RES, V52, P127, DOI 10.1023/A:1005823711838; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; Croce R, 1996, BIOCHEMISTRY-US, V35, P8572, DOI 10.1021/bi960214m; Croce R, 1998, BIOCHEMISTRY-US, V37, P17355, DOI 10.1021/bi9813227; Croce R, 2002, BBA-BIOENERGETICS, V1556, P29, DOI 10.1016/S0005-2728(02)00304-3; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Elrad D, 2004, CURR GENET, V45, P61, DOI 10.1007/s00294-003-0460-x; Ganeteg U, 2004, PLANT MOL BIOL, V54, P641, DOI 10.1023/B:PLAN.0000040813.05224.94; Ganeteg U, 2004, PLANT PHYSIOL, V134, P502, DOI 10.1104/pp.103.033324; Ganeteg U, 2001, PLANT PHYSIOL, V127, P150, DOI 10.1104/pp.127.1.150; Germano M, 2002, FEBS LETT, V525, P121, DOI 10.1016/S0014-5793(02)03100-9; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Haldrup A, 1999, PLANT J, V17, P689, DOI 10.1046/j.1365-313X.1999.00419.x; HAWORTH P, 1983, BIOCHIM BIOPHYS ACTA, V724, P151, DOI 10.1016/0005-2728(83)90036-1; Ihalainen JA, 2000, BIOCHEMISTRY-US, V39, P8625, DOI 10.1021/bi0007369; Jansson S, 1996, PLANT PHYSIOL, V112, P409, DOI 10.1104/pp.112.1.409; Jansson S, 1997, BBA-BIOENERGETICS, V1320, P297, DOI 10.1016/S0005-2728(97)00033-9; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kargul J, 2003, J BIOL CHEM, V278, P16135, DOI 10.1074/jbc.M300262200; Klimmek F, 2005, BIOCHEMISTRY-US, V44, P3065, DOI 10.1021/bi047873g; Knoetzel H, 2002, FEBS LETT, V510, P145, DOI 10.1016/S0014-5793(01)03253-7; Krauss N, 1996, NAT STRUCT BIOL, V3, P965, DOI 10.1038/nsb1196-965; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM E, 1984, FEBS LETT, V168, P10, DOI 10.1016/0014-5793(84)80197-0; MALKIN R, 1985, PHYSIOL VEG, V23, P619; Morosinotto T, 2003, J BIOL CHEM, V278, P49223, DOI 10.1074/jbc.M309203200; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; NAGAI K, 1987, METHOD ENZYMOL, V153, P461; PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x; PETER GF, 1991, J BIOL CHEM, V266, P16745; Ruban AV, 2003, NATURE, V421, P648, DOI 10.1038/nature01344; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Schmid VHR, 1997, P NATL ACAD SCI USA, V94, P7667, DOI 10.1073/pnas.94.14.7667; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; Storf S, 2004, BIOCHEMISTRY-US, V43, P9214, DOI 10.1021/bi0498196; Takahashi Y, 2004, BIOCHEMISTRY-US, V43, P7816, DOI 10.1021/bi035988z; Tokutsu R, 2004, PLANT CELL PHYSIOL, V45, P138, DOI 10.1093/pcp/pch013; Van Amerongen H, 2000, PHOTOSYNTHERIC EXCIT; WALTERS RG, 1994, PLANTA, V195, P248, DOI 10.1007/BF00199685; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Zhang H, 1997, PLANT PHYSIOL, V115, P1525, DOI 10.1104/pp.115.4.1525	51	38	40	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31050	31058		10.1074/jbc.M502935200	http://dx.doi.org/10.1074/jbc.M502935200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15983042	hybrid			2022-12-27	WOS:000231487800049
J	Berteaux, N; Lottin, V; Monte, D; Pinte, S; Quatannens, B; Coll, J; Hondermarck, H; Curgy, JJ; Dugimont, T; Adriaenssens, E				Berteaux, N; Lottin, V; Monte, D; Pinte, S; Quatannens, B; Coll, J; Hondermarck, H; Curgy, JJ; Dugimont, T; Adriaenssens, E			H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; IMPRINTED H19; TRANSCRIPTION FACTOR; THIOREDOXIN; OVEREXPRESSION; ACTIVATION; FAMILY; IGF2; TUMORIGENICITY; IDENTIFICATION	The imprinted H19 gene has riboregulatory functions. We show here that H19 transcription is up-regulated during the S-phase of growth-stimulated cells and that the H19 promoter is activated by E2F1 in breast cancer cells. H19 repression by pRb and E2F6 confirms the E2F1-dependent control of the H19 promoter. Consistently, we demonstrate by chromatin immunoprecipitation assays that endogenous E2F1 is recruited to the H19 promoter in vivo. The functionality of E2F promoter sites was further confirmed by gel shift and mutagenesis experiments, revealing that these sites are required for binding and promoter response to E2F1 exogenous expression and serum stimulation. Furthermore, we show that H19 overexpression confers a growth advantage on breast cancer cells released from growth arrest as well as in asynchronously growing cells. The H19 knockdown by small interfering RNA duplexes impedes S-phase entry in both wild-type and stably H19-transfected cells. Based on these findings, we conclude that the H19 RNA is actively linked to E2F1 to promote cell cycle progression of breast cancer cells. This clearly supports the H19 oncogenic function in breast tumor genesis.	USTL, INSERM, ERI8, UPRES EA 1033,IFR 118, F-59655 Villeneuve Dascq, France; Inst Pasteur, CNRS, UMR 8117, F-59019 Lille, France; Inst Pasteur, CNRS, UMR 8526, F-59019 Lille, France; Inst Pasteur, CNRS, UMR 8527, IBL, F-59019 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Curgy, JJ (corresponding author), USTL, INSERM, ERI8, UPRES EA 1033,IFR 118, SN3, F-59655 Villeneuve Dascq, France.	curgy@univ-lille1.fr		monte, didier/0000-0002-0613-6203				Adriaenssens E, 1998, AM J PATHOL, V153, P1597, DOI 10.1016/S0002-9440(10)65748-3; Adriaenssens E, 2002, EXP CELL RES, V275, P215, DOI 10.1006/excr.2002.5500; Adriaenssens E, 1999, ONCOGENE, V18, P4460, DOI 10.1038/sj.onc.1202819; ARIEL I, 1995, UROLOGY, V45, P335, DOI 10.1016/0090-4295(95)80030-1; Ariel I, 2000, AM J MED GENET, V91, P46, DOI 10.1002/(SICI)1096-8628(20000306)91:1<46::AID-AJMG8>3.0.CO;2-I; Ayesh S, 2002, MOL CARCINOGEN, V35, P63, DOI 10.1002/mc.10075; Berggren M, 1996, ANTICANCER RES, V16, P3459; Blais A, 2002, J BIOL CHEM, V277, P31679, DOI 10.1074/jbc.M204554200; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; Cartwright P, 1998, ONCOGENE, V17, P611, DOI 10.1038/sj.onc.1201975; Conner EA, 2000, ONCOGENE, V19, P5054, DOI 10.1038/sj.onc.1203885; Cooper MJ, 1996, J UROLOGY, V155, P2120, DOI 10.1016/S0022-5347(01)66120-2; DOUCRASY S, 1993, INT J ONCOL, V2, P753; Dugimont T, 1998, ONCOGENE, V16, P2395, DOI 10.1038/sj.onc.1201742; Dugimont T, 1995, BIOL CELL, V85, P117, DOI 10.1016/0248-4900(96)85272-5; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; DYSON N, 1994, J CELL SCI, P81; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ELKIN M, 1995, FEBS LETT, V374, P57, DOI 10.1016/0014-5793(95)01074-O; Fry CJ, 1999, J BIOL CHEM, V274, P15883, DOI 10.1074/jbc.274.22.15883; Gallegos A, 1996, CANCER RES, V56, P5765; GASDASKA JR, 1995, CELL GROWTH DIFFER, V6, P1643; GELMANN EP, 1992, INT J CANCER, V50, P665, DOI 10.1002/ijc.2910500431; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; Hibi K, 1996, CANCER RES, V56, P480; IKEDA MA, 1993, MOL CELL BIOL, V13, P7029, DOI 10.1128/MCB.13.11.7029; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Joubel A, 1996, CELL MOL BIOL, V42, P1159; Juan V, 2000, NUCLEIC ACIDS RES, V28, P1221, DOI 10.1093/nar/28.5.1221; KASID A, 1987, CANCER RES, V47, P5733; KONDO M, 1995, ONCOGENE, V10, P1193; Kopf E, 1998, FEBS LETT, V432, P123, DOI 10.1016/S0014-5793(98)00841-2; Li YM, 1998, J BIOL CHEM, V273, P28247, DOI 10.1074/jbc.273.43.28247; Lottin S, 2003, RRD HUM PAT, V1, P9; Lottin S, 2002, ONCOGENE, V21, P1625, DOI 10.1038/sj.onc.1205233; Lottin S, 2002, CARCINOGENESIS, V23, P1885, DOI 10.1093/carcin/23.11.1885; Ma YH, 2003, MOL CANCER THER, V2, P73; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Okamoto K, 1997, P NATL ACAD SCI USA, V94, P5367, DOI 10.1073/pnas.94.10.5367; OTHANI K, 1999, FRONT BIOSCI, V4, P793; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; PACHNIS V, 1984, P NATL ACAD SCI-BIOL, V81, P5523, DOI 10.1073/pnas.81.17.5523; PEEPER DS, 1993, MOL BIOL REP, V17, P197, DOI 10.1007/BF00986728; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierce AM, 1998, ONCOGENE, V16, P1267, DOI 10.1038/sj.onc.1201666; RACHMILEWITZ J, 1995, ONCOGENE, V11, P863; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Scrable H J, 1990, Adv Cancer Res, V54, P25, DOI 10.1016/S0065-230X(08)60807-6; Sears R, 1997, MOL CELL BIOL, V17, P5227, DOI 10.1128/MCB.17.9.5227; Sorensen TS, 1996, MOL CELL BIOL, V16, P5888; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Takahashi Y, 2000, GENE DEV, V14, P804; Takaishi S, 2003, DIGEST DIS SCI, V48, P379, DOI 10.1023/A:1021952132241; Tevosian SG, 1996, CELL GROWTH DIFFER, V7, P43; Trimarchi JM, 1998, P NATL ACAD SCI USA, V95, P2850, DOI 10.1073/pnas.95.6.2850; Vigo E, 1999, MOL CELL BIOL, V19, P6379; VOUTILAINEN R, 1994, ENDOCRINOLOGY, V134, P2051, DOI 10.1210/en.134.5.2051; Wang A, 2000, J BIOL CHEM, V275, P4532, DOI 10.1074/jbc.275.6.4532; Wilkin F, 2000, EUR J BIOCHEM, V267, P4020, DOI 10.1046/j.1432-1327.2000.01438.x; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40; Zwicker J, 1997, TRENDS GENET, V13, P3, DOI 10.1016/S0168-9525(96)30112-1	67	293	320	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2005	280	33					29625	29636		10.1074/jbc.M504033200	http://dx.doi.org/10.1074/jbc.M504033200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	954SX	15985428	hybrid			2022-12-27	WOS:000231176200031
J	Nogales, J; Canales, A; Jimenez-Barbero, J; Garcia, JL; Diaz, E				Nogales, J; Canales, A; Jimenez-Barbero, J; Garcia, JL; Diaz, E			Molecular characterization of the gallate dioxygenase from Pseudomonas putida KT2440 - The prototype of a new subgroup of extradiol dioxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOMONAS-PAUCIMOBILIS SYK-6; PSEUDOMONAS-PUTIDA KT2440; ESCHERICHIA-COLI; PROTOCATECHUATE 4,5-DIOXYGENASE; 2-AMINOPHENOL 1,6-DIOXYGENASE; BIOCHEMICAL-PROPERTIES; CATABOLIC PATHWAYS; CLONING VECTORS; PURIFICATION; DEGRADATION	In this work we have characterized the galA gene product from Pseudomonas putida KT2440, a ring- cleavage dioxygenase that acts specifically on gallate to produce 4- oxalomesaconate. The protein is a trimer composed by three identical subunits of 47.6 kDa ( 419 amino acids) that uses Fe2+ as the main cofactor. The gallate dioxygenase showed maximum activity at pH 7.0, and the K-m and V-max values for gallate were 144 mu M and 53.2 mu mol/ min/ mg of protein, respectively. A phylogenetic study suggests that the gallate dioxygenase from P. putida KT2440 is the prototype of a new subgroup of type II extradiol dioxygenases that share a common ancestor with protocatechuate 4,5- dioxygenases and whose two- domain architecture might have evolved from the fusion of the large and small subunits of the latter. A three- dimensional model for the N- terminal domain ( residues 1 - 281) and C- terminal domain ( residues 294 - 420) of the gallate dioxygenase from P. putida KT2440 was generated by comparison with the crystal structures of the large ( LigB) and small ( LigA) subunits of the protocatechuate 4,5- dioxygenase from Sphingomonas paucimobilis SYK- 6. The expression of the galA gene was specifically induced when P. putida KT2440 cells grew in the presence of gallate. A P. putida KT2440 galA mutant strain was unable to use gallate as the sole carbon source and it did not show gallate dioxygenase activity, suggesting that the GalA protein is the only dioxygenase involved in gallate cleavage in this bacterium. This work points to the existence of a new pathway that is devoted to the catabolism of gallic acid and that remained unknown in the paradigmatic P. putida KT2440 strain.	CSIC, Ctr Invest Biol, Dept Mol Microbiol, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Diaz, E (corresponding author), CSIC, Ctr Invest Biol, Dept Mol Microbiol, Ramiro Maeztu 9, Madrid 28040, Spain.	ediaz@cib.csic.es	Canales, Angeles/K-7499-2015; JIMENEZ-BARBERO, JESUS/D-4431-2014; Nogales, Juan/Y-8829-2019; Garcia Lopez, Jose Luis/G-9139-2015; Diaz, Eduardo/F-8605-2016	Canales, Angeles/0000-0003-0542-3080; JIMENEZ-BARBERO, JESUS/0000-0001-5421-8513; Garcia Lopez, Jose Luis/0000-0002-9238-2485; Nogales, Juan/0000-0002-4961-0833; Diaz, Eduardo/0000-0002-9731-6524				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DeLano W.L, PYMOL MOL GRAPHICS S; DeLong EF, 2004, ENVIRON MICROBIOL, V6, P875, DOI 10.1111/j.1462-2920.2004.00668.x; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; dos Santos VAPM, 2004, ENVIRON MICROBIOL, V6, P1264, DOI 10.1111/j.1462-2920.2004.00734.x; Eaton RW, 2001, J BACTERIOL, V183, P3689, DOI 10.1128/JB.183.12.3689-3703.2001; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; Hara H, 2000, J BACTERIOL, V182, P6950, DOI 10.1128/JB.182.24.6950-6957.2000; JAMALUDDIN MP, 1977, J BACTERIOL, V129, P690, DOI 10.1128/JB.129.2.690-697.1977; Jimenez JI, 2004, PSEUDOMONAS, VOL 3: BIOSYNTHESIS OF MACROMOLECULES AND MOLECULAR METABOLISM, P425; Jimenez JI, 2002, ENVIRON MICROBIOL, V4, P824, DOI 10.1046/j.1462-2920.2002.00370.x; Kasai D, 2004, J BACTERIOL, V186, P4951, DOI 10.1128/JB.186.15.4951-4959.2004; KERSTEN PJ, 1982, J BACTERIOL, V152, P1154; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEE YLT, 1977, J BACTERIOL, V131, P1016, DOI 10.1128/JB.131.3.1016-1017.1977; Maruyama K, 2004, BIOSCI BIOTECH BIOCH, V68, P1434, DOI 10.1271/bbb.68.1434; MARUYAMA K, 1983, J BIOCHEM, V93, P557, DOI 10.1093/oxfordjournals.jbchem.a134210; Minton A.P., 1994, MODERN ANAL ULTRACEN, P81; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; NODA Y, 1990, J BACTERIOL, V172, P2704, DOI 10.1128/jb.172.5.2704-2709.1990; Peng X, 1998, APPL ENVIRON MICROB, V64, P2520; Providenti MA, 2001, MICROBIOL-SGM, V147, P2157, DOI 10.1099/00221287-147-8-2157; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTORO J, 1992, J MAGN RESON, V97, P202, DOI 10.1016/0022-2364(92)90250-B; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHMIDT SR, 1995, EUR J BIOCHEM, V228, P425, DOI 10.1111/j.1432-1033.1995.00425.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SPARNINS VL, 1975, J BACTERIOL, V124, P1374, DOI 10.1128/JB.124.3.1374-1381.1975; Speicher David W., 1994, Methods (Orlando), V6, P262, DOI 10.1006/meth.1994.1028; Spence EL, 1996, J BACTERIOL, V178, P5249, DOI 10.1128/jb.178.17.5249-5256.1996; Sugimoto K, 1999, STRUCTURE, V7, P953, DOI 10.1016/S0969-2126(99)80122-1; Takenaka S, 1997, J BIOL CHEM, V272, P14727, DOI 10.1074/jbc.272.23.14727; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaillancourt FH, 2004, PSEUDOMONAS, VOL 3: BIOSYNTHESIS OF MACROMOLECULES AND MOLECULAR METABOLISM, P359; Wackett LP, 2003, NAT BIOTECHNOL, V21, P136, DOI 10.1038/nbt0203-136; Wattiau P, 2001, RES MICROBIOL, V152, P861, DOI 10.1016/S0923-2508(01)01269-4; WOLGEL SA, 1993, J BACTERIOL, V175, P4414, DOI 10.1128/JB.175.14.4414-4426.1993; Wu JF, 2005, ARCH MICROBIOL, V183, P1, DOI 10.1007/s00203-004-0738-5; ZABINSKI R, 1972, BIOCHEMISTRY-US, V11, P3212, DOI 10.1021/bi00767a012	48	43	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2005	280	42					35382	35390		10.1074/jbc.M502585200	http://dx.doi.org/10.1074/jbc.M502585200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973ZN	16030014	hybrid, Green Published			2022-12-27	WOS:000232561200037
J	Gascon, S; Deogracias, R; Sobrado, M; Roda, JM; Renart, J; Rodriguez-Pena, A; Diaz-Guerra, M				Gascon, S; Deogracias, R; Sobrado, M; Roda, JM; Renart, J; Rodriguez-Pena, A; Diaz-Guerra, M			Transcription of the NR1 subunit of the N-methyl-D-aspartate receptor is down-regulated by excitotoxic stimulation and cerebral ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA RECEPTORS; CORTICAL-NEURONS; MESSENGER-RNA; RAT; EXPRESSION; TRAFFICKING; ACTIVATION; CALPAIN; GENE; CLEAVAGE	The N-methyl-D-aspartate (NMDA) type of glutamate receptor (NMDAR) plays central roles in normal and pathological neuronal functioning. We have examined the regulation of the NR1 subunit of the NMDAR in response to excessive activation of this receptor in in vitro and in vivo models of excitotoxicity. NR1 protein expression in cultured cortical neurons was specifically reduced by stimulation with 100 mu M NMDA or glutamate. NMDA decreased NR1 protein amounts by 71% after 8 h. Low NMDA concentrations (<= 10 mu M) had no effect. NR1 down-regulation was inhibited by the general NMDAR antagonist DL-AP5 and also by ifenprodil, which specifically antagonizes NMDARs containing NR2B subunits. Arrest of NMDAR signaling with DL-AP5 after brief exposure to NMDA did not prevent subsequent NR1 decrease. Down-regulation of NR1 did not involve calpain cleavage but resulted from a decrease in de novo synthesis consequence of reduced mRNA amounts. In contrast, NMDA did not alter the expression of NR2A mRNA or newly synthesized protein. In neurons transiently transfected with an NR1 promoter/luciferase reporter construct, promoter activity was reduced by 68% after 2 h of stimulation with NMDA, and its inhibition required extracellular calcium. A similar mechanism of autoregulation of the receptor probably operates during cerebral ischemia, because NR1 mRNA and protein were strongly decreased at early stages of blood reperfusion in the infarcted brains of rats subjected to occlusion of the middle cerebral artery. Because NR1 is the obligatory subunit of NMDARs, this regulatory mechanism will be fundamental to NMDAR functioning.	UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; Hosp La Paz, Unidad Invest Cerebrovasc, Madrid 28029, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Universitario La Paz	Diaz-Guerra, M (corresponding author), UAM, CSIC, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.	mdiazguerra@iib.uam.es	Deogracias, Ruben/I-5751-2015; Renart, Jaime/B-7661-2009; Díaz-Guerra, Margarita/F-3212-2018; SOBRADO, MONICA/B-4482-2017	Deogracias, Ruben/0000-0002-9279-7867; Renart, Jaime/0000-0001-6620-3706; Díaz-Guerra, Margarita/0000-0002-4478-0956; Rodriguez-Pena, Angeles/0000-0002-2515-4626; Gascon, Sergio/0000-0001-8756-7082				Adamec E, 1998, MOL BRAIN RES, V54, P35, DOI 10.1016/S0169-328X(97)00304-5; Awobuluyi M, 2003, J NEUROCHEM, V87, P1066, DOI 10.1046/j.1471-4159.2003.02048.x; Bai G, 2003, J NEUROCHEM, V86, P992, DOI 10.1046/j.1471-4159.2003.01922.x; BAI G, 1995, J BIOL CHEM, V270, P7737, DOI 10.1074/jbc.270.13.7737; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; BULLER AL, 1994, J NEUROSCI, V14, P5471; Calderone A, 2003, J NEUROSCI, V23, P2112; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Chazot PL, 1997, J NEUROCHEM, V68, P507; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Dong YN, 2004, J NEUROSCI, V24, P11035, DOI 10.1523/JNEUROSCI.3722-04.2004; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; ISHII T, 1993, J BIOL CHEM, V268, P2836; Kim JB, 2004, J NEUROCHEM, V89, P1271, DOI 10.1111/j.1471-4159.2004.02429.x; KOH JY, 1988, J NEUROSCI, V8, P2153, DOI 10.1523/jneurosci.08-06-02153.1988; Lau GC, 2004, J NEUROCHEM, V88, P564, DOI 10.1046/j.1471-4159.2003.02156.x; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; LIU TH, 1989, AM J PHYSIOL, V256, pH589, DOI 10.1152/ajpheart.1989.256.2.H589; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Prybylowski K, 2002, J NEUROSCI, V22, P8902; ROSE K, 1993, METHODS TOXICOLOGY, V1, P46; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tovar KR, 2002, NEURON, V34, P253; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Westbrook Gary L., 1994, Current Opinion in Neurobiology, V4, P337, DOI 10.1016/0959-4388(94)90094-9; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200	44	58	62	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					35018	35027		10.1074/jbc.M504108200	http://dx.doi.org/10.1074/jbc.M504108200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16049015	hybrid			2022-12-27	WOS:000232403900075
J	Chang, AN; Harada, K; Ackerman, MJ; Potter, JD				Chang, AN; Harada, K; Ackerman, MJ; Potter, JD			Functional consequences of hypertrophic and dilated cardiomyopathy-causing mutations in alpha-tropomyosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC-MUSCLE CONTRACTION; TROPONIN-T; THIN FILAMENT; ADENOSINE-TRIPHOSPHATASE; FORCE DEVELOPMENT; ESCHERICHIA-COLI; CA2+ REGULATION; COILED-COIL; MYOSIN; BINDING	To study the functional consequences of various cardiomyopathic mutations in human cardiac alpha-tropomyosin (Tm), a method of depletion/reconstitution of native Tm and troponin (Tn) complex (Tm-Tn) in cardiac myofibril preparations has been developed. The endogenous Tm-Tn complex was selectively removed from myofibrils and replaced with recombinant wild-type or mutant proteins. Successful depletion and reconstitution steps were verified by SDS-gel electrophoresis and by the loss and regain of Ca2+-dependent regulation of ATPase activity. Five Tm mutations were chosen for this study: the hypertrophic cardiomyopathy (HCM) mutations E62Q, E180G, and L185R and the dilated cardiomyopathy (DCM) mutations E40K and E54K. Through the use of this new depletion/ reconstitution method, the functional consequences of these mutations were determined utilizing myofibrillar ATPase measurements. The results of our studies showed that 1) depletion of > 80% of Tm-Tn from myofibrils resulted in a complete loss of the Ca2+-regulated ATPase activity and a significant loss in the maximal ATPase activity, 2) reconstitution of exogenous wild-type Tm-Tn resulted in complete regain in the calcium regulation and in the maximal ATPase activity, and 3) all HCM-associated Tm mutations increased the Ca2+ sensitivity of ATPase activity and all had decreased abilities to inhibit ATPase activity. In contrast, the DCM-associated mutations both decreased the Ca2+ sensitivity of ATPase activity and had no effect on the inhibition of ATPase activity. These findings have demonstrated that the mutations which cause HCM and DCM disrupt discrete mechanisms, which may culminate in the distinct cardiomyopathic phenotypes.	Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; Mayo Clin & Mayo Fdn, Mayo Clin Coll Med, Dept Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Mayo Clin Coll Med, Dept Pediat, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Mayo Clin Coll Med, Dept Mol Pharmacol, Rochester, MN 55905 USA	University of Miami; Mayo Clinic; Mayo Clinic; Mayo Clinic	Potter, JD (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave R-189, Miami, FL 33136 USA.	jdpotter@miami.edu			NHLBI NIH HHS [HL67415] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067415] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bing W, 2000, J MOL CELL CARDIOL, V32, P1489, DOI 10.1006/jmcc.2000.1182; Bing W, 1997, BIOCHEM BIOPH RES CO, V236, P760, DOI 10.1006/bbrc.1997.7045; Golitsina N, 1999, BIOCHEMISTRY-US, V38, P3850, DOI 10.1021/bi9950701; Golitsina N, 1997, BIOCHEMISTRY-US, V36, P4637, DOI 10.1021/bi962970y; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; Hilario E, 2004, EUR J BIOCHEM, V271, P4132, DOI 10.1111/j.1432-1033.2004.04351.x; HITCHCOCKDEGREGORI SE, 1987, J BIOL CHEM, V262, P9730; Jongbloed RJ, 2003, J AM COLL CARDIOL, V41, P981, DOI 10.1016/S0735-1097(02)03005-X; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; KENTISH JC, 1984, J PHYSIOL-LONDON, V352, P353, DOI 10.1113/jphysiol.1984.sp015296; Knollmann BC, 2001, J BIOL CHEM, V276, P10039, DOI 10.1074/jbc.M006745200; KOMINZ DR, 1969, ARCH BIOCHEM BIOPHYS, V129, P609, DOI 10.1016/0003-9861(69)90221-5; Kremneva E, 2004, BIOPHYS J, V87, P3922, DOI 10.1529/biophysj.104.048793; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Mestroni L, 1999, J AM COLL CARDIOL, V34, P181, DOI 10.1016/S0735-1097(99)00172-2; Michele DE, 2002, CIRC RES, V91, P255, DOI 10.1161/01.RES.0000027530.58419.82; MIZRA M, 2004, J MUSCLE RES CELL M, V25, P276; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Olson TM, 2001, J MOL CELL CARDIOL, V33, P723, DOI 10.1006/jmcc.2000.1339; PERRY SV, 1958, BIOCHEM J, V68, P5, DOI 10.1042/bj0680005; PERRY SV, 1966, BIOCHEM J, V99, pC1, DOI 10.1042/bj0990001C; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; Prabhakar R, 2001, J MOL CELL CARDIOL, V33, P1815, DOI 10.1006/jmcc.2001.1445; SCHAUB MC, 1967, BIOCHEM J, V104, P263, DOI 10.1042/bj1040263; SHENG ZL, 1992, J BIOL CHEM, V267, P25407; Singh A, 2003, BIOCHEMISTRY-US, V42, P14114, DOI 10.1021/bi0348462; SOLARO RJ, 1971, BIOCHIM BIOPHYS ACTA, V245, P259, DOI 10.1016/0005-2728(71)90033-8; Szczesna D, 1996, J BIOL CHEM, V271, P8381, DOI 10.1074/jbc.271.14.8381; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Szczesna-Cordary D, 2004, J BIOL CHEM, V279, P3535, DOI 10.1074/jbc.M307092200; Takahashi-Yanaga F, 2001, J MOL CELL CARDIOL, V33, P2095, DOI 10.1006/jmcc.2001.1473; Tobacman LS, 2002, J BIOL CHEM, V277, P27636, DOI 10.1074/jbc.M201768200; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; URBANCIKOVA M, 1994, J BIOL CHEM, V269, P24310; Van Driest SL, 2005, MAYO CLIN PROC, V80, P463, DOI 10.4065/80.4.463; Van Driest SL, 2002, CIRCULATION, V106, P3085, DOI 10.1161/01.CIR.0000042675.59901.14; Van Driest SL, 2002, AM J CARDIOL, V90, P1123, DOI 10.1016/S0002-9149(02)02780-7; Yanaga F, 1999, J BIOL CHEM, V274, P8806, DOI 10.1074/jbc.274.13.8806	40	68	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34343	34349		10.1074/jbc.M505014200	http://dx.doi.org/10.1074/jbc.M505014200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16043485	hybrid			2022-12-27	WOS:000232229700077
J	Contestabile, A; Fila, T; Bartesaghi, R; Ciani, E				Contestabile, A; Fila, T; Bartesaghi, R; Ciani, E			Cyclic AMP-mediated regulation of transcription factor Lot1 expression in cerebellar granule cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; ZINC-FINGER PROTEIN; ELEMENT-BINDING PROTEIN; FOS GENE-EXPRESSION; KINASE-A PATHWAY; C-FOS; MAP KINASE; RAT-BRAIN; DEPENDENT TRANSCRIPTION; NEUROTROPHIC ACTIVITY	Lot1, a zinc finger transcription factor acting as a tumor suppressor gene on tumoral cells, is highly expressed during brain development. In developing rat cerebellum, Lot1 expression is high in cerebellar granule cells (CGC), a neuronal population undergoing postnatal neurogenesis. The time course of Lot1 cerebellar expression closely matches the expression of pituitary adenylate cyclase-activating polypeptide ( PACAP) receptors coupled to adenylyl cyclase. The aim of this study was to ascertain whether Lot1 expression is regulated by cAMP-dependent pathways and to identify mechanisms of Lot1 activation in CGC cultures. Our results show that Lot1 expression in CGC is cAMP-dependent, as treatments with either forskolin or PACAP-38 induced an increase in its expression at both the mRNA and protein levels. This effect on Lot1 expression was mimicked by dibutyryl cAMP and suppressed by protein kinase A and MEK inhibitors. In parallel, we found that treatments with forskolin and PACAP-38 in precursor CGC inhibited bromodeoxyuridine incorporation by 25 and 35%, respectively, indicating a negative effect on neuronal precursor proliferation. Luciferase reporter analysis and mutagenesis of the Lot1 promoter region indicated a crucial role of the AP1-binding site ( located at - 268 bp) in cAMP- induced Lot1 transcription. In addition, cotransfection experiments indicated that the c-Fos/c-Jun heterodimer is responsible for cAMP- dependent Lot1 transcriptional activation. In conclusion, our data demonstrate that, in CGC, Lot1 is under the transcriptional control of cAMP through an AP1 site regulated by the c-Fos/c-Jun heterodimer and suggest that this gene may be an important element of the cAMP- mediated pathway that regulates neuronal proliferation through the protein kinase A-MEK signaling cascade.	Univ Bologna, Dept Human & Gen Physiol, I-40126 Bologna, Italy	University of Bologna	Ciani, E (corresponding author), Univ Bologna, Dept Human & Gen Physiol, Piazza Porta San Donato 2, I-40126 Bologna, Italy.	elisabetta.ciani@unibo.it	Ciani, Elisabetta/AAL-6462-2020; Contestabile, Andrea/F-9908-2013	Contestabile, Andrea/0000-0002-5417-4722; ciani, elisabetta/0000-0003-3130-5168				Abdollahi A, 1997, CANCER RES, V57, P2029; Abdollahi A, 1997, ONCOGENE, V14, P1973, DOI 10.1038/sj.onc.1201034; Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BASILLE M, 1993, NEUROSCIENCE, V57, P329, DOI 10.1016/0306-4522(93)90066-O; Basille M, 2000, J COMP NEUROL, V425, P495; BASILLE M, 1995, J NEUROCHEM, V65, P1318; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Campard PK, 1997, DNA CELL BIOL, V16, P323, DOI 10.1089/dna.1997.16.323; Chang JY, 1996, NEUROSCI LETT, V206, P181, DOI 10.1016/S0304-3940(96)12468-X; Ciani E, 2003, DEV BRAIN RES, V142, P193, DOI 10.1016/S0165-3806(03)00092-0; Ciani E, 1995, J MOL NEUROSCI, V6, P131, DOI 10.1007/BF02736772; Ciani E, 2002, J NEUROCHEM, V82, P1282, DOI 10.1046/j.1471-4159.2002.01080.x; Contestabile Antonio, 2002, Cerebellum, V1, P41, DOI 10.1080/147342202753203087; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Dicicco-Bloom E, 1998, ANN NY ACAD SCI, V865, P274, DOI 10.1111/j.1749-6632.1998.tb11188.x; DIDIER M, 1992, MOL BRAIN RES, V12, P249, DOI 10.1016/0169-328X(92)90091-O; Dugan LL, 1999, J BIOL CHEM, V274, P25842, DOI 10.1074/jbc.274.36.25842; FAVIT A, 1995, NEUROENDOCRINOLOGY, V61, P377, DOI 10.1159/000126859; Fujioka T, 2004, J NEUROSCI, V24, P319, DOI 10.1523/JNEUROSCI.1065.03.2004; Gabellini N, 2004, MOL NEUROBIOL, V30, P91, DOI 10.1385/MN:30:1:091; GALLO V, 1982, P NATL ACAD SCI-BIOL, V79, P7919, DOI 10.1073/pnas.79.24.7919; Gillardon F, 1998, MOL BRAIN RES, V61, P207, DOI 10.1016/S0169-328X(98)00202-2; Harmar AJ, 1998, PHARMACOL REV, V50, P265; Hoffmann A, 1998, ANN NY ACAD SCI, V865, P49, DOI 10.1111/j.1749-6632.1998.tb11162.x; HOLT JT, 1986, P NATL ACAD SCI USA, V83, P4794, DOI 10.1073/pnas.83.13.4794; Huang SM, 2000, MOL CELL BIOL, V20, P1855, DOI 10.1128/MCB.20.5.1855-1867.2000; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Jaworski DM, 2000, DEV BRAIN RES, V120, P27, DOI 10.1016/S0165-3806(99)00192-3; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kas K, 1998, J BIOL CHEM, V273, P23026, DOI 10.1074/jbc.273.36.23026; Kas K, 1997, NAT GENET, V15, P170, DOI 10.1038/ng0297-170; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Lioudyno M, 1998, J NEUROSCI RES, V51, P243, DOI 10.1002/(SICI)1097-4547(19980115)51:2<243::AID-JNR13>3.0.CO;2-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu NR, 1997, P NATL ACAD SCI USA, V94, P3357, DOI 10.1073/pnas.94.7.3357; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MASUO Y, 1994, NEUROSCI LETT, V170, P43, DOI 10.1016/0304-3940(94)90234-8; MASUO Y, 1992, BRAIN RES, V575, P113, DOI 10.1016/0006-8993(92)90430-H; Moody TW, 2003, PEPTIDES, V24, P163, DOI 10.1016/S0196-9781(02)00290-5; MULLER R, 1984, NATURE, V311, P438, DOI 10.1038/311438a0; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Nicot A, 2002, J NEUROSCI, V22, P9244; Nielsen HS, 1998, NEUROREPORT, V9, P2639, DOI 10.1097/00001756-199808030-00039; Pagotto U, 1999, ENDOCRINOLOGY, V140, P987, DOI 10.1210/en.140.2.987; Pandey SC, 2004, PHARMACOL THERAPEUT, V104, P47, DOI 10.1016/j.pharmthera.2004.08.002; Pennuto M, 2002, MOL BIOL CELL, V13, P2706, DOI 10.1091/mbc.E02-01-0036; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rodriguez-Henche N, 2002, BBA-GENE STRUCT EXPR, V1576, P157, DOI 10.1016/S0167-4781(02)00303-2; RUTHER U, 1987, NATURE, V325, P412, DOI 10.1038/325412a0; Spengler D, 1997, EMBO J, V16, P2814, DOI 10.1093/emboj/16.10.2814; Suh JH, 2001, NAT NEUROSCI, V4, P123, DOI 10.1038/83936; Tabuchi A, 2001, NEUROSCI RES, V39, P85, DOI 10.1016/S0168-0102(00)00200-5; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Valente T, 2004, NEUROSCIENCE, V128, P323, DOI 10.1016/j.neuroscience.2004.06.056; Valente T, 2001, MECH DEVELOP, V108, P207, DOI 10.1016/S0925-4773(01)00492-0; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Varrault A, 1998, P NATL ACAD SCI USA, V95, P8835, DOI 10.1073/pnas.95.15.8835; Vaudry D, 2000, P NATL ACAD SCI USA, V97, P13390, DOI 10.1073/pnas.97.24.13390; Vaudry D, 1998, NEUROSCIENCE, V84, P801, DOI 10.1016/S0306-4522(97)00545-9; Vaudry D, 1999, P NATL ACAD SCI USA, V96, P9415, DOI 10.1073/pnas.96.16.9415; Vaudry D, 1998, ANN NY ACAD SCI, V865, P92, DOI 10.1111/j.1749-6632.1998.tb11167.x; Villalba M, 1997, J NEUROSCI, V17, P83, DOI 10.1523/JNEUROSCI.17-01-00083.1997; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Waschek JA, 2002, DEV NEUROSCI-BASEL, V24, P14, DOI 10.1159/000064942; Waschek JA, 1998, P NATL ACAD SCI USA, V95, P9602, DOI 10.1073/pnas.95.16.9602; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298	69	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33541	33551		10.1074/jbc.M413323200	http://dx.doi.org/10.1074/jbc.M413323200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16061485	hybrid			2022-12-27	WOS:000232058100054
J	Khanna, H; Hurd, TW; Lillo, C; Shu, XH; Parapuram, SK; He, S; Akimoto, M; Wright, AF; Margolis, B; Williams, DS; Swaroop, A				Khanna, H; Hurd, TW; Lillo, C; Shu, XH; Parapuram, SK; He, S; Akimoto, M; Wright, AF; Margolis, B; Williams, DS; Swaroop, A			RPGR-ORF15, which is mutated in retinitis pigmentosa, associates with SMC1, SMC3, and microtubule transport proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; GTPASE REGULATOR; DELTA-SUBUNIT; KINESIN-II; SUBCELLULAR-LOCALIZATION; MYOSIN-VIIA; RPGR EXON; MUTATIONS; INTERACTS; POLARITY	Mutations in the retinitis pigmentosa GTPase regulator ( RPGR) gene account for almost 20% of patients with retinitis pigmentosa. Most mutations are detected in alternatively spliced RPGR-ORF15 isoform(s), which are primarily but not exclusively expressed in the retina. We show that, in addition to the axoneme, the RPGR-ORF15 protein is localized to the basal bodies of photoreceptor connecting cilium and to the tip and axoneme of sperm flagella. Mass spectrometric analysis of proteins that were immunoprecipitated from the retinal axoneme-enriched fraction using an anti-ORF15 antibody identified two chromosome-associated proteins, structural maintenance of chromosomes (SMC) 1 and SMC3. Using pulldown assays, we demonstrate that the interaction of RPGR with SMC1 and SMC3 is mediated, at least in part, by the RCC1-like domain of RPGR. This interaction was not observed with phosphorylation-deficient mutants of SMC1. Both SMC1 and SMC3 localized to the cilia of retinal photoreceptors and Madin-Darby canine kidney cells, suggesting a broader physiological relevance of this interaction. Additional immunoprecipitation studies revealed the association of RPGR-ORF15 isoform( s) with the intraflagellar transport polypeptide IFT88 as well as microtubule motor proteins, including KIF3A, p150(Glued), and p50-dynamitin. Inhibition of dynein function by overexpressing p50 abrogated the localization of RPGR-ORF15 to basal bodies. Taken together, these results provide novel evidence for the possible involvement of RPGR-ORF15 in microtubule organization and regulation of transport in primary cilia.	Univ Michigan, Dept Ophthalmol & Visual Sci, WK Kellogg Eye Ctr, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48105 USA; Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Kyoto Univ Hosp, Translat Res Ctr, Sakyo Ku, Kyoto 6068507, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Edinburgh; Kyoto University	Swaroop, A (corresponding author), Univ Michigan, Dept Ophthalmol & Visual Sci, WK Kellogg Eye Ctr, 1000 Wall St, Ann Arbor, MI 48105 USA.	swaroop@umich.edu	Akimoto, Masayuki/AAP-3676-2020; Lillo, Concepcion/A-6321-2009	Lillo, Concepcion/0000-0001-5814-9826; Akimoto, Masayuki/0000-0002-5899-2925; Swaroop, Anand/0000-0002-1975-1141	NATIONAL EYE INSTITUTE [R29EY007961, R01EY007961, P30EY007003, P30EY012598, R01EY013408, F31EY007003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069605] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY013408, F31 EY007003, P30 EY007003, EY13408, EY07961, P30 EY012598, R01 EY007961, EY07003, EY12598] Funding Source: Medline; NIDDK NIH HHS [R01 DK069605, DK069605] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARSHAVSKY VY, 2003, SCI STKE, pPE43; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Besharse JC, 2003, ADV EXP MED BIOL, V533, P157; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Boylan JP, 2000, HUM MOL GENET, V9, P2085, DOI 10.1093/hmg/9.14.2085; Breuer DK, 2002, AM J HUM GENET, V70, P1545, DOI 10.1086/340848; Buraczynska M, 1997, AM J HUM GENET, V61, P1287, DOI 10.1086/301646; Cole CN, 1998, CURR BIOL, V8, pR368, DOI 10.1016/S0960-9822(98)70239-8; Cook TA, 2001, J BIOL CHEM, V276, P5248, DOI 10.1074/jbc.M004690200; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; FISHMAN GA, 1978, ARCH OPHTHALMOL-CHIC, V96, P822, DOI 10.1001/archopht.1978.03910050428005; Friedman JS, 2004, J BIOL CHEM, V279, P47233, DOI 10.1074/jbc.M408298200; Gibbs D, 2004, J CELL SCI, V117, P6473, DOI 10.1242/jcs.01580; Hong DH, 2001, J BIOL CHEM, V276, P12091, DOI 10.1074/jbc.M009351200; Hong DH, 2002, INVEST OPHTH VIS SCI, V43, P3373; Hong DH, 2000, P NATL ACAD SCI USA, V97, P3649, DOI 10.1073/pnas.060037497; Hong DH, 2003, INVEST OPHTH VIS SCI, V44, P2413, DOI 10.1167/iovs.02-1206; HUNTER DG, 1988, ARCH OPHTHALMOL-CHIC, V106, P362; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Iannaccone A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.11.e118; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kirschner R, 1999, HUM MOL GENET, V8, P1571, DOI 10.1093/hmg/8.8.1571; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Linari M, 1999, P NATL ACAD SCI USA, V96, P1315, DOI 10.1073/pnas.96.4.1315; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Mavlyutov TA, 2002, HUM MOL GENET, V11, P1899, DOI 10.1093/hmg/11.16.1899; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; Mitton KP, 2003, HUM MOL GENET, V12, P365, DOI 10.1093/hmg/ddg035; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Sharon D, 2003, AM J HUM GENET, V73, P1131, DOI 10.1086/379379; Shu X, 2005, HUM MOL GENET, V14, P1183, DOI 10.1093/hmg/ddi129; Strunnikov AV, 1998, TRENDS CELL BIOL, V8, P454, DOI 10.1016/S0962-8924(98)01370-1; SZCZESNY PJ, 1995, GRAEF ARCH CLIN EXP, V233, P275, DOI 10.1007/BF00177649; VANDORP DB, 1992, HUM GENET, V88, P331, DOI 10.1007/BF00197269; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Vervoort R, 2002, HUM MUTAT, V19, P486, DOI 10.1002/humu.10057; Williams DS, 2002, VISION RES, V42, P455, DOI 10.1016/S0042-6989(01)00228-0; Yan D, 1998, J BIOL CHEM, V273, P19656, DOI 10.1074/jbc.273.31.19656; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993	53	125	136	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33580	33587		10.1074/jbc.M505827200	http://dx.doi.org/10.1074/jbc.M505827200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16043481	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000232058100059
J	Kuroyanagi, M; Yamada, K; Hatsugai, N; Kondo, M; Nishimura, M; Hara-Nishimura, I				Kuroyanagi, M; Yamada, K; Hatsugai, N; Kondo, M; Nishimura, M; Hara-Nishimura, I			Vacuolar processing enzyme is essential for mycotoxin-induced cell death in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEED STORAGE PROTEINS; CASPASE-LIKE ACTIVITY; SALICYLIC-ACID; ACTIVATION; FAMILY; VPE; PRECURSOR; EXPRESSION; FUMONISINS; PROTEASES	Some compatible pathogens secrete toxins to induce host cell death and promote their growth. The toxin-induced cell death is a pathogen strategy for infection. To clarify the executioner of the toxin-induced cell death, we examined a fungal toxin (fumonisin B1 (FB1))-induced cell death of Arabidopsis plants. FB1-induced cell death was accompanied with disruption of vacuolar membrane followed by lesion formation. The features of FB1-induced cell death were completely abolished in the Arabidopsis vacuolar processing enzyme (VPE)-null mutant, which lacks all four VPE genes of the genome. Interestingly, an inhibitor of caspase-1 abolished FB1-induced lesion formation, as did a VPE inhibitor. The VPE-null mutant had no detectable activities of caspase-1 or VPE in the FB1-treated leaves, although wild-type leaves had the caspase-1 and VPE activities, both of which were inhibited by a caspase-1 inhibitor. gamma VPE is the most essential among the four VPE homologues for FB1-induced cell death in Arabidopsis leaves. Recombinant gamma VPE recognized a VPE substrate with K-m = 30.3 mu M and a caspase-1 substrate with K-m = 44.2 mu M, which is comparable with the values for mammalian caspase-1. The gamma VPE precursor was self-catalytically converted into the mature form exhibiting caspase-1 activity. These in vivo and in vitro analyses demonstrate that gamma VPE is the proteinase that exhibits a caspase-1 activity. We show that VPE exhibiting a caspase-1 activity is a key molecule in toxin-induced cell death. Our findings suggest that a susceptible response of toxin-induced cell death is caused by the VPE-mediated vacuolar mechanism similar to a resistance response of hypersensitive cell death.	Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Hara-Nishimura, I (corresponding author), Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan.	ihnishi@gr.bot.kyoto-u.ac.jp	Yamada, Kenji/C-4336-2018; Hatsugai, Noriyuki/O-9156-2015	Yamada, Kenji/0000-0003-4872-3729; Hatsugai, Noriyuki/0000-0002-5708-4263; Nishimura, Mikio/0000-0001-7960-9721; Kuroyanagi, Miwa/0000-0003-4362-8415				Asai T, 2000, PLANT CELL, V12, P1823, DOI 10.1105/tpc.12.10.1823; Coffeen WC, 2004, PLANT CELL, V16, P857, DOI 10.1105/tpc.017947; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Danon A, 2000, PLANT PHYSIOL BIOCH, V38, P647, DOI 10.1016/S0981-9428(00)01178-5; del Pozo O, 1998, CURR BIOL, V8, P1129, DOI 10.1016/S0960-9822(98)70469-5; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Gilchrist DG, 1998, ANNU REV PHYTOPATHOL, V36, P393, DOI 10.1146/annurev.phyto.36.1.393; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Gruis D, 2002, PLANT CELL, V14, P2863, DOI 10.1105/tpc.005009; Gruis DF, 2004, PLANT CELL, V16, P270, DOI 10.1105/tpc.016378; Hara-Nishimura I, 1998, HDB PROTEOLYTIC ENZY, P746; HARANISHIMURA I, 1991, FEBS LETT, V294, P89, DOI 10.1016/0014-5793(91)81349-D; HARANISHIMURA I, 1993, PLANT CELL, V5, P1651, DOI 10.1105/tpc.5.11.1651; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Hiraiwa N, 1999, FEBS LETT, V447, P213, DOI 10.1016/S0014-5793(99)00286-0; Hiraiwa N, 1997, PLANT J, V12, P819, DOI 10.1046/j.1365-313X.1997.12040819.x; Jones AM, 2001, PLANT PHYSIOL, V125, P94, DOI 10.1104/pp.125.1.94; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kinoshita T, 1999, PLANT J, V19, P43, DOI 10.1046/j.1365-313X.1999.00497.x; Kuroyanagi M, 2002, PLANT CELL PHYSIOL, V43, P143, DOI 10.1093/pcp/pcf035; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lam E, 2000, PLANT MOL BIOL, V44, P417, DOI 10.1023/A:1026509012695; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Lincoln JE, 2002, P NATL ACAD SCI USA, V99, P15217, DOI 10.1073/pnas.232579799; Mitsuhashi N, 2001, PLANT CELL, V13, P2361; MOLINEAUX SM, 1993, P NATL ACAD SCI USA, V90, P1809, DOI 10.1073/pnas.90.5.1809; Nakaune S, 2005, PLANT CELL, V17, P876, DOI 10.1105/tpc.104.026872; NELSON PE, 1993, ANNU REV PHYTOPATHOL, V31, P233, DOI 10.1146/annurev.py.31.090193.001313; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Stone JM, 2000, PLANT CELL, V12, P1811, DOI 10.1105/tpc.12.10.1811; Suarez MF, 2004, CURR BIOL, V14, pR339, DOI 10.1016/j.cub.2004.04.019; Talanian RV, 1997, J BIOL CHEM, V272, P9677; TAVERNIER E, 1993, BIOCHIM BIOPHYS ACTA, V1167, P242, DOI 10.1016/0005-2760(93)90225-X; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; WANG E, 1991, J BIOL CHEM, V266, P14486; Wang H, 1996, PLANT CELL, V8, P375, DOI 10.1105/tpc.8.3.375; Woltering EJ, 2004, TRENDS PLANT SCI, V9, P469, DOI 10.1016/j.tplants.2004.08.001; Yamada K, 2004, PLANTA, V218, P599, DOI 10.1007/s00425-003-1131-3; Yamada K, 1999, J BIOL CHEM, V274, P2563, DOI 10.1074/jbc.274.4.2563; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w	46	167	187	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32914	32920		10.1074/jbc.M504476200	http://dx.doi.org/10.1074/jbc.M504476200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16043487	hybrid			2022-12-27	WOS:000231920300046
J	Zhang, YM; Rock, CO; Jackowski, S				Zhang, YM; Rock, CO; Jackowski, S			Feedback regulation of murine pantothenate kinase 3 by coenzyme A and coenzyme A thioesters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-ASSOCIATED NEURODEGENERATION; HALLERVORDEN-SPATZ-SYNDROME; STAPHYLOCOCCUS-AUREUS; RAT-LIVER; DISULFIDE REDUCTASE; IRON ACCUMULATION; ESCHERICHIA-COLI; GENE; COA; BIOSYNTHESIS	Pantothenate kinase catalyzes a key regulatory step in coenzyme A biosynthesis, and there are four mammalian genes that encode isoforms of this enzyme. Pantothenate kinase isoform PanK3 is highly related to the previously characterized PanK1 beta isoform ( 79% identical, 91% similar), and these two almost identical proteins are expressed most highly in the same tissues. PanK1 beta and PanK3 had very similar molecular sizes, oligomeric form, cytoplasmic cellular location, and kinetic constants for ATP and pantothenate. However, these two PanK isoforms possessed distinct regulatory properties. PanK3 was significantly more sensitive to feedback regulation by acetyl- CoA ( IC50 = 1 mu M) than PanK1 beta ( IC50 = 10 mu M), and PanK3 was stringently regulated by long- chain acyl- CoA ( IC50 = 2 mu M), whereas PanK1 beta was not. Domain swapping experiments localized the difference in the two proteins to a 48- amino- acid domain, where they are the most divergent. Consistent with these more stringent regulatory properties, metabolic labeling experiments showed that coenzyme A ( CoA) levels in cells overexpressing PanK3 were lower than in cells overexpressing an equivalent amount of PanK1 beta. Thus, the distinct regulatory properties exhibited by the family of the pantothenate kinases allowed the rate of CoA biosynthesis to be controlled by regulatory signals from CoA thioesters involved in different branches of intermediary metabolism.	St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Jackowski, S (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	suzanne.jackowski@stjude.org	Jackowski, Suzanne/N-8168-2018	Jackowski, Suzanne/0000-0002-6855-1429	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062896] Funding Source: NIH RePORTER; NCI NIH HHS [CA 21765] Funding Source: Medline; NIGMS NIH HHS [GM62896] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BHUIYAN AKMJ, 1988, BIOCHEM J, V253, P337, DOI 10.1042/bj2530337; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; delCardayre SB, 1998, J BIOL CHEM, V273, P5752, DOI 10.1074/jbc.273.10.5752; delCardayre SB, 1998, J BIOL CHEM, V273, P5744, DOI 10.1074/jbc.273.10.5744; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; HALVORSEN O, 1982, EUR J BIOCHEM, V124, P211, DOI 10.1111/j.1432-1033.1982.tb05927.x; HALVORSEN O, 1983, BIOCHEM PHARMACOL, V32, P1126, DOI 10.1016/0006-2952(83)90638-X; HORIE S, 1986, J BIOCHEM, V99, P1345, DOI 10.1093/oxfordjournals.jbchem.a135602; Hortnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Johnson MA, 2004, ANN NY ACAD SCI, V1012, P282, DOI 10.1196/annals.1306.023; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; KONDRUP J, 1973, BIOCHEM J, V132, P373, DOI 10.1042/bj1320373; Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005; Kuo YM, 2005, HUM MOL GENET, V14, P49, DOI 10.1093/hmg/ddi005; Leonardi R, 2005, J BIOL CHEM, V280, P3314, DOI 10.1074/jbc.M411608200; Luba J, 1999, BIOCHEMISTRY-US, V38, P2725, DOI 10.1021/bi9825899; LUND H, 1986, BIOCHIM BIOPHYS ACTA, V876, P685, DOI 10.1016/0005-2760(86)90058-5; Ni XH, 2002, INT J BIOCHEM CELL B, V34, P109, DOI 10.1016/S1357-2725(01)00114-5; Ramaswamy G, 2004, J LIPID RES, V45, P17, DOI 10.1194/jlr.M300279-JLR200; REIBEL DK, 1981, AM J PHYSIOL, V240, pE597, DOI 10.1152/ajpendo.1981.240.6.E597; REIBEL DK, 1981, AM J PHYSIOL, V240, P606; ROBISHAW JD, 1982, J BIOL CHEM, V257, P967; Rock CO, 2003, J BACTERIOL, V185, P3410, DOI 10.1128/JB.185.11.3410-3415.2003; Rock CO, 2002, GENE, V291, P35, DOI 10.1016/S0378-1119(02)00564-4; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; SAVOLAINEN MJ, 1977, BIOCHEM PHARMACOL, V26, P425, DOI 10.1016/0006-2952(77)90202-7; SKREDE S, 1979, EUR J BIOCHEM, V98, P223, DOI 10.1111/j.1432-1033.1979.tb13180.x; SMITH CM, 1980, BIOCHEM J, V188, P175, DOI 10.1042/bj1880175; SMITH CM, 1978, J NUTR, V108, P854, DOI 10.1093/jn/108.5.854; SONG WJ, 1994, J BIOL CHEM, V269, P27051; SONG WJ, 1992, J BACTERIOL, V174, P6411, DOI 10.1128/JB.174.20.6411-6417.1992; Stolz LE, 1998, GENETICS, V148, P1715; Thomas M, 2004, MOVEMENT DISORD, V19, P36, DOI 10.1002/mds.10650; VANBROEKHOVEN A, 1981, BIOCHEM BIOPH RES CO, V100, P305, DOI 10.1016/S0006-291X(81)80097-6; VANVELDHOVEN PP, 1986, BIOCHEM BIOPH RES CO, V139, P1195, DOI 10.1016/S0006-291X(86)80304-7; VOLTTI H, 1979, BIOCHEM J, V182, P95, DOI 10.1042/bj1820095; WANG HY, 1991, ARCH BIOCHEM BIOPHYS, V289, P274, DOI 10.1016/0003-9861(91)90472-U; Williamson J R, 1979, Methods Enzymol, V55, P200; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	43	61	64	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32594	32601		10.1074/jbc.M506275200	http://dx.doi.org/10.1074/jbc.M506275200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16040613	hybrid			2022-12-27	WOS:000231920300006
J	Opresko, PL; Mason, PA; Podell, ER; Lei, M; Hickson, ID; Cech, TR; Bohr, VA				Opresko, PL; Mason, PA; Podell, ER; Lei, M; Hickson, ID; Cech, TR; Bohr, VA			POT1 stimulates RecQ helicases WRN and BLM to unwind telomeric DNA substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; WERNER-SYNDROME; SYNDROME PROTEIN; BINDING PROTEIN; FISSION YEAST; CELLS; TRF1; END; LENGTH; RECOGNITION	Defects in human RecQ helicases WRN and BLM are responsible for the cancer-prone disorders Werner syndrome and Bloom syndrome. Cellular phenotypes of Werner syndrome and Bloom syndrome, including genomic instability and premature senescence, are consistent with telomere dysfunction. RecQ helicases are proposed to function in dissociating alternative DNA structures during recombination and/or replication at telomeric ends. Here we report that the telomeric single-strand DNA-binding protein, POT1, strongly stimulates WRN and BLM to unwind long telomeric forked duplexes and D-loop structures that are otherwise poor substrates for these helicases. This stimulation is dependent on the presence of telomeric sequence in the duplex regions of the substrates. In contrast, POT1 failed to stimulate a bacterial 3'-5'-helicase. We find that purified POT1 binds to WRN and BLM in vitro and that full-length POT1 ( splice variant 1) precipitates a higher amount of endogenous WRN protein, compared with BLM, from the HeLa nuclear extract. We propose roles for the cooperation of POT1 with RecQ helicases WRN and BLM in resolving DNA structures at telomeric ends, in a manner that protects the telomeric 3' tail as it is exposed during unwinding.	NIA, Lab Mol Gerontol, Baltimore, MD 21224 USA; Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA; Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Canc Res UK Labs, Oxford OX3 9DS, England	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Cancer Research UK; University of Oxford	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, Baltimore, MD 21224 USA.	vbohr@nih.gov	Hickson, Ian/AAJ-7548-2020; Bohr, Vilhelm/AAP-5931-2020	Opresko, Patricia/0000-0002-6470-2189; Hickson, Ian/0000-0002-0583-566X	NATIONAL INSTITUTE ON AGING [Z01AG000726, ZIAAG000726] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Armbruster BN, 2004, MOL CELL BIOL, V24, P3552, DOI 10.1128/MCB.24.8.3552-3561.2004; Bai YL, 2003, HUM GENET, V113, P337, DOI 10.1007/s00439-003-0972-y; Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Colgin L, 2004, CURR BIOL, V14, pR901, DOI 10.1016/j.cub.2004.09.075; Colgin LM, 2003, CURR BIOL, V13, P942, DOI 10.1016/S0960-9822(03)00339-7; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Davalos AR, 2003, J CELL BIOL, V162, P1197, DOI 10.1083/jcb.200304016; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; Du XB, 2004, MOL CELL BIOL, V24, P8437, DOI 10.1128/MCB.24.19.8437-8446.2004; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Erzberger JP, 1998, NUCLEIC ACIDS RES, V26, P2771, DOI 10.1093/nar/26.11.2771; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Lillard-Wetherell K, 2004, HUM MOL GENET, V13, P1919, DOI 10.1093/hmg/ddh193; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Loayza D, 2004, J BIOL CHEM, V279, P13241, DOI 10.1074/jbc.M312309200; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Mandell JG, 2005, J BIOL CHEM, V280, P5249, DOI 10.1074/jbc.M412756200; Mandell JG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r1; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; Mattern KA, 2004, MOL CELL BIOL, V24, P5587, DOI 10.1128/MCB.24.12.5587-5594.2004; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2004, J BIOL CHEM, V279, P18099, DOI 10.1074/jbc.R300034200; Opresko PL, 2003, CARCINOGENESIS, V24, P791, DOI 10.1093/carcin/bgg034; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Shen JC, 2003, MECH AGEING DEV, V124, P921, DOI 10.1016/S0047-6374(03)00164-7; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Veldman T, 2004, CURR BIOL, V14, P2264, DOI 10.1016/j.cub.2004.12.031; von Kobbe C, 2002, J BIOL CHEM, V277, P22035, DOI 10.1074/jbc.M200914200; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005	49	145	152	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32069	32080		10.1074/jbc.M505211200	http://dx.doi.org/10.1074/jbc.M505211200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16030011	hybrid			2022-12-27	WOS:000231794800006
J	Isabel, MPV; Hume, RI; Krejci, E; Akaaboune, M				Isabel, MPV; Hume, RI; Krejci, E; Akaaboune, M			In vivo regulation of acetylcholinesterase insertion at the neuromuscular junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN SKELETAL-MUSCLE; CRYSTAL-STRUCTURE; METABOLIC STABILIZATION; CIRCULATORY RESIDENCE; ALPHA-BUNGAROTOXIN; PERIPHERAL SITE; TAIL SUBUNIT; FASCICULIN 2; LIVING MICE; RECEPTOR	The efficiency of synaptic transmission between nerve and muscle depends on the number and density of acetylcholinesterase molecules ( AChE) at the neuromuscular junction. However, little is known about the way this density is maintained and regulated in vivo. By using time lapse and quantitative fluorescence imaging assays in living mice, we demonstrated that insertion of new AChEs occurs within hours of saturating pre-existing AChEs with fasciculin2, a snake toxin that selectively labels AChE. In the absence of muscle postsynaptic activity or evoked nerve presynaptic neurotransmitter release, AChE insertion was decreased significantly, whereas direct stimulation of the muscle completely restored AChE insertion to control levels. This activity-dependent AChE insertion is mediated by intracellular calcium. In muscle stimulated in the presence of a Ca2+ channel blocker or calcium-permeable Ca2+ chelator, AChE insertion into synapses was significantly decreased, whereas ryanodine or ionophore A12387 treatment of blocked and unstimulated synapses significantly increased AChE insertion. These results demonstrated that synaptic activity is critical for AChE insertion and indicated that a rise in intracellular calcium either through voltage-gated calcium channels or from intracellular stores is critical for proper AChE insertion into the adult synapse.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Univ Paris 05, UFR Biomed, INSERM U686 Biol Jonct Neuromusculaires, F-75006 Paris, France	University of Michigan System; University of Michigan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Akaaboune, M (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ Ave, Ann Arbor, MI 48109 USA.	makaabou@umich.edu	Martinez-Pena y Valenzuela, Isabel/AAI-9845-2020; , Richard/AAI-5000-2020	Hume, Richard/0000-0001-9807-112X; , Isabel/0000-0002-2196-9297	NINDS NIH HHS [NS047332] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047332] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; ANDREOSE JS, 1993, J NEUROSCI, V13, P3433; Anglister L, 1998, J NEUROSCI METH, V81, P63, DOI 10.1016/S0165-0270(98)00015-6; ANGLISTER L, 1994, NEURON, V12, P783, DOI 10.1016/0896-6273(94)90331-X; Arikawa-Hirasawa E, 2002, NAT NEUROSCI, V5, P119, DOI 10.1038/nn801; BARNARD EA, 1971, NATURE, V234, P207, DOI 10.1038/234207a0; BEAM KG, 1988, J GEN PHYSIOL, V91, P781, DOI 10.1085/jgp.91.6.781; BETZ H, 1981, EUR J BIOCHEM, V117, P131; Borges LS, 2002, J NEUROBIOL, V50, P69, DOI 10.1002/neu.10020; BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0; CARONI P, 1993, J NEUROSCI, V13, P1315; Cartaud A, 2004, J CELL BIOL, V165, P505, DOI 10.1083/jcb.200307164; Chitlaru T, 2002, BIOCHEM J, V363, P619, DOI 10.1042/0264-6021:3630619; Chitlaru T, 2001, BIOCHEM J, V354, P613, DOI 10.1042/0264-6021:3540613; COGNARD C, 1986, P NATL ACAD SCI USA, V83, P517, DOI 10.1073/pnas.83.2.517; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; DARVENIZA P, 1979, BIOCHEM J, V181, P545, DOI 10.1042/bj1810545; DELAPORTE S, 1984, DEV BIOL, V106, P450, DOI 10.1016/0012-1606(84)90244-6; Deprez P, 2003, J BIOL CHEM, V278, P23233, DOI 10.1074/jbc.M301384200; DMYTRENKO GM, 1993, EXP CELL RES, V206, P323, DOI 10.1006/excr.1993.1153; EASTMAN J, 1995, J BIOL CHEM, V270, P19694, DOI 10.1074/jbc.270.34.19694; FAIRHURST AS, 1973, BIOCHEM PHARMACOL, V22, P2815, DOI 10.1016/0006-2952(73)90148-2; FAIRHURST AS, 1974, AM J PHYSIOL, V227, P1124, DOI 10.1152/ajplegacy.1974.227.5.1124; Feng GP, 1999, J CELL BIOL, V144, P1349, DOI 10.1083/jcb.144.6.1349; Harel M, 1995, STRUCTURE, V3, P1355, DOI 10.1016/S0969-2126(01)00273-8; JENDEN DJ, 1969, PHARMACOL REV, V21, P1; KARLSSON E, 1984, J PHYSIOLOGY PARIS, V79, P232; KASPRZAK H, 1985, J NEUROSCI, V5, P951; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; LOMO T, 1980, J PHYSIOL-LONDON, V303, P173, DOI 10.1113/jphysiol.1980.sp013279; Marchot P, 1998, TOXICON, V36, P1613, DOI 10.1016/S0041-0101(98)00154-8; MARCHOT P, 1993, J BIOL CHEM, V268, P12458; MCCLESKEY EW, 1985, J PHYSIOL-LONDON, V361, P231, DOI 10.1113/jphysiol.1985.sp015643; MCMANAMAN JL, 1981, J NEUROSCI, V1, P771, DOI 10.1523/JNEUROSCI.01-07-00771.1981; Megeath LJ, 1998, J NEUROSCI, V18, P672; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; OMalley JP, 1997, J CELL BIOL, V138, P159, DOI 10.1083/jcb.138.1.159; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; RADIC Z, 1994, J BIOL CHEM, V269, P11233; RADIC Z, 1995, J BIOL CHEM, V270, P20391, DOI 10.1074/jbc.270.35.20391; Radic Z, 1997, J BIOL CHEM, V272, P23265, DOI 10.1074/jbc.272.37.23265; Radic Z, 2001, J BIOL CHEM, V276, P4622, DOI 10.1074/jbc.M006855200; ROGERS AW, 1969, J CELL BIOL, V41, P665, DOI 10.1083/jcb.41.3.665; Rosenberry TL, 1996, BIOCHEMISTRY-US, V35, P685, DOI 10.1021/bi952431d; Rotundo RL, 1997, J CELL BIOL, V136, P367, DOI 10.1083/jcb.136.2.367; ROTZLER S, 1991, NATURE, V349, P337, DOI 10.1038/349337a0; RUBIN LL, 1980, NATURE, V283, P264, DOI 10.1038/283264a0; SALPETER MM, 1972, J HISTOCHEM CYTOCHEM, V20, P1059, DOI 10.1177/20.12.1059; SALPETER MM, 1979, J NEUROCYTOL, V8, P95, DOI 10.1007/BF01206461; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Turney SG, 1996, J NEUROSCI METH, V64, P199, DOI 10.1016/0165-0270(95)00135-2; VANMIER P, 1994, J NEUROSCI, V14, P5672; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; WECKER L, 1986, FUND APPL TOXICOL, V6, P172, DOI 10.1016/0272-0590(86)90273-3; WEINBERG CB, 1979, DEV BIOL, V68, P631, DOI 10.1016/0012-1606(79)90233-1	60	5	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31801	31808		10.1074/jbc.M502874200	http://dx.doi.org/10.1074/jbc.M502874200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15998641	hybrid			2022-12-27	WOS:000231665200059
J	Bergeron, S; Madathiparambil, T; Swanson, PC				Bergeron, S; Madathiparambil, T; Swanson, PC			Both high mobility group (HMG)-boxes and the acidic tail of HMGB1 regulate recombination-activating gene (RAG)-mediated recombination signal synapsis and cleavage in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROPERTIES; V(D)J RECOMBINATION; PROTEIN HMGB1; BOX DOMAINS; COMPLEXES; RAG-1; HMG-1; TRANSPOSITION; TRANSCRIPTION; RECOGNITION	RAG-1 and RAG-2 initiate V(D) J recombination through synapsis and cleavage of a 12/23 pair of V( D) J recombination signal sequences (RSS). RAG-RSS complex assembly and activity in vitro is promoted by high mobility group proteins of the "HMG-box" family, exemplified by HMGB1. How HMGB1 stimulates the DNA binding and cleavage activity of the RAG complex remains unclear. HMGB1 contains two homologous HMG-box DNA binding domains, termed A and B, linked by a stretch of basic residues to a highly acidic C-terminal tail. To identify determinants of HMGB1 required for stimulation of RAG-mediated RSS binding and cleavage, we prepared an extensive panel of mutant HMGB1 proteins and tested their ability to augment RAG-mediated RSS binding and cleavage activity. Using a combination of mobility shift and in-gel cleavage assays, we find that HMGB1 promotes RAG-mediated cleavage largely through the activity of box B, but optimal stimulation requires a functional A box tethered in the correct orientation. Box A or B mutants fail to promote RAG synaptic complex formation, but this defect is alleviated when the acidic tail is removed from these mutants.	Creighton Univ, Med Ctr, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	Creighton University	Swanson, PC (corresponding author), Creighton Univ, Med Ctr, Dept Med Microbiol & Immunol, 2500 Calif Plaza, Omaha, NE 68178 USA.	pswanson@creighton.edu			NCRR NIH HHS [P20 RR016469, C06 RR017417] Funding Source: Medline; NIAID NIH HHS [R01 AI055599-01, R01 AI055599] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017417, P20RR016469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055599] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aidinis V, 1999, MOL CELL BIOL, V19, P6532; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Baumann M, 2003, EMBO J, V22, P5197, DOI 10.1093/emboj/cdg487; Bonaldi T, 2002, EMBO J, V21, P6865, DOI 10.1093/emboj/cdf692; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Costello E, 1997, EMBO J, V16, P5943, DOI 10.1093/emboj/16.19.5943; Ellwood KB, 2000, MOL CELL BIOL, V20, P4359, DOI 10.1128/MCB.20.12.4359-4370.2000; GE H, 1994, J BIOL CHEM, V269, P17136; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Kasparkova J, 2003, BIOCHEMISTRY-US, V42, P1234, DOI 10.1021/bi026695t; Knapp S, 2004, BIOCHEMISTRY-US, V43, P11992, DOI 10.1021/bi049364k; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; Lee KB, 2000, J MOL BIOL, V304, P135, DOI 10.1006/jmbi.2000.4206; Li WH, 1997, MOL CELL BIOL, V17, P6932, DOI 10.1128/MCB.17.12.6932; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Mitsouras K, 2002, MOL CELL BIOL, V22, P4390, DOI 10.1128/MCB.22.12.4390-4401.2002; Mo XM, 2000, NUCLEIC ACIDS RES, V28, P1228, DOI 10.1093/nar/28.5.1228; ONATE SA, 1994, MOL CELL BIOL, V14, P3376, DOI 10.1128/MCB.14.5.3376; Ramstein J, 1999, EUR J BIOCHEM, V260, P692, DOI 10.1046/j.1432-1327.1999.00185.x; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Stros M, 1998, J BIOL CHEM, V273, P10355; Stros M, 2000, J BIOL CHEM, V275, P35699, DOI 10.1074/jbc.M007167200; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Swanson PC, 2004, J BIOL CHEM, V279, P4034, DOI 10.1074/jbc.M311100200; Swanson PC, 2002, MOL CELL BIOL, V22, P7790, DOI 10.1128/MCB.22.22.7790-7801.2002; Swanson PC, 2002, MOL CELL BIOL, V22, P1340, DOI 10.1128/MCB.22.5.1340-1351.2002; Swanson PC, 1999, MOL CELL BIOL, V19, P3674; Swanson PC, 1998, IMMUNITY, V9, P115, DOI 10.1016/S1074-7613(00)80593-2; Swanson PC, 2001, MOL CELL BIOL, V21, P449, DOI 10.1128/MCB.21.2.449-458.2001; TEO SH, 1995, EUR J BIOCHEM, V230, P943, DOI 10.1111/j.1432-1033.1995.tb20640.x; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Ueda T, 2004, BIOCHEMISTRY-US, V43, P9901, DOI 10.1021/bi035975l; vanGent DC, 1997, EMBO J, V16, P2665, DOI 10.1093/emboj/16.10.2665; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; Webb M, 1999, J MOL BIOL, V294, P373, DOI 10.1006/jmbi.1999.3150; Zayed H, 2003, NUCLEIC ACIDS RES, V31, P2313, DOI 10.1093/nar/gkg341	40	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31314	31324		10.1074/jbc.M503063200	http://dx.doi.org/10.1074/jbc.M503063200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994314	Green Accepted, hybrid			2022-12-27	WOS:000231487800079
J	Yang, L; Carlson, SG; McBurney, D; Horton, WE				Yang, L; Carlson, SG; McBurney, D; Horton, WE			Multiple signals induce endoplasmic reticulum stress in both primary and immortalized chondrocytes resulting in loss of differentiation, impaired cell growth, and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; ARTICULAR-CARTILAGE; RAT CHONDROCYTES; EXPRESSION; GADD153; DEATH; CHOP; PROTEOGLYCAN; ACTIVATION; MUTATIONS	The endoplasmic reticulum is the site of synthesis and folding of secretory proteins and is sensitive to changes in the internal and external environment of the cell. Both physiological and pathological conditions may perturb the function of the endoplasmic reticulum, resulting in endoplasmic reticulum stress. The chondrocyte is the only resident cell found in cartilage and is responsible for synthesis and turnover of the abundant extracellular matrix and may be sensitive to endoplasmic reticulum stress. Here we report that glucose withdrawal, tunicamycin, and thapsigargin induce up-regulation of GADD153 and caspase-12, two markers of endoplasmic reticulum stress, in both primary chondrocytes and a chondrocyte cell line. Other agents such as interleukin-1 beta or tumor necrosis factor alpha induced a minimal or no induction of GADD153, respectively. The endoplasmic reticulum stress resulted in decreased chondrocyte growth based on cell counts, up-regulation of p21, and decreased PCNA expression. In addition, perturbation of endoplasmic reticulum function resulted in decreased accumulation of an Alcian Blue positive matrix by chondrocytes and decreased expression of type II collagen at the protein level. Further, quantitative realtime PCR was used to demonstrate a down-regulation of steady state mRNA levels coding for aggrecan, collagen II, and link protein in chondrocytes exposed to endoplasmic reticulum stress-inducing conditions. Ultimately, endoplasmic reticulum stress resulted in chondrocyte apoptosis, as evidenced by DNA fragmentation and annexin V staining. These findings have potentially important implications regarding consequences of endoplasmic reticulum stress in cartilage biology.	Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA; Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA	Northeast Ohio Medical University (NEOMED); Cleveland Clinic Foundation	Horton, WE (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, 4209 State Route 44, Rootstown, OH 44272 USA.	wehj@neoucom.edu	Yang, Ling/C-8000-2011	Yang, Ling/0000-0002-3105-3063				Adams CS, 1998, ANAT RECORD, V250, P418; Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; BARONE MV, 1994, GENE DEV, V8, P453, DOI 10.1101/gad.8.4.453; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736; Delot E, 1998, J BIOL CHEM, V273, P26692, DOI 10.1074/jbc.273.41.26692; Erickson GR, 2003, OSTEOARTHR CARTILAGE, V11, P187, DOI 10.1053/S1063-4584(02)00347-3; EYRE DR, 1991, SEMIN ARTHRITIS RHEU, V21, P2, DOI 10.1016/0049-0172(91)90035-X; Gartel AL, 2002, MOL CANCER THER, V1, P639; Goggs R, 2003, VET J, V166, P140, DOI 10.1016/S1090-0233(02)00331-3; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Harris TE, 2001, J BIOL CHEM, V276, P29200, DOI 10.1074/jbc.M011587200; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; Horton WE, 1998, IN VITRO CELL DEV-AN, V34, P378; HORTON WE, 1988, EXP CELL RES, V178, P457, DOI 10.1016/0014-4827(88)90414-4; HORTON WE, 1991, J BIOL CHEM, V266, P24804; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kinkel MD, 2004, ANAT REC PART A, V279A, P720, DOI 10.1002/ar.a.20063; Kinkel MD, 2003, J CELL BIOCHEM, V88, P941, DOI 10.1002/jcb.10442; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee RB, 2002, BIORHEOLOGY, V39, P133; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; LOESER RF, 2004, SCI AGING KNOWLEDGE, V29, pE31; Luo W, 1996, J BIOL CHEM, V271, P16447, DOI 10.1074/jbc.271.28.16447; Maddox BK, 1997, J BIOL CHEM, V272, P30993, DOI 10.1074/jbc.272.49.30993; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; McLaughlin SH, 1998, MATRIX BIOL, V16, P369, DOI 10.1016/S0945-053X(98)90010-5; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Mroz PJ, 2003, BIOCHEM J, V376, P511, DOI 10.1042/BJ20030982; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Oliver BL, 2005, J CELL PHYSIOL, V204, P45, DOI 10.1002/jcp.20261; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pelletier JP, 2000, ARTHRITIS RHEUM-US, V43, P1290, DOI 10.1002/1529-0131(200006)43:6<1290::AID-ANR11>3.0.CO;2-R; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rutishauser J, 2002, SWISS MED WKLY, V132, P211; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Shikhman AR, 2001, J IMMUNOL, V166, P5155, DOI 10.4049/jimmunol.166.8.5155; Smith RL, 2004, CLIN ORTHOP RELAT R, pS89, DOI 10.1097/01.blo.0000143938.30681.9d; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; VERTEL BM, 1989, J CELL BIOL, V109, P1827, DOI 10.1083/jcb.109.4.1827; VERTEL BM, 1993, J CELL SCI, V104, P939; Vranka J, 2001, MATRIX BIOL, V20, P439, DOI 10.1016/S0945-053X(01)00148-2; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Yagi A, 2003, J CELL BIOCHEM, V90, P1242, DOI 10.1002/jcb.10711; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	53	85	93	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31156	31165		10.1074/jbc.M501069200	http://dx.doi.org/10.1074/jbc.M501069200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16000304	hybrid			2022-12-27	WOS:000231487800062
J	Yatsula, B; Lin, S; Read, AJ; Poholek, A; Yates, K; Yue, DX; Hui, P; Perkins, AS				Yatsula, B; Lin, S; Read, AJ; Poholek, A; Yates, K; Yue, DX; Hui, P; Perkins, AS			Identification of binding sites of EVI1 in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOGENOUS LEUKEMIAS; MYELOID-TRANSFORMING GENE; ZINC-FINGER PROTEIN; HEMATOPOIETIC-CELLS; CONSENSUS SEQUENCE; CO-REPRESSOR; EXPRESSION; TRANSCRIPTION; ACTIVATION; GATA-2	The leukemia- associated protein EVI1 possesses seven zinc fingers within an N- terminal domain ( amino acids 1 - 250) that binds to GACAAGATA. Single amino acid missense mutants of EVI1 were developed that failed to bind DNA either in vitro, as assessed by gel shift assay, or in vivo, as shown by transactivation studies. Specifically, mutation R205N lacks high affinity binding to the GACAAGATA motif. Putative EVI1 target genes were identified by using an EVI1-( 1 - 250)VP16 fusion protein that acts as a transcriptional activator with the binding specificity of EVI1. Sixteen genes induced in NIH 3T3 cells by wild type EVI1- VP16 but not by mutant forms were identified. Sequence analysis revealed evolutionarily conserved GACAA-GATA-like motifs within 10 kb of their transcription start sites, and by chromatin immunoprecipitation in fibroblasts, we showed occupancy of many of these sites by EVI1- VP16. To assess whether native EVI1 binds to these sites in EVI1- transformed myeloid cells, we performed chromatin immunoprecipitation in 32Dcl3 and NFS58 cells, using anti- EVI1 antisera, and we showed that the majority of these sites is bound by wild type EVI1. These putative target genes include Gadd45g, Gata2, Zfpm2/ Fog2, Skil ( SnoN), Klf5 ( BTEB2), Dcn, and Map3k14 ( Nik). In this study we demonstrated for the first time that the N- terminal DNA binding domain of EVI1 has the capacity to bind to endogenous genes. We hypothesized that these genes play a critical role in EVI1- induced transformation.	Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University	Perkins, AS (corresponding author), POB 208023, New Haven, CT 06520 USA.	archibald.perkins@yale.edu		Read, Andrew/0000-0001-7336-8496	PHS HHS [R01 81216] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bartholomew C, 1997, ONCOGENE, V14, P569, DOI 10.1038/sj.onc.1200864; BARTHOLOMEW C, 1989, ONCOGENE, V4, P529; BARTHOLOMEW C, 1994, ONCOGENE, V9, P939; BERG JM, 1988, P NATL ACAD SCI USA, V85, P99, DOI 10.1073/pnas.85.1.99; BORDEREAUX D, 1990, ONCOGENE, V5, P925; BOYER PL, 1993, ONCOGENE, V8, P457; Cheng T, 1996, P NATL ACAD SCI USA, V93, P13158, DOI 10.1073/pnas.93.23.13158; Chi YQ, 2003, J BIOL CHEM, V278, P49806, DOI 10.1074/jbc.M309645200; CHODOSH LA, 1986, MOL CELL BIOL, V6, P4723, DOI 10.1128/MCB.6.12.4723; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DELWEL R, 1993, MOL CELL BIOL, V13, P4291, DOI 10.1128/MCB.13.7.4291; Ezoe S, 2002, BLOOD, V100, P3512, DOI 10.1182/blood-2002-04-1177; Fears S, 1996, P NATL ACAD SCI USA, V93, P1642, DOI 10.1073/pnas.93.4.1642; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; FICHELSON S, 1992, LEUKEMIA, V6, P93; FUNABIKI T, 1994, ONCOGENE, V9, P1575; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; HOCHULI E, 1990, GENETIC ENG PRINCIPL, V2, P87; Ikonomi P, 2000, EXP HEMATOL, V28, P1423, DOI 10.1016/S0301-472X(00)00553-1; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; KELLER JR, 1988, J EXP MED, V168, P737, DOI 10.1084/jem.168.2.737; KhannaGupta A, 1996, ONCOGENE, V12, P563; Kilbey A, 1998, ONCOGENE, V16, P2287, DOI 10.1038/sj.onc.1201732; Kilbey A, 1999, CELL GROWTH DIFFER, V10, P601; Kim JH, 1998, ONCOGENE, V17, P1527, DOI 10.1038/sj.onc.1202331; KLEVIT RE, 1991, SCIENCE, V253, P1367, DOI 10.1126/science.1896847; KREIDER BL, 1993, P NATL ACAD SCI USA, V90, P6454, DOI 10.1073/pnas.90.14.6454; Kumano K, 2001, BLOOD, V98, P3283, DOI 10.1182/blood.V98.12.3283; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; KUROKAWA M, 1995, ONCOGENE, V11, P833; MITANI K, 1994, EMBO J, V13, P504, DOI 10.1002/j.1460-2075.1994.tb06288.x; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MORISHITA K, 1990, ONCOGENE, V5, P963; MORISHITA K, 1992, MOL CELL BIOL, V12, P183, DOI 10.1128/MCB.12.1.183; MORISHITA K, 1995, ONCOGENE, V10, P1961; MORISHITA K, 1992, P NATL ACAD SCI USA, V89, P3937, DOI 10.1073/pnas.89.9.3937; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; NUCIFORA G, 1994, P NATL ACAD SCI USA, V91, P4004, DOI 10.1073/pnas.91.9.4004; Palmer S, 2001, J BIOL CHEM, V276, P25834, DOI 10.1074/jbc.M102343200; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; PERKINS AS, 1991, DEVELOPMENT, V111, P479; Perkins AS, 1996, J BIOL CHEM, V271, P1104, DOI 10.1074/jbc.271.2.1104; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; RIGGS AD, 1970, J MOL BIOL, V48, P67, DOI 10.1016/0022-2836(70)90219-6; SHIMAMOTO T, 1994, LEUKEMIA, V8, P1176; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; SHOCKETT P, 1995, P NATL ACAD SCI USA, V92, P6522, DOI 10.1073/pnas.92.14.6522; Sitailo S, 1999, LEUKEMIA, V13, P1639, DOI 10.1038/sj.leu.2401585; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; SUZUKAWA K, 1994, BLOOD, V84, P2681; TANAKA T, 1994, J BIOL CHEM, V269, P24020; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679	61	48	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30712	30722		10.1074/jbc.M504293200	http://dx.doi.org/10.1074/jbc.M504293200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16006653	hybrid			2022-12-27	WOS:000231487800010
J	Xu, AG; Lei, L; Irvine, KD				Xu, AG; Lei, L; Irvine, KD			Regions of Drosophila Notch that contribute to ligand binding and the modulatory influence of fringe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-FUCOSYL-TRANSFERASE; FACTOR-LIKE REPEATS; PROTEIN O-FUCOSYL-TRANSFERASE-1; ABRUPTEX MUTATIONS; DELTA INTERACTIONS; SERRATE; RECEPTOR; JAGGED1; DOMAIN; PAIR	Two glycosyltransferases that transfer sugars to epidermal growth factor (EGF) domains, OFUT1 and Fringe, regulate Notch signaling. To characterize the impact of glycosylation at the 23 consensus O-fucose sites in Drosophila Notch, we conducted deletion mapping and site-specific mutagenesis and then assayed the binding of soluble forms of Notch to cell-surface ligands. Our results support the conclusion that EGF11 and EGF12 are essential for ligand binding, but indicate that other EGF domains also make substantial contributions to ligand binding. Characterization of Notch deletion constructs and O-fucose site mutants further revealed that no single site or region can account for the influence of Fringe on Notch-ligand binding. Additionally, we observed an influence of Fringe on a Notch fragment including only 4 of its 36 EGF domains (EGF10 - 13). Together, our observations imply that glycosylation influences Notch-ligand interactions through a distributive mechanism that involves local interactions with multiple EGF domains and led us to suggest a structural model for how Notch interacts with its ligands.	Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Lei, L (corresponding author), Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, 190 Frellinghuysen Rd, Piscataway, NJ 08854 USA.	irvine@waksman.rutgers.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054594] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM54594] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brennan K, 1999, DEV BIOL, V216, P230, DOI 10.1006/dbio.1999.9501; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; de Celis JF, 2000, DEVELOPMENT, V127, P1291; DECELIS JF, 1993, P NATL ACAD SCI USA, V90, P4037, DOI 10.1073/pnas.90.9.4037; DECELIS JF, 1994, GENETICS, V136, P183; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Fleming RJ, 1998, SEMIN CELL DEV BIOL, V9, P599, DOI 10.1006/scdb.1998.0260; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; KELLEY MR, 1987, CELL, V51, P539, DOI 10.1016/0092-8674(87)90123-1; Klein T, 1998, DEVELOPMENT, V125, P2951; Klueg KM, 1999, J CELL SCI, V112, P3289; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lawrence N, 2000, DEVELOPMENT, V127, P3185; Lei L, 2003, DEVELOPMENT, V130, P6411, DOI 10.1242/dev.00883; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; Perez L, 2005, MECH DEVELOP, V122, P479, DOI 10.1016/j.mod.2004.12.007; Powell PA, 2001, NATURE, V409, P626, DOI 10.1038/35054566; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Saha S, 2001, STRUCTURE, V9, P451, DOI 10.1016/S0969-2126(01)00606-2; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614	41	61	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30158	30165		10.1074/jbc.M505569200	http://dx.doi.org/10.1074/jbc.M505569200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15994325	hybrid			2022-12-27	WOS:000231362500023
J	Fujimoto, M; Takaki, E; Hayashi, T; Kitaura, Y; Tanaka, Y; Inouye, S; Nakai, A				Fujimoto, M; Takaki, E; Hayashi, T; Kitaura, Y; Tanaka, Y; Inouye, S; Nakai, A			Active HSF1 significantly suppresses polyglutamine aggregate formation in cellular and mouse models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK TRANSCRIPTION FACTOR-1; NEURONAL INTRANUCLEAR INCLUSIONS; TRUNCATED ANDROGEN RECEPTOR; HUNTINGTONS-DISEASE GENE; EXPANDED CAG REPEAT; HEAT-SHOCK; MOLECULAR CHAPERONES; PROTEIN AGGREGATION; HSP40 CHAPERONES; MICE	Polyglutamine diseases are inherited neurodegenerative diseases characterized by misfolding and aggregation of proteins possessing expanded polyglutamine repeats. As overexpression of some heat shock protein (Hsp) suppresses polyglutamine aggregates and cell death, it is assumed that combined overexpression of Hsps will suppress that more effectively. Here, we examined the impact of active forms of heat shock transcription factor 1 (HSF1), which induces a set of Hsps, on polyglutamine inclusion formation and disease progression. We found that active HSF1 suppressed polyglutamine inclusion formation more significantly than any combination of Hsps in culture cells, possibly by regulating expression of unknown genes, as well as major Hsps. We crossed R6/2 Huntington disease mice with transgenic mice expressing an active HSF1 (HSF1Tg). Analysis of the skeletal muscle revealed that the polyglutamine inclusion formation and its weight loss were improved in R6/2/HSF1Tg mice. Unexpectedly, the life span of R6/2/HSF1Tg mice was significantly improved, although active HSF1 is not expressed in the brain. These results indicated that active HSF1 has a strong inhibitory effect on polyglutamine aggregate formation in vivo and in vitro.	Yamaguchi Univ, Sch Med, Dept Biochem & Mol Biol, Ube, Yamaguchi 7758505, Japan; Osaka Med Coll, Dept Med 3, Osaka 5698686, Japan	Yamaguchi University; Osaka Medical College	Nakai, A (corresponding author), Yamaguchi Univ, Sch Med, Dept Biochem & Mol Biol, Ube, Yamaguchi 7758505, Japan.	anakai@yamaguchi-u.ac.jp	Longo, Kenneth A/A-5631-2010					Adachi H, 2003, J NEUROSCI, V23, P2203; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Carmichael J, 2000, P NATL ACAD SCI USA, V97, P9701, DOI 10.1073/pnas.170280697; Chai YH, 1999, J NEUROSCI, V19, P10338; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hansson O, 2003, BRAIN RES, V970, P47, DOI 10.1016/S0006-8993(02)04275-0; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; HAYASHI T, 1995, AM HEART J, V129, P946, DOI 10.1016/0002-8703(95)90116-7; Helmlinger D, 2004, J BIOL CHEM, V279, P55969, DOI 10.1074/jbc.M409062200; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hurlbert MS, 1999, DIABETES, V48, P649, DOI 10.2337/diabetes.48.3.649; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Inouye S, 2003, MOL CELL BIOL, V23, P5882, DOI 10.1128/MCB.23.16.5882-5895.2003; Ishihara K, 2003, J BIOL CHEM, V278, P25143, DOI 10.1074/jbc.M302975200; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kato K, 1998, J BIOL CHEM, V273, P28346, DOI 10.1074/jbc.273.43.28346; Katoh Y, 2004, FEBS LETT, V565, P28, DOI 10.1016/j.febslet.2003.12.085; Katsuki K, 2004, FEBS LETT, V571, P187, DOI 10.1016/j.febslet.2004.06.087; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Komatsuda A, 1999, NEPHROL DIAL TRANSPL, V14, P1385, DOI 10.1093/ndt/14.6.1385; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Meriin AB, 2001, J CELL BIOL, V153, P851, DOI 10.1083/jcb.153.4.851; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Myers RH, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P301; Nakai A, 2000, EMBO J, V19, P1545, DOI 10.1093/emboj/19.7.1545; NAKAI A, 1995, MOL CELL BIOL, V15, P5168; OHTSUKA K, 1993, BIOCHEM BIOPH RES CO, V197, P235, DOI 10.1006/bbrc.1993.2466; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; Orth M, 2003, J NEUROCHEM, V87, P1, DOI 10.1046/j.1471-4159.2003.02009.x; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Rimoldi M, 2001, BRAIN RES BULL, V56, P353, DOI 10.1016/S0361-9230(01)00602-5; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Xia WL, 1999, CELL STRESS CHAPERON, V4, P8, DOI 10.1054/csac.1998.0113; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	59	163	171	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34908	34916		10.1074/jbc.M506288200	http://dx.doi.org/10.1074/jbc.M506288200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16051598	hybrid			2022-12-27	WOS:000232403900063
J	Tudor, EL; Perkinton, MS; Schmidt, A; Ackerley, S; Brownlees, J; Jacobsen, NJO; Byers, HL; Ward, M; Hall, A; Leigh, PN; Shaw, CE; McLoughlin, DM; Miller, CCJ				Tudor, EL; Perkinton, MS; Schmidt, A; Ackerley, S; Brownlees, J; Jacobsen, NJO; Byers, HL; Ward, M; Hall, A; Leigh, PN; Shaw, CE; McLoughlin, DM; Miller, CCJ			ALS2/Alsin regulates Rac-PAK signaling and neurite outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEOTIDE EXCHANGE FACTOR; ACTIVATED PROTEIN-KINASE; GROWTH CONE COLLAPSE; CU,ZN SUPEROXIDE-DISMUTASE; RHO-GTPASES; ADAPTER PROTEIN; ALS2 GENE; PHOSPHATASE EXPRESSION; SPASTIC PARALYSIS	Rac and its downstream effectors p21-activated kinase (PAK) family kinases regulate actin dynamics within growth cones to control neurite outgrowth during development. The activity of Rac is stimulated by guanine nucleotide exchange factors ( GEFs) that promote GDP release and GTP binding. ALS2/Alsin is a recently described GEF that contains a central domain that is predicted to regulate the activities of Rac and/or Rho and Cdc42 activities. Mutations in ALS2 cause some recessive familial forms of amyotrophic lateral sclerosis (ALS) but the function of ALS2 is poorly understood. Here we demonstrate that ALS2 is present within growth cones of neurons, in which it co-localizes with Rac. Furthermore, ALS2 stimulates Rac but not Rho or Cdc42 activities, and this induces a corresponding increase in PAK1 activity. Finally, we demonstrate that ALS2 promotes neurite outgrowth. Defects in these functions may therefore contribute to motor neuron demise in ALS.	Kings Coll London, Inst Psychiat, Dept Neurosci, London SE5 8AF, England; Kings Coll London, Dept Neurol, Inst Psychiat, London SE5 8AF, England; Kings Coll London, Old Age Psychiat Sect, Inst Psychiat, London SE5 8AF, England; UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; Proteome Sci Plc, Inst Psychiat, London SE5 8AF, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; University College London; University of London; King's College London	Miller, CCJ (corresponding author), Kings Coll London, Inst Psychiat, Dept Neurosci, POB P037,De Crespigny Pk,Denmark Hill, London SE5 8AF, England.	chris.miller@iop.kcl.ac.uk	Leigh, Peter/AAD-5638-2019; Miller, Christopher/H-5733-2012	Miller, Christopher/0000-0002-5130-1845; Ward, Malcolm/0000-0003-2164-6938; McLoughlin, Declan/0000-0003-4574-2799; Shaw, Christopher/0000-0003-0251-0146	MRC [G0000749] Funding Source: UKRI; Medical Research Council [G0000749] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ackerley S, 2004, MOL CELL NEUROSCI, V26, P354, DOI 10.1016/j.mcn.2004.02.009; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Brownlees J, 2002, HUM MOL GENET, V11, P2837, DOI 10.1093/hmg/11.23.2837; Brownlees J, 2000, J CELL SCI, V113, P401; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Devon RS, 2003, CLIN GENET, V64, P210, DOI 10.1034/j.1399-0004.2003.00138.x; Devon RS, 2005, NEUROBIOL DIS, V18, P243, DOI 10.1016/j.nbd.2004.10.002; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Eymard-Pierre E, 2002, AM J HUM GENET, V71, P518, DOI 10.1086/342359; Figlewicz DA, 2003, AMYOTROPH LATERAL SC, V4, P225, DOI 10.1080/14660820310011287; Gros-Louis F, 2003, ANN NEUROL, V53, P144, DOI 10.1002/ana.10422; Guidato S, 1998, J NEUROCHEM, V70, P335; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hu JH, 2003, J NEUROCHEM, V85, P422, DOI 10.1046/j.1471-4159.2003.01669.x; Hu JH, 2003, J NEUROCHEM, V85, P432, DOI 10.1046/j.1471-4159.2003.01670.x; Jin Z, 1997, J NEUROSCI, V17, P6256; Kanekura K, 2005, J BIOL CHEM, V280, P4532, DOI 10.1074/jbc.M410508200; KANEKURA K, 2004, J BIOL CHEM; Kuhn TB, 1999, J NEUROSCI, V19, P1965; Kunita R, 2004, J BIOL CHEM, V279, P38626, DOI 10.1074/jbc.M406120200; Lee JH, 2004, J BIOL CHEM, V279, P49099, DOI 10.1074/jbc.M405602200; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Lundquist EA, 2003, CURR OPIN NEUROBIOL, V13, P384, DOI 10.1016/s0959-4388(03)00071-0; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; May V, 2002, J NEUROSCI, V22, P6980; Mourelatos Z, 1996, P NATL ACAD SCI USA, V93, P5472, DOI 10.1073/pnas.93.11.5472; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Penzes P, 2001, J NEUROSCI, V21, P8426, DOI 10.1523/JNEUROSCI.21-21-08426.2001; Perkinton MS, 2004, J BIOL CHEM, V279, P22084, DOI 10.1074/jbc.M311479200; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Standen CL, 2003, MOL CELL NEUROSCI, V24, P851, DOI 10.1016/j.mcn.2003.07.002; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; TOPP JD, 2004, J BIOL CHEM; Tortarolo M, 2003, MOL CELL NEUROSCI, V23, P180, DOI 10.1016/S1044-7431(03)00022-8; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Yamanaka K, 2003, P NATL ACAD SCI USA, V100, P16041, DOI 10.1073/pnas.2635267100; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	53	67	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34735	34740		10.1074/jbc.M506216200	http://dx.doi.org/10.1074/jbc.M506216200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16049005	hybrid, Green Published			2022-12-27	WOS:000232403900044
J	Parri, M; Buricchi, F; Taddei, ML; Giannoni, E; Raugei, G; Ramponi, G; Chiarugi, P				Parri, M; Buricchi, F; Taddei, ML; Giannoni, E; Raugei, G; Ramponi, G; Chiarugi, P			EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE; OVEREXPRESSION; ACTIVATION; RECEPTORS; FAMILY; ADHESION; PTP; PHOSPHORYLATION; TUMORIGENICITY; PROTEINS	Ephrin kinases and their ephrin ligands transduce repulsion of cells in axon guidance, migration, invasiveness, and tumor growth, exerting a negative signaling on cell proliferation and adhesion. A key role of their kinase activity has been confirmed by mutant kinase inactive receptors that shift the cellular response from repulsion to adhesion. Our present study aimed to investigate the role of low molecular weight protein-tyrosine phosphatase (LMW-PTP) in ephrinA1/EphA2 signaling. LMW-PTP, by means of dephosphorylation of EphA2 kinase, negatively regulates the ephrinA1-mediated repulsive response, cell proliferation, cell adhesion and spreading, and the formation of retraction fibers, thereby confirming the relevance of the net level of tyrosine phosphorylation of Eph receptors. LMW-PTP interferes with ephrin-mediated mitogen-activated protein kinase signaling likely through inhibition of p120RasGAP binding to the activated EphA2 kinase, thereby confirming the key role of mitogen-activated protein kinase inhibition by ephrinA1 repulsive signaling. We conclude that LMW-PTP acts as a terminator of EphA2 signaling causing an efficient negative feedback loop on the biological response mediated by ephrinA1 and pointing on tyrosine phosphorylation as the main event orchestrating the repulsive response.	Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy; Univ Florence, Ctr Res Transfer & High Educ Study Mol & Clin Lev, I-50134 Florence, Italy	University of Florence; University of Florence	Chiarugi, P (corresponding author), Univ Florence, Dept Biochem Sci, Viale Morgagni 50, I-50134 Florence, Italy.	paola.chiarugi@unifi.it	Giannoni, Elisa/AAE-2092-2020; Chiarugi, Paola/CDD-7988-2022	raugei, giovanni/0000-0003-1294-786X; Giannoni, Elisa/0000-0001-7136-1098; Chiarugi, Paola/0000-0001-7655-2969				Baker RK, 2003, DEV DYNAM, V228, P128, DOI 10.1002/dvdy.10354; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Chiarugi P, 2004, ONCOGENE, V23, P3905, DOI 10.1038/sj.onc.1207508; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; EASTY DJ, 1995, INT J CANCER, V60, P129, DOI 10.1002/ijc.2910600119; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Erdmann KS, 2003, EUR J BIOCHEM, V270, P4789, DOI 10.1046/j.1432-1033.2003.03895.x; Fukushima N, 2002, MOL CELL NEUROSCI, V20, P271, DOI 10.1006/mcne.2002.1123; Giannoni E., 2000, Molecular Cell Biology Research Communications, V3, P264, DOI 10.1006/mcbr.2000.0228; Gu C, 2001, MOL CELL BIOL, V21, P4579, DOI 10.1128/MCB.21.14.4579-4597.2001; Harrington RJ, 2002, DEVELOPMENT, V129, P2141; Holder N, 1999, DEVELOPMENT, V126, P2033; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Holmberg J, 2002, TRENDS NEUROSCI, V25, P239, DOI 10.1016/S0166-2236(02)02149-5; Kikawa KD, 2002, J BIOL CHEM, V277, P39274, DOI 10.1074/jbc.M207127200; Kim I, 2002, FASEB J, V16, P1126, DOI 10.1096/fj.01-0805fje; KIYOKAWA E, 1994, CANCER RES, V54, P3645; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Miao H, 2003, J CELL BIOL, V162, P1281, DOI 10.1083/jcb.200304018; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; MITCHISON TJ, 1992, CELL MOTIL CYTOSKEL, V22, P135, DOI 10.1002/cm.970220207; Nagashima KI, 2002, MOL BIOL CELL, V13, P4231, DOI 10.1091/mbc.E02-04-0181; Nakamoto M, 2002, MICROSC RES TECHNIQ, V59, P58, DOI 10.1002/jemt.10177; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pratt RL, 2002, ONCOGENE, V21, P7690, DOI 10.1038/sj.onc.1205758; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Tang XX, 2000, P NATL ACAD SCI USA, V97, P10936, DOI 10.1073/pnas.190123297; Tong JF, 2003, J BIOL CHEM, V278, P6111, DOI 10.1074/jbc.M208972200; Varelias A, 2002, CANCER, V95, P862, DOI 10.1002/cncr.10749; Vindis C, 2003, J CELL BIOL, V162, P661, DOI 10.1083/jcb.200302073; Vogt T, 1998, CLIN CANCER RES, V4, P791; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Walker-Daniels J, 1999, PROSTATE, V41, P275, DOI 10.1002/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xu Z, 2003, J BIOL CHEM, V278, P24767, DOI 10.1074/jbc.M302454200; Zelinski DP, 2001, CANCER RES, V61, P2301	42	65	68	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34008	34018		10.1074/jbc.M502879200	http://dx.doi.org/10.1074/jbc.M502879200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16051609	hybrid			2022-12-27	WOS:000232229700039
J	Swarts, HGP; Koenderink, JB; Willems, PHGM; De Pont, JJHHM				Swarts, HGP; Koenderink, JB; Willems, PHGM; De Pont, JJHHM			The non-gastric H,K-ATPase is oligomycin-sensitive and can function as an H+,NH4+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-K+-ATPASE; H+,K+-ATPASE ALPHA-SUBUNIT; RAT DISTAL COLON; CORTICAL COLLECTING DUCT; HUMAN ATP1AL1 GENE; BETA-SUBUNITS; ADENOSINE TRIPHOSPHATASE; APICAL MEMBRANES; EXPRESSION; PHOSPHORYLATION	We used the baculovirus/ Sf9 expression system to gain new information on the mechanistic properties of the rat non-gastric H, K-ATPase, an enzyme that is implicated in potassium homeostasis. The alpha(2)-subunit of this enzyme (HK alpha(2)) required a beta-subunit for ATPase activity thereby showing a clear preference for NaK beta(1) over NaK beta(3) and gastric HK beta. NH4+, K+, and Na+ maximally increased the activity of HK alpha(2)-NaK beta(1) to 24.0, 14.2, and 5.0 mu mol P-i center dot mg(-1) protein center dot h(-1), respectively. The enzyme was inhibited by relatively high concentrations of ouabain and SCH 28080, whereas it was potently inhibited by oligomycin. From the phosphorylation level in the presence of oligomycin and the maximal NH4+-stimulated ATPase activity, a turnover number of 20,000 min(-1) was determined. All three cations decreased the steady-state phosphorylation level and enhanced the dephosphorylation rate, disfavoring the hypothesis that Na+ can replace H+ as the activating cation. The potency with which vanadate inhibited the cation-activated enzyme decreased in the order K+ > NH4+ > Na+, indicating that K+ is a stronger E-2 promoter than NH4+, whereas in the presence of Na+ the enzyme is in the E-1 form. For K+ and NH4+, the E-2 to E-1 conformational equilibrium correlated with their efficacy in the ATPase reaction, indicating that here the transition from E-2 to E-1 is rate-limiting. Conversely, the low maximal ATPase activity with Na+ is explained by a poor stimulatory effect on the dephosphorylation rate. These data show that NH4+ can replace K+ with similar affinity but higher efficacy as an extracellular activating cation in rat nongastric H, K-ATPase.	Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	De Pont, JJHHM (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Biochem 160, POB 9101, NL-6500 HB Nijmegen, Netherlands.	J.dePont@ncmls.ru.nl	Willems, P.H.G.M./L-4759-2015; Koenderink, Jan/N-3578-2014	Willems, P.H.G.M./0000-0002-0915-1599; 				Adams G, 2001, BIOCHEMISTRY-US, V40, P5765, DOI 10.1021/bi010191y; Asano S, 1998, AM J PHYSIOL-CELL PH, V275, pC669, DOI 10.1152/ajpcell.1998.275.3.C669; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BUFFINMEYER B, 1997, AM J PHYSIOL-RENAL, V41, pF124; Burnay M, 2003, J BIOL CHEM, V278, P19237, DOI 10.1074/jbc.M300946200; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Codina J, 1998, J BIOL CHEM, V273, P7894, DOI 10.1074/jbc.273.14.7894; Codina J, 1997, AM J PHYSIOL-RENAL, V272, pF22, DOI 10.1152/ajprenal.1997.272.1.F22; Codina J, 1999, J BIOL CHEM, V274, P19693, DOI 10.1074/jbc.274.28.19693; Codina J, 1996, J BIOL CHEM, V271, P29759, DOI 10.1074/jbc.271.47.29759; Cougnon M, 1998, P NATL ACAD SCI USA, V95, P6516, DOI 10.1073/pnas.95.11.6516; Cougnon M, 1996, J BIOL CHEM, V271, P7277, DOI 10.1074/jbc.271.13.7277; COUGNON M, 1999, AM J PHYSIOL, V46, pC280; Crambert G, 2002, AM J PHYSIOL-CELL PH, V283, pC305, DOI 10.1152/ajpcell.00590.2001; FAHN S, 1968, J BIOL CHEM, V243, P1993; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; Geering K, 2000, BIOCHEMISTRY-US, V39, P12688, DOI 10.1021/bi0009791; Grishin AV, 1998, J BIOL CHEM, V273, P27772, DOI 10.1074/jbc.273.43.27772; Grishin AV, 1996, AM J PHYSIOL-RENAL, V271, pF539, DOI 10.1152/ajprenal.1996.271.3.F539; GUSTIN MC, 1982, J BIOL CHEM, V257, P9629; Hermsen HPH, 1998, BIOCHEM J, V331, P465, DOI 10.1042/bj3310465; Jaisser F, 1996, AM J PHYSIOL-CELL PH, V270, pC679, DOI 10.1152/ajpcell.1996.270.2.C679; Jaisser F, 1999, AM J PHYSIOL-RENAL, V276, pF812, DOI 10.1152/ajprenal.1999.276.6.F812; KLAASSEN CHW, 1995, BIOCHEM BIOPH RES CO, V210, P907, DOI 10.1006/bbrc.1995.1743; KLAASSEN CHW, 1993, FEBS LETT, V329, P277, DOI 10.1016/0014-5793(93)80237-O; Koenderink JB, 1999, J BIOL CHEM, V274, P11604, DOI 10.1074/jbc.274.17.11604; Kone BC, 1998, J BIOL CHEM, V273, P2543, DOI 10.1074/jbc.273.5.2543; Kraut JA, 1998, KIDNEY INT, V53, P958, DOI 10.1111/j.1523-1755.1998.00841.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE JS, 1995, J CLIN INVEST, V96, P2002, DOI 10.1172/JCI118247; Li J, 2004, KIDNEY INT, V66, P1068, DOI 10.1111/j.1523-1755.2004.00856.x; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Martin DW, 1999, BIOCHEMISTRY-US, V38, P7485, DOI 10.1021/bi983019b; MODYANOV NN, 1995, AM J PHYSIOL-CELL PH, V269, pC992, DOI 10.1152/ajpcell.1995.269.4.C992; Nakamura S, 1999, KIDNEY INT, V56, P2160, DOI 10.1046/j.1523-1755.1999.00780.x; Pestov NB, 1998, FEBS LETT, V440, P320, DOI 10.1016/S0014-5793(98)01483-5; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sangan P, 2000, AM J PHYSIOL-CELL PH, V278, pC182, DOI 10.1152/ajpcell.2000.278.1.C182; Sangan P, 1999, AM J PHYSIOL-CELL PH, V276, pC350, DOI 10.1152/ajpcell.1999.276.2.C350; SANGAN PC, 1997, AM J PHYSIOL, V41, pC685; SWARTS HGP, 1995, J BIOL CHEM, V270, P7890, DOI 10.1074/jbc.270.14.7890; Swarts HGP, 1998, EMBO J, V17, P3029, DOI 10.1093/emboj/17.11.3029; Swarts HGP, 1996, J BIOL CHEM, V271, P29764, DOI 10.1074/jbc.271.47.29764; WALLMARK B, 1979, J BIOL CHEM, V254, P1899; ZHOU XM, 1992, AM J PHYSIOL, V263, pF1134; ZHOU XM, 1992, AM J PHYSIOL, V263, pF43, DOI 10.1152/ajprenal.1992.263.1.F43	48	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33115	33122		10.1074/jbc.M504535200	http://dx.doi.org/10.1074/jbc.M504535200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16046397	Green Published, hybrid			2022-12-27	WOS:000232058100005
J	Chou, YT; Gierasch, LM				Chou, YT; Gierasch, LM			The conformation of a signal peptide bound by Escherichia coli preprotein translocase SecA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATPASE ACTIVITY; PROTEIN EXPORT; PRECURSOR PROTEINS; HYDROPHOBIC REGION; CATALYTIC CYCLE; MODEL MEMBRANES; MATURE REGION; WILD-TYPE; SEQUENCE; BINDING	To understand the structural nature of signal sequence recognition by the preprotein translocase SecA, we have characterized the interactions of a signal peptide corresponding to a LamB signal sequence (modified to enhance aqueous solubility) with SecA by NMR methods. One-dimensional NMR studies showed that the signal peptide binds SecA with a moderately fast exchange rate ( K-d similar to 10(-5) (M)). The line-broadening effects observed from one-dimensional and two-dimensional NMR spectra indicated that the binding mode does not equally immobilize all segments of this peptide. The positively charged arginine residues of the n-region and the hydrophobic residues of the h-region had less mobility than the polar residues of the c-region in the SecA-bound state, suggesting that this peptide has both electrostatic and hydrophobic interactions with the binding pocket of SecA. Transferred nuclear Over-hauser experiments revealed that the h-region and part of the c-region of the signal peptide form an alpha helical conformation upon binding to SecA. One side of the hydrophobic core of the helical h-region appeared to be more strongly bound in the binding pocket, whereas the extreme C terminus of the peptide was not intimately involved. These results argue that the positive charges at the n-region and the hydrophobic helical h-region are the selective features for recognition of signal sequences by SecA and that the signal peptide-binding site on SecA is not fully buried within its structure.	Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	gierasch@biochem.umass.edu	Gierasch, Lila M/D-1494-2009		NIGMS NIH HHS [GM034962] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034962] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baud C, 2005, PROTEIN EXPRES PURIF, V40, P336, DOI 10.1016/j.pep.2004.12.009; Baud C, 2002, J BIOL CHEM, V277, P13724, DOI 10.1074/jbc.M200047200; Benach J, 2003, J BIOL CHEM, V278, P3628, DOI 10.1074/jbc.M205992200; BIEKER KL, 1990, CELL, V61, P833, DOI 10.1016/0092-8674(90)90193-I; BREUKINK E, 1995, J BIOL CHEM, V270, P7902, DOI 10.1074/jbc.270.14.7902; BRIGGS MS, 1986, SCIENCE, V233, P206, DOI 10.1126/science.2941862; BRIGGS MS, 1984, BIOCHEMISTRY-US, V23, P3111, DOI 10.1021/bi00309a001; BRUCH MD, 1990, J BIOL CHEM, V265, P3851; BRUCH MD, 1989, BIOCHEMISTRY-US, V28, P8554, DOI 10.1021/bi00447a043; CAMPBELL AP, 1993, ANNU REV BIOPH BIOM, V22, P99, DOI 10.1146/annurev.bb.22.060193.000531; Cavanagh John, 1996, P95; Chou YT, 2002, J BIOL CHEM, V277, P50985, DOI 10.1074/jbc.M209237200; CLORE GM, 1983, J MAGN RESON, V53, P423, DOI 10.1016/0022-2364(83)90215-9; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; CUNNINGHAM K, 1989, P NATL ACAD SCI USA, V86, P8630, DOI 10.1073/pnas.86.22.8630; Dalbey RE, 2004, BBA-MOL CELL RES, V1694, P37, DOI 10.1016/j.bbamcr.2004.03.009; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; Duong F, 1999, EMBO J, V18, P3263, DOI 10.1093/emboj/18.12.3263; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; EMR SD, 1981, CELL, V23, P79, DOI 10.1016/0092-8674(81)90272-5; EMR SD, 1983, P NATL ACAD SCI-BIOL, V80, P4599, DOI 10.1073/pnas.80.15.4599; Fekkes P, 1999, MICROBIOL MOL BIOL R, V63, P161, DOI 10.1128/MMBR.63.1.161-173.1999; FLOWER AM, 1994, J BACTERIOL, V176, P5607, DOI 10.1128/JB.176.18.5607-5614.1994; GENNITY J, 1990, J BIOENERG BIOMEMBR, V22, P233, DOI 10.1007/BF00763167; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; GOLDSTEIN J, 1991, J BIOL CHEM, V266, P14413; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; HOYT DW, 1991, J BIOL CHEM, V266, P14406; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Izard JW, 1996, J BIOL CHEM, V271, P21579, DOI 10.1074/jbc.271.35.21579; IZARD JW, 1994, MOL MICROBIOL, V13, P765, DOI 10.1111/j.1365-2958.1994.tb00469.x; KIMURA E, 1991, J BIOL CHEM, V266, P6600; Kourtz L, 2000, MOL MICROBIOL, V37, P1342, DOI 10.1046/j.1365-2958.2000.02078.x; LANDRY SJ, 1992, NATURE, V355, P455, DOI 10.1038/355455a0; LIAN LY, 1994, METHOD ENZYMOL, V239, P657; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; MCKNIGHT CJ, 1991, P NATL ACAD SCI USA, V88, P5799, DOI 10.1073/pnas.88.13.5799; MCKNIGHT CJ, 1989, J BIOL CHEM, V264, P17293; Miller A, 1998, J BIOL CHEM, V273, P11409, DOI 10.1074/jbc.273.19.11409; Mori H, 1997, BBA-BIOMEMBRANES, V1326, P23, DOI 10.1016/S0005-2736(97)00004-7; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; RIZO J, 1993, BIOCHEMISTRY-US, V32, P4881, DOI 10.1021/bi00069a025; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Schmidt M, 2000, J BIOL CHEM, V275, P15440, DOI 10.1074/jbc.M000605200; Sharma V, 2003, P NATL ACAD SCI USA, V100, P2243, DOI 10.1073/pnas.0538077100; Sianidis G, 2001, EMBO J, V20, P961, DOI 10.1093/emboj/20.5.961; STADER J, 1986, J BIOL CHEM, V261, P5075; Triplett TL, 2001, J BIOL CHEM, V276, P19648, DOI 10.1074/jbc.M100098200; ULBRANDT ND, 1992, J BIOL CHEM, V267, P15184; van der Wolk JPW, 1998, EMBO J, V17, P3631, DOI 10.1093/emboj/17.13.3631; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; Vrontou E, 2004, BBA-MOL CELL RES, V1694, P67, DOI 10.1016/j.bbamcr.2004.06.003; Wang LG, 2000, J BIOL CHEM, V275, P10154, DOI 10.1074/jbc.275.14.10154; Wang ZL, 1999, BIOCHEMISTRY-US, V38, P12537, DOI 10.1021/bi991070p; WANG ZL, 1993, BIOCHEMISTRY-US, V32, P13991, DOI 10.1021/bi00213a032; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P27	58	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32753	32760		10.1074/jbc.M507532200	http://dx.doi.org/10.1074/jbc.M507532200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16046390	hybrid			2022-12-27	WOS:000231920300026
J	Roque, A; Iloro, I; Ponte, I; Arrondo, JLR; Suau, P				Roque, A; Iloro, I; Ponte, I; Arrondo, JLR; Suau, P			DNA-induced secondary structure of the carboxyl-terminal domain of histone H1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; ALPHA-HELICES; H-1; CHROMATIN; PROTEINS; BINDING; SUBFRACTIONS; 3(10)-HELICES; TRANSCRIPTION; CONDENSATION	We have studied the secondary structure of the carboxyl-terminal domains of linker histone H1 subtypes H1 degrees (C-H1 degrees) and H1t (C-H1t), free in solution and bound to DNA, by IR spectroscopy. The carboxyl-terminal domain has little structure in aqueous solution but becomes extensively folded upon interaction with DNA. The secondary structure elements present in the bound carboxyl-terminal domain include the alpha-helix, beta-structure, turns, and open loops. The structure of the bound domain shows a significant dependence on salt concentration. In low salt (10 mM NaCl), there is a residual amount of random coil, 7% in C-H1 degrees and 12% in C-H1t. In physiological salt concentrations ( 140 mM NaCl), the carboxyl termini become fully structured. Under these conditions, C-H1 degrees contained 24% alpha-helix, 25% alpha-structure, 17% open loops, and 33% turns. The latter component could include a substantial proportion of the 310 helix. Despite their low sequence identity (similar to 30%), the representation of the different structural motifs in C-H1t was similar to that in C-H1 degrees. Examination of the changes in the amide I components in the 20-80 degrees C temperature interval showed that the secondary structure of the DNA-bound C-H1t is for the most part extremely stable. The H1 carboxyl-terminal domain appears to belong to the so-called disordered proteins, undergoing coupled binding and folding.	Univ Autonoma Barcelona, Fac Ciencias, Dept Bioquim & Biol Mol, Bellaterra 08193, Barcelona, Spain; Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain	Autonomous University of Barcelona; University of Basque Country	Suau, P (corresponding author), Univ Autonoma Barcelona, Fac Ciencias, Dept Bioquim & Biol Mol, Bellaterra 08193, Barcelona, Spain.	pere.suau@uab.es	Ponte, Inma/AGN-5337-2022; Iloro, Ibon/L-6022-2014; Suau, Pedro/D-2695-2009; Córdova, Alicia Roque/W-5229-2019; Roque, Alicia/H-7756-2015; Ponte, Inma/E-6848-2015	Iloro, Ibon/0000-0002-9537-1714; Suau, Pedro/0000-0001-6673-8209; Córdova, Alicia Roque/0000-0002-6206-6481; Roque, Alicia/0000-0002-6206-6481; Ponte, Inma/0000-0002-9448-6915				ALLAN J, 1986, J MOL BIOL, V187, P591, DOI 10.1016/0022-2836(86)90337-2; ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; ARRONDO JLR, 1994, BIOCHEMISTRY-US, V33, P11650, DOI 10.1021/bi00204a029; Arrondo JR, 2003, J BACTERIOL, V185, P4226, DOI 10.1128/JB.185.14.4226-4232.2003; Bharath MMS, 2002, PROTEINS, V49, P71, DOI 10.1002/prot.10204; BOUVET P, 1994, GENE DEV, V8, P1147, DOI 10.1101/gad.8.10.1147; Bracken C, 2004, CURR OPIN STRUC BIOL, V14, P570, DOI 10.1016/j.sbi.2004.08.003; BUCCI LR, 1982, EXP CELL RES, V140, P111, DOI 10.1016/0014-4827(82)90162-8; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; CHURCHILL MEA, 1991, TRENDS BIOCHEM SCI, V16, P92, DOI 10.1016/0968-0004(91)90040-3; CLARK DJ, 1988, EMBO J, V7, P69, DOI 10.1002/j.1460-2075.1988.tb02784.x; DOMINGUEZ V, 1992, DEVELOPMENT, V115, P181; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; DYSON HJ, 1988, J MOL BIOL, V201, P201, DOI 10.1016/0022-2836(88)90447-0; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; HALL JM, 1985, BIOCHEMISTRY-US, V24, P7765, DOI 10.1021/bi00347a040; HARTMAN PG, 1977, EUR J BIOCHEM, V77, P45, DOI 10.1111/j.1432-1033.1977.tb11639.x; Hendzel MJ, 2004, J BIOL CHEM, V279, P20028, DOI 10.1074/jbc.M400070200; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; IZAURRALDE E, 1989, J MOL BIOL, V210, P573, DOI 10.1016/0022-2836(89)90133-2; KENNEDY DF, 1991, BIOCHEMISTRY-US, V30, P6541, DOI 10.1021/bi00240a026; KHADAKE JR, 1995, BIOCHEMISTRY-US, V34, P15792, DOI 10.1021/bi00048a025; KHOCHBIN S, 1994, EUR J BIOCHEM, V225, P501, DOI 10.1111/j.1432-1033.1994.00501.x; Khochbin S, 2001, GENE, V271, P1, DOI 10.1016/S0378-1119(01)00495-4; Lee HL, 1998, EMBO J, V17, P1454, DOI 10.1093/emboj/17.5.1454; LENNOX RW, 1982, J BIOL CHEM, V257, P5183; LENNOX RW, 1984, J BIOL CHEM, V259, P669; LIAO LW, 1981, J BIOL CHEM, V256, P124; Lu X, 2004, J BIOL CHEM, V279, P8701, DOI 10.1074/jbc.M311348200; MANNING GS, 1979, BIOPOLYMERS, V18, P2929, DOI 10.1002/bip.1979.360181203; MIICK SM, 1992, NATURE, V359, P653, DOI 10.1038/359653a0; PANYIM S, 1969, BIOCHEM BIOPH RES CO, V37, P1042, DOI 10.1016/0006-291X(69)90237-X; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; Ponte I, 1998, MOL BIOL EVOL, V15, P702, DOI 10.1093/oxfordjournals.molbev.a025973; Ponte I, 2003, MOL BIOL EVOL, V20, P371, DOI 10.1093/molbev/msg041; Reisdorf WC, 1996, BIOCHEMISTRY-US, V35, P1383, DOI 10.1021/bi951589v; RODRIGUEZ AT, 1991, BIOPHYS CHEM, V39, P145, DOI 10.1016/0301-4622(91)85016-J; Roque A, 2004, NUCLEIC ACIDS RES, V32, P6111, DOI 10.1093/nar/gkh945; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; SUBIRANA JA, 1990, BIOPOLYMERS, V29, P1351, DOI 10.1002/bip.360291003; Talasz H, 1998, J BIOL CHEM, V273, P32236, DOI 10.1074/jbc.273.48.32236; Tanaka M, 2001, DEVELOPMENT, V128, P655; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; Vermaak D, 1998, CURR BIOL, V8, P533, DOI 10.1016/S0960-9822(98)70206-4; Vila R, 2000, PROTEIN SCI, V9, P627; Vila R, 2002, PROTEIN SCI, V11, P214, DOI 10.1110/ps.29602; Vila R, 2001, J BIOL CHEM, V276, P46429, DOI 10.1074/jbc.M106952200; Vila R, 2001, J BIOL CHEM, V276, P30898, DOI 10.1074/jbc.M104189200; Widlak P, 2005, BIOCHEMISTRY-US, V44, P7871, DOI 10.1021/bi050100n; WILSON RW, 1979, BIOCHEMISTRY-US, V18, P2192, DOI 10.1021/bi00578a009; Wolffe AP, 1997, BIOESSAYS, V19, P249, DOI 10.1002/bies.950190311; ZLATANOVA J, 1992, J CELL SCI, V103, P889	54	76	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32141	32147		10.1074/jbc.M505636200	http://dx.doi.org/10.1074/jbc.M505636200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16006555	hybrid			2022-12-27	WOS:000231794800014
J	Inagaki, K; Kobayashi, H; Yoshida, R; Kanada, Y; Fukuda, Y; Yagyu, T; Kondo, T; Kurita, N; Kitanaka, T; Yamada, Y; Sakamoto, Y; Suzuki, M; Kanayama, N; Terao, T				Inagaki, K; Kobayashi, H; Yoshida, R; Kanada, Y; Fukuda, Y; Yagyu, T; Kondo, T; Kurita, N; Kitanaka, T; Yamada, Y; Sakamoto, Y; Suzuki, M; Kanayama, N; Terao, T			Suppression of urokinase expression and invasion by a soybean Kunitz trypsin inhibitor are mediated through inhibition of Src-dependent signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELL INVASION; PROTEASE INHIBITOR; BINDING-SITES; UP-REGULATION; KINASE; BIKUNIN; ACTIVATION; TRANSDUCTION; PROMOTION; PROTEINS	A soybean Kunitz trypsin inhibitor (KTI) interacts with cells as a negative modulator of the invasive cells. Using complementary pharmacological and genetic approaches, we provide novel findings regarding mechanisms by which KTI inhibits signaling pathways in ovarian cancer cells leading to invasion. Transforming growth factor-beta 1 (TGF-beta 1) directly activates Src kinase, which in turn activates ERK-phosphatidylinositol 3-kinase/Akt, the downstream targets of Src, for urokinase-type plasminogen activator (uPA) up-regulation in human ovarian cancer HRA cells. Preincubation of the HRA cells with KTI reduced the ability of TGF-beta 1 to trigger the uPA expression at the gene level and at the protein level. To further elucidate the mechanism of the KTI-dependent suppressive effect of TGF-beta 1-induced uPA expression and invasion, we investigated which signaling pathway transduced by KTI is responsible for this inhibitory effect. Here, we show that 1) KTI suppressed TGF-beta 1-induced phosphorylation of Src, ERK1/2, and Akt by 40-60%; 2) KTI was insensitive to suppress the phosphorylation of ERK1/2 and Akt in the constitutively active (CA)-c-Src (Y529F) cells; 3) uPA expression was up-regulated in TGF-beta 1-stimulated HRA cells and in unstimulated Y529F cells; 4) the addition of KTI reduced the TGF-beta 1-induced increase of uPA gene and protein expression in the wild-type c-Src-transfected cells (in contrast, KTI could not inhibit uPA expression in the Y529F cells); and 5) CA-c-Src transfection resulted in a 2-fold increase in invasiveness, whereas KTI did not reduce invasion of the Y529F cells. Using additional complementary genetic approaches (CA-MEK1, CA-Akt, or kinase-dead-Akt), we conclude that KTI may suppress uPA expression and promotion of invasion possibly through one or more upstream targets of Src.	NetForce Co Ltd, Nagoya, Aichi 4530801, Japan; Hamamatsu Univ Sch Med, Dept Obstet & Gynecol, Hamamatsu, Shizuoka 4313192, Japan; Fuji Oil Co Ltd, Tsukuba R&D Ctr, Food Sci Res Inst, Tsukuba, Ibaraki 3002497, Japan; Comp Technol Integrat Co Ltd, Izumisano, Osaka, Japan; Toyohashi Univ Technol, Dept Knowledge Based Informat Engn, Toyohashi, Aichi 4418580, Japan; Nara Med Univ, Dept Obstet & Gynecol, Kashihara, Nara 6348522, Japan	Hamamatsu University School of Medicine; Fuji Oil Co., Ltd.; Toyohashi University of Technology; Nara Medical University	Kobayashi, H (corresponding author), NetForce Co Ltd, Taiko 3-1-18, Nagoya, Aichi 4530801, Japan.	hirokoba@hama-med.ac.jp						Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Derrien A, 2003, J BIOL CHEM, V278, P16107, DOI 10.1074/jbc.M210371200; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Friedman M, 2001, J AGR FOOD CHEM, V49, P1069, DOI 10.1021/jf0009246; Fukuda K, 1998, ONCOGENE, V16, P3349, DOI 10.1038/sj.onc.1201896; Hirashima Y, 2001, J BIOL CHEM, V276, P13650, DOI 10.1074/jbc.M009906200; Jacob A, 2002, J BIOL CHEM, V277, P23420, DOI 10.1074/jbc.M202485200; KOBAYASHI H, 1994, J BIOL CHEM, V269, P20642; KOBAYASHI H, 1995, BRIT J CANCER, V72, P1131, DOI 10.1038/bjc.1995.476; Kobayashi H, 2004, CLIN EXP METASTAS, V21, P159, DOI 10.1023/B:CLIN.0000024751.73174.c2; Kobayashi H, 2004, INT J CANCER, V112, P519, DOI 10.1002/ijc.20430; Kobayashi H, 2003, BIOL CHEM, V384, P749, DOI 10.1515/BC.2003.083; Kobayashi H, 2003, J BIOL CHEM, V278, P7790, DOI 10.1074/jbc.M210407200; Kobayashi H, 2002, EUR J BIOCHEM, V269, P3945, DOI 10.1046/j.1432-1033.2002.03068.x; Kobayashi H, 2001, J BIOL CHEM, V276, P2015, DOI 10.1074/jbc.M007650200; Kobayashi H, 2000, J BIOL CHEM, V275, P21185, DOI 10.1074/jbc.M907862199; Kobayashi H, 2000, MOL HUM REPROD, V6, P735, DOI 10.1093/molehr/6.8.735; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Liu Q, 1998, J IMMUNOL, V160, P1393; Morel JCM, 2002, J BIOL CHEM, V277, P34679, DOI 10.1074/jbc.M206337200; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Sutor SL, 1999, J BIOL CHEM, V274, P7002, DOI 10.1074/jbc.274.11.7002; Suzuki M, 2003, INT J CANCER, V104, P289, DOI 10.1002/ijc.10950; Suzuki M, 2003, J BIOL CHEM, V278, P14640, DOI 10.1074/jbc.M300239200; Suzuki M, 2002, J BIOL CHEM, V277, P8022, DOI 10.1074/jbc.M108545200; Suzuki M, 2001, BBA-PROTEIN STRUCT M, V1547, P26, DOI 10.1016/S0167-4838(01)00167-4; Tanaka Y, 2004, J BIOL CHEM, V279, P8567, DOI 10.1074/jbc.M309131200; Xi SC, 2003, J BIOL CHEM, V278, P31574, DOI 10.1074/jbc.M303499200	30	13	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31428	31437		10.1074/jbc.M501406200	http://dx.doi.org/10.1074/jbc.M501406200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16002410	hybrid			2022-12-27	WOS:000231665200013
J	Sandu, C; Gavathiotis, E; Huang, T; Wegorzewska, I; Werner, MH				Sandu, C; Gavathiotis, E; Huang, T; Wegorzewska, I; Werner, MH			A mechanism for death receptor discrimination by death adaptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE; BINDING SURFACE; EFFECTOR DOMAIN; CELL-DEATH; FADD; APOPTOSIS; COMPLEX; PROTEIN; TNF; IDENTIFICATION	The death domain and death effector domain are two common motifs that mediate protein-protein interactions between components of cell death signaling complexes. The mechanism by which these domains engage their binding partners has been explored by extensive mutagenesis of two death adaptors, FADD and TRADD, suggesting that a death adaptor can discriminate its intended binding partners from other proteins harboring similar motifs. Death adaptors are found to utilize one of two topologically conserved surfaces for protein-protein interaction, whether that partner is another adaptor or its cognate receptor. These surfaces are topologically related to the interaction between death domains observed in the x-ray crystal structure of the Drosophila adaptor Tube bound to Pelle kinase. Comparing the topology of protein-protein interactions for FADD complexes to TRADD complexes reveals that FADD uses a Tube-like surface in each of its death motifs to engage either CD95 or TRADD. TRADD reverses these roles, employing a Pelle-like surface to interact with either receptor TNFR1 or adaptor FADD. Since death adaptors display a Tube-like or Pelle-like preference for engaging their binding partners, Tube/Pelle-like pairing provides a mechanism for death adaptor discrimination of death receptors.	Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA	Rockefeller University	Werner, MH (corresponding author), Rockefeller Univ, Lab Mol Biophys, 1230 York Ave,Box 42, New York, NY 10021 USA.	mwerner@portugal.rockefeller.edu	Sandu, Cristinel/A-3063-2008	Gavathiotis, Evripidis/0000-0001-6319-8331				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bang S, 2000, J BIOL CHEM, V275, P36217, DOI 10.1074/jbc.M006620200; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Chou FL, 2003, J BIOL CHEM, V278, P52587, DOI 10.1074/jbc.M309322200; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Harper N, 2003, J BIOL CHEM, V278, P25534, DOI 10.1074/jbc.M303399200; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hill JM, 2004, J BIOL CHEM, V279, P1474, DOI 10.1074/jbc.M304996200; Hill JM, 2002, EMBO J, V21, P6494, DOI 10.1093/emboj/cdf641; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; JAATTELA M, 1995, ONCOGENE, V10, P2297; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Kuai J, 2004, J BIOL CHEM, V279, P53266, DOI 10.1074/jbc.M411037200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Peter ME, 1998, CURR OPIN IMMUNOL, V10, P545, DOI 10.1016/S0952-7915(98)80222-7; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; REED JC, 2004, SCI STKE; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sukits SF, 2001, J MOL BIOL, V310, P895, DOI 10.1006/jmbi.2001.4790; Telliez JB, 2000, J MOL BIOL, V300, P1323, DOI 10.1006/jmbi.2000.3899; Thomas LR, 2004, J BIOL CHEM, V279, P32780, DOI 10.1074/jbc.M401680200; Thomas LR, 2002, J BIOL CHEM, V277, P34343, DOI 10.1074/jbc.M204169200; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1	30	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31974	31980		10.1074/jbc.M506938200	http://dx.doi.org/10.1074/jbc.M506938200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16006552	hybrid			2022-12-27	WOS:000231665200077
J	Jalil, MA; Begum, L; Contreras, L; Pardo, B; Iijima, M; Li, MX; Ramos, M; Marmol, P; Horiuchi, M; Shimotsu, K; Nakagawa, S; Okubo, A; Sameshima, M; Isashiki, Y; del Arco, A; Kobayashi, K; Satrustegui, J; Saheki, T				Jalil, MA; Begum, L; Contreras, L; Pardo, B; Iijima, M; Li, MX; Ramos, M; Marmol, P; Horiuchi, M; Shimotsu, K; Nakagawa, S; Okubo, A; Sameshima, M; Isashiki, Y; del Arco, A; Kobayashi, K; Satrustegui, J; Saheki, T			Reduced N-acetylaspartate levels in mice lacking aralar, a brain- and muscle-type mitochondrial aspartate-glutamate carrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN LIPID-SYNTHESIS; ACETYL-L-ASPARTATE; NERVOUS-SYSTEM; GENE; CALCIUM; METABOLISM; EXPRESSION; CITRIN; MOUSE; GALACTOCEREBROSIDE	Aralar is a mitochondrial calcium-regulated aspartate-glutamate carrier mainly distributed in brain and skeletal muscle, involved in the transport of aspartate from mitochondria to cytosol, and in the transfer of cytosolic reducing equivalents into mitochondria as a member of the malate-aspartate NADH shuttle. In the present study, we describe the characteristics of aralar-deficient (Aralar(-/-)) mice, generated by a gene-trap method, showing no aralar mRNA and protein, and no detectable malate-aspartate shuttle activity in skeletal muscle and brain mitochondria. Aralar-/- mice were growth-retarded, exhibited generalized tremoring, and had pronounced motor coordination defects along with an impaired myelination in the central nervous system. Analysis of lipid components showed a marked decrease in the myelin lipid galactosyl cerebroside. The content of the myelin lipid precursor, N-acetylaspartate, and that of aspartate are drastically decreased in the brain of Aralar(-/-) mice. The defect in N-acetylaspartate production was also observed in cell extracts from primary neuronal cultures derived from Aralar(-/-) mouse embryos. These results show that aralar plays an important role in myelin formation by providing aspartate for the synthesis of N-acetylaspartate in neuronal cells.	Kagoshima Univ, Dept Mol Metab & Biochem Genet, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan; Kagoshima Univ, Lab Neuroanat, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan; Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan; Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Univ Castilla La Mancha, Fac Ciencias Med Ambiente, Toledo 45071, Spain	Kagoshima University; Kagoshima University; Kagoshima University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidad de Castilla-La Mancha	Saheki, T (corresponding author), Kagoshima Univ, Dept Mol Metab & Biochem Genet, Grad Sch Med & Dent Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	takesah@m.kufm.kagoshima-u.ac.jp	Satrustegui, Jorgina/R-6732-2019; Contreras, Laura/ABG-7620-2021; Contreras, Laura/A-2296-2015; del Arco, Araceli/R-5653-2019	Contreras, Laura/0000-0003-1157-4942; Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667; RAMOS GOMEZ, MILAGROS/0000-0001-5798-9508; del Arco, Araceli/0000-0002-6839-542X				Barker PB, 2001, ANN NEUROL, V49, P423, DOI 10.1002/ana.90; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; BAUMANN NA, 1968, EUR J BIOCHEM, V4, P340, DOI 10.1111/j.1432-1033.1968.tb00216.x; BEAUDET AL, 1995, METABOLIC MOL BASIS, P4599; Begum L, 2002, BBA-GENE STRUCT EXPR, V1574, P283, DOI 10.1016/S0167-4781(01)00376-1; Bhakoo KK, 2001, J NEUROCHEM, V79, P211, DOI 10.1046/j.1471-4159.2001.00561.x; BIRD TD, 1978, J NEUROCHEM, V31, P387, DOI 10.1111/j.1471-4159.1978.tb12479.x; Bjartmar C, 2002, ANN NEUROL, V51, P51, DOI 10.1002/ana.10052; Bosio A, 1996, P NATL ACAD SCI USA, V93, P13280, DOI 10.1073/pnas.93.23.13280; BURRI R, 1991, DEV NEUROSCI-BASEL, V13, P403, DOI 10.1159/000112191; CAMMER W, 1984, J NEUROCHEM, V42, P1372, DOI 10.1111/j.1471-4159.1984.tb02797.x; Chakraborty G, 2001, J NEUROCHEM, V78, P736, DOI 10.1046/j.1471-4159.2001.00456.x; CHEESEMAN AJ, 1988, J NEUROCHEM, V50, P1559, DOI 10.1111/j.1471-4159.1988.tb03044.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; DADAMO AF, 1966, J NEUROCHEM, V13, P961, DOI 10.1111/j.1471-4159.1966.tb10292.x; del Arco A, 2000, BIOCHEM J, V345, P725, DOI 10.1042/0264-6021:3450725; del Arco A, 2002, EUR J BIOCHEM, V269, P3313, DOI 10.1046/j.1432-1033.2002.03018.x; del Arco A, 1998, J BIOL CHEM, V273, P23327, DOI 10.1074/jbc.273.36.23327; Demougeot C, 2001, J NEUROCHEM, V77, P408, DOI 10.1046/j.1471-4159.2001.00285.x; Heidenhain M., 1896, Z WISS MIKROSK, V13, P186; Hisaoka S, 2001, NEURORADIOLOGY, V43, P496, DOI 10.1007/s002340000520; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; Kirmani BF, 2003, DEV BRAIN RES, V140, P105, DOI 10.1016/S0165-3806(02)00592-8; Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667; Levitt JG, 2003, BIOL PSYCHIAT, V54, P1355, DOI 10.1016/S0006-3223(03)00688-7; Lu ZH, 2004, MOL BRAIN RES, V122, P71, DOI 10.1016/j.molbrainres.2003.12.002; MACALA LJ, 1983, J LIPID RES, V24, P1243; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; Madhavarao CN, 2003, J NEUROCHEM, V86, P824, DOI 10.1046/j.1471-4159.2003.01905.x; Marcus J, 2002, BBA-GEN SUBJECTS, V1573, P406, DOI 10.1016/S0304-4165(02)00410-5; Martin E, 2001, ANN NEUROL, V49, P518, DOI 10.1002/ana.102; MARTINEZSERRANO A, 1992, MOL BIOL CELL, V3, P235, DOI 10.1091/mbc.3.2.235; Matalon R, 2000, J GENE MED, V2, P165; MEHTA V, 1995, MOL BRAIN RES, V31, P151, DOI 10.1016/0169-328X(95)00044-S; Otsuka H, 1999, NEURORADIOLOGY, V41, P517, DOI 10.1007/s002340050795; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; PATEL TB, 1979, BIOCHEM J, V184, P539, DOI 10.1042/bj1840539; Ramos M, 2003, DEV BRAIN RES, V143, P33, DOI 10.1016/S0165-3806(03)00097-X; Ramoz N, 2004, AM J PSYCHIAT, V161, P662, DOI 10.1176/appi.ajp.161.4.662; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; Ruiz F, 1998, NEUROREPORT, V9, P1277; Saheki T, 2002, J HUM GENET, V47, P333, DOI 10.1007/s100380200046; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Sanchez-Abarca LI, 2001, GLIA, V36, P321, DOI 10.1002/glia.1119; Sanz R, 2000, CYTOGENET CELL GENET, V89, P143, DOI 10.1159/000015595; Scherer SS, 1997, NEURON, V18, P13, DOI 10.1016/S0896-6273(01)80042-8; Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2; Sinasac DS, 2004, MOL CELL BIOL, V24, P527, DOI 10.1128/MCB.24.2.527-536.2004; SVENNERHOLM L, 1956, J NEUROCHEM, V1, P42, DOI 10.1111/j.1471-4159.1956.tb12053.x; Takeda Y, 2003, J NEUROBIOL, V56, P252, DOI 10.1002/neu.10222; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Yasuda T, 2000, HUM GENET, V107, P537, DOI 10.1007/s004390000430; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	55	123	126	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31333	31339		10.1074/jbc.M505286200	http://dx.doi.org/10.1074/jbc.M505286200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15987682	hybrid			2022-12-27	WOS:000231487800081
J	Rompler, M; Schulz, A; Pitra, C; Coop, G; Przeworski, M; Paabo, S; Schoneberg, T				Rompler, M; Schulz, A; Pitra, C; Coop, G; Przeworski, M; Paabo, S; Schoneberg, T			The rise and fall of the chemoattractant receptor GPR33	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CHEMOKINE RECEPTOR; STATISTICAL-METHOD; HIV-1 INFECTION; HUMAN-DISEASES; GENE; RESISTANCE; EVOLUTION; RECOMBINATION; INDIVIDUALS	Chemokine and chemoattractant receptors are members of the large superfamily of G protein- coupled receptors ( GPCR), which control leukocyte chemotaxis. In addition to their physiological role, several chemokine and chemoattractant receptors, such as CCR5 and Duffy, have been directly associated with pathogen entry. GPR33 is an orphan chemoattractant GPCR that was previously identified as a pseudogene in humans. GPR33 evolved in mammals about 125 - 190 million years ago. The cloning and analysis of more than 120 mammalian GPR33 orthologs from 16 of 18 eutherian orders revealed an inactivation of this chemoattractant GPCR not only in humans, but also in several great ape and rodent species. Intriguingly, in all ape and some rodent species where the inactivation occurred, samples harbored both pseudogene and intact gene variants. The analysis of over 1200 human individuals representing all major linguistic groups revealed that the intact allele of GPR33 is still present in the human population. Estimates of the age of the human alleles suggest inactivation in the past 1 million years. Similarly, analysis of more than 120 wild- caught gray rats ( Rattus norvegicus), revealed that inactivation of gpr33 is worldwide fixed and occurred in less than 0.7 million years ago. The coincidental inactivation and its fixation in several species of distantly related mammalian orders suggest a selective pressure on this chemoattractant receptor gene.	Univ Leipzig, Fac Med, Inst Biochem, Max Planck Inst Interin, D-04103 Leipzig, Germany; Inst Zoo & Wildlife Res, Dept Evolut Genet, D-10315 Berlin, Germany; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	Leipzig University; Max Planck Society; Leibniz Institut fur Zoo und Wildtierforschung; University of Oxford; Brown University; Max Planck Society	Schoneberg, T (corresponding author), Univ Leipzig, Fac Med, Inst Biochem, Max Planck Inst Interin, Deutscher Pl 6, D-04103 Leipzig, Germany.	schoberg@medizin.uni-leipzig.de		Coop, Graham/0000-0001-8431-0302				Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; [Anonymous], PHYLIP PHYLOGENY INF; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; BERRIDGE MJ, 1983, BIOCHEM J, V212, P849, DOI 10.1042/bj2120849; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; Dubois JYF, 2002, J MOL EVOL, V55, P522, DOI 10.1007/s00239-002-2347-8; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; FU YX, 1993, GENETICS, V133, P693; Galvani AP, 2003, P NATL ACAD SCI USA, V100, P15276, DOI 10.1073/pnas.2435085100; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; Griffiths RC, 2003, THEOR POPUL BIOL, V64, P241, DOI 10.1016/S0040-5809(03)00075-3; GRIFFITHS RC, 1997, PROGR POPULATION GEN, P165; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; Helgason A, 2003, AM J HUM GENET, V72, P1370, DOI 10.1086/375453; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Kaessmann H, 2002, J INTERN MED, V251, P1, DOI 10.1046/j.1365-2796.2002.00907.x; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Marchese A, 1998, GENOMICS, V50, P281, DOI 10.1006/geno.1998.5297; Migeotte I, 2002, EUR J IMMUNOL, V32, P494, DOI 10.1002/1521-4141(200202)32:2<494::AID-IMMU494>3.0.CO;2-Y; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Mombaerts P, 2001, ANNU REV GENOM HUM G, V2, P493, DOI 10.1146/annurev.genom.2.1.493; Musser G G, 1993, MAMMAL SPECIES WORLD; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Przeworski M, 2002, GENETICS, V160, P1179; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1998, EUR J IMMUNOL, V28, P1689, DOI 10.1002/(SICI)1521-4141(199805)28:05<1689::AID-IMMU1689>3.0.CO;2-I; Schoneberg T, 2002, REV PHYSIOL BIOCH P, V144, P143; Schoneberg T, 1997, J CLIN INVEST, V100, P1547, DOI 10.1172/JCI119678; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vaughn MW, 2002, J IMMUNOL, V169, P3363, DOI 10.4049/jimmunol.169.6.3363; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1	43	24	24	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31068	31075		10.1074/jbc.M503586200	http://dx.doi.org/10.1074/jbc.M503586200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15987686	Green Published, hybrid			2022-12-27	WOS:000231487800051
J	Suzuki, T; Ishihara, K; Migaki, H; Ishihara, K; Nagao, M; Yamaguchi-Iwai, Y; Kambe, T				Suzuki, T; Ishihara, K; Migaki, H; Ishihara, K; Nagao, M; Yamaguchi-Iwai, Y; Kambe, T			Two different zinc transport complexes of cation diffusion facilitator proteins localized in the secretory pathway operate to activate alkaline phosphatases in vertebrate cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; CONFERS RESISTANCE; CRYSTAL-STRUCTURE; CLONING; EXPRESSION; SPECIFICITY; TRANSITION; EFFLUX; ZNT7	Zinc is an essential component for the catalytic activity of numerous zinc- requiring enzymes. However, until recently little has been known about the molecules involved in the pathways required for supplying zinc to these enzymes. We showed recently ( Suzuki, T., Ishihara, K., Migaki, H., Matsuura, W., Kohda, A., Okumura, K., Nagao, M., Yamaguchi- Iwai, Y., and Kambe, T. ( 2005) J. Biol. Chem. 280, 637 - 643) that zinc transporters, ZnT5 and ZnT7, are required for the activation of zinc- requiring enzymes, alkaline phosphatases ( ALPs), by transporting zinc into the lumens of the Golgi apparatus and the vesicular compartments where ALPs locate and converting apoALPs to holoALPs. ZnT6 is also located in the vesicular compartments like ZnT5 and ZnT7. However, the functions of ZnT6 and relationships among these three transporters have not been characterized yet. Here, we characterized the cellular function of ZnT6 together with ZnT5 and ZnT7 by gene- targeting studies using DT40 cells. ZnT6- deficient DT40 cells showed low ALP activity, suggesting that ZnT6 is required for the activation of zinc-requiring enzymes like ZnT5 and ZnT7. Combined disruptions of three transporter genes and re- expressions of transgenes revealed that ZnT5 and ZnT6 work in the same pathway, whereas ZnT7 acts alone. Furthermore, co- immunoprecipitation studies revealed that ZnT5 and ZnT6 formed hetero- oligomers, whereas ZnT7 formed homo- oligomers. Interestingly, the Ser- rich loop in ZnT6, a potential zinc- binding site, was dispensable for the zinc- supplying function of ZnT5/ ZnT6 hetero- oligomers, suggesting that the His- rich loop in ZnT5 may be important for zinc binding and that the loop in ZnT6 may acquire another function in the hetero- oligomer formation. These results suggest that two different zinc transport complexes operate to activate ALPs.	Kyoto Univ, Grad Sch Biostudies, Div Life Sci, Kyoto 6068502, Japan; Sugiyama Jogakuen Univ, Sch Life Studies, Dept Food & Nutr, Nagoya, Aichi 4648662, Japan	Kyoto University	Kambe, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Life Sci, Kyoto 6068502, Japan.	kambe1@kais.kyoto-u.ac.jp	Ishihara, Kengo/J-7913-2019	Ishihara, Kengo/0000-0001-9374-5033				Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; Bloss T, 2002, PLANTA, V214, P783, DOI 10.1007/s00425-001-0677-1; Chimienti F, 2003, CURR DRUG TARGETS, V4, P323, DOI 10.2174/1389450033491082; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; Li LT, 1998, J BIOL CHEM, V273, P22181, DOI 10.1074/jbc.273.35.22181; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Murgia C, 1999, AM J PHYSIOL-GASTR L, V277, pG1231, DOI 10.1152/ajpgi.1999.277.6.G1231; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; PAULSEN LT, 1997, J MEMBRANE BIOL, V156, P99; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Zhang Y, 1998, EMBO J, V17, P7304, DOI 10.1093/emboj/17.24.7304	31	129	137	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30956	30962		10.1074/jbc.M506902200	http://dx.doi.org/10.1074/jbc.M506902200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994300	hybrid			2022-12-27	WOS:000231487800038
J	Tsuge, H; Kawakami, R; Sakuraba, H; Ago, H; Miyano, M; Aki, K; Katunuma, N; Ohshima, T				Tsuge, H; Kawakami, R; Sakuraba, H; Ago, H; Miyano, M; Aki, K; Katunuma, N; Ohshima, T			Crystal structure of a novel FAD-, FMN-, and ATP-containing L-proline dehydrogenase complex from Pyrococcus horikoshii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID DEHYDROGENASE; HYPERTHERMOPHILIC ARCHAEON; SALMONELLA-TYPHIMURIUM; 3-DIMENSIONAL STRUCTURE; THERMOCOCCUS-PROFUNDUS; ANGSTROM RESOLUTION; SARCOSINE OXIDASE; PROTEIN; REDUCTASE; FLAVOPROTEIN	Two novel types of dye- linked (L)- proline dehydrogenase complex ( PDH1 and PDH2) were found in a hyperthermophilic archaeon, Pyrococcus horikoshii OT3. Here we report the first crystal structure of PDH1, which is a heterooctameric complex (alpha beta) (4) containing three different cofactors: FAD, FMN, and ATP. The structure was determined by x- ray crystallography to a resolution of 2.86 angstrom. The structure of the beta subunit, which is an L- proline dehydrogenase catalytic component containing FAD as a cofactor, was similar to that of monomeric sarcosine oxidase. On the other hand, the alpha subunit possessed a unique structure composed of a classical dinucleotide fold domain with ATP, a central domain, an N- terminal domain, and a Cys- clustered domain. Serving as a third cofactor, FMN was located at the interface between the alpha and beta subunits in a novel configuration. The observed structure suggests that FAD and FMN are incorporated into an electron transfer system, with electrons passing from the former to the latter. The function of ATP is unknown, but it may play a regulatory role. Although the structure of the alpha subunit differs from that of the beta subunit, except for the presence of an analogous dinucleotide domain with a different cofactor, the structural characteristics of PDH1 suggest that each represents a divergent enzyme that arose from a common ancestral flavoenzyme and that they eventually formed a complex to gain a new function. The structural characteristics described here reveal the PDH1 complex to be a unique diflavin dehydrogenase containing a novel electron transfer system.	Tokushima Bunri Univ, Inst Hlth Sci, Yamashiro, Tokushima 7708514, Japan; Univ Tokushima, Fac Engn, Dept Biol Sci & Technol, Tokushima 7708506, Japan; RIKEN, Harima SPring 8, Struct Biophys Lab, Sayo, Hyogo 6795148, Japan; Univ Tokushima, Inst Enzyme Res, Tokushima, Tokushima 7708503, Japan	Tokushima Bunri University; Tokushima University; RIKEN; Tokushima University	Tsuge, H (corresponding author), Tokushima Bunri Univ, Inst Hlth Sci, 180 Nishihamabouji, Yamashiro, Tokushima 7708514, Japan.	tsuge@tokushima.bunri-u.ac.jp; ohshima@bio.tokushima-u.ac.jp	Tsuge, Hideaki/ABF-6424-2021; Miyano, Masashi/R-2785-2016	Miyano, Masashi/0000-0003-2253-6175; Ago, Hideo/0000-0002-9040-488X; Tsuge, Hideaki/0000-0003-0166-9163				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNS CM, 1995, J MOL BIOL, V247, P125, DOI 10.1006/jmbi.1994.0127; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Eschenbrenner M, 2001, BIOCHEMISTRY-US, V40, P5352, DOI 10.1021/bi010101p; GRAHAM SB, 1984, J BIOL CHEM, V259, P2656; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; KARPLUS PA, 1987, J MOL BIOL, V195, P701, DOI 10.1016/0022-2836(87)90191-4; Kawakami R, 2004, EXTREMOPHILES, V8, P99, DOI 10.1007/s00792-003-0368-x; KAWAKAMI R, 2005, IN PRESS EUR J BIOCH; Lee YH, 2003, NAT STRUCT BIOL, V10, P109, DOI 10.1038/nsb885; LIM LW, 1988, J BIOL CHEM, V263, P3075; MALOY SR, 1983, J BACTERIOL, V154, P561, DOI 10.1128/JB.154.2.561-568.1983; Mattevi A, 1996, P NATL ACAD SCI USA, V93, P7496, DOI 10.1073/pnas.93.15.7496; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MENZEL R, 1981, J BIOL CHEM, V256, P9755; MENZEL R, 1981, J BIOL CHEM, V256, P9762; Mizutani H, 1996, J BIOCHEM-TOKYO, V120, P14; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Sakuraba H, 2001, APPL ENVIRON MICROB, V67, P1470, DOI 10.1128/AEM.67.4.1470-1475.2001; Satomura T, 2002, J BIOL CHEM, V277, P12861, DOI 10.1074/jbc.M112272200; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Trickey P, 1999, STRUCTURE, V7, P331, DOI 10.1016/S0969-2126(99)80043-4; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411	27	36	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31045	31049		10.1074/jbc.C500234200	http://dx.doi.org/10.1074/jbc.C500234200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16027125	hybrid			2022-12-27	WOS:000231487800048
J	Vial, C; Evans, RJ				Vial, C; Evans, RJ			Disruption of lipid rafts inhibits P2X(1) receptor-mediated currents and arterial vasoconstriction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CHAIN KINASE ACTIVATION; CA2+ TRANSIENTS; MESENTERIC-ARTERY; ADENYLYL-CYCLASE; VAS-DEFERENS; ION CHANNELS; MEMBRANE MICRODOMAINS; POTASSIUM CHANNELS; NERVE-STIMULATION	P2X(1) receptors for ATP are ligand- gated cation channels expressed on a range of smooth muscle preparations and blood platelets. The receptors appear to be clustered close to sympathetic nerve varicosities and mediate the underlying membrane potential changes and constriction following nerve stimulation in a range of arteries and resistance arterioles. In this study we have used discontinuous sucrose density gradients, Western blot analysis, and cholesterol measurements to show that recombinant and smooth muscle ( rat tail artery, vas deferens, and bladder) P2X(1) receptors are present in cholesterol- rich lipid rafts and co- localize with the lipid raft markers flotillin- 1 and - 2. Lipid rafts are specialized lipid membrane microdomains involved in signaling and trafficking. To determine whether lipid raft association was essential for P2X(1) receptor channel function we used the cholesterol- depleting agent methyl-beta cyclodextrin ( 10 mM for 1 h). This led to a redistribution of the P2X(1) receptor throughout the sucrose gradient and reduced P2X(1) receptor- mediated ( alpha, beta-methylene ATP, 10 mu M) currents in HEK293 cells by > 90% and contractions of the rat tail artery by similar to 50%. However contractions evoked by potassium chloride ( 60 mM) were unaffected by methyl- beta- cyclodextrin and the inactive analogue alpha- cyclodextrin had no effect on P2X(1) receptor- mediated currents or contractions. P2X(1) receptors are subject to ongoing regulation by receptors and kinases, and the present results suggest that lipid rafts are an essential component in the maintenance of these localized signaling domains and play an important role in P2X(1) receptor- mediated control of arteries.	Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk			Wellcome Trust [065573] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bang B, 2005, EXP DERMATOL, V14, P266, DOI 10.1111/j.0906-6705.2005.00283.x; BENHAM CD, 1989, J PHYSIOL-LONDON, V419, P689, DOI 10.1113/jphysiol.1989.sp017893; BENHAM CD, 1987, NATURE, V328, P275, DOI 10.1038/328275a0; Berry DA, 1999, ELECTROPHORESIS, V20, P2059, DOI 10.1002/(SICI)1522-2683(19990701)20:10<2059::AID-ELPS2059>3.0.CO;2-T; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Brady JD, 2004, MOL PHARMACOL, V65, P503, DOI 10.1124/mol.65.3.503; Brain KL, 2002, J PHYSIOL-LONDON, V541, P849, DOI 10.1113/jphysiol.2002.019612; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Dreja K, 2002, ARTERIOSCL THROM VAS, V22, P1267, DOI 10.1161/01.ATV.0000023438.32585.A1; Ennion SJ, 2001, FEBS LETT, V489, P154, DOI 10.1016/S0014-5793(01)02102-0; EVANS RJ, 1992, N-S ARCH PHARMACOL, V345, P424; EVANS RJ, 1992, BRIT J PHARMACOL, V106, P242, DOI 10.1111/j.1476-5381.1992.tb14323.x; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Galbiati F, 1999, J BIOL CHEM, V274, P5843, DOI 10.1074/jbc.274.9.5843; Gitterman DP, 2001, BRIT J PHARMACOL, V132, P1201, DOI 10.1038/sj.bjp.0703925; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Hansen MA, 1999, J AUTONOM NERV SYST, V75, P147, DOI 10.1016/S0165-1838(98)00189-1; Hechler B, 2003, J EXP MED, V198, P661, DOI 10.1084/jem.20030144; Heppner TJ, 2005, J PHYSIOL-LONDON, V564, P201, DOI 10.1113/jphysiol.2004.077826; Hering H, 2003, J NEUROSCI, V23, P3262; IINO M, 1994, EMBO J, V13, P5026, DOI 10.1002/j.1460-2075.1994.tb06831.x; Inscho EW, 2004, ACTA PHYSIOL SCAND, V181, P445, DOI 10.1111/j.1365-201X.2004.01317.x; Inscho EW, 2003, J CLIN INVEST, V112, P1895, DOI 10.1172/JCI200318499; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Lai EC, 2003, J CELL BIOL, V162, P365, DOI 10.1083/jcb.200307087; Lamont C, 2003, J PHYSIOL-LONDON, V549, P801, DOI 10.1113/jphysiol.2003.043380; Lamont C, 2002, CIRC RES, V91, P454, DOI 10.1161/01.RES.0000035060.98415.4B; Lee H, 2001, J BIOL CHEM, V276, P35150, DOI 10.1074/jbc.M104530200; Lewis CJ, 2000, BRIT J PHARMACOL, V129, P124, DOI 10.1038/sj.bjp.0702993; Lewis CJ, 2001, DRUG DEVELOP RES, V52, P164, DOI 10.1002/ddr.1111; Lewis CJ, 2000, BRIT J PHARMACOL, V131, P1659, DOI 10.1038/sj.bjp.0703744; Lewis CJ, 2000, J PHYSIOL-LONDON, V527, P315, DOI 10.1111/j.1469-7793.2000.00315.x; Li JH, 2004, CIRCULATION, V110, P3049, DOI 10.1161/01.CIR.0000147188.46287.1B; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; Malmsjo M, 1999, CARDIOVASC RES, V43, P219, DOI 10.1016/S0008-6363(99)00060-7; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; Mulryan K, 2000, NATURE, V403, P86, DOI 10.1038/47495; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Ostrom RS, 2002, MOL PHARMACOL, V61, P473, DOI 10.1124/mol.61.3.473; Ostrom RS, 2001, J BIOL CHEM, V276, P42063, DOI 10.1074/jbc.M105348200; Oury C, 2004, J BIOL CHEM, V279, P26266, DOI 10.1074/jbc.M402032200; Oury C, 2003, BLOOD, V101, P3969, DOI 10.1182/blood-2002-10-3215; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Ralevic V, 1998, PHARMACOL REV, V50, P413; RAMME D, 1987, N-S ARCH PHARMACOL, V336, P267; Reungpatthanaphong P, 2004, J BIOENERG BIOMEMBR, V36, P533, DOI 10.1007/s10863-004-9000-8; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Sampson LJ, 2004, CIRC RES, V95, P1012, DOI 10.1161/01.RES.0000148634.47095.ab; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Toth-Zsamboki E, 2003, J BIOL CHEM, V278, P46661, DOI 10.1074/jbc.M308452200; Vacca F, 2004, J NEUROSCI RES, V76, P653, DOI 10.1002/jnr.20069; Vial C, 2004, BIOCHEM J, V382, P101, DOI 10.1042/BJ20031910; Vial C, 2002, MOL PHARMACOL, V62, P1438, DOI 10.1124/mol.62.6.1438; Vial C, 2002, BRIT J PHARMACOL, V135, P363, DOI 10.1038/sj.bjp.0704486; Wang LW, 2003, ARTERIOSCL THROM VAS, V23, P1370, DOI 10.1161/01.ATV.0000080350.37408.5A; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200	58	82	82	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30705	30711		10.1074/jbc.M504256200	http://dx.doi.org/10.1074/jbc.M504256200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16006561	Green Accepted, hybrid			2022-12-27	WOS:000231487800009
J	Jia, ZJ; Barbier, L; Stuart, H; Amraei, M; Pelech, S; Dennis, JW; Metalnikov, P; O'Donnell, P; Nabi, IR				Jia, ZJ; Barbier, L; Stuart, H; Amraei, M; Pelech, S; Dennis, JW; Metalnikov, P; O'Donnell, P; Nabi, IR			Tumor cell pseudopodial protrusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN MESSENGER-RNA; BETA-ACTIN; TYROSINE KINASE; C-MET; POLY(A)-BINDING PROTEIN-1; CARCINOMA CELLS; POTENTIAL ROLE; LUNG-CANCER; RHO-KINASE; MDCK CELLS	The pseudopodial protrusions of Moloney sarcoma virus ( MSV)-Madin-Darby canine kidney ( MDCK)-invasive ( INV) variant cells were purified on 1-mu m pore polycarbonate filters that selectively allow passage of the pseudopodial domains but not the cell body. The purified pseudopodial fraction contains phosphotyrosinated proteins, including Met and FAK, and various signaling proteins, including Raf1, MEK1, ERK2, PKB alpha ( Akt1), GSK3 alpha, GSK3 beta, Rb, and Stat3. Pseudopodial proteins identified by liquid chromatography tandem mass spectrometry included actin and actin-regulatory proteins ( ERM, calpain, filamin, myosin, Sra-1, and IQGAP1), tubulin, vimentin, adhesion proteins ( vinculin, talin, and beta 1 integrin), glycolytic enzymes, proteins associated with protein translation, RNA translocation, and ubiquitin-mediated protein degradation, as well as protein chaperones ( HSP90 and HSC70) and signaling proteins ( RhoGDI and ROCK). Inhibitors of MEK1 ( U0126) and HSP90 ( geldanamycin) significantly reduced MSV-MDCK-INV cell motility and pseudopod expression, and geldanamycin treatment inhibited Met phosphorylation and induced the expression of actin stress fibers. ROCK inhibition did not inhibit cell motility but transformed the pseudopodial protrusions of MSV-MDCK-INV cells into extended lamellipodia. Dominant negative Rho disrupted pseudopod expression and, in serum-starved cells, L-alpha-lysophosphatidic acid ( oleoyl) activation of Rho induced pseudopodial protrusions or, in the presence of the ROCK inhibitor, extended lamellipodia. RNA was localized to the actin-rich pseudopodial domains of MSV-MDCK-INV cells, but the extent of colocalization with dense actin ruffles was reduced in the extended lamellipodia formed upon ROCK inhibition. Rho/ROCK activation in epithelial tumor cells therefore regulates RNA translocation to a pseudopodial domain that contains proteins involved in signaling, cytoskeleton remodeling, cell adhesion, glycolysis, and protein translation and degradation.	Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada; Kinexus Bioinformat Corp, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of British Columbia; Universite de Montreal; University of British Columbia; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Nabi, IR (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, 2177 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	irnabi@interchange.ubc.ca	Nabi, Ivan R/C-5493-2009; Dennis, James/E-7268-2013; Nabi, Ivan/GWZ-5144-2022	Nabi, Ivan/0000-0002-0670-0513; Metalnikov, Pavel/0000-0003-3261-4421				Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Beckner ME, 2005, LAB INVEST, V85, P316, DOI 10.1038/labinvest.3700239; BECKNER ME, 1990, JNCI-J NATL CANCER I, V82, P1836, DOI 10.1093/jnci/82.23.1836; Beviglia L, 1999, INT J CANCER, V83, P640, DOI 10.1002/(SICI)1097-0215(19991126)83:5<640::AID-IJC13>3.0.CO;2-D; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Cardone RA, 2005, MOL BIOL CELL, V16, P3117, DOI 10.1091/mbc.e04-10-0945; Chen HC, 1998, J BIOL CHEM, V273, P25777, DOI 10.1074/jbc.273.40.25777; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Croft DR, 2004, CANCER RES, V64, P8994, DOI 10.1158/0008-5472.CAN-04-2052; Cullen BR, 2003, J CELL SCI, V116, P587, DOI 10.1242/jcs.00268; Day RM, 1999, ONCOGENE, V18, P3399, DOI 10.1038/sj.onc.1202683; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; DERMAN MP, 1995, AM J PHYSIOL-RENAL, V268, pF1211, DOI 10.1152/ajprenal.1995.268.6.F1211; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Gregson HC, 2001, J BIOL CHEM, V276, P47575, DOI 10.1074/jbc.M103364200; HILL MA, 1994, J CELL BIOL, V126, P1221, DOI 10.1083/jcb.126.5.1221; HOOCK TC, 1991, J CELL BIOL, V112, P653, DOI 10.1083/jcb.112.4.653; HOUTHAEVE T, 1995, FEBS LETT, V376, P91, DOI 10.1016/0014-5793(95)01242-7; Hung W, 2001, J BIOL CHEM, V276, P12395, DOI 10.1074/jbc.M010715200; Izawa T, 2000, BIOCHEM BIOPH RES CO, V278, P72, DOI 10.1006/bbrc.2000.3772; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Kamei T, 1999, ONCOGENE, V18, P6776, DOI 10.1038/sj.onc.1203114; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Lagana A, 2000, J CELL SCI, V113, P3649; Latham VM, 2001, CURR BIOL, V11, P1010, DOI 10.1016/S0960-9822(01)00291-3; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Le PU, 1998, CANCER RES, V58, P1631; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com; Liu G, 2002, MOL BIOL CELL, V13, P579, DOI 10.1091/mbc.01-03-0140; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; Maulik G, 2002, CLIN CANCER RES, V8, P620; Maulik G, 2002, J CELL MOL MED, V6, P539, DOI 10.1111/j.1582-4934.2002.tb00453.x; Moriyama K, 2002, J CELL SCI, V115, P1591; Nabi IR, 1999, J CELL SCI, V112, P1803; Nguyen TN, 2000, EXP CELL RES, V258, P171, DOI 10.1006/excr.2000.4929; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Royal I, 1997, J CELL PHYSIOL, V173, P196, DOI 10.1002/(SICI)1097-4652(199711)173:2<196::AID-JCP20>3.0.CO;2-D; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Vadnais J, 2002, J BIOL CHEM, V277, P48342, DOI 10.1074/jbc.M209481200; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Webb CP, 2000, CANCER RES, V60, P342; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Woods AJ, 2002, J BIOL CHEM, V277, P6428, DOI 10.1074/jbc.M109446200; Woods AJ, 2005, MOL CELL BIOL, V25, P3763, DOI 10.1128/MCB.25.9.3763-3773.2005; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	60	60	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30564	30573		10.1074/jbc.M501754200	http://dx.doi.org/10.1074/jbc.M501754200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15985431	hybrid			2022-12-27	WOS:000231362500072
J	Larson, HN; Weiner, H; Hurley, TD				Larson, HN; Weiner, H; Hurley, TD			Disruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase "Asian" variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURIFICATION; INVOLVEMENT; MECHANISM; CATALYSIS; DISORDER; LYSINE; ORDER; GENE; RAT	Mitochondrial aldehyde dehydrogenase ( ALDH2) is the major enzyme that oxidizes ethanol-derived acetaldehyde. A nearly inactive form of the enzyme, ALDH2*2, is found in about 40% of the East Asian population. This variant enzyme is defined by a glutamate to lysine substitution at residue 487 located within the oligomerization domain. ALDH2*2 has an increased Km for its coenzyme, NAD(+), and a decreased k(cat), which lead to low activity in vivo. Here we report the 2.1 angstrom crystal structure of ALDH2*2. The structure shows a large disordered region located at the dimer interface that includes much of the coenzyme binding cleft and a loop of residues that form the base of the active site. As a consequence of these structural changes, the variant enzyme exhibits rigid body rotations of its catalytic and coenzyme-binding domains relative to the oligomerization domain. These structural perturbations are the direct result of the inability of lysine 487 to form important stabilizing hydrogen bonds with arginines 264 and 475. Thus, the elevated K-m for coenzyme exhibited by this variant probably reflects the energetic penalty for reestablishing this site for productive coenzyme binding, whereas the structural alterations near the active site are consistent with the lowered V-max.	Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hurley, TD (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	thurley@iupui.edu		HURLEY, THOMAS/0000-0002-5942-1163	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011982] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA011982, R01 AA 11982] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		AMBROZIAK W, 1989, BIOCHEMISTRY-US, V28, P5367, DOI 10.1021/bi00439a008; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bordelon T, 2004, J BIOL CHEM, V279, P43085, DOI 10.1074/jbc.M406139200; BROSS P, 1995, J BIOL CHEM, V270, P10284, DOI 10.1074/jbc.270.17.10284; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen ZQ, 2002, P NATL ACAD SCI USA, V99, P8306, DOI 10.1073/pnas.122225199; ENOMOTO N, 1991, HEPATOLOGY, V13, P1071, DOI 10.1002/hep.1840130611; FARRES J, 1994, J BIOL CHEM, V269, P13854; GHENBOT G, 1992, PROTEIN EXPRES PURIF, V3, P470, DOI 10.1016/1046-5928(92)90064-4; GREENBAUM AL, 1971, ARCH BIOCHEM BIOPHYS, V143, P617, DOI 10.1016/0003-9861(71)90247-5; Hammen PK, 2002, BIOCHEMISTRY-US, V41, P7156, DOI 10.1021/bi012197t; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hurley TD, 2001, CHEM-BIOL INTERACT, V130, P3, DOI 10.1016/S0009-2797(00)00217-9; Hurley TD, 2002, PHARMACOGENOMICS SEA, P417, DOI DOI 10.1002/3527600752; JENG JJ, 1991, ARCH BIOCHEM BIOPHYS, V289, P214, DOI 10.1016/0003-9861(91)90464-T; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KIM JJP, 1988, P NATL ACAD SCI USA, V85, P6677, DOI 10.1073/pnas.85.18.6677; Lamb AL, 1999, BIOCHEMISTRY-US, V38, P6003, DOI 10.1021/bi9900471; Moore SA, 1998, STRUCTURE, V6, P1541, DOI 10.1016/S0969-2126(98)00152-X; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Ni L, 1997, J BIOL CHEM, V272, P18823, DOI 10.1074/jbc.272.30.18823; Ni L, 1999, PROTEIN SCI, V8, P2784; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng GS, 1999, PHARMACOGENETICS, V9, P463; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Seitz HK, 2001, ALCOHOL CLIN EXP RES, V25, p137S, DOI 10.1097/00000374-200105051-00024; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; TAKAHASHI K, 1980, ARCH BIOCHEM BIOPHYS, V205, P571, DOI 10.1016/0003-9861(80)90140-X; WEINER H, 1976, J BIOL CHEM, V251, P3853; Yokoyama A, 1999, ALCOHOL CLIN EXP RES, V23, P1705, DOI 10.1097/00000374-199911000-00001; ZHENG CF, 1993, ALCOHOL CLIN EXP RES, V17, P828, DOI 10.1111/j.1530-0277.1993.tb00849.x; Zhou JZ, 2000, BIOCHEMISTRY-US, V39, P12019, DOI 10.1021/bi001221k	33	79	88	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30550	30556		10.1074/jbc.M502345200	http://dx.doi.org/10.1074/jbc.M502345200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15983043	hybrid, Green Accepted			2022-12-27	WOS:000231362500070
J	ElAntak, L; Ansaldi, M; Guerlesquin, F; Mejean, V; Morelli, X				ElAntak, L; Ansaldi, M; Guerlesquin, F; Mejean, V; Morelli, X			Structural and genetic analyses reveal a key role in prophage excision for the TorI response regulator inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; DNA-BINDING DOMAIN; ESCHERICHIA-COLI K-12; TRIPLE-RESONANCE NMR; BACTERIOPHAGE-LAMBDA; XIS PROTEIN; DIRECTIONALITY FACTORS; PATHOGENICITY ISLAND; NUCLEOTIDE-SEQUENCE; SHIGELLA-FLEXNERI	TorI ( Tor inhibition protein) has been identified in Escherichia coli as a protein inhibitor acting through protein-protein interaction with the TorR response regulator. This interaction, which does not interfere with TorR DNA binding activity, probably prevents the recruitment of RNA polymerase to the torC promoter. In this study we have solved the solution structure of TorI, which adopts a prokaryotic winged-helix arrangement. Despite no primary sequence similarity, the three-dimensional structure of TorI is highly homologous to the (lambda)Xis, Mu bacteriophage repressor (MuR-DBD), and transposase (MuA-DBD) structures. We propose that the TorI protein is the structural missing link between the (lambda)Xis and MuR proteins. Moreover, in vivo assays demonstrated that TorI plays an essential role in prophage excision. Heteronuclear NMR experiments and site-directed mutagenesis studies have pinpointed out key residues involved in the DNA binding activity of TorI. Our findings suggest that TorI-related proteins identified in various pathogenic bacterial genomes define a new family of atypical excisionases.	CNRS, IBSM, Unite Bioenerget & Ingn Prot, F-13402 Marseille, France; CNRS, IBSM, Chim Bacterienne Lab, F-13402 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Morelli, X (corresponding author), CNRS, IBSM, Unite Bioenerget & Ingn Prot, 31 Chemin Joseph Aiguier, F-13402 Marseille, France.	morelli@ibsm.cnrs-mrs.fr	morelli, xavier/A-9218-2016; ELANTAK, Latifa/S-7004-2019	morelli, xavier/0000-0001-8101-7901; ANSALDI, Mireille/0000-0002-2878-0702; Mejean, Vincent/0000-0001-6533-5846				Abbani M, 2005, J MOL BIOL, V347, P11, DOI 10.1016/j.jmb.2005.01.019; ABREMSKI K, 1982, J BIOL CHEM, V257, P9658; Ansaldi M, 1996, ANAL BIOCHEM, V234, P110, DOI 10.1006/abio.1996.0060; Ansaldi M, 2004, P NATL ACAD SCI USA, V101, P9423, DOI 10.1073/pnas.0401927101; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; BAX A, 1990, J MAGN RESON, V87, P620, DOI 10.1016/0022-2364(90)90320-9; Casjens S, 2004, J MOL BIOL, V339, P379, DOI 10.1016/j.jmb.2004.03.068; Cho EH, 2000, J BACTERIOL, V182, P5807, DOI 10.1128/JB.182.20.5807-5812.2000; Cho EH, 2002, J BACTERIOL, V184, P5200, DOI 10.1128/JB.184.18.5200-5203.2002; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; CLUBB RT, 1994, STRUCTURE, V2, P1041, DOI 10.1016/S0969-2126(94)00107-3; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLano W.L, PYMOL MOL GRAPHICS S; DEVARGAS LM, 1991, P NATL ACAD SCI USA, V88, P588, DOI 10.1073/pnas.88.2.588; Friedman DI, 1992, CURR OPIN GENET DEV, V2, P727, DOI 10.1016/S0959-437X(05)80133-9; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Ilangovan U, 1999, BIOCHEMISTRY-US, V38, P8367, DOI 10.1021/bi990530b; Jourlin C, 1997, J MOL BIOL, V267, P770, DOI 10.1006/jmbi.1997.0919; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lesic B, 2004, MOL MICROBIOL, V52, P1337, DOI 10.1111/j.1365-2958.2004.04073.x; Lewis JA, 2001, NUCLEIC ACIDS RES, V29, P2205, DOI 10.1093/nar/29.11.2205; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Luck SN, 2004, J BACTERIOL, V186, P5551, DOI 10.1128/JB.186.16.5551-5554.2004; NUMRYCH TE, 1991, J BACTERIOL, V173, P5954, DOI 10.1128/jb.173.19.5954-5963.1991; NUMRYCH TE, 1992, EMBO J, V11, P3797, DOI 10.1002/j.1460-2075.1992.tb05465.x; Rogov VV, 2003, EUR J BIOCHEM, V270, P4846, DOI 10.1111/j.1432-1033.2003.03884.x; Rudd KE, 1999, RES MICROBIOL, V150, P653, DOI 10.1016/S0923-2508(99)00126-6; Sam MD, 2004, J MOL BIOL, V338, P229, DOI 10.1016/j.jmb.2004.02.053; Sam MD, 2002, J MOL BIOL, V324, P791, DOI 10.1016/S0022-2836(02)01150-6; SIMON G, 1994, J BACTERIOL, V176, P5601, DOI 10.1128/JB.176.18.5601-5606.1994; SIMON G, 1995, MOL MICROBIOL, V17, P971, DOI 10.1111/j.1365-2958.1995.mmi_17050971.x; THOMPSON JF, 1987, J MOL BIOL, V195, P481, DOI 10.1016/0022-2836(87)90177-X; VOGEL JL, 1991, J BACTERIOL, V173, P6568, DOI 10.1128/jb.173.20.6568-6577.1991; VUISTER GW, 1994, J BIOMOL NMR, V4, P193; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wojciak JM, 2001, NAT STRUCT BIOL, V8, P84	39	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2005	280	44					36802	36808		10.1074/jbc.M507409200	http://dx.doi.org/10.1074/jbc.M507409200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	978VT	16079126	Green Published, hybrid			2022-12-27	WOS:000232901800034
J	Patterson, HM; Brannigan, JA; Cutting, SM; Wilson, KS; Wilkinson, AJ; AB, E; Diercks, T; de Jong, RN; Truffault, V; Folkers, GE; Kaptein, R				Patterson, HM; Brannigan, JA; Cutting, SM; Wilson, KS; Wilkinson, AJ; AB, E; Diercks, T; de Jong, RN; Truffault, V; Folkers, GE; Kaptein, R			The structure of bypass of forespore C, an intercompartmental signaling factor during sporulation in Bacillus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; TORSION ANGLE DYNAMICS; CHEMICAL-SHIFT INDEX; GENE-EXPRESSION; MOTHER-CELL; SPORE FORMATION; SUBTILIS; PRO-SIGMA(K); SPOIVB; ASSIGNMENT	Sporulation in Bacillus subtilis begins with an asymmetric cell division giving rise to smaller forespore and larger mother cell compartments. Different programs of gene expression are subsequently directed by compartment-specific RNA polymerase sigma-factors. In the final stages, spore coat proteins are synthesized in the mother cell under the control of RNA polymerase containing sigma(K), (E sigma(K)). sigma(K) is synthesized as an inactive zymogen, pro-sigma(K), which is activated by proteolytic cleavage. Processing of pro-sigma(K) is performed by SpoIVFB, a metalloprotease that resides in a complex with SpoIVFA and bypass of forespore (Bof) A in the outer forespore membrane. Ensuring coordination of events taking place in the two compartments, pro-sigma(K) processing in the mother cell is delayed until appropriate signals are received from the forespore. Cell-cell signaling is mediated by SpoIVB and BofC, which are expressed in the forespore and secreted to the intercompartmental space where they regulate pro-sigma(K) processing by mechanisms that are not yet fully understood. Here we present the three-dimensional structure of BofC determined by solution state NMR. BofC is a monomer made up of two domains. The N-terminal domain, containing a four-stranded beta-sheet onto one face of which an alpha-helix is packed, closely resembles the third immunoglobulin-binding domain of protein G from Streptococcus. The C-terminal domain contains a three-stranded beta-sheet and three alpha-helices in a novel domain topology. The sequence connecting the domains contains a conserved DISP motif to which mutations that affect BofC activity map. Possible roles for BofC in the sigma(K) checkpoint are discussed in the light of sequence and structure comparisons.	Univ York, Dept Chem, Struct Biol Lab, York YO10 5YW, N Yorkshire, England; Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Univ Utrecht, NMR Dept, Bijvoet Ctr, NL-3584 CH Utrecht, Netherlands	University of York - UK; University of London; Royal Holloway University London; Utrecht University	Wilkinson, AJ (corresponding author), Univ York, Dept Chem, Struct Biol Lab, York YO10 5YW, N Yorkshire, England.	ajw@ysbl.york.ac.uk	Diercks, Tammo/AAT-3731-2021; AB, Eiso/H-8177-2012; Diercks, Tammo/G-1167-2011; Folkers, Gert E/C-2863-2009	Diercks, Tammo/0000-0002-5200-0905; Diercks, Tammo/0000-0002-5200-0905; Folkers, Gert E/0000-0003-1070-0505; Wilkinson, Anthony/0000-0003-4577-9479; AB, Eiso/0000-0002-5758-0435; de Jong, Rob N./0000-0002-9300-6633; Wilson, Keith/0000-0002-3581-2194	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BJORCK L, 1990, BACTERIAL IMMUNOGLOB, V1, P113; Boyle, 1990, BACTERIAL IMMUNOGLOB; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CUTTING S, 1991, J MOL BIOL, V221, P1237; CUTTING S, 1990, CELL, V62, P239, DOI 10.1016/0092-8674(90)90362-I; DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691; Diercks T, 1999, J BIOMOL NMR, V15, P177, DOI 10.1023/A:1008367912535; Dong TC, 2004, J BIOL CHEM, V279, P43468, DOI 10.1074/jbc.M407048200; Dong TC, 2003, MOL MICROBIOL, V49, P1425, DOI 10.1046/j.1365-2958.2003.03651.x; Furrer J, 2004, J MAGN RESON, V166, P39, DOI 10.1016/j.jmr.2003.09.013; Gomez M, 1997, MICROBIOL-UK, V143, P157, DOI 10.1099/00221287-143-1-157; GOMEZ M, 1995, J BACTERIOL, V177, P4825, DOI 10.1128/jb.177.16.4825-4827.1995; Green DH, 2000, J BACTERIOL, V182, P278, DOI 10.1128/JB.182.2.278-285.2000; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Hoa NT, 2002, J BACTERIOL, V184, P191, DOI 10.1128/JB.184.1.191-199.2002; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KADKHODAIE M, 1991, J MAGN RESON, V91, P437, DOI 10.1016/0022-2364(91)90210-K; Kroos L, 2002, J BACTERIOL, V184, P5393, DOI 10.1128/JB.184.19.5393-5401.2002; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leutner M, 1998, J BIOMOL NMR, V11, P31, DOI 10.1023/A:1008298226961; LOSICK R, 1992, NATURE, V355, P601, DOI 10.1038/355601a0; LU SJ, 1990, P NATL ACAD SCI USA, V87, P9722, DOI 10.1073/pnas.87.24.9722; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Munoz E, 1998, EUR J IMMUNOL, V28, P2591, DOI 10.1002/(SICI)1521-4141(199808)28:08<2591::AID-IMMU2591>3.0.CO;2-P; Nagarajan Vasantha, 1993, P713; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Oke V, 1997, MOL MICROBIOL, V23, P223, DOI 10.1046/j.1365-2958.1997.2091573.x; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Resnekov O, 1998, P NATL ACAD SCI USA, V95, P3162, DOI 10.1073/pnas.95.6.3162; Rudner DZ, 2002, GENE DEV, V16, P1007, DOI 10.1101/gad.977702; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; Stragier P., 2002, BACILLUS SUBTILIS IT, P519; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wakeley P, 2000, MOL MICROBIOL, V36, P1415, DOI 10.1046/j.1365-2958.2000.01962.x; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yu YTN, 2000, J BACTERIOL, V182, P3305, DOI 10.1128/JB.182.11.3305-3309.2000; Zhang B, 1998, J BACTERIOL, V180, P2434, DOI 10.1128/JB.180.9.2434-2441.1998; Zhou RB, 2004, P NATL ACAD SCI USA, V101, P6385, DOI 10.1073/pnas.0307709101; Zimmerman DE, 1997, J MOL BIOL, V269, P592, DOI 10.1006/jmbi.1997.1052	45	4	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2005	280	43					36214	36220		10.1074/jbc.M506910200	http://dx.doi.org/10.1074/jbc.M506910200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	976IM	16049010	hybrid, Green Published			2022-12-27	WOS:000232726900053
J	Amemiya-Kudo, M; Oka, J; Ide, T; Matsuzaka, T; Sone, H; Yoshikawa, T; Yahagi, N; Ishibashi, S; Osuga, J; Yamada, N; Murase, T; Shimano, H				Amemiya-Kudo, M; Oka, J; Ide, T; Matsuzaka, T; Sone, H; Yoshikawa, T; Yahagi, N; Ishibashi, S; Osuga, J; Yamada, N; Murase, T; Shimano, H			Sterol regulatory element-binding proteins activate insulin gene promoter directly and indirectly through synergy with BETA2/E47	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; BETA-CELLS; PANCREATIC-ISLETS; NUCLEAR SREBP-1C; DNA-BINDING; EXPRESSION; LIVER; MICE; STIMULATION; INDUCTION	Insulin gene expression is regulated by pancreatic beta cell-specific factors, PDX-1 and BETA2/E47. Here we have demonstrated that the insulin promoter is a novel target for SREBPs established as lipid-synthetic transcription factors. Promoter analyses of rat insulin I gene in non-beta cells revealed that nuclear SREBP-1c activates the insulin promoter through three novel SREBP-binding sites (SREs), two of which overlap with E-boxes, binding sites for BETA2/ E47. SREBP-1c activation of the insulin promoter was markedly enhanced by co-expression of BETA2/ E47. This synergistic activation by SREBP-1c/ BETA2/ E47 was not mediated through SREs but through the E-boxes on which BETA2/ E47 physically interacts with SREBP-1c, suggesting a novel function of SREBP as a co-activator. These two cis-DNA regions, E1 and E2, with an appropriate distance separating them, were mandatory for the synergism, which implicates formation of SREBP-1c center dot BETA2 center dot E47 complex in a DNA looping structure for efficient recruitment of CREB- binding protein/ p300. However, in the presence of PDX1, the synergistic action of SREBP-1c with BETA2/E47 was canceled. SREBP-1c-mediated activation of the insulin promoter and expression became overt in beta cell lines and isolated islets when endogenous PDX-1 expression was low. This cryptic SREBP-1c action might play a compensatory role in insulin expression in diabetes with beta cell lipotoxicity.	Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Minato Ku, Tokyo 1058470, Japan; Univ Tokyo, Dept Diabet & Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Internal Med Endocrinol & Metab, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058575, Japan	Toranomon Hospital; University of Tokyo; University of Tsukuba; University of Tsukuba	Shimano, H (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Internal Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	shimano-tky@umin.ac.jp	Shimano, Hitoshi/V-1761-2019; Sone, Hirohito/ABC-9346-2021; Yahagi, Naoya/D-2360-2014; Shimano, Hitoshi/AAI-5648-2020	Shimano, Hitoshi/0000-0002-5562-5572; Sone, Hirohito/0000-0003-1263-2817; Yahagi, Naoya/0000-0002-1823-1865; 				Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Andreolas C, 2002, DIABETES, V51, P2536, DOI 10.2337/diabetes.51.8.2536; ARONHEIM A, 1993, P NATL ACAD SCI USA, V90, P8063, DOI 10.1073/pnas.90.17.8063; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Diraison F, 2004, BIOCHEM J, V378, P769, DOI 10.1042/BJ20031277; Ericsson J, 1996, J BIOL CHEM, V271, P24359, DOI 10.1074/jbc.271.40.24359; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; Glick E, 2000, J BIOL CHEM, V275, P2199, DOI 10.1074/jbc.275.3.2199; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; ItkinAnsari P, 1996, ENDOCRINOLOGY, V137, P3540, DOI 10.1210/en.137.8.3540; Kajihara M, 2003, BIOCHEM BIOPH RES CO, V312, P831, DOI 10.1016/j.bbrc.2003.10.196; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; Kaneto H, 2002, J BIOL CHEM, V277, P12998, DOI 10.1074/jbc.M111148200; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Marshak S, 1996, P NATL ACAD SCI USA, V93, P15057, DOI 10.1073/pnas.93.26.15057; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Matsuzaka T, 2004, DIABETES, V53, P560, DOI 10.2337/diabetes.53.3.560; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; MELLOUL D, 1993, P NATL ACAD SCI USA, V90, P3865, DOI 10.1073/pnas.90.9.3865; Najima Y, 2005, J BIOL CHEM, V280, P27523, DOI 10.1074/jbc.M414549200; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Ohneda K, 2000, MOL CELL BIOL, V20, P900, DOI 10.1128/MCB.20.3.900-911.2000; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; Olson LK, 1998, MOL ENDOCRINOL, V12, P207, DOI 10.1210/me.12.2.207; PERMUTT MA, 1972, J BIOL CHEM, V247, P1194; PETERSEN HV, 1994, P NATL ACAD SCI USA, V91, P10465, DOI 10.1073/pnas.91.22.10465; Qiu Y, 1998, MOL CELL BIOL, V18, P2957, DOI 10.1128/MCB.18.5.2957; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Shapiro AMJ, 1996, CELL TRANSPLANT, V5, P631, DOI 10.1016/S0963-6897(96)00084-X; Sharma A, 1999, MOL CELL BIOL, V19, P704; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 2002, VITAM HORM, V65, P167, DOI 10.1016/S0083-6729(02)65064-2; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Takahashi A, 2005, DIABETES, V54, P492, DOI 10.2337/diabetes.54.2.492; Wang HY, 2003, J BIOL CHEM, V278, P16622, DOI 10.1074/jbc.M212488200; Wolberger C, 1998, CURR OPIN GENET DEV, V8, P552, DOI 10.1016/S0959-437X(98)80010-5; Yamamoto T, 2004, J BIOL CHEM, V279, P12027, DOI 10.1074/jbc.M310333200; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	50	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34577	34589		10.1074/jbc.M506718200	http://dx.doi.org/10.1074/jbc.M506718200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16055439	hybrid			2022-12-27	WOS:000232403900026
J	Chang, SA; Bralley, P; Jones, GH				Chang, SA; Bralley, P; Jones, GH			The absB gene encodes a double strand-specific endoribonuclease that cleaves the read-through transcript of the rpsO-pnp operon in Streptomyces coelicolor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RIBONUCLEASE-III; POLYNUCLEOTIDE PHOSPHORYLASE; MESSENGER; PURIFICATION; MECHANISM	The absB locus of Streptomyces coelicolor encodes a homolog of bacterial RNase III. We cloned and overexpressed the absB gene product and purified a decahistidine-tagged version of the protein. We show here that AbsB is active against double-stranded RNA transcripts derived from synthetic DNAs but is inactive with single-stranded homopolymers. We thus designate the absB product RNase IIIS. Using T7 RNA polymerase and a cloned template containing the rpsO-pnp intergenic region, we synthesized an RNA substrate representing a portion of the read-through transcript normally produced in S. coelicolor. This transcript contains the sequences that form the putative rpsO terminator and those that form an intergenic stem-loop structure thought to be the site for RNase IIIS processing of the read-through transcript. We show that RNase IIIS does cleave that model transcript, with primary and secondary cleavage sites in an internal loop in the stem-loop structure. We have identified the primary and secondary cleavage sites by primer extension and demonstrate the further processing of the initial cleavage products. Thus, as is the case in Escherichia coli, the read-through transcript from rpsO-pnp is cleaved by RNase IIIS in S. coelicolor. However, the cleavage sites are different in the two systems. The positions of the cleavage sites in the stem-loop of the S. coelicolor transcript are more akin to those identified in the processing of bacteriophage T7 mRNAs. A kinetic assay for RNase IIIS was developed, and kinetic parameters for the reaction utilizing the model transcript from rpsO-pnp were determined.	Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Jones, GH (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	george.h.jones@emory.edu						Aceti DJ, 1998, J BACTERIOL, V180, P3100, DOI 10.1128/JB.180.12.3100-3106.1998; ADAMIDIS T, 1992, J BACTERIOL, V174, P4622, DOI 10.1128/JB.174.14.4622-4628.1992; BABITZKE P, 1993, J BACTERIOL, V175, P229, DOI 10.1128/JB.175.1.229-239.1993; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bralley P, 2004, J BACTERIOL, V186, P3160, DOI 10.1128/JB.186.10.3160-3172.2004; Bralley P, 2003, MICROBIOL-SGM, V149, P2173, DOI 10.1099/mic.0.26334-0; Calin-Jageman I, 2003, NUCLEIC ACIDS RES, V31, P2381, DOI 10.1093/nar/gkg329; Calin-Jageman I, 2003, BIOCHEMISTRY-US, V42, P5025, DOI 10.1021/bi030004r; Campbell FE, 2002, J MOL BIOL, V317, P21, DOI 10.1006/jmbi.2002.5413; DUNN JJ, 1973, P NATL ACAD SCI USA, V70, P3296, DOI 10.1073/pnas.70.12.3296; FRANKLIN RM, 1966, P NATL ACAD SCI USA, V55, P1504, DOI 10.1073/pnas.55.6.1504; He B, 1997, PROTEIN EXPRES PURIF, V9, P142, DOI 10.1006/prep.1996.0663; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI HL, 1993, NUCLEIC ACIDS RES, V21, P1919, DOI 10.1093/nar/21.8.1919; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; PORTIER C, 1987, EMBO J, V6, P2165, DOI 10.1002/j.1460-2075.1987.tb02484.x; Price B, 1999, J BACTERIOL, V181, P6142, DOI 10.1128/JB.181.19.6142-6151.1999; REGNIER P, 1986, J MOL BIOL, V187, P23, DOI 10.1016/0022-2836(86)90403-1; ROBERTLEMEUR M, 1992, EMBO J, V11, P2633, DOI 10.1002/j.1460-2075.1992.tb05329.x; ROBERTLEMEUR M, 1994, NUCLEIC ACIDS RES, V22, P397, DOI 10.1093/nar/22.3.397; ROBERTSON HD, 1968, J BIOL CHEM, V243, P82; Sasaki N, 1998, GENE, V222, P17, DOI 10.1016/S0378-1119(98)00447-8; Sun WM, 2001, BIOCHEMISTRY-US, V40, P5102, DOI 10.1021/bi010022d; Zhang KJ, 1997, P NATL ACAD SCI USA, V94, P13437, DOI 10.1073/pnas.94.25.13437	24	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33213	33219		10.1074/jbc.M503440200	http://dx.doi.org/10.1074/jbc.M503440200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16076842	hybrid			2022-12-27	WOS:000232058100016
J	Wu, SD; Xie, P; Welsh, K; Li, CL; Ni, CZ; Zhu, XW; Reed, JC; Satterthwait, AC; Bishop, GA; Ely, KR				Wu, SD; Xie, P; Welsh, K; Li, CL; Ni, CZ; Zhu, XW; Reed, JC; Satterthwait, AC; Bishop, GA; Ely, KR			LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATENT MEMBRANE-PROTEIN; NF-KAPPA-B; RECEPTOR-ASSOCIATED FACTOR-3; FACTOR-INDUCED APOPTOSIS; GROWTH TRANSFORMATION; MOLECULAR MECHANISMS; BCL-2 HOMOLOG; BAFF RECEPTOR; CELL-DEATH; 1 ENGAGES	Epstein-Barr virus is a human herpesvirus that causes infectious mononucleosis and lymphoproliferative malignancies. LMP1 ( latent membrane protein-1), which is encoded by this virus and which is essential for transformation of B lymphocytes, acts as a constitutively active mimic of the tumor necrosis factor receptor (TNFR) CD40. LMP1 is an integral membrane protein containing six transmembrane segments and a cytoplasmic domain at the C terminus that binds to intracellular TNFR-associated factors (TRAFs). TRAFs are intracellular co-inducers of downstream signaling from CD40 and other TNFRs, and TRAF3 is required for activation of B lymphocytes by LMP1. Cytoplasmic C-terminal activation region 1 of LMP1 bears a motif (PQQAT) that conforms to the TRAF recognition motif PVQET in CD40. In this study, we report the crystal structure of this portion of LMP1 C-terminal activation region-1 ((204)PQQATDD(210)) bound in complex with TRAF3. The PQQAT motif is bound in the same binding crevice on TRAF3 where CD40 is bound, providing a molecular mechanism for LMP1 to act as a CD40 decoy for TRAF3. The LMP1 motif is presented in the TRAF3 crevice as a close structural mimic of the PVQET motif in CD40, and the intermolecular contacts are similar. However, the viral protein makes a unique contact: a hydrogen bond network formed between Asp(210) in LMP1 and Tyr(395) and Arg(393) in TRAF3. This intermolecular contact is not made in the CD40-TRAF3 complex. The additional hydrogen bonds may stabilize the complex and strengthen the binding to permit LMP1 to compete with CD40 for binding to the TRAF3 crevice, influencing downstream signaling to B lymphocytes and contributing to dysregulated signaling by LMP1.	Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Wu, SD (corresponding author), Burnham Inst, Ctr Canc, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ely@burnham.org	Li, Chenglong/E-7182-2010	Li, Chenglong/0000-0003-3174-8719; Bishop, Gail/0000-0002-1291-5078	NATIONAL CANCER INSTITUTE [R01CA099997, P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049993, R56AI028847, R29AI028847, R56AI049993, R01AI028847] Funding Source: NIH RePORTER; NCI NIH HHS [CA69381, CA99997] Funding Source: Medline; NIAID NIH HHS [AI28847, AI49993] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Benedict CA, 2003, CURR OPIN IMMUNOL, V15, P59, DOI 10.1016/S0952-7915(02)00018-3; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; BHAT TN, 1984, J APPL CRYSTALLOGR, V17, P244, DOI 10.1107/S0021889884011456; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Bishop GA, 2002, J LEUKOCYTE BIOL, V72, P19; Bishop GA, 2002, MICROBES INFECT, V4, P853, DOI 10.1016/S1286-4579(02)01605-2; Bishop GA, 2001, IMMUNOL RES, V24, P97, DOI 10.1385/IR:24:2:097; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Busch LK, 1999, J IMMUNOL, V162, P2555; Busch LK, 2001, J IMMUNOL, V167, P5805, DOI 10.4049/jimmunol.167.10.5805; Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; Chung JY, 2002, J CELL SCI, V115, P679; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Ely KR, 2002, J MOL RECOGNIT, V15, P286, DOI 10.1002/jmr.589; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; HAMANO T, 1982, J IMMUNOL, V129, P1403; Hatzivassiliou E, 2002, FRONT BIOSCI, V7, pD319, DOI 10.2741/hatziva; Haxhinasto SA, 2003, J IMMUNOL, V171, P4655, DOI 10.4049/jimmunol.171.9.4655; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hostager BS, 1999, J IMMUNOL, V162, P6307; Hostager BS, 1996, J IMMUNOL, V157, P1047; HUEN DS, 1995, ONCOGENE, V10, P549; Izumi KM, 1999, MOL CELL BIOL, V19, P5759; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P12592, DOI 10.1073/pnas.94.23.12592; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuhne MR, 1997, J EXP MED, V186, P337, DOI 10.1084/jem.186.2.337; Li CL, 2003, J BIOL CHEM, V278, P50523, DOI 10.1074/jbc.M309381200; Li CL, 2002, STRUCTURE, V10, P403, DOI 10.1016/S0969-2126(02)00733-5; LIEBOWITZ D, 1986, J VIROL, V58, P233, DOI 10.1128/JVI.58.1.233-237.1986; Lyons SF, 1998, SEMIN ONCOL, V25, P461; Marshall WL, 1999, VIROLOGY, V256, P1, DOI 10.1006/viro.1999.9599; McFarland EDC, 1999, ONCOGENE, V18, P6959, DOI 10.1038/sj.onc.1203217; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; Morrison MD, 2005, J BIOL CHEM, V280, P10018, DOI 10.1074/jbc.M413634200; NEILAN JG, 1993, J VIROL, V67, P4391, DOI 10.1128/JVI.67.7.4391-4394.1993; Ni CZ, 2000, P NATL ACAD SCI USA, V97, P10395, DOI 10.1073/pnas.97.19.10395; Ni CZ, 2004, J IMMUNOL, V173, P7394, DOI 10.4049/jimmunol.173.12.7394; Ni CZ, 2002, ACTA CRYSTALLOGR D, V58, P1340, DOI 10.1107/S0907444902008958; OTWINOWSKI Z, 1993, CCP4 STUDY WEEKEND D, P55; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Sarid R, 1997, NAT MED, V3, P293, DOI 10.1038/nm0397-293; TALLEY AK, 1995, MOL CELL BIOL, V15, P2359; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; ThorleyLawson DA, 1996, TRENDS MICROBIOL, V4, P204, DOI 10.1016/S0966-842X(96)90020-7; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; Xie P, 2004, J IMMUNOL, V173, P5546, DOI 10.4049/jimmunol.173.9.5546; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; [No title captured]	59	48	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33620	33626		10.1074/jbc.M502511200	http://dx.doi.org/10.1074/jbc.M502511200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16009714	hybrid			2022-12-27	WOS:000232058100063
J	Drosopoulos, WC; DiRenzo, R; Prasad, VR				Drosopoulos, WC; DiRenzo, R; Prasad, VR			Human telomerase RNA template sequence is a determinant of telomere repeat extension rate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAHYMENA-TELOMERASE; ADDITION PROCESSIVITY; REVERSE-TRANSCRIPTASE; MAMMALIAN TELOMERASE; BOUNDARY DEFINITION; MUTANT TELOMERASE; IN-VITRO; EXPRESSION; REQUIREMENT; NUCLEOTIDE	Human telomerase is a specialized reverse transcriptase that utilizes an integral RNA subunit to template the synthesis of telomeres. In the present study, we demonstrate that the human telomerase template sequence not only determines the composition, but also the rate of synthesis, of telomere repeats. Mutagenesis of the template sequence identified variants that reconstitute enzymes with repeat extension rates that were either faster or slower than wild type template. Changes in extension rate could not be attributed solely to altered heteroduplex melting, strongly suggesting that specific interactions between telomerase template, protein, and products contribute significantly in determining repeat extension rate. Furthermore, some substitutions that had no effect on extension rate led to striking increases in repeat processivity, indicating that processivity and extension rates can be regulated independently of each other. Our results suggest that telomerase RNA template sequence is a key determinant of the contribution of telomerase to telomere length regulation.	Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Prasad, VR (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	prasad@aecom.yu.edu	Prasad, Vinayaka R./A-1029-2011	Prasad, Vinayaka/0000-0002-9461-0189	NATIONAL CANCER INSTITUTE [K01CA087542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030861] Funding Source: NIH RePORTER; NCI NIH HHS [K01-CACA87542] Funding Source: Medline; NIAID NIH HHS [R01-AI30861] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AUTEXIER C, 1994, GENE DEV, V8, P563, DOI 10.1101/gad.8.5.563; Boyer PL, 1996, METHOD ENZYMOL, V275, P538; Bryan TM, 2000, J BIOL CHEM, V275, P24199, DOI 10.1074/jbc.M003246200; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen JL, 2003, EMBO J, V22, P304, DOI 10.1093/emboj/cdg024; Collins K, 1999, ANNU REV BIOCHEM, V68, P187, DOI 10.1146/annurev.biochem.68.1.187; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Gavory G, 2002, NUCLEIC ACIDS RES, V30, P4470, DOI 10.1093/nar/gkf575; GILLEY D, 1995, GENE DEV, V9, P2214, DOI 10.1101/gad.9.18.2214; Gilley D, 1996, MOL CELL BIOL, V16, P66; Guiducci C, 2001, ONCOGENE, V20, P714, DOI 10.1038/sj.onc.1204145; Henning KA, 1998, P NATL ACAD SCI USA, V95, P5667, DOI 10.1073/pnas.95.10.5667; Jarstfer MB, 2002, BIOCHEMISTRY-US, V41, P151, DOI 10.1021/bi011649z; Kelleher C, 2002, TRENDS BIOCHEM SCI, V27, P572, DOI 10.1016/S0968-0004(02)02206-5; Kim MM, 2001, P NATL ACAD SCI USA, V98, P7982, DOI 10.1073/pnas.131211098; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Lai CK, 2003, MOL CELL, V11, P1673, DOI 10.1016/S1097-2765(03)00232-6; Lai CK, 2002, GENE DEV, V16, P415, DOI 10.1101/gad.962602; Maine IP, 1999, BIOCHEMISTRY-US, V38, P15325, DOI 10.1021/bi991596+; Marusic L, 1997, MOL CELL BIOL, V17, P6394, DOI 10.1128/MCB.17.11.6394; McCormickGraham M, 1997, EMBO J, V16, P3233, DOI 10.1093/emboj/16.11.3233; Miller MC, 2002, P NATL ACAD SCI USA, V99, P6585, DOI 10.1073/pnas.102024699; Moriarty TJ, 2004, MOL CELL BIOL, V24, P3720, DOI 10.1128/MCB.24.9.3720-3733.2004; Prescott J, 1997, GENE DEV, V11, P528, DOI 10.1101/gad.11.4.528; Prescott JC, 2000, MOL CELL BIOL, V20, P2941, DOI 10.1128/MCB.20.8.2941-2948.2000; Rivera MA, 2004, J BIOL CHEM, V279, P53770, DOI 10.1074/jbc.M407768200; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tzfati Y, 2000, SCIENCE, V288, P863, DOI 10.1126/science.288.5467.863; Ware TL, 2000, EMBO J, V19, P3119, DOI 10.1093/emboj/19.12.3119; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526; Ye AJ, 1999, MOL CELL BIOL, V19, P2887; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0	33	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32801	32810		10.1074/jbc.M506319200	http://dx.doi.org/10.1074/jbc.M506319200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16061476	hybrid			2022-12-27	WOS:000231920300032
J	Koh, YH; von Arnim, CAF; Hyman, BT; Tanzi, RE; Tesco, G				Koh, YH; von Arnim, CAF; Hyman, BT; Tanzi, RE; Tesco, G			BACE is degraded via the lysosomal pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; SECRETASE CYTOSOLIC DOMAIN; BETA-SECRETASE; ALZHEIMERS-DISEASE; GGA PROTEINS; HUMAN-BRAIN; A-BETA; PROTEASOME; UBIQUITIN; CLEAVAGE	Amyloid plaques are formed by aggregates of amyloid-beta-peptide, a 37-43-amino acid fragment ( primarily A beta(40) and A beta(42)) generated by proteolytic processing of the amyloid precursor protein (APP) by beta- and gamma-secretases. A type I transmembrane aspartyl protease, BACE (beta-site APP cleaving enzyme), has been identified to be the beta- secretase. BACE is targeted through the secretory pathway to the plasma membrane where it can be internalized to endosomes. The carboxyl terminus of BACE contains a di-leucine-based signal for sorting of transmembrane proteins to endosomes and lysosomes. In this study, we set out to determine whether BACE is degraded by the lysosomal pathway and whether the di-leucine motif is necessary for targeting BACE to the lysosomes. Here we show that lysosomal inhibitors, chloroquine and NH4Cl, lead to accumulation of endogenous and ectopically expressed BACE in a variety of cell types, including primary neurons. Furthermore, the inhibition of lysosomal hydrolases results in the redistribution and accumulation of BACE in the late endosomal/lysosomal compartments (lysosome-associated membrane protein 2 (LAMP2)-positive). In contrast, the BACE-LL/AA mutant, in which Leu(499) and Leu(500) in the COOH-terminal sequence ( DDISLLK) were replaced by alanines, only partially co-localized with LAMP2-positive compartments following inhibition of lysosomal hydrolases. Collectively, our data indicate that BACE is transported to the late endosomal/lysosomal compartments where it is degraded via the lysosomal pathway and that the di-leucine motif plays a role in sorting BACE to lysosomes.	MA Gen Hosp, Genet & Aging Res Unit, Mass Gen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; MA Gen Hosp, Alzheimer Dis Res Lab, Mass Gen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA		Tanzi, RE (corresponding author), MA Gen Hosp, Genet & Aging Res Unit, Mass Gen Inst Neurodegenerat Dis, 114 16th St,C3009, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu; tescog@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454	NATIONAL INSTITUTE OF MENTAL HEALTH [K12MH069281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012406, P01AG015379] Funding Source: NIH RePORTER; NIA NIH HHS [R01AG12406, 5P01AG15379] Funding Source: Medline; NIMH NIH HHS [1K12MH069281-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Berezovska O, 1999, MOL BRAIN RES, V69, P273, DOI 10.1016/S0169-328X(99)00119-9; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Citron M, 2000, MOL MED TODAY, V6, P392, DOI 10.1016/S1357-4310(00)01759-7; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fujita H, 2001, J INVEST DERM SYMP P, V6, P19, DOI 10.1046/j.0022-202x.2001.00009.x; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Haniu M, 2000, J BIOL CHEM, V275, P21099, DOI 10.1074/jbc.M002095200; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; He XY, 2003, BIOCHEMISTRY-US, V42, P12174, DOI 10.1021/bi035199h; He XY, 2002, FEBS LETT, V524, P183, DOI 10.1016/S0014-5793(02)03052-1; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Hussain I, 2003, J BIOL CHEM, V278, P36264, DOI 10.1074/jbc.M304186200; KIRSCHKE H, 1987, LYSOSOMES THEIR ROLE; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Marcinkiewicz M, 2000, J NEUROCHEM, V75, P2133, DOI 10.1046/j.1471-4159.2000.0752133.x; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Pastorino L, 2002, MOL CELL NEUROSCI, V19, P175, DOI 10.1006/mcne.2001.1065; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; POPE A, 1984, NEUROCHEM RES, V9, P291, DOI 10.1007/BF00963980; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; Vassar R, 2005, SUB CELL BIOCHEM, V38, P79; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2001, J MOL NEUROSCI, V17, P157, DOI 10.1385/JMN:17:2:157; von Arnim CAF, 2004, J CELL SCI, V117, P5437, DOI 10.1242/jcs.01422; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010	45	136	139	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32499	32504		10.1074/jbc.M506199200	http://dx.doi.org/10.1074/jbc.M506199200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16033761	hybrid			2022-12-27	WOS:000231794800058
J	Kotaja, N; Macho, B; Sassone-Corsi, P				Kotaja, N; Macho, B; Sassone-Corsi, P			Microtubule-independent and protein kinase A-mediated function of kinesin KIF17b controls the intracellular transport of activator of CREM in testis (ACT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERM-CELL DIFFERENTIATION; SOLUBLE ADENYLYL-CYCLASE; SEMINIFEROUS EPITHELIUM; SPERMATOGENIC CELLS; CATALYTIC SUBUNIT; EXPRESSION; SPERM; MICE; SPERMIOGENESIS; MODULATION	Kinesins are motor proteins that transport their cargos along microtubules in an ATP- dependent manner. The testis-specific kinesin KIF17b was shown to directly regulate cAMP-response element modulator (CREM)-dependent transcription by determining the subcellular localization of the activator of CREM in testis ( ACT), the testis-specific coactivator of CREM in postmeiotic male germ cells. CREM is a crucial transcriptional regulator of many important genes required for spermatid maturation, as demonstrated by the complete block of sperm development at the first steps of spermiogenesis in crem-null mice. To better understand the complex regulation of postmeiotic germ cell differentiation, we further characterized the ACT-KIF17b interaction, the function of KIF17b, and the signaling pathways governing its action. In this study, we demonstrated that the abilities of KIF17b to shuttle between the nuclear and the cytoplasmic compartments and to transport ACT are neither dependent on its motor domain nor on microtubules, thus revealing a novel microtubule-independent function for kinesins. We also showed that the cyclic AMP-dependent protein kinase A mediates the phosphorylation of KIF17b, and this modification is important for its subcellular localization. These results indicate that cyclic AMP signaling controls CREM-mediated transcription in male germ cells through modification of KIF17b function.	Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sassone-Corsi, P (corresponding author), Inst Genet & Biol Mol & Cellulaire, BP 10142, F-67404 Illkirch Graffenstaden, France.	paolosc@igbmc.u-strasbg.fr	Sassone-Corsi, Paolo/H-6182-2011	Kotaja, Noora/0000-0003-1503-9170				Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; DELMAS V, 1993, MOL ENDOCRINOL, V7, P1502, DOI 10.1210/me.7.11.1502; Fimia GM, 1999, NATURE, V398, P165, DOI 10.1038/18237; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Kamal A, 2002, CURR OPIN CELL BIOL, V14, P63, DOI 10.1016/S0955-0674(01)00295-2; KANGASNIEMI M, 1990, ANAT RECORD, V227, P62, DOI 10.1002/ar.1092270108; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Kotaja N, 2004, P NATL ACAD SCI USA, V101, P10620, DOI 10.1073/pnas.0401947101; LONNERBERG P, 1992, BIOL REPROD, V46, P1057, DOI 10.1095/biolreprod46.6.1057; Macho B, 2002, SCIENCE, V298, P2388, DOI 10.1126/science.1077265; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; PARVINEN M, 1982, ENDOCR REV, V3, P404, DOI 10.1210/edrv-3-4-404; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; San Agustin JT, 2001, BIOL REPROD, V65, P151, DOI 10.1095/biolreprod65.1.151; San Agustin JT, 2000, MOL BIOL CELL, V11, P3031, DOI 10.1091/mbc.11.9.3031; Sassone-Corsi P, 1998, SEMIN CELL DEV BIOL, V9, P475, DOI 10.1006/scdb.1998.0200; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Skalhegg B.S., 1997, FRONT BIOSCI, V2, P331; Ullas KS, 2003, J BIOL CHEM, V278, P52673, DOI 10.1074/jbc.M308365200; Weinbauer GF, 1999, ANDROLOGIA, V31, P249, DOI 10.1046/j.1439-0272.1999.00295.x; Woehlke G, 2000, NAT REV MOL CELL BIO, V1, P50, DOI 10.1038/35036069; Xie F, 2004, DEV BIOL, V265, P196, DOI 10.1016/j.ydbio.2003.09.020	30	35	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31739	31745		10.1074/jbc.M505971200	http://dx.doi.org/10.1074/jbc.M505971200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16002395	hybrid			2022-12-27	WOS:000231665200051
J	Robinson, FL; Dixon, JE				Robinson, FL; Dixon, JE			The phosphoinositide-3-phosphatase MTMR2 associates with MTMR13, a membrane-associated pseudophosphatase also mutated in type 4B Charcot-Marie-Tooth disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOTUBULARIN-RELATED PROTEIN-2; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; PHOSPHATASE MYOTUBULARIN; IMPAIRED SPERMATOGENESIS; CAENORHABDITIS-ELEGANS; SENSORY NEUROPATHY; MAMMALIAN-CELLS; ONSET GLAUCOMA; SBF2 MUTATION; GRAM DOMAIN	Charcot-Marie- Tooth disease type 4B (CMT4B) is a severe, demyelinating peripheral neuropathy characterized by distinctive, focally folded myelin sheaths. CMT4B is caused by recessively inherited mutations in either myotubularin-related 2 (MTMR2) or MTMR13 ( also called SET-binding factor 2). MTMR2 encodes a member of the myotubularin family of phosphoinositide-3- phosphatases, which dephosphorylate phosphatidylinositol 3-phosphate ( PI( 3) P) and bisphosphate PI( 3,5) P-2. MTMR13 encodes a large, uncharacterized member of the myotubularin family. The MTMR13 phosphatase domain is catalytically inactive because the essential Cys and Arg residues are absent. Given the genetic association of both MTMR2 and MTMR13 with CMT4B, we investigated the biochemical relationship between these two proteins. We found that the endogenous MTMR2 and MTMR13 proteins are associated in human embryonic kidney 293 cells. MTMR2-MTMR13 association is mediated by coiled-coil sequences present in each protein. We also examined the cellular localization of MTMR2 and MTMR13 using fluorescence microscopy and subcellular fractionation. We found that (i) MTMR13 is a predominantly membrane-associated protein; (ii) MTMR2 and MTMR13 cofractionate in both a light membrane fraction and a cytosolic fraction; and (iii) MTMR13 membrane association is mediated by the segment of the protein which contains the pseudophosphatase domain. This work, which describes the first cellular or biochemical investigation of the MTMR13 pseudophosphatase protein, suggests that MTMR13 functions in association with MTMR2. Loss of MTMR13 function in CMT4B2 patients may lead to alterations in MTMR2 function and subsequent alterations in 3-phosphoinositide signaling. Such a mechanism would explain the strikingly similar phenotypes of patients with recessive mutations in either MTMR2 or MTMR13.	Univ Calif San Diego, Dept Pharmacol, Sch Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dixon, JE (corresponding author), Univ Calif San Diego, Dept Pharmacol, Sch Med, Leichtag Bldg,Rm 284,9500 Gilman Dr, La Jolla, CA 92093 USA.	jedixon@ucsd.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS047846] Funding Source: NIH RePORTER; NICHD NIH HHS [5 T32 HD07203-20] Funding Source: Medline; NIDDK NIH HHS [2R01 DK018024-31] Funding Source: Medline; NINDS NIH HHS [1 F32 NS047846-01A1] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Begley MJ, 2003, MOL CELL, V12, P1391, DOI 10.1016/S1097-2765(03)00486-6; Ben Othmane K, 1999, GENOMICS, V62, P344, DOI 10.1006/geno.1999.6028; Benstead TJ, 2001, CAN J NEUROL SCI, V28, P199, DOI 10.1017/S0317167100001347; Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Berger P, 2002, HUM MOL GENET, V11, P1569, DOI 10.1093/hmg/11.13.1569; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Bolino A, 2004, J CELL BIOL, V167, P711, DOI 10.1083/jcb.200407010; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Buj-Bello A, 2002, P NATL ACAD SCI USA, V99, P15060, DOI 10.1073/pnas.212498399; Buj-Bello A, 2002, HUM MOL GENET, V11, P2297, DOI 10.1093/hmg/11.19.2297; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Chaussade C, 2003, MOL ENDOCRINOL, V17, P2448, DOI 10.1210/me.2003-0261; Conforti FL, 2004, NEUROLOGY, V63, P1327, DOI 10.1212/01.WNL.0000140617.02312.80; Cooke FT, 2002, ARCH BIOCHEM BIOPHYS, V407, P143, DOI 10.1016/S0003-9861(02)00487-3; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; Doerks T, 2000, TRENDS BIOCHEM SCI, V25, P483, DOI 10.1016/S0968-0004(00)01664-9; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Efe JA, 2005, CURR OPIN CELL BIOL, V17, P402, DOI 10.1016/j.ceb.2005.06.002; Firestein R, 2002, J CLIN INVEST, V109, P1165, DOI [10.1172/JCI200212589, 10.1172/JCI0212589]; Firestein R, 2001, J CELL SCI, V114, P2921; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hirano R, 2004, NEUROLOGY, V63, P577, DOI 10.1212/01.WNL.0000133211.40288.9A; Howard TL, 2001, J CELL SCI, V114, P2395; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ikonomov OC, 2003, MOL BIOL CELL, V14, P4581, DOI 10.1091/mbc.E03-04-0222; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim SA, 2003, P NATL ACAD SCI USA, V100, P4492, DOI 10.1073/pnas.0431052100; Kim SA, 2002, J BIOL CHEM, V277, P4526, DOI 10.1074/jbc.M111087200; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Laporte J, 2002, J CELL SCI, V115, P3105; Laporte J, 2002, BIOCHEM BIOPH RES CO, V291, P305, DOI 10.1006/bbrc.2002.6445; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Li JCH, 2000, J CELL PHYSIOL, V185, P366, DOI 10.1002/1097-4652(200012)185:3<366::AID-JCP7>3.0.CO;2-1; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mochizuki Y, 2003, P NATL ACAD SCI USA, V100, P9768, DOI 10.1073/pnas.1333958100; Nandurkar HH, 2003, P NATL ACAD SCI USA, V100, P8660, DOI 10.1073/pnas.1033097100; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; OHNISHI A, 1989, MUSCLE NERVE, V12, P568, DOI 10.1002/mus.880120707; Parrish WR, 2004, MOL BIOL CELL, V15, P3567, DOI 10.1091/mbc.E04-03-0209; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Quattrone A, 1996, NEUROLOGY, V46, P1318, DOI 10.1212/WNL.46.5.1318; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Saifi GM, 2003, J INVEST MED, V51, P261, DOI 10.1136/jim-51-05-14; Sato TK, 2001, SCIENCE, V294, P1881, DOI 10.1126/science.1065763; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Shisheva A, 2001, CELL BIOL INT, V25, P1201, DOI 10.1006/cbir.2001.0803; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Taylor GS, 2003, METHOD ENZYMOL, V366, P43; Tronchere H, 2004, J BIOL CHEM, V279, P7304, DOI 10.1074/jbc.M311071200; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; Walker DM, 2001, CURR BIOL, V11, P1600, DOI 10.1016/S0960-9822(01)00501-2; Whiteford CC, 1997, BIOCHEM J, V323, P597, DOI 10.1042/bj3230597; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Xue YZ, 2003, J BIOL CHEM, V278, P34380, DOI 10.1074/jbc.M303259200	67	81	88	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31699	31707		10.1074/jbc.M505159200	http://dx.doi.org/10.1074/jbc.M505159200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15998640	hybrid			2022-12-27	WOS:000231665200046
J	Sakaue, F; Saito, T; Sato, Y; Asada, A; Ishiguro, K; Hasegawa, M; Hisanaga, S				Sakaue, F; Saito, T; Sato, Y; Asada, A; Ishiguro, K; Hasegawa, M; Hisanaga, S			Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK5 ACTIVATOR P35; IN-VITRO PHOSPHORYLATION; PAIRED HELICAL FILAMENTS; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; MASS-SPECTROMETRY; NEUROFIBRILLARY TANGLES; WILD-TYPE; MUTATIONS; PROTEIN	One of the major pathological hallmarks of Alzheimer disease is neurofibrillary tangles. Neurofibrillary tangles are bundles of paired helical filaments composed of hyperphosphorylated tau. Cyclin-dependent kinase 5 (Cdk5) is one of the tau protein kinases that increase paired helical filament epitopes in tau by phosphorylation. Recently, various mutations of tau have been identified in frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17). Here, we investigated the phosphorylation of FTDP-17 mutant tau proteins, K257T, P301L, P301S, and R406W, by Cdk5 complexed with p35, p25, or p39 in vitro and in cultured cells. The extent of phosphorylation by all Cdk5 species was slightly lower in mutant tau than in wild-type tau. Major phosphorylation sites, including Ser(202), Ser(235), and Ser(404), were the same among the wild-type, K257T, P301L, and P301S tau proteins phosphorylated by any Cdk5. On the other hand, R406W tau was less phosphorylated at Ser(404) than were the other variants. This was not due to the simple replacement of amino acid Arg(406) with Trp close to the phosphorylation site, because Ser(404) in a R406W peptide was equally phosphorylated in a wild-type peptide. The decreased phosphorylation of mutant tau by Cdk5s was canceled when tau protein bound to microtubules was phosphorylated. These results indicate that FTDP-17 mutations do not affect the phosphorylatability of tau by Cdk5 complexed with p35, p25, or p39 and may explain part of the discrepancy reported previously between in vivo and in vitro phosphorylation of FTDP-17 tau mutants.	Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan; Tokyo Inst Psychiat, Dept Mol Neurobiol, Tokyo 1568585, Japan	Tokyo Metropolitan University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Tokyo Institute of Psychiatry	Hisanaga, S (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	hisanaga-shinichi@c.metro-u.ac.jp		Sakaue, Fumika/0000-0003-1364-8730				Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Connell JW, 2001, FEBS LETT, V493, P40, DOI 10.1016/S0014-5793(01)02267-0; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; DeTure M, 2002, AM J PATHOL, V161, P1711, DOI 10.1016/S0002-9440(10)64448-3; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Goedert M, 2001, CURR OPIN GENET DEV, V11, P343, DOI 10.1016/S0959-437X(00)00200-8; Hanger DP, 1998, J NEUROCHEM, V71, P2465; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hashiguchi M, 2002, J BIOL CHEM, V277, P44525, DOI 10.1074/jbc.M207426200; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; ILLENBERGER S, 1998, MOL BIOL CELL, V9, P195; Imahori K, 1997, J BIOCHEM, V121, P179; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; ISHIGURO K, 1992, J BIOL CHEM, V267, P10897; Ishiguro K, 1995, NEUROSCI LETT, V202, P81, DOI 10.1016/0304-3940(95)12206-0; Johnson Gail V. W., 1998, Alzheimer's Disease Review, V3, P125; Krishnamurthy PK, 2004, J BIOL CHEM, V279, P7893, DOI 10.1074/jbc.M311203200; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu F, 2002, FEBS LETT, V530, P209, DOI 10.1016/S0014-5793(02)03487-7; Lund ET, 2001, J NEUROCHEM, V76, P1221, DOI 10.1046/j.1471-4159.2001.00130.x; Mack TGA, 2001, NEUROSCIENCE, V108, P701, DOI 10.1016/S0306-4522(01)00434-1; Matsumura N, 1999, AM J PATHOL, V154, P1649, DOI 10.1016/S0002-9440(10)65420-X; Miyasaka T, 2001, AM J PATHOL, V158, P373, DOI 10.1016/S0002-9440(10)63979-X; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Nath R, 2000, BIOCHEM BIOPH RES CO, V274, P16, DOI 10.1006/bbrc.2000.3070; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Perez M, 2000, J NEUROCHEM, V74, P2583, DOI 10.1046/j.1471-4159.2000.0742583.x; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Reed LA, 1997, ANN NEUROL, V42, P564, DOI 10.1002/ana.410420406; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Takahashi S, 2003, J BIOL CHEM, V278, P10506, DOI 10.1074/jbc.M211964200; Tang D, 1996, Prog Cell Cycle Res, V2, P205; Taniguchi S, 2001, FEBS LETT, V489, P46, DOI 10.1016/S0014-5793(00)02431-5; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Wada Y, 1998, J BIOCHEM-TOKYO, V124, P738, DOI 10.1093/oxfordjournals.jbchem.a022174; Yoo BC, 2001, NATURE, V411, P763, DOI 10.1038/35081146	47	33	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31522	31529		10.1074/jbc.M504792200	http://dx.doi.org/10.1074/jbc.M504792200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15994305	hybrid			2022-12-27	WOS:000231665200024
J	Yang, CH; Murti, A; Pfeffer, LM				Yang, CH; Murti, A; Pfeffer, LM			Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; GLUTATHIONE-S-TRANSFERASE; PROTEIN-TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; SPLENIC MICROARCHITECTURE; INDUCED TRANSCRIPTION; SIGNAL-TRANSDUCTION; COMPLEMENTS DEFECTS; ESCHERICHIA-COLI; IMMUNE-RESPONSES	Type I interferons (IFNs) play critical roles in the host defense by modulating the expression of various genes via the IFN-dependent activation of signal transducers and activators of transcription and NF-kappa B (nuclear factor kappa B) transcription factors. Previous studies established that IFN alpha/beta activates NF-kappa B to promote cell survival through a phosphatidylinositol 3-kinase (PI3K)/Akt pathway, which involves serine phosphorylation and degradation of I kappa B alpha. We now describe a second pathway by which IFNs activate NF-kappa B that is independent of I kappa B degradation. This pathway involves NF-kappa B-inducing kinase (NIK) and the tumor necrosis factor receptor-associated factor-2 (TRAF2) and results in IFN alpha/beta-induced processing of the p100/NF-kappa B2 precursor into p52. IFN alpha/beta stimulates NF-kappa B DNA binding and NF-kappa B-dependent transcription. Whereas expression of NIK and TRAF2 constructs causes NF-kappa B activation, expression of dominant negative NIK and TRAF2 constructs blocks IFN-promoted NF-kappa B activation and IFN-stimulated kappa B-dependent transcription and IFN alpha/beta-induced processing of the p100/NF-kappa B2 precursor into p52. In contrast, PI3K does not mediate IFN alpha/beta-induced p100 processing, although PI3K is involved in the pathway resulting in I kappa B alpha degradation. Moreover, whereas IFN promotes cell survival in lymphoblastoid cells, expression of dominant negative NIK and TRAF2 constructs enhances IFN-induced apoptosis. Our results for the first time place NIK and TRAF2, previously shown to function in TNF signaling, within the IFN signal transduction pathway. Thus, IFN induces NF-kappa B activation to mediate IFN-dependent cell survival signals through a "canonical" pathway of I kappa B alpha proteolysis mediated by PI3K/Akt and a "noncanonical" pathway of p100 processing mediated by NIK/TRAF.	Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Memphis, TN 38163 USA; Univ Tennessee, Canc Inst, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Pfeffer, LM (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, 930 Madison Ave,Rm 530, Memphis, TN 38163 USA.	lpfeffer@utmem.edu		Pfeffer, Lawrence/0000-0003-2809-1234	NATIONAL CANCER INSTITUTE [R01CA073753] Funding Source: NIH RePORTER; NCI NIH HHS [CA73753, R01 CA073753] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Blanco FL, 1998, BIOTECHNIQUES, V24, P354, DOI 10.2144/98243bm04; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Chawla-Sarkar M, 2002, J IMMUNOL, V169, P847, DOI 10.4049/jimmunol.169.2.847; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Cremer I, 1999, VIROLOGY, V253, P241, DOI 10.1006/viro.1998.9470; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Einhorn S, 1996, J INTERF CYTOK RES, V16, P275, DOI 10.1089/jir.1996.16.275; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; FRIEDMAN RL, 1985, NATURE, V314, P637, DOI 10.1038/314637a0; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; LARNER AC, 1986, J BIOL CHEM, V261, P453; Luftig M, 2004, P NATL ACAD SCI USA, V101, P141, DOI 10.1073/pnas.2237183100; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Marinari B, 2004, P NATL ACAD SCI USA, V101, P6098, DOI 10.1073/pnas.0308688101; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; OLIVEIRA IC, 1994, MOL CELL BIOL, V14, P5300, DOI 10.1128/MCB.14.8.5300; Ozes ON, 1999, NATURE, V401, P82; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Pfeffer LM, 2004, J BIOL CHEM, V279, P31304, DOI 10.1074/jbc.M308975200; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Snapper CM, 1996, J EXP MED, V184, P1537, DOI 10.1084/jem.184.4.1537; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; VAN AD, 1996, SCIENCE, V274, P787; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; YAN CH, 1996, J BIOL CHEM, V271, P8057; Yang CH, 2004, EXP CELL RES, V298, P197, DOI 10.1016/j.yexcr.2004.04.008; Yang CH, 1998, P NATL ACAD SCI USA, V95, P5568, DOI 10.1073/pnas.95.10.5568; Yang CH, 2000, P NATL ACAD SCI USA, V97, P13631, DOI 10.1073/pnas.250477397; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Ye H, 2000, P NATL ACAD SCI USA, V97, P8961, DOI 10.1073/pnas.160241997; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004	63	62	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31530	31536		10.1074/jbc.M503120200	http://dx.doi.org/10.1074/jbc.M503120200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16009713	hybrid, Green Accepted			2022-12-27	WOS:000231665200025
J	Deaton, RA; Su, C; Valencia, TG; Grant, SR				Deaton, RA; Su, C; Valencia, TG; Grant, SR			Transforming growth factor-beta 1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; PROTEIN-KINASE; IN-VIVO; TRANSCRIPTION FACTOR; ALPHA-ACTIN; CARG ELEMENTS; CELLS; DIFFERENTIATION; RHO; PROMOTER	Differentiated vascular smooth muscle cells (SMCs) exhibit a work phenotype characterized by expression of several well documented contractile apparatus-associated proteins. However, SMCs retain the ability to de-differentiate into a proliferative phenotype, which is involved in the progression of vascular diseases such as atherosclerosis and restenosis. Understanding the mechanisms involved in maintaining SMC differentiation is critical for preventing proliferation associated with vascular disease. In this study, the molecular mechanisms through which transforming growth factor-beta 1 (TGF-beta 1) induces differentiation of SMCs were examined. TGF-beta 1 stimulated actin re-organization, inhibited cell proliferation, and up-regulated SMC marker gene expression in PAC-1 SMCs. These effects were blocked by pretreatment of cells with either HA1077 or Y-27632, which inhibit the kinases downstream of RhoA. Moreover, TGF-beta 1 activated RhoA and its downstream target PKN. Overexpression of active PKN alone was sufficient to increase the transcriptional activity of the promoters that control expression of smooth muscle (SM) alpha-actin, SM-myosin heavy chain, and SM22 alpha. In addition, PKN increased the activities of serum-response factor (SRF), GATA, and MEF2-dependent enhancer-reporters. RNA interference-mediated inhibition of PKN abolished TGF-beta 1-induced activation of SMC marker gene promoters. Finally, examination of MAPK signaling demonstrated that TGF-beta 1 increased the activity of p38 MAPK, which was required for activation of the SMC marker gene promoters. Co-expression of dominant negative p38 MAPK was sufficient to block PKN-mediated activation of the SMC marker gene promoters as well as the serum-response factor, GATA, and MEF2 enhancers. Taken together, these results identify components of an important intracellular signaling pathway through which TGF-beta 1 activates PKN to promote differentiation of SMCs.	Univ Texas, Hlth Sci Ctr, Dept Integrat Physiol, Inst Cardiovasc Res, Ft Worth, TX 76107 USA; Univ Texas, Hlth Sci Ctr, Dept Biomed Sci, Ft Worth, TX 76107 USA	University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Arlington	Grant, SR (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Integrat Physiol, Inst Cardiovasc Res, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	sgrant@hsc.unt.edu	Su, Chang/A-2158-2010; Deaton, Rebecca A/HGU-5484-2022	Deaton, Rebecca A/0000-0001-7569-1924; Su, Chang/0000-0001-5428-0878	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067152] Funding Source: NIH RePORTER; NHLBI NIH HHS [R0-1 HL67152] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adam PJ, 2000, J BIOL CHEM, V275, P37798, DOI 10.1074/jbc.M006323200; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; BARBEE RW, 1993, BIOCHEM BIOPH RES CO, V190, P70, DOI 10.1006/bbrc.1993.1012; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; BJORKERUD S, 1991, ARTERIOSCLER THROMB, V11, P892, DOI 10.1161/01.ATV.11.4.892; Boehm Manfred, 2003, Prog Cell Cycle Res, V5, P19; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Garat C, 2000, J BIOL CHEM, V275, P22537, DOI 10.1074/jbc.M003000200; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Grainger DJ, 1998, J CELL SCI, V111, P2977; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Han JH, 1997, FEBS LETT, V403, P19, DOI 10.1016/S0014-5793(97)00021-5; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Hirschi KK, 2002, J BIOL CHEM, V277, P6287, DOI 10.1074/jbc.M106649200; Hu YH, 1997, ARTERIOSCL THROM VAS, V17, P2808, DOI 10.1161/01.ATV.17.11.2808; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Izumi Y, 2001, CIRC RES, V88, P1120, DOI 10.1161/hh1101.091267; Katoh Y, 1998, J BIOL CHEM, V273, P1511, DOI 10.1074/jbc.273.3.1511; Kim S, 1998, CIRCULATION, V97, P1731, DOI 10.1161/01.CIR.97.17.1731; Kintscher U, 2003, BIOCHEM BIOPH RES CO, V305, P552, DOI 10.1016/S0006-291X(03)00802-7; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Mack CP, 1999, CIRC RES, V84, P852; Manabe I, 2001, J CLIN INVEST, V107, P823, DOI 10.1172/JCI11385; Mano T, 1999, CIRC RES, V84, P647, DOI 10.1161/01.RES.84.6.647; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Masszi A, 2003, AM J PHYSIOL-RENAL, V284, pF911, DOI 10.1152/ajprenal.00183.2002; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; OWENS GK, 1995, PHYSIOL REV, V75, P487; OWENS GK, 1988, J CELL BIOL, V107, P771, DOI 10.1083/jcb.107.2.771; Page K, 2001, AM J PHYSIOL-LUNG C, V280, pL955, DOI 10.1152/ajplung.2001.280.5.L955; Parmacek MS, 2001, CURR TOP DEV BIOL, V51, P69, DOI 10.1016/S0070-2153(01)51002-9; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; ROTHMAN A, 1992, CIRCULATION, V86, P1977, DOI 10.1161/01.CIR.86.6.1977; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; Shen X, 2001, J BIOL CHEM, V276, P15362, DOI 10.1074/jbc.M009534200; SHIMIZU RT, 1995, J BIOL CHEM, V270, P7631, DOI 10.1074/jbc.270.13.7631; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; Suzuki E, 1996, GENOMICS, V38, P283, DOI 10.1006/geno.1996.0630; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; Takahashi M, 2003, J BIOCHEM, V133, P181, DOI 10.1093/jb/mvg022; Takano H, 1998, MOL CELL BIOL, V18, P1580, DOI 10.1128/MCB.18.3.1580; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; White SL, 1996, J BIOL CHEM, V271, P15008, DOI 10.1074/jbc.271.25.15008; YAMAGATA T, 1995, MOL CELL BIOL, V15, P3830; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zilberman A, 1998, CIRC RES, V82, P566, DOI 10.1161/01.RES.82.5.566	57	105	115	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31172	31181		10.1074/jbc.M504774200	http://dx.doi.org/10.1074/jbc.M504774200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15980430	hybrid			2022-12-27	WOS:000231487800064
J	Fotinopoulou, A; Tsachaki, M; Vlavaki, M; Poulopoulos, A; Rostagno, A; Frangione, B; Ghiso, J; Efthimiopoulos, S				Fotinopoulou, A; Tsachaki, M; Vlavaki, M; Poulopoulos, A; Rostagno, A; Frangione, B; Ghiso, J; Efthimiopoulos, S			BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (A beta) production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL BRITISH DEMENTIA; ALZHEIMERS-DISEASE; MOLECULAR-CLONING; GENE; EXPRESSION; BRAIN; CDNA; PEPTIDES; SEQUENCE; DOMAIN	Transmembrane proteins BRI2 and amyloid precursor protein (APP) co-localize with amyloid beta(A beta) lesions in sporadic Alzheimer disease and mutations in both precursor proteins are linked to early-onset familial cases of cerebral amyloidosis associated with dementia and/or cerebral hemorrhage. A specific interaction between BRI2 and APP was unveiled by immunoprecipitation experiments using transfected and non-transfected cells. The use of deletion mutants further revealed that stretches 648-719 of APP751 and 46-106 of BRI2, both inclusive of the full transmembrane domains, are sufficient for the interaction. Removal of most of the APP and BRI2 extracellular domains without affecting the interaction implies that both proteins interact when are expressed on the same cell membrane (cis) rather than on adjacent cells (trans). The presence of BRI2 had a modulatory effect on APP processing, specifically increasing the levels of cellular APP as well as beta-secretase-generated COOH-terminal fragments while decreasing the levels of alpha-secretase-generated COOH-terminal fragments as well as the secretion of total APP and A beta peptides. Determining the precise molecular pathways affected by the specific binding between APP and BRI2 could result in the identification of common therapeutic targets for these sporadic and familial neurodegenerative disorders.	Univ Athens, Dept Biol, Div Anim & Human Physiol, Athens 15784, Greece; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA	National & Kapodistrian University of Athens; New York University; New York University	Efthimiopoulos, S (corresponding author), Univ Athens, Dept Biol, Div Anim & Human Physiol, Athens 15784, Greece.	efthis@biol.uoa.gr	Rostagno, Agueda/A-5801-2008; Poulopoulos, Alexandros/C-3659-2008; Efthimiopoulos, Spiros/H-3956-2013	Poulopoulos, Alexandros/0000-0002-5318-7388; Efthimiopoulos, Spiros/0000-0001-9244-4570; Rostagno, Agueda/0000-0002-6817-2074	NIA NIH HHS [AG05891, AG08721, AG10491] Funding Source: Medline; NINDS NIH HHS [NS38777] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG005891, R01AG008721, P01AG010491, R01AG005891] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; Akiyama H, 2004, ACTA NEUROPATHOL, V107, P53, DOI 10.1007/s00401-003-0783-1; ANDERSON JP, 1989, EMBO J, V8, P3627, DOI 10.1002/j.1460-2075.1989.tb08536.x; Cam JA, 2004, J BIOL CHEM, V279, P29639, DOI 10.1074/jbc.M313893200; Choi SI, 2003, FASEB J, V17, P373, DOI 10.1096/fj.03-0730fje; CHOIMIURA NH, 1992, ACTA NEUROPATHOL, V83, P260, DOI 10.1007/BF00296787; CORIA F, 1988, LAB INVEST, V58, P454; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; EFTHIMIOPOULOS S, 1994, J NEUROSCI RES, V38, P81, DOI 10.1002/jnr.490380111; EIKELENBOOM P, 1994, VIRCHOWS ARCH, V424, P421, DOI 10.1007/BF00190565; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Ghiso J, 2002, ADV DRUG DELIVER REV, V54, P1539, DOI 10.1016/S0169-409X(02)00149-7; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; Kinoshita A, 2003, J BIOL CHEM, V278, P41182, DOI 10.1074/jbc.M306403200; MCGEER PL, 1992, BRAIN RES, V579, P337, DOI 10.1016/0006-8993(92)90071-G; Perret E, 2004, P NATL ACAD SCI USA, V101, P16472, DOI 10.1073/pnas.0402085101; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Pittois K, 1998, GENE, V217, P141, DOI 10.1016/S0378-1119(98)00354-0; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Sato T, 2004, GENES CELLS, V9, P791, DOI 10.1111/j.1365-2443.2004.00763.x; SNOW AD, 1987, LAB INVEST, V56, P120; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Vidal R, 2001, GENE, V266, P95, DOI 10.1016/S0378-1119(01)00374-2	28	90	98	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30768	30772		10.1074/jbc.C500231200	http://dx.doi.org/10.1074/jbc.C500231200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16027166	hybrid			2022-12-27	WOS:000231487800016
J	Heo, J; Campbell, SL				Heo, J; Campbell, SL			Mechanism of redox-mediated guanine nucleotide exchange on redox-active rho GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-SPECIES GENERATION; NITRIC-OXIDE SYNTHASES; SMOOTH-MUSCLE-CELLS; XANTHINE OXIDOREDUCTASE; SUPEROXIDE-DISMUTASE; PROTEIN INTERACTIONS; SIGNAL-TRANSDUCTION; ACTIVATION; RAS; P21(RAS)	Rho GTPases regulate multiple cellular processes including actin cytoskeletal rearrangements, transcriptional regulation, and oxidant production. The studies described herein demonstrate that small molecule redox agents, in addition to protein regulatory factors, can regulate the activity of redox- active Rho GTPases. A novel ( GXXXXGK( S/ T) C) motif, conserved in a number of Rho GTPases, appears critical for redox- mediated guanine nucleotide dissociation in vitro. A detailed molecular mechanism for redox regulation of GXXXXGK( S/ T) C motif- containing Rho GTPases is proposed.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Campbell, SL (corresponding author), Univ N Carolina, Dept Biochem & Biophys, 530 Mary Ellen Jones Bldg, Chapel Hill, NC 27599 USA.	campbesl@med.unc.edu	, Proteomics Core UNC/AFQ-7201-2022	campbell, sharon/0000-0003-0311-409X	NCI NIH HHS [R01CA89614-O1A1] Funding Source: Medline; NHLBI NIH HHS [P01 HL45100] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089614] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045100] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Adams PD, 2004, BIOCHEMISTRY-US, V43, P9968, DOI 10.1021/bi0490901; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; Bae GU, 2004, EXP CELL RES, V300, P476, DOI 10.1016/j.yexcr.2004.07.013; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Bonini MG, 2004, BIOCHEMISTRY-US, V43, P344, DOI 10.1021/bi035606p; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennan LA, 2003, DNA CELL BIOL, V22, P317, DOI 10.1089/104454903322216662; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chang YZ, 2002, CIRC RES, V91, P390, DOI 10.1161/01.RES.0000033524.92083.64; Delarue FL, 2001, ONCOGENE, V20, P6531, DOI 10.1038/sj.onc.1204801; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feltham JL, 1997, BIOCHEMISTRY-US, V36, P8755, DOI 10.1021/bi970694x; Godber BLJ, 2000, J BIOL CHEM, V275, P7757, DOI 10.1074/jbc.275.11.7757; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Heo J, 2005, BIOCHEMISTRY-US, V44, P6573, DOI 10.1021/bi047443q; Heo J, 2005, J MOL BIOL, V346, P1423, DOI 10.1016/j.jmb.2004.12.050; Heo J, 2005, J BIOL CHEM, V280, P12438, DOI 10.1074/jbc.M414282200; Heo JY, 2004, BIOCHEMISTRY-US, V43, P2314, DOI 10.1021/bi035275g; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Hodges GR, 2000, FREE RADICAL BIO MED, V29, P434, DOI 10.1016/S0891-5849(00)00298-7; Jourd'heuil D, 2003, J BIOL CHEM, V278, P15720, DOI 10.1074/jbc.M300203200; KHAN AU, 1994, P NATL ACAD SCI USA, V91, P12365, DOI 10.1073/pnas.91.26.12365; Kone BC, 2000, ACTA PHYSIOL SCAND, V168, P27; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; Mori K, 2004, CANCER RES, V64, P7464, DOI 10.1158/0008-5472.CAN-04-1725; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; POU S, 1992, J BIOL CHEM, V267, P24173; REINSTEIN J, 1991, J BIOL CHEM, V266, P17700; STEINMAN HM, 1974, J BIOL CHEM, V249, P7326; Stenmark H, 2001, GENOME BIOL, V2; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Turcotte S, 2003, J CELL SCI, V116, P2247, DOI 10.1242/jcs.00427; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wainwright MS, 2003, DEV BRAIN RES, V146, P79, DOI 10.1016/j.devbrainres.2003.09.012; Wardman P, 1996, RADIAT RES, V145, P523, DOI 10.2307/3579270; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Werner E, 2004, J CELL SCI, V117, P143, DOI 10.1242/jcs.00937; Wojciak-Stothard B, 2005, AM J PHYSIOL-LUNG C, V288, pL749, DOI 10.1152/ajplung.00361.2004; Yun HY, 1998, P NATL ACAD SCI USA, V95, P5773, DOI 10.1073/pnas.95.10.5773; Zhao TM, 2003, J CLIN INVEST, V112, P1732, DOI 10.1172/JCI200319108	48	93	95	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31003	31010		10.1074/jbc.M504768200	http://dx.doi.org/10.1074/jbc.M504768200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994296	Green Published, hybrid			2022-12-27	WOS:000231487800043
J	Nieto, N; Cederbaum, AI				Nieto, N; Cederbaum, AI			S-adenosylmethionine blocks collagen I production by preventing transforming growth factor-beta induction of the COL1A2 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC STELLATE CELLS; ADENOSYL-L-METHIONINE; FAR-UPSTREAM ENHANCER; HISTONE DEACETYLASE INHIBITOR; NECROSIS-FACTOR-ALPHA; RAT-LIVER FIBROSIS; GENE-EXPRESSION; LIPID-PEROXIDATION; OXIDATIVE STRESS; TRANSGENIC MICE	To study the antifibrogenic mechanisms of S- adenosylmethionine ( AdoMet), transgenic mice harboring the - 17 kb to + 54 bp of the collagen alpha 2 ( I) promoter ( COL1A2) cloned upstream from the beta- gal reporter gene were injected with carbon tetrachloride ( CCl4) to induce fibrosis and coadministered either AdoMet or saline. Control groups received AdoMet or mineral oil. AdoMet lowered the pathology in CCl4- treated mice as shown by transaminase levels, hematoxylin and eosin, Masson's trichrome staining, and collagen I expression. beta- Galactosidase activity indicated activation of the COL1A2 promoter in stellate cells from CCl4- treated mice and repression of such activation by AdoMet. Lipid peroxidation, transforming growth factor- beta ( TGF beta) expression, and decreases in glutathione levels were prevented by AdoMet. Incubation of primary stellate cells with AdoMet down- regulated basal and TGF beta- induced collagen I and alpha- smooth muscle actin proteins. AdoMet metabolites down- regulated collagen I protein and mRNA levels. AdoMet repressed basal and TGF beta- induced reporter activity in stellate cells transfected with COL1A2 promoter deletion constructs. AdoMet blocked TGF beta induction of the - 378 bp region of the COL1A2 promoter and prevented the phosphorylation of extracellular signal-regulated kinase 1/ 2 and the binding of Sp1 to the TGF beta- responsive element. These observations unveil a novel mechanism by which AdoMet could ameliorate liver fibrosis.	Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Nieto, N (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, 1 Gustave L Levy Pl,Box 1603, New York, NY 10029 USA.	natalia.nieto@mssm.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK069286, R01DK069286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014132, R56AA003312, R01AA003312] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA 03312, AA 14132] Funding Source: Medline; NIDDK NIH HHS [DK69286] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antoniv TT, 2001, J BIOL CHEM, V276, P21754, DOI 10.1074/jbc.M101397200; BARAK AJ, 1993, ALCOHOL CLIN EXP RES, V17, P552, DOI 10.1111/j.1530-0277.1993.tb00798.x; BEDOSSA P, 1994, HEPATOLOGY, V19, P1262, DOI 10.1016/0270-9139(94)90876-1; BOAST S, 1990, J BIOL CHEM, V265, P13351; BouGharios G, 1996, J CELL BIOL, V134, P1333, DOI 10.1083/jcb.134.5.1333; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; Chawla RK, 1998, AM J PHYSIOL-GASTR L, V275, pG125, DOI 10.1152/ajpgi.1998.275.1.G125; Colell A, 1997, HEPATOLOGY, V26, P699, DOI 10.1053/jhep.1997.v26.pm0009303501; CORRALES F, 1992, HEPATOLOGY, V16, P1022, DOI 10.1002/hep.1840160427; De Val S, 2002, J BIOL CHEM, V277, P9286, DOI 10.1074/jbc.M111040200; Deulofeu R, 2000, CLIN SCI, V99, P315, DOI 10.1042/CS20000127; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Finkelstein JD, 2003, AM J CLIN NUTR, V77, P1094, DOI 10.1093/ajcn/77.5.1094; Gasso M, 1996, J HEPATOL, V25, P200, DOI 10.1016/S0168-8278(96)80074-2; Greenwel P, 1997, J BIOL CHEM, V272, P19738, DOI 10.1074/jbc.272.32.19738; GREENWEL P, 1995, MOL CELL BIOL, V15, P6813; Greenwel P, 2000, MOL CELL BIOL, V20, P912, DOI 10.1128/MCB.20.3.912-918.2000; Greenwel P, 2000, HEPATOLOGY, V31, P109, DOI 10.1002/hep.510310118; Huang ZZ, 1998, AM J PHYSIOL-GASTR L, V275, pG14, DOI 10.1152/ajpgi.1998.275.1.G14; Inagaki Y, 2003, HEPATOLOGY, V38, P890, DOI 10.1053/jhep.2003.50408; INAGAKI Y, 1995, J BIOL CHEM, V270, P3353, DOI 10.1074/jbc.270.7.3353; INAGAKI Y, 1995, HEPATOLOGY, V22, P573, DOI 10.1016/0270-9139(95)90582-0; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; Kinbara T, 2002, J CELL PHYSIOL, V190, P375, DOI 10.1002/jcp.10046; LIEBER CS, 1990, HEPATOLOGY, V11, P165, DOI 10.1002/hep.1840110203; Lieber CS, 2002, ALCOHOL, V27, P173, DOI 10.1016/S0741-8329(02)00230-6; LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu SC, 2002, ALCOHOL, V27, P155, DOI 10.1016/S0741-8329(02)00226-4; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; Mato JM, 1999, J HEPATOL, V30, P1081, DOI 10.1016/S0168-8278(99)80263-3; NAKATSUKASA H, 1990, J CLIN INVEST, V85, P1833, DOI 10.1172/JCI114643; NIEDERREITHER K, 1992, J CELL BIOL, V119, P1361, DOI 10.1083/jcb.119.5.1361; Nieto N, 1999, HEPATOLOGY, V30, P987, DOI 10.1002/hep.510300433; Nieto N, 2002, HEPATOLOGY, V35, P62, DOI 10.1053/jhep.2002.30362; Nieto N, 2001, HEPATOLOGY, V33, P597, DOI 10.1053/jhep.2001.22520; Nieto N, 2000, J BIOL CHEM, V275, P20136, DOI 10.1074/jbc.M001422200; Niki T, 1999, HEPATOLOGY, V29, P858, DOI 10.1002/hep.510290328; Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003; Parola M, 1998, J CLIN INVEST, V102, P1942, DOI 10.1172/JCI1413; PASCALE RM, 1992, CANCER RES, V52, P4979; REINKE LA, 1985, DRUG METAB DISPOS, V13, P548; Rombouts K, 2002, EXP CELL RES, V278, P184, DOI 10.1006/excr.2002.5577; Shimizu I, 1999, HEPATOLOGY, V29, P149, DOI 10.1002/hep.510290108; ShimizuSaito K, 1997, HEPATOLOGY, V26, P424, DOI 10.1002/hep.510260224; Simile MM, 2001, J HEPATOL, V34, P386, DOI 10.1016/S0168-8278(00)00078-7; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; SOHN DH, 1991, BIOCHEM BIOPH RES CO, V179, P449, DOI 10.1016/0006-291X(91)91391-O; Song ZY, 2003, J NUTR BIOCHEM, V14, P591, DOI 10.1016/S0955-2863(03)00116-5; TIERNEY DJ, 1992, ARCH BIOCHEM BIOPHYS, V293, P9, DOI 10.1016/0003-9861(92)90358-4; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tsukada S, 2005, J BIOL CHEM, V280, P10055, DOI 10.1074/jbc.M409381200; TSUKAMOTO H, 1993, ALCOHOL, V10, P465, DOI 10.1016/0741-8329(93)90066-W; VENDEMIALE G, 1989, SCAND J GASTROENTERO, V24, P407, DOI 10.3109/00365528909093067; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200	56	44	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30963	30974		10.1074/jbc.M503569200	http://dx.doi.org/10.1074/jbc.M503569200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15983038	hybrid			2022-12-27	WOS:000231487800039
J	Rapedius, M; Soom, M; Shumilina, E; Schulze, D; Schonherr, R; Kirsch, C; Lang, F; Tucker, SJ; Baukrowitz, T				Rapedius, M; Soom, M; Shumilina, E; Schulze, D; Schonherr, R; Kirsch, C; Lang, F; Tucker, SJ; Baukrowitz, T			Long chain CoA esters as competitive antagonists of phosphatidylinositol 4,5-bisphosphate activation in Kir channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; RECTIFIER POTASSIUM CHANNELS; ACYL-COA; INWARD RECTIFICATION; PIP2; METABOLISM; SENSITIVITY; INHIBITION; MECHANISM; PHOSPHOINOSITIDES	Long chain fatty acid esters of coenzyme A (LC-CoA) are potent activators of ATP-sensitive (K-ATP) channels, and elevated levels have been implicated in the pathophysiology of type 2 diabetes. This stimulatory effect is thought to involve a mechanism similar to phosphatidylinositol 4,5-bisphosphate (PIP2), which activates all known inwardly rectifying potassium (Kir) channels. However, the effect of LC-CoA on other Kir channels has not been well characterized. In this study, we show that in contrast to their stimulatory effect on K-ATP channels, LC-CoA ( e. g. oleoyl-CoA) potently and reversibly inhibits all other Kir channels tested (Kir1.1, Kir2.1, Kir3.4, Kir7.1). We also demonstrate that the inhibitory potency of the LC-CoA increases with the chain length of the fatty acid chain, while both its activatory and inhibitory effects critically depend on the presence of the 3 '-ribose phosphate on the CoA group. Biochemical studies also demonstrate that PIP2 and LC-CoA bind with similar affinity to the C-terminal domains of Kir2.1 and Kir6.2 and that PIP2 binding can be competitively antagonized by LC-CoA, suggesting that the mechanism of LC-CoA inhibition involves displacement of PIP2. Furthermore, we demonstrate that in contrast to its stimulatory effect on K-ATP channels, phosphatidylinositol 3,4-bisphosphate has an inhibitory effect on Kir1.1 and Kir2.1. These results demonstrate a bi-directional modulation of Kir channel activity by LC-CoA and phosphoinositides and suggest that changes in fatty acid metabolism ( e. g. LC-CoA production) could have profound and widespread effects on cellular electrical activity.	Univ Jena, Inst Physiol 2, D-07743 Jena, Germany; Univ Tubingen, Dept Physiol 1, D-72076 Tubingen, Germany; Univ Jena, D-07747 Jena, Germany; Univ Jena, Inst Biochem, D-07743 Jena, Germany; Univ Oxford, Physiol Lab, Oxford Ctr Gene Funct, Oxford OX1 3PT, England	Friedrich Schiller University of Jena; Eberhard Karls University of Tubingen; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Oxford	Baukrowitz, T (corresponding author), Univ Jena, Inst Physiol 2, Teichgraben 8, D-07743 Jena, Germany.	thbau@mti.uni-jena.de	Tucker, Stephen J./ABE-6741-2020; Schönherr, Roland/K-8713-2013; Tucker, Stephen J./ABE-7468-2020	Tucker, Stephen J./0000-0001-8996-2000; Schönherr, Roland/0000-0003-0633-0775; Tucker, Stephen J./0000-0001-8996-2000; Baukrowitz, Thomas/0000-0003-4562-0505				BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Baukrowitz T, 2000, BIOCHEM PHARMACOL, V60, P735, DOI 10.1016/S0006-2952(00)00267-7; Baukrowitz T, 1999, EMBO J, V18, P847, DOI 10.1093/emboj/18.4.847; Branstrom R, 2004, DIABETOLOGIA, V47, P277, DOI 10.1007/s00125-003-1299-x; Faergeman NJ, 1997, BIOCHEM J, V323, P1; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FULCERI R, 1994, CELL CALCIUM, V15, P109, DOI 10.1016/0143-4160(94)90049-3; Gamper N, 2002, PFLUG ARCH EUR J PHY, V443, P625, DOI 10.1007/s00424-001-0741-5; Gribble FM, 1998, J BIOL CHEM, V273, P26383, DOI 10.1074/jbc.273.41.26383; HEBERT SC, 2002, PHYSIOL REV, V85, P319; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Larsson O, 1996, J BIOL CHEM, V271, P10623, DOI 10.1074/jbc.271.18.10623; Liu GX, 2001, CIRC RES, V88, P918, DOI 10.1161/hh0901.089881; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Reimann F, 1999, J PHYSIOL-LONDON, V520, P661, DOI 10.1111/j.1469-7793.1999.00661.x; Riedel MJ, 2003, DIABETES, V52, P2630, DOI 10.2337/diabetes.52.10.2630; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Schulze D, 2003, J BIOL CHEM, V278, P10500, DOI 10.1074/jbc.M208413200; Schulze D, 2003, J PHYSIOL-LONDON, V552, P357, DOI 10.1113/jphysiol.2003.047035; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Tarasov A, 2004, DIABETES, V53, pS113, DOI 10.2337/diabetes.53.suppl_3.S113; VANDERVUSSE GJ, 1992, PHYSIOL REV, V72, P881, DOI 10.1152/physrev.1992.72.4.881; Xie LH, 1999, P NATL ACAD SCI USA, V96, P15292, DOI 10.1073/pnas.96.26.15292	30	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30760	30767		10.1074/jbc.M503503200	http://dx.doi.org/10.1074/jbc.M503503200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15980413	hybrid			2022-12-27	WOS:000231487800015
J	Takagi, Y; Chadick, JZ; Davis, JA; Asturias, FJ				Takagi, Y; Chadick, JZ; Davis, JA; Asturias, FJ			Preponderance of free mediator in the yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTIONAL ACTIVATION; PROTEIN IDENTIFICATIONS; PREINITIATION COMPLEX; INITIATION COMPLEX; NUCLEAR RECEPTORS; REPEAT DOMAIN; CELL-CYCLE; IN-VITRO; HOLOENZYME	Biochemical evidence suggesting that the predominant form of Mediator in the yeast Saccharomyces cerevisiae might be one in which the complex is associated with RNA polymerase II to form a holoenzyme has led to the proposition of a holoenzyme-based model for transcription initiation. We report that polymerase-free Mediator, isolated early on during a whole-cell extract fractionation protocol, is in fact the most abundant form of the Mediator complex. The existence of free Mediator would make possible independent recruitment of Mediator and RNA polymerase II to the preinitiation complex. This is in agreement with reports from in vivo studies of time and spatial independence of Mediator and RNA polymerase II promoter interaction, with current models of preinitiation complex structure in which promoter DNA upstream of the transcription start site is positioned between Mediator and polymerase, and with the proposed role of Mediator as the major component of the Scaffold complex involved in transcription reinitiation.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94035 USA	Scripps Research Institute; Stanford University	Asturias, FJ (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	asturias@scripps.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036659, R01GM067167] Funding Source: NIH RePORTER; NCRR NIH HHS [RR11823] Funding Source: Medline; NIGMS NIH HHS [R01 GM36659, R01 GM67167] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asturias FJ, 2004, CURR OPIN STRUC BIOL, V14, P121, DOI 10.1016/j.sbi.2004.03.007; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Borggrefe T, 2001, J BIOL CHEM, V276, P47150, DOI 10.1074/jbc.M109581200; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; BURATOWSKI S, 1991, P NATL ACAD SCI USA, V88, P7509, DOI 10.1073/pnas.88.17.7509; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Cosma MP, 2001, MOL CELL, V7, P1213, DOI 10.1016/S1097-2765(01)00266-0; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Farrell S, 1996, GENE DEV, V10, P2359, DOI 10.1101/gad.10.18.2359; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Fondell JD, 1999, P NATL ACAD SCI USA, V96, P1959, DOI 10.1073/pnas.96.5.1959; Gaudreau L, 1998, MOL CELL, V1, P913, DOI 10.1016/S1097-2765(00)80090-8; Gaudreau L, 1997, CELL, V89, P55, DOI 10.1016/S0092-8674(00)80182-8; Griesenbeck J, 2004, METHOD ENZYMOL, V375, P170; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; JAZWINSKI SM, 1990, METHOD ENZYMOL, V182, P154; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; Kellogg DR, 2002, METHOD ENZYMOL, V351, P172; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Koleske AJ, 1996, METHOD ENZYMOL, V273, P176; KOLESKE AJ, 1995, TRENDS BIOCHEM SCI, V20, P113, DOI 10.1016/S0968-0004(00)88977-X; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Kuras L, 2003, P NATL ACAD SCI USA, V100, P13887, DOI 10.1073/pnas.2036346100; Lee YC, 1999, MOL CELL BIOL, V19, P2967; Lee YC, 1997, MOL CELL BIOL, V17, P4622, DOI 10.1128/MCB.17.8.4622; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Linder T, 2004, J BIOL CHEM, V279, P49455, DOI 10.1074/jbc.M409046200; Liu Y, 2001, J BIOL CHEM, V276, P7169, DOI 10.1074/jbc.M009586200; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Myers LC, 1997, METHODS, V12, P212, DOI 10.1006/meth.1997.0473; Myers LC, 1999, P NATL ACAD SCI USA, V96, P67, DOI 10.1073/pnas.96.1.67; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; NONET ML, 1989, GENETICS, V123, P715; PONTICELLI AS, 1990, MOL CELL BIOL, V10, P2832, DOI 10.1128/MCB.10.6.2832; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; SAYRE MH, 1992, J BIOL CHEM, V267, P23383; STOFFLER G, 1983, MODERN METHODS PROTE, P409; Taatjes DJ, 2004, MOL CELL, V14, P675, DOI 10.1016/j.molcel.2004.05.014; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Takagi Y, 2003, J BIOL CHEM, V278, P43897, DOI 10.1074/jbc.C300417200; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; TISCHENDORF GW, 1974, MOL GEN GENET, V134, P187, DOI 10.1007/BF00267715	56	13	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31200	31207		10.1074/jbc.C500150200	http://dx.doi.org/10.1074/jbc.C500150200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16002404	hybrid			2022-12-27	WOS:000231487800067
J	Wu, JH; Goswami, R; Kim, LK; Miller, WE; Peppel, K; Freedman, NJ				Wu, JH; Goswami, R; Kim, LK; Miller, WE; Peppel, K; Freedman, NJ			The platelet-derived growth factor receptor-beta phosphorylates and activates g protein-coupled receptor kinase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; SRC TYROSINE KINASE; AGONIST-DEPENDENT PHOSPHORYLATION; EXCHANGER REGULATORY FACTOR; C-SRC; G(BETA-GAMMA) SUBUNITS; PDGF RECEPTOR; 2 GRK2; DESENSITIZATION; DEGRADATION	G protein- coupled receptor kinase- 2 ( GRK2) serinephosphorylates the platelet- derived growth factor receptor-beta ( PDGFR beta), and thereby diminishes signaling by the receptor. Because activation of GRK2 may involve phosphorylation of its N- terminal tyrosines by cSrc, we tested whether the PDGFR beta itself could tyrosine-phosphorylate and activate GRK2. To do so, we used wild type ( WT) and Y857F mutant PDGFR beta s in HEK cells, which lack endogenous PDGFRs. The Y857F PDGFR beta autophosphorylates normally but does not phosphorylate exogenous substrates. Although PDGF-stimulated Y857F and WT PDGFR beta s activated c- Src equivalently, the WT PDGFR beta tyrosine- phosphorylated GKR2 60- fold more than the Y857F PDGFR beta in intact cells. With purified GRK2 and either WT or Y857F PDGFR beta s immunoprecipitated from HEK cells, GRK2 tyrosyl phosphorylation was PDGF- dependent and required the WT PDGFR beta, even though the WT and Y857F PDGFR beta s autophosphorylated equivalently. This PDGFR beta- mediated GRK2 tyrosyl phosphorylation enhanced GRK2 activity: GRK2- mediated seryl phosphorylation of the PDGFR beta was 9- fold greater for the WT than for the Y857F in response to PDGF, but equivalent when GRK2 was activated by sequential stimulation of beta(2)- adrenergic and PDGF- beta receptors. Furthermore, both PDGFR beta- mediated GRK2 tyrosyl phosphorylation and GRK2- mediated PDGFR beta seryl phosphorylation were reduced similar to 50% in intact cells by mutation to phenylalanine of three tyrosines in the N- terminal domain of GRK2. We conclude that the activated PDGFR beta itself phosphorylates GRK2 tyrosyl residues and thereby activates GRK2, which then serine- phosphorylates and desensitizes the PDGFR beta.	Duke Univ, Ctr Med, Dept Med Cardiol, Durham, NC 27710 USA	Duke University	Freedman, NJ (corresponding author), Duke Univ, Ctr Med, Dept Med Cardiol, Box 3187, Durham, NC 27710 USA.	neil.freedman@duke.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063288, R01HL064744, R01HL077185] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL64744, HL77185, HL63288] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARAK LS, 1994, J BIOL CHEM, V269, P2790; Baxter RM, 1998, J BIOL CHEM, V273, P17050, DOI 10.1074/jbc.273.27.17050; BENOVIC JL, 1986, NATURE, V321, P869, DOI 10.1038/321869a0; BENOVIC JL, 1987, J BIOL CHEM, V262, P17251; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bioukar EB, 1999, J BIOL CHEM, V274, P21457, DOI 10.1074/jbc.274.30.21457; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; BUTT E, 1994, J BIOL CHEM, V269, P14509; Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; CHIARUGI P, 1995, FEBS LETT, V372, P49, DOI 10.1016/0014-5793(95)00947-8; Collins SP, 1999, J BIOL CHEM, V274, P8391, DOI 10.1074/jbc.274.13.8391; Elorza A, 2003, J BIOL CHEM, V278, P29164, DOI 10.1074/jbc.M304314200; Fan GF, 2001, J BIOL CHEM, V276, P13240, DOI 10.1074/jbc.M011578200; Freedman NJ, 2002, J BIOL CHEM, V277, P48261, DOI 10.1074/jbc.M204431200; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; George D, 2001, SEMIN ONCOL, V28, P27, DOI 10.1053/sonc.2001.29185; Heldin CH, 1998, BIOCHIM BIOPHYS ACTA, V1378, P79; Hildreth KL, 2004, J BIOL CHEM, V279, P41775, DOI 10.1074/jbc.M403274200; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; INGLESE J, 1993, J BIOL CHEM, V268, P23735; KASHISHIAN A, 1992, EMBO J, V11, P1373, DOI 10.1002/j.1460-2075.1992.tb05182.x; KLINGHOFFER RA, 1995, J BIOL CHEM, V270, P22208, DOI 10.1074/jbc.270.38.22208; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; LUTTRELL LM, 1995, J BIOL CHEM, V270, P16495, DOI 10.1074/jbc.270.28.16495; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Matveev SV, 2002, AM J PHYSIOL-CELL PH, V282, pC935, DOI 10.1152/ajpcell.00349.2001; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; MORI S, 1992, J BIOL CHEM, V267, P6429; Oak JN, 2001, MOL PHARMACOL, V60, P92, DOI 10.1124/mol.60.1.92; ONORATO JJ, 1995, J BIOL CHEM, V270, P21346, DOI 10.1074/jbc.270.36.21346; Oppermann M, 1996, P NATL ACAD SCI USA, V93, P7649, DOI 10.1073/pnas.93.15.7649; Penela P, 1998, J BIOL CHEM, V273, P35238, DOI 10.1074/jbc.273.52.35238; Penela P, 2001, EMBO J, V20, P5129, DOI 10.1093/emboj/20.18.5129; Peppel K, 2002, J MOL CELL CARDIOL, V34, P1399, DOI 10.1006/jmcc.2002.2092; Peppel K, 2000, CIRCULATION, V102, P793, DOI 10.1161/01.CIR.102.7.793; Pitcher JA, 1999, J BIOL CHEM, V274, P34531, DOI 10.1074/jbc.274.49.34531; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; RICHARDSON RM, 1993, J BIOL CHEM, V268, P13650; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sano H, 2001, CIRCULATION, V103, P2955, DOI 10.1161/01.CIR.103.24.2955; Sarnago S, 1999, J BIOL CHEM, V274, P34411, DOI 10.1074/jbc.274.48.34411; Sarnago S, 2003, MOL PHARMACOL, V64, P629, DOI 10.1124/mol.64.3.629; SHIH ML, 1994, P NATL ACAD SCI USA, V91, P12193, DOI 10.1073/pnas.91.25.12193; SORKIN A, 1991, J CELL BIOL, V112, P469, DOI 10.1083/jcb.112.3.469; Walter AO, 1999, ONCOGENE, V18, P1911, DOI 10.1038/sj.onc.1202513; Yamamoto M, 1999, EXP CELL RES, V247, P380, DOI 10.1006/excr.1998.4379; Zhou Songyang, 1995, Nature (London), V373, P536	54	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31027	31035		10.1074/jbc.M501473200	http://dx.doi.org/10.1074/jbc.M501473200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994317	hybrid			2022-12-27	WOS:000231487800046
J	Alberghini, A; Recalcati, S; Tacchini, L; Santambrogio, P; Campanella, A; Cairo, G				Alberghini, A; Recalcati, S; Tacchini, L; Santambrogio, P; Campanella, A; Cairo, G			Loss of the von Hippel Lindau tumor suppressor disrupts iron homeostasis in renal carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR-I; TRANSFERRIN RECEPTOR GENE; REGULATORY PROTEIN-2; FERRITIN SYNTHESIS; NEOPLASTIC-CELLS; HELA-CELLS; POSTTRANSCRIPTIONAL REGULATION; MOLECULAR CONTROL; OXIDATIVE STRESS; NITRIC-OXIDE	Given the modulation of iron metabolism by hypoxia and the high iron requirement of neoplastic cells, we investigated iron metabolism in a human renal cancer cell line with a mutated von Hippel Lindau (VHL) tumor suppressor gene (RCC10) and in a transfectant clone with wild-type VHL (RCC63). The loss of VHL strongly up-regulated transferrin receptor expression in RCC10 cells as a result of hypoxia inducible factor-1 (HIF-1)-mediated transcriptional activation, leading to an increased uptake of transferrin-bound Fe-55. Increased iron availability did not compromise the resistance of VHL-defective cells to oxidative stress or promote faster cell multiplication. Surprisingly, the content of ferritin H and L subunits and ferritin mRNA levels were considerably lower in the RCC10 than in the RCC63 cells. Despite the similarities between HIF-1 and iron regulatory protein 2 (IRP2), we found no evidence of specific regulation of IRP2 by VHL. However, both IRP2 and IRP1 were slightly activated in RCC10 cells, thus indicating that this cell line has a somewhat reduced labile iron pool (LIP). The finding that RCC10 cells had a lower ferritin content but more ferritin-associated 55Fe than RCC63 explains why VHL-lacking cells may have a smaller LIP despite increased iron uptake. We also found a correlation between cytoprotection from iron-mediated damage and efficient incorporation into ferritin of both transferrin and non-transferrin-bound 55Fe. This study shows that, like oncogene activation, the loss of an oncosuppressor rearranges the expression pattern of the genes of iron metabolism to increase iron availability. However, in the case of VHL loss, mechanisms affecting iron handling by ferritin somehow counteract the effects that the reduced content of this protective protein may have on proliferation and oxidant sensitivity.	Univ Milan, Inst Gen Pathol, I-20133 Milan, Italy; Hosp San Raffaele, Prot Engn Unit, Dibit Sci Inst Recovery & Care, I-20132 Milan, Italy; Osped Maggiore Policlin, Milan, Italy	University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico	Cairo, G (corresponding author), Univ Milan, Inst Gen Pathol, Via Mangiagalli 31, I-20133 Milan, Italy.	gaetano.cairo@unimi.it	Tacchini, Lorenza/L-1418-2016; recalcati, stefania/M-5045-2016; Campanella, Alessandro/N-8315-2015; Santambrogio, Paolo/AAN-3837-2020; Cairo, Gaetano/M-5104-2016	Tacchini, Lorenza/0000-0002-4863-178X; recalcati, stefania/0000-0002-2115-8283; Campanella, Alessandro/0000-0002-3463-1199; Santambrogio, Paolo/0000-0002-5481-2130; Cairo, Gaetano/0000-0002-8147-4720				Baba M, 2001, ONCOGENE, V20, P2727, DOI 10.1038/sj.onc.1204397; Bianchi L, 1999, NUCLEIC ACIDS RES, V27, P4223, DOI 10.1093/nar/27.21.4223; Bluyssen HAR, 2004, FEBS LETT, V556, P137, DOI 10.1016/S0014-5793(03)01392-9; Bonnah RA, 2004, CELL MICROBIOL, V6, P473, DOI 10.1111/j.1462-5822.2004.00376.x; Bradley SJ, 1997, BRIT J HAEMATOL, V99, P337, DOI 10.1046/j.1365-2141.1997.4143221.x; CAIRO G, 1985, BIOCHEM BIOPH RES CO, V133, P314, DOI 10.1016/0006-291X(85)91877-7; Cairo G, 2002, FREE RADICAL BIO MED, V32, P1237, DOI 10.1016/S0891-5849(02)00825-0; CAIRO G, 1993, EXP CELL RES, V206, P255, DOI 10.1006/excr.1993.1145; Cairo G, 2000, BIOCHEM J, V352, P241, DOI 10.1042/0264-6021:3520241; CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700; Caltagirone A, 2001, J BIOL CHEM, V276, P19738, DOI 10.1074/jbc.M100245200; Campanella A, 2004, BIOCHEMISTRY-US, V43, P195, DOI 10.1021/bi035386f; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Corna G, 2004, J BIOL CHEM, V279, P13738, DOI 10.1074/jbc.M310106200; Corsi B, 2002, J BIOL CHEM, V277, P22430, DOI 10.1074/jbc.M105372200; Cozzi A, 2004, BLOOD, V103, P2377, DOI 10.1182/blood-2003-06-1842; Cuevas Y, 2003, CANCER RES, V63, P6877; Denko NC, 2003, ONCOGENE, V22, P5907, DOI 10.1038/sj.onc.1206703; GUO B, 1995, J BIOL CHEM, V270, P16529, DOI 10.1074/jbc.270.28.16529; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Jiang YD, 2003, MOL CANCER RES, V1, P453; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Kwok JC, 2004, MOL PHARMACOL, V65, P181, DOI 10.1124/mol.65.1.181; Kwok JC, 2002, CRIT REV ONCOL HEMAT, V42, P65, DOI 10.1016/S1040-8428(01)00213-X; Kwok JC, 2003, MOL PHARMACOL, V63, P849, DOI 10.1124/mol.63.4.849; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Minotti G, 2001, CANCER RES, V61, P8422; PIETRANGELO A, 1992, GASTROENTEROLOGY, V102, P802, DOI 10.1016/0016-5085(92)90161-Q; PIETRANGELO A, 1995, GASTROENTEROLOGY, V108, P208, DOI 10.1016/0016-5085(95)90026-8; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; Ratcliffe PJ, 2003, NAT CELL BIOL, V5, P7, DOI 10.1038/ncb0103-7; Recalcati S, 1998, BLOOD, V91, P1059, DOI 10.1182/blood.V91.3.1059.1059_1059_1066; Recalcati S, 1999, EUR J BIOCHEM, V259, P304, DOI 10.1046/j.1432-1327.1999.00038.x; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Tacchini L, 2003, EXP CELL RES, V290, P391, DOI 10.1016/S0014-4827(03)00348-3; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wang J, 2005, BBA-MOL CELL RES, V1743, P79, DOI 10.1016/j.bbamcr.2004.08.011; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; WHITE K, 1988, J BIOL CHEM, V263, P8938; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; Wykoff CC, 2004, BRIT J CANCER, V90, P1235, DOI 10.1038/sj.bjc.6601657; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Zatyka M, 2002, CANCER RES, V62, P3803	52	32	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30120	30128		10.1074/jbc.M500971200	http://dx.doi.org/10.1074/jbc.M500971200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15985433	hybrid			2022-12-27	WOS:000231362500018
J	Brodin, P; de Jonge, MI; Majlessi, L; Leclerc, C; Nilges, M; Cole, ST; Brosch, R				Brodin, P; de Jonge, MI; Majlessi, L; Leclerc, C; Nilges, M; Cole, ST; Brosch, R			Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCED PROTECTION; CALMETTE-GUERIN; BOVIS BCG; ESAT-6; RD1; PROTEINS; PATHOGENESIS; ATTENUATION; DELETION; MICROTI	Proteins of the 6-kDa early secreted antigenic target (ESAT-6) secretion system-1 of Mycobacterium tuberculosis are not only strongly involved in the anti-mycobacterial Th1-host immune response but are also key players for virulence. In this study, protein engineering together with bioinformatic, immunological, and virulence analyses allowed us to pinpoint regions of the ESAT-6 molecule that are critical for its biological activity in M. tuberculosis. Mutation of the Trp-Xaa-Gly motif, conserved in a wide variety of ESAT-6-like proteins, abolished complex formation with the partner protein CFP-10, induction of specific T-cell responses, and virulence. Replacement of conserved Leu residues interfered with secretion, coiled-coil formation, and virulence, whereas certain mutations at the extreme C terminus did not affect secretion but caused attenuation, possibly because of altered ESAT-6 targeting or trafficking. In contrast, the mutation of several residues on the outer surface of the four-helical bundle structure of the ESAT-6 center dot CFP-10 complex showed much less effect. Construction of recombinant BCG expressing ESAT-6 with a C-terminal hexahistidine tag allowed us to co-purify ESAT-6 and CFP-10, experimentally confirming their strong interaction both in and outside of the mycobacterial cell. The strain induced potent, antigen-specific T-cell responses and intermediate in vivo growth in mice, suggesting that it remained immunogenic and biologically active despite the tag. Together with previous NMR data, the results of this study have allowed a biologically relevant model of the ESAT-6 center dot CFP-10 complex to be constructed that is critical for understanding the structure-function relationship in tuberculosis pathogenesis.	Inst Pasteur, Unite Genet Mol Bacterienne, F-75724 Paris, France; Inst Pasteur, INSERM, E352, Unite Biol Regulat Immunitaires, F-75724 Paris, France; Inst Pasteur, Unite Bioinformat Struct, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Brosch, R (corresponding author), Inst Pasteur, Unite Genet Mol Bacterienne, 28 Rue Dr Roux, F-75724 Paris, France.	rbrosch@pasteur.fr	Brosch, Roland/ABB-4108-2021; Brodin, Priscille/N-6979-2019; Nilges, Michael/E-4803-2011; Brosch, Roland/AAZ-3850-2021; Brodin, Priscille/E-5802-2014; de Jonge, Marien I./P-5869-2015	Brodin, Priscille/0000-0003-0991-7344; Nilges, Michael/0000-0002-1451-8092; Brosch, Roland/0000-0003-2587-3863; Brodin, Priscille/0000-0003-0991-7344; de Jonge, Marien I./0000-0003-2812-5895; deboosere, Nathalie/0000-0002-2873-5485				Agou F, 2002, J BIOL CHEM, V277, P17464, DOI 10.1074/jbc.M201964200; Brodin P, 2004, J INFECT DIS, V190, P115, DOI 10.1086/421468; Brodin P, 2002, INFECT IMMUN, V70, P5568, DOI 10.1128/IAI.70.10.5568-5578.2002; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brosch R, 1998, INFECT IMMUN, V66, P2221, DOI 10.1128/IAI.66.5.2221-2229.1998; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Horn C, 1999, J BIOL CHEM, V274, P32023, DOI 10.1074/jbc.274.45.32023; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Kwok SC, 2004, J BIOL CHEM, V279, P21576, DOI 10.1074/jbc.M401074200; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Lightbody KL, 2004, FEMS MICROBIOL LETT, V238, P255, DOI 10.1016/j.femsle.2004.07.043; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570; Mostowy S, 2004, J BACTERIOL, V186, P104, DOI 10.1128/JB.186.1.104-109.2003; NILGES M, 1991, PROTEIN ENG, V4, P649, DOI 10.1093/protein/4.6.649; Okkels LM, 2004, PROTEOMICS, V4, P2954, DOI 10.1002/pmic.200400906; Okkels LM, 2004, J BACTERIOL, V186, P2487, DOI 10.1128/JB.186.8.2487-2491.2004; Pallen MJ, 1997, MOL MICROBIOL, V25, P423, DOI 10.1046/j.1365-2958.1997.4901850.x; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Renshaw PS, 2004, J BIOMOL NMR, V30, P225, DOI 10.1023/B:JNMR.0000048852.40853.5c; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606	30	115	139	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					33953	33959		10.1074/jbc.M503515200	http://dx.doi.org/10.1074/jbc.M503515200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16048998	hybrid			2022-12-27	WOS:000232229700032
J	Champagne, KS; Sissler, M; Larrabee, Y; Doublie, S; Francklyn, SS				Champagne, KS; Sissler, M; Larrabee, Y; Doublie, S; Francklyn, SS			Activation of the hetero-octameric ATP phosphoribosyl transferase through subunit interface rearrangement by a tRNA synthetase paralog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TRIPHOSPHATE SYNTHETASE; ADENOSINE-TRIPHOSPHATE; HISTIDINE BIOSYNTHESIS; 1ST ENZYME; SPECIFICITY; INHIBITION; TRANSITION; PURINE; PHOSPHATE	ATP phosphoribosyl transferase (ATP-PRT) joins ATP and 5-phosphoribosyl-1- pyrophosphate ( PRPP) in a highly regulated reaction that initiates histidine biosynthesis. The unusual hetero-octameric version of ATP-PRT includes four HisG(S) catalytic subunits based on the periplasmic binding protein fold and four HisZ regulatory subunits that resemble histidyl-tRNA synthetases. Here, we present the first structure of a PRPP-bound ATP-PRT at 2.9 angstrom and provide a structural model for allosteric activation based on comparisons with other inhibited and activated ATP-PRTs from both the hetero-octameric and hexameric families. The activated state of the octameric enzyme is characterized by an interstitial phosphate ion in the HisZ-HisG interface and new contacts between the HisZ motif 2 loop and the HisGS dimer interface. These contacts restructure the interface to recruit conserved residues to the active site, where they activate pyrophosphate to promote catalysis. Additionally, mutational analysis identifies the histidine binding sites within a region highly conserved between HisZ and the functional HisRS. Through the oligomerization and functional re-assignment of protein domains associated with aminoacylation and phosphate binding, the HisZ-HisG octameric ATP-PRT acquired the ability to initiate the synthesis of a key metabolic intermediate in an allosterically regulated fashion.	Univ Vermont, Markey Ctr Mol Genet, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; Univ Vermont, Dept Biochem, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Doublie, S (corresponding author), Univ Vermont, Markey Ctr Mol Genet, Dept Microbiol & Mol Genet, Stafford Hall,95 Carrigan Dr, Burlington, VT 05405 USA.	sdoublie@uvm.edu	Glass, Karen C./AAV-1076-2021	Glass, Karen C./0000-0002-2761-733X; Doublie, Sylvie/0000-0002-6294-5304; SISSLER, Marie/0000-0001-8594-5238	NIGMS NIH HHS [GM62239, R01 GM054899-10, GM54899] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062239, R01GM054899] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnez JG, 1997, P NATL ACAD SCI USA, V94, P7144, DOI 10.1073/pnas.94.14.7144; ARNEZ JG, 1995, EMBO J, V14, P4143, DOI 10.1002/j.1460-2075.1995.tb00088.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BELL RM, 1974, J BIOL CHEM, V249, P4110; Bond JP, 2000, J MOL EVOL, V50, P339, DOI 10.1007/s002399910037; Bovee ML, 2002, BIOCHEMISTRY-US, V41, P11838, DOI 10.1021/bi020243z; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; Cho Y, 2003, J BIOL CHEM, V278, P8333, DOI 10.1074/jbc.M212124200; DeLano W.L, PYMOL MOL GRAPHICS S; DELORME C, 1992, J BACTERIOL, V174, P6571, DOI 10.1128/JB.174.20.6571-6579.1992; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Eads JC, 1997, STRUCTURE, V5, P47, DOI 10.1016/S0969-2126(97)00165-2; Eriksen TA, 2000, NAT STRUCT BIOL, V7, P303; Fedorov A, 2001, BIOCHEMISTRY-US, V40, P853, DOI 10.1021/bi002499f; Francklyn C, 2003, P NATL ACAD SCI USA, V100, P9650, DOI 10.1073/pnas.1934245100; Francklyn C, 2005, AMINOACYL TRNA SYNTH, P135; GOITEIN RK, 1978, J BIOL CHEM, V253, P2963; Hawko SA, 2001, BIOCHEMISTRY-US, V40, P1930, DOI 10.1021/bi0025316; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLUNGSOYR L, 1971, BIOCHIM BIOPHYS ACTA, V227, P327, DOI 10.1016/0005-2744(71)90064-7; Lohkamp B, 2004, J MOL BIOL, V336, P131, DOI 10.1016/j.jmb.2003.12.020; MARTIN RG, 1963, J BIOL CHEM, V238, P257; Mayans O, 2002, EMBO J, V21, P3245, DOI 10.1093/emboj/cdf298; MORTON DP, 1976, ARCH BIOCHEM BIOPHYS, V175, P677, DOI 10.1016/0003-9861(76)90559-2; MORTON DP, 1977, ARCH BIOCHEM BIOPHYS, V181, P643, DOI 10.1016/0003-9861(77)90270-3; MUSICK WDL, 1981, CRC CR REV BIOCH MOL, V11, P1, DOI 10.3109/10409238109108698; Nakatsu T, 1998, NAT STRUCT BIOL, V5, P15, DOI 10.1038/nsb0198-15; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARSONS SM, 1974, J BIOL CHEM, V249, P4119; Qiu XY, 1999, BIOCHEMISTRY-US, V38, P12296, DOI 10.1021/bi990482v; Quiocho FA, 1996, KIDNEY INT, V49, P943, DOI 10.1038/ki.1996.132; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Schramm VL, 2004, PROG NUCLEIC ACID RE, V78, P261, DOI 10.1016/S0079-6603(04)78007-1; Schramm VL, 2003, ACCOUNTS CHEM RES, V36, P588, DOI 10.1021/ar0200495; Sinha SC, 2001, CURR OPIN STRUC BIOL, V11, P733, DOI 10.1016/S0959-440X(01)00274-3; Sissler M, 1999, P NATL ACAD SCI USA, V96, P8985, DOI 10.1073/pnas.96.16.8985; SMITH JL, 1994, SCIENCE, V264, P1427, DOI 10.1126/science.8197456; Smith JL, 1999, NAT STRUCT BIOL, V6, P502, DOI 10.1038/9266; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Vega MC, 2005, MOL MICROBIOL, V55, P675, DOI 10.1111/j.1365-2958.2004.04422.x; Vogel H.J., 1971, METABOLIC REGULATION, V5, P349; VOLL MJ, 1967, J BIOL CHEM, V242, P1760; Wang ZM, 1997, NAT STRUCT BIOL, V4, P519, DOI 10.1038/nsb0797-519; Willemoes M, 2000, J BIOL CHEM, V275, P35408, DOI 10.1074/jbc.M006346200; Winkler M.E., 1987, ESCHERICHIA COLI SAL, P395; Yaremchuk A, 2001, J MOL BIOL, V309, P989, DOI 10.1006/jmbi.2001.4712	50	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34096	34104		10.1074/jbc.M505041200	http://dx.doi.org/10.1074/jbc.M505041200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16051603	hybrid			2022-12-27	WOS:000232229700050
J	Nakagawa, M; Oliva, JL; Kothapalli, D; Fournier, A; Assoian, RK; Kazanietz, MG				Nakagawa, M; Oliva, JL; Kothapalli, D; Fournier, A; Assoian, RK; Kazanietz, MG			Phorbol ester-induced G(1) phase arrest selectively mediated by protein kinase C delta-dependent induction of p21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER CELLS; INTESTINAL EPITHELIAL-CELLS; VASCULAR ENDOTHELIAL-CELLS; PROSTATE-CANCER; PKC-DELTA; COLON CARCINOGENESIS; CLINICAL DEVELOPMENT; TUMOR PROMOTION; DNA-SYNTHESIS; MUSCLE-CELLS	Although protein kinase C (PKC) has been widely implicated in the positive and negative control of proliferation, the underlying cell cycle mechanisms regulated by individual PKC isozymes are only partially understood. In this report, we show that PKC delta mediates phorbol ester-induced G(1) arrest in lung adenocarcinoma cells and establish an essential role for this novel PKC in controlling the expression of the cell cycle inhibitor p21. Activation of PKC with phorbol 12-myristate 13-acetate (PMA) in early G(1) phase impaired progression of lung adenocarcinoma cells into S phase, an effect that was completely abolished by specific depletion of PKC delta, but not PKC alpha. Although the PKC effect was unrelated to the inhibition of cyclin D1 expression, PKC activation significantly up-regulated p21 and down-regulated Rb hyperphosphorylation and cyclin A expression. Elevations in p21 mRNA and protein by PMA were mediated by PKC delta but not PKC alpha. Studies using luciferase reporters also revealed an essential role for PKC delta in the PMA-induced inhibition of Rb-dependent cyclin A promoter activity. Finally, we showed that the cell cycle inhibitory effect of PKC delta is greatly attenuated by RNA interference-mediated knock-down of p21. Our results identify a novel link between PKC delta and G(1) arrest via p21 up-regulation and highlight the complexities in the downstream effectors of PKC isozymes in the context of cell cycle progression and proliferation.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Kazanietz, MG (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 816 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelo@spirit.gcrc.upenn.edu			NCI NIH HHS [R25-CA101871, CA-89202, CA-95237] Funding Source: Medline; NIGMS NIH HHS [GM-51878] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R25CA101871, R01CA089202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051878] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akashi M, 1999, BIOCHEM J, V337, P607, DOI 10.1042/0264-6021:3370607; Alisi A, 2004, J CELL PHYSIOL, V201, P259, DOI 10.1002/jcp.20060; Ashton AW, 1999, J BIOL CHEM, V274, P20805, DOI 10.1074/jbc.274.30.20805; Barry OP, 2001, CURR PHARM DESIGN, V7, P1725, DOI 10.2174/1381612013397041; BORNER C, 1995, J BIOL CHEM, V270, P78, DOI 10.1074/jbc.270.1.78; Buitrago CG, 2003, J BIOL CHEM, V278, P2199, DOI 10.1074/jbc.M205732200; Clamp A, 2002, ANTI-CANCER DRUG, V13, P673, DOI 10.1097/00001813-200208000-00001; Clark AS, 2003, CANCER RES, V63, P780; Clark JA, 2004, J BIOL CHEM, V279, P9233, DOI 10.1074/jbc.M312268200; DeVries TA, 2004, J BIOL CHEM, V279, P45603, DOI 10.1074/jbc.M407448200; Ding L, 2002, J BIOL CHEM, V277, P35305, DOI 10.1074/jbc.M201460200; Fima E, 2001, ONCOGENE, V20, P6794, DOI 10.1038/sj.onc.1204885; Frey MR, 2000, J CELL BIOL, V151, P763, DOI 10.1083/jcb.151.4.763; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Gavrielides MV, 2004, CURR DRUG TARGETS, V5, P431, DOI 10.2174/1389450043345380; Han ZT, 1998, P NATL ACAD SCI USA, V95, P5357, DOI 10.1073/pnas.95.9.5357; Han ZT, 1998, P NATL ACAD SCI USA, V95, P5362, DOI 10.1073/pnas.95.9.5362; Hemstrom TH, 2005, EXP CELL RES, V305, P200, DOI 10.1016/j.yexcr.2004.12.017; Heusch WL, 1998, CARCINOGENESIS, V19, P551, DOI 10.1093/carcin/19.4.551; Kothapalli D, 2003, MOL PHARMACOL, V64, P249, DOI 10.1124/mol.64.2.249; Lahn M, 2004, ONCOLOGY-BASEL, V67, P1, DOI 10.1159/000080279; Lahn Michael, 2004, Clin Lung Cancer, V6, P184, DOI 10.3816/CLC.2004.n.032; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; Livneh E, 1996, ONCOGENE, V12, P1545; Lu ZM, 1997, MOL CELL BIOL, V17, P3418, DOI 10.1128/MCB.17.6.3418; Mandil R, 2001, CANCER RES, V61, P4612; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Reddig PJ, 1999, CANCER RES, V59, P5710; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Strair RK, 2002, CLIN CANCER RES, V8, P2512; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Tortora G, 2003, SEMIN ONCOL, V30, P26, DOI 10.1016/S0093-7754(03)00282-3; Vrana JA, 1999, BIOCHEM PHARMACOL, V58, P121, DOI 10.1016/S0006-2952(99)00077-5; Wu DQ, 2002, CANCER RES, V62, P2423; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Yu DS, 2002, BIOCHEMISTRY-US, V41, P11888, DOI 10.1021/bi020270p; Yu WS, 2003, J BIOL CHEM, V278, P11167, DOI 10.1074/jbc.M211424200; Zeng YX, 1996, ONCOGENE, V12, P1557; Zhao X, 1997, J BIOL CHEM, V272, P22751, DOI 10.1074/jbc.272.36.22751; Zhong MH, 2002, ONCOGENE, V21, P1071, DOI 10.1038/sj/onc/1205165; ZHOU W, 1993, J BIOL CHEM, V268, P23041; ZHOU W, 1994, BIOCHEM BIOPH RES CO, V199, P191, DOI 10.1006/bbrc.1994.1213; Zou YY, 1998, J NATL CANCER I, V90, P1130, DOI 10.1093/jnci/90.15.1130	46	64	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					33926	33934		10.1074/jbc.M505748200	http://dx.doi.org/10.1074/jbc.M505748200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16055435	hybrid			2022-12-27	WOS:000232229700029
J	Rasschaert, J; Ladriere, L; Urbain, M; Dogusan, Z; Katabua, B; Sato, S; Akira, S; Gysemans, C; Mathieu, C; Eizirik, DL				Rasschaert, J; Ladriere, L; Urbain, M; Dogusan, Z; Katabua, B; Sato, S; Akira, S; Gysemans, C; Mathieu, C; Eizirik, DL			Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA plus interferon-gamma-induced apoptosis in primary pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEPENDENT DIABETES-MELLITUS; ISLET CELLS; IFN-BETA; ENTEROVIRUS INFECTION; TRANSGENIC MICE; INNATE IMMUNITY; INDUCED GENES; NITRIC-OXIDE; PRONE BB	Viral infections and local production of cytokines probably contribute to the pathogenesis of Type 1 diabetes. The viral replicative intermediate double-stranded RNA ( dsRNA, tested in the form of polyinosinic-polycytidylic acid, PIC), in combination with the cytokine interferon-gamma (IFN-gamma), triggers beta-cell apoptosis. We have previously observed by microarray analysis that PIC induces expression of several mRNAs encoding for genes downstream of Toll-like receptor 3 (TLR3) signaling pathway. In this report, we show that exposure of beta-cells to dsRNA in combination with IFN-alpha, -beta, or -gamma significantly increases apoptosis. Moreover, dsRNA induces TLR3 mRNA expression and activates NF-kappa B and the IFN-beta promoter in a TRIF-dependent manner. dsRNA also induces an early ( 1 h) and sustained increase in IFN-beta mRNA expression, and blocking IFN-beta with a specific antibody partially prevents PIC plus IFN-gamma-induced beta-cell death. On the other hand, dsRNA plus IFN-gamma does not induce apoptosis in INS-1E cells, and expression of TLR3 and type I IFNs mRNAs is not detected in these cells. Of note, disruption of the STAT-1 signaling pathway protects beta-cells against dsRNA plus IFN-gamma-induced beta-cell apoptosis. This study suggests that dsRNA plus IFN-gamma triggers beta-cell apoptosis by two complementary pathways, namely TLR3-TRIF-NF-kappa B and STAT-1.	Univ Libre Bruxelles, Expt Med Lab, B-1070 Brussels, Belgium; Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; Katholieke Univ Leuven, Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium	Universite Libre de Bruxelles; Osaka University; KU Leuven	Rasschaert, J (corresponding author), Univ Libre Bruxelles, Expt Med Lab, Route de Lennik 808,CP 618, B-1070 Brussels, Belgium.	jrasscha@ulb.ac.be	mathieu, chantal/ABD-5505-2021; Akira, Shizuo/C-3134-2009	mathieu, chantal/0000-0002-4055-5233; Sato, Shintaro/0000-0001-5156-3354; gysemans, conny/0000-0003-3559-6089; Rasschaert, Joanne/0000-0002-9388-7995; DOGUSAN, ZEYNEP/0000-0002-1506-669X				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alba A, 2004, J IMMUNOL, V173, P6667, DOI 10.4049/jimmunol.173.11.6667; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Besser D, 1999, MOL CELL BIOL, V19, P1401; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Cardozo AK, 2003, DIABETOLOGIA, V46, P255, DOI 10.1007/s00125-002-1017-0; Cardozo AK, 2001, DIABETES, V50, P909, DOI 10.2337/diabetes.50.5.909; Delaney CA, 1997, ENDOCRINOLOGY, V138, P2610, DOI 10.1210/en.138.6.2610; Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279; Doyle SE, 2003, J IMMUNOL, V170, P3565, DOI 10.4049/jimmunol.170.7.3565; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; EWEL CH, 1992, DIABETES, V41, P1016, DOI 10.2337/diabetes.41.8.1016; Giannoukakis N, 2000, J BIOL CHEM, V275, P36509, DOI 10.1074/jbc.M005943200; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Haverkos HW, 2003, BIOMED PHARMACOTHER, V57, P379, DOI 10.1016/j.biopha.2003.03.001; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Heitmeier MR, 1999, J BIOL CHEM, V274, P12531, DOI 10.1074/jbc.274.18.12531; Hertzog PJ, 2003, TRENDS IMMUNOL, V24, P534, DOI 10.1016/j.it.2003.08.006; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; HUANG XJ, 1995, DIABETES, V44, P658, DOI 10.2337/diabetes.44.6.658; Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Jun HS, 2003, DIABETES-METAB RES, V19, P8, DOI 10.1002/dmrr.337; Jun HS, 2001, DIABETOLOGIA, V44, P271, DOI 10.1007/s001250051614; Jung DY, 2005, J IMMUNOL, V174, P6467, DOI 10.4049/jimmunol.174.10.6467; Kharroubi I, 2003, BIOCHEM BIOPH RES CO, V312, P1118, DOI 10.1016/j.bbrc.2003.11.042; Kobayashi M, 2003, J CLIN INVEST, V111, P1297, DOI 10.1172/JCI200317085; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; LERNMARK A, 1997, TXB DIABETES; LING Z, 1994, DIABETOLOGIA, V37, P15; Ling ZD, 1998, ENDOCRINOLOGY, V139, P1540, DOI 10.1210/en.139.4.1540; Ling ZD, 2000, DIABETES, V49, P340, DOI 10.2337/diabetes.49.3.340; Liu DB, 2000, DIABETES, V49, P1116, DOI 10.2337/diabetes.49.7.1116; Liu DB, 2002, ENDOCRINOLOGY, V143, P1225, DOI 10.1210/en.143.4.1225; Liu DB, 2001, ENDOCRINOLOGY, V142, P2593, DOI 10.1210/en.142.6.2593; Lonnrot M, 2000, DIABETES, V49, P1314, DOI 10.2337/diabetes.49.8.1314; Matsumoto M, 2004, MICROBIOL IMMUNOL, V48, P147, DOI 10.1111/j.1348-0421.2004.tb03500.x; Matsumoto S, 2005, J BIOL CHEM, V280, P25687, DOI 10.1074/jbc.M412784200; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pavlovic D, 1999, EUR CYTOKINE NETW, V10, P403; Pelegrin M, 1998, J BIOL CHEM, V273, P12332, DOI 10.1074/jbc.273.20.12332; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806; Rasschaert J, 2003, DIABETOLOGIA, V46, P1641, DOI 10.1007/s00125-003-1245-y; RHODES CJ, 1985, BIOCHEM J, V228, P87, DOI 10.1042/bj2280087; Ruckdeschel K, 2004, J IMMUNOL, V173, P3320, DOI 10.4049/jimmunol.173.5.3320; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; SOBEL DO, 1994, DIABETES, V43, P518, DOI 10.2337/diabetes.43.4.518; SOBEL DO, 1992, DIABETES, V41, P515, DOI 10.2337/diabetes.41.4.515; SOMOZA N, 1994, J IMMUNOL, V153, P1360; Stephanou A, 2003, INT J EXP PATHOL, V84, P239, DOI 10.1111/j.0959-9673.2003.00363.x; Stephanou A, 2000, J BIOL CHEM, V275, P10002, DOI 10.1074/jbc.275.14.10002; STEWART TA, 1993, SCIENCE, V260, P1942, DOI 10.1126/science.8100367; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Triantafilou K, 2004, J VIROL, V78, P11313, DOI 10.1128/JVI.78.20.11313-11320.2004; Vassileva G, 2003, J IMMUNOL, V170, P5748, DOI 10.4049/jimmunol.170.11.5748; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wen L, 2004, J IMMUNOL, V172, P3173, DOI 10.4049/jimmunol.172.5.3173; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Ylipaasto P, 2004, DIABETOLOGIA, V47, P225, DOI 10.1007/s00125-003-1297-z; YOON JW, 1997, TXB DIABETES; Zipris D, 2005, J IMMUNOL, V174, P131, DOI 10.4049/jimmunol.174.1.131	69	138	141	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					33984	33991		10.1074/jbc.M502213200	http://dx.doi.org/10.1074/jbc.M502213200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16027122	hybrid			2022-12-27	WOS:000232229700036
J	Meurer, S; Pioch, S; Gross, S; Muller-Esterl, W				Meurer, S; Pioch, S; Gross, S; Muller-Esterl, W			Reactive oxygen species induce tyrosine phosphorylation of and src kinase recruitment to NO-sensitive guanylyl cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; NITRIC-OXIDE; GROWTH-FACTOR; C-SRC; ACTIVATION; MECHANISM; BINDING; PHOSPHATASES; INVOLVEMENT; INHIBITION	Soluble guanylyl cyclase (sGC) is the major cytosolic receptor for nitric oxide (NO) that converts GTP into the second messenger cGMP in a NO-dependent manner. Other factors controlling this key enzyme are intracellular proteins such as Hsp90 and PSD95, which bind to sGC and modulate its activity, stability, and localization. To date little is known about the effects of posttranslational modifications of sGC, although circumstantial evidence suggests that reversible phosphorylation may contribute to sGC regulation. Here we demonstrate that inhibitors of protein-tyrosine phosphatases such as pervanadate and bisperoxo(1,10-phenanthroline) oxovanadate( V) as well as reactive oxygen species such as H2O2 induce specific tyrosine phosphorylation of the beta(1) but not of the alpha(1) subunit of sGC. Tyrosine phosphorylation of sGC beta(1) is also inducible by pervanadate and H2O2 in intact PC12 cells, rat aortic smooth muscle cells, and in rat aortic tissues, indicating that tyrosine phosphorylation of sGC may also occur in vivo. We have mapped the major tyrosine phosphorylation site to position 192 of beta(1), where it forms part of a highly acidic phospho-acceptor site for Src-like kinases. In the phosphorylated state Tyr(P)-192 exposes a docking site for SH2 domains and efficiently recruits Src and Fyn to sGC beta(1), thereby promoting multiple phosphorylation of the enzyme. Our results demonstrate that sGC is subject to tyrosine phosphorylation and interaction with Src-like kinases, revealing an unexpected cross-talk between the NO/cGMP and tyrosine kinase signaling pathways at the level of sGC.	Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Muller-Esterl, W (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	office@biochem2.de						Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; Andreopoulos S, 2000, GEN PHARMACOL-VASC S, V34, P147, DOI 10.1016/S0306-3623(00)00062-8; Balashova N, 2005, J BIOL CHEM, V280, P2186, DOI 10.1074/jbc.M411545200; Bellamy TC, 2002, P NATL ACAD SCI USA, V99, P507, DOI 10.1073/pnas.012368499; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; BRUNATI AM, 1995, FEBS LETT, V367, P149, DOI 10.1016/0014-5793(95)00555-N; BUECHLER WA, 1994, ANN NY ACAD SCI, V714, P151; Chen ZJ, 2001, J STEROID BIOCHEM, V78, P451, DOI 10.1016/S0960-0760(01)00122-4; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Ferrero R, 2000, J NEUROCHEM, V75, P2029, DOI 10.1046/j.1471-4159.2000.0752029.x; Filippov G, 1997, J CLIN INVEST, V100, P942, DOI 10.1172/JCI119610; Gross S, 1999, J BIOL CHEM, V274, P26378, DOI 10.1074/jbc.274.37.26378; HARTENECK C, 1990, FEBS LETT, V272, P221, DOI 10.1016/0014-5793(90)80489-6; Herrlich P, 2000, BIOCHEM PHARMACOL, V59, P35, DOI 10.1016/S0006-2952(99)00298-1; Houston M, 1999, J BIOL CHEM, V274, P4985, DOI 10.1074/jbc.274.8.4985; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x; Koesling D, 1999, METHODS, V19, P485, DOI 10.1006/meth.1999.0891; Koesling D, 1999, Rev Physiol Biochem Pharmacol, V135, P41, DOI 10.1007/BFb0033669; Kostic TS, 2004, MOL ENDOCRINOL, V18, P458, DOI 10.1210/me.2003-0015; Kyprianou N, 1997, PROSTATE, V32, P266; LOUIS JC, 1993, BIOCHIM BIOPHYS ACTA, V1177, P299, DOI 10.1016/0167-4889(93)90126-A; Lucas KA, 2000, PHARMACOL REV, V52, P375; Martin E, 2003, P NATL ACAD SCI USA, V100, P9208, DOI 10.1073/pnas.1633590100; Matsuoka H, 2004, J BIOL CHEM, V279, P5975, DOI 10.1074/jbc.M311278200; McPhee I, 1999, J BIOL CHEM, V274, P11796, DOI 10.1074/jbc.274.17.11796; Meurer S, 2004, J BIOL CHEM, V279, P49346, DOI 10.1074/jbc.M410565200; Mulsch A, 2001, CIRCULATION, V103, P2188; Murthy KS, 2001, BIOCHEM J, V360, P199, DOI 10.1042/0264-6021:3600199; Nedvetsky PI, 2002, P NATL ACAD SCI USA, V99, P16510, DOI 10.1073/pnas.262701999; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Rosado JA, 2004, J BIOL CHEM, V279, P1665, DOI 10.1074/jbc.M307963200; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Russwurm M, 2001, J BIOL CHEM, V276, P44647, DOI 10.1074/jbc.M105587200; SACHSENMAIER C, 1994, CELL, V78, P963, DOI 10.1016/0092-8674(94)90272-0; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Suzaki Y, 2002, J BIOL CHEM, V277, P9614, DOI 10.1074/jbc.M111790200; Venema RC, 2003, AM J PHYSIOL-HEART C, V285, pH669, DOI 10.1152/ajpheart.01025.2002; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; Yu XM, 1999, P NATL ACAD SCI USA, V96, P7697, DOI 10.1073/pnas.96.14.7697; Zabel U, 1999, J BIOL CHEM, V274, P18149, DOI 10.1074/jbc.274.26.18149; Zhou ZM, 2004, J BIOL CHEM, V279, P24935, DOI 10.1074/jbc.M402105200; ZHUANG S, 2004, AM J PHYSIOL-RENAL, V286, P858; ZWILLER J, 1985, J BIOL CHEM, V260, P1350; ZWILLER J, 1981, BIOCHEM BIOPH RES CO, V101, P1381, DOI 10.1016/0006-291X(81)91600-4	49	41	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33149	33156		10.1074/jbc.M507565200	http://dx.doi.org/10.1074/jbc.M507565200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16079134	hybrid			2022-12-27	WOS:000232058100009
J	Zhang, XY; Fan, SJ; Meng, QH; Ma, YX; Katiyar, P; Schlegel, R; Rosen, EM				Zhang, XY; Fan, SJ; Meng, QH; Ma, YX; Katiyar, P; Schlegel, R; Rosen, EM			BRCA1 interaction with human papillomavirus oncoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; PROMOTER HYPERMETHYLATION; SPORADIC BREAST; IN-VIVO; PROTEINS; GENE; P53; E6; INHIBITION; CARCINOMA	Previously, we reported that BRCA1 strongly represses the transcriptional activity of estrogen receptor-alpha(ER-alpha) in human breast and prostate cancer cells but only weakly inhibits ER-alpha in cervical cancer cells. We now report that introduction of the human papillomavirus E7 or E6 oncogenes into human papillomavirus- negative cells rescues the BRCA1 repression of ER-alpha activity and that the E7 and E6 oncoproteins interact directly with BRCA1 in vitro and associate with BRCA1 in vivo in cultured cells. This interaction involves at least two contact points on BRCA1, one within an N-terminal site shown previously to interact with ER-alpha and the other in a C-terminal region of BRCA1 containing the first BRCA1 C-terminal domain. Point mutations within the zinc finger domains of E7 and E6 inactivated the binding to the N terminus of BRCA1 and reduced their ability to rescue BRCA1 inhibition of ER-alpha. E6 and E7 also antagonized the ability of BRCA1 to inhibit c-MycE-box-mediated transactivation and human telomerase reverse transcriptase promoter activity, in a manner dependent upon the zinc finger domains. Finally, the ability of E6 and E7 to antagonize BRCA1 did not involve proteolytic degradation of BRCA1. These findings suggest functional interactions of BRCA1 with E7 and E6. The potential significance of these findings is discussed.	Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Pathol, Washington, DC 20057 USA	Georgetown University; Georgetown University	Rosen, EM (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Preclin Sci Bldg,Rm GM12B,3970 Reservoir Rd NW,Bo, Washington, DC 20057 USA.	emr36@georgetown.edu			NATIONAL CANCER INSTITUTE [R01CA082599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009169] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Aprelikova ON, 1999, P NATL ACAD SCI USA, V96, P11866, DOI 10.1073/pnas.96.21.11866; Arbeit JM, 1996, P NATL ACAD SCI USA, V93, P2930, DOI 10.1073/pnas.93.7.2930; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brehm A, 1999, EMBO J, V18, P2449, DOI 10.1093/emboj/18.9.2449; CASEY G, 1991, ONCOGENE, V6, P1791; Chai YL, 1999, ONCOGENE, V18, P263, DOI 10.1038/sj.onc.1202323; de Villiers EM, 2005, BREAST CANCER RES, V7, pR1, DOI 10.1186/bcr940; de Villiers EM, 2003, INT J CANCER, V103, P705, DOI 10.1002/ijc.10868; Einstein MH, 2002, CANCER INVEST, V20, P1080, DOI 10.1081/CNV-120005927; Elson DA, 2000, CANCER RES, V60, P1267; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; Fan SJ, 2002, CANCER RES, V62, P141; Fan SJ, 2001, ONCOGENE, V20, P77, DOI 10.1038/sj.onc.1204073; Fan SJ, 2001, ONCOGENE, V20, P4827, DOI 10.1038/sj.onc.1204666; Fan SJ, 2001, ONCOGENE, V20, P8215, DOI 10.1038/sj.onc.1205033; Fan SJ, 1998, ONCOGENE, V16, P3069, DOI 10.1038/sj.onc.1202116; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; Franco EL, 2003, CANCER J, V9, P348, DOI 10.1097/00130404-200309000-00004; Henttu PMA, 1997, MOL CELL BIOL, V17, P1832, DOI 10.1128/MCB.17.4.1832; HURWITZ DR, 1985, P NATL ACAD SCI USA, V82, P163, DOI 10.1073/pnas.82.1.163; Johannsson O, 1999, EUR J CANCER, V35, P1248, DOI 10.1016/S0959-8049(99)00135-5; JONES L, 2005, ONCOGENE, V93; LIANG XH, 1995, J CELL BIOCHEM, V57, P509, DOI 10.1002/jcb.240570316; Liu XF, 2005, J BIOL CHEM, V280, P10807, DOI 10.1074/jbc.M410343200; Ma YX, 2005, ONCOGENE, V24, P1831, DOI 10.1038/sj.onc.1208190; Maclean J, 2005, EXPERT REV ANTICANC, V5, P97, DOI 10.1586/14737140.5.1.97; Meissner JD, 1999, J GEN VIROL, V80, P1725, DOI 10.1099/0022-1317-80-7-1725; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miyai K, 2004, GYNECOL ONCOL, V94, P115, DOI 10.1016/j.ygyno.2004.04.013; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; Narayan G, 2004, CANCER RES, V64, P2994, DOI 10.1158/0008-5472.CAN-04-0245; Narayan Gopeshwar, 2003, Mol Cancer, V2, P24, DOI 10.1186/1476-4598-2-24; Narod SA, 2001, ANN NY ACAD SCI, V952, P36, DOI 10.1111/j.1749-6632.2001.tb02726.x; Ouchi T, 2000, P NATL ACAD SCI USA, V97, P5208, DOI 10.1073/pnas.080469697; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Peng SW, 2004, J VIROL, V78, P8468, DOI 10.1128/JVI.78.16.8468-8476.2004; Pestell RG, 1996, CELL GROWTH DIFFER, V7, P1337; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Robson ME, 2004, BREAST CANCER RES, V6, pR8, DOI 10.1186/bcr658; Rosen EM, 2003, J CELL PHYSIOL, V196, P19, DOI 10.1002/jcp.10257; ROSEN EM, 2005, IN PRESS ENDOCR RELA; ROWELL S, 1994, AM J HUM GENET, V55, P861; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Scheffner M, 2003, SEMIN CANCER BIOL, V13, P59, DOI 10.1016/S1044-579X(02)00100-1; SEEDORF K, 1987, EMBO J, V6, P139, DOI 10.1002/j.1460-2075.1987.tb04731.x; Staff S, 2003, CANCER RES, V63, P4978; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Veldman T, 2003, P NATL ACAD SCI USA, V100, P8211, DOI 10.1073/pnas.1435900100; Wang Q, 1998, ONCOGENE, V17, P1939, DOI 10.1038/sj.onc.1202403; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Xiong JB, 2003, MOL CELL BIOL, V23, P8668, DOI 10.1128/MCB.23.23.8668-8690.2003; Xu JW, 2005, ENDOCRINOLOGY, V146, P2031, DOI 10.1210/en.2004-0409; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; ZHU JY, 1992, J VIROL, V66, P2780, DOI 10.1128/JVI.66.5.2780-2791.1992; Zimmermann H, 1999, J VIROL, V73, P6209, DOI 10.1128/JVI.73.8.6209-6219.1999	58	62	68	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33165	33177		10.1074/jbc.M505124200	http://dx.doi.org/10.1074/jbc.M505124200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	15983032	hybrid			2022-12-27	WOS:000232058100011
J	Oka, T; Vasile, E; Penman, M; Novina, CD; Dykxhoorn, DM; Ungar, D; Hughson, FM; Krieger, M				Oka, T; Vasile, E; Penman, M; Novina, CD; Dykxhoorn, DM; Ungar, D; Hughson, FM; Krieger, M			Genetic analysis of the subunit organization and function of the conserved oligomeric golgi (COG) complex - Studies of Cog5- and Cog7-deficient mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; HAMSTER-CELL MUTANTS; ENDOPLASMIC-RETICULUM; PROTEIN COMPLEX; TRANSPORT; RETROGRADE; SEC34P; IDENTIFICATION; GLYCOSYLATION; LOCALIZATION	The conserved oligomeric Golgi (COG) complex is an eight-subunit (Cog1-8) peripheral Golgi protein involved in Golgi-associated membrane trafficking and glycoconjugate synthesis. We have analyzed the structure and function of COG using Cog1 or Cog2 null Chinese hamster ovary cell mutants, fibroblasts from a patient with Cog7-deficient congenital disorders of glycosylation, and stable Cog5-deficient HeLa cells generated by RNA interference. Although the dilation of some Golgi cisternae in Cog5-deficient cells resembled that observed in Cog1- or Cog2-deficient cells, their global glycosylation defects (less severe) and intracellular processing and function of low density lipoprotein receptors (essentially normal) differed from Cog1- and Cog2-deficient cells. Immunoblotting, gel filtration, and immunofluorescence microscopy analyses of the COG-deficient cells and cell extracts indicated that 1) Cog2-4 and Cog5-7 form stable subcomplexes, 2) Cog1 mediates Golgi association of a Cog2-4 plus Cog8 subcomplex, 3) Cog8 associates stably with both Cog5-7 and Cog1-4 subcomplexes, and thus 4) Cog8 helps assemble the Cog1-4 and Cog5-7 subcomplexes into the complete COG complex. This model of the subunit organization of COG is in excellent agreement with in vitro data presented in an accompanying paper (Ungar, D., Oka, T., Vasile, E., Krieger, M., and Hughson, F. M. (2005) J. Biol. Chem. 280, 32729-32735). Only one or two of the seven Cog1- or Cog2-dependent Golgi membrane proteins called GEARs are also sensitive to Cog5 or Cog7 deficiency, indicating that the COG subunits play distinctive roles in controlling Golgi structure and function.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Harvard Univ, Sch Med, Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Kyushu University; Princeton University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Krieger, M (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	krieger@mit.edu	Dykxhoorn, Derek M/D-1357-2015; Ungar, Daniel/A-5302-2012	Ungar, Daniel/0000-0002-9852-6160	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059115] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59115] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Axelsson MAB, 2001, GLYCOBIOLOGY, V11, P633, DOI 10.1093/glycob/11.8.633; Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Berger EG, 2002, GLYCOBIOLOGY, V12, p29R, DOI 10.1093/glycob/12.2.29R; Bidlingmaier Scott, 2002, Functional and Integrative Genomics, V1, P345, DOI 10.1007/s10142-001-0043-1; Bruinsma P, 2004, J BIOL CHEM, V279, P39814, DOI 10.1074/jbc.M405500200; Chatterton JE, 1999, P NATL ACAD SCI USA, V96, P915, DOI 10.1073/pnas.96.3.915; Conde R, 2003, YEAST, V20, P1189, DOI 10.1002/yea.1032; Conibear E, 2003, MOL BIOL CELL, V14, P1610, DOI 10.1091/mbc.E02-10-0654; Corbacho I, 2004, FEMS YEAST RES, V4, P437, DOI 10.1016/S1567-1356(03)00162-4; CUMMINGS RD, 1983, J BIOL CHEM, V258, P5261; Farkas RM, 2003, MOL BIOL CELL, V14, P190, DOI 10.1091/mbc.E02-06-0343; Fotso P, 2005, J BIOL CHEM, V280, P27613, DOI 10.1074/jbc.M504597200; Harris SL, 1996, J CELL BIOL, V132, P985, DOI 10.1083/jcb.132.6.985; Kim DW, 1999, MOL BIOL CELL, V10, P3317, DOI 10.1091/mbc.10.10.3317; Kim DW, 2001, TRAFFIC, V2, P820, DOI 10.1034/j.1600-0854.2001.21111.x; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; KOZARSKY KF, 1986, J CELL BIOL, V102, P1567, DOI 10.1083/jcb.102.5.1567; KRIEGER M, 1983, CELL, V33, P413, DOI 10.1016/0092-8674(83)90423-3; KRIEGER M, 1981, J MOL BIOL, V150, P167, DOI 10.1016/0022-2836(81)90447-2; Loh E, 2004, J BIOL CHEM, V279, P24640, DOI 10.1074/jbc.M400662200; Loh E, 2002, J BIOL CHEM, V277, P21955, DOI 10.1074/jbc.M202326200; Martinez-Menarguez JA, 2001, J CELL BIOL, V155, P1213, DOI 10.1083/jcb.200108029; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Oka T, 2005, J BIOCHEM, V137, P109, DOI 10.1093/jb/mvi024; Oka T, 2004, MOL BIOL CELL, V15, P2423, DOI 10.1091/mbc.E03-09-0699; Opat AS, 2001, BIOCHIMIE, V83, P763, DOI 10.1016/S0300-9084(01)01312-8; Pelham HRB, 2001, J CELL BIOL, V155, P1099, DOI 10.1083/jcb.200110160; PODOS SD, 1994, J CELL BIOL, V127, P679, DOI 10.1083/jcb.127.3.679; Puri S, 2002, TRAFFIC, V3, P641, DOI 10.1034/j.1600-0854.2002.30906.x; Ram RJ, 2002, MOL BIOL CELL, V13, P1484, DOI 10.1091/mbc.01-10-0495; REDDY P, 1989, MOL CELL BIOL, V9, P4799, DOI 10.1128/MCB.9.11.4799; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Siniossoglou S, 2001, EMBO J, V20, P5991, DOI 10.1093/emboj/20.21.5991; Skrincosky D, 1997, J BIOL CHEM, V272, P22695, DOI 10.1074/jbc.272.36.22695; Sollner TH, 2004, CURR OPIN CELL BIOL, V16, P429, DOI 10.1016/j.ceb.2004.06.015; Spelbrink RG, 1999, MOL BIOL CELL, V10, P4263, DOI 10.1091/mbc.10.12.4263; Storrie B, 2002, TRAFFIC, V3, P521, DOI 10.1034/j.1600-0854.2002.30802.x; Suvorova ES, 2002, J CELL BIOL, V157, P631, DOI 10.1083/jcb.200111081; Suvorova ES, 2001, J BIOL CHEM, V276, P22810, DOI 10.1074/jbc.M011624200; Ungar D, 2005, J BIOL CHEM, V280, P32729, DOI 10.1074/jbc.M504590200; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; VanRheenen SM, 1999, J CELL BIOL, V147, P729, DOI 10.1083/jcb.147.4.729; VanRheenen SM, 1998, J CELL BIOL, V141, P1107, DOI 10.1083/jcb.141.5.1107; Walter DM, 1998, J BIOL CHEM, V273, P29565, DOI 10.1074/jbc.273.45.29565; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Whyte JRC, 2002, J CELL SCI, V115, P2627; Whyte JRC, 2001, DEV CELL, V1, P527, DOI 10.1016/S1534-5807(01)00063-6; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041; Wuestehube LJ, 1996, GENETICS, V142, P393; Zerfaoui M, 2002, GLYCOBIOLOGY, V12, P15, DOI 10.1093/glycob/12.1.15; Zhang T, 1997, J CELL BIOL, V139, P1157, DOI 10.1083/jcb.139.5.1157; Zolov SN, 2005, J CELL BIOL, V168, P747, DOI 10.1083/jcb.200412003	58	73	76	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32736	32745		10.1074/jbc.M505558200	http://dx.doi.org/10.1074/jbc.M505558200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16051600	hybrid			2022-12-27	WOS:000231920300024
J	Bennetts, B; Rychkov, GY; Ng, HL; Morton, CJ; Stapleton, D; Parker, MW; Cromer, BA				Bennetts, B; Rychkov, GY; Ng, HL; Morton, CJ; Stapleton, D; Parker, MW; Cromer, BA			Cytoplasmic ATP-sensing domains regulate gating of skeletal muscle ClC-1 chloride channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC GENERALIZED EPILEPSIES; NEPHROLITHIASIS KIDNEY-STONES; TEMPERATURE-DEPENDENCE; CBS DOMAINS; K+-CHANNEL; FORCE PRODUCTION; MOLECULAR-BASIS; MUTATIONS; PROTEIN; FIBERS	ClC proteins are a family of chloride channels and transporters that are found in a wide variety of prokaryotic and eukaryotic cell types. The mammalian voltage-gated chloride channel ClC-1 is important for controlling the electrical excitability of skeletal muscle. Reduced excitability of muscle cells during metabolic stress can protect cells from metabolic exhaustion and is thought to be a major factor in fatigue. Here we identify a novel mechanism linking excitability to metabolic state by showing that ClC-1 channels are modulated by ATP. The high concentration of ATP in resting muscle effectively inhibits ClC-1 activity by shifting the voltage gating to more positive potentials. ADP and AMP had similar effects to ATP, but IMP had no effect, indicating that the inhibition of ClC-1 would only be relieved under anaerobic conditions such as intense muscle activity or ischemia, when depleted ATP accumulates as IMP. The resulting increase in ClC-1 activity under these conditions would reduce muscle excitability, thus contributing to fatigue. We show further that the modulation by ATP is mediated by cystathionine beta-synthase-related domains in the cytoplasmic C terminus of ClC-1. This defines a function for these domains as gating-modulatory domains sensitive to intracellular ligands, such as nucleotides, a function that is likely to be conserved in other ClC proteins.	St Vincents Inst, Fitzroy, Vic 3065, Australia; Univ Adelaide, Adelaide, SA 5005, Australia; Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	St. Vincent's Institute of Medical Research; University of Adelaide; University of Melbourne	Cromer, BA (corresponding author), St Vincents Inst, 9 Princes St, Fitzroy, Vic 3065, Australia.	bcromer@svi.edu.au	Cromer, Brett/AAQ-6533-2020; Morton, Craig/GON-8638-2022; Parker, Michael W/F-9069-2013	Morton, Craig/0000-0001-5452-5193; Parker, Michael W/0000-0002-3101-1138; Cromer, Brett/0000-0003-0743-1535; Rychkov, Grigori/0000-0002-2788-2977				Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Aromataris EC, 2001, MOL PHARMACOL, V60, P200, DOI 10.1124/mol.60.1.200; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bennetts B, 2001, J PHYSIOL-LONDON, V535, P83, DOI 10.1111/j.1469-7793.2001.t01-1-00083.x; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Cuppoletti J, 2004, J BIOL CHEM, V279, P21849, DOI 10.1074/jbc.M312567200; Debold EP, 2004, AM J PHYSIOL-CELL PH, V287, pC673, DOI 10.1152/ajpcell.00044.2004; Deymeer F, 1998, MUSCLE NERVE, V21, P1334, DOI 10.1002/(SICI)1097-4598(199810)21:10<1334::AID-MUS16>3.0.CO;2-1; Duffield M, 2003, J GEN PHYSIOL, V121, P149, DOI 10.1085/jgp.20028741; Dutka TL, 2004, J PHYSIOL-LONDON, V560, P451, DOI 10.1113/jphysiol.2004.069112; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Estevez R, 2004, J PHYSIOL-LONDON, V557, P363, DOI 10.1113/jphysiol.2003.058453; Fong PY, 1998, AM J PHYSIOL-CELL PH, V274, pC966, DOI 10.1152/ajpcell.1998.274.4.C966; Gong B, 2000, AM J PHYSIOL-CELL PH, V279, pC1351, DOI 10.1152/ajpcell.2000.279.5.C1351; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GURNETT CA, 1995, J BIOL CHEM, V270, P9035, DOI 10.1074/jbc.270.16.9035; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Hellsten Y, 1999, J PHYSIOL-LONDON, V520, P909, DOI 10.1111/j.1469-7793.1999.00909.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IDSTROM JP, 1990, AM J PHYSIOL, V258, pH1668, DOI 10.1152/ajpheart.1990.258.6.H1668; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Karatzaferi C, 2001, PFLUG ARCH EUR J PHY, V442, P467, DOI 10.1007/s004240100552; Konrad M, 2000, J AM SOC NEPHROL, V11, P1449, DOI 10.1681/ASN.V1181449; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lamb GD, 1995, J PHYSIOL-LONDON, V489, P349, DOI 10.1113/jphysiol.1995.sp021056; Lloyd SE, 1997, HUM MOL GENET, V6, P1233, DOI 10.1093/hmg/6.8.1233; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; MORISAKI T, 1992, P NATL ACAD SCI USA, V89, P6457, DOI 10.1073/pnas.89.14.6457; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nielsen OB, 2001, J PHYSIOL-LONDON, V536, P161, DOI 10.1111/j.1469-7793.2001.t01-1-00161.x; Niemeyer MI, 2004, PHYSIOL GENOMICS, V19, P74, DOI 10.1152/physiolgenomics.00070.2004; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; PALADE PT, 1977, J GEN PHYSIOL, V69, P325, DOI 10.1085/jgp.69.3.325; Papponen H, 2005, EXP NEUROL, V191, P163, DOI 10.1016/j.expneurol.2004.07.018; Pedersen TH, 2005, J GEN PHYSIOL, V125, P237, DOI 10.1085/jgp.200409173; Pedersen TH, 2004, SCIENCE, V305, P1144, DOI 10.1126/science.1101141; Ponting CP, 1997, J MOL MED-JMM, V75, P160; Pusch M, 1997, J GEN PHYSIOL, V109, P105, DOI 10.1085/jgp.109.1.105; Pusch M, 2002, HUM MUTAT, V19, P423, DOI 10.1002/humu.10063; Roosild TP, 2004, TRENDS BIOCHEM SCI, V29, P39, DOI 10.1016/j.tibs.2003.11.008; Rychkov GY, 1996, J PHYSIOL-LONDON, V497, P423, DOI 10.1113/jphysiol.1996.sp021778; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Sejersted OM, 2000, PHYSIOL REV, V80, P1411, DOI 10.1152/physrev.2000.80.4.1411; Simpson Bronwyn J, 2004, Hum Mutat, V24, P185, DOI 10.1002/humu.9260; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; Szentesi P, 2001, J PHYSIOL-LONDON, V531, P393, DOI 10.1111/j.1469-7793.2001.0393i.x; Tucker SJ, 1998, CURR OPIN NEUROBIOL, V8, P316, DOI 10.1016/S0959-4388(98)80055-X; Tullson P C, 1991, Exerc Sport Sci Rev, V19, P507; Vanoye CG, 2002, J PHYSIOL-LONDON, V539, P373, DOI 10.1113/jphysiol.2001.013115; Westerblad H, 1998, ACTA PHYSIOL SCAND, V162, P253, DOI 10.1046/j.1365-201X.1998.0301f.x; Wollnik B, 1997, HUM MOL GENET, V6, P1943, DOI 10.1093/hmg/6.11.1943; Zarembinski TI, 1998, P NATL ACAD SCI USA, V95, P15189, DOI 10.1073/pnas.95.26.15189; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v	58	97	98	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32452	32458		10.1074/jbc.M502890200	http://dx.doi.org/10.1074/jbc.M502890200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16027167	Green Accepted, hybrid			2022-12-27	WOS:000231794800052
J	Brown, AK; Sridharan, S; Kremer, L; Lindenberg, S; Dover, LG; Sacchettini, JC; Besra, GS				Brown, AK; Sridharan, S; Kremer, L; Lindenberg, S; Dover, LG; Sacchettini, JC; Besra, GS			Probing the mechanism of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III mtFabH - Factors influencing catalysis and substrate specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOLIC ACID BIOSYNTHESIS; FATTY-ACID; CRYSTAL-STRUCTURE; ACP SYNTHASE; BIOCHEMICAL-CHARACTERIZATION; CONDENSING ENZYME; ESCHERICHIA-COLI; FABH; IDENTIFICATION; CONDENSATION	Mycolic acids are the dominant feature of the Mycobacterium tuberculosis cell wall. These alpha-alkyl, beta-hydroxy fatty acids are formed by the condensation of two fatty acids, a long meromycolic acid and a shorter C-24-C-26 fatty acid. The component fatty acids are produced via a combination of type I and II fatty acid synthases (FAS) with FAS-I products being elongated by FAS-II toward meromycolic acids. The beta-ketoacyl-acyl carrier protein (ACP) synthase III encoded by mtfabH (mtFabH) links FAS-I and FAS-II, catalyzing the condensation of FAS-I-derived acyl-CoAs with malonyl-acyl carrier protein ( ACP). The acyl-CoA chain length specificity of mtFabH was assessed in vitro; the enzyme extended longer, physiologically relevant acyl-CoA primers when paired with AcpM, its natural partner, than with Escherichia coli ACP. The ability of the enzyme to use E. coli ACP suggests that a similar mode of binding is likely with both ACPs, yet it is clear that unique factors inherent to AcpM modulate the substrate specificity of mtFabH. Mutation of proposed key mtFabH residues was used to define their catalytic roles. Substitution of supposed acyl-CoA binding residues reduced transacylation, with double substitutions totally abrogating activity. Mutation of Arg(46) revealed its more critical role in malonyl-AcpM decarboxylation than in the acyl-CoA binding role. Interestingly, this effect was suppressed intragenically by Arg(161) -> Ala substitution. Our structural studies suggested that His(258), previously implicated in malonyl-ACP decarboxylation, also acts as an anchor point for a network of water molecules that we propose promotes deprotonation and transacylation of Cys(122).	Newcastle Univ, Sch Cellular & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; Univ Montpellier 2, CNRS, UMR 5539, Lab Dynam Interact Membranaires, F-34095 Montpellier, France	Newcastle University - UK; University of Birmingham; Texas A&M University System; Texas A&M University College Station; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Besra, GS (corresponding author), Newcastle Univ, Sch Cellular & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	g.besra@bham.ac.uk	Dover, Lynn G/F-3021-2010; Dover, Lynn George/Q-6778-2019; Kremer, Laurent/M-4935-2017	Dover, Lynn G/0000-0002-4776-2665; Dover, Lynn George/0000-0002-4776-2665; Kremer, Laurent/0000-0002-6604-4458; Brown, Alistair/0000-0003-0479-8294; Besra, Gurdyal/0000-0002-5605-0395	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bloch K, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P1; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choi KH, 2000, J BIOL CHEM, V275, P28201; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; Dover LG, 2004, FEMS MICROBIOL REV, V28, P225, DOI 10.1016/j.femsre.2003.10.001; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; He X, 2002, ANTIMICROB AGENTS CH, V46, P1310, DOI 10.1128/AAC.46.5.1310-1318.2002; He X, 2000, ANAL BIOCHEM, V282, P107, DOI 10.1006/abio.2000.4594; Heath RJ, 1996, J BIOL CHEM, V271, P10996, DOI 10.1074/jbc.271.18.10996; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Hong X, 2004, BIOMACROMOLECULES, V5, P1066, DOI 10.1021/bm0345155; Jez JM, 2000, J BIOL CHEM, V275, P39640, DOI 10.1074/jbc.M008569200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kaye K, 1996, EPIDEMIOL REV, V18, P52, DOI 10.1093/oxfordjournals.epirev.a017916; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Kremer L, 2001, J BIOL CHEM, V276, P27967, DOI 10.1074/jbc.M103687200; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Lu YJ, 2004, BIOCHEM CELL BIOL, V82, P145, DOI 10.1139/o03-076; McGuire KA, 2001, BIOCHEMISTRY-US, V40, P9836, DOI 10.1021/bi0105577; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Musayev F, 2005, J MOL BIOL, V346, P1313, DOI 10.1016/j.jmb.2004.12.044; Nachega JB, 2003, CLIN INFECT DIS, V36, pS24, DOI 10.1086/344657; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paolo WF, 2004, LANCET INFECT DIS, V4, P287, DOI 10.1016/S1473-3099(04)01004-7; PETERSON DO, 1977, J BIOL CHEM, V252, P5735; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Qiu XY, 1999, J BIOL CHEM, V274, P36465, DOI 10.1074/jbc.274.51.36465; Reddy V, 2003, ACTA CRYSTALLOGR D, V59, P2200, DOI 10.1107/S0907444903020316; Scarsdale JN, 2001, J BIOL CHEM, V276, P20516, DOI 10.1074/jbc.M010762200; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Slayden RA, 1996, ANTIMICROB AGENTS CH, V40, P2813, DOI 10.1128/AAC.40.12.2813; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Toossi Z, 2001, CLIN EXP IMMUNOL, V123, P233, DOI 10.1046/j.1365-2249.2001.01401.x; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; WALLIS RS, 1992, RES MICROBIOL, V143, P398, DOI 10.1016/0923-2508(92)90053-Q; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Yuan Y, 1998, J BIOL CHEM, V273, P21282, DOI 10.1074/jbc.273.33.21282; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200	46	50	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32539	32547		10.1074/jbc.M413216200	http://dx.doi.org/10.1074/jbc.M413216200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16040614	hybrid			2022-12-27	WOS:000231794800063
J	Ferreiro, DU; Dellarole, M; Nadra, AD; de Prat-Gay, G				Ferreiro, DU; Dellarole, M; Nadra, AD; de Prat-Gay, G			Free energy contributions to direct readout of a DNA sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAPILLOMAVIRUS E2 PROTEINS; BINDING DOMAIN; RECOGNITION; SPECIFICITY; FLEXIBILITY; INTERFACES; CODE; DISCRIMINATION; ENDONUCLEASE; CONSERVATION	The energetic contributions of individual DNA-contacting side chains to specific DNA recognition in the human papillomavirus 16 E2C-DNA complex is small (less than 1.0 kcal mol(-1)), independent of the physical and chemical nature of the interaction, and is strictly additive. The sum of the individual contributions differs 1.0 kcal mol(-1) from the binding energy of the wild- type protein. This difference corresponds to the contribution from the deformability of the DNA, known as "indirect readout." Thus, we can dissect the energetic contribution to DNA binding into 90% direct and 10% indirect readout components. The lack of high energy interactions indicates the absence of "hot spots," such as those found in protein-protein interfaces. These results are compatible with a highly dynamic and " wet" protein-DNA interface, yet highly specific and tight, where individual interactions are constantly being formed and broken.	Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Leloir, RA-1405 Buenos Aires, DF, Argentina; Univ Buenos Aires, Fac Ciencias Exactas & Nat, RA-1405 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires; University of Buenos Aires	de Prat-Gay, G (corresponding author), Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Leloir, Patricias Argentinas 435, RA-1405 Buenos Aires, DF, Argentina.	gpratgay@leloir.org.ar	Nadra, Alejandro/A-5668-2009	Nadra, Alejandro/0000-0002-7860-3245; Prat Gay, Gonzalo/0000-0001-5748-6863; Ferreiro, Diego/0000-0002-7869-4247	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alexander KA, 1996, BIOCHEMISTRY-US, V35, P9864, DOI 10.1021/bi960447d; Anderson EM, 2003, BIOCHEMISTRY-US, V42, P3751, DOI 10.1021/bi027047c; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Dell G, 2003, J MOL BIOL, V334, P979, DOI 10.1016/j.jmb.2003.10.009; Engler LE, 2001, J MOL BIOL, V307, P619, DOI 10.1006/jmbi.2000.4428; Ferreiro DU, 2000, BIOCHEMISTRY-US, V39, P14692, DOI 10.1021/bi001694r; Ferreiro DU, 2003, J MOL BIOL, V331, P89, DOI 10.1016/S0022-2836(03)00720-4; FERSHT A, 1999, STRUCTURE MECH PROTE, P129; Gromiha MM, 2004, J MOL BIOL, V337, P285, DOI 10.1016/j.jmb.2004.01.033; HAM J, 1991, TRENDS BIOCHEM SCI, V16, P440, DOI 10.1016/0968-0004(91)90172-R; HARRINGTON RE, 1994, PROG NUCLEIC ACID RE, V47, P195, DOI 10.1016/S0079-6603(08)60253-6; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; Hegde RS, 2002, ANNU REV BIOPH BIOM, V31, P343, DOI 10.1146/annurev.biophys.31.100901.142129; Hines CS, 1998, J MOL BIOL, V276, P809, DOI 10.1006/jmbi.1997.1578; Janin J, 1999, STRUCT FOLD DES, V7, pR277, DOI 10.1016/S0969-2126(00)88333-1; Jen-Jacobson L, 2000, STRUCTURE, V8, P1015, DOI 10.1016/S0969-2126(00)00501-3; JenJacobson L, 1997, BIOPOLYMERS, V44, P153; Kim SS, 2000, J BIOL CHEM, V275, P31245, DOI 10.1074/jbc.M004541200; Kurpiewski MR, 2004, STRUCTURE, V12, P1775, DOI 10.1016/j.str.2004.07.016; Levy Y, 2004, P NATL ACAD SCI USA, V101, P3325, DOI 10.1073/pnas.0400157101; Liang H, 1996, BIOCHEMISTRY-US, V35, P2095, DOI 10.1021/bi951932w; Lima LMTR, 2004, J BIOL CHEM, V279, P47968, DOI 10.1074/jbc.M407696200; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; MATTHEWS BW, 1988, NATURE, V335, P294, DOI 10.1038/335294a0; Mauricio L, 1997, J BIOL CHEM, V272, P19295, DOI 10.1074/jbc.272.31.19295; MCBRIDE AA, 1991, J BIOL CHEM, V266, P18411; Mok YK, 2000, PROTEIN SCI, V9, P799; Mok YK, 1996, NAT STRUCT BIOL, V3, P711, DOI 10.1038/nsb0896-711; Mok YK, 1996, PROTEIN SCI, V5, P310; Nadra AD, 2004, J BIOMOL NMR, V30, P211, DOI 10.1023/B:JNMR.0000048942.96866.76; Oobatake M, 2003, PROTEINS, V53, P33, DOI 10.1002/prot.10438; Pabo CO, 2000, J MOL BIOL, V301, P597, DOI 10.1006/jmbi.2000.3918; Rozenberg H, 1998, P NATL ACAD SCI USA, V95, P15194, DOI 10.1073/pnas.95.26.15194; RUIZSANZ J, 1995, BIOCHEMISTRY-US, V34, P1695, DOI 10.1021/bi00005a026; SANDERS CM, 1994, NUCLEIC ACIDS RES, V22, P4890, DOI 10.1093/nar/22.23.4890; SARAI A, 1989, BIOCHEMISTRY-US, V28, P7842, DOI 10.1021/bi00445a046; Selvaraj S, 2002, J MOL BIOL, V322, P907, DOI 10.1016/S0022-2836(02)00846-X; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; VONHIPPEL PH, 1986, P NATL ACAD SCI USA, V83, P1608; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Zhang YL, 2004, P NATL ACAD SCI USA, V101, P8337, DOI 10.1073/pnas.0402319101	41	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32480	32484		10.1074/jbc.M505706200	http://dx.doi.org/10.1074/jbc.M505706200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16000299	hybrid, Green Published			2022-12-27	WOS:000231794800055
J	Hausmann, S; Shuman, S				Hausmann, S; Shuman, S			Giardia lamblia RNA cap guanine-N2 methyltransferase (Tgs2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; IN-VITRO; SACCHAROMYCES-CEREVISIAE; TRANSLATION; HYPERMETHYLATION; PROTEIN; GENE; POSITION-10; EFFICIENCY; MECHANISM	Tgs1 is the enzyme responsible for converting 7-methyl-guanosine RNA caps to the 2,2,7-trimethylguanosine cap structures of small nuclear and small nucleolar RNAs. Whereas budding yeast Saccharomyces cerevisiae and fission yeast Schizosaccharomyces pombe encode a single Tgs1 protein, the primitive eukaryote Giardia lamblia encodes two paralogs, Tgs1 and Tgs2. Here we show that purified Tgs2 is a monomeric enzyme that catalyzes methyl transfer from AdoMet ( Km of 6 mu M) to m(7)GDP (K-m of 65 mu M; k(cat) of 14 min(-1)) to form m(2,7)GDP. Tgs2 also methylates m(7)GTP (K-m of 30 mu M; kcat of 13 min(-1)) and m(7)GpppA (K-m of 7 mu M;k(cat) of 14 min(-1)) but is unreactive with GDP, GTP, GpppA, ATP, CTP, or UTP. We find that the conserved residues Asp-68, Glu-91, and Trp-143 are essential for Tgs2 methyltransferase activity in vitro. The m2,7GDP product formed by Tgs2 can be converted tom2,2,7GDP by S. pombe Tgs1 in the presence of excess AdoMet. However, Giardia Tgs2 itself is apparently unable to add a second methyl group at guanine-N2. This result implies that 2,2,7-trimethylguanosine caps in Giardia are either synthesized by Tgs1 alone or by the sequential action of Tgs2 and Tgs1. The specificity of Tgs2 raises the prospect that some Giardia mRNAs might contain dimethylguanosine caps.	Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Amer Canc Soc, Atlanta, GA 30329 USA.	s-shuman@ski.mskcc.org			NIGMS NIH HHS [GM52470] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052470] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armengaud J, 2004, J BIOL CHEM, V279, P37142, DOI 10.1074/jbc.M403845200; BUSCH H, 1982, ANNU REV BIOCHEM, V51, P617, DOI 10.1146/annurev.bi.51.070182.003153; Cai A, 1999, BIOCHEMISTRY-US, V38, P8538, DOI 10.1021/bi9830213; Constantinesco F, 1999, J MOL BIOL, V291, P375, DOI 10.1006/jmbi.1999.2976; DARZYNKIEWICZ E, 1988, NUCLEIC ACIDS RES, V16, P8953, DOI 10.1093/nar/16.18.8953; ELLIS SR, 1986, J BIOL CHEM, V261, P9703; Fabrega C, 2004, MOL CELL, V13, P77, DOI 10.1016/S1097-2765(03)00522-7; Grudzien E, 2004, RNA, V10, P1479, DOI 10.1261/rna.7380904; Hausmann S, 2005, J BIOL CHEM, V280, P20404, DOI 10.1074/jbc.M501073200; Hausmann S, 2005, J BIOL CHEM, V280, P12077, DOI 10.1074/jbc.M412063200; Hausmann S, 2005, J BIOL CHEM, V280, P4021, DOI 10.1074/jbc.C400554200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HSUCHEN CC, 1976, NATURE, V264, P190, DOI 10.1038/264190a0; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; Komonyi O, 2005, J BIOL CHEM, V280, P12397, DOI 10.1074/jbc.M409251200; Li L, 2005, EUKARYOT CELL, V4, P948, DOI 10.1128/EC.4.5.948-959.2005; Li L, 2004, J BIOL CHEM, V279, P14656, DOI 10.1074/jbc.M309879200; LIOU RF, 1990, MOL CELL BIOL, V10, P1764, DOI 10.1128/MCB.10.4.1764; Liu JM, 2000, NUCLEIC ACIDS RES, V28, P3445, DOI 10.1093/nar/28.18.3445; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Mouaikel J, 2003, NUCLEIC ACIDS RES, V31, P4899, DOI 10.1093/nar/gkg656; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; NIU XH, 1994, MOL BIOCHEM PARASIT, V66, P49, DOI 10.1016/0166-6851(94)90035-3; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; PLESSEL G, 1994, MOL CELL BIOL, V14, P4160, DOI 10.1128/MCB.14.6.4160; Purushothaman SK, 2005, MOL CELL BIOL, V25, P4359, DOI 10.1128/MCB.25.11.4359-4370.2005; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Speckmann WA, 2000, NUCLEIC ACIDS RES, V28, P4467, DOI 10.1093/nar/28.22.4467; TERNS MP, 1995, EMBO J, V14, P4860, DOI 10.1002/j.1460-2075.1995.tb00167.x; Tscherne JS, 1999, J BIOL CHEM, V274, P924, DOI 10.1074/jbc.274.2.924; VANDUIJN LP, 1986, VIRUS RES, V5, P61, DOI 10.1016/0168-1702(86)90065-1; Yu DC, 1998, MOL BIOCHEM PARASIT, V96, P151, DOI 10.1016/S0166-6851(98)00126-1	32	32	34	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32101	32106		10.1074/jbc.M506438200	http://dx.doi.org/10.1074/jbc.M506438200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16046409	hybrid			2022-12-27	WOS:000231794800009
J	Potter, MD; Barbero, S; Cheresh, DA				Potter, MD; Barbero, S; Cheresh, DA			Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; N-CADHERIN; ADHERENS JUNCTIONS; MOLECULAR-BASIS; ADHESION; MORPHOGENESIS; ANGIOGENESIS; ASSOCIATION; GROWTH; PERMEABILITY	In several pathological conditions, epithelial cells demonstrate a breakdown of barrier function and acquire an invasive phenotype. Endothelial cells in particular are maintained in a mesenchymal state during the cell invasion phase of angiogenesis. We show here that tyrosine phosphorylation of the adherens junction protein VE-cadherin at two critical tyrosines, Tyr-658 and Tyr-731, via tyrosine kinase activation or phosphatase inactivation was sufficient to prevent the binding of p120- and beta-catenin, respectively, to the cytoplasmic tail of VE-cadherin. In fact, phosphorylation at either site led to the inhibition of cell barrier function. Cells expressing wild-type VE-cadherin showed decreased cell migration compared with cells lacking VE-cadherin, whereas expression of VE-cadherin with a simple phosphomimetic tyrosine-to-glutamic acid mutation of Y658E or Y731E was sufficient to restore the migratory response. These findings demonstrate that a single phosphorylation event within the VE-cadherin cytoplasmic tail is sufficient to maintain cells in a mesenchymal state.	Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Cheresh, DA (corresponding author), Univ Calif San Diego, Moores Canc Ctr, 3855 Hlth Sci Dr 0803, La Jolla, CA 92093 USA.	dcheresh@ucsd.edu			NCI NIH HHS [CA45726, CA95262, CA78045, 5F32CA097885, CA50286] Funding Source: Medline; NEI NIH HHS [EY14174] Funding Source: Medline; NHLBI NIH HHS [HL57900] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA045726, F32CA097885, P01CA078045, R37CA050286, R01CA050286, R01CA095262] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY014174] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057900] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Burden-Gulley SM, 1999, J CELL BIOL, V144, P1323, DOI 10.1083/jcb.144.6.1323; Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Dejana E, 2000, INT J DEV BIOL, V44, P743; Dejana E, 1999, EXP CELL RES, V252, P13, DOI 10.1006/excr.1999.4601; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Esser S, 1998, J CELL SCI, V111, P1853; Ferber A, 2002, EXP CELL RES, V274, P35, DOI 10.1006/excr.2001.5436; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Handschuh G, 1999, ONCOGENE, V18, P4301, DOI 10.1038/sj.onc.1202790; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Iyer S, 2004, AM J PHYSIOL-LUNG C, V286, pL1143, DOI 10.1152/ajplung.00305.2003; Lambeng N, 2005, CIRC RES, V96, P384, DOI 10.1161/01.RES.0000156652.99586.9f; Lampugnani MG, 2002, MOL BIOL CELL, V13, P1175, DOI 10.1091/mbc.01-07-0368; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Takeda H, 1995, J CELL BIOL, V131, P1839, DOI 10.1083/jcb.131.6.1839; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Verin AD, 2005, AM J PATHOL, V166, P955, DOI 10.1016/S0002-9440(10)62316-4; Vincent PA, 2004, AM J PHYSIOL-CELL PH, V286, pC987, DOI 10.1152/ajpcell.00522.2003; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Young BA, 2003, AM J PHYSIOL-LUNG C, V285, pL63, DOI 10.1152/ajplung.00423.2002	39	260	264	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31906	31912		10.1074/jbc.M505568200	http://dx.doi.org/10.1074/jbc.M505568200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16027153	hybrid			2022-12-27	WOS:000231665200070
J	Winayanuwattikun, P; Ketterman, AJ				Winayanuwattikun, P; Ketterman, AJ			An electron-sharing network involved in the catalytic mechanism is functionally conserved in different glutathione transferase classes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-CAPPING BOX; S-TRANSFERASE; ACTIVE-SITE; EVOLUTIONARY STRATEGIES; SUBSTRATE GLUTATHIONE; DIRECTED MUTAGENESIS; ENZYMATIC-PROPERTIES; CRYSTAL-STRUCTURE; PROTON RELEASE; T2-2 DISCLOSES	In Anopheles dirus glutathione transferase D3-3, there are electrostatic interactions between the negatively charged glutamyl alpha-carboxylate group of glutathione, the positively charged Arg-66, and the negatively charged Asp-100. This ionic interaction is stabilized by a network of hydrogen bonds from Ser-65, Thr-158, Thr-162, and a conserved water-mediated contact. This alternating ionic bridge interaction between negatively and positively charged residues stabilized by a network of hydrogen bonding we have named an electron-sharing network. We show that the electron- sharing network assists the glutamyl alpha-carboxylate of glutathione to function as a catalytic base accepting the proton from the thiol group forming an anionic glutathione, which is a crucial step in the glutathione transferase ( GST) catalysis. Kinetic studies demonstrate that the mutation of electron- sharing network residues results in a decreased ability to lower the pK(a) of the thiol group of glutathione. Although the residues that contribute to the electron- sharing network are not conserved in the primary sequence, structural characterizations indicate that the presence of the network can be mapped to the same region in all GST classes. A structural diversification but functional conservation suggests a significant role for the electron- sharing network in catalysis as the purpose was maintained during the divergent evolution of GSTs. This network appears to be a functionally conserved motif that contributes to the "base-assisted deprotonation" model suggested to be essential for the glutathione ionization step of the catalytic mechanism.	Mahidol Univ, Inst Mol Biol & Genet, Salaya 73170, Nakhon Pathom, Thailand	Mahidol University	Winayanuwattikun, P (corresponding author), Mahidol Univ, Inst Mol Biol & Genet, Salaya Campus,25-25 Putthamonthol,Rd 4, Salaya 73170, Nakhon Pathom, Thailand.	frakt@mahidol.ac.th						Aceto A, 1997, BIOCHEM J, V322, P229, DOI 10.1042/bj3220229; AHMAD H, 1990, ARCH BIOCHEM BIOPHYS, V278, P398, DOI 10.1016/0003-9861(90)90277-6; Allardyce CS, 1999, BIOCHEM J, V343, P525, DOI 10.1042/0264-6021:3430525; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Armstrong RN, 2001, CHEM-BIOL INTERACT, V133, P167; BJORNESTEDT R, 1995, J MOL BIOL, V247, P765; Board PG, 1997, BIOCHEM J, V328, P929; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CACCURI AM, 1994, BIOCHEM BIOPH RES CO, V200, P1428, DOI 10.1006/bbrc.1994.1610; Caccuri AM, 2001, J BIOL CHEM, V276, P5427, DOI 10.1074/jbc.M002819200; Caccuri AM, 2001, J BIOL CHEM, V276, P5432, DOI 10.1074/jbc.M002818200; Caccuri AM, 1998, BIOCHEMISTRY-US, V37, P3028, DOI 10.1021/bi971903g; Caccuri AM, 1999, BIOCHEM J, V344, P419, DOI 10.1042/0264-6021:3440419; Caccuri AM, 1996, J BIOL CHEM, V271, P16193, DOI 10.1074/jbc.271.27.16193; Caccuri AM, 1997, J BIOL CHEM, V272, P29681, DOI 10.1074/jbc.272.47.29681; CHEN WJ, 1988, BIOCHEMISTRY-US, V27, P647, DOI 10.1021/bi00402a023; Dragani B, 1997, J BIOL CHEM, V272, P25518, DOI 10.1074/jbc.272.41.25518; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; Gustafsson A, 2001, BIOCHEMISTRY-US, V40, P15835, DOI 10.1021/bi010429i; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; JAKOBY WB, 1980, ENZYMATIC BASIS DETO, V2, P63; Jirajaroenrat K, 2001, INSECT BIOCHEM MOLEC, V31, P867, DOI 10.1016/S0965-1748(01)00032-7; JOHNSON WW, 1993, J BIOL CHEM, V268, P11508; Ketterer B, 2001, CHEM-BIOL INTERACT, V138, P27, DOI 10.1016/S0009-2797(01)00277-0; KOLM RH, 1992, BIOCHEM J, V285, P537, DOI 10.1042/bj2850537; Kong GKW, 2003, J BIOL CHEM, V278, P1291, DOI 10.1074/jbc.M209581200; KONG KH, 1993, PROTEIN ENG, V6, P93, DOI 10.1093/protein/6.1.93; LIU SX, 1992, J BIOL CHEM, V267, P4296; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; MANNERVIK B, 1992, BIOCHEM J, V282, P305, DOI 10.1042/bj2820305; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; MANOHARAN TH, 1992, J BIOL CHEM, V267, P18940; MANOHARAN TH, 1992, J MOL BIOL, V226, P319, DOI 10.1016/0022-2836(92)90949-K; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; MOTOYAMA N, 1978, INSECT BIOCHEM, V8, P337, DOI 10.1016/0020-1790(78)90019-7; Nilsson LO, 2002, BBA-PROTEIN STRUCT M, V1597, P157; Oakley AJ, 2001, PROTEIN SCI, V10, P2176, DOI 10.1110/ps.21201; Pemble SE, 1996, BIOCHEM J, V319, P749, DOI 10.1042/bj3190749; PEMBLE SE, 1992, BIOCHEM J, V287, P957, DOI 10.1042/bj2870957; Rossjohn J, 2000, J MOL BIOL, V302, P295, DOI 10.1006/jmbi.2000.4054; Rossjohn J, 1998, STRUCTURE, V6, P309, DOI 10.1016/S0969-2126(98)00034-3; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Stenberg G, 2001, CHEM-BIOL INTERACT, V133, P49; STENBERG G, 1991, BIOCHEM J, V274, P549, DOI 10.1042/bj2740549; Tan KL, 1996, BIOCHEM J, V319, P315, DOI 10.1042/bj3190315; WIDERSTEIN M, 1992, BIOCHEM J, V285, P377, DOI 10.1042/bj2850377; Widersten M, 1996, BIOCHEMISTRY-US, V35, P7731, DOI 10.1021/bi9601619; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Winayanuwattikun P, 2004, BIOCHEM J, V382, P751, DOI 10.1042/BJ20040697; Wolf AV, 1985, HDB CHEM PHYSICS, pD; Wongtrakul J, 2003, INSECT BIOCHEM MOLEC, V33, P971, DOI 10.1016/S0965-1748(03)00103-6	52	52	52	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31776	31782		10.1074/jbc.M502612200	http://dx.doi.org/10.1074/jbc.M502612200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16012173	hybrid			2022-12-27	WOS:000231665200056
J	Landa, LR; Harbeck, M; Kaihara, K; Chepurny, O; Kitiphongspattana, K; Graf, O; Nikolaev, VO; Lohse, MJ; Holz, GG; Roe, MW				Landa, LR; Harbeck, M; Kaihara, K; Chepurny, O; Kitiphongspattana, K; Graf, O; Nikolaev, VO; Lohse, MJ; Holz, GG; Roe, MW			Interplay of Ca2+ and cAMP signaling in the insulin-secreting MIN6 beta-cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; CA2+-INHIBITABLE ADENYLYL-CYCLASE; PLASMA-MEMBRANE CA2+-ATPASE; C6-2B GLIOMA-CELLS; PANCREATIC-ISLETS; NONEXCITABLE CELLS; EPAC ACTIVATION; CALCIUM; EXPRESSION; RELEASE	Ca2+ and cAMP are important second messengers that regulate multiple cellular processes. Although previous studies have suggested direct interactions between Ca2+ and cAMP signaling pathways, the underlying mechanisms remain unresolved. In particular, direct evidence for Ca2+-regulated cAMP production in living cells is incomplete. Genetically encoded fluorescence resonance energy transfer-based biosensors have made possible real-time imaging of spatial and temporal gradients of intracellular cAMP concentration in single living cells. Here, we used confocal microscopy, fluorescence resonance energy transfer, and insulin-secreting MIN6 cells expressing Epac1-camps, a biosynthetic unimolecular cAMP indicator, to better understand the role of intracellular Ca2+ in cAMP production. We report that depolarization with high external K+, tolbutamide, or glucose caused a rapid increase in cAMP that was dependent on extracellular Ca2+ and inhibited by nitrendipine, a Ca2+ channel blocker, or 2', 5'-dideoxyadenosine, a P-site antagonist of transmembrane adenylate cyclases. Stimulation of MIN6 cells with glucose in the presence of tetraethylammonium chloride generated concomitant Ca2+ and cAMP oscillations that were abolished in the absence of extracellular Ca2+ and blocked by 2', 5'-dideoxyadenosine or 3- isobutyl-1-methylxanthine, an inhibitor of phosphodiesterase. Simultaneous measurements of Ca2+ and cAMP concentrations with Fura-2 and Epac1-camps, respectively, revealed a close temporal and causal interrelationship between the increases in cytoplasmic Ca2+ and cAMP levels following membrane depolarization. These findings indicate highly coordinated interplay between Ca2+ and cAMP signaling in electrically excitable endocrine cells and suggest that Ca2+-dependent cAMP oscillations are derived from an increase in adenylate cyclase activity and periodic activation and inactivation of cAMP-hydrolyzing phosphodiesterase.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany	University of Chicago; New York University; University of Wurzburg	Roe, MW (corresponding author), Univ Chicago, Dept Med, MC-1027,5841 S Maryland Ave, Chicago, IL 60637 USA.	mroe@medicine.bsd.uchicago.edu	Holz, George G/A-3386-2012; Lohse, Martin J/A-7160-2012; Nikolaev, Vyacheslav/AAT-7746-2020	Lohse, Martin J/0000-0002-0599-3510; Holz, George/0000-0002-1781-3580; Kaihara, Kelly/0000-0002-1277-6418	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK064162, R01DK063493, R29DK045817, R21DK068822, R01DK045817] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK045817, R21 DK068822, DK63493, DK45817, DK68822, DK64162, R01 DK063493, R21 DK064162] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agnihotri N, 1997, J NEUROSCI RES, V47, P555, DOI 10.1002/(SICI)1097-4547(19970301)47:5<555::AID-JNR11>3.0.CO;2-X; Ang KL, 2002, J NEUROCHEM, V81, P422, DOI 10.1046/j.1471-4159.2002.00903.x; Antoni FA, 1997, TRENDS ENDOCRIN MET, V8, P7, DOI 10.1016/S1043-2760(96)00206-8; Beltran C, 1996, BIOCHEMISTRY-US, V35, P7591, DOI 10.1021/bi952806v; BOOKER G, 1973, SCIENCE, V182, P933; Bruce JIE, 2003, CELL CALCIUM, V34, P431, DOI 10.1016/S0143-4160(03)00150-7; Bruce JIE, 2002, J BIOL CHEM, V277, P48172, DOI 10.1074/jbc.M208393200; CHIONO M, 1995, J BIOL CHEM, V270, P1149, DOI 10.1074/jbc.270.3.1149; Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Cooper DMF, 1998, J BIOL CHEM, V273, P27703, DOI 10.1074/jbc.273.42.27703; Dean WL, 1997, J BIOL CHEM, V272, P15113, DOI 10.1074/jbc.272.24.15113; DeBernardi MA, 1996, P NATL ACAD SCI USA, V93, P4577, DOI 10.1073/pnas.93.10.4577; Delmeire D, 2003, DIABETOLOGIA, V46, P1383, DOI 10.1007/s00125-003-1203-8; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dyer JL, 2005, J BIOL CHEM, V280, P8936, DOI 10.1074/jbc.M410045200; Fagan KA, 1998, J BIOL CHEM, V273, P9297, DOI 10.1074/jbc.273.15.9297; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Goaillard JM, 2001, J PHYSIOL-LONDON, V530, P79, DOI 10.1111/j.1469-7793.2001.0079m.x; Goraya TA, 2004, J BIOL CHEM, V279, P40494, DOI 10.1074/jbc.M313441200; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guenifi A, 2000, HISTOCHEM CELL BIOL, V113, P81, DOI 10.1007/s004180050010; Guillou JL, 1999, J BIOL CHEM, V274, P35539, DOI 10.1074/jbc.274.50.35539; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; KARL RC, 1975, J BIOL CHEM, V250, P4575; Leech CA, 1999, BIOCHEM BIOPH RES CO, V254, P703, DOI 10.1006/bbrc.1998.9906; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; Mehats C, 2002, TRENDS ENDOCRIN MET, V13, P29, DOI 10.1016/S1043-2760(01)00523-9; NAKADE S, 1994, J BIOL CHEM, V269, P6735; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Pyne NJ, 2003, DIABETOLOGIA, V46, P1179, DOI 10.1007/s00125-003-1176-7; RAPP PE, 1977, J THEOR BIOL, V66, P497, DOI 10.1016/0022-5193(77)90299-5; RASMUSSEN H, 1981, CALCIUM CAMP SYNARCH; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; Roe MW, 1998, J BIOL CHEM, V273, P10402, DOI 10.1074/jbc.273.17.10402; ROOS W, 1977, NATURE, V266, P259, DOI 10.1038/266259a0; SCHULTZ JE, 1992, SCIENCE, V255, P600, DOI 10.1126/science.1371017; Tian YR, 2003, MOL CELL ENDOCRINOL, V204, P75, DOI 10.1016/S0303-7207(03)00126-6; VALVERDE I, 1979, SCIENCE, V206, P225, DOI 10.1126/science.225798; Zaccolo M, 2003, TRENDS NEUROSCI, V26, P53, DOI 10.1016/S0166-2236(02)00017-6	47	162	166	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31294	31302		10.1074/jbc.M505657200	http://dx.doi.org/10.1074/jbc.M505657200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15987680	Green Accepted, hybrid			2022-12-27	WOS:000231487800077
J	Wullschleger, S; Loewith, R; Oppliger, W; Hall, MN				Wullschleger, S; Loewith, R; Oppliger, W; Hall, MN			Molecular organization of target of rapamycin complex 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-GROWTH; ACTIN CYTOSKELETON; TRYPTOPHAN PERMEASE; BINDING PARTNER; MAMMALIAN TOR; YEAST; PATHWAY; NUTRIENT; RAPTOR	The target of rapamycin ( TOR), a highly conserved serine/ threonine kinase, plays a central role in the control of eukaryotic cell growth. TOR exists in two functionally and structurally distinct complexes, TOR complex 1 ( TORC1) and TOR complex 2 ( TORC2). TORC1 controls cell growth via a rapamycin- sensitive signaling branch regulating translation, transcription, nutrient uptake, ribosome biogenesis, and autophagy. TORC2 controls the organization of the actin cytoskeleton through a rapamycin- insensitive signaling branch and in yeast consists of the six proteins AVO1, AVO2, AVO3, BIT61, LST8, and TOR2. Here we have focused on the characterization of TORC2. Our studies suggest that TORC2 is oligomeric, likely a TORC2- TORC2 dimer. AVO1 and AVO3 bind cooperatively to the N- terminal HEAT repeat region in TOR2 and are required for TORC2 integrity. AVO2 is a nonessential peripheral protein associated with AVO1 and AVO3. LST8 binds separately to the C- terminal kinase domain region in TOR2 and appears to modulate both the integrity and kinase activity of TORC2. TORC2 autophosphorylates sites in AVO1 and AVO3, but TORC2 kinase activity is not required for TORC2 integrity. We have demonstrated that mammalian TOR is also oligomeric. The architecture of TORC2 is discussed in the context of TORC2 assembly and regulation.	Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland	University of Basel	Hall, MN (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.	M.Hall@unibas.ch	Loewith, Robbie J/S-6289-2016	Loewith, Robbie J/0000-0002-2482-603X; Wullschleger, Stephan/0000-0002-5521-2276; Hall, Michael N/0000-0002-2998-0757				Alarcon CM, 1999, MOL BIOL CELL, V10, P2531, DOI 10.1091/mbc.10.8.2531; Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200; Liu ZC, 2001, EMBO J, V20, P7209, DOI 10.1093/emboj/20.24.7209; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Loewith Robbie, 2004, VVolume 42, P139; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Roberg KJ, 1997, GENETICS, V147, P1569; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609	36	182	192	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30697	30704		10.1074/jbc.M505553200	http://dx.doi.org/10.1074/jbc.M505553200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16002396	Green Accepted, hybrid			2022-12-27	WOS:000231487800008
J	Eisenhauer, HA; Shames, S; Pawelek, PD; Coulton, JW				Eisenhauer, HA; Shames, S; Pawelek, PD; Coulton, JW			Siderophore transport through Escherichia coli outer membrane receptor FhuA with disulfide-tethered cork and barrel domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERRICHROME-IRON RECEPTOR; HUMAN P-GLYCOPROTEIN; CROSS-LINKING; IN-VIVO; OXALOBACTER-FORMIGENES; COBALAMIN TRANSPORTER; CONFORMATIONAL-CHANGE; CRYSTAL-STRUCTURE; BOUND-STATES; PROTEIN	The hydroxamate siderophore receptor FhuA is a TonB-dependent outer membrane protein of Escherichia coli composed of a C-terminal 22-stranded beta-barrel occluded by an N-terminal globular cork domain. During siderophore transport into the periplasm, the FhuA cork domain has been proposed to undergo conformational changes that allow transport through the barrel lumen; alternatively, the cork may be completely displaced from the barrel. To probe such changes, site-directed cysteine mutants in the cork domain ( L109C and Q112C) and in the barrel domain ( S356C and M383C) were created within the putative siderophore transport pathway. Molecular modeling predicted that the double cysteine mutants L109C/S356C and Q112C/M383C would form disulfide bonds, thereby tethering the cork and barrel domains. The double cysteine FhuA mutants were denatured under nonreducing conditions and fluorescently labeled with thiol-specific Oregon Green maleimide. Subsequent SDS-PAGE analysis revealed two distinct species: FhuA containing a disulfide bond and FhuA with free sulfhydryl groups. To address the role of the putative siderophore transport pathway and to evaluate possible rearrangements of the cork domain during ferricrocin transport, disulfide bond formation was enhanced by an oxidative catalyst. Cells containing double cysteine FhuA mutants that were subjected to oxidation during ferricrocin transport exhibited disulfide bond formation to near completion. After disulfide tethering of the cork to the barrel, ferricrocin transport was equivalent to transport by untreated cells. These results demonstrate that blocking the putative siderophore transport pathway does not abrogate ferricrocin uptake. We propose that, during siderophore transport through FhuA, the cork domain remains within the barrel rather than being displaced.	McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	McGill University	Coulton, JW (corresponding author), McGill Univ, Dept Microbiol & Immunol, Rm 403,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	james.coulton@mcgill.ca	Pawelek, Peter/E-7950-2014	Pawelek, Peter/0000-0002-8361-6593				Aziz QH, 2002, J BIOL CHEM, V277, P42719, DOI 10.1074/jbc.M207258200; Bonhivers M, 2001, BIOCHEMISTRY-US, V40, P2606, DOI 10.1021/bi001725i; Bos C, 1997, FEMS MICROBIOL LETT, V153, P311; Braun M, 1999, MOL MICROBIOL, V33, P1037, DOI 10.1046/j.1365-2958.1999.01546.x; Braun V, 2002, FEBS LETT, V529, P78, DOI 10.1016/S0014-5793(02)03185-X; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Cadieux N, 1999, P NATL ACAD SCI USA, V96, P10673, DOI 10.1073/pnas.96.19.10673; CHERVITZ SA, 1995, J BIOL CHEM, V270, P24043, DOI 10.1074/jbc.270.41.24043; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; COULTON JW, 1983, J BACTERIOL, V156, P1315, DOI 10.1128/JB.156.3.1315-1321.1983; Endriss F, 2003, J BACTERIOL, V185, P4683, DOI 10.1128/JB.185.16.4683-4692.2003; FADRUS H, 1975, ANALYST, V100, P549, DOI 10.1039/an9750000549; Faraldo-Gomez JD, 2003, BIOPHYS J, V85, P1406, DOI 10.1016/S0006-3495(03)74573-1; Ferguson AD, 2004, CELL, V116, P15, DOI 10.1016/S0092-8674(03)01030-4; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Fu DX, 2001, J BIOL CHEM, V276, P8753, DOI 10.1074/jbc.M008417200; HANTKE K, 1981, MOL GEN GENET, V182, P288, DOI 10.1007/BF00269672; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; Hughson AG, 1996, P NATL ACAD SCI USA, V93, P11546, DOI 10.1073/pnas.93.21.11546; Klebba PE, 2003, FRONT BIOSCI, V8, pS1422, DOI 10.2741/1233; Larsen RA, 2003, MOL MICROBIOL, V49, P211, DOI 10.1046/j.1365-2958.2003.03579.x; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Loo TW, 2004, J BIOL CHEM, V279, P18232, DOI 10.1074/jbc.M400229200; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; MOECK GS, 1995, J BACTERIOL, V177, P6118, DOI 10.1128/jb.177.21.6118-6125.1995; Moeck GS, 1996, MOL MICROBIOL, V22, P459, DOI 10.1046/j.1365-2958.1996.00112.x; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Scott DC, 2001, J BIOL CHEM, V276, P13025, DOI 10.1074/jbc.M011282200; Usher KC, 2001, P NATL ACAD SCI USA, V98, P10676, DOI 10.1073/pnas.181353398; Van Gelder P, 2002, J BACTERIOL, V184, P2994, DOI 10.1128/JB.184.11.2994-2999.2002; Ye LW, 2001, J BACTERIOL, V183, P2490, DOI 10.1128/JB.183.8.2490-2496.2001	31	45	45	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30574	30580		10.1074/jbc.M506708200	http://dx.doi.org/10.1074/jbc.M506708200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15994322	Green Accepted, hybrid			2022-12-27	WOS:000231362500073
J	Galkin, A; Brandt, U				Galkin, A; Brandt, U			Superoxide radical formation by pure complex I (NADH : Ubiquinone oxidoreductase) from Yarrowia lipolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART SUBMITOCHONDRIAL PARTICLES; IRON-SULFUR CENTERS; ADENINE-DINUCLEOTIDE; HYDROGEN-PEROXIDE; CYTOCHROME-C; CONFORMATIONAL-CHANGE; OXIDATION-REDUCTION; RESPIRATORY-CHAIN; ELECTRON-TRANSFER; REDUCED FLAVINS	Generation of reactive oxygen species (ROS) is increasingly recognized as an important cellular process involved in numerous physiological and pathophysiological processes. Complex I ( NADH: ubiquinone oxidoreductase) is considered as one of the major sources of ROS within mitochondria. Yet, the exact site and mechanism of superoxide production by this large membrane-bound multiprotein complex has remained controversial. Here we show that isolated complex 1 from Yarrowia lipolytica forms superoxide at a rate of 0.15% of the rate measured for catalytic turnover. Superoxide production is not inhibited by ubiquinone analogous inhibitors. Because mutant complex I lacking a detectable iron-sulfur cluster N2 exhibited the same rate of ROS production, this terminal redox center could be excluded as a source of electrons. From the effect of different ubiquinone derivatives and pH on this side reaction of complex I we concluded that oxygen accepts electrons from FMNH2 or FMN semiquinone either directly or via more hydrophilic ubiquinone derivatives.	Goethe Univ Frankfurt, Zentrum Biol Chem, Fac Med, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Brandt, U (corresponding author), Goethe Univ Frankfurt, Zentrum Biol Chem, Fac Med, Theodor Stern Kai 7,Haus 26, D-60590 Frankfurt, Germany.	brandt@zbc.kgu.de	Brandt, Ulrich/GLV-1242-2022; Brandt, Ulrich/C-4406-2008	Brandt, Ulrich/0000-0003-1869-6811; Brandt, Ulrich/0000-0003-1869-6811				Ahlers PM, 2000, J BIOL CHEM, V275, P23577, DOI 10.1074/jbc.M002074200; BALLOU D, 1969, BIOCHEM BIOPH RES CO, V36, P898, DOI 10.1016/0006-291X(69)90288-5; BEHAR D, 1970, J PHYS CHEM-US, V74, P3209, DOI 10.1021/j100711a009; Bottcher B, 2002, J BIOL CHEM, V277, P17970, DOI 10.1074/jbc.M112357200; BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8; BOVERIS A, 1984, METHOD ENZYMOL, V105, P429; Brandt U, 2003, FEBS LETT, V545, P9, DOI 10.1016/S0014-5793(03)00387-9; BUNIK V, 1995, FEBS LETT, V371, P167, DOI 10.1016/0014-5793(95)00904-N; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Drose S, 2002, BBA-BIOENERGETICS, V1556, P65, DOI 10.1016/S0005-2728(02)00307-9; Eschemann A, 2005, J BIOL CHEM, V280, P3138, DOI 10.1074/jbc.M411217200; Faig M, 2000, P NATL ACAD SCI USA, V97, P3177, DOI 10.1073/pnas.050585797; FORMAN HJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P396, DOI 10.1016/0003-9861(73)90636-X; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Genova ML, 2001, FEBS LETT, V505, P364, DOI 10.1016/S0014-5793(01)02850-2; Grgic L, 2004, J BIOL CHEM, V279, P21193, DOI 10.1074/jbc.M313180200; Hasegawa T, 2004, BBA-GEN SUBJECTS, V1670, P19, DOI 10.1016/j.bbagen.2003.10.008; Hatefi Y, 1967, METHOD ENZYMOL, V10, P235; Herrero A, 2000, J BIOENERG BIOMEMBR, V32, P609, DOI 10.1023/A:1005626712319; HINKLE PC, 1967, J BIOL CHEM, V242, P5169; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; INGLEDEW WJ, 1980, BIOCHEM J, V186, P111, DOI 10.1042/bj1860111; KAKINUMA K, 1978, BIOCHIM BIOPHYS ACTA, V538, P50, DOI 10.1016/0304-4165(78)90251-9; Kashani-Poor N, 2001, BBA-BIOENERGETICS, V1504, P363, DOI 10.1016/S0005-2728(00)00266-8; Kerscher SJ, 1999, J CELL SCI, V112, P2347; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; KRISHNAMOORTHY G, 1988, J BIOL CHEM, V263, P17566; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Kwong LK, 1998, ARCH BIOCHEM BIOPHYS, V350, P118, DOI 10.1006/abbi.1997.0489; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; LOWE HJ, 1956, J BIOL CHEM, V221, P983; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979; MAJANDER A, 1994, J BIOL CHEM, V269, P21037; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; MASSEY V, 1969, BIOCHEM BIOPH RES CO, V36, P891, DOI 10.1016/0006-291X(69)90287-3; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; McLennan HR, 2000, J BIOENERG BIOMEMBR, V32, P153, DOI 10.1023/A:1005507913372; MISRA HP, 1972, J BIOL CHEM, V247, P188; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Ohnishi ST, 2005, J BIOENERG BIOMEMBR, V37, P1, DOI 10.1007/s10863-005-4117-y; Ohnishi T, 2005, FEBS LETT, V579, P500, DOI 10.1016/j.febslet.2004.11.107; Okun JG, 1999, J BIOL CHEM, V274, P2625, DOI 10.1074/jbc.274.5.2625; RAGAN CI, 1977, BIOCHEM J, V163, P605, DOI 10.1042/bj1630605; RAGAN CI, 1975, J BIOL CHEM, V250, P8472; Raha S, 2000, FREE RADICAL BIO MED, V29, P170, DOI 10.1016/S0891-5849(00)00338-5; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Sun H, 2003, ARCH BIOCHEM BIOPHYS, V419, P198, DOI 10.1016/j.abb.2003.08.028; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129; Trimmer BA, 2001, SCIENCE, V292, P2486, DOI 10.1126/science.1059833; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; VALLIN I, 1964, BIOCHIM BIOPHYS ACTA, V92, P446, DOI 10.1016/0926-6569(64)90004-5; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Yamaguchi M, 1998, J BIOL CHEM, V273, P8094, DOI 10.1074/jbc.273.14.8094	57	131	134	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30129	30135		10.1074/jbc.M504709200	http://dx.doi.org/10.1074/jbc.M504709200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15985426	hybrid			2022-12-27	WOS:000231362500019
J	Guo, JJ; Chu, M; Abbeyquaye, T; Chen, CY				Guo, JJ; Chu, M; Abbeyquaye, T; Chen, CY			Persistent nicotine treatment potentiates amplification of the dihydrofolate reductase gene in rat lung epithelial cells as a consequence of Ras activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOMIC INSTABILITY; P53 FUNCTION; RECEPTOR EXPRESSION; CYCLE CONTROL; PROTEIN; CANCER; APOPTOSIS; GROWTH; PATHWAY; INDUCE	Although nicotine has been suggested to promote lung carcinogenesis, the mechanism of its action in this process remains unknown. The present investigation demonstrates that the treatment of rat lung epithelial cells with nicotine for various periods differentially mobilizes multiple intracellular pathways. Protein kinase C and phosphoinositide 3-OH-kinase are transiently activated after the treatment. Also, Ras and its downstream effector ERK1/2 are activated after long term exposure to nicotine. The activation of Ras by nicotine treatment is responsible for the subsequent perturbation of the methotrexate ( MTX)-mediated G(1) cell cycle restriction as well as an increase in production of reactive oxygen species. When p53 expression is suppressed by introducing E6, persistent exposure to nicotine enables dihydrofolate reductase gene amplification in the presence of methotrexate ( MTX) and the formation of the MTX-resistant colonies. Altering the activity of phosphoinositide 3-OH-kinase has no effect on dihydrofolate reductase amplification. However, the suppression of protein kinase C dramatically affects the colony formation in soft agar. Thus, our data suggest that persistent exposure to nicotine perturbs the G1 checkpoint and causes DNA damage through the increase of the production of reactive oxygen species. However, a third element rendered by loss of p53 is required for the initiation of the process of gene amplification. Under p53-deficient conditions, the establishment of a full oncogenic transformation, in response to long term nicotine exposure, is achieved through the cooperation of multiple signaling pathways.	Boston Univ, Sch Med, Dept Pathol, Canc Res Ctr, Boston, MA 02118 USA	Boston University	Chen, CY (corresponding author), Boston Univ, Sch Med, Dept Pathol, Canc Res Ctr, K522,80 E Concord St, Boston, MA 02118 USA.	yanyan@bu.edu			NATIONAL CANCER INSTITUTE [R01CA100498] Funding Source: NIH RePORTER; NCI NIH HHS [1R01CA100498] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Azzoli CG, 1998, MOL CARCINOGEN, V21, P50, DOI 10.1002/(SICI)1098-2744(199801)21:1<50::AID-MC7>3.0.CO;2-T; BOS JL, 1989, CANCER RES, V49, P4682; Brognard J, 2001, CANCER RES, V61, P3986; BROWN PC, 1983, MOL CELL BIOL, V3, P1097, DOI 10.1128/MCB.3.6.1097; Chen CY, 1998, CELL DEATH DIFFER, V5, P984, DOI 10.1038/sj.cdd.4400448; Chu M, 2005, J BIOL CHEM, V280, P6369, DOI 10.1074/jbc.M408947200; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; Downward J, 1997, CURR BIOL, V7, pR258, DOI 10.1016/S0960-9822(06)00116-3; Fukasawa K, 1997, MOL CELL BIOL, V17, P506, DOI 10.1128/MCB.17.1.506; GARBONE DP, 1992, ADV INTERNAL MED, V37, P153; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Heusch WL, 1998, CARCINOGENESIS, V19, P551, DOI 10.1093/carcin/19.4.551; Hsu SL, 1998, BIOCHEM J, V333, P57, DOI 10.1042/bj3330057; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Joneson T, 1997, J MOL MED-JMM, V75, P587, DOI 10.1007/s001090050143; KAHN S, 1987, ANTICANCER RES, V7, P639; Kampfer S, 2001, J BIOL CHEM, V276, P42834, DOI 10.1074/jbc.M102047200; Kawakami Y, 2003, P NATL ACAD SCI USA, V100, P9470, DOI 10.1073/pnas.1633695100; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Liou JS, 2000, J BIOL CHEM, V275, P39001, DOI 10.1074/jbc.M007154200; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; Ma PH, 2002, MOL CELL BIOL, V22, P2928, DOI 10.1128/MCB.22.9.2928-2938.2002; Macklin KD, 1998, J PHARMACOL EXP THER, V287, P435; Mai HQ, 2003, J BIOL CHEM, V278, P1886, DOI 10.1074/jbc.M209044200; MANECKJEE R, 1990, P NATL ACAD SCI USA, V87, P3294, DOI 10.1073/pnas.87.9.3294; MANECKJEE R, 1994, CELL GROWTH DIFFER, V5, P1033; Maus ADJ, 1998, MOL PHARMACOL, V54, P779, DOI 10.1124/mol.54.5.779; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; Minna JD, 2003, J CLIN INVEST, V111, P31, DOI 10.1172/JCI200317492; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Paulson TG, 1998, MOL CELL BIOL, V18, P3089, DOI 10.1128/MCB.18.5.3089; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Prives C, 1993, CURR OPIN CELL BIOL, V5, P214, DOI 10.1016/0955-0674(93)90105-Y; RAKESH KJ, 1988, NEW ENGL J MED, V319, P1318; RILEY DJ, 1994, ANNU REV CELL BIOL, V10, P1, DOI 10.1146/annurev.cb.10.110194.000245; Rusanescu G, 2001, MOL CELL BIOL, V21, P2650, DOI 10.1128/MCB.21.8.2650-2658.2001; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SMITH KA, 1995, PHILOS T ROY SOC B, V347, P49, DOI 10.1098/rstb.1995.0008; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vaziri C, 1996, J BIOL CHEM, V271, P13642, DOI 10.1074/jbc.271.23.13642; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; Wani MA, 1997, SOMAT CELL MOLEC GEN, V23, P123, DOI 10.1007/BF02679971; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; WRIGHT SC, 1993, FASEB J, V7, P1045, DOI 10.1096/fasebj.7.11.8370474; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7	51	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30422	30431		10.1074/jbc.M504688200	http://dx.doi.org/10.1074/jbc.M504688200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15983034	hybrid			2022-12-27	WOS:000231362500055
J	Long, JY; Zuo, DM; Park, M				Long, JY; Zuo, DM; Park, M			Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates transcriptional repression of E-cadherin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TERMINAL BINDING-PROTEIN; SUMO-1 MODIFICATION; GENE-EXPRESSION; TGF-BETA; TUMOR PROGRESSION; COREPRESSOR CTBP; BREAST-CANCER; ZEB PROTEINS; FACTOR SNAIL	Epithelial- mesenchymal transition ( EMT) is important in embryonic development and tumorigenesis. Smad- interacting protein 1 ( SIP1) can induce EMT by repressing the transcription of E- cadherin through recruitment of the corepressor C- terminal- binding protein ( CtBP). How the activity of SIP1 is regulated still remains unclear. Here we show in vivo and in vitro that SIP1 is covalently modified by sumoylation at two conserved sites, Lys(391) and Lys(866). The polycomb protein Pc2, but not the PIAS ( protein inhibitor of activated STAT) family proteins, acts as a Small ubiquitin- like modifier E3 ligase for SIP1. Sumoylation of SIP1 does not affect its subcellular localization, but regulates its transcriptional activity. Compared with the wild- type, a SIP1 sumoylation null mutant shows more potent repression on E- cadherin transcription but similar repression on two transforming growth factor-beta- responsive reporter genes and comparable activation on vitamin D3 receptor transcription. Coexpression of SIP1 with Pc2 can partially relieve E- cadherin repression by SIP1. We further show that SIP1 sumoylation disrupts the recruitment of CtBP. Thus SIP1 sumoylation regulates its transcriptional activity in a promoter context- dependent manner and may represent an important intervention target to modulate EMT in tumorigenesis.	McGill Univ, Ctr Hlth, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3A 1A1, Canada	McGill University; McGill University; McGill University; McGill University	Park, M (corresponding author), McGill Univ, Ctr Hlth, Mol Oncol Grp, 687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	morag.park@mcgill.ca	Long, Jianyin/H-8261-2013					Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cavallaro U, 2002, CANCER LETT, V176, P123, DOI 10.1016/S0304-3835(01)00759-5; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Costantino ME, 2002, BIOCHEM BIOPH RES CO, V296, P368, DOI 10.1016/S0006-291X(02)00880-X; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dillner NB, 2002, MOL CELL ENDOCRINOL, V192, P85, DOI 10.1016/S0303-7207(02)00088-6; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; Furusawa T, 1999, MOL CELL BIOL, V19, P8581; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Hajra KM, 2002, CANCER RES, V62, P1613; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kagey MH, 2005, EMBO J, V24, P108, DOI 10.1038/sj.emboj.7600506; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kim YH, 1999, P NATL ACAD SCI USA, V96, P12350, DOI 10.1073/pnas.96.22.12350; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Lazarova DL, 2001, CELL GROWTH DIFFER, V12, P319; Lee PSW, 2003, J BIOL CHEM, V278, P27853, DOI 10.1074/jbc.M301755200; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Long JY, 2004, BIOCHEM J, V379, P23, DOI 10.1042/BJ20031867; Long JY, 2004, P NATL ACAD SCI USA, V101, P99, DOI 10.1073/pnas.0307598100; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Mowat DR, 2003, J MED GENET, V40, P305, DOI 10.1136/jmg.40.5.305; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Postigo AA, 2003, EMBO J, V22, P2443, DOI 10.1093/emboj/cdg225; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Postigo AA, 2000, P NATL ACAD SCI USA, V97, P6391, DOI 10.1073/pnas.97.12.6391; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Sewalt RGAB, 1999, MOL CELL BIOL, V19, P777; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsai CN, 2002, P NATL ACAD SCI USA, V99, P10084, DOI 10.1073/pnas.152059399; van Grunsven LA, 2003, J BIOL CHEM, V278, P26135, DOI 10.1074/jbc.M300597200; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Weger S, 2003, EXP CELL RES, V290, P13, DOI 10.1016/S0014-4827(03)00292-1; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	70	118	129	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2005	280	42					35477	35489		10.1074/jbc.M504477200	http://dx.doi.org/10.1074/jbc.M504477200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973ZN	16061479	hybrid, Green Published			2022-12-27	WOS:000232561200048
J	Nair, D; Kim, Y; Myers, LC				Nair, D; Kim, Y; Myers, LC			Mediator and TFIIH govern carboxyl-terminal domain-dependent transcription in yeast extracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; REPEAT DOMAIN; FUNCTIONAL INTERACTION; GENERAL TRANSCRIPTION; PREINITIATION COMPLEX; DNA-REPAIR; REQUIREMENT; HOLOENZYME	In Saccharomyces cerevisiae, the RNA polymerase II (RNA Pol II) carboxyl-terminal domain (CTD) is required for viability, and truncation of the CTD results in promoter dependent transcriptional defects. ACTD-lessRNAPol II is unable to support transcription in yeast extracts, but basal transcription reactions reconstituted from highly purified general transcription factors are CTD-independent. To reconcile these two findings, we have taken a biochemical approach using yeast extracts and asked whether there is a factor in the cell that confers CTD-dependence upon transcription. By placing a cleavage site for the tobacco etch virus protease prior to the CTD, we have created a highly specific method for removing the CTD from RNA Pol II in yeast whole cell extracts. Using derivatives of this strain, we have analyzed the role of the Srb8-11 complex, Mediator, and TFIIH, in CTD-dependent basal transcription by either mutation or immunodepletion of their function. We have found that Mediator is a direct intermediary of CTD-dependent basal transcription in extracts and that the requirement for Mediator and the CTD in basal transcription originates from their ability to compensate for a limiting amount of TFIIH activity in extracts.	Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Myers, LC (corresponding author), Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA.	larry.myers@dartmouth.edu			NIGMS NIH HHS [GM62483, R01 GM062483] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062483] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; ALLISON LA, 1989, P NATL ACAD SCI USA, V86, P2794, DOI 10.1073/pnas.86.8.2794; Bjorklund S, 2004, ADV PROTEIN CHEM, V67, P43; Borggrefe T, 2002, J BIOL CHEM, V277, P44202, DOI 10.1074/jbc.M207195200; Brachmann CB, 1998, YEAST, V14, P115; BUERMEYER AB, 1992, MOL CELL BIOL, V12, P2250, DOI 10.1128/MCB.12.5.2250; BUERMEYER AB, 1995, J BIOL CHEM, V270, P6798, DOI 10.1074/jbc.270.12.6798; Bushnell DA, 1996, J BIOL CHEM, V271, P20170, DOI 10.1074/jbc.271.33.20170; Cang Y, 1999, EMBO J, V18, P6662, DOI 10.1093/emboj/18.23.6662; Carlson M, 1997, ANNU REV CELL DEV BI, V13, P1, DOI 10.1146/annurev.cellbio.13.1.1; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DAHMUS ME, 1995, BBA-GENE STRUCT EXPR, V1261, P171, DOI 10.1016/0167-4781(94)00233-S; Gadbois EL, 1997, P NATL ACAD SCI USA, V94, P3145, DOI 10.1073/pnas.94.7.3145; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gilfillan S, 2005, J BIOL CHEM, V280, P6222, DOI 10.1074/jbc.M406343200; Goppelt A, 1996, NUCLEIC ACIDS RES, V24, P4450, DOI 10.1093/nar/24.22.4450; Guidi BW, 2004, J BIOL CHEM, V279, P29114, DOI 10.1074/jbc.M404426200; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; HENGARTNER CJ, 1995, GENE DEV, V9, P897, DOI 10.1101/gad.9.8.897; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; KANG ME, 1993, J BIOL CHEM, V268, P25033; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; Kong SE, 2002, DNA REPAIR, V1, P731, DOI 10.1016/S1568-7864(02)00080-0; KUCHIN S, 1995, P NATL ACAD SCI USA, V92, P4006, DOI 10.1073/pnas.92.9.4006; Lee YC, 1998, MOL CELL BIOL, V18, P5364, DOI 10.1128/MCB.18.9.5364; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; LI Y, 1994, P NATL ACAD SCI USA, V91, P2362, DOI 10.1073/pnas.91.6.2362; LIAO SM, 1991, GENE DEV, V5, P2431, DOI 10.1101/gad.5.12b.2431; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Myers LC, 1997, METHODS, V12, P212, DOI 10.1006/meth.1997.0473; Myers LC, 2002, MOL CELL, V10, P883, DOI 10.1016/S1097-2765(02)00644-5; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; NONET ML, 1989, GENETICS, V123, P715; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; PETERSON CL, 1991, CELL, V64, P1135, DOI 10.1016/0092-8674(91)90268-4; Prelich G, 2002, EUKARYOT CELL, V1, P153, DOI 10.1128/EC.1.2.153-162.2002; Rani PG, 2004, MOL CELL BIOL, V24, P1709, DOI 10.1128/MCB.24.4.1709-1720.2004; Ranish JA, 2004, NAT GENET, V36, P707, DOI 10.1038/ng1385; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Reeves WM, 2003, MOL CELL BIOL, V23, P349, DOI 10.1128/MCB.23.1.349-358.2003; Sakurai H, 2000, J BIOL CHEM, V275, P37251, DOI 10.1074/jbc.M004364200; Samuelsen CO, 2003, P NATL ACAD SCI USA, V100, P6422, DOI 10.1073/pnas.1030497100; SCAFE C, 1990, NATURE, V347, P491, DOI 10.1038/347491a0; SERIZAWA H, 1993, NATURE, V363, P371, DOI 10.1038/363371a0; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; SVEJSTRUP JQ, 1995, CELL, V80, P21, DOI 10.1016/0092-8674(95)90447-6; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T	52	12	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					33739	33748		10.1074/jbc.M506067200	http://dx.doi.org/10.1074/jbc.M506067200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16076843	hybrid			2022-12-27	WOS:000232229700009
J	Vreys, V; Delande, N; Zhang, Z; Coomans, C; Roebroek, A; Durr, J; David, G				Vreys, V; Delande, N; Zhang, Z; Coomans, C; Roebroek, A; Durr, J; David, G			Cellular uptake of mammalian heparanase precursor involves low density lipoprotein receptor-related proteins, mannose 6-phosphate receptors, and heparan sulfate Proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; CLONING; ACTIVATION; SECRETION; ENZYME	Mammalian heparanase, strongly implicated in the regulation of cell growth, migration, and differentiation, plays a crucial role in inflammation, angiogenesis, and metastasis. There is thus a clear need for understanding how heparanase activity is regulated. Cells can generate an active form of the enzyme from a larger inactive precursor protein by a process of secretion-recapture, internalization, and proteolytic processing in late endosomes/lysosomes. Cell surface heparan sulfate proteoglycans are the sole known components with a role in this trafficking of the heparanase precursor. Here, we provide evidence that heparan sulfate proteoglycans are not strictly required for this process. More importantly, by heparanase transfection, binding, and uptake experiments and by using a combination of specific inhibitors and receptor-defective cells, we have identified low density lipoprotein receptor-related proteins and mannose 6-phosphate receptors as key elements of the receptor system that mediates the capture of secreted heparanase precursor and its trafficking to the intracellular site of processing/activation.	Univ Leuven, Ctr Human Genet, Dept Human Genet, Lab Glycobiol & Dev Genet, B-3000 Leuven, Belgium; Univ Leuven, Dept Human Genet, Lab Mouse Genet, B-3000 Leuven, Belgium; Flanders Interuniv Inst Biotechnol, B-3000 Leuven, Belgium	KU Leuven; KU Leuven	David, G (corresponding author), Univ Leuven, Ctr Human Genet, Dept Human Genet, Lab Glycobiol & Dev Genet, Campus Gasthuisberg Onderwijs & Navorsing,Herestr, B-3000 Leuven, Belgium.	guido.david@med.kuleuven.ac.be						Bame KJ, 2001, GLYCOBIOLOGY, V11, p91R, DOI 10.1093/glycob/11.6.91R; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Fairbanks MB, 1999, J BIOL CHEM, V274, P29587, DOI 10.1074/jbc.274.42.29587; FITZGERALD DJ, 1995, J CELL BIOL, V129, P1533, DOI 10.1083/jcb.129.6.1533; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Goldshmidt O, 2002, P NATL ACAD SCI USA, V99, P10031, DOI 10.1073/pnas.152070599; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; JI ZS, 1994, ARTERIOSCLER THROMB, V14, P2025, DOI 10.1161/01.ATV.14.12.2025; Kussie PH, 1999, BIOCHEM BIOPH RES CO, V261, P183, DOI 10.1006/bbrc.1999.0962; Levy-Adam F, 2003, BIOCHEM BIOPH RES CO, V308, P885, DOI 10.1016/S0006-291X(03)01478-5; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; LORIES V, 1989, J BIOL CHEM, V264, P7009; McKenzie E, 2003, BIOCHEM J, V373, P423, DOI 10.1042/BJ20030318; Nadav L, 2002, J CELL SCI, V115, P2179; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Parish CR, 2001, BIOCHIM BIOPHYS ACTA, V1471, P99, DOI DOI 10.1016/S0304-419X(01)00017-8; POHLMANN R, 1995, J BIOL CHEM, V270, P27311, DOI 10.1074/jbc.270.45.27311; Simizu S, 2004, J BIOL CHEM, V279, P2697, DOI 10.1074/jbc.M300541200; Strickland DK, 2003, J THROMB HAEMOST, V1, P1663, DOI 10.1046/j.1538-7836.2003.00330.x; Toyoshima M, 1999, J BIOL CHEM, V274, P24153, DOI 10.1074/jbc.274.34.24153; VASSILIOU G, 1994, J BIOL CHEM, V269, P15172; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; WILLNOW TE, 1994, J CELL SCI, V107, P719; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068	29	71	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33141	33148		10.1074/jbc.M503007200	http://dx.doi.org/10.1074/jbc.M503007200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16046412	hybrid			2022-12-27	WOS:000232058100008
J	Zhao, WM; Fang, GW				Zhao, WM; Fang, GW			Anillin is a substrate of anaphase-promoting complex/cyclosome (APC/C) that controls spatial contractility of myosin during late cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY LIGHT-CHAIN; SHORT-INTERFERING RNAS; KINESIN-LIKE PROTEIN; MAMMALIAN-CELLS; CULTURED-CELLS; MITOTIC SPINDLE; CLEAVAGE FURROW; HAIRPIN RNAS; MITOSIS; COMPLEX	Anillin, an actin-binding protein localized at the cleavage furrow, is required for cytokinesis. Through an in vitro expression screen, we identified anillin as a substrate of the anaphase-promoting complex/ cyclosome (APC/C), a ubiquitin ligase that controls mitotic progression. We found that the levels of anillin fluctuate in the cell cycle, peaking in mitosis and dropping drastically during mitotic exit. Ubiquitination of anillin required a destruction-box and was mediated by Cdh1, an activator of APC/C. Overexpression of Cdh1 reduced the levels of anillin, whereas inactivation of APC/CCdh1 increased the half-life of anillin. Functionally, anillin was required for the completion of cytokinesis. In anillin knockdown cells, the cleavage furrow ingressed but failed to complete the ingression. At late cytokinesis, the cytosol and DNA in knockdown cells underwent rapid myosin-based oscillatory movement across the furrow. During this movement, RhoA and active myosin were absent from the cleavage furrow, and myosin was redistributed to cortical patches, which powers the random oscillatory movement. We concluded that anillin functions to maintain the localization of active myosin, thereby ensuring the spatial control of concerted contraction during cytokinesis.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Fang, GW (corresponding author), Stanford Univ, Dept Biol Sci, 337 Campus Dr,MC-5020,Lokey Chem Biol Bldg,Rm 137, Stanford, CA 94305 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062852] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM062852] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Echard A, 2003, CURR BIOL, V13, P373, DOI 10.1016/S0960-9822(03)00127-1; Eda M, 2001, J CELL SCI, V114, P3273; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hayashi K, 1999, J CELL SCI, V112, P1149; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; Komatsu S, 2000, J BIOL CHEM, V275, P34512, DOI 10.1074/jbc.M003019200; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Liu XQ, 2004, J CELL SCI, V117, P3233, DOI 10.1242/jcs.01173; Lustig KD, 1997, METHOD ENZYMOL, V283, P83; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Oegema K, 2000, J CELL BIOL, V150, P539, DOI 10.1083/jcb.150.3.539; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Somma MP, 2002, MOL BIOL CELL, V13, P2448, DOI 10.1091/mbc.01-12-0589; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Tasto JJ, 2003, J CELL BIOL, V160, P1093, DOI 10.1083/jcb.200211126; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; YAMAKITA Y, 1994, J CELL BIOL, V124, P129, DOI 10.1083/jcb.124.1.129; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	39	103	106	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33516	33524		10.1074/jbc.M504657200	http://dx.doi.org/10.1074/jbc.M504657200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16040610	hybrid			2022-12-27	WOS:000232058100051
J	Kaiser, RA; Liang, QR; Bueno, O; Huang, Y; Lackey, T; Klevitsky, R; Hewett, TE; Molkentin, JD				Kaiser, RA; Liang, QR; Bueno, O; Huang, Y; Lackey, T; Klevitsky, R; Hewett, TE; Molkentin, JD			Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; N-TERMINAL KINASE; CARDIAC MYOCYTE APOPTOSIS; SIGNAL-TRANSDUCTION; MAP KINASES; SUPPRESSES APOPTOSIS; DEPENDENT ACTIVATION; OXIDATIVE STRESS; CROSS-TALK; PATHWAY	The c- Jun NH2- terminal kinase ( JNK) branch of the mitogen- activated protein kinase signaling cascade has been implicated in the regulation of apoptosis in a variety of mammalian cell types. In the heart, disagreement persists concerning the role that JNKs may play in regulating apoptosis, since both pro- and antiapoptotic regulatory functions have been reported in cultured cardiomyocytes. Here we report the first analysis of cardiomyocyte cell death due to JNK inhibition or activation in vivo using genetically modified mice. Three separate mouse models with selective JNK inhibition were assessed for ventricular damage and apoptosis levels following ischemia- reperfusion injury. jnk1 -/-, jnk2 -/-, and transgenic mice expressing dominant negative JNK1/2 within the heart were each shown to have less JNK activity in the heart and less injury and cellular apoptosis in vivo following ischemia- reperfusion injury. To potentially address the reciprocal gain- of- function phenotype associated with sustained JNK activation, transgenic mice were generated that express MKK7 in the heart. These transgenic mice displayed elevated cardiac c- Jun kinase activity but, ironically, were also significantly protected from ischemia- reperfusion. Mechanistically, JNK- inhibited mice showed increased phosphorylation of the proapoptotic factor Bad at position 112, whereas MKK7 transgenic mice showed decreased phosphorylation of this site. Collectively, these results underscore the complexity associated with JNK signaling in regulating apoptosis, such that sustained inhibition or activation both elicit cellular protection in vivo, although probably through different mechanisms.	Univ Cincinnati, Div Mol Cardiovasc Biol, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; Univ S Dakota, Sch Med, Cardiovasc Res Inst, Sioux Falls, SD 57105 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of South Dakota	Molkentin, JD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Mol Cardiovasc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	jeff.molkentin@cchmc.org	Hewett, Timothy/G-1023-2011; Hewett, Timothy Edwin/GLT-1556-2022; Hewett, Timothy E/E-3241-2011	Molkentin, Jeffery/0000-0002-3558-6529	NHLBI NIH HHS [HL073550] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL073550] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andreka P, 2001, CIRC RES, V88, P305, DOI 10.1161/01.RES.88.3.305; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Dougherty CJ, 2002, BIOCHEM J, V362, P561, DOI 10.1042/0264-6021:3620561; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Gabai VL, 2000, J BIOL CHEM, V275, P38088, DOI 10.1074/jbc.M006632200; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gulick J, 1997, CIRC RES, V80, P655, DOI 10.1161/01.RES.80.5.655; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Hreniuk D, 2001, MOL PHARMACOL, V59, P867, DOI 10.1124/mol.59.4.867; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kwon SH, 2003, J MOL CELL CARDIOL, V35, P615, DOI 10.1016/S0022-2828(03)00084-1; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Liang QR, 2003, EMBO J, V22, P5079, DOI 10.1093/emboj/cdg474; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Martindale JJ, 2005, J BIOL CHEM, V280, P669, DOI 10.1074/jbc.M406690200; Minamino T, 1999, P NATL ACAD SCI USA, V96, P15127, DOI 10.1073/pnas.96.26.15127; Nishitai G, 2004, J BIOL CHEM, V279, P1621, DOI 10.1074/jbc.M310335200; Petrich BG, 2003, FASEB J, V17, P749, DOI 10.1096/fj.02-0438fje; Petrich BG, 2002, CIRC RES, V91, P640, DOI 10.1161/01.RES.0000035854.11082.01; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; Remondino A, 2003, CIRC RES, V92, P136, DOI 10.1161/01.RES.0000054624.03539.B4; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Sadoshima J, 2002, J CLIN INVEST, V110, P271, DOI 10.1172/JCI200214938; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Whitmarsh AJ, 2001, METHOD ENZYMOL, V332, P319; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911	50	101	111	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32602	32608		10.1074/jbc.M500684200	http://dx.doi.org/10.1074/jbc.M500684200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16043490	hybrid			2022-12-27	WOS:000231920300007
J	Shiflett, AM; Bishop, JR; Pahwa, A; Hajduk, SL				Shiflett, AM; Bishop, JR; Pahwa, A; Hajduk, SL			Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOME LYTIC FACTOR; HAPTOGLOBIN-RELATED PROTEIN; APOLIPOPROTEIN-L GENE; NORMAL HUMAN-SERUM; BRUCEI-BRUCEI; AFRICAN TRYPANOSOMES; TRYPANOCIDAL FACTOR; PRIMATE SERA; L-I; LYSIS	Human innate immunity to non- pathogenic species of African trypanosomes is provided by human high density lipoprotein ( HDL) particles. Here we show that native human HDLs containing hapto- globin- related protein ( Hpr), apolipoprotein L- I ( apoL- I) and apolipoprotein A- I ( apoA- I) are the principle antimicrobial molecules providing protection from trypanosome infection. Other HDL subclasses containing either apoA- I and apoL- I or apoA- I and Hpr have reduced trypanolytic activity, whereas HDL subclasses lacking apoL- I and Hpr are non- toxic to trypanosomes. Highly purified, lipid- free Hpr and apoL- I were both toxic to Trypanosoma brucei brucei but with specific activities at least 500- fold less than those of native HDLs, suggesting that association of these apolipoproteins within the HDL particle was necessary for optimal cytotoxicity. These studies show that HDLs can serve as platforms for the assembly of multiple synergistic proteins and that these assemblies may play a critical role in the evolution of primate- specific innate immunity to trypanosome infection.	Josephine Bay Paul Ctr, Global Infect Dis Program, Marine Biol Lab, Woods Hole, MA 02543 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Alabama, Sch Med, Birmingham, AL 35294 USA	Marine Biological Laboratory - Woods Hole; University of California System; University of California San Diego; University of Alabama System; University of Alabama Birmingham	Hajduk, SL (corresponding author), Josephine Bay Paul Ctr, Global Infect Dis Program, Marine Biol Lab, 7 MBL St,M-S 127, Woods Hole, MA 02543 USA.	shajduk@mbl.edu			NCI NIH HHS [P30 CA 1314] Funding Source: Medline; NIAID NIH HHS [AI054496, AI39033] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K11CA001314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039033, R03AI054496, R21AI039033] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bishop JR, 2001, MOL BIOCHEM PARASIT, V118, P33, DOI 10.1016/S0166-6851(01)00361-9; Bowman, 1993, HEPATIC PLASMA PROTE, P159; Drain J, 2001, J BIOL CHEM, V276, P30254, DOI 10.1074/jbc.M010198200; Duchateau PN, 2001, J LIPID RES, V42, P620; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; Green HP, 2003, J BIOL CHEM, V278, P422, DOI 10.1074/jbc.M207215200; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; HAJDUK SL, 1989, J BIOL CHEM, V264, P5210; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; JONA A, 1986, METHOD ENZYMOL, P553; LORENZ P, 1994, T ROY SOC TROP MED H, V88, P487, DOI 10.1016/0035-9203(94)90443-X; Lugli EB, 2004, MOL BIOCHEM PARASIT, V138, P9, DOI 10.1016/j.molbiopara.2004.07.004; MAEDA N, 1985, J BIOL CHEM, V260, P6698; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Muranjan M, 1998, J BIOL CHEM, V273, P3884, DOI 10.1074/jbc.273.7.3884; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Poelvoorde P, 2004, MOL BIOCHEM PARASIT, V134, P155, DOI 10.1016/j.molbiopara.2003.11.006; Portela MPM, 2000, MOL BIOCHEM PARASIT, V110, P273, DOI 10.1016/S0166-6851(00)00277-2; Raper J, 1996, J EXP MED, V183, P1023, DOI 10.1084/jem.183.3.1023; RAPER J, 2002, T R SOC TROP MED HYG, V96, P145; RIFKIN MR, 1978, P NATL ACAD SCI USA, V75, P3450, DOI 10.1073/pnas.75.7.3450; RIFKIN MR, 1991, EXP PARASITOL, V72, P216, DOI 10.1016/0014-4894(91)90139-N; SEED JR, 1990, J PROTOZOOL, V37, P393, DOI 10.1111/j.1550-7408.1990.tb01163.x; Shimamura M, 2001, MOL BIOCHEM PARASIT, V115, P227, DOI 10.1016/S0166-6851(01)00292-4; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Tomlinson S, 1997, MOL BIOCHEM PARASIT, V86, P117, DOI 10.1016/S0166-6851(97)90013-X; TYTLER EM, 1995, MOL BIOCHEM PARASIT, V69, P9, DOI 10.1016/0166-6851(94)00172-J; Vanhamme L, 2004, INT J PARASITOL, V34, P887, DOI 10.1016/j.ijpara.2004.04.008; Vanhamme L, 2001, TRENDS PARASITOL, V17, P338, DOI 10.1016/S1471-4922(01)01922-5; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461	31	129	133	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32578	32585		10.1074/jbc.M503510200	http://dx.doi.org/10.1074/jbc.M503510200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16046400	Green Published, hybrid			2022-12-27	WOS:000231920300004
J	Ensenauer, R; He, M; Willard, JM; Goetzman, ES; Corydon, TJ; Vandahl, BB; Mohsen, AW; Isaya, G; Vockley, J				Ensenauer, R; He, M; Willard, JM; Goetzman, ES; Corydon, TJ; Vandahl, BB; Mohsen, AW; Isaya, G; Vockley, J			Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; COENZYME-A DEHYDROGENASE; LONG-CHAIN; INTERMEDIATE PEPTIDASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURES; CHROMOSOMAL ASSIGNMENT; ISOVALERIC ACIDEMIA; MOLECULAR-CLONING; HUMAN-FIBROBLASTS	Unsaturated fatty acids play an important role in the prevention of human diseases such as diabetes, obesity, cancer, and neurodegeneration. However, their oxidation in vivo by acyl-CoA dehydrogenases (ACADs) that catalyze the first step of each cycle of mitochondrial fatty acid beta-oxidation is not entirely understood. Recently, a novel ACAD (ACAD-9) of unknown function that is highly homologous to human very-long-chain acyl-CoA dehydrogenase was identified by large-scale random sequencing. To characterize its enzymatic role, we have expressed ACAD-9 in Escherichia coli, purified it, and determined its pattern of substrate utilization. The N terminus of the mature form of the enzyme was identified by in vitro mitochondrial import studies of precursor protein. A 37-amino acid leader peptide was cleaved sequentially by two mitochondrial peptidases to yield a predicted molecular mass of 65 kDa for the mature subunit. Submitochondrial fractionation studies found native ACAD-9 to be associated with the mitochondrial membrane. Gel filtration analysis indicated that, like very-long-chain acyl-CoA dehydrogenase, ACAD-9 is a dimer, in contrast to the other known ACADs, which are tetramers. Purified mature ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates (C16:1-, C18:1-, C18:2-, C22:6-CoA). These results suggest a previously unrecognized role for ACAD-9 in the mitochondrial beta-oxidation of long-chain unsaturated fatty acids. Because of the substrate specificity and abundance of ACAD-9 in brain, we speculate that it may play a role in the turnover of lipid membrane unsaturated fatty acids that are essential for membrane integrity and structure.	Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15213 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Med Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Univ Munich, Dr Von Haunerschen Kinderspital, Childrens Res Ctr, D-80337 Munich, Germany; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15213 USA; Univ Aarhus, Dept Human Genet, DK-8000 Aarhus, Denmark; Univ Aarhus, Inst Med Microbiol & Immunol, DK-8000 Aarhus, Denmark	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Munich; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Aarhus University; Aarhus University	Vockley, J (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, 3705 5th Ave, Pittsburgh, PA 15213 USA.	gerard.vockley@chp.edu	Vockley, Jerry/B-5210-2016; Vockley, Jerry/AAF-8523-2020; Mohsen, Al-Walid/D-6577-2018	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457; Mohsen, Al-Walid/0000-0002-0096-5959; Corydon, Thomas Juhl/0000-0003-3588-6350	NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER; NIA NIH HHS [R01-AG15709] Funding Source: Medline; NIDDK NIH HHS [R01-DK4548] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andresen BS, 1996, HUM MOL GENET, V5, P461, DOI 10.1093/hmg/5.4.461; Andresen BS, 1999, AM J HUM GENET, V64, P479, DOI 10.1086/302261; AOYAMA T, 1994, J BIOL CHEM, V269, P19088; AOYAMA T, 1995, AM J HUM GENET, V57, P273; Arechaga I, 2000, FEBS LETT, V482, P215, DOI 10.1016/S0014-5793(00)02054-8; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Battaile KP, 1998, BBA-LIPID LIPID MET, V1390, P333, DOI 10.1016/S0005-2760(97)00185-9; Battaile KP, 2004, J BIOL CHEM, V279, P16526, DOI 10.1074/jbc.M400034200; Battaile KP, 2002, J BIOL CHEM, V277, P12200, DOI 10.1074/jbc.M111296200; Belury MA, 2002, ANNU REV NUTR, V22, P505, DOI 10.1146/annurev.nutr.22.021302.121842; Benatti P, 2004, J AM COLL NUTR, V23, P281, DOI 10.1080/07315724.2004.10719371; BRANDA SS, 1995, J BIOL CHEM, V270, P27366, DOI 10.1074/jbc.270.45.27366; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Cavadini P, 2002, METHODS, V26, P298, DOI 10.1016/S1046-2023(02)00035-X; Chew A, 1997, GENOMICS, V40, P493, DOI 10.1006/geno.1996.4586; Corydon Thomas Juhl, 2003, Methods Mol Biol, V232, P183; Corydon TJ, 1998, J BIOL CHEM, V273, P13065, DOI 10.1074/jbc.273.21.13065; Cox KB, 2001, HUM MOL GENET, V10, P2069, DOI 10.1093/hmg/10.19.2069; de Boer HA., 1986, MAXIMIZING GENE EXPR, P225; DeLany JP, 2000, AM J CLIN NUTR, V72, P905; DJORDJEVIC S, 1995, BIOCHEMISTRY-US, V34, P2163, DOI 10.1021/bi00007a009; Edman P, 1975, PROTEIN SEQUENCE DET, P232; FRERMAN FE, 1985, BIOCHEM MED METAB B, V33, P38, DOI 10.1016/0006-2944(85)90124-3; Fu ZJ, 2004, BIOCHEMISTRY-US, V43, P9674, DOI 10.1021/bi049290c; Fusconi E, 2003, TUMORI J, V89, P624, DOI 10.1177/030089160308900606; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Hiltunen JK, 2000, BBA-MOL CELL BIOL L, V1484, P117, DOI 10.1016/S1388-1981(00)00013-5; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P412, DOI 10.1016/0003-2697(88)90208-4; IKEDA Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P662, DOI 10.1016/0003-9861(87)90072-5; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; ISAYA G, 1995, METHOD ENZYMOL, V248, P556; IZAI K, 1992, J BIOL CHEM, V267, P1027; KELLY DP, 1989, J BIOL CHEM, V264, P18921; Kim JJP, 2004, EUR J BIOCHEM, V271, P483, DOI 10.1046/j.1432-1033.2003.03948.x; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592; Le WP, 2000, BBA-MOL CELL BIOL L, V1485, P121, DOI 10.1016/S1388-1981(00)00034-2; Lee HJ, 1996, BIOCHEMISTRY-US, V35, P12412, DOI 10.1021/bi9607867; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; Liang X, 2001, BIOCHEM SOC T, V29, P279, DOI 10.1042/BST0290279; MAO LF, 1995, ARCH BIOCHEM BIOPHYS, V321, P221, DOI 10.1006/abbi.1995.1389; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; Mohsen AA, 1998, BIOCHEMISTRY-US, V37, P10325, DOI 10.1021/bi973096r; MOHSEN AWA, 1995, GENE, V160, P263, DOI 10.1016/0378-1119(95)00256-6; Montine KS, 2004, CHEM PHYS LIPIDS, V128, P117, DOI 10.1016/j.chemphyslip.2003.10.010; ROE CR, 2001, METABOLIC MOL BASES, P2297; Roe DS, 2001, CLIN CHIM ACTA, V312, P55, DOI 10.1016/S0009-8981(01)00594-0; Souri M, 1998, FEBS LETT, V426, P187, DOI 10.1016/S0014-5793(98)00343-3; Sweetman L., 2001, METABOLIC MOL BASES, P2125; Tiffany KA, 1997, BIOCHEMISTRY-US, V36, P8455, DOI 10.1021/bi970422u; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Vockley J, 2000, METHOD ENZYMOL, V324, P241; VOCKLEY J, 1992, J BIOL CHEM, V267, P2494; Vockley J, 2002, NEUROMUSCULAR DISORD, V12, P235, DOI 10.1016/S0960-8966(01)00308-X; Wahrburg U, 2004, EUR J NUTR, V43, P6, DOI 10.1007/s00394-004-1103-9; Wanders RJA, 1998, BBA-LIPID LIPID MET, V1393, P35, DOI 10.1016/S0005-2760(98)00053-8; Zhang J, 2002, BIOCHEM BIOPH RES CO, V297, P1033, DOI 10.1016/S0006-291X(02)02336-7	59	74	77	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32309	32316		10.1074/jbc.M504460200	http://dx.doi.org/10.1074/jbc.M504460200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16020546	hybrid			2022-12-27	WOS:000231794800034
J	Giraud, E; Zappa, S; Vuillet, L; Adriano, JM; Hannibal, L; Fardoux, J; Berthomieu, C; Bouyer, P; Pignol, D; Vermeglio, A				Giraud, E; Zappa, S; Vuillet, L; Adriano, JM; Hannibal, L; Fardoux, J; Berthomieu, C; Bouyer, P; Pignol, D; Vermeglio, A			A new type of bacteriophytochrome acts in tandem with a classical bacteriophytochrome to control the antennae synthesis in Rhodopseudomonas palustris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOACTIVE YELLOW PROTEIN; CHROMATIC ADAPTATION; AGROBACTERIUM-TUMEFACIENS; HISTIDINE KINASES; LOW-LIGHT; PHYTOCHROME; PHOTORECEPTOR; CHROMOPHORE; PERCEPTION; SIMILARITY	Phytochromes are chromoproteins found in plants and bacteria that switch between two photointerconvertible forms via the photoisomerization of their chromophore. These two forms, Pr and Pfr, absorb red and far- red light, respectively. We have characterized the biophysical and biochemical properties of two bacteriophytochromes, RpBphP2 and RpBphP3, from the photosynthetic bacterium Rhodopseudomonas palustris. Their genes are contiguous and localized near the pucBAd genes encoding the polypeptides of the light harvesting complexes LH4, whose synthesis depends on the light intensity. At variance with all ( bacterio) phytochromes studied so far, the light-induced isomerization of the chromophore of RpBphP3 converts the Pr form to a form absorbing at shorter wavelength around 645 nm, designated as Pnr for near red. The quantum yield for the transformation of Pr into Pnr is about 6-fold smaller than for the reverse reaction. Both RpBphP2 and RpBphP3 auto-phosphorylate in their dark-adapted Pr forms and transfer their phosphate to a common response regulator Rpa3017. Under semi-aerobic conditions, LH4 complexes replace specifically the LH2 complexes in wild-type cells illuminated by wavelengths comprised between 680 and 730 nm. In contrast, mutants deleted in each of these two bacteriophytochromes display no variation in the composition of their light harvesting complexes whatever the light intensity. From both the peculiar properties of these bacteriophytochromes and the phenotypes of their deletion mutants, we propose that they operate in tandem to control the synthesis of LH4 complexes by measuring the relative intensities of 645 and 710 nm lights.	Univ Aix Marseille 2, CEA,CNRS, Cadarache DEVM, Lab Bioenerget Cellulaire,UMR 6191, F-13108 St Paul Les Durance, France; INRA, Lab Symbioses Trop & Mediterraneennes, IRD, CIRAD,AGROM,UM2, F-34398 Montpellier, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Vermeglio, A (corresponding author), Univ Aix Marseille 2, CEA,CNRS, Cadarache DEVM, Lab Bioenerget Cellulaire,UMR 6191, F-13108 St Paul Les Durance, France.	avermeglio@cea.fr	Giraud, Eric/GLS-1036-2022; Berthomieu, Catherine/AAX-9559-2021	PIGNOL, David/0000-0002-8070-0319; Berthomieu, Catherine/0000-0001-8784-5396				Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; BOGORAD L, 1975, ANNU REV PLANT PHYS, V26, P369, DOI 10.1146/annurev.pp.26.060175.002101; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; DEMARSAC NT, 1977, J BACTERIOL, V130, P82, DOI 10.1128/JB.130.1.82-91.1977; EVANS MB, 1990, BIOCHIM BIOPHYS ACTA, V1016, P71, DOI 10.1016/0005-2728(90)90008-R; Foerstendorf H, 1996, BIOCHEMISTRY-US, V35, P10793, DOI 10.1021/bi960960r; Foerstendorf H, 2001, BIOCHEMISTRY-US, V40, P14952, DOI 10.1021/bi0156916; Giraud E, 2004, PHOTOCH PHOTOBIO SCI, V3, P587, DOI 10.1039/b315770a; Giraud E, 2004, J BIOL CHEM, V279, P15076, DOI 10.1074/jbc.M312113200; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; Hartigan N, 2002, BIOPHYS J, V82, P963, DOI 10.1016/S0006-3495(02)75456-8; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Jiang ZY, 1999, SCIENCE, V285, P406, DOI 10.1126/science.285.5426.406; JOLIOT P, 1980, J CHIM PHYS PCB, V77, P209, DOI 10.1051/jcp/1980770209; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; KOKOTEK W, 1989, GENE, V84, P467, DOI 10.1016/0378-1119(89)90522-2; Kyndt JA, 2004, PHOTOCH PHOTOBIO SCI, V3, P519, DOI 10.1039/b315731h; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; LINSCHITZ H, 1966, J BIOL CHEM, V241, P3395; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; SINESHCHEKOV VA, 1995, BBA-BIOENERGETICS, V1228, P125, DOI 10.1016/0005-2728(94)00173-3; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; TADROS MH, 1989, EMBO J, V8, P1303, DOI 10.1002/j.1460-2075.1989.tb03509.x; Terauchi K, 2004, MOL MICROBIOL, V51, P567, DOI 10.1046/j.1365-2958.2003.03853.x; Vila X, 1996, ECOL MODEL, V87, P59, DOI 10.1016/0304-3800(94)00205-3; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Yoshihara S, 2004, PLANT CELL PHYSIOL, V45, P1729, DOI 10.1093/pcp/pch214; Yoshihara S, 2000, PLANT CELL PHYSIOL, V41, P1299, DOI 10.1093/pcp/pce010	31	116	124	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32389	32397		10.1074/jbc.M506890200	http://dx.doi.org/10.1074/jbc.M506890200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16009707	hybrid			2022-12-27	WOS:000231794800044
J	Qiu, LY; Krieger, E; Schaftenaar, G; Swarts, HGP; Willems, PHGM; De Pont, JJHHM; Koenderink, JB				Qiu, LY; Krieger, E; Schaftenaar, G; Swarts, HGP; Willems, PHGM; De Pont, JJHHM; Koenderink, JB			Reconstruction of the complete ouabain-binding pocket of Na,K-ATPase in gastric H,K-ATPase by substitution of only seven amino acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4TH TRANSMEMBRANE SEGMENT; SITE-DIRECTED MUTAGENESIS; ALPHA-SUBUNIT; CARDIAC-GLYCOSIDES; EXTRACELLULAR DOMAIN; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURES; RESISTANT ENZYME; FORCE-FIELD; RESIDUES	Although cardiac glycosides have been used as drugs for more than 2 centuries and their primary target, the sodium pump (Na, K-ATPase), has already been known for 4 decades, their exact binding site is still elusive. In our efforts to define the molecular basis of digitalis glycosides binding we started from the fact that a closely related enzyme, the gastric H, K-ATPase, does not bind glycosides like ouabain. Previously, we showed that a chimera of these two enzymes, in which only the M3-M4 and M5-M6 hairpins were of Na, K- ATPase, bound ouabain with high affinity (Koenderink, J. B., Hermsen, H. P. H., Swarts, H. G. P., Willems, P. H. G. M., and De Pont, J. J. H. H. M. ( 2000) Proc. Natl. Acad. Sci. U. S. A. 97, 11209 11214). We also demonstrated that only three amino acids (Phe(783), Thr(797), and Asp(804)) present in the M5-M6 hairpin of Na,K-ATPase were sufficient to confer high affinity ouabain binding to a chimera which contained in addition the M3-M4 hairpin of Na, K-ATPase (Qiu, L. Y., Koenderink, J. B., Swarts, H. G., Willems, P. H., and De Pont, J. J. H. H. M. ( 2003) J. Biol. Chem. 278, 47240 - 47244). To further pinpoint the ouabain-binding site here we used a chimerabased loss-of-function strategy and identified four amino acids (Glu(312), Val(314), Ile(315), Gly(319)), all present in M4, as being important for ouabain binding. In a final gain-of-function study we showed that a gastric H, K- ATPase that contained Glu312, Val314, Ile315, Gly319, Phe783, Thr797, and Asp804 of Na, K- ATPase bound ouabain with the same affinity as the native enzyme. Based on the E2P crystal structure of Ca2+ -ATPase we constructed a homology model for the ouabain-binding site of Na, K- ATPase involving all seven amino acids as well as several earlier postulated amino acids.	Radboud Univ Nijmegen, Med Ctr, Dept Biochem 160, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol Toxicol 233, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, NL-6500 GL Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	De Pont, JJHHM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Biochem 160, Nijmegen Ctr Mol Life Sci, POB 9101, NL-6500 HB Nijmegen, Netherlands.	J.DePont@ncmls.ru.nl	Schaftenaar, Gijs/Q-8665-2018; Willems, P.H.G.M./L-4759-2015; Koenderink, Jan/N-3578-2014	Willems, P.H.G.M./0000-0002-0915-1599; 				Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; ANTOLOVIC R, 1995, FEBS LETT, V368, P169, DOI 10.1016/0014-5793(95)00637-O; ASKEW GR, 1994, J BIOL CHEM, V269, P24120; BURNS EL, 1993, J BIOL CHEM, V268, P25632; Burns EL, 1996, J BIOL CHEM, V271, P15879, DOI 10.1074/jbc.271.27.15879; CANESSA CM, 1993, J BIOL CHEM, V268, P17722; CANESSA CM, 1992, EMBO J, V11, P1681, DOI 10.1002/j.1460-2075.1992.tb05218.x; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Crambert G, 2004, MOL PHARMACOL, V65, P335, DOI 10.1124/mol.65.2.335; Croyle ML, 1997, EUR J BIOCHEM, V248, P488, DOI 10.1111/j.1432-1033.1997.00488.x; FENG JN, 1994, BIOCHEMISTRY-US, V33, P4218, DOI 10.1021/bi00180a015; FORTES PAG, 1977, BIOCHEMISTRY-US, V16, P531, DOI 10.1021/bi00622a030; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Horisberger JD, 2004, J BIOL CHEM, V279, P29542, DOI 10.1074/jbc.M400585200; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; KANO I, 1990, BIOCHEM CELL BIOL, V68, P1262, DOI 10.1139/o90-187; Koenderink JB, 2000, P NATL ACAD SCI USA, V97, P11209, DOI 10.1073/pnas.200109597; Koenderink JB, 1999, J BIOL CHEM, V274, P11604, DOI 10.1074/jbc.274.17.11604; Koenderink JB, 2004, J BIOL CHEM, V279, P16417, DOI 10.1074/jbc.M400020200; Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; MCPARLAND RA, 1991, SODIUM PUMP RECENT D, P297; Mense M, 2000, J BIOL CHEM, V275, P1749, DOI 10.1074/jbc.275.3.1749; OBRIEN WJ, 1993, J BIOL CHEM, V268, P7707; Palasis M, 1996, J BIOL CHEM, V271, P14176, DOI 10.1074/jbc.271.24.14176; Paula S, 2005, BIOCHEMISTRY-US, V44, P498, DOI 10.1021/bi048680w; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Qiu LY, 2003, J BIOL CHEM, V278, P47240, DOI 10.1074/jbc.M308833200; ROSSI B, 1988, METHOD ENZYMOL, V156, P323; SATOH K, 1989, BIOCHIM BIOPHYS ACTA, V994, P104, DOI 10.1016/0167-4838(89)90149-0; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; SCHATZMANN HJ, 1953, HELV PHYSIOL PHARM A, V11, P346; SCHULTHEIS PJ, 1993, J BIOL CHEM, V268, P22686; SCHULTHEIS PJ, 1993, BIOCHEMISTRY-US, V32, P544, DOI 10.1021/bi00053a020; SHULL GE, 1986, J BIOL CHEM, V261, P6788; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Sweadner KJ, 2001, BIOCHEM J, V356, P685, DOI 10.1042/0264-6021:3560685; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; VILSEN B, 1995, FEBS LETT, V363, P179, DOI 10.1016/0014-5793(95)00313-X; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; VRIEND G, 1992, J MOL GRAPHICS, V8, P29	47	57	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32349	32355		10.1074/jbc.M505168200	http://dx.doi.org/10.1074/jbc.M505168200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16051601	hybrid, Green Published			2022-12-27	WOS:000231794800039
J	Yu, YH; Sweeney, MD; Saad, OM; Crown, SE; Handel, TM; Leary, JA				Yu, YH; Sweeney, MD; Saad, OM; Crown, SE; Handel, TM; Leary, JA			Chemokine-glycosaminoglycan binding - Specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTION IN-VIVO; HEPARAN-SULFATE; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE; SMALL-MOLECULE; RECEPTOR; OLIGOMERIZATION; GROWTH; IDENTIFICATION; MICROARRAYS	Glycosaminoglycans (GAGs) have recently been demonstrated to be required for the in vivo activity of several chemokines. Minimally, the interaction is thought to provide a mechanism for retention at the site of secretion and the formation of chemokine gradients that provide directional cues for receptor bearing cells, particularly in the presence of shear forces. Thus, a key issue will be to determine the sequence and structure of the GAGs that bind to specific chemokines. Herein, we describe amass spectrometry assay that was developed to detect protein-oligosaccharide noncovalent complexes, in this case chemokine-GAG interactions, and to select for high affinity GAGs. The process is facilitated by the ability of electrospray ionization to transfer the intact noncovalent complexes from solution into the gas phase. The elemental composition as well as the binding stoichiometry can be calculated from the mass of the complex. Ligands of the chemokine receptor, CCR2 (MCP-1/CCL2, MCP-2/CCL8, MCP-3/CCL7, MCP-4/CCL13, and Eotaxin/CCL11), and the CCR10 ligand CTACK/CCL27 were screened against a small, highly sulfated, heparin oligosaccharide library with limited structural variation. The results revealed heparin octasaccharides with 11 and 12 sulfates as binders. Oligomerization of some chemokines was observed upon GAG binding, whereas in other instances only the monomeric noncovalent complex was identified. The results indicate that, in contrast to the apparent redundancy in the chemokine system, where several chemokines bind and activate the same receptor, these chemokines could be differentiated into two groups based on the stoichiometry of their complexes with the heparin oligosaccharides.	Univ Calif Davis, Genome Ctr, Dept Chem, Davis, CA 95616 USA; Univ Calif Davis, Genome Ctr, Dept Mol Cell Biol, Davis, CA 95616 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Leary, JA (corresponding author), Univ Calif Davis, Genome Ctr, Dept Chem, Davis, CA 95616 USA.	jaleary@ucdavis.edu			NIAID NIH HHS [AI37113-09] Funding Source: Medline; NIGMS NIH HHS [GM63581] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063581] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Blaszczyk J, 2000, BIOCHEMISTRY-US, V39, P14075, DOI 10.1021/bi0009340; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BOURIN MC, 1993, BIOCHEM J, V289, P313, DOI 10.1042/bj2890313; Cao L, UNPUB; Crump MP, 1998, J BIOL CHEM, V273, P22471, DOI 10.1074/jbc.273.35.22471; Delehedde M, 2002, BIOCHEM J, V366, P235, DOI 10.1042/BJ20011718; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Feizi T, 2004, NAT REV MOL CELL BIO, V5, P582, DOI 10.1038/nrm1428; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Harmer NJ, 2004, J MOL BIOL, V339, P821, DOI 10.1016/j.jmb.2004.04.031; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Ji QC, 2003, RAPID COMMUN MASS SP, V17, P794, DOI 10.1002/rcm.981; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; KATO M, 1994, J BIOL CHEM, V269, P18881; Keiser N, 2001, NAT MED, V7, P123, DOI 10.1038/83263; Kim KS, 1996, FEBS LETT, V395, P277, DOI 10.1016/0014-5793(96)01024-1; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Lu DS, 1999, J MOL BIOL, V292, P361, DOI 10.1006/jmbi.1999.3089; PAOLINI JF, 1994, J IMMUNOL, V153, P2704; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Power CA, 2003, J IMMUNOL METHODS, V273, P73, DOI 10.1016/S0022-1759(02)00419-2; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2003, SEMIN IMMUNOL, V15, P57, DOI 10.1016/S1044-5323(02)00128-8; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; ROT A, 1993, EUR J IMMUNOL, V23, P303, DOI 10.1002/eji.1830230150; Saad OM, 2004, J AM SOC MASS SPECTR, V15, P1274, DOI 10.1016/j.jasms.2004.05.008; Smith AW, 1997, SCAND AUDIOL, V26, P11; Sobott F, 2002, CURR OPIN STRUC BIOL, V12, P729, DOI 10.1016/S0959-440X(02)00400-1; Tully SE, 2004, J AM CHEM SOC, V126, P7736, DOI 10.1021/ja0484045; Wieboldt R, 1997, ANAL CHEM, V69, P1683, DOI 10.1021/ac9610265; Yu YH, 2004, J AM SOC MASS SPECTR, V15, P1400, DOI 10.1016/j.jasms.2004.06.002; ZUBAREV RA, 1995, ANAL CHEM, V67, P3793, DOI 10.1021/ac00116a028	41	79	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32200	32208		10.1074/jbc.M505738200	http://dx.doi.org/10.1074/jbc.M505738200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16033763	hybrid			2022-12-27	WOS:000231794800021
J	Dulac, C; Michels, AA; Fraldi, A; Bonnet, F; Van Nguyen, T; Napolitano, G; Lania, L; Bensaude, O				Dulac, C; Michels, AA; Fraldi, A; Bonnet, F; Van Nguyen, T; Napolitano, G; Lania, L; Bensaude, O			Transcription-dependent association of multiple positive transcription elongation factor units to a HEXIM multimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; RNA-POLYMERASE-II; P-TEFB; FACTOR-B; GENE-EXPRESSION; CLP-1 GENE; HIV-1 TAT; 7SK SNRNA; KINASE; PROTEIN	The positive transcription elongation factor ( P-TEFb) comprises a kinase, CDK9, and a Cyclin T1 or T2. Its activity is inhibited by association with the HEXIM1 or HEXIM2 protein bound to 7SK small nuclear RNA. HEXIM1 and HEXIM2 were found to form stable homo- and hetero-oligomers. Using yeast two-hybrid and transfection assays, we have now shown that the C-terminal domains of HEXIM proteins directly interact with each other. Hydrodynamic parameters measured by glycerol gradient ultracentrifugation and gel-permeation chromatography demonstrate that both purified recombinant and cellular HEXIM1 proteins form highly anisotropic particles. Chemical cross-links suggest that HEXIM1 proteins form dimers. The multimeric nature of HEXIM1 is maintained in P-TEFb(.)HEXIM1(.)7SK RNA complexes. Multiple P-TEFb modules are found in the inactive P-TEFb(.)HEXIM1(.)7SK complexes. It is proposed that 7SK RNA binding to a HEXIM1 multimer promotes the simultaneous recruitment and hence inactivation of multiple P-TEFb units.	CNRS, UMR 8541, Ecole Normale Super, Lab Regulat Express Genet, F-75230 Paris, France; Univ Naples Federico II, Dipartimento Biol Strutt & Funz, I-80134 Naples, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Naples Federico II	Bensaude, O (corresponding author), CNRS, UMR 8541, Ecole Normale Super, Lab Regulat Express Genet, 46 Rue Ulm, F-75230 Paris, France.	bensaude@biologie.ens.fr	Fraldi, Alessandro/AAB-2243-2021	Bensaude, Olivier/0000-0002-0259-6608; Napolitano, Giuliana/0000-0002-1637-6016; Michels, Annemieke/0000-0002-1735-1697; Fraldi, Alessandro/0000-0002-7795-0720	Telethon [TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Byers SA, 2005, J BIOL CHEM, V280, P16360, DOI 10.1074/jbc.M500424200; Fraldi A, 2001, J CELL BIOCHEM, P247; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Garriga J, 2004, GENE, V337, P15, DOI 10.1016/j.gene.2004.05.007; Giudicelli F, 2001, GENE DEV, V15, P567, DOI 10.1101/gad.189801; Huang F, 2004, MECH DEVELOP, V121, P559, DOI 10.1016/j.mod.2004.04.012; Huang FC, 2002, GENE, V292, P245, DOI 10.1016/S0378-1119(02)00596-6; Kusuhara M, 1999, BIOMED RES-TOKYO, V20, P273, DOI 10.2220/biomedres.20.273; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Licciardo P, 2001, AIDS, V15, P301, DOI 10.1097/00002030-200102160-00002; Medlin JE, 2003, EMBO J, V22, P925, DOI 10.1093/emboj/cdg077; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Ouchida R, 2003, GENES CELLS, V8, P95, DOI 10.1046/j.1365-2443.2003.00618.x; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Sano M, 2004, EMBO J, V23, P3559, DOI 10.1038/sj.emboj.7600351; Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778; Schulte A, 2005, J BIOL CHEM, V280, P24968, DOI 10.1074/jbc.M501431200; Shimizu N, 2005, P NATL ACAD SCI USA, V102, P8555, DOI 10.1073/pnas.0409863102; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Wittmann BM, 2003, CANCER RES, V63, P5151; WITTMANN BM, 2005, IN PRESS ONCOGENE, V24; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2005, J BIOL CHEM, V280, P16368, DOI 10.1074/jbc.M500912200; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; ZIEVE G, 1976, CELL, V8, P19, DOI 10.1016/0092-8674(76)90181-1	31	49	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30619	30629		10.1074/jbc.M502471200	http://dx.doi.org/10.1074/jbc.M502471200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15994294	hybrid			2022-12-27	WOS:000231362500079
J	Nguyen, Q; Lee, CM; Le, A; Reddy, EP				Nguyen, Q; Lee, CM; Le, A; Reddy, EP			JLP associates with kinesin light chain 1 through a novel leucine zipper-like domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST AXONAL-TRANSPORT; KINESIN HEAVY-CHAIN; SCAFFOLD PROTEIN; KINASE; IDENTIFICATION; ACTIVATION; APOPTOSIS; NEURONS; COMPLEX; FAMILY	Scaffolding proteins exist in eukaryotes to properly assemble signaling proteins into specific multimeric functional complexes. JLP is a novel leucine zipper protein belonging to a family of scaffolding proteins that assemble JNK signaling modules. JLP is a proline-rich protein that contains two leucine zipper domains and a highly conserved C-terminal domain. We have identified kinesin light chain 1 ( KLC1) as a binding partner for the second leucine zipper domain of JLP using yeast two-hybrid screening. The interaction domain of KLC1 was mapped to its tetratripeptide repeat, which contains a novel leucine zipper-like domain that is crucial for the interaction with JLP. Mutations of Leu-280, Leu-287, Val-294, and Leu-301 within this domain of KLC1 disrupted its ability to associate with JLP. Immunofluorescence studies showed that JLP and KLC1 co-localized in the cytoplasm and that the localization of JLP was dependent on its second leucine zipper. Ectopic expression of a dominant negative form of KLC1 resulted in the mislocalization of endogenous JLP. Moreover, the association between JLP and KLC1 occurred in vivo and was important in the formation of ternary complex with JNK1. These results identify a novel protein-protein interaction between KLC1 and JLP that involves leucine zipper-like domains and support the role of motor proteins in the spatial regulation of signaling modules.	Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Reddy, EP (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, 3307 N Broad St,AHP Rm 154, Philadelphia, PA 19140 USA.	reddy@temple.edu	Lee, Clement M./E-7104-2012; Reddy, E. Premkumar/F-6233-2011	Lee, Clement M./0000-0003-3486-8492; 	NATIONAL CANCER INSTITUTE [R24CA088261] Funding Source: NIH RePORTER; NCI NIH HHS [R24 CA88261] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUSUBEL EM, 1989, CURRENT PROTOCOLS MO; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Bowman AB, 1999, J CELL BIOL, V146, P165; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Cross R, 1999, NAT CELL BIOL, V1, pE119, DOI 10.1038/12947; Diefenbach RJ, 1998, BIOCHEMISTRY-US, V37, P16663, DOI 10.1021/bi981163r; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Gindhart JG, 1996, TRENDS BIOCHEM SCI, V21, P52, DOI 10.1016/0968-0004(96)80865-6; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hollenbeck PJ, 2001, J CELL BIOL, V152, pF25, DOI 10.1083/jcb.152.5.F25; Hurd DD, 1996, GENETICS, V144, P1075; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Liu YS, 1996, FREE RADICAL BIO MED, V21, P771, DOI 10.1016/0891-5849(96)00176-1; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Namgung U, 2001, TOXICOL APPL PHARM, V174, P130, DOI 10.1006/taap.2001.9200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rahman A, 1998, J BIOL CHEM, V273, P15395, DOI 10.1074/jbc.273.25.15395; SKOUFIAS DA, 1994, J BIOL CHEM, V269, P1477; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; WARREN TG, 1984, CELL, V39, P547, DOI 10.1016/0092-8674(84)90461-6; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Yasuda J, 1999, MOL CELL BIOL, V19, P7245	32	48	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30185	30191		10.1074/jbc.M505499200	http://dx.doi.org/10.1074/jbc.M505499200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15987681	hybrid			2022-12-27	WOS:000231362500026
J	Zandy, AJ; Lakhani, S; Zheng, T; Flavell, RA; Bassnett, S				Zandy, AJ; Lakhani, S; Zheng, T; Flavell, RA; Bassnett, S			Role of the executioner caspases during lens development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBER CELL-DIFFERENTIATION; ORGANELLE DEGRADATION; MEMBRANE SKELETON; DNA-DEGRADATION; TRANSGENIC MICE; EYE LENS; TGF-BETA; APOPTOSIS; CATARACT; ACTIVATION	The notion that the cell death machinery is utilized during lens organelle degradation is supported by the observation that well characterized apoptotic substrates are cleaved during this process. Here, we test directly the role of executioner caspases ( caspase-3, -6, and -7) in fiber cell differentiation. The distribution of mRNA, protein, and enzymatic activity for each caspase was determined in the mouse lens. Transcripts for all three executioner caspases were identified in lens fiber cells by real time RT-PCR, although only caspase- 6 and -7 proteins were detected subsequently by Western blot analysis. Endogenous proteolytic activity was noted for caspase-3 but not caspase- 6 or -7. We tested the role of executioner caspases in organelle degradation by examining lenses from mice deficient in each caspase. Knock-out lenses appeared grossly normal with the exception of caspase-3(-/-) lenses, which exhibited marked cataracts at the anterior lens pole. The distribution of lens organelles was mapped by confocal microscopy. There was no significant difference in the size of the lens organelle-free zone ( OFZ)(1) between wild-type and knock-out lenses. In response to treatment with staurosporine, caspase- 3 and -6 ( but not caspase-7) enzymatic activities were induced. We generated double knock-out animals to examine the phenotype of lenses deficient in both caspase-3 and -6. Histological examination of such lenses indicated the presence of a properly formed OFZ. Thus, no single executioner caspase ( nor a combination of caspase-3 and -6) is required for organelle loss, although caspase-3 activity may be required for other aspects of lens transparency.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Biogen Idec Inc, Cambridge, MA USA	Washington University (WUSTL); Washington University (WUSTL); Yale University; Howard Hughes Medical Institute; Yale University; Biogen	Zandy, AJ (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave,Campus Box 8096, St Louis, MO 63110 USA.	ajzandy@artsci.wustl.edu	Lakhani, Sunil R/I-1970-2018	Lakhani, Sunil R/0000-0003-4067-2760; Lakhani, Saquib/0000-0003-3235-3460; Bassnett, Steven/0000-0002-8337-2760	NATIONAL EYE INSTITUTE [R01EY012260, P30EY002687, R01EY009852] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY012260, R01EY009852, EY02687, P30 EY002687] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		APPLEBY DW, 1977, P NATL ACAD SCI USA, V74, P5579, DOI 10.1073/pnas.74.12.5579; Bassnett S, 2003, J EXP BIOL, V206, P4353, DOI 10.1242/jeb.00670; Bassnett S, 1997, J CELL BIOL, V137, P37, DOI 10.1083/jcb.137.1.37; Bassnett S, 2002, EXP EYE RES, V74, P1, DOI 10.1006/exer.2001.1111; BASSNETT S, 1995, INVEST OPHTH VIS SCI, V36, P1793; BASSNETT S, 1992, DEV DYNAM, V194, P85, DOI 10.1002/aja.1001940202; BASSNETT S, 1992, CURR EYE RES, V11, P1227, DOI 10.3109/02713689208999548; Buki KG, 1997, BBA-PROTEIN STRUCT M, V1338, P100, DOI 10.1016/S0167-4838(96)00189-6; CAPETANAKI Y, 1989, J CELL BIOL, V109, P1653, DOI 10.1083/jcb.109.4.1653; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Dahm R, 1998, EUR J CELL BIOL, V75, P237, DOI 10.1016/S0171-9335(98)80118-0; Dahm R, 1999, OPHTHALMIC RES, V31, P163, DOI 10.1159/000055530; Denault JB, 2003, J BIOL CHEM, V278, P34042, DOI 10.1074/jbc.M305110200; Duan HJ, 1996, J BIOL CHEM, V271, P16720, DOI 10.1074/jbc.271.28.16720; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Faulkner-Jones B, 2003, EXP EYE RES, V77, P463, DOI 10.1016/S0014-4835(03)00172-6; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Foley JD, 2004, J BIOL CHEM, V279, P32142, DOI 10.1074/jbc.M313683200; FONT RL, 1966, ARCH OPHTHALMOL-CHIC, V75, P475, DOI 10.1001/archopht.1966.00970050477006; Fromm L, 1997, DEV GENET, V20, P276, DOI 10.1002/(SICI)1520-6408(1997)20:3<276::AID-DVG10>3.0.CO;2-6; HAMAI Y, 1975, INVEST OPHTH VISUAL, V14, P517; HAMAI Y, 1974, EXP EYE RES, V18, P537, DOI 10.1016/0014-4835(74)90060-8; Ishizaki Y, 1998, J CELL BIOL, V140, P153, DOI 10.1083/jcb.140.1.153; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lee A, 2000, DEV DYNAM, V217, P257, DOI 10.1002/(SICI)1097-0177(200003)217:3<257::AID-DVDY4>3.0.CO;2-5; Lee A, 2001, J BIOL CHEM, V276, P20735, DOI 10.1074/jbc.M009723200; Lee EH, 2002, MOL VIS, V8, P235; Leonard JR, 2002, J NEUROPATH EXP NEUR, V61, P673, DOI 10.1093/jnen/61.8.673; Lockshin RA, 2004, ONCOGENE, V23, P2766, DOI 10.1038/sj.onc.1207514; Lovicu FJ, 2002, BRIT J OPHTHALMOL, V86, P220, DOI 10.1136/bjo.86.2.220; Majima K, 2003, OPHTHALMOLOGICA, V217, P215, DOI 10.1159/000068971; Maruno Kevin A, 2002, Clin Exp Optom, V85, P76; McAvoy JW, 2000, CLIN EXP OPHTHALMOL, V28, P133, DOI 10.1046/j.1442-9071.2000.00310.x; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Sanders EJ, 2003, DIFFERENTIATION, V71, P425, DOI 10.1046/j.1432-0436.2003.7107005.x; Schwerk C, 2003, BIOCHEM PHARMACOL, V66, P1453, DOI 10.1016/S0006-2952(03)00497-0; Shiokawa D, 1999, NUCLEIC ACIDS RES, V27, P4083, DOI 10.1093/nar/27.20.4083; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Weil M, 1999, CURR BIOL, V9, P361, DOI 10.1016/S0960-9822(99)80162-6; Wride MA, 1999, DEV BIOL, V213, P142, DOI 10.1006/dbio.1999.9375; Yin XY, 2001, CELL COMMUN ADHES, V8, P373, DOI 10.3109/15419060109080756; Yin XY, 2001, J BIOL CHEM, V276, P34567, DOI 10.1074/jbc.M106073200; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343; Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593	47	89	90	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30263	30272		10.1074/jbc.M504007200	http://dx.doi.org/10.1074/jbc.M504007200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15994297	hybrid			2022-12-27	WOS:000231362500035
J	Sulton, D; Pagan-Rodriguez, D; Zhou, X; Liu, YD; Hujer, AM; Bethel, CR; Helfand, MS; Thomson, JM; Anderson, VE; Buynak, JD; Ng, LM; Bonomo, RA				Sulton, D; Pagan-Rodriguez, D; Zhou, X; Liu, YD; Hujer, AM; Bethel, CR; Helfand, MS; Thomson, JM; Anderson, VE; Buynak, JD; Ng, LM; Bonomo, RA			Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 beta-lactamase - Insights into the mechanism of inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RTEM BETA-LACTAMASE; IONIZATION MASS-SPECTROMETRY; ESCHERICHIA-COLI; CLASS-A; TAZOBACTAM; MUTAGENESIS; TEM-1; VARIANT; INTERMEDIATE; PENICILLIN	Clavulanic acid is a potent mechanism-based inhibitor of TEM-1 and SHV-1 beta-lactamases, enzymes that confer resistance to beta-lactams in many Gram-negative pathogens. This compound has enjoyed widespread clinical use as part of beta-lactam beta-lactamase inhibitor therapy directed against penicillin-resistant pathogens. Unfortunately, the emergence of clavulanic acid-resistant variants of TEM-1 and SHV-1 beta-lactamase significantly compromise the efficacy of this combination. A single amino acid change at Ambler position Ser(130) (Ser -> Gly) results in resistance to inactivation by clavulanate in the SHV1 and TEM-1 beta-lactamases. Herein, we investigated the inactivation of SHV-1 and the inhibitor-resistant S130G variant beta-lactamases by clavulanate. Using liquid chromatography electrospray ionization mass spectrometry, we detected multiple modified proteins when SHV-1 beta-lactamase is inactivated by clavulanate. Matrix-assisted laser desorption ionization-time of flight mass spectrometry was used to study tryptic digests of SHV-1 and S130G beta-lactamases (+/- inactivation with clavulanate) and identified peptides modified at the active site Ser(70). Ultraviolet (UV) difference spectral studies comparing SHV-1 and S130G beta-lactamases inactivated by clavulanate showed that the formation of reaction intermediates with absorption maxima at 227 and 280nm are diminished and delayed when S130G beta-lactamase is inactivated. We conclude that the clavulanic acid inhibition of the S130G variant beta-lactamase must follow a branch of the normal inactivation pathway. These findings highlight the importance of understanding the intermediates formed in the inactivation process of inhibitor-resistant beta-lactamases and suggest how strategic chemical design can lead to novel ways to inhibit beta-lactamases.	Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; Mass Spectrometry Facil, Cleveland, OH 44115 USA; Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; So Methodist Univ, Dept Chem, Dallas, TX 75275 USA	University System of Ohio; Cleveland State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University; Southern Methodist University	Bonomo, RA (corresponding author), Cleveland State Univ, Dept Chem, 2121 Euclid Ave, Cleveland, OH 44115 USA.	Robert.Bonomo@med.va.gov	Anderson, Vernon/W-2673-2019	Anderson, Vernon Emmett/0000-0002-1699-7621	NIGMS NIH HHS [T32 GM07250] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brown RPA, 1996, BIOCHEMISTRY-US, V35, P12421, DOI 10.1021/bi961044g; BUSH K, 1993, ANTIMICROB AGENTS CH, V37, P851, DOI 10.1128/AAC.37.4.851; CARTWRIGHT SJ, 1979, NATURE, V278, P360, DOI 10.1038/278360a0; CHARNAS RL, 1981, BIOCHEMISTRY-US, V20, P3214, DOI 10.1021/bi00514a035; CHARNAS RL, 1978, BIOCHEMISTRY-US, V17, P2185, DOI 10.1021/bi00604a025; CHEN CCH, 1992, J MOL BIOL, V224, P1103, DOI 10.1016/0022-2836(92)90472-V; DELAIRE M, 1992, J BIOL CHEM, V267, P20600; FISHER J, 1978, BIOCHEMISTRY-US, V17, P2180, DOI 10.1021/bi00604a024; FISHER J, 1981, BIOCHEMISTRY-US, V20, P2726, DOI 10.1021/bi00513a004; GORBACH SL, 1994, INTENS CARE MED, V20, P27; Helfand Marion S., 2003, Current Drug Targets - Infectious Disorders, V3, P9, DOI 10.2174/1568005033342181; Helfand MS, 2003, J BIOL CHEM, V278, P52724, DOI 10.1074/jbc.M306059200; Helfand MS, 2003, BIOCHEMISTRY-US, V42, P13386, DOI 10.1021/bi035716w; Hujer AM, 2001, BBA-PROTEIN STRUCT M, V1547, P37, DOI 10.1016/S0167-4838(01)00164-9; KNOX JR, 1995, ANTIMICROB AGENTS CH, V39, P2593, DOI 10.1128/AAC.39.12.2593; Kuzin AP, 2001, BIOCHEMISTRY-US, V40, P1861, DOI 10.1021/bi0022745; Massova I, 1999, CURR PHARM DESIGN, V5, P929; Meroueh SO, 2002, J AM CHEM SOC, V124, P9422, DOI 10.1021/ja026547q; Nukaga M, 2003, BIOCHEMISTRY-US, V42, P13152, DOI 10.1021/bi034986b; Padayatti PS, 2004, BIOCHEMISTRY-US, V43, P843, DOI 10.1021/bi035985m; Pagan-Rodriguez D, 2004, J BIOL CHEM, V279, P19494, DOI 10.1074/jbc.M311669200; SAVES I, 1995, J BIOL CHEM, V270, P18240, DOI 10.1074/jbc.270.31.18240; Sun T, 2004, BIOCHEMISTRY-US, V43, P14111, DOI 10.1021/bi0487903; Swaren P, 1999, BIOCHEMISTRY-US, V38, P9570, DOI 10.1021/bi990758z; Vakulenko SB, 1998, ANTIMICROB AGENTS CH, V42, P1542, DOI 10.1128/AAC.42.7.1542; Wang XJ, 2002, J BIOL CHEM, V277, P32149, DOI 10.1074/jbc.M204212200; Yang Y, 2000, J BIOL CHEM, V275, P26674	27	59	60	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2005	280	42					35528	35536		10.1074/jbc.M501251200	http://dx.doi.org/10.1074/jbc.M501251200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973ZN	15987690	hybrid			2022-12-27	WOS:000232561200054
J	Baldini, G; Martelli, AM; Tabellini, G; Horn, C; Machaca, K; Narducci, P; Baldini, G				Baldini, G; Martelli, AM; Tabellini, G; Horn, C; Machaca, K; Narducci, P; Baldini, G			Rabphilin localizes with the cell actin cytoskeleton and stimulates association of granules with F-actin cross-linked by alpha-actinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PC12 NEUROENDOCRINE CELLS; INSULIN-SECRETING CELLS; SMALL SYNAPTIC VESICLES; RAB3 EFFECTOR PROTEIN; DENSE-CORE VESICLES; REGULATED EXOCYTOSIS; CHROMAFFIN CELLS; PLASMA-MEMBRANE; BINDING-PROTEIN; NEUROTRANSMITTER RELEASE	In endocrine cell, granules accumulate within an F-actin-rich region below the plasma membrane. The mechanisms involved in this process are largely unknown. Rabphilin is a cytosolic protein that is expressed in neurons and neuroendocrine cells and binds with high affinity to members of the Rab3 family of GTPases localized to synaptic vesicles and dense core granules. Rabphilin also interacts with alpha-actinin, a protein that cross-links F-actin into bundles and networks and associates with the granule membrane. Here we asked whether rabphilin, in addition to its granule localization, also interacts with the cell actin cytoskeleton. Immunofluorescence and immunoelectron microscopy show that rabphilin localizes to the sub-plasmalemmal actin cytoskeleton both in neuroendocrine and unspecialized cells. By using purified components, it is found that association of rabphilin with F-actin is dependent on added alpha-actinin. In an in vitro assay, granules, unlike endosomes or mitochondria, associate with F-actin cross-linked by alpha-actinin. Rabphilin is shown to stimulate this process. Rabphilin enhances by similar to 8-fold the granule ability to localize within regions of elevated concentration of cross-linked F-actin. These results suggest that rabphilin, by interacting with alpha-actinin, organizes the cell cytoskeleton to facilitate granule localization within F-actin-rich regions.	Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; Univ Trieste, Dipartimento Morfol Umana Normale, I-34138 Trieste, Italy; Univ Bologna, Dipartimento Sci Anat Umane & Fisiopatol Apparato, Sez Anat, Cell Signaling Lab, I-40126 Bologna, Italy; IOR, Ist Trapianti Organo & Immunocitol, CNR, Sez Bologna, I-40136 Bologna, Italy; Univ Brescia, Dipartimento Sci Biomed & Biotecnol, Sez Citol & Istol, I-25123 Brescia, Italy	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Trieste; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); University of Brescia	Baldini, G (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, 4301 W Markham St,Slot 516, Little Rock, AR 72205 USA.	gbaldini@uams.edu	Machaca, Khaled/AAF-3579-2019	Machaca, Khaled/0000-0001-6215-2411	NIDDK NIH HHS [R01-DK53293] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053293] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arribas M, 1997, EUR J CELL BIOL, V74, P209; Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; BADER MF, 1983, NEUROSCIENCE, V8, P165, DOI 10.1016/0306-4522(83)90036-2; Baldini G, 1998, J CELL BIOL, V140, P305, DOI 10.1083/jcb.140.2.305; BENFENATI F, 1992, NEURON, V8, P377, DOI 10.1016/0896-6273(92)90303-U; Cheviet S, 2004, TRENDS CELL BIOL, V14, P525, DOI 10.1016/j.tcb.2004.08.001; Chung SH, 1999, J BIOL CHEM, V274, P18113, DOI 10.1074/jbc.274.25.18113; CHUNG SH, 1995, J BIOL CHEM, V270, P16714, DOI 10.1074/jbc.270.28.16714; Coghill ID, 2003, J BIOL CHEM, V278, P24139, DOI 10.1074/jbc.M213259200; Coppola T, 2001, J CELL SCI, V114, P1757; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; DARCHEN F, 1995, J CELL SCI, V108, P1639; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Fukuda M, 2004, J BIOL CHEM, V279, P13065, DOI 10.1074/jbc.M306812200; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Giovedi S, 2004, J BIOL CHEM, V279, P43769, DOI 10.1074/jbc.M404168200; Giovedi S, 2004, J BIOL CHEM, V279, P43760, DOI 10.1074/jbc.M403293200; Gonzalez L, 1999, CELL, V96, P755, DOI 10.1016/S0092-8674(00)80585-1; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Haynes LP, 2001, J BIOL CHEM, V276, P9726, DOI 10.1074/jbc.M006959200; Iezzi M, 1999, MOL ENDOCRINOL, V13, P202, DOI 10.1210/me.13.2.202; Joberty G, 1999, J CELL SCI, V112, P3579; JOCKUSH BM, 1977, NATURE, V270, P628, DOI 10.1038/270628a0; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Kato M, 1996, J BIOL CHEM, V271, P31775, DOI 10.1074/jbc.271.50.31775; Koticha DK, 2002, J CELL SCI, V115, P3341; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; Manabe S, 2004, BIOCHEM BIOPH RES CO, V316, P218, DOI 10.1016/j.bbrc.2004.02.026; Martelli AM, 2000, TRAFFIC, V1, P976, DOI 10.1034/j.1600-0854.2000.011207.x; MARTYS JL, 1995, J BIOL CHEM, V270, P25976, DOI 10.1074/jbc.270.43.25976; McKiernan CJ, 1996, MOL CELL BIOL, V16, P4985; MIZOGUCHI A, 1994, BIOCHEM BIOPH RES CO, V202, P1235, DOI 10.1006/bbrc.1994.2063; Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150; NAKATA T, 1992, J NEUROSCI, V12, P2186; NOEL G, 1989, J NEUROCHEM, V52, P1050, DOI 10.1111/j.1471-4159.1989.tb01846.x; Nonet ML, 1997, J NEUROSCI, V17, P8061; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Pelletier O, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.148102; RIBONI L, 1995, J BIOL CHEM, V270, P26868, DOI 10.1074/jbc.270.45.26868; Rudolf R, 2001, MOL BIOL CELL, V12, P1353, DOI 10.1091/mbc.12.5.1353; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Stahl B, 1996, EMBO J, V15, P1799, DOI 10.1002/j.1460-2075.1996.tb00529.x; Staunton J, 2001, J NEUROSCI, V21, P9255, DOI 10.1523/JNEUROSCI.21-23-09255.2001; Sunshine C, 2000, EXP CELL RES, V257, P1, DOI 10.1006/excr.2000.4855; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; WACHSSTOCK DH, 1987, BIOCHEM BIOPH RES CO, V146, P554, DOI 10.1016/0006-291X(87)90564-X; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Weber E, 1996, J BIOL CHEM, V271, P6963, DOI 10.1074/jbc.271.12.6963; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; YAMAGUCHI T, 1993, J BIOL CHEM, V268, P27164; Zhao SL, 2002, ENDOCRINOLOGY, V143, P1817, DOI 10.1210/en.143.5.1817	59	15	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34974	34984		10.1074/jbc.M502695200	http://dx.doi.org/10.1074/jbc.M502695200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16043482	hybrid			2022-12-27	WOS:000232403900071
J	Ling, C; Yao, YN; Zheng, YG; Wei, H; Wang, L; Wu, XF; Wang, ED				Ling, C; Yao, YN; Zheng, YG; Wei, H; Wang, L; Wu, XF; Wang, ED			The C-terminal appended domain of human cytosolic leucyl-tRNA synthetase is indispensable in its interaction with arginyl-tRNA synthetase in the multi-tRNA synthetase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; PROTEIN-PROTEIN INTERACTIONS; ESCHERICHIA-COLI; RAT-LIVER; MACROMOLECULAR ASSEMBLAGE; ACCELERATED PUBLICATION; STRUCTURAL-ANALYSIS; BINDING DOMAIN; COILED-COIL; IN-VITRO	Human cytosolic leucyl-tRNA synthetase is one component of a macromolecular aminoacyl-tRNA synthetase complex. This is unlike prokaryotic and lower eukaryotic LeuRSs that exist as free soluble enzymes. There is little known about it, since the purified enzyme has been unavailable. Herein, human cytosolic leucyl-tRNA synthetase was heterologously expressed in a baculovirus system and purified to homogeneity. The molecular mass ( 135 kDa) of the enzyme is close to the theoretical value derived from its cDNA. The kinetic constants of the enzyme for ATP, leucine, and tRNALeu in the ATP-PPi exchange and tRNA leucylation reactions were determined, and the results showed that it is quite active as a free enzyme. Humancytosolic leucyl-tRNA synthetase expressed in human 293 T cells localizes predominantly to the cytosol. Additionally, it is found to have a long C-terminal extension that is absent from bacterial and yeast LeuRSs. A C-terminal 89-amino acid truncated human cytosolic leucyl-tRNA synthetase was constructed and purified, and the catalytic activities, thermal stability, and subcellular location were found to be almost identical to native enzyme. In vivo and in vitro experiments, however, show that the C-terminal extension of human cytosolic leucyl-tRNA synthetase is indispensable for its interaction with the N-terminal of human cytosolic arginyl-tRNA synthetase in the macromolecular complex. Our results also indicate that the two molecules interact with each other only through their appended domains.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Wang, ED (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	edwang@sibs.ac.cn	Zheng, Yonggang/B-5009-2011					Agou F, 1996, J BIOL CHEM, V271, P29295, DOI 10.1074/jbc.271.46.29295; Ahn HC, 2003, FEBS LETT, V542, P119, DOI 10.1016/S0014-5793(03)00362-4; CIRAKOGLU B, 1985, EUR J BIOCHEM, V151, P101, DOI 10.1111/j.1432-1033.1985.tb09074.x; DANG CV, 1979, J BIOL CHEM, V254, P5350; DEUTSCHER MP, 1982, J BIOL CHEM, V257, P6003; DEUTSCHER MP, 1984, J CELL BIOL, V99, P373, DOI 10.1083/jcb.99.2.373; DIETRICH A, 1983, J BIOL CHEM, V258, P2386; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; ESCALANTE C, 1994, MOL CELL BIOCHEM, V140, P55, DOI 10.1007/BF00928366; ESCALANTE C, 1993, J BIOL CHEM, V268, P6014; FILONENKO VV, 1994, J BIOL CHEM, V269, P17375; Francin M, 2003, J BIOL CHEM, V278, P1472, DOI 10.1074/jbc.M208802200; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Gill SK, 2003, J BIOL CHEM, V278, P20217, DOI 10.1074/jbc.M213153200; Graindorge JS, 2005, BIOCHEMISTRY-US, V44, P1344, DOI 10.1021/bi049024z; Guigou L, 2004, BIOCHEMISTRY-US, V43, P4592, DOI 10.1021/bi036150e; Han JM, 2003, BIOCHEM BIOPH RES CO, V303, P985, DOI 10.1016/S0006-291X(03)00485-6; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JOHNSON DL, 1980, J BIOL CHEM, V255, P4362; Jorgensen R, 2000, J BIOL CHEM, V275, P16820, DOI 10.1074/jbc.275.22.16820; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; KERN D, 1981, BIOCHIM BIOPHYS ACTA, V653, P83, DOI 10.1016/0005-2787(81)90106-4; Kim T, 2000, J BIOL CHEM, V275, P21768, DOI 10.1074/jbc.M002404200; Ko YG, 2000, J CELL BIOL, V149, P567, DOI 10.1083/jcb.149.3.567; Kost TA, 2002, TRENDS BIOTECHNOL, V20, P173, DOI 10.1016/S0167-7799(01)01911-4; Li T, 1999, BIOCHEMISTRY-US, V38, P13063, DOI 10.1021/bi990384+; Li Y, 1998, SCI CHINA SER C, V41, P225, DOI 10.1007/BF02895095; MURAMATSU T, 1992, NUCLEOS NUCLEOT NUCL, V11, P719, DOI 10.1080/07328319208021736; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Nathanson L, 2000, J BIOL CHEM, V275, P31559, DOI 10.1074/jbc.C000385200; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; NORCUM MT, 1989, J BIOL CHEM, V264, P15043; Norcum MT, 1998, PROTEIN SCI, V7, P79, DOI 10.1002/pro.5560070108; NORCUM MT, 1991, J BIOL CHEM, V266, P15398; Norcum MT, 2000, J BIOL CHEM, V275, P17921, DOI 10.1074/jbc.C000266200; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Park SG, 1999, J BIOL CHEM, V274, P16673, DOI 10.1074/jbc.274.24.16673; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; RABEN N, 1994, J BIOL CHEM, V269, P24277; REED VS, 1994, J BIOL CHEM, V269, P32937; Rho SB, 1996, P NATL ACAD SCI USA, V93, P10128, DOI 10.1073/pnas.93.19.10128; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Rho SB, 1998, J BIOL CHEM, V273, P11267, DOI 10.1074/jbc.273.18.11267; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; SHIBA K, 1994, J BIOL CHEM, V269, P30049; Shiba K, 1998, NUCLEIC ACIDS RES, V26, P5045, DOI 10.1093/nar/26.22.5045; SHIBA K, 1994, P NATL ACAD SCI USA, V91, P7435, DOI 10.1073/pnas.91.16.7435; SIHAG RK, 1983, J BIOL CHEM, V258, P1846; SYLVERS LA, 1993, BIOCHEMISTRY-US, V32, P3836, DOI 10.1021/bi00066a002; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; TAMURA K, 1992, NUCLEIC ACIDS RES, V20, P2335, DOI 10.1093/nar/20.9.2335; Valgardsdottir R, 2001, J BIOL CHEM, V276, P32056, DOI 10.1074/jbc.M011629200; VELLEKAMP G, 1987, J BIOL CHEM, V262, P9927; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wu H, 1995, BIOCHEMISTRY-US, V34, P16327, DOI 10.1021/bi00050a013; Xu MG, 2002, J BIOL CHEM, V277, P41590, DOI 10.1074/jbc.M205126200; Yang DCH, 1996, CURR TOP CELL REGUL, V34, P101, DOI 10.1016/S0070-2137(96)80004-5; Yao YN, 2003, FEBS LETT, V534, P139, DOI 10.1016/S0014-5793(02)03833-4	58	39	48	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34755	34763		10.1074/jbc.M413511200	http://dx.doi.org/10.1074/jbc.M413511200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16055448	hybrid			2022-12-27	WOS:000232403900047
J	Borucki, B; von Stetten, D; Seibeck, S; Lamparter, T; Michael, N; Mroginski, MA; Otto, H; Murgida, DH; Heyn, MP; Hildebrandt, P				Borucki, B; von Stetten, D; Seibeck, S; Lamparter, T; Michael, N; Mroginski, MA; Otto, H; Murgida, DH; Heyn, MP; Hildebrandt, P			Light-induced proton release of phytochrome is coupled to the transient deprotonation of the tetrapyrrole chromophore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAMAN; PHOTOTRANSFORMATION; CYANOBACTERIAL; ABSORPTION; KINETICS; SPECTRA; PROTEIN	The P-r-->P-fr phototransformation of the bacteriophytochrome Agp1 from Agrobacterium tumefaciens and the structures of the biliverdin chromophore in the parent states and the cryogenically trapped intermediate Meta-R-C were investigated with resonance Raman spectroscopy and flash photolysis. Strong similarities with the resonance Raman spectra of plant phytochrome A indicate that in Agp1 the methine bridge isomerization state of the chromophore is ZZZasa in P-r and ZZEssa in P-fr, with all pyrrole nitrogens being protonated. Photoexcitation of P-r is followed by ( at least) three thermal relaxation components in the formation of Pfr with time constants of 230 mu s and 3.1 and 260 ms. H2O/D2O exchange reveals kinetic isotope effects of 1.9, 2.6, and 1.3 for the respective transitions that are accompanied by changes of the amplitudes. The second and the third relaxation correspond to the formation and decay of Meta-R-C, respectively. Resonance Raman measurements of Meta-R-C indicate that the chromophore adopts a deprotonated ZZE configuration. Measurements with a pH indicator dye show that formation and decay of Meta-R-C are associated with proton release and uptake, respectively. The stoichiometry of the proton release corresponds to one proton per photoconverted molecule. The coupling of transient chromophore deprotonation and proton release, which is likely to be an essential element in the P-r-->P-fr photoconversion mechanism of phytochromes in general, may play a crucial role for the structural changes in the final step of the Pfr formation that switch between the active and the inactive state of the photoreceptor.	Tech Univ Berlin, Inst Chem, Max Volmer Lab, D-10623 Berlin, Germany; Free Univ Berlin, Fachbereich Phys, Inst Expt Phys, D-14195 Berlin, Germany; Free Univ Berlin, Inst Biol Pflanzenphysiol, D-14195 Berlin, Germany	Technical University of Berlin; Free University of Berlin; Free University of Berlin	Hildebrandt, P (corresponding author), Tech Univ Berlin, Inst Chem, Max Volmer Lab, Sekretariat PC14,Str 17,Juni 135, D-10623 Berlin, Germany.	Hildebrandt@chem.tu-berlin.de	Lamparter, Tilman/E-4421-2013; Hildebrandt, Peter/J-5658-2014; Murgida, Daniel H./F-2350-2018	Lamparter, Tilman/0000-0003-4327-9737; Hildebrandt, Peter/0000-0003-1030-5900; von Stetten, David/0000-0001-7906-9788; Murgida, Daniel H./0000-0001-5173-0183				Andel F, 1996, BIOCHEMISTRY-US, V35, P15997, DOI 10.1021/bi962175k; ARAMENDIA PF, 1987, BIOCHEMISTRY-US, V26, P1418, DOI 10.1021/bi00379a031; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Borucki B, 2003, BIOCHEMISTRY-US, V42, P13684, DOI 10.1021/bi035511n; Borucki B, 2002, BIOCHEMISTRY-US, V41, P10026, DOI 10.1021/bi0256227; Borucki B, 1999, J PHYS CHEM B, V103, P6371, DOI 10.1021/jp990679x; EILFELD P, 1985, Z NATURFORSCH C, V40, P109; Foerstendorf H, 2001, BIOCHEMISTRY-US, V40, P14952, DOI 10.1021/bi0156916; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Heyne K, 2002, BIOPHYS J, V82, P1004, DOI 10.1016/S0006-3495(02)75460-X; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; KENDRICK RE, 1994, PHOTOMORPOGENESIS PL; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; Lamparter T, 2004, FEBS LETT, V573, P1, DOI 10.1016/j.febslet.2004.07.050; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Matysik J, 1997, J PHARMACEUT BIOMED, V15, P1319, DOI 10.1016/S0731-7085(96)01964-4; MIZUTANI Y, 1994, BIOCHEMISTRY-US, V33, P153, DOI 10.1021/bi00167a020; Mroginski MA, 2004, J AM CHEM SOC, V126, P16734, DOI 10.1021/ja043959l; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Remberg A, 1997, BIOCHEMISTRY-US, V36, P13389, DOI 10.1021/bi971563z; RUDIGER W, 1983, P NATL ACAD SCI-BIOL, V80, P6244, DOI 10.1073/pnas.80.20.6244; Schmidt P, 1998, PHOTOCHEM PHOTOBIOL, V68, P754, DOI 10.1111/j.1751-1097.1998.tb02541.x; Song PS, 1999, J BIOCHEM MOL BIOL, V32, P215; van Thor JJ, 2001, BIOCHEMISTRY-US, V40, P11460, DOI 10.1021/bi002651d; Vierstra RD, 2000, SEMIN CELL DEV BIOL, V11, P511, DOI 10.1006/scdb.2000.0206; ZHANG CF, 1992, J AM CHEM SOC, V114, P4569, DOI 10.1021/ja00038a019	27	130	137	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34358	34364		10.1074/jbc.M505493200	http://dx.doi.org/10.1074/jbc.M505493200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16061486	hybrid			2022-12-27	WOS:000232229700079
J	den Hengst, CD; van Hijum, SAFT; Geurts, JMW; Nauta, A; Kok, J; Kuipers, OP				den Hengst, CD; van Hijum, SAFT; Geurts, JMW; Nauta, A; Kok, J; Kuipers, OP			The Lactococcus lactis CodY regulon - Identification of a conserved cis-regulatory element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-ACETOLACTATE DECARBOXYLASE; COMPLETE GENOME SEQUENCE; AMINO-ACID BIOSYNTHESIS; BACILLUS-SUBTILIS; STREPTOCOCCUS-PNEUMONIAE; TRANSCRIPTION INITIATION; NUTRITIONAL REPRESSION; ARGININE METABOLISM; INTRACELLULAR POOL; GENE INACTIVATION	CodY of Lactococcus lactis MG1363 is a transcriptional regulator that represses the expression of several genes encoding proteins of the proteolytic system. DNA microarray analysis, comparing the expression profiles of L. lactis MG1363 and an isogenic strain in which codY was mutated, was used to determine the CodY regulon. In peptide-rich medium and exponentially growing cells, where CodY exerts strong repressing activity, the expression of over 30 genes was significantly increased upon removal of codY. The differentially expressed genes included those predominantly involved in amino acid transport and metabolism. In addition, several genes belonging to other functional categories were derepressed, stressing the pleiotropic role of CodY. Scrutinizing the transcriptome data with bioinformatics tools revealed the presence of a novel overrepresented motif in the upstream regions of several of the genes derepressed in L. lactis MG1363 Delta codY. Evidence is presented that this 15-bp cis-sequence, AATTTTCWGAAAATT, serves as a high affinity binding site for CodY, as shown by electrophoretic mobility shift assays and DNase I footprinting analyses. The presence of this CodY-box is sufficient to evoke CodY-mediated regulation in vivo. A copy of this motif is also present in the upstream region of codY itself. It is shown that CodY regulates its own synthesis and requires the CodY-box and branched-chain amino acids to interact with its promoter.	Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Genet, NL-9751 NN Haren, Netherlands; Friesland Foods Corp Res, NL-7400 AB Deventer, Netherlands	University of Groningen	Kuipers, OP (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Genet, Kerklaan 30, NL-9751 NN Haren, Netherlands.	O.P.Kuipers@rug.nl	Kok, Jan/C-9972-2012; Kuipers, Oscar/B-6752-2009; van Hijum, Sacha/F-6445-2014	Kuipers, Oscar/0000-0001-5596-7735; van Hijum, Sacha/0000-0003-0741-2991				Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bergara F, 2003, J BACTERIOL, V185, P3118, DOI 10.1128/JB.185.10.3118-3126.2003; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Chambellon E, 2003, APPL ENVIRON MICROB, V69, P3061, DOI 10.1128/AEM.69.6.3061-3068.2003; Chaussee MA, 2004, J BACTERIOL, V186, P7091, DOI 10.1128/JB.186.21.7091-7099.2004; CHOPIN A, 1993, FEMS MICROBIOL REV, V12, P21, DOI [10.1016/0168-6445(93)90056-F, 10.1111/j.1574-6976.1993.tb00011.x]; CROW VL, 1982, J BACTERIOL, V150, P1024, DOI 10.1128/JB.150.3.1024-1032.1982; Debarbouille M, 1999, J BACTERIOL, V181, P2059, DOI 10.1128/JB.181.7.2059-2066.1999; DELORME C, 1993, J BACTERIOL, V175, P4391, DOI 10.1128/JB.175.14.4391-4399.1993; den Hengst CD, 2005, J BACTERIOL, V187, P512, DOI 10.1128/JB.187.2.512-521.2005; Eda S, 2000, BIOSCI BIOTECH BIOCH, V64, P484, DOI 10.1271/bbb.64.484; Fisher SH, 1996, J BACTERIOL, V178, P3779, DOI 10.1128/jb.178.13.3779-3784.1996; Fisher SH, 1999, MOL MICROBIOL, V32, P223, DOI 10.1046/j.1365-2958.1999.01333.x; FOUCAUD C, 1995, J BACTERIOL, V177, P4652, DOI 10.1128/jb.177.16.4652-4657.1995; GAJIC O, 2003, THESIS U GRONINGEN G; GASSON MJ, 1983, J BACTERIOL, V154, P1; GODON JJ, 1992, J BACTERIOL, V174, P6580, DOI 10.1128/JB.174.20.6580-6589.1992; GODON JJ, 1993, J BACTERIOL, V175, P4383, DOI 10.1128/JB.175.14.4383-4390.1993; Goupil-Feuillerat N, 2000, J BACTERIOL, V182, P5399, DOI 10.1128/JB.182.19.5399-5408.2000; GoupilFeuillerat N, 1997, J BACTERIOL, V179, P6285, DOI 10.1128/JB.179.20.6285-6293.1997; Guedon E, 2001, MOL MICROBIOL, V40, P1227, DOI 10.1046/j.1365-2958.2001.02470.x; Guedon E, 2001, J BACTERIOL, V183, P3614, DOI 10.1128/JB.183.12.3614-3622.2001; HAGTING A, 1994, J BIOL CHEM, V269, P11391; Holo H, 1995, Methods Mol Biol, V47, P195; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Inaoka T, 2003, J BIOL CHEM, V278, P2169, DOI 10.1074/jbc.M208722200; ISRAELSEN H, 1995, APPL ENVIRON MICROB, V61, P2540, DOI 10.1128/AEM.61.7.2540-2547.1995; Joseph P, 2005, J BACTERIOL, V187, P4127, DOI 10.1128/JB.187.12.4127-4139.2005; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kim HJ, 2003, J BACTERIOL, V185, P1672, DOI 10.1128/JB.185.5.1672-1680.2003; Kok J, 2003, LACTIC ACID BACTERIA, V3, P189; Kuipers OP, 2002, ANTON LEEUW INT J G, V82, P113, DOI 10.1023/A:1020691801251; Kunji ERS, 1996, ANTON LEEUW INT J G, V70, P187, DOI 10.1007/BF00395933; Kunji ERS, 1996, MOL MICROBIOL, V21, P123, DOI 10.1046/j.1365-2958.1996.6231339.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lamarque M, 2004, J BACTERIOL, V186, P6492, DOI 10.1128/JB.186.19.6492-6500.2004; Lapujade P, 1998, APPL ENVIRON MICROB, V64, P2485; Larsen R, 2004, J BACTERIOL, V186, P1147, DOI 10.1128/JB.186.4.1147-1157.2004; Leenhouts K, 1998, APPL MICROBIOL BIOT, V49, P417, DOI 10.1007/s002530051192; LEENHOUTS KJ, 1991, J BACTERIOL, V173, P4794, DOI 10.1128/jb.173.15.4794-4798.1991; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Marugg JD, 1996, J BACTERIOL, V178, P1525, DOI 10.1128/jb.178.6.1525-1531.1996; MARUGG JD, 1995, J BACTERIOL, V177, P2982, DOI 10.1128/jb.177.11.2982-2989.1995; Molle V, 2003, J BACTERIOL, V185, P1911, DOI 10.1128/JB.185.6.1911-1922.2003; MORISHITA T, 1995, BIOSCI BIOTECH BIOCH, V59, P251, DOI 10.1271/bbb.59.251; Overweg K, 2000, INFECT IMMUN, V68, P4180, DOI 10.1128/IAI.68.7.4180-4188.2000; Petranovic D, 2004, MOL MICROBIOL, V53, P613, DOI 10.1111/j.1365-2958.2004.04136.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanders JW, 1998, MOL GEN GENET, V257, P681, DOI 10.1007/s004380050697; Sanz Y, 2003, FEMS MICROBIOL LETT, V227, P33, DOI 10.1016/S0378-1097(03)00662-1; Sanz Y, 2001, ARCH MICROBIOL, V175, P334, DOI 10.1007/s002030100270; Serror P, 1996, MOL MICROBIOL, V20, P843, DOI 10.1111/j.1365-2958.1996.tb02522.x; Serror P, 1996, J BACTERIOL, V178, P5910, DOI 10.1128/jb.178.20.5910-5915.1996; Shivers RP, 2005, MOL MICROBIOL, V56, P1549, DOI 10.1111/j.1365-2958.2005.04634.x; Shivers RP, 2004, MOL MICROBIOL, V53, P599, DOI 10.1111/j.1365-2958.2004.04135.x; SLACK FJ, 1995, MOL MICROBIOL, V15, P689, DOI 10.1111/j.1365-2958.1995.tb02378.x; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Tojo S, 2005, MOL MICROBIOL, V56, P1560, DOI 10.1111/j.1365-2958.2005.04635.x; TYNKKYNEN S, 1993, J BACTERIOL, V175, P7523, DOI 10.1128/JB.175.23.7523-7532.1993; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Wang H, 2000, J DAIRY SCI, V83, P1912, DOI 10.3168/jds.S0022-0302(00)75066-1; Wray LV, 1997, J BACTERIOL, V179, P5494, DOI 10.1128/jb.179.17.5494-5501.1997; WRAY LV, 1994, J BACTERIOL, V176, P5466, DOI 10.1128/JB.176.17.5466-5473.1994; Yue HB, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.8.e41; Yvon M, 2000, APPL ENVIRON MICROB, V66, P571, DOI 10.1128/AEM.66.2.571-577.2000	68	160	161	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34332	34342		10.1074/jbc.M502349200	http://dx.doi.org/10.1074/jbc.M502349200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16040604	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000232229700076
J	Anwer, MS; Gillin, H; Mukhopadhyay, S; Balasubramaniyam, N; Suchy, FJ; Ananthanarayanan, M				Anwer, MS; Gillin, H; Mukhopadhyay, S; Balasubramaniyam, N; Suchy, FJ; Ananthanarayanan, M			Dephosphorylation of Ser-226 facilitates plasma membrane retention of Ntcp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAUROCHOLATE COTRANSPORTING POLYPEPTIDE; NA+/TAUROCHOLATE COTRANSPORT; ACID UPTAKE; RAT-LIVER; TRANSPORT; PHOSPHORYLATION; TRANSLOCATION; STIMULATION; SERINE	Ntcp is a phosphoprotein, and its translocation by cAMP to the plasma membrane is associated with dephosphorylation. However, the phosphorylation site(s) of Ntcp is not known. Thus, the aim of the present study was to determine the potential Ntcp phosphorylation sites and whether any of these phosphorylation sites is involved in Ntcp translocation. To determine the potential phosphorylation sites, metabolically labeled [P-32] Ntcp isolated from hepatocytes was digested with clostripain and then subjected to SDS-PAGE followed by autoradiography. Clostripain digestion resulted in two phosphorylated peptides, and cAMP decreased phosphorylation of one of the peptides (7.8 K-d), which contains the putative third cytoplasmic loop with three serine ( Ser-213, Ser-226, and Ser-227) and two threonine (Thr-219 and Thr-225) residues. To determine whether any one of these serine/threonine residues is phosphorylated and/or is involved in Ntcp translocation, each of these serine/threonine residues were mutated to alanine. HuH-7 cells were transiently transfected with the wild-type and the mutated Ntcps followed by determination of taurocholate uptake and Ntcp expression, translocation and phosphorylation. Mutation of only Ser-226 resulted in 30% decrease in Ntcp phosphorylation and in 2.5 and 3.2-fold increases in taurocholate uptake and Ntcp retention in the plasmamembrane, respectively. Cyclic AMP failed to further decrease phosphorylation and increase translocation of S226A-Ntcp. Taken together, these results suggest that the Ser-226 in the third cytoplasmic loop of Ntcp is phosphorylated and cAMP may increase Ntcp translocation to the plasma membrane by dephosphorylating Ntcp at this site.	Tufts Univ, Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA; Mt Sinai Med Ctr, Dept Pediat, New York, NY 10029 USA	Tufts University; Icahn School of Medicine at Mount Sinai	Anwer, MS (corresponding author), Tufts Univ, Sch Vet Med, Dept Biomed Sci, 200 Westboro Rd, North Grafton, MA 01536 USA.	Sawkat.Anwer@Tufts.Edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020632, R01HD020632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033436] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-20632] Funding Source: Medline; NIDDK NIH HHS [DK-33436] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANANTHANARAYANAN M, 1994, AM J PHYSIOL-GASTR L, V267, pG637, DOI 10.1152/ajpgi.1994.267.4.G637; ANWER MS, 1976, H-S Z PHYSIOL CHEM, V357, P1477, DOI 10.1515/bchm2.1976.357.2.1477; BERTORELLO AM, 1991, P NATL ACAD SCI USA, V88, P11359, DOI 10.1073/pnas.88.24.11359; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Dranoff JA, 1999, HEPATOLOGY, V30, P223, DOI 10.1002/hep.510300136; Glavy JS, 2000, J BIOL CHEM, V275, P1479, DOI 10.1074/jbc.275.2.1479; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE JC, 1990, J BIOL CHEM, V265, P19768; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meier PJ, 2000, NEWS PHYSIOL SCI, V15, P89; Mukhopadhayay S, 1997, AM J PHYSIOL-GASTR L, V273, pG842, DOI 10.1152/ajpgi.1997.273.4.G842; Mukhopadhyay S, 1998, J BIOL CHEM, V273, P30039, DOI 10.1074/jbc.273.45.30039; Mukhopadhyay S, 1998, HEPATOLOGY, V28, P1629, DOI 10.1002/hep.510280624; STIEGER B, 1994, GASTROENTEROLOGY, V107, P1781, DOI 10.1016/0016-5085(94)90821-4; Trauner M, 1999, J HEPATOL, V31, P165, DOI 10.1016/S0168-8278(99)80179-2; Webster CRL, 2002, J BIOL CHEM, V277, P28578, DOI 10.1074/jbc.M201937200; Webster CRL, 2002, AM J PHYSIOL-GASTR L, V283, pG44, DOI 10.1152/ajpgi.00530.2001; Wolkoff AW, 2003, AM J PHYSIOL-GASTR L, V284, pG175, DOI 10.1152/ajpgi.00409.2002	19	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33687	33692		10.1074/jbc.M502151200	http://dx.doi.org/10.1074/jbc.M502151200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16027164	hybrid			2022-12-27	WOS:000232058100071
J	Grujic, M; Braga, T; Lukinius, A; Eloranta, ML; Knight, SD; Pejler, G; Abrink, M				Grujic, M; Braga, T; Lukinius, A; Eloranta, ML; Knight, SD; Pejler, G; Abrink, M			Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; MEDIATED APOPTOSIS; CHONDROITIN SULFATE; DNA FRAGMENTATION; CORE PROTEIN; TARGET-CELLS; MAST-CELLS; PROTEOGLYCAN; INDUCTION; HEPARIN	Cytotoxic T lymphocytes eliminate infected and tumor cells mainly by perforin/granzyme-induced apoptosis. Earlier studies suggested that serglycin-proteoglycans form macromolecular complexes with granzymes and perforin in the cytotoxic granule. Serglycin-proteoglycans may also be involved in the delivery of the cytolytic machinery into target cells. We have developed a serglycin-deficient mouse strain, and here we studied the importance of serglycin-proteoglycans for various aspects of cytotoxic T lymphocyte function. (SO42-)-S-35 radiolabeling of serglycin-deficient cells demonstrated a dramatic reduction of incorporated label as compared with wild type cells, indicating that serglycin is by far the dominating proteoglycan species produced by the cytotoxic T lymphocyte. Moreover, lack of serglycin resulted in impaired ability of cytotoxic T lymphocytes to produce secretory granule of high electron density, although granule of lower electron density were produced both in wild type and serglycin-deficient cells. The serglycin deficiency did not affect the mRNA expression for granzyme A, granzyme B, or perforin. However, the storage of granzyme B, but not granzyme A, Fas ligand, or perforin, was severely defective in serglycin-deficient cells. Serglycin-deficient cells did not display defects in late cytotoxicity toward target cell lines. Taken together, these results point to a key role for serglycin in the storage of granzyme B and for secretory granule maturation but argue against a major role for serglycin in the apoptosis mediated by cytotoxic T lymphocytes.	Swedish Univ Agr Sci, Ctr Biomed, Dept Mol Biosci, S-75123 Uppsala, Sweden; Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden; Swedish Univ Agr Sci, Uppsala Biomed Ctr, SE-75324 Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University; Swedish University of Agricultural Sciences	Abrink, M (corresponding author), Swedish Univ Agr Sci, Ctr Biomed, Dept Mol Biosci, Box 575, S-75123 Uppsala, Sweden.	magnus.abrink@bmc.uu.se	Knight, Stefan/D-4315-2015; Åbrink, Magnus/AAK-8346-2020	Abrink, Magnus/0000-0002-1335-3927; Knight, Stefan/0000-0002-7180-8758				Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; Darmon AJ, 1996, J BIOL CHEM, V271, P21709, DOI 10.1074/jbc.271.36.21709; ELLIOTT JF, 1993, MOL IMMUNOL, V30, P749, DOI 10.1016/0161-5890(93)90146-3; Ewen C, 2003, J IMMUNOL METHODS, V276, P89, DOI 10.1016/S0022-1759(03)00073-5; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Galvin JP, 1999, J IMMUNOL, V162, P5345; Grossman WJ, 2003, CURR OPIN IMMUNOL, V15, P544, DOI 10.1016/S0952-7915(03)00099-2; Henningsson F, 2002, BIOL CHEM, V383, P793, DOI 10.1515/BC.2002.083; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Hink-Schauer C, 2003, NAT STRUCT BIOL, V10, P535, DOI 10.1038/nsb945; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Kelso A, 2002, INT IMMUNOL, V14, P605, DOI 10.1093/intimm/dxf028; KJELLEN L, 1989, BIOCHEM J, V263, P105, DOI 10.1042/bj2630105; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; LUKINIUS A, 1995, AM J PATHOL, V146, P429; MACDERMOTT RP, 1985, J EXP MED, V162, P1771, DOI 10.1084/jem.162.6.1771; Manakil JF, 2001, J DENT RES, V80, P1704, DOI 10.1177/00220345010800080501; MASSON D, 1990, BIOCHEMISTRY-US, V29, P11229, DOI 10.1021/bi00503a011; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; Oynebraten I, 2000, J LEUKOCYTE BIOL, V67, P183, DOI 10.1002/jlb.67.2.183; PEJLER G, 1995, EUR J BIOCHEM, V233, P192, DOI 10.1111/j.1432-1033.1995.192_1.x; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Raja SM, 2003, CURR OPIN IMMUNOL, V15, P528, DOI 10.1016/S0952-7915(03)00111-0; Raja SM, 2002, J BIOL CHEM, V277, P49523, DOI 10.1074/jbc.M209607200; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; SCHMIDT RE, 1985, NATURE, V318, P289, DOI 10.1038/318289a0; STEVENS RL, 1985, J BIOL CHEM, V260, P4194; STEVENS RL, 1988, J BIOL CHEM, V263, P7287; Tchougounova E, 2001, FASEB J, V15, P2763, DOI 10.1096/fj.01-0486fje; Trapani JA, 2003, J CELL BIOL, V160, P223, DOI 10.1083/jcb.200210150; Trapani JA, 2001, GENOME BIOL, V2; Waugh SM, 2000, NAT STRUCT BIOL, V7, P762, DOI 10.1038/78992; Zhang D, 2001, P NATL ACAD SCI USA, V98, P5746, DOI 10.1073/pnas.101329598; Zhang D, 2001, J BIOL CHEM, V276, P3683, DOI 10.1074/jbc.M005390200	44	79	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33411	33418		10.1074/jbc.M501708200	http://dx.doi.org/10.1074/jbc.M501708200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16046402	hybrid			2022-12-27	WOS:000232058100039
J	Calautti, E; Li, J; Saoncella, S; Brissette, JL; Goetinck, PF				Calautti, E; Li, J; Saoncella, S; Brissette, JL; Goetinck, PF			Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; PROTEIN-KINASE-C; E-CADHERIN; TERMINAL DIFFERENTIATION; PATHWAY; EPIDERMIS; ACTIVATION; SURVIVAL	Signaling pathways regulating the differentiation program of epidermal cells overlap widely with those activated during apoptosis. How differentiating cells remain protected from premature death, however, is still poorly defined. We show here that the phosphoinositide 3-kinase ( PI3K)/ Akt pathway is activated at early stages of mouse keratinocyte differentiation both in culture and in the intact epidermis in vivo. Expression of active Akt in keratinocytes promotes growth arrest and differentiation, whereas pharmacological blockade of PI3K inhibits the expression of "late" differentiation markers and leads to death of cells that would otherwise differentiate. Mechanistically, the activation of the PI3K/Akt pathway in keratinocyte differentiation depends on the activity of the epidermal growth factor receptor and Src families of tyrosine kinases and the engagement of E- cadherin- mediated adhesion. During this process, PI3K associates increasingly with cadherin- catenin protein complexes bearing tyrosine phosphorylated YXXM motifs. Thus, the PI3K signaling pathway regulates the choice between epidermal cell differentiation and death at the cross-talk between tyrosine kinases and cadherin- associated catenins.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Calautti, E (corresponding author), Osped Civile Venezia, Epithelial Stem Cell Res Ctr, Veneto Eye Bank Fdn, Castello 6777, I-30122 Venice, Italy.	enzo.calautti@cbrc2.mgh.harvard.edu	Calautti, Enzo/M-8283-2018	Calautti, Enzo/0000-0002-4439-9709	NIAMS NIH HHS [AR454284] Funding Source: Medline; NICHD NIH HHS [HD-37490] Funding Source: Medline; Telethon [TCP06001] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037490] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anderson KE, 2003, INT J BIOCHEM CELL B, V35, P1028, DOI 10.1016/S1357-2725(02)00270-4; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; Calautti E, 1998, J CELL BIOL, V141, P1449, DOI 10.1083/jcb.141.6.1449; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Foster FM, 2003, J CELL SCI, V116, P3037, DOI 10.1242/jcs.00609; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Gandarillas A, 2000, EXP GERONTOL, V35, P53, DOI 10.1016/S0531-5565(99)00088-1; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Janes SM, 2004, J CELL SCI, V117, P4157, DOI 10.1242/jcs.01302; Laprise P, 2004, J CELL PHYSIOL, V199, P32, DOI 10.1002/jcp.10432; Li Y, 2003, MOL CELL BIOL, V23, P6255, DOI 10.1128/MCB.23.17.6255-6266.2003; Maruoka Y, 1997, BIOCHEM BIOPH RES CO, V238, P886, DOI 10.1006/bbrc.1997.7405; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Nolte RT, 1996, NAT STRUCT BIOL, V3, P364, DOI 10.1038/nsb0496-364; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Rendl M, 2002, J INVEST DERMATOL, V119, P1150, DOI 10.1046/j.1523-1747.2002.19532.x; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Saoncella S, 2004, J BIOL CHEM, V279, P47172, DOI 10.1074/jbc.C400299200; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Seitz CS, 2000, J CLIN INVEST, V105, P253, DOI 10.1172/JCI7630; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Tinkle CL, 2004, P NATL ACAD SCI USA, V101, P552, DOI 10.1073/pnas.0307437100; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Watt FM, 1989, CURR OPIN CELL BIOL, V1, P1107, DOI 10.1016/S0955-0674(89)80058-4; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Young P, 2003, EMBO J, V22, P5723, DOI 10.1093/emboj/cdg560	41	169	169	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32856	32865		10.1074/jbc.M506119200	http://dx.doi.org/10.1074/jbc.M506119200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16036919	hybrid			2022-12-27	WOS:000231920300039
J	Inaba, K; Takahashi, YH; Ito, K				Inaba, K; Takahashi, YH; Ito, K			Reactivities of quinone-free DsbB from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; MEMBRANE-PROTEIN DSBB; RESPIRATORY-CHAIN; ELECTRON-TRANSPORT; CYSTEINE RESIDUES; FORMATION PATHWAY; REDOX PROPERTIES; UBIQUINONE; MECHANISM; CATALYSIS	DsbB is a disulfide oxidoreductase present in the Escherichia coli plasma membrane. Its cysteine pairs, Cys(41)-Cys(44) and Cys(104)-Cys(130), facing the periplasm, as well as the bound quinone molecules play crucial roles in oxidizing DsbA, the protein dithiol oxidant in the periplasm. In this study, we characterized quinone-free forms of DsbB prepared from mutant cells unable to synthesize ubiquinone and menaquinone. While such preparations lacked detectable quinones, previously reported lauroylsarcosine treatment was ineffective in removing DsbB-associated quinones. Moreover, DsbB-bound quinone was shown to contribute to the redox-dependent fluorescence changes observed with DsbB. Now we reconfirmed that redox potentials of cysteine pairs of quinone-free DsbB are lower than that of DsbA, as far as determined in dithiothreitol redox buffer. Nevertheless, the quinone-free DsbB was able to oxidize similar to 40% of DsbA in a 1:1 stoichiometric reaction, in which hemi-oxidized forms of DsbB having either disulfide are generated. It was suggested that the DsbB-DsbA system is designed in such a way that specific interaction of the two components enables the thiol-disulfide exchanges in the "forward" direction. In addition, a minor fraction of quinone-free DsbB formed the DsbA-DsbB disulfide complex stably. Our results show that the rapid and the slow pathways of DsbA oxidation can proceed up to significant points, after which these reactions must be completed and recycled by quinones under physiological conditions. We discuss the significance of having such multiple reaction pathways for the DsbB-dependent DsbA oxidation.	Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; Japan Sci & Technol Agcy, CREST, Kyoto 6068507, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Ito, K (corresponding author), Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan.	kito@virus.kyoto-u.ac.jp		Inaba, Kenji/0000-0001-8229-0467				Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; Bader MW, 2000, J BIOL CHEM, V275, P26082, DOI 10.1074/jbc.M003850200; Bunoust O, 2005, J BIOL CHEM, V280, P3407, DOI 10.1074/jbc.M407746200; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Grauschopf U, 2003, EMBO J, V22, P3503, DOI 10.1093/emboj/cdg356; GUILHOT C, 1995, P NATL ACAD SCI USA, V92, P9895, DOI 10.1073/pnas.92.21.9895; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2004, J BIOL CHEM, V279, P6761, DOI 10.1074/jbc.M310765200; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; JANDER G, 1994, EMBO J, V13, P5121, DOI 10.1002/j.1460-2075.1994.tb06841.x; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kadokura H, 2002, EMBO J, V21, P2354, DOI 10.1093/emboj/21.10.2354; KISHIGAMI S, 1995, J BIOL CHEM, V270, P17072, DOI 10.1074/jbc.270.29.17072; Kishigami S, 1996, GENES CELLS, V1, P201, DOI 10.1046/j.1365-2443.1996.d01-233.x; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; MAJIMA E, 1995, BBA-GEN SUBJECTS, V1243, P336, DOI 10.1016/0304-4165(94)00159-U; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Regeimbal J, 2002, J BIOL CHEM, V277, P32706, DOI 10.1074/jbc.M205433200; Sevier CS, 2005, PROTEIN SCI, V14, P1630, DOI 10.1110/ps.051355705; Takahashi YH, 2004, J BIOL CHEM, V279, P47057, DOI 10.1074/jbc.M407153200; Tie JK, 2003, J BIOL CHEM, V278, P45468, DOI 10.1074/jbc.M309164200; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; WATMOUGH NJ, 1991, BIOCHEMISTRY-US, V30, P1317, DOI 10.1021/bi00219a023	25	36	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					33035	33044		10.1074/jbc.M506189200	http://dx.doi.org/10.1074/jbc.M506189200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16027117	hybrid			2022-12-27	WOS:000231920300058
J	McAlinden, A; Havlioglu, N; Liang, L; Davies, SR; Sandell, LJ				McAlinden, A; Havlioglu, N; Liang, L; Davies, SR; Sandell, LJ			Alternative splicing of type II procollagen Exon 2 is regulated by the combination of a weak 5 ' splice site and an adjacent intronic stem-loop Cis element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; RICH AMINO-PROPEPTIDE; SECONDARY STRUCTURE; SR-PROTEINS; HNRNP A1; DIFFERENTIAL EXPRESSION; U1 SNRNP; SEQUENCES; BINDING; TISSUE	Alternative splicing of the type II procollagen gene (COL2A1) is developmentally regulated during chondrogenesis. Chondroprogenitor cells produce the type IIA procollagen isoform by splicing (including) exon 2 during pre-mRNA processing, whereas differentiated chondrocytes synthesize the type IIB procollagen isoform by exon 2 skipping (exclusion). Using a COL2A1 mini-gene and chondrocytes at various stages of differentiation, we identified a non-classical consensus splicing sequence in intron 2 adjacent to the 5 ' splice site, which is essential in regulating exon 2 splicing. RNA mapping confirmed this region contains secondary structure in the form of a stem-loop. Mutational analysis identified three cis elements within the conserved double-stranded stem region that are functional only in the context of the natural weak 5 ' splice site of exon 2; they are 1) a uridine-rich enhancer element in all cell types tested except differentiated chondrocytes; 2) an adenine-rich silencer element, and 3) an enhancer cis element functional in the context of secondary structure. This is the first report identifying key cis elements in the COL2A1 gene that modulate the cell type-specific alternative splicing switch of exon 2 during cartilage development.	Washington Univ, Dept Orthopaed Surg, Sch Med, St Louis, MO 63110 USA; Washington Univ, Dept Cell Biol, Sch Med, St Louis, MO 63110 USA; St Louis Univ, Dept Pathol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Saint Louis University	McAlinden, A (corresponding author), Washington Univ, Dept Orthopaed Surg, Sch Med, 660 S Euclid Ave,Box 8233, St Louis, MO 63110 USA.	amcalind@msnotes.wustl.edu		McAlinden, Audrey/0000-0001-8433-4224; Davies, Sherri/0000-0002-7141-8354	NIAMS NIH HHS [AR48250, AR036994] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036994, R03AR048250] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Aigner T, 1999, ARTHRITIS RHEUM, V42, P1443, DOI 10.1002/1529-0131(199907)42:7<1443::AID-ANR18>3.0.CO;2-A; ALAKOKKO L, 1995, BIOCHEM J, V308, P923, DOI 10.1042/bj3080923; Atkinson BL, 1997, J CELL BIOCHEM, V65, P325, DOI 10.1002/(SICI)1097-4644(19970601)65:3<325::AID-JCB3>3.0.CO;2-U; BALVAY L, 1993, BIOESSAYS, V15, P165, DOI 10.1002/bies.950150304; BALVAY L, 1992, NUCLEIC ACIDS RES, V20, P3987, DOI 10.1093/nar/20.15.3987; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Burge CB, 1999, RNA WORLD, P525; CAPUTI M, 1994, NUCLEIC ACIDS RES, V22, P1018, DOI 10.1093/nar/22.6.1018; Carstens RP, 2000, MOL CELL BIOL, V20, P7388, DOI 10.1128/MCB.20.19.7388-7400.2000; Charlet-B N, 2002, MOL CELL, V9, P649, DOI 10.1016/S1097-2765(02)00479-3; Chen YW, 2001, MATRIX BIOL, V20, P589, DOI 10.1016/S0945-053X(01)00169-X; Coleman TP, 1998, BIOCHEMISTRY-US, V37, P15941, DOI 10.1021/bi9808058; COOPER TA, 1985, J BIOL CHEM, V260, P1140; COOPER TA, 2001, SCI STKE; D'Souza I, 2002, J BIOL CHEM, V277, P26587, DOI 10.1074/jbc.M203794200; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; DELGATTO F, 1995, MOL CELL BIOL, V15, P4825; DELGATTO F, 1997, MOL CELL BIOL, V18, P2205; Denker AE, 1999, DIFFERENTIATION, V64, P67, DOI 10.1046/j.1432-0436.1999.6420067.x; Dirksen WP, 2003, J BIOL CHEM, V278, P9722, DOI 10.1074/jbc.M207969200; Dirksen WP, 2000, AM J PHYSIOL-CELL PH, V278, pC589, DOI 10.1152/ajpcell.2000.278.3.C589; DORVAL BC, 1991, SCIENCE, V252, P1823, DOI 10.1126/science.2063195; ESTES PA, 1992, J BIOL CHEM, V267, P14902; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fernandes RJ, 1997, EUR J BIOCHEM, V247, P620, DOI 10.1111/j.1432-1033.1997.00620.x; FISZMAN MY, 1992, SYM SOC EXP BIOL, V46, P355; Forch P, 2002, EMBO J, V21, P6882, DOI 10.1093/emboj/cdf668; FUJITA H, 1991, BIOCHEM BIOPH RES CO, V174, P946, DOI 10.1016/0006-291X(91)91510-J; Gallego ME, 1996, BIOCHIMIE, V78, P457, DOI 10.1016/0300-9084(96)84752-3; Gallego ME, 1997, EMBO J, V16, P1772, DOI 10.1093/emboj/16.7.1772; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; GOODING C, 1994, EMBO J, V13, P3861, DOI 10.1002/j.1460-2075.1994.tb06697.x; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Grover A, 1999, J BIOL CHEM, V274, P15134, DOI 10.1074/jbc.274.21.15134; Guil S, 2003, MOL CELL BIOL, V23, P2927, DOI 10.1128/MCB.23.8.2927-2941.2003; Hatano H, 2002, J ORTHOPAED RES, V20, P516, DOI 10.1016/S0736-0266(01)00123-1; Hertel KJ, 1997, CURR OPIN CELL BIOL, V9, P350, DOI 10.1016/S0955-0674(97)80007-5; Hou VC, 2001, CURR OPIN HEMATOL, V8, P74, DOI 10.1097/00062752-200103000-00003; Ihanamaki T, 2002, CURR EYE RES, V24, P439, DOI 10.1076/ceyr.24.6.439.8594; Ismaili N, 2001, RNA, V7, P182, DOI 10.1017/S1355838201001807; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Larrain J, 2000, DEVELOPMENT, V127, P821; LAVIGUEUR A, 1993, GENE DEV, V7, P2405, DOI 10.1101/gad.7.12a.2405; LIBRI D, 1990, MOL CELL BIOL, V10, P5036, DOI 10.1128/MCB.10.10.5036; Liu ZR, 2002, MOL CELL BIOL, V22, P5443, DOI 10.1128/MCB.22.15.5443-5450.2002; LUI VCH, 1995, DEV DYNAM, V203, P198, DOI 10.1002/aja.1002030208; Mackie EJ, 1998, MICROSC RES TECHNIQ, V43, P102; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McAlinden Audrey, 2004, Birth Defects Res C Embryo Today, V72, P51, DOI 10.1002/bdrc.20004; Muro AF, 1999, MOL CELL BIOL, V19, P2657; NG LJ, 1993, DEV BIOL, V159, P403, DOI 10.1006/dbio.1993.1251; Nishiyama T, 2003, J BONE MINER RES, V18, P1716, DOI 10.1359/jbmr.2003.18.9.1716; Ohe K, 2002, P NATL ACAD SCI USA, V99, P1146, DOI 10.1073/pnas.022645899; Puig O, 1999, GENE DEV, V13, P569, DOI 10.1101/gad.13.5.569; Reardon A, 2000, MATRIX BIOL, V19, P169, DOI 10.1016/S0945-053X(00)00058-5; ROESSER JR, 1993, J BIOL CHEM, V268, P8366; RYAN MC, 1990, J BIOL CHEM, V265, P10334; SANDELL LJ, 1994, DEV DYNAM, V199, P129, DOI 10.1002/aja.1001990206; Schaal TD, 1999, MOL CELL BIOL, V19, P261; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shukla S, 2004, J BIOL CHEM, V279, P13668, DOI 10.1074/jbc.M314138200; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Tange TO, 2001, EMBO J, V20, P5748; Uporova TM, 2000, J CELL BIOCHEM, V76, P341; Valcarcel J, 1996, TRENDS BIOCHEM SCI, V21, P296, DOI 10.1016/0968-0004(96)10039-6; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zhang D, 1999, GENE DEV, V13, P581, DOI 10.1101/gad.13.5.581; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	78	36	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32700	32711		10.1074/jbc.M505940200	http://dx.doi.org/10.1074/jbc.M505940200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16076844	hybrid			2022-12-27	WOS:000231920300020
J	Robert, X; Haser, R; Mori, H; Svensson, B; Aghajari, N				Robert, X; Haser, R; Mori, H; Svensson, B; Aghajari, N			Oligosaccharide binding to barley alpha-amylase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ALPHA-AMYLASE; X-RAY-STRUCTURE; 2.1 ANGSTROM RESOLUTION; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; STARCH-BINDING; CYCLODEXTRIN GLYCOSYLTRANSFERASE; STRUCTURAL-ANALYSIS; CATALYTIC (BETA/ALPHA)(8)-BARREL; COMPLEX STRUCTURES	Enzymatic subsite mapping earlier predicted 10 binding subsites in the active site substrate binding cleft of barley alpha-amylase isozymes. The three-dimensional structures of the oligosaccharide complexes with barley alpha-amylase isozyme 1 (AMY1) described here give for the first time a thorough insight into the substrate binding by describing residues defining 9 subsites, namely -7 through +2. These structures support that the pseudotetrasaccharide inhibitor acarbose is hydrolyzed by the active enzymes. Moreover, sugar binding was observed to the starch granule-binding site previously determined in barley alpha-amylase isozyme 2 (AMY2), and the sugar binding modes are compared between the two isozymes. The "sugar tongs" surface binding site discovered in the AMY1-thio-DP4 complex is confirmed in the present work. A site that putatively serves as an entrance for the substrate to the active site was proposed at the glycone part of the binding cleft, and the crystal structures of the catalytic nucleophile mutant (AMY1(D180A)) complexed with acarbose and maltoheptaose, respectively, suggest an additional role for the nucleophile in the stabilization of the Michaelis complex. Furthermore, probable roles are outlined for the surface binding sites. Our data support a model in which the two surface sites in AMY1 can interact with amylose chains in their naturally folded form. Because of the specificities of these two sites, they may locate/orient the enzyme in order to facilitate access to the active site for polysaccharide chains. Moreover, the sugar tongs surface site could also perform the unraveling of amylose chains, with the aid of Tyr-380 acting as "molecular tweezers."	UCBL 1, UMR 5086, CNRS,IFR 128 BioSci Lyon Gerland, Inst Biol & Chim Prot,Lab BioCristallog, F-69367 Lyon, France; Carlsberg Lab, Dept Chem, DK-2500 Copenhagen, Denmark; Tech Univ Denmark, Bioctr, Biochem & Nutr Grp, DK-2800 Lyngby, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Technical University of Denmark	Aghajari, N (corresponding author), UCBL 1, UMR 5086, CNRS,IFR 128 BioSci Lyon Gerland, Inst Biol & Chim Prot,Lab BioCristallog, 7 Passage Vercors, F-69367 Lyon, France.	n.aghajari@ibcp.fr	ROBERT, Xavier/C-3879-2015; Aghajari, Nushin B.H./P-1906-2016	ROBERT, Xavier/0000-0002-6174-8595; Aghajari, Nushin B.H./0000-0002-2245-2679; Svensson, Birte/0000-0002-2993-8196				Abe A, 2004, J MOL BIOL, V335, P811, DOI 10.1016/j.jmb.2003.10.078; Aghajari N, 2002, BIOCHEMISTRY-US, V41, P4273, DOI 10.1021/bi0160516; AJANDOUZ EH, 1992, BIOCHIM BIOPHYS ACTA, V1159, P193, DOI 10.1016/0167-4838(92)90025-9; Andre G, 1999, BIOPOLYMERS, V50, P751, DOI 10.1002/(SICI)1097-0282(199912)50:7<751::AID-BIP8>3.3.CO;2-X; Bak-Jensen KS, 2004, J BIOL CHEM, V279, P10093, DOI 10.1074/jbc.M312825200; BOZONNET S, 2005, IN PRESS BIOL BRATIS, V60; Brayer GD, 2000, BIOCHEMISTRY-US, V39, P4778, DOI 10.1021/bi9921182; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; Brzozowski AM, 2000, BIOCHEMISTRY-US, V39, P9099, DOI 10.1021/bi0000317; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Coutinho PM, 1999, ROY SOC CH, P3; DATTA AK, 1995, NUCLEIC ACIDS RES, V23, P4530, DOI 10.1093/nar/23.21.4530; Dauter Z, 1999, BIOCHEMISTRY-US, V38, P8385, DOI 10.1021/bi990256l; Davies GJ, 2005, ACTA CRYSTALLOGR D, V61, P190, DOI 10.1107/S0907444904027118; delRio G, 1997, FEBS LETT, V416, P221, DOI 10.1016/S0014-5793(97)01192-7; Fujimoto Z, 1998, J MOL BIOL, V277, P393, DOI 10.1006/jmbi.1997.1599; Gessler K, 1999, P NATL ACAD SCI USA, V96, P4246, DOI 10.1073/pnas.96.8.4246; GIBSON RM, 1987, CARLSBERG RES COMMUN, V52, P373, DOI 10.1007/BF02907525; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; IMBERTY A, 1988, J MOL BIOL, V201, P365, DOI 10.1016/0022-2836(88)90144-1; IMBERTY A, 1989, INT J BIOL MACROMOL, V11, P177, DOI 10.1016/0141-8130(89)90065-2; Jensen MT, 2003, J CEREAL SCI, V38, P289, DOI 10.1016/S0733-5210(03)00032-8; Juge N, 1996, PROTEIN EXPRES PURIF, V8, P204, DOI 10.1006/prep.1996.0093; Kadziola A, 1998, J MOL BIOL, V278, P205, DOI 10.1006/jmbi.1998.1683; Kagawa M, 2003, J BACTERIOL, V185, P6981, DOI 10.1128/JB.185.23.6981-6984.2003; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; KNEGTEL RMK, 1995, J BIOL CHEM, V270, P29256, DOI 10.1074/jbc.270.49.29256; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, P50; Li CM, 2005, BIOCHEMISTRY-US, V44, P3347, DOI 10.1021/bi048334e; Linden A, 2003, J BIOL CHEM, V278, P9875, DOI 10.1074/jbc.M211339200; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; MACGREGOR EA, 1994, CARBOHYD RES, V257, P249, DOI 10.1016/0008-6215(94)80039-1; Machius M, 1996, J MOL BIOL, V260, P409, DOI 10.1006/jmbi.1996.0410; Matsui I, 1997, J BIOL CHEM, V272, P22456, DOI 10.1074/jbc.272.36.22456; MCFEETERS RF, 1980, ANAL BIOCHEM, V103, P302, DOI 10.1016/0003-2697(80)90614-4; Mori H, 2002, EUR J BIOCHEM, V269, P5377, DOI 10.1046/j.1432-1033.2002.03185.x; Mori H, 2001, EUR J BIOCHEM, V268, P6545, DOI 10.1046/j.0014-2956.2001.02609.x; MUNDY J, 1983, CARLSBERG RES COMMUN, V48, P81, DOI 10.1007/BF02906171; Ohtaki A, 2004, J BIOL CHEM, V279, P31033, DOI 10.1074/jbc.M404311200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payan F, 2003, J PROTEIN CHEM, V22, P275, DOI 10.1023/A:1025072520607; Przylas I, 2000, J MOL BIOL, V296, P873, DOI 10.1006/jmbi.1999.3503; QIAN MX, 1995, PROTEIN SCI, V4, P747; QIAN MX, 1994, BIOCHEMISTRY-US, V33, P6284, DOI 10.1021/bi00186a031; Qian MX, 2001, BIOCHEMISTRY-US, V40, P7700, DOI 10.1021/bi0102050; Ramasubbu N, 2003, J MOL BIOL, V325, P1061, DOI 10.1016/S0022-2836(02)01326-8; Robert X, 2003, STRUCTURE, V11, P973, DOI 10.1016/S0969-2126(03)00151-5; Robert X, 2002, BIOLOGIA, V57, P59; Robert X, 2002, ACTA CRYSTALLOGR D, V58, P683, DOI 10.1107/S090744490200166X; Rodenburg KW, 2000, EUR J BIOCHEM, V267, P1019, DOI 10.1046/j.1432-1327.2000.01094.x; ROUSSEL A, 1992, BIOGRAPHICS; Sambrook J., 1989, MOL CLONING, pA1; Skov LK, 2002, J BIOL CHEM, V277, P47741, DOI 10.1074/jbc.M207860200; SOGAARD M, 1990, GENE, V94, P173, DOI 10.1016/0378-1119(90)90384-4; SOGAARD M, 1993, J BIOL CHEM, V268, P22480; Uitdehaag JCM, 1999, J BIOL CHEM, V274, P34868, DOI 10.1074/jbc.274.49.34868; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; VILLETTE JR, 1992, BIOTECHNOL APPL BIOC, V16, P57; WESELAKE RJ, 1983, CEREAL CHEM, V60, P98	62	60	61	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32968	32978		10.1074/jbc.M505515200	http://dx.doi.org/10.1074/jbc.M505515200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16030022	hybrid			2022-12-27	WOS:000231920300051
J	Iram, SH; Cronan, JE				Iram, SH; Cronan, JE			Unexpected functional diversity among FadR fatty acid transcriptional regulatory proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACYL-COENZYME; INDUCIBLE SYSTEM; GENE FADR; METABOLISM; BINDING; DEGRADATION; CONSTRUCTION; POLYMERASE; EXPRESSION	The FadR protein of Escherichia coli has been shown to play a dual role in transcription of the genes of bacterial fatty acid metabolism. The protein acts as a repressor of beta-oxidation and an activator of unsaturated fatty acid synthesis. FadR DNA binding is antagonized by long chain acyl-CoAs, and thus FadR acts as a sensor of fatty acid availability in the environment. When viewed from a genomic viewpoint, FadR proteins are unusual in that the DNA binding domain is very highly conserved among FadR-containing bacteria, whereas the C-terminal acyl-CoA binding domain shows only weak conservation. To further our understanding of the role of FadR in bacterial lipid metabolism we have examined the in vivo and in vitro properties of a diverse set of FadR proteins expressed in E. coli. In addition to E. coli FadR the proteins examined were those of Salmonella enterica, Vibrio cholerae, Pasteurella multocida, and Haemophilus influenzae. These FadR proteins were found to differ markedly in their effects on repression and induction of beta-oxidation in E. coli and in their acyl-CoA binding abilities as measured by isothermal titration calorimetry. The E. coli and S. enterica proteins were the most similar, although they differed in their effects on utilization of oleic acid and acyl-CoA binding affinities, whereas the P. multocida and H. influenzae proteins showed only weak repression and poor acyl-CoA binding affinities. The V. cholerae FadR was strikingly superior to the other proteins in the amplitude of its regulatory response, and it bound long chain acyl-CoAs appreciably more strongly than the E. coli and S. enterica proteins. The significance of these findings is discussed in view of the protein sequences and the physiological niches occupied by these organisms.	Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, Urbana, IL 61801 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Iram, Surtaj Hussain/T-5510-2019; Cronan, John/V-6626-2019	Iram, Surtaj/0000-0002-0672-0936	NIAID NIH HHS [AI15650] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BLACK PN, 1994, BBA-LIPID LIPID MET, V1210, P123, DOI 10.1016/0005-2760(94)90113-9; BRENNAN RG, 1993, CELL, V74, P773, DOI 10.1016/0092-8674(93)90456-Z; Campbell JW, 2003, MOL MICROBIOL, V47, P793, DOI 10.1046/j.1365-2958.2003.03341.x; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; CLARK D, 1981, J BACTERIOL, V148, P521, DOI 10.1128/JB.148.2.521-526.1981; Clark D. P., 1996, ESCHERICHIA COLI SAL, P343; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DiRusso CC, 1998, J BIOL CHEM, V273, P33652, DOI 10.1074/jbc.273.50.33652; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; DIRUSSO CC, 1985, J BACTERIOL, V161, P583, DOI 10.1128/JB.161.2.583-588.1985; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gui LZ, 1996, J BACTERIOL, V178, P4704, DOI 10.1128/jb.178.15.4704-4709.1996; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; HENRY MF, 1992, CELL, V70, P671, DOI 10.1016/0092-8674(92)90435-F; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KLEIN K, 1971, EUR J BIOCHEM, V19, P442, DOI 10.1111/j.1432-1033.1971.tb01334.x; MILLER JH, 1992, SHORT COURSE BACTERI, P268; Miller JH, 1972, EXPT MOL GENETICS, P201; NUNN WD, 1983, J BACTERIOL, V154, P554, DOI 10.1128/JB.154.2.554-560.1983; NUNN WD, 1986, J BIOL CHEM, V261, P167; OVERATH P, 1969, EUR J BIOCHEM, V7, P559; PAULI G, 1972, EUR J BIOCHEM, V29, P553, DOI 10.1111/j.1432-1033.1972.tb02021.x; Raman N, 1997, J BIOL CHEM, V272, P30645, DOI 10.1074/jbc.272.49.30645; RAMAN N, 1995, J BIOL CHEM, V270, P1092, DOI 10.1074/jbc.270.3.1092; Sadovskaya NS, 2001, MOL BIOL+, V35, P862, DOI 10.1023/A:1013238318852; SIMONS RW, 1980, J BACTERIOL, V143, P726, DOI 10.1128/JB.143.2.726-730.1980; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; van Aalten DMF, 2000, EMBO J, V19, P5167, DOI 10.1093/emboj/19.19.5167; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; Wang HH, 2003, J BACTERIOL, V185, P4930, DOI 10.1128/JB.185.16.4930-4937.2003; WEEKS G, 1970, J BIOL CHEM, V245, P1913; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200	37	40	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32148	32156		10.1074/jbc.M504054200	http://dx.doi.org/10.1074/jbc.M504054200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16027119	hybrid			2022-12-27	WOS:000231794800015
J	Mizuarai, S; Miki, S; Araki, H; Takahashi, K; Kotani, H				Mizuarai, S; Miki, S; Araki, H; Takahashi, K; Kotani, H			Identification of dicarboxylate carrier Slc25a10 as malate transporter in de novo fatty acid synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; ACETYL-COA CARBOXYLASE; WHITE ADIPOSE-TISSUE; CAENORHABDITIS-ELEGANS; MICROARRAY ANALYSIS; GENE-EXPRESSION; TRICARBOXYLATE; CITRATE; MICE; CELLS	Mitochondrial solute carrier family 25 member 10 (Slc25a10) transports dicarboxylates such as malate or succinate across the mitochondrial inner membrane. Although fatty acid synthesis in adipose tissue or the liver is initiated by citrate transport in exchange for malate across the mitochondrial membrane, the transporter responsible for supplying malate during citrate transport has not been identified. In the present study, we clarified the role of Slc25a10 in supplying malate for citrate transport and examined the effect of Slc25a10 suppression on the lipogenic pathway and lipid accumulation. We have reported an Slc25a10 increase in white adipose tissue in obese mouse models and a decrease in a fasted mouse model using expression profiles. Next, we examined the effect of Slc25a10 suppression by small interfering RNA on citrate transport in the lipogenic cell lines HepG2 and 3T3-L1. We observed that inhibition of malate transport by Slc25a10 suppression significantly reduced the citrate transport from the mitochondria to the cytosol. We also found that suppression of Slc25a10 down-regulated the lipogenic pathway, indicated by decreases in ACC1 expression and malonyl-CoA level. Furthermore, suppression of Slc25a10 decreased triglyceride lipid accumulation in adipose-differentiated 3T3-L1 cells. These results suggested that Slc25a10 plays an important role in supplying malate for citrate transport required for fatty acid synthesis and indicated that inhibition of Slc25a10 might effectively reduce lipid accumulation in adipose tissues.	Banyu Pharmaceut Co Ltd, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan	Merck & Company; Novartis	Kotani, H (corresponding author), Banyu Pharmaceut Co Ltd, Tsukuba Res Inst, Okubo 3, Tsukuba, Ibaraki 3002611, Japan.	hidehito_kotani@merck.com						Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Das K, 1999, BIOCHEM J, V344, P313, DOI 10.1042/0264-6021:3440313; Deng X, 2004, ENDOCRINOLOGY, V145, P5847, DOI 10.1210/en.2004-0371; Fei YJ, 2004, BIOCHEM J, V379, P191, DOI 10.1042/BJ20031807; Fiermonte G, 1998, J BIOL CHEM, V273, P24754, DOI 10.1074/jbc.273.38.24754; GUO KY, 2004, AM J PHYSIOL, V28, pR122; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Harwood HJ, 2003, J BIOL CHEM, V278, P37099, DOI 10.1074/jbc.M304481200; INDIVERI C, 1993, BIOCHIM BIOPHYS ACTA, V1143, P310, DOI 10.1016/0005-2728(93)90202-Q; Inoue K, 2002, BIOCHEM J, V367, P313, DOI 10.1042/BJ20021132; Kajimoto K, 2005, MOL GENET METAB, V85, P46, DOI 10.1016/j.ymgme.2005.01.006; KAPLAN RS, 1990, J BIOL CHEM, V265, P13379; KEAY S, 1980, P NATL ACAD SCI-BIOL, V77, P4099, DOI 10.1073/pnas.77.7.4099; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Lopez IP, 2003, OBES RES, V11, P188, DOI 10.1038/oby.2003.30; LOWRY OH, 1972, FLEXIBLE SYSTEM ENZY, P149; Majima E, 2001, J BIOL CHEM, V276, P9792, DOI 10.1074/jbc.M007222200; Mao JQ, 2003, P NATL ACAD SCI USA, V100, P7515, DOI 10.1073/pnas.1332670100; Mashiko S, 2003, ENDOCRINOLOGY, V144, P1793, DOI 10.1210/en.2002-0119; Matsuzaka T, 2002, J LIPID RES, V43, P911; Munday MR, 2002, BIOCHEM SOC T, V30, P1059, DOI 10.1042/bst0301059; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; ROBINSON BH, 1970, EUR J BIOCHEM, V15, P263, DOI 10.1111/j.1432-1033.1970.tb01003.x; ROBINSON BH, 1971, EUR J BIOCHEM, V20, P65, DOI 10.1111/j.1432-1033.1971.tb01363.x; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Takahashi K, 2003, J BIOL CHEM, V278, P46654, DOI 10.1074/jbc.M309895200; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Unami A, 2004, BIOCHEM PHARMACOL, V67, P555, DOI 10.1016/j.bcp.2003.09.010; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WATSON JA, 1970, J BIOL CHEM, V245, P5993; ZARA V, 1995, BBA-BIOMEMBRANES, V1239, P33, DOI 10.1016/0005-2736(95)00125-M	32	58	59	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32434	32441		10.1074/jbc.M503152200	http://dx.doi.org/10.1074/jbc.M503152200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16027120	hybrid			2022-12-27	WOS:000231794800050
J	Graveleau, C; Zaha, VG; Mohajer, A; Banerjee, RR; Dudley-Rucker, N; Steppan, CM; Rajala, MW; Scherer, PE; Ahima, RS; Lazar, MA; Abel, ED				Graveleau, C; Zaha, VG; Mohajer, A; Banerjee, RR; Dudley-Rucker, N; Steppan, CM; Rajala, MW; Scherer, PE; Ahima, RS; Lazar, MA; Abel, ED			Mouse and human resistins impair glucose transport in primary mouse cardiomyocytes, and oligomerization is required for this biological action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; EXPRESSION; OBESITY; GENE; ASSOCIATION; CELLS; ACRP30/ADIPONECTIN	The adipocytokine resistin impairs glucose tolerance and insulin sensitivity in rodents. Here, we examined the effect of resistin on glucose uptake in isolated adult mouse cardiomyocytes. Murine resistin reduced insulin-stimulated glucose uptake, establishing the heart as a resistin target tissue. Notably, human resistin also impaired insulin action in mouse cardiomyocytes, providing the first evidence that human and mouse resistin homologs have similar functions. Resistin is a cysteine-rich molecule that circulates as a multimer of a dimeric form dependent upon a single intermolecular disulfide bond, which, in the mouse, involves Cys(26); mutation of this residue to alanine (C26A) produces a monomeric molecule that appears to be bioactive in the liver. Remarkably, unlike native resistin, monomeric C26A resistin had no effect on basal or insulin-stimulated glucose uptake in mouse cardiomyocytes. Resistin impairs glucose uptake in cardiomyocytes by mechanisms that involve altered vesicle trafficking. Thus, in cardiomyocytes, both mouse and human resistins directly impair glucose transport; and in contrast to effects on the liver, these actions of resistin require oligomerization.	Univ Utah, Sch Med, Div Endocrinol Diabet & Metab, Salt Lake City, UT 84112 USA; Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA; Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Pennsylvania; Yeshiva University; Albert Einstein College of Medicine	Abel, ED (corresponding author), Univ Utah, Sch Med, Div Endocrinol Diabet & Metab, 15 North 2030 East,Bldg 533,Rm 3410B, Salt Lake City, UT 84112 USA.	dale.abel@hmbg.utah.edu	Scherer, Philipp E/K-7819-2012; Banerjee, Ronadip/U-6649-2019; Ahima, Rexford/W-1394-2019; Lazar, Mitchell A/AAF-3738-2019	Scherer, Philipp E/0000-0003-0680-3392; Zaha, Vlad/0000-0003-4878-891X; Abel, E. Dale/0000-0001-5290-0738	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK058073, R01DK049780, P01DK049210, R01DK055758, R01DK092065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK55758, DK49210, DK49780, DK58073, R01 DK092065] Funding Source: Medline; NIGMS NIH HHS [T32-GM07288] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abel ED, 2004, MOL ENDOCRINOL, V18, P2491, DOI 10.1210/me.2004-0175; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Banerjee RR, 2003, J MOL MED, V81, P218, DOI 10.1007/s00109-003-0428-9; Banerjee RR, 2001, J BIOL CHEM, V276, P25970, DOI 10.1074/jbc.M103109200; Belke DD, 2002, J CLIN INVEST, V109, P629, DOI 10.1172/JCI200213946; Chen J, 2002, J ENDOCRINOL, V175, P499, DOI 10.1677/joe.0.1750499; ECKEL J, 1985, BASIC RES CARDIOL, V80, P103; Engert JC, 2002, DIABETES, V51, P1629, DOI 10.2337/diabetes.51.5.1629; Fain JN, 2003, BIOCHEM BIOPH RES CO, V300, P674, DOI 10.1016/S0006-291X(02)02864-4; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Jonke J, 2002, OBES RES, V10, P1; Kamin D, 2005, J CLIN ENDOCR METAB, V90, P3423, DOI 10.1210/jc.2005-0287; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Ma XW, 2002, J CLIN ENDOCR METAB, V87, P4407, DOI 10.1210/jc.2002-020109; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; McTernan PG, 2002, J CLIN ENDOCR METAB, V87, P2407, DOI 10.1210/jc.87.5.2407; Moon B, 2003, AM J PHYSIOL-ENDOC M, V285, pE106, DOI 10.1152/ajpendo.00457.2002; Muse ED, 2004, J CLIN INVEST, V114, P232, DOI 10.1172/JCI200421270; Nagaev I, 2001, BIOCHEM BIOPH RES CO, V285, P561, DOI 10.1006/bbrc.2001.5173; Osawa H, 2004, AM J HUM GENET, V75, P678, DOI 10.1086/424761; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Patel SD, 2004, SCIENCE, V304, P1154, DOI 10.1126/science.1093466; Pravenec M, 2003, J BIOL CHEM, V278, P45209, DOI 10.1074/jbc.M304869200; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Rangwala SM, 2004, DIABETES, V53, P1937, DOI 10.2337/diabetes.53.8.1937; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Satoh H, 2004, J CLIN INVEST, V114, P224, DOI 10.1172/JCI200420785; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Sentinelli F, 2002, DIABETES, V51, P860, DOI 10.2337/diabetes.51.3.860; Steppan CM, 2005, MOL CELL BIOL, V25, P1569, DOI 10.1128/MCB.25.4.1569-1575.2005; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; TAEGTMEYER H, 1994, CURR PROB CARDIOLOGY, V19, P61, DOI 10.1016/0146-2806(94)90008-6; Tan MS, 2003, J CLIN ENDOCR METAB, V88, P1258, DOI 10.1210/jc.2002-021453; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Wang H, 2002, J CLIN ENDOCR METAB, V87, P2520, DOI 10.1210/jc.87.6.2520; Yang RZ, 2003, BIOCHEM BIOPH RES CO, V310, P927, DOI 10.1016/j.bbrc.2003.09.093	38	86	87	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31679	31685		10.1074/jbc.M504008200	http://dx.doi.org/10.1074/jbc.M504008200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15983036	hybrid			2022-12-27	WOS:000231665200044
J	Klein, JB; Barati, MT; Wu, R; Gozal, D; Sachleben, LR; Kausar, H; Trent, JO; Gozal, E; Rane, MJ				Klein, JB; Barati, MT; Wu, R; Gozal, D; Sachleben, LR; Kausar, H; Trent, JO; Gozal, E; Rane, MJ			Akt-mediated valosin-containing protein 97 phosphorylation regulates its association with ubiquitinated proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; RAT HIPPOCAMPAL SLICES; INTERMITTENT HYPOXIA; MEMBRANE-FUSION; CELL-DEATH; IN-VITRO; ACTIVATED PROTEIN-KINASE-2; TYROSINE PHOSPHORYLATION; PROTEOMIC IDENTIFICATION; GENOMIC CONSEQUENCES	Hypoxia is a common environmental stress that influences signaling pathways and cell function. Previous studies from our laboratory have identified significant differences in cellular responses to sustained or intermittent hypoxia with the latter proving more cytotoxic. We hypothesized that differences in susceptibility of neurons to intermittent ( IH) and sustained hypoxia ( SH) are mediated by altered Akt signaling. SH, but not IH, induced a significant increase in Akt activation in rat CA1 hippocampal region extracts compared with room air controls. Akt immunoprecipitations followed by proteomic analysis identified valosin-containing protein ( VCP) as an Akt-binding protein. In addition, VCP expression and association with Akt was enhanced during SH, and this association was decreased upon phosphoinositide 3-kinase/Akt pathway blockade with LY294002. Active recombinant Akt phosphorylated recombinant VCP in vitro. Site-directed mutagenesis studies identified Ser(352), Ser(746), and Ser(748) as Akt phosphorylation sites on VCP. In addition, rat CA1 hippocampal tissue exposed to SH exhibited an acidic pI shift of VCP. Protein phosphatase 2A treatment inhibited this acidic shift consistent with SH-induced phosphorylation of VCP in vivo. PC-12 cells transfected with active Akt, but not dominant negative Akt or vector, induced VCP expression and an acidic shift in VCP pI, which was inhibited by protein phosphatase 2A treatment. Furthermore, VCP association with ubiquitinated proteins was demonstrated in vector-transfected PC-12 cell lysates, whereas active Akt-transfected cells demonstrated a marked decrease in association of VCP with ubiquitinated proteins. We concluded that Akt phosphorylates VCP in vitro and in vivo, and VCP phosphorylation releases it from ubiquitinated substrate protein( s) possibly allowing ubiquitinated protein( s) to be degraded by the proteosome.	Univ Louisville, Core Proteom Lab, Louisville, KY 40202 USA; Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; Univ Louisville, Dept Med, Louisville, KY 40202 USA; Vet Affairs Med Ctr, Louisville, KY 40206 USA; Univ Louisville, Dept Pediat, Louisville, KY 40202 USA; Univ Louisville, Dept Pharmacol, Louisville, KY 40202 USA; Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Louisville; University of Louisville; University of Louisville	Rane, MJ (corresponding author), Univ Louisville, Core Proteom Lab, 570 S Preston St,Baxter 1 Bldg South 102C, Louisville, KY 40202 USA.	mrane@louisville.edu	Klein, Jon/B-9833-2013; Gozal, David/M-9492-2017; Gozal, David/ABH-3805-2020	trent, John/0000-0002-7346-4231	NHLBI NIH HHS [HL69932, HL66358, HL074296] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066358, R01HL074296, R01HL069932] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bernaudin M, 1998, EXP NEUROL, V150, P30, DOI 10.1006/exnr.1997.6728; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; DAVOLIO C, 1995, NEUROSCI LETT, V192, P29, DOI 10.1016/0304-3940(95)11600-2; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; FLETCHER EC, 1995, AM J MED, V98, P118, DOI 10.1016/S0002-9343(99)80395-7; Geussova G, 2002, MOL REPROD DEV, V63, P366, DOI 10.1002/mrd.10156; Gozal D, 1998, PEDIATRICS, V102, P616, DOI 10.1542/peds.102.3.616; Gozal D, 2001, J NEUROSCI, V21, P2442, DOI 10.1523/JNEUROSCI.21-07-02442.2001; Gozal E, 2002, J NEUROCHEM, V83, P331, DOI 10.1046/j.1471-4159.2002.01134.x; Gozal E, 2001, NEUROSCI LETT, V305, P197, DOI 10.1016/S0304-3940(01)01853-5; Gozal E, 2001, J APPL PHYSIOL, V90, P1995, DOI 10.1152/jappl.2001.90.5.1995; GOZAL E, 2004, AM J PHYSIOL, V288, pC535; Hatakeyama S, 2004, GENES CELLS, V9, P533, DOI 10.1111/j.1356-9597.2004.00742.x; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hirai K, 2004, MOL BRAIN RES, V124, P51, DOI 10.1016/j.molbrainres.2004.02.009; Hui AS, 2003, HYPERTENSION, V42, P1130, DOI 10.1161/01.HYP.0000101691.12358.26; Imamura S, 2003, FEBS LETT, V549, P14, DOI 10.1016/S0014-5793(03)00723-3; Ishigaki S, 2004, J BIOL CHEM, V279, P51376, DOI 10.1074/jbc.M406683200; Kadar T, 1998, J NEURAL TRANSM, V105, P987, DOI 10.1007/s007020050107; Klein JB, 2003, RESP PHYSIOL NEUROBI, V136, P91, DOI 10.1016/S1569-9048(03)00074-0; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kreisman NR, 2000, J NEUROPHYSIOL, V83, P1031, DOI 10.1152/jn.2000.83.2.1031; Kreisman NR, 1999, J NEUROPHYSIOL, V82, P320, DOI 10.1152/jn.1999.82.1.320; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lavoie C, 2000, P NATL ACAD SCI USA, V97, P13637, DOI 10.1073/pnas.240278097; Lawlor MA, 2001, J CELL SCI, V114, P2903; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; Maurizi Michael R., 2001, EMBO Reports, V2, P980, DOI 10.1093/embo-reports/kve229; Mayr PSM, 1999, EUR J CELL BIOL, V78, P224, DOI 10.1016/S0171-9335(99)80055-7; NABETANI M, 1994, DEV NEUROSCI-BASEL, V16, P301, DOI 10.1159/000112123; Nagahama M, 2003, MOL BIOL CELL, V14, P262, DOI 10.1091/mbc.02-07-0115; Neubauer JA, 2001, J APPL PHYSIOL, V90, P1593, DOI 10.1152/jappl.2001.90.4.1593; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Partridge JJ, 2003, MOL BIOL CELL, V14, P4221, DOI 10.1091/mbc.E03-02-0111; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; PLEASURE IT, 1993, NATURE, V365, P459, DOI 10.1038/365459a0; Powell DW, 2003, MOL CELL BIOL, V23, P5376, DOI 10.1128/MCB.23.15.5376-5387.2003; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Rao RV, 2004, J BIOL CHEM, V279, P177, DOI 10.1074/jbc.M304490200; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Saito A, 2004, J NEUROSCI, V24, P1584, DOI 10.1523/JNEUROSCI.5209-03.2004; Singh S, 2003, J BIOL CHEM, V278, P36410, DOI 10.1074/jbc.M306428200; STRASSER U, 1995, BRAIN RES, V687, P167, DOI 10.1016/0006-8993(95)00519-V; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Thongboonkerd V, 2002, J BIOL CHEM, V277, P16599, DOI 10.1074/jbc.M200746200; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Vakser IA, 1996, BIOPOLYMERS, V39, P455, DOI 10.1002/(SICI)1097-0282(199609)39:3<455::AID-BIP16>3.3.CO;2-8; Vakser IA, 1997, PROTEINS, P226; Vakser IA, 1996, PROTEIN ENG, V9, P741, DOI 10.1093/protein/9.9.741; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Waugh MG, 2003, BIOCHEM J, V373, P57, DOI 10.1042/BJ20030089; Wilde GJC, 1997, J NEUROCHEM, V69, P883; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yamada T, 2000, FEBS LETT, V466, P287, DOI 10.1016/S0014-5793(99)01673-7; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002; Zhang SH, 1999, J BIOL CHEM, V274, P17806, DOI 10.1074/jbc.274.25.17806; Zhang SXL, 2003, FASEB J, V17, P1709, DOI 10.1096/fj.02-1111fje; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200; Zwickl P, 1999, NAT CELL BIOL, V1, pE97, DOI 10.1038/12097	74	52	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31870	31881		10.1074/jbc.M501802200	http://dx.doi.org/10.1074/jbc.M501802200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16027165	hybrid			2022-12-27	WOS:000231665200066
J	Park, IH; Chen, J				Park, IH; Chen, J			Mammalian target of rapamycin (mTOR) signaling is required for a late-stage fusion process during skeletal myotube maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR BINDING PROTEIN-5; P70 S6 KINASE; SATELLITE CELL-ACTIVITY; EXTRACELLULAR-MATRIX; SENSITIVE PATHWAY; MUSCLE GROWTH; DIFFERENTIATION; PHOSPHORYLATION; ACTIVATION; RAPTOR	Skeletal myogenesis is a well orchestrated cascade of events regulated by multiple signaling pathways, one of which is recently characterized by its sensitivity to the bacterial macrolide rapamycin. Previously we reported that the mammalian target of rapamycin (mTOR) regulates the initiation of the differentiation program in mouse C2C12 myoblasts by controlling the expression of insulin-like growth factor-II in a kinase-independent manner. Here we provide experimental evidence suggesting that a different mode of mTOR signaling regulates skeletal myogenesis at a later stage. In the absence of endogenous mTOR function in C2C12 cells treated with rapamycin, a kinase-inactive mTOR fully supports myogenin expression, but causes a delay in contractile protein expression. Myoblasts fuse to form nascent myotubes in the absence of kinase-active mTOR, whereas the formation of mature myotubes by further fusion requires the catalytic activity of mTOR. Therefore, the two stages of myocyte fusion are molecularly separable at the level of mTOR signaling. In addition, our data suggest that a factor secreted into the culture medium is responsible for mediating the function of mTOR in regulating the late-stage fusion leading to mature myotubes. Furthermore, taking advantage of the unique features of cells stably expressing a mutant mTOR, we have performed cDNA microarray analysis to compare global gene expression profiles between mature and nascent myotubes, the results of which have implicated classes of genes and revealed candidate regulators in myotube maturation or functions of mature myotubes.	Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Chen, J (corresponding author), 601 S Goodwin Ave,B107, Urbana, IL 61801 USA.	jiechen@uiuc.edu		Chen, Jie/0000-0002-7887-3747	NIAMS NIH HHS [AR48914] Funding Source: Medline; NIGMS NIH HHS [GM58064] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM058064, R01GM058064] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; Conejo R, 2001, J CELL PHYSIOL, V186, P82, DOI 10.1002/1097-4652(200101)186:1<82::AID-JCP1001>3.0.CO;2-R; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; DARR KC, 1989, J APPL PHYSIOL, V67, P1827, DOI 10.1152/jappl.1989.67.5.1827; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Horsley V, 2003, J CELL BIOL, V161, P111, DOI 10.1083/jcb.200208085; James PL, 1996, J CELL BIOL, V133, P683, DOI 10.1083/jcb.133.3.683; JAMES PL, 1993, J BIOL CHEM, V268, P22305; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; Moran JL, 2002, PHYSIOL GENOMICS, V10, P103, DOI 10.1152/physiolgenomics.00011.2002; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Phelan JN, 1997, ANAT REC, V247, P179, DOI 10.1002/(SICI)1097-0185(199702)247:2<179::AID-AR4>3.0.CO;2-T; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; ROTWEIN P, 1995, MOL ENDOCRINOL, V9, P913, DOI 10.1210/me.9.7.913; Rousse S, 1998, ENDOCRINOLOGY, V139, P1487, DOI 10.1210/en.139.4.1487; Shu LL, 2002, J BIOL CHEM, V277, P16726, DOI 10.1074/jbc.M112285200; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; Tang BL, 2001, INT J BIOCHEM CELL B, V33, P33, DOI 10.1016/S1357-2725(00)00061-3; Wilson EM, 2004, MOL BIOL CELL, V15, P497, DOI 10.1091/mbc.E03-05-0351; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0	45	68	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					32009	32017		10.1074/jbc.M506120200	http://dx.doi.org/10.1074/jbc.M506120200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16043480	hybrid			2022-12-27	WOS:000231665200081
J	Sobotka, R; Komenda, J; Bumba, L; Tichy, M				Sobotka, R; Komenda, J; Bumba, L; Tichy, M			Photosystem II assembly in CP47 mutant of Synechocystis sp PCC 6803 is dependent on the level of chlorophyll precursors regulated by ferrochelatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGONUCLEOTIDE-DIRECTED MUTAGENESIS; TETRAPYRROLE BIOSYNTHETIC-PATHWAY; DNA MICROARRAY ANALYSIS; GENE-EXPRESSION; PCC 6803; HISTIDINE-RESIDUES; HEME-BIOSYNTHESIS; BINDING PROTEIN; DIMETHYL ESTER; D1 PRECURSOR	Accumulation of chlorophyll and expression of the chlorophyll (Chl)-binding CP47 protein that serves as the core antenna of photosystem II are indispensable for the assembly of a functional photosystem II. We have characterized the CP47 mutant with an impaired photosystem II assembly and its two spontaneous pseudorevertants with their much improved photoautotrophic growth. The complementing mutations in these pseudorevertants were previously mapped to the ferrochelatase gene ( 1). We demonstrated that complementing mutations dramatically decrease ferrochelatase activity in pseudorevertants and that this decrease is responsible for their improved photoautotrophic growth. Photo-autotrophic growth of the CP47 mutant was also restored by in vivo inhibition of ferrochelatase by a specific inhibitor. The decrease in ferrochelatase activity in pseudorevertants was followed by increased steady-state levels of Chl precursors and Chl, leading to CP47 accumulation and photosystem II assembly. Similarly, supplementation of the CP47 mutant with the Chl precursor Mg-protoporphyrin IX increased the number of active photosystem-II centers, suggesting that synthesis of the mutated CP47 protein is enhanced by an increased Chl availability in the cell. The probable role of ferrochelatase in the regulation of Chl biosynthesis is discussed.	Univ S Bohemia, Inst Phys Biol, Nove Hrady 37333, Czech Republic; Inst Microbiol, Dept Autotroph Microorganisms, Trebon 37971, Czech Republic; Acad Sci Czech Republ, Inst Plant Mol Biol, CR-37005 Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Sobotka, R (corresponding author), Univ S Bohemia, Inst Phys Biol, Nove Hrady 37333, Czech Republic.	sobotka@alga.cz	Bumba, Ladislav/ABC-9943-2020; Bumba, Ladislav/H-2494-2014; Tichy, Martin/B-6545-2008; Komenda, Josef/H-4083-2014; Sobotka, Roman/J-3077-2014	Bumba, Ladislav/0000-0001-6659-5447; Tichy, Martin/0000-0003-2814-1959; Komenda, Josef/0000-0003-4588-0382; Sobotka, Roman/0000-0001-5909-3879				Bricker TM, 2002, PHOTOSYNTH RES, V72, P131, DOI 10.1023/A:1016128715865; CAMADRO JM, 1988, J BIOL CHEM, V263, P11675; Cornah JE, 2003, TRENDS PLANT SCI, V8, P224, DOI 10.1016/S1360-1385(03)00064-5; DEMATTEIS F, 1980, BIOCHEM J, V189, P645, DOI 10.1042/bj1890645; EATONRYE JJ, 1991, PLANT MOL BIOL, V17, P1165, DOI 10.1007/BF00028733; Eichacker LA, 1996, J BIOL CHEM, V271, P32174, DOI 10.1074/jbc.271.50.32174; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; HAAG E, 1993, BIOCHEMISTRY-US, V32, P4444, DOI 10.1021/bi00067a037; He QF, 1998, P NATL ACAD SCI USA, V95, P5830, DOI 10.1073/pnas.95.10.5830; Hihara Y, 2003, J BACTERIOL, V185, P1719, DOI 10.1128/JB.185.5.1719-1725.2003; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; HOUGHTON JD, 1982, BIOCHEM J, V208, P479, DOI 10.1042/bj2080479; Jung S, 2004, PLANT SCI, V167, P789, DOI 10.1016/j.plantsci.2004.05.038; KANAZIREVA E, 1995, J BACTERIOL, V177, P6693, DOI 10.1128/jb.177.22.6693-6694.1995; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Manna P, 1997, EUR J BIOCHEM, V247, P666, DOI 10.1111/j.1432-1033.1997.00666.x; Matsumoto F, 2004, PLANT PHYSIOL, V135, P2379, DOI 10.1104/pp.104.042408; Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365; Olsson U, 2002, J BACTERIOL, V184, P4018, DOI 10.1128/JB.184.14.4018-4024.2002; PAKRASI HB, 1989, PLANT CELL, V1, P591, DOI 10.2307/3868946; Papenbrock J, 1999, PLANTA, V208, P264, DOI 10.1007/s004250050558; Papenbrock J, 2001, PLANT J, V28, P41, DOI 10.1046/j.1365-313X.2001.01126.x; PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SHEN GZ, 1993, BIOCHEMISTRY-US, V32, P5109, DOI 10.1021/bi00070a019; SHEN GZ, 1994, BIOCHEMISTRY-US, V33, P7379, DOI 10.1021/bi00189a044; SHIBA T, 1992, J GEN APPL MICROBIOL, V38, P439, DOI 10.2323/jgam.38.439; Singh DP, 2002, PLANT MOL BIOL, V50, P773, DOI 10.1023/A:1019959224271; Steiger S, 1999, J PHOTOCH PHOTOBIO B, V52, P14, DOI 10.1016/S1011-1344(99)00094-9; STILLMAN LC, 1978, ANAL BIOCHEM, V91, P166, DOI 10.1016/0003-2697(78)90827-8; Suzuki T, 2002, J BIOL CHEM, V277, P4731, DOI 10.1074/jbc.M105613200; Thomas H, 1997, NEW PHYTOL, V136, P163, DOI 10.1046/j.1469-8137.1997.00737.x; Tichy M, 2000, EUR J BIOCHEM, V267, P6296, DOI 10.1046/j.1432-1327.2000.01718.x; Vavilin DV, 2002, PHYSIOL PLANTARUM, V115, P9, DOI 10.1034/j.1399-3054.2002.1150102.x; Xu H, 2002, J BIOL CHEM, V277, P42726, DOI 10.1074/jbc.M205237200; Yaronskaya E, 2003, PLANT J, V35, P512, DOI 10.1046/j.1365-313X.2003.01825.x; YU JJ, 1990, PLANT CELL, V2, P315; Zavgorodnyaya A, 1997, PLANT J, V12, P169, DOI 10.1046/j.1365-313X.1997.12010169.x	40	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31595	31602		10.1074/jbc.M505976200	http://dx.doi.org/10.1074/jbc.M505976200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16027152	hybrid			2022-12-27	WOS:000231665200033
J	Steegborn, C; Litvin, TN; Hess, KC; Capper, AB; Taussig, R; Buck, J; Levin, LR; Wu, H				Steegborn, C; Litvin, TN; Hess, KC; Capper, AB; Taussig, R; Buck, J; Levin, LR; Wu, H			A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC MECHANISM; PURIFICATION; BICARBONATE; PROGRAM; PERSPECTIVES; RECEPTORS; DOMAINS; BINDING; TISSUES; CELLS	Catechol estrogens are steroid metabolites that elicit physiological responses through binding to a variety of cellular targets. We show here that catechol estrogens directly inhibit soluble adenylyl cyclases and the abundant trans-membrane adenylyl cyclases. Catechol estrogen inhibition is non-competitive with respect to the substrate ATP, and we solved the crystal structure of a catechol estrogen bound to a soluble adenylyl cyclase from Spirulina platensis in complex with a substrate analog. The catechol estrogen is bound to a newly identified, conserved hydrophobic patch near the active center but distinct from the ATP-binding cleft. Inhibitor binding leads to a chelating interaction between the catechol estrogen hydroxyl groups and the catalytic magnesium ion, distorting the active site and trapping the enzyme substrate complex in a non-productive conformation. This novel inhibition mechanism likely applies to other adenylyl cyclase inhibitors, and the identified ligand-binding site has important implications for the development of specific adenylyl cyclase inhibitors.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	Cornell University; Cornell University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wu, H (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, W206,1300 York Ave, New York, NY 10021 USA.	haowu@med.cornell.edu	Hess, Kenneth/K-6546-2019	Hess, Kenneth/0000-0003-1377-6070; Levin, Lonny/0000-0002-5204-6356	NICHD NIH HHS [R01 HD038722] Funding Source: Medline; NIGMS NIH HHS [R01 GM053645, GM53645] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053645] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alanko J, 1998, BIOCHEM PHARMACOL, V55, P101, DOI 10.1016/S0006-2952(97)00398-5; Bertini R, 2004, P NATL ACAD SCI USA, V101, P11791, DOI 10.1073/pnas.0402090101; Bieger B, 2001, EMBO J, V20, P433, DOI 10.1093/emboj/20.3.433; BRAUN T, 1990, P SOC EXP BIOL MED, V194, P58; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Buck J, 2002, METHOD ENZYMOL, V345, P95; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Das SK, 1997, P NATL ACAD SCI USA, V94, P12786, DOI 10.1073/pnas.94.24.12786; Dessauer CW, 1999, TRENDS PHARMACOL SCI, V20, P205, DOI 10.1016/S0165-6147(99)01310-3; Dessauer CW, 1997, J BIOL CHEM, V272, P22272, DOI 10.1074/jbc.272.35.22272; Dubey RK, 2004, J PHARMACOL EXP THER, V308, P403, DOI 10.1124/jpet.103.058057; Ebina T, 1997, J MOL CELL CARDIOL, V29, P1247, DOI 10.1006/jmcc.1996.0362; ENGLUND PT, 1969, J BIOL CHEM, V244, P3038; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Haunso A, 2003, MOL PHARMACOL, V63, P624, DOI 10.1124/mol.63.3.624; Jaleel M, 2004, BIOCHEMISTRY-US, V43, P8247, DOI 10.1021/bi036234n; JONES TA, 1991, O MANUAL; KLEYWEGT GJ, 1994, ESF CCP4 NEWSLETTER, V31, P9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Levy DE, 2003, J MED CHEM, V46, P2177, DOI 10.1021/jm0205604; Liehr JG, 1996, P NATL ACAD SCI USA, V93, P3294, DOI 10.1073/pnas.93.8.3294; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; LLOYD T, 1978, J BIOL CHEM, V253, P4841; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Otwinowski Z, 1993, DENZO FILM PROCESSIN; PAUL SM, 1977, NATURE, V266, P559, DOI 10.1038/266559a0; PAUL SM, 1977, SCIENCE, V197, P657, DOI 10.1126/science.877577; Philips BJ, 2004, BIOCHEMISTRY-US, V43, P6698, DOI 10.1021/bi036154j; Salomon Y, 1979, Adv Cyclic Nucleotide Res, V10, P35; SMIGEL MD, 1986, J BIOL CHEM, V261, P1976; Soudijn W, 2004, DRUG DISCOV TODAY, V9, P752, DOI 10.1016/S1359-6446(04)03220-9; Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880; Tang WJ, 1998, MOL PHARMACOL, V54, P231, DOI 10.1124/mol.54.2.231; TAUSSIG R, 1994, METHOD ENZYMOL, V238, P95; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Yan SZ, 2002, METHOD ENZYMOL, V345, P231; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1; Zippin JH, 2001, TRENDS ENDOCRIN MET, V12, P366, DOI 10.1016/S1043-2760(01)00454-4; [No title captured]	48	65	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31754	31759		10.1074/jbc.M507144200	http://dx.doi.org/10.1074/jbc.M507144200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16002394	hybrid, Green Accepted			2022-12-27	WOS:000231665200053
J	Suzuki, A; Kusakai, G; Shimojo, Y; Chen, J; Ogura, T; Kobayashi, M; Esumi, H				Suzuki, A; Kusakai, G; Shimojo, Y; Chen, J; Ogura, T; Kobayashi, M; Esumi, H			Involvement of transforming growth factor-beta 1 signaling in hypoxia-induced tolerance to glucose starvation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR-BETA; TGF-BETA; NUTRIENT DEPRIVATION; CELL-PROLIFERATION; TUMOR HYPOXIA; NITRIC-OXIDE; CANCER-CELLS; YEAST SNF1; AKT	Because survival and growth of human hepatoma cells are maintained by nutrient, especially glucose, glucose starvation induces acute cell death. The cell death is markedly suppressed by hypoxia, and we have reported involvement of AMP-activated protein kinase-alpha (AMPK-alpha), Akt, and ARK5 in hypoxia-induced tolerance. In the current study we investigated the mechanism of hypoxia-induced tolerance in human hepatoma cell line HepG2. ARK5 expression was induced in HepG2 cells when they were subjected to glucose starvation, and we found that glucose starvation transiently induced Akt and AMPK-alpha phosphorylation and that hypoxia prolonged phosphorylation of both protein kinases. We also found that hypoxia-induced tolerance was partially abrogated by blocking the Akt/ARK5 system or by suppressing AMPK-alpha expression and that suppression of both completely abolished the tolerance, suggesting that AMPK-alpha activation signaling and the Akt/ARK5 system play independent essential roles in hypoxia-induced tolerance. By using chemical compounds that specifically inhibit kinase activity of type I-transforming growth factor-beta (TGF-beta) receptor, we showed an involvement of TGF-beta in hypoxia-induced tolerance. TGF-beta 1 mRNA expression was induced by hypoxia in an hypoxia-inducible factor-1 alpha-independent manner, and addition of recombinant TGF-beta suppressed cell death during glucose starvation even under normoxic condition. AMPK-alpha, Akt, and ARK5 were activated by TGF-beta 1, and Akt and AMPK-alpha phosphorylation, which was prolonged by hypoxia, was suppressed by an inhibitor of type I TGF-beta receptor. Based on these findings, we propose that hypoxia-induced tumor cell tolerance to glucose starvation is caused by hypoxia-induced TGF-beta 1 through AMPK-alpha activation and the Akt/ARK5 system.	Natl Canc Ctr, Res Inst E, Canc Physiol Project, Kashiwa, Chiba 2778577, Japan; Natl Canc Ctr, Res Inst E, Investigat Treatment Div, Kashiwa, Chiba 2778577, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; Hokkaido Univ, Inst Med Genet, Div Canc Pathobiol, Kita Ku, Sapporo, Hokkaido 0600815, Japan	National Cancer Center - Japan; National Cancer Center - Japan; University of Tokyo; Hokkaido University	Esumi, H (corresponding author), Natl Canc Ctr, Res Inst E, Canc Physiol Project, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	hesumi@east.ncc.go.jp						Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Benson JR, 2004, LANCET ONCOL, V5, P229, DOI 10.1016/S1470-2045(04)01426-3; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; CARLING D, 1994, J BIOL CHEM, V269, P11442; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Charames GS, 2003, CURR MOL MED, V3, P589, DOI 10.2174/1566524033479456; Chen J, 2003, AM J PATHOL, V162, P1283, DOI 10.1016/S0002-9440(10)63924-7; Cutroneo KR, 2003, J CELL BIOCHEM, V90, P1, DOI 10.1002/jcb.10599; Denko NC, 2001, CANCER RES, V61, P795; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; El-Rifai W, 2002, SEMIN RADIAT ONCOL, V12, P128, DOI 10.1053/srao.2002.30815; Esumi H, 2002, J BIOL CHEM, V277, P32791, DOI 10.1074/jbc.M112270200; Folkman J, 2001, P NATL ACAD SCI USA, V98, P398, DOI 10.1073/pnas.98.2.398; Folkman J, 1974, Adv Cancer Res, V19, P331, DOI 10.1016/S0065-230X(08)60058-5; Gold LI, 1999, CRIT REV ONCOGENESIS, V10, P303; Goto D, 1998, FEBS LETT, V430, P201, DOI 10.1016/S0014-5793(98)00658-9; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Izuishi K, 2000, CANCER RES, V60, P6201; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Kawabata M, 1999, ANN NY ACAD SCI, V886, P73, DOI 10.1111/j.1749-6632.1999.tb09402.x; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kimura H, 2000, BLOOD, V95, P189, DOI 10.1182/blood.V95.1.189.001k05_189_197; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lefebvre DL, 2001, BIOCHEM J, V355, P297, DOI 10.1042/0264-6021:3550297; Lynch HT, 1999, J MED GENET, V36, P801; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; MASSAGUE J, 1992, CANCER SURV, V12, P81; Matsuyama S, 2003, CANCER RES, V63, P7791; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Nam SY, 2002, ONCOGENE, V21, P337, DOI 10.1038/sj.onc.1205068; Norman JT, 2000, KIDNEY INT, V58, P2351, DOI 10.1046/j.1523-1755.2000.00419.x; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Roman C, 2001, MICROSC RES TECHNIQ, V52, P450, DOI 10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Srinivasan S, 2002, AM J PHYSIOL-ENDOC M, V283, pE784, DOI 10.1152/ajpendo.00177.2002; Suzuki A, 2004, BIOCHEM BIOPH RES CO, V324, P986, DOI 10.1016/j.bbrc.2004.09.145; Suzuki A, 2004, ONCOGENE, V23, P7067, DOI 10.1038/sj.onc.1207963; Suzuki A, 2003, BIOCHEM BIOPH RES CO, V311, P156, DOI 10.1016/j.bbrc.2003.09.184; Suzuki A, 2003, ONCOGENE, V22, P6177, DOI 10.1038/sj.onc.1206899; Suzuki A, 2003, J BIOL CHEM, V278, P48, DOI 10.1074/jbc.M206025200; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; Wahl SM, 2004, J LEUKOCYTE BIOL, V76, P15, DOI 10.1189/jlb.1103539; Warren SM, 2001, J SURG RES, V99, P147, DOI 10.1006/jsre.2001.6128; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Yan ZF, 2002, J BIOL CHEM, V277, P9870, DOI 10.1074/jbc.M107646200; Zhang H, 2003, BLOOD, V101, P2253, DOI 10.1182/blood-2002-02-0629; Zhou SH, 2005, J BIOL CHEM, V280, P22688, DOI 10.1074/jbc.M412953200	64	45	54	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31557	31563		10.1074/jbc.M503714200	http://dx.doi.org/10.1074/jbc.M503714200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16014625	hybrid			2022-12-27	WOS:000231665200028
J	Dominguez, D; Tournoy, J; Hartmann, D; Huth, T; Cryns, K; Deforce, S; Serneels, L; Camacho, IE; Marjaux, E; Craessaerts, K; Roebroek, AJM; Schwake, M; D'Hooge, R; Bach, P; Kalinke, U; Moechars, D; Alzheimer, C; Reiss, K; Saftig, P; De Strooper, B				Dominguez, D; Tournoy, J; Hartmann, D; Huth, T; Cryns, K; Deforce, S; Serneels, L; Camacho, IE; Marjaux, E; Craessaerts, K; Roebroek, AJM; Schwake, M; D'Hooge, R; Bach, P; Kalinke, U; Moechars, D; Alzheimer, C; Reiss, K; Saftig, P; De Strooper, B			Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE; KNOCKOUT MICE; HIPPOCAMPAL-NEURONS; PEPTIDE PRODUCTION; ASPARTYL PROTEASE; ALZHEIMER-DISEASE; SODIUM-CHANNELS; E-SELECTIN; BACE1	beta-Secretase (BACE1) is the rate-limiting protease for the generation of the amyloid beta-peptide (A beta) in Alzheimer disease. Mice in which the bace1 gene is inactivated are reported to be healthy. However, the presence of a homologous gene encoding BACE2 raises the possibility of compensatory mechanisms. Therefore, we have generated bace1, bace2, and double knockout mice. We report here that BACE1 mice display a complex phenotype. A variable but significant number of BACE1 offspring died in the first weeks after birth. The surviving mice remained smaller than their littermate controls and presented a hyperactive behavior. Electrophysiologically, subtle alterations in the steady-state inactivation of voltage-gated sodium channels in BACE1-deficient neurons were observed. In contrast, bace2 knockout mice displayed an overall healthy phenotype. However, a combined deficiency of BACE2 and BACE1 enhanced the bace1(-/-) lethality phenotype. At the biochemical level, we have confirmed that BACE1 deficiency results in an almost complete block of A beta generation in neurons, but not in glia. As glia are 10 times more abundant in brain compared with neurons, our data indicate that BACE2 could indeed contribute to A beta generation in the brains of Alzheimer disease and, in particular, Down syndrome patients. In conclusion, our data challenge the general idea of BACE1 as a safe drug target and call for some caution when claiming that no major side effects should be expected from blocking BACE1 activity.	Univ Kiel, Inst Biochem, Dept Physiol, D-24098 Kiel, Germany; Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol VIB4, B-3000 Louvain, Belgium; Univ Kiel, Dept Biochem, D-24118 Kiel, Germany; Johnson & Johnson Pharmaceut Res & Dev, B-2340 Beerse, Belgium; Katholieke Univ Leuven, Lab Biol Psychol, B-3000 Louvain, Belgium; Paul Ehrlich Inst, Div Immunol, D-63225 Langen, Germany	University of Kiel; KU Leuven; University of Kiel; Johnson & Johnson; Janssen Pharmaceuticals; KU Leuven; Paul Ehrlich Institute	Saftig, P (corresponding author), Univ Kiel, Inst Biochem, Dept Physiol, Olshausenstr 40, D-24098 Kiel, Germany.	psaftig@biochem.uni-kiel.de; bart.destrooper@med.kuleuven.ac.be	Espuny, Ira/AAM-1991-2021; Reiss, Karina/B-3175-2010; de+Strooper, Bart/Z-1638-2019; Schwake, Michael/F-5381-2010; Saftig, Paul/A-7966-2010; Bach, Patrick/AAF-5716-2019; tournoy, jos/AAR-1965-2020; De Strooper, Bart/F-6507-2012	Espuny, Ira/0000-0002-2356-2159; Bach, Patrick/0000-0001-5962-019X; tournoy, jos/0000-0002-0265-9154; De Strooper, Bart/0000-0001-5455-5819; Huth, Tobias/0000-0002-6414-8923; Serneels, Lutgarde/0000-0002-5463-4231; Schwake, Michael/0000-0002-4173-2166; Kalinke, Ulrich/0000-0003-0503-9564				Acquati F, 2000, FEBS LETT, V468, P59, DOI 10.1016/S0014-5793(00)01192-3; ALZHEIMER C, 1994, J PHYSIOL-LONDON, V479, P199, DOI 10.1113/jphysiol.1994.sp020288; Basi G, 2003, J BIOL CHEM, V278, P31512, DOI 10.1074/jbc.M300169200; Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; DESTROOPER B, 1995, EMBO J, V14, P4932, DOI 10.1002/j.1460-2075.1995.tb00176.x; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Fluhrer R, 2002, J NEUROCHEM, V81, P1011, DOI 10.1046/j.1471-4159.2002.00908.x; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hussain I, 2000, MOL CELL NEUROSCI, V16, P609, DOI 10.1006/mcne.2000.0884; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Isom LL, 2002, NOVART FDN SYMP, V241, P124; Isom LL, 2002, FRONT BIOSCI, V7, P12; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2003, NEUROBIOL DIS, V14, P81, DOI 10.1016/S0969-9961(03)00104-9; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Motonaga K, 2002, NEUROSCI LETT, V326, P64, DOI 10.1016/S0304-3940(02)00287-2; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Simons M, 1996, J NEUROSCI, V16, P899; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Solans A, 2000, CYTOGENET CELL GENET, V89, P177, DOI 10.1159/000015608; TEDDER TF, 1995, J EXP MED, V181, P2259, DOI 10.1084/jem.181.6.2259; Tienari PJ, 1996, COLD SPRING HARB SYM, V61, P575; Tournoy J, 2004, HUM MOL GENET, V13, P1321, DOI 10.1093/hmg/ddh151; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; WATSON SR, 1991, NATURE, V349, P164, DOI 10.1038/349164a0; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Wong PC, 2001, SCIENCE, V293, P1434; Xia LJ, 2002, J CLIN INVEST, V109, P939; Yan RQ, 2001, J BIOL CHEM, V276, P34019, DOI 10.1074/jbc.M105583200; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769	42	281	293	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30797	30806		10.1074/jbc.M505249200	http://dx.doi.org/10.1074/jbc.M505249200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15987683	Green Published, hybrid			2022-12-27	WOS:000231487800020
J	Zang, Z; Fang, QM; Pegg, AE; Guengerich, FP				Zang, Z; Fang, QM; Pegg, AE; Guengerich, FP			Kinetic analysis of steps in the repair of damaged DNA by human O-6-alkylguanine-DNA alkyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; STEADY-STATE; BINDING; ALKYLATION; MECHANISM; OLIGODEOXYNUCLEOTIDES; O-6-BENZYLGUANINE; INACTIVATION; RECOGNITION; SPECIFICITY	Rates of individual steps in the removal of alkyl groups from O-6-methyl (Me) and -benzyl (Bz) guanine in oligonucleotides by human O-6-alkylguanine DNA alkyltransferase (AGT) were estimated using rapid reaction kinetic methods. The overall reaction yields hyperbolic plots of rate versus AGT concentration for O-6-MeG but linear plots for the O-6-BzG reaction, which is similar to 100-fold faster. The binding of AGT and DNA (double-stranded 30-mer/36-mer complex) appears to be diffusion-limited. The rate of dissociation of the complex is similar to 25-fold slower (similar to 1 s(-1)) for DNA containing O-6-MeG or O-6-BzG than unmodified DNA. The fluorescent dC-analog 6-methylpyrrolo[2,3-d]pyrimidine-2(3H) one deoxyribonucleoside (pyrrolo dC), which pairs with G, was positioned opposite G, O-6-MeG, or O-6-BzG and used as a probe of the rate of base flipping. A rapid increase of fluorescence (k similar to 200 s(-1)) was observed with O-6-MeG and O-6-BzG and AGT but not with a Gly mutation at Arg(128), which has been implicated in base flipping with crystal structures. Only weak and slower fluorescence changes were observed with G: pyrrolo dC or T: 2-aminopurine pairs. These rate estimates were used in a kinetic model in which AGT binds and scans DNA rapidly, flips O-6-alkylG residues, transfers the alkyl group in a chemical step that is rate-limiting in the case of O-6-MeG but not O-6-BzG, and releases the dealkylated DNA. The results explain the overall patterns of rates of alkyl group removal versus AGT concentration and the effects of the mutations, as well as the greater affinity of AGT for DNA with O-6-alkylG lesions.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,23rd & Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Fang, Qingming/B-6839-2008	Fang, Qingming/0000-0002-4006-0636	NCI NIH HHS [R01 CA18137] Funding Source: Medline; NIEHS NIH HHS [P30 ES00267, R01 ES10546] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA018137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, R01ES010546] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BECKETT D, 2003, KINETIC ANAL MACROMO, V267, P171; Bender K, 1996, NUCLEIC ACIDS RES, V24, P2087, DOI 10.1093/nar/24.11.2087; BHATTACHARYYA D, 1990, EUR J BIOCHEM, V193, P337, DOI 10.1111/j.1432-1033.1990.tb19343.x; CHAN CL, 1993, ARCH BIOCHEM BIOPHYS, V300, P193, DOI 10.1006/abbi.1993.1027; Christmann M, 2003, TOXICOLOGY, V193, P3, DOI 10.1016/S0300-483X(03)00287-7; Crone TM, 1996, MUTAT RES-DNA REPAIR, V363, P15, DOI 10.1016/0921-8777(95)00058-5; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; DOLAN ME, 1991, CARCINOGENESIS, V12, P2305, DOI 10.1093/carcin/12.12.2305; DOLAN ME, 1988, CARCINOGENESIS, V9, P2139, DOI 10.1093/carcin/9.11.2139; Duguid EM, 2003, CHEM BIOL, V10, P827, DOI 10.1016/j.chembiol.2003.08.007; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Furge LL, 1997, BIOCHEMISTRY-US, V36, P6475, DOI 10.1021/bi9627267; Goodtzova K, 1998, BIOCHEMISTRY-US, V37, P12489, DOI 10.1021/bi9811718; Goodtzova K, 1997, J BIOL CHEM, V272, P8332, DOI 10.1074/jbc.272.13.8332; Guengerich FP, 2003, BIOCHEMISTRY-US, V42, P10965, DOI 10.1021/bi034937z; Hazra TK, 1997, BIOCHEMISTRY-US, V36, P5769, DOI 10.1021/bi963085i; Krosky DJ, 2005, BIOCHEMISTRY-US, V44, P5949, DOI 10.1021/bi050084u; Krosky DJ, 2004, BIOCHEMISTRY-US, V43, P4188, DOI 10.1021/bi036303y; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LIEM LK, 1993, J MOL BIOL, V231, P950, DOI 10.1006/jmbi.1993.1344; Liu LP, 2004, J BIOL CHEM, V279, P4250, DOI 10.1074/jbc.M311105200; Meyer AS, 2003, CHEM RES TOXICOL, V16, P1405, DOI 10.1021/tx0341254; Mijal RS, 2004, CHEM RES TOXICOL, V17, P424, DOI 10.1021/tx0342417; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; PEGG AE, 1993, BIOCHEMISTRY-US, V32, P11998, DOI 10.1021/bi00096a009; PEGG AE, 1995, PROG NUCLEIC ACID RE, V51, P167, DOI 10.1016/S0079-6603(08)60879-X; Pegg AE, 1998, J BIOL CHEM, V273, P10863, DOI 10.1074/jbc.273.18.10863; Rasimas JJ, 2004, PROTEIN SCI, V13, P301, DOI 10.1110/ps.03319404; Rasimas JJ, 2003, BIOCHEMISTRY-US, V42, P980, DOI 10.1021/bi026970b; Rasimas JJ, 2003, J BIOL CHEM, V278, P7973, DOI 10.1074/jbc.M211854200; Spratt TE, 1999, BIOCHEMISTRY-US, V38, P6801, DOI 10.1021/bi982908w; Stivers JT, 1999, BIOCHEMISTRY-US, V38, P952, DOI 10.1021/bi9818669; Terashima I, 1997, CHEM RES TOXICOL, V10, P1234, DOI 10.1021/tx9700580; Vora RA, 1998, PROTEINS, V32, P3; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1027, DOI 10.1021/bi011495n; Zang H, 2005, J BIOL CHEM, V280, P1165, DOI 10.1074/jbc.M405996200	37	59	60	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30873	30881		10.1074/jbc.M505283200	http://dx.doi.org/10.1074/jbc.M505283200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16000301	hybrid			2022-12-27	WOS:000231487800028
J	Raychowdhury, MK; McLaughlin, M; Ramos, AJ; Montalbetti, N; Bouley, R; Ausiello, DA; Cantiello, HF				Raychowdhury, MK; McLaughlin, M; Ramos, AJ; Montalbetti, N; Bouley, R; Ausiello, DA; Cantiello, HF			Characterization of single channel currents from primary cilia of renal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION CHANNELS; CATION CHANNELS; SENSORY CILIA; POLYCYSTIN-2; MEMBRANE; K+; PROTEIN; CYSTIN; FLOW; NA+	The primary cilium is a ubiquitous, non-motile microtubular organelle lacking the central pair of microtubules found in motile cilia. Primary cilia are surrounded by a membrane, which has a unique complement of membrane proteins, and may thus be functionally different from the plasma membrane. The function of the primary cilium remains largely unknown. However, primary cilia have important sensory transducer properties, including the response of renal epithelial cells to fluid flow or mechanical stimulation. Recently, renal cystic diseases have been associated with dysfunctional ciliary proteins. Although the sensory properties of renal epithelial primary cilia may be associated with functional channel activity in the organelle, information in this regard is still lacking. This may be related to the inherent difficulties in assessing electrical activity in this rather small and narrow organelle. In the present study, we provide the first direct electrophysiological evidence for the presence of single channel currents from isolated primary cilia of LLC-PK1 renal epithelial cells. Several channel phenotypes were observed, and addition of vasopressin increased cation channel activity, which suggests the regulation, by the cAMP pathway of ciliary conductance. Ion channel reconstitution of ciliary versus plasma membranes indicated a much higher channel density in cilia. At least three channel proteins, polycystin-2, TRPC1, and interestingly, the alpha-epithelial sodium channel, were immunodetected in this organelle. Ion channel activity in the primary cilium of renal cells may be an important component of its role as a sensory transducer.	MA Gen Hosp E, Renal Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Buenos Aires, Fac Farm & Bioquim, Dept Fisicoquim & Quim Analit, Lab Canales Ion, RA-1113 Buenos Aires, DF, Argentina	Harvard University; Harvard Medical School; University of Buenos Aires	Cantiello, HF (corresponding author), MA Gen Hosp E, Renal Unit, 149 13th St, Charlestown, MA 02129 USA.	cantiello@helix.mgh.harvard.edu	Montalbetti, Nicolas/T-4212-2019	Montalbetti, Nicolas/0000-0003-2897-9540				Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; BRAY D, 1992, CELL MOVEMENTS, P265; Delgado R, 2003, J NEUROPHYSIOL, V90, P2022, DOI 10.1152/jn.01167.2002; EHRLICH BE, 1984, SCIENCE, V225, P427, DOI 10.1126/science.6330895; FRINGS S, 1991, J GEN PHYSIOL, V97, P1, DOI 10.1085/jgp.97.1.1; FRINGS S, 1990, BIOPHYS J, V57, P1091, DOI 10.1016/S0006-3495(90)82627-8; FRINGS S, 1991, J GEN PHYSIOL, V97, P725, DOI 10.1085/jgp.97.4.725; FUJIWARA C, 1988, J BIOCHEM, V104, P344, DOI 10.1093/oxfordjournals.jbchem.a122471; FujiwaraHirashima C, 1996, BBA-BIOMEMBRANES, V1280, P207, DOI 10.1016/0005-2736(95)00292-8; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Honda E, 1995, BRAIN RES, V703, P79, DOI 10.1016/0006-8993(95)01072-6; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; JORQUERA O, 1995, AM J PHYSIOL-CELL PH, V269, pC1235, DOI 10.1152/ajpcell.1995.269.5.C1235; LABARCA P, 1988, J BIOENERG BIOMEMBR, V20, P551, DOI 10.1007/BF00768919; LABARCA P, 1988, P NATL ACAD SCI USA, V85, P944, DOI 10.1073/pnas.85.3.944; Larsson HP, 1997, BIOPHYS J, V72, P1193, DOI 10.1016/S0006-3495(97)78767-8; Mitchell KAP, 2004, CELL MOTIL CYTOSKEL, V59, P62, DOI 10.1002/cm.20025; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Murphy GJ, 2003, NEURON, V37, P639, DOI 10.1016/S0896-6273(03)00057-6; Nakamura T, 1996, BIOPHYS J, V70, P813, DOI 10.1016/S0006-3495(96)79625-X; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; OOSAWA Y, 1988, CELL STRUCT FUNCT, V13, P51, DOI 10.1247/csf.13.51; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Praetorius HA, 2005, ANNU REV PHYSIOL, V67, P515, DOI 10.1146/annurev.physiol.67.040403.101353; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P69, DOI 10.1007/s00232-002-1042-4; Raychowdhury MK, 2004, J BIOL CHEM, V279, P20137, DOI 10.1074/jbc.M311946200; RIEDER CL, 1979, J ULTRA MOL STRUCT R, V68, P173, DOI 10.1016/S0022-5320(79)90152-7; ROBERTS WM, 1992, METHOD ENZYMOL, V207, P155; Schwartz EA, 1997, AM J PHYSIOL-RENAL, V272, pF132, DOI 10.1152/ajprenal.1997.272.1.F132; Stuhmer W., 1983, SINGLE CHANNEL RECOR, P123; Wheatley DN, 2000, BIOL CELL, V92, P573, DOI 10.1016/S0248-4900(00)01108-4; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001	38	54	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34718	34722		10.1074/jbc.M507793200	http://dx.doi.org/10.1074/jbc.M507793200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16079132	hybrid			2022-12-27	WOS:000232403900042
J	Stenberg, F; Chovanec, P; Maslen, SL; Robinson, CV; Ilag, LL; von Heijne, G; Daley, DO				Stenberg, F; Chovanec, P; Maslen, SL; Robinson, CV; Ilag, LL; von Heijne, G; Daley, DO			Protein complexes of the Escherichia coli cell envelope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; INTEGRAL MEMBRANE-PROTEINS; UBIQUINONE-BINDING-SITE; OUTER-MEMBRANE; CRYSTAL-STRUCTURE; MULTIDRUG EFFLUX; SACCHAROMYCES-CEREVISIAE; PROTEOMIC APPROACH; MASS-SPECTROMETRY; INTERACTION MAP	Protein complexes are an intrinsic aspect of life in the membrane. Knowing which proteins are assembled in these complexes is therefore essential to understanding protein function(s). Unfortunately, recent high throughput protein interaction studies have failed to deliver any significant information on proteins embedded in the membrane, and many membrane protein complexes remain ill defined. In this study, we have optimized the blue native-PAGE technique for the study of membrane protein complexes in the inner and outer membranes of Escherichia coli. In combination with second dimension SDS-PAGE and mass spectrometry, we have been able to identify 43 distinct protein complexes. In addition to a number of well characterized complexes, we have identified known and orphan proteins in novel oligomeric states. For two orphan proteins, YhcB and YjdB, our findings enable a tentative functional assignment. We propose that YhcB is a hitherto unidentified additional subunit of the cytochrome bd oxidase and that YjdB, which co-localizes with the ZipA protein, is involved in cell division. Our reference two-dimensional blue native-SDS-polyacrylamide gels will facilitate future studies of the assembly and composition of E. coli membrane protein complexes during different growth conditions and in different mutant backgrounds.	Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; Stockholm Univ, Prote Facil, Dept Analyt Chem, SE-10691 Stockholm, Sweden; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Stockholm University; Stockholm University; University of Cambridge	Daley, DO (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	ddaley@dbb.su.se	von Heijne, Gunnar/F-5576-2011; von Heijne, Gunnar/AAH-9389-2019	von Heijne, Gunnar/0000-0002-4490-8569; Ilag, Leopold/0000-0003-3678-7100; Chovanec, Peter/0000-0002-7063-2658; Daley, Daniel/0000-0002-6425-5059; robinson, carol/0000-0001-7829-5505				Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Casadio R, 2003, PROTEIN SCI, V12, P1158, DOI 10.1110/ps.0223603; CHOI DS, 1986, J BIOL CHEM, V261, P8953; Ciambella C, 2005, PROTEOMICS, V5, P746, DOI 10.1002/pmic.200401129; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Dalbey RE, 2004, BBA-MOL CELL RES, V1694, P37, DOI 10.1016/j.bbamcr.2004.03.009; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Daniels C, 1999, MOL MICROBIOL, V34, P181, DOI 10.1046/j.1365-2958.1999.01591.x; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; DEVRIJE T, 1987, BIOCHIM BIOPHYS ACTA, V900, P63, DOI 10.1016/0005-2736(87)90278-1; Doyle SM, 2004, J MOL BIOL, V341, P199, DOI 10.1016/j.jmb.2004.06.021; DRIESSEN AJM, 1993, BIOCHEMISTRY-US, V32, P13190, DOI 10.1021/bi00211a030; Eubel H, 2004, PLANT PHYSIOL, V134, P1450, DOI 10.1104/pp.103.038018; Fountoulakis M, 2003, AMINO ACIDS, V24, P19, DOI 10.1007/s00726-002-0339-z; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hartinger J, 1996, ANAL BIOCHEM, V240, P126, DOI 10.1006/abio.1996.0339; Heazlewood JL, 2003, PLANT PHYSIOL, V132, P230, DOI 10.1104/pp.102.018986; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansch L, 1996, PLANT J, V9, P357, DOI 10.1046/j.1365-313X.1996.09030357.x; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; Kennedy KA, 2004, J BIOL CHEM, V279, P33290, DOI 10.1074/jbc.M403796200; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Lowe J, 2004, ANNU REV BIOPH BIOM, V33, P177, DOI 10.1146/annurev.biophys.33.110502.132647; MASTERS PS, 1981, J BACTERIOL, V147, P805, DOI 10.1128/JB.147.3.805-819.1981; MILLER MJ, 1988, J BIOL CHEM, V263, P5235; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Or E, 2005, J BIOL CHEM, V280, P9097, DOI 10.1074/jbc.M413947200; Paetzel M, 2000, PHARMACOL THERAPEUT, V87, P27, DOI 10.1016/S0163-7258(00)00064-4; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Price GP, 2000, FEMS MICROBIOL LETT, V193, P51, DOI 10.1016/S0378-1097(00)00453-5; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rais I, 2004, PROTEOMICS, V4, P2567, DOI 10.1002/pmic.200400829; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; Robillard GT, 1999, BBA-REV BIOMEMBRANES, V1422, P73, DOI 10.1016/S0304-4157(99)00002-7; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schagger H, 2001, J BIOL CHEM, V276, P37861; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Schneider D, 2003, J BIOL CHEM, V278, P3105, DOI 10.1074/jbc.M206287200; SCHRODER I, 1994, MICROBIOL-UK, V140, P731, DOI 10.1099/00221287-140-4-731; Shevchenko A, 2000, METH MOL B, V146, P1, DOI 10.1385/1-59259-045-4:1; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SPELBRINK REJ, 2005, J BIOL CHEM; Stagljar I, 2002, TRENDS BIOCHEM SCI, V27, P559, DOI 10.1016/S0968-0004(02)02197-7; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Uetz P, 2005, FEBS LETT, V579, P1821, DOI 10.1016/j.febslet.2005.02.001; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524; van Lis R, 2003, PLANT PHYSIOL, V132, P318, DOI 10.1104/pp.102.018325; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; Wang Y, 1999, INFECT IMMUN, V67, P4751, DOI 10.1128/IAI.67.9.4751-4756.1999; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wimley WC, 2002, PROTEIN SCI, V11, P301, DOI 10.1110/ps.29402; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; YAMADA M, 1993, J BIOL CHEM, V268, P12812; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Zgurskaya HI, 2000, J BACTERIOL, V182, P4264, DOI 10.1128/JB.182.15.4264-4267.2000; Zhai YF, 2002, PROTEIN SCI, V11, P2196, DOI 10.1110/ps.0209002; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	80	167	225	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34409	34419		10.1074/jbc.M506479200	http://dx.doi.org/10.1074/jbc.M506479200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16079137	hybrid			2022-12-27	WOS:000232403900006
J	Lai, WS; Carrick, DM; Blackshear, PJ				Lai, WS; Carrick, DM; Blackshear, PJ			Influence of nonameric AU-rich tristetraprolin-binding sites on mRNA deadenylation and turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; ELEMENT; DEGRADATION; DOMAIN; HUR; DESTABILIZATION; STABILITY; MARCKS	Tristetraprolin (TTP), a member of the tandem CCCH zinc finger protein family, promotes deadenylation of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor mRNAs after binding to the AU-rich elements ( ARE) in their 3'-untranslated regions. The high affinity TTP-ARE binding occurs between the tandem zinc finger domain and the preferred nonamer UUAUUUAUU. By mutating a well defined core sequence of 24 bases from the tumor necrosis factor-alpha ARE, we compared the influence of four possible nonameric TTP-binding sites in the wildtype ARE with that of a single binding site in the mutated probe on the binding of TTP to the RNA and the subsequent deadenylation of the poly( A) tail. By inserting this 24-base ARE into an otherwise stable transcript, we also attempted to determine the extent of the instability conferred by the presence of one or two TTP-binding sites. These sites were created or modified by mutating the As in the UUAUUUAUU nonamer or by changing the central U in the nonamer, in both cases to C residues. The results suggest that even a single nonamer TTP-binding site can confer at least partial sensitivity to the TTP-mediated mRNA turnover on an otherwise stable mRNA, but that two binding sites make the transcript much more unstable. Even though the central U of the nonamer binding site was predicted by structural studies possibly to permit base substitution, mutation of this U to C greatly inhibited the binding of TTP to the ARE, thus reducing the ability of the TTP to promote deadenylation and instability of the mRNA.	NIEHS, Neurobiol Lab, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Off Clin Res, NIH, Res Triangle Pk, NC 27709 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University	Blackshear, PJ (corresponding author), NIEHS, Neurobiol Lab, NIH, A2-05,111 Alexander Dr, Res Triangle Pk, NC 27709 USA.	Black009@niehs.nih.gov	Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080, Z01ES090080] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; BLACKSHEAR PJ, 1992, J BIOL CHEM, V267, P13540; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; LEVINE TD, 1993, MOL CELL BIOL, V13, P3494, DOI 10.1128/MCB.13.6.3494; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; UMEKAGE T, 1991, FEBS LETT, V286, P147, DOI 10.1016/0014-5793(91)80961-2; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	21	44	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34365	34377		10.1074/jbc.M506757200	http://dx.doi.org/10.1074/jbc.M506757200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16061475	hybrid			2022-12-27	WOS:000232229700080
J	Zhou, XW; Kafsack, BFC; Cole, RN; Beckett, P; Shen, RF; Carruthers, VB				Zhou, XW; Kafsack, BFC; Cole, RN; Beckett, P; Shen, RF; Carruthers, VB			The opportunistic pathogen Toxoplasma gondii deploys a diverse legion of invasion and survival proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NUCLEOSIDE TRIPHOSPHATE HYDROLASE; DENSE GRANULE PROTEIN; PARASITOPHOROUS VACUOLE MEMBRANE; HOST-CELL INVASION; MASS-SPECTROMETRY; MOLECULAR CHARACTERIZATION; MICRONEME PROTEIN; APICOMPLEXAN PARASITES; PLASMODIUM-FALCIPARUM; SURFACE-ANTIGEN	Host cell invasion is an essential step during infection by Toxoplasma gondii, an intracellular protozoan that causes the severe opportunistic disease toxoplasmosis in humans. Recent evidence strongly suggests that proteins discharged from Toxoplasma apical secretory organelles (micronemes, dense granules, and rhoptries) play key roles in host cell invasion and survival during infection. However, to date, only a limited number of secretory proteins have been discovered, and the full spectrum of effector molecules involved in parasite invasion and survival remains unknown. To address these issues, we analyzed a large cohort of freely released Toxoplasma secretory proteins by using two complementary methodologies, two-dimensional electrophoresis/mass spectrometry and liquid chromatography/electrospray ionization-tandem mass spectrometry (MudPIT, shotgun proteomics). Visualization of Toxoplasma secretory products by two-dimensional electrophoresis revealed similar to 100 spots, most of which were successfully identified by protein microsequencing or matrix-assisted laser desorption ionization-mass spectrometry analysis. Many proteins were present in multiple species suggesting they are subjected to substantial posttranslational modification. Shotgun proteomic analysis of the secretory fraction revealed several additional products, including novel putative adhesive proteins, proteases, and hypothetical secretory proteins similar to products expressed by other related parasites including Plasmodium, the etiologic agent of malaria. A subset of novel proteins were re-expressed as fusions to yellow fluorescent protein, and this initial screen revealed shared and distinct localizations within secretory compartments of T. gondii tachyzoites. These findings provided a uniquely broad view of Toxoplasma secretory proteins that participate in parasite survival and pathogenesis during infection.	Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Baltimore, MD 21205 USA; NHLBI, NIH, Bethesda, MD 20892 USA; GE Healthcare, Piscataway, NJ 08855 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); General Electric	Carruthers, VB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	vcarruth@jhsph.edu		Kafsack, Bjorn F.C./0000-0003-0089-1096; Carruthers, Vern/0000-0001-6859-8895	NCRR NIH HHS [1S10-RR14702] Funding Source: Medline; NIAID NIH HHS [R21AI053797, R01 AI046675, R21 AI053797] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046675, R21AI053797] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Aramini JJ, 1999, EPIDEMIOL INFECT, V122, P305, DOI 10.1017/S0950268899002113; ASAI T, 1995, J BIOL CHEM, V270, P11391, DOI 10.1074/jbc.270.19.11391; Bahia-Oliveira LMG, 2003, EMERG INFECT DIS, V9, P55; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Barta JR, 1997, METHODS, V13, P81, DOI 10.1006/meth.1997.0501; Bender A, 2003, MOL BIOCHEM PARASIT, V132, P59, DOI 10.1016/j.molbiopara.2003.07.001; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BERMUDES D, 1994, MOL BIOCHEM PARASIT, V68, P247, DOI 10.1016/0166-6851(94)90169-4; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Boothroyd JC, 1998, INT J PARASITOL, V28, P3, DOI 10.1016/S0020-7519(97)00182-3; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Bromley E, 2003, PROTEOMICS, V3, P1553, DOI 10.1002/pmic.200300479; Brossier F, 2003, J BIOL CHEM, V278, P6229, DOI 10.1074/jbc.M209837200; Brown PJ, 2000, MOL BIOCHEM PARASIT, V107, P91, DOI 10.1016/S0166-6851(00)00179-1; Brydges SD, 2000, MOL BIOCHEM PARASIT, V111, P51, DOI 10.1016/S0166-6851(00)00296-6; BURG JL, 1988, J IMMUNOL, V141, P3584; Carey KL, 2000, MOL BIOCHEM PARASIT, V105, P25, DOI 10.1016/S0166-6851(99)00160-7; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Carruthers Vern B., 1999, Parasitology International, V48, P1; CESBRON JY, 1985, J IMMUNOL METHODS, V83, P151, DOI 10.1016/0022-1759(85)90068-7; CESBRONDELAUW MF, 1989, P NATL ACAD SCI USA, V86, P7537, DOI 10.1073/pnas.86.19.7537; Chen HF, 2003, CHINESE MED J-PEKING, V116, P1561; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Cohen AM, 2002, INT J PARASITOL, V32, P39, DOI 10.1016/S0020-7519(01)00308-3; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Delorme V, 2003, MOL BIOL CELL, V14, P1900, DOI 10.1091/mbc.E02-08-0462; Delorme V, 2002, MICROBES INFECT, V4, P271, DOI 10.1016/S1286-4579(02)01538-1; Dlugonska H, 2001, PARASITOL RES, V87, P634, DOI 10.1007/s004360000367; Donahue CG, 2000, MOL BIOCHEM PARASIT, V111, P15, DOI 10.1016/S0166-6851(00)00289-9; Dowse T, 2004, CURR OPIN MICROBIOL, V7, P388, DOI 10.1016/j.mib.2004.06.013; Drummelsmith J, 2003, MOL CELL PROTEOMICS, V2, P146, DOI 10.1074/mcp.M200085-MCP200; DUBEY JP, 1994, J AM VET MED ASSOC, V205, P1593; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; Ducret A, 1998, PROTEIN SCI, V7, P706, DOI 10.1002/pro.5560070320; Dzierszinski F, 2001, J MOL BIOL, V309, P1017, DOI 10.1006/jmbi.2001.4730; Dzierszinski F, 2000, MOL MICROBIOL, V37, P574, DOI 10.1046/j.1365-2958.2000.02014.x; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ersfeld Klaus, 2003, Current Issues in Molecular Biology, V5, P61; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fourmaux MN, 1996, MOL BIOCHEM PARASIT, V83, P201, DOI 10.1016/S0166-6851(96)02773-9; Garcia-Reguet N, 2000, CELL MICROBIOL, V2, P353, DOI 10.1046/j.1462-5822.2000.00064.x; Graves PR, 2002, MICROBIOL MOL BIOL R, V66, P39, DOI 10.1128/MMBR.66.1.39-63.2002; Gubbels MJ, 2004, MOL BIOCHEM PARASIT, V137, P99, DOI 10.1016/j.molbiopara.2004.05.007; Harper JM, 2004, INT J PARASITOL, V34, P1047, DOI 10.1016/j.ijpara.2004.05.006; Harper JM, 2004, MOL BIOCHEM PARASIT, V134, P201, DOI 10.1016/j.molbiopara.2003.12.001; Hehl A, 1997, MOL BIOCHEM PARASIT, V89, P271, DOI 10.1016/S0166-6851(97)00126-6; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; HIGH KP, 1994, J BIOL CHEM, V269, P9105; Hoff EF, 2001, EXP PARASITOL, V97, P77, DOI 10.1006/expr.2000.4585; Huynh MH, 2004, CELL MICROBIOL, V6, P771, DOI 10.1111/j.1462-5822.2004.00403.x; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Jacobs D, 1998, MOL BIOCHEM PARASIT, V91, P237, DOI 10.1016/S0166-6851(97)00204-1; Jacobs D, 1999, CLIN DIAGN LAB IMMUN, V6, P24, DOI 10.1128/CDLI.6.1.24-29.1999; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Jewett TJ, 2004, J BIOL CHEM, V279, P9362, DOI 10.1074/jbc.M312590200; Kaasch AJ, 2000, J BIOL CHEM, V275, P1112, DOI 10.1074/jbc.275.2.1112; Kadota K, 2004, P NATL ACAD SCI USA, V101, P16310, DOI 10.1073/pnas.0406187101; Koyama T, 2001, VET PARASITOL, V96, P65, DOI 10.1016/S0304-4017(00)00424-6; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; LECORDIER L, 1993, MOL BIOCHEM PARASIT, V59, P143, DOI 10.1016/0166-6851(93)90015-P; Lee Y, 2002, GENOME RES, V12, P493, DOI 10.1101/gr.212002; LERICHE MA, 1990, PARASITOL RES, V76, P559, DOI 10.1007/BF00932560; Li L, 2004, NUCLEIC ACIDS RES, V32, pD326, DOI 10.1093/nar/gkh112; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lingelbach K, 1998, J CELL SCI, V111, P1467; Lourenco EV, 2001, GLYCOBIOLOGY, V11, P541, DOI 10.1093/glycob/11.7.541; Lyons RE, 1998, INT J PARASITOL, V28, P1041, DOI 10.1016/S0020-7519(98)00074-5; LYONS RE, 1995, PARASITE IMMUNOL, V17, P353, DOI 10.1111/j.1365-3024.1995.tb00902.x; Manger ID, 1998, INFECT IMMUN, V66, P2237, DOI 10.1128/IAI.66.5.2237-2244.1998; Meek B, 2002, FEBS LETT, V522, P104, DOI 10.1016/S0014-5793(02)02911-3; Meek B, 2002, INT IMMUNOL, V14, P1291, DOI 10.1093/intimm/dxf091; Meissner M, 2002, J CELL SCI, V115, P563; Mercier C, 2002, MOL BIOL CELL, V13, P2397, DOI 10.1091/mbc.E02-01-0021; Miller SA, 2001, J BIOL CHEM, V276, P45341, DOI 10.1074/jbc.M106665200; Monteiro VG, 2001, J STRUCT BIOL, V136, P181, DOI 10.1006/jsbi.2002.4444; Morris MT, 2002, J BIOL CHEM, V277, P45259, DOI 10.1074/jbc.M205517200; Nakaar V, 1998, MOL BIOCHEM PARASIT, V92, P229, DOI 10.1016/S0166-6851(97)00220-X; Nakaar V, 2003, J CELL SCI, V116, P2311, DOI 10.1242/jcs.00382; Nakaar V, 1999, J BIOL CHEM, V274, P5083, DOI 10.1074/jbc.274.8.5083; Neudeck A, 2002, MICROBES INFECT, V4, P581, DOI 10.1016/S1286-4579(02)01576-9; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ngo HM, 2003, J BIOL CHEM, V278, P5343, DOI 10.1074/jbc.M208291200; Odberg-Ferragut C, 2000, MOL BIOCHEM PARASIT, V106, P121, DOI 10.1016/S0166-6851(99)00211-X; Onnerfjord P, 1999, RAPID COMMUN MASS SP, V13, P315; Paba J, 2004, PROTEOMICS, V4, P1052, DOI 10.1002/pmic.200300637; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PRINCE JB, 1989, MOL BIOCHEM PARASIT, V34, P3, DOI 10.1016/0166-6851(89)90014-5; PRINCE JB, 1990, MOL BIOCHEM PARASIT, V43, P97, DOI 10.1016/0166-6851(90)90134-8; Pszenny V, 2002, MOL BIOCHEM PARASIT, V121, P283, DOI 10.1016/S0166-6851(02)00045-2; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Rabenau KE, 2001, MOL MICROBIOL, V41, P537, DOI 10.1046/j.1365-2958.2001.02513.x; Reichmann G, 2002, MOL BIOCHEM PARASIT, V119, P43, DOI 10.1016/S0166-6851(01)00397-8; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; SANTORO F, 1985, CLIN EXP IMMUNOL, V62, P262; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Silverman JA, 1998, J BIOL CHEM, V273, P12352, DOI 10.1074/jbc.273.20.12352; Sinai AP, 1997, J CELL SCI, V110, P2117; Sinai AP, 1997, ANNU REV MICROBIOL, V51, P415, DOI 10.1146/annurev.micro.51.1.415; Soldati D, 2004, CURR OPIN CELL BIOL, V16, P32, DOI 10.1016/j.ceb.2003.11.013; Son Eui-Sun, 2001, Korean Journal of Parasitology, V39, P133, DOI 10.3347/kjp.2001.39.2.133; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sullivan WJ, 2004, BIOCHEM J, V380, P523, DOI 10.1042/BJ20040262; Suzuki Y, 2000, J CLIN MICROBIOL, V38, P3967, DOI 10.1128/JCM.38.11.3967-3970.2000; Tomley FM, 2001, TRENDS PARASITOL, V17, P81, DOI 10.1016/S1471-4922(00)01761-X; TONEY DM, 1994, J IMMUNOL, V152, P2952; Vollmer M, 2001, J BIOL CHEM, V276, P5483, DOI 10.1074/jbc.M009452200; Wan KL, 1997, MOL BIOCHEM PARASIT, V84, P203, DOI 10.1016/S0166-6851(96)02796-X; Yang SM, 1997, GENE, V184, P1, DOI 10.1016/S0378-1119(96)00566-5; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	119	97	113	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34233	34244		10.1074/jbc.M504160200	http://dx.doi.org/10.1074/jbc.M504160200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16002397	hybrid, Green Accepted			2022-12-27	WOS:000232229700066
J	Zheng, CY; Lu, X; Hansen, JC; Jeffrey, JH				Zheng, CY; Lu, X; Hansen, JC; Jeffrey, JH			Salt-dependent intra- and internucleosomal interactions of the H3 tail domain in a model oligonucleosomal array	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME CORE PARTICLE; CHROMATIN FIBER; LINKER DNA; HISTONE ACETYLATION; BINDING; TRANSCRIPTION; COMPACTION; REVEAL	The core histone tail domains are known to be key regulators of chromatin structure and function. The tails are required for condensation of nucleosome arrays into secondary and tertiary chromatin structures, yet little is known regarding tail structures or sites of tail interactions in chromatin. We have developed a system to test the hypothesis that the tails participate in internucleosomal interactions during salt-dependent chromatin condensation, and here we used it to examine interactions of the H3 tail domain. We found that the H3 tail participates primarily in intranucleosome interactions when the nucleosome array exists in an extended "beads-onastring" conformation and that tail interactions reorganize to engage in primarily internucleosome interactions as the array successively undergoes salt-dependent folding and oligomerization. These results indicated that the location and interactions of the H3 tail domain are dependent upon the degree of condensation of the nucleosomal array, suggesting amechanism by which alterations in tail interactions may elaborate different structural and functional states of chromatin.	Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	University of Rochester; Colorado State University	Jeffrey, JH (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.	jjhs@mail.rochester.edu			NIGMS NIH HHS [GM45916, GM52426] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045916, R29GM045916, R01GM052426] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN J, 1982, J CELL BIOL, V93, P285, DOI 10.1083/jcb.93.2.285; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Butler PJG, 1998, J MOL BIOL, V281, P401, DOI 10.1006/jmbi.1998.1954; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; GEORGEL P, 1993, J BIOL CHEM, V268, P1947; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; Harp JM, 2000, ACTA CRYSTALLOGR D, V56, P1513, DOI 10.1107/S0907444900011847; Hayes JJ, 1997, METHODS, V12, P2, DOI 10.1006/meth.1997.0441; HONG L, 1993, J BIOL CHEM, V268, P305; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; NACHEVA GA, 1989, CELL, V58, P27, DOI 10.1016/0092-8674(89)90399-1; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; Scrittori L, 2001, J BIOL CHEM, V276, P30002, DOI 10.1074/jbc.M102701200; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; STEFANOVSKY VY, 1989, NUCLEIC ACIDS RES, V17, P10069, DOI 10.1093/nar/17.23.10069; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; WIDOM J, 1989, ANNU REV BIOPHYS BIO, V18, P365, DOI 10.1146/annurev.biophys.18.1.365; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; YAO J, 1991, BIOCHEMISTRY-US, V30, P8408, DOI 10.1021/bi00098a019; YAO J, 1990, P NATL ACAD SCI USA, V87, P7603, DOI 10.1073/pnas.87.19.7603; Zheng CY, 2004, METHOD ENZYMOL, V375, P179; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200	30	79	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33552	33557		10.1074/jbc.M507241200	http://dx.doi.org/10.1074/jbc.M507241200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16079127	hybrid			2022-12-27	WOS:000232058100055
J	Zhang, Y; Wang, DX; Johnson, AD; Papp, AC; Sadee, W				Zhang, Y; Wang, DX; Johnson, AD; Papp, AC; Sadee, W			Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; GENE POLYMORPHISMS; FUNCTIONAL POLYMORPHISM; SUBSTANCE DEPENDENCE; ASSOCIATION; ADDICTION; ALCOHOL; BRAIN; LOCUS; SUSCEPTIBILITY	As a primary target for opioid drugs and peptides, the mu opioid receptor ( OPRM1) plays a key role in pain perception and addiction. Genetic variants of OPRM1 have been implicated in predisposition to drug addiction, in particular the single nucleotide polymorphism A118G, leading to an N40D substitution, with an allele frequency of 10 - 32%, and uncertain functions. We have measured allele- specific mRNA expression of OPRM1 in human autopsy brain tissues, using A118G as a marker. In 8 heterozygous samples measured, the A118 mRNA allele was 1.5 - 2.5- fold more abundant than the G118 allele. Transfection into Chinese hamster ovary cells of a cDNA representing only the coding region of OPRM1, carrying adenosine, guanosine, cytidine, and thymidine in position 118, resulted in 1.5- fold lower mRNA levels only for OPRM1- G118, and more than 10- fold lower OPRM1 protein levels, measured by Western blotting and receptor binding assay. After transfection and inhibition of transcription with actinomycin D, analysis of mRNA turnover failed to reveal differences in mRNA stability between A118 and G118 alleles, indicating a defect in transcription or mRNA maturation. These results indicate that OPRM1- G118 is a functional variant with deleterious effects on both mRNA and protein yield. Clarifying the functional relevance of polymorphisms associated with susceptibility to a complex disorder such as drug addiction provides a foundation for clinical association studies.	Ohio State Univ, Dept Pharmacol, Coll Med & Publ Hlth, Program Pharmacogenom, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Sadee, W (corresponding author), Ohio State Univ, Dept Pharmacol, Coll Med & Publ Hlth, Program Pharmacogenom, 5072 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	sadee-1@medctr.osu.edu	Johnson, Andrew D/G-6520-2013; Wang, Danxin/I-5810-2019	Johnson, Andrew D/0000-0001-6369-5178; Wang, Danxin/0000-0002-7134-3065	NATIONAL INSTITUTE ON DRUG ABUSE [R21DA018744] Funding Source: NIH RePORTER; NIDA NIH HHS [DA018744] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Arraiano Cecilia Maria, 2003, Molecular Microbiology, V49, P267, DOI 10.1046/j.1365-2958.2003.03545.x; Bart G, 2004, MOL PSYCHIATR, V9, P547, DOI 10.1038/sj.mp.4001504; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Befort K, 2001, J BIOL CHEM, V276, P3130, DOI 10.1074/jbc.M006352200; Beyer A, 2004, J NEUROCHEM, V89, P553, DOI 10.1111/j.1471-4159.2004.02340.x; Bond C, 1998, P NATL ACAD SCI USA, V95, P9608, DOI 10.1073/pnas.95.16.9608; Bray NJ, 2004, MOL PSYCHIATR, V9, P109, DOI 10.1038/sj.mp.4001366; Bray NJ, 2003, AM J HUM GENET, V73, P152, DOI 10.1086/376578; Byers PH, 2002, J CLIN INVEST, V109, P3, DOI 10.1172/JCI14841; Crowley JJ, 2003, PSYCHIAT GENET, V13, P169, DOI 10.1097/00041444-200309000-00006; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Gscheidel N, 2000, POL J PHARMACOL, V52, P27; Hernandez-Avila CA, 2003, AM J MED GENET B, V118B, P60, DOI 10.1002/ajmg.b.10054; Herz A, 1997, PSYCHOPHARMACOLOGY, V129, P99, DOI 10.1007/s002130050169; Hirota T, 2004, HUM MOL GENET, V13, P2959, DOI 10.1093/hmg/ddh313; Hoehe MR, 2000, HUM MOL GENET, V9, P2895, DOI 10.1093/hmg/9.19.2895; Johnson AD, 2005, PHARMACOL THERAPEUT, V106, P19, DOI 10.1016/j.pharmthera.2004.11.001; Kreek MJ, 1996, NEUROCHEM RES, V21, P1469, DOI 10.1007/BF02532387; Kreek MJ, 1996, J ADDICT DIS, V15, P73, DOI 10.1300/J069v15n04_05; Kreek MJ, 2004, NEUROMOL MED, V5, P85, DOI 10.1385/NMM:5:1:085; Kreek MJ, 1996, MOL PSYCHIATR, V1, P232; KROSLAK T, 2003, INT NARC RES C PERP; LaForge KS, 2000, EUR J PHARMACOL, V410, P249, DOI 10.1016/S0014-2999(00)00819-0; Le Hellard S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf070; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Luo XG, 2003, AM J MED GENET B, V120B, P97, DOI 10.1002/ajmg.b.20034; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Oslin DW, 2003, NEUROPSYCHOPHARMACOL, V28, P1546, DOI 10.1038/sj.npp.1300219; Peckys D, 1999, NEUROSCIENCE, V88, P1093, DOI 10.1016/S0306-4522(98)00251-6; Pinsonneault J, 2004, J PHARMACOL EXP THER, V311, P1088, DOI 10.1124/jpet.104.073098; Schinka JA, 2002, MOL PSYCHIATR, V7, P224, DOI 10.1038/sj.mp.4000951; Stamatoyannopoulos JA, 2004, GENOMICS, V84, P449, DOI 10.1016/j.ygeno.2004.05.002; Szeto CYK, 2001, NEUROREPORT, V12, P1103, DOI 10.1097/00001756-200105080-00011; Tan EC, 2003, NEUROREPORT, V14, P569, DOI 10.1097/00001756-200303240-00008; Wand GS, 2002, NEUROPSYCHOPHARMACOL, V26, P106, DOI 10.1016/S0893-133X(01)00294-9; Wang DX, 2005, MOL PHARMACOL, V67, P2173, DOI 10.1124/mol.104.010272; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Yan H, 2004, CURR OPIN ONCOL, V16, P39, DOI 10.1097/00001622-200401000-00008; Zhang YH, 2004, GENE, V341, P93, DOI 10.1016/j.gene.2004.07.017; Zuker M, 1998, RNA, V4, P669, DOI 10.1017/S1355838298980116; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	449	462	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32618	32624		10.1074/jbc.M504942200	http://dx.doi.org/10.1074/jbc.M504942200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16046395	hybrid			2022-12-27	WOS:000231920300009
J	Fikaris, AJ; Kao, GD; Brown, EJ; Kazanietz, MG; Meinkoth, JL				Fikaris, AJ; Kao, GD; Brown, EJ; Kazanietz, MG; Meinkoth, JL			Protein kinase C delta stimulates apoptosis by initiating G(1) phase cell cycle progression and S phase arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; RAT-THYROID CELLS; ABL TYROSINE KINASE; GLAND ACINAR-CELLS; PKC-DELTA; PHORBOL ESTER; SUBSTRATE-SPECIFICITY; IONIZING-RADIATION; DNA-SYNTHESIS; LATE G1	Overexpression of protein kinase C delta(PKC delta) stimulates apoptosis in a wide variety of cell types through a mechanism that is incompletely understood. PKC delta-deficient cells are impaired in their response to DNA damage-induced apoptosis, suggesting that PKC delta is required to mount an appropriate apoptotic response under conditions of stress. The mechanism through which it does so remains elusive. In addition to effects on cell survival, PKC delta elicits pleiotropic effects on cellular proliferation. We now provide the first evidence that the ability of PKC delta to stimulate apoptosis is intimately linked to its ability to stimulate G(1) phase cell cycle progression. Using an adenoviral-based expression system to express PKC alpha, -delta, and -epsilon in epithelial cells, we demonstrate that a modest increase in PKC delta activity selectively stimulates quiescent cells to initiate G1 phase cell cycle progression. Rather than completing the cell cycle, PKC delta-infected cells arrest in S phase, an event that triggers caspase-dependent apoptotic cell death. Apoptosis was preceded by the activation of cell cycle checkpoints, culminating in the phosphorylation of Chk-1 and p53. Strikingly, blockade of S phase entry using the phosphatidylinositol 3-kinase inhibitor LY294002 prevented checkpoint activation and apoptosis. In contrast, inhibitors of mitogen-activated protein kinase cascades failed to prevent apoptosis. These findings demonstrate that the biological effects of PKC delta can be extended to include positive regulation of G1 phase cell cycle progression. Importantly, they reveal the existence of a novel, cell cycle-dependent mechanism through which PKC delta stimulates cell death.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Meinkoth, JL (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, Rm 1251 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	meinkoth@pharm.med.upenn.edu	Meinkoth, Judy L/G-2900-2010		NCI NIH HHS [CA-109543, CA-92537, CA-89202] Funding Source: Medline; NIDDK NIH HHS [DK-45696] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA092537, R01CA089202, R01CA109543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045696] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Cass LA, 1999, MOL CELL BIOL, V19, P5882; Castellone MD, 2003, ONCOGENE, V22, P246, DOI 10.1038/sj.onc.1206112; Cheng GJ, 2003, MOL ENDOCRINOL, V17, P450, DOI 10.1210/me.2002-0344; Cheng GJ, 2001, ONCOGENE, V20, P7334, DOI 10.1038/sj.onc.1204928; Clark AS, 2003, CANCER RES, V63, P780; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Ettinger SL, 1996, J BIOL CHEM, V271, P14514, DOI 10.1074/jbc.271.24.14514; Fernandez N, 2000, ENDOCRINOLOGY, V141, P146, DOI 10.1210/en.141.1.146; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Garcia-Bermejo ML, 2002, J BIOL CHEM, V277, P645, DOI 10.1074/jbc.M107639200; Goerke A, 2002, J BIOL CHEM, V277, P32054, DOI 10.1074/jbc.M203734200; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; Harrington EO, 1997, J BIOL CHEM, V272, P7390, DOI 10.1074/jbc.272.11.7390; HATADA T, 1992, CANCER, V70, P2918, DOI 10.1002/1097-0142(19921215)70:12<2918::AID-CNCR2820701231>3.0.CO;2-5; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Izzard RA, 1999, CANCER RES, V59, P2581; Kazanietz MG, 2000, BIOCHEM PHARMACOL, V60, P1417, DOI 10.1016/S0006-2952(00)00470-6; KAZANIETZ MG, 1993, MOL PHARMACOL, V44, P298; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Kilpatrick LE, 2002, AM J PHYSIOL-CELL PH, V283, pC48, DOI 10.1152/ajpcell.00385.2001; Kitamura K, 2003, GENES CELLS, V8, P311, DOI 10.1046/j.1365-2443.2003.00635.x; Knauf JA, 1999, J BIOL CHEM, V274, P23414, DOI 10.1074/jbc.274.33.23414; Knauf JA, 2002, J CLIN ENDOCR METAB, V87, P2150, DOI 10.1210/jc.87.5.2150; KOBAYASHI K, 1993, THYROID, V3, P25, DOI 10.1089/thy.1993.3.25; Kumar V, 2000, EMBO J, V19, P1087, DOI 10.1093/emboj/19.5.1087; Kupperman E, 1996, ENDOCRINOLOGY, V137, P96, DOI 10.1210/en.137.1.96; Lee YJ, 2002, CELL GROWTH DIFFER, V13, P237; Lewis AE, 2004, MOL ENDOCRINOL, V18, P2321, DOI 10.1210/me.2004-0104; Li LW, 1999, MOL CELL BIOL, V19, P8547; Liu JH, 2003, CANCER RES, V63, P1153; Mitsutake N, 2001, ONCOGENE, V20, P989, DOI 10.1038/sj.onc.1204179; Nakaigawa N, 1996, BIOCHEM BIOPH RES CO, V222, P95, DOI 10.1006/bbrc.1996.0703; PREVOSTEL C, 1995, ONCOGENE, V11, P669; Ren J, 2002, J BIOL CHEM, V277, P33758, DOI 10.1074/jbc.M110667200; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Reyland ME, 2000, CELL DEATH DIFFER, V7, P1200, DOI 10.1038/sj.cdd.4400744; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rosenzweig KE, 1997, CLIN CANCER RES, V3, P1149; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Sherman SI, 2003, LANCET, V361, P501, DOI 10.1016/S0140-6736(03)12488-9; Shirokawa JM, 2000, MOL ENDOCRINOL, V14, P1725, DOI 10.1210/me.14.11.1725; Sun XG, 2000, J BIOL CHEM, V275, P7470, DOI 10.1074/jbc.275.11.7470; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Wang JW, 2003, MOL ENDOCRINOL, V17, P1425, DOI 10.1210/me.2003-0041; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; Yuan ZM, 1998, ONCOGENE, V16, P1643, DOI 10.1038/sj.onc.1201698; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	54	44	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32107	32114		10.1074/jbc.M504432200	http://dx.doi.org/10.1074/jbc.M504432200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16051606	hybrid			2022-12-27	WOS:000231794800010
J	Pittman, MS; Robinson, HC; Poole, RK				Pittman, MS; Robinson, HC; Poole, RK			A bacterial glutathione transporter (Escherichia coli CydDC) exports reductant to the periplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE-BOND FORMATION; BD QUINOL OXIDASE; CYTOCHROME-BD; RESPIRATORY-CHAIN; REDOX STATE; STREPTOCOCCUS-MUTANS; N-ETHYLMALEIMIDE; GENE-PRODUCT; AMINO-ACIDS; PROTEIN	Glutathione (GSH), a major biological antioxidant, maintains redox balance in prokaryotes and eukaryotic cells and forms exportable conjugates with compounds of pharmacological and agronomic importance. However, no GSH transporter has been characterized in a prokaryote. We show here that a heterodimeric ATP-binding cassette-type transporter, CydDC, mediates GSH transport across the Escherichia coli cytoplasmic membrane. In everted membrane vesicles, GSH is imported via an ATP-driven, protonophore-insensitive, orthovanadate-sensitive mechanism, equating with export to the periplasm in intact cells. GSH transport and cytochrome bd quinol oxidase assembly are abolished in the cydD1 mutant. Glutathione disulfide ( GSSG) was not transported in either Cyd(+) or Cyd(-) strains. Exogenous GSH restores defective swarming motility and benzylpenicillin sensitivity in a cydD mutant and also benzylpenicillin sensitivity in a gshA mutant defective in GSH synthesis. Overexpression of the cydDC operon in dsbD mutants defective in disulfide bond formation restores dithiothreitol tolerance and periplasmic cytochrome b assembly, revealing redundant pathways for reductant export to the periplasm. These results identify the first prokaryotic GSH transporter and indicate a key role for GSH in periplasmic redox homeostasis.	Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Poole, RK (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Firth Court, Sheffield S10 2TN, S Yorkshire, England.	r.poole@sheffield.ac.uk			Biotechnology and Biological Sciences Research Council [BB/C514174/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		AMBUDKAR SV, 1984, J BIOL CHEM, V259, P6142; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; BEBBINGTON KJ, 1993, FEMS MICROBIOL LETT, V112, P19; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BUTLER J, 1976, ANAL BIOCHEM, V75, P674, DOI 10.1016/0003-2697(76)90129-9; Carelli S, 1997, MOL BIOL CELL, V8, P564; Cook GM, 2000, MICROBIOL-SGM, V146, P527, DOI 10.1099/00221287-146-2-527; CROOKE H, 1995, MOL MICROBIOL, V15, P1139, DOI 10.1111/j.1365-2958.1995.tb02287.x; Cruz-Ramos H, 2004, MICROBIOL-SGM, V150, P3415, DOI 10.1099/mic.0.27191-0; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Dartigalongue C, 2000, EMBO J, V19, P5980, DOI 10.1093/emboj/19.22.5980; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; de Crouy-Chanel A, 2001, RES MICROBIOL, V152, P663, DOI 10.1016/S0923-2508(01)01245-1; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; Dmello R, 1996, MICROBIOL-UK, V142, P755, DOI 10.1099/00221287-142-4-755; Fabianek RA, 2000, FEMS MICROBIOL REV, V24, P303, DOI 10.1111/j.1574-6976.2000.tb00544.x; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; Ferguson GP, 1997, J BACTERIOL, V179, P1007, DOI 10.1128/jb.179.4.1007-1012.1997; GEORGIOU CD, 1987, J BACTERIOL, V169, P2107, DOI 10.1128/jb.169.5.2107-2112.1987; Goldman BS, 1996, J BACTERIOL, V178, P6348, DOI 10.1128/jb.178.21.6348-6351.1996; Goldman BS, 1996, J BACTERIOL, V178, P6338, DOI 10.1128/jb.178.21.6338-6347.1996; Gralnick J, 2000, J BACTERIOL, V182, P5180, DOI 10.1128/JB.182.18.5180-5187.2000; GREENBERG JT, 1986, J BACTERIOL, V168, P1026, DOI 10.1128/jb.168.2.1026-1029.1986; Hoober KL, 1996, J BIOL CHEM, V271, P30510, DOI 10.1074/jbc.271.48.30510; Hosie AHF, 2001, RES MICROBIOL, V152, P259, DOI 10.1016/S0923-2508(01)01197-4; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; INOUE M, 1985, J BIOL CHEM, V260, P326; Jamai A, 1996, PLANT PHYSIOL, V111, P1145, DOI 10.1104/pp.111.4.1145; Kalnenieks U, 1998, FEMS MICROBIOL LETT, V168, P91; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; Konings WN, 2002, IUBMB LIFE, V53, P213, DOI 10.1080/15216540212646; Krebs H A, 1967, Adv Enzyme Regul, V5, P409, DOI 10.1016/0065-2571(67)90029-5; Krupp R, 2001, J BIOL CHEM, V276, P3696, DOI 10.1074/jbc.M009500200; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Linton KJ, 1998, MOL MICROBIOL, V28, P5, DOI 10.1046/j.1365-2958.1998.00764.x; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MARTENSSON J, 1990, P NATL ACAD SCI USA, V87, P7185, DOI 10.1073/pnas.87.18.7185; McLaggan D, 2000, APPL ENVIRON MICROB, V66, P1393, DOI 10.1128/AEM.66.4.1393-1399.2000; MEISTER A, 1988, J BIOL CHEM, V263, P17205; MISSIAKAS D, 1995, EMBO J, V14, P3415, DOI 10.1002/j.1460-2075.1995.tb07347.x; OBRIAN MR, 2002, ADV MICROBIAL PHYSL, P257; Parry J, 2002, FEMS MICROBIOL LETT, V209, P81, DOI 10.1111/j.1574-6968.2002.tb11113.x; Pittman MS, 2002, J BIOL CHEM, V277, P49841, DOI 10.1074/jbc.M205615200; POOLE RK, 1989, J GEN MICROBIOL, V135, P1865; POOLE RK, 1993, MOL MICROBIOL, V10, P421, DOI 10.1111/j.1365-2958.1993.tb02673.x; POOLE RK, 1994, FEMS MICROBIOL LETT, V117, P217, DOI 10.1111/j.1574-6968.1994.tb06768.x; POOLE RK, 1986, J GEN MICROBIOL, V132, P1525; Raina S, 1997, ANNU REV MICROBIOL, V51, P179, DOI 10.1146/annurev.micro.51.1.179; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sherrill C, 1998, J BACTERIOL, V180, P1454, DOI 10.1128/JB.180.6.1454-1459.1998; Siegele DA, 1996, J BACTERIOL, V178, P6091, DOI 10.1128/jb.178.21.6091-6096.1996; STEWART V, 1988, J BACTERIOL, V170, P1589, DOI 10.1128/jb.170.4.1589-1597.1988; THOMAS EL, 1984, J BACTERIOL, V157, P240, DOI 10.1128/JB.157.1.240-246.1984; THONYMEYER L, 1995, J BACTERIOL, V177, P4321; TROWER MK, 1993, BIOCHIM BIOPHYS ACTA, V1143, P109, DOI 10.1016/0005-2728(93)90223-3; TUGGLE CK, 1985, J BACTERIOL, V162, P448, DOI 10.1128/JB.162.1.448-450.1985; Vergauwen B, 2003, J BACTERIOL, V185, P5555, DOI 10.1128/JB.185.18.5555-5562.2003; WILLIS RC, 1974, ARCH BIOCHEM BIOPHYS, V161, P64, DOI 10.1016/0003-9861(74)90235-5; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Zhang J, 2004, FEBS LETT, V561, P58, DOI 10.1016/S0014-5793(04)00125-5	65	123	131	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32254	32261		10.1074/jbc.M503075200	http://dx.doi.org/10.1074/jbc.M503075200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16040611	hybrid			2022-12-27	WOS:000231794800027
J	Bachhuber, T; Konig, J; Voelcker, T; Murle, B; Schreiber, R; Kunzelmann, K				Bachhuber, T; Konig, J; Voelcker, T; Murle, B; Schreiber, R; Kunzelmann, K			Cl- interference with the epithelial Na+ channel ENaC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PDZ-INTERACTING DOMAIN; COLLECTING DUCT CELLS; CYSTIC-FIBROSIS; SODIUM-CHANNEL; XENOPUS OOCYTES; CHLORIDE CHANNEL; FUNCTIONAL INTERACTIONS; PURINERGIC STIMULATION; SURFACE EXPRESSION	The cystic fibrosis transmembrane conductance regulator (CFTR) is a protein kinase A and ATP-regulated Cl- channel that also controls the activity of other membrane transport proteins, such as the epithelial Na+ channel ENaC. Previous studies demonstrated that cytosolic domains of ENaC are critical for down-regulation of ENaC by CFTR, whereas others suggested a role of cytosolic Cl- ions. We therefore examined in detail the anion dependence of ENaC and the role of its cytosolic domains for the inhibition by CFTR and the Cl- channel CLC-0. Coexpression of rat ENaC with human CFTR or the human Cl- channel CLC-0 caused inhibition of amiloride-sensitive Na+ currents after cAMP-dependent stimulation and in the presence of a 100 mM bath Cl- concentration. After activation of CFTR by 3-isobutyl-1-methylxanthine and forskolin or expression of CLC-0, the intracellular Cl- concentration was increased in Xenopus oocytes in the presence of a high bath Cl- concentration, which inhibited ENaC without changing surface expression of alpha beta gamma ENaC. In contrast, a 5 mM bath Cl- concentration reduced the cytosolic Cl- concentration and enhanced ENaC activity. ENaC was also inhibited by injection of Cl- into oocytes and in inside/out macropatches by exposure to high cytosolic Cl- concentrations. The effect of Cl- was mimicked by Br-, NO3-, and I-. Inhibition by Cl- was reduced in trimeric channels with a truncated COOH terminus of beta ENaC and gamma ENaC, and it was no longer detected in dimeric alpha beta gamma ENaC channels. Deletion of the NH2 terminus of alpha-, beta-, or gamma ENaC, mutations in the NH2-terminal phosphatidylinositol bisphosphate-binding domain of beta ENaC and gamma EnaC, and activation of phospholipase C, all reduced ENaC activity but allowed for Cl--dependent inhibition of the remaining ENaC current. The results confirm a role of the carboxyl terminus of beta ENaC for Cl-- dependent inhibition of the Na+ channel, which, however, may only be part of a complex regulation of ENaC by CFTR.	Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany	University of Regensburg	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	uqkkunze@mailbox.uq.edu.au	Schreiber, Robert/Q-7550-2019	Kunzelmann, Karl/0000-0002-4583-7037				Adam G, 2005, PFLUG ARCH EUR J PHY, V449, P470, DOI 10.1007/s00424-004-1356-4; Berdiev BK, 2000, BIOPHYS J, V78, P1881, DOI 10.1016/S0006-3495(00)76737-3; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Boucher RC, 1999, J PHYSIOL-LONDON, V516, P631, DOI 10.1111/j.1469-7793.1999.0631u.x; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Boucherot A, 2001, BBA-BIOMEMBRANES, V1515, P64, DOI 10.1016/S0005-2736(01)00396-0; Briel M, 1998, J PHYSIOL-LONDON, V508, P825, DOI 10.1111/j.1469-7793.1998.825bp.x; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Chabot H, 1999, J MEMBRANE BIOL, V169, P175, DOI 10.1007/s002329900529; Chalfant ML, 1999, J BIOL CHEM, V274, P32889, DOI 10.1074/jbc.274.46.32889; Chen TY, 1998, J GEN PHYSIOL, V112, P715, DOI 10.1085/jgp.112.6.715; Cuffe JE, 2000, J PHYSIOL-LONDON, V524, P77, DOI 10.1111/j.1469-7793.2000.00077.x; DINUDOM A, 1995, J PHYSIOL-LONDON, V487, P549, DOI 10.1113/jphysiol.1995.sp020899; DINUDOM A, 1993, J MEMBRANE BIOL, V135, P289; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; GRUBB BR, 1994, AM J PHYSIOL, V266, pC1478, DOI 10.1152/ajpcell.1994.266.5.C1478; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; Hopf A, 1999, J BIOL CHEM, V274, P13894, DOI 10.1074/jbc.274.20.13894; Hubner M, 1999, FEBS LETT, V459, P443, DOI 10.1016/S0014-5793(99)01291-0; Ismailov II, 1996, J BIOL CHEM, V271, P4725; Ji HL, 2000, J BIOL CHEM, V275, P27947; Jiang QS, 2000, J BIOL CHEM, V275, P13266, DOI 10.1074/jbc.275.18.13266; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; Komwatana P, 1998, J MEMBRANE BIOL, V162, P225, DOI 10.1007/s002329900360; Konig J, 2002, BBA-BIOMEMBRANES, V1565, P17, DOI 10.1016/S0005-2736(02)00502-3; Konig J, 2001, EMBO REP, V2, P1047, DOI 10.1093/embo-reports/kve232; Konstas AA, 2003, PFLUG ARCH EUR J PHY, V445, P513, DOI 10.1007/s00424-002-0957-z; Konstas AA, 2002, J BIOL CHEM, V277, P25377, DOI 10.1074/jbc.M201925200; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Kunzelmann K, 1999, Rev Physiol Biochem Pharmacol, V137, P1; Kunzelmann K, 1997, KIDNEY BLOOD PRESS R, V20, P151, DOI 10.1159/000174129; Kunzelmann K, 2004, FASEB J, V18, P142, DOI 10.1096/fj.04-2314fje; KUNZELMANN K, 1995, PFLUG ARCH EUR J PHY, V431, P1, DOI 10.1007/BF00374371; Kunzelmann K, 2001, KIDNEY INT, V60, P455, DOI 10.1046/j.1523-1755.2001.060002455.x; Kunzelmann K, 1997, FEBS LETT, V400, P341, DOI 10.1016/S0014-5793(96)01414-7; KUNZELMANN K, 2003, PFLUGERS ARCH, V445, P505; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Mall M, 1999, AM J PHYSIOL-GASTR L, V277, pG709, DOI 10.1152/ajpgi.1999.277.3.G709; Mall M, 1996, FEBS LETT, V381, P47, DOI 10.1016/0014-5793(96)00079-8; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Matsui H, 2000, J CLIN INVEST, V105, P1419, DOI 10.1172/JCI4546; Mehta A, 2005, PEDIATR PULM, V39, P292, DOI 10.1002/ppul.20147; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Nagel G, 2005, J PHYSIOL-LONDON, V564, P671, DOI 10.1113/jphysiol.2004.079046; Nagel G, 2001, EMBO REP, V2, P249, DOI 10.1093/embo-reports/kve045; Niisato N, 2004, AM J PHYSIOL-RENAL, V287, pF932, DOI 10.1152/ajprenal.00131.2004; Oceandy D, 2002, HUM MOL GENET, V11, P1059, DOI 10.1093/hmg/11.9.1059; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; Rochelle LG, 2000, AM J PHYSIOL-LUNG C, V279, pL14, DOI 10.1152/ajplung.2000.279.1.L14; Schreiber R, 1999, P NATL ACAD SCI USA, V96, P5310, DOI 10.1073/pnas.96.9.5310; Schreiber R, 2004, J MEMBRANE BIOL, V199, P85, DOI 10.1007/s00232-004-0679-6; Schreiber R, 2003, J MEMBRANE BIOL, V192, P101, DOI 10.1007/s00232-002-1067-8; SCHWIEBERT EM, 1999, PHYSL REV S, V79, P145; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Suaud L, 2002, J BIOL CHEM, V277, P50341, DOI 10.1074/jbc.M209641200; Suaud L, 2002, J BIOL CHEM, V277, P8928, DOI 10.1074/jbc.M111482200; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Xie Y, 2004, AM J PHYSIOL-RENAL, V287, pF722, DOI 10.1152/ajprenal.00135.2004; Yan WS, 2004, J BIOL CHEM, V279, P23183, DOI 10.1074/jbc.M402373200; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200	64	46	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31587	31594		10.1074/jbc.M504347200	http://dx.doi.org/10.1074/jbc.M504347200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16027156	hybrid			2022-12-27	WOS:000231665200032
J	Cai, L; Holoweckyj, N; Schaller, MD; Bear, JE				Cai, L; Holoweckyj, N; Schaller, MD; Bear, JE			Phosphorylation of coronin 1B by protein kinase C regulates interaction with Arp2/3 and cell motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING-PROTEIN; GROWTH-FACTOR; MICROTUBULE CYTOSKELETONS; PHORBOL ESTER; DICTYOSTELIUM; ASSOCIATION; FAMILY; REGION	Coronins are a conserved family of WD repeat-containing, actin-binding proteins that regulate cell motility in a variety of model organisms. Our results show that Coronin 1B is a ubiquitously expressed member of the mammalian Coronin gene family that co-localizes with the Arp2/3 complex at the leading edge of fibroblasts, and co-immunoprecipitates with this complex. Pharmacological experiments show that the interaction between Coronin 1B and the Arp2/3 complex is regulated by protein kinase C (PKC) phosphorylation. Coronin 1B is phosphorylated by PKC both in vitro and in vivo. Using tryptic peptide mapping and mutagenesis, we have identified serine 2 (Ser-2) on Coronin 1B as the major residue phosphorylated by PKC in vivo. Rat2 fibroblasts expressing the Coronin 1B S2A mutant show enhanced ruffling in response to phorbol 12-myristate 13-acetate (PMA) and increased speed in single cell tracking assays. Cells expressing the Coronin 1B S2D mutant have attenuated PMA-induced ruffling and slower cell speed. Expression of the S2A mutant partially protects cells from the inhibitory effects of PMA on cell speed, whereas expression of the S2D mutant renders cells hypersensitive to its effects. These data demonstrate that Coronin 1B regulates leading edge dynamics and cell motility in fibroblasts, and that its ability to control motility and interactions with the Arp2/3 complex are regulated by PKC phosphorylation at Ser-2. Furthermore, Coronin 1B phosphorylation is responsible for a significant fraction of the effects of PMA on fibroblast motility.	Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Bear, JE (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, CB 7295, Chapel Hill, NC 27599 USA.	jbear@email.unc.edu			NATIONAL CANCER INSTITUTE [R01CA090901] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045100] Funding Source: NIH RePORTER; NCI NIH HHS [CA90901] Funding Source: Medline; NHLBI NIH HHS [HL45100] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Asano S, 2001, GENES CELLS, V6, P225, DOI 10.1046/j.1365-2443.2001.00416.x; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bharathi V, 2004, J CELL SCI, V117, P1911, DOI 10.1242/jcs.01034; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; Di Giovanni S, 2005, J BIOL CHEM, V280, P2084, DOI 10.1074/jbc.M411975200; DUGINA VB, 1987, P NATL ACAD SCI USA, V84, P4122, DOI 10.1073/pnas.84.12.4122; FRIDMAN R, 1990, J CELL PHYSIOL, V142, P55, DOI 10.1002/jcp.1041420108; GLOWACKA D, 1992, J NEUROSCI RES, V31, P263, DOI 10.1002/jnr.490310207; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Hacker U, 1997, J CELL SCI, V110, P105; Heil-Chapdelaine RA, 1998, CURR BIOL, V8, P1281, DOI 10.1016/S0960-9822(07)00539-8; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Itoh S, 2002, BIOL PHARM BULL, V25, P837, DOI 10.1248/bpb.25.837; Jackson D, 2005, ONCOGENE, V24, P3067, DOI 10.1038/sj.onc.1208465; KELLER HU, 1989, INT J CANCER, V44, P934, DOI 10.1002/ijc.2910440531; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; LUO KX, 1991, METHOD ENZYMOL, V201, P149; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mishima M, 1999, J CELL SCI, V112, P2833; Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Oku T, 2005, BIOCHEM J, V387, P325, DOI 10.1042/BJ20041020; Overbergh L, 2003, J Biomol Tech, V14, P33; Parente JA, 1999, J BIOL CHEM, V274, P3017, DOI 10.1074/jbc.274.5.3017; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Spoerl Z, 2002, J BIOL CHEM, V277, P48858, DOI 10.1074/jbc.M205136200; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Ziegler WH, 2002, J BIOL CHEM, V277, P7396, DOI 10.1074/jbc.M110008200	33	76	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31913	31923		10.1074/jbc.M504146200	http://dx.doi.org/10.1074/jbc.M504146200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16027158	Green Published, hybrid			2022-12-27	WOS:000231665200071
J	Kacprzak, MM; Than, ME; Juliano, L; Juliano, MA; Bode, W; Lindberg, I				Kacprzak, MM; Than, ME; Juliano, L; Juliano, MA; Bode, W; Lindberg, I			Mutations of the PC2 substrate binding pocket alter enzyme specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROHORMONE CONVERTASE 2; FURIN; 7B2; INHIBITION; PEPTIDE; PURIFICATION; ENDOPROTEASE; CLEAVAGE; DOMAIN; CELLS	By taking advantage of the recently published furin structure, whose catalytic domain shares high homology with other proprotein convertases, we designed mutations in the catalytic domain of PC2, altering residues Ser(206), Thr(271), Asp(278), ArgGlu(282), AlaSer(323), Leu(341), Asn(365), and Ser(380), which are both conserved and specific to this convertase, and substituting residues specific to PC1 and/or furin. In order to investigate the determinants of PC2 specificity, we have tested the mutated enzymes against a set of proenkephalin-derived substrates, as well as substrates representing Arg, Ala, Leu, Phe, and Glu positional scanning variants of a peptide B-derived substrate. We found that the exchange of the Ser206 residue with Arg or Lys led to a total loss of activity. Increased positive charge of the substrate generally resulted in an increased specificity constant. Most intriguingly, the RE281GR mutation, corresponding to a residue placed distantly in the S6 pocket, evoked the largest changes in the specificity pattern. The D278E and N356S mutations resulted in distinct alterations in PC2 substrate preferences. However, when other residues that distinguish PC2 from other convertases were substituted with PC1-like or furin-like equivalents, there was no significant alteration of the PC2 specificity pattern, suggesting that the overall structure of the substrate binding cleft rather than individual residues specifies substrate binding.	Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, New Orleans, LA 70112 USA; Max Planck Inst Biochem, Dept Struct Res, D-82152 Martinsried, Germany; Escola Paulista Med, Dept Biophys, BR-04044020 Sao Paulo, Brazil	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Max Planck Society; Universidade Federal de Sao Paulo (UNIFESP)	Lindberg, I (corresponding author), Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, 1901 Perdido St, New Orleans, LA 70112 USA.	ilindb@lsuhsc.edu	Lindberg, Iris/Q-3825-2019; Juliano, Luiz/D-7204-2012; Than, Manuel/F-7536-2015	Juliano, Luiz/0000-0002-5589-2822; Than, Manuel/0000-0002-4707-9225	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA005084, R01DA005084] Funding Source: NIH RePORTER; NIDA NIH HHS [DA05084, R56 DA005084] Funding Source: Medline; NIDDK NIH HHS [R01 DK049703] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Apletalina E, 1998, J BIOL CHEM, V273, P26589, DOI 10.1074/jbc.273.41.26589; Apletalina EV, 2000, J BIOL CHEM, V275, P14667, DOI 10.1074/jbc.275.19.14667; Bebbington CR, 1987, DNA CLONING PRACTICA, VIII, P163; BENJANNET S, 1995, FEBS LETT, V362, P151, DOI 10.1016/0014-5793(95)00228-2; Cameron A., 2001, ENZYMES, V22, P291; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; Day R, 1998, J BIOL CHEM, V273, P829, DOI 10.1074/jbc.273.2.829; DelNery E, 1997, BIOCHEM J, V323, P427, DOI 10.1042/bj3230427; Dey A, 2005, ENDOCRINOLOGY, V146, P713, DOI 10.1210/en.2004-1118; DICKINSON CJ, 1995, J CLIN INVEST, V96, P1425, DOI 10.1172/JCI118178; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; HATSUZAWA K, 1992, J BIOL CHEM, V267, P16094; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Hirata IY, 1995, LETT PEPT SCI, V1, P299, DOI DOI 10.1007/BF00119771; Johanning K, 1998, J BIOL CHEM, V273, P22672, DOI 10.1074/jbc.273.35.22672; Kacprzak MM, 2004, J BIOL CHEM, V279, P36788, DOI 10.1074/jbc.M400484200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lamango NS, 1996, ARCH BIOCHEM BIOPHYS, V330, P238, DOI 10.1006/abbi.1996.0249; LINDBERG I, 1995, BIOCHEMISTRY-US, V34, P5486, DOI 10.1021/bi00016a020; Lusson J, 1997, BIOCHEM J, V326, P737, DOI 10.1042/bj3260737; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Muller L, 1997, J CELL BIOL, V139, P625, DOI 10.1083/jcb.139.3.625; Muller L, 2000, PROG NUCLEIC ACID RE, V63, P69, DOI 10.1016/S0079-6603(08)60720-5; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; REHEMTULLA A, 1993, BIOCHEMISTRY-US, V32, P11586, DOI 10.1021/bi00094a015; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SEIDAH NG, 1994, METHOD ENZYMOL, V244, P171; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; TURK D, 1992, THESIS TU MUENCHEN G; Zhou A, 1998, J BIOL CHEM, V273, P11107, DOI 10.1074/jbc.273.18.11107; Zhu XR, 1998, J BIOL CHEM, V273, P1158, DOI 10.1074/jbc.273.2.1158	34	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31850	31858		10.1074/jbc.M505567200	http://dx.doi.org/10.1074/jbc.M505567200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16002408	hybrid			2022-12-27	WOS:000231665200064
J	Lee, FY; Kast-Woelbern, HR; Chang, J; Luo, GZ; Jones, SA; Fishbein, MC; Edwards, PA				Lee, FY; Kast-Woelbern, HR; Chang, J; Luo, GZ; Jones, SA; Fishbein, MC; Edwards, PA			alpha-Crystallin is a target gene of the farnesoid X-activated receptor in human livers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; SALT EXPORT PUMP; B-CRYSTALLIN; NUCLEAR RECEPTOR; A-CRYSTALLIN; BILE-ACIDS; CHOLESTEROL 7-ALPHA-HYDROXYLASE; MOLECULAR CHAPERONE; MISSENSE MUTATION; ABC TRANSPORTER	alpha-Crystallins comprise 35% of soluble proteins in the ocular lens and possess chaperone-like functions. Furthermore, the alpha A subunit ( alpha A-crystallin) of alpha crystallin is thought to be "lens-specific" as only very low levels of expression were detected in a few non-lenticular tissues. Here we report that human alpha A-crystallin is expressed in human livers and is regulated by farnesoid X-activated receptor ( FXR) in response to FXR agonists. alpha A-Crystallin was identified in a microarray screen as one of the most highly induced genes after treatment of HepG2 cells with the synthetic FXR ligand GW4064. Northern blot and quantitative realtime PCR analyses confirmed that alpha A-crystallin expression was induced in HepG2-derived cell lines and human primary hepatocytes and hepatic stellate cells in response to either natural or synthetic FXR ligands. Transient transfection studies and electrophoretic mobility shift assays revealed a functional FXR response element located in intron 1 of the human alpha A-crystallin gene. Importantly, immunohistochemical staining of human liver sections showed increased alpha A-crystallin expression in cholangiocytes and hepatocytes. As a member of the small heat shock protein family possessing chaperone-like activity, alpha A-crystallin may be involved in protection of hepatocytes from the toxic effects of high concentrations of bile acids, as would occur in disease states such as cholestasis.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; GlaxoSmithKline Inc, Res & Dev, Res Triangle Pk, NC 27709 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; GlaxoSmithKline	Edwards, PA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, 10833 Le Conte Ave,33-257 CHS, Los Angeles, CA 90095 USA.	pedwards@mednet.ucla.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068445, P01HL030568] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL30568, HL68445] Funding Source: Medline; NIGMS NIH HHS [GM07185] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alison M, 1998, PHILOS T R SOC B, V353, P877, DOI 10.1098/rstb.1998.0252; Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Anisfeld AM, 2005, J LIPID RES, V46, P458, DOI 10.1194/jlr.M400292-JLR200; Anisfeld AM, 2003, J BIOL CHEM, V278, P20420, DOI 10.1074/jbc.M302505200; Barbier O, 2003, GASTROENTEROLOGY, V124, P1926, DOI 10.1016/S0016-5085(03)00388-3; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; BHAT SP, 1991, EUR J BIOCHEM, V202, P775, DOI 10.1111/j.1432-1033.1991.tb16432.x; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7; Claudel T, 2004, EXPERT OPIN INV DRUG, V13, P1135, DOI 10.1517/13543784.13.9.1135; Deleuze JF, 1996, HEPATOLOGY, V23, P904, DOI 10.1002/hep.510230435; Derham BK, 1999, PROG RETIN EYE RES, V18, P463, DOI 10.1016/S1350-9462(98)00030-5; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; DUELAND S, 1993, J LIPID RES, V34, P923; Edwards PA, 2002, J LIPID RES, V43, P2; Fitzgerald ML, 2002, J MOL MED, V80, P271, DOI 10.1007/s00109-001-0318-y; FITZGERALD PG, 1991, CURR EYE RES, V10, P417, DOI 10.3109/02713689109001750; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Ganea E, 2000, BIOCHEM J, V345, P467, DOI 10.1042/0264-6021:3450467; Gangalum RK, 2004, J BIOL CHEM, V279, P43374, DOI 10.1074/jbc.C400371200; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Goenka S, 2001, BIOCHEM J, V359, P547, DOI 10.1042/0264-6021:3590547; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Hatters DM, 2001, J BIOL CHEM, V276, P33755, DOI 10.1074/jbc.M105285200; Hofmann AF, 1999, ARCH INTERN MED, V159, P2647, DOI 10.1001/archinte.159.22.2647; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Huang L, 2003, J BIOL CHEM, V278, P51085, DOI 10.1074/jbc.M308321200; Huber RM, 2002, GENE, V290, P35, DOI 10.1016/S0378-1119(02)00557-7; JAWORSKI CJ, 1989, NATURE, V337, P752, DOI 10.1038/337752a0; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; KANTOROW M, 1995, J BIOL CHEM, V270, P17215, DOI 10.1074/jbc.270.29.17215; KANTOROW M, 1994, P NATL ACAD SCI USA, V91, P3112, DOI 10.1073/pnas.91.8.3112; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Kast HR, 2001, MOL ENDOCRINOL, V15, P1720, DOI 10.1210/me.15.10.1720; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1080, P173, DOI 10.1016/0167-4838(91)90146-Q; Kida M, 2003, HEPATOL RES, V27, P151, DOI 10.1016/S1386-6346(03)00201-8; KING CR, 1983, CELL, V32, P707, DOI 10.1016/0092-8674(83)90056-9; Kliewer SA, 2002, J LIPID RES, V43, P359; Kullak-Ublick GA, 2004, GASTROENTEROLOGY, V126, P322, DOI 10.1053/j.gastro.2003.06.005; Kullak-Ublick GA, 2003, J HEPATOL, V39, P628, DOI 10.1016/S0168-8278(03)00397-0; Laffitte BA, 2000, J BIOL CHEM, V275, P10638, DOI 10.1074/jbc.275.14.10638; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Li MK, 2004, SEMIN LIVER DIS, V24, P21; LI YC, 1990, J BIOL CHEM, V265, P12012; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Liu YP, 2003, J CLIN INVEST, V112, P1678, DOI 10.1172/JCI200318945; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Mak PA, 2002, J LIPID RES, V43, P2037, DOI 10.1194/jlr.C200014-JLR200; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; MERCK KB, 1993, J BIOL CHEM, V268, P1046; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Muchowski PJ, 1999, INVEST OPHTH VIS SCI, V40, P951; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pauli-Magnus C, 2005, J CLIN GASTROENTEROL, V39, pS103, DOI 10.1097/01.mcg.0000155550.29643.7b; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; Pinzani M, 2004, DIGEST LIVER DIS, V36, P231, DOI 10.1016/j.dld.2004.01.003; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Quinlan RA, 1996, TRENDS CELL BIOL, V6, P123, DOI 10.1016/0962-8924(96)20001-7; Reddy GB, 2002, FEBS LETT, V522, P59, DOI 10.1016/S0014-5793(02)02884-3; Reddy GB, 2001, BIOCHEM BIOPH RES CO, V282, P712, DOI 10.1006/bbrc.2001.4642; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Roskams TA, 2003, SEMIN LIVER DIS, V23, P385; RUETZ S, 1994, CELL, V77, P1071, DOI 10.1016/0092-8674(94)90446-4; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; SEOL WG, 1995, MOL ENDOCRINOL, V9, P72, DOI 10.1210/me.9.1.72; Sherlock S, 1998, Clin Liver Dis, V2, P217, DOI 10.1016/S1089-3261(05)70004-0; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; SRINIVASAN AN, 1992, J BIOL CHEM, V267, P23337; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; TAKEMOTO L, 1993, BIOCHEM J, V294, P435, DOI 10.1042/bj2940435; Toh S, 1999, AM J HUM GENET, V64, P739, DOI 10.1086/302292; Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; Zhang Y, 2001, J BIOL CHEM, V276, P43018, DOI 10.1074/jbc.M107823200; Zhang YQ, 2003, J BIOL CHEM, V278, P104, DOI 10.1074/jbc.M209505200	90	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31792	31800		10.1074/jbc.M503182200	http://dx.doi.org/10.1074/jbc.M503182200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16012168	hybrid			2022-12-27	WOS:000231665200058
J	Bae, E; Phillips, GN				Bae, E; Phillips, GN			Identifying and engineering ion pairs in adenylate kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CHARGE-CHARGE INTERACTIONS; COLD SHOCK PROTEIN; THERMOPHILIC HOMOLOG; EXTREME ENVIRONMENTS; SALT BRIDGES; STABILITY; ENZYMES; THERMOSTABILITY; SURFACE	Molecular dynamics simulations were performed to study thermal stabilization of proteins via electrostatic interactions of ion pairs. Dynamic motions of four ion pairs previously proposed to be important in thermal stability of adenylate kinase from the thermophile Bacillus stearothermophilus were monitored during the simulation. One of the four ion pairs identified in the crystal structure, Lys(180)-Asp(114), was not maintained in close contact suggesting that the ion pair does not contribute to thermal stability. Among the other three ion pairs, the ion pair Arg(116)-Glu(198) was proposed to be the most important for stability. To predict behaviors of the ion pairs when engineered into a mesophilic homologue to increase stability, in silico mutants of adenylate kinase from the mesophile Bacillus subtilis were generated, and their molecular dynamics simulations were carried out. The ion pairs in the mutant simulations displayed similar behaviors to those in the simulation of the thermophilic protein. To validate the results of the simulations experimentally, the same mutants were produced in vitro and their thermal stabilities were measured using differential scanning calorimetry. In agreement with the simulations, the Lys(180)-Asp(114) did not result in any increase in stability by itself or additive effect with other ion pairs, whereas a mutant with the Arg(116)-Glu(198) exhibited the highest stability among the mutants having one of the four ion pairs. These results provide specific knowledge about stability in adenylate kinases and more generally suggest that molecular dynamics simulations can provide valuable information for identifying and engineering ion pairs.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Phillips, GN (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	phillips@biochem.wisc.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR13790] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; Berry MB, 1998, PROTEIN-STRUCT FUNCT, V32, P275; Bruins ME, 2001, APPL BIOCHEM BIOTECH, V90, P155, DOI 10.1385/ABAB:90:2:155; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Butterwick JA, 2004, J MOL BIOL, V339, P855, DOI 10.1016/j.jmb.2004.03.055; Colombo G, 1999, J AM CHEM SOC, V121, P6895, DOI 10.1021/ja990420s; Criswell AR, 2003, J MOL BIOL, V330, P1087, DOI 10.1016/S0022-2836(03)00655-7; D'Amico S, 2003, J BIOL CHEM, V278, P7891, DOI 10.1074/jbc.M212508200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Bakker PIW, 1999, J MOL BIOL, V285, P1811, DOI 10.1006/jmbi.1998.2397; ERIKSSON MAL, 1995, BIOPHYS J, V68, P402, DOI 10.1016/S0006-3495(95)80203-1; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fields PA, 2001, COMP BIOCHEM PHYS A, V129, P417, DOI 10.1016/S1095-6433(00)00359-7; GLASER P, 1992, BIOCHEMISTRY-US, V31, P3038, DOI 10.1021/bi00127a002; Grimsley GR, 1999, PROTEIN SCI, V8, P1843, DOI 10.1110/ps.8.9.1843; Grottesi A, 2002, PROTEINS, V46, P287, DOI 10.1002/prot.10045; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibarra-Molero B, 1999, BIOCHEMISTRY-US, V38, P8138, DOI 10.1021/bi9905819; JAENICKE R, 1991, EUR J BIOCHEM, V202, P715, DOI 10.1111/j.1432-1033.1991.tb16426.x; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Liang ZX, 2004, BIOCHEMISTRY-US, V43, P14676, DOI 10.1021/bi049004x; Loladze VV, 1999, BIOCHEMISTRY-US, V38, P16419, DOI 10.1021/bi992271w; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makhatadze GI, 2004, J MOL BIOL, V336, P929, DOI 10.1016/j.jmb.2003.12.058; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Perl D, 2000, NAT STRUCT BIOL, V7, P380; PERRIER V, 1994, BIOCHEMISTRY-US, V33, P9960, DOI 10.1021/bi00199a019; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Sanchez-Ruiz JM, 2001, TRENDS BIOTECHNOL, V19, P132, DOI 10.1016/S0167-7799(00)01548-1; SOMERO GN, 1978, ANNU REV ECOL SYST, V9, P1, DOI 10.1146/annurev.es.09.110178.000245; Spector S, 2000, BIOCHEMISTRY-US, V39, P872, DOI 10.1021/bi992091m; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P2597, DOI 10.1021/bi951988q; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wintrode PL, 2003, J MOL BIOL, V327, P745, DOI 10.1016/S0022-2836(03)00147-5	38	54	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30943	30948		10.1074/jbc.M504216200	http://dx.doi.org/10.1074/jbc.M504216200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15995248	hybrid			2022-12-27	WOS:000231487800036
J	Cheshenko, N; Liu, W; Satlin, LM; Herold, BC				Cheshenko, N; Liu, W; Satlin, LM; Herold, BC			Focal adhesion kinase plays a pivotal role in herpes simplex virus entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 GLYCOPROTEIN-H; TOPICAL MICROBICIDES; CELLS; ACTIVATION; INFECTION; TRANSPORT; FAK; PHOSPHORYLATION; PATHWAYS; PROTEINS	Development of strategies to prevent herpes simplex virus (HSV) infection requires knowledge of cellular pathways harnessed by the virus for invasion. This study demonstrates that HSV induces rapid phosphorylation of focal adhesion kinase (FAK) in several human target cells and that phosphorylation is important for entry post-binding. Nuclear transport of the viral tegument protein VP16, transport of viral capsids to the nuclear pore, and downstream events ( including expression of immediate-early genes and viral plaque formation) were substantially reduced in cells transfected with dominant-negative mutants of FAK or small interfering RNA designed to inhibit FAK expression. These observations were substantiated using mouse embryonic fibroblast cells derived from embryonic FAK-deficient mice. Infection was reduced by > 90 % in knockout cells relative to control cells and was further reduced if the knockout cells were transfected with small interfering RNA targeting proline-rich tyrosine kinase-2, which was also phosphorylated in response to HSV. The knockout cells were permissive for viral binding, and virus triggered an intracellular calcium response, but nuclear transport was inhibited. Together, these results support a novel model for invasion that implicates FAK phosphorylation as important for delivery of viral capsids to the nuclear pore.	Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Herold, BC (corresponding author), Mt Sinai Sch Med, Dept Pediat, 1 Gustave L Levy Pl,POB 1657, New York, NY 10029 USA.	betsy.herold@mssm.edu	Cheshenko, Natalia/ABF-5896-2021	Herold, Betsy/0000-0001-9974-0786	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061679, R56AI061679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064104, R29DK038470, R01DK038470] Funding Source: NIH RePORTER; NIAID NIH HHS [AI061679] Funding Source: Medline; NICHD NIH HHS [HD43733] Funding Source: Medline; NIDDK NIH HHS [DK38470, DK64104] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cheshenko N, 2003, J CELL BIOL, V163, P283, DOI 10.1083/jcb.200301084; Cheshenko N, 2002, J GEN VIROL, V83, P2247, DOI 10.1099/0022-1317-83-9-2247; Cicala C, 2000, P NATL ACAD SCI USA, V97, P1178, DOI 10.1073/pnas.97.3.1178; CICALA C, 1999, J VIROL, V72, P9992; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Dohner K, 2002, MOL BIOL CELL, V13, P2795, DOI 10.1091/mbc.01-07-0348; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Foster TP, 2004, J VIROL, V78, P13262, DOI 10.1128/JVI.78.23.13262-13277.2004; Galdiero M, 1997, J VIROL, V71, P2163, DOI 10.1128/JVI.71.3.2163-2170.1997; Gelman IH, 2003, CELL BIOL INT, V27, P507, DOI 10.1016/S1065-6995(03)00078-7; HEROLD BC, 1994, J GEN VIROL, V75, P1211, DOI 10.1099/0022-1317-75-6-1211; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; ILLC D, 1995, NATURE, V377, P539; Keller MJ, 2005, J ANTIMICROB CHEMOTH, V55, P420, DOI 10.1093/jac/dki056; Keller MJ, 2003, J ANTIMICROB CHEMOTH, V51, P1099, DOI 10.1093/jac/dkg214; KRISTENSSON K, 1986, J GEN VIROL, V67, P2023, DOI 10.1099/0022-1317-67-9-2023; Naranatt PP, 2003, J VIROL, V77, P1524, DOI 10.1128/JVI.77.2.1524-1539.2003; Naranatt PP, 2005, J VIROL, V79, P1191, DOI 10.1128/JVI.79.2.1191-1206.2005; Natarajan K, 2002, INVEST OPHTH VIS SCI, V43, P2685; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Parry C, 2005, J GEN VIROL, V86, P7, DOI 10.1099/vir.0.80567-0; Qie LX, 1999, VIROLOGY, V256, P220, DOI 10.1006/viro.1999.9673; Sharma-Walia N, 2004, J VIROL, V78, P4207, DOI 10.1128/JVI.78.8.4207-4223.2004; Smith GA, 2002, ANNU REV CELL DEV BI, V18, P135, DOI 10.1146/annurev.cellbio.18.012502.105920; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Topp KS, 1997, EXP EYE RES, V64, P343, DOI 10.1006/exer.1996.0209; Wang FZ, 2003, J VIROL, V77, P3131, DOI 10.1128/JVI.77.5.3131-3147.2003; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066	29	47	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31116	31125		10.1074/jbc.M503518200	http://dx.doi.org/10.1074/jbc.M503518200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994312	hybrid			2022-12-27	WOS:000231487800057
J	Ray, RM; Bhattacharya, S; Johnson, LR				Ray, RM; Bhattacharya, S; Johnson, LR			Protein phosphatase 2A regulates apoptosis in intestinal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE; BAD PHOSPHORYLATION; POLYAMINES; BCL-2; DEPHOSPHORYLATION; INHIBITORS; KINASE; DEATH; PP2A; MITOCHONDRIA	Polyamine depletion prevents apoptosis by increasing serine/threonine phosphorylation leading to either inactivation or activation of pro- and anti-apoptotic proteins, respectively. Despite evidence that protein kinases are regulators of apoptosis, a specific role for protein phosphatases in regulating cell survival has not been established. In this study, we show that polyamine depletion inhibits serine/threonine phosphatase 2A (PP2A). Inhibition of PP2A in cells depleted of polyamines correlated well with increased phosphorylation of Bad at Ser(112). Bad Ser(112) phosphorylation in response to tumor necrosis factor (TNF)-alpha treatment decreased with time in cells grown in control as well as those grown in the presence of alpha-difluoromethylornithine plus putrescine. However, a sustained increase in the levels of Bad Ser112 phosphorylation was maintained in response to TNF-alpha treatment in cells grown in the presence of alpha-difluoromethylornithine. Inhibition of PP2A by okadaic acid and fostriecin or PP2A small interfering RNA transfection significantly decreased TNF-alpha-induced apoptosis in control and polyamine-depleted cells. Inhibition of PP2A by okadaic acid: 1) increased Bad and Bcl-2 phosphorylation at Ser(112) and Ser(70), respectively; 2) increased ERK activity; 3) prevented JNK activation; 4) prevented cytochrome c release, and activation of caspases-9 and -3 in response to TNF-alpha. Inhibition of MEK1 by U0126 prevented phosphorylation of Bad at Ser(112). These results indicate that polyamines regulate PP2A activity, and inhibition of PP2A in response to polyamine depletion increases steady state levels of Bad and Bcl-2 proteins and their phosphorylation and thereby prevents cytochrome c release, caspase-9, and caspase-3 activation.	Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Ray, RM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rray@physio1.utmem.edu	Bhattacharya, Sujoy/AAD-2253-2022	Bhattacharya, Sujoy/0000-0003-4443-9691	NIDDK NIH HHS [DK-16505] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016505, R37DK016505] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; Ayllon V, 2000, EMBO J, V19, P2237, DOI 10.1093/emboj/19.10.2237; Bernstein HG, 1999, PROG NEUROBIOL, V57, P485, DOI 10.1016/S0301-0082(98)00065-3; Bhattacharya S, 2005, APOPTOSIS, V10, P759, DOI 10.1007/s10495-005-2943-3; Bhattacharya S, 2003, AM J PHYSIOL-GASTR L, V285, pG980, DOI 10.1152/ajpgi.00206.2003; Chatfield K, 2004, BIOCHEM BIOPH RES CO, V323, P1313, DOI 10.1016/j.bbrc.2004.09.003; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; CORNWELL T, 1986, J CYCLIC NUCL PROT, V11, P373; Deng WL, 2005, AM J PHYSIOL-GASTR L, V289, pG599, DOI 10.1152/ajpgi.00564.2004; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kramer DL, 1997, CANCER RES, V57, P5521; Lewy DS, 2002, CURR MED CHEM, V9, P2005, DOI 10.2174/0929867023368809; Lin CKE, 1997, EXP CELL RES, V237, P231, DOI 10.1006/excr.1997.3794; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; MAY WS, 1994, J BIOL CHEM, V269, P26865; MCCORMACK SA, 1993, AM J PHYSIOL, V264, pG367, DOI 10.1152/ajpgi.1993.264.2.G367; MCCORMACK SA, 1992, AM J PHYSIOL, V263, pG426, DOI 10.1152/ajpgi.1992.263.3.G426; Monti MG, 1998, LIFE SCI, V62, P799, DOI 10.1016/S0024-3205(97)01181-8; Noda T, 1998, AM J PHYSIOL-GASTR L, V274, pG270, DOI 10.1152/ajpgi.1998.274.2.G270; Penning LC, 1998, CYTOKINE, V10, P423, DOI 10.1006/cyto.1997.0310; PERSSON L, 1996, POLYAMINES CANC BASI, P19; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Ray RM, 2003, J BIOL CHEM, V278, P13039, DOI 10.1074/jbc.M208741200; Ray RM, 1999, AM J PHYSIOL-CELL PH, V276, pC684, DOI 10.1152/ajpcell.1999.276.3.C684; Ray RM, 2000, AM J PHYSIOL-CELL PH, V278, pC480, DOI 10.1152/ajpcell.2000.278.3.C480; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Scheid MP, 1999, J BIOL CHEM, V274, P31108, DOI 10.1074/jbc.274.43.31108; Schipper RG, 2000, SEMIN CANCER BIOL, V10, P55, DOI 10.1006/scbi.2000.0308; Seiler N, 1996, INT J BIOCHEM CELL B, V28, P843, DOI 10.1016/1357-2725(96)00021-0; Sim ATR, 1999, CELL CALCIUM, V26, P209, DOI 10.1054/ceca.1999.0072; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Tewari M, 1998, ORAL ONCOL, V34, P538, DOI 10.1016/S1368-8375(98)00044-X; TUNG HYL, 1985, EUR J BIOCHEM, V149, P305, DOI 10.1111/j.1432-1033.1985.tb08927.x; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; WANG JY, 1991, GASTROENTEROLOGY, V100, P333, DOI 10.1016/0016-5085(91)90200-5; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yuan Q, 2002, AM J PHYSIOL-CELL PH, V282, pC1290, DOI 10.1152/ajpcell.00351.2001; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X	49	63	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31091	31100		10.1074/jbc.M503041200	http://dx.doi.org/10.1074/jbc.M503041200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994315	hybrid			2022-12-27	WOS:000231487800054
J	Beernink, PT; Hwang, M; Ramirez, M; Murphy, MB; Doyle, SA; Thelen, MP				Beernink, PT; Hwang, M; Ramirez, M; Murphy, MB; Doyle, SA; Thelen, MP			Specificity of protein interactions mediated by BRCT domains of the XRCC1 DNA repair protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; STRAND BREAK REPAIR; LIGASE III-ALPHA; ABASIC SITE REPAIR; POLYMERASE-BETA; POLY(ADP-RIBOSE) POLYMERASE; PHYSICALLY INTERACTS; AP-ENDONUCLEASE; GLYCOSYLASE; DAMAGE	Protein interactions critical to DNA repair and cell cycle control systems are often coordinated by modules that belong to a superfamily of structurally conserved BRCT domains. Because the mechanisms of BRCT interactions and their significance are not well understood, we sought to define the affinity and specificity of those BRCT modules that orchestrate base excision repair and single-strand break repair. Common to these pathways is the essential XRCC1 DNA repair protein, which interacts with at least nine other proteins and DNA. Here, we characterized the interactions of four purified BRCT domains, two from XRCC1 and their two partners from DNA ligase III alpha and poly( ADP-ribosyl) polymerase 1. A monoclonal antibody was selected that recognizes the ligase III alpha BRCT domain, but not the other BRCT domains, and was used to capture the relevant ligase III alpha BRCT complex. To examine the assembly states of isolated BRCT domains and pairwise domain complexes, we used size-exclusion chromatography coupled with on-line light scattering. This analysis indicated that isolated BRCT domains form homo-oligomers and that the BRCT complex between the C-terminal XRCC1 domain and the ligase III alpha domain is a heterotetramer with 2: 2 stoichiometry. Using affinity capture and surface plasmon resonance methods, we determined that specific heteromeric interactions with high nanomolar dissociation constants occur between pairs of cognate BRCT domains. A structural model for a XRCC1(.)DNA ligase III alpha heterotetramer is proposed as a core base excision repair complex, which constitutes a scaffold for higher order complexes to which other repair proteins and DNA are brought into proximity.	Lawrence Livermore Natl Lab, Biosci Directorate, Livermore, CA 94551 USA; Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Beernink, PT (corresponding author), Childrens Hosp Oakland, Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	pbeernink@chori.org	Thelen, Michael/C-6834-2008; Thelen, Michael P/G-2032-2014	Thelen, Michael/0000-0002-2479-5480; Thelen, Michael P/0000-0002-2479-5480				BEERNINK PT, 1994, PROTEIN SCI, V3, P1383, DOI 10.1002/pro.5560030904; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017; Du LL, 2004, J BIOL CHEM, V279, P38409, DOI 10.1074/jbc.M403326200; Dulic A, 2001, BIOCHEMISTRY-US, V40, P5906, DOI 10.1021/bi002701e; Fan JS, 2004, NUCLEIC ACIDS RES, V32, P2193, DOI 10.1093/nar/gkh556; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Hazra TK, 2001, PROG NUCLEIC ACID RE, V68, P193; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Krishnan VV, 2001, BIOCHEMISTRY-US, V40, P13158, DOI 10.1021/bi010979g; Kubota Y, 2003, DNA REPAIR, V2, P407, DOI 10.1016/S1568-7864(02)00242-2; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Kumaresan KR, 2002, BIOCHEMISTRY-US, V41, P890, DOI 10.1021/bi011614z; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lomax ME, 2004, DNA REPAIR, V3, P289, DOI 10.1016/j.dnarep.2003.11.006; Luo H, 2004, MOL CELL BIOL, V24, P8356, DOI 10.1128/MCB.24.19.8356-8365.2004; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Marintchev A, 2000, NUCLEIC ACIDS RES, V28, P2049, DOI 10.1093/nar/28.10.2049; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; PANAYOTOU G, 1993, MOL CELL BIOL, V13, P3567, DOI 10.1128/MCB.13.6.3567; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Parker A, 2001, J BIOL CHEM, V276, P5547, DOI 10.1074/jbc.M008463200; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; PETERSON CB, 1994, PROTEIN SCI, V3, P960; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Privezentzev CV, 2001, MUTAT RES-FUND MOL M, V480, P277, DOI 10.1016/S0027-5107(01)00186-5; Shen NR, 1998, NUCLEIC ACIDS RES, V26, P1032, DOI 10.1093/nar/26.4.1032; Taylor RM, 1998, CURR BIOL, V8, P877, DOI 10.1016/S0960-9822(07)00350-8; Thornton K, 1999, PROTEIN EXPRES PURIF, V16, P236, DOI 10.1006/prep.1999.1070; Thornton KH, 2001, PROTEIN EXPRES PURIF, V21, P401, DOI 10.1006/prep.2001.1391; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Vidal AE, 2001, NUCLEIC ACIDS RES, V29, P1285, DOI 10.1093/nar/29.6.1285; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Yamane K, 2000, BIOCHEM BIOPH RES CO, V279, P678, DOI 10.1006/bbrc.2000.3983; Yang HJ, 2001, NUCLEIC ACIDS RES, V29, P743, DOI 10.1093/nar/29.3.743; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang XD, 1998, EMBO J, V17, P6404, DOI 10.1093/emboj/17.21.6404	49	43	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30206	30213		10.1074/jbc.M502155200	http://dx.doi.org/10.1074/jbc.M502155200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15987676	hybrid			2022-12-27	WOS:000231362500029
J	Najima, Y; Yahagi, N; Takeuchi, Y; Matsuzaka, T; Sekiya, M; Nakagawa, Y; Amemiya-Kudo, M; Okazaki, H; Okazaki, S; Tamura, Y; Iizuka, Y; Ohashi, K; Harada, K; Gotoda, T; Nagai, R; Kadowaki, T; Ishibashi, S; Yamada, N; Osuga, J; Shimano, H				Najima, Y; Yahagi, N; Takeuchi, Y; Matsuzaka, T; Sekiya, M; Nakagawa, Y; Amemiya-Kudo, M; Okazaki, H; Okazaki, S; Tamura, Y; Iizuka, Y; Ohashi, K; Harada, K; Gotoda, T; Nagai, R; Kadowaki, T; Ishibashi, S; Yamada, N; Osuga, J; Shimano, H			High mobility group protein-B1 interacts with sterol regulatory element-binding proteins to enhance their DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPROTEIN RECEPTOR GENE; FATTY-ACID SYNTHASE; HELIX-LOOP-HELIX; TRANSGENIC MICE; TRANSCRIPTIONAL ACTIVATION; CHOLESTEROL-SYNTHESIS; PROMOTER; HMG1; EXPRESSION; LIVERS	Sterol regulatory element-binding proteins (SREBPs) are transcription factors that are predominately involved in the regulation of lipogenic and cholesterogenic enzyme gene expression. To identify unknown proteins that interact with SREBP, we screened nuclear extract proteins with S-35-labeled SREBP-1 bait in Far Western blotting analysis. Using this approach, high mobility group protein-B1 (HMGB1), a chromosomal protein, was identified as a novel SREBP interacting protein. In vitro glutathione S-transferase pull-down and in vivo coimmunoprecipitation studies confirmed an interaction between HMGB1 and both SREBP-1 and -2. The protein-protein interaction was mediated through the helix-loop-helix domain of SREBP-1, residues 309-344, and the A box of HMGB1. Furthermore, an electrophoretic mobility shift assay demonstrated that HMGB1 enhances SREBPs binding to their cognate DNA sequences. Moreover, luciferase reporter analyses, including RNA interference technique showed that HMGB1 potentiates the transcriptional activities of SREBP in cultured cells. These findings raise the intriguing possibility that HMGB1 is potentially involved in the regulation of lipogenic and cholesterogenic gene transcription.	Univ Tsukuba, Inst Clin Med, Dept Internal Med, Tsukuba, Ibaraki 3058575, Japan; Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo 1138655, Japan	University of Tsukuba; University of Tokyo	Shimano, H (corresponding author), Univ Tsukuba, Inst Clin Med, Dept Internal Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	shimano-tky@umin.ac.jp	Shimano, Hitoshi/V-1761-2019; Shimano, Hitoshi/AAI-5648-2020; Najima, Yuho/W-3858-2019; Yahagi, Naoya/D-2360-2014	Shimano, Hitoshi/0000-0002-5562-5572; Najima, Yuho/0000-0001-8910-0021; Yahagi, Naoya/0000-0002-1823-1865				Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Bennett MK, 1999, J BIOL CHEM, V274, P13025, DOI 10.1074/jbc.274.19.13025; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Bianchi ME, 2000, EMBO REP, V1, P109, DOI 10.1093/embo-reports/kvd030; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Brickman JM, 1999, P NATL ACAD SCI USA, V96, P10679, DOI 10.1073/pnas.96.19.10679; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; BUSTIN M, 2002, SCI STKE, pE39; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Ericsson J, 1999, J BIOL CHEM, V274, P14508, DOI 10.1074/jbc.274.20.14508; Ericsson J, 1996, P NATL ACAD SCI USA, V93, P945, DOI 10.1073/pnas.93.2.945; Ericsson J, 1996, J BIOL CHEM, V271, P24359, DOI 10.1074/jbc.271.40.24359; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; Fragiadakis GS, 2004, EMBO J, V23, P333, DOI 10.1038/sj.emboj.7600043; GE H, 1994, J BIOL CHEM, V269, P17136; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; Misawa K, 2003, J BIOL CHEM, V278, P36176, DOI 10.1074/jbc.M302387200; Moreira JMA, 2000, EMBO J, V19, P6804, DOI 10.1093/emboj/19.24.6804; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; Rae FK, 2004, ONCOGENE, V23, P3067, DOI 10.1038/sj.onc.1207360; Rishi V, 2004, J BIOL CHEM, V279, P11863, DOI 10.1074/jbc.M308000200; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Sato R, 2000, J BIOL CHEM, V275, P12497, DOI 10.1074/jbc.275.17.12497; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Yamamoto T, 2004, J BIOL CHEM, V279, P12027, DOI 10.1074/jbc.M310333200; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; Zeng LF, 2004, EMBO J, V23, P950, DOI 10.1038/sj.emboj.7600106	42	34	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2005	280	30					27523	27532		10.1074/jbc.M414549200	http://dx.doi.org/10.1074/jbc.M414549200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	947WS	16040616	hybrid			2022-12-27	WOS:000230678600008
J	Heidemann, AC; Schipke, CG; Kettenmann, H				Heidemann, AC; Schipke, CG; Kettenmann, H			Extracellular application of nicotinic acid adenine dinucleotide phosphate induces Ca2+ signaling in astrocytes in situ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; SEA-URCHIN EGGS; GLIAL-CELLS; CALCIUM; NAADP; RELEASE; CD38; BRAIN; 2ND-MESSENGER; MECHANISMS	Nicotinic acid adenine dinucleotide phosphate (NAADP(+)) has been identified as a novel second messenger triggering Ca2+ release from intracellular stores. Here we report that murine cortical astrocytes in culture and in acute slices respond with transient intracellular Ca2+ increases to extracellularly applied NAADP(+) and express the NAADP(+)-producing enzyme CD38. The Ca2+ transients triggered by NAADP(+) occurred with an average delay of 35 s as compared with ATP-triggered Ca2+ signaling, suggesting that NAADP(+) may have to enter the cell to act. Blockage of connexin hemichannels (a possible entry route for NAADP(+) into the cell) reduced the number of astrocytes responding to NAADP(+). Disruption of lysosomes as the suggested site of NAADP(+) receptors reduced the number of astrocytes responding to NAADP(+) strongly. The NAADP(+)-triggeredCa(2+) signal also depended on intact endoplasmic reticulum Ca2+ stores linked to activation of inositol 1,4,5-risphosphate receptors and on the activity of voltage-gated Ca2+ channels. Adenosine receptor-mediated signaling contributes to the NAADP+evoked signal, since it is strongly reduced by the adenosine receptor blocker CGS-15943. Moreover, NAADP(+) triggered responses in all other cell types (cultured cerebellar neurons, microglia, and oligodendrocytes) of the central nervous system.	Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kettenmann, H (corresponding author), Max Delbruck Ctr Mol Med, 10 Robert Rossle Str, D-13092 Berlin, Germany.	kettenmann@mdc-berlin.de	Kettenmann, Helmut/AAJ-5142-2021	Kettenmann, Helmut/0000-0001-8208-0291				Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Bak J, 1999, CURR BIOL, V9, P751, DOI 10.1016/S0960-9822(99)80335-2; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Brailoiu E, 2001, MOL PHARMACOL, V60, P718; Bruzzone S, 2001, FASEB J, V15, P10; Cancela JM, 2003, PFLUG ARCH EUR J PHY, V446, P322, DOI 10.1007/s00424-003-1035-x; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Ceni C, 2003, BIOCHEM J, V370, P175, DOI 10.1042/BJ20020604; Chini EN, 2002, BIOCHEM J, V362, P125, DOI 10.1042/0264-6021:3620125; CHINI EN, 1995, BIOCHEM BIOPH RES CO, V209, P167, DOI 10.1006/bbrc.1995.1485; Churamani D, 2004, BIOCHEM J, V380, P449, DOI 10.1042/BJ20031754; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Diaz-Hernandez M, 2002, J PHARMACOL EXP THER, V301, P441, DOI 10.1124/jpet.301.2.441; Esguerra M, 2002, GLIA, V39, P314, DOI 10.1002/glia.10115; Franco L, 1998, FASEB J, V12, P1507; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Gerasimenko J, 2003, BIOCHEM SOC T, V31, P76, DOI 10.1042/bst0310076; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Guse AH, 2004, CURR MOL MED, V4, P239, DOI 10.2174/1566524043360771; HAAS B, 2005, IN PRESS CEREB CORTE; Hotta T, 2000, J NEUROCHEM, V74, P669, DOI 10.1046/j.1471-4159.2000.740669.x; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Lee HC, 1997, J BIOL CHEM, V272, P4172, DOI 10.1074/jbc.272.7.4172; Lyons SA, 1998, J CEREBR BLOOD F MET, V18, P521, DOI 10.1097/00004647-199805000-00007; Matyash V, 2001, MOL CELL NEUROSCI, V18, P664, DOI 10.1006/mcne.2001.1047; MEYER HD, 2002, BIOCHIM BIOPHYS ACTA, V1582, P178; Moccia F, 2003, FASEB J, V17, P1907, DOI 10.1096/fj.03-0178fje; Newman EA, 2005, J NEUROSCI, V25, P5502, DOI 10.1523/JNEUROSCI.1354-05.2005; Patel S, 2000, J BIOL CHEM, V275, P36495, DOI 10.1074/jbc.C000458200; Patel S, 2004, BIOL CELL, V96, P19, DOI 10.1016/j.biolcel.2003.12.001; Peters O, 2003, J NEUROSCI, V23, P9888; Santella L, 2000, J BIOL CHEM, V275, P8301, DOI 10.1074/jbc.275.12.8301; SCHNITZER J, 1981, J NEUROIMMUNOL, V1, P471, DOI 10.1016/0165-5728(81)90024-2; SHEN SS, 1993, DEV BIOL, V157, P157, DOI 10.1006/dbio.1993.1120; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Verderio C, 2001, J NEUROCHEM, V78, P646, DOI 10.1046/j.1471-4159.2001.00455.x; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Yamada M, 1997, BRAIN RES, V756, P52, DOI 10.1016/S0006-8993(97)00117-0; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zocchi E, 1999, FASEB J, V13, P273, DOI 10.1096/fasebj.13.2.273	46	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2005	280	42					35630	35640		10.1074/jbc.M507338200	http://dx.doi.org/10.1074/jbc.M507338200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973ZN	16061474	hybrid			2022-12-27	WOS:000232561200066
J	Yuste, VJ; Sanchez-Lopez, I; Sole, C; Moubarak, RS; Bayascas, JR; Dolcet, X; Encinas, M; Susin, SA; Comella, JX				Yuste, VJ; Sanchez-Lopez, I; Sole, C; Moubarak, RS; Bayascas, JR; Dolcet, X; Encinas, M; Susin, SA; Comella, JX			The contribution of apoptosis-inducing factor, caspase-activated DNase, and inhibitor of caspase-activated DNase to the nuclear phenotype and DNA degradation during apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRAGMENTATION FACTOR; CHROMATIN CONDENSATION; CHROMOSOMAL DNA; CYCLOPHILIN-A; CLEAVAGE; DEATH; INVOLVEMENT; THYMOCYTES; ABSENCE; MOUSE	We have assessed the contribution of apoptosis- inducing factor ( AIF) and inhibitor of caspase- activated DNase ( ICAD) to the nuclear morphology and DNA degradation pattern in staurosporine-induced apoptosis. Expression of D117E ICAD, a mutant that is resistant to caspase cleavage at residue 117, prevented low molecular weight ( LMW) DNA fragmentation, stage II nuclear morphology, and detection of terminal deoxynucleotidyl transferase staining. However, high molecular weight ( HMW) DNA fragmentation and stage I nuclear morphology remained unaffected. On the other hand, expression of either D224E or wild type ICAD had no effect on DNA fragmentation or nuclear morphology. In addition, both HMW and LMW DNA degradation required functional executor caspases. Interestingly, silencing of endogenous AIF abolished type I nuclear morphology without any effect on HMW or LMW DNA fragmentation. Together, these results demonstrate that AIF is responsible for stage I nuclear morphology and suggest that HMW DNA degradation is a caspase- activated DNase and AIF independent process.	Univ Lleida, Fac Med, Dept Ciencies Med Basiques, Cell Signalling & Apoptosis Grp, E-25008 Lleida, Spain; Hosp Univ Arnau Vilanova, Lab Rec, E-25198 Lleida, Spain; Inst Pasteur, CNRS, URA 1961, Apoptose & Syst Immunitaire Grp,Dept Immunol, F-75015 Paris, France	Universitat de Lleida; University Hospital Arnau de Vilanova; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Comella, JX (corresponding author), Univ Lleida, Fac Med, Dept Ciencies Med Basiques, Cell Signalling & Apoptosis Grp, Montserrat Roig 2, E-25008 Lleida, Spain.	joan.comella@cmb.udl.es	Susin, Santos A/Q-6754-2017; Comella, Joan/GQA-4279-2022; Dolcet, Xavi/B-5665-2009; Encinas, Mario/B-5600-2009; Sole Serra, Carme/A-4470-2008; Comella, Joan X/D-7333-2012; Bayascas, Jose R/C-9450-2011; Yuste, Victor J./C-7071-2008	Susin, Santos A/0000-0002-3366-1628; Dolcet, Xavi/0000-0003-1921-0449; Encinas, Mario/0000-0003-3509-7431; Sole Serra, Carme/0000-0003-4543-7401; Comella, Joan X/0000-0002-6218-0786; Bayascas, Jose R/0000-0002-6096-2151; Yuste, Victor J./0000-0001-5322-9261; Sanchez Lopez, Isabel/0000-0003-1218-3636; Moubarak, Rana/0000-0003-2096-1258				Boix J, 1997, NEUROPHARMACOLOGY, V36, P811, DOI 10.1016/S0028-3908(97)00030-0; Cande C, 2004, ONCOGENE, V23, P1514, DOI 10.1038/sj.onc.1207279; Creagh EM, 2001, BIOCHEM SOC T, V29, P696, DOI 10.1042/0300-5127:0290696; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Halenbeck R, 1998, CURR BIOL, V8, P537, DOI 10.1016/S0960-9822(98)79298-X; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Lecoeur H, 2002, EXP CELL RES, V277, P1, DOI 10.1006/excr.2002.5537; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Lu ZG, 2004, CELL RES, V14, P134, DOI 10.1038/sj.cr.7290212; McIlroy D, 1999, ONCOGENE, V18, P4401, DOI 10.1038/sj.onc.1202868; Montague JW, 1997, J BIOL CHEM, V272, P6677, DOI 10.1074/jbc.272.10.6677; Mukae N, 1998, P NATL ACAD SCI USA, V95, P9123, DOI 10.1073/pnas.95.16.9123; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Nagata T, 2000, J IMMUNOL, V165, P4281, DOI 10.4049/jimmunol.165.8.4281; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; Parrish JZ, 2003, MOL CELL, V11, P987, DOI 10.1016/S1097-2765(03)00095-9; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Sakahira H, 1999, J BIOL CHEM, V274, P15740, DOI 10.1074/jbc.274.22.15740; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sakahira H, 1999, CURR BIOL, V9, P543, DOI 10.1016/S0960-9822(99)80240-1; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; Samejima K, 1998, J CELL BIOL, V143, P225, DOI 10.1083/jcb.143.1.225; Sotolongo B, 2005, J ANDROL, V26, P272; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; UCKER DS, 1992, MOL CELL BIOL, V12, P3060, DOI 10.1128/MCB.12.7.3060; Walker PR, 1999, ANN NY ACAD SCI, V887, P48, DOI 10.1111/j.1749-6632.1999.tb07921.x; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yuste VJ, 2001, J BIOL CHEM, V276, P22323, DOI 10.1074/jbc.M100072200; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480; Zhang JH, 2000, BIOCHEM BIOPH RES CO, V274, P225, DOI 10.1006/bbrc.2000.3122	36	77	84	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2005	280	42					35670	35683		10.1074/jbc.M504015200	http://dx.doi.org/10.1074/jbc.M504015200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973ZN	16049016	hybrid			2022-12-27	WOS:000232561200070
J	Gianni, S; Engstrom, A; Larsson, M; Calosci, N; Malatesta, F; Eklund, L; Ngang, CC; Travaglini-Allocatelli, C; Jemth, P				Gianni, S; Engstrom, A; Larsson, M; Calosci, N; Malatesta, F; Eklund, L; Ngang, CC; Travaglini-Allocatelli, C; Jemth, P			The kinetics of PDZ domain-ligand interactions and implications for the binding mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTP-BL; POSTSYNAPTIC PROTEIN; RECOGNITION; PEPTIDES; DETERMINANTS; SPECIFICITY; DYNAMICS; AFFINITY; PSD-95; TARGET	PDZ domains are protein adapter modules present in a few hundred human proteins. They play important roles in scaffolding and signal transduction. PDZ domains usually bind to the C termini of their target proteins. To assess the binding mechanism of this interaction we have performed the first in-solution kinetic study for PDZ domains and peptides corresponding to target ligands. Both PDZ3 from postsynaptic density protein 95 and PDZ2 from protein tyrosine phosphatase L1 bind their respective target peptides through an apparent A + B --> A center dot B mechanism without rate-limiting conformational changes. But a mutant with a fluorescent probe (Trp) outside of the binding pocket suggests that slight changes in the structure take place upon binding in protein tyrosine phosphatase-L1 PDZ2. For PDZ3 from postsynaptic density protein 95 the pH dependence of the binding reaction is consistent with a one-step mechanism with one titratable group. The salt dependence of the interaction shows that the formation of electrostatic interactions is rate-limiting for the association reaction but not for dissociation of the complex.	Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi SFanelli, I-00185 Rome, Italy; Univ Roma La Sapienza, CNR, Ist Biol & Patol Mol, I-00185 Rome, Italy; Univ Aquila, Dept Pure & Appl Biol, I-67010 Coppito, Italy	Uppsala University; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; University of L'Aquila	Jemth, P (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, BMC Box 582, SE-75123 Uppsala, Sweden.	Per.Jemth@imbim.uu.se	Larsson, Marten/A-5992-2012; gianni, stefano/C-8536-2009; Malatesta, Francesco/AAT-4757-2020	Gianni, Stefano/0000-0003-1653-1925; Travaglini-Allocatelli, Carlo/0000-0001-8735-1126; Eklund, Lars/0000-0002-0572-9410; Larsson, Marten/0000-0002-7855-9539				Bronsted JN, 1924, J AM CHEM SOC, V46, P555, DOI 10.1021/ja01668a006; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; DeLano WL, 2002, PYMOL USERS MANUAL; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Erdmann KS, 2000, ONCOGENE, V19, P3894, DOI 10.1038/sj.onc.1203725; Feng HQ, 2005, J MOL BIOL, V346, P345, DOI 10.1016/j.jmb.2004.11.040; Ferrer M, 2005, PROTEIN ENG DES SEL, V18, P165, DOI 10.1093/protein/gzi018; Fersht A, 1999, STRUCTURE MECH PROTE, P132; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Fuh G, 2000, J BIOL CHEM, V275, P21486, DOI 10.1074/jbc.275.28.21486; Fujii N, 2003, J AM CHEM SOC, V125, P12074, DOI 10.1021/ja035540l; Gao XL, 2001, J BIOL CHEM, V276, P42219, DOI 10.1074/jbc.M105760200; Gee SH, 1998, J BIOL CHEM, V273, P21980, DOI 10.1074/jbc.273.34.21980; GEIGER T, 1987, J BIOL CHEM, V262, P785; Gianni S, 2005, PROTEIN ENG DES SEL, V18, P389, DOI 10.1093/protein/gzi047; Harris BZ, 2003, BIOCHEMISTRY-US, V42, P2797, DOI 10.1021/bi027061p; Harris BZ, 2001, BIOCHEMISTRY-US, V40, P5921, DOI 10.1021/bi010142l; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Kim E, 1998, J BIOL CHEM, V273, P1591, DOI 10.1074/jbc.273.3.1591; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kozlov G, 2002, J MOL BIOL, V320, P813, DOI 10.1016/S0022-2836(02)00544-2; Li T, 2004, BIOORG MED CHEM LETT, V14, P1385, DOI 10.1016/j.bmcl.2003.09.103; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Madsen KL, 2005, J BIOL CHEM, V280, P20539, DOI 10.1074/jbc.M500577200; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; MOORE WJ, 1983, BASIC PHYS CHEM, P370; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Piserchio A, 2002, J BIOL CHEM, V277, P6967, DOI 10.1074/jbc.M109453200; Saro D, 2004, ORG LETT, V6, P3429, DOI 10.1021/ol049181q; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Udugamasooriya G, 2005, ORG LETT, V7, P1203, DOI 10.1021/ol0475966; Walma T, 2002, J MOL BIOL, V316, P1101, DOI 10.1006/jmbi.2002.5402; Wang L, 2005, J BIOL CHEM, V280, P26992, DOI 10.1074/jbc.M503555200; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064	38	76	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34805	34812		10.1074/jbc.M506017200	http://dx.doi.org/10.1074/jbc.M506017200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16049001	hybrid			2022-12-27	WOS:000232403900052
J	Jiang, PH; Cui, M; Zhao, BH; Snyder, LA; Benard, LMJ; Osman, R; Max, M; Margolskee, RF				Jiang, PH; Cui, M; Zhao, BH; Snyder, LA; Benard, LMJ; Osman, R; Max, M; Margolskee, RF			Identification of the cyclamate interaction site within the transmembrane domain of the human sweet taste receptor subunit T1R3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UMAMI TASTE; CONFORMATIONAL-CHANGES; CA2+-SENSING RECEPTOR; ALLOSTERIC MODULATOR; MAMMALIAN SWEET; BINDING-SITE; TRANSDUCTION; ACTIVATION; PREFERENCE; LACTISOLE	The artificial sweetener cyclamate tastes sweet to humans, but not to mice. When expressed in vitro, the human sweet receptor ( a heterodimer of two taste receptor subunits: hT1R2 + hT1R3) responds to cyclamate, but the mouse receptor (mT1R2 + mT1R3) does not. Using mixed-species pairings of human and mouse sweet receptor subunits, we determined that responsiveness to cyclamate requires the human form of T1R3. Using chimeras, we determined that it is the transmembrane domain of hT1R3 that is required for the sweet receptor to respond to cyclamate. Using directed mutagenesis, we identified several amino acid residues within the transmembrane domain of T1R3 that determine differential responsiveness to cyclamate of the human versus mouse sweet receptors. Alanine-scanning mutagenesis of residues predicted to line a transmembrane domain binding pocket in hT1R3 identified six residues specifically involved in responsiveness to cyclamate. Using molecular modeling, we docked cyclamate within the transmembrane domain of T1R3. Our model predicts substantial overlap in the hT1R3 binding pockets for the agonist cyclamate and the inverse agonist lactisole. The transmembrane domain of T1R3 is likely to play a critical role in the interconversion of the sweet receptor from the ground state to the active state.	CUNY Mt Sinai Sch Med, Howard Hughes Med Inst, Dept Neurosci, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA	City University of New York (CUNY) System; Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Margolskee, RF (corresponding author), CUNY Mt Sinai Sch Med, Howard Hughes Med Inst, Dept Neurosci, POB 1065,1425 Madison Ave, New York, NY 10029 USA.	bob@inka.mssm.edu		Margolskee, Robert/0000-0002-9572-2887	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC007721, R01DC003055, F32DC007021, R01DC003155] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC003055, 1F32 DC007021-01, 1R03 DC007721-01, DC003155] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bachmanov AA, 2001, CHEM SENSES, V26, P905, DOI 10.1093/chemse/26.7.905; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Binet V, 2004, J BIOL CHEM, V279, P29085, DOI 10.1074/jbc.M400930200; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Frisch M.J., 2016, GAUSSIAN 16 REVISION; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Gilbertson TA, 2000, CURR OPIN NEUROBIOL, V10, P519, DOI 10.1016/S0959-4388(00)00118-5; Gilbertson TA, 2003, NEUROREPORT, V14, P905, DOI 10.1097/01.wnr.0000074346.81633.76; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Jiang P, 2005, CHEM SENSES, V30, pI17, DOI 10.1093/chemse/bjh091; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Malherbe P, 2003, J BIOL CHEM, V278, P8340, DOI 10.1074/jbc.M211759200; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; Petrel C, 2004, J BIOL CHEM, V279, P18990, DOI 10.1074/jbc.M400724200; Petrel C, 2003, J BIOL CHEM, V278, P49487, DOI 10.1074/jbc.M308010200; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; RICHARDS RK, 1951, J AM PHARM ASSOC SCI, V40, P1; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Ward SDC, 2002, J BIOL CHEM, V277, P2247, DOI 10.1074/jbc.M107647200; Winnig M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-22; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	33	167	174	4	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34296	34305		10.1074/jbc.M505255200	http://dx.doi.org/10.1074/jbc.M505255200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16076846	hybrid			2022-12-27	WOS:000232229700072
J	Zalfa, F; Adinolfi, S; Napoli, I; Kuhn-Holsken, E; Urlaub, H; Achsel, T; Pastore, A; Bagni, C				Zalfa, F; Adinolfi, S; Napoli, I; Kuhn-Holsken, E; Urlaub, H; Achsel, T; Pastore, A; Bagni, C			Fragile X mental retardation protein (FMRP) binds specifically to the brain cytoplasmic RNAs BC1/BC200 via a novel RNA-binding motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; NEURONAL BC1; TRANSLATION; LOCALIZATION; PRODUCT; DOMAIN; GENE; RIBONUCLEOPROTEIN; IDENTIFICATION; RECOGNITION	Fragile X mental retardation protein (FMRP), the protein responsible for the fragile X syndrome, is an RNA-binding protein involved in localization and translation of neuronal mRNAs. One of the RNAs known to interact with FMRP is the dendritic non-translatable brain cytoplasmic RNA 1 BC1 RNA that works as an adaptor molecule linking FMRP and some of its regulated mRNAs. Here, we showed that the N terminus of FMRP binds strongly and specifically to BC1 and to its potential human analog BC200. This region does not contain a motif known to specifically recognize RNA and thus constitutes a new RNA-binding motif. We further demonstrated that FMRP recognition involves the 5' stem loop of BC1 and that this is the region that exhibits complementarity to FMRP target mRNAs, raising the possibility that FMRP plays a direct role in BC1/ mRNA annealing.	Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy; Natl Inst Med Res, Mol Struct Div, London NW7 1AA, England; Fdn Santa Lucia, Ist Ric & Cura Carattere Sci, Ist Neurosci Sperimentali, I-00179 Rome, Italy; Max Planck Inst Biophys Chem, Mass Spectrometry Grp, Dept Cellular Biochem, D-37077 Gottingen, Germany	University of Rome Tor Vergata; MRC National Institute for Medical Research; IRCCS Santa Lucia; Max Planck Society	Bagni, C (corresponding author), Univ Roma Tor Vergata, Dipartimento Biol, Via Ric Sci 1, I-00133 Rome, Italy.	claudia.bagni@uniroma2.it	Zalfa, Francesca/J-7759-2018	Zalfa, Francesca/0000-0002-1922-9468; Bagni, Claudia/0000-0002-4419-210X; Napoli, Ilaria/0000-0002-0649-1950; ADINOLFI, Salvatore/0000-0003-1319-5516	Telethon [GGP02357] Funding Source: Medline	Telethon(Fondazione Telethon)		Adinolfi S, 1999, RNA, V5, P1248, DOI 10.1017/S1355838299990647; Adinolfi S, 2003, BIOCHEMISTRY-US, V42, P10437, DOI 10.1021/bi034909g; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bovia F, 1997, NUCLEIC ACIDS RES, V25, P318, DOI 10.1093/nar/25.2.318; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Cheng JG, 1996, DNA CELL BIOL, V15, P549, DOI 10.1089/dna.1996.15.549; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Feng Y, 1997, J NEUROSCI, V17, P1539; Gabus C, 2004, NUCLEIC ACIDS RES, V32, P2129, DOI 10.1093/nar/gkh535; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Khandjian EW, 1999, BIOCHEM CELL BIOL, V77, P331, DOI 10.1139/bcb-77-4-331; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Muddashetty RS, 2002, J MOL BIOL, V321, P433, DOI 10.1016/S0022-2836(02)00655-1; Muslimov IA, 1997, J NEUROSCI, V17, P4722; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Ramos A, 2003, RNA, V9, P1198, DOI 10.1261/rna.5960503; Reis SA, 2004, J MOL HISTOL, V35, P389; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Steiner T, 2002, EMBO J, V21, P4641, DOI 10.1093/emboj/cdf455; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Tamanini F, 1999, HUM MOL GENET, V8, P863, DOI 10.1093/hmg/8.5.863; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; Wang HD, 2002, J NEUROSCI, V22, P10232; West NC, 2002, J MOL BIOL, V321, P423, DOI 10.1016/S0022-2836(02)00542-9; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	44	103	105	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33403	33410		10.1074/jbc.M504286200	http://dx.doi.org/10.1074/jbc.M504286200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16006558	Green Published, hybrid			2022-12-27	WOS:000232058100038
J	Nguyen, T; Sherratt, PJ; Nioi, P; Yang, CS; Pickett, CB				Nguyen, T; Sherratt, PJ; Nioi, P; Yang, CS; Pickett, CB			Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; TRANSCRIPTION FACTOR NRF2; PROTEIN-KINASE-C; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; NF-E2-RELATED FACTOR-2; PROTEASOMAL DEGRADATION; OXIDOREDUCTASE-1 GENE; SULFHYDRYL-GROUPS; FEMALE MICE	Nrf2 regulates the expression of genes encoding antioxidant proteins involved in cellular redox homeostasis. Previous studies have suggested that activation of Nrf2 is mediated by mechanisms promoting its dissociation from Keap1, a cytosolic repressor that acts to sequester the transcription factor in the cytoplasm. As a short-lived protein, Nrf2 is also activated by mechanisms leading to its stabilization in cells under stress, and recent evidence indicates that Keap1 has an active role in the control of its stability. In this report, using immunocytochemistry, cell fractionation, and chromatin immunoprecipitation analyses, we found that Nrf2 is primarily a nuclear protein and that it is expressed and recruited to the chromatin constitutively to drive basal gene expression. Furthermore, we found evidence indicating that Keap1 may repress Nrf2 activity by transiently shuttling into the nucleus to promote its ubiquitylation. The data suggested that the steady-state level of Nrf2 is maintained by a dynamic pathway that balances its constitutive expression with a Keap1-regulated degradation process downstream of its role as a transcriptional activator. We suggest that the stabilization of Nrf2 in cells under stress represents the central regulatory response mediated by mechanisms that interfere with its interaction with Keap1, leading to the induction of antioxidant enzymes important to maintain cellular redox homeostasis.	Schering Plough Res Inst, Kenilworth, NJ 07033 USA; Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ 08854 USA	Merck & Company; Schering-Plough Research Institute; Rutgers State University New Brunswick	Pickett, CB (corresponding author), Schering Plough Res Inst, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	cecil.pickett@spcorp.com						Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chanas SA, 2002, BIOCHEM J, V365, P405, DOI 10.1042/BJ20020320; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Hayashi A, 2003, BIOCHEM BIOPH RES CO, V310, P824, DOI 10.1016/j.bbrc.2003.09.086; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Li J, 2002, J BIOL CHEM, V277, P388, DOI 10.1074/jbc.M109380200; McMahon M, 2001, CANCER RES, V61, P3299; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Morimitsu Y, 2002, J BIOL CHEM, V277, P3456, DOI 10.1074/jbc.M110244200; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Yoh K, 2001, KIDNEY INT, V60, P1343, DOI 10.1046/j.1523-1755.2001.00939.x; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	50	287	300	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32485	32492		10.1074/jbc.M503074200	http://dx.doi.org/10.1074/jbc.M503074200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16000310	hybrid			2022-12-27	WOS:000231794800056
J	Yew, KH; Hembree, M; Prasadan, K; Preuett, B; McFall, C; Benjes, C; Crowley, A; Sharp, S; Tulachan, S; Mehta, S; Tei, E; Gittes, G				Yew, KH; Hembree, M; Prasadan, K; Preuett, B; McFall, C; Benjes, C; Crowley, A; Sharp, S; Tulachan, S; Mehta, S; Tei, E; Gittes, G			Cross-talk between bone morphogenetic protein and transforming growth factor-beta signaling is essential for exendin-4-induced insulin-positive differentiation of AR42J cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSDUCTION; EXPRESSION; ENDODERM; SMAD1	A key goal of cellular engineering is to manipulate progenitor cells to become beta-cells, allowing cell replacement therapy to cure diabetes mellitus. As a paradigm for cell engineering, we have studied the molecular mechanisms by which AR42J cells become beta-cells. Bone morphogenetic proteins (BMPs), implicated in a myriad of developmental pathways, have not been well studied in insulin-positive differentiation. We found that the canonical intracellular mediators of BMP signaling, Smad-1 and Smad-8, were significantly elevated in AR42J cells undergoing insulin-positive differentiation in response to exendin-4 treatment, suggesting a role for BMP signaling in beta-cell formation. Similarly, endogenous BMP-2 ligand and ALK-1 receptor ( activin receptor-like kinase-1; known to activate Smads 1 and 8) mRNAs were specifically up-regulated in exendin-4-treated AR42J cells. Surprisingly, Smad-1 and Smad-8 levels were suppressed by the addition of BMP-soluble receptor inhibition of BMP ligand binding to its receptor. Here, insulin-positive differentiation was also ablated. BMP-2 ligand antisense also strongly inhibited Smad-1 and Smad-8 expression, again with the abolition of insulin-positive differentiation. These results demonstrate a previously unrecognized key role for BMP signaling in mediating insulin- positive differentiation through the intracellular Smad signaling pathway. In short, BMP signaling may represent a novel downstream target of exendin-4 (glucagon-like peptide 1) signaling and potentially serve as an upstream regulator of transforming growth factor-beta isoform signaling to differentiate the acinar-like AR42J cells into insulin- secreting cells.	Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gittes, G (corresponding author), Childrens Hosp Pittsburgh, 3705 5th Ave, Pittsburgh, PA 15213 USA.	george.gittes@chp.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064952, R01DK058400] Funding Source: NIH RePORTER; NIDDK NIH HHS [1 R01 DK064952-01, 1 R01 DK58400-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aoki H, 2001, J CELL SCI, V114, P1483; Arora K, 1996, ANN NY ACAD SCI, V785, P80, DOI 10.1111/j.1749-6632.1996.tb56246.x; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Brorson M, 2001, HISTOCHEM CELL BIOL, V116, P263, DOI 10.1007/s004180100316; Dick A, 1999, DEV DYNAM, V216, P285, DOI 10.1002/(SICI)1097-0177(199911)216:3<285::AID-DVDY7>3.0.CO;2-L; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Jiang FX, 2002, J CELL SCI, V115, P753; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; MonsoroBurq AH, 1996, DEVELOPMENT, V122, P3607; Nishimura R, 2003, FRONT BIOSCI, V8, pS275, DOI 10.2741/1049; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tiso N, 2002, MECH DEVELOP, V118, P29, DOI 10.1016/S0925-4773(02)00252-6; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; Vrljicak P, 2004, AM J PHYSIOL-RENAL, V286, pF625, DOI 10.1152/ajprenal.00152.2003; Weaver M, 1999, DEVELOPMENT, V126, P4005; Yamashita H, 1996, BONE, V19, P569, DOI 10.1016/S8756-3282(96)00259-1; Yew KH, 2004, DIABETES, V53, P2824, DOI 10.2337/diabetes.53.11.2824	18	32	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32209	32217		10.1074/jbc.M505465200	http://dx.doi.org/10.1074/jbc.M505465200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16020542	hybrid			2022-12-27	WOS:000231794800022
J	Chen, L; Kurokawa, J; Kass, RS				Chen, L; Kurokawa, J; Kass, RS			Phosphorylation of the A-kinase-anchoring protein Yotiao contributes to protein kinase A regulation of a heart potassium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKAP SIGNALING COMPLEXES; LONG-QT SYNDROME; PKA PHOSPHORYLATION; NA+ CHANNEL; RECEPTOR; SUBUNIT; COMPARTMENTATION; REQUIREMENT; SCAFFOLD; BINDING	Regulation of the heart by the sympathetic nervous system, fundamental to the physiological response to stress and exercise, requires coordinated phosphorylation of multiple downstream molecular targets, including the I-Ks (slowly activating potassium current) channel. Sympathetic nervous system stimulation increases intracellular cAMP for which targeted regulation is directed in large part by distinct scaffold or anchoring proteins. Yotiao is an A-kinase-anchoring protein (AKAP) that recruits the cyclic AMP-dependent protein kinase (protein kinase A (PKA)) and protein phosphatase 1 to the carboxyl terminus of the I-Ks channel to form a molecular complex and control its phosphorylation state, crucial to the cardiac cellular response to sympathetic nervous system stimulation. Here we report that Yotiao itself is a substrate for PKA phosphorylation, and we identify a Yotiao amino-terminal (N-T) residue (Ser-43) that is PKA-phosphorylated in response to beta-adrenergic receptor stimulation. The replacement of Ser-43 by Ala ablates the PKA phosphorylation of N-T Yotiao and markedly diminishes the functional response of the wild type and pseudo-phosphorylated I-Ks channel to cAMP but neither prevents the PKA phosphorylation of KCNQ1 nor its binding to Yotiao. These results suggest, for the first time, a critical role for the PKA phosphorylation of an AKAP in the functional regulation of an ion channel protein and postphosphorylation allosteric modulation of the I-Ks channel by Yotiao.	Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; Tokyo Med & Dent Univ, Dept Bioinformat Pharmacol, Tokyo 1010062, Japan	Columbia University; Tokyo Medical & Dental University (TMDU)	Kass, RS (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pharmacol, 630 W 168th St, New York, NY 10032 USA.	rsk20@columbia.edu	Kurokawa, Junko/ABF-7557-2021; Kurokawa, Junko/Q-6287-2017	Kurokawa, Junko/0000-0002-9098-0908; Kurokawa, Junko/0000-0002-9098-0908	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044365] Funding Source: NIH RePORTER; NHLBI NIH HHS [1R01-HL 44365, R01 HL044365-13, R01 HL044365] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abriel H, 2001, CIRC RES, V88, P740, DOI 10.1161/hh0701.089668; Angelo R, 1998, J BIOL CHEM, V273, P14633, DOI 10.1074/jbc.273.23.14633; Bauman AL, 2004, NEUROPHARMACOLOGY, V46, P299, DOI 10.1016/j.neuropharm.2003.09.016; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Gray PC, 1997, J BIOL CHEM, V272, P6297, DOI 10.1074/jbc.272.10.6297; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kapiloff MS, 2002, MOL PHARMACOL, V62, P193, DOI 10.1124/mol.62.2.193; Kass RS, 2003, TRENDS CARDIOVAS MED, V13, P52, DOI 10.1016/S1050-1738(02)00211-6; KASS RS, 1982, J PHYSIOL-LONDON, V322, P541, DOI 10.1113/jphysiol.1982.sp014054; Kurokawa J, 2004, P NATL ACAD SCI USA, V101, P16374, DOI 10.1073/pnas.0405583101; Kurokawa J, 2003, P NATL ACAD SCI USA, V100, P2122, DOI 10.1073/pnas.0434935100; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Paavonen KJ, 2001, HEART, V86, P39, DOI 10.1136/heart.86.1.39; Reinitz CA, 1997, ARCH BIOCHEM BIOPHYS, V348, P391, DOI 10.1006/abbi.1997.0401; Tao JC, 2003, EMBO J, V22, P6419, DOI 10.1093/emboj/cdg628; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Terrenoire C, 2005, CIRC RES, V96, pE25, DOI 10.1161/01.RES.0000160555.58046.9a; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	27	66	73	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31347	31352		10.1074/jbc.M505191200	http://dx.doi.org/10.1074/jbc.M505191200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16002409	hybrid			2022-12-27	WOS:000231665200003
J	Gsandtner, I; Charalambous, C; Stefan, E; Ogris, E; Freissmuth, M; Zezula, J				Gsandtner, I; Charalambous, C; Stefan, E; Ogris, E; Freissmuth, M; Zezula, J			Heterotrimeric G protein-independent signaling of a G protein-coupled receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR; MAP KINASE STIMULATION; A(2A)-ADENOSINE RECEPTOR; EXCHANGE FACTOR; BREFELDIN-A; DOWNSTREAM ACTIVATION; ARF6; ARNO; DESENSITIZATION; ENDOCYTOSIS	The A(2A) adenosine receptor is a prototypical G(s)-coupled receptor, but it also signals, e. g. to mitogen-activated protein ( MAP) kinase, via a pathway that is independent of heterotrimeric G proteins. Truncation of the carboxyl terminus affects the strength of the signal through these alternative pathways. In a yeast two-hybrid interaction hunt, we screened a human brain library for proteins that bound to the juxtamembrane portion of the carboxyl terminus of the A(2A) receptor. This approach identified ARNO/cytohesin-2, a nucleotide exchange factor for the small ( monomeric) G proteins of the Arf ( ADP-ribosylation factor) family, as a potential interaction partner. We confirmed a direct interaction by mutual pull down ( of fusion proteins expressed in bacteria) and by immunoprecipitation of the proteins expressed in mammalian cells. To circumvent the long term toxicity associated with overexpression of ARNO/cytohesin-2, we created stable cell lines that stably expressed the A(2A) receptor and where ARNO/cytohesin-2 or the dominant negative version E156K-ARNO/cytohesin-2 was inducible by mifepristone. Cyclic AMP accumulation induced by an A(2A)-specific agonist was neither altered by ARNO/ cytohesin-2 nor by the dominant negative version. This was also true for agonist-induced desensitization. In contrast, expression of dominant negative E156K-ARNO/cytohesin-2 and of dominant negative T27N-Arf6 abrogated the sustained phase of MAP kinase stimulation induced by the A(2A) receptor. We therefore conclude that ARNO/ cytohesin-2 is required to support the alternative, heterotrimeric G protein-independent, signaling pathway of A(2A) receptor, which is stimulation of MAP kinase.	Med Univ Vienna, Inst Pharmacol, Ctr Biomol Med & Pharmacol, A-1090 Vienna, Austria; Med Univ Vienna, Dept Biochem Med, Vienna Bioctr, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Vienna Biocenter (VBC)	Zezula, J (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Biomol Med & Pharmacol, Wahringer Str 13A, A-1090 Vienna, Austria.	juergen.zezula@meduniwien.ac.at		Stefan, Eduard/0000-0003-3650-4713; Freissmuth, Michael/0000-0001-9398-1765; Ogris, Egon/0000-0001-5950-9264				Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Di Fiore PP, 2003, NATURE, V424, P624, DOI 10.1038/424624a; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; Heuss C, 2000, TRENDS NEUROSCI, V23, P469, DOI 10.1016/S0166-2236(00)01643-X; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Hunzicker-Dunn M, 2003, J BIOL CHEM, V278, P42744, DOI 10.1074/jbc.M306133200; Klinger M, 2002, CELL SIGNAL, V14, P99, DOI 10.1016/S0898-6568(01)00235-2; Klinger M, 2002, J BIOL CHEM, V277, P32490, DOI 10.1074/jbc.M200556200; Klinger M, 2002, N-S ARCH PHARMACOL, V366, P287, DOI 10.1007/s00210-002-0617-z; Korkhov VM, 2004, J BIOL CHEM, V279, P55728, DOI 10.1074/jbc.M409449200; Kudlacek O, 2001, J BIOL CHEM, V276, P3010, DOI 10.1074/jbc.M007910200; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Mukherjee S, 2001, J BIOL CHEM, V276, P6524, DOI 10.1074/jbc.C000725200; Mukherjee S, 2000, P NATL ACAD SCI USA, V97, P5901, DOI 10.1073/pnas.100127097; NANOFF C, 1993, J RECEPTOR RES, V13, P961, DOI 10.3109/10799899309073703; NANOFF C, 1991, MOL PHARMACOL, V39, P130; Nordstrom JL, 2003, STEROIDS, V68, P1085, DOI 10.1016/j.steroids.2003.07.008; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; RAMKUMAR V, 1991, MOL PHARMACOL, V40, P639; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Sata M, 1999, P NATL ACAD SCI USA, V96, P2752, DOI 10.1073/pnas.96.6.2752; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Seidel MG, 1999, J BIOL CHEM, V274, P25833, DOI 10.1074/jbc.274.36.25833; Sexl V, 1997, J BIOL CHEM, V272, P5792, DOI 10.1074/jbc.272.9.5792; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Song J, 1998, J CELL SCI, V111, P2257; Theis MG, 2004, P NATL ACAD SCI USA, V101, P11221, DOI 10.1073/pnas.0402901101; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Yeong FM, 2003, CURR BIOL, V13, P2058, DOI 10.1016/j.cub.2003.10.032	38	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31898	31905		10.1074/jbc.M506515200	http://dx.doi.org/10.1074/jbc.M506515200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16027149	hybrid			2022-12-27	WOS:000231665200069
J	Suvarna, N; Borgland, SL; Wang, J; Phamluong, K; Auberson, YP; Bonci, A; Ron, D				Suvarna, N; Borgland, SL; Wang, J; Phamluong, K; Auberson, YP; Bonci, A; Ron, D			Ethanol alters trafficking and functional N-methyl-D-aspartate receptor NR2 subunit ratio via H-Ras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; CELL-SURFACE EXPRESSION; SRC TYROSINE KINASE; NMDA-RECEPTOR; GLUTAMATE RECEPTORS; ACUTE TOLERANCE; FYN-KINASE; C0 DOMAIN; SENSITIVITY; INHIBITION	The N-methyl-D-aspartate receptor (NMDAR) plays a critical role in synaptic plasticity and is one of the main targets for alcohol (ethanol) in the brain. Trafficking of the NMDAR is emerging as a key regulatory mechanism that underlies channel activity and synaptic plasticity. Here we show that exposure of hippocampal neurons to ethanol increases the internalization of the NR2A but not NR2B subunit of the NMDAR via the endocytic pathway. We further observed that ethanol exposure results in NR2A endocytosis through the activation of H-Ras and the inhibition of the tyrosine kinase Src. Importantly, ethanol treatment alters functional subunit composition from NR2A/NR2B- to mainly NR2B-containing NMDARs. Our results suggest that addictive drugs such as ethanol alter NMDAR trafficking and subunit composition. This may be an important mechanism by which ethanol exerts its effects on NMDARs to produce alcohol-induced aberrant plasticity.	Ernest Gallo Clin & Res Ctr, Dept Neurol, Emeryville, CA 94608 USA; Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; Ernest Gallo Res Ctr, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Novartis; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Ron, D (corresponding author), Ernest Gallo Clin & Res Ctr, Dept Neurol, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	dorit@itsa.ucsf.edu	Wang, Jun/M-2337-2016; Borgland, Stephanie/GPC-5260-2022; Auberson, Yves/AAF-6538-2019; Borgland, Stephanie/M-2936-2016; Wang, Jun/N-8472-2015	Wang, Jun/0000-0002-0085-4722; Borgland, Stephanie/0000-0001-7546-5687; Auberson, Yves/0000-0001-5800-4811; Borgland, Stephanie/0000-0001-7546-5687; Wang, Jun/0000-0002-0085-4722	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013438] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01AA013438-03] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Allgaier C, 2002, NEUROCHEM INT, V41, P377, DOI 10.1016/S0197-0186(02)00046-3; Alvestad RM, 2003, J BIOL CHEM, V278, P11020, DOI 10.1074/jbc.M210167200; Ambrosini A, 2000, MOL BRAIN RES, V75, P54, DOI 10.1016/S0169-328X(99)00294-6; Anders DL, 1999, ALCOHOL CLIN EXP RES, V23, P357, DOI 10.1111/j.1530-0277.1999.tb04122.x; Anders DL, 2000, J BIOL CHEM, V275, P15019, DOI 10.1074/jbc.275.20.15019; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Blevins T, 1997, J NEUROCHEM, V69, P2345; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; CHU B, 1995, J NEUROCHEM, V65, P140; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Diamond I, 1997, PHYSIOL REV, V77, P1, DOI 10.1152/physrev.1997.77.1.1; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Dunah AW, 2004, MOL PHARMACOL, V65, P121, DOI 10.1124/mol.65.1.121; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; Fang M, 2003, J BIOL CHEM, V278, P36669, DOI 10.1074/jbc.M303520200; FARRANT M, 1994, NATURE, V368, P335, DOI 10.1038/368335a0; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Grimwood S, 1996, J NEUROCHEM, V66, P2239; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; GROSSHANS DR, 2002, SCI STKE, V137, pPL8; GROVER CA, 1994, BRAIN RES, V642, P70, DOI 10.1016/0006-8993(94)90906-7; Hendricson AW, 2002, J PHARMACOL EXP THER, V301, P938, DOI 10.1124/jpet.301.3.938; Honse Y, 2003, NEUROSCIENCE, V122, P689, DOI 10.1016/S0306-4522(03)00603-1; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Krystal JH, 2003, PHARMACOL THERAPEUT, V99, P79, DOI 10.1016/S0163-7258(03)00054-8; Krystal JH, 2003, ANN NY ACAD SCI, V1003, P176, DOI 10.1196/annals.1300.010; Kumari M, 2000, PROG DRUG RES, V54, P152; KUNER T, 1993, NEUROREPORT, V5, P297, DOI 10.1097/00001756-199312000-00029; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; Li HF, 2003, BRIT J PHARMACOL, V139, P73, DOI 10.1038/sj.bjp.0705198; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; LOVINGER DM, 1995, J PHARMACOL EXP THER, V274, P164; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; LOVINGER DM, 1990, J NEUROSCI, V10, P1372; Ludvig N, 2001, BRAIN RES, V900, P252, DOI 10.1016/S0006-8993(01)02319-8; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Manabe T, 2000, J NEUROSCI, V20, P2504; MASOOD K, 1994, MOL PHARMACOL, V45, P324; McGough NNH, 2004, J NEUROSCI, V24, P10542, DOI 10.1523/JNEUROSCI.3714-04.2004; MIRSHAHI T, 1995, NEUROPHARMACOLOGY, V34, P347, DOI 10.1016/0028-3908(94)00155-L; Mirshahi T, 1998, J NEUROCHEM, V71, P1095; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORRISETT RA, 1991, NEUROPHARMACOLOGY, V30, P1173, DOI 10.1016/0028-3908(91)90162-5; MORRISETT RA, 1993, J NEUROSCI, V13, P2264; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Nagy J, 2004, CNS NEUROL DISORD-DR, V3, P169, DOI 10.2174/1568007043337409; Nong Y, 2004, CURR OPIN NEUROBIOL, V14, P353, DOI 10.1016/j.conb.2004.05.001; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Okabe S, 1999, J NEUROSCI, V19, P7781; Popp RL, 1998, NEUROPHARMACOLOGY, V37, P45, DOI 10.1016/S0028-3908(97)00186-X; Popp RL, 1999, J PHARMACOL EXP THER, V289, P1564; Prybylowski K, 2004, J BIOL CHEM, V279, P9673, DOI 10.1074/jbc.R300029200; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Ron D, 2004, NEUROSCIENTIST, V10, P325, DOI 10.1177/1073858404263516; Ronald KM, 2001, J BIOL CHEM, V276, P44729, DOI 10.1074/jbc.M102800200; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Siggins GR, 2003, ANN NY ACAD SCI, V1003, P196, DOI 10.1196/annals.1300.012; Smothers CT, 2001, NEUROCHEM INT, V38, P333, DOI 10.1016/S0197-0186(00)00094-2; Thornton C, 2003, J BIOL CHEM, V278, P23823, DOI 10.1074/jbc.M302389200; Tovar KR, 2002, NEURON, V34, P253; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wadia JS, 2003, CURR PROTEIN PEPT SC, V4, P97, DOI 10.2174/1389203033487289; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Yaka R, 2003, J NEUROSCI, V23, P3623	70	61	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31450	31459		10.1074/jbc.M504120200	http://dx.doi.org/10.1074/jbc.M504120200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16009711	hybrid			2022-12-27	WOS:000231665200016
J	Yadav, A; Kalita, A; Dhillon, S; Banerjee, K				Yadav, A; Kalita, A; Dhillon, S; Banerjee, K			JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY NEUROTROPHIC FACTOR; NECROSIS-FACTOR-ALPHA; FACTOR-I; GENE-EXPRESSION; MAMMALIAN LENS; STAT-PATHWAY; IGF-I; BRAIN; RECEPTOR; ACTIVATION	Janus kinases ( JAK) and signal transducers and activator of transcription ( STAT) proteins are activated in response to many cytokines and growth factors and are well studied in the immune system. This study was conducted to examine the role of the JAK/STAT pathway in neurons in response to tumor necrosis factor-alpha ( TNF alpha) and insulin-like growth factor-1 ( IGF-1), which play a major role during neurodegeneration, and to study their effect on expression of suppressors of cytokine signaling 3 ( SOCS-3), belonging to the novel family of feedback regulators of cytokine and growth factor activities. In this report, we showed that TNF alpha is inhibitory to the survival of primary cortical neurons at higher doses and that IGF-1 can rescue TNF alpha-stimulated cell death. We showed that the JAK/STAT pathway is involved in this rescue as tyrphostin AG490, a specific inhibitor of JAK/STAT, completely inhibits cell survival in response to IGF-1. STAT3 gets tyrosine-phosphorylated and translocated to the nucleus in response to IGF-1. Northern blot, semi-quantitative reverse transcription-PCR, and real time PCR experiments demonstrated that the JAK/STAT pathway also up-regulated SOCS-3 mainly in response to IGF-1. SOCS-3 associated with the IGF receptor and blocked further STAT3 activation. To our knowledge, this is the first report that demonstrated the importance of the JAK/STAT pathway and the role of SOCS-3 in the survival of neurons in response to IGF-1. We have subsequently shown that SOCS-3 overexpression, on one hand, leads to neuroblastoma cell death and on the other hand leads to primary cell differentiation, indicating the involvement of SOCS-3 in cell survival and differentiation.	Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Banerjee, K (corresponding author), Natl Inst Immunol, Eukaryot Gene Express Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	kakoli@nii.res.in		Yadav, Ajay/0000-0003-3321-4198				Bartoe JL, 2002, MOL BRAIN RES, V107, P108, DOI 10.1016/S0169-328X(02)00452-7; Botchkina GI, 1997, MOL MED, V3, P765, DOI 10.1007/BF03401714; Carmichael ST, 2003, CURR OPIN NEUROL, V16, P699, DOI 10.1097/00019052-200312000-00009; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; De-Fraja C, 2000, INT J DEV NEUROSCI, V18, P439, DOI 10.1016/S0736-5748(00)00007-1; Dey BR, 1998, J BIOL CHEM, V273, P24095, DOI 10.1074/jbc.273.37.24095; Dore S, 1997, TRENDS NEUROSCI, V20, P326; Dunn SL, 2005, MOL ENDOCRINOL, V19, P925, DOI 10.1210/me.2004-0353; Ebong S, 2004, MOL VIS, V10, P122; Ebong S, 2004, INVEST OPHTH VIS SCI, V45, P872, DOI 10.1167/iovs.03-0311; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Fujitani Y, 1997, ONCOGENE, V14, P751, DOI 10.1038/sj.onc.1200907; Goldshmit Y, 2004, J BIOL CHEM, V279, P16349, DOI 10.1074/jbc.M312873200; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Guan J, 1996, NEUROREPORT, V7, P632, DOI 10.1097/00001756-199601310-00061; HATTTEN MB, 2002, CULTURING NERVE CELL, P419; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Kaur N, 2005, J NEUROCHEM, V92, P1521, DOI 10.1111/j.1471-4159.2004.02990.x; Kaur N, 2002, CELL SIGNAL, V14, P419, DOI 10.1016/S0898-6568(01)00280-7; Kenchappa P, 2004, J NEUROSCI RES, V76, P466, DOI 10.1002/jnr.20081; Kim OS, 2002, J BIOL CHEM, V277, P40594, DOI 10.1074/jbc.M203885200; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Peterson WM, 2000, J NEUROSCI, V20, P4081; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Russo VC, 2004, ENDOCRINOLOGY, V145, P4103, DOI 10.1210/en.2003-1767; Sass G, 2005, BIOCHEM J, V385, P537, DOI 10.1042/BJ20040279; Starr R, 1999, BIOESSAYS, V21, P47, DOI 10.1002/(SICI)1521-1878(199901)21:1<47::AID-BIES6>3.0.CO;2-N; TALLEY AK, 1995, MOL CELL BIOL, V15, P2359; Uddin S, 1997, BLOOD, V90, P2574; Venters HD, 1999, P NATL ACAD SCI USA, V96, P9879, DOI 10.1073/pnas.96.17.9879; Vinkemeier U, 2004, J CELL BIOL, V167, P197, DOI 10.1083/jcb.200407163; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; Wang JP, 2002, J NEUROSCI RES, V67, P423, DOI 10.1002/jnr.10145; Zong CS, 2000, J BIOL CHEM, V275, P15099, DOI 10.1074/jbc.M000089200; Zong CS, 1998, J BIOL CHEM, V273, P28065, DOI 10.1074/jbc.273.43.28065	43	108	117	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31830	31840		10.1074/jbc.M501316200	http://dx.doi.org/10.1074/jbc.M501316200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15998644	hybrid			2022-12-27	WOS:000231665200062
J	Anderson, LL; Marshall, GR; Crocker, E; Smith, SO; Baranski, TJ				Anderson, LL; Marshall, GR; Crocker, E; Smith, SO; Baranski, TJ			Motion of carboxyl terminus of G alpha is restricted upon G protein activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYZED NUCLEOTIDE EXCHANGE; HETEROTRIMERIC G-PROTEIN; CRYSTAL-STRUCTURE; BETA-GAMMA; SYNTHETIC PEPTIDES; GTP HYDROLYSIS; BINDING-SITES; RECEPTOR; TRANSDUCIN; SUBUNIT	The carboxyl terminus of the G protein alpha subunit plays a key role in interactions with G protein- coupled receptors. Previous studies that have incorporated co-valently attached probes have demonstrated that the carboxyl terminus undergoes conformational changes upon G protein activation. To examine the conformational changes that occur at the carboxyl terminus of G alpha subunits upon G protein activation in a more native system, we generated a semisynthetic G alpha subunit, site-specifically labeled in its carboxyl terminus with C-13 amino acids. Using expressed protein ligation, 9- mer peptides were ligated to recombinant G alpha(i1) subunits lacking the corresponding carboxyl- terminal residues. In a receptor- G protein reconstitution assay, the truncated G alpha(i1) subunit could not be activated by receptor; whereas the semisynthetic protein demonstrated functionality that was comparable with recombinant G alpha(i1). To study the conformation of the carboxyl terminus of the semisynthetic G protein, we applied high resolution solution NMR to G alpha subunits containing 13C labels at the corresponding sites in G alpha(i1): Leu- 348 ( uniform), Gly-352 ( alpha carbon), and Phe- 354 ( ring). In the GDP- bound state, the spectra of the ligated carboxyl terminus appeared similar to the spectra obtained for C-13- labeled free peptide. Upon titration with increasing concentrations of AlF4-, the C-13 resonances demonstrated a marked loss of signal intensity in the semisynthetic G alpha subunit but not in free peptide subjected to the same conditions. Because AlF4- complexes with GDP to stabilize an activated state of the G alpha subunit, these results suggest that the G alpha carboxyl terminus is highly mobile in its GDP- bound state but adopts an ordered conformation upon activation by AlF4-.	Washington Univ, Dept Med, St Louis, MO 63110 USA; Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Washington Univ, Dept Mol Biol, St Louis, MO 63110 USA; Washington Univ, Dept Pharmacol, St Louis, MO 63110 USA; SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Struct Biol, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Baranski, TJ (corresponding author), Washington Univ, Dept Med, 660 S Euclid Ave,Campus Box 8127, St Louis, MO 63110 USA.	baranski@wustl.edu		Marshall, Garland/0000-0002-3098-0332	NATIONAL EYE INSTITUTE [R01EY012113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063720, R01GM041412] Funding Source: NIH RePORTER; NEI NIH HHS [EY12113] Funding Source: Medline; NIGMS NIH HHS [R01 GM041412, R01 GM063720, T32GM0878, GM63720-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayers B, 1999, BIOPOLYMERS, V51, P343, DOI 10.1002/(SICI)1097-0282(1999)51:5<343::AID-BIP4>3.0.CO;2-W; Conklin BR, 1996, MOL PHARMACOL, V50, P885; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; DENKER BM, 1992, J BIOL CHEM, V267, P9998; DHANASEKARAN N, 1988, J BIOL CHEM, V263, P17942; DRATZ EA, 1993, NATURE, V363, P276, DOI 10.1038/363276a0; FAWZI AB, 1991, J BIOL CHEM, V266, P12194; HAGA K, 1986, J BIOL CHEM, V261, P133; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hamm HE, 2001, P NATL ACAD SCI USA, V98, P4819, DOI 10.1073/pnas.011099798; Hansen JL, 2000, CIRC RES, V87, P753, DOI 10.1161/01.RES.87.9.753; Hellmich MR, 1997, P NATL ACAD SCI USA, V94, P751, DOI 10.1073/pnas.94.2.751; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Klco JM, 2003, J BIOL CHEM, V278, P35345, DOI 10.1074/jbc.M305606200; Koenig BW, 2002, J MOL BIOL, V322, P441, DOI 10.1016/S0022-2836(02)00745-3; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Natochin M, 2001, J NEUROCHEM, V77, P202, DOI 10.1046/j.1471-4159.2001.00221.x; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Perler FB, 1998, CELL, V92, P1, DOI 10.1016/S0092-8674(00)80892-2; RASENICK MM, 1994, J BIOL CHEM, V269, P21519; Sheikh SP, 1999, J BIOL CHEM, V274, P17033, DOI 10.1074/jbc.274.24.17033; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Yang CS, 1999, J BIOL CHEM, V274, P2379, DOI 10.1074/jbc.274.4.2379; Yu B, 1998, J BIOL CHEM, V273, P30183, DOI 10.1074/jbc.273.46.30183	34	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31019	31026		10.1074/jbc.M503690200	http://dx.doi.org/10.1074/jbc.M503690200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15983037	Green Accepted, hybrid			2022-12-27	WOS:000231487800045
J	Chan, SP; Cheng, SC				Chan, SP; Cheng, SC			The Prp19-associated complex is required for specifying interactions of U5 and U6 with pre-mRNA during spliceosome activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-PAIRING INTERACTION; SMALL NUCLEAR-RNA; PRP19P-ASSOCIATED COMPLEX; FUNCTIONAL-ANALYSIS; SITE SELECTION; CROSS-LINKING; U1 SNRNA; YEAST; PROTEIN; ASSOCIATION	Activation of the spliceosome involves a major structural change in the spliceosome, including release of U1 and U4 small nuclear ribonucleoprotein particles and the addition of a large protein complex, the Prp19-associated complex. We previously showed that the Prp19-associated complex is required for stable association of U5 and U6 with the spliceosome after U4 is released. Changes within the spliceosome upon binding of the Prp19-associated complex include remodeling of the U6/5' splice site interaction and destabilization of Lsm proteins to allow further interaction of U6 with the intron sequence. Here, we further analyzed interactions of U5 and U6 with pre-mRNA at various stages of spliceosome assembly from initial binding of tri- small nuclear ribonucleoprotein complex to the activated spliceosome to reveal stepwise changes of interactions. We demonstrate that both U5 and U6 interacted with pre-mRNA in dynamic manners spanning over a large region of U6 and the 5' exon sequences prior to the activation of the spliceosome. During spliceosome activation, interactions were locked down to small regions, and the Prp19-associated complex was required for defining the specificity of interaction of U5 and U6 with the 5' splice site to stabilize their association with the spliceosome after U4 is dissociated.	Acad Sinica, Inst Mol Biol, Nankang 115, Taiwan	Academia Sinica - Taiwan	Cheng, SC (corresponding author), Acad Sinica, Inst Mol Biol, Nankang 115, Taiwan.	mbscc@ccvax.sinica.edu.tw	Cheng, Soo-Chen/AAZ-7956-2021	Cheng, Soo-Chen/0000-0002-7570-9415; Chan, Shih-Peng/0000-0001-6322-2821				Alvi RK, 2001, RNA, V7, P1013, DOI 10.1017/S135583820101041X; Awasthi S, 2001, J BIOL CHEM, V276, P31004, DOI 10.1074/jbc.M100022200; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Burge CB, 1999, RNA WORLD, P525; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen CH, 2002, NUCLEIC ACIDS RES, V30, P1029, DOI 10.1093/nar/30.4.1029; Chen CH, 2001, J BIOL CHEM, V276, P488, DOI 10.1074/jbc.M006958200; Chen HR, 1998, MOL CELL BIOL, V18, P2196, DOI 10.1128/MCB.18.4.2196; Chen JYF, 2001, MOL CELL, V7, P227, DOI 10.1016/S1097-2765(01)00170-8; CHENG SC, 1994, NUCLEIC ACIDS RES, V22, P1548, DOI 10.1093/nar/22.9.1548; CHENG SC, 1990, METHOD ENZYMOL, V181, P89; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Johnson TL, 2001, GENE DEV, V15, P1957, DOI 10.1101/gad.895601; Kuhn AN, 1999, MOL CELL, V3, P65, DOI 10.1016/S1097-2765(00)80175-6; LESSER CF, 1993, SCIENCE, V262, P1982, DOI 10.1126/science.8266093; Li ZR, 1996, RNA, V2, P879; LIN RJ, 1985, J BIOL CHEM, V260, P4780; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Maroney PA, 2000, MOL CELL, V6, P317, DOI 10.1016/S1097-2765(00)00032-0; Newman AJ, 1995, RNA, V1, P968; Newman AJ, 1997, EMBO J, V16, P5797, DOI 10.1093/emboj/16.19.5797; NEWMAN AJ, 1992, CELL, V68, P743, DOI 10.1016/0092-8674(92)90149-7; O'Keefe RT, 1998, EMBO J, V17, P565, DOI 10.1093/emboj/17.2.565; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; SAWA H, 1992, P NATL ACAD SCI USA, V89, P11269, DOI 10.1073/pnas.89.23.11269; SAWA H, 1992, GENE DEV, V6, P244, DOI 10.1101/gad.6.2.244; SERAPHIN B, 1988, EMBO J, V7, P2533, DOI 10.1002/j.1460-2075.1988.tb03101.x; SILICIANO PG, 1988, GENE DEV, V2, P1258, DOI 10.1101/gad.2.10.1258; SONTHEIMER EJ, 1993, SCIENCE, V262, P1989, DOI 10.1126/science.8266094; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; TARN WY, 1993, P NATL ACAD SCI USA, V90, P10821, DOI 10.1073/pnas.90.22.10821; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; Tsai WY, 1999, J BIOL CHEM, V274, P9455, DOI 10.1074/jbc.274.14.9455; van Nues RW, 2001, GENETICS, V157, P1451; Will CL, 1997, CURR OPIN CELL BIOL, V9, P320, DOI 10.1016/S0955-0674(97)80003-8; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; WYATT JR, 1992, GENE DEV, V6, P2542, DOI 10.1101/gad.6.12b.2542; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4; ZHUANG Y, 1989, GENE DEV, V3, P1545, DOI 10.1101/gad.3.10.1545	39	87	88	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31190	31199		10.1074/jbc.M505060200	http://dx.doi.org/10.1074/jbc.M505060200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994330	hybrid			2022-12-27	WOS:000231487800066
J	Magdesian, MH; Nery, AA; Martins, AHB; Juliano, MA; Juliano, L; Ulrich, H; Ferreira, ST				Magdesian, MH; Nery, AA; Martins, AHB; Juliano, MA; Juliano, L; Ulrich, H; Ferreira, ST			Peptide blockers of the inhibition of neuronal nicotinic acetylcholine receptors by amyloid beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; PROTEIN; IDENTIFICATION; BETA-AMYLOID(1-42); NEUROTOXICITY; GENERATION; BINDING	Alzheimer disease ( AD) is characterized by accumulation of the neurotoxic amyloid beta peptide ( A beta) and by the loss of cholinergic neurons and nicotinic acetylcholine receptors ( nAChRs) throughout the brain. Direct inhibition of nAChRs by A beta has also been suggested to contribute to cholinergic dysfunction in AD. In an effort to find ligands capable of blocking A beta- induced inhibition of nAChRs, we have screened a phage display library to identify peptides that bind to A beta. Using this approach, we identified a heptapeptide denoted IQ, which binds with nanomolar affinity to A beta and is homologous to the acetylcholine- binding protein and to most subtypes of nAChRs. Rapid kinetic whole- cell current- recording measurements showed that A beta inhibits nAChR function in a dose- dependent manner in neuronal differentiated PC12 cells and that nanomolar concentrations of IQ completely block the inhibition by A beta. These results indicate that the A beta binding site in nAChRs is homologous to the IQ peptide and that this is a relevant target for A beta neurotoxicity in AD and, more generally, for the regulation of nAChR function by soluble A beta in a physiological context. Furthermore, the results suggest that the IQ peptide may be a lead for the development of novel drugs to block the inhibition of nAChRs in AD.	Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21944590 Rio De Janeiro, RJ, Brazil; Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil; Univ Fed Sao Paulo, Dept Biofis, BR-04044020 Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, Av Brigadeiro Trompowsky S-N,Bloco H Sala 19,CCS, BR-21944590 Rio De Janeiro, RJ, Brazil.	ferreira@bioqmed.ufrj.br	Ulrich, Henning/C-5245-2013; Ferreira, Sergio/AAZ-1576-2020; Juliano, Luiz/D-7204-2012	Ulrich, Henning/0000-0002-2114-3815; Ferreira, Sergio/0000-0001-7160-9866; Juliano, Luiz/0000-0002-5589-2822				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azzazy HME, 2002, CLIN BIOCHEM, V35, P425, DOI 10.1016/S0009-9120(02)00343-0; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; CORRINGER PJ, 1995, J BIOL CHEM, V270, P11749, DOI 10.1074/jbc.270.20.11749; De Felice FG, 2002, CELL MOL NEUROBIOL, V22, P545, DOI 10.1023/A:1021832302524; Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200; Espinoza-Fonseca LM, 2004, BIOCHEM BIOPH RES CO, V320, P587, DOI 10.1016/j.bbrc.2004.05.207; Grassi F, 2003, J PHYSIOL-LONDON, V547, P147, DOI 10.1113/jphysiol.2002.035436; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hess GP, 2003, BIOCHEMISTRY-US, V42, P6106, DOI 10.1021/bi020677u; HO PL, 1992, J CELL PHYSIOL, V150, P647, DOI 10.1002/jcp.1041500326; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Kang CK, 2003, NEUROBIOL DIS, V14, P146, DOI 10.1016/S0969-9961(03)00105-0; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1; Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598; Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com; Magdesian MH, 2001, J BIOL CHEM, V276, P19382, DOI 10.1074/jbc.M011474200; Martin SE, 2004, BRAIN RES, V1022, P254, DOI 10.1016/j.brainres.2004.07.016; MIRZABEKOV T, 1994, BIOCHEM BIOPH RES CO, V202, P1142, DOI 10.1006/bbrc.1994.2047; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; Nishiki T, 1997, BIOCHEM BIOPH RES CO, V239, P57, DOI 10.1006/bbrc.1997.7427; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Stephan A, 2001, J NEUROSCI, V21, P5703, DOI 10.1523/JNEUROSCI.21-15-05703.2001; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tozaki H, 2002, BIOCHEM BIOPH RES CO, V294, P42, DOI 10.1016/S0006-291X(02)00429-1; UDGAONKAR JB, 1987, P NATL ACAD SCI USA, V84, P8758, DOI 10.1073/pnas.84.24.8758; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631; Wu J, 2004, J BIOL CHEM, V279, P37842, DOI 10.1074/jbc.M400335200; Ye CP, 2004, NEUROSCI LETT, V366, P320, DOI 10.1016/j.neulet.2004.05.060	34	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31085	31090		10.1074/jbc.M502406200	http://dx.doi.org/10.1074/jbc.M502406200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15987688	hybrid			2022-12-27	WOS:000231487800053
J	Carrotta, R; Manno, M; Bulone, D; Martorana, V; San Biagio, PL				Carrotta, R; Manno, M; Bulone, D; Martorana, V; San Biagio, PL			Protofibril formation of amyloid beta-protein at low pH via a non-cooperative elongation mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATE AGGREGATION PATHWAYS; ATOMIC-FORCE MICROSCOPY; IN-VITRO MODEL; ALZHEIMERS-DISEASE; FIBRIL GROWTH; KINETICS; FIBRILLOGENESIS; PEPTIDE; OLIGOMERS; ASSOCIATION	Deposition of the amyloid beta-protein (A beta) in senile or diffuse plaques is a distinctive feature of Alzheimer's disease. The role of A beta aggregates in the etiology of the disease is still controversial. The formation of linear aggregates, known as amyloid fibrils, has been proposed as the onset and the cause of pathological deposition. Yet, recent findings suggest that a more crucial role is played by prefibrillar oligomeric assemblies of A beta that are highly toxic in the extracellular environment. In the present work, the mechanism of protofibril formation is studied at pH 3.1, starting from a solution of oligomeric precursors. By combining static light scattering and photon correlation spectroscopy, the growth of the mass and the size of aggregates are determined at different temperatures. Analysis and scaling of kinetic data reveal that under the studied conditions protofibrils are formed via a single non-cooperative elongation mechanism, not prompted by nucleation. This process is well described as a linear colloidal aggregation due to diffusion and coalescence of growing aggregates. The rate of elongation follows an Arrhenius law with an activation enthalpy of 15 kcal mol(-1). Such a value points to a conformational change of peptides or oligomers being involved in binding to protofibrils or in general to a local reorganization of each aggregate. These results contribute to establishing a clearer relation at the molecular level between the fibrillation mechanism and fibrillar precursors. The observation of a non-cooperative aggregation pathway supports the hypothesis that amyloid formation may represent an escape route from a dangerous condition, induced by the presence of toxic oligomeric species.	Italian Natl Res Council, Inst Biophys, I-90146 Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Manno, M (corresponding author), Italian Natl Res Council, Inst Biophys, Via U La Malfa 153, I-90146 Palermo, Italy.	mauro.manno@pa.ibf.cnr.it	Manno, Mauro/F-1385-2010; bulone, donatella/AAB-6116-2022	Manno, Mauro/0000-0001-9843-0428; bulone, donatella/0000-0002-5841-9133; Martorana, Vincenzo/0000-0001-7092-6077; Carrotta, Rita/0000-0003-4628-2819; SAN BIAGIO, PIER LUIGI/0000-0002-4622-7361				Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Bauer R, 2000, BIOPHYS J, V79, P1030, DOI 10.1016/S0006-3495(00)76357-0; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Blackley HKL, 2000, J MOL BIOL, V298, P833, DOI 10.1006/jmbi.2000.3711; Blackley HKL, 1999, EXP NEUROL, V158, P437, DOI 10.1006/exnr.1999.7114; Bulone D, 2001, BIOPHYS CHEM, V91, P61, DOI 10.1016/S0301-4622(01)00155-7; Carrotta R, 2001, PROTEIN SCI, V10, P1312, DOI 10.1110/ps.42501; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; DEGENNES PG, 1979, SCALING CONCEPTS POL, P38; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Family F., 1984, KINETIC AGGREGATION; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Flyvbjerg H, 1996, P NATL ACAD SCI USA, V93, P5975, DOI 10.1073/pnas.93.12.5975; Gorman PM, 2003, J MOL BIOL, V325, P743, DOI 10.1016/S0022-2836(02)01279-2; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; HILL TL, 1983, BIOPHYS J, V44, P285, DOI 10.1016/S0006-3495(83)84301-X; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Huang THJ, 2000, J MOL BIOL, V297, P73, DOI 10.1006/jmbi.2000.3559; Huang THJ, 2000, J BIOL CHEM, V275, P36436, DOI 10.1074/jbc.M005698200; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Kheterpal I, 2003, BIOCHEMISTRY-US, V42, P14092, DOI 10.1021/bi0357816; Khurana R, 2003, BIOPHYS J, V85, P1135, DOI 10.1016/S0006-3495(03)74550-0; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klug GMJA, 2003, EUR J BIOCHEM, V270, P4282, DOI 10.1046/j.1432-1033.2003.03815.x; Krapivsky PL, 1996, PHYS REV E, V54, P3553, DOI 10.1103/PhysRevE.54.3553; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Kusumoto Y, 1998, P NATL ACAD SCI USA, V95, P12277, DOI 10.1073/pnas.95.21.12277; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; MAGID L, 1993, DYNAMIC LIGHT SCATTE, P554; McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482; Modler AJ, 2003, J MOL BIOL, V325, P135, DOI 10.1016/S0022-2836(02)01175-0; Murphy RM, 2000, J STRUCT BIOL, V130, P109, DOI 10.1006/jsbi.2000.4253; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r; NICOLAI T, 1993, LIGHT SCATTERING PRI, P201; OLIVIER BJ, 1990, PHYS REV A, V41, P2093, DOI 10.1103/PhysRevA.41.2093; Oosawa F., 1975, THERMODYNAMICS POLYM; Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6; PORTE G, 1981, J PHYS CHEM-US, V85, P2511, DOI 10.1021/j150617a020; Relini A, 2004, J MOL BIOL, V338, P943, DOI 10.1016/j.jmb.2004.03.054; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SHEN CL, 1994, BIOPHYS J, V67, P1238, DOI 10.1016/S0006-3495(94)80593-4; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stepanek P., 1993, DYNAMIC LIGHT SCATTE, P177; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; TAYLOR TW, 1987, PHYS REV A, V36, P5415, DOI 10.1103/PhysRevA.36.5415; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thunecke M, 1998, J PEPT RES, V52, P509; TIRADO MM, 1984, J CHEM PHYS, V81, P2047, DOI 10.1063/1.447827; TOMSKI SJ, 1992, ARCH BIOCHEM BIOPHYS, V294, P630, DOI 10.1016/0003-9861(92)90735-F; VANDONGEN PGJ, 1985, PHYS REV LETT, V54, P1396, DOI 10.1103/PhysRevLett.54.1396; VICSEK T, 1984, PHYS REV LETT, V52, P1669, DOI 10.1103/PhysRevLett.52.1669; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WEITZ DA, 1986, PHYS REV LETT, V57, P2037, DOI 10.1103/PhysRevLett.57.2037; WEITZ DA, 1984, PHYS REV LETT, V53, P1657, DOI 10.1103/PhysRevLett.53.1657; Westlind-Danielsson A, 2001, BIOCHEMISTRY-US, V40, P14736, DOI 10.1021/bi010375c; Xu SH, 2001, BIOPHYS J, V81, P446, DOI 10.1016/S0006-3495(01)75712-8; YAMAKAWA H, 1973, MACROMOLECULES, V6, P407, DOI 10.1021/ma60033a018; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Yong W, 2002, P NATL ACAD SCI USA, V99, P150, DOI 10.1073/pnas.012584899	79	103	106	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30001	30008		10.1074/jbc.M500052200	http://dx.doi.org/10.1074/jbc.M500052200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15985437	hybrid			2022-12-27	WOS:000231362500004
J	Singh, D; Solan, JL; Taffet, SM; Javier, R; Lampe, PD				Singh, D; Solan, JL; Taffet, SM; Javier, R; Lampe, PD			Connexin 43 interacts with zona occludens-1 and-2 proteins in a cell cycle stage-specific manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEIN; TUMOR-SUPPRESSOR PROTEIN; TIGHT JUNCTION; C-SRC; TISSUE DISTRIBUTION; ZONULA OCCLUDENS-1; POSSIBLE MECHANISM; MOLECULAR-CLONING; CARDIAC MYOCYTES; PDZ DOMAINS	Gap junction channels play an important role in cell growth control, secretion and embryonic development. Gap junctional communication and channel assembly can be regulated by protein-protein interaction with kinases and phosphatases. We have utilized tandem mass spectrometry ( MS/MS) sequence analysis as a screen to identify proteins from cell lysates that interact with the C-terminal cytoplasmic region of connexin 43 ( Cx43). MS/MS analysis of tryptic fragments yielded several proteins including zona occludens-1 ( ZO-1), a structural protein previously identified to interact with Cx43, and ZO-2, a potential novel interacting partner. We confirmed the interaction of ZO-2 with Cx43 by using a combination of fusion protein "pull down," co-immunoprecipitation, and co-localization experiments. We show that the C-terminal region of Cx43 is necessary for interaction with the PDZ2 domain of ZO-2. Far Western analysis revealed that ZO-2 can directly bind to Cx43 independent of other interacting partners. Immunofluorescence studies indicate that both ZO-1 and ZO-2 can co-localize with Cx43 within the plasma membrane at apparent gap junctional structures. We examined Cx43 interaction with ZO-1 and ZO-2 at different stages of the cell cycle and found that Cx43 had a strong preference for interaction with ZO-1 during G(0), whereas ZO-2 interaction occurred approximately equally during G(0) and S phases. Since essentially all of the Cx43 in G(0) cells is assembled into Triton X-100-resistant junctions, Cx43ZO-1 interaction may contribute to their stability.	Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA; SUNY Upstate Med Univ, Dept Microbiol, Syracuse, NY 13210 USA; Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Baylor College of Medicine	Lampe, PD (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, POB 19024,Mailstop M5C800,1100 Fairview Ave N, Seattle, WA 98109 USA.	plampe@fhcrc.org			NCI NIH HHS [R01 CA058541] Funding Source: Medline; NIAMS NIH HHS [AR47963, R01 AR047963] Funding Source: Medline; NIGMS NIH HHS [R01 GM055632, GM55632] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055632] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Barker RJ, 2002, CIRC RES, V90, P317, DOI 10.1161/hh0302.104471; Bowling N, 2001, J MOL CELL CARDIOL, V33, P789, DOI 10.1006/jmcc.2000.1349; Butkevich E, 2004, CURR BIOL, V14, P650, DOI 10.1016/j.cub.2004.03.063; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Fu CT, 2004, J BIOL CHEM, V279, P36943, DOI 10.1074/jbc.M403952200; Gellhaus A, 2004, J BIOL CHEM, V279, P36931, DOI 10.1074/jbc.M404073200; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; Giepmans BNG, 2001, CELL COMMUN ADHES, V8, P219, DOI 10.3109/15419060109080727; Giepmans BNG, 2001, J BIOL CHEM, V276, P8544, DOI 10.1074/jbc.M005847200; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Glaunsinger BA, 2001, EMBO J, V20, P5578, DOI 10.1093/emboj/20.20.5578; Goldberg GS, 2002, J BIOL CHEM, V277, P36725, DOI 10.1074/jbc.M109797200; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; Kamberov E, 2000, J BIOL CHEM, V275, P11425, DOI 10.1074/jbc.275.15.11425; Kausalya PJ, 2001, FEBS LETT, V505, P92, DOI 10.1016/S0014-5793(01)02786-7; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; Laing JG, 2001, J BIOL CHEM, V276, P23051, DOI 10.1074/jbc.M100303200; Lampe PD, 1998, J CELL SCI, V111, P833; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Nielsen PA, 2002, J BIOL CHEM, V277, P38272, DOI 10.1074/jbc.M205348200; Segretain D, 2004, BIOCHIMIE, V86, P241, DOI 10.1016/j.biochi.2004.05.003; Seki A, 2004, CIRC RES, V95, P22, DOI 10.1161/01.RES.0000140737.62245.c5; Singh D, 2003, CELL COMMUN ADHES, V10, P215, DOI 10.1080/714040430; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Solan JL, 2003, J CELL SCI, V116, P2203, DOI 10.1242/jcs.00428; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Toyofuku T, 2001, J BIOL CHEM, V276, P1780, DOI 10.1074/jbc.M005826200; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Wu JC, 2003, J CELL BIOCHEM, V88, P823, DOI 10.1002/jcb.10390; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	43	106	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30416	30421		10.1074/jbc.M506799200	http://dx.doi.org/10.1074/jbc.M506799200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15980428	hybrid, Green Accepted			2022-12-27	WOS:000231362500054
J	Qu, XX; Hao, P; Song, XJ; Jiang, SM; Liu, YX; Wang, PG; Rao, X; Song, HD; Wang, SY; Zuo, Y; Zheng, AH; Luo, M; Wang, HL; Deng, F; Wang, HZ; Hu, ZH; Ding, MX; Zhao, GP; Deng, HK				Qu, XX; Hao, P; Song, XJ; Jiang, SM; Liu, YX; Wang, PG; Rao, X; Song, HD; Wang, SY; Zuo, Y; Zheng, AH; Luo, M; Wang, HL; Deng, F; Wang, HZ; Hu, ZH; Ding, MX; Zhao, GP; Deng, HK			Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; SARS-CORONAVIRUS; AMINOPEPTIDASE-N; FUNCTIONAL-CHARACTERIZATION; NEUTRALIZING ANTIBODIES; EFFICIENT REPLICATION; VIRUS TYPE-1; RECEPTOR; GLYCOPROTEIN; EXPRESSION	Severe acute respiratory syndrome coronavirus (SARS-CoV) is a recently identified human coronavirus. The extremely high homology of the viral genomic sequences between the viruses isolated from human (huSARS-CoV) and those of palm civet origin (pcSARSCoV) suggested possible palm civet-to-human transmission. Genetic analysis revealed that the spike ( S) protein of pcSARS-CoV and huSARS-CoV was subjected to the strongest positive selection pressure during transmission, and there were six amino acid residues within the receptor-binding domain of the S protein being potentially important for SARS progression and tropism. Using the single-round infection assay, we found that a two-amino acid substitution (N479K/T487S) of a huSARS-CoV for those of pcSARSCoV almost abolished its infection of human cells expressing the SARS-CoV receptor ACE2 but no effect upon the infection of mouse ACE2 cells. Although single substitution of these two residues had no effects on the infectivity of huSARS-CoV, these recombinant S proteins bound to human ACE2 with different levels of reduced affinity, and the two-amino acid-substituted S protein showed extremely low affinity. On the contrary, substitution of these two amino acid residues of pcSARS-CoV for those of huSRAS-CoV made pcSARS-CoV capable of infecting human ACE2-expressing cells. These results suggest that amino acid residues at position 479 and 487 of the S protein are important determinants for SARS-CoV tropism and animal-to-human transmission.	Chinese Acad Sci, Shanghai Inst Biol Sci, Ctr Hlth Sci, Bioinformat Ctr,Inst Plant Physiol & Ecol, Shanghai 200031, Peoples R China; Peking Univ, Coll Life Sci, Dept Cell Biol & Genet, Beijing 100871, Peoples R China; Shanghai Med Univ 2, Ruijin Hosp, Pole Sinfrancais Rech Sci Vivant & Genom, State Key Lab Med Genom, Shanghai 200025, Peoples R China; Chinese Natl Human Genome Ctr, Shanghai 201203, Peoples R China; Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; Fudan Univ, Sch Life Sci, Dept Microbiol, State Key lab Genet Engn, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Peking University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Fudan University	Zhao, GP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Ctr Hlth Sci, Bioinformat Ctr,Inst Plant Physiol & Ecol, Shanghai 200031, Peoples R China.	gpzhao@sibs.ac.cn; hongkui_deng@pku.edu.cn	Liu, Yanxia/T-1338-2019; zheng, aihua/E-5153-2011; Hu, Zhihong/AAS-2215-2020; Song, Huai-Dong/G-8961-2011	Hu, Zhihong/0000-0002-1560-0928; Zuo, Yu/0000-0002-9303-7480; Zhao, Guo-Ping/0000-0002-7621-6620; Hao, Pei/0000-0002-1498-7059; Wang, Peigang/0000-0001-6045-2007				Babcock GJ, 2004, J VIROL, V78, P4552, DOI 10.1128/JVI.78.9.4552-4560.2004; Bernini A, 2004, BIOCHEM BIOPH RES CO, V325, P1210, DOI 10.1016/j.bbrc.2004.10.156; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; DUBIN G, 1994, J VIROL, V68, P2478, DOI 10.1128/JVI.68.4.2478-2485.1994; DVEKSLER GS, 1993, J VIROL, V67, P1; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; HOLMES KV, 1993, ADV EXP MED BIOL, V342, P261; Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Li WH, 2004, J VIROL, V78, P11429, DOI 10.1128/JVI.78.20.11429-11433.2004; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Nie YC, 2004, J INFECT DIS, V190, P1119, DOI 10.1086/423286; Nie YC, 2004, BIOCHEM BIOPH RES CO, V321, P994, DOI 10.1016/j.bbrc.2004.07.060; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Schickli JH, 2004, J VIROL, V78, P9073, DOI 10.1128/JVI.78.17.9073-9083.2004; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Subbarao K, 2004, J VIROL, V78, P3572, DOI 10.1128/JVI.78.7.3572-3577.2004; Tresnan DB, 1998, ADV EXP MED BIOL, V440, P69; Wang PG, 2004, BIOCHEM BIOPH RES CO, V315, P439, DOI 10.1016/j.bbrc.2004.01.076; Wang Z, 2004, VIROLOGY, V330, P332, DOI 10.1016/j.virol.2004.09.023; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054; Yang ZY, 2005, P NATL ACAD SCI USA, V102, P797, DOI 10.1073/pnas.0409065102; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zhang H, 2004, J VIROL, V78, P6938, DOI 10.1128/JVI.78.13.6938-6945.2004	34	118	130	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2005	280	33					29588	29595		10.1074/jbc.M500662200	http://dx.doi.org/10.1074/jbc.M500662200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	954SX	15980414	hybrid, Green Published			2022-12-27	WOS:000231176200026
J	Colige, A; Ruggiero, F; Vandenberghe, I; Dubail, J; Kesteloot, F; Van Beeumen, J; Beschin, A; Brys, L; Lapiere, CM; Nusgens, B				Colige, A; Ruggiero, F; Vandenberghe, I; Dubail, J; Kesteloot, F; Van Beeumen, J; Beschin, A; Brys, L; Lapiere, CM; Nusgens, B			Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I-III and V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-1; BOVINE DERMATOSPARAXIS; N-PROTEINASE; COLLAGEN-V; AGGRECANASE-1; ACTIVATION; CLEAVAGE; PROPEPTIDE; BINDING; MATRIX	Processing of fibrillar collagens is required to generate collagen monomers able to self-assemble into elongated and cylindrical collagen fibrils. ADAMTS-2 belongs to the "A disintegrin and metalloproteinase with thrombospondin type 1 motifs" ( ADAMTS) family. It is responsible for most of the processing of the aminopropeptide of type I procollagen in the skin, and it also cleaves type II and type III procollagens. ADAMTS are complex secreted enzymes that are implicated in various physiological and pathological processes. Despite accumulating evidence indicating that their activity is regulated by ancillary domains, additional information is required for a better understanding of the specific function of each domain. We have generated 17 different recombinant forms of bovine ADAMTS-2 and characterized their processing, activity, and cleavage specificity. The results indicated the following: (i) activation of the ADAMTS-2 zymogen involves several cleavages, by proprotein convertases and C-terminal processing, and generates at least seven distinct processed forms; (ii) the C-terminal domain negatively regulates enzyme activity, whereas two thrombospondin type 1 repeats are enhancer regulators; (iii) the 104-kDa form displays the highest aminoprocollagen peptidase activity on procollagen type I; (iv) ADAMTS-2 processes the aminopropeptide of alpha 1 type V procollagen homotrimer at the end of the variable domain; and ( v) the cleaved sequence (PA) is different from the previously described sites (( P/A) Q) for ADAMTS-2, redefining its cleavage specificity. This finding and the existence of multiple processed forms of ADAMTS-2 strongly suggest that ADAMTS-2 may be involved in function(s) other than processing of fibrillar procollagen types I - III.	Univ Liege, Lab Connect Tissues Biol, Ctr Biomed Integrat Genoprote, B-4000 Sart Tilman Par Liege, Belgium; Univ Ghent, Lab Eiwitbiochem & Eiwitengn, B-9000 Ghent, Belgium; Vrije Univ Brussels VIB, Dept Cellular & Mol Interact, Lab Cellulaire & Mol Immunol, B-1050 Brussels, Belgium; CNRS, UMR 5086, IFR Biosci 128, Inst Biol & Chim Prot, F-69367 Lyon, France	University of Liege; Ghent University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Colige, A (corresponding author), Univ Liege, Lab Connect Tissues Biol, Ctr Biomed Integrat Genoprote, Tour Pathol,B23-3, B-4000 Sart Tilman Par Liege, Belgium.	acolige@ulg.ac.be	Dubail, Johanne/AAB-1980-2021; Beschin, Alain/L-2154-2014	Dubail, Johanne/0000-0001-9124-9765; Beschin, Alain/0000-0001-8478-6941; RUGGIERO, Florence/0000-0003-2915-5359				Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; Bissonnette L, 2004, BIOCHEM J, V379, P757, DOI 10.1042/BJ20031902; Blelloch R, 1999, NATURE, V399, P586, DOI 10.1038/21196; BROEK DL, 1985, J BIOL CHEM, V260, P555; Cabral WA, 2003, J BIOL CHEM, V278, P10006, DOI 10.1074/jbc.M212523200; COLIGE A, 1995, J BIOL CHEM, V270, P16724, DOI 10.1074/jbc.270.28.16724; Colige A, 2004, J INVEST DERMATOL, V123, P656, DOI 10.1111/j.0022-202X.2004.23406.x; Colige A, 1997, P NATL ACAD SCI USA, V94, P2374, DOI 10.1073/pnas.94.6.2374; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Colige A, 2002, J BIOL CHEM, V277, P5756, DOI 10.1074/jbc.M105601200; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083; FICHARD A, 1995, MATRIX BIOL, V14, P515, DOI 10.1016/S0945-053X(05)80001-0; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Gopalakrishnan B, 2004, J BIOL CHEM, V279, P30904, DOI 10.1074/jbc.M402252200; GUO NH, 1992, P NATL ACAD SCI USA, V89, P3040, DOI 10.1073/pnas.89.7.3040; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kessler E, 2001, J BIOL CHEM, V276, P27051, DOI 10.1074/jbc.M102921200; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; Loechel F, 2001, FEBS LETT, V506, P65, DOI 10.1016/S0014-5793(01)02873-3; Longpre JM, 2004, J BIOL CHEM, V279, P33237, DOI 10.1074/jbc.M313151200; Majerus EM, 2003, J BIOL CHEM, V278, P46643, DOI 10.1074/jbc.M309872200; MORADIAMELI M, 1994, EUR J BIOCHEM, V221, P987, DOI 10.1111/j.1432-1033.1994.tb18815.x; NIYIBIZI C, 1993, BIOCHIM BIOPHYS ACTA, V1203, P304, DOI 10.1016/0167-4838(93)90099-D; NUSGENS BV, 1992, NAT GENET, V1, P214, DOI 10.1038/ng0692-214; Rodriguez-Manzaneque JC, 2000, J BIOL CHEM, V275, P33471, DOI 10.1074/jbc.M002599200; RUGGIERO F, 1994, EXP CELL RES, V210, P215, DOI 10.1006/excr.1994.1032; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Tortorella MD, 2004, J BIOL CHEM, V279, P17554, DOI 10.1074/jbc.M313041200; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Wang WM, 2003, J BIOL CHEM, V278, P19549, DOI 10.1074/jbc.M300767200; Zheng XL, 2003, J BIOL CHEM, V278, P30136, DOI 10.1074/jbc.M305331200	36	83	86	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34397	34408		10.1074/jbc.M506458200	http://dx.doi.org/10.1074/jbc.M506458200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16046392	hybrid, Green Submitted			2022-12-27	WOS:000232403900005
J	Knight, PJ; Thirumurugan, K; Xu, YH; Wang, F; Kalverda, AP; Stafford, WF; Sellers, JR; Peckham, M				Knight, PJ; Thirumurugan, K; Xu, YH; Wang, F; Kalverda, AP; Stafford, WF; Sellers, JR; Peckham, M			The predicted coiled-coil domain of myosin 10 forms a novel elongated domain that lengthens the head	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; LARGE STEP-SIZE; UNCONVENTIONAL MYOSINS; ION-PAIRS; STABILITY; HELIX; VI; PROCESSIVITY; COEFFICIENTS; SEQUENCES	Myosin 10 contains a region of predicted coiled coil 120 residues long. However, the highly charged nature and pattern of charges in the proximal 36 residues appear incompatible with coiled-coil formation. Circular dichroism, NMR, and analytical ultracentrifugation show that a synthesized peptide containing this region forms a stable single alpha-helix (SAH) domain in solution and does not dimerize to form a coiled coil even at millimolar concentrations. Additionally, electron microscopy of a recombinant myosin 10 containing the motor, the three calmodulin binding domains, and the full-length predicted coiled coil showed that it was mostly monomeric at physiological protein concentration. In dimers the molecules were joined only at their extreme distal ends, and no coiled-coil tail was visible. Furthermore, the neck lengths of both monomers and dimers were much longer than expected from the number of calmodulin binding domains. In contrast, micrographs of myosin 5 heavy meromyosin obtained under the same conditions clearly showed a coiled-coil tail, and the necks were the predicted length. Thus the predicted coiled coil of myosin 10 forms a novel elongated structure in which the proximal region is a SAH domain and the distal region is a SAH domain ( or has an unknown extended structure) that dimerizes only at its end. Sequence comparisons show that similar structures may exist in the predicted coiled-coil domains of myosins 6 and 7a and MyoM and could function to increase the size of the working stroke.	Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Sch Biochem & Microbiol, Leeds LS2 9JT, W Yorkshire, England; Boston Biomed Res Inst, Analyt Ultracentrifugat Res Lab, Boston, MA 02472 USA; NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA	University of Leeds; University of Leeds; University of Leeds; Boston Biomedical Research Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Peckham, M (corresponding author), Univ Leeds, Sch Biomed Sci, Worsley Bldg, Leeds LS2 9JT, W Yorkshire, England.	m.peckham@leeds.ac.uk	Peckham, Michelle/J-4991-2015; Thirumurugan, Kavitha/B-3282-2010; Stafford, Walter/ABC-6553-2020	Peckham, Michelle/0000-0002-3754-2028; Thirumurugan, Kavitha/0000-0002-4673-4099; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL004231, ZIAHL004231] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/C004906/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Berg JS, 2000, J CELL SCI, V113, P3439; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Burgess SA, 2004, J STRUCT BIOL, V147, P247, DOI 10.1016/j.jsb.2004.04.004; Burkhard P, 2002, J MOL BIOL, V318, P901, DOI 10.1016/S0022-2836(02)00114-6; ELLIOTT A, 1978, J MOL BIOL, V123, P505, DOI 10.1016/0022-2836(78)90204-8; Hodge T, 2000, J CELL SCI, V113, P3353; Houdusse A, 1996, STRUCTURE, V4, P1475, DOI 10.1016/S0969-2126(96)00154-2; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; Kuhlman B, 1997, J MOL BIOL, V270, P640, DOI 10.1006/jmbi.1997.1146; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; Litowski JR, 2001, J PEPT RES, V58, P477, DOI 10.1034/j.1399-3011.2001.10972.x; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; LYU PCC, 1992, J MOL BIOL, V223, P343, DOI 10.1016/0022-2836(92)90735-3; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; OFFER G, 1995, J MOL BIOL, V249, P967, DOI 10.1006/jmbi.1995.0352; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Turbedsky K, 2005, J MOL BIOL, V345, P351, DOI 10.1016/j.jmb.2004.10.049; Wang EZ, 1996, ARCH BIOCHEM BIOPHYS, V329, P156, DOI 10.1006/abbi.1996.0204; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P162	30	124	126	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34702	34708		10.1074/jbc.M504887200	http://dx.doi.org/10.1074/jbc.M504887200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16030012	hybrid			2022-12-27	WOS:000232403900040
J	Stieber, J; Stockl, G; Herrmann, S; Hassfurth, B; Hofmann, F				Stieber, J; Stockl, G; Herrmann, S; Hassfurth, B; Hofmann, F			Functional expression of the human HCN3 channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CATION CHANNEL; PACEMAKER CHANNELS; MODULATION; KINETICS; LINKER; DOMAIN; HEART	Hyperpolarization-activated, cyclic nucleotide-gated cation (HCN) channels underlie the inward pacemaker current, termed I-f/I-h, in a variety of tissues. Many details are known for the HCN subtypes 1, 2, and 4. We now successfully cloned the cDNA for HCN3 from human brain and compared the electrophysiological properties of hHCN3 to the other three HCN subtypes. Overexpression of human HCN3 channels in HEK293 cells resulted in a functional channel protein. Similar to hHCN2 channels, hHCN3 channels are activated with a rather slow time constant of 1244 +/- 526 ms at - 100 mV, which is a greater time constant than that of HCN1 but a smaller one than that of HCN4 channels. The membrane potential for half-maximal activation V-1/2 was - 77 +/- 5.4 mV, and the reversal potential E-rev was - 20.5 +/- 4 mV, resulting in a permeability ratio P-Na/ P-K of 0.3. Like all other HCNs, hHCN3 was inhibited rapidly and reversibly by extracellular cesium and slowly and irreversibly by extracellular applied ZD7288. Surprisingly, the human HCN3 channel was not modulated by intracellular cAMP, a hallmark of the other known HCN channels. Sequence comparison revealed > 80% homology of the transmembrane segments, the pore region, and the cyclic nucleotide binding domain of hHCN3 with the other HCN channels. The missing response to cAMP distinguishes human HCN3 from both the well cAMP responding HCN subtypes 2 and 4 and the weak responding subtype 1.	Tech Univ Munich, Inst Pharmakol & Toxikol, D-80802 Munich, Germany	Technical University of Munich	Stieber, J (corresponding author), Tech Univ Munich, Inst Pharmakol & Toxikol, Biedersteiner Str 29, D-80802 Munich, Germany.	stieber@ipt.med.tu-muenchen.de						Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; BOSMITH R, 1993, BRIT J PHARMACOL, V353, P64; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Ludwig A, 1999, CELL PHYSIOL BIOCHEM, V9, P179, DOI 10.1159/000016315; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Macri V, 2004, J BIOL CHEM, V279, P16832, DOI 10.1074/jbc.M400518200; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Moroni A, 2001, J BIOL CHEM, V276, P29233, DOI 10.1074/jbc.M100830200; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Qu JH, 2002, PFLUG ARCH EUR J PHY, V444, P597, DOI 10.1007/s00424-002-0860-7; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Shi WM, 1999, CIRC RES, V85, pE1; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Stieber J, 2003, J BIOL CHEM, V278, P33672, DOI 10.1074/jbc.M305318200; Tran N, 2002, J BIOL CHEM, V277, P43588, DOI 10.1074/jbc.M208477200; Tsang SY, 2004, J BIOL CHEM, V279, P43752, DOI 10.1074/jbc.M408747200; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zong XG, 2001, J BIOL CHEM, V276, P6313, DOI 10.1074/jbc.M010326200	28	109	114	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34635	34643		10.1074/jbc.M502508200	http://dx.doi.org/10.1074/jbc.M502508200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16043489	hybrid			2022-12-27	WOS:000232403900032
J	Yang, TX; Zhang, AH; Honeggar, M; Kohan, DE; Mizel, D; Sanders, K; Hoidal, JR; Briggs, JP; Schnermann, JB				Yang, TX; Zhang, AH; Honeggar, M; Kohan, DE; Mizel, D; Sanders, K; Hoidal, JR; Briggs, JP; Schnermann, JB			Hypertonic induction of COX-2 in collecting duct cells by reactive oxygen species of mitochondrial origin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSMOTIC RESPONSE ELEMENT; CYCLOOXYGENASE-2 EXPRESSION; NADPH OXIDASE; TYROSINE PHOSPHORYLATION; PROSTAGLANDIN SYNTHESIS; P38 KINASE; IN-VIVO; STRESS; KIDNEY; RAT	Our previous studies have documented MAPK mediation of the hypertonicity-induced stimulation of COX-2 expression in cultured renal medullary epithelial cells (Yang, T., Huang, Y., Heasley, L. E., Berl, T., Schnermann, J. B., and Briggs, J. P. (2000) J. Biol. Chem. 275, 23281-23286). The present study extends this observation by examining the role of reactive oxygen species (ROSs). ROS levels, determined using dichlorodihydrofluorescence diacetate and cytochrome c, were rapidly and significantly increased following exposure of mIMCD-K2 cells to media made hypertonic by adding NaCl. Hypertonic treatment (550 mosmol/kg) for 16 h induced a 5.6-fold increase in COX-2 protein levels and comparable increases in prostaglandin E-2 release, both of which were completely abolished by the NADPH oxidase inhibitor diphenyleneiodonium (25-50 mu M). The general antioxidant N-acetyl-L-cysteine (6 mM), and the superoxide dismutase mimetic TEMPO (2.0 mM) reduced COX-2 levels by 75.6 and 79.8%, respectively. Exposure of mIMCD-K2 cells to exogenous O-2(-center dot) generated by the xanthine/xanthine oxidase system mimicked the effect of hypertonicity on COX-2 expression and prostaglandin E2 release. The increases in phosphorylation of ERK1/2 and p38 were detected 20 min following the hypertonic treatment and were both prevented by N-acetyl-L-cysteine. The increases in ROSs in response to hypertonic treatment were completely blocked by any one of the mitochondrial inhibitors tested, such as rotenone, thenoyltrifluoroacetone, or carbonyl cyanide m-chlorophenylhydrazone, associated with remarkable inhibition of COX-2 expression. In contrast, the increases in ROSs were not significantly altered in IMCD cells deficient in either gp91(phox) or p47(phox), nor were the increases in COX-2 expression. We conclude that ROSs derived from mitochondria, but not NADPH oxidase, mediate the hypertonicity-induced phosphorylation of MAPK and the stimulation of COX-2 expression.	Univ Utah, Res Serv 151 E, Dept Internal Med, Salt Lake City, UT 84148 USA; Vet Affairs Med Ctr, Res Serv 151 E, Salt Lake City, UT 84148 USA; NIDDK, NIH, Bethesda, MD 20892 USA	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Yang, TX (corresponding author), Univ Utah, Res Serv 151 E, Dept Internal Med, Bldg 2,500 Foothill Dr, Salt Lake City, UT 84148 USA.	tianxin.yang@hsc.utah.edu	Briggs, Josephine P/B-9394-2009	Briggs, Josephine P/0000-0003-0798-1190	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK043408, R01DK066592, R21DK069490, K01DK064981] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL079453] Funding Source: Medline; NIDDK NIH HHS [R21 DK069490, K01 DK064981, R01 DK066592] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adegboyega PA, 2004, APPL IMMUNOHISTO M M, V12, P71; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Berl T, 1997, AM J PHYSIOL-RENAL, V272, pF305, DOI 10.1152/ajprenal.1997.272.3.F305; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; BURG MB, 1995, AM J PHYSIOL-RENAL, V268, pF983, DOI 10.1152/ajprenal.1995.268.6.F983; Campean V, 2003, AM J PHYSIOL-RENAL, V285, pF19, DOI 10.1152/ajprenal.00443.2002; Denkert C, 1998, ARCH BIOCHEM BIOPHYS, V354, P172, DOI 10.1006/abbi.1998.0661; Ferguson S, 1999, J AM SOC NEPHROL, V10, P2261; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Handler JS, 2001, KIDNEY INT, V60, P408, DOI 10.1046/j.1523-1755.2001.060002408.x; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Kapus A, 1999, J BIOL CHEM, V274, P8093, DOI 10.1074/jbc.274.12.8093; KING CR, 1989, ONCOGENE, V4, P13; Kitiyakara C, 2003, J AM SOC NEPHROL, V14, P2775, DOI 10.1097/01.ASN.0000092145.90389.65; Ko BCB, 2002, J BIOL CHEM, V277, P46085, DOI 10.1074/jbc.M208138200; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Kultz D, 1997, J BIOL CHEM, V272, P13165, DOI 10.1074/jbc.272.20.13165; Lunn JA, 2004, J BIOL CHEM, V279, P45266, DOI 10.1074/jbc.M314132200; Moeckel GW, 2003, J BIOL CHEM, V278, P19352, DOI 10.1074/jbc.M302209200; Nadkarni V, 1999, J BIOL CHEM, V274, P20185, DOI 10.1074/jbc.274.29.20185; Neuhofer W, 2004, KIDNEY INT, V65, P431, DOI 10.1111/j.1523-1755.2004.00387.x; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; RUIS H, 1995, BIOESSAYS, V17, P959, DOI 10.1002/bies.950171109; Schumacher K, 2002, CELL PHYSIOL BIOCHEM, V12, P63, DOI 10.1159/000063782; Sheikh-Hamad D, 1998, J BIOL CHEM, V273, P1832, DOI 10.1074/jbc.273.3.1832; SIMMONS DL, 1989, P NATL ACAD SCI USA, V86, P1178, DOI 10.1073/pnas.86.4.1178; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Teufelhofer O, 2003, TOXICOL SCI, V76, P376, DOI 10.1093/toxsci/kfg234; Wojtaszek PA, 1998, J BIOL CHEM, V273, P800, DOI 10.1074/jbc.273.2.800; WU JM, 1993, SCI CHINA SER B, V36, P948; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; Yang TX, 2000, J BIOL CHEM, V275, P23281, DOI 10.1074/jbc.M910237199; Yang TX, 1999, AM J PHYSIOL-RENAL, V277, pF1, DOI 10.1152/ajprenal.1999.277.1.F1; YANG TX, 1993, AM J PHYSIOL, V264, pF684, DOI 10.1152/ajprenal.1993.264.4.F684; Yang TX, 1998, AM J PHYSIOL-RENAL, V274, pF481, DOI 10.1152/ajprenal.1998.274.3.F481; ZHANG F, 1995, BIOCHEM J, V312, P135, DOI 10.1042/bj3120135; Zhang Z, 2004, P NATL ACAD SCI USA, V101, P9491, DOI 10.1073/pnas.0402961101; Zhao HY, 2003, AM J PHYSIOL-RENAL, V285, pF281, DOI 10.1152/ajprenal.00030.2003	42	63	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34966	34973		10.1074/jbc.M502430200	http://dx.doi.org/10.1074/jbc.M502430200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16024921	hybrid			2022-12-27	WOS:000232403900070
J	Han, SW; Ritzenthaler, JD; Wingerd, B; Roman, J				Han, SW; Ritzenthaler, JD; Wingerd, B; Roman, J			Activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) increases the expression of prostaglandin E-2 receptor subtype EP4 - The roles of phosphatidylinositol 3-kinase and CCAAT/enhancer-binding protein beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA CELL-GROWTH; C/EBP-BETA; GENE-EXPRESSION; EP4 RECEPTOR; UP-REGULATION; LUNG-CANCER; TRANSCRIPTIONAL CONTROL; PROSTANOID RECEPTORS; MEDIATED ACTIVATION; COLORECTAL-CANCER	The prostaglandin E-2 receptor subtype EP4 has been implicated in the growth and progression of human non-small cell lung carcinoma (NSCLC). However, the factors that control its expression have not been entirely elucidated. Our studies show that NSCLC cells express peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) protein and that treatment with a selective PPAR beta/delta agonist (GW501516) increases EP4 mRNA and protein levels. GW501516 induced NSCLC cell proliferation, and this effect was prevented by PPAR beta/delta antisense or EP4 short interfering RNA ( siRNA). GW501516 increased the phosphorylation of Akt and decreased PTEN expression. The selective inhibitor of phosphatidylinositol 3-kinase (PI3-K), wortmannin, and PPAR beta/delta antisense, abrogated the effect of GW501516 on EP4 expression, whereas that of the inhibitor of Erk did not. GW501516 also increased EP4 promoter activity through effects on the region between - 1555 and - 992 bp in the EP4 promoter, and mutation of the CCAAT/enhancer-binding protein (C/EBP) site in this region abrogated the effect of GW501516. GW501516 increased not only the binding activity of C/EBP to the NF-IL6 site in the EP4 promoter, which was prevented by the inhibitor of PI3-K, but also increased C/EBP beta protein in a dose- and PPAR beta/ delta-dependent manner. The effect of GW501516 on EP4 protein was eliminated in the presence of C/EBP beta siRNA. Finally, we showed that pretreatment of NSCLC with GW501516 further increased NSCLC cell proliferation in response to exogenous dimethylprostaglandin E-2 (PGE(2)) that was diminished in the presence of PPAR beta/delta antisense and EP4 siRNA. Taken together, these findings suggest that activation of PPAR beta/delta induces PGE(2) receptor subtype EP4 expression through PI3-K signals and increases human lung carcinoma cell proliferation in response to PGE(2). The increase in transcription of the EP4 gene by PPAR beta/delta agonist was associated with increased C/EBP binding activity in the NF-IL6 site of EP4 promoter region and C/EBP beta protein expression that were mediated through both PI3-K/Akt and PPAR beta/delta signaling pathways.	Emory Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; Vet Affairs Med Ctr, Atlanta, GA 30033 USA	Emory University; Michigan State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Han, SW (corresponding author), Emory Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Whitehead Biores Bldg,615 Michael St,Suite 205-M, Atlanta, GA 30322 USA.	shan2@emory.edu						Arakawa T, 1996, J BIOL CHEM, V271, P29569, DOI 10.1074/jbc.271.47.29569; Asano T, 2002, CLIN CANCER RES, V8, P1157; Bepler G, 2004, J CLIN ONCOL, V22, P1878, DOI 10.1200/JCO.2004.12.002; Chien EK, 2003, AM J OBSTET GYNECOL, V189, P1501, DOI 10.1067/S0002-9378(03)00764-6; Chu KM, 2004, CELL SIGNAL, V16, P477, DOI 10.1016/j.cellsig.2003.09.004; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Dohadwala M, 2002, J BIOL CHEM, V277, P50828, DOI 10.1074/jbc.M210707200; Foord SM, 1996, GENOMICS, V35, P182, DOI 10.1006/geno.1996.0337; Glinghammar B, 2003, BIOCHEM BIOPH RES CO, V308, P361, DOI 10.1016/S0006-291X(03)01384-6; Grimm SL, 2003, J MAMMARY GLAND BIOL, V8, P191, DOI 10.1023/A:1025900908026; Guo SD, 2001, J BIOL CHEM, V276, P8516, DOI 10.1074/jbc.M008542200; Gupta RA, 2000, P NATL ACAD SCI USA, V97, P13275, DOI 10.1073/pnas.97.24.13275; Gupta RA, 2004, NAT MED, V10, P245, DOI 10.1038/nm993; Han SW, 2004, INT J CANCER, V111, P322, DOI 10.1002/ijc.20281; Han SW, 2004, CLIN CANCER RES, V10, P1911, DOI 10.1158/1078-0432.CCR-03-0985; Han SW, 2004, BIOCHEM BIOPH RES CO, V314, P1093, DOI 10.1016/j.bbrc.2004.01.007; Hu B, 2004, J IMMUNOL, V173, P4661, DOI 10.4049/jimmunol.173.7.4661; Hull MA, 2004, MOL CANCER THER, V3, P1031; Keshamouni VG, 2004, ONCOGENE, V23, P100, DOI 10.1038/sj.onc.1206885; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; LANCHON P, 1995, MOL CELL ENDOCRINOL, V111, P219; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Miyashita T, 2003, BIOCHEM BIOPH RES CO, V312, P397, DOI 10.1016/j.bbrc.2003.10.141; Mutoh M, 2002, CANCER RES, V62, P28; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; PASS HI, 2000, LUNG CANC ETIOLOGY E, P367; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Piwien-Pilipuk G, 2001, J BIOL CHEM, V276, P19664, DOI 10.1074/jbc.M010193200; Pozzi A, 2004, J BIOL CHEM, V279, P29797, DOI 10.1074/jbc.M313989200; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Shao JY, 2002, CANCER RES, V62, P3282; Smith SA, 2004, J NEUROSCI RES, V77, P240, DOI 10.1002/jnr.20153; Southall MD, 2001, J BIOL CHEM, V276, P16083, DOI 10.1074/jbc.M011408200; Stabile Laura P, 2003, J Gend Specif Med, V6, P37; Suenaga A, 2004, VASC PHARMACOL, V41, P51, DOI 10.1016/j.vph.2004.03.006; Timoshenko AV, 2003, EXP CELL RES, V289, P265, DOI 10.1016/S0014-4827(03)00269-6; Tsuboi H, 2004, BIOCHEM BIOPH RES CO, V322, P1066, DOI 10.1016/j.bbrc.2004.08.018; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Wessells J, 2004, MOL CELL BIOL, V24, P3238, DOI 10.1128/MCB.24.8.3238-3250.2004; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	44	55	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33240	33249		10.1074/jbc.M507617200	http://dx.doi.org/10.1074/jbc.M507617200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16061473	hybrid			2022-12-27	WOS:000232058100019
J	Placido, A; Gagliardi, D; Gallerani, R; Grienenberger, JM; Marechal-Drouard, L				Placido, A; Gagliardi, D; Gallerani, R; Grienenberger, JM; Marechal-Drouard, L			Fate of a larch unedited tRNA precursor expressed in potato mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT-MITOCHONDRIA; MESSENGER-RNA; RIBOSOMAL-RNA; POLYADENYLATION; GENES; DEGRADATION; PREREQUISITE; RECOGNITION; ELEMENTS; IMPORT	In higher plant mitochondria, post-transcriptional C to U conversion known as editing mostly affects mRNAs. However, three tRNAs were also shown to be edited. Among them, three editing sites were identified in larch mitochondrial tRNAHis. We have previously shown that only the edited version can undergo maturation in vitro. In this paper, we introduced via direct DNA uptake the edited or unedited version of larch mitochondrial trnH into isolated potato mitochondria and expressed them under the control of potato mitochondrial 18 S rRNA promoter. As expected, the edited form of larch mitochondrial tRNAHis precursor was processed in the isolated organelles. By contrast, no mature tRNAHis was detected when using the unedited version of trnH. However, precursor molecules could be characterized by reverse transcription-PCR. These data demonstrate that the potato mitochondrial editing machinery is not able to recognize these "foreign" editing sites and confirm that these unedited tRNA precursor molecules are not correctly processed in organello. As a consequence, the fate of these RNA precursor molecules is likely to be degradation. Indeed, we detected by PCR two 3'-end truncated precursor RNAs. Interestingly, both RNA species exhibit poly( A) tails, a hallmark of degradation in plant mitochondria. Taken together, these data suggest that, in plant mitochondria, a defective unedited RNA precursor that cannot be processed to give a mature stable tRNA, is degraded through a polyadenylation-dependent pathway.	CNRS, UPR 2357, Inst Biol Mol Plantes, F-67084 Strasbourg, France; Univ Bari, CNR, Dipartimento Biochim & Biol Mol, I-70126 Bari, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR); Universita degli Studi di Bari Aldo Moro	Marechal-Drouard, L (corresponding author), CNRS, UPR 2357, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	laurence.drouard@ibmp-ulp.u-strabg.fr	Gagliardi, Dominique/AAS-1783-2021; Drouard, Laurence/D-2385-2010; Gagliardi, Dominique/P-2834-2016	Gagliardi, Dominique/0000-0002-5871-7544; Drouard, Laurence/0000-0001-6537-524X; Gagliardi, Dominique/0000-0002-5871-7544				BURKARD U, 1988, J BIOL CHEM, V263, P9578; Choury D, 2004, NUCLEIC ACIDS RES, V32, P6397, DOI 10.1093/nar/gkh969; COOLEY L, 1982, P NATL ACAD SCI-BIOL, V79, P6475, DOI 10.1073/pnas.79.21.6475; Farre JC, 2002, PLANT J, V29, P203, DOI 10.1046/j.1365-313x.2002.01207.x; Farre JC, 2001, MOL CELL BIOL, V21, P6731, DOI 10.1128/MCB.21.20.6731-6737.2001; Farre JC, 2001, NUCLEIC ACIDS RES, V29, P2484, DOI 10.1093/nar/29.12.2484; Fey J, 1999, FEBS LETT, V458, P124, DOI 10.1016/S0014-5793(99)01140-0; Fey J, 2000, RNA, V6, P470, DOI 10.1017/S1355838200992380; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; Gagliardi D, 1999, EMBO J, V18, P3757, DOI 10.1093/emboj/18.13.3757; Gagliardi D, 2004, ADV PHOTO RESPIRAT, V17, P55; Gagliardi D, 2001, J BIOL CHEM, V276, P43541, DOI 10.1074/jbc.M106601200; Giese A, 1996, MOL GEN GENET, V252, P429, DOI 10.1007/BF02173008; HIMENO H, 1989, NUCLEIC ACIDS RES, V17, P7855, DOI 10.1093/nar/17.19.7855; Koulintchenko M, 2003, EMBO J, V22, P1245, DOI 10.1093/emboj/cdg128; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Kuhn J, 2001, MOL CELL BIOL, V21, P731, DOI 10.1128/MCB.21.3.731-742.2001; Kuhn K, 2005, NUCLEIC ACIDS RES, V33, P337, DOI 10.1093/nar/gki179; Kunzmann A, 1998, P NATL ACAD SCI USA, V95, P108, DOI 10.1073/pnas.95.1.108; Li ZW, 2002, EMBO J, V21, P1132, DOI 10.1093/emboj/21.5.1132; Li ZW, 1998, P NATL ACAD SCI USA, V95, P12158, DOI 10.1073/pnas.95.21.12158; Lupold DS, 1999, PLANT CELL, V11, P1565, DOI 10.1105/tpc.11.8.1565; Marchfelder A, 1996, J BIOL CHEM, V271, P1898, DOI 10.1074/jbc.271.4.1898; Marchfelder A, 1996, MOL BIOL REP, V22, P151, DOI 10.1007/BF00988721; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; MARECHAL L, 1986, PLANT MOL BIOL, V7, P245, DOI 10.1007/BF00752898; MarechalDrouard L, 1996, MOL CELL BIOL, V16, P3504; MarechalDrouard L, 1996, NUCLEIC ACIDS RES, V24, P3229, DOI 10.1093/nar/24.16.3229; Perrin R, 2004, NUCLEIC ACIDS RES, V32, P5174, DOI 10.1093/nar/gkh852; Perrin R, 2004, J BIOL CHEM, V279, P25440, DOI 10.1074/jbc.M401182200; SMALL I, 1992, EMBO J, V11, P1291, DOI 10.1002/j.1460-2075.1992.tb05172.x; Staudinger M, 2005, MOL GENET GENOMICS, V273, P130, DOI 10.1007/s00438-005-1117-x; SUTTON CA, 1995, MOL CELL BIOL, V15, P1377; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; WEBER F, 1990, NUCLEIC ACIDS RES, V18, P5027, DOI 10.1093/nar/18.17.5027	35	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33573	33579		10.1074/jbc.M505269200	http://dx.doi.org/10.1074/jbc.M505269200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16061472	hybrid			2022-12-27	WOS:000232058100058
J	Liu, YY; Kvaratskhelia, M; Hess, S; Qu, YX; Zou, Y				Liu, YY; Kvaratskhelia, M; Hess, S; Qu, YX; Zou, Y			Modulation of replication protein A function by its hyperphosphorylation-induced conformational change involving DNA binding domain B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; MASS-SPECTROMETRY; P34 SUBUNIT; INDUCED PHOSPHORYLATION; CHEMICAL-MODIFICATION; RPA PHOSPHORYLATION; IONIZING-RADIATION; SURFACE-TOPOLOGY; KINASE-ACTIVITY; HUMAN-CELLS	Human replication protein A (RPA), composed of RPA70, RPA32, and RPA14 subunits, undergoes hyperphosphorylation in cells in response to DNA damage. Hyperphosphorylation that occurs predominately in the N-terminal region of RPA32 is believed to play a role in modulating the cellular activities of RPA essential for almost all DNA metabolic pathways. To understand how the hyperphosphorylation modulates the functions of RPA, we compared the structural characteristics of full-length native and hyper-phosphorylated RPAs using mass spectrometric protein footprinting, fluorescence spectroscopy, and limited proteolysis. Our mass spectrometric data showed that of 24 lysines and 18 arginines readily susceptible to small chemical reagent modification in native RPA, the three residues Lys-343, Arg-335, and Arg-382, located in DNA binding domain B (DBD- B) of RPA70, were significantly shielded in the hyperphosphorylated protein. Tryptophan fluorescence studies indicated significant quenching of Trp-361, located in the DBD- B domain, induced by hyperphosphorylation of RPA. Consistently, DBD- B became more resistant to the limited proteolysis by chymotrypsin after RPA hyperphosphorylation. Taken together, our results indicate that upon hyperphosphorylation of RPA32 N terminus ( RPA32N), RPA undergoes a conformational change involving the single-stranded DNA binding cleft of DBD- B. Comparison of the interactions of native and hyperphosphorylated RPAs with short single-stranded oligonucleotides or partial DNA duplexes with a short 5 ' or 3 ' single-stranded DNA tails showed reduced affinity for the latter protein. We propose that the hyperphosphorylation may play a role in modulating the cellular pathways by altering the DBD-B-mediated RPA-DNA and RPA-protein interactions, hypothetically via the interaction of hyperphosphorylated RPA32N with DBD- B.	E Tennessee State Univ, James H Quillen Coll Med, Dept Biochem & Mol Biol, Johnson City, TN 37614 USA; Ohio State Univ, Hlth Sci Ctr, Coll Pharm, Ctr Retrovirus Res, Columbus, OH 43210 USA; Ctr Comprehens Canc, Columbus, OH 43210 USA; NIDDK, Prote & Mass Spectrometry Facil, NIH, Bethesda, MD 20892 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	East Tennessee State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Georgia; University of Georgia	Zou, Y (corresponding author), E Tennessee State Univ, James H Quillen Coll Med, Dept Biochem & Mol Biol, Johnson City, TN 37614 USA.	zouy@etsu.edu	Hess, Sonja/K-4842-2013; Zou, Yue/ABA-8429-2020	Hess, Sonja/0000-0002-5904-9816; 	NCI NIH HHS [R01 CA086927, R56 CA086927, CA86927] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R56CA086927, R01CA086927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK070004] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abramova NA, 1997, P NATL ACAD SCI USA, V94, P7186, DOI 10.1073/pnas.94.14.7186; Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; Barr SM, 2003, CURR BIOL, V13, P1047, DOI 10.1016/S0960-9822(03)00376-2; Bennett KL, 2000, METH MOL B, V146, P113, DOI 10.1385/1-59259-045-4:113; Binz SK, 2003, J BIOL CHEM, V278, P35584, DOI 10.1074/jbc.M305388200; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993; Block WD, 2004, NUCLEIC ACIDS RES, V32, P997, DOI 10.1093/nar/gkh265; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkarev A, 1999, EMBO J, V18, P4498, DOI 10.1093/emboj/18.16.4498; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Bochkareva E, 1998, J BIOL CHEM, V273, P3932, DOI 10.1074/jbc.273.7.3932; Bochkareva E, 2000, J BIOL CHEM, V275, P27332; BOUBNOV NV, 1995, MOL CELL BIOL, V15, P5700; Brill SJ, 1998, MOL CELL BIOL, V18, P7225, DOI 10.1128/MCB.18.12.7225; BRUSH GS, 1994, P NATL ACAD SCI USA, V91, P12520, DOI 10.1073/pnas.91.26.12520; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; Dart DA, 2004, J BIOL CHEM, V279, P16433, DOI 10.1074/jbc.M314212200; DUTTA A, 1992, EMBO J, V11, P2189, DOI 10.1002/j.1460-2075.1992.tb05278.x; Fried LM, 1996, P NATL ACAD SCI USA, V93, P13825, DOI 10.1073/pnas.93.24.13825; Gately DP, 1998, MOL BIOL CELL, V9, P2361, DOI 10.1091/mbc.9.9.2361; Gomes XV, 1996, BIOCHEMISTRY-US, V35, P5586, DOI 10.1021/bi9526995; Henricksen LA, 1996, NUCLEIC ACIDS RES, V24, P3107, DOI 10.1093/nar/24.15.3107; HEYDUK E, 1994, BIOCHEMISTRY-US, V33, P9643, DOI 10.1021/bi00198a033; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jackson D, 2002, J MOL BIOL, V321, P133, DOI 10.1016/S0022-2836(02)00541-7; Jacobs DM, 1999, J BIOMOL NMR, V14, P321, DOI 10.1023/A:1008373009786; Kerr ID, 2003, EMBO J, V22, P2561, DOI 10.1093/emboj/cdg272; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; Kvaratskhelia M, 2002, P NATL ACAD SCI USA, V99, P15988, DOI 10.1073/pnas.252550199; Lao Y, 2000, BIOCHEMISTRY-US, V39, P850, DOI 10.1021/bi991704s; Lavrik OI, 1999, NUCLEIC ACIDS RES, V27, P4235, DOI 10.1093/nar/27.21.4235; LEE SH, 1995, J BIOL CHEM, V270, P12801, DOI 10.1074/jbc.270.21.12801; Leite JF, 2002, BIOCHEMISTRY-US, V41, P6140, DOI 10.1021/bi015895m; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; Liu YY, 2005, BIOCHEM J, V385, P519, DOI 10.1042/BJ20041151; Mass G, 2001, NUCLEIC ACIDS RES, V29, P3892, DOI 10.1093/nar/29.18.3892; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Niu HW, 1997, J BIOL CHEM, V272, P12634, DOI 10.1074/jbc.272.19.12634; Nuss JE, 2005, BIOCHEMISTRY-US, V44, P8428, DOI 10.1021/bi0480584; Oakley GG, 2003, BIOCHEMISTRY-US, V42, P3255, DOI 10.1021/bi026377u; Oakley GG, 2001, MOL BIOL CELL, V12, P1199, DOI 10.1091/mbc.12.5.1199; PAN ZQ, 1994, P NATL ACAD SCI USA, V91, P8343, DOI 10.1073/pnas.91.18.8343; Park JS, 1999, J BIOL CHEM, V274, P32520, DOI 10.1074/jbc.274.45.32520; Patrick SM, 2005, BIOCHEMISTRY-US, V44, P8438, DOI 10.1021/bi048057b; Pestryakov PE, 2004, NUCLEIC ACIDS RES, V32, P1894, DOI 10.1093/nar/gkh346; Pestryakov PE, 2003, J BIOL CHEM, V278, P17515, DOI 10.1074/jbc.M301265200; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Shell SM, 2005, BIOCHEMISTRY-US, V44, P971, DOI 10.1021/bi048208a; SHIVJI MKK, 1995, BIOCHEMISTRY-US, V34, P5011, DOI 10.1021/bi00015a012; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; SUCKAU D, 1992, P NATL ACAD SCI USA, V89, P5630, DOI 10.1073/pnas.89.12.5630; Treuner K, 1999, NUCLEIC ACIDS RES, V27, P1499, DOI 10.1093/nar/27.6.1499; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; YAMASAKI RB, 1980, ANAL BIOCHEM, V109, P32, DOI 10.1016/0003-2697(80)90006-8; Yang ZG, 2002, BIOCHEMISTRY-US, V41, P13012, DOI 10.1021/bi026064z; Zappacosta F, 1996, PROTEIN SCI, V5, P802, DOI 10.1002/pro.5560050502; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896; Zou Y, 1998, J MOL BIOL, V281, P107, DOI 10.1006/jmbi.1998.1903	64	48	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32775	32783		10.1074/jbc.M505705200	http://dx.doi.org/10.1074/jbc.M505705200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16006651	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000231920300029
J	Oltean, S; Banerjee, R				Oltean, S; Banerjee, R			A B-12-responsive internal ribosome entry site (IRES) element in human methionine synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERCUTANEOUS CORONARY INTERVENTION; HOMOCYSTEINE-LOWERING THERAPY; CONTROLS GENE-EXPRESSION; MESSENGER-RNA STRUCTURE; X-LINKED INHIBITOR; MEDIATED TRANSLATION; PLASMA HOMOCYSTEINE; MYXOCOCCUS-XANTHUS; HEPATITIS-C; FOLIC-ACID	Regulation of homocysteine, a sulfur- containing amino acid that is a risk factor for cardiovascular diseases, is poorly understood. Methionine synthase ( MS) is a key enzyme that clears intracellular homocysteine, and its activity is induced by its cofactor, vitamin B-12, at a translational level. In this study, we demonstrate that translation of MS, which has a long and highly structured 5'- untranslated region, is initiated from an internal ribosome entry site ( IRES), which is modulated by B-12. The minimal IRES element spans 71 bases immediately upstream of the initiation codon. Electrophoretic mobility shift analysis reveals the presence of a B-12- dependent protein- RNA complex and suggests the possibility that B-12- dependent increase of IRES efficiency is mediated via a protein. Modulation of the IRES- dependent translation of an essential gene by the cofactor of the encoded enzyme represents a novel example of a gene- nutrient interaction.	Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Banerjee, R (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	rbanerjee1@unl.edu		Oltean, Sebastian/0000-0001-7890-8439	NIDDK NIH HHS [DK64959] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064959] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Cervantes M, 2002, J BACTERIOL, V184, P2215, DOI 10.1128/JB.184.8.2215-2224.2002; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; HELLEN CUT, 1993, P NATL ACAD SCI USA, V90, P7642, DOI 10.1073/pnas.90.16.7642; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; HERSHEY J, 2000, INITIATION PROTEIN S, P33; Holcik M, 2003, MOL CELL BIOL, V23, P280, DOI 10.1128/MCB.23.1.280-288.2003; Holcik M, 2000, ONCOGENE, V19, P4174, DOI 10.1038/sj.onc.1203765; Holcik M, 2000, MOL CELL BIOL, V20, P4648, DOI 10.1128/MCB.20.13.4648-4657.2000; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; KOLHOUSE JF, 1977, P NATL ACAD SCI USA, V74, P921, DOI 10.1073/pnas.74.3.921; KOZICH V, 1995, HUM MOL GENET, V4, P623, DOI 10.1093/hmg/4.4.623; Lopez-Rubio JJ, 2002, J BIOL CHEM, V277, P7262, DOI 10.1074/jbc.M110351200; Lott WB, 2001, P NATL ACAD SCI USA, V98, P4916, DOI 10.1073/pnas.081072798; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; MANGUM JH, 1969, BIOCHEMISTRY-US, V8, P3496, DOI 10.1021/bi00837a002; MELLMAN IS, 1977, P NATL ACAD SCI USA, V74, P916, DOI 10.1073/pnas.74.3.916; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Nevins TA, 2003, J BIOL CHEM, V278, P3572, DOI 10.1074/jbc.M206781200; Oltean S, 2003, J BIOL CHEM, V278, P20778, DOI 10.1074/jbc.M300845200; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; Paoloni-Giacobino A, 2003, CLIN NUTR, V22, P429, DOI 10.1016/S0261-5614(03)00064-5; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Schnyder G, 2003, AM J CARDIOL, V91, P1265, DOI 10.1016/S0002-9149(03)00281-9; Schnyder G, 2002, JAMA-J AM MED ASSOC, V288, P973, DOI 10.1001/jama.288.8.973; Schnyder G, 2001, NEW ENGL J MED, V345, P1593, DOI 10.1056/NEJMoa011364; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; Swanson DA, 2001, MOL CELL BIOL, V21, P1058, DOI 10.1128/MCB.21.4.1058-1065.2001; Takyar SS, 2002, J MOL BIOL, V319, P1, DOI 10.1016/S0022-2836(02)00300-5; Watkins D, 2002, AM J HUM GENET, V71, P143, DOI 10.1086/341354; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2003, CHEMBIOCHEM, V4, P1024, DOI 10.1002/cbic.200300685; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	35	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32662	32668		10.1074/jbc.M501964200	http://dx.doi.org/10.1074/jbc.M501964200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16051610	hybrid			2022-12-27	WOS:000231920300015
J	Thoden, JB; Holden, HM				Thoden, JB; Holden, HM			The molecular architecture of human N-acetylgalactosamine kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN MOTOR DOMAIN; HUMAN GALACTOKINASE; PHOSPHOMEVALONATE KINASE; SUBSTRATE-SPECIFICITY; MEVALONATE KINASE; CRYSTAL-STRUCTURE; II GALACTOSEMIA; MECHANISM; SUPERFAMILY; ACTIVATION	Galactokinase plays a key role in normal galactose metabolism by catalyzing the conversion of alpha-(D)-galactose to galactose 1-phosphate. Within recent years, the three-dimensional structures of human galactokinase and two bacterial forms of the enzyme have been determined. Originally, the gene encoding galactokinase in humans was mapped to chromosome 17. An additional gene, encoding a protein with sequence similarity to galactokinase, was subsequently mapped to chromosome 15. Recent reports have shown that this second gene (GALK2) encodes an enzyme with greater activity against GalNAc than galactose. This enzyme, GalNAc kinase, has been implicated in a salvage pathway for the reutilization of free GalNAc derived from the degradation of complex carbohydrates. Here we report the first structural analysis of a GalNAc kinase. The structure of the human enzyme was solved in the presence of MnAMPPNP and GalNAc or MgATP and GalNAc ( which resulted in bound products in the active site). The enzyme displays a distinctly bilobal appearance with its active site wedged between the two domains. The N- terminal region is dominated by a seven-stranded mixed beta-sheet, whereas the C-terminal motif contains two layers of anti-parallel beta-sheet. The overall topology displayed by GalNAc kinase places it into the GHMP superfamily of enzymes, which generally function as small molecule kinases. From this investigation, the geometry of the GalNAc kinase active site before and after catalysis has been revealed, and the determinants of substrate specificity have been defined on a molecular level.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Holden, HM (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	Hazel_Holden@biochem.wisc.edu			NIDDK NIH HHS [DK47814] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047814, R56DK047814] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADMIRAAL SJ, 1995, CHEM BIOL, V2, P729, DOI 10.1016/1074-5521(95)90101-9; ELSEVIER SM, 1974, NATURE, V251, P633, DOI 10.1038/251633a0; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Fu ZJ, 2002, J BIOL CHEM, V277, P18134, DOI 10.1074/jbc.M200912200; Hartley A, 2004, J MOL BIOL, V337, P387, DOI 10.1016/j.jmb.2004.01.043; Hoffmeister D, 2003, P NATL ACAD SCI USA, V100, P13184, DOI 10.1073/pnas.2235011100; Holden HM, 2004, CELL MOL LIFE SCI, V61, P2471, DOI 10.1007/s00018-004-4160-6; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Krishna SS, 2001, BIOCHEMISTRY-US, V40, P10810, DOI 10.1021/bi010851z; LEE RT, 1992, P NATL ACAD SCI USA, V89, P10887, DOI 10.1073/pnas.89.22.10887; NAKAMAYE KL, 1985, BIOCHEMISTRY-US, V24, P5226, DOI 10.1021/bi00340a041; NAVAZA J, 1987, ACTA CRYSTALLOGR A, V43, P645, DOI 10.1107/S0108767387098787; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pastuszak I, 1996, J BIOL CHEM, V271, P23653, DOI 10.1074/jbc.271.39.23653; Pastuszak I, 1996, J BIOL CHEM, V271, P20776, DOI 10.1074/jbc.271.34.20776; Pilloff D, 2003, J BIOL CHEM, V278, P4510, DOI 10.1074/jbc.M210551200; Platt A, 2000, P NATL ACAD SCI USA, V97, P3154, DOI 10.1073/pnas.97.7.3154; Platt A, 1998, EMBO J, V17, P4086, DOI 10.1093/emboj/17.14.4086; Reece RJ, 2000, CELL MOL LIFE SCI, V57, P1161, DOI 10.1007/PL00000756; Romanowski MJ, 2002, PROTEINS, V47, P568, DOI 10.1002/prot.10118; SCHWEINS T, 1994, NAT STRUCT BIOL, V1, P476, DOI 10.1038/nsb0794-476; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; STAMBOLIAN D, 1995, NAT GENET, V10, P307, DOI 10.1038/ng0795-307; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thoden JB, 2005, J BIOL CHEM, V280, P9662, DOI 10.1074/jbc.M412916200; Thoden JB, 2003, J BIOL CHEM, V278, P33305, DOI 10.1074/jbc.M304789200; Thorson JS, 2004, CHEMBIOCHEM, V5, P16, DOI 10.1002/cbic.200300620; THORSON JS, 2002, GLYCOSYLATED NATURAL; Timson David J, 2003, BMC Biochem, V4, P16, DOI 10.1186/1471-2091-4-16; Timson DJ, 2003, EUR J BIOCHEM, V270, P1767, DOI 10.1046/j.1432-1033.2003.03538.x; Timson DJ, 2002, BIOCHIMIE, V84, P265, DOI 10.1016/S0300-9084(02)01399-8; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Yang D, 2002, J BIOL CHEM, V277, P9462, DOI 10.1074/jbc.M110787200; Yang J, 2004, CHEMBIOCHEM, V5, P992, DOI 10.1002/cbic.200400041; Zenke FT, 1996, SCIENCE, V272, P1662, DOI 10.1126/science.272.5268.1662; Zhou T, 2000, STRUCTURE, V8, P1247, DOI 10.1016/S0969-2126(00)00533-5	39	64	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32784	32791		10.1074/jbc.M505730200	http://dx.doi.org/10.1074/jbc.M505730200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16006554	hybrid			2022-12-27	WOS:000231920300030
J	Zhu, JX; Goldoni, S; Bix, G; Owens, RT; McQuillan, DJ; Reed, CC; Iozzo, RV				Zhu, JX; Goldoni, S; Bix, G; Owens, RT; McQuillan, DJ; Reed, CC; Iozzo, RV			Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH PROTEOGLYCANS; CHICK-EMBRYO FIBROBLASTS; DOWN-REGULATION; EGF RECEPTOR; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; UP-REGULATION; CELL-GROWTH; SUPPRESSION; KINASE	Decorin inhibits the epidermal growth factor receptor ( EGFR) by down-regulating its tyrosine kinase activity, thereby blocking the growth of a variety of transformed cells and tumor xenografts. In this study we provide evidence that decorin directly binds to the EGFR causing its dimerization, internalization, and ultimately its degradation. Using various pharmacological agents to disrupt clathrin-dependent and -independent endocytosis, we demonstrate that decorin evokes a protracted internalization of the EGFR primarily via caveolar-mediated endocytosis. In contrast to EGF, decorin targets the EGFR to caveolae, but not to early or recycling endosomes. Ultimately, however, both EGF- and decorin-induced pathways converge into late endosomes/lysosomes for final degradation. Thus, we have discovered a novel biological mechanism for decorin that could explain its anti-proliferative and anti-oncogenic mode of action.	Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; LifeCell Corp, Branchburg, NJ 08876 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Cell Biol & Signaling Program, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Rm 249 Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.	iozzo@mail.jci.tju.edu	Iozzo, Renato/AAS-1980-2020	Iozzo, Renato/0000-0002-5908-5112	NCI NIH HHS [R01 CA39481, R01 CA47282] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047282, R01CA039481] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abulrob A, 2004, ONCOGENE, V23, P6967, DOI 10.1038/sj.onc.1207911; Bailly M, 2000, MOL BIOL CELL, V11, P3873, DOI 10.1091/mbc.11.11.3873; Biglari A, 2004, CANCER GENE THER, V11, P721, DOI 10.1038/sj.cgt.7700783; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Chen X, 2002, J BIOL CHEM, V277, P49631, DOI 10.1074/jbc.M208327200; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; FAN Z, 1995, J CELL BIOL, V131, P235, DOI 10.1083/jcb.131.1.235; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Gulli LF, 1996, CELL GROWTH DIFFER, V7, P173; Hausser H, 1998, ARCH BIOCHEM BIOPHYS, V349, P363, DOI 10.1006/abbi.1997.0471; HAUSSER H, 1991, J CELL BIOL, V114, P45, DOI 10.1083/jcb.114.1.45; Iozzo RV, 1999, PROG NUCLEIC ACID RE, V62, P19; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Kjer-Nielsen L, 1999, J CELL SCI, V112, P1645; Kolettas E, 1998, EUR J BIOCHEM, V254, P266, DOI 10.1046/j.1432-1327.1998.2540266.x; LAMAZE C, 1995, J CELL BIOL, V129, P47, DOI 10.1083/jcb.129.1.47; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Miyasaka Y, 2001, BRIT J CANCER, V85, P228, DOI 10.1054/bjoc.2001.1901; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Nash MA, 2002, CLIN CANCER RES, V8, P1754; Nash MA, 1999, CANCER RES, V59, P6192; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; NORTHWOOD IC, 1988, J BIOL CHEM, V263, P7450; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Perez S, 2001, ONCOGENE, V20, P1135, DOI 10.1038/sj.onc.1204200; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Ramamurthy P, 1996, J BIOL CHEM, V271, P19578, DOI 10.1074/jbc.271.32.19578; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Ringerike T, 2002, J CELL SCI, V115, P1331; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; Santiago-Garcia J, 2003, J BIOL CHEM, V278, P6942, DOI 10.1074/jbc.M208358200; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; SANTRA M, 1995, P NATL ACAD SCI USA, V92, P7016, DOI 10.1073/pnas.92.15.7016; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schmidt MHH, 2003, P NATL ACAD SCI USA, V100, P6505, DOI 10.1073/pnas.1031790100; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Schonherr E, 2001, J BIOL CHEM, V276, P40687, DOI 10.1074/jbc.M105426200; Shridhar V, 2001, CANCER RES, V61, P5895; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Tran KT, 2004, WOUND REPAIR REGEN, V12, P262, DOI 10.1111/j.1067-1927.2004.012302.x; Troup S, 2003, CLIN CANCER RES, V9, P207; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Vial E, 2000, ONCOGENE, V19, P1772, DOI 10.1038/sj.onc.1203493; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wang XQ, 2002, J BIOL CHEM, V277, P47028, DOI 10.1074/jbc.M208257200; Xaus J, 2001, BLOOD, V98, P2124, DOI 10.1182/blood.V98.7.2124; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0	70	159	163	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32468	32479		10.1074/jbc.M503833200	http://dx.doi.org/10.1074/jbc.M503833200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	15994311	hybrid			2022-12-27	WOS:000231794800054
J	Kim, JY; Saffen, D				Kim, JY; Saffen, D			Activation of M1 muscarinic acetylcholine receptors stimulates the formation of a multiprotein complex centered on TRPC6 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; TRANSIENT RECEPTOR; CALCIUM-RELEASE; CA2+ CHANNEL; PHEOCHROMOCYTOMA CELLS; SIGNALING COMPLEX; CRYSTAL-STRUCTURE; PROTEIN; CALCINEURIN; IMMUNOPHILIN	In this study we showed that stimulation of M1 muscarinic acetylcholine receptors (mAChRs) activates endogenous transient receptor potential-canonical, subtype 6 (TRPC6), channels in neuronal PC12D cells. Activation of TRPC6 channels is correlated with the formation of a multiprotein complex containing M1 mAChRs, TRPC6 channels, and protein kinase C (PKC). Formation of the M1 mAChR-TRPC6-PKC complex is transient, with highest levels reached similar to 2 min after stimulation of M1 mAChRs. PKC in the complex phosphorylates TRPC6 on a conserved serine residue in the carboxyl-terminal domain (Ser(768) in the TRPC6A isoform and Ser(714) in the TRPC6B isoform). The immunophilin FKBP12, the phosphatase calcineurin, and Ca2+-binding protein calmodulin are also recruited to the M1 mAChR-TRPC6-PKC complex following activation of M1 mAChRs and remain stably associated with the TRPC6 channels after M1 mAChRs and PKC have disassociated. Binding of FKBP12, calcineurin, and calmodulin to TRPC6 channels is blocked by the following: 1) inhibition of PKC; 2) mutation of the PKC phosphorylation site (Ser(7168/714)) in the channels; or 3) pretreatment with FK506 or rapamycin, immunosuppressants that directly bind FKBP12. Inhibition of FKBP12 binding blocks the dephosphorylation of TRPC6 channels and the disassociation of M1 mAChRs, without affecting disassociation of PKC. The calcineurin inhibitor cyclosporin A also blocks the dephosphorylation of TRPC6 and prevents the disassociation of M1 mAChRs. Together, these results show that activated TRPC6 channels form the center of a dynamic multiprotein complex that includes PKC and calcineurin, which respectively phosphorylate and dephosphorylate the channels. Phosphorylation of the TRPC6 channels by PKC is required for the binding of FKBP12, which in turn is required for the binding of calcineurin and calmodulin. Subsequent dephosphorylation of the channels by calcineurin is required for the disassociation of M1 mAChRs.	Ohio State Univ, Coll Med & Publ Hlth, Dept Pharmacol, Columbus, OH 43210 USA; Ohio State Univ, Coll Med & Publ Hlth, Dept Psychiat, Columbus, OH 43210 USA; Ohio State Univ, Coll Med & Publ Hlth, Grad Program Mol Cellular & Dev Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Saffen, D (corresponding author), Ohio State Univ, Coll Med & Publ Hlth, Dept Pharmacol, 5072C Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	saffen.1@osu.edu						ALDAPE RA, 1992, J BIOL CHEM, V267, P16029; Balzer M, 1999, CARDIOVASC RES, V42, P543, DOI 10.1016/S0008-6363(99)00025-5; Beech DJ, 2003, CELL CALCIUM, V33, P433, DOI 10.1016/S0143-4160(03)00054-X; Berridge MJ, 2001, NOVART FDN SYMP, V239, P52; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Bultynck G, 2003, BIOCHEM BIOPH RES CO, V311, P1181, DOI 10.1016/j.bbrc.2003.08.084; Cameron AM, 1997, J BIOL CHEM, V272, P27582, DOI 10.1074/jbc.272.44.27582; CAMERON AM, 1995, P NATL ACAD SCI USA, V92, P1784, DOI 10.1073/pnas.92.5.1784; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Groschner K, 1998, FEBS LETT, V437, P101, DOI 10.1016/S0014-5793(98)01212-5; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; Jin L, 2002, P NATL ACAD SCI USA, V99, P13522, DOI 10.1073/pnas.212504399; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; KATOHSEMBA R, 1987, J NEUROSCI RES, V17, P36, DOI 10.1002/jnr.490170106; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Liu XB, 2003, J BIOL CHEM, V278, P11337, DOI 10.1074/jbc.M213271200; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; Putney JW, 2004, TRENDS CELL BIOL, V14, P282, DOI 10.1016/j.tcb.2004.04.002; Putney JW, 2001, J CELL SCI, V114, P2223; Rosado JA, 2002, J BIOL CHEM, V277, P42157, DOI 10.1074/jbc.M207320200; Rosado JA, 2001, BIOCHEM J, V356, P191, DOI 10.1042/0264-6021:3560191; SCHILLING WP, 1989, J BIOL CHEM, V264, P12838; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; Singh BB, 2002, MOL CELL, V9, P739, DOI 10.1016/S1097-2765(02)00506-3; Sinkins WG, 2004, J BIOL CHEM, V279, P34521, DOI 10.1074/jbc.M401156200; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; YAMAGUCHI DT, 1989, J BIOL CHEM, V264, P197; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhang L, 2001, J BIOL CHEM, V276, P13331, DOI 10.1074/jbc.M008914200; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698	61	73	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					32035	32047		10.1074/jbc.M500429200	http://dx.doi.org/10.1074/jbc.M500429200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15994335	hybrid			2022-12-27	WOS:000231665200084
J	Koga, S; Yogo, K; Yoshikawa, K; Samori, H; Goto, M; Uchida, T; Ishida, N; Takeya, T				Koga, S; Yogo, K; Yoshikawa, K; Samori, H; Goto, M; Uchida, T; Ishida, N; Takeya, T			Physical and functional association of c-Src and adhesion and degranulation promoting adaptor protein (ADAP) in osteoclastogenesis in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FYN-BINDING PROTEIN; SIGNAL-TRANSDUCTION PATHWAYS; NECROSIS-FACTOR RECEPTOR; ALPHA(V)BETA(3) INTEGRIN; TYROSINE-PHOSPHATASE; KINASE-ACTIVITY; DEFICIENT MICE; CELL-ADHESION; DIFFERENTIATION; TCR	c-Src plays a crucial role in osteoclastogenesis. In this study, we searched for c-Src-binding proteins using a combination of pull-down assays and mass spectrometric analysis, and identified the association of adhesion and degranulation promoting adaptor protein ( ADAP) with c-Src in RAW264 cells and osteoclast precursors prepared from bone marrow cells. The kinase activity and the SH2 domain of c-Src were required for this association and Tyr(807) in the extreme carboxyl terminus of ADAP was identified as a major recognition site. ADAP was found to be expressed in cells at the pre-fusion stage and localized mainly in the leading edge of lamellipodia and in pseudopodia. Tyrosine phosphorylation of ADAP was induced in an integrin-dependent manner, and the level was Src kinase-dependent. ADAP-knockdown RAW264 cells showed retarded migration and formed few multinucleated cells. Cas, known to be phosphorylated by c-Src, was identified as a major tyrosine-phosphorylated protein in differentiating RAW264 cells and the phosphorylation appeared to be decreased in ADAP-knockdown cells. ADAP thus may play an important role as a partner of c-Src for cell migration and progression to the multinucleated cell stage in osteoclastogenesis in vitro.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Nara Institute of Science & Technology	Takeya, T (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan.	ttakeya@bs.naist.jp		Yogo, Keiichiro/0000-0003-2051-6891				Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Banin S, 1996, CURR BIOL, V6, P981, DOI 10.1016/S0960-9822(02)00642-5; Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Chambers TJ, 2000, J PATHOL, V192, P4; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; Deleuil F, 2003, CELL MICROBIOL, V5, P53, DOI 10.1046/j.1462-5822.2003.00236.x; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Galan JE, 1996, ANNU REV CELL DEV BI, V12, P221, DOI 10.1146/annurev.cellbio.12.1.221; Geng LP, 1999, J IMMUNOL, V163, P5753; Geng LP, 2001, P NATL ACAD SCI USA, V98, P11527, DOI 10.1073/pnas.191378198; Giuriato S, 2000, BIOCHEM J, V348, P107, DOI 10.1042/0264-6021:3480107; Griffiths EK, 2002, CURR OPIN IMMUNOL, V14, P317, DOI 10.1016/S0952-7915(02)00334-5; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Hamid N, 1999, MICROB PATHOGENESIS, V27, P231, DOI 10.1006/mpat.1999.0301; Heuer K, 2004, STRUCTURE, V12, P603, DOI 10.1016/j.str.2004.02.021; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; HORNE WC, 1992, J CELL BIOL, V119, P1003, DOI 10.1083/jcb.119.4.1003; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Kumagai N, 2004, BIOCHEM BIOPH RES CO, V325, P758, DOI 10.1016/j.bbrc.2004.10.094; Kuwana R, 2002, MICROBIOL-SGM, V148, P3971, DOI 10.1099/00221287-148-12-3971; LOWE C, 1993, P NATL ACAD SCI USA, V90, P4485, DOI 10.1073/pnas.90.10.4485; Meiyanto E, 2001, BIOCHEM BIOPH RES CO, V282, P278, DOI 10.1006/bbrc.2001.4564; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; Nakamura I, 1999, J CELL SCI, V112, P3985; Nakamura I, 1998, ENDOCRINOLOGY, V139, P5182, DOI 10.1210/en.139.12.5182; Peterson EJ, 2003, IMMUNOL REV, V192, P113, DOI 10.1034/j.1600-065X.2003.00026.x; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Raab M, 1999, J BIOL CHEM, V274, P21170, DOI 10.1074/jbc.274.30.21170; Rohrschneider LR, 2000, GENE DEV, V14, P505; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; ROSENSHINE I, 1993, BIOESSAYS, V15, P17, DOI 10.1002/bies.950150104; SAKAI N, 2004, PRECLINICA, V2, P57; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; TAKEYA T, 1983, CELL, V32, P881, DOI 10.1016/0092-8674(83)90073-9; Tanaka S, 2003, J BONE MINER METAB, V21, P123, DOI 10.1007/s007740300021; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Thomas M, 2002, P NATL ACAD SCI USA, V99, P14640, DOI 10.1073/pnas.192581499; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Troen BR, 2003, EXP GERONTOL, V38, P605, DOI 10.1016/S0531-5565(03)00069-X; Veale M, 1999, J BIOL CHEM, V274, P28427, DOI 10.1074/jbc.274.40.28427; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	55	11	13	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31564	31571		10.1074/jbc.M502703200	http://dx.doi.org/10.1074/jbc.M502703200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16020549	hybrid			2022-12-27	WOS:000231665200029
J	Andreeva, AV; Kutuzov, MA; Vaiskunaite, R; Profirovic, J; Meigs, TE; Predescu, S; Malik, AB; Voyno-Yasenetskaya, T				Andreeva, AV; Kutuzov, MA; Vaiskunaite, R; Profirovic, J; Meigs, TE; Predescu, S; Malik, AB; Voyno-Yasenetskaya, T			G alpha(12) interaction with alpha SNAP induces VE-cadherin localization endothelial junctions and regulates barrier function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEIN G(13); SIGNALING PATHWAYS; MAMMALIAN-CELLS; MEMBRANE-FUSION; P115 RHOGEF; SUBUNIT; RECEPTOR; TRANSFORMATION; ACTIVATION; EXPRESSION	The involvement of heterotrimeric G proteins in the regulation of adherens junction function is unclear. We identified alpha SNAP as an interactive partner of G alpha(12) using yeast two-hybrid screening. glutathione S-transferase pull-down assays showed the selective interaction of alpha SNAP with G alpha(12) in COS- 7 as well as in human umbilical vein endothelial cells. Using domain swapping experiments, we demonstrated that the N-terminal region of G alpha(12) ( 1-37 amino acids) was necessary and sufficient for its interaction with alpha SNAP. G alpha(13) with its N-terminal extension replaced by that of G alpha(12) acquired the ability to bind to alpha SNAP, whereas G alpha(12) with its N terminus replaced by that of G alpha(13) lost this ability. Using four point mutants of alpha SNAP, which alter its ability to bind to the SNARE complex, we determined that the convex rather than the concave surface of alpha SNAP was involved in its interaction with G alpha(12). Co-transfection of human umbilical vein endothelial cells with G alpha(12) and alpha SNAP stabilized VE-cadherin at the plasma membrane, whereas down-regulation of alpha SNAP with siRNA resulted in the loss of VE-cadherin from the cell surface and, when used in conjunction with G alpha 12 overexpression, decreased endothelial barrier function. Our results demonstrate a direct link between the alpha subunit of G(12) and alpha SNAP, an essential component of the membrane fusion machinery, and implicate a role for this interaction in regulating the membrane localization of VE-cadherin and endothelial barrier function.	Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; Univ N Carolina, Asheville, NC 28804 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina - Asheville	Voyno-Yasenetskaya, T (corresponding author), Univ Illinois, Dept Pharmacol, Coll Med, MC 868,835 S Wolcott Ave, Chicago, IL 60612 USA.	tvy@uic.edu	voyno-yasenetskaya, tatyana/A-3171-2008	Kutuzov, Mikhail/0000-0003-3386-4350; Predescu, Sanda/0000-0002-9386-6756; Malik, Asrar/0000-0002-8205-7128	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056159, R01GM065160, R55GM056159] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL06078] Funding Source: Medline; NIGMS NIH HHS [GM65160, GM56159] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmadian MR, 1997, FEBS LETT, V408, P315, DOI 10.1016/S0014-5793(97)00422-5; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Chae TH, 2004, NAT GENET, V36, P264, DOI 10.1038/ng1302; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Ellis CA, 1999, AM J PHYSIOL-CELL PH, V276, pC38, DOI 10.1152/ajpcell.1999.276.1.C38; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; JIANG HP, 1993, FEBS LETT, V330, P319, DOI 10.1016/0014-5793(93)80896-3; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Krakstad BF, 2004, P NATL ACAD SCI USA, V101, P10314, DOI 10.1073/pnas.0401366101; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; Meigs TE, 2002, J BIOL CHEM, V277, P24594, DOI 10.1074/jbc.M201984200; Meigs TE, 2001, P NATL ACAD SCI USA, V98, P519, DOI 10.1073/pnas.021350998; Meyer TN, 2003, AM J PHYSIOL-CELL PH, V285, pC1281, DOI 10.1152/ajpcell.00548.2002; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Nagao M, 1999, ONCOGENE, V18, P4425, DOI 10.1038/sj.onc.1202832; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Peifer M, 2003, J CELL BIOL, V163, P437, DOI 10.1083/jcb.200310090; Plonk SG, 1998, J BIOL CHEM, V273, P4823, DOI 10.1074/jbc.273.9.4823; Ponimaskin EG, 2002, J BIOL CHEM, V277, P20812, DOI 10.1074/jbc.M112216200; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; STRATHMANN MP, 1991, P NATL ACAD SCI USA, V88, P5582, DOI 10.1073/pnas.88.13.5582; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Vaiskunaite R, 2000, J BIOL CHEM, V275, P26206, DOI 10.1074/jbc.M001863200; Vaiskunaite R, 2001, FASEB J, V15, pA206; Vincent PA, 2004, AM J PHYSIOL-CELL PH, V286, pC987, DOI 10.1152/ajpcell.00522.2003; VOYNOYASENETSKAYA TA, 1994, ONCOGENE, V9, P2559; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; Yamaguchi Y, 2003, J BIOL CHEM, V278, P14936, DOI 10.1074/jbc.M301409200; Zhu DG, 2004, J BIOL CHEM, V279, P54983, DOI 10.1074/jbc.C400508200	46	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30376	30383		10.1074/jbc.M502844200	http://dx.doi.org/10.1074/jbc.M502844200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15980433	hybrid			2022-12-27	WOS:000231362500049
J	Lambert, DW; Yarski, M; Warner, FJ; Thornhill, P; Parkin, ET; Smith, AI; Hooper, NM; Turner, AJ				Lambert, DW; Yarski, M; Warner, FJ; Thornhill, P; Parkin, ET; Smith, AI; Hooper, NM; Turner, AJ			Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL RECEPTOR; PROTEOLYTIC RELEASE; ENZYME; CLEAVAGE; PROTEIN; EXPRESSION; DISINTEGRIN; IDENTIFICATION; JUXTAMEMBRANE; INHIBITORS	Angiotensin-converting enzyme-2 (ACE2) is a critical regulator of heart function and a cellular receptor for the causative agent of severe-acute respiratory syndrome (SARS), SARS- CoV (coronavirus). ACE2 is a type I transmembrane protein, with an extracellular N-terminal domain containing the active site and a short intracellular C-terminal tail. A soluble form of ACE2, lacking its cytosolic and transmembrane domains, has been shown to block binding of the SARS- CoV spike protein to its receptor. In this study, we examined the ability of ACE2 to undergo proteolytic shedding and investigated the mechanisms responsible for this shedding event. We demonstrated that ACE2, heterologously expressed in HEK293 cells and endogenously expressed in Huh7 cells, undergoes metalloproteinase-mediated, phorbol ester-inducible ectodomain shedding. By using inhibitors with differing potency toward different members of the ADAM (a disintegrin and metalloproteinase) family of proteases, we identified ADAM17 as a candidate mediator of stimulated ACE2 shedding. Furthermore, ablation of ADAM17 expression using specific small interfering RNA duplexes reduced regulated ACE2 shedding, whereas overexpression of ADAM17 significantly increased shedding. Taken together, these data provided direct evidence for the involvement of ADAM17 in the regulated ectodomain shedding of ACE2. The identification of ADAM17 as the protease responsible for ACE2 shedding may provide new insight into the physiological roles of ACE2.	Univ Leeds, Sch Biochem & Microbiol, Proteolysis Res Grp, Leeds LS2 9JT, W Yorkshire, England; Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia	University of Leeds; Monash University	Lambert, DW (corresponding author), Univ Leeds, Sch Biochem & Microbiol, Proteolysis Res Grp, Leeds LS2 9JT, W Yorkshire, England.	d.w.lambert@leeds.ac.uk		Smith, Ian/0000-0002-4143-2892; Parkin, Edward/0000-0003-3270-3184; Hooper, Nigel/0000-0002-5811-3484				Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 2002, FEBS LETT, V524, P154, DOI 10.1016/S0014-5793(02)03047-8; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; ARRIBAS J, 1995, J CELL BIOL, V128, P433, DOI 10.1083/jcb.128.3.433; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; BELDENT V, 1993, J BIOL CHEM, V268, P26428; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BOSENBERG MW, 1993, J CELL BIOL, V122, P95, DOI 10.1083/jcb.122.1.95; Brosnihan KB, 2003, HYPERTENSION, V42, P749, DOI 10.1161/01.HYP.0000085220.53285.11; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Donoghue M, 2003, J MOL CELL CARDIOL, V35, P1043, DOI 10.1016/S0022-2828(03)00177-9; Ehlers MRW, 1996, BIOCHEMISTRY-US, V35, P9549, DOI 10.1021/bi9602425; EHLERS MRW, 1989, BIOCHEMISTRY-US, V28, P5311, DOI 10.1021/bi00439a001; ERDOS EG, 1975, CIRC RES, V36, P247, DOI 10.1161/01.RES.36.2.247; Eriksson U, 2002, CURR BIOL, V12, pR745, DOI 10.1016/S0960-9822(02)01255-1; Garton KJ, 2003, J BIOL CHEM, V278, P37459, DOI 10.1074/jbc.M305877200; Gillim-Ross L, 2004, J CLIN MICROBIOL, V42, P3196, DOI 10.1128/JCM.42.7.3196-3206.2004; Gough PJ, 2004, J IMMUNOL, V172, P3678, DOI 10.4049/jimmunol.172.6.3678; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hirata M, 2001, BIOCHEM BIOPH RES CO, V283, P915, DOI 10.1006/bbrc.2001.4879; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hussain I, 2003, J BIOL CHEM, V278, P36264, DOI 10.1074/jbc.M304186200; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; Lee MH, 2002, BIOCHEM J, V364, P227, DOI 10.1042/bj3640227; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; PALECANDA A, 1992, EUR J IMMUNOL, V22, P1279, DOI 10.1002/eji.1830220524; Pang S, 2001, BIOCHEM J, V358, P185, DOI 10.1042/0264-6021:3580185; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Parvathy S, 1998, BIOCHEMISTRY-US, V37, P1680, DOI 10.1021/bi972034y; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Rosendahl MS, 1997, J BIOL CHEM, V272, P24588, DOI 10.1074/jbc.272.39.24588; Sadhukhan R, 1999, J BIOL CHEM, V274, P10511, DOI 10.1074/jbc.274.15.10511; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Wang PG, 2004, BIOCHEM BIOPH RES CO, V315, P439, DOI 10.1016/j.bbrc.2004.01.076; Wang XD, 2002, J BIOL CHEM, V277, P50510, DOI 10.1074/jbc.M208738200; WOODMAN ZL, 2005, IN PRESS BIOCH J; Zisman LS, 2003, CIRCULATION, V108, P1707, DOI 10.1161/01.CIR.0000094734.67990.99	40	464	482	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30113	30119		10.1074/jbc.M505111200	http://dx.doi.org/10.1074/jbc.M505111200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15983030	Green Published, hybrid			2022-12-27	WOS:000231362500017
J	Vetrano, AM; Heck, DE; Mariano, TM; Mishin, V; Laskin, DL; Laskin, JD				Vetrano, AM; Heck, DE; Mariano, TM; Mishin, V; Laskin, DL; Laskin, JD			Characterization of the oxidase activity in mammalian catalase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; OXIDATIVE STRESS; HORSERADISH-PEROXIDASE; FLUORIDE INHIBITION; COMPOUND-I; MECHANISM; NADPH; KINETICS; PURIFICATION; BENZIDINE	Catalase is a highly conserved heme- containing antioxidant enzyme known for its ability to degrade hydrogen peroxide into water and oxygen. In low concentrations of hydrogen peroxide, the enzyme also exhibits peroxidase activity. We report that mammalian catalase also possesses oxidase activity. This activity, which is detected in purified catalases, cell lysates, and intact cells, requires oxygen and utilizes electron donor substrates in the absence of hydrogen peroxide or any added cofactors. Using purified bovine catalase and 10- acetyl- 3,7- dihydroxyphenoxazine as the substrate, the oxidase activity was found to be temperature- dependent and displays a pH optimum of 7 - 9. The K-m for the substrate is 2.4 x 10(-4) M, and V-max is 4.7 x 10(-5) M/ s. Endogenous substrates, including the tryptophan precursor indole, the neurotransmitter precursor beta- phenylethylamine, and a variety of peroxidase and laccase substrates, as well as carcinogenic benzidines, were found to be oxidized by catalase or to inhibit this activity. Several dietary plant micronutrients that inhibit carcinogenesis, including indole- 3- carbinol, indole- 3- carboxaldehyde, ferulic acid, vanillic acid, and epigallocatechin-3- gallate, were effective inhibitors of the activity of catalase oxidase. Difference spectroscopy revealed that catalase oxidase/ substrate interactions involve the heme- iron; the resulting spectra show time- dependent decreases in the ferric heme of the enzyme with corresponding increases in the formation of an oxyferryl intermediate, potentially reflecting a compound II- like intermediate. These data suggest a mechanism of oxidase activity involving the formation of an oxygen- bound, substrate- facilitated reductive intermediate. Our results describe a novel function for catalase potentially important in metabolism of endogenous substrates and in the action of carcinogens and chemopreventative agents.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Laskin, JD (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, 170 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	jlaskin@eohsi.rutgers.edu		Laskin, Debra/0000-0003-1832-7311	NATIONAL CANCER INSTITUTE [R01CA100994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004738, P01ES006897, R01ES003647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034310] Funding Source: NIH RePORTER; NCI NIH HHS [CA100994] Funding Source: Medline; NIEHS NIH HHS [ES06897, ES03647, ES004738, ES05022] Funding Source: Medline; NIGMS NIH HHS [GM034310] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASSON CT, 1985, MOL CELL BIOCHEM, V67, P151, DOI 10.1007/BF02370174; Brignall M S, 2001, Altern Med Rev, V6, P580; Campos R, 2001, J BIOTECHNOL, V89, P131, DOI 10.1016/S0168-1656(01)00303-0; CHANCE B, 1950, BIOCHEM J, V46, P387, DOI 10.1042/bj0460387; CHANCE B, 1952, ARCH BIOCHEM BIOPHYS, V37, P301, DOI 10.1016/0003-9861(52)90194-X; CHANCE B, 1971, BIOCHEM J, V122, P225, DOI 10.1042/bj1220225; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; DEISSEROTH A, 1970, PHYSIOL REV, V50, P319, DOI 10.1152/physrev.1970.50.3.319; Gazaryan IG, 1996, BIOCHEM J, V313, P841, DOI 10.1042/bj3130841; Guengerich FP, 2004, DRUG METAB REV, V36, P159, DOI 10.1081/DMR-120033996; HALEY TJ, 1975, CLIN TOXICOL, V8, P13, DOI 10.3109/15563657508988044; Heck DE, 2003, J BIOL CHEM, V278, P22432, DOI 10.1074/jbc.C300048200; Hunt CR, 1998, CANCER RES, V58, P3986; Ivancich A, 1997, BIOCHEMISTRY-US, V36, P9356, DOI 10.1021/bi970886s; Johannes C, 2000, J BIOTECHNOL, V78, P193, DOI 10.1016/S0168-1656(00)00208-X; JONES P, 1977, J THEOR BIOL, V69, P457, DOI 10.1016/0022-5193(77)90152-7; JOSEPHY PD, 1985, ENVIRON HEALTH PERSP, V64, P171, DOI 10.2307/3430007; KEHRER JP, 1993, CRIT REV TOXICOL, V23, P21, DOI 10.3109/10408449309104073; KEILIN D, 1955, BIOCHEM J, V60, P310, DOI 10.1042/bj0600310; KEILIN D, 1951, BIOCHEM J, V49, P88, DOI 10.1042/bj0490088; Kirkman HN, 1999, J BIOL CHEM, V274, P13908, DOI 10.1074/jbc.274.20.13908; KIRKMAN HN, 1987, J BIOL CHEM, V262, P660; KREMER ML, 1970, BIOCHIM BIOPHYS ACTA, V198, P199, DOI 10.1016/0005-2744(70)90052-5; Loewen PC, 2004, BIOCHEMISTRY-US, V43, P3089, DOI 10.1021/bi035663i; MIYAHARA T, 1982, J BIOCHEM-TOKYO, V91, P525, DOI 10.1093/oxfordjournals.jbchem.a133725; Nagai M, 2003, MICROBIOL-SGM, V149, P2455, DOI 10.1099/mic.0.26414-0; Nicholls P, 2001, ADV INORG CHEM, V51, P51; Ozdemir H, 2001, PREP BIOCHEM BIOTECH, V31, P125, DOI 10.1081/PB-100103378; PerezGilabert M, 1997, FREE RADICAL BIO MED, V23, P548, DOI 10.1016/S0891-5849(97)00118-4; Phan TN, 2001, ORAL MICROBIOL IMMUN, V16, P28, DOI 10.1034/j.1399-302x.2001.160105.x; Putnam CD, 2000, J MOL BIOL, V296, P295, DOI 10.1006/jmbi.1999.3458; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Rota C, 1999, FREE RADICAL BIO MED, V27, P873, DOI 10.1016/S0891-5849(99)00137-9; SILKAITIS RP, 1976, BRAIN RES, V114, P105, DOI 10.1016/0006-8993(76)91010-6; Singh R, 2004, J BIOL CHEM, V279, P43098, DOI 10.1074/jbc.M406374200; SPITZ DR, 1993, J CELL PHYSIOL, V156, P72, DOI 10.1002/jcp.1041560111; TESTA B, 1995, METABOLISM DRUGS OTH, P363; TESTA B, 1995, METABOLISM DRUGS OTH, P357; THIBODEAU EA, 1990, ORAL MICROBIOL IMMUN, V5, P328, DOI 10.1111/j.1399-302X.1990.tb00435.x; Veitch NC, 2004, PHYTOCHEMISTRY, V65, P249, DOI 10.1016/j.phytochem.2003.10.022; Wargovich MJ, 2000, CARCINOGENESIS, V21, P1149, DOI 10.1093/carcin/21.6.1149; Xu F, 1996, BIOCHEMISTRY-US, V35, P7608, DOI 10.1021/bi952971a; Yang CS, 2001, ANNU REV NUTR, V21, P381, DOI 10.1146/annurev.nutr.21.1.381; Zamocky M, 1999, PROG BIOPHYS MOL BIO, V72, P19, DOI 10.1016/S0079-6107(98)00058-3; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	45	108	110	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2005	280	42					35372	35381		10.1074/jbc.M503991200	http://dx.doi.org/10.1074/jbc.M503991200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973ZN	16079130	hybrid			2022-12-27	WOS:000232561200036
J	Banas, A; Carlsson, AS; Huang, B; Lenman, M; Banas, W; Lee, M; Noiriel, A; Benveniste, P; Schaller, H; Bouvier-Nave, P; Stymne, S				Banas, A; Carlsson, AS; Huang, B; Lenman, M; Banas, W; Lee, M; Noiriel, A; Benveniste, P; Schaller, H; Bouvier-Nave, P; Stymne, S			Cellular sterol ester synthesis in plants is performed by an enzyme (phospholipid : sterol acyltransferase) different from the yeast and mammalian acyl-CoA : sterol acyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; DIACYLGLYCEROL ACYLTRANSFERASE; ARABIDOPSIS-THALIANA; TOBACCO MUTANT; OVERPRODUCES STEROLS; SPINACH LEAVES; SINAPIS-ALBA; KEY ENZYME; TRIACYLGLYCEROL; ESTERIFICATION	A gene encoding a sterol ester-synthesizing enzyme was identified in Arabidopsis. The cDNA of the Arabidopsis gene At1g04010 (AtPSAT) was overexpressed in Arabidopsis behind the cauliflower mosaic virus 35S promoter. Microsomal membranes from the leaves of overexpresser lines catalyzed the transacylation of acyl groups from phosphatidylethanolamine to sterols. This activity correlated with the expression level of the AtPSAT gene, thus demonstrating that this gene encodes a phospholipid: sterol acyltransferase (PSAT). Properties of the AtPSAT were examined in microsomal fractions from the tissues of an overexpresser. The enzyme did not utilize neutral lipids, had the highest activity with phosphatidylethanolamine, had a 5-fold preference for the sn-2 position, and utilized both saturated and unsaturated fatty acids. Various sterols and sterol intermediates, including triterpenic precursors, were acylated by the PSAT, whereas other triterpenes were not. Sterol selectivity studies showed that the enzyme is activated by end product sterols and that sterol intermediates are preferentially acylated by the activated enzyme. This indicates that PSAT both regulates the pool of free sterols as well as limits the amount of free sterol intermediates in the membranes. Two T-DNA insertion mutants in the AtPSAT gene, with strongly reduced ( but still measurable) levels of sterol esters in their tissues, had no detectable PSAT activity in the microsomal fractions, suggesting that Arabidopsis possess other enzyme(s) capable of acylating sterols. The AtPSAT is the only intracellular enzyme found so far that catalyzes an acyl-CoA-independent sterol ester formation. Thus, PSAT has a similar physiological function in plant cells as the unrelated acyl-CoA: sterol acyltransferase has in animal cells.	Swedish Univ Agr Sci, Dept Crop Sci, SE-23053 Alnarp, Sweden; Hubei Univ, Coll Life Sci, Wuhan 430062, Peoples R China; ScanBi AB, S-23052 Alnarp, Sweden; Univ Podlasie, Inst Biol, PL-08110 Siedlce, Poland; CNRS, Dept Isoprenoides, Inst Bot, Inst Biol Mol Plantes, F-67083 Strasbourg, France	Swedish University of Agricultural Sciences; Hubei University; Scania; University of Podlasie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Carlsson, AS (corresponding author), Swedish Univ Agr Sci, Dept Crop Sci, POB 44, SE-23053 Alnarp, Sweden.	anders.carlsson@vv.slu.se		Carlsson, Anders/0000-0002-8525-9753; Lee, Michael/0000-0002-6643-1984; Banas, Antoni/0000-0001-9397-7627; Schaller, Hubert/0000-0002-4099-4447				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BACH TJ, 1986, LIPIDS, V21, P82, DOI 10.1007/BF02534307; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; BOUVIERNAVE P, 1995, PLANT SCI, V110, P11, DOI 10.1016/0168-9452(95)04181-S; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Chenchik A, 1996, BIOTECHNIQUES, V21, P526; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; DEMEL RA, 1976, BIOCHIM BIOPHYS ACTA, V457, P109, DOI 10.1016/0304-4157(76)90008-3; DYAS L, 1993, PHYTOCHEMISTRY, V34, P17, DOI 10.1016/S0031-9422(00)90777-5; GARCIA RE, 1978, PLANT PHYSIOL, V62, P348, DOI 10.1104/pp.62.3.348; GARCIA RE, 1978, ARCH BIOCHEM BIOPHYS, V190, P315, DOI 10.1016/0003-9861(78)90281-3; GONDET L, 1994, PLANT PHYSIOL, V105, P509, DOI 10.1104/pp.105.2.509; Hobbs DH, 1999, FEBS LETT, V452, P145, DOI 10.1016/S0014-5793(99)00646-8; Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0; KANDA P, 1981, J LIPID RES, V22, P877; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LEWIS TA, 1987, BIOCHIM BIOPHYS ACTA, V921, P205, DOI 10.1016/0005-2760(87)90020-8; MAILLOTVERNIER P, 1991, MOL GEN GENET, V231, P33, DOI 10.1007/BF00293818; Noiriel A, 2004, EUR J BIOCHEM, V271, P3752, DOI 10.1111/j.1432-1033.2004.04317.x; NOIRIEL A, 2004, THESIS U L PASTEUR S; Peelman F, 1998, PROTEIN SCI, V7, P587, DOI 10.1002/pro.5560070307; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schaeffer A, 2001, PLANT J, V25, P605, DOI 10.1046/j.1365-313x.2001.00994.x; SCHALLER H, 1995, PLANT PHYSIOL, V109, P761, DOI 10.1104/pp.109.3.761; Stahl U, 2004, PLANT PHYSIOL, V135, P1324, DOI 10.1104/pp.104.044354; STOBART AK, 1985, BIOCHEM J, V232, P217, DOI 10.1042/bj2320217; Sturley SL, 1997, CURR OPIN LIPIDOL, V8, P167, DOI 10.1097/00041433-199706000-00007; THORNTON J, 1988, BIOCHIM BIOPHYS ACTA, V959, P153, DOI 10.1016/0005-2760(88)90026-4; Wang JC, 2003, BIOCHEMISTRY-US, V42, P13941, DOI 10.1021/biO35460u; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; ZIMOWSKI J, 1981, PHYTOCHEMISTRY, V20, P1795, DOI 10.1016/0031-9422(81)84006-X; ZIMOWSKI J, 1981, PHYTOCHEMISTRY, V20, P1799, DOI 10.1016/0031-9422(81)84007-1	36	46	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34626	34634		10.1074/jbc.M504459200	http://dx.doi.org/10.1074/jbc.M504459200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16020547	hybrid			2022-12-27	WOS:000232403900031
J	Padayatti, PS; Helfand, MS; Totir, MA; Carey, MP; Carey, PR; Bonomo, RA; van den Akker, F				Padayatti, PS; Helfand, MS; Totir, MA; Carey, MP; Carey, PR; Bonomo, RA; van den Akker, F			High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 beta-lactamase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED INHIBITORS; ACYL-ENZYME INTERMEDIATE; ESCHERICHIA-COLI; INACTIVATION; RESISTANCE; TAZOBACTAM; MUTANT; SULFONES	Antibiotic resistance mediated by constantly evolving beta-lactamases is a serious threat to human health. The mechanism of inhibition of these enzymes by therapeutic beta-lactamase inhibitors is probed using a novel approach involving Raman microscopy and x-ray crystallography. We have presented here the high resolution crystal structures of the beta-lactamase inhibitors sulbactam and clavulanic acid bound to the deacylation-deficient E166A variant of SHV-1 beta-lactamase. Our previous Raman measurements have identified the trans-enamine species for both inhibitors and were used to guide the soaking time and concentration to achieve full occupancy of the active sites. The two inhibitor-bound x-ray structures revealed a linear trans-enamine intermediate covalently attached to the active site Ser-70 residue. This intermediate was thought to play a key role in the transient inhibition of class A beta-lactamases. Both the Raman and x-ray data indicated that the clavulanic acid intermediate is decarboxylated. When compared with our previously determined tazobactam-bound inhibitor structure, our new inhibitor-bound structures revealed an increased disorder in the tail region of the inhibitors as well as in the enamine skeleton. The x-ray crystallographic observations correlated with the broadening of the O-C=C-N (enamine) symmetric stretch Raman band near 1595 cm(-1). Band broadening in the sulbactam and clavulanic acid intermediates reflected a heterogeneous conformational population that results from variations of torsional angles in the O-(C=O)-C=C=NH-C skeleton. These observations led us to conclude that the conformational stability of the trans-enamine form is critical for their transient inhibitory efficacy.	Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; Louis Stokes Cleveland Vet Affairs Med Ctr, Div Res, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	van den Akker, F (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem RT500, 10900 Euclid Ave, Cleveland, OH 44106 USA.	focco.vandenakker@case.edu		Padayatti, Pius/0000-0002-1384-3774				Bonomo R.A., 1999, FRONT BIOSCI, V4, P34; Bonomo RA, 2001, BBA-PROTEIN STRUCT M, V1547, P196, DOI 10.1016/S0167-4838(01)00175-3; BONOMO RA, 1995, BBA-PROTEIN STRUCT M, V1247, P121, DOI 10.1016/0167-4838(94)00188-M; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; BRENNER DG, 1984, BIOCHEMISTRY-US, V23, P5839, DOI 10.1021/bi00319a025; BRENNER DG, 1981, BIOCHEMISTRY-US, V20, P3680, DOI 10.1021/bi00516a003; BRENNER DG, 1984, BIOCHEMISTRY-US, V23, P5833, DOI 10.1021/bi00319a024; Brown RPA, 1996, BIOCHEMISTRY-US, V35, P12421, DOI 10.1021/bi961044g; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bush Karen, 2002, Curr Opin Investig Drugs, V3, P1284; CAREY PR, 1973, BIOCHEMISTRY-US, V12, P2198, DOI 10.1021/bi00736a004; CHARNAS RL, 1981, BIOCHEMISTRY-US, V20, P3214, DOI 10.1021/bi00514a035; CHARNAS RL, 1978, BIOCHEMISTRY-US, V17, P2185, DOI 10.1021/bi00604a025; CHEN CCH, 1992, J MOL BIOL, V224, P1103, DOI 10.1016/0022-2836(92)90472-V; Chen CCH, 2001, BIOCHEMISTRY-US, V40, P2351, DOI 10.1021/bi002277h; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V55, P760; FISHER J, 1978, BIOCHEMISTRY-US, V17, P2180, DOI 10.1021/bi00604a024; FISHER J, 1980, BIOCHEMISTRY-US, V19, P2895, DOI 10.1021/bi00554a012; FISHER J, 1981, BIOCHEMISTRY-US, V20, P2726, DOI 10.1021/bi00513a004; FISHER J, 1980, PHILOS T ROY SOC B, V289, P309, DOI 10.1098/rstb.1980.0048; Georgopapadakou NH, 2004, EXPERT OPIN INV DRUG, V13, P1307, DOI 10.1517/13543784.13.10.1307; Giakkoupi P, 1998, FEMS MICROBIOL LETT, V160, P49, DOI 10.1016/S0378-1097(98)00009-3; Helfand Marion S., 2003, Current Drug Targets - Infectious Disorders, V3, P9, DOI 10.2174/1568005033342181; Helfand MS, 2003, BIOCHEMISTRY-US, V42, P13386, DOI 10.1021/bi035716w; Hokenson MJ, 2000, BIOCHEMISTRY-US, V39, P6538, DOI 10.1021/bi9928041; Ibuka A, 1999, J MOL BIOL, V285, P2079, DOI 10.1006/jmbi.1998.2432; IMTIAZ U, 1994, BIOCHEMISTRY-US, V33, P5728, DOI 10.1021/bi00185a009; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kuzin AP, 1999, BIOCHEMISTRY-US, V38, P5720, DOI 10.1021/bi990136d; Kuzin AP, 2001, BIOCHEMISTRY-US, V40, P1861, DOI 10.1021/bi0022745; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee N, 2003, DRUGS, V63, P1511, DOI 10.2165/00003495-200363140-00006; Lin S, 1999, BBA-PROTEIN STRUCT M, V1432, P125, DOI 10.1016/S0167-4838(99)00025-4; Nathan C, 2004, NATURE, V431, P899, DOI 10.1038/431899a; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; Padayatti PS, 2004, BIOCHEMISTRY-US, V43, P843, DOI 10.1021/bi035985m; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Sulton D, 2005, J BIOL CHEM, V280, P35528, DOI 10.1074/jbc.M501251200; Sun T, 2004, BIOCHEMISTRY-US, V43, P14111, DOI 10.1021/bi0487903; Therrien C, 2000, FEMS MICROBIOL REV, V24, P251, DOI 10.1111/j.1574-6976.2000.tb00541.x; Williams JD, 1997, CLIN INFECT DIS, V24, P494, DOI 10.1093/clinids/24.3.494; ZAFARALLA G, 1992, BIOCHEMISTRY-US, V31, P3847, DOI 10.1021/bi00130a016	43	58	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2005	280	41					34900	34907		10.1074/jbc.M505333200	http://dx.doi.org/10.1074/jbc.M505333200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	971SD	16055923	hybrid			2022-12-27	WOS:000232403900062
J	Petit, A; Kawarai, T; Paitel, E; Sanjo, N; Maj, M; Scheid, M; Chen, FS; Gu, YJ; Hasegawa, H; Salehi-Rad, S; Wang, L; Rogaeva, E; Fraser, P; Robinson, B; St George-Hyslop, P; Tandon, A				Petit, A; Kawarai, T; Paitel, E; Sanjo, N; Maj, M; Scheid, M; Chen, FS; Gu, YJ; Hasegawa, H; Salehi-Rad, S; Wang, L; Rogaeva, E; Fraser, P; Robinson, B; St George-Hyslop, P; Tandon, A			Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT ALPHA-SYNUCLEIN; 2 PARTS; PTEN; GENE; PATHWAY; DJ-1; STIMULI	Mutations in the PTEN-induced kinase 1 (PINK1) gene have recently been implicated in autosomal recessive early onset Parkinson Disease ( 1, 2). To investigate the role of PINK1 in neurodegeneration, we designed human and murine neuronal cell lines expressing either wild-type PINK1 or PINK1 bearing a mutation associated with Parkinson Disease. We show that under basal and staurosporine-induced conditions, the number of terminal deoxynucleotidyl-transferase-mediated dUTP nick end labeling (TUNEL)-positive cells was lower in wild-type PINK1 expressing SH-SY5Y cells than in mock-transfected cells. This phenotype was due to a PINK1-mediated reduction in cytochrome c release from mitochondria, which prevents subsequent caspase-3 activation. We show that overexpression of wild-type PINK1 strongly reduced both basal and staurosporine-induced caspase 3 activity. Overexpression of wild-type PINK1 also reduced the levels of cleaved caspase-9, caspase-3, caspase-7, and activated poly(ADP-ribose) polymerase under both basal and staurosporine-induced conditions. In contrast, Parkinson disease-related mutations and a kinase-inactive mutation in PINK1 abrogated the protective effect of PINK1. Together, these results suggest that PINK1 reduces the basal neuronal pro-apoptotic activity and protects neurons from staurosporine-induced apoptosis. Loss of this protective function may therefore underlie the degeneration of nigral dopaminergic neurons in patients with PINK1 mutations.	Univ Toronto, Ctr Res Neurodegenerat Dis, Dept Med Neurol, Toronto, ON M5S 3H2, Canada; Hosp Sick Children, Res Inst, Metab res Programme, Toronto, ON M5G 1X8, Canada; York Univ, Dept Biol, N York, ON M3J 1P3, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); York University - Canada	St George-Hyslop, P (corresponding author), Univ Toronto, Ctr Res Neurodegenerat Dis, Dept Med Neurol, 6 Queens Pk Crescent W, Toronto, ON M5S 3H2, Canada.	p.hyslop@utoronto.ca	Maj, Mary/R-6969-2019; Kawarai, Toshitaka/C-2822-2013	Kawarai, Toshitaka/0000-0003-4547-8131; Petit-Paitel, Agnes/0000-0003-1138-9966; St George-Hyslop, Peter/0000-0003-0796-7209; Sanjo, Nobuo/0000-0002-1226-2425; Maj, Mary/0000-0002-9258-2823				Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Gary DS, 2002, NEUROMOL MED, V2, P261, DOI 10.1385/NMM:2:3:261; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lee M, 2001, J NEUROCHEM, V76, P998, DOI 10.1046/j.1471-4159.2001.00149.x; Paitel E, 2003, J BIOL CHEM, V278, P10061, DOI 10.1074/jbc.M211580200; Parsons R, 2004, SEMIN CELL DEV BIOL, V15, P171, DOI 10.1016/j.semcdb.2003.12.021; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rogaeva E, 2004, ARCH NEUROL-CHICAGO, V61, P1898, DOI 10.1001/archneur.61.12.1898; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200	18	257	321	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					34025	34032		10.1074/jbc.M505143200	http://dx.doi.org/10.1074/jbc.M505143200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16079129	hybrid			2022-12-27	WOS:000232229700041
J	Gaur, T; Lengner, CJ; Hovhannisyan, H; Bhat, RA; Bodine, PVN; Komm, BS; Javed, A; van Wijnen, AJ; Stein, JL; Stein, GS; Lian, JB				Gaur, T; Lengner, CJ; Hovhannisyan, H; Bhat, RA; Bodine, PVN; Komm, BS; Javed, A; van Wijnen, AJ; Stein, JL; Stein, GS; Lian, JB			Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-5; HIGH BONE-DENSITY; OSTEOBLAST DIFFERENTIATION; WNT/BETA-CATENIN; BETA-CATENIN; CLEIDOCRANIAL DYSPLASIA; RUNX/CBFA/AML FACTORS; TRANSCRIPTION FACTORS; LIMB DEVELOPMENT; MUTANT MICE	Both activating and null mutations of proteins required for canonical WNT signaling have revealed the importance of this pathway for normal skeletal development. However, tissue-specific transcriptional mechanisms through which WNT signaling promotes the differentiation of bone-forming cells have yet to be identified. Here, we address the hypothesis that canonical WNT signaling and the bone-related transcription factor RUNX2/CBFA1/ AML3 are functionally linked components of a pathway required for the onset of osteoblast differentiation. Our findings show that, in bone of the SFRP1 ( secreted frizzled-related protein-1)-null mouse, which exhibits activated WNT signaling and a high bone mass phenotype, there is a significant increase in expression of T-cell factor (TCF)-1, Runx2, and the RUNX2 target gene osteocalcin. We demonstrate by mutational analysis that a functional TCF regulatory element responsive to canonical WNT signaling resides in the promoter of the Runx2 gene ( - 97 to - 93). By chromatin immunoprecipitation, recruitment of beta-catenin and TCF1 to the endogenous Runx2 gene is shown. Coexpression of TCF1 with canonical WNT proteins resulted in a 2-5-fold activation of Runx2 promoter activity and a 7-8-fold induction of endogenous mRNA in mouse pluripotent mesenchymal and osteoprogenitor cells. This enhancement was abrogated by SFRP1. Taken together, our results provide evidence for direct regulation of Runx2 by canonical WNT signaling and suggest that Runx2 is a target of beta-catenin/TCF1 for the stimulation of bone formation. We propose that WNT/TCF1 signaling, like bone morphogenetic protein/transforming growth factor-beta signaling, activates Runx2 gene expression in mesenchymal cells for the control of osteoblast differentiation and skeletal development.	Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA; Wyeth Res, Womens Hlth Res Inst, Collegeville, PA 19426 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Pfizer	Lian, JB (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, 55 Lake Ave N, Worcester, MA 01655 USA.	jane.lian@umassmed.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946; Javed, Amjad/0000-0002-0847-8266; Lengner, Christopher/0000-0002-0574-5189	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, P01AR048818, R01AR039588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR39588, P01 AR48818, R01 AR049069] Funding Source: Medline; NIDDK NIH HHS [P30 DK32520] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adamska M, 2004, DEV BIOL, V272, P134, DOI 10.1016/j.ydbio.2004.04.026; Afzal F, 2005, J CELL PHYSIOL, V204, P63, DOI 10.1002/jcp.20258; Akhter MP, 2004, BONE, V35, P162, DOI 10.1016/j.bone.2004.02.018; AUGUSTINE K, 1993, DEV GENET, V14, P500, DOI 10.1002/dvg.1020140611; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brault V, 2001, DEVELOPMENT, V128, P1253; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Church VL, 2002, INT J DEV BIOL, V46, P927; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Derfoul A, 2004, DIFFERENTIATION, V72, P209, DOI 10.1111/j.1432-0436.2004.07205003.x; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoang BH, 1998, DEV DYNAM, V212, P364, DOI 10.1002/(SICI)1097-0177(199807)212:3<364::AID-AJA4>3.0.CO;2-F; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Hovhannisyan H, 2003, MOL CELL BIOL, V23, P1460, DOI 10.1128/MCB.23.4.1460-1469.2003; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Ikeya M, 2001, MECH DEVELOP, V103, P27, DOI 10.1016/S0925-4773(01)00338-0; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; KARAPLIS A, 2002, PRINCIPLES BONE BIOL, P3; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kobayashi T, 2005, ENDOCRINOLOGY, V146, P1012, DOI 10.1210/en.2004-1343; KOCKX M, 1994, J CELL BIOCHEM, V54, P47, DOI 10.1002/jcb.240540106; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lengner CJ, 2004, J CELL PHYSIOL, V200, P327, DOI 10.1002/jcp.20118; Lengner CJ, 2002, MECH DEVELOP, V114, P167, DOI 10.1016/S0925-4773(02)00050-3; Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; LIAN JB, 2003, PRIMER METABOLIC BON, P13; Little RD, 2002, NEW ENGL J MED, V347, P943; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Niemann S, 2004, AM J HUM GENET, V74, P558, DOI 10.1086/382196; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pandur P, 2002, BIOESSAYS, V24, P881, DOI 10.1002/bies.10164; Paredes R, 2004, MOL CELL BIOL, V24, P8847, DOI 10.1128/MCB.24.20.8847-8861.2004; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Soshnikova N, 2003, GENE DEV, V17, P1963, DOI 10.1101/gad.263003; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Vaes BLT, 2005, BONE, V36, P803, DOI 10.1016/j.bone.2005.02.001; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yoshida T, 2003, BLOOD CELL MOL DIS, V30, P184, DOI 10.1016/S1079-9796(03)00020-2; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zaidi SK, 2002, P NATL ACAD SCI USA, V99, P8048, DOI 10.1073/pnas.112664499; ZAKANY J, 1993, NATURE, V362, P546, DOI 10.1038/362546a0; Zambotti A, 2002, J BIOL CHEM, V277, P41497, DOI 10.1074/jbc.M204271200; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239	69	860	918	5	92	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33132	33140		10.1074/jbc.M500608200	http://dx.doi.org/10.1074/jbc.M500608200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16043491	hybrid			2022-12-27	WOS:000232058100007
J	Wong, C; Jin, ZG				Wong, C; Jin, ZG			Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; TRANS-GOLGI NETWORK; FACTOR RECEPTORS; DNA-SYNTHESIS; AUTOPHOSPHORYLATION SITE; TRANSDUCTION PATHWAY; PKC-MU; VEGF; STRESS; PHOSPHORYLATION	Vascular endothelial growth factor ( VEGF) is essential for many angiogenic processes both in normal conditions and in pathological conditions. However, the signaling pathways involved in VEGF-induced angiogenesis are not well defined. Protein kinase D (PKD), a newly described serine/threonine protein kinase, has been implicated in many signal transduction pathways and in cell proliferation. We hypothesized that PKD would mediate VEGF signaling and function in endothelial cells. Here we found that VEGF rapidly and strongly stimulated PKD phosphorylation and activation in endothelial cells via VEGF receptor 2 (VEGFR2). The pharmacological inhibitors for phospholipase C gamma (PLC gamma) and protein kinase C(PKC) significantly inhibited VEGF-induced PKD activation, suggesting the involvement of the PLC gamma/PKC pathway. In particular, PKC alpha was critical for VEGF-induced PKD activation since both overexpression of adenovirus PKC alpha dominant negative mutant and reduction of PKC alpha expression by small interfering RNA markedly inhibited VEGF-induced PKD activation. Importantly, we found that small interfering RNA knockdown of PKD and PKC alpha expression significantly attenuated ERK activation and DNA synthesis in endothelial cells by VEGF. Taken together, our results demonstrated for the first time that VEGF activates PKD via the VEGFR2/PLC gamma/ PKC alpha pathway and revealed a critical role of PKD in VEGF-induced ERK signaling and endothelial cell proliferation.	Univ Rochester, Med Ctr, Dept Med, Cardiovasc Res Inst, Rochester, NY 14642 USA	University of Rochester	Jin, ZG (corresponding author), Univ Rochester, Med Ctr, Dept Med, Cardiovasc Res Inst, 601 Elmwood Ave,Box 679, Rochester, NY 14642 USA.	zheng-gen_jin@urmc.rochester.edu			NHLBI NIH HHS [R01 HL080611, HL080611, R01 HL080611-05] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080611] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carpenter L, 2001, J BIOL CHEM, V276, P5368, DOI 10.1074/jbc.M010036200; Claesson-Welsh L, 2003, BIOCHEM SOC T, V31, P20, DOI 10.1042/bst0310020; Endo K, 2000, J BIOL CHEM, V275, P18476, DOI 10.1074/jbc.M002266200; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Hausser A, 2001, FEBS LETT, V492, P39, DOI 10.1016/S0014-5793(01)02219-0; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Jin ZG, 2005, J BIOL CHEM, V280, P12305, DOI 10.1074/jbc.M500294200; Jin ZG, 2004, ARTERIOSCL THROM VAS, V24, P1186, DOI 10.1161/01.ATV.0000130664.51010.28; Jin ZG, 2003, CIRC RES, V93, P354, DOI 10.1161/01.RES.0000089257.94002.96; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Karkkainen MJ, 2000, ONCOGENE, V19, P5598, DOI 10.1038/sj.onc.1203855; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Lungu AO, 2004, J BIOL CHEM, V279, P48794, DOI 10.1074/jbc.M313897200; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Petrova TV, 1999, EXP CELL RES, V253, P117, DOI 10.1006/excr.1999.4707; ROSALES OR, 1992, BIOCHEM BIOPH RES CO, V189, P40, DOI 10.1016/0006-291X(92)91522-R; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tan MQ, 2003, J BIOL CHEM, V278, P2824, DOI 10.1074/jbc.M211523200; Traub O, 1997, J BIOL CHEM, V272, P31251, DOI 10.1074/jbc.272.50.31251; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Van Lint J, 2002, INT J BIOCHEM CELL B, V34, P577, DOI 10.1016/S1357-2725(01)00163-7; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	44	142	145	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33262	33269		10.1074/jbc.M503198200	http://dx.doi.org/10.1074/jbc.M503198200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16006559	hybrid, Green Accepted			2022-12-27	WOS:000232058100021
J	Sharoni, M; Steiner-Mordoch, S; Schuldiner, S				Sharoni, M; Steiner-Mordoch, S; Schuldiner, S			Exploring the binding domain of EmrE, the smallest multidrug transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SUBSTRATE-BINDING; LACTOSE PERMEASE; MEMBRANE-PROTEIN; SITE; ANTIPORTER; CHANNEL; H+; RESISTANCE; RESIDUES	EmrE is a small multidrug transporter in Escherichia coli that extrudes various positively charged drugs across the plasma membrane in exchange with protons, thereby rendering cells resistant to these compounds. Biochemical experiments indicate that the basic functional unit of EmrE is a dimer where the common binding site for protons and substrate is formed by the interaction of an essential charged residue (Glu(14)) from both EmrE monomers. Previous studies implied that other residues in the vicinity of Glu14 are part of the binding domain. Alkylation of Cys replacements in the same transmembrane domain inhibits the activity of the protein and this inhibition is fully prevented by substrates of EmrE. To monitor directly the reaction we tested also the extent of modification using fluorescein-5-maleimide. While most residues are not accessible or only partially accessible, four, Y4C, 15C, L7C, and A10C, were modified at least 80%. Furthermore, preincubation with tetraphenylphosphonium reduces the reaction of two of these residues by up to 80%. To study other essential residues we generated functional hetero-oligomers and challenged them with various methane thiosulfonates. Taken together the findings imply the existence of a binding cavity accessible to alkylating reagents where at least three residues from TM1, Tyr(40) from TM2, and Trp(63) in TM3 are involved in substrate binding.	Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Schuldiner, S (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	Shimon.Schuldiner@huji.ac.il	Schuldiner, Shimon/F-7628-2012	Schuldiner, Shimon/0000-0002-4874-6237	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER; NINDS NIH HHS [NS16708] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1994, J BIOL CHEM, V269, P14865; Butler PJG, 2004, J MOL BIOL, V340, P797, DOI 10.1016/j.jmb.2004.05.014; Elbaz Y, 2005, BIOCHEMISTRY-US, V44, P7369, DOI 10.1021/bi050356t; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; GRINIUS LL, 1994, J BIOL CHEM, V269, P29998; Gutman N, 2003, J BIOL CHEM, V278, P16082, DOI 10.1074/jbc.M213120200; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Koteiche HA, 2003, BIOCHEMISTRY-US, V42, P6099, DOI 10.1021/bi0342867; Ma C, 2004, P NATL ACAD SCI USA, V101, P2852, DOI 10.1073/pnas.0400137101; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Ninio S, 2003, J BIOL CHEM, V278, P12000, DOI 10.1074/jbc.M213119200; Ninio S, 2001, J BIOL CHEM, V276, P48250, DOI 10.1074/jbc.M108231200; Rotem D, 2001, J BIOL CHEM, V276, P48243, DOI 10.1074/jbc.M108229200; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schuldiner S, 2001, J MOL MICROB BIOTECH, V3, P155; Schuldiner S, 2001, NEWS PHYSIOL SCI, V16, P130; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Schwaiger M, 1998, EUR J BIOCHEM, V254, P610, DOI 10.1046/j.1432-1327.1998.2540610.x; Soskine M, 2004, J BIOL CHEM, V279, P9951, DOI 10.1074/jbc.M312853200; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tate CG, 2001, EMBO J, V20, P77, DOI 10.1093/emboj/20.1.77; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; Weinglass AB, 2005, J BIOL CHEM, V280, P7487, DOI 10.1074/jbc.M413555200; Weinglass AB, 2001, BIOCHEMISTRY-US, V40, P769, DOI 10.1021/bi002171m; XU M, 1993, J BIOL CHEM, V268, P21505; Ye LW, 2001, J BACTERIOL, V183, P2490, DOI 10.1128/JB.183.8.2490-2496.2001; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; Yerushalmi H, 2000, FEBS LETT, V476, P93, DOI 10.1016/S0014-5793(00)01677-X; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200; Yerushalmi H, 1996, J BIOL CHEM, V271, P31044, DOI 10.1074/jbc.271.49.31044; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	38	32	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32849	32855		10.1074/jbc.M504910200	http://dx.doi.org/10.1074/jbc.M504910200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16049002	hybrid			2022-12-27	WOS:000231920300038
J	Arai, N; Ito, D; Inoue, T; Shibata, T; Takahashi, H				Arai, N; Ito, D; Inoue, T; Shibata, T; Takahashi, H			Heteroduplex joint formation by a stoichiometric complex of Rad51 and Rad52 of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; ESCHERICHIA-COLI RECA; DNA STRAND EXCHANGE; CLOSED CIRCULAR DNA; YEAST RAD51; GENETIC-RECOMBINATION; SUPERHELICAL DNA; BRANCH MIGRATION; DUPLEX DNA; MULTIPLE PATHWAYS	Both Rad51 and Rad52 are required for homologous genetic recombination in Saccharomyces cerevisiae. Rad51 promotes heteroduplex joint formation, a general step in homologous recombination. Rad52 facilitates the binding of Rad51 to replication protein A (RPA)-coated single-stranded DNA. The requirement of RPA can be avoided in vitro, if the single-stranded DNA is short. Using short single-stranded DNA and homologous double-stranded DNA, in the absence of RPA, we found that Rad52 ( optimal at three per Rad51) was still required for Rad51-promoted heteroduplex joint formation in vitro, as assayed by the formation of D-loops, suggesting another role for Rad52. Rad51 has to bind to the single-stranded DNA before the addition of double-stranded DNA for efficient D-loop formation. Immunoprecipitation and single-stranded DNA-bead precipitation analyses revealed the presence of the free and DNA-bound complexes of Rad51 and Rad52 at a 1 to 2 stoichiometry. In the presence of single-stranded DNA, in addition to Rad51, Rad52 was required for extensive untwisting that is an intermediate step toward D-loop formation. Thus, these results suggest that the formation of the stoichiometric complex of Rad52 with Rad51 on single-stranded DNA is required for the functional binding of the protein-single-stranded DNA complex to the double-stranded DNA to form D-loops.	Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Fujisawa, Kanagawa 2528510, Japan; RIKEN, Discovert Res Inst, Wako, Saitama 3510198, Japan	Nihon University; RIKEN	Arai, N (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Fujisawa, Kanagawa 2528510, Japan.	narai@brs.nihon-u.ac.jp						ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; ARAI N, 1992, J BIOL CHEM, V267, P3514; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P6018, DOI 10.1073/pnas.78.10.6018; CUNNINGHAM RP, 1979, NATURE, V281, P191, DOI 10.1038/281191a0; CUNNINGHAM RP, 1980, CELL, V20, P223, DOI 10.1016/0092-8674(80)90250-0; DICAPUA E, 1982, J MOL BIOL, V157, P87, DOI 10.1016/0022-2836(82)90514-9; DONOVAN JW, 1994, GENE DEV, V8, P2552, DOI 10.1101/gad.8.21.2552; FLORY J, 1984, P NATL ACAD SCI-BIOL, V81, P7026, DOI 10.1073/pnas.81.22.7026; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; KAGAWA W, 2003, THESIS U TOKYO; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Kurumizaka H, 1999, J MOL BIOL, V291, P537, DOI 10.1006/jmbi.1999.2950; LIU JH, 1995, EMBO J, V14, P4599, DOI 10.1002/j.1460-2075.1995.tb00139.x; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Namsaraev E, 1997, MOL CELL BIOL, V17, P5359, DOI 10.1128/MCB.17.9.5359; New JH, 2002, J BIOL CHEM, V277, P26171, DOI 10.1074/jbc.M203670200; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nishinaka T, 1998, P NATL ACAD SCI USA, V95, P11071, DOI 10.1073/pnas.95.19.11071; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; OHTANI T, 1982, NATURE, V299, P86, DOI 10.1038/299086a0; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Petukhova G, 2000, GENE DEV, V14, P2206, DOI 10.1101/gad.826100; RADDING CM, 1977, J MOL BIOL, V116, P825, DOI 10.1016/0022-2836(77)90273-X; RATTRAY AJ, 1995, GENETICS, V139, P45; RATTRAY AJ, 1994, GENETICS, V138, P587; Rice KP, 2001, J BIOL CHEM, V276, P38570, DOI 10.1074/jbc.M105678200; Shen ZY, 1996, J BIOL CHEM, V271, P148, DOI 10.1074/jbc.271.1.148; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; SHIBATA T, 1983, METHOD ENZYMOL, V100, P197; SHIBATA T, 1982, J BIOL CHEM, V257, P3981; SHIBATA T, 1981, J BIOL CHEM, V256, P7565; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; SUGAWARA N, 1995, NATURE, V373, P84, DOI 10.1038/373084a0; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 2000, MUTAT RES-FUND MOL M, V451, P257, DOI 10.1016/S0027-5107(00)00054-3; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tracy RB, 1997, GENE DEV, V11, P3423, DOI 10.1101/gad.11.24.3423; TSANG SS, 1985, J MOL BIOL, V185, P295, DOI 10.1016/0022-2836(85)90405-X; WIEGAND RC, 1977, J MOL BIOL, V116, P805, DOI 10.1016/0022-2836(77)90272-8; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959	55	8	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32218	32229		10.1074/jbc.M507521200	http://dx.doi.org/10.1074/jbc.M507521200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16033757	hybrid			2022-12-27	WOS:000231794800023
J	Lee, MS; Edwards, RA; Thede, GL; Glover, JNM				Lee, MS; Edwards, RA; Thede, GL; Glover, JNM			Structure of the BRCT repeat domain of MDC1 and its specificity for the free COOH-terminal end of the gamma-H2AX histone tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; CRYSTAL-STRUCTURE; ELECTRON-DENSITY; PHOSPHOPEPTIDE; CANCER; RECOGNITION; BREAST; REGION; BACH1; P53	MDC1 ( mediator of DNA damage checkpoint protein 1) regulates the recognition and repair of DNA double strand breaks in mammalian cells through its interactions with nuclear foci containing the COOH-terminally phosphorylated form of the histone variant, H2AX. Here we demonstrate that the tandem BRCT repeats of MDC1 directly bind to the phosphorylated tail of H2AX-Ser(P)-Gln-Glu-Tyr, in a manner that is critically dependent on the free carboxylate group of the COOH-terminal Tyr residue. We have determined the x-ray crystal structure of the MDC1 BRCT repeats at 1.45 angstrom resolution. By a comparison with the structure of the BRCA1 BRCT bound to a phosphopeptide, we suggest that two arginine residues in MDC1, Arg(1932) and Arg(1933) may recognize the COOH terminus of the peptide as well as the penultimate Glu of H2AX, while Gln(2013) may provide additional specificity for the COOH-terminal Tyr.	Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Glover, JNM (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	mark.glover@ualberta.ca						Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Joo WS, 2002, GENE DEV, V16, P583, DOI 10.1101/gad.959202; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Williams RS, 2003, J BIOL CHEM, V278, P2630, DOI 10.1074/jbc.M210019200; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004	23	98	103	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32053	32056		10.1074/jbc.C500273200	http://dx.doi.org/10.1074/jbc.C500273200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16049003	hybrid			2022-12-27	WOS:000231794800003
J	Sun, Y; Buki, KG; Ettala, O; Vaaraniemi, JP; Vaananen, HK				Sun, Y; Buki, KG; Ettala, O; Vaaraniemi, JP; Vaananen, HK			Possible role of direct Rac1-Rab7 interaction in ruffled border formation of osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL GTPASE RAB7; ENDOCYTIC PATHWAY; BONE-RESORPTION; PROTEIN RILP; RHO GTPASES; MEMBRANE; ACTIN; RAC1; TRANSPORT; CDC42	Rab7 has been shown to regulate the late steps of the endocytic pathway. In bone-resorbing osteoclasts, it is involved in formation of the ruffled border, which is a late endosomal-like compartment in the plasma membrane. Here we report a new Rab7-interacting protein, Rac1, another small GTPase protein that binds to the GTP-form of Rab7 as found with a two-hybrid system. We demonstrate further that Rab7 colocalizes with Rac1 at the fusion zone of the ruffled border in bone-resorbing osteoclasts. In other cell types, such as fibroblast-like cells, partial colocalization is perinuclear. Because Rac1 is known to control the actin cytoskeleton through its effectors, the Rab7-Rac1 interaction may mediate late endosomal transport between microtubules and microfilaments enabling endosomal vesicles to switch tracks and may thus also regulate ruffled border formation in osteoclasts.	Turku Univ, Inst Biomed, Dept Anat, FI-20700 Turku, Finland	University of Turku	Vaananen, HK (corresponding author), Turku Univ, Inst Biomed, Dept Anat, Kiinamyllynkatu 10, FI-20700 Turku, Finland.	kalervo.vaananen@utu.fi		Ettala, Otto/0000-0003-1011-4602				BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; CAVIER P, 1999, CURR OPIN CELL BIOL, V11, P466; Dong JB, 2004, J BIOL CHEM, V279, P21334, DOI 10.1074/jbc.M401022200; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; Mattson NP, 1997, J BONE MINER RES, V12, P753, DOI 10.1359/jbmr.1997.12.5.753; MERESSE S, 1995, J CELL SCI, V108, P3349; Mizuno K, 2003, MOL BIOL CELL, V14, P3741, DOI 10.1091/mbc.E02-08-0495; MOLL J, 1991, ONCOGENE, V6, P863; Mulari MTK, 2003, TRAFFIC, V4, P113, DOI 10.1034/j.1600-0854.2003.40206.x; Nomura N, 1994, DNA Res, V1, P223, DOI 10.1093/dnares/1.5.223; Olkkonen VM, 1997, INT REV CYTOL, V176, P1, DOI 10.1016/S0074-7696(08)61608-3; Palokangas H, 1997, J CELL SCI, V110, P1767; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; SALO J, 1996, J CELL SCI, V106, P301; Salo J., 1994, MOL BIOL CELL S, V5, P431; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; SHIRSAT NV, 1990, ONCOGENE, V5, P769; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Vaananen HK, 2000, J CELL SCI, V113, P377; VAANANEN HK, 1990, J CELL BIOL, V111, P1305, DOI 10.1083/jcb.111.3.1305; VAANANEN HK, 1995, J CELL SCI, V108, P2729; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; WANG T, 2000, MOL BIOL CELL, V13, P4317; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Weernink PAO, 2004, J BIOL CHEM, V279, P7840, DOI 10.1074/jbc.M312737200; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zerial M, 1993, CURR OPIN CELL BIOL, V5, P613, DOI 10.1016/0955-0674(93)90130-I; Zhang X, 2005, ARTHRITIS RHEUM-US, V52, P1297, DOI 10.1002/art.20984; Zhao H., 2000, CALCIFIED TISSUE INT, V52, pS63; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200	49	57	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32356	32361		10.1074/jbc.M414213200	http://dx.doi.org/10.1074/jbc.M414213200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16040606	hybrid			2022-12-27	WOS:000231794800040
J	Han, JH; Tsukada, Y; Hara, E; Kitamura, N; Tanaka, T				Han, JH; Tsukada, Y; Hara, E; Kitamura, N; Tanaka, T			Hepatocyte growth factor induces redistribution of p21(CIP1) and p27(KIP1) through ERK-dependent p16(INK4a) up-regulation, leading to cell cycle arrest at G(1) in HepG2 hepatoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MET RECEPTOR; TYROSINE KINASE; SCATTER FACTOR; INDUCED PROLIFERATION; TRANSCRIPTION FACTOR; MOLECULAR-CLONING; CDK INHIBITORS; EXPRESSION; PROTEINS; LIVER	Hepatocyte growth factor (HGF) has an anti-proliferative effect on many types of tumor cell lines and tumors in vivo. We found previously that inhibition of HGF-induced proliferation in HepG2 hepatoma cells is caused by cell cycle arrest at G(1) through a high intensity ERK signal, which represses Cdk2 activity. To examine further the mechanisms of G(1) arrest by HGF, we analyzed the Cdk inhibitor p16(INK4a), which has an anti-proliferative function through cell cycle arrest at G1. We found that HGF treatment drastically increased endogenous p16 levels. Knockdown of p16 with small interfering RNA reversed the arrest, indicating that the induction of p16 is required for G(1) arrest by HGF. Analysis of the promoter of the human p16 gene identified the proximal Ets-binding site as a responsive element for HGF, and this responded to the high intensity ERK signal. HGF treatment of the cells led to a redistribution of p21(CIP1) and p27(KIP1) from Cdk4 to Cdk2. The redistribution was blocked by the knockdown of p16 with small interfering RNA, which restored the Cdk2 activity repressed by HGF, demonstrating the requirement of p16 induction for the redistribution and eventual repression of Cdk2 activity. Our results reveal a signaling pathway for G(1) arrest induced by HGF.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Univ Tokushima, Inst Genome Res, Div Prot Informat, Tokushima 7708503, Japan	Tokyo Institute of Technology; Tokushima University	Tanaka, T (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	ttanaka@bio.titech.ac.jp	Han, Junhong/L-5264-2013; Tanaka, Toshiaki/C-5567-2013	Tanaka, Toshiaki/0000-0002-9448-1452; Han, Junhong/0000-0002-3371-8698				BIRCHMEIER C, 1993, ANNU REV CELL BIOL, V9, P511, DOI 10.1146/annurev.cb.09.110193.002455; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bond J, 2004, EXP CELL RES, V292, P151, DOI 10.1016/j.yexcr.2003.09.021; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Calbo J, 2004, CELL DEATH DIFFER, V11, P1055, DOI 10.1038/sj.cdd.4401481; CHAN FKM, 1995, MOL CELL BIOL, V15, P2682; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; DURO D, 1995, ONCOGENE, V11, P21; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Furge KA, 2000, ONCOGENE, V19, P5582, DOI 10.1038/sj.onc.1203859; HALABAN R, 1992, ONCOGENE, V7, P2195; Hara E, 1996, MOL CELL BIOL, V16, P859; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Jiang H, 1998, MOL CELL BIOL, V18, P5284, DOI 10.1128/MCB.18.9.5284; KAN M, 1991, BIOCHEM BIOPH RES CO, V174, P331, DOI 10.1016/0006-291X(91)90524-B; KOMADA M, 1992, EUR J BIOCHEM, V204, P857, DOI 10.1111/j.1432-1033.1992.tb16705.x; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; LIU ML, 1995, CARCINOGENESIS, V16, P841, DOI 10.1093/carcin/16.4.841; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; MAO L, 1995, CANCER RES, V55, P2995; MATSUMOTO K, 1992, Critical Reviews in Oncogenesis, V3, P27; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; Mitra J, 1999, MOL CELL BIOL, V19, P3916; MIYAZAKI M, 1992, CELL BIOL INT REP, V16, P145, DOI 10.1016/S0309-1651(06)80108-6; MIYAZAWA K, 1989, BIOCHEM BIOPH RES CO, V163, P967, DOI 10.1016/0006-291X(89)92316-4; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; NAGNASS AU, 1994, BIOCHEM BIOPH RES CO, V202, P701; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NALDINI L, 1991, ONCOGENE, V6, P501; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Oikawa T, 2004, CANCER SCI, V95, P626, DOI 10.1111/j.1349-7006.2004.tb03320.x; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; PARRY D, 1995, EMBO J, V14, P503, DOI 10.1002/j.1460-2075.1995.tb07026.x; Paumelle R, 2002, ONCOGENE, V21, P2309, DOI 10.1038/sj.onc.1205297; POON RYC, 1995, MOL BIOL CELL, V6, P1197, DOI 10.1091/mbc.6.9.1197; QUELLE DE, 1995, CELL, V83, P993; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Reynisdottir I, 1997, GENE DEV, V11, P492, DOI 10.1101/gad.11.4.492; ROSEN EM, 1994, J CELL BIOL, V127, P1783, DOI 10.1083/jcb.127.6.1783; Rottinger E, 2004, DEVELOPMENT, V131, P1075, DOI 10.1242/dev.01000; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; SantoniRugiu E, 1996, P NATL ACAD SCI USA, V93, P9577, DOI 10.1073/pnas.93.18.9577; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shima N, 1998, J CELL PHYSIOL, V177, P130, DOI 10.1002/(SICI)1097-4652(199810)177:1<130::AID-JCP14>3.3.CO;2-O; SHIMA N, 1991, CELL BIOL INT REP, V15, P397, DOI 10.1016/0309-1651(91)90128-6; SHIMA N, 1991, BIOCHEM BIOPH RES CO, V180, P1151, DOI 10.1016/S0006-291X(05)81187-8; SHIOTA G, 1992, P NATL ACAD SCI USA, V89, P373, DOI 10.1073/pnas.89.1.373; STONE S, 1995, CANCER RES, V55, P2988; Swarbrick A, 2000, MOL CELL BIOL, V20, P2581, DOI 10.1128/MCB.20.7.2581-2591.2000; TAJIMA H, 1992, EXP CELL RES, V202, P423, DOI 10.1016/0014-4827(92)90095-P; TAJIMA H, 1991, FEBS LETT, V291, P229, DOI 10.1016/0014-5793(91)81291-F; Tsukada Y, 2004, J BIOCHEM, V136, P701, DOI 10.1093/jb/mvh177; Tsukada Y, 2001, J BIOL CHEM, V276, P40968, DOI 10.1074/jbc.M010890200; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Vaque JP, 2005, J BIOL CHEM, V280, P1112, DOI 10.1074/jbc.M409503200; VIGNA E, 1994, CELL MOL BIOL, V40, P597; WEIDNER KM, 1993, AM J RESP CELL MOL, V8, P229, DOI 10.1165/ajrcmb/8.3.229; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177; Zhang YW, 2003, J CELL BIOCHEM, V88, P408, DOI 10.1002/jcb.10358	69	49	52	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31548	31556		10.1074/jbc.M503431200	http://dx.doi.org/10.1074/jbc.M503431200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16014626	hybrid			2022-12-27	WOS:000231665200027
J	Kumar, P; Wang, CC				Kumar, P; Wang, CC			Depletion of anaphase-promoting complex or cyclosome (APC/C) subunit homolog APC1 or CDC27 of Trypanosoma brucei arrests the procyclic form in metaphase but the bloodstream form in anaphase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; RNA INTERFERENCE; BUDDING YEAST; DNA-REPLICATION; GENE-EXPRESSION; PROTEIN; IDENTIFICATION; PROTEASOME; MITOSIS; PROTEOLYSIS	The anaphase-promoting complex or cyclosome ( APC/C) is a multiprotein subunit E3 ubiquitin ligase complex that controls segregation of chromosomes and exit from mitosis in eukaryotes. It triggers elimination of key cell cycle regulators such as securin and mitotic cyclins during mitosis by polyubiquitinating them for proteasome degradation. Seven core subunit homologs of APC/C ( APC1, APC2, APC11, CDC16, CDC23, CDC27, and DOC1) were identified in the Trypanosoma brucei genome data base. Expression of six of them was individually ablated by RNA interference in both the procyclic and bloodstream forms of T. brucei. Only the CDC27- and APC1-depleted cells were enriched in the G(2)/M phase with inhibited growth. Further studies indicated that T. brucei APC1 and CDC27 failed to complement the corresponding deletion mutants of budding yeast. However, their depletion from procyclic-form T. brucei enriched cells with two kinetoplasts and an enlarged nucleus possessing short metaphase-like mitotic spindles, suggesting that APC1 and CDC27 may play essential roles in promoting anaphase in the procyclic form. Their depletion from the bloodstream form, however, enriched cells with two kinetoplasts and two nuclei connected through a microtubule bundle, suggesting a late anaphase arrest. This is the first time functional APC/C subunit homologs were identified in T. brucei. The apparent differential activities of this putative APC/C in two distinct developmental stages suggest an unusual function. The apparent lack of functional involvement of some of the other individual structural subunit homologs of APC/C may indicate the structural uniqueness of T. brucei APC/C.	Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Wang, CC (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ccwang@cgl.ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021786, R56AI021786, R21AI021786] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-21786] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arhin GK, 2004, METH MOL B, V270, P277; BIRKETT CR, 1985, FEBS LETT, V187, P211, DOI 10.1016/0014-5793(85)81244-8; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Grossberger R, 1999, J BIOL CHEM, V274, P14500, DOI 10.1074/jbc.274.20.14500; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Heichman KA, 1996, CELL, V85, P39, DOI 10.1016/S0092-8674(00)81080-6; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Irniger S, 1997, J CELL SCI, V110, P1523; Kramer KM, 1998, EMBO J, V17, P498, DOI 10.1093/emboj/17.2.498; LAMB JR, 1994, EMBO J, V13, P4321, DOI 10.1002/j.1460-2075.1994.tb06752.x; Li JL, 2003, BIOCHEM BIOPH RES CO, V306, P918, DOI 10.1016/S0006-291X(03)01084-2; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Li ZY, 2002, J BIOL CHEM, V277, P42686, DOI 10.1074/jbc.M207183200; Li ZY, 2002, J BIOL CHEM, V277, P15486, DOI 10.1074/jbc.M109029200; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P195, DOI 10.1016/S0968-0004(97)01058-X; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Morris JC, 2001, MOL BIOCHEM PARASIT, V117, P111, DOI 10.1016/S0166-6851(01)00334-6; Mutomba MC, 1997, MOL BIOCHEM PARASIT, V90, P491, DOI 10.1016/S0166-6851(97)00197-7; Ohta T, 1999, ONCOGENE, V18, P6758, DOI 10.1038/sj.onc.1203115; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Peters JM, 1996, SCIENCE, V274, P1199, DOI 10.1126/science.274.5290.1199; Ploubidou A, 1999, J CELL SCI, V112, P4641; SASSE R, 1988, J CELL SCI, V90, P577; Smith KN, 1999, YEAST, V15, P1255, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1255::AID-YEA451>3.0.CO;2-L; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; TUGENDREICH S, 1993, P NATL ACAD SCI USA, V90, P10031, DOI 10.1073/pnas.90.21.10031; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODWARD R, 1990, J CELL SCI, V95, P49; Yamashita YM, 1996, NATURE, V384, P276, DOI 10.1038/384276a0; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3; Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216	45	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31783	31791		10.1074/jbc.M504326200	http://dx.doi.org/10.1074/jbc.M504326200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15994309	hybrid			2022-12-27	WOS:000231665200057
J	Sergiev, PV; Lesnyak, DV; Burakovsky, DE; Kiparisov, SV; Leonov, AA; Bogdanov, AA; Brimacombe, R; Dontsova, OA				Sergiev, PV; Lesnyak, DV; Burakovsky, DE; Kiparisov, SV; Leonov, AA; Bogdanov, AA; Brimacombe, R; Dontsova, OA			Alteration in location of a conserved GTPase-associated center of the ribosome induced by mutagenesis influences the structure of peptidyltransferase center and activity of elongation factor G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TRANSFER-RNA; CRYOELECTRON MICROSCOPY; EF-G; MUTATIONS; TRANSLOCATION; PROTEIN; LOOP; SUBUNIT; MODEL	Translocation catalyzed by elongation factor G occurs after the peptidyltransferase reaction on the large ribosomal subunit. Deacylated tRNA in the P-site stimulates multiple turnover GTPase activity of EF-G. We suggest that the allosteric signal from the peptidyltransferase center that activates EF-G may involve the alteration in the conformation of elongation factor binding center of the ribosome. The latter consists of the moveable GTPase-associated center and the sarcin-ricin loop that keeps its position on the ribosome during translation elongation. The position of the GTPase-associated center was altered by mutagenesis. An insertion of additional base pair at positions C1030/G1124 was lethal and affected function of EF-G, but not that of EF-Tu. Structure probing revealed a putative allosteric signal pathway connecting the P-site with the binding site of the elongation factors. The results are consistent with the different structural requirements for EF-G and EF-Tu function, where the integrity of the path between the peptidyltransferase center and both GTPase-associated center and sarcin-ricin loop is important for EF-G binding.	Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119992, Russia; Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119992, Russia; Moscow MV Lomonosov State Univ, Dept Bioinformat & Bioengn, Moscow 119992, Russia; Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Lomonosov Moscow State University; Lomonosov Moscow State University; Lomonosov Moscow State University; Max Planck Society	Dontsova, OA (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Bldg A, Moscow 119992, Russia.	dontsova@genebee.msu.su	Sergiev, Petr V/D-7493-2012; Dontsova, Olga/T-6072-2019; Bogdanov, Alexey A/L-1407-2013	Sergiev, Petr V/0000-0001-8866-1863; 				Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; Asai T, 1999, P NATL ACAD SCI USA, V96, P1971, DOI 10.1073/pnas.96.5.1971; BARTETZKO A, 1988, METHOD ENZYMOL, V164, P650; Belova L, 2001, P NATL ACAD SCI USA, V98, P3726, DOI 10.1073/pnas.071527498; BERGEMANN K, 1983, J BIOL CHEM, V258, P5105; Blaha G, 2000, METHOD ENZYMOL, V317, P292; CUNDLIFFE E, 1981, EUR J BIOCHEM, V118, P47, DOI 10.1111/j.1432-1033.1981.tb05484.x; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; EGEBJERG J, 1989, EMBO J, V8, P607, DOI 10.1002/j.1460-2075.1989.tb03415.x; Ehrenberg M, 1990, RIBOSOMES PROTEIN SY, P101; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; Gregory ST, 1999, J MOL BIOL, V285, P1475, DOI 10.1006/jmbi.1998.2410; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harger JW, 2002, TRENDS BIOCHEM SCI, V27, P448, DOI 10.1016/S0968-0004(02)02149-7; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Leonov AA, 2003, J BIOL CHEM, V278, P25664, DOI 10.1074/jbc.M302873200; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; MOINE H, 1994, J MOL BIOL, V243, P402, DOI 10.1006/jmbi.1994.1668; OCONNOR M, 1993, P NATL ACAD SCI USA, V90, P9214, DOI 10.1073/pnas.90.19.9214; POWERS T, 1990, P NATL ACAD SCI USA, V87, P1042, DOI 10.1073/pnas.87.3.1042; Sergiev PV, 2000, J MOL BIOL, V299, P379, DOI 10.1006/jmbi.2000.3739; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1	29	19	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31882	31889		10.1074/jbc.M505670200	http://dx.doi.org/10.1074/jbc.M505670200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16014631	hybrid			2022-12-27	WOS:000231665200067
J	Bertoncini, CW; Fernandez, CO; Griesinger, C; Jovin, TM; Zweckstetter, M				Bertoncini, CW; Fernandez, CO; Griesinger, C; Jovin, TM; Zweckstetter, M			Familial mutants of alpha-synuclein with increased neurotoxicity have a destabilized conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-LINKED MUTATIONS; PARKINSONS-DISEASE; STRUCTURAL-CHARACTERIZATION; NEURODEGENERATIVE DISEASE; UNFOLDED PROTEINS; DIPOLAR COUPLINGS; NMR; AGGREGATION; SYSTEM; DEGRADATION	A30P and A53T mutations of the presynaptic protein alpha- synuclein are associated with familial forms of Parkinson disease. NMR spectroscopy demonstrates that Parkinsonism- linked mutations greatly perturb specific tertiary interactions essential for the native state of alpha- synuclein. However, alpha- synuclein is not completely unfolded but exhibits structural fluctuations on the time scale of secondary structure formation and loses its native conformation gradually when protein stability decreases. The redistribution of the ensemble of alpha- synuclein conformers may underlie toxic gain- of- function by fostering self- association and altered binding affinity to ligands and receptors.	Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany; Univ Nacl Rosario, Inst Biol Mol & Celular Rosario, Consejo Nacl Invest Cient & Tecn, RA-2000 Rosario, Argentina	Max Planck Society; Max Planck Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Zweckstetter, M (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Fassberg 11, D-37077 Gottingen, Germany.	cfernan@gwdg.de; mzwecks@gwdg.de		Fernandez, Claudio Oscar/0000-0003-0454-7735; Bertoncini, Carlos/0000-0001-7695-2882; Zweckstetter, Markus/0000-0002-2536-6581				Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P14, DOI 10.1016/S0028-3908(03)00140-0; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee JC, 2004, P NATL ACAD SCI USA, V101, P16466, DOI 10.1073/pnas.0407307101; Li J, 2002, NEUROTOXICOLOGY, V23, P553, DOI 10.1016/S0161-813X(02)00066-9; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Mohana-Borges R, 2004, J MOL BIOL, V340, P1131, DOI 10.1016/j.jmb.2004.05.022; Morar AS, 2001, PROTEIN SCI, V10, P2195, DOI 10.1110/ps.24301; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Syme CD, 2002, EUR J BIOCHEM, V269, P148, DOI 10.1046/j.0014-2956.2001.02633.x; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n	35	142	144	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30649	30652		10.1074/jbc.C500288200	http://dx.doi.org/10.1074/jbc.C500288200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16020550	Green Published, hybrid			2022-12-27	WOS:000231487800002
J	Friedemann, J; Grosse, F; Zhang, SS				Friedemann, J; Grosse, F; Zhang, SS			Nuclear DNA helicase II (RNA helicase A) interacts with Werner syndrome helicase and stimulates its exonuclease activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME PROTEIN; FUNCTIONAL INTERACTION; POLYMERASE-DELTA; NUCLEOLAR LOCALIZATION; MALELESS PROTEIN; GENE-EXPRESSION; RECQ HELICASES; COMPLEX; REPLICATION; CELLS	Nuclear DNA helicase II (NDH II), alternatively named RNA helicase A, is involved in transcription and RNA processing. Here, we report that NDH II interacts with the Werner syndrome helicase WRN, an enzyme associated with premature aging and predisposition to tumorigenesis. NDH II was co-purified with WRN, DNA polymerase delta, and replication protein A (70 kDa) during several steps of conventional column chromatography. Co-immunoprecipitations revealed an association between NDH II, WRN, and polymerase delta. We demonstrate a direct protein-protein interaction between WRN and NDH II that is mediated by the N-terminal double-strand RNA-binding domain II and C-terminal RGG box of NDH II and the N-terminal exonuclease domain of WRN. WRN inhibited the DNA-dependent NTPase and DNA helicase activities of NDH II. On the other hand, the 3' -> 5' exonuclease activity of WRN was increased by the presence of NDH II. NDH II directly stimulated the exonuclease domain of WRN, whereas the exonuclease domain of WRN suppressed the DNA-dependent (but not RNA-dependent) ATPase activity of NDH II. These results suggest that the double-strand RNA-binding domain II and RGG box of NDH II together form a protein-protein interaction surface that contacts the exonuclease domain of WRN. Furthermore, NDH II enhanced the degradation of D-loop DNA by the WRN exonuclease. Taken together, these results suggest that NDH II plays a role in promoting the DNA processing function of WRN, which in turn might be necessary for maintaining genomic stability.	Inst Mol Biotechnol, Dept Biochem, D-07708 Jena, Germany		Grosse, F (corresponding author), Inst Mol Biotechnol, Dept Biochem, Beutenbergstr 11,Postfach 100 813, D-07745 Jena, Germany.	fgrosse@imb-jena.de						Abdelhaleem M, 2004, BBA-REV CANCER, V1704, P37, DOI 10.1016/j.bbcan.2004.05.001; Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Balajee AS, 1999, MOL BIOL CELL, V10, P2655, DOI 10.1091/mbc.10.8.2655; Brosh RM, 2001, J BIOL CHEM, V276, P35093, DOI 10.1074/jbc.M103332200; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cooper MP, 2000, GENE DEV, V14, P907; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Du XB, 2004, MOL CELL BIOL, V24, P8437, DOI 10.1128/MCB.24.19.8437-8446.2004; Heyer WD, 2004, CURR BIOL, V14, pR895, DOI 10.1016/j.cub.2004.09.073; Hieronymus H, 2004, GENE DEV, V18, P2652, DOI 10.1101/gad.1241204; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; Kamath-Loeb AS, 2000, P NATL ACAD SCI USA, V97, P4603, DOI 10.1073/pnas.97.9.4603; Kamath-Loeb AS, 2001, J BIOL CHEM, V276, P16439, DOI 10.1074/jbc.M100253200; Khakhar RR, 2003, TRENDS CELL BIOL, V13, P493, DOI 10.1016/S0962-8924(03)00171-5; KURODA MI, 1991, CELL, V66, P935, DOI 10.1016/0092-8674(91)90439-6; Kyng KJ, 2003, P NATL ACAD SCI USA, V100, P12259, DOI 10.1073/pnas.2130723100; Lebel M, 1999, J BIOL CHEM, V274, P37795, DOI 10.1074/jbc.274.53.37795; LEE CG, 1993, J BIOL CHEM, V268, P16822; LEE CG, 1992, J BIOL CHEM, V267, P4398; Machwe A, 2004, ONCOGENE, V23, P149, DOI 10.1038/sj.onc.1206906; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; Mischo HE, 2005, J BIOL CHEM, V280, P9586, DOI 10.1074/jbc.M411444200; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Pellizzoni L, 2001, J CELL BIOL, V152, P75, DOI 10.1083/jcb.152.1.75; Reichman TW, 2003, J MOL BIOL, V332, P85, DOI 10.1016/S0022-2836(03)00885-4; Schlegel BP, 2003, ONCOGENE, V22, P983, DOI 10.1038/sj.onc.1206195; Shen JC, 2000, TRENDS GENET, V16, P213, DOI 10.1016/S0168-9525(99)01970-8; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Shiratori M, 2002, ONCOGENE, V21, P2447, DOI 10.1038/sj.onc.1205334; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; Szekely AM, 2000, P NATL ACAD SCI USA, V97, P11365, DOI 10.1073/pnas.97.21.11365; Tang HL, 1997, SCIENCE, V276, P1412, DOI 10.1126/science.276.5317.1412; Terns MP, 2001, CURR BIOL, V11, pR862, DOI 10.1016/S0960-9822(01)00517-6; Vijg J, 2004, TRENDS GENET, V20, P221, DOI 10.1016/j.tig.2004.04.007; von Kobbe C, 2002, J BIOL CHEM, V277, P22035, DOI 10.1074/jbc.M200914200; ZHANG SS, 1994, BIOCHEMISTRY-US, V33, P3906, DOI 10.1021/bi00179a016; ZHANG SS, 1995, J BIOL CHEM, V270, P16422, DOI 10.1074/jbc.270.27.16422; Zhang SS, 1997, J BIOL CHEM, V272, P11487; Zhang SS, 2004, NUCLEIC ACIDS RES, V32, P1, DOI 10.1093/nar/gkg933; ZHANG SS, 1991, J BIOL CHEM, V266, P20483; Zhang SS, 1999, J CELL SCI, V112, P2693	44	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31303	31313		10.1074/jbc.M503882200	http://dx.doi.org/10.1074/jbc.M503882200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15995249	hybrid			2022-12-27	WOS:000231487800078
J	Reddig, PJ; Xu, D; Juliano, RL				Reddig, PJ; Xu, D; Juliano, RL			Regulation of p21-activated kinase-independent Rac1 signal transduction by nischarin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RHO-GTPASES; PROTEIN-KINASE; CELL-CYCLE; NUCLEAR-LOCALIZATION; DEPENDENT PATHWAY; POLYBASIC REGION; ACTIVATION; EXPRESSION; RAS	Nischarin regulates Rac1- dependent cell motility by interaction with and inhibition of the p21- activated kinase ( PAK1). In addition to regulating the activation of PAK1, Rac1 controls multiple downstream pathways to regulate cell growth and differentiation, as well as cell motility. Signaling by a constitutively activated Rac1 mutant deficient in PAK binding ( Rac1Q61L- 40C) was examined to determine whether Nischarin impinges on these other Rac1 effector pathways. Nischarin formed immunoprecipitatable complexes with Rac1Q61L and Rac1Q61L- 40C when the proteins were co- expressed. In NIH3T3 cells, Rac1Q61L and Rac1Q61L- 40C stimulation of a minimal NF- kappa B response element or the cyclin D1 promoter, a downstream target of NF- kappa B, was inhibited by co- expression of Nischarin. Additionally, suppression of endogenous Nischarin protein with small interfering RNA in PC12 cells enhanced Rac1Q61L and Rac1Q61L- 40C activation of NF- kappa B. In further support of Nischarin suppressing PAK independent Rac signaling, foci formation in monolayers of NIH3T3 cells by Rac1Q61L- 40C in cooperation with c- Raf/ CAAX was inhibited by the presence of Nischarin. Nischarin alters the cellular localization of Rac1Q61L and Rac1Q61L- 40C to vesicles and this positively correlates with the repression of the Rac1 signal. Thus, Nischarin, in addition to regulating the PAK strand of Rac1 signaling, can also regulate other links in the web of Rac1 signaling pathways.	Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Juliano, RL (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, 1017 Mary Eleen Jones Bldg,CB 7365, Chapel Hill, NC 27599 USA.	arjay@med.unc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026165] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01-HL4500] Funding Source: Medline; NIGMS NIH HHS [GM26165] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Alahari SK, 2004, BIOCHEM J, V377, P449, DOI 10.1042/BJ20030411; Alahari SK, 2003, EXP CELL RES, V288, P415, DOI 10.1016/S0014-4827(03)00233-7; Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Boyer L, 2004, MOL BIOL CELL, V15, P1124, DOI 10.1091/mbc.E03-05-0301; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cammarano MS, 2001, J BIOL CHEM, V276, P25876, DOI 10.1074/jbc.M011345200; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Joneson T, 1999, MOL CELL BIOL, V19, P5892; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; Joyce D, 1999, J BIOL CHEM, V274, P25245, DOI 10.1074/jbc.274.36.25245; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Lim KP, 2004, J BIOL CHEM, V279, P54770, DOI 10.1074/jbc.M411315200; Matos P, 2003, J BIOL CHEM, V278, P50442, DOI 10.1074/jbc.M308215200; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Page K, 1999, J BIOL CHEM, V274, P22065, DOI 10.1074/jbc.274.31.22065; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Radhakrishna H, 1999, J CELL SCI, V112, P855; Reyes-Reyes M, 2001, J CELL SCI, V114, P1579; Ridley AJ, 2001, DEV CELL, V1, P160, DOI 10.1016/S1534-5807(01)00029-6; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; Tang Y, 1999, MOL CELL BIOL, V19, P1881; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6	49	24	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30994	31002		10.1074/jbc.M502546200	http://dx.doi.org/10.1074/jbc.M502546200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	16002401	hybrid, Green Published			2022-12-27	WOS:000231487800042
J	Gohil, VM; Thompson, MN; Greenberg, ML				Gohil, VM; Thompson, MN; Greenberg, ML			Synthetic lethal interaction of the mitochondrial phosphatidylethanolamine and cardiolipin biosynthetic pathways in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMORPHIC PHASE-BEHAVIOR; TEMPERATURE SENSITIVITY; SUBCELLULAR MEMBRANES; LIPID-COMPOSITION; ESCHERICHIA-COLI; CARBON-SOURCES; NULL ALLELE; WILD-TYPE; SYNTHASE; GENE	Saccharomyces cerevisiae mitochondria contain enzymes required for synthesis of the phospholipids cardiolipin ( CL) and phosphatidylethanolamine ( PE), which are enriched in mitochondrial membranes. Previous studies indicated that PE may compensate for the lack of CL, and vice versa. These data suggest that PE and CL have overlapping functions and that the absence of both lipids may be lethal. To address this hypothesis, we determined whether the crd1 Delta mutant, which lacks CL, was viable in genetic backgrounds in which PE synthesis was genetically blocked. Deletion of the mitochondrial PE pathway gene PSD1 was synthetically lethal with the crd1 Delta mutant, whereas deletion of the Golgi and endoplasmic reticulum pathway genes PSD2 and DPL1 did not result in synthetic lethality. A 20- fold reduction in phosphatidylcholine did not affect the growth of crd1 Delta cells. Supplementation with ethanolamine, which led to increased PE synthesis, or with propanolamine, which led to synthesis of the novel phospholipid phosphatidylpropanolamine, failed to rescue the synthetic lethality of the crd1 Delta psd1 Delta cells. These results suggest that mitochondrial biosynthesis of PE is essential for the viability of yeast mutants lacking CL.	Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall,Biol Sci Bldg, Detroit, MI 48202 USA.	MLGREEN@sun.science.wayne.edu		Gohil, Vishal/0000-0002-9920-2563	NHLBI NIH HHS [HL62263] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062263] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Choi JY, 2004, J BIOL CHEM, V279, P42321, DOI 10.1074/jbc.M405074200; CULLIS PR, 1978, BIOCHIM BIOPHYS ACTA, V513, P31, DOI 10.1016/0005-2736(78)90109-8; DAUM G, 1982, J BIOL CHEM, V257, P3028; de Kruijff B, 1997, CURR OPIN CHEM BIOL, V1, P564, DOI 10.1016/S1367-5931(97)80053-1; Dzugasova V, 1998, CURR GENET, V34, P297, DOI 10.1007/s002940050399; FOLCH J, 1957, J BIOL CHEM, V226, P497; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200; JAKOVCIC S, 1971, J CELL BIOL, V48, P490, DOI 10.1083/jcb.48.3.490; Janitor M, 1996, FEMS MICROBIOL LETT, V140, P43; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 1999, MOL MICROBIOL, V31, P373, DOI 10.1046/j.1365-2958.1999.01181.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; MENON AK, 1992, J BIOL CHEM, V267, P15277; RIETVELD AG, 1993, J BIOL CHEM, V268, P12427; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; SCHLAME M, 1991, J BIOL CHEM, V266, P22398; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; TAMAI KT, 1990, BIOCHIM BIOPHYS ACTA, V1046, P214, DOI 10.1016/0005-2760(90)90192-Z; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Tuller G, 1999, YEAST, V15, P1555, DOI 10.1002/(SICI)1097-0061(199910)15:14<1555::AID-YEA479>3.0.CO;2-Z; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; VASILENKO I, 1982, BIOCHIM BIOPHYS ACTA, V684, P282, DOI 10.1016/0005-2736(82)90018-9; Wikstrom M, 2004, J BIOL CHEM, V279, P10484, DOI 10.1074/jbc.M310183200; Zhong Q, 2005, MOL BIOL CELL, V16, P665, DOI 10.1091/mbc.E04-09-0808; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	38	108	108	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2005	280	42					35410	35416		10.1074/jbc.M505478200	http://dx.doi.org/10.1074/jbc.M505478200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973ZN	16036913	hybrid			2022-12-27	WOS:000232561200040
J	Sakoh, M; Ito, K; Akiyama, Y				Sakoh, M; Ito, K; Akiyama, Y			Proteolytic activity of HtpX, a membrane-bound and stress-controlled protease from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FTSH-MEDIATED PROTEOLYSIS; SIGMA-FACTOR; GENE; SECY; PROTEINS; EXPRESSION; SUBSTRATE; SUBUNIT; PRODUCT; COMPLEX	Escherichia coli HtpX is a putative membrane-bound zinc metalloprotease that has been suggested to participate in the proteolytic quality control of membrane proteins in conjunction with FtsH, a membrane-bound and ATP-dependent protease. Here, we biochemically characterized HtpX and confirmed its proteolytic activities against membrane and soluble proteins. HtpX underwent self-degradation upon cell disruption or membrane solubilization. Consequently, we purified HtpX under denaturing conditions and then refolded it in the presence of a zinc chelator. When supplemented with Zn2+, the purified enzyme exhibited self-cleavage activity. In the presence of zinc, it also degraded casein and cleaved a solubilized membrane protein, SecY. We verified its ability to cleave SecY in vivo by overproducing both HtpX and SecY. These results showed that HtpX is a zinc-dependent endoprotease member of the membrane-localized proteolytic system in E. coli.	Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan	Kyoto University	Akiyama, Y (corresponding author), Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan.	yakiyama@virus.kyoto-u.ac.jp						Ades SE, 2004, CURR OPIN MICROBIOL, V7, P157, DOI 10.1016/j.mib.2004.02.010; AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; Akiyama Y, 1998, MOL MICROBIOL, V28, P803, DOI 10.1046/j.1365-2958.1998.00843.x; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; AKIYAMA Y, 1995, J BIOL CHEM, V270, P23485, DOI 10.1074/jbc.270.40.23485; Akiyama Y, 2003, J BIOL CHEM, V278, P18146, DOI 10.1074/jbc.M302152200; Akiyama Y, 1996, FEBS LETT, V399, P26, DOI 10.1016/S0014-5793(96)01283-5; AKIYAMA Y, 1985, EMBO J, V4, P3351, DOI 10.1002/j.1460-2075.1985.tb04088.x; Akiyama Y, 2000, EMBO J, V19, P3888, DOI 10.1093/emboj/19.15.3888; AKIYAMA Y, 2004, HDB PROTEOLYTIC ENZY, P794; Chiba S, 2002, J BACTERIOL, V184, P4775, DOI 10.1128/JB.184.17.4775-4782.2002; Chiba S, 2000, EMBO REP, V1, P47, DOI 10.1093/embo-reports/kvd005; Coltri PP, 2004, CURR MICROBIOL, V48, P391, DOI 10.1007/s00284-003-4179-1; Davis R., 1980, ADV BACTERIAL GENETI; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Grigorova IL, 2004, GENE DEV, V18, P2686, DOI 10.1101/gad.1238604; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; ITO K, 1984, MOL GEN GENET, V197, P204, DOI 10.1007/BF00330964; Kaser M, 2003, J BIOL CHEM, V278, P46414, DOI 10.1074/jbc.M305584200; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; Kihara A, 1998, J MOL BIOL, V279, P175, DOI 10.1006/jmbi.1998.1781; Kihara A, 1999, EMBO J, V18, P2970, DOI 10.1093/emboj/18.11.2970; KORNITZER D, 1991, J BACTERIOL, V173, P2944, DOI 10.1128/JB.173.9.2944-2953.1991; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; SAWANO A, 2000, NUCLEIC ACIDS RES, V28, P78, DOI DOI 10.1093/NAR/28.16.E78; Shimohata N, 2002, GENES CELLS, V7, P653, DOI 10.1046/j.1365-2443.2002.00554.x; SHIMOIKE T, 1995, J BIOL CHEM, V270, P5519, DOI 10.1074/jbc.270.10.5519; TAM A, 1998, HDB PROTEOLYTIC ENZY, P1094; Vickerman MM, 2002, ORAL MICROBIOL IMMUN, V17, P22, DOI 10.1046/j.0902-0055.2001.00000.x	32	87	93	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33305	33310		10.1074/jbc.M506180200	http://dx.doi.org/10.1074/jbc.M506180200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16076848	hybrid			2022-12-27	WOS:000232058100026
J	Vainonen, JP; Hansson, M; Vener, AV				Vainonen, JP; Hansson, M; Vener, AV			STN8 protein kinase in Arabidopsis thaliana is specific in phosphorylation of photosystem II core proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HARVESTING COMPLEX II; THYLAKOID PROTEIN; IN-VIVO; STATE TRANSITIONS; D1 PROTEIN; CHLAMYDOMONAS-REINHARDTII; PHOTOSYNTHETIC MEMBRANES; PHOSPHOPROTEOME ANALYSIS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE	Combination of reversed genetics with analyses of in vivo protein phosphorylation in Arabidopsis thaliana revealed that STN8 protein kinase is specific in phosphorylation of N-terminal threonine residues in D1, D2, and CP43 proteins, and Thr-4 in the PsbH protein of photosystem II. Phosphorylation of D1, D2, and CP43 in the light-exposed leaves of two Arabidopsis lines with T-DNA insertions in the stn8 gene was found significantly reduced in the assays with anti-phosphothreonine antibodies. Protein phosphorylation in each of the mutants was quantified comparatively to the wild type by mass spectrometric analyses of phosphopeptides released from the photosynthetic membranes and differentially labeled with stable isotopes. The lack of STN8 caused 50 - 60% reduction in D1 and D2 phosphorylation, but did not change the phosphorylation level of two peptides that could correspond to light-harvesting proteins encoded by seven different genes in Arabidopsis. Phosphorylation of the PsbH protein at Thr-4 was completely abolished in the plants lacking STN8. Phosphorylation of Thr-4 in the wild type required both light and prior phosphorylation at Thr-2, indicating that STN8 is a light-activated kinase that phosphorylates Thr-4 only after another kinase phosphorylates Thr-2. Analysis of the STN8 catalytic domain suggests that selectivity of STN8 in phosphorylation of the very N-terminal residues in D1, D2, and CP43, and Thr-4 in PsbH pre-phosphorylated at Thr-2 may be explained by the long loops obstructing entrance into the kinase active site and seven additional basic residues in the vicinity of the catalytic site, as compared with the homologous STN7 kinase responsible for phosphorylation of light-harvesting proteins.	Linkoping Univ, Div Cell Biol, SE-58185 Linkoping, Sweden	Linkoping University	Vener, AV (corresponding author), Linkoping Univ, Div Cell Biol, SE-58185 Linkoping, Sweden.	aleve@ibk.liu.se						Adams WW, 2001, PHOTOSYNTH RES, V67, P51, DOI 10.1023/A:1010688528773; Allen JF, 2003, SCIENCE, V299, P1530, DOI 10.1126/science.1082833; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aro EM, 2004, METH MOL B, V274, P271; Aro EM, 2003, ANTIOXID REDOX SIGN, V5, P55, DOI 10.1089/152308603321223540; Baena-Gonzalez E, 1999, PLANTA, V208, P196, DOI 10.1007/s004250050550; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; BENNETT J, 1980, EUR J BIOCHEM, V104, P85, DOI 10.1111/j.1432-1033.1980.tb04403.x; Booij-James IS, 2002, PLANT PHYSIOL, V130, P2069, DOI 10.1104/pp.013441; Carlberg I, 1999, BIOCHEMISTRY-US, V38, P3197, DOI 10.1021/bi982506o; Carlberg I, 1996, PHOTOSYNTH RES, V47, P145, DOI 10.1007/BF00016177; CLELAND RE, 1990, AUST J PLANT PHYSIOL, V17, P641, DOI 10.1071/PP9900641; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Ebbert V, 1996, PHOTOSYNTH RES, V50, P257, DOI 10.1007/BF00033124; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Finazzi G, 2001, J BIOL CHEM, V276, P9770, DOI 10.1074/jbc.M010092200; Gomez SM, 2002, MOL CELL PROTEOMICS, V1, P46, DOI 10.1074/mcp.M100007-MCP200; GREER DH, 1986, PLANTA, V168, P253, DOI 10.1007/BF00402971; Hansson M, 2003, MOL CELL PROTEOMICS, V2, P550, DOI 10.1074/mcp.M300050-MCP200; He T, 2004, J AM SOC MASS SPECTR, V15, P363, DOI 10.1016/j.jasms.2003.11.004; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kieselbach T, 1998, J BIOL CHEM, V273, P6710, DOI 10.1074/jbc.273.12.6710; Koivuniemi A, 1995, BIOCHEMISTRY-US, V34, P16022, DOI 10.1021/bi00049a016; Loyet KM, 2005, MOL CELL PROTEOMICS, V4, P235, DOI 10.1074/mcp.R400011-MCP200; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; MATTOO AK, 1987, P NATL ACAD SCI USA, V84, P1497, DOI 10.1073/pnas.84.6.1497; MATTOO AK, 1981, P NATL ACAD SCI-BIOL, V78, P1572, DOI 10.1073/pnas.78.3.1572; Noren H, 1999, BIOSCIENCE REP, V19, P499, DOI 10.1023/A:1020280710067; OHAD I, 1984, J CELL BIOL, V99, P481, DOI 10.1083/jcb.99.2.481; Rintamaki E, 1997, J BIOL CHEM, V272, P30476, DOI 10.1074/jbc.272.48.30476; Rintamaki E, 2000, P NATL ACAD SCI USA, V97, P11644, DOI 10.1073/pnas.180054297; RINTAMAKI E, 1995, PLANTA, V195, P379, DOI 10.1007/BF00202595; Rintamaki E, 1996, J BIOL CHEM, V271, P14870, DOI 10.1074/jbc.271.25.14870; Rokka A, 2000, PLANT PHYSIOL, V123, P1525, DOI 10.1104/pp.123.4.1525; Snyders S, 2001, J BIOL CHEM, V276, P32169, DOI 10.1074/jbc.M102539200; Snyders S, 1999, J BIOL CHEM, V274, P9137, DOI 10.1074/jbc.274.14.9137; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Till JH, 2002, STRUCTURE, V10, P1187, DOI 10.1016/S0969-2126(02)00814-6; Turkina MV, 2004, FEBS LETT, V564, P104, DOI 10.1016/S0014-5793(04)00323-0; Tyystjarvi E, 1996, P NATL ACAD SCI USA, V93, P2213, DOI 10.1073/pnas.93.5.2213; Vener AV, 2001, J BIOL CHEM, V276, P6959, DOI 10.1074/jbc.M009394200; Vener AV, 1998, CURR OPIN PLANT BIOL, V1, P217, DOI 10.1016/S1369-5266(98)80107-6; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; Vener AV, 1999, BIOCHEMISTRY-US, V38, P14955, DOI 10.1021/bi990971v; VENER AV, 1995, J BIOL CHEM, V270, P25225, DOI 10.1074/jbc.270.42.25225; VENER AV, 2005, PHOTOPROTECTION PHOT, P107; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	51	164	172	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33679	33686		10.1074/jbc.M505729200	http://dx.doi.org/10.1074/jbc.M505729200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16040609	hybrid			2022-12-27	WOS:000232058100070
J	Slawson, C; Zachara, NE; Vosseller, K; Cheung, WD; Lane, MD; Hart, GW				Slawson, C; Zachara, NE; Vosseller, K; Cheung, WD; Lane, MD; Hart, GW			Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; GLCNAC TRANSFERASE; CELL-CYCLE; NUCLEOCYTOPLASMIC PROTEINS; CYTOPLASMIC PROTEINS; INSULIN-RESISTANCE; CLONAL EXPANSION; BINDING PROTEIN; POTENTIAL ROLE; X-CHROMOSOME	The dynamic modification of nuclear and cytoplasmic proteins with O-linked beta-N-acetylglucosamine (O-GlcNAc) is a regulatory post-translational modification that is rapidly responsive to morphogens, hormones, nutrients, and cellular stress. Here we show that O-GlcNAc is an important regulator of the cell cycle. Increased O-GlcNAc (pharmacologically or genetically) results in growth defects linked to delays in G(2)/M progression, altered mitotic phosphorylation, and cyclin expression. Overexpression of O-GlcNAcase, the enzyme that removes O-GlcNAc, induces amitotic exit phenotype accompanied by a delay in mitotic phosphorylation, altered cyclin expression, and pronounced disruption in nuclear organization. Overexpression of the O-GlcNAc transferase, the enzyme that adds O-GlcNAc, results in a polyploid phenotype with faulty cytokinesis. Notably, O-GlcNAc transferase is concentrated at the mitotic spindle and midbody at M phase. These data suggest that dynamic O-GlcNAc processing is a pivotal regulatory component of the cell cycle, controlling cell cycle progression by regulating mitotic phosphorylation, cyclin expression, and cell division.	Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California San Francisco	Hart, GW (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu		Hart, Gerald/0000-0001-7812-4351	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD013563, R37HD013563] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA042486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671] Funding Source: NIH RePORTER; NCI NIH HHS [CA42486] Funding Source: Medline; NICHD NIH HHS [HD13563] Funding Source: Medline; NIDDK NIH HHS [DK61671] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams PD, 2001, BBA-REV CANCER, V1471, pM123, DOI 10.1016/S0304-419X(01)00019-1; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; Bailis JM, 2003, CELL CYCLE, V2, P303, DOI 10.4161/cc.2.4.434; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; CHOU CF, 1993, J BIOL CHEM, V268, P4465; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dudognon P, 2004, FEBS LETT, V561, P44, DOI 10.1016/S0014-5793(04)00109-7; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Fang B, 2001, EXP CELL RES, V263, P243, DOI 10.1006/excr.2000.5110; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Haltiwanger RS, 1997, J BIOL CHEM, V272, P8752, DOI 10.1074/jbc.272.13.8752; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; HUBER KR, 1987, BRIT J CANCER, V55, P653, DOI 10.1038/bjc.1987.133; JACKSON SP, 1989, P NATL ACAD SCI USA, V86, P1781, DOI 10.1073/pnas.86.6.1781; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; KEARSE KP, 1991, P NATL ACAD SCI USA, V88, P1701, DOI 10.1073/pnas.88.5.1701; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; LEVENBERG B, 1957, J BIOL CHEM, V225, P163; Logarinho E, 1998, J CELL SCI, V111, P2897; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Miller MW, 1999, ARCH BIOCHEM BIOPHYS, V367, P51, DOI 10.1006/abbi.1999.1237; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Robertson LA, 2004, J ALZHEIMERS DIS, V6, P489; Schultz J, 2002, FEBS LETT, V529, P179, DOI 10.1016/S0014-5793(02)03322-7; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Slawson C, 2003, CURR OPIN STRUC BIOL, V13, P631, DOI 10.1016/j.sbi.2003.08.003; Slawson C, 2002, BBA-GEN SUBJECTS, V1573, P121, DOI 10.1016/S0304-4165(02)00369-0; Slawson C, 2001, BBA-MOL BASIS DIS, V1537, P147, DOI 10.1016/S0925-4439(01)00067-9; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Sumegi M, 2003, BIOCHEM BIOPH RES CO, V312, P1284, DOI 10.1016/j.bbrc.2003.11.074; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Walgren JLE, 2003, AM J PHYSIOL-ENDOC M, V284, pE424, DOI 10.1152/ajpendo.00382.2002; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; WICE BM, 1985, J BIOL CHEM, V260, P139; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	65	216	226	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32944	32956		10.1074/jbc.M503396200	http://dx.doi.org/10.1074/jbc.M503396200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16027160	hybrid			2022-12-27	WOS:000231920300049
J	Smith, GB; Umbach, JA; Hirano, A; Gundersen, CB				Smith, GB; Umbach, JA; Hirano, A; Gundersen, CB			Interaction between constitutively expressed heat shock protein, Hsc 70, and cysteine string protein is important for cortical granule exocytosis in Xenopus oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAEVIS OOCYTES; NEUROTRANSMITTER EXOCYTOSIS; NEUROMUSCULAR-JUNCTIONS; REGULATED EXOCYTOSIS; COGNATE PROTEIN; CALCIUM-CHANNEL; MEMBRANE-FUSION; MESSENGER-RNA; C-TERMINUS; J-DOMAIN	In many species, binding of sperm to the egg initiates cortical granule exocytosis, an event that contributes to a sustained block of polyspermy. Interestingly, cortical granule exocytosis can be elicited in immature Xenopus oocytes by the protein kinase C activator, phorbol- 12- myristate- 13- acetate. In this study, we investigated the role of cysteine string protein ( csp) in phorbol- 12- myristate- 13- acetate- evoked cortical granule exocytosis. Prior work indicated that csp is associated with cortical granules of Xenopus oocytes. In oocytes exhibiting > 20- fold overexpression of full- length Xenopus csp, cortical granule exocytosis was reduced by similar to 80%. However, csp overexpression did not affect constitutive exocytosis. Subcellular fractionation and confocal fluorescence microscopy revealed that little or none of the overexpressed csp was associated with cortical granules. This accumulation of csp at sites other than cortical granules suggested that mislocalized csp might sequester a protein that is important for regulated exocytosis. Because the NH2- terminal region of csp includes a J- domain, which interacts with constitutively expressed 70- kDa heat shock proteins ( Hsc 70), we evaluated the effect of overexpressing the J- domain of csp. Although the native J- domain of csp inhibited cortical granule exocytosis, point mutations that interfere with J- domain binding to Hsc 70 eliminated this inhibition. These data indicate that csp interaction with Hsc 70 molecular chaperones is vital for regulated secretion in Xenopus oocytes.	Univ Calif Los Angeles, David P Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David P Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David P Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gundersen, CB (corresponding author), Univ Calif Los Angeles, David P Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	cgundersen@mednet.ucla.edu		Gundersen, Cameron/0000-0002-1552-6086	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031934] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS031934] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ali A, 1996, COMP BIOCHEM PHYS B, V113, P681, DOI 10.1016/0305-0491(95)02081-0; Ali A, 1996, BBA-GENE STRUCT EXPR, V1309, P174, DOI 10.1016/S0167-4781(96)00156-X; Arnold C, 2004, J EXP BIOL, V207, P1323, DOI 10.1242/jeb.00898; Augustine GJ, 1996, ANNU REV PHARMACOL, V36, P659, DOI 10.1146/annurev.pa.36.040196.003303; BALINSKY B. I., 1963, ACTA EMBRYOL ET MORPHOL EXPTL, V6, P55; BEMENT WM, 1989, J CELL BIOL, V108, P885, DOI 10.1083/jcb.108.3.885; BEMENT WM, 1990, CELL REGUL, V1, P315, DOI 10.1091/mbc.1.3.315; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Boal F, 2004, BIOCHEMISTRY-US, V43, P16212, DOI 10.1021/bi048612+; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Brown H, 1998, EMBO J, V17, P5048, DOI 10.1093/emboj/17.17.5048; Buchner E, 1997, TRENDS NEUROSCI, V20, P223, DOI 10.1016/S0166-2236(96)10082-5; BURGOYNE RD, 1993, BIOCHEM J, V293, P305, DOI 10.1042/bj2930305; Chamberlain LH, 1998, MOL BIOL CELL, V9, P2259, DOI 10.1091/mbc.9.8.2259; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chamberlain LH, 2000, J NEUROCHEM, V74, P1781, DOI 10.1046/j.1471-4159.2000.0741781.x; Chamberlain LH, 1997, J BIOL CHEM, V272, P31420, DOI 10.1074/jbc.272.50.31420; CHARBONNEAU M, 1984, DEV BIOL, V102, P90, DOI 10.1016/0012-1606(84)90177-5; Chen S, 2002, J PHYSIOL-LONDON, V538, P383, DOI 10.1113/jphysiol.2001.013397; Cordeiro ML, 2004, NEUROPSYCHOPHARMACOL, V29, P39, DOI 10.1038/sj.npp.1300288; Dawson-Scully K, 2000, J NEUROSCI, V20, P6039, DOI 10.1523/JNEUROSCI.20-16-06039.2000; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; Graham ME, 2000, J NEUROSCI, V20, P1281; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; Gundersen CB, 2002, J CELL SCI, V115, P1313; Gundersen CB, 2001, CELL TISSUE RES, V303, P211, DOI 10.1007/s004410000314; GUNDERSEN CB, 1984, NATURE, V308, P421, DOI 10.1038/308421a0; GUNDERSEN CB, 1995, J THEOR BIOL, V172, P269, DOI 10.1006/jtbi.1995.0023; GUNDERSEN CB, 1994, J BIOL CHEM, V269, P19197; GURDON JB, 1971, NATURE, V233, P177, DOI 10.1038/233177a0; HERBERTS C, 1993, INT J DEV BIOL, V37, P397; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kohan SA, 2003, J EXP ZOOL PART A, V300A, P113, DOI 10.1002/jez.a.10317; LANE CD, 1980, EUR J BIOCHEM, V111, P225; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; MANDELL RB, 1990, J CELL BIOL, V111, P1775, DOI 10.1083/jcb.111.5.1775; Mastrogiacomo A, 1998, BBA-MOL CELL RES, V1401, P239, DOI 10.1016/S0167-4889(97)00160-2; Poage RE, 1999, J NEUROPHYSIOL, V82, P50, DOI 10.1152/jn.1999.82.1.50; SCHUEL H, 1978, GAMETE RES, V1, P299, DOI 10.1002/mrd.1120010311; Stahl B, 1999, EUR J CELL BIOL, V78, P375, DOI 10.1016/S0171-9335(99)80079-X; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Umbach JA, 1998, J NEUROSCI, V18, P3233; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; Umbach JA, 1997, J NEUROSCI, V17, P7203; Zampighi GA, 1999, J GEN PHYSIOL, V113, P507, DOI 10.1085/jgp.113.4.507; Zhang H, 1998, FEBS LETT, V437, P267, DOI 10.1016/S0014-5793(98)01233-2; Zhang H, 1999, J CELL SCI, V112, P1345; Zinsmaier KE, 2001, BIOCHEM PHARMACOL, V62, P1, DOI 10.1016/S0006-2952(01)00648-7; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	50	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32669	32675		10.1074/jbc.M501806200	http://dx.doi.org/10.1074/jbc.M501806200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16055447	Green Accepted, hybrid			2022-12-27	WOS:000231920300016
J	Gesty-Palmer, D; El Shewy, H; Kohout, TA; Luttrell, LM				Gesty-Palmer, D; El Shewy, H; Kohout, TA; Luttrell, LM			beta-arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SIGNAL-REGULATED KINASE-1; BETA-ARRESTIN; ANGIOTENSIN-II; EGF RECEPTOR; MAP KINASE; ERK ACTIVATION; TRANSACTIVATION; ENDOCYTOSIS; PATHWAYS	G protein-coupled receptors often employ novel signaling mechanisms, such as transactivation of epidermal growth factor (EGF) receptors or G protein-independent signals transmitted by beta-arrestins, to control the activity of extracellular signal-regulated kinases 1 and 2 (ERK1/2). In this study we investigated the role of beta-arrestins in lysophosphatidic acid (LPA) receptor-stimulated ERK1/ 2 activation using fibroblast lines derived from wild type, beta-arrestin 1, beta-arrestin 2, and beta-arrestin 1/2 knock-out mice. LPA stimulation produced robust ERK1/ 2 phosphorylation in all four backgrounds. In cells lacking beta-arrestin 2, > 80% of LPA-stimulated ERK1/ 2 phosphorylation was mediated by transactivated EGF receptors. In contrast, ERK1/ 2 activation in cells expressing beta-arrestin 2 was predominantly EGF receptor-independent. Introducing FLAG epitope-tagged beta-arrestin 2 into the beta-arrestin 1/2 null background restored EGF receptor-independent ERK1/ 2 activation, indicating that beta-arrestin 2 expression confers ERK1/ 2 activation via a distinct mechanism. To determine the contributions of beta-arrestin 2, transactivated EGF receptors, and ERK1/ 2 to LPA-stimulated transcriptional responses, we employed gene expression arrays containing cDNA markers for G protein-coupled receptor-mediated signaling. In the beta-arrestin 1/2 null background, 1 h of exposure to LPA significantly increased transcription of seven marker genes. Six of these responses were EGF receptor-dependent, and two required ERK1/ 2 activation. In beta-arrestin 2 expressing cells, three of the seven LPA-stimulated transcriptional responses observed in the beta-arrestin 1/2 null background were lost. The four residual responses were independent of EGF receptor transactivation, but all were ERK1/2-dependent. These data indicate that beta-arrestin 2 functions both to attenuate EGF receptor transactivation-dependent signaling and to promote a distinct subset of ERK1/2-mediated responses to LPA receptor activation.	Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Durham Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Durham, NC 27705 USA; Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; Neurocrine Biosci Inc, Dept Exploratory Discovery, San Diego, CA 92121 USA; Neurocrine Biosci Inc, Dept Mol Biol, San Diego, CA 92121 USA	Medical University of South Carolina; Medical University of South Carolina; Duke University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Neurocrine Biosciences; Neurocrine Biosciences	Luttrell, LM (corresponding author), Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, 96 Jonathan Lucas St,816 CSB,POB 250624, Charleston, SC 29425 USA.	luttrell@musc.edu		Luttrell, Louis/0000-0003-2805-6949	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064353, R01DK055524, R56DK055524] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK55524, DK64353] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmed I, 2003, MOL ENDOCRINOL, V17, P1607, DOI 10.1210/me.2002-0040; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Grewal SS, 2000, J BIOL CHEM, V275, P34433, DOI 10.1074/jbc.M004728200; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; Heeneman S, 2000, J BIOL CHEM, V275, P15926, DOI 10.1074/jbc.M909616199; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LINSEMAN DA, 1995, J BIOL CHEM, V270, P12563, DOI 10.1074/jbc.270.21.12563; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Terrillon S, 2004, EMBO J, V23, P3950, DOI 10.1038/sj.emboj.7600387; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wei HJ, 2004, J BIOL CHEM, V279, P48255, DOI 10.1074/jbc.M406205200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	43	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32157	32167		10.1074/jbc.M507460200	http://dx.doi.org/10.1074/jbc.M507460200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16027114	hybrid			2022-12-27	WOS:000231794800016
J	Kim, JK; Xu, Y; Xu, XJ; Keene, DR; Gurusiddappa, S; Liang, XW; Wary, KK; Hook, M				Kim, JK; Xu, Y; Xu, XJ; Keene, DR; Gurusiddappa, S; Liang, XW; Wary, KK; Hook, M			A novel binding site in collagen type III for integrins alpha(1)beta(1) and alpha(2)beta(1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRINS ALPHA(1)BETA(1); I-DOMAIN; RECOGNITION; SEQUENCE; IDENTIFICATION; RECEPTORS; DISEASES; CLONING; GFOGER	Previously identified high affinity integrin-binding motifs in collagens, GFOGER and GLOGER, are not present in type III collagen. Here, we first characterized the binding of recombinant I domains from integrins alpha(1) and alpha(2) (alpha(1)I and alpha(2)I) to fibrillar collagen types I-III and showed that each I domain bound to the three types of collagens with similar affinities. Using rotary shadowing followed by electron microscopy, we identified a high affinity binding region in human type III collagen recognized by alpha(1)I and alpha(2)I. Examination of the region revealed the presence of two sequences that contain the critical GERmotif, GROGER and GAOGER. Collagen-like peptides containing these two motifs were synthesized, and their triple helical nature was confirmed by circular dichroism spectroscopy. Experiments show that the GROGER-containing peptide was able to bind both alpha(1)I and alpha(2)I with high affinity and effectively inhibit the binding of alpha(1)I and alpha(2)I to type III and I collagens, whereas the GAOGER-containing peptide was considerably less effective. Furthermore, the GROGER-containing peptide supported adhesion of human lung fibroblast cells when coated on a culture dish. Thus, we have identified a novel high affinity binding sequence for the collagen-binding integrin I domains.	Texas A&M Univ, Syst Hlth Sci Ctr, Ctr Extracellular Matrix Biol, Inst Biosci & Technol, Houston, TX 77030 USA; Shriners Hosp Children, Portland, OR 97201 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Hook, M (corresponding author), Texas A&M Univ, Syst Hlth Sci Ctr, Ctr Extracellular Matrix Biol, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	mhook@ibt.tamhsc.edu		Wary, Kishore/0000-0001-8851-8565; Liang, Xiaowen/0000-0002-6174-2951	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044415] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR44415] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gullberg DE, 2002, PROG HISTOCHEM CYTO, V37, P9; Hulmes DJS, 1992, ESSAYS BIOCHEM, V27, P49; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; KRAMER RH, 1989, J BIOL CHEM, V264, P4684; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; PATTI JM, 1992, J BIOL CHEM, V267, P4766; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; RAMACHANDRAN GN, 1988, INT J PEPT PROT RES, V31, P1; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200	24	84	94	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32512	32520		10.1074/jbc.M502431200	http://dx.doi.org/10.1074/jbc.M502431200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16043429	hybrid			2022-12-27	WOS:000231794800060
J	Nakamura, F; Hartwig, JH; Stossel, TP; Szymanski, PT				Nakamura, F; Hartwig, JH; Stossel, TP; Szymanski, PT			Ca2+ and calmodulin regulate the binding of filamin A to actin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; ALPHA-ACTININ; CH DOMAINS; PROTEINS; SMOOTH; SEQUENCE; SUPERFAMILY; SENSITIVITY; DYSTROPHIN; MECHANICS	Filamin A (FLNa) cross-links actin filaments (F-actin) into three-dimensional gels in cells, attaches F-actin to membrane proteins, and is a scaffold that collects numerous and diverse proteins. We report that Ca2+-calmodulin binds the actin-binding domain (ABD) of FLNa and dissociates FLNa from F- actin, thereby dissolving (FLNaF)-F-.-actin gels. The FLNa ABD has two calponin homology domains (CH1 and CH2) separated by a linker. Recombinant CH1 but neither FLNa nor its ABD binds Ca2+-calmodulin in the absence of F- actin. Extending recombinant CH1 to include the negatively charged region linker domain makes it, like full-length FLNa, unable to bind Ca2+-calmodulin. Ca2+-calmodulin does, however, dissociate the FLNa ABD from F- actin provided that the CH2 domain is present. These findings identify the first evidence for direct regulation of FLNa, implicating amechanism whereby Ca2+-calmodulin selectively targets the (FLNaF)-F-.-actin complex.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Nakamura, F (corresponding author), Brigham & Womens Hosp, Div Hematol, Karp Family Res Labs 6F, 1 Blackfan Circle, Boston, MA 02115 USA.	fnakamura@rics.bwh.harvard.edu	Nakamura, Fumihiko/N-5476-2016	Nakamura, Fumihiko/0000-0002-6872-4246	NHLBI NIH HHS [HL19429, HL56252] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056252, R37HL019429, R01HL019429] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Banuelos S, 1998, STRUCTURE, V6, P1419, DOI 10.1016/S0969-2126(98)00141-5; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERS DM, 1982, AM J PHYSIOL, V242, pC404, DOI 10.1152/ajpcell.1982.242.5.C404; BRESNICK AR, 1991, J BIOL CHEM, V266, P12989; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Gimona M, 1998, CURR BIOL, V8, pR674; HARTWIG JH, 1995, PROTEIN PROFILE, V2, P703; HARTWIG JH, 1986, J CELL BIOL, V103, P1007, DOI 10.1083/jcb.103.3.1007; HARTWIG JH, 1981, J MOL BIOL, V145, P563, DOI 10.1016/0022-2836(81)90545-3; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; JARRETT HW, 1995, J BIOL CHEM, V270, P5578, DOI 10.1074/jbc.270.10.5578; KINOSIAN HJ, 1991, BIOCHIM BIOPHYS ACTA, V1077, P151, DOI 10.1016/0167-4838(91)90052-2; LEVINE BA, 1992, FEBS LETT, V298, P44, DOI 10.1016/0014-5793(92)80019-D; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Nakamura F, 2002, J BIOL CHEM, V277, P9148, DOI 10.1074/jbc.M111297200; PACAUD M, 1993, BIOCHEMISTRY-US, V32, P363, DOI 10.1021/bi00052a045; RADDING W, 1994, J CELL PHYSIOL, V160, P17, DOI 10.1002/jcp.1041600104; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; SOBEL JS, 1988, DEV BIOL, V126, P47, DOI 10.1016/0012-1606(88)90237-0; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Stradal T, 1998, FEBS LETT, V431, P134, DOI 10.1016/S0014-5793(98)00751-0; Szymanska G, 1997, ANAL BIOCHEM, V252, P96, DOI 10.1006/abio.1997.2319; Szymanski PT, 2002, AM J PHYSIOL-CELL PH, V282, pC94, DOI 10.1152/ajpcell.00257.2001; Tang JH, 2001, J MOL BIOL, V310, P845, DOI 10.1006/jmbi.2001.4789; TANSEY MG, 1994, J BIOL CHEM, V269, P9912; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; WINDER SJ, 1995, FEBS LETT, V357, P125, DOI 10.1016/0014-5793(94)01347-4; WINDER SJ, 1995, J CELL SCI, V108, P63; WINDER SJ, 1993, BIOCHEMISTRY-US, V32, P13327, DOI 10.1021/bi00211a046; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; YASUTAKA O, 1995, BIOCHEMISTRY-US, V34, P6745, DOI 10.1021/bi00020a020	35	61	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32426	32433		10.1074/jbc.M502203200	http://dx.doi.org/10.1074/jbc.M502203200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16030015	hybrid			2022-12-27	WOS:000231794800049
J	Huang, CJ; Chang, JG; Wu, SC; Choo, KB				Huang, CJ; Chang, JG; Wu, SC; Choo, KB			Negative transcriptional modulation and silencing of the Bi-exonic Rnf35 gene in the preimplantation embryo - Binding of the CCAAT-displacement protein/Cux to the untranslated exon 1 sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE EMBRYO; CUT REPEATS; EXPRESSION PATTERNS; DIFFERENT MODES; DNA-BINDING; PROMOTER; ACTIVATION; REPRESSION; ELEMENT; REGION	Previous works have indicated promiscuous transcription from the zygotic genome immediately after fertilization. The mouse Rnf35 gene is bi- exonic in structure and is transcribed in the preimplantation embryo until it is permanently silenced at the blastocyst stage of development. We have previously shown that Rnf35 transcription is positively regulated by the nuclear factor Y. Using the uniquely permissive Chinese hamster ovary- K1 cell line in transient transfection assays, we demonstrate in this work that the Rnf35 promoter was negatively modulated by a cis- cognate repressor element, designated as the downstream exon 1 repressor, or DER, residing between + 72 and + 95 in the untranslated exon 1 of the Rnf35 gene. Simultaneous mutagenesis of the two half- sections, DER1 and DER2, of the DER sequence was required for derepression suggesting participation of multiple proteins in the DER- dependent transcriptional repression. Electrophoretic mobility shift assays demonstrated that the 3 '- half of DER ( DER2) was targeted by the repressor CCAAT- displacement protein ( CDP)/ Cux. Chromatin immunoprecipitation experiments further demonstrated in vivo CDP- DER association in the blastocyst and the 8.5day embryo. Furthermore, the DER- dependent repression was partially relieved in vivo in co- transfection with an antisense CDP construct. Transcription of the Cdp gene was shown to first occur between the eight- cell and the blastocyst stages, correlating and possibly explaining the onset of Rnf35 silencing at the blastocyst stage. Taken together, our results suggest that the evolutionarily acquired exon 1 of Rnf35, and possibly exon 1 of other similarly structured bi- exonic early embryonic genes, contributes to transcriptional modulation and silencing in the developing mouse embryo.	Vet Gen Hosp, Dept Med Res & Educ, Taipei 11217, Taiwan; Chinese Culture Univ, Coll Agr, Dept Anim Sci, Taipei 111, Taiwan; Chinese Culture Univ, Coll Agr, Grad Inst Biotechnol, Taipei 111, Taiwan; China Med Univ Hosp, Dept Mol Med, Taichung 404, Taiwan; Natl Taiwan Univ, Coll BioResources & Agr, Dept Anim Sci, Taipei 106, Taiwan	Chinese Culture University; Chinese Culture University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Taiwan University	Choo, KB (corresponding author), Vet Gen Hosp, Dept Med Res & Educ, Taipei 11217, Taiwan.	kbchu@vghtpe.gov.tw	Chang, Jan-Gowth/C-9544-2009	Wu, Shinn-Chih/0000-0001-8881-1550				AUFIERO B, 1994, P NATL ACAD SCI USA, V91, P7757, DOI 10.1073/pnas.91.16.7757; Banan M, 1997, J BIOL CHEM, V272, P18440, DOI 10.1074/jbc.272.29.18440; Barbaric S, 1998, MOL CELL BIOL, V18, P2629, DOI 10.1128/MCB.18.5.2629; Bevilacqua A, 2000, DEVELOPMENT, V127, P1541; Bevilacqua A, 1997, NUCLEIC ACIDS RES, V25, P1333, DOI 10.1093/nar/25.7.1333; Bhoite LT, 2002, J BIOL CHEM, V277, P37612, DOI 10.1074/jbc.M206125200; Boudreau F, 2002, MOL CELL BIOL, V22, P5467, DOI 10.1128/MCB.22.15.5467-5478.2002; Chen HH, 2002, GENOMICS, V79, P18, DOI 10.1006/geno.2001.6664; Chen HH, 2002, GENOMICS, V80, P140, DOI 10.1006/geno.2002.6808; Choo KB, 2002, NUCLEIC ACIDS RES, V30, P4836, DOI 10.1093/nar/gkf623; Choo KB, 2001, MOL REPROD DEV, V59, P249, DOI 10.1002/mrd.1029; CHRISTIANS E, 1995, DEVELOPMENT, V121, P113; di Silvio A, 1999, NUCLEIC ACIDS RES, V27, P2578; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; EMAMI KH, 1995, MOL CELL BIOL, V15, P5906; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Goebel P, 2002, J IMMUNOL, V169, P2477, DOI 10.4049/jimmunol.169.5.2477; HARADA R, 1995, MOL CELL BIOL, V15, P129, DOI 10.1128/MCB.15.1.129; Huang CJ, 2005, BIOCHEM J, V387, P367, DOI 10.1042/BJ20041364; Huang CJ, 2004, GENE, V324, P117, DOI 10.1016/j.gene.2003.09.022; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kim EC, 1997, CELL GROWTH DIFFER, V8, P1329; Ko MSH, 2000, DEVELOPMENT, V127, P1737; Last TJ, 1998, GENE, V221, P267, DOI 10.1016/S0378-1119(98)00415-6; Li S, 1999, J BIOL CHEM, V274, P7803, DOI 10.1074/jbc.274.12.7803; Liu TYC, 2003, MOL REPROD DEV, V64, P52, DOI 10.1002/mrd.10218; Ma J, 2001, BIOL REPROD, V64, P1713, DOI 10.1095/biolreprod64.6.1713; Mailly F, 1996, MOL CELL BIOL, V16, P5346; MANEJWALA FM, 1991, DEV BIOL, V144, P301, DOI 10.1016/0012-1606(91)90423-Z; Matsumoto K, 1998, EMBO J, V17, P2107, DOI 10.1093/emboj/17.7.2107; Matsumoto K, 1998, TRENDS CELL BIOL, V8, P318, DOI 10.1016/S0962-8924(98)01300-2; Moon NS, 2000, J BIOL CHEM, V275, P31325, DOI 10.1074/jbc.M002912200; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; Nirodi C, 2001, J BIOL CHEM, V276, P26122, DOI 10.1074/jbc.M102872200; Proudfoot N, 2000, TRENDS BIOCHEM SCI, V25, P290, DOI 10.1016/S0968-0004(00)01591-7; ROTHSTEIN JL, 1992, GENE DEV, V6, P1190, DOI 10.1101/gad.6.7.1190; Schultz RM, 1999, J EXP ZOOL, V285, P276, DOI 10.1002/(SICI)1097-010X(19991015)285:3&lt;276::AID-JEZ11&gt;3.0.CO;2-K; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Smale ST, 1998, COLD SPRING HARB SYM, V63, P21, DOI 10.1101/sqb.1998.63.21; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; STATON JAL, 2003, REPRODUCION, V125, P457; Truscott M, 2003, MOL CELL BIOL, V23, P3013, DOI 10.1128/MCB.23.8.3013-3028.2003; Worrad DM, 1997, MOL REPROD DEV, V46, P268, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;268::AID-MRD5&gt;3.0.CO;2-N; Young JM, 2002, HUM MOL GENET, V11, P1153, DOI 10.1093/hmg/11.10.1153; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhou TY, 2002, NUCLEIC ACIDS RES, V30, P4145, DOI 10.1093/nar/gkf537	47	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30681	30688		10.1074/jbc.M413144200	http://dx.doi.org/10.1074/jbc.M413144200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994318	Green Published, hybrid			2022-12-27	WOS:000231487800006
J	Jaeger, T; Arsic, M; Mayer, C				Jaeger, T; Arsic, M; Mayer, C			Scission of the lactyl ether bond of N-acetylmuramic acid by Escherichia coli "etherase"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL MUREIN; BETA-ARYL ETHER; IDENTIFICATION; MECHANISM; HYDROLYSIS; CLEAVAGE; PATHWAY; GENES; ELIMINATION; SPECIFICITY	The ubiquitous bacterial cell wall sugar N-acetylmuramic acid (MurNAc) carries a unique (D)-lactyl ether substituent at the C3 position. Recently, we proposed an etherase capable of cleaving this lactyl ether to be part of the novel bacterial MurNAc dissimilation pathway ( Dahl, U., Jaeger, T., Nguyen, B. T., Sattler, J.M., Mayer, C. (2004) J. Bacteriol. 186, 2385 - 2392). Here, we report the identification of the first known MurNAc etherase. The encoding gene murQ is located at 55 min on the Escherichia coli chromosome adjacent to murP, the MurNAc-specific phosphotransferase system. A murQ deletion mutant could not grow on MurNAc as the sole source of carbon and energy but could be complemented by expressing murQ from a plasmid. The mutant had no obvious phenotype when grown on different carbon sources but accumulated MurNAc 6-phosphate at millimolar concentrations from externally supplied MurNAc. Purified MurQ-His(6) fusion protein and extracts of cells expressing murQ both catalyze the cleavage of MurNAc 6-phosphate, with GlcNAc 6-phosphate and D-lactate being the primary products. The O-18 label from enriched water is incorporated into the sugar molecule, showing that the C3-O bond is cleaved and reformed by the enzyme. Moreover, an intermediate was detected and identified as an unsaturated sugar molecule. Based on this observation, we suggested a lyase-type mechanism (beta-elimination/ hydration) for the cleavage of the lactyl ether bond of MurNAc 6-phosphate. Close homologs of murQ were found on the chromosome of several bacteria, and amino acid sequence similarity with the N-terminal domain of human glucokinase-regulatory protein (GckR or GKRP) was recognized.	Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany	University of Konstanz	Mayer, C (corresponding author), Univ Konstanz, Fachbereich Biol, D-78459 Constance, Germany.	ch.mayer@uni-konstanz.de	Mayer, Christoph/S-8666-2017	Mayer, Christoph/0000-0003-4731-4851				BADET B, 1987, BIOCHEMISTRY-US, V26, P1940, DOI 10.1021/bi00381a023; Bateman A, 1999, TRENDS BIOCHEM SCI, V24, P94, DOI 10.1016/S0968-0004(99)01357-2; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Dahl U, 2004, J BACTERIOL, V186, P2385, DOI 10.1128/JB.186.8.2385-2392.2004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FRINGS J, 1994, ARCH MICROBIOL, V162, P199, DOI 10.1007/s002030050125; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; ISHIBASHI T, 1983, EUR J BIOCHEM, V132, P23, DOI 10.1111/j.1432-1033.1983.tb07320.x; JOLLES P, 1969, ANGEW CHEM INT EDIT, V8, P227, DOI 10.1002/anie.196902271; Masai E, 2003, J BACTERIOL, V185, P1768, DOI 10.1128/JB.185.6.1768-1775.2003; MASAI E, 1991, J BACTERIOL, V173, P7950, DOI 10.1128/jb.173.24.7950-7955.1991; Masai E, 1999, J IND MICROBIOL BIOT, V23, P364, DOI 10.1038/sj.jim.2900747; MAYER C, 2005, CELLULAR MOL BIOL; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Park JT, 2001, J BACTERIOL, V183, P3842, DOI 10.1128/JB.183.13.3842-3847.2001; PARQUET C, 1983, EUR J BIOCHEM, V133, P371, DOI 10.1111/j.1432-1033.1983.tb07472.x; Parsons JF, 2003, BIOCHEMISTRY-US, V42, P5684, DOI 10.1021/bi027385d; PETERSON D, 1974, ARCH BIOCHEM BIOPHYS, V162, P135, DOI 10.1016/0003-9861(74)90112-X; Rajan SS, 2004, STRUCTURE, V12, P1619, DOI 10.1016/j.str.2004.06.020; REISSIG JL, 1955, J BIOL CHEM, V217, P959; ROLLS JP, 1972, J BACTERIOL, V112, P894, DOI 10.1128/JB.112.2.894-902.1972; SELTMANN G, 2002, BACTERIAL CELL WALL, P105; SNYDER F, 1973, BIOCHIM BIOPHYS ACTA, V316, P259, DOI 10.1016/0005-2760(73)90018-0; Speranza G, 2002, J BIOL CHEM, V277, P11684, DOI 10.1074/jbc.M111059200; SPIER JL, 1964, CHEMISTRY, V37, P6; TIPPER DJ, 1968, BIOCHEMISTRY-US, V7, P1441, DOI 10.1021/bi00844a029; Uehara T, 2005, J BACTERIOL, V187, P3643, DOI 10.1128/JB.187.11.3643-3649.2005; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; VanSchaftingen E, 1997, BIOCHEM SOC T, V25, P136, DOI 10.1042/bst0250136; Varrot A, 2005, J MOL BIOL, V346, P423, DOI 10.1016/j.jmb.2004.11.058; White GF, 1996, MICROBIOL REV, V60, P216, DOI 10.1128/MMBR.60.1.216-232.1996; Wiame E, 2002, J BIOL CHEM, V277, P42523, DOI 10.1074/jbc.M200863200; Yip VLY, 2004, J AM CHEM SOC, V126, P8354, DOI 10.1021/ja047632w; YOUNG IG, 1969, BIOCHIM BIOPHYS ACTA, V177, P401, DOI 10.1016/0304-4165(69)90302-X; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	35	43	44	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30100	30106		10.1074/jbc.M502208200	http://dx.doi.org/10.1074/jbc.M502208200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15983044	hybrid			2022-12-27	WOS:000231362500015
J	Santama, N; Ogg, SC; Malekkou, A; Zographos, SE; Weis, K; Lamond, AI				Santama, N; Ogg, SC; Malekkou, A; Zographos, SE; Weis, K; Lamond, AI			Characterization of hCINAP, a novel coilin-interacting protein encoded by a transcript from the transcription factor TAFIID(32) locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAJAL BODIES; GENE-EXPRESSION; ASSOCIATION; SNRNA; SMN; IDENTIFICATION; TRANSPORT; REVEALS; CLONING; LINK	Coilin is a marker protein for the Cajal body, a subnuclear domain acting as a site for assembly and maturation of nuclear RNA-protein complexes. Using a yeast two-hybrid screen to identify coilin-interacting proteins, we have identified hCINAP ( human coilin interacting nuclear ATPase protein), a nuclear factor of 172 amino acids with a P-loop nucleotide binding motif and ATPase activity. The hCINAP protein sequence is highly conserved across its full-length from human to plants and yeast and is ubiquitously expressed in all human tissues and cell lines tested. The yeast orthologue of CINAP is a single copy, essential gene. Tagged hCINAP is present in complexes containing coilin in mammalian cells and recombinant, Escherichia coli expressed hCINAP binds directly to coilin in vitro. The 214 carboxyl-terminal residues of coilin appear essential for the interaction with hCINAP. Both immunofluorescence and fluorescent protein tagging show that hCINAP is specifically nuclear and distributed in a widespread, diffuse nucleoplasmic pattern, excluding nucleoli, with some concentration also in Cajal bodies. Overexpression of hCINAP in HeLa cells results in a decrease in the average number of Cajal bodies per nucleus, consistent with it affecting either the stability of Cajal bodies and/or their rate of assembly. The hCINAP mRNA is an alternatively spliced transcript from the TAF9 locus, which encodes the basal transcription factor subunit TAFIID(32). However, hCINAP and TAFIID(32) mRNAs are translated from different ATG codons and use distinct reading frames, resulting in them having no identity in their respective protein sequences.	Univ Cyprus, Dept Biol Sci, CY-1678 Nicosia, Cyprus; Cyprus Inst Neurol & Genet, CY-1678 Nicosia, Cyprus; Univ Dundee, Div Gene Regulat & Express, Dundee DD1 5EH, Scotland; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of Cyprus; University of Dundee; University of California System; University of California Berkeley	Santama, N (corresponding author), Univ Cyprus, Dept Biol Sci, POB 20537, CY-1678 Nicosia, Cyprus.	santama@ucy.ac.cy; a.i.lamond@lifesci.dundee.ac.uk	Zographos, Spyros/H-9058-2013; Weis, Karsten/F-5719-2011; Santama, Niovi/GLR-7648-2022	Zographos, Spyros/0000-0001-8455-2352; Weis, Karsten/0000-0001-7224-925X; Santama, Niovi/0000-0002-8370-8674; Ogg, Stephen/0000-0003-4157-1654; Malekkou, Anna/0000-0001-5918-9213	Wellcome Trust [073980] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bellini M, 1998, MOL BIOL CELL, V9, P2987, DOI 10.1091/mbc.9.10.2987; BOHMANN K, 1995, J CELL BIOL, V131, P817, DOI 10.1083/jcb.131.4.817; Carvalho T, 1999, J CELL BIOL, V147, P715, DOI 10.1083/jcb.147.4.715; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Frey MR, 1999, CURR BIOL, V9, P126, DOI 10.1016/S0960-9822(99)80066-9; Frey MR, 2001, J CELL BIOL, V154, P499, DOI 10.1083/jcb.200105084; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Hu RM, 2000, P NATL ACAD SCI USA, V97, P9543, DOI 10.1073/pnas.160270997; Isaac C, 1998, J CELL BIOL, V142, P319, DOI 10.1083/jcb.142.2.319; Juhnke H, 2000, MOL MICROBIOL, V35, P936, DOI 10.1046/j.1365-2958.2000.01768.x; KAMBACH C, 1992, J CELL BIOL, V118, P11, DOI 10.1083/jcb.118.1.11; KANDELSLEWIS S, 1993, SCIENCE, V262, P2035, DOI 10.1126/science.8266100; KLEMM RD, 1995, P NATL ACAD SCI USA, V92, P5788, DOI 10.1073/pnas.92.13.5788; Ladomery M, 1997, BIOESSAYS, V19, P903, DOI 10.1002/bies.950191010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai CH, 2000, GENOME RES, V10, P703, DOI 10.1101/gr.10.5.703; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Nachury MV, 1998, P NATL ACAD SCI USA, V95, P582, DOI 10.1073/pnas.95.2.582; Ogg SC, 2002, J CELL BIOL, V159, P17, DOI 10.1083/jcb.200206111; Ren H, 2005, P NATL ACAD SCI USA, V102, P303, DOI 10.1073/pnas.0407459102; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santama N, 1998, EMBO J, V17, P5855, DOI 10.1093/emboj/17.20.5855; Shopland LS, 2001, MOL BIOL CELL, V12, P565, DOI 10.1091/mbc.12.3.565; Shpargel KB, 2003, J CELL SCI, V116, P303, DOI 10.1242/jcs.00211; Skamnaki VT, 1999, BIOCHEMISTRY-US, V38, P14718, DOI 10.1021/bi991454f; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stelzer E H, 1991, Semin Cell Biol, V2, P145; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; WEIS K, 1995, SCIENCE, V268, P1049, DOI 10.1126/science.7754385	33	29	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2005	280	43					36429	36441		10.1074/jbc.M501982200	http://dx.doi.org/10.1074/jbc.M501982200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	976IM	16079131	hybrid			2022-12-27	WOS:000232726900077
J	Verriere, VA; Hynes, D; Faherty, S; Devaney, J; Bousquet, J; Harvey, BJ; Urbach, V				Verriere, VA; Hynes, D; Faherty, S; Devaney, J; Bousquet, J; Harvey, BJ; Urbach, V			Rapid effects of dexamethasone on intracellular pH and Na+/H+ exchanger activity in human bronchial epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; 17 BETA-ESTRADIOL; H+ ANTIPORT; GLUCOCORTICOID-RECEPTOR; NONGENOMIC ACTIONS; NA/H-EXCHANGE; ALDOSTERONE; MEMBRANE; ACTIVATION; TRANSPORT	Glucocorticoids have been shown to produce rapid nongenomic responses in airway epithelia. By using an intracellular pH (pH(i)) spectrofluorescence imaging system and the NH4Cl acid-loading technique, we have shown that the synthetic glucocorticoid, dexamethasone, accelerated intracellular pH recovery after an acid load in a human bronchial epithelial cell line (16HBE14o(-) cells). Exposure to NH4Cl ( 20 mM) elicited an intracellular acidification, followed by a pH(i) recovery. Inhibition of the Na+/H+ exchanger decreased the steady-state pH(i) and antagonized the dexamethasone stimulation of pH(i) regulation. The rapid effect of dexamethasone on pH(i) was neither affected by the inhibitor of transcription, cycloheximide, nor by the classical glucocorticoid and mineralocorticoid receptors antagonists, RU486 and spironolactone, respectively. The dexamethasone effect on pH(i) regulation was reduced by inhibitors of adenylate cyclase, cAMP-dependent protein kinase and mitogen-activated protein kinase (ERK1/2). By using a PepTag assay system and Western blotting, we have shown that dexamethasone stimulated cAMP-dependent protein kinase and mitogen-activated protein kinase activities. Taken together our results provide evidence for the rapid stimulation of Na+/H+ exchange activity by glucocorticoids in bronchial epithelial cells via a nongenomic mechanism involving cAMP-dependent protein kinase and mitogen-activated protein kinase ERK1/2 pathways.	CHU A Villeneuve, INSERM, U454, F-34295 Montpellier, France; Beaumont Hosp, Royal Coll Surg Ireland, Mol Med Labs, Dublin 9, Ireland	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Royal College of Surgeons - Ireland	Urbach, V (corresponding author), CHU A Villeneuve, INSERM, U454, F-34295 Montpellier, France.	urbach@montp.inserm.fr	Harvey, Brian J/A-5120-2010; Urbach, Valerie/C-3615-2012; Harvey, Brian/AAJ-4085-2020	Harvey, Brian J/0000-0002-7388-8034; Urbach, Valerie/0000-0001-7437-9365; Harvey, Brian/0000-0002-7388-8034; Faherty, Sheila/0000-0002-7317-7136; Faherty, Sheila/0000-0001-9618-0912; Devaney, James/0000-0002-7489-5463				Al-Bazzaz F J, 2001, JOP, V2, P285; Alvaro D, 2002, GASTROENTEROLOGY, V122, P1058, DOI 10.1053/gast.2002.32374; Ambuhl PM, 1999, J CLIN INVEST, V103, P429, DOI 10.1172/JCI2913; Andres M, 1997, CELL MOL LIFE SCI, V53, P673, DOI 10.1007/s000180050087; BAUM M, 1994, AM J PHYSIOL, V267, pF437, DOI 10.1152/ajprenal.1994.267.3.F437; BONANNO JA, 1991, OPTOMETRY VISION SCI, V68, P682, DOI 10.1097/00006324-199109000-00002; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; Bousquet J, 2000, CLIN EXP ALLERGY, V30, P2; COOPER GJ, 1994, J PHYSIOL-LONDON, V479, P423, DOI 10.1113/jphysiol.1994.sp020306; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Croxtall JD, 2002, BRIT J PHARMACOL, V135, P511, DOI 10.1038/sj.bjp.0704474; Daufeldt S, 2003, J STEROID BIOCHEM, V85, P9, DOI 10.1016/S0960-0760(03)00141-9; DECOURSEY TE, 1994, J GEN PHYSIOL, V103, P755, DOI 10.1085/jgp.103.5.755; Doolan CM, 2000, BRIT J PHARMACOL, V129, P1375, DOI 10.1038/sj.bjp.0703193; Ebata S, 1999, KIDNEY INT, V56, P1400, DOI 10.1046/j.1523-1755.1999.00674.x; Fan Y, 2002, BIOCHEM BIOPH RES CO, V293, P979, DOI 10.1016/S0006-291X(02)00339-X; Gekle M, 2002, STEROIDS, V67, P499, DOI 10.1016/S0039-128X(01)00183-0; GRINSTEIN S, 1985, P NATL ACAD SCI USA, V82, P1429, DOI 10.1073/pnas.82.5.1429; Gu Q, 1996, J NEUROSCI, V16, P3620; GUERRA L, 1993, J MEMBRANE BIOL, V135, P209; Gupta N, 2001, KIDNEY INT, V60, P173, DOI 10.1046/j.1523-1755.2001.00784.x; Hamann S, 2000, PFLUG ARCH EUR J PHY, V440, P84, DOI 10.1007/s004240051025; Harvey BJ, 2002, BBA-BIOMEMBRANES, V1566, P116, DOI 10.1016/S0005-2736(02)00589-8; Harvey BJ, 2001, NEWS PHYSIOL SCI, V16, P174; Harvey BJ, 2000, KIDNEY INT, V57, P1395, DOI 10.1046/j.1523-1755.2000.00981.x; IBARROLA I, 1992, J MEMBRANE BIOL, V125, P185; JENTSCH TJ, 1986, J BIOL CHEM, V261, P2120; KINSELLA JL, 1990, SEMIN NEPHROL, V10, P330; Koukouritaki SB, 1996, J CELL BIOCHEM, V62, P251, DOI 10.1002/(SICI)1097-4644(199608)62:2<251::AID-JCB13>3.0.CO;2-O; Larsson B, 2003, ENDOCRINOLOGY, V144, P1726, DOI 10.1210/en.2002-221060; Limbourg FP, 2002, J CLIN INVEST, V110, P1729, DOI 10.1172/JCI200215481; LIN H, 1992, INVEST OPHTH VIS SCI, V33, P3528; LUBMAN RL, 1995, AM J RESP CELL MOL, V12, P211, DOI 10.1165/ajrcmb.12.2.7865219; LUBMAN RL, 1989, AM J PHYSIOL, V257, pL438, DOI 10.1152/ajplung.1989.257.6.L438; LUBMAN RL, 1994, AM J PHYSIOL, V266, pL138, DOI 10.1152/ajplung.1994.266.2.L138; Maguire D, 1999, STEROIDS, V64, P51, DOI 10.1016/S0039-128X(98)00096-8; Marchetti MC, 2003, TOXICOL LETT, V139, P175, DOI 10.1016/S0378-4274(02)00431-9; Muto S, 2000, KIDNEY INT, V57, P2319, DOI 10.1046/j.1523-1755.2000.00092.x; NOEL J, 1995, AM J PHYSIOL-CELL PH, V268, pC283, DOI 10.1152/ajpcell.1995.268.2.C283; NORD EP, 1987, AM J PHYSIOL, V252, pC490, DOI 10.1152/ajpcell.1987.252.5.C490; NORD EP, 1988, J BIOL CHEM, V263, P5599; PARADISO AM, 1992, AM J PHYSIOL, V262, pL757, DOI 10.1152/ajplung.1992.262.6.L757; Picotto G, 1996, MOL CELL ENDOCRINOL, V119, P129, DOI 10.1016/0303-7207(96)03799-9; ROSENBERG SO, 1991, AM J PHYSIOL, V260, pC868, DOI 10.1152/ajpcell.1991.260.4.C868; SELVAGGIO AM, 1986, AM J PHYSIOL, V251, pC558, DOI 10.1152/ajpcell.1986.251.4.C558; Solito E, 2003, ENDOCRINOLOGY, V144, P1164, DOI 10.1210/en.2002-220592; STEINER A, 1989, J HYPERTENS, V7, pS140, DOI 10.1097/00004872-198900076-00066; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Thwaites DT, 2002, GASTROENTEROLOGY, V122, P1322, DOI 10.1053/gast.2002.32992; TOBEY NA, 1992, GASTROENTEROLOGY, V103, P830, DOI 10.1016/0016-5085(92)90014-P; Urbach V, 2002, J PHYSIOL-LONDON, V545, P869, DOI 10.1113/jphysiol.2002.028183; Urbach V, 2002, J PHYSIOL-LONDON, V543, P13, DOI 10.1113/jphysiol.2001.015180; Urbach V, 2001, J PHYSIOL-LONDON, V537, P267, DOI 10.1111/j.1469-7793.2001.0267k.x; Wehling M, 1996, BIOCHEM BIOPH RES CO, V223, P181, DOI 10.1006/bbrc.1996.0866; Wehling M, 1997, ANNU REV PHYSIOL, V59, P365, DOI 10.1146/annurev.physiol.59.1.365; WILLUMSEN NJ, 1992, J PHYSIOL-LONDON, V455, P247, DOI 10.1113/jphysiol.1992.sp019300; WINTER DC, 1999, J PHYSIOL-LONDON, V1, P17; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; YUN CHC, 1993, J BIOL CHEM, V268, P206; ZADUNAISKY JA, 1989, INVEST OPHTH VIS SCI, V30, P2332; ZALLOCCHI M, 2003, MED SCI MONITOR, V9, P85; Zhou J, 2003, J ENDOCRINOL, V177, pR1, DOI 10.1677/joe.0.177R001	62	30	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2005	280	43					35807	35814		10.1074/jbc.M506584200	http://dx.doi.org/10.1074/jbc.M506584200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	976IM	16040608	hybrid			2022-12-27	WOS:000232726900006
J	Chen, SH; Lin, F; Hamm, HE				Chen, SH; Lin, F; Hamm, HE			RACK1 binds to a signal transfer region of G beta gamma and inhibits phospholipase C beta 2 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEIN; CRYSTAL-STRUCTURE; REPEAT PROTEINS; AMINO-TERMINUS; SWISS-MODEL; SUBUNIT; STIMULATION; RESOLUTION; COMPLEX; DOMAIN	Receptor for Activated C Kinase 1 (RACK1), a novel G beta gamma-interacting protein, selectively inhibits the activation of a subclass of G beta gamma effectors such as phospholipase C beta 2 (PLC beta 2) and adenylyl cyclase II by direct binding to G beta gamma (Chen, S., Dell, E. J., Lin, F., Sai, J., and Hamm, H. E. (2004) J. Biol. Chem. 279, 17861 - 17868). Here we have mapped the RACK1 binding sites on G beta gamma. We found that RACK1 interacts with several different G beta gamma isoforms, including G beta(1)gamma(1), G beta(1)gamma(2), and G beta(5)gamma(2), with similar affinities, suggesting that the conserved residues between G beta(1) and G beta(5) may be involved in their binding to RACK1. We have confirmed this hypothesis and shown that several synthetic peptides corresponding to the conserved residues can inhibit the RACK1/G beta gamma interaction as monitored by fluorescence spectroscopy. Interestingly, these peptides are located at one side of G beta(1) and have little overlap with the G alpha subunit binding interface. Additional experiments indicate that the G beta gamma contact residues for RACK1, in particular the positively charged amino acids within residues 44 - 54 of G beta(1), are also involved in the interaction with PLC beta 2 and play a critical role in G beta gamma-mediated PLC beta 2 activation. These data thus demonstrate that RACK1 can regulate the activity of a G beta gamma effector by competing for its binding to the signal transfer region of G beta gamma.	Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Hamm, HE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Rm 442,Robinson Res Bldg, Nashville, TN 37232 USA.	Heidi.Hamm@Vanderbilt.edu	Hamm, Heidi E/G-2374-2014	chen, songhai/0000-0001-7316-7125; Lin, Fang/0000-0003-2179-7031				Bonacci TM, 2005, J BIOL CHEM, V280, P10174, DOI 10.1074/jbc.M412514200; Buck E, 2002, J BIOL CHEM, V277, P49707, DOI 10.1074/jbc.M205553200; Buck E, 1999, SCIENCE, V283, P1332, DOI 10.1126/science.283.5406.1332; Buck E, 2001, J BIOL CHEM, V276, P36014, DOI 10.1074/jbc.M103228200; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Chen SH, 2004, J MOL CELL CARDIOL, V37, P399, DOI 10.1016/j.yjmcc.2004.04.019; Chen SH, 2004, J BIOL CHEM, V279, P17861, DOI 10.1074/jbc.M313727200; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dell EJ, 2002, J BIOL CHEM, V277, P49888, DOI 10.1074/jbc.M202755200; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; INGLESE J, 1994, P NATL ACAD SCI USA, V91, P3637, DOI 10.1073/pnas.91.9.3637; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Myung CS, 2000, P NATL ACAD SCI USA, V97, P9311, DOI 10.1073/pnas.97.16.9311; Panchenko MP, 1998, J BIOL CHEM, V273, P28298, DOI 10.1074/jbc.273.43.28298; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17032; Preininger AM, 2003, BIOCHEMISTRY-US, V42, P7931, DOI 10.1021/bi0345438; Schulz R, 2001, PHARMACOL RES, V43, P1, DOI 10.1006/phrs.2000.0757; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Yan K, 1997, J BIOL CHEM, V272, P2056; Yoshikawa DM, 2001, J BIOL CHEM, V276, P11246, DOI 10.1074/jbc.M006073200; Zhang SY, 1996, J BIOL CHEM, V271, P20208, DOI 10.1074/jbc.271.33.20208	30	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33445	33452		10.1074/jbc.M505422200	http://dx.doi.org/10.1074/jbc.M505422200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16051595	hybrid			2022-12-27	WOS:000232058100043
J	Kennaway, CK; Benesch, JLP; Gohlke, U; Wang, LC; Robinson, CV; Orlova, EV; Saibil, HR; Keep, NH				Kennaway, CK; Benesch, JLP; Gohlke, U; Wang, LC; Robinson, CV; Orlova, EV; Saibil, HR; Keep, NH			Dodecameric structure of the small heat shock protein Acr1 from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CRYSTALLIN; HYPOXIC RESPONSE; 2-COMPONENT SYSTEM; HSP16.3; BINDING; DISSOCIATION; EXCHANGE; ANTIGEN; FAMILY; DOMAIN	Small heat shock proteins are a ubiquitous and diverse family of stress proteins that have in common an alpha-crystallin domain. Mycobacterium tuberculosis has two small heat shock proteins, Acr1 (alpha-crystallin-related protein 1, or Hsp16.3/16-kDa antigen) and Acr2 (HrpA), both of which are highly expressed under different stress conditions. Small heat shock proteins form large oligomeric assemblies and are commonly polydisperse. Nanoelectrospray mass spectrometry showed that Acr2 formed a range of oligomers composed of dimers and tetramers, whereas Acr1 was a dodecamer. Electron microscopy of Acr2 showed a variety of particle sizes. Using three-dimensional analysis of negative stain electron microscope images, we have shown that Acr1 forms a tetrahedral assembly with 12 polypeptide chains. The atomic structure of a related alpha-crystallin domain dimer was docked into the density to build a molecular structure of the dodecameric Acr1 complex. Along with the differential regulation of these two proteins, the differences in their quaternary structures demonstrated here supports their distinct functional roles.	Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England; Univ London Birkbeck Coll, Inst Struct Mol Biol, London WC1E 7HX, England; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of London; Birkbeck University London; University of London; Birkbeck University London; University of Cambridge	Keep, NH (corresponding author), Univ London Birkbeck Coll, Sch Crystallog, Malet St, London WC1E 7HX, England.	n.keep@mail.cryst.bbk.ac.uk	Keep, N/C-2759-2008; Keep, Nicholas/R-3493-2019; Gohlke, Ulrich/B-8641-2016; Kennaway, Christopher/B-2592-2012; Orlova, Elena/CAF-8290-2022; Benesch, Justin/A-4250-2008	Keep, N/0000-0002-5042-1837; Keep, Nicholas/0000-0002-5042-1837; robinson, carol/0000-0001-7829-5505; Benesch, Justin/0000-0002-1507-3742; Orlova, Elena/0000-0003-3371-415X				Abulimiti A, 2003, J MOL BIOL, V326, P1013, DOI 10.1016/S0022-2836(03)00018-4; Chang ZY, 1996, J BIOL CHEM, V271, P7218, DOI 10.1074/jbc.271.12.7218; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Florczyk MA, 2003, INFECT IMMUN, V71, P5332, DOI 10.1128/IAI.71.9.5332-5343.2003; Franzetti B, 2002, EMBO J, V21, P2132, DOI 10.1093/emboj/21.9.2132; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Gu LX, 2002, J MOL BIOL, V319, P517, DOI 10.1016/S0022-2836(02)00311-X; Haley DA, 2000, J MOL BIOL, V298, P261, DOI 10.1006/jmbi.2000.3657; HARAUZ G, 1986, OPTIK, V73, P146; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; LEE BY, 1992, INFECT IMMUN, V60, P2066, DOI 10.1128/IAI.60.5.2066-2074.1992; LEPAULT J, 1986, METHOD ENZYMOL, V127, P719; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Matuszewska M, 2005, J BIOL CHEM, V280, P12292, DOI 10.1074/jbc.M412706200; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Russo S, 2004, J BIOL CHEM, V279, P51275, DOI 10.1074/jbc.M409455200; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Smith JM, 1999, J STRUCT BIOL, V125, P223, DOI 10.1006/jsbi.1998.4073; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Sobott F, 2002, J BIOL CHEM, V277, P38921, DOI 10.1074/jbc.M206060200; Stewart GR, 2005, MOL MICROBIOL, V55, P1127, DOI 10.1111/j.1365-2958.2004.04450.x; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Stromer T, 2004, J BIOL CHEM, V279, P11222, DOI 10.1074/jbc.M310149200; Studer S, 2002, EUR J BIOCHEM, V269, P3578, DOI 10.1046/j.1432-1033.2002.03049.x; Tabira Y, 2000, MICROB PATHOGENESIS, V29, P213, DOI 10.1006/mpat.2000.0384; Valdez MM, 2002, EUR J BIOCHEM, V269, P1806, DOI 10.1046/j.1432-1033.2002.02812.x; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; VERBON A, 1992, J BACTERIOL, V174, P1352, DOI 10.1128/jb.174.4.1352-1359.1992; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015; Wilkinson KA, 2005, J IMMUNOL, V174, P4237, DOI 10.4049/jimmunol.174.7.4237; Wintrode PL, 2003, BIOCHEMISTRY-US, V42, P10667, DOI 10.1021/bi034117m; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996	44	83	86	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33419	33425		10.1074/jbc.M504263200	http://dx.doi.org/10.1074/jbc.M504263200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16046399	hybrid			2022-12-27	WOS:000232058100040
J	Dias-Gunasekara, S; Gubbens, J; van Lith, M; Dunne, C; Williams, JAG; Kataky, R; Scoones, D; Lapthorn, A; Bulleid, NJ; Benham, AM				Dias-Gunasekara, S; Gubbens, J; van Lith, M; Dunne, C; Williams, JAG; Kataky, R; Scoones, D; Lapthorn, A; Bulleid, NJ; Benham, AM			Tissue-specific expression and dimerization of the endoplasmic reticulum oxidoreductase Ero1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; BOND FORMATION; SECRETORY PATHWAY; STRESS; ERO1P; ERO1-L-ALPHA; DOMAIN; GLUTATHIONE; OXIDATION; CHAPERONE	Endoplasmic reticulum oxidoreductases (Eros) are essential for the formation of disulfide bonds. Understanding disulfide bond catalysis in mammals is important because of the involvement of protein misfolding in conditions such as diabetes, arthritis, cancer, and aging. Mammals express two related Ero proteins, Ero1 alpha and Ero1 beta. Ero1 beta is incompletely characterized but is of physiological interest because it is induced by the unfolded protein response. Here, we show that Ero1 beta can form homodimers and mixed heterodimers with Ero1 alpha, in addition to Ero-PDI dimers. Ero-Ero dimers require the Ero active site, occur in vivo, and can be modeled onto the Ero1p crystal structure. Our data indicate that the Ero1 beta protein is constitutively strongly expressed in the stomach and the pancreas, but in a cell-specific fashion. In the stomach, selective expression of Ero1 beta occurs in the enzyme-producing chief cells. In pancreatic islets, Ero1 beta expression is high, but is inversely correlated with PDI and PDIp levels, demonstrating that cell-specific differences exist in the regulation of oxidative protein folding in vivo.	Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; Univ Durham, Dept Chem, Durham DH1 3LE, England; James Cook Univ Hosp, Dept Pathol, Middlesbrough TS4 3BW, Cleveland, England; Univ Glasgow, Dept Chem, Glasgow G12 8QQ, Lanark, Scotland; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Durham University; Durham University; James Cook University Hospital; University of Glasgow; University of Manchester	Benham, AM (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	Adam.benham@durham.ac.uk	Williams, J A Gareth/F-6618-2012; Kataky, Ritu/B-1800-2009; Benham, Adam/AAC-6606-2019; Gubbens, Jacob/C-8448-2013	Williams, J A Gareth/0000-0002-4688-3000; Kataky, Ritu/0000-0002-6386-9606; Lapthorn, Adrian/0000-0002-2197-8134; Benham, Adam/0000-0002-0919-7431; Van Lith, Marcel/0000-0003-0225-5501; Bulleid, Neil/0000-0002-9839-5279	Wellcome Trust [074081] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alanen HI, 2003, ANTIOXID REDOX SIGN, V5, P367, DOI 10.1089/152308603768295096; Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Bader MW, 2001, EMBO J, V20, P1555, DOI 10.1093/emboj/20.7.1555; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Bertoli G, 2004, J BIOL CHEM, V279, P30047, DOI 10.1074/jbc.M403192200; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200; DeSilva MG, 1997, DNA CELL BIOL, V16, P269, DOI 10.1089/dna.1997.16.269; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Frand AR, 2000, MOL BIOL CELL, V11, P2833, DOI 10.1091/mbc.11.9.2833; Gess B, 2003, EUR J BIOCHEM, V270, P2228, DOI 10.1046/j.1432-1033.2003.03590.x; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Klappa P, 2001, BIOCHEM J, V354, P553, DOI 10.1042/0264-6021:3540553; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; May D, 2005, ONCOGENE, V24, P1011, DOI 10.1038/sj.onc.1208325; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Norgaard P, 2001, J CELL BIOL, V152, P553, DOI 10.1083/jcb.152.3.553; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Russell SJ, 2004, J BIOL CHEM, V279, P18861, DOI 10.1074/jbc.M400575200; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; van Lith M, 2005, J BIOL CHEM, V280, P1376, DOI 10.1074/jbc.M408651200; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhao Z, 2003, J BIOL CHEM, V278, P43292, DOI 10.1074/jbc.M306945200	37	70	73	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					33066	33075		10.1074/jbc.M505023200	http://dx.doi.org/10.1074/jbc.M505023200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16012172	hybrid			2022-12-27	WOS:000231920300061
J	Profirovic, J; Gorovoy, M; Niu, JX; Pavlovic, S; Voyno-Yasenetskaya, T				Profirovic, J; Gorovoy, M; Niu, JX; Pavlovic, S; Voyno-Yasenetskaya, T			A novel mechanism of g protein-dependent phosphorylation of vasodilator-stimulated phosphoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIN-BASED MOTILITY; AMP-INDEPENDENT ACTIVATION; HUMAN ENDOTHELIAL-CELLS; HUMAN-PLATELETS; ENA/VASP PROTEINS; FOCAL ADHESION; NITRIC-OXIDE; SERINE/THREONINE KINASE; LISTERIA-MONOCYTOGENES	Vasodilator-stimulated phosphoprotein (VASP) is a major substrate of protein kinaseA (PKA). Here we described the novel mechanism of VASP phosphorylation via cAMP-independent PKA activation. We showed that in human umbilical vein endothelial cells (HUVECs) alpha-thrombin induced phosphorylation of VASP. Specific inhibition of G alpha(13) protein by the RGS domain of a guanine nucleotide exchange factor, p115RhoGEF, inhibited thrombin-dependent phosphorylation of VASP. More importantly, G alpha(13)-induced VASP phosphorylation was dependent on activation of RhoA and mitogen-activated protein kinase kinase kinase, MEKK1, leading to the stimulation of the NF-B-kappa signaling pathway. alpha-Thrombin-dependent VASP phosphorylation was inhibited by small interfering RNA-mediated knockdown of RhoA, whereas G alpha(13)-dependent VASP phosphorylation was inhibited by a specific RhoA inhibitor botulinum toxin C3 and by a dominant negative mutant of MEKK1. We determined that G alpha(13)-dependent VASP phosphorylation was also inhibited by specific PKA inhibitors, PKI and H-89. In addition, the expression of phosphorylation-deficient I kappa B and pretreatment with the proteasome inhibitor MG-132 abolished G alpha(13)- and alpha-thrombin-induced VASP phosphorylation. In summary, we have described a novel pathway of G alpha 13-induced VASP phosphorylation that involves activation of RhoA and MEKK1, phosphorylation and degradation of I kappa B, release of PKA catalytic subunit from the complex with I kappa B and NF-kappa B, and subsequent phosphorylation of VASP.	Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Voyno-Yasenetskaya, T (corresponding author), Univ Illinois, Dept Pharmacol, Coll Med, MC 868,835 S Wolcott Ave, Chicago, IL 60612 USA.	tvy@uic.edu	voyno-yasenetskaya, tatyana/A-3171-2008		NHLBI NIH HHS [HL06078] Funding Source: Medline; NIGMS NIH HHS [GM65160, GM56159] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM056159, R01GM065160, R01GM056159] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2001, CURR OPIN CELL BIOL, V13, P158, DOI 10.1016/S0955-0674(00)00193-9; Berestetskaya YV, 1998, J BIOL CHEM, V273, P27816, DOI 10.1074/jbc.273.43.27816; BOURNE HR, 1993, NEURON S, V10, P65; Browning DD, 2001, J BIOL CHEM, V276, P13039, DOI 10.1074/jbc.M009187200; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; BUTT E, 1994, J BIOL CHEM, V269, P14509; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dan C, 2001, J BIOL CHEM, V276, P32115, DOI 10.1074/jbc.M100871200; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DRAIJER R, 1995, CIRC RES, V77, P897, DOI 10.1161/01.RES.77.5.897; Dulin NO, 2001, J BIOL CHEM, V276, P20827, DOI 10.1074/jbc.C100195200; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HAFFNER C, 1995, EMBO J, V14, P19, DOI 10.1002/j.1460-2075.1995.tb06971.x; HALBRUGGE M, 1989, EUR J BIOCHEM, V185, P41, DOI 10.1111/j.1432-1033.1989.tb15079.x; HALBRUGGE M, 1990, J CHROMATOGR, V521, P335, DOI 10.1016/0021-9673(90)85057-3; Han YH, 2002, J BIOL CHEM, V277, P49877, DOI 10.1074/jbc.M209107200; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Harris TE, 1997, BIOCHEM BIOPH RES CO, V232, P648, DOI 10.1006/bbrc.1997.6344; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hirano M, 1996, J BIOL CHEM, V271, P13234, DOI 10.1074/jbc.271.22.13234; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Massberg S, 2004, BLOOD, V103, P136, DOI 10.1182/blood-2002-11-3417; McDonald LJ, 1996, P SOC EXP BIOL MED, V211, P1; Meyer CF, 1996, J BIOL CHEM, V271, P8971, DOI 10.1074/jbc.271.15.8971; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Niu JX, 2001, CURR BIOL, V11, P1686, DOI 10.1016/S0960-9822(01)00530-9; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Pando MP, 2000, J BIOL CHEM, V275, P21278, DOI 10.1074/jbc.M002532200; Patterson CE, 2000, ENDOTHELIUM-NEW YORK, V7, P287, DOI 10.3109/10623320009072215; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Scheschonka A, 2000, MOL PHARMACOL, V58, P719, DOI 10.1124/mol.58.4.719; Sechi AS, 2004, FRONT BIOSCI, V9, P1294, DOI 10.2741/1324; Skoble J, 2001, J CELL BIOL, V155, P89, DOI 10.1083/jcb.200106061; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Vaiskunaite R, 2000, J BIOL CHEM, V275, P26206, DOI 10.1074/jbc.M001863200; Venema RC, 1996, J BIOL CHEM, V271, P6435, DOI 10.1074/jbc.271.11.6435; VOYNOYASENETSKAYA T, 1994, J BIOL CHEM, V269, P4721; VOYNOYASENETSKAYA TA, 1994, ONCOGENE, V9, P2559; VoynoYasenetskaya TA, 1996, J BIOL CHEM, V271, P21081, DOI 10.1074/jbc.271.35.21081; Walders-Harbeck B, 2002, FEBS LETT, V529, P275, DOI 10.1016/S0014-5793(02)03356-2; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B; XU NZ, 1994, BIOCHEM BIOPH RES CO, V201, P603, DOI 10.1006/bbrc.1994.1744; YAN MH, 1994, NATURE, V372, P798; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HL, 2001, J PHARMACOL EXP THER, V297, P837; Zieger M, 2001, BIOCHEM BIOPH RES CO, V282, P952, DOI 10.1006/bbrc.2001.4683	73	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32866	32876		10.1074/jbc.M501361200	http://dx.doi.org/10.1074/jbc.M501361200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16046415	hybrid			2022-12-27	WOS:000231920300040
J	Adamson, TE; Shutt, DC; Price, DH				Adamson, TE; Shutt, DC; Price, DH			Functional coupling of cleavage and polyadenylation with transcription of mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II ELONGATION COMPLEXES; CELL-FREE SYSTEM; POLYMERASE-II; IN-VITRO; P-TEFB; POLY(A) POLYMERASE; PROCESSING FACTORS; 3'-END FORMATION; TERMINATION; KINASE	Cleavage and polyadenylation define the 3' ends of almost all eukaryotic mRNAs and are thought to occur during transcription. We describe a human in vitro system utilizing an immobilized template, in which transcripts in RNA polymerase II elongation complexes are efficiently cleaved and polyadenylated. Because the cleavage rate of free RNA is much slower, we conclude that cleavage is functionally coupled to transcription. Inhibition of positive transcription elongation factor b(P-TEFb) had only a modest negative effect on cleavage, as long as transcripts were long enough to contain the polyadenylation signal. In contrast, removal of the carboxyl-terminal domain of the large subunit of RNA polymerase II had a dramatic negative effect on cleavage. Unexpectedly, the 5' portion of transcript after cleavage remained associated with the template in a functional, polyadenylation-competent complex. Efficient cleavage required 5' capping by the human capping enzyme, but the reduction of cleavage seen of transcripts in COOH-terminal domain-less polymerase elongation complexes, was not because of lack of capping.	Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Price, DH (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.	david-price@uiowa.edu	Price, David H/F-6173-2010	Price, David/0000-0002-5597-385X	NIGMS NIH HHS [GM35500] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035500] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamson TE, 2003, METHOD ENZYMOL, V371, P264; Adamson TE, 2003, MOL CELL BIOL, V23, P4046, DOI 10.1128/MCB.23.12.4046-4055.2003; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Bird G, 2004, MOL CELL BIOL, V24, P8963, DOI 10.1128/MCB.24.20.8963-8969.2004; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; CHENKIANG S, 1982, CELL, V28, P575, DOI 10.1016/0092-8674(82)90212-4; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; COOPER DL, 1978, J BIOL CHEM, V253, P8375; Cramer P, 2001, FEBS LETT, V498, P179, DOI 10.1016/S0014-5793(01)02485-1; Flaherty SM, 1997, P NATL ACAD SCI USA, V94, P11893, DOI 10.1073/pnas.94.22.11893; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Hirose Y, 2000, GENE DEV, V14, P1415; Howe KJ, 2002, BBA-GENE STRUCT EXPR, V1577, P308, DOI 10.1016/S0167-4781(02)00460-8; Jiang Y, 2004, MOL CELL, V14, P375, DOI 10.1016/S1097-2765(04)00234-5; Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim SJ, 2003, J BIOL CHEM, V278, P41691, DOI 10.1074/jbc.M306304200; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Liu MY, 1998, J BIOL CHEM, V273, P25541, DOI 10.1074/jbc.273.40.25541; MANLEY JL, 1983, CELL, V33, P595, DOI 10.1016/0092-8674(83)90440-3; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Martin G, 2004, J MOL BIOL, V341, P911, DOI 10.1016/j.jmb.2004.06.047; MIFFLIN RC, 1991, J BIOL CHEM, V266, P19593; MOORE CL, 1985, CELL, V41, P845, DOI 10.1016/S0092-8674(85)80065-9; Moteki S, 2002, MOL CELL, V10, P599, DOI 10.1016/S1097-2765(02)00660-3; MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Park NJ, 2004, MOL CELL BIOL, V24, P4092, DOI 10.1128/MCB.24.10.4092-4103.2004; PRESCOTT JC, 1992, J BIOL CHEM, V267, P8175; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Skaar DA, 2002, MOL CELL, V10, P1429, DOI 10.1016/S1097-2765(02)00731-1; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Xie Z, 1996, J BIOL CHEM, V271, P11043, DOI 10.1074/jbc.271.19.11043; Yonaha M, 2000, EMBO J, V19, P3770, DOI 10.1093/emboj/19.14.3770; Yonaha M, 1999, MOL CELL, V3, P593, DOI 10.1016/S1097-2765(00)80352-4; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019	47	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32262	32271		10.1074/jbc.M505532200	http://dx.doi.org/10.1074/jbc.M505532200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16041059	hybrid			2022-12-27	WOS:000231794800028
J	Johnson, NP; Baase, WA; von Hippel, PH				Johnson, NP; Baase, WA; von Hippel, PH			Low energy CD of RNA hairpin unveils a loop conformation required for lambda N antitermination activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-T4 DNA-POLYMERASE; 2-AMINOPURINE FLUORESCENCE; NUCLEOTIDE INCORPORATION; CIRCULAR-DICHROISM; PHAGE-LAMBDA; TRANSCRIPTIONAL ANTITERMINATION; KLENOW FRAGMENT; PROTEIN; COMPLEX; BINDING	N protein coded by phage lambda is a transcription factor that stimulates the antitermination activity of Escherichia coli RNA polymerase by binding specifically to the nascent RNA transcript at a stem-loop structure called boxB. We use a new biophysical technique, involving the monitoring of the low energy circular dichroism spectra of 2-aminopurine residues site-specifically placed in the boxB RNA loop, to investigate this binding interaction. The low energy CDspectra of these 2-aminopurine probes reflect specific asymmetric interactions with adjacent nucleotide bases. Consequently, these CD spectra provide detailed and specific conformational information about the RNA chain at these chromophores that cannot be obtained from changes in the related fluorescence signals of these probes. CD changes were observed on binding the N peptide to boxB RNA that correspond to structural changes that had been previously seen by NMR, thus validating our experimental approach. The low energy CD method was then used to quantify the ordered and disordered states of the free hairpin loop and to show that a significant fraction of the boxB loop assumes a product-like structure in the absence of protein. A boxB derivative with an intact stem and a reduced concentration of ordered loop was identified and used to show that the extent of the reaction between protein and boxB depends on the concentration of structured loop in the RNA reactant population. This result has general implications for the conformational specificity of RNA- protein interactions.	CNRS, Inst Pharmacol & Biol Struct, UMR 5089, F-31077 Toulouse, France; Univ Oregon, Dept Chem, Eugene, OR 97403 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Oregon; University of Oregon	von Hippel, PH (corresponding author), CNRS, Inst Pharmacol & Biol Struct, UMR 5089, 205 Route Narbonne, F-31077 Toulouse, France.	petevh@molbio.uoregon.edu		von Hippel, Peter H./0000-0003-2512-8097	NIGMS NIH HHS [GM-15792, GM-29158] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029158, R37GM015792, R01GM015792] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARIK S, 1987, CELL, V50, P885, DOI 10.1016/0092-8674(87)90515-0; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P409; Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015; CHATTOPADHYAY S, 1995, P NATL ACAD SCI USA, V92, P4061, DOI 10.1073/pnas.92.9.4061; Cilley CD, 1997, RNA, V3, P57; da Silva EF, 2002, J BIOL CHEM, V277, P40640, DOI 10.1074/jbc.M203315200; ERITJA R, 1986, NUCLEIC ACIDS RES, V14, P5869, DOI 10.1093/nar/14.14.5869; FREY MW, 1995, BIOCHEMISTRY-US, V34, P9185, DOI 10.1021/bi00028a031; Friedman DI., 1983, LAMBDA 2, P21; GOODMAN MF, 1977, P NATL ACAD SCI USA, V74, P4806, DOI 10.1073/pnas.74.11.4806; GREENBLATT J, 1993, NATURE, V364, P401, DOI 10.1038/364401a0; GRIEVE SJ, 2005, NAT REV MOL STRUCT B, V6, P221; HEUS HA, 1991, SCIENCE, V253, P191, DOI 10.1126/science.1712983; Jean JM, 2001, P NATL ACAD SCI USA, V98, P37, DOI 10.1073/pnas.011442198; Johnson NP, 2005, P NATL ACAD SCI USA, V102, P7169, DOI 10.1073/pnas.0502359102; Johnson NP, 2004, P NATL ACAD SCI USA, V101, P3426, DOI 10.1073/pnas.0400591101; JOHNSON WC, 1969, BIOPOLYMERS, V8, P715, DOI 10.1002/bip.1969.360080603; JOHNSON WC, 1969, BIOPOLYMERS, V8, P409; Legault P, 1998, CELL, V93, P289, DOI 10.1016/S0092-8674(00)81579-2; Mandal SS, 2002, BIOCHEMISTRY-US, V41, P4399, DOI 10.1021/bi015723p; Mogridge J, 1998, MOL CELL, V1, P265, DOI 10.1016/S1097-2765(00)80027-1; NODWELL JR, 1991, GENE DEV, V5, P2141, DOI 10.1101/gad.5.11.2141; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; RIPPE K, 1995, TRENDS BIOCHEM SCI, V20, P500, DOI 10.1016/S0968-0004(00)89117-3; Rist M, 2002, CHEMPHYSCHEM, V3, P704, DOI 10.1002/1439-7641(20020816)3:8<704::AID-CPHC704>3.0.CO;2-F; ROSENBERG M, 1978, NATURE, V272, P414, DOI 10.1038/272414a0; SALSTROM JS, 1978, J MOL BIOL, V124, P195, DOI 10.1016/0022-2836(78)90156-0; Scharpf M, 2000, EUR J BIOCHEM, V267, P2397, DOI 10.1046/j.1432-1327.2000.01251.x; SMAGOWICZ J, 1974, Journal of Luminescence, V8, P210, DOI 10.1016/0022-2313(74)90057-X; SOWERS LC, 1986, P NATL ACAD SCI USA, V83, P5434, DOI 10.1073/pnas.83.15.5434; Su LL, 1997, GENE DEV, V11, P2214, DOI 10.1101/gad.11.17.2214; TAN RY, 1995, P NATL ACAD SCI USA, V92, P5282, DOI 10.1073/pnas.92.12.5282; VanGilst MR, 1997, BIOCHEMISTRY-US, V36, P1514, DOI 10.1021/bi961920q; WANG MLJ, 1981, J BIOL CHEM, V256, P7097; WARD DC, 1969, J BIOL CHEM, V244, P1228; WHALEN W A, 1990, New Biologist, V2, P975	36	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32177	32183		10.1074/jbc.M504619200	http://dx.doi.org/10.1074/jbc.M504619200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16033760	hybrid			2022-12-27	WOS:000231794800018
J	Cleary, J; Sitwala, KV; Khodadoust, MS; Kwok, RPS; Mor-Vaknin, N; Cebrat, M; Cole, PA; Markovitz, DM				Cleary, J; Sitwala, KV; Khodadoust, MS; Kwok, RPS; Mor-Vaknin, N; Cebrat, M; Cole, PA; Markovitz, DM			p300/CBP-associated factor drives DEK into interchromatin granule clusters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; POSTTRANSLATIONAL PROTEIN MODIFICATIONS; SCAFFOLD ATTACHMENT FACTOR; EXON JUNCTION COMPLEX; BREAST-CANCER CELLS; MESSENGER-RNA; REVERSIBLE ACETYLATION; GENE-EXPRESSION; HUMAN SPLICEOSOME; NUCLEAR SPECKLES	DEK is a mammalian protein that has been implicated in the pathogenesis of autoimmune diseases and cancer, including acute myeloid leukemia, melanoma, glioblastoma, hepatocellular carcinoma, and bladder cancer. In addition, DEK appears to participate in multiple cellular processes, including transcriptional repression, mRNA processing, and chromatin remodeling. Sub-nuclear distribution of this protein, with the attendant functional ramifications, has remained a controversial topic. Here we report that DEK undergoes acetylation in vivo at lysine residues within the first 70 N-terminal amino acids. Acetylation of DEK decreases its affinity for DNA elements within the promoter, which is consistent with the involvement of DEK in transcriptional repression. Furthermore, deacetylase inhibition results in accumulation of DEK within interchromatin granule clusters ( IGCs), sub-nuclear structures that contain RNA processing factors. Overexpression of P/CAF acetylase drives DEK into IGCs, and addition of a newly developed, synthetic, cell-permeable P/CAF inhibitor blocks this movement. To our knowledge, this is the first reported example of acetylation playing a direct role in relocation of a protein to IGCs, and this may explain how DEK can function in multiple pathways that take place in distinct sub-nuclear compartments. These findings also suggest that DEK-associated malignancies and autoimmune diseases might be amenable to treatment with agents that alter acetylation.	Univ Michigan, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA; Johns Hopkins Univ, Cell & Mol Biol Program, Baltimore, MD 21205 USA; Johns Hopkins Univ, Program Immunol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Univ Wroclaw, Fac Chem, PL-50383 Wroclaw, Poland	University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Wroclaw	Markovitz, DM (corresponding author), Univ Michigan, Dept Internal Med, Div Infect Dis, 5220 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	dmarkov@umich.edu	Khodadoust, Michael/AAU-3936-2020; Cebrat, Marek A/G-9754-2011; Khodadoust, Michael/K-7764-2019	Khodadoust, Michael/0000-0001-9061-7351; Cebrat, Marek A/0000-0003-4975-4025; Khodadoust, Michael/0000-0001-9061-7351	NCI NIH HHS [T32 CA88784-03, T32 CA07863] Funding Source: Medline; NIDDK NIH HHS [5P-60-DK20572] Funding Source: Medline; NIGMS NIH HHS [GM62437] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA088784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062437, R37GM062437] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexiadis V, 2000, GENE DEV, V14, P1308; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Casas S, 2003, LEUKEMIA LYMPHOMA, V44, P1935, DOI 10.1080/1042819031000119299; Chakraborty S, 2001, J BIOL CHEM, V276, P44936, DOI 10.1074/jbc.M106733200; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chubb JR, 2003, CELL, V112, P403, DOI 10.1016/S0092-8674(03)00078-3; Daibata M, 2004, INT J CANCER, V108, P845, DOI 10.1002/ijc.11647; Dong XW, 2000, ARTHRITIS RHEUM-US, V43, P85, DOI 10.1002/1529-0131(200001)43:1<85::AID-ANR11>3.0.CO;2-D; Doyle HA, 2002, CURR OPIN RHEUMATOL, V14, P244, DOI 10.1097/00002281-200205000-00009; Doyle HA, 2001, TRENDS IMMUNOL, V22, P443, DOI 10.1016/S1471-4906(01)01976-7; Edmondson DG, 2002, J BIOL CHEM, V277, P29496, DOI 10.1074/jbc.M200651200; Evans AJ, 2004, AM J PATHOL, V164, P285, DOI 10.1016/S0002-9440(10)63118-5; Faulkner NE, 2001, J BIOL CHEM, V276, P25804, DOI 10.1074/jbc.M006454200; Fu GK, 1997, P NATL ACAD SCI USA, V94, P1811, DOI 10.1073/pnas.94.5.1811; Galasinski SC, 2002, J BIOL CHEM, V277, P2579, DOI 10.1074/jbc.M107894200; Gohring F, 1997, EMBO J, V16, P7361, DOI 10.1093/emboj/16.24.7361; Grottke C, 2000, INT J CANCER, V88, P535, DOI 10.1002/1097-0215(20001115)88:4<535::AID-IJC4>3.0.CO;2-V; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guidez F, 2005, MOL CELL BIOL, V25, P5552, DOI 10.1128/MCB.25.13.5552-5566.2005; Hayakawa F, 2004, J LEUKOCYTE BIOL, V75, P529, DOI 10.1189/jlb.0603289; He Q, 2000, P NATL ACAD SCI USA, V97, P5768, DOI 10.1073/pnas.100108697; Hollenbach AD, 2002, J CELL SCI, V115, P3319; Jang ER, 2004, ONCOGENE, V23, P1724, DOI 10.1038/sj.onc.1207315; Kappes F, 2001, J BIOL CHEM, V276, P26317, DOI 10.1074/jbc.M100162200; Kashanchi F, 1998, J BIOL CHEM, V273, P34646, DOI 10.1074/jbc.273.51.34646; Kataoka N, 2004, J BIOL CHEM, V279, P7009, DOI 10.1074/jbc.M307692200; Kim MS, 2003, CANCER RES, V63, P7291; Kim VN, 2001, MOL CELLS, V12, P1; Kipp M, 2000, J BIOL CHEM, V275, P5031, DOI 10.1074/jbc.275.7.5031; Kondoh N, 1999, CANCER RES, V59, P4990; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kroes RA, 2000, CANCER LETT, V156, P191, DOI 10.1016/S0304-3835(00)00462-6; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; Larramendy ML, 2002, HAEMATOLOGICA, V87, P569; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; Mintz PJ, 1999, EMBO J, V18, P4308, DOI 10.1093/emboj/18.15.4308; Nagatani G, 2001, CANCER RES, V61, P1592; Neugebauer KM, 2000, ARTHRITIS RHEUM, V43, P1768, DOI 10.1002/1529-0131(200008)43:8<1768::AID-ANR13>3.0.CO;2-9; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; Poux AN, 2002, P NATL ACAD SCI USA, V99, P14065, DOI 10.1073/pnas.222373899; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Reichert VL, 2002, GENE DEV, V16, P2778, DOI 10.1101/gad.1030602; REVZIN A, 1990, CONCEPTS BIOCH, V67, P749; Sacco-Bubulya P, 2002, J CELL BIOL, V156, P425, DOI 10.1083/jcb.200107017; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Schubert S, 2004, ONCOGENE, V23, P1392, DOI 10.1038/sj.onc.1207255; SIERAKOWSKA H, 1993, CLIN EXP IMMUNOL, V94, P435; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Spector DL, 1996, EXP CELL RES, V229, P189, DOI 10.1006/excr.1996.0358; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tani M, 2004, GENE CHROMOSOME CANC, V40, P146, DOI 10.1002/gcc.20027; Tomita A, 2000, ONCOGENE, V19, P444, DOI 10.1038/sj.onc.1203329; Tong X, 2004, BIOCHEM BIOPH RES CO, V317, P463, DOI 10.1016/j.bbrc.2004.03.066; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; Waldmann T, 2003, NUCLEIC ACIDS RES, V31, P7003, DOI 10.1093/nar/gkg864; Waldmann T, 2002, J BIOL CHEM, V277, P24988, DOI 10.1074/jbc.M204045200; WEEKS KM, 1992, BIOCHEMISTRY-US, V31, P10281, DOI 10.1021/bi00157a015; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zirwes RF, 1997, MOL BIOL CELL, V8, P231, DOI 10.1091/mbc.8.2.231	71	48	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31760	31767		10.1074/jbc.M500884200	http://dx.doi.org/10.1074/jbc.M500884200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15987677	hybrid			2022-12-27	WOS:000231665200054
J	Hogestatt, ED; Jonsson, BAG; Ermund, A; Andersson, DA; Bjork, H; Alexander, JP; Cravatt, BF; Basbaum, AI; Zygmunt, PM				Hogestatt, ED; Jonsson, BAG; Ermund, A; Andersson, DA; Bjork, H; Alexander, JP; Cravatt, BF; Basbaum, AI; Zygmunt, PM			Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLOID RECEPTOR; CANNABINOID-RECEPTOR; IN-VIVO; ANANDAMIDE TRANSPORT; CAPSAICIN; VR1; PARACETAMOL; INHIBITION; PAIN; RAT	Acetaminophen ( paracetamol) is a popular domestic analgesic and antipyretic agent with a weak anti-inflammatory action and a low incidence of adverse effects as compared with aspirin and other non-steroidal anti-inflammatory drugs. Here we show that acetaminophen, following deacetylation to its primary amine, is conjugated with arachidonic acid in the brain and the spinal cord to form the potent TRPV1 agonist N-arachidonoyl-phenolamine (AM404). This conjugation is absent in mice lacking the enzyme fatty acid amide hydrolase. AM404 also inhibits purified cyclooxygenase (COX)-1 and COX-2 and prostaglandin synthesis in lipopolysaccharide-stimulated RAW264.7 macrophages. This novel metabolite of acetaminophen also acts on the endogenous cannabinoid system, which, together with TRPV1 and COX, is present in the pain and thermoregulatory pathways. These findings identify fatty acid conjugation as a novel pathway for drug metabolism and provide a molecular mechanism for the occurrence of the analgesic N-acylphenolamine AM404 in the nervous system following treatment with acetaminophen.	Lund Univ, Div Clin Chem, SE-22185 Lund, Sweden; Lund Univ, Div Pharmacol, SE-22185 Lund, Sweden; Lund Univ, Div Occupat & Environm Med & Psychiat Epidemiol, SE-22185 Lund, Sweden; Scripps Res Inst, Skaggs Inst Chem Biol, Dept Cell Biol & Chem, La Jolla, CA 92037 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	Lund University; Lund University; Lund University; Scripps Research Institute; University of California System; University of California San Francisco	Zygmunt, PM (corresponding author), Lund Univ, Div Clin Chem, SE-22185 Lund, Sweden.	peter.zygmunt@med.lu.se	Ermund, Anna/AAG-3160-2020; Andersson, David A/C-3435-2008	Andersson, David A/0000-0001-7451-8548; Zygmunt, Peter/0000-0002-5102-8199; Ermund, Anna/0000-0002-3233-043X; Jonsson, Bo/0000-0002-8767-0589	NIDCR NIH HHS [DE08377] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Abbott FV, 2000, BEHAV BRAIN RES, V112, P177, DOI 10.1016/S0166-4328(00)00179-0; Bae YC, 2004, J COMP NEUROL, V478, P62, DOI 10.1002/cne.20272; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Bisogno T, 2000, BIOCHEM J, V351, P817, DOI 10.1042/0264-6021:3510817; Boutaud O, 2002, P NATL ACAD SCI USA, V99, P7130, DOI 10.1073/pnas.102588199; Burstein SH, 2000, PROSTAG OTH LIPID M, V61, P29, DOI 10.1016/S0090-6980(00)00053-8; CLISSOLD SP, 1986, DRUGS, V32, P46, DOI 10.2165/00003495-198600324-00005; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Deutsch DG, 2002, PROSTAG LEUKOTR ESS, V66, P201, DOI 10.1054/plef.2001.0358; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Egertova M, 2003, NEUROSCIENCE, V119, P481, DOI 10.1016/S0306-4522(03)00145-3; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; FERREIRA SH, 1978, EUR J PHARMACOL, V53, P39, DOI 10.1016/0014-2999(78)90265-0; FLOWER RJ, 1972, NATURE, V240, P410, DOI 10.1038/240410a0; Fowler CJ, 1997, PHARMACOL TOXICOL, V80, P103, DOI 10.1111/j.1600-0773.1997.tb00291.x; Garcia-Martinez C, 2002, P NATL ACAD SCI USA, V99, P2374, DOI 10.1073/pnas.022285899; GREEN K, 1989, PROSTAG OTH LIPID M, V37, P311, DOI 10.1016/0090-6980(89)90001-4; Guhring H, 2002, EUR J PHARMACOL, V454, P153, DOI 10.1016/S0014-2999(02)02485-8; HANEL AM, 1982, BIOCHEM PHARMACOL, V31, P3307, DOI 10.1016/0006-2952(82)90565-2; Hardman J.G., 1996, GOODMAN GILSMANS PHA, P617; Huang SM, 2001, J BIOL CHEM, V276, P42639, DOI 10.1074/jbc.M107351200; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; JANUSZ JM, 1993, J MED CHEM, V36, P2595, DOI 10.1021/jm00070a002; Kalgutkar AS, 2000, P NATL ACAD SCI USA, V97, P925, DOI 10.1073/pnas.97.2.925; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Melck D, 1999, BIOCHEM BIOPH RES CO, V262, P275, DOI 10.1006/bbrc.1999.1105; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Morisset V, 2001, EUR J PHARMACOL, V429, P93, DOI 10.1016/S0014-2999(01)01309-7; NEWTON JF, 1982, TOXICOL APPL PHARM, V65, P336, DOI 10.1016/0041-008X(82)90017-5; OBRIEN WF, 1993, AM J OBSTET GYNECOL, V168, P1164, DOI 10.1016/0002-9378(93)90362-M; Ouellet M, 2001, ARCH BIOCHEM BIOPHYS, V387, P273, DOI 10.1006/abbi.2000.2232; Patricelli MP, 1998, BIOCHEMISTRY-US, V37, P15177, DOI 10.1021/bi981733n; Pelissier T, 1996, J PHARMACOL EXP THER, V278, P8; Piomelli D, 1999, P NATL ACAD SCI USA, V96, P5802, DOI 10.1073/pnas.96.10.5802; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Pomonis JD, 2003, J PHARMACOL EXP THER, V306, P387, DOI 10.1124/jpet.102.046268; Price TJ, 2005, NEUROPHARMACOLOGY, V49, P25, DOI 10.1016/j.neuropharm.2005.01.031; Rodella LF, 2005, EUR J PHARMACOL, V508, P139, DOI 10.1016/j.ejphar.2004.12.031; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Suh YG, 2003, BIOORG MED CHEM LETT, V13, P4389, DOI 10.1016/j.bmcl.2003.09.024; Szallasi A, 2000, TRENDS NEUROSCI, V23, P491, DOI 10.1016/S0166-2236(00)01630-1; Szallasi A, 1999, PHARMACOL REV, V51, P159; Urban L, 2000, PAIN, V89, P65, DOI 10.1016/S0304-3959(00)00349-3; Vaz ZR, 1996, J PHARMACOL EXP THER, V278, P304; Wahl P, 2001, MOL PHARMACOL, V59, P9, DOI 10.1124/mol.59.1.9; Werner MU, 2002, EPIDEMIOLOGY, V13, P605, DOI 10.1097/00001648-200209000-00023; Zygmunt PM, 2000, EUR J PHARMACOL, V396, P39, DOI 10.1016/S0014-2999(00)00207-7; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	52	300	311	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31405	31412		10.1074/jbc.M501489200	http://dx.doi.org/10.1074/jbc.M501489200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	15987694	hybrid			2022-12-27	WOS:000231665200010
J	Liang, L; Deng, L; Chen, YP; Li, GC; Shao, CS; Tischfield, JA				Liang, L; Deng, L; Chen, YP; Li, GC; Shao, CS; Tischfield, JA			Modulation of DNA end joining by nuclear proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; IN-VITRO; HOMOLOGOUS RECOMBINATION; KU80-DEFICIENT CELLS; MAMMALIAN-CELLS; REPAIR PROTEINS; BACKUP PATHWAYS; ERROR-PRONE; LIGASE-IV; KU	DNA double strand breaks in mammalian cells are primarily repaired by homologous recombination and non-homologous end joining (NHEJ). NHEJ may either be error-free or mutagenic with deletions or insertions at the joint. Recent studies showed that DNA ends can also be joined via microhomologous sequences flanking the break point especially when proteins responsible for NHEJ, such as Ku, are absent. Microhomology-mediated end joining (MHEJ) is always accompanied by a deletion that spans one of the two homologous sequences and the intervening sequence, if any. In this study we evaluated several factors affecting the relative contribution of MHEJ to DNA end joining using nuclear extracts and DNA substrates containing 10-bp repeats at the ends. We found that the occurrence of MHEJ is determined by the relative abundance of nuclear proteins. At low DNA/protein ratios, an error-free end-joining mechanism predominated over MHEJ. As the DNA/protein ratio increased, MHEJ became predominant. We show that the nuclear proteins that contribute to the inhibition of the error-prone MHEJ include Ku and histone H1. Treatment of extracts with flap endonuclease 1 antiserum significantly reduced MHEJ. Addition of a 17-bp intervening sequence between the microhomologous sequences significantly reduced the efficiency of MHEJ. Thus, this cell-free assay provides a platform for evaluating factors modulating end joining.	State Univ New Jersey, Nelson Biol Labs, Dept Genet, Piscataway, NJ 08854 USA; Mem Sloan Kettering Canc Ctr, Dept Med Phys, Dept Radiat Onocl, New York, NY 10021 USA	Rutgers State University New Brunswick; Memorial Sloan Kettering Cancer Center	Liang, L (corresponding author), State Univ New Jersey, Nelson Biol Labs, Dept Genet, 604 Allison Rd,Rm B211, Piscataway, NJ 08854 USA.	liang@biology.rutgers.edu	Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342; Tischfield, Jay/0000-0003-3217-8287	NCI NIH HHS [CA 78497, CA 56909] Funding Source: Medline; NIEHS NIH HHS [ES011633] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA056909, R01CA078497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011633] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bentley J, 2004, NUCLEIC ACIDS RES, V32, P5249, DOI 10.1093/nar/gkh842; Blanco MG, 2004, J BIOL CHEM, V279, P26797, DOI 10.1074/jbc.M402832200; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DT, 2003, BIOCHEM CELL BIOL, V81, P221, DOI 10.1139/o03-049; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen S, 2001, J BIOL CHEM, V276, P24323, DOI 10.1074/jbc.M010544200; Dibiase SJ, 2000, CANCER RES, V60, P1245; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Feldmann E, 2000, NUCLEIC ACIDS RES, V28, P2585, DOI 10.1093/nar/28.13.2585; Gottlich B, 1998, EUR J BIOCHEM, V258, P387, DOI 10.1046/j.1432-1327.1998.2580387.x; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; JESSBERGER R, 1991, MOL CELL BIOL, V11, P445, DOI 10.1128/MCB.11.1.445; Kabotyanski EB, 1998, NUCLEIC ACIDS RES, V26, P5333, DOI 10.1093/nar/26.23.5333; Liang F, 1996, J BIOL CHEM, V271, P14405, DOI 10.1074/jbc.271.24.14405; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; MILES C, 1989, MUTAT RES, V227, P97, DOI 10.1016/0165-7992(89)90004-3; MORRIS T, 1993, P NATL ACAD SCI USA, V90, P1392, DOI 10.1073/pnas.90.4.1392; Nagaki S, 1998, BIOCHEM BIOPH RES CO, V246, P137, DOI 10.1006/bbrc.1998.8589; Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921; Perrault R, 2004, J CELL BIOCHEM, V92, P781, DOI 10.1002/jcb.20104; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Shao C, 1996, CYTOGENET CELL GENET, V75, P216, DOI 10.1159/000134486; Shao CS, 1999, P NATL ACAD SCI USA, V96, P9230, DOI 10.1073/pnas.96.16.9230; Smith J, 2003, NUCLEIC ACIDS RES, V31, P2157, DOI 10.1093/nar/gkg317; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000; Tauchi H, 2002, NATURE, V420, P93, DOI 10.1038/nature01125; Tseng HM, 2004, J BIOL CHEM, V279, P47580, DOI 10.1074/jbc.M404492200; Verkaik NS, 2002, EUR J IMMUNOL, V32, P701, DOI 10.1002/1521-4141(200203)32:3<701::AID-IMMU701>3.0.CO;2-T; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang HC, 2001, NUCLEIC ACIDS RES, V29, P1653, DOI 10.1093/nar/29.8.1653; Wang HC, 2003, NUCLEIC ACIDS RES, V31, P5377, DOI 10.1093/nar/gkg728; Wilson TE, 1999, J BIOL CHEM, V274, P23599, DOI 10.1074/jbc.274.33.23599; Wu XT, 1999, P NATL ACAD SCI USA, V96, P1303, DOI 10.1073/pnas.96.4.1303; Yamanaka S, 2002, BIOCHEM BIOPH RES CO, V292, P268, DOI 10.1006/bbrc.2002.6647; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	43	51	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31442	31449		10.1074/jbc.M503776200	http://dx.doi.org/10.1074/jbc.M503776200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16012167	hybrid			2022-12-27	WOS:000231665200015
J	Onodera, J; Ohsumi, Y				Onodera, J; Ohsumi, Y			Autophagy is required for maintenance of amino acid levels and protein synthesis under nitrogen starvation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DEFICIENT MUTANTS; YEAST-CELLS; MACROAUTOPHAGY; SPORULATION; DEGRADATION; MACHINERY; DELIVERY; VACUOLAR; MEIOSIS	Autophagy is a transport system of cytoplasmic components to the lysosome/vacuole for degradation well conserved in eukaryotes. Autophagy is strongly induced by nutrient starvation. Several specific proteins, including amino acid synthesis enzymes and vacuolar enzymes, are increased during nitrogen starvation in wildtype cells but not in autophagy-defective Delta atg7 cells despite similar mRNA levels. We further examined deficiencies in these cells. Bulk protein synthesis was substantially reduced in Delta atg7 cells under nitrogen starvation compared with wild-type cells. The total intracellular amino acid pool was reduced in Delta atg7 cells, and the levels of several amino acids fell below critical values. In contrast, wild-type cells maintained amino acid levels compatible with life. Autophagy-defective cells fail to maintain physiologic amino acid levels, and their inability to synthesize new proteins may explain most phenotypes associated with autophagy mutants at least partly.	Grad Univ Adv Studies, Div Mol Cell Biol, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan	Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Ohsumi, Y (corresponding author), Grad Univ Adv Studies, Div Mol Cell Biol, Natl Inst Basic Biol, Nishigonaka 38, Okazaki, Aichi 4448585, Japan.	yohsumi@nibb.ac.jp	Ohsumi, Yoshinori/C-6449-2009	Ohsumi, Yoshinori/0000-0003-2384-2166				BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Burke D, 2000, METHOD YEAST GENETIC; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Grabowska D, 2003, J BIOL CHEM, V278, P13984, DOI 10.1074/jbc.M210076200; Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x; Hamasaki M, 2003, CELL STRUCT FUNCT, V28, P49; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; KITAMOTO K, 1988, J BACTERIOL, V170, P2683, DOI 10.1128/jb.170.6.2683-2686.1988; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kupiec Martin, 1997, P889; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; OHSUMI Y, 1988, J BACTERIOL, V170, P2676, DOI 10.1128/jb.170.6.2676-2682.1988; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Otto GP, 2004, J BIOL CHEM, V279, P15621, DOI 10.1074/jbc.M311139200; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; SEGLEN PO, 1987, LYSOSOMES THEIR ROLE, P371; SIKORSKI RS, 1989, GENETICS, V122, P19; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; ZUBENKO GS, 1981, GENETICS, V97, P45	30	326	337	0	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31582	31586		10.1074/jbc.M506736200	http://dx.doi.org/10.1074/jbc.M506736200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16027116	hybrid			2022-12-27	WOS:000231665200031
J	Tretyakova, I; Zolotukhin, AS; Tan, W; Bear, J; Propst, F; Ruthel, G; Felber, BK				Tretyakova, I; Zolotukhin, AS; Tan, W; Bear, J; Propst, F; Ruthel, G; Felber, BK			Nuclear export factor family protein participates in cytoplasmic mRNA trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROUGH ENDOPLASMIC-RETICULUM; CONTAINING RIBONUCLEOPROTEIN-PARTICLES; HUMAN-IMMUNODEFICIENCY-VIRUS; PERIPHERAL NERVOUS-SYSTEM; GREEN FLUORESCENT PROTEIN; BINDING PROTEIN; MOLECULAR-CLONING; HIPPOCAMPAL-NEURONS; MAMMALIAN STAUFEN; PORE COMPLEX	In eukaryotes, the nuclear export of mRNA is mediated by nuclear export factor 1 (NXF1) receptors. Metazoans encode additional NXF1-related proteins of unknown function, which share homology and domain organization with NXF1. Some mammalian NXF1-related genes are expressed preferentially in the brain and are thought to participate in neuronal mRNA metabolism. To address the roles of NXF1-related factors, we studied the two mouse NXF1 homologues, mNXF2 and mNXF7. In neuronal cells, mNXF2, but not mNXF7, exhibited mRNA export activity similar to that of Tip-associated protein/NXF1. Surprisingly, mNXF7 incorporated into mobile particles in the neurites that contained poly(A) and ribosomal RNA and colocalized with Staufen1-containing transport granules, indicating a role in neuronal mRNA trafficking. Yeast two-hybrid interaction, coimmunoprecipitation, and in vitro binding studies showed that NXF proteins bound to brain-specific microtubule-associated proteins (MAP) such as MAP1B and the WD repeat protein Unrip. Both in vitro and in vivo, MAP1B also bound to NXF export cofactor U2AF as well as to Staufen1 and Unrip. These findings revealed a network of interactions likely coupling the export and cytoplasmic trafficking of mRNA. We propose a model in which MAP1B tethers the NXF-associated mRNA to microtubules and facilitates their translocation along dendrites while Unrip provides a scaffold for the assembly of these transport intermediates.	NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Ctr Canc Res,NIH, Frederick, MD 21702 USA; Univ Vienna, Vienna Bioctr, Inst Biochem & Mol Cell Biol, A-1030 Vienna, Austria; Goldbelt Raven LLC, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Vienna; Vienna Biocenter (VBC)	Felber, BK (corresponding author), NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Ctr Canc Res,NIH, Bldg 535,Rm 209, Frederick, MD 21702 USA.	felber@mail.ncifcrf.gov	Ruthel, Gordon/GYU-9133-2022	Ruthel, Gordon/0000-0001-9193-5589	NATIONAL CANCER INSTITUTE [ZIABC010334, Z01BC010334] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Barbarese E, 1999, J NEUROCYTOL, V28, P263, DOI 10.1023/A:1007097226688; BARBARESE E, 1995, J CELL SCI, V108, P2781; Bear J, 1999, MOL CELL BIOL, V19, P6306; Braun IC, 2001, J BIOL CHEM, V276, P20536, DOI 10.1074/jbc.M100400200; Carson J H, 2001, Results Probl Cell Differ, V34, P69; Carson JH, 2001, CURR OPIN NEUROBIOL, V11, P558, DOI 10.1016/S0959-4388(00)00249-X; Datta PK, 2000, MOL CELL BIOL, V20, P3157, DOI 10.1128/MCB.20.9.3157-3167.2000; Datta PK, 1998, J BIOL CHEM, V273, P34671, DOI 10.1074/jbc.273.52.34671; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Forler D, 2004, MOL CELL BIOL, V24, P1155, DOI 10.1128/MCB.24.3.1155-1167.2004; GARNER CC, 1990, J NEUROCHEM, V55, P146, DOI 10.1111/j.1471-4159.1990.tb08832.x; Gonzalez-Billault C, 2004, J NEUROBIOL, V58, P48, DOI 10.1002/neu.10283; Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1; Guzik BW, 2001, MOL CELL BIOL, V21, P2545, DOI 10.1128/MCB.21.7.2545-2554.2001; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Heidemann SR, 2003, METHOD CELL BIOL, V71, P51, DOI 10.1016/S0091-679X(03)01004-5; Herold A, 2001, RNA, V7, P1768; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; HUANG XJ, 1991, J VIROL, V65, P2131, DOI 10.1128/JVI.65.4.2131-2134.1991; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Hunt SL, 1999, GENE DEV, V13, P437, DOI 10.1101/gad.13.4.437; Izaurralde E, 2004, NAT STRUCT MOL BIOL, V11, P210, DOI 10.1038/nsmb0304-210; Izaurralde Elisa, 2002, Results Probl Cell Differ, V35, P133; Jin L, 2003, GENE DEV, V17, P3075, DOI 10.1101/gad.1155703; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Jun L, 2001, CURR BIOL, V11, P1381, DOI 10.1016/S0960-9822(01)00419-5; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; KOSIK KS, 2002, SCI STKE, pPE16; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Kuersten S, 2004, MOL CELL, V14, P599, DOI 10.1016/j.molcel.2004.05.004; Lai MC, 2004, J BIOL CHEM, V279, P31745, DOI 10.1074/jbc.C400173200; Levesque L, 2001, J BIOL CHEM, V276, P44953, DOI 10.1074/jbc.M106558200; Macchi P, 2003, J NEUROSCI, V23, P5778; Macchi P, 2003, MOL BIOL CELL, V14, P1570, DOI 10.1091/mbc.E02-08-0505; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Marion RM, 1999, MOL CELL BIOL, V19, P2212; Martinez CY, 2003, METHOD CELL BIOL, V71, P339, DOI 10.1016/S0091-679X(03)01016-1; Matsuda S, 2000, CANCER RES, V60, P13; MCDONALD D, 1992, J VIROL, V66, P7232, DOI 10.1128/JVI.66.12.7232-7238.1992; Mei X, 2000, BRAIN RES BULL, V53, P801, DOI 10.1016/S0361-9230(00)00416-0; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; Monshausen M, 2004, NEUROMOL MED, V6, P127, DOI 10.1385/NMM:6:2-3:127; Muslimov IA, 1997, J NEUROSCI, V17, P4722; Noiges R, 2002, J NEUROSCI, V22, P2106, DOI 10.1523/JNEUROSCI.22-06-02106.2002; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Opal P, 2003, J BIOL CHEM, V278, P34691, DOI 10.1074/jbc.M302785200; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Roegiers F, 2000, TRENDS CELL BIOL, V10, P220, DOI 10.1016/S0962-8924(00)01767-0; Sasaki M, 2005, GENOMICS, V85, P641, DOI 10.1016/j.ygeno.2005.01.003; Smith R, 2004, NEUROSCIENTIST, V10, P495, DOI 10.1177/1073858404266759; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Snee M, 2002, J CELL SCI, V115, P4661, DOI 10.1242/jcs.00137; Stauber RH, 1998, BIOTECHNIQUES, V24, P462, DOI 10.2144/98243rr01; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Tan W, 2005, NUCLEIC ACIDS RES, V33, P3855, DOI 10.1093/nar/gki706; Tan W, 2000, RNA, V6, P1762, DOI 10.1017/S1355838200000832; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Togel M, 1998, J CELL BIOL, V143, P695, DOI 10.1083/jcb.143.3.695; Villace P, 2004, NUCLEIC ACIDS RES, V32, P2411, DOI 10.1093/nar/gkh552; Vinciguerra P, 2004, CURR OPIN CELL BIOL, V16, P285, DOI 10.1016/j.ceb.2004.03.013; Wickham L, 1999, MOL CELL BIOL, V19, P2220; Zolotukhin AS, 2002, J BIOL CHEM, V277, P3935, DOI 10.1074/jbc.M107598200	70	42	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2005	280	36					31981	31990		10.1074/jbc.M502736200	http://dx.doi.org/10.1074/jbc.M502736200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961LZ	16014633	hybrid			2022-12-27	WOS:000231665200078
J	Murbartian, J; Lei, QB; Sando, JJ; Bayliss, DA				Murbartian, J; Lei, QB; Sando, JJ; Bayliss, DA			Sequential phosphorylation mediates receptor- and kinase-induced inhibition of TREK-1 background potassium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; K+; EXPRESSION; FAMILY	Background potassium channels determine membrane potential and input resistance and serve as prominent effectors for modulatory regulation of cellular excitability. TREK-1 is a two-pore domain background K+ channel ( KCNK2, K2P2.1) that is sensitive to a variety of physicochemical and humoral factors. In this work, we used a recombinant expression system to show that activation of G alpha(q)-coupled receptors leads to inhibition of TREK-1 channels via protein kinase C ( PKC), and we identified a critical phosphorylation site in a key regulatory domain that mediates inhibition of the channel. In HEK 293 cells co-expressing TREK-1 and either the thyrotropin-releasing hormone receptor ( TRHR1) or the Orexin receptor ( Orx1R), agonist stimulation induced robust channel inhibition that was suppressed by a bisindolylmaleimide PKC inhibitor but not by a protein kinase A blocker (( R-p)cAMP-S). Channel inhibition by agonists or by direct activators of PKC ( phorbol dibutyrate) and PKA ( forskolin) was disrupted not only by alanine or aspartate mutations at an identified PKA site ( Ser-333) in the C terminus, but also at a more proximal regulatory site in the cytoplasmic C terminus ( Ser-300); S333A and S300A mutations enhanced basal TREK-1 current, whereas S333D and S300D substitutions mimicked phosphorylation and strongly diminished currents. When studied in combination, TREK-1 current density was enhanced in S300A/S333D but reduced in S300D/S333A mutant channels. Channel mutants were expressed and appropriately targeted to cell membranes. Together, these data support a sequential phosphorylation model in which receptor-induced kinase activation drives modification at Ser-333 that enables subsequent phosphorylation at Ser-300 to inhibit TREK- 1 channel activity.	Univ Virginia, Hlth Syst, Dept Pharmacol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Bayliss, DA (corresponding author), Univ Virginia, Hlth Syst, Dept Pharmacol, POB 800735,1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	dab3y@virginia.edu		Murbartian, Janet/0000-0001-5776-1167	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033583, R29NS033583] Funding Source: NIH RePORTER; NINDS NIH HHS [NS33583, R01 NS033583] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Gershengorn MC, 1996, PHYSIOL REV, V76, P175, DOI 10.1152/physrev.1996.76.1.175; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Hervieu GJ, 2001, NEUROSCIENCE, V103, P899, DOI 10.1016/S0306-4522(01)00030-6; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; KIM GD, 1994, J BIOL CHEM, V269, P19933; Koh SD, 2001, J BIOL CHEM, V276, P44338, DOI 10.1074/jbc.M108125200; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lopes CMB, 2005, J PHYSIOL-LONDON, V564, P117, DOI 10.1113/jphysiol.2004.081935; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Maingret F, 2002, BIOCHEM BIOPH RES CO, V292, P339, DOI 10.1006/bbrc.2002.6674; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Patel AJ, 2001, CURR OPIN CELL BIOL, V13, P422, DOI 10.1016/S0955-0674(00)00231-3; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Talley EM, 2003, NEUROSCIENTIST, V9, P46, DOI 10.1177/1073858402239590; Vinton BB, 1998, BIOCHEM J, V330, P1433, DOI 10.1042/bj3301433; Zeng WZ, 2003, J BIOL CHEM, V278, P16852, DOI 10.1074/jbc.M300619200	27	118	119	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30175	30184		10.1074/jbc.M503862200	http://dx.doi.org/10.1074/jbc.M503862200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	16006563	hybrid			2022-12-27	WOS:000231362500025
J	Ohnuma, M; Terui, Y; Tamakoshi, M; Mitome, H; Niitsu, M; Samejima, K; Kawashima, E; Oshima, T				Ohnuma, M; Terui, Y; Tamakoshi, M; Mitome, H; Niitsu, M; Samejima, K; Kawashima, E; Oshima, T			N-1-aminopropylagmatine, a new polyamine produced as a key intermediate in polyamine biosynthesis of an extreme thermophile, Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LYSINE DECARBOXYLASE; SPERMIDINE SYNTHASE; CLONING; GENE; TEMPERATURE; PUTRESCINE; BINDING; ENZYME; SITE	In the extreme thermophile Thermus thermophilus, a disruption mutant of a gene homologous to speB ( coding for agmatinase = agmatine ureohydrolase) accumulated N-1-aminopropylagmatine (N-8-amidino-1,8-diamino-4-azaoctane, N-8-amidinospermidine), a new compound, whereas all other polyamines produced by the wild-type strain were absent from the cells. Double disruption of speB and speE ( polyamine aminopropyltransferase) resulted in the disappearance of N-1-aminopropylagmatine and the accumulation of agmatine. These results suggested the following. 1) N-1-Aminopropylagmatine is produced from agmatine by the action of an enzyme coded by speE. 2) N-1-Aminopropylagmatine is a metabolic intermediate in the biosynthesis of unique polyamines found in the thermophile. 3) N-1-Aminopropylagmatine is a substrate of the SpeB homolog. They further suggest a new biosynthetic pathway in T. thermophilus, by which polyamines are formed from agmatine via N-1-aminopropylagmatine. To confirm our speculation, we purified the expression product of the speB homolog and confirmed that the enzyme hydrolyzes N-1-aminopropylagmatine to spermidine but does not act on agmatine.	Tokyo Univ Pharm & Life Sci, Dept Mol Biol, Hachioji, Tokyo 1920392, Japan; Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan; Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 5300248, Japan	Tokyo University of Pharmacy & Life Sciences; Tokyo University of Pharmacy & Life Sciences; Josai University	Oshima, T (corresponding author), Tokyo Univ Pharm & Life Sci, Dept Mol Biol, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	toshima@ls.toyaku.ac.jp						BANNARD RAB, 1958, CAN J CHEM, V36, P1541, DOI 10.1139/v58-225; Carvajal N, 1999, BIOCHEM BIOPH RES CO, V264, P196, DOI 10.1006/bbrc.1999.1505; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; JAKUS J, 1993, J BIOL CHEM, V268, P13151; KAKEGAWA T, 1988, ARCH BIOCHEM BIOPHYS, V261, P250, DOI 10.1016/0003-9861(88)90339-6; KIRINO H, 1990, J BIOCHEM-TOKYO, V107, P661; Korolev S, 2002, NAT STRUCT BIOL, V9, P27, DOI 10.1038/nsb737; KOYAMA Y, 1986, J BACTERIOL, V166, P338, DOI 10.1128/jb.166.1.338-340.1986; LAWSON WB, 1968, H-S Z PHYSIOL CHEM, V349, P251, DOI 10.1515/bchm2.1968.349.1.251; NIITSU M, 1993, J CHROMATOGR, V641, P115, DOI 10.1016/0021-9673(93)83465-5; Nureki O, 2002, ACTA CRYSTALLOGR D, V58, P1129, DOI 10.1107/S0907444902006601; OHNOIWASHITA Y, 1975, ARCH BIOCHEM BIOPHYS, V171, P490, DOI 10.1016/0003-9861(75)90058-2; OSHIMA T, 1983, METHOD ENZYMOL, V94, P401; OSHIMA T, 1989, PHYSL POLYAMINES, V2, P36; Pantazaki AA, 1999, MOL CELL BIOCHEM, V195, P55, DOI 10.1023/A:1006984618465; PARK MH, 1993, BIOFACTORS, V4, P95; Perozich J, 1998, BBA-PROTEIN STRUCT M, V1382, P23, DOI 10.1016/S0167-4838(97)00131-3; RAINA A, 1983, METHOD ENZYMOL, V94, P257; RAY PH, 1971, J BACTERIOL, V108, P227, DOI 10.1128/JB.108.1.227-235.1971; ROBIN Y, 1967, COMP BIOCHEM PHYSIOL, V22, P787, DOI 10.1016/0010-406X(67)90771-2; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TAKADA T, 1993, APPL ENVIRON MICROB, V59, P2737, DOI 10.1128/AEM.59.8.2737-2739.1993; Takatsuka Y, 2000, J BACTERIOL, V182, P6732, DOI 10.1128/JB.182.23.6732-6741.2000; Tamakoshi M, 1999, FEMS MICROBIOL LETT, V173, P431, DOI 10.1016/S0378-1097(99)00101-9; Tamakoshi M, 1997, J BACTERIOL, V179, P4811, DOI 10.1128/jb.179.15.4811-4814.1997; TANAKA T, 1981, J BIOCHEM-TOKYO, V89, P677, DOI 10.1093/oxfordjournals.jbchem.a133245; Terui Y, 2005, BIOCHEM J, V388, P427, DOI 10.1042/BJ20041778; UZAWA T, 1993, J BIOCHEM-TOKYO, V114, P478, DOI 10.1093/oxfordjournals.jbchem.a124203; WERTHEIMER SJ, 1983, BIOCHEM BIOPH RES CO, V114, P882, DOI 10.1016/0006-291X(83)90863-X; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZAPPIA V, 1977, ANAL BIOCHEM, V79, P535, DOI 10.1016/0003-2697(77)90427-4	33	52	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30073	30082		10.1074/jbc.M413332200	http://dx.doi.org/10.1074/jbc.M413332200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15983049	hybrid			2022-12-27	WOS:000231362500012
J	Quezada, CM; Hamel, DJ; Gradinaru, C; Bilwes, AM; Dahlquist, FW; Crane, BR; Simon, MI				Quezada, CM; Hamel, DJ; Gradinaru, C; Bilwes, AM; Dahlquist, FW; Crane, BR; Simon, MI			Structural and chemical requirements for histidine phosphorylation by the chemotaxis kinase CheA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ASYMMETRIC PHOSPHORYLATION; PHOSPHOTRANSFER DOMAIN; RESONANCE ASSIGNMENTS; SERINE-PROTEASE; ACTIVE-SITE; SPECTROSCOPY; PHOSPHORELAY; BINDING; SENSOR	The CheA histidine kinase initiates the signal transduction pathway of bacterial chemotaxis by autophosphorylating a conserved histidine on its phosphotransferase domain ( P1). Site-directed mutations of neighboring conserved P1 residues ( Glu-67, Lys-48, and His-64) show that a hydrogen-bonding network controls the reactivity of the phospho-accepting His ( His-45) in Thermotoga maritima CheA. In particular, the conservative mutation E67Q dramatically reduces phospho-transfer to P1 without significantly affecting the affinity of P1 for the CheA ATP-binding domain. High resolution crystallographic studies revealed that although all mutants disrupt the hydrogen-bonding network to varying degrees, none affect the conformation of His-45. N-15-NMR chemical shift studies instead showed that Glu-67 functions to stabilize the unfavored (NH)-H-delta 1 tautomer of His-45, thereby rendering the N-epsilon 2 imidazole unprotonated and well positioned for accepting the ATP phosphoryl group.	CALTECH, Dept Biol 147 75, Pasadena, CA 91125 USA; Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	California Institute of Technology; Cornell University; University of California System; University of California Santa Barbara	Simon, MI (corresponding author), CALTECH, Dept Biol 147 75, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	simonm@caltech.edu		Bilwes Crane, Alexandrine/0000-0001-9922-0692	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066775, R01GM059544] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI 19296] Funding Source: Medline; NIGMS NIH HHS [R01-GM066775, 5R01GM059544-25] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACHOVCHIN WW, 1986, BIOCHEMISTRY-US, V25, P7751, DOI 10.1021/bi00371a070; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hirschman A, 2001, BIOCHEMISTRY-US, V40, P13876, DOI 10.1021/bi0113622; Ikegami T, 2001, BIOCHEMISTRY-US, V40, P375, DOI 10.1021/bi001619g; Inouye M, 2003, HISTIDINE KINASES SI; JACKSON AP, 1993, P NATL ACAD SCI USA, V90, P11232, DOI 10.1073/pnas.90.23.11232; Janiak-Spens F, 2000, MOL MICROBIOL, V37, P136, DOI 10.1046/j.1365-2958.2000.01973.x; Kato M, 1997, CELL, V88, P717, DOI 10.1016/S0092-8674(00)81914-5; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Matsushika A, 1998, BIOSCI BIOTECH BIOCH, V62, P2236, DOI 10.1271/bbb.62.2236; MCEVOY MM, 1995, BIOCHEMISTRY-US, V34, P13871, DOI 10.1021/bi00042a019; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mourey L, 2001, J BIOL CHEM, V276, P31074, DOI 10.1074/jbc.M101943200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Quezada CM, 2004, J MOL BIOL, V341, P1283, DOI 10.1016/j.jmb.2004.06.061; SCHUSTER II, 1979, J ORG CHEM, V44, P3864, DOI 10.1021/jo01336a025; Sculimbrene BR, 2002, J AM CHEM SOC, V124, P11653, DOI 10.1021/ja027402m; Sculimbrene BR, 2001, J AM CHEM SOC, V123, P10125, DOI 10.1021/ja016779+; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Xu QP, 1999, J MOL BIOL, V292, P1039, DOI 10.1006/jmbi.1999.3143; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; Zhou HJ, 1997, BIOCHEMISTRY-US, V36, P699, DOI 10.1021/bi961663p	28	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30581	30585		10.1074/jbc.M505316200	http://dx.doi.org/10.1074/jbc.M505316200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15994328	hybrid, Green Accepted			2022-12-27	WOS:000231362500074
J	Lee, HC				Lee, HC			Nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated calcium signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYCLIC-ADP-RIBOSE; NAADP MOBILIZES CA2+; PANCREATIC-ACINAR; ACTIVE-SITE; CA2+-MOBILIZING MESSENGER; INOSITOL TRISPHOSPHATE; CRYSTAL-STRUCTURE; RELEASE; CD38; RECEPTORS	Nicotinic acid adenine dinucleotide phosphate ( NAADP)(2) is a metabolite of NADP that was first identified as the most potent Ca2+ stores mobilizing molecule in sea urchin egg homogenates more than a decade ago ( 1, 2). It has since been shown to be effective in a wide variety of cells, from plant to animal, including human ( reviewed in Refs. 3 - 5). Its mechanism of action is distinct from those of cyclic ADP- ribose ( cADPR) and inositol trisphosphate ( IP3), and the stores it targets are separate as well ( reviewed in Ref. 6). Recent evidence establishes that NAADP fulfills the criteria of being a second messenger for mobilizing Ca2+ stores ( reviewed in Ref. 7). This article reviews the structure, functions, and the enzymatic synthesis of this new addition to the list of Ca2+ messengers.	Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Lee, HC (corresponding author), Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA.	leehc@tc.umn.edu	Lee, Hon Cheung/C-4329-2009					Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Albrieux M, 1998, J BIOL CHEM, V273, P14566, DOI 10.1074/jbc.273.23.14566; Bak J, 2001, CURR BIOL, V11, P987, DOI 10.1016/S0960-9822(01)00269-X; Bak J, 1999, CURR BIOL, V9, P751, DOI 10.1016/S0960-9822(99)80335-2; Berridge G, 2002, J BIOL CHEM, V277, P43717, DOI 10.1074/jbc.M203224200; Billington RA, 2002, J PHYSIOL-LONDON, V544, P107, DOI 10.1113/jphysiol.2002.030098; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Brailoiu E, 2001, MOL PHARMACOL, V60, P718; Cancela JM, 2002, EMBO J, V21, P909, DOI 10.1093/emboj/21.5.909; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Chameau P, 2001, PFLUG ARCH EUR J PHY, V443, P289, DOI 10.1007/s004240100691; Churchill GC, 2000, J BIOL CHEM, V275, P38687, DOI 10.1074/jbc.M005827200; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2001, J BIOL CHEM, V276, P11223, DOI 10.1074/jbc.M009335200; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Dammermann W, 2005, J BIOL CHEM, V280, P21394, DOI 10.1074/jbc.M413085200; Dickinson GD, 2003, BIOCHEM J, V375, P805, DOI 10.1042/BJ20030672; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Gerasimenko JV, 2003, J CELL BIOL, V163, P271, DOI 10.1083/jcb.200306134; Graeff R, 2001, J BIOL CHEM, V276, P12169, DOI 10.1074/jbc.M011299200; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Langhorst MF, 2004, CELL SIGNAL, V16, P1283, DOI 10.1016/j.cellsig.2004.03.013; Lee HC, 2000, CHEM IMMUNOL, V75, P39; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2003, CURR BIOL, V13, pR186, DOI 10.1016/S0960-9822(03)00120-9; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 1997, J BIOL CHEM, V272, P20378, DOI 10.1074/jbc.272.33.20378; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Lee HC, 2000, J CELL SCI, V113, P4413; Lee HC, 1996, RECENT PROG HORM RES, V51, P355; Lee HC, 1997, J BIOL CHEM, V272, P4172, DOI 10.1074/jbc.272.7.4172; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; LEE HC, 2002, CYCLIC ADP RIBOSE NA; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; Navazio L, 2000, P NATL ACAD SCI USA, V97, P8693, DOI 10.1073/pnas.140217897; Patel S, 2000, J BIOL CHEM, V275, P36495, DOI 10.1074/jbc.C000458200; Prasad GS, 1996, NAT STRUCT BIOL, V3, P957, DOI 10.1038/nsb1196-957; Tohgo A, 1997, J BIOL CHEM, V272, P3879, DOI 10.1074/jbc.272.7.3879; WALSETH TF, 1993, BIOCHIM BIOPHYS ACTA, V1178, P235, DOI 10.1016/0167-4889(93)90199-Y; Yamamoto-Katayama S, 2002, J MOL BIOL, V316, P711, DOI 10.1006/jmbi.2001.5386; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Yusufi ANK, 2002, EXP BIOL MED, V227, P36, DOI 10.1177/153537020222700107; Yusufi ANK, 2001, BIOCHEM J, V353, P531, DOI 10.1042/0264-6021:3530531	59	101	103	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2005	280	40					33693	33696		10.1074/jbc.R500012200	http://dx.doi.org/10.1074/jbc.R500012200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	969JF	16076847	hybrid			2022-12-27	WOS:000232229700002
J	Zhang, ZC; Rehmann, H; Price, LS; Riedl, J; Bos, JL				Zhang, ZC; Rehmann, H; Price, LS; Riedl, J; Bos, JL			AF6 negatively regulates Rap1-induced cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAS-BINDING DOMAIN; GENE-EXPRESSION; AF-6 INTERACTS; RAP1 EFFECTOR; PROTEIN AF-6; GTPASE; ACTIVATION; MOLECULE; LYMPHOCYTE; JUNCTIONS	AF6 is involved in the connection of membrane-associated proteins to the actin cytoskeleton. It binds to Ras-like small GTPases and is suggested to be an effector of both Ras and Rap. Here we show that knockdown of AF6 in T cells by RNA interference enhanced Rap1-induced integrin-mediated cell adhesion, whereas overexpression of AF6 had the opposite effect. Interestingly, AF6-induced inhibition of cell adhesion correlated with an increase in RapGTP levels. Like AF6, protein KIAA1849 contains a Ras association domain and interacted with Rap1. However, KIAA1849 did not inhibit Rap1-induced cell adhesion. We concluded that AF6 is a negative regulator of Rap-induced cell adhesion. We proposed that AF6 inhibits Rap-mediated cell adhesion by sequestering RapGTP in an unproductive complex and thus prevents the interaction of Rap1 not only with effectors that mediate adhesion but also with Rap GTPase-activating proteins. Thus, AF6 may buffer RapGTP in resting T cells and maintain them in a non-adherent state.	Univ Med Ctr, Dept Physiol Chem, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr, Ctr Biomed Genet, NL-3508 AB Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Bos, JL (corresponding author), Univ Med Ctr Utrecht, Dept Physiol Chem, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	J.L.Bos@med.uu.nl						Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Boettner B, 2003, GENETICS, V165, P159; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Herrmann C, 1996, PROG BIOPHYS MOL BIO, V66, P1, DOI 10.1016/S0079-6107(96)00015-6; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Kuriyama M, 1996, J BIOL CHEM, V271, P607, DOI 10.1074/jbc.271.2.607; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; MEDEMA RH, 1992, MOL CELL BIOL, V12, P3425, DOI 10.1128/MCB.12.8.3425; Nagase T, 2001, DNA RES, V8, P85, DOI 10.1093/dnares/8.2.85; PRASAD R, 1993, CANCER RES, V53, P5624; Price LS, 2004, J BIOL CHEM, V279, P35127, DOI 10.1074/jbc.M404917200; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Su L, 2003, J BIOL CHEM, V278, P15232, DOI 10.1074/jbc.M211888200; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	31	38	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2005	280	39					33200	33205		10.1074/jbc.M505057200	http://dx.doi.org/10.1074/jbc.M505057200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	966YG	16051602	hybrid			2022-12-27	WOS:000232058100014
J	Peterfy, M; Phan, J; Reue, K				Peterfy, M; Phan, J; Reue, K			Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-BETA; TRANSCRIPTION FACTOR; MESSENGER-RNA; INSULIN; GENE; PROTEIN; LIPODYSTROPHY; MUTATION; OBESITY; CELLS	We recently identified mutations in the Lpin1 ( lipin) gene to be responsible for lipodystrophy in the fatty liver dystrophy (fld) mouse strain. Previous studies revealed that lipin plays a critical role in adipogenesis, explaining the adipose-deficient phenotype of the fld mouse. In the current study, we demonstrate that alternative mRNA splicing generates two lipin isoforms, lipin-alpha and lipin-beta, which are differentially expressed during adipocyte differentiation. Lipin-alpha expression peaks at day 2 of 3T3-L1 cell differentiation, after which its levels gradually decrease. In contrast, lipin-beta expression is transiently elevated at 10 h, followed by a drop to background levels at 20 h and a gradual increase between days 2 and 6 of differentiation. The two lipin isoforms also exhibit differences in subcellular localization. Lipin-alpha is predominantly nuclear, whereas lipin-beta is primarily located in the cytoplasm of 3T3-L1 adipocytes, suggesting distinct cellular functions. Using primary mouse embryonic fibroblasts expressing either lipin-alpha or lipin-alpha, we demonstrate functional differences between the two isoforms. Whereas effect of lipin-beta expression is the induction of lipogenic genes. In vivo, overexpression of lipin-beta specifically in mature adipocytes leads to elevated expression of lipogenic genes and adipocyte hypertrophy, confirming a role of lipin-beta in the regulation of lipogenesis. In conclusion, our data suggest that the two lipin isoforms have distinct, but complementary, functions in adipogenesis, with lipin-alpha playing a primary role in differentiation and lipin-beta being predominantly involved in lipogenesis.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Reue, K (corresponding author), 11301 Wilshire Blvd,Bldg 113,Rm 312, Los Angeles, CA 90073 USA.	reuek@ucla.edu		Phan, Jack/0000-0001-5977-6004	NHLBI NIH HHS [HL24841] Funding Source: Medline; NIGMS NIH HHS [GM08042] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Caricasole A, 2002, J BIOL CHEM, V277, P4790, DOI 10.1074/jbc.M110249200; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; CHALFANT CE, 1995, J BIOL CHEM, V270, P13326, DOI 10.1074/jbc.270.22.13326; DIAMOND RH, 1993, J BIOL CHEM, V268, P15185; Ganesh S, 2002, BIOCHEM BIOPH RES CO, V291, P1134, DOI 10.1006/bbrc.2002.6590; Garg A, 2000, AM J MED, V108, P143, DOI 10.1016/S0002-9343(99)00414-3; Holmes KD, 2002, J BIOL CHEM, V277, P1457, DOI 10.1074/jbc.M107809200; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Kamai Y, 1996, J BIOL CHEM, V271, P9883, DOI 10.1074/jbc.271.17.9883; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Lopez AJ, 1995, DEV BIOL, V172, P396, DOI 10.1006/dbio.1995.8050; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Ozaita A, 2002, J NEUROPHYSIOL, V88, P394, DOI 10.1152/jn.2002.88.1.394; Pasqualini C, 2001, MOL ENDOCRINOL, V15, P894, DOI 10.1210/me.15.6.894; Patel NA, 2001, J BIOL CHEM, V276, P22648, DOI 10.1074/jbc.M101260200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, DRUG NEWS PERSPECT, V18, P5, DOI 10.1358/dnp.2005.18.1.877165; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Reue K, 2000, J LIPID RES, V41, P1067; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; SELL SM, 1994, J BIOL CHEM, V269, P30769; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Tange Y, 2002, J CELL SCI, V115, P4375, DOI 10.1242/jcs.00135; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wang ZH, 1996, RNA, V2, P1241; XU L, 1994, NUCLEIC ACIDS RES, V22, P646, DOI 10.1093/nar/22.4.646	30	174	187	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32883	32889		10.1074/jbc.M503885200	http://dx.doi.org/10.1074/jbc.M503885200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16049017	hybrid			2022-12-27	WOS:000231920300042
J	Rockenstein, E; Mante, M; Alford, M; Adame, A; Crews, L; Hashimoto, M; Esposito, L; Mucke, L; Masliah, E				Rockenstein, E; Mante, M; Alford, M; Adame, A; Crews, L; Hashimoto, M; Esposito, L; Mucke, L; Masliah, E			High beta-secretase activity elicits neurodegeneration in transgenic mice despite reductions in amyloid-beta levels - Implications for the treatment of Alzheimer disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-CLEAVING ENZYME; CARBOXYL-TERMINAL FRAGMENT; PRECURSOR PROTEIN; GAMMA-SECRETASE; MOUSE MODEL; IN-VIVO; PLAQUE PATHOLOGY; ALPHA-SYNUCLEIN; KNOCKOUT MICE; BACE	Amyloid-beta peptides (A beta) are widely presumed to play a causal role in Alzheimer disease. Release of A beta from the amyloid precursor protein (APP) requires proteolysis by the beta-site APP-cleaving enzyme (BACE1). Although increased BACE1 activity in Alzheimer disease brains and human ( h) BACE1 transgenic (tg) mice results in altered APP cleavage, the contribution of these molecular alterations to neurodegeneration is unclear. We therefore used the murine Thy1 promoter to express high levels of hBACE1, with or without hAPP, in neurons of tg mice. Compared with hAPP mice, hBACE1/hAPP doubly tg mice had increased levels of APP C-terminal fragments (C89, C83) and decreased levels of full-length APP and A beta. In contrast to non-tg controls and hAPP mice, hBACE1 mice and hBACE1/hAPP mice showed degeneration of neurons in the neocortex and hippocampus and degradation of myelin. Neurological deficits were also more severe in hBACE1 and hBACE1/hAPP mice than in hAPP mice. These results demonstrate that high levels of BACE1 activity are sufficient to elicit neurodegeneration and neurological decline in vivo. This pathogenic pathway involves the accumulation of APP C-terminal fragments but does not depend on increased production of human A beta. Thus, inhibiting BACE1 may block not only A beta-dependent but also A beta-independent pathogenic mechanisms.	Univ Calif San Diego, Dept Neurosci, Sch Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, Sch Med, La Jolla, CA 92093 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	emasliah@ucsd.edu	Crews, Leslie/B-7584-2014	Crews, Leslie/0000-0003-0704-0067	NIA NIH HHS [AG10869, AG022074, AG18840, AG5131] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG022074, R29AG010869] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson JJ, 2005, BIOCHEM PHARMACOL, V69, P689, DOI 10.1016/j.bcp.2004.11.015; Ando K, 1999, J NEUROSCI, V19, P4421; Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Berger-Sweeney J, 1999, MOL BRAIN RES, V66, P150, DOI 10.1016/S0169-328X(99)00014-5; Bodendorf U, 2002, J NEUROCHEM, V80, P799, DOI 10.1046/j.0022-3042.2002.00770.x; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chiocco MJ, 2004, J BIOL CHEM, V279, P52535, DOI 10.1074/jbc.M409680200; Citron M, 2002, NEUROBIOL AGING, V23, P1017, DOI 10.1016/S0197-4580(02)00122-7; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Durkin JT, 1999, J BIOL CHEM, V274, P20499, DOI 10.1074/jbc.274.29.20499; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Jung SS, 1999, NEUROBIOL AGING, V20, P249, DOI 10.1016/S0197-4580(99)00051-2; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim HS, 2000, FASEB J, V14, P1508, DOI 10.1096/fj.14.11.1508; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; Kirschling CM, 2003, NEUROREPORT, V14, P1243, DOI 10.1097/00001756-200307010-00011; Kitazume S, 2005, J BIOL CHEM, V280, P8589, DOI 10.1074/jbc.M409417200; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, J NEURAL TRANSM-SUPP, P175; Mohajeri MH, 2004, J NEURAL TRANSM, V111, P413, DOI 10.1007/s00702-003-0057-z; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mucke L, 2000, AM J PATHOL, V157, P2003, DOI 10.1016/S0002-9440(10)64839-0; Muresan Z, 2004, HUM MOL GENET, V13, P475, DOI 10.1093/hmg/ddh054; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; OsterGranite ML, 1996, J NEUROSCI, V16, P6732; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; Rossner S, 2001, J NEUROSCI RES, V64, P437; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sinha S, 2000, ANN NY ACAD SCI, V920, P206; SISODIA SS, 1993, J NEUROSCI, V13, P3136; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; Song DK, 1998, J NEUROCHEM, V71, P875; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Willem M, 2004, AM J PATHOL, V165, P1621, DOI 10.1016/S0002-9440(10)63419-0; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Xia WM, 2003, J CELL SCI, V116, P2839, DOI 10.1242/jcs.00651; Zheng H, 1996, ANN NY ACAD SCI, V777, P421, DOI 10.1111/j.1749-6632.1996.tb34456.x	59	75	77	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32957	32967		10.1074/jbc.M507016200	http://dx.doi.org/10.1074/jbc.M507016200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16027115	hybrid			2022-12-27	WOS:000231920300050
J	Takahashi, K; Nakagawa, M; Young, SG; Yamanaka, S				Takahashi, K; Nakagawa, M; Young, SG; Yamanaka, S			Differential membrane localization of ERas and Rheb, two Ras-related proteins involved in the phosphatidylinositol 3-kinase/mTOR pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; TSC2 GAP ACTIVITY; K-RAS; MAMMALIAN TARGET; H-RAS; GENE; GOLGI; CELLS; ASSOCIATION; GROWTH	Two Ras-related proteins, ERas and Rheb, which are involved in the phosphatidylinositol 3-kinase pathway, display high GTP affinity and have atypical CAAX motifs. The factors governing the intracellular localization of ERas and Rheb are incompletely understood. In the current study, we show by confocal microscopy that ERas is localized to the plasma membrane, whereas Rheb is confined to the endomembranes. Membrane localization of the two proteins was abolished by mutation of the cysteine of the CAAX motif. Membrane targeting was also abolished by a farnesyltransferase inhibitor but not by a geranylgeranyltransferase inhibitor. In mouse fibroblasts deficient in either Rce1 ( Ras converting enzyme 1) or Icmt ( isoprenylcysteine carboxyl methyltransferase), ERas was mislocalized mainly to the Golgi apparatus, whereas Rheb showed diffuse localization. Mutation of cysteines in the hypervariable region of ERas prevented the plasma membrane localization of ERas, very strongly suggesting that palmitoylation of the cysteines is essential for membrane targeting. The hypervariable region of Rheb does not contain cysteines or polybasic residues, and when it was replaced with the hypervariable region of H-Ras, Rheb displayed plasma membrane localization. These data indicate that ERas shares the same posttranslational modifications with H-Ras and N-Ras and is localized at the plasmamembrane. Rheb also shares the same membrane-targeting pathway but because of the absence of palmitoylation is located on endomembranes.	Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan; Japan Sci & Technol Agcy, CREST, Kyoto 6068507, Japan; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA	Kyoto University; Japan Science & Technology Agency (JST); University of California System; University of California Los Angeles	Yamanaka, S (corresponding author), Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp	Takahashi, Kazutoshi/ABE-5504-2020	Takahashi, Kazutoshi/0000-0002-5329-8395; Young, Stephen/0000-0001-7270-3176	NCI NIH HHS [CA103999-01, CA099506] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA103999, R01CA099506] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; BERANGER F, 1991, P NATL ACAD SCI USA, V88, P1606, DOI 10.1073/pnas.88.5.1606; Bergo MO, 2000, J BIOL CHEM, V275, P17605, DOI 10.1074/jbc.C000079200; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Bivona TG, 2003, CURR OPIN CELL BIOL, V15, P136, DOI 10.1016/S0955-0674(03)00016-4; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Clark GJ, 1997, J BIOL CHEM, V272, P10608; COX AD, 1995, METHOD ENZYMOL, V255, P195; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Karbowniczek M, 2004, J BIOL CHEM, V279, P29930, DOI 10.1074/jbc.M402591200; Kato M, 1999, MOL REPROD DEV, V54, P43, DOI 10.1002/(SICI)1098-2795(199909)54:1&lt;43::AID-MRD6&gt;3.0.CO;2-N; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; LERNER EC, 1995, J BIOL CHEM, V270, P26802, DOI 10.1074/jbc.270.45.26802; Lerner EC, 1997, ONCOGENE, V15, P1283, DOI 10.1038/sj.onc.1201296; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; McGuire TF, 1996, J BIOL CHEM, V271, P27402, DOI 10.1074/jbc.271.44.27402; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nomura K, 2004, J BIOL CHEM, V279, P22664, DOI 10.1074/jbc.M314169200; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333	32	78	82	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2005	280	38					32768	32774		10.1074/jbc.M506280200	http://dx.doi.org/10.1074/jbc.M506280200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	964ZU	16046393	hybrid			2022-12-27	WOS:000231920300028
J	Alderwick, LJ; Radmacher, E; Seidel, M; Gande, R; Hitchen, PG; Morris, HR; Dell, A; Sahm, H; Eggeling, L; Besra, GS				Alderwick, LJ; Radmacher, E; Seidel, M; Gande, R; Hitchen, PG; Morris, HR; Dell, A; Sahm, H; Eggeling, L; Besra, GS			Deletion of Cg-emb in corynebacterianeae leads to a novel truncated cell wall arabinogalactan, whereas inactivation of Cg-ubiA results in an Arabinan-deficient mutant with a cell wall galactan core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOLIC ACID BIOSYNTHESIS; MYCOBACTERIUM-TUBERCULOSIS; ETHAMBUTOL RESISTANCE; MASS-SPECTROMETRY; GENOME SEQUENCE; IDENTIFICATION; PEPTIDOGLYCAN; SMEGMATIS; ARABINOSYLATION; RECOGNITION	The cell wall of Mycobacterium tuberculosis has a complex ultrastructure that consists of mycolic acids connected to peptidoglycan via arabinogalactan (AG) and abbreviated as the mAGP complex. The mAGP complex is crucial for the survival and pathogenicity of M. tuberculosis and is the target of several anti-tubercular agents. Apart from sharing a similar mAGP and the availability of the complete genome sequence, Corynebacterium glutamicum has proven useful in the study of orthologous M. tuberculosis genes essential for viability. Here we examined the effects of particular genes involved in AG polymerization by gene deletion in C. glutamicum. The anti-tuberculosis drug ethambutol is thought to target a set of arabinofuranosyltransferases (Emb) that are involved in arabinan polymerization. Deletion of emb in C. glutamicum results in a slow growing mutant with profound morphological changes. Chemical analysis revealed a dramatic reduction of arabinose resulting in a novel truncated AG structure possessing only terminal arabinofuranoside (t-Araf) residues with a corresponding loss of cell wall bound mycolic acids. Treatment of wild-type C. glutamicum with ethambutol and subsequent cell wall analyses resulted in an identical phenotype comparable to the C. glutamicum emb deletion mutant. Additionally, disruption of ubiA in C. glutamicum, the first enzyme involved in the biosynthesis of the sugar donor decaprenol phosphoarabinose (DPA), resulted in a complete loss of cell wall arabinan. Herein, we establish for the first time, (i) that in contrast to M. tuberculosis embA and embB mutants, deletion of C. glutamicum emb leads to a highly truncated AG possessing t-Araf residues, (ii) the exact site of attachment of arabinan chains in AG, and (iii) DPA is the only Araf sugar donor in AG biosynthesis suggesting the presence of a novel enzyme responsible for "priming" the galactan domain for further elaboration by Emb, resulting in the final maturation of the native AG polysaccharide.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Res Ctr Luelich, Inst Biotechnol 1, D-52425 Julich, Germany; Univ London Imperial Coll Sci Technol & Med, Fac Life Sci, Div Mol Biosci, London SW7 2AZ, England; MSCAN, Mass Spectrometry Res & Training Ctr, Ascot SL5 7PZ, Berks, England	University of Birmingham; Imperial College London	Besra, GS (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	g.besra@bham.ac.uk		Besra, Gurdyal/0000-0002-5605-0395; Alderwick, Luke/0000-0002-1257-6053				Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; BESRA GS, 1995, BIOCHEMISTRY-US, V34, P4257, DOI 10.1021/bi00013a015; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; DAFFE M, 1990, J BIOL CHEM, V265, P6734; De Sousa-D'Auria C, 2003, FEMS MICROBIOL LETT, V224, P35, DOI 10.1016/S0378-1097(03)00396-3; Dover LG, 2004, FEMS MICROBIOL REV, V28, P225, DOI 10.1016/j.femsre.2003.10.001; Eggeling L, 2005, HDB CORYNEBACTERIUM, P535; Escuyer VE, 2001, J BIOL CHEM, V276, P48854, DOI 10.1074/jbc.M102272200; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; Hancock IC, 2002, MICROBIOL-SGM, V148, P3059, DOI 10.1099/00221287-148-10-3059; Huang HR, 2005, J BIOL CHEM, V280, P24539, DOI 10.1074/jbc.M504068200; Kacem R, 2004, MICROBIOL-SGM, V150, P73, DOI 10.1099/mic.0.26583-0; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Klutts JS, 2002, ARCH BIOCHEM BIOPHYS, V398, P229, DOI 10.1006/abbi.2001.2723; Kremer L, 2001, J BIOL CHEM, V276, P26430, DOI 10.1074/jbc.M102022200; LEE RE, 1995, J AM CHEM SOC, V117, P11829, DOI 10.1021/ja00153a002; Lee RE, 1997, GLYCOBIOLOGY, V7, P1121, DOI 10.1093/glycob/7.8.1121; MCNEIL M, 1990, J BIOL CHEM, V265, P18200; MCNEIL M, 1991, J BIOL CHEM, V266, P13217; Mergaert P, 1996, MOL MICROBIOL, V21, P409, DOI 10.1046/j.1365-2958.1996.6451366.x; Mergaert P, 1997, MOL MICROBIOL, V25, P811, DOI 10.1111/j.1365-2958.1997.mmi526.x; Mikusova K, 2000, J BIOL CHEM, V275, P33890, DOI 10.1074/jbc.M006875200; Mikusova K, 1996, J BIOL CHEM, V271, P7820, DOI 10.1074/jbc.271.13.7820; Mills JA, 2004, J BIOL CHEM, V279, P43540, DOI 10.1074/jbc.M407782200; Nakamura Y, 2003, GENE, V317, P149, DOI 10.1016/S0378-1119(03)00653-X; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Radmacher E, 2005, MICROBIOL-SGM, V151, P1359, DOI 10.1099/mic.0.27804-0; Ramaswamy SV, 2004, J MED MICROBIOL, V53, P107, DOI 10.1099/jmm.0.05343-0; Ramaswamy SV, 2000, ANTIMICROB AGENTS CH, V44, P326, DOI 10.1128/AAC.44.2.326-336.2000; Sahm H, 2000, BIOL CHEM, V381, P899, DOI 10.1515/BC.2000.111; Sanders DAR, 2001, NAT STRUCT BIOL, V8, P858, DOI 10.1038/nsb1001-858; SINGH S, 1994, MICROBIOS, V77, P217; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P1677, DOI 10.1128/AAC.41.8.1677; TAKAYAMA K, 1979, ANTIMICROB AGENTS CH, V16, P240, DOI 10.1128/AAC.16.2.240; TAKAYAMA K, 1989, ANTIMICROB AGENTS CH, V33, P1493, DOI 10.1128/AAC.33.9.1493; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; Trivedi OA, 2005, MOL CELL, V17, P631, DOI 10.1016/j.molcel.2005.02.009; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Weston A, 1998, TUBERCLE LUNG DIS, V78, P123, DOI 10.1016/S0962-8479(98)80005-1; WOLUCKA BA, 1994, J BIOL CHEM, V269, P23328; Xin Y, 1997, BBA-GEN SUBJECTS, V1335, P231, DOI 10.1016/S0304-4165(97)00002-0; Yagi T, 2003, J BIOL CHEM, V278, P26497, DOI 10.1074/jbc.M302216200; Zhang N, 2003, MOL MICROBIOL, V50, P69, DOI 10.1046/j.1365-2958.2003.03681.x	47	109	118	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32362	32371		10.1074/jbc.M506339200	http://dx.doi.org/10.1074/jbc.M506339200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16040600	hybrid, Green Published			2022-12-27	WOS:000231794800041
J	Pelz, A; Wieland, KP; Putzbach, K; Hentschel, P; Albert, K; Gotz, F				Pelz, A; Wieland, KP; Putzbach, K; Hentschel, P; Albert, K; Gotz, F			Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAROTENOID BIOSYNTHESIS; INTERCELLULAR-ADHESION; MEVALONATE PATHWAY; GENOME SEQUENCE; EXPRESSION; GENES; EPIDERMIDIS; 4,4'-DIAPONEUROSPORENE; IDENTIFICATION; ESSENTIALITY	Most Staphylococcus aureus strains produce the orange carotenoid staphyloxanthin. The staphyloxanthin biosynthesis genes are organized in an operon, crtOPQMN, with sigma(B)-dependent promoter upstream of crtO and a termination region downstream of crtN. The functions of the five encoded enzymes were predicted on the basis of their sequence similarity to known enzymes and by product analysis of gene deletion mutants. The first step in staphyloxanthin biosynthesis is the head-to-head condensation of two molecules of farnesyl diphosphate to form dehydrosqualene (4,4'-diapophytoene), catalyzed by the dehydrosqualene synthase CrtM. The dehydrosqualene desaturase CrtN dehydrogenates dehydrosqualene to form the yellow, main intermediate 4,4'-diaponeurosporene. CrtP, very likely a mixed function oxidase, oxidizes the terminal methyl group of 4,4'-diaponeurosporene to form 4,4'-diaponeurosporenic acid. CrtQ, a glycosyltransferase, esterifies glucose at the C-1" position with the carboxyl group of 4,4'-diaponeurosporenic acid to yield glycosyl 4,4'-diaponeurosporenoate; this compound was the major product in the clone expressing crtPQMN. In the final step, the acyltransferase CrtO esterifies glucose at the C-6" position with the carboxyl group of 12-methyltetradecanoic acid to yield staphyloxanthin. Staphyloxanthin overexpressed in Staphylococcus carnosus (pTX-crtOPQMN) and purified was analyzed by high pressure liquid chromatography-mass spectroscopy and NMR spectroscopy. Staphyloxanthin was identified as beta-D-glucopyranosyl 1-O( 4,4'-diaponeurosporen-4-oate)-6-O-(12-methyltetradecanoate).	Univ Tubingen, Dept Microbial Genet, D-72076 Tubingen, Germany; Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Gotz, F (corresponding author), Univ Tubingen, Dept Microbial Genet, Waldhauser Str 70-8, D-72076 Tubingen, Germany.	friedrich.goetz@uni-tuebingen.de						Armstrong GA, 1997, ANNU REV MICROBIOL, V51, P629, DOI 10.1146/annurev.micro.51.1.629; ARMSTRONG GA, 1990, P NATL ACAD SCI USA, V87, P9975, DOI 10.1073/pnas.87.24.9975; BOTELLA JA, 1995, EUR J BIOCHEM, V233, P238, DOI 10.1111/j.1432-1033.1995.238_1.x; Campobasso N, 2004, J BIOL CHEM, V279, P44883, DOI 10.1074/jbc.M407882200; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; GOTZ F, 1987, FEMS MICROBIOL LETT, V40, P285, DOI 10.1016/0378-1097(87)90391-0; GOTZ F, 2004, PROCARYOTES; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Kaneda K, 2001, P NATL ACAD SCI USA, V98, P932, DOI 10.1073/pnas.020472198; KREUTZ B, 1984, GENE, V31, P301, DOI 10.1016/0378-1119(84)90226-9; Kullik I, 1998, J BACTERIOL, V180, P4814, DOI 10.1128/JB.180.18.4814-4820.1998; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lang S, 2000, FEMS IMMUNOL MED MIC, V29, P213, DOI 10.1111/j.1574-695X.2000.tb01525.x; MARSHALL JH, 1981, J BACTERIOL, V147, P914, DOI 10.1128/JB.147.3.914-919.1981; MARSHALL JH, 1981, J BACTERIOL, V147, P900, DOI 10.1128/JB.147.3.900-913.1981; MARSHALL JH, 1972, 3RD INT S CAR CLUJ, P56; MOSS GP, 1979, PURE APPL CHEM, V51, P507, DOI 10.1351/pac197951030507; Peschel A, 1996, FEMS MICROBIOL LETT, V137, P279; PESCHEL A, 1993, MOL MICROBIOL, V9, P31, DOI 10.1111/j.1365-2958.1993.tb01666.x; Pinner M, 1932, J INFECT DIS, V50, P185, DOI 10.1093/infdis/50.3.185; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; ROSENSTEIN R, 1992, J BACTERIOL, V174, P3676, DOI 10.1128/JB.174.11.3676-3683.1992; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; Schumann G, 1996, MOL GEN GENET, V252, P658, DOI 10.1007/s004380050274; Takaichi S, 1997, ARCH MICROBIOL, V168, P277, DOI 10.1007/s002030050499; Takami H, 2002, NUCLEIC ACIDS RES, V30, P3927, DOI 10.1093/nar/gkf526; Voynova NE, 2004, J BACTERIOL, V186, P61, DOI 10.1128/JB.186.1.61-67.2004; WIELAND B, 1994, J BACTERIOL, V176, P7719, DOI 10.1128/JB.176.24.7719-7726.1994; WIELAND KP, 1995, GENE, V158, P91, DOI 10.1016/0378-1119(95)00137-U; Wilding EI, 2000, J BACTERIOL, V182, P4319, DOI 10.1128/JB.182.15.4319-4327.2000; Wilding EI, 2000, J BACTERIOL, V182, P5147, DOI 10.1128/JB.182.18.5147-5152.2000	33	221	239	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32493	32498		10.1074/jbc.M505070200	http://dx.doi.org/10.1074/jbc.M505070200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16020541	hybrid			2022-12-27	WOS:000231794800057
J	Raschle, T; Amrhein, N; Fitzpatrick, TB				Raschle, T; Amrhein, N; Fitzpatrick, TB			On the two components of pyridoxal 5 '-phosphate synthase from Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; VITAMIN-B-6 BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; INCORPORATION PATTERN; GLUTAMINE HYDROLYSIS; NITROGEN ATOM; YEAST; PATHWAY; HISTIDINE; ORIGIN	Vitamin B6 is an essential nutrient in the human diet. It can act as a co-enzyme for numerous metabolic enzymes and has recently been shown to be a potent antioxidant. Plants and microorganisms have the ability to make the compound. Yet, studies of vitamin B6 biosynthesis have been mainly restricted to Escherichia coli, where the vitamin is synthesized from 1-deoxy-D-xylulose5-phosphate and 4-phosphohydroxy-L-threonine. Recently, a novel pathway for its synthesis has been discovered, involving two genes (PDX1 and PDX2) neither of which is homologous to any of those participating in the E. coli pathway. In Bacillus subtilis, YaaD and YaaE represent the PDX1 and PDX2 homolog, respectively. The two proteins form a complex that functions as a glutamine amidotransferase, with YaaE as the glutaminase domain and YaaD as the acceptor and pyridoxal 5'-phosphate (PLP) synthesis domain. In this report we corroborate a recent report on the identification of the substrates of YaaD and provide unequivocal proof of the identity of the reaction product. We show that both the glutaminase and synthase reactions are dependent on the respective protein partner. The synthase reaction can also utilize an external ammonium source but, in contrast to other glutamine amidotransferases, is dependent on YaaE under certain conditions. Furthermore, we report on the detailed characterization of the inhibition of the glutaminase domain, and thus PLP synthesis, by the glutamine analog acivicin. Employing pull-out assays and native-PAGE, we provide evidence for the dissociation of the bi-enzyme complex under these conditions. The results are discussed in light of the nature of the interaction of the two components of the enzyme complex.	ETH, Inst Pflanzenwissensch, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Fitzpatrick, TB (corresponding author), ETH, Inst Pflanzenwissensch, Univ Str 2, CH-8092 Zurich, Switzerland.	teresa.fitzpatrick@ipw.biol.ethz.ch						Banks J, 2004, BIOORG MED CHEM LETT, V14, P1633, DOI 10.1016/j.bmcl.2004.01.065; Bauer JA, 2004, J BIOL CHEM, V279, P2704, DOI 10.1074/jbc.M310311200; Belitsky BR, 2004, J BACTERIOL, V186, P1191, DOI 10.1128/JB.186.4.1191-1196.2004; Burns KE, 2005, J AM CHEM SOC, V127, P3682, DOI 10.1021/ja042792t; Cane DE, 1998, J AM CHEM SOC, V120, P1936, DOI 10.1021/ja9742085; Cane DE, 1999, J AM CHEM SOC, V121, P7722, DOI 10.1021/ja9914947; Cane DE, 2000, J AM CHEM SOC, V122, P4213, DOI 10.1021/ja000224h; Chittur SV, 2001, BIOCHEMISTRY-US, V40, P876, DOI 10.1021/bi0014047; Dong YX, 2004, EUR J BIOCHEM, V271, P745, DOI 10.1111/j.1432-1033.2003.03973.x; Ehrenshaft M, 1999, P NATL ACAD SCI USA, V96, P9374, DOI 10.1073/pnas.96.16.9374; Ehrenshaft M, 2001, J BACTERIOL, V183, P3383, DOI 10.1128/JB.183.11.3383-3390.2001; Fitzpatrick TB, 2003, J BIOL CHEM, V278, P19891, DOI 10.1074/jbc.M211778200; Galperin MY, 1997, MOL MICROBIOL, V24, P443, DOI 10.1046/j.1365-2958.1997.3671706.x; Gupta RN, 2001, J AM CHEM SOC, V123, P11353, DOI 10.1021/ja0113201; Hill RE, 1996, J BIOL CHEM, V271, P30426, DOI 10.1074/jbc.271.48.30426; Jain SK, 2001, FREE RADICAL BIO MED, V30, P232, DOI 10.1016/S0891-5849(00)00462-7; KLEM TJ, 1993, BIOCHEMISTRY-US, V32, P5177, DOI 10.1021/bi00070a029; Kondo H, 2004, BIOCHEM J, V379, P65, DOI 10.1042/BJ20031268; Laber B, 1999, FEBS LETT, V449, P45, DOI 10.1016/S0014-5793(99)00393-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM HM, 1990, J BACTERIOL, V172, P6518, DOI 10.1128/jb.172.11.6518-6528.1990; Miles BW, 2002, J BIOL CHEM, V277, P4368, DOI 10.1074/jbc.M108582200; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P1; NAKAMURA J, 1995, J BIOL CHEM, V270, P23450, DOI 10.1074/jbc.270.40.23450; Osmani AH, 1999, J BIOL CHEM, V274, P23565, DOI 10.1074/jbc.274.33.23565; Sakai A, 2002, J BIOSCI BIOENG, V93, P309, DOI 10.1263/jbb.93.309; Tanaka K, 2000, J NUTR SCI VITAMINOL, V46, P55; TAZUYA K, 1995, BBA-GEN SUBJECTS, V1244, P113, DOI 10.1016/0304-4165(94)00205-C; Thoden JB, 1999, BIOCHEMISTRY-US, V38, P16158, DOI 10.1021/bi991741j; Thoden JB, 1998, BIOCHEMISTRY-US, V37, P8825, DOI 10.1021/bi9807761; Wrenger C, 2005, J BIOL CHEM, V280, P5242, DOI 10.1074/jbc.M412475200; Zalkin H, 1998, ADV ENZYMOL RAMB, V72, P87; Zeidler J, 2003, J AM CHEM SOC, V125, P13094, DOI 10.1021/ja030261j; Zeidler J, 2003, J ORG CHEM, V68, P3486, DOI 10.1021/jo020730k; Zeidler J, 2002, J AM CHEM SOC, V124, P4542, DOI 10.1021/ja012708z	35	103	107	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32291	32300		10.1074/jbc.M501356200	http://dx.doi.org/10.1074/jbc.M501356200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16030023	hybrid, Green Published			2022-12-27	WOS:000231794800032
J	Yang, Y; Kovacs, M; Xu, Q; Anderson, JB; Sellers, JR				Yang, Y; Kovacs, M; Xu, Q; Anderson, JB; Sellers, JR			Myosin VIIB from Drosophila is a high duty ratio motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC MECHANISM; UNCONVENTIONAL MYOSINS; FLUORESCENT-PROBE; HEAVY-MEROMYOSIN; V PROCESSIVITY; RELAY LOOP; ACTIN; COMPLEX; BINDING; IDENTIFICATION	Myosin VII is an unconventional myosin widely expressed in organisms ranging from amoebae to mammals that has been shown to play vital roles in cell adhesion and phagocytosis. Here we present the first study of the mechanism of action of a myosin VII isoform. We have expressed a truncated single-headed Drosophila myosin VIIB construct in the baculovirus-Sf9 system that bound calmodulin light chains. By using steady-state and transient kinetic methods, we showed that myosin VIIB exhibits a fast release of phosphate and a slower, rate-limiting ADP release from actomyosin. As a result, myosin VIIB will be predominantly strongly bound to actin during steady-state ATP hydrolysis ( its duty ratio will be at least 80%). This kinetic pattern is in many respects similar to that of the single-molecule vesicle transporters myosin V and VI. The enzymatic properties of myosin VIIB provide a kinetic basis for processivity upon possible dimerization via the C-terminal domains of the heavy chain. Our experiments also revealed conformational heterogeneity of the actomyosin VIIB complex in the absence of nucleotide.	NHLBI, NIH, Lab Mol Physiol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sellers, JR (corresponding author), NHLBI, NIH, Lab Mol Physiol, Bldg 10,Rm 8N202, Bethesda, MD 20892 USA.	sellersj@nhlbi.nih.gov	Kovacs, Mihaly/A-6841-2011	Kovacs, Mihaly/0000-0002-1200-4741	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL004232, ZIAHL004232] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Baker JP, 1997, J MOL BIOL, V272, P523, DOI 10.1006/jmbi.1997.1232; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; El-Amraoui A, 2002, EMBO REP, V3, P463, DOI 10.1093/embo-reports/kvf090; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Hasson T, 1996, GENOMICS, V36, P431, DOI 10.1006/geno.1996.0488; Hasson T, 1999, CURR BIOL, V9, pR838, DOI 10.1016/S0960-9822(00)80040-8; Inoue A, 2003, J BIOL CHEM, V278, P5478, DOI 10.1074/jbc.M210489200; Kiehart DP, 2004, GENETICS, V168, P1337, DOI 10.1534/genetics.104.026369; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kovacs M, 2005, J BIOL CHEM, V280, P15071, DOI 10.1074/jbc.M500616200; Kovacs M, 2004, BIOCHEMISTRY-US, V43, P4219, DOI 10.1021/bi036007l; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Malnasi-Csizmadia A, 2001, J BIOL CHEM, V276, P19483, DOI 10.1074/jbc.M010886200; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Park S, 2000, BIOCHEMISTRY-US, V39, P11732, DOI 10.1021/bi000945t; Petit C, 2001, ANNU REV GENOM HUM G, V2, P271, DOI 10.1146/annurev.genom.2.1.271; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Sellers J. R., 1999, MYOSINS; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Titus MA, 1999, CURR BIOL, V9, P1297, DOI 10.1016/S0960-9822(00)80051-2; Todi SV, 2005, CURR BIOL, V15, P862, DOI 10.1016/j.cub.2005.03.050; Toth J, 2005, J BIOL CHEM, V280, P30594, DOI 10.1074/jbc.M505209200; Tuxworth RI, 2001, CURR BIOL, V11, P318, DOI 10.1016/S0960-9822(01)00097-5; Udovichenko IP, 2002, J CELL SCI, V115, P445; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, BIOCHEMISTRY-US, V39, P5555, DOI 10.1021/bi000133x; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yamashita RA, 2000, J MUSCLE RES CELL M, V21, P491, DOI 10.1023/A:1026589626422; Yengo CM, 2000, J BIOL CHEM, V275, P25481, DOI 10.1074/jbc.M002910200; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v	40	33	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2005	280	37					32061	32068		10.1074/jbc.M506765200	http://dx.doi.org/10.1074/jbc.M506765200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	963HM	16055438	hybrid			2022-12-27	WOS:000231794800005
J	Clark, R; Ali Ansari, M; Dash, S; Geeves, MA; Coluccio, LM				Clark, R; Ali Ansari, M; Dash, S; Geeves, MA; Coluccio, LM			Loop 1 of transducer region in mammalian class I myosin, Myo1b, modulates actin affinity, ATPase activity, and nucleotide access	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT KINETIC-ANALYSIS; SMOOTH-MUSCLE MYOSIN; SURFACE LOOPS; MOTOR DOMAIN; ADP RELEASE; RAT-LIVER; BINDING; ISOFORMS; PROTEIN; ALPHA	Loop 1, a flexible surface loop in the myosin motor domain, comprises in part the transducer region that lies near the nucleotide-binding site and is proposed from structural studies to be responsible for the kinetic tuning of product release following ATP hydrolysis ( 1). Biochemical studies have shown that loop 1 affects the affinity of actin-myosin-II for ADP, motility and the V-max of the actin-activated Mg2+-ATPase activity, possibly through P-i release (2-8). To test the influence of loop 1 on the mammalian class I myosin, Myo1b, chimeric molecules in which (i) loop 1 of a truncated form of Myo1b, Myo1b(1IQ), was replaced with either loop 1 from other myosins; (ii) loop 1 was replaced with glycine; or (iii) some amino acids in the loop were substituted with alanine and were expressed in baculovirus, and their interactions with actin and nucleotide were evaluated. The steady-state actin-activated ATPase activity; rate of ATP-induced dissociation of actin from Myo1b(1IQ); rate of ADP release from actin-Myo1b(1IQ); and the affinity of actin for Myo1b(1IQ) and Myo1b(1IQ)center dot ADP differed in the chimeras versus wild type, indicating that loop 1 has a much wider range of effects on the coupling between actin and nucleotide binding events than previously thought. In particular, the biphasic ATP-induced dissociation of actin from actin-Myo1b(1IQ) was significantly altered in the chimeras. This provided evidence that loop 1 contributes to the accessibility of the nucleotide pocket and is involved in the integration of information from the actin-, nucleotide-, gamma-P-i-, and calmodulin-binding sites and predicts that loop 1 modulates the load dependence of the motor.	Boston Biomed Res Inst, Watertown, MA 02472 USA; Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England	Boston Biomedical Research Institute; University of Kent	Coluccio, LM (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.	coluccio@bbri.org	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068080] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM068080] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ASHLEY CC, 1977, J PHYSIOL-LONDON, V270, P627, DOI 10.1113/jphysiol.1977.sp011972; Balish MF, 1999, ARCH BIOCHEM BIOPHYS, V370, P285, DOI 10.1006/abbi.1999.1409; COLUCCIO LM, 1993, CELL MOTIL CYTOSKEL, V24, P189, DOI 10.1002/cm.970240306; Coluccio LR, 1999, J BIOL CHEM, V274, P21575, DOI 10.1074/jbc.274.31.21575; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Goodson HV, 1999, J MOL BIOL, V287, P173, DOI 10.1006/jmbi.1999.2565; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; Kurzawa SE, 1996, J MUSCLE RES CELL M, V17, P669, DOI 10.1007/BF00154061; Kurzawa-Goertz SE, 1998, BIOCHEMISTRY-US, V37, P7517, DOI 10.1021/bi972844+; Lauzon AM, 1998, J MUSCLE RES CELL M, V19, P825, DOI 10.1023/A:1005489501357; MOISESCU DG, 1978, J PHYSIOL-LONDON, V275, P241, DOI 10.1113/jphysiol.1978.sp012188; Murphy CT, 2000, J MUSCLE RES CELL M, V21, P139, DOI 10.1023/A:1005610007209; Murphy CT, 1998, BIOCHEMISTRY-US, V37, P6738, DOI 10.1021/bi972903j; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Perreault-Micale C, 2000, J BIOL CHEM, V275, P21618, DOI 10.1074/jbc.M000363200; PerreaultMicale CL, 1996, J MUSCLE RES CELL M, V17, P543, DOI 10.1007/BF00124354; POLLARD TD, 1982, METHOD CELL BIOL, V24, P333; Raposo G, 1999, MOL BIOL CELL, V10, P1477, DOI 10.1091/mbc.10.5.1477; Rovner AS, 1997, J MUSCLE RES CELL M, V18, P103, DOI 10.1023/A:1018689102122; RUPPERT C, 1993, J CELL BIOL, V120, P1393, DOI 10.1083/jcb.120.6.1393; RUPPERT C, 1995, J CELL SCI, V108, P3775; Sellers J. R., 1999, MYOSINS; SHERR EH, 1993, J CELL BIOL, V120, P1405, DOI 10.1083/jcb.120.6.1405; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104	31	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					30935	30942		10.1074/jbc.M504698200	http://dx.doi.org/10.1074/jbc.M504698200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15980431	hybrid			2022-12-27	WOS:000231487800035
J	Regala, RP; Weems, C; Jamieson, L; Copland, JA; Thompson, EA; Fields, AP				Regala, RP; Weems, C; Jamieson, L; Copland, JA; Thompson, EA; Fields, AP			Atypical protein kinase C iota plays a critical role in human lung cancer cell growth and tumorigenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; RAS-MEDIATED REORGANIZATION; DRUG-INDUCED APOPTOSIS; COLON CARCINOGENESIS; ACTIN CYTOSKELETON; BINDING PROTEIN; CYCLIN D1; IN-VIVO; ZETA; TRANSFORMATION	Atypical protein kinase C ( aPKC) isozymes function in epithelial cell polarity, proliferation, and survival and have been implicated in cellular transformation. However, the role of these enzymes in human cancer is largely unexplored. Here, we report that aPKC iota is highly expressed in human non-small cell lung cancer cell lines, whereas the closely related aPKC isozyme PKC iota is undetectable in these cells. Disruption of PKC iota signaling reveals that PKC iota is dispensable for adherent growth of non-small cell lung cancer cells but is required for transformed growth in soft agar in vitro and for tumorigenicity in vivo. Molecular dissection of signaling downstream of PKC iota demonstrates that Rac1 is a critical molecular target for PKC iota-dependent transformation, whereas PKC iota is not necessary for NF kappa B activation in vitro or in vivo. Expression of the PB1 domain of PKC iota (PKC iota- (1-113)) blocks PKC iota-dependent Rac1 activity and inhibits cellular transformation indicating a role for this domain in the transforming activity of PKC iota. Taken together, our data demonstrate that PKC iota is a critical lung cancer gene that activates a Rac1 -> Pak -> Mek1,2 -> Erk1,2 signaling pathway required for transformed growth. Our data indicate that PKC iota may be an attractive molecular target for mechanism-based therapies for treatment of lung cancer.	Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Fields, AP (corresponding author), Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Griffin Canc Res Bldg,Rm 312,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	fields.alan@mayo.edu			NATIONAL CANCER INSTITUTE [R01CA081436] Funding Source: NIH RePORTER; NCI NIH HHS [CA81436] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM CANC SOC, 2004, SURV RES CANC STAT, P4; Bible KC, 1999, ANAL BIOCHEM, V267, P217, DOI 10.1006/abio.1998.2980; Bjorkoy G, 1997, J BIOL CHEM, V272, P11557; CARBONE D, 1992, AM J MED, V93, P13; Cheng QW, 2000, ONCOGENE, V19, P4936, DOI 10.1038/sj.onc.1203861; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Coghlan MP, 2000, MOL CELL BIOL, V20, P2880, DOI 10.1128/MCB.20.8.2880-2889.2000; DIAZMECO MT, 1994, J BIOL CHEM, V269, P31706; Dong LQ, 1999, J BIOL CHEM, V274, P8117, DOI 10.1074/jbc.274.12.8117; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Fields Alan P, 2003, Methods Mol Biol, V233, P519; Gazdar AF, 1999, JNCI-J NATL CANCER I, V91, P299, DOI 10.1093/jnci/91.4.299; Grunicke HH, 2003, ADV ENZYME REGUL, V43, P213, DOI 10.1016/S0065-2571(02)00032-8; Gustafson WC, 2004, J BIOL CHEM, V279, P9400, DOI 10.1074/jbc.M312840200; Hellbert K, 2000, ADV ENZYME REGUL, V40, P49, DOI 10.1016/S0065-2571(99)00038-2; Jamieson L, 1999, J BIOL CHEM, V274, P3927, DOI 10.1074/jbc.274.7.3927; Jiang YX, 2001, ONCOGENE, V20, P2254, DOI 10.1038/sj.onc.1204293; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kampfer S, 2001, J BIOL CHEM, V276, P42834, DOI 10.1074/jbc.M102047200; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lu Y, 2001, ONCOGENE, V20, P4777, DOI 10.1038/sj.onc.1204607; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; MAYO MW, 2000, BIOCHIM BIOPHYS ACTA, V1470, P55; Minna JD, 1996, NAT MED, V2, P974, DOI 10.1038/nm0996-974; Moscat J, 2000, EMBO REP, V1, P399, DOI 10.1093/embo-reports/kvd098; Moscat J, 2001, ADV ENZYME REGUL, V41, P99, DOI 10.1016/S0065-2571(00)00009-1; Murray NR, 1997, J BIOL CHEM, V272, P27521, DOI 10.1074/jbc.272.44.27521; Murray NR, 2002, J CELL BIOL, V157, P915, DOI 10.1083/jcb.200201127; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; Mwanjewe J, 2001, BIOCHEM J, V359, P211, DOI 10.1042/0264-6021:3590211; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Noda Y, 2001, GENES CELLS, V6, P107, DOI 10.1046/j.1365-2443.2001.00404.x; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Salgia R, 1998, J CLIN ONCOL, V16, P1207, DOI 10.1200/JCO.1998.16.3.1207; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Schiller JH, 2001, ONCOLOGY-BASEL, V61, P1, DOI 10.1159/000055385; Soloff RS, 2004, J IMMUNOL, V173, P3250, DOI 10.4049/jimmunol.173.5.3250; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Uberall F, 1999, J CELL BIOL, V144, P413, DOI 10.1083/jcb.144.3.413; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Webster JC, 2002, ENDOCRINOLOGY, V143, P3866, DOI 10.1210/en.2002-220188; Wooten MW, 2001, J BIOL CHEM, V276, P7709, DOI 10.1074/jbc.C000869200; Yu WS, 2003, J BIOL CHEM, V278, P11167, DOI 10.1074/jbc.M211424200; Zhang J, 2004, J BIOL CHEM, V279, P22118, DOI 10.1074/jbc.M400774200	57	160	174	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2005	280	35					31109	31115		10.1074/jbc.M505402200	http://dx.doi.org/10.1074/jbc.M505402200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	958ZX	15994303	hybrid			2022-12-27	WOS:000231487800056
J	Huan, CM; Sashital, D; Hailemariam, T; Kelly, ML; Roman, CAJ				Huan, CM; Sashital, D; Hailemariam, T; Kelly, ML; Roman, CAJ			Renal carcinoma-associated transcription factors TFE3 and TFEB are leukemia inhibitory factor-responsive transcription activators of E-cadherin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MESENCHYMAL TRANSITIONS; MICROPHTHALMIA; EXPRESSION; MITF; GENE; DOMAINS; BINDING; FAMILY; CELLS	Translocations of the genes encoding the related transcription factors TFE3 and TFEB are almost exclusively associated with a rare juvenile subset of renal cell carcinoma and lead to overexpression of TFE3 or TFEB protein sequences. A better understanding of how deregulated TFE3 and TFEB contribute to the transformation process requires elucidating more of the normal cellular processes in which they participate. Here we identify TFE3 and TFEB as cell type-specific leukemia inhibitory factor-responsive activators of E-cadherin. Overexpression of TFE3 or TFEB in 3T3 cells activated endogenous and reporter E-cadherin expression. Conversely, endogenous TFE3 and/or TFEB was required for endogenous E-cadherin expression in primary mouse embryonic fibroblasts and human embryonic kidney cells. Chromatin precipitation analyses and E-cadherin promoter reporter gene assays revealed that E-cadherin induction by TFE3 or TFEB was primarily or exclusively direct and mitogen-activated protein kinase-dependent in those cell types. In mouse embryonic fibroblasts, TFE3 and TFEB activation of E-cadherin was responsive to leukemia inhibitory factor. In 3T3 cells, TFE3 and TFEB expression also induced expression of Wilms' tumor-1, another E-cadherin activator. In contrast, E-cadherin expression in model mouse and canine renal epithelial cell lines was indifferent to inhibition of endogenous TFE3 and/or TFEB and was reduced by TFE3 or TFEB overexpression. These results reveal new cell type-specific activities of TFE3 and TFEB which may be affected by their mutation.	Suny Downstate Med Ctr, Dept Microbiol & Immunol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Morse Inst Mol Genet, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Mol & Cellular Biol Program, Sch Grad Studies, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Dept Med, Div Hematol & Oncol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Roman, CAJ (corresponding author), Suny Downstate Med Ctr, Dept Microbiol & Immunol, 450 Clarkson Ave,Box 44, Brooklyn, NY 11203 USA.	Christopher.Roman@Downstate.edu			NIDDK NIH HHS [R21 DK065011-02] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK065011] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Argani P, 2003, ADV ANAT PATHOL, V10, P243, DOI 10.1097/00125480-200309000-00001; Aubert J, 1999, J BIOL CHEM, V274, P24965, DOI 10.1074/jbc.274.35.24965; Barasch J, 2001, CURR OPIN NEPHROL HY, V10, P429, DOI 10.1097/00041552-200105000-00021; Barasch J, 1999, CELL, V99, P377, DOI 10.1016/S0092-8674(00)81524-X; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; Bodmer D, 2002, HUM MOL GENET, V11, P2489, DOI 10.1093/hmg/11.20.2489; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Davis IJ, 2003, P NATL ACAD SCI USA, V100, P6051, DOI 10.1073/pnas.0931430100; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Fisher DE, 2000, PIGM CELL RES, V13, P145, DOI 10.1034/j.1600-0749.13.s8.26.x; Giangrande PH, 2004, EMBO J, V23, P1336, DOI 10.1038/sj.emboj.7600134; Giroldi LA, 1997, BIOCHEM BIOPH RES CO, V241, P453, DOI 10.1006/bbrc.1997.7831; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hershey CL, 2004, BONE, V34, P689, DOI 10.1016/j.bone.2003.08.014; Hosono S, 1999, ONCOGENE, V18, P417, DOI 10.1038/sj.onc.1202311; Hosono S, 2000, J BIOL CHEM, V275, P10943, DOI 10.1074/jbc.275.15.10943; Hua XX, 2000, J BIOL CHEM, V275, P33205, DOI 10.1074/jbc.C000568200; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Kawata Y, 2002, J BIOL CHEM, V277, P11375, DOI 10.1074/jbc.M111284200; Kuiper RP, 2003, HUM MOL GENET, V12, P1661, DOI 10.1093/hmg/ddg178; Mansky KC, 2002, J LEUKOCYTE BIOL, V71, P295; Mathur M, 2003, ONCOGENE, V22, P5031, DOI 10.1038/sj.onc.1206643; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; MBALAVIELE G, 1995, J CLIN INVEST, V95, P2757, DOI 10.1172/JCI117979; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Patil S, 2000, J BIOL CHEM, V275, P38363, DOI 10.1074/jbc.M004861200; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Price ER, 1998, J BIOL CHEM, V273, P17983, DOI 10.1074/jbc.273.29.17983; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; QURESHI SA, 1991, J BIOL CHEM, V266, P20594; Rehli M, 1999, GENOMICS, V56, P111, DOI 10.1006/geno.1998.5588; ROMAN C, 1991, SCIENCE, V254, P94, DOI 10.1126/science.1840705; ROMAN C, 1992, MOL CELL BIOL, V12, P817, DOI 10.1128/MCB.12.2.817; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; RUEZINSKY D, 1991, GENE DEV, V5, P29, DOI 10.1101/gad.5.1.29; Sakurai H, 1997, AM J PHYSIOL-RENAL, V272, pF139, DOI 10.1152/ajprenal.1997.272.1.F139; Sato S, 1997, ONCOGENE, V14, P3083, DOI 10.1038/sj.onc.1201298; Stahl PJ, 2001, AM J PATHOL, V159, P1187, DOI 10.1016/S0002-9440(10)62503-5; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Steingrimsson E, 2002, P NATL ACAD SCI USA, V99, P4477, DOI 10.1073/pnas.072071099; Steingrimsson E, 1998, DEVELOPMENT, V125, P4607; Tachibana M, 1996, NAT GENET, V14, P50, DOI 10.1038/ng0996-50; Torban E, 1998, BBA-MOL CELL RES, V1401, P53, DOI 10.1016/S0167-4889(97)00119-5; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Weilbaecher KN, 1998, J EXP MED, V187, P775, DOI 10.1084/jem.187.5.775; Weterman MAJ, 2001, P NATL ACAD SCI USA, V98, P13808, DOI 10.1073/pnas.241304198; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Wu M, 2000, GENE DEV, V14, P301; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703	54	30	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30225	30235		10.1074/jbc.M502380200	http://dx.doi.org/10.1074/jbc.M502380200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15994295	hybrid			2022-12-27	WOS:000231362500031
J	Merlo, P; Fulco, M; Costanzo, A; Mangiacasale, R; Strano, S; Blandino, G; Taya, Y; Lavia, P; Levrero, M				Merlo, P; Fulco, M; Costanzo, A; Mangiacasale, R; Strano, S; Blandino, G; Taya, Y; Lavia, P; Levrero, M			A role of p73 in mitotic exit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ABL; PHOSPHATASE CDC14; TARGET GENES; DNA-DAMAGE; DIFFERENTIATION; IDENTIFICATION; MICROARRAY; EXPRESSION; INDUCTION; MITOSIS	The p53-related p73 proteins regulate developmental processes, cell growth, and DNA damage response. p73 function is regulated by post-translational modifications and protein-protein interactions. At the G(2)/M transition, p73 is phosphorylated at Thr-86 by the p34cdc2/cyclin B complex; this is associated with its exclusion from condensed chromosomes and loss of DNA binding and transcriptional activation ability. Here we showed that p73 hypo-phosphorylated species reappear during mitotic exit, concomitant with p73 relocalization to telophase nuclei and recovered ability to activate transcription. Functional knock-out of p73 gene expression by small interfering RNAs ( siRNAs) alters mitotic progression, yielding an increase of ana-telophase cells, the accumulation of aberrant late mitotic figures, and the appearance of abnormalities in the subsequent interphase. This p73 activity at the M-to-G(1) transition is mediated by its transactivating function because expression of the transcription dominant negative mutant p73DD induces the same mitotic exit phenotype. We also found that the cyclin-dependent kinase inhibitor Kip2/p57 gene is a specific target of p73 regulation during mitotic exit and re-entry into G(1). Both knock-out of p73 gene expression by siRNAs and abrogation of p73-dependent transcription by the p73DD mutant abrogate Kip2/p57 increase at the M-to-G(1) transition. Moreover, similar abnormalities ( e. g. delay in late mitotic stages with the accumulation of aberrant ana-telophase figures, and abnormalities in the following interphase) are observed in cultures in which the expression of Kip2/p57 is abrogated by siRNAs. These results identify a novel p73-Kip2/p57 pathway that coordinates mitotic exit and transition to G(1).	Fdn Andrea Cesapino, Lab Gene Express, I-00161 Rome, Italy; Univ Roma Tor Vergata, Dept Dermatol, I-00133 Rome, Italy; CNR, Inst Mol Biol & Pathol, Genet Sect, I-00185 Rome, Italy; Regina Elena Canc Ctr, Mol Oncogenesis Lab, I-00158 Rome, Italy; Natl Canc Ctr, Tokyo 1004, Japan; Univ Roma La Sapienza, Dept Internal Med, I-00161 Rome, Italy	University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); National Cancer Center - Japan; Sapienza University Rome	Levrero, M (corresponding author), Fdn Andrea Cesapino, Lab Gene Express, I-00161 Rome, Italy.	levmax@tin.it	strano, sabrina/B-6743-2013; Costanzo, Antonio/D-3896-2012; Blandino, Giovanni/B-1137-2013; Lavia, Patrizia/AAL-3982-2021; Strano, Sabrina/K-9654-2016; Lavia, Patrizia/J-5793-2019; Merlo, Paola/K-5330-2014; Costanzo, Antonio/GZG-2433-2022; Levrero, Massimo/G-5680-2016	strano, sabrina/0000-0002-6341-4230; Blandino, Giovanni/0000-0002-6970-2241; Lavia, Patrizia/0000-0003-3310-6701; Merlo, Paola/0000-0003-0105-7044; Costanzo, Antonio/0000-0001-9697-2557; Levrero, Massimo/0000-0002-4978-0875	Telethon [E.1325] Funding Source: Medline	Telethon(Fondazione Telethon)		Agami R, 1999, NATURE, V399, P809; Balint E, 2002, P NATL ACAD SCI USA, V99, P3529, DOI 10.1073/pnas.062491899; Bergamaschi D, 2003, CANCER CELL, V3, P387, DOI 10.1016/S1535-6108(03)00079-5; Ciciarello M, 2001, J BIOL CHEM, V276, P19205, DOI 10.1074/jbc.M009528200; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; De Laurenzi V, 2000, J BIOL CHEM, V275, P15226, DOI 10.1074/jbc.275.20.15226; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Fontemaggi G, 2002, J BIOL CHEM, V277, P43359, DOI 10.1074/jbc.M205573200; Fulco M, 2003, J BIOL CHEM, V278, P49196, DOI 10.1074/jbc.M304921200; Gaiddon C, 2003, J BIOL CHEM, V278, P27421, DOI 10.1074/jbc.M300251200; Gong JG, 1999, NATURE, V399, P806; Gorbsky GJ, 2001, CURR BIOL, V11, pR1001, DOI 10.1016/S0960-9822(01)00609-1; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Knapp D, 1996, MOL CELL BIOL, V16, P5701; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Levrero M, 2000, J CELL SCI, V113, P1661; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Sanchez-Prieto R, 2002, ONCOGENE, V21, P974, DOI 10.1038/sj.onc.1205134; Sciortino S, 2001, EMBO REP, V2, P1018, DOI 10.1093/embo-reports/kve223; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tritarelli A, 2004, MOL BIOL CELL, V15, P3751, DOI 10.1091/mbc.E03-12-0900; Tullo A, 2003, ONCOGENE, V22, P8738, DOI 10.1038/sj.onc.1206967; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Vossio S, 2002, ONCOGENE, V21, P3796, DOI 10.1038/sj.onc.1205465; Wan YSY, 2003, IMMUNITY, V18, P331, DOI 10.1016/S1074-7613(03)00053-0; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	34	33	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30354	30360		10.1074/jbc.M500635200	http://dx.doi.org/10.1074/jbc.M500635200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15985436	hybrid			2022-12-27	WOS:000231362500046
J	Novotny, M; Datta, S; Biswas, R; Hamilton, T				Novotny, M; Datta, S; Biswas, R; Hamilton, T			Functionally independent AU-rich sequence motifs regulate KC (CXCL1) mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ACTIVATED PROTEIN-KINASE; C-FOS; CODING REGION; ELEMENTS; STABILITY; HUR; DESTABILIZATION; STABILIZATION; TRISTETRAPROLIN	Certain pro-inflammatory chemokine mRNAs containing adenine/uridine-rich sequence elements (AREs) in their 3' untranslated regions (3'-UTRs) are known to exhibit constitutive instability and sensitivity to pro-inflammatory stimuli resulting in the stabilization of the message. Using tetR-regulated transcription we now show that the 3'-UTR of the mouse CXCL1 ( KC) mRNA contains at least two ARE motifs that are structurally and functionally distinct. A fragment of 77 nucleotides containing 4 clustered AUUUA pentamers located at the 5'-end of the KC 3'-UTR is only modestly unstable yet promotes markedly enhanced, post-transcriptional protein production in response to either interleukin-1 alpha(IL-1 alpha) or lipopolysaccharide (LPS), suggesting translational regulation. In contrast, a fragment containing 3 isolated AUUUA pentamers corresponding to the residual 3' 400 nucleotides of the KC 3'-UTR confers both instability and is stabilized in response to IL-1 alpha. Although the clustered AUUUA pentamers in the upstream region are required for stimulus sensitivity, mutation of all three pentamers in the downstream region has little or no effect on either instability or stimulus sensitivity. The upstream region is comparably stabilized in response to either IL-1 alpha or LPS, whereas the AUUUA-independent downstream determinant is differentially more sensitive to IL-1 alpha. Finally, using UV-induced RNA cross-linking, these functionally independent sequences exhibit different patterns of interaction with RNA-binding proteins. Collectively, these findings document the presence of multiple independent determinants of KC mRNA function and demonstrate that these operate via distinct mechanisms.	Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Hamilton, T (corresponding author), Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, NB30,9500 Euclid Ave, Cleveland, OH 44195 USA.	hamiltt@ccf.org	Biswas, Roopa/AAC-4928-2020	Hamilton, Thomas/0000-0002-9817-242X	NCI NIH HHS [CA39621] Funding Source: Medline; NIAID NIH HHS [AI50739] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050739] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Biswas R, 2003, J IMMUNOL, V170, P6202, DOI 10.4049/jimmunol.170.12.6202; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; CHEN CYA, 1995, MOL CELL BIOL, V15, P5777; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; CHEN CYA, 1992, MOL CELL BIOL, V12, P5748, DOI 10.1128/MCB.12.12.5748; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Datta S, 2004, J IMMUNOL, V173, P2755, DOI 10.4049/jimmunol.173.4.2755; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Hamilton TA, 2002, IMMUNOL RES, V25, P229, DOI 10.1385/IR:25:3:229; Han J, 1990, Eur Cytokine Netw, V1, P71; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Kishore R, 1999, J IMMUNOL, V162, P2457; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; KRUYS V, 1989, SCIENCE, V245, P852, DOI 10.1126/science.2672333; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Lewis T, 1998, J BIOL CHEM, V273, P13781, DOI 10.1074/jbc.273.22.13781; Li XX, 1999, MOL CELL BIOL, V19, P4643; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; OHMORI Y, 1994, BIOCHEM BIOPH RES CO, V198, P590, DOI 10.1006/bbrc.1994.1086; OQUENDO P, 1989, J BIOL CHEM, V264, P4133; Paste M, 2003, EUR J BIOCHEM, V270, P1590, DOI 10.1046/j.1432-1033.2003.03530.x; Phillips K, 2004, P NATL ACAD SCI USA, V101, P2011, DOI 10.1073/pnas.0400148101; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; RAJ NBK, 1993, FASEB J, V7, P702, DOI 10.1096/fasebj.7.8.8500695; Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Shim J, 2002, MOL CELLS, V14, P323; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2003, MOL CELL BIOL, V23, P3506, DOI 10.1128/MCB.23.10.3506-3515.2003; Sully G, 2004, BIOCHEM J, V377, P629, DOI 10.1042/BJ20031484; Tebo J, 2003, J BIOL CHEM, V278, P12085, DOI 10.1074/jbc.M212992200; Tebo JM, 2000, J BIOL CHEM, V275, P12987, DOI 10.1074/jbc.275.17.12987; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wilson GM, 1999, PROG NUCLEIC ACID RE, V62, P257; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Winzen R, 2004, MOL CELL BIOL, V24, P4835, DOI 10.1128/MCB.24.11.4835-4847.2004; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952	54	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2005	280	34					30166	30174		10.1074/jbc.M502280200	http://dx.doi.org/10.1074/jbc.M502280200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	957IC	15994316	hybrid			2022-12-27	WOS:000231362500024
J	Tai, LK; Zheng, QL; Pan, S; Jin, ZG; Berk, BC				Tai, LK; Zheng, QL; Pan, S; Jin, ZG; Berk, BC			Flow activates ERK1/2 and endothelial nitric oxide synthase via a pathway involving PECAM1, SHP2, and Tie2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE-1; PROTEIN-TYROSINE PHOSPHATASES; SHEAR-STRESS; PLATELET; KINASE; RECEPTOR; PHOSPHORYLATION; TRANSDUCTION; ROLES; CD31	Blood flow modulates endothelial cell (EC) functions through specific signaling events. Previous data show that flow stimulates SHP2 translocation to cell membranes and binding to phosphotyrosine proteins. Flow-induced ERK1/2 phosphorylation depends on SHP2 phosphatase activity and SHP2 binding to phospho-PECAM1 ( platelet endothelial adhesion molecule 1), suggesting that SHP2 forms a signaling module with PECAM1. We hypothesized that flow induces assembly of the multi-protein complexes with SHP2 that are required for downstream signaling. ECs were exposed to flow for 10 min, and endogenous SHP2 was immunoprecipitated. SHP2-associated proteins were analyzed by SDS-PAGE and identified by mass spectrometry. Tie2 and several known SHP2-binding proteins were identified in flow-induced SHP2 complexes. Flow significantly increased tyrosine phosphorylation of both Tie2 and PECAM1 and their association with SHP2. To evaluate their functional roles, ECs were treated with Tie2 or PECAM1 small interfering RNA ( siRNA). Tie2 and PECAM1 expression decreased > 80% after siRNA treatment, and flow-stimulated phosphorylation of ERK1/2, Akt, and endothelial nitric oxide synthase was significantly inhibited by Tie2 and PECAM1 siRNA. Tie2 phosphorylation by flow was significantly inhibited by PECAM1 siRNA treatment. These results establish Tie2 transactivation via PECAM1 as an early event in flow-mediated mechanotransduction and suggest an important role for a PECAM1-SHP2-Tie2 pathway in flow-mediated signal transduction.	Univ Rochester, Inst Cardiovasc Res, Rochester, NY 14642 USA; Univ Rochester, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Berk, BC (corresponding author), Univ Rochester, Inst Cardiovasc Res, Box 679,601 Elmwood Ave, Rochester, NY 14642 USA.	Bradford_Berk@urmc.rochester.edu		Berk, Bradford/0000-0002-2767-4115; Pan, Shi/0000-0002-8247-2110	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064839, R01HL080611] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; Chen BPC, 2001, PHYSIOL GENOMICS, V7, P55, DOI 10.1152/physiolgenomics.2001.7.1.55; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Davies PF, 1997, J VASC RES, V34, P208, DOI 10.1159/000159224; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; Duncan GS, 1999, J IMMUNOL, V162, P3022; Dusserre N, 2004, ARTERIOSCL THROM VAS, V24, P1796, DOI 10.1161/01.ATV.0000141133.32496.41; FENG GS, 1994, ONCOGENE, V9, P1545; Fujikawa K, 1999, EXP CELL RES, V253, P663, DOI 10.1006/excr.1999.4693; Henshall TL, 2001, J IMMUNOL, V166, P3098, DOI 10.4049/jimmunol.166.5.3098; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Ichinose J, 2004, BIOCHEM BIOPH RES CO, V324, P1143, DOI 10.1016/j.bbrc.2004.09.173; Ilan N, 1999, J CELL SCI, V112, P3005; Jackson DE, 1997, J BIOL CHEM, V272, P6986, DOI 10.1074/jbc.272.11.6986; Jin ZG, 2003, CIRC RES, V93, P354, DOI 10.1161/01.RES.0000089257.94002.96; Jones N, 1999, J BIOL CHEM, V274, P30896, DOI 10.1074/jbc.274.43.30896; Kano Y, 2000, CIRC RES, V86, P425, DOI 10.1161/01.RES.86.4.425; Kim I, 2002, FASEB J, V16, P1126, DOI 10.1096/fj.01-0805fje; Kogata N, 2003, MOL BIOL CELL, V14, P3553, DOI 10.1091/mbc.E03-02-0080; Lee HJ, 2003, BIOCHEM BIOPH RES CO, V304, P399, DOI 10.1016/S0006-291X(03)00592-8; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Okuda M, 1999, J BIOL CHEM, V274, P26803, DOI 10.1074/jbc.274.38.26803; Osawa M, 1997, EUR J CELL BIOL, V72, P229; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Pi XC, 2004, CIRC RES, V94, P362, DOI 10.1161/01.RES.0000112406.27800.6F; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schwachtgen JL, 1998, J CLIN INVEST, V101, P2540, DOI 10.1172/JCI1404; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Solowiej A, 2003, AM J PATHOL, V162, P953, DOI 10.1016/S0002-9440(10)63890-4; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tai LK, 2002, ARTERIOSCL THROM VAS, V22, P1790, DOI 10.1161/01.ATV.0000034475.40227.40; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Yan C, 1999, J BIOL CHEM, V274, P143, DOI 10.1074/jbc.274.1.143; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	38	34	34	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2005	280	33					29620	29624		10.1074/jbc.M501243200	http://dx.doi.org/10.1074/jbc.M501243200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	954SX	15985432	hybrid			2022-12-27	WOS:000231176200030
